<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Bersama Kita Sehat &#45; : Multidisciplinary</title>
<link>https://edusehat.com/en/rss/category/Multidisciplinary</link>
<description>Bersama Kita Sehat &#45; : Multidisciplinary</description>
<dc:language>en</dc:language>
<dc:rights>2025&#45;2055 PS Global Media &#45; Hak Cipta</dc:rights>

<item>
<title>The Physicians Foundation Survey Finds Lack of Access to Nutritious Food is Undermining Chronic Disease Care and Prevention</title>
<link>https://edusehat.com/en/the-physicians-foundation-survey-finds-lack-of-access-to-nutritious-food-is-undermining-chronic-disease-care-and-prevention</link>
<guid>https://edusehat.com/en/the-physicians-foundation-survey-finds-lack-of-access-to-nutritious-food-is-undermining-chronic-disease-care-and-prevention</guid>
<description><![CDATA[ New survey examines how gaps in access to healthy foods are impacting chronic disease outcomes and what it will take to close them. BOSTON, June 30, 2026 — The Physicians Foundation today announced findings from its 2026 Survey of America’s Physicians: Impact of Healthy Food on Chronic Disease Care and Prevention, revealing a critical disconnect […]
The post The Physicians Foundation Survey Finds Lack of Access to Nutritious Food is Undermining Chronic Disease Care and Prevention appeared first on The Physicians Foundation. ]]></description>
<enclosure url="https://physiciansfoundation.org/wp-content/themes/physicians-foundation/assets/build/images/admin/defaults/default-image.webp" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 20:10:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>The, Physicians, Foundation, Survey, Finds, Lack, Access, Nutritious, Food, Undermining, Chronic, Disease, Care, and, Prevention</media:keywords>
<content:encoded><![CDATA[<p class="wp-block-paragraph"><em>New survey examines how gaps in access to healthy foods are impacting chronic disease outcomes and what it will take to close them.</em></p>



<p class="wp-block-paragraph"><strong>BOSTON, June 30, 2026 </strong>— The Physicians Foundation today announced findings from its 2026 <a href="https://physiciansfoundation.org/research/food-as-medicine-in-chronic-disease-care/" target="_blank" rel="noreferrer noopener"><em>Survey of America’s Physicians: Impact of Healthy Food on Chronic Disease Care and Prevention</em></a>, revealing a critical disconnect in U.S. healthcare: while physicians recognize nutrition as foundational to preventing and managing chronic disease, the healthcare system is not fully equipped to enable its use – leaving many patients unable to follow clinical guidance.</p>



<p class="wp-block-paragraph">Chronic disease may be diagnosed in the exam room, but too often it is shaped by whether patients can access nutritious food and make healthy lifestyle choices. At a moment when national attention is increasingly focused on nutrition as a core tool for improving health, a survey of more than 1,000 U.S. physicians, conducted in collaboration with <em>Medscape</em>, finds that gaps in access to key drivers of health – particularly healthy food – are contributing to worsening control of chronic conditions and limiting physicians’ ability to deliver effective care.</p>



<p class="wp-block-paragraph">Key findings point to widespread challenges affecting both patients and physicians – and potential solutions to address these issues:</p>



<ul class="wp-block-list">
<li>More than three quarters of physicians (78%) encounter patients at least monthly whose chronic disease care is compromised by a lack of access to healthy food.</li>



<li>Nearly half of physicians (45%) report that patients with chronic diseases frequently or almost always experience worsening control of symptoms primarily due to drivers of health, rather than clinical factors alone.</li>



<li>68% of physicians support insurance coverage for healthy food benefits to make it easier for patients with chronic conditions to make healthier lifestyle or diet choices.</li>
</ul>



<p class="wp-block-paragraph">“Physicians understand that nutrition is a critical clinical intervention to prevent and manage chronic disease,” said Dr. Gary Price, President of The Physicians Foundation. “When patients lack access to the healthy foods they need and therefore cannot follow clinical recommendations, it undermines care and leads to worse outcomes. As our survey makes clear, insurance coverage for nutritious food benefits is a crucial tool in enabling patients to follow their doctors’ guidance to eat real food.”</p>



<p class="wp-block-paragraph">The Physicians Foundation’s findings reinforce the growing recognition across the country – including by leadership at the federal and state level – that improving access to nutritious food is essential to addressing diet-related and other chronic diseases and reducing healthcare costs. Aligning healthcare coverage, policy frameworks, and community resources to support nutrition-based care will be critical to improving outcomes and supporting both patients and physicians.</p>



<p class="wp-block-paragraph">The Physicians Foundation is advancing <a href="https://physiciansfoundation.org/research/">research</a> to better integrate drivers of health into care delivery and improve chronic disease outcomes. </p>



<p class="wp-block-paragraph">Read the full survey results and methodology <a href="https://physiciansfoundation.org/research/food-as-medicine-in-chronic-disease-care/" target="_blank" rel="noreferrer noopener">here.</a><br></p>



<h3 class="wp-block-heading"><strong>About The Physicians Foundation </strong></h3>



<p class="wp-block-paragraph">The Physicians Foundation is a public charity seeking to advance the work of practicing physicians and help them facilitate the delivery of high-quality health care to patients. As the U.S. health care system continues to evolve, The Physicians Foundation is steadfast in strengthening the physician-patient relationship, supporting medical practices’ sustainability and helping physicians navigate the changing health care system. The Physicians Foundation pursues its mission through research, education and innovative grant making that improves physician wellbeing, strengthens physician leadership, addresses drivers of health and lifts physician perspectives. For more information, visit <a href="https://www.physiciansfoundation.org/">www.physiciansfoundation.org</a>.</p>
<p>The post <a href="https://physiciansfoundation.org/the-physicians-foundation-survey-finds-lack-of-access-to-nutritious-food-is-undermining-chronic-disease-care-and-prevention/">The Physicians Foundation Survey Finds Lack of Access to Nutritious Food is Undermining Chronic Disease Care and Prevention</a> appeared first on <a href="https://physiciansfoundation.org/">The Physicians Foundation</a>.</p>]]> </content:encoded>
</item>

<item>
<title>Megbízható kaszinó: app és mobil használati útmutató</title>
<link>https://edusehat.com/en/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato</link>
<guid>https://edusehat.com/en/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato</guid>
<description><![CDATA[ Megbízható kaszinó – gyakorlati útmutató kezdőknek Az online szerencsejáték piac hatalmas, és a megbízható kaszinó keresése sok magyar játékos számára elsődleges feladat. A cikkben lépésről‑lépésre bemutatom, milyen szempontok alapján érdemes dönteni, és hol találod a legfrissebb ajánlatokat. A részletes listát megtalálod a https://ome2021.hu/ oldalon. 1. Mit jelent a “megbízható kaszinó”? 2. Engedélyek és biztonság – […]
The post Megbízható kaszinó: app és mobil használati útmutató appeared first on The Physicians Foundation. ]]></description>
<enclosure url="https://i.ytimg.com/vi/VQ99zBKjEFw/hqdefault.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 28 May 2026 14:15:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Megbízható, kaszinó:, app, és, mobil, használati, útmutató</media:keywords>
<content:encoded><![CDATA[<figure data-affgun-media="hero"><img decoding="async" src="https://i.ytimg.com/vi/VQ99zBKjEFw/hqdefault.jpg" alt="" loading="lazy" referrerpolicy="no-referrer"></figure>
<h1>Megbízható kaszinó – gyakorlati útmutató kezdőknek</h1>
<p>Az online szerencsejáték piac hatalmas, és a <strong>megbízható kaszinó</strong> keresése sok magyar játékos számára elsődleges feladat. A cikkben lépésről‑lépésre bemutatom, milyen szempontok alapján érdemes dönteni, és hol találod a legfrissebb ajánlatokat. A részletes listát megtalálod a <a href="https://ome2021.hu/">https://ome2021.hu/</a> oldalon.</p>
<nav aria-label="Table of contents">
<ol>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#1-mit-jelent-a-megbzhat-kaszin">1. Mit jelent a “megbízható kaszinó”?</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#2-engedlyek-s-biztonsg-mire-figyeljnk">2. Engedélyek és biztonság – mire figyeljünk?</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#3-regisztrci-s-azonosts-els-lpsek">3. Regisztráció és azonosítás – első lépések</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#4-bnuszok-s-felttelek-hogyan-olvassuk-a-kiszmtst">4. Bónuszok és feltételek – hogyan olvassuk a kiszámítást?</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#5-fizetsi-mdok-s-kifizets-sebessge">5. Fizetési módok és kifizetés sebessége</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#6-mobil-s-asztali-lmny-app-vagy-web">6. Mobil és asztali élmény – app vagy web?</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#7-gyflszolglat-s-felels-jtk">7. Ügyfélszolgálat és felelős játék</a></li>
<li><a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/#8-sszegzs-a-legfontosabb-mrszmok">8. Összegzés – a legfontosabb mérőszámok</a></li>
</ol>
</nav>
<h2>1. Mit jelent a “megbízható kaszinó”?</h2>
<div data-affgun-media="video"></div>
<p>Egy megbízható kaszinó több, mint egy vonzó dizájn vagy nagy nyeremény. Alapvető, hogy rendelkezzen érvényes licenccel, átlátható szabályokkal és tiszta pénzügyi folyamatokkal. A magyar játékosok számára a leggyakrabban elfogadott engedélyek a Máltai (MGA), az Egyesült Királyság (UKGC) vagy a Gibraltári hatóságok által kiadottak.</p>
<p>Az ilyen engedélyek biztosítják, hogy a játékokat független tesztlaborok (pl. eCOGRA) ellenőrizték, és az RTP (visszatérítési arány) a nyilvánosan elérhető adatbázisban is ellenőrizhető. Ha a kaszinó honlapján hiányzik a licencinformáció vagy nehezen megtalálható, az már egy piros jel.</p>
<h2>2. Engedélyek és biztonság – mire figyeljünk?</h2>
<p>A legfontosabb biztonsági tényező a szabályozó hatóság. Egy magyar játékos számára a legbiztonságosabb, ha a kaszinó egy EU‑tagállam hatóságának felügyelete alatt áll, mert így a pénzügyi tranzakciók és a személyes adatok védelme is erősebben garantált.</p>
<p>Ezen felül keress SSL‑titkosítást (HTTPS) a címsorban, valamint független audit jelentéseket, amelyekben látható a játékok RNG (véletlen szám generátor) minősítése. Ha a weboldal megemlíti a “fair play” vagy “responsible gambling” programokat, az további bizalomépítő jel.</p>
<h2>3. Regisztráció és azonosítás – első lépések</h2>
<p>A regisztráció folyamata általában három lépésből áll: e‑mail cím megadása, jelszó választása és a felhasználói név beállítása. Sok kaszinó ma már engedélyezi a közösségi média fiókkal való bejelentkezést, ami gyorsabb, de kevésbé biztonságos lehet, ha a másik fiókod már kompromittálódott.</p>
<p>Az azonosítás (KYC) során a játékosnak általában feltölt egy személyi igazolványt vagy útlevelet, egy lakcímigazoló dokumentumot és egy bankszámlakivonatot. Ez a lépés elkerülhető csak akkor, ha a játékos kis összegű befizetést és kivételt hajt végre, de a nagyobb nyeremények esetén kötelező.</p>
<h2>4. Bónuszok és feltételek – hogyan olvassuk a kiszámítást?</h2>
<p>A legtöbb <strong>megbízható kaszinó</strong> vonzó welcome bonus-szal kecsegtet: 100 % befizetési bónusz + ingyenes pörgetések. Azonban a tényleges értéket a wagering requirements (áttétel) határozza meg. Ha egy 200 € bónusz 30‑szoros áttételt igényel, akkor a játékosnak legalább 6 000 €-t kell megjátszania, mielőtt a nyeremények kifizetésre kerülnek.</p>
<p>A feltételek közül a leggyakoribbak:</p>
<ul>
<li>Maximum áttekinthető nyeremény (pl. 100 €-nél nem több).</li>
<li>Játékok hozzájárulási aránya (pl. slotok 100 %, asztali játékok 20 %).</li>
<li>Lejárati idő (30‑90 nap).</li>
</ul>
<p>Mindig olvasd el a “Bónusz feltételek” részt, és ha valami nem világos, kérdezd meg az ügyfélszolgálatot.</p>
<h2>5. Fizetési módok és kifizetés sebessége</h2>
<p>A magyar játékosok körében a legnépszerűbb befizetési módok a bankkártya, a Trustly és a Skrill. A kifizetés sebessége nagyban függ a választott módtól: a bankkártyás visszautalás akár 2‑3 munkanapig is tarthat, míg az e‑pénztárcák (Skrill, Neteller) gyakran 24 órán belül megjelennek a számlán.</p>
<p>Az alábbi táblázatban összegzem a leggyakoribb fizetési módok átlagos feldolgozási idejét:</p>
<table border="1" cellpadding="5" cellspacing="0">
<thead>
<tr>
<th>Fizetési mód</th>
<th>Befizetés</th>
<th>Kifizetés</th>
<th>Átlagos sebesség</th>
</tr>
</thead>
<tbody>
<tr>
<td>Visa / MasterCard</td>
<td>Azonnal</td>
<td>2‑3 munkanap</td>
<td>Közepes</td>
</tr>
<tr>
<td>Trustly</td>
<td>Azonnal</td>
<td>0‑24 óra</td>
<td>Gyors</td>
</tr>
<tr>
<td>Skrill / Neteller</td>
<td>0‑15 perc</td>
<td>0‑24 óra</td>
<td>Gyors</td>
</tr>
<tr>
<td>Banki átutalás</td>
<td>1‑2 nap</td>
<td>2‑5 nap</td>
<td>Lassú</td>
</tr>
</tbody>
</table>
<p>Mindig ellenőrizd, hogy a kaszinó milyen díjat számít fel a tranzakciókért. Néhány platform ingyenes befizetést kínál, de a kifizetéskor díjat vonhat le, különösen a banki átutalásoknál.</p>
<h2>6. Mobil és asztali élmény – app vagy web?</h2>
<p>A modern <strong>megbízható kaszinó</strong>k mind asztali, mind mobil felületen elérhetők. Ha gyakran játszol útközben, érdemes olyan operátort választani, amely natív mobil app‑ot kínál iOS‑re és Androidra. Az appok általában gyorsabb betöltési időt és jobb értesítési rendszert biztosítanak.</p>
<p>Azok számára, akik a böngészőből szeretik a játékot, a responsív weboldal ugyanúgy funkcionál, mint a desktop verzió. Fontos, hogy a mobil verzió is tartalmazza a licencinformációt, a felelős játék linkeket és a támogatási csatornákat.</p>
<h2>7. Ügyfélszolgálat és felelős játék</h2>
<p>Az ügyfélszolgálat minősége gyakran elhanyagolt, pedig kulcsfontosságú a felhasználói élményben. A legjobb kaszinók 24/7 elérhető chat‑et, telefonos vonalat és e‑mail támogatást kínálnak, magyar nyelvű operátorokkal. Egy gyors válaszidő (legyen 5‑10 perc a chatben) nagyban növeli a bizalmat.</p>
<p>A felelős játék programok – önkorlátozás, betéti limitek, időkorlátok – szintén kötelező elemek. Ha egy kaszinó nyíltan kommunikál a “responsible gambling” irányelveiről, az további bizonyíték arra, hogy komolyan veszi a játékosok jólétét.</p>
<h2>8. Összegzés – a legfontosabb mérőszámok</h2>
<p>Összegezve, egy <strong>megbízható kaszinó</strong> kiválasztásakor a következőket kell mérlegelned:</p>
<ul>
<li>Érvényes licenc és független auditok.</li>
<li>Átlátható bónuszfeltételek (átkelt, max nyeremény, lejárat).</li>
<li>Gyors és díjmentes fizetési módok, különösen a kifizetés sebessége.</li>
<li>Mobil app vagy responsív web, ami zökkenőmentes élményt nyújt.</li>
<li>24/7 ügyfélszolgálat magyar nyelven és felelős játék programok.</li>
</ul>
<p>Ezeknek a tényezőknek a figyelembevétele segít abban, hogy ne csak szórakoztató, hanem biztonságos környezetben játssz, és a nyeremények valóban elérhetőek legyenek. Ha bármelyik pontban bizonytalan vagy, ne habozz felkeresni a támogatást, vagy további információkat keresni a fent említett forrásokban.</p>
<p>The post <a href="https://physiciansfoundation.org/megbizhato-kaszino-app-es-mobil-hasznalati-utmutato/">Megbízható kaszinó: app és mobil használati útmutató</a> appeared first on <a href="https://physiciansfoundation.org/">The Physicians Foundation</a>.</p>]]> </content:encoded>
</item>

<item>
<title>NCDs in Advanced East Asia: From Disease Burden to the Challenge of Continuity in Aging Societies</title>
<link>https://edusehat.com/en/ncds-in-advanced-east-asia-from-disease-burden-to-the-challenge-of-continuity-in-aging-societies</link>
<guid>https://edusehat.com/en/ncds-in-advanced-east-asia-from-disease-burden-to-the-challenge-of-continuity-in-aging-societies</guid>
<description><![CDATA[ This blog was written by Chiang Kuan Yu, MD, Hospital Medicine, Master’s Health Policy and Management, National Taiwan University, Associate Director &amp; Program Lead of Global Health Diplomacy, STUF United […] ]]></description>
<enclosure url="https://globalhealth.org/wp-content/uploads/2026/04/iStock-1722270216-768x512.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 29 Apr 2026 01:50:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NCDs, Advanced, East, Asia:, From, Disease, Burden, the, Challenge, Continuity, Aging, Societies</media:keywords>
<content:encoded><![CDATA[<p><em>This blog was written by Chiang Kuan Yu, MD, Hospital Medicine, Master’s Health Policy and Management, National Taiwan University, Associate Director & Program Lead of Global Health Diplomacy, STUF United Fund</em></p>



<p>The noncommunicable disease (NCD) challenge in advanced East Asia is often misunderstood. Unlike in many Western contexts—where obesity, metabolic syndrome, and cardiovascular risk dominate the narrative—countries such as Japan, South Korea, Taiwan, and Singapore are increasingly defined by a different reality: rapid population ageing, multimorbidity, frailty, and breakdowns in continuity of care after hospitalization.</p>



<p>This does not mean the NCD burden is lighter. Rather, it presents differently. While obesity rates remain lower than in countries like the United States, East Asian populations often develop conditions such as Type 2 Diabetes at lower body mass indices, with higher risks of stroke and kidney disease. In short, the region faces a less visible—but equally serious—metabolic risk profile, compounded by the complexities of ageing.</p>



<p>Nowhere is this more evident than in Japan, where nearly 30% of the population is over 65. Its Community-based Integrated Care System reflects a shift away from disease-specific care toward coordinated support that integrates health services, long-term care, and social needs. South Korea and Taiwan are following similar trajectories under even faster demographic pressure, while Singapore’s system highlights another critical issue: the challenge of ensuring smooth transitions from hospital to home. High readmission rates among older adults underscore that hospital care alone is not enough.</p>



<p>This points to a central insight: in ageing societies, the NCD challenge is no longer just about managing disease—it is about maintaining function. The greatest risks often emerge after discharge, when patients must navigate rehabilitation, home-based care, and long-term support systems. Evidence from integrated hospital models shows improvements in inpatient outcomes, but far less impact on long-term recovery, readmissions, or functional decline. The gap lies in continuity of care.</p>



<p>From a systems perspective, this is where resilience matters most. As emphasized by the World Health Organization, resilient health systems are not defined solely by access to services, but by their ability to coordinate care across the full continuum—from prevention and treatment to rehabilitation and long-term support. Continuity of care is not just an operational concern; it is foundational to delivering people-centered health systems that can respond to ageing populations and rising demand.</p>



<p>East Asia’s experience offers a critical lesson for the global health community: the future of NCD policy must move beyond disease metrics alone. It must prioritize function, integration, and the lived realities of ageing populations. As more countries approach similar demographic shifts, these lessons will only grow more relevant.</p>



<p><strong>Key Calls to Action for Global Health Advocates:</strong></p>



<ul class="wp-block-list">
<li><strong>Reframe the NCD agenda:</strong> Move beyond disease-specific metrics to include ageing, multimorbidity, and functional outcomes.</li>



<li><strong>Invest in continuity of care:</strong> Prioritize systems that connect hospital, primary care, rehabilitation, and long-term care services.</li>



<li><strong>Strengthen community-based care models:</strong> Support policies that enable older adults to age with dignity in their communities.</li>



<li><strong>Elevate post-acute and long-term care:</strong> Ensure these services are fully integrated into UHC strategies and financing frameworks.</li>



<li><strong>Promote people-centered health systems:</strong> Advocate for care models that are coordinated, accessible, and responsive across the life course.</li>
</ul>



<p>As global populations age, the question is no longer just how to treat chronic disease—but how to sustain health, function, and dignity over time.</p>



<p><strong>References:</strong></p>



<ol class="wp-block-list has-small-font-size">
<li><a href="https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/overweight-and-obesity_0bf9c422.html">OECD, Health at a Glance 2025 — Overweight and obesity</a></li>



<li><a href="https://www.who.int/europe/news-room/fact-sheets/item/cardiovascular-diseases">WHO Europe — Cardiovascular diseases fact sheet</a></li>



<li><a href="https://www.cdc.gov/nchs/data/hestat/hestat111.htm">U.S. CDC Prevalence of Overweight, Obesity, and Severe Obesity Among Adults Age 20 and Older: United States, 1960–1962 Through August 2021–August 2023</a></li>



<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3708105/">Review article on type 2 diabetes in East Asians (PMC)</a></li>



<li><a href="file:///Users/julietglassroth/Downloads/United%20States%20(PubMed)%20%20https:/pubmed.ncbi.nlm.nih.gov/23551121">Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the</a></li>



<li><a href="https://www.stat.go.jp/english/data/jinsui/2024np/index.html">Statistics Bureau of Japan — Current Population Estimates as of October 1, 2024</a></li>



<li><a href="https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hukushi_kaigo/kaigo_koureisha/chiiki-houkatsu/index.html">Japan Ministry of Health, Labour and Welfare — Community-based Integrated Care System</a></li>



<li><a href="https://www.koreatimes.co.kr/southkorea/society/20260104/over-20-of-koreans-65-and-older-in-2025-data">Yonhap / Korea Times — Over 20% of Koreans 65 and older in 2025</a></li>



<li><a href="https://pubmed.ncbi.nlm.nih.gov/37489714/">PubMed / PMC — Trends in Frailty Prevalence Among Older Adults in Korea: 2008 to 2020</a></li>



<li><a href="https://www.taipeitimes.com/News/front/archives/2026/01/09/2003850335">Taiwan MOI-related reporting — Taiwan officially became a super-aged society, 20.06% aged 65+ at end-2025</a></li>



<li><a href="https://www.taiwannews.com.tw/en/news/596578">Taiwan NDC projection, via reporting and official portal</a></li>



<li><a href="https://www.population.gov.sg/our-population/population-trends/longevity/">Singapore National Population and Talent Division — Longevity / Population in Brief 2025</a></li>



<li><a href="https://www.moh.gov.sg/newsroom/elderly-patients-readmitted-within-30-days-after-discharge-from-hospital">Singapore Ministry of Health — Elderly Patients Readmitted within 30 Days after Discharge From Hospital</a></li>



<li><a href="https://www.population.gov.sg/our-population/population-trends/longevity/">Singapore, Longevity</a></li>



<li><a href="https://www.moh.gov.sg/others/resources-and-statistics/population-and-vital-statistics">Singapore, Population And Vital Statistics</a></li>



<li><a href="https://www.airitilibrary.com/Article/Detail/U0001-1238250806478007">Impact of Hospitalist Care on Outcomes of Inpatient Care: A Retrospective Cohort Study at a Single Community Hospital, Chiang Kuan Yu</a></li>



<li><a href="https://www.who.int/health-topics/integrated-people-centered-care">WHO, Integrated people-centred care</a></li>



<li><a href="https://www.who.int/health-topics/primary-health-care">WHO, Primary health care</a></li>
</ol>



<p></p>]]> </content:encoded>
</item>

<item>
<title>People who can&amp;apos;t afford dental care may be at higher risk of developing cardiovascular disease, dementia</title>
<link>https://edusehat.com/en/people-who-cant-afford-dental-care-may-be-at-higher-risk-of-developing-cardiovascular-disease-dementia-9826</link>
<guid>https://edusehat.com/en/people-who-cant-afford-dental-care-may-be-at-higher-risk-of-developing-cardiovascular-disease-dementia-9826</guid>
<description><![CDATA[ Being unable to afford dental care may increase a person&#039;s risk of developing cardiovascular disease or dementia, according to a new study led by researchers at Boston University School of Public Health (BUSPH).
Published in The Journals of Gerontology, Series A, the study found that older people who forego necessary dental procedures because of financial barriers may be more likely to experience heart failure, a heart attack, a stroke, or dementia.
Poor oral health has been previously linked to cardiovascular and neurological conditions, but the prior research was mostly limited to specific oral health issues, such as periodontitis or tooth loss. Being unable to pay for dental care is a modifiable problem that, if addressed, could potentially lower people’s chances of developing more serious or fatal health conditions.
“Cost is one of the main barriers to dental care,” says study lead author Ms. Mabeline Velez, an instructor of health policy and health services research at BUSPH and a PhD candidate at Boston University’s Henry M. Goldman School of Dental Medicine. “As a result, people often delay critical care or they accept the coverage available, which may be more drastic measures—such as getting a tooth pulled than is clinically indicated. Tooth loss, especially early in life, can cause a whole set of health problems later in life including increased mortality. Finding ways to make dental care more accessible and affordable for everyone is a preventative measure that we can take to improve health outcomes down the line.”
For the study, Velez and colleagues from BUSPH and the University of California, San Francisco utilized survey data among participants ages 55 and older in the All of Us study, an initiative that the National Institutes of Health launched in 2017 to develop a diverse database on a variety of health conditions. Analyzing electronic health records and survey responses, the team examined the associations of unmet dental care needs due to cost with new diagnoses of heart failure, heart attacks, strokes, and all-cause dementia. A total of 88,496 people were analyzed for incident heart attacks, 86,593 people for heart failure, 88,410 people for strokes, and 92,272 people for dementia.
They found that people who skipped dental checkups and procedures because they could not afford them had higher incidence of all of the above conditions. On a population level, eliminating the financial barriers that prevented people from receiving dental care could prevent 2-4 percent of each outcome among older adults. With the exception of strokes, the associations were reduced after the researchers accounted for socioeconomic, behavioral, and clinical factors. 
The researchers note that this weakened relationship signals that further data is needed to understand and address the underlying or systemic drivers of chronic diseases.
“Multiple studies have evaluated pieces of this puzzle, but this is the first time we can point to  financial barriers to care as being linked with the incidence of cardiovascular disease and dementia: two leading causes of disability and death among older adults,” says study senior author Dr. Kendra Sims, assistant professor of epidemiology at BUSPH. “This study serves as an indicator that if we alleviate upstream factors such as financial constraints, we can prevent chronic disease.”
Fewer than 30 percent of US adults 65 and older have dental insurance and nearly 8 percent say they are unable to afford necessary dental care. Medicare and Medicaid do provide dental coverage, but that coverage is limited and often excludes preventive services. Medicaid dental coverage also varies widely by state, and in some instances, only covers emergency care. 
Policies that facilitate access to preventive dental care could widely reduce poor oral health outcomes, with benefits that extend to cardiovascular and cognitive outcomes, the researchers say. For example, states that extended dental care under the Affordable Care Act reported an increase in dental visits, fewer missing teeth, and better overall oral functioning. 
These dental visits also present an opportunity to conduct other health screenings.
“People who can access and afford routine dental care typically visit the dentist twice a year,” Dr. Sims says. “What if insurance could cover screening for cardiovascular risk factors like diabetes or hypertension when a patient is in the chair?” 
For her dissertation, Ms. Velez is exploring how periodontitis, a condition where plaque built up on the gums causes inflammation and infection, can eventually lead to cardiovascular issues. 
“Periodontitis is very common, but it is a treatable disease,” she says. “I hope this new insight will encourage doctors to integrate dental care into general practice.”Reference:Mabeline Velez, Peter T Buto, Anna M Pederson, Jennifer Weuve, Audrey R Murchland, Jingxuan Wang, M Maria Glymour, Kendra D Sims, Associations of unmet dental care needs due to cost with incident cardiovascular disease and dementia: a prospective study in the All of Us cohort, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag023, https://doi.org/10.1093/gerona/glag023
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>People, who, cant, afford, dental, care, may, higher, risk, developing, cardiovascular, disease, dementia</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.webp"><p>Being unable to afford dental care may increase a person's risk of developing <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease</a> or <a href="https://medicaldialogues.in/topics/dementia">dementia</a>, according to a new study led by researchers at Boston University School of Public Health (BUSPH).
</p><p>Published in <i>The Journals of Gerontology</i>, Series A, the study found that older people who forego necessary dental procedures because of financial barriers may be more likely to experience <a href="https://medicaldialogues.in/topics/heart-failure">heart failure</a>, a<a href="https://medicaldialogues.in/topics/heart-attack"> heart attack</a>, a stroke, or dementia.
</p><p>Poor oral health has been previously linked to cardiovascular and neurological conditions, but the prior research was mostly limited to specific oral health issues, such as periodontitis or tooth loss. Being unable to pay for dental care is a modifiable problem that, if addressed, could potentially lower people’s chances of developing more serious or fatal health conditions.
</p><p>“Cost is one of the main barriers to dental care,” says study lead author Ms. Mabeline Velez, an instructor of health policy and health services research at BUSPH and a PhD candidate at Boston University’s Henry M. Goldman School of Dental Medicine. “As a result, people often delay critical care or they accept the coverage available, which may be more drastic measures—such as getting a tooth pulled than is clinically indicated. Tooth loss, especially early in life, can cause a whole set of health problems later in life including increased mortality. Finding ways to make dental care more accessible and affordable for everyone is a preventative measure that we can take to improve health outcomes down the line.”
</p><p>For the study, Velez and colleagues from BUSPH and the University of California, San Francisco utilized survey data among participants ages 55 and older in the All of Us study, an initiative that the National Institutes of Health launched in 2017 to develop a diverse database on a variety of health conditions. Analyzing electronic health records and survey responses, the team examined the associations of unmet dental care needs due to cost with new diagnoses of heart failure, heart attacks, strokes, and all-cause dementia. A total of 88,496 people were analyzed for incident heart attacks, 86,593 people for heart failure, 88,410 people for strokes, and 92,272 people for dementia.
</p><p>They found that people who skipped dental checkups and procedures because they could not afford them had higher incidence of all of the above conditions. On a population level, eliminating the financial barriers that prevented people from receiving dental care could prevent 2-4 percent of each outcome among older adults. With the exception of strokes, the associations were reduced after the researchers accounted for socioeconomic, behavioral, and clinical factors. 
</p><p>The researchers note that this weakened relationship signals that further data is needed to understand and address the underlying or systemic drivers of chronic diseases.
</p><p>“Multiple studies have evaluated pieces of this puzzle, but this is the first time we can point to  financial barriers to care as being linked with the incidence of cardiovascular disease and dementia: two leading causes of disability and death among older adults,” says study senior author Dr. Kendra Sims, assistant professor of epidemiology at BUSPH. “This study serves as an indicator that if we alleviate upstream factors such as financial constraints, we can prevent chronic disease.”
</p><p>Fewer than 30 percent of US adults 65 and older have dental insurance and nearly 8 percent say they are unable to afford necessary dental care. Medicare and Medicaid do provide dental coverage, but that coverage is limited and often excludes preventive services. Medicaid dental coverage also varies widely by state, and in some instances, only covers emergency care. 
</p><p>Policies that facilitate access to preventive dental care could widely reduce poor oral health outcomes, with benefits that extend to cardiovascular and cognitive outcomes, the researchers say. For example, states that extended dental care under the Affordable Care Act reported an increase in dental visits, fewer missing teeth, and better overall oral functioning. 
</p><p>These dental visits also present an opportunity to conduct other health screenings.
</p><p>“People who can access and afford routine dental care typically visit the dentist twice a year,” Dr. Sims says. “What if insurance could cover screening for cardiovascular risk factors like diabetes or hypertension when a patient is in the chair?” 
</p><p>For her dissertation, Ms. Velez is exploring how periodontitis, a condition where plaque built up on the gums causes inflammation and infection, can eventually lead to cardiovascular issues. 
</p><p>“Periodontitis is very common, but it is a treatable disease,” she says. “I hope this new insight will encourage doctors to integrate dental care into general practice.”</p><p>Reference:</p><p>Mabeline Velez, Peter T Buto, Anna M Pederson, Jennifer Weuve, Audrey R Murchland, Jingxuan Wang, M Maria Glymour, Kendra D Sims, Associations of unmet dental care needs due to cost with incident cardiovascular disease and dementia: a prospective study in the All of Us cohort, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag023, https://doi.org/10.1093/gerona/glag023
</p><p></p>]]> </content:encoded>
</item>

<item>
<title>Protests erupt after Kerala BDS student&amp;apos;s death, HoD accused of severe harassment</title>
<link>https://edusehat.com/en/protests-erupt-after-kerala-bds-students-death-hod-accused-of-severe-harassment</link>
<guid>https://edusehat.com/en/protests-erupt-after-kerala-bds-students-death-hod-accused-of-severe-harassment</guid>
<description><![CDATA[ Thiruvananthapuram: The death of a BDS student of Ancharakandi Dental College in Kannur, has triggered widespread protests, multiple inquiries, and serious allegations of sustained harassment by faculty.Classmates of the student have levelled grave charges against Head of Department accusing him of routine intimidation, body shaming, and both mental and physical abuse.
According to students, the circumstances leading to his death reveal unheard-of cruelty, including bizarre punitive practices that allegedly broke students psychologically and physically, reports IANSAlso Read:BDS student dies after fall in Kannur, Harassment allegations surface, 2 faculty suspendedThey firmly reject earlier reports attributing the suicide to threats from loan apps, calling it a fabricated narrative aimed at shielding the college authorities and the accused faculty.
According to IANS report, students allege that the faculty wielded undue influence over internal marks and viva evaluations, using this to silence dissent through threats of failure.
Instances of verbal humiliation, including insults in front of parents, and physical abuse such as hitting and forcing students into degrading punishments have also been cited.
The protests have intensified, with students boycotting classes and demanding immediate action.
Activists of the KSU and the MSF staged a march to the college, forcing entry into the campus and holding a sit-in, before being removed and arrested by police.
Protesters asserted they would not allow any teacher accused of misconduct, including communal remarks, to be protected.
The Akhil Bharatiya Vidyarthi Parishad (ABVP) has also escalated the issue, submitting a complaint to Union Minister of State for Tribal Affairs Durgadas Uikey and the National Medical Commission, seeking a transparent and comprehensive probe and strict action against all those responsible.
The complaint alleges that, a first-year student from Thiruvananthapuram, died by suicide after facing brutal treatment, including caste and racial abuse by faculty members.
At the national level, the National Commission for Scheduled Castes has ordered an inquiry based on a complaint by BJP leader P. Shyamraj, directing the state DGP to submit a report within five days.
Meanwhile, Kerala Education Minister V. Sivankutty has assured that the government stands firmly with the student&#039;s family, promising a thorough investigation and all necessary support, including facilitating a meeting with the Chief Minister.
Police have registered two FIRs, one on the unnatural death and another against a loan app, though inconsistencies in the latter have raised further questions.
Statements from students and faculty are being recorded, while suspended teachers named in the case are reportedly absconding, facing possible arrest under non-bailable charges.Also Read:Three MBBS students of Malabar Medical College killed in tragic road accident in Kerala ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341530-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-77.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Protests, erupt, after, Kerala, BDS, students, death, HoD, accused, severe, harassment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341530-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-77.webp"><p><b>Thiruvananthapuram:</b> The death of a <a href="https://medicaldialogues.in/topics/BDS-student">BDS student</a> of Ancharakandi Dental College in Kannur, has triggered widespread <a href="https://medicaldialogues.in/topics/protests">protests</a>, multiple inquiries, and serious allegations of sustained harassment by faculty.</p><p>Classmates of the student have levelled grave charges against Head of Department accusing him of routine intimidation, body shaming, and both mental and physical abuse.
</p><p>According to students, the circumstances leading to his death reveal unheard-of cruelty, including bizarre punitive practices that allegedly broke students psychologically and physically, reports IANS</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/kerala/bds-student-dies-after-fall-in-kannur-harassment-allegations-surface-2-faculty-suspended-168526">Also Read:BDS student dies after fall in Kannur, Harassment allegations surface, 2 faculty suspended</a></div><p>They firmly reject earlier reports attributing the suicide to threats from loan apps, calling it a fabricated narrative aimed at shielding the college authorities and the accused faculty.
</p><p>According to IANS report, students allege that the faculty wielded undue influence over internal marks and viva evaluations, using this to silence dissent through threats of failure.
</p><p>Instances of verbal humiliation, including insults in front of parents, and physical abuse such as hitting and forcing students into degrading punishments have also been cited.
</p><p>The protests have intensified, with students boycotting classes and demanding immediate action.
</p><p>Activists of the KSU and the MSF staged a march to the college, forcing entry into the campus and holding a sit-in, before being removed and arrested by police.
</p><p>Protesters asserted they would not allow any teacher accused of misconduct, including communal remarks, to be protected.
</p><p>The Akhil Bharatiya Vidyarthi Parishad (ABVP) has also escalated the issue, submitting a complaint to Union Minister of State for Tribal Affairs Durgadas Uikey and the National Medical Commission, seeking a transparent and comprehensive probe and strict action against all those responsible.
</p><p>The complaint alleges that, a first-year student from Thiruvananthapuram, died by suicide after facing brutal treatment, including caste and racial abuse by faculty members.
</p><p>At the national level, the National Commission for Scheduled Castes has ordered an inquiry based on a complaint by BJP leader P. Shyamraj, directing the state DGP to submit a report within five days.
</p><p>Meanwhile, Kerala Education Minister V. Sivankutty has assured that the government stands firmly with the student's family, promising a thorough investigation and all necessary support, including facilitating a meeting with the Chief Minister.
</p><p>Police have registered two FIRs, one on the unnatural death and another against a loan app, though inconsistencies in the latter have raised further questions.
</p><p>Statements from students and faculty are being recorded, while suspended teachers named in the case are reportedly absconding, facing possible arrest under non-bailable charges.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/three-mbbs-students-of-malabar-medical-college-killed-in-tragic-road-accident-in-kerala-166736">Also Read:Three MBBS students of Malabar Medical College killed in tragic road accident in Kerala</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Researchers Identify Two Easy Eating Habits That May Aid Weight Loss</title>
<link>https://edusehat.com/en/researchers-identify-two-easy-eating-habits-that-may-aid-weight-loss</link>
<guid>https://edusehat.com/en/researchers-identify-two-easy-eating-habits-that-may-aid-weight-loss</guid>
<description><![CDATA[ What if when you eat matters just as much as what you eat? Emerging research suggests that meal timing could play a key role in maintaining a healthy weight.
A study published in the International Journal of Behavioral Nutrition and Physical Activity found that two simple habits—eating earlier in the day and extending the overnight fasting window—are associated with a lower body mass index (BMI) over time. The research, led by the Barcelona Institute for Global Health analyzed data from over 7,000 adults aged 40 to 65, with follow-up assessments conducted five years later.
The findings point toward the growing field of chrononutrition, which explores how meal timing interacts with the body’s internal clock, or circadian rhythm. Researchers suggest that eating earlier aligns better with the body’s natural metabolic processes, improving calorie burning and appetite regulation. Participants who combined an early dinner with an early breakfast and a longer overnight fast tended to maintain healthier weight levels.
However, not all fasting patterns showed benefits. A subgroup of men who practiced intermittent fasting by skipping breakfast and delaying their first meal until the afternoon did not experience lower body weight. 
The study also revealed gender differences. Women generally had lower BMI, healthier dietary patterns such as closer adherence to the Mediterranean diet, and lower alcohol intake. However, they also reported poorer mental health and greater caregiving responsibilities, highlighting the complex interplay between lifestyle and health outcomes.
While the findings are promising, researchers caution that they are observational and do not prove causation. Still, the results reinforce previous evidence linking early eating patterns with reduced risks of metabolic conditions like type 2 diabetes and cardiovascular disease.
Overall, the research suggests that aligning eating habits with the body’s natural rhythms could be a simple yet effective strategy for long-term weight management.
REFERENCE: Luciana Pons-Muzzo, Rafael de Cid, Mireia Obón-Santacana, Kurt Straif, Kyriaki Papantoniou, Isabel Santonja, Manolis Kogevinas, Anna Palomar-Cros, Camille Lassale. Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study). International Journal of Behavioral Nutrition and Physical Activity, 2024; 21 (1) DOI: 10.1186/s12966-024-01639-x
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341527-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-76.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Researchers, Identify, Two, Easy, Eating, Habits, That, May, Aid, Weight, Loss</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341527-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-76.webp"><p>What if when you eat matters just as much as what you eat? Emerging research suggests that meal timing could play a key role in maintaining a healthy weight.
</p><p>A study published in the<i> International Journal of Behavioral Nutrition and Physical Activity </i>found that two simple habits—eating earlier in the day and extending the overnight fasting window—are associated with a lower body mass index (BMI) over time. The research, led by the Barcelona Institute for Global Health analyzed data from over 7,000 adults aged 40 to 65, with follow-up assessments conducted five years later.
</p><p>The findings point toward the growing field of chrononutrition, which explores how meal timing interacts with the body’s internal clock, or circadian rhythm. Researchers suggest that eating earlier aligns better with the body’s natural metabolic processes, improving calorie burning and appetite regulation. Participants who combined an early dinner with an early breakfast and a longer overnight fast tended to maintain healthier weight levels.
</p><p>However, not all fasting patterns showed benefits. A subgroup of men who practiced intermittent fasting by skipping breakfast and delaying their first meal until the afternoon did not experience lower body weight. 
</p><p>The study also revealed gender differences. Women generally had lower BMI, healthier dietary patterns such as closer adherence to the Mediterranean diet, and lower alcohol intake. However, they also reported poorer mental health and greater caregiving responsibilities, highlighting the complex interplay between lifestyle and health outcomes.
</p><p>While the findings are promising, researchers caution that they are observational and do not prove causation. Still, the results reinforce previous evidence linking early eating patterns with reduced risks of metabolic conditions like type 2 diabetes and cardiovascular disease.
</p><p>Overall, the research suggests that aligning eating habits with the body’s natural rhythms could be a simple yet effective strategy for long-term weight management.
</p><p><b>REFERENCE:</b> Luciana Pons-Muzzo, Rafael de Cid, Mireia Obón-Santacana, Kurt Straif, Kyriaki Papantoniou, Isabel Santonja, Manolis Kogevinas, Anna Palomar-Cros, Camille Lassale. Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study). International Journal of Behavioral Nutrition and Physical Activity, 2024; 21 (1) DOI: 10.1186/s12966-024-01639-x
</p>]]> </content:encoded>
</item>

<item>
<title>Study Explores When Omega&#45;3 Supplements Benefit Mental Health and When They Do Not</title>
<link>https://edusehat.com/en/study-explores-when-omega-3-supplements-benefit-mental-health-and-when-they-do-not</link>
<guid>https://edusehat.com/en/study-explores-when-omega-3-supplements-benefit-mental-health-and-when-they-do-not</guid>
<description><![CDATA[ Can a simple nutrient shift influence how the mind feels and functions? A growing body of research suggests that omega-3 fatty acids may play a meaningful, though complex, role in mental health.
A recent review published in the journal Frontiers in Nutrition highlights how omega-3 supplements could impact brain function through anti-inflammatory and neuroprotective mechanisms. Mental health disorders, including depression, anxiety, and schizophrenia, are increasingly being linked to chronic inflammation and imbalances in fatty acid metabolism. Modern diets, often high in omega-6 fatty acids and low in omega-3s, may further contribute to this imbalance.
Omega-3 fatty acids, particularly EPA and DHA, are essential components of brain cell membranes. DHA, for instance, makes up a significant portion of neuronal membranes and supports neurotransmission, synaptic plasticity, and protection against cell damage. EPA, on the other hand, is more closely associated with anti-inflammatory and potential antidepressant effects.
These fatty acids may also influence the hypothalamic-pituitary-adrenal (HPA) axis, helping regulate stress responses and reduce excess cortisol levels. Additionally, omega-3s can affect key neurotransmitters like serotonin and dopamine, which are often disrupted in mental health conditions. 
Despite these promising mechanisms, the clinical evidence remains mixed. Some studies suggest omega-3 supplementation may reduce depressive symptoms or delay the progression of early psychosis, while others show limited or inconsistent results—especially in chronic or advanced conditions. 
Importantly, omega-3s are not a standalone treatment. Experts emphasize their role as a complementary approach alongside established therapies such as medication and psychotherapy. 
Overall, omega-3 fatty acids represent a promising but still evolving area in mental health research, underscoring the intricate connection between diet, brain biology, and emotional well-being.
REFERENCE: Fleig, K., Haslinger, L., Dawczynski, C., et al. (2026). Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition. DOI: https://doi.org/10.3389/fnut.2026.1748196. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1748196/full
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341523-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-75.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Explores, When, Omega-3, Supplements, Benefit, Mental, Health, and, When, They, Not</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341523-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-75.webp"><p>Can a simple nutrient shift influence how the mind feels and functions? A growing body of research suggests that omega-3 fatty acids may play a meaningful, though complex, role in mental health.
</p><p>A recent review published in the journal<i> Frontiers in Nutrition</i> highlights how omega-3 supplements could impact brain function through anti-inflammatory and neuroprotective mechanisms. Mental health disorders, including depression, anxiety, and schizophrenia, are increasingly being linked to chronic inflammation and imbalances in fatty acid metabolism. Modern diets, often high in omega-6 fatty acids and low in omega-3s, may further contribute to this imbalance.
</p><p>Omega-3 fatty acids, particularly EPA and DHA, are essential components of brain cell membranes. DHA, for instance, makes up a significant portion of neuronal membranes and supports neurotransmission, synaptic plasticity, and protection against cell damage. EPA, on the other hand, is more closely associated with anti-inflammatory and potential antidepressant effects.
</p><p>These fatty acids may also influence the hypothalamic-pituitary-adrenal (HPA) axis, helping regulate stress responses and reduce excess cortisol levels. Additionally, omega-3s can affect key neurotransmitters like serotonin and dopamine, which are often disrupted in mental health conditions. 
</p><p>Despite these promising mechanisms, the clinical evidence remains mixed. Some studies suggest omega-3 supplementation may reduce depressive symptoms or delay the progression of early psychosis, while others show limited or inconsistent results—especially in chronic or advanced conditions. 
</p><p>Importantly, omega-3s are not a standalone treatment. Experts emphasize their role as a complementary approach alongside established therapies such as medication and psychotherapy. 
</p><p>Overall, omega-3 fatty acids represent a promising but still evolving area in mental health research, underscoring the intricate connection between diet, brain biology, and emotional well-being.
</p><p><b>REFERENCE:</b> Fleig, K., Haslinger, L., Dawczynski, C., et al. (2026). Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition. DOI: https://doi.org/10.3389/fnut.2026.1748196. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1748196/full
</p>]]> </content:encoded>
</item>

<item>
<title>New Study Links Common Sweeteners to Long&#45;Term Metabolic Changes Across Generations</title>
<link>https://edusehat.com/en/new-study-links-common-sweeteners-to-long-term-metabolic-changes-across-generations</link>
<guid>https://edusehat.com/en/new-study-links-common-sweeteners-to-long-term-metabolic-changes-across-generations</guid>
<description><![CDATA[ That &quot;zero-calorie&quot; sweetener in your drink might not be as metabolically neutral as it seems.
A new study published in Frontiers in Nutrition suggests that commonly used non-nutritive sweeteners like sucralose and stevia may influence metabolism in unexpected ways—potentially even across generations. While these sweeteners are widely used as sugar substitutes, concerns have been growing about their long-term health effects.
In this study, researchers from the Universidad de Chile tested the effects of these sweeteners in mice. The animals were given water containing either sucralose, stevia, or no sweetener, at doses comparable to typical human consumption. The researchers then tracked metabolic changes not only in the original mice but also in their offspring across two generations.
The results revealed subtle but notable changes. Mice exposed to sweeteners showed altered glucose tolerance—an early indicator of metabolic dysfunction. These effects varied by sex and type of sweetener, but were more consistent and long-lasting with sucralose.
The study also found disruptions in the gut microbiome. While microbial diversity increased, the production of beneficial compounds called short-chain fatty acids decreased. These compounds are important for gut health and metabolic regulation. Additionally, changes in gene expression linked to inflammation and metabolism were observed, suggesting possible epigenetic effects—biological changes that can be passed to future generations.
Interestingly, these changes did not lead to immediate disease, such as diabetes, but may represent early warning signs of metabolic imbalance. Researchers emphasize that the findings do not prove causation and may not directly translate to humans.
Still, the study raises important questions about how artificial sweeteners interact with the body over time. While not a cause for alarm, the researchers suggest moderation and further investigation into their long-term effects on human health.
REFERENCE: Concha Celume, F., et al. (2026). Artificial and natural non-nutritive sweeteners drive divergent gut and genetic responses across generations. Frontiers in Nutrition. DOI: 10.3389/fnut.2026.1694149. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1694149/full
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341519-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-74.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Study, Links, Common, Sweeteners, Long-Term, Metabolic, Changes, Across, Generations</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341519-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-74.webp"><p>That "zero-calorie" sweetener in your drink might not be as metabolically neutral as it seems.
</p><p>A new study published in <i>Frontiers in Nutrition</i> suggests that commonly used non-nutritive sweeteners like sucralose and stevia may influence metabolism in unexpected ways—potentially even across generations. While these sweeteners are widely used as sugar substitutes, concerns have been growing about their long-term health effects.
</p><p>In this study, researchers from the Universidad de Chile tested the effects of these sweeteners in mice. The animals were given water containing either sucralose, stevia, or no sweetener, at doses comparable to typical human consumption. The researchers then tracked metabolic changes not only in the original mice but also in their offspring across two generations.
</p><p>The results revealed subtle but notable changes. Mice exposed to sweeteners showed altered glucose tolerance—an early indicator of metabolic dysfunction. These effects varied by sex and type of sweetener, but were more consistent and long-lasting with sucralose.
</p><p>The study also found disruptions in the gut microbiome. While microbial diversity increased, the production of beneficial compounds called short-chain fatty acids decreased. These compounds are important for gut health and metabolic regulation. Additionally, changes in gene expression linked to inflammation and metabolism were observed, suggesting possible epigenetic effects—biological changes that can be passed to future generations.
</p><p>Interestingly, these changes did not lead to immediate disease, such as diabetes, but may represent early warning signs of metabolic imbalance. Researchers emphasize that the findings do not prove causation and may not directly translate to humans.
</p><p>Still, the study raises important questions about how artificial sweeteners interact with the body over time. While not a cause for alarm, the researchers suggest moderation and further investigation into their long-term effects on human health.
</p><p><b>REFERENCE:</b> Concha Celume, F., et al. (2026). Artificial and natural non-nutritive sweeteners drive divergent gut and genetic responses across generations. Frontiers in Nutrition. DOI: 10.3389/fnut.2026.1694149. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1694149/full
</p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 14/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-14april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-14april2026</guid>
<description><![CDATA[ Here are the top medical news for today:New Study Links Common Sweeteners to Long-Term Metabolic Changes Across Generations
That “zero-calorie” sweetener in your drink might not be as metabolically neutral as it seems.A new study published in Frontiers in Nutrition suggests that commonly used non-nutritive sweeteners like sucralose and stevia may influence metabolism in unexpected ways—potentially even across generations. While these sweeteners are widely used as sugar substitutes, concerns have been growing about their long-term health effects.
In this study, researchers from the Universidad de Chile tested the effects of these sweeteners in mice. The animals were given water containing either sucralose, stevia, or no sweetener, at doses comparable to typical human consumption. The researchers then tracked metabolic changes not only in the original mice but also in their offspring across two generations.
The results revealed subtle but notable changes. Mice exposed to sweeteners showed altered glucose tolerance—an early indicator of metabolic dysfunction. These effects varied by sex and type of sweetener, but were more consistent and long-lasting with sucralose.
The study also found disruptions in the gut microbiome. While microbial diversity increased, the production of beneficial compounds called short-chain fatty acids decreased. These compounds are important for gut health and metabolic regulation. Additionally, changes in gene expression linked to inflammation and metabolism were observed, suggesting possible epigenetic effects—biological changes that can be passed to future generations.
Interestingly, these changes did not lead to immediate disease, such as diabetes, but may represent early warning signs of metabolic imbalance. Researchers emphasize that the findings do not prove causation and may not directly translate to humans.
Still, the study raises important questions about how artificial sweeteners interact with the body over time. While not a cause for alarm, the researchers suggest moderation and further investigation into their long-term effects on human health.
REFERENCE: Concha Celume, F., et al. (2026). Artificial and natural non-nutritive sweeteners drive divergent gut and genetic responses across generations. Frontiers in Nutrition. DOI: 10.3389/fnut.2026.1694149. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1694149/full
Study Explores When Omega-3 Supplements Benefit Mental Health and When They Do NotCan a simple nutrient shift influence how the mind feels and functions? A growing body of research suggests that omega-3 fatty acids may play a meaningful—though complex—role in mental health.A recent review published in the journal Frontiers in Nutrition highlights how omega-3 supplements could impact brain function through anti-inflammatory and neuroprotective mechanisms. Mental health disorders, including depression, anxiety, and schizophrenia, are increasingly being linked to chronic inflammation and imbalances in fatty acid metabolism. Modern diets, often high in omega-6 fatty acids and low in omega-3s, may further contribute to this imbalance.
Omega-3 fatty acids, particularly EPA and DHA, are essential components of brain cell membranes. DHA, for instance, makes up a significant portion of neuronal membranes and supports neurotransmission, synaptic plasticity, and protection against cell damage. EPA, on the other hand, is more closely associated with anti-inflammatory and potential antidepressant effects.
These fatty acids may also influence the hypothalamic-pituitary-adrenal (HPA) axis, helping regulate stress responses and reduce excess cortisol levels. Additionally, omega-3s can affect key neurotransmitters like serotonin and dopamine, which are often disrupted in mental health conditions. 
Despite these promising mechanisms, the clinical evidence remains mixed. Some studies suggest omega-3 supplementation may reduce depressive symptoms or delay the progression of early psychosis, while others show limited or inconsistent results—especially in chronic or advanced conditions. 
Importantly, omega-3s are not a standalone treatment. Experts emphasize their role as a complementary approach alongside established therapies such as medication and psychotherapy. 
Overall, omega-3 fatty acids represent a promising but still evolving area in mental health research, underscoring the intricate connection between diet, brain biology, and emotional well-being.
REFERENCE: Fleig, K., Haslinger, L., Dawczynski, C., et al. (2026). Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition. DOI: https://doi.org/10.3389/fnut.2026.1748196. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1748196/full
Researchers Identify Two Easy Eating Habits That May Aid Weight LossWhat if when you eat matters just as much as what you eat? Emerging research suggests that meal timing could play a key role in maintaining a healthy weight.A study published in the International Journal of Behavioral Nutrition and Physical Activity found that two simple habits—eating earlier in the day and extending the overnight fasting window—are associated with a lower body mass index (BMI) over time. The research, led by the Barcelona Institute for Global Health analyzed data from over 7,000 adults aged 40 to 65, with follow-up assessments conducted five years later.
The findings point toward the growing field of chrononutrition, which explores how meal timing interacts with the body’s internal clock, or circadian rhythm. Researchers suggest that eating earlier aligns better with the body’s natural metabolic processes, improving calorie burning and appetite regulation. Participants who combined an early dinner with an early breakfast and a longer overnight fast tended to maintain healthier weight levels.
However, not all fasting patterns showed benefits. A subgroup of men who practiced intermittent fasting by skipping breakfast and delaying their first meal until the afternoon did not experience lower body weight. 
The study also revealed gender differences. Women generally had lower BMI, healthier dietary patterns such as closer adherence to the Mediterranean diet, and lower alcohol intake. However, they also reported poorer mental health and greater caregiving responsibilities, highlighting the complex interplay between lifestyle and health outcomes.
While the findings are promising, researchers caution that they are observational and do not prove causation. Still, the results reinforce previous evidence linking early eating patterns with reduced risks of metabolic conditions like type 2 diabetes and cardiovascular disease.
Overall, the research suggests that aligning eating habits with the body’s natural rhythms could be a simple yet effective strategy for long-term weight management.
REFERENCE: Luciana Pons-Muzzo, Rafael de Cid, Mireia Obón-Santacana, Kurt Straif, Kyriaki Papantoniou, Isabel Santonja, Manolis Kogevinas, Anna Palomar-Cros, Camille Lassale. Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study). International Journal of Behavioral Nutrition and Physical Activity, 2024; 21 (1) DOI: 10.1186/s12966-024-01639-x
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341528-top-medical-19.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 14April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341528-top-medical-19.webp"><p><b>Here are the top medical news for today:</b></p><p><b>New Study Links Common Sweeteners to Long-Term Metabolic Changes Across Generations
</b></p><p>That “zero-calorie” sweetener in your drink might not be as metabolically neutral as it seems.</p><p>A new study published in Frontiers in Nutrition suggests that commonly used non-nutritive sweeteners like sucralose and stevia may influence metabolism in unexpected ways—potentially even across generations. While these sweeteners are widely used as sugar substitutes, concerns have been growing about their long-term health effects.
</p><p>In this study, researchers from the Universidad de Chile tested the effects of these sweeteners in mice. The animals were given water containing either sucralose, stevia, or no sweetener, at doses comparable to typical human consumption. The researchers then tracked metabolic changes not only in the original mice but also in their offspring across two generations.
</p><p>The results revealed subtle but notable changes. Mice exposed to sweeteners showed altered glucose tolerance—an early indicator of metabolic dysfunction. These effects varied by sex and type of sweetener, but were more consistent and long-lasting with sucralose.
</p><p>The study also found disruptions in the gut microbiome. While microbial diversity increased, the production of beneficial compounds called short-chain fatty acids decreased. These compounds are important for gut health and metabolic regulation. Additionally, changes in gene expression linked to inflammation and metabolism were observed, suggesting possible epigenetic effects—biological changes that can be passed to future generations.
</p><p>Interestingly, these changes did not lead to immediate disease, such as diabetes, but may represent early warning signs of metabolic imbalance. Researchers emphasize that the findings do not prove causation and may not directly translate to humans.
</p><p>Still, the study raises important questions about how artificial sweeteners interact with the body over time. While not a cause for alarm, the researchers suggest moderation and further investigation into their long-term effects on human health.
</p><p><b>REFERENCE:</b> Concha Celume, F., et al. (2026). Artificial and natural non-nutritive sweeteners drive divergent gut and genetic responses across generations. Frontiers in Nutrition. DOI: 10.3389/fnut.2026.1694149. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1694149/full
</p><p><b></b></p><p><b>Study Explores When Omega-3 Supplements Benefit Mental Health and When They Do Not</b></p><p>Can a simple nutrient shift influence how the mind feels and functions? A growing body of research suggests that omega-3 fatty acids may play a meaningful—though complex—role in mental health.</p><p>A recent review published in the journal Frontiers in Nutrition highlights how omega-3 supplements could impact brain function through anti-inflammatory and neuroprotective mechanisms. Mental health disorders, including depression, anxiety, and schizophrenia, are increasingly being linked to chronic inflammation and imbalances in fatty acid metabolism. Modern diets, often high in omega-6 fatty acids and low in omega-3s, may further contribute to this imbalance.
</p><p>Omega-3 fatty acids, particularly EPA and DHA, are essential components of brain cell membranes. DHA, for instance, makes up a significant portion of neuronal membranes and supports neurotransmission, synaptic plasticity, and protection against cell damage. EPA, on the other hand, is more closely associated with anti-inflammatory and potential antidepressant effects.
</p><p>These fatty acids may also influence the hypothalamic-pituitary-adrenal (HPA) axis, helping regulate stress responses and reduce excess cortisol levels. Additionally, omega-3s can affect key neurotransmitters like serotonin and dopamine, which are often disrupted in mental health conditions. 
</p><p>Despite these promising mechanisms, the clinical evidence remains mixed. Some studies suggest omega-3 supplementation may reduce depressive symptoms or delay the progression of early psychosis, while others show limited or inconsistent results—especially in chronic or advanced conditions. 
</p><p>Importantly, omega-3s are not a standalone treatment. Experts emphasize their role as a complementary approach alongside established therapies such as medication and psychotherapy. 
</p><p>Overall, omega-3 fatty acids represent a promising but still evolving area in mental health research, underscoring the intricate connection between diet, brain biology, and emotional well-being.
</p><p><b>REFERENCE: </b>Fleig, K., Haslinger, L., Dawczynski, C., et al. (2026). Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential. Frontiers in Nutrition. DOI: https://doi.org/10.3389/fnut.2026.1748196. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1748196/full
</p><p><b></b></p><p><b>Researchers Identify Two Easy Eating Habits That May Aid Weight Loss</b></p><p>What if when you eat matters just as much as what you eat? Emerging research suggests that meal timing could play a key role in maintaining a healthy weight.</p><p>A study published in the International Journal of Behavioral Nutrition and Physical Activity found that two simple habits—eating earlier in the day and extending the overnight fasting window—are associated with a lower body mass index (BMI) over time. The research, led by the Barcelona Institute for Global Health analyzed data from over 7,000 adults aged 40 to 65, with follow-up assessments conducted five years later.
</p><p>The findings point toward the growing field of chrononutrition, which explores how meal timing interacts with the body’s internal clock, or circadian rhythm. Researchers suggest that eating earlier aligns better with the body’s natural metabolic processes, improving calorie burning and appetite regulation. Participants who combined an early dinner with an early breakfast and a longer overnight fast tended to maintain healthier weight levels.
</p><p>However, not all fasting patterns showed benefits. A subgroup of men who practiced intermittent fasting by skipping breakfast and delaying their first meal until the afternoon did not experience lower body weight. 
</p><p>The study also revealed gender differences. Women generally had lower BMI, healthier dietary patterns such as closer adherence to the Mediterranean diet, and lower alcohol intake. However, they also reported poorer mental health and greater caregiving responsibilities, highlighting the complex interplay between lifestyle and health outcomes.
</p><p>While the findings are promising, researchers caution that they are observational and do not prove causation. Still, the results reinforce previous evidence linking early eating patterns with reduced risks of metabolic conditions like type 2 diabetes and cardiovascular disease.
</p><p>Overall, the research suggests that aligning eating habits with the body’s natural rhythms could be a simple yet effective strategy for long-term weight management.
</p><p><b>REFERENCE: </b>Luciana Pons-Muzzo, Rafael de Cid, Mireia Obón-Santacana, Kurt Straif, Kyriaki Papantoniou, Isabel Santonja, Manolis Kogevinas, Anna Palomar-Cros, Camille Lassale. Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study). International Journal of Behavioral Nutrition and Physical Activity, 2024; 21 (1) DOI: 10.1186/s12966-024-01639-x
</p>]]> </content:encoded>
</item>

<item>
<title>MBBS intern stipend disparity row: Govt says issue falls under NMC, no further action</title>
<link>https://edusehat.com/en/mbbs-intern-stipend-disparity-row-govt-says-issue-falls-under-nmc-no-further-action</link>
<guid>https://edusehat.com/en/mbbs-intern-stipend-disparity-row-govt-says-issue-falls-under-nmc-no-further-action</guid>
<description><![CDATA[ New Delhi: Amid the long-standing demand to amend the Compulsory Rotating Medical Internship (CRMI) Regulations, 2021, to ensure a uniform stipend for MBBS interns across the country, the Ministry of Health and Family Welfare has now stated that it will not take any further action, saying the matter falls entirely within the domain of the National Medical Commission (NMC).The information in this regard was shared in response to a Right to Information (RTI) application filed by Kerala-based ophthalmologist and RTI activist Dr KV Babu, who sought clarity on whether the NMC and its Under-Graduate Medical Education Board (UGMEB) plan to amend the CRMI Regulations to remove disparity in stipend paid to interns across institutions.On February 22, 2026, Dr Babu submitted RTI applications to the UGMEB and the Medical Education Policy (MEP) section of the Ministry, seeking action on stipend parity.While the Under-Graduate Medical Education Board reiterated its earlier position that any amendment to the CRMI Regulations, 2021 would require consideration through the statutory process and consultation with all concerned authorities, the Medical Education Policy (MEP) section of the Ministry of Health and Family Welfare, in its RTI reply, clearly outlined its stand on the issue.In its response dated April 2, 2026, the Ministry stated, &quot;The National Medical Commission (NMC) is the apex statutory body constituted under the National Medical Commission Act, 2019, for regulating medical education and profession in the country. All matters relating to framing, amendment, and implementation of medical education regulations fall within the domain of NMC. Therefore, in view of the above, no further action is required to be taken by the MEP Section in the matter, as the subject falls within the domain of the National Medical Commission (NMC).&quot;Stipend disparity:The issue was first raised by Dr Babu in June 2022, when he wrote to the Ministry alleging that his suggestions on stipend parity were ignored while finalising the CRMI Regulations, 2021. Despite this, he continued to send multiple reminders.Medical Dialogues had previously reported that the doctor requested that the centre withdraw the Gazette Notification dated November 18, 2021, which notified the Compulsory Rotating Medical Internship (CRMI) Regulations, 2021. He stated that his earlier comments submitted on July 24, 2021, regarding stipend parity were not incorporated before the regulations were finalised. He requested the Government to re-gazette the regulations.In his representation, he specifically sought an amendment to Clause 6.3 relating to the stipend, which includes - &quot;All the candidates pursuing compulsory rotating internship at the institution from which the MBBS course was completed, shall be paid stipend on par with the stipend being paid to the interns of the State Govt. Medical Institution / Central Government Medical Institution in the State / Union Territory where the institution is located.&quot;While the government medical colleges pay interns between Rs 20,000 and Rs 30,000, private colleges either pay half of that or none at all. Data from NMC in 2025 showed that 60 of 555 medical colleges were not paying stipends, and many were paying nominal stipends of less than Rs 5,000 per month.The Supreme Court in its order dated October 28, 2025, pulled up the NMC for delaying action on stipend-related issues. The Court observed that the Commission was “dragging its feet” and directed it to take appropriate steps, while also asking the Ministry to ensure compliance.Following this, the doctor again approached the Ministry in November 2025. On this, the MEP section wrote to the NMC in November and December 2025, asking it to examine the issue of stipend provisions for undergraduate interns under CRMI Regulations, 2021, keeping in view similar provisions in PGMER Regulations, 2023.However, in its reply dated February 18, 2026, the Under-Graduate Medical Education Board (UGMEB) under NMC noted that any amendment to the existing rule would require a statutory process.It stated, &quot;As per the CRMI Regulation 2021 it is stated that, the existing regulation already provides for the payment of stipend to interns. However, the actual implementation, including the rate of stipend, is undertaken by the respective States/UTs in accordance with their financial capacity and budgetary provisions. The regulation has been notifled after deliberations with concerned authoritles, experts and competent authorities assigned at the time of formulation of the regulation, The above regulation being statutory notifled after due approval and consultation with MoHFW and the same is laid in the parliament. In view of the above, any amendment to the CRMI Regulations, 2021 , if required would need consideration in accordance with the statritory process and after due consultation with all concerned concerned authorities.&quot;The issue of 19 posts being vacant at NMC, out of the 54 sanctioned strength, was also highlighted in the Parliament.In response, he again wrote to both the Ministry and NMC on February 22, 2026, requesting an amendment of the regulations. He later filed RTI applications with both authorities. While the UGMEB reportedly reiterated its earlier response, the Ministry declined to intervene, stating the matter is under NMC’s jurisdiction.&quot;The National Medical Commission (NMC) is the apex statutory body constituted under the National Medical Commission Act, 2019, for regulating medical education and profession in the country. All matters relating to framing, amendment, and implementation of medical education regulations fall within the domain of NMC. Therefore, in view of the above, no further action is required to be taken by the MEP Section in the matter, as the subject falls within the domain of the National Medical Commission (NMC),&quot; mentioned the government&#039;s response to the RTI. Dr Babu further alleged inconsistency in the Ministry’s approach, stating that while MEP section of the Ministry of Health and Family Welfare has been reluctant to direct the Under-Graduate Medical Education Board on amending the CRMI Regulations for stipend parity, it had promptly intervened in May 2022 on another matter. He pointed out that, based on a representation dated May 3, 2022, the Ministry had directed the National Medical Commission to convene a joint meeting under Section 50 of the NMC Act by May 31, 2022, regarding suggestions for the “Swasth Bharat” roadmap.Commenting on the matter, Dr Babu told Medical Dialogues, &quot;The issue of stipend parity has been pending with the NMC &amp; GOI for almost five years. Though following the SC order of 28th October 2025, the Govt took a proactive decision to amend CRMI regulations in line with PGME regulations, the nominated, almost vacant, UGMEB is not inclined to amend the regulations for stipend parity even after harsh criticism from the SC &amp; communications from the Govt.&quot;He further said, &quot;It should be noted that, though  GOI have the authority to direct the NMC/UGMEB to amend the regulations for stipend parity, they are absolving the responsibility, though they had no hesitation in directing the NMC to act on issues which suits them earlier. It should be presumed that the GOI &amp; the nominated vacant UGMEB are hand in glove in denying stipend parity to the interns.&quot;Also Read:Any amendment to CRMI regulations requires statutory process: NMC on MBBS intern stipend disparity row ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/14/332933-stipend.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MBBS, intern, stipend, disparity, row:, Govt, says, issue, falls, under, NMC, further, action</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/14/332933-stipend.webp"><p><b>New Delhi:</b> Amid the long-standing demand to amend the Compulsory Rotating Medical Internship (CRMI) Regulations, 2021, to ensure a uniform <a href="https://medicaldialogues.in/topics/stipend" target="_blank">stipend </a>for MBBS interns across the country, the Ministry of Health and Family Welfare has now stated that it will not take any further action, saying the matter falls entirely within the domain of the <a href="https://medicaldialogues.in/health-news/nmc" target="_blank">National Medical Commission</a> (NMC).</p><p>The information in this regard was shared in response to a Right to Information (RTI) application filed by Kerala-based ophthalmologist and RTI activist Dr KV Babu, who sought clarity on whether the NMC and its Under-Graduate Medical Education Board (UGMEB) plan to amend the CRMI Regulations to remove disparity in stipend paid to interns across institutions.</p><p>On February 22, 2026, Dr Babu submitted RTI applications to the UGMEB and the Medical Education Policy (MEP) section of the Ministry, seeking action on stipend parity.</p><p>While the Under-Graduate Medical Education Board reiterated its earlier position that any amendment to the CRMI Regulations, 2021 would require consideration through the statutory process and consultation with all concerned authorities, the Medical Education Policy (MEP) section of the Ministry of Health and Family Welfare, in its RTI reply, clearly outlined its stand on the issue.</p><p>In its response dated April 2, 2026, the Ministry stated, <i>"The National Medical Commission (NMC) is the apex statutory body constituted under the National Medical Commission Act, 2019, for regulating medical education and profession in the country. All matters relating to framing, amendment, and implementation of medical education regulations fall within the domain of NMC. Therefore, in view of the above, no further action is required to be taken by the MEP Section in the matter, as the subject falls within the domain of the National Medical Commission (NMC)."</i></p><p><b>Stipend disparity:</b></p><p>The issue was first raised by Dr Babu in June 2022, when he wrote to the Ministry alleging that his suggestions on stipend parity were ignored while finalising the CRMI Regulations, 2021. Despite this, he continued to send multiple reminders.</p><p>Medical Dialogues had previously reported that the doctor requested that the centre withdraw the Gazette Notification dated November 18, 2021, which notified the Compulsory Rotating Medical Internship (CRMI) Regulations, 2021. He stated that his earlier comments submitted on July 24, 2021, regarding stipend parity were not incorporated before the regulations were finalised. He requested the Government to re-gazette the regulations.</p><p>In his representation, he specifically sought an amendment to Clause 6.3 relating to the stipend, which includes - "All the candidates pursuing compulsory rotating internship at the institution from which the MBBS course was completed, shall be paid stipend on par with the stipend being paid to the interns of the State Govt. Medical Institution / Central Government Medical Institution in the State / Union Territory where the institution is located."</p><p>While the government medical colleges pay interns between Rs 20,000 and Rs 30,000, private colleges either pay half of that or none at all. Data from NMC in 2025 showed that 60 of 555 medical colleges were not paying stipends, and many were paying nominal stipends of less than Rs 5,000 per month.</p><p>The Supreme Court in its order dated October 28, 2025, pulled up the NMC for delaying action on stipend-related issues. The Court observed that the Commission was “dragging its feet” and directed it to take appropriate steps, while also asking the Ministry to ensure compliance.</p><p>Following this, the doctor again approached the Ministry in November 2025. On this, the MEP section wrote to the NMC in November and December 2025, asking it to examine the issue of stipend provisions for undergraduate interns under CRMI Regulations, 2021, keeping in view similar provisions in PGMER Regulations, 2023.</p><p>However, in its reply dated February 18, 2026, the Under-Graduate Medical Education Board (UGMEB) under NMC noted that any amendment to the existing rule would require a statutory process.</p><p>It stated, "As per the CRMI Regulation 2021 it is stated that, the existing regulation already provides for the payment of stipend to interns. However, the actual implementation, including the rate of stipend, is undertaken by the respective States/UTs in accordance with their financial capacity and budgetary provisions. The regulation has been notifled after deliberations with concerned authoritles, experts and competent authorities assigned at the time of formulation of the regulation, The above regulation being statutory notifled after due approval and consultation with MoHFW and the same is laid in the parliament. In view of the above, any amendment to the CRMI Regulations, 2021 , if required would need consideration in accordance with the statritory process and after due consultation with all concerned concerned authorities."</p><p>The issue of 19 posts being vacant at NMC, out of the 54 sanctioned strength, was also highlighted in the Parliament.</p><p>In response, he again wrote to both the Ministry and NMC on February 22, 2026, requesting an amendment of the regulations. He later filed RTI applications with both authorities. While the UGMEB reportedly reiterated its earlier response, the Ministry declined to intervene, stating the matter is under NMC’s jurisdiction.</p><p><i>"The National Medical Commission (NMC) is the apex statutory body constituted under the National Medical Commission Act, 2019, for regulating medical education and profession in the country. All matters relating to framing, amendment, and implementation of medical education regulations fall within the domain of NMC. Therefore, in view of the above, no further action is required to be taken by the MEP Section in the matter, as the subject falls within the domain of the National Medical Commission (NMC)," </i>mentioned the government's response to the RTI. </p><p>Dr Babu further alleged inconsistency in the Ministry’s approach, stating that while MEP section of the Ministry of Health and Family Welfare has been reluctant to direct the Under-Graduate Medical Education Board on amending the CRMI Regulations for stipend parity, it had promptly intervened in May 2022 on another matter. He pointed out that, based on a representation dated May 3, 2022, the Ministry had directed the National Medical Commission to convene a joint meeting under Section 50 of the NMC Act by May 31, 2022, regarding suggestions for the “Swasth Bharat” roadmap.</p><p>Commenting on the matter, Dr Babu told Medical Dialogues, "The issue of stipend parity has been pending with the NMC & GOI for almost five years. Though following the SC order of 28th October 2025, the Govt took a proactive decision to amend CRMI regulations in line with PGME regulations, the nominated, almost vacant, UGMEB is not inclined to amend the regulations for stipend parity even after harsh criticism from the SC & communications from the Govt."</p><p>He further said, "It should be noted that, though  GOI have the authority to direct the NMC/UGMEB to amend the regulations for stipend parity, they are absolving the responsibility, though they had no hesitation in directing the NMC to act on issues which suits them earlier. It should be presumed that the GOI & the nominated vacant UGMEB are hand in glove in denying stipend parity to the interns."</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/education/any-amendment-to-crmi-regulations-requires-statutory-process-nmc-on-mbbs-intern-stipend-disparity-row-165206"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/02/21/328771-stipend-5.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/any-amendment-to-crmi-regulations-requires-statutory-process-nmc-on-mbbs-intern-stipend-disparity-row-165206"><span class="read-this-also">Also Read:</span>Any amendment to CRMI regulations requires statutory process: NMC on MBBS intern stipend disparity row</a><div></div></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>AIIMS INI SS July 2026 session seat matrix revised for 10 DM, MCh specialities, details</title>
<link>https://edusehat.com/en/aiims-ini-ss-july-2026-session-seat-matrix-revised-for-10-dm-mch-specialities-details</link>
<guid>https://edusehat.com/en/aiims-ini-ss-july-2026-session-seat-matrix-revised-for-10-dm-mch-specialities-details</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS) has announced revisions in seat allocation for various DM and MCh super specialty courses under the INI-SS Entrance Examination for the July 2026 session. As per the latest update issued in continuation of the previously published prospectus, changes have been made to the number of seats across select specialties at AIIMS New Delhi, AIIMS Bhopal, and PGIMER, Chandigarh, based on recent communications from these institutes, given below-
 
 
 
 
 
 
 
 
 
  Sl.No.
  Courses/Specialty
  Institute
  Earlier GeneralSeats
  Earlier SponsoredSeats
  Earlier ForeignSeats
  Revised GeneralSeats
  Revised SponsoredSeats
  Revised ForeignSeats
 
 
  1
  DM- MEDICAL ONCOLOGY
  AIIMS NEW DELHI
  10
  03
  00
  08
  03
  00
 
 
  2
  DM-GASTROENTEROLOGY
  AIIMS NEW DELHI
  01
  00
  00
  04
  00
  00
 
 
  3
  DM-NEONATOLOGY
  PGIMER
  00
  02
  00
  03
  02
  00
 
 
  4
  DM-NEUROANAESTHESIOLOGY &amp; NEUROCRITICAL CARE
  PGIMER
  04
  05
  01
  05
  05
  01
 
 
  5
  DM-NEUROIMAGING AND INTERVENTIONAL NEURORADIOLOGY
  PGIMER
  01
  02
  01
  02
  02
  01
 
 
  6
  DM-NEUROLOGY
  PGIMER
  03
  06
  00
  04
  06
  00
 
 
  7
  DM-PEDIATRIC NEUROLOGY
  PGIMER
  01
  03
  00
  02
  03
  00
 
 
  8
  DM-PEDIATRIC CRITICAL CARE
  PGIMER
  02
  02
  01
  03
  02
  01
 
 
  9
  M.CH. NEUROSURGERY
  PGIMER
  02
  10
  01
  03
  10
  01
 
 
  10
  DM-UROLOGY
  AIIMS BHOPAL
  00
  04
  00
  00
  03
  00
 All other contents of the Prospectus for July 2026 remain the sameTo view the notice, click the link mentioned here- https://medicaldialogues.in/pdf_upload/2026/04/14/1776080525441-681280407-341558.pdfMedical dialogues had earlier reported that, The All India Institute of Medical Sciences (AIIMS)  released the detailed prospectus and schedule for the INI SS July 2026 session, announcing that online registration process, with the last date set for April 13, 2026.The entrance examination for admission to DM/M.Ch. super-speciality courses across premier institutes, including AIIMS and other Institutes of National Importance, is scheduled to be conducted in computer-based mode on April 25, 2026, while the academic session is set to begin from July 1, 2026.All the concerned candidates are advised to take note of the schedule, seat position as well as eligibility criteria as mentioned below along with other details.Date of Uploading Prospectus and Starting of Online Registration30.03.2026MondayLast date of Online Registration13.04.2026MondayStatus of Application &amp; Rejected application with reason for rejection. Applicants Are required to check status through the Registration Status of My Page after Login.15.04.2026WednesdayLast date for Ministry of Health &amp; Family Welfare, Govt. of India to forward an approval regarding “No Objection” to the Foreign National. Sponsorship certificate duly signed by competent authority for candidates applied under Sponsored seats should also be reached at Examination Section.15.04.2026WednesdayFinalization of Centers and allotment of Roll No’s/Admit Card on website.18.04.2026SaturdayWritten Test through online(CBT)mode25.04.2026SaturdayExpected date of declaration of Result (for all INIs)To be announcedExpected date of declaration of Result(Stage-I) only for AIIMS &amp; PGIMER applicantsTo be announcedFinal ResultTo be announcedCourse Start Date: 01st July 2026, Last date for admission in the course: 31st August, 2026 Last date for fulfillment of Eligibility for admission: 31st July, 2026, (However, sponsored category candidates, applying at PGIMER, Chandigarh must also fulfill Other Eligibility Conditions and Requirements for admissions i.e. “That the candidateconcerned shall be a regular/permanent employee of the deputing/sponsoring authority and should have beencontinually working for three years (on or before 30th June/31st December for July &amp; January session respectively” ofPGIMER, Prospectus Part-B Clause 3.1.(B).1.(a)]Application Fee (Mode of payment: Through Debit/Credit Card/Net Banking)All ApplicantsRs.4000.00+Transaction Charges As applicable (Non-Refundable)PWBDExemptedValidity of Category (OBC/EWS/SC/ST/PWBD) Certificate• Any category certificate will be considered valid only if it is in Hindi/English Language and valid as per detailprovided in the prospectus and issued by competent authority for admission in Central Govt. Institution.• Category Certificate must be uploaded on or before the last date of Online Application is 13.04.2026.Įast date for Online Registration of Application on AIIMS website 13.04.2026Note:-• In case of change of date examination, the current announced date 25.04.2026 will be considered valid for validity of certificate as where required.• To facilitate quick redressal of queries, Kindly use “Raise a query” link on My Page after login Replies/Clarifications will only be given through Online Portal.• Results for INI-SS will be only available on websiteAlso Read:AIIMS begins registrations for INI SS July 2026 session, check seat position, eligibility criteria, all admission details here ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/31/324800-seat-matrix-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, INI, July, 2026, session, seat, matrix, revised, for, DM, MCh, specialities, details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/31/324800-seat-matrix-1.webp"><p><b>New Delhi: </b>The All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/AIIMS">AIIMS</a>) has announced revisions in seat allocation for various DM and MCh super specialty courses under the <a href="https://medicaldialogues.in/topics/INI-SS">INI-SS</a> Entrance Examination for the July 2026 session.</p><p> As per the latest update issued in continuation of the previously published prospectus, changes have been made to the number of seats across select specialties at AIIMS New Delhi, AIIMS Bhopal, and PGIMER, Chandigarh, based on recent communications from these institutes, given below-</p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="1099">
 <colgroup><col width="64">
 <col width="256">
 <col width="126">
 <col width="126">
 <col width="105">
 <col width="89">
 <col width="109">
 <col width="112" span="2">
 </colgroup><tbody><tr height="30">
  <td height="30" class="xl65" width="64"><b>Sl.No.</b></td>
  <td class="xl65" width="256"><b>Courses/Specialty</b></td>
  <td class="xl65" width="126"><b>Institute</b></td>
  <td class="xl66" width="126"><div><b>Earlier General</b></div><b><div><b>Seats</b></div></b></td>
  <td class="xl66" width="105"><div><b>Earlier Sponsored</b></div><b><div><b>Seats</b></div></b></td>
  <td class="xl66" width="89"><div><b>Earlier Foreign</b></div><b><div><b>Seats</b></div></b></td>
  <td class="xl66" width="109"><div><b>Revised General</b></div><b><div><b>Seats</b></div></b></td>
  <td class="xl66" width="112"><div><b>Revised Sponsored</b></div><b><div><b>Seats</b></div></b></td>
  <td class="xl66" width="112"><div><b>Revised Foreign</b></div><b><div><b>Seats</b></div></b></td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">1</td>
  <td class="xl68" width="256">DM- MEDICAL ONCOLOGY</td>
  <td class="xl67" width="126">AIIMS NEW DELHI</td>
  <td class="xl69">10</td>
  <td class="xl70">03</td>
  <td class="xl70">00</td>
  <td class="xl70">08</td>
  <td class="xl70">03</td>
  <td class="xl70">00</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">2</td>
  <td class="xl68" width="256">DM-GASTROENTEROLOGY</td>
  <td class="xl67" width="126">AIIMS NEW DELHI</td>
  <td class="xl70">01</td>
  <td class="xl70">00</td>
  <td class="xl70">00</td>
  <td class="xl70">04</td>
  <td class="xl70">00</td>
  <td class="xl70">00</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">3</td>
  <td class="xl68" width="256">DM-NEONATOLOGY</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">00</td>
  <td class="xl70">02</td>
  <td class="xl70">00</td>
  <td class="xl70">03</td>
  <td class="xl70">02</td>
  <td class="xl70">00</td>
 </tr>
 <tr height="32">
  <td height="32" class="xl71">4</td>
  <td class="xl68" width="256">DM-NEUROANAESTHESIOLOGY & NEUROCRITICAL CARE</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">04</td>
  <td class="xl70">05</td>
  <td class="xl70">01</td>
  <td class="xl70">05</td>
  <td class="xl70">05</td>
  <td class="xl70">01</td>
 </tr>
 <tr height="32">
  <td height="32" class="xl71">5</td>
  <td class="xl68" width="256">DM-NEUROIMAGING AND INTERVENTIONAL NEURORADIOLOGY</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">01</td>
  <td class="xl70">02</td>
  <td class="xl70">01</td>
  <td class="xl70">02</td>
  <td class="xl70">02</td>
  <td class="xl70">01</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">6</td>
  <td class="xl68" width="256">DM-NEUROLOGY</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">03</td>
  <td class="xl70">06</td>
  <td class="xl70">00</td>
  <td class="xl70">04</td>
  <td class="xl70">06</td>
  <td class="xl70">00</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">7</td>
  <td class="xl68" width="256">DM-PEDIATRIC NEUROLOGY</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">01</td>
  <td class="xl70">03</td>
  <td class="xl70">00</td>
  <td class="xl70">02</td>
  <td class="xl70">03</td>
  <td class="xl70">00</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">8</td>
  <td class="xl68" width="256">DM-PEDIATRIC CRITICAL CARE</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">02</td>
  <td class="xl70">02</td>
  <td class="xl70">01</td>
  <td class="xl70">03</td>
  <td class="xl70">02</td>
  <td class="xl70">01</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">9</td>
  <td class="xl68" width="256">M.CH. NEUROSURGERY</td>
  <td class="xl67" width="126">PGIMER</td>
  <td class="xl70">02</td>
  <td class="xl69">10</td>
  <td class="xl70">01</td>
  <td class="xl70">03</td>
  <td class="xl69">10</td>
  <td class="xl70">01</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl71">10</td>
  <td class="xl68" width="256">DM-UROLOGY</td>
  <td class="xl67" width="126">AIIMS BHOPAL</td>
  <td class="xl70">00</td>
  <td class="xl70">04</td>
  <td class="xl70">00</td>
  <td class="xl70">00</td>
  <td class="xl70">03</td>
  <td class="xl70">00</td>
 </tr></tbody></table></div><p>All other contents of the Prospectus for July 2026 remain the same</p><p><b><i>To view the notice, click the link mentioned here- <a href="https://medicaldialogues.in/pdf_upload/2026/04/14/1776080525441-681280407-341558.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/14/1776080525441-681280407-341558.pdf</a></i></b></p><p>Medical dialogues had earlier reported that, The All India Institute of Medical Sciences (AIIMS)  released the detailed prospectus and schedule for the INI SS July 2026 session, announcing that online registration process, with the last date set for April 13, 2026.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The entrance examination for admission to DM/M.Ch. super-speciality courses across premier institutes, including AIIMS and other Institutes of National Importance, is scheduled to be conducted in computer-based mode on April 25, 2026, while the academic session is set to begin from July 1, 2026.</p><p>All the concerned candidates are advised to take note of the schedule, seat position as well as eligibility criteria as mentioned below along with other details.</p></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="489"><colgroup><col width="287"><col width="138"><col width="64"></colgroup><tbody><tr height="31"><td height="31" class="xl66" width="287">Date of Uploading Prospectus and Starting of Online Registration</td><td class="xl67" width="138">30.03.2026</td><td class="xl76" width="64">Monday</td></tr><tr height="20"><td height="20" class="xl68" width="287">Last date of Online Registration</td><td class="xl69" width="138">13.04.2026</td><td class="xl77" width="64">Monday</td></tr><tr height="46"><td height="46" class="xl70" width="287">Status of Application & Rejected application with reason for rejection. Applicants Are required to check status through the Registration Status of My Page after Login.</td><td class="xl75" width="138">15.04.2026</td><td class="xl78" width="64">Wednesday</td></tr><tr height="77"><td height="77" class="xl71" width="287">Last date for Ministry of Health & Family Welfare, Govt. of India to forward an approval regarding “No Objection” to the Foreign National. Sponsorship certificate duly signed by competent authority for candidates applied under Sponsored seats should also be reached at Examination Section.</td><td class="xl72" width="138">15.04.2026</td><td class="xl79" width="64">Wednesday</td></tr><tr height="31"><td height="31" class="xl68" width="287">Finalization of Centers and allotment of Roll No’s/Admit Card on website.</td><td class="xl72" width="138">18.04.2026</td><td class="xl77" width="64">Saturday</td></tr><tr height="20"><td height="20" class="xl73" width="287">Written Test through online(CBT)mode</td><td class="xl69" width="138">25.04.2026</td><td class="xl77" width="64">Saturday</td></tr><tr height="20"><td height="20" class="xl74" width="287">Expected date of declaration of Result (for all INIs)</td><td class="xl69" width="138">To be announced</td><td class="xl80" width="64"></td></tr><tr height="31"><td height="31" class="xl74" width="287">Expected date of declaration of Result(Stage-I) only for AIIMS & PGIMER applicants</td><td class="xl69" width="138">To be announced</td><td class="xl65"></td></tr><tr height="20"><td height="20" class="xl68" width="287">Final Result</td><td class="xl69" width="138">To be announced</td><td class="xl65"></td></tr><tr height="153"><td colspan="3" height="153" class="xl81" width="489">Course Start Date: 01st July 2026, Last date for admission in the course: 31st August, 2026 Last date for fulfillment of Eligibility for admission: 31st July, 2026, (However, sponsored category candidates, applying at PGIMER, Chandigarh must also fulfill Other Eligibility Conditions and Requirements for admissions i.e. “That the candidate</td></tr><tr height="62"><td colspan="3" height="62" class="xl81" width="489">concerned shall be a regular/permanent employee of the deputing/sponsoring authority and should have been</td></tr><tr height="62"><td colspan="3" height="62" class="xl81" width="489">continually working for three years (on or before 30th June/31st December for July & January session respectively” of</td></tr><tr height="31"><td colspan="3" height="31" class="xl83" width="489">PGIMER, Prospectus Part-B Clause 3.1.(B).1.(a)]</td></tr></tbody></table></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="364"><colgroup><col width="95"><col width="269"></colgroup><tbody><tr height="75"><td colspan="2" height="75" class="xl68" width="364">Application Fee (Mode of payment: Through Debit/Credit Card/Net Banking)</td></tr><tr height="27"><td height="27" class="xl70" width="95">All Applicants</td><td class="xl65" width="269">Rs.4000.00+Transaction Charges As applicable (Non-Refundable)</td></tr><tr height="20"><td height="20" class="xl66" width="95">PWBD</td><td class="xl67" width="269">Exempted</td></tr></tbody></table></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="314"><colgroup><col width="314"></colgroup><tbody><tr height="31"><td height="31" class="xl65" width="314">Validity of Category (OBC/EWS/SC/ST/PWBD) Certificate</td></tr><tr height="33"><td height="33" class="xl66" width="314">• Any category certificate will be considered valid only if it is in Hindi/English Language and valid as per detail</td></tr><tr height="33"><td height="33" class="xl67" width="314">provided in the prospectus and issued by competent authority for admission in Central Govt. Institution.</td></tr><tr height="34"><td height="34" class="xl68" width="314">• Category Certificate must be uploaded on or before the last date of Online Application is 13.04.2026.</td></tr><tr height="36"><td height="36" class="xl69" width="314">Įast date for Online Registration of Application on AIIMS website 13.04.2026</td></tr></tbody></table></div><p>Note:-</p><p>• In case of change of date examination, the current announced date 25.04.2026 will be considered valid for validity of certificate as where required.</p><p>• To facilitate quick redressal of queries, Kindly use “Raise a query” link on My Page after login Replies/Clarifications will only be given through Online Portal.</p><p>• Results for INI-SS will be only available on website</p></div><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/aiims-begins-registrations-for-ini-ss-july-2026-session-check-seat-position-eligibility-criteria-all-admission-details-here-167672">Also Read:AIIMS begins registrations for INI SS July 2026 session, check seat position, eligibility criteria, all admission details here</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS Rajkot holds its first convocation, 49 MBBS graduates conferred degrees</title>
<link>https://edusehat.com/en/aiims-rajkot-holds-its-first-convocation-49-mbbs-graduates-conferred-degrees</link>
<guid>https://edusehat.com/en/aiims-rajkot-holds-its-first-convocation-49-mbbs-graduates-conferred-degrees</guid>
<description><![CDATA[ Rajkot: The All India Institute of Medical Sciences (AIIMS) Rajkot organised its first convocation ceremony recently. At the convocation ceremony, degrees were conferred upon the first batch of 49 MBBS graduates. 10 medals and certificates of merit were also awarded. These included an institutional medal, as well as gold, silver, and bronze medals for the first, second, and third professional years.President of India, Smt. Droupadi Murmu addressed the first convocation ceremony of the All India Institute of Medical Sciences (AIIMS), Rajkot, marking a significant milestone in the institution&#039;s journey as it graduated its inaugural batch of medical students. Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel was also present.Congratulating the graduating students, the President described the occasion as a moment of pride not only for the students but also for all those associated with the establishment of the institution. “You are the first batch graduating from this institution. In that sense, you are the first brand ambassadors of AIIMS Rajkot. Your work and conduct will shape the reputation of this institution”, she said.Also Read:AIIMS Rajkot MBBS suicide case: HC seeks state reply after 5 accused students appeal to quash abetment chargeHighlighting the rich cultural and historical significance of the Saurashtra region, the President noted its association with sacred sites and the life of Mahatma Gandhi. She called upon all stakeholders of AIIMS Rajkot to work in the spirit of service and public welfare, guided by the ideals of duty and compassion.Emphasizing the noble nature of the medical profession, the President said, “Medicine is not just a profession, it is a commitment to the service of humanity. This profession requires not only scientific knowledge but also sensitivity, patience and humility.” She urged the graduating students to uphold empathy, patience, and humility in their practice, adding that “the white coat you wear symbolizes the trust that people place in doctors during times of illness and uncertainty.”
The President underscored the important role played by AIIMS institutions in providing affordable, world-class tertiary healthcare, and in advancing medical education, research, and public health. She expressed satisfaction that AIIMS graduates are contributing to healthcare leadership both in India and abroad, reflecting the high standards of these institutions.
Referring to AIIMS Rajkot as a young and evolving institution, the President stressed the importance of a clear vision, good governance, and transparency in ensuring its long-term success. She also highlighted the need to address region-specific health challenges, including maternal and child health and genetic disorders such as sickle cell anemia.Acknowledging the rapid technological advancements in healthcare, the President said, “Artificial Intelligence, robotics, precision medicine and digital health services are transforming the nature and possibilities of healthcare.” She encouraged students to embrace innovation while retaining the human touch, noting that “human compassion in medicine can never be replaced.” Quoting Mahatma Gandhi, the President reminded the graduates of the value of service: “Now that you have the opportunity to render service, pour your soul into it and learn to enjoy it thoroughly.”
The President also highlighted the importance of ethical values in medical practice, stating that while being a good doctor is important, being guided by compassion, integrity, and altruism is even more essential.
In the context of India’s goal of becoming Viksit Bharat by 2047, the President emphasized that accessible and quality healthcare is a critical pillar. She noted that the Government of India has taken several steps in this direction and called for continued collaboration among all stakeholders, including premier institutions like AIIMS.
Expressing confidence in the future of AIIMS Rajkot, the President said that the institution would play a vital role in advancing equitable healthcare and setting new benchmarks in medical education and research.Concluding her address, the President extended her best wishes to the graduating students, urging them to serve with dedication, lead with integrity, and uphold the noble ideals of the medical profession.Also Read:5 accused classmates in AIIMS Rajkot MBBS medico&#039;s suicide case get bail ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341541-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-78.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Rajkot, holds, its, first, convocation, MBBS, graduates, conferred, degrees</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341541-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-78.webp"><p><b>Rajkot: </b>The All India Institute of Medical Sciences (AIIMS) Rajkot organised its first convocation ceremony recently. </p><p>At the convocation ceremony, degrees were conferred upon the first batch of 49 MBBS graduates. 10 medals and certificates of merit were also awarded. These included an institutional medal, as well as gold, silver, and bronze medals for the first, second, and third professional years.</p><p><a href="https://medicaldialogues.in/topics/President">President</a> of India, Smt. Droupadi Murmu addressed the first convocation ceremony of the All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/AIIMS">AIIMS</a>), Rajkot, marking a significant milestone in the institution's journey as it graduated its inaugural batch of <a href="https://medicaldialogues.in/topics/medical-students">medical students</a>. Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel was also present.</p><p>Congratulating the graduating students, the President described the occasion as a moment of pride not only for the students but also for all those associated with the establishment of the institution. “You are the first batch graduating from this institution. In that sense, you are the first brand ambassadors of <a href="https://medicaldialogues.in/topics/AIIMS-Rajkot">AIIMS Rajkot</a>. Your work and conduct will shape the reputation of this institution”, she said.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/gujarat/aiims-rajkot-mbbs-suicide-case-hc-seeks-state-reply-after-5-accused-students-appeal-to-quash-abetment-charge-168400">Also Read:AIIMS Rajkot MBBS suicide case: HC seeks state reply after 5 accused students appeal to quash abetment charge</a></div><p>Highlighting the rich cultural and historical significance of the Saurashtra region, the President noted its association with sacred sites and the life of Mahatma Gandhi. She called upon all stakeholders of AIIMS Rajkot to work in the spirit of service and public welfare, guided by the ideals of duty and compassion.</p><p>Emphasizing the noble nature of the medical profession, the President said, “Medicine is not just a profession, it is a commitment to the service of humanity. This profession requires not only scientific knowledge but also sensitivity, patience and humility.” She urged the graduating students to uphold empathy, patience, and humility in their practice, adding that “the white coat you wear symbolizes the trust that people place in doctors during times of illness and uncertainty.”
</p><p>The President underscored the important role played by AIIMS institutions in providing affordable, world-class tertiary healthcare, and in advancing medical education, research, and public health. She expressed satisfaction that AIIMS graduates are contributing to healthcare leadership both in India and abroad, reflecting the high standards of these institutions.
</p><p>Referring to AIIMS Rajkot as a young and evolving institution, the President stressed the importance of a clear vision, good governance, and transparency in ensuring its long-term success. She also highlighted the need to address region-specific health challenges, including maternal and child health and genetic disorders such as sickle cell anemia.</p><p>Acknowledging the rapid technological advancements in healthcare, the President said, “Artificial Intelligence, robotics, precision medicine and digital health services are transforming the nature and possibilities of healthcare.” She encouraged students to embrace innovation while retaining the human touch, noting that “human compassion in medicine can never be replaced.” Quoting Mahatma Gandhi, the President reminded the graduates of the value of service: “Now that you have the opportunity to render service, pour your soul into it and learn to enjoy it thoroughly.”
</p><p>The President also highlighted the importance of ethical values in medical practice, stating that while being a good doctor is important, being guided by compassion, integrity, and altruism is even more essential.
</p><p>In the context of India’s goal of becoming Viksit Bharat by 2047, the President emphasized that accessible and quality healthcare is a critical pillar. She noted that the Government of India has taken several steps in this direction and called for continued collaboration among all stakeholders, including premier institutions like AIIMS.
</p><p>Expressing confidence in the future of AIIMS Rajkot, the President said that the institution would play a vital role in advancing equitable healthcare and setting new benchmarks in medical education and research.</p><p>Concluding her address, the President extended her best wishes to the graduating students, urging them to serve with dedication, lead with integrity, and uphold the noble ideals of the medical profession.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/gujarat/5-accused-classmates-in-aiims-rajkot-mbbs-medicos-suicide-case-get-bail-167983">Also Read:5 accused classmates in AIIMS Rajkot MBBS medico's suicide case get bail</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>MBBS abroad admission fraud: Aspirant duped of Rs 10.85 lakh over Georgia seat promise</title>
<link>https://edusehat.com/en/mbbs-abroad-admission-fraud-aspirant-duped-of-rs-1085-lakh-over-georgia-seat-promise</link>
<guid>https://edusehat.com/en/mbbs-abroad-admission-fraud-aspirant-duped-of-rs-1085-lakh-over-georgia-seat-promise</guid>
<description><![CDATA[ Varanasi: In a shocking incident of MBBS admission fraud, a medical aspirant was allegedly duped of Rs 10.85 lakh by an education consultancy that promised to secure him admission in Georgia.Acting on the instructions of the Police Commissioner, the Bhelupur Police Station has registered an FIR against the operators of a Group, based in Durgakund, following a complaint filed by the student&#039;s mother.The complainant alleged that her son was cheated out of Rs 10.85 lakh by the firm, which had promised to secure a seat in a medical institution in Georgia. The accused reportedly collected the money over five months through cash and cheque, but failed to provide admission.Also read- Rs 16 lakh for MBBS degrees? Vyapam-linked fraud alleged at Gwalior&#039;s medical collegeAs per a latest media report by Live Hindustan, the family said they were repeatedly shown documents related to admission to gain their trust. However, upon verification, all documents were found to be fake. The student was neither enrolled in any foreign university nor had any visa or passport formalities completed.The complaint further stated that on October 3, 2025, the accused took the student’s original documents, including passport, Class 10 and 12 mark sheets, certificates, and Aadhaar card, on the pretext of processing admission. These were allegedly sent to their office in Noida.The family was initially told they would be sent to Georgia on October 25, 2025. The date was then changed to October 30, and then to November 10, but no progress was made.When the family grew suspicious and demanded their money and documents back, the accused allegedly asked them to pay an additional Rs 2 lakh and refused to return the original certificates until the amount was paid.The family has also alleged that they received abusive calls and death threats. This has left the family in a state of extreme fear and mental distressGiven the seriousness of the matter, the police have registered a case and have begun an investigation into the matter. Also read- MBBS admission fraud: MR duped of Rs 4.5 lakh, accused arrested ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/25/334975-mbbs-admission-fraud-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MBBS, abroad, admission, fraud:, Aspirant, duped, 10.85, lakh, over, Georgia, seat, promise</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/25/334975-mbbs-admission-fraud-1.webp"><div><b>Varanasi: </b><span>In a shocking incident of MBBS admission <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud</a>, a medical aspirant was allegedly duped of Rs 10.85 lakh by an education consultancy that promised to secure him <a href="https://medicaldialogues.in/topics/mbbs-admission" target="_blank">admission</a> in Georgia.</span></div><div><span>Acting on the instructions of the Police Commissioner, the Bhelupur Police Station has registered an FIR against the operators of a Group, based in Durgakund, following a complaint filed by the student's mother.</span></div><div><p>The complainant alleged that her son was cheated out of Rs 10.85 lakh by the firm, which had promised to secure a seat in a medical institution in Georgia. The accused reportedly collected the money over five months through cash and cheque, but failed to provide admission.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/madhya-pradesh/rs-16-lakh-for-mbbs-degrees-vyapam-linked-fraud-alleged-at-gwaliors-medical-college-168432" target="_blank">Rs 16 lakh for MBBS degrees? Vyapam-linked fraud alleged at Gwalior's medical college</a></b></p><p>As per a latest media report by <a href="https://www.livehindustan.com/career/georgia-mbbs-fraud-rm-group-education-case-cheating-10-lakh-student-documents-threats-varanasi-news-201776003475646.html#google_vignette" target="_blank" rel="nofollow">Live Hindustan</a>, the family said they were repeatedly shown documents related to admission to gain their trust. However, upon verification, all documents were found to be fake. The student was neither enrolled in any foreign university nor had any visa or passport formalities completed.</p><p>The complaint further stated that on October 3, 2025, the accused took the student’s original documents, including passport, Class 10 and 12 mark sheets, certificates, and Aadhaar card, on the pretext of processing admission. These were allegedly sent to their office in Noida.</p><p>The family was initially told they would be sent to Georgia on October 25, 2025. The date was then changed to October 30, and then to November 10, <span>but no progress was made.</span></p><p>When the family grew suspicious and demanded their money and documents back, the accused allegedly asked them to pay an additional Rs 2 lakh and refused to return the original certificates until the amount was paid.</p><p>The family has also alleged that they received abusive calls and death threats. This has left the family in a state of extreme fear and mental distress</p><p>Given the seriousness of the matter, the police have registered a case and have begun an investigation into the matter. </p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/madhya-pradesh/mbbs-admission-fraud-mr-duped-of-rs-45-lakh-accused-arrested-167691" target="_blank">MBBS admission fraud: MR duped of Rs 4.5 lakh, accused arrested</a></b></p></div>]]> </content:encoded>
</item>

<item>
<title>Rajasthan private hospitals announce 24&#45;hour shutdown over hospital director&amp;apos;s arrest</title>
<link>https://edusehat.com/en/rajasthan-private-hospitals-announce-24-hour-shutdown-over-hospital-directors-arrest</link>
<guid>https://edusehat.com/en/rajasthan-private-hospitals-announce-24-hour-shutdown-over-hospital-directors-arrest</guid>
<description><![CDATA[ Jaipur: The Indian Medical Association (IMA) on Monday led a 24-hour statewide shutdown of private healthcare services in Rajasthan, as doctors’ bodies and private hospital associations launched a boycott of the Rajasthan Government Health Scheme (RGHS) following the arrest of a doctor over alleged irregularities.
The shutdown, which began at 8 am on April 14 and will continue until 8 am on April 15, has resulted in the suspension of OPD, IPD, and emergency services in private hospitals across the state, severely affecting healthcare access for patients.  Also Read:Jaipur Hospital operator arrested over alleged RGHS fraudMedical Dialogues recently reported that a private hospital operator in Jaipur was arrested on Sunday for allegedly submitting forged and fabricated documents under the Rajasthan Government Health Scheme (RGHS).At a meeting chaired by IMA Rajasthan state president Dr Mahesh Chandra Sharma, representatives of private hospitals unanimously decided to stop generating new transaction IDs (TID) under RGHS. Patients already admitted will continue to receive treatment, but hospitals will not issue a fresh TID if required, reports TOI.
The association has warned that the boycott will continue until the arrested doctor is released and concerns related to the case are addressed. According to the news reports, the protest has received widespread support from prominent healthcare bodies, including the Rajasthan Alliance of Hospital Associations, Private Hospitals and Nursing Homes Association (PHNHA), UPCHAR, AHPI Rajasthan, and PHNHS.
Dr. Sharma stated that the arrest has created a climate of fear and resentment among doctors, arguing that the action was taken without adequate dialogue or fair process. He warned that such measures could seriously disrupt healthcare delivery in the state. He further added that doctors have resolved to collectively boycott treatment services in the future if similar arrests occur over alleged irregularities in government schemes.
Speaking to TOI, IMA Rajasthan zonal secretary Dr Anurag Sharma said there was “deep anger” among doctors across the state. He said the medical board formed in the matter had not found any medical negligence, yet criminal action had been taken against a reputed doctor over what he described as alleged minor RGHS irregularities, adding that the arrest had hurt the dignity and morale of the fraternity.
PHNHA representative Dr. Vijay Kapoor also criticized the manner of the arrest, alleging that due legal process was not followed and that the doctor in the case was not given an opportunity to present his case. He claimed the doctor was treated “like a hardened criminal,” sparking outrage among healthcare professionals statewide.
Doctors’ associations have warned that if the doctor is not released and the concerns surrounding the case are not addressed, the agitation could escalate into a prolonged statewide shutdown of medical services.
The ongoing shutdown is expected to impact RGHS beneficiaries significantly, particularly affecting new admissions and approvals at empanelled private hospitals.
Also Read:Rajasthan private hospitals suspend cashless medicine services over unpaid dues ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/27/337103-telangana.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Rajasthan, private, hospitals, announce, 24-hour, shutdown, over, hospital, directors, arrest</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/27/337103-telangana.webp"><p><b>Jaipur:</b> The Indian Medical Association (<a href="https://medicaldialogues.in/topics/ima">IMA</a>) on Monday led a 24-hour statewide shutdown of private healthcare services in <a href="https://medicaldialogues.in/state-news/rajasthan">Rajasthan</a>, as <a href="https://medicaldialogues.in/topics/doctors">doctors’ </a>bodies and private hospital associations launched a boycott of the Rajasthan Government Health Scheme (<a href="https://medicaldialogues.in/topics/rghs">RGHS</a>) following the arrest of a doctor over alleged irregularities.
</p><p>The shutdown, which began at 8 am on April 14 and will continue until 8 am on April 15, has resulted in the suspension of OPD, IPD, and emergency services in private hospitals across the state, severely affecting healthcare access for patients.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jaipur-hospital-operator-arrested-over-alleged-rghs-fraud-168498"><b>Also Read:Jaipur Hospital operator arrested over alleged RGHS fraud</b></a></p><p>Medical Dialogues recently reported that a private hospital operator in Jaipur was arrested on Sunday for allegedly submitting forged and fabricated documents under the Rajasthan Government Health Scheme (RGHS).</p><p>At a meeting chaired by IMA Rajasthan state president Dr Mahesh Chandra Sharma, representatives of private hospitals unanimously decided to stop generating new transaction IDs (TID) under RGHS. Patients already admitted will continue to receive treatment, but hospitals will not issue a fresh TID if required, reports <a href="https://timesofindia.indiatimes.com/city/jaipur/pvt-hospitals-boycott-rghs-after-doctors-arrest-ima-calls-24-hour-shutdown/articleshow/130244976.cms" rel="nofollow">TOI</a>.
</p><p>The association has warned that the boycott will continue until the arrested doctor is released and concerns related to the case are addressed. </p><p>According to the news reports, the protest has received widespread support from prominent healthcare bodies, including the Rajasthan Alliance of Hospital Associations, Private Hospitals and Nursing Homes Association (PHNHA), UPCHAR, AHPI Rajasthan, and PHNHS.
</p><p>Dr. Sharma stated that the arrest has created a climate of fear and resentment among doctors, arguing that the action was taken without adequate dialogue or fair process. He warned that such measures could seriously disrupt healthcare delivery in the state. He further added that doctors have resolved to collectively boycott treatment services in the future if similar arrests occur over alleged irregularities in government schemes.
</p><p>Speaking to TOI, IMA Rajasthan zonal secretary Dr Anurag Sharma said there was “deep anger” among doctors across the state. He said the medical board formed in the matter had not found any medical negligence, yet criminal action had been taken against a reputed doctor over what he described as alleged minor RGHS irregularities, adding that the arrest had hurt the dignity and morale of the fraternity.
</p><p>PHNHA representative Dr. Vijay Kapoor also criticized the manner of the arrest, alleging that due legal process was not followed and that the doctor in the case was not given an opportunity to present his case. He claimed the doctor was treated “like a hardened criminal,” sparking outrage among healthcare professionals statewide.
</p><p>Doctors’ associations have warned that if the doctor is not released and the concerns surrounding the case are not addressed, the agitation could escalate into a prolonged statewide shutdown of medical services.
</p><p>The ongoing shutdown is expected to impact RGHS beneficiaries significantly, particularly affecting new admissions and approvals at empanelled private hospitals.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/rajasthan/rajasthan-private-hospitals-suspend-cashless-medicine-services-over-unpaid-dues-167450"><b>Also Read:Rajasthan private hospitals suspend cashless medicine services over unpaid dues</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Kottayam doctor&amp;apos;s car set on fire, accused succumbs to injuries</title>
<link>https://edusehat.com/en/kottayam-doctors-car-set-on-fire-accused-succumbs-to-injuries</link>
<guid>https://edusehat.com/en/kottayam-doctors-car-set-on-fire-accused-succumbs-to-injuries</guid>
<description><![CDATA[ Kottayam: In a shocking incident, a car belonging to a prominent doctor was reportedly set ablaze by his former security guard in Kottayam on Monday morning, an act that later led to the death of the accused after he sustained severe burn injuries. The victim identified as the former Head of the Endocrinology Department at Kottayam Medical College. The incident occurred around 7:30 am at his residence near the Gandhinagar–Medical College Road. The fire was first noticed by a domestic worker who had arrived at the premises for routine chores, reports the Daily.Also Read:Nagpur doctor arrested for abetting suicide of 28-year-old air hostessAccording to officials at the Kottayam Fire Station, they received information around 8.10 am that a car parked at a doctor’s residence had caught fire, reports PTI.Emergency services, including the Fire Force and local police, rushed to the spot. Upon arrival, they found the accused lying near the burning vehicle with severe burn injuries. He was immediately transported to Kottayam Medical College Hospital for treatment, but succumbed to his injuries later in the evening.
Authorities stated that the accused had been employed as a night watchman at the doctor’s residence. He had reportedly been dismissed from his job recently, which may have contributed to the motive behind the act. Police are also exploring the possibility that he was dealing with mental health issues.
The fire was prevented from spreading to the house after employees from a nearby petrol pump rushed to the spot with fire extinguishers and doused the flames. However, one window of the house was damaged in the fire, reports Onmanorama.
The accused is survived by his wife and two children. His funeral is scheduled to take place on Tuesday at 3:30 pm.
Medical Dialogues had previously reported that a car carrying a doctor couple suddenly caught fire in Maharashtra&#039;s Beed district; fortunately, no casualties were reported, police said. The incident took place near Mahajanwadi crossroad on Manjarsumba-Patoda road in Beed tehsil at around 6.15 am when the couple was heading towards their farmland. Also Read:Doctor couple escapes unhurt as car catches fire in Beed ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/25/334945-death-6.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kottayam, doctors, car, set, fire, accused, succumbs, injuries</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/25/334945-death-6.webp"><p><b>Kottayam: </b>In a shocking incident, a car belonging to a prominent<a href="https://medicaldialogues.in/topics/doctors"> doctor </a>was reportedly set ablaze by his former security guard in Kottayam on Monday morning, an act that later led to the death of the accused after he sustained severe <a href="https://speciality.medicaldialogues.in/topics/burn-injury">burn injuries</a>. </p><p>The victim identified as the former Head of the<a href="https://medicaldialogues.in/diabetes-endocrinology/news"> Endocrinology </a>Department at <a href="https://medicaldialogues.in/topics/kottayam-medical-college">Kottayam Medical College</a>. The incident occurred around 7:30 am at his residence near the Gandhinagar–Medical College Road. The fire was first noticed by a domestic worker who had arrived at the premises for routine chores, reports the Daily.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/nagpur-doctor-arrested-for-abetting-suicide-of-28-year-old-air-hostess-168561">Also Read:Nagpur doctor arrested for abetting suicide of 28-year-old air hostess</a></p><p>According to officials at the Kottayam Fire Station, they received information around 8.10 am that a car parked at a doctor’s residence had caught fire, reports PTI.</p><p>Emergency services, including the Fire Force and local police, rushed to the spot. Upon arrival, they found the accused lying near the burning vehicle with severe burn injuries. He was immediately transported to Kottayam Medical College Hospital for treatment, but succumbed to his injuries later in the evening.
</p><p>Authorities stated that the accused had been employed as a night watchman at the doctor’s residence. He had reportedly been dismissed from his job recently, which may have contributed to the motive behind the act. Police are also exploring the possibility that he was dealing with mental health issues.
</p><p>The fire was prevented from spreading to the house after employees from a nearby petrol pump rushed to the spot with fire extinguishers and doused the flames. However, one window of the house was damaged in the fire, reports <a href="https://www.onmanorama.com/news/kerala/2026/04/14/kottayam-professor-car-fire.html" rel="nofollow">Onmanorama.</a>
</p><p>The accused is survived by his wife and two children. His funeral is scheduled to take place on Tuesday at 3:30 pm.
</p><p>Medical Dialogues had previously reported that a car carrying a doctor couple suddenly caught fire in Maharashtra's Beed district; fortunately, no casualties were reported, police said. The incident took place near Mahajanwadi crossroad on Manjarsumba-Patoda road in Beed tehsil at around 6.15 am when the couple was heading towards their farmland. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/doctor-couple-escapes-unhurt-as-car-catches-fire-in-beed-164835"><b>Also Read:Doctor couple escapes unhurt as car catches fire in Beed</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Kolkata doctor offers Rs 500 discount if patients say Jai Shree Ram at clinic</title>
<link>https://edusehat.com/en/kolkata-doctor-offers-rs-500-discount-if-patients-say-jai-shree-ram-at-clinic</link>
<guid>https://edusehat.com/en/kolkata-doctor-offers-rs-500-discount-if-patients-say-jai-shree-ram-at-clinic</guid>
<description><![CDATA[ Kolkata: A city-based cardiologist is offering a Rs 500 discount on consultation fee to patients who say &#039;Jai Shree Ram&#039; at his clinic, believing his move to change the political regime in West Bengal.According to the recent PTI report, interventional cardiologist Dr P K Hazra put up a poster, featuring his photo wearing a BJP scarf, in his private clinic announcing the offer. He also shared the poster on social media.Responding to the issue, senior Trinamool Congress leader Dr Nirmal Maji stated that Hazra wants to be in the good books of the BJP to safeguard his wealth.Also Read:Supreme Court notice to Centre, States over free treatment to poor patients at private hospitalsSpeaking to PTI, Hazra said, &quot;This is entirely my idea. As a doctor over the years, I have faced questions from several of my patients about why they have to go to other states for treatment. I feel bad every time I see patients from Bengal going to Assam, Odisha, or South India, and not the reverse happening. I think we need a change in this trend. That is the reason I came up with this idea.&quot; The director of the Interventional Cardiology Department at a private hospital said he is offering this discount to patients who consult him at his chamber in south Kolkata and not at the hospital.Hazra said that the poster was prepared by one of his patients, which states that patients invoking the &#039;Jai Shree Ram&#039; slogan would receive a special discount on the doctor’s consultation fees.&quot;I am not directly associated with the BJP, but I admire the way other states under their rule have progressed,&quot; he said.The physician claimed that he had expected to receive a BJP ticket from Pingla in Paschim Medinipur district, from where he hails.&quot;When that did not happen, I thought this could be a better way to inspire people to vote for a change in the state,&quot; Hazra said, reports PTI.He, however, also praised Chief Minister Mamata Banerjee for her work.&quot;She (Banerjee) has done good work, but given the pace at which other states have progressed, Bengal is lagging. But much more needs to be done. If the BJP comes to power, there may be some progress,&quot; he said.According to him, the &quot;tussle&quot; between the Centre and the TMC government has impacted the progress of the healthcare system.BJP Rajya Sabha MP Rahul Sinha welcomed the move by Hazra.&quot;I think this will inspire other doctors to come forward and take similar decisions to realise the state&#039;s need for a change for the betterment of the healthcare infrastructure,&quot; Sinha, a former Bengal BJP president, told PTI.TMC leader Dr Nirmal Maji claimed that Hazra&#039;s attempt was a game plan to get into the good books of the BJP.&quot;He is trying to get into the BJP&#039;s washing machine and get a clean image. He wants to protect himself and all the money and wealth he has accumulated,&quot; Maji, a doctor by profession, told PTI when contacted.Such moves will not help the BJP win the elections, as the TMC has the people&#039;s support, claimed Maji, a candidate of the Goghat (SC) assembly constituency.Elections to the 294-member West Bengal assembly will be held on April 23 and 29. Votes will be counted on May 4.Also Read:4 Tamil Nadu Private medical colleges partner to offer free STD treatment ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341546-dr-p-k-hazra.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 17:45:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kolkata, doctor, offers, 500, discount, patients, say, Jai, Shree, Ram, clinic</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341546-dr-p-k-hazra.webp"><div class="pasted-from-word-wrapper"><p><span>Kolkata: A city-based cardiologist is offering a Rs 500 discount on consultation fee to patients who say 'Jai Shree Ram' at his clinic, believing his move to change the political regime in West Bengal.</span></p><p>According to the recent PTI report, interventional cardiologist Dr P K Hazra put up a poster, featuring his photo wearing a BJP scarf, in his private clinic announcing the offer. He also shared the poster on social media.</p><p>Responding to the issue, senior Trinamool Congress leader Dr Nirmal Maji stated that Hazra wants to be in the good books of the BJP to safeguard his wealth.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/supreme-court-notice-to-centre-states-over-free-treatment-to-poor-patients-at-private-hospitals-154440"><b>Also Read:Supreme Court notice to Centre, States over free treatment to poor patients at private hospitals</b></a></p><p>Speaking to PTI, Hazra said, "This is entirely my idea. As a doctor over the years, I have faced questions from several of my patients about why they have to go to other states for treatment. I feel bad every time I see patients from Bengal going to Assam, Odisha, or South India, and not the reverse happening. I think we need a change in this trend. That is the reason I came up with this idea." The director of the Interventional Cardiology Department at a private hospital said he is offering this discount to patients who consult him at his chamber in south Kolkata and not at the hospital.</p><p>Hazra said that the poster was prepared by one of his patients, which states that patients invoking the 'Jai Shree Ram' slogan would receive a special discount on the doctor’s consultation fees.</p><p>"I am not directly associated with the BJP, but I admire the way other states under their rule have progressed," he said.</p><p>The physician claimed that he had expected to receive a BJP ticket from Pingla in Paschim Medinipur district, from where he hails.</p><p>"When that did not happen, I thought this could be a better way to inspire people to vote for a change in the state," Hazra said, reports PTI.</p><p>He, however, also praised Chief Minister Mamata Banerjee for her work.</p><p>"She (Banerjee) has done good work, but given the pace at which other states have progressed, Bengal is lagging. But much more needs to be done. If the BJP comes to power, there may be some progress," he said.</p><p>According to him, the "tussle" between the Centre and the TMC government has impacted the progress of the healthcare system.</p><p>BJP Rajya Sabha MP Rahul Sinha welcomed the move by Hazra.</p><p>"I think this will inspire other doctors to come forward and take similar decisions to realise the state's need for a change for the betterment of the healthcare infrastructure," Sinha, a former Bengal BJP president, told PTI.</p><p>TMC leader Dr Nirmal Maji claimed that Hazra's attempt was a game plan to get into the good books of the BJP.</p><p>"He is trying to get into the BJP's washing machine and get a clean image. He wants to protect himself and all the money and wealth he has accumulated," Maji, a doctor by profession, told PTI when contacted.</p><p>Such moves will not help the BJP win the elections, as the TMC has the people's support, claimed Maji, a candidate of the Goghat (SC) assembly constituency.</p><p>Elections to the 294-member West Bengal assembly will be held on April 23 and 29. Votes will be counted on May 4.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/4-tamil-nadu-private-medical-colleges-partner-to-offer-free-std-treatment-155145"><b>Also Read:4 Tamil Nadu Private medical colleges partner to offer free STD treatment</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Calcium Supplementation May Increase Cardiovascular Risk in Established CVD, Finds Study</title>
<link>https://edusehat.com/en/calcium-supplementation-may-increase-cardiovascular-risk-in-established-cvd-finds-study</link>
<guid>https://edusehat.com/en/calcium-supplementation-may-increase-cardiovascular-risk-in-established-cvd-finds-study</guid>
<description><![CDATA[ China: A retrospective cohort study from Hong Kong has found that calcium supplementation alone may increase the risk of recurrent cardiovascular events in individuals with established cardiovascular disease (CVD). However, this increased risk was not observed when calcium was combined with vitamin D, suggesting a potential protective or mitigating role of vitamin D. Overall, the findings do not support the cardiovascular safety of calcium supplementation alone in patients with pre-existing CVD.         The study, published in the Journal of the American Heart Association, was led by Xiaowen Zhang from the Department of Pharmacology and Pharmacy, The University of Hong Kong. It aimed to clarify the long-debated relationship between calcium supplement use and cardiovascular outcomes, particularly in individuals already diagnosed with major cardiovascular conditions.For this purpose, the researchers conducted a large population-based retrospective cohort study involving individuals aged 40 years or older who were newly diagnosed with CVD between 2006 and 2015. Patients prescribed calcium supplements were compared with those who had never received such prescriptions. Using propensity score matching to ensure comparable baseline characteristics, the study included 17,720 patients in each group. Statistical analysis was performed using Cox proportional hazard models to estimate the risk of recurrent cardiovascular events.    The following were the key findings:Calcium supplementation was associated with a modest but statistically significant increase in the risk of recurrent cardiovascular events.Patients using calcium supplements had a higher likelihood of CVD-related hospitalizations or emergency department visits.The increased risk was more pronounced with calcium-only supplementation.No similar increase in risk was observed when calcium was combined with vitamin D.The association between calcium supplementation and recurrent cardiovascular events was stronger in men than in women.These findings indicate potential sex-based differences in cardiovascular risk related to supplement use.The study adds to growing evidence suggesting that calcium supplementation, particularly when used without vitamin D, may not be as safe as previously assumed in high-risk populations. While calcium is commonly prescribed for bone health, especially in older adults, its potential cardiovascular implications warrant careful consideration.The authors emphasized that clinicians should exercise caution when recommending calcium supplements to patients with established cardiovascular disease. The combination of calcium with vitamin D may represent a safer alternative, although further research is needed to confirm this observation.Overall, the study highlights the importance of individualized treatment decisions, particularly in patients with pre-existing cardiovascular conditions. It also highlights the need for clinicians to balance the benefits of calcium supplementation for bone health against its potential risks for cardiovascular outcomes.Reference: https://doi.org/10.1161/JAHA.125.047455 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/01/311948-calcium-supplements.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Calcium, Supplementation, May, Increase, Cardiovascular, Risk, Established, CVD, Finds, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/01/311948-calcium-supplements.webp"><p><span>China: A retrospective cohort study from Hong Kong has found that <a href="https://medicaldialogues.in/topics/calcium-supplements">calcium supplementation</a> alone may increase the risk of recurrent cardiovascular events in individuals with established <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease (CVD)</a>. However, this increased risk was not observed when calcium was combined with vitamin D, suggesting a potential protective or mitigating role of vitamin D. Overall, the findings do not support the cardiovascular safety of calcium supplementation alone in patients with pre-existing CVD.         </span></p><div class="pasted-from-word-wrapper"><div>The study, published in the <i><a href="https://medicaldialogues.in/topics/journal-of-the-american-heart-association">Journal of the American Heart Association</a>,</i> was led by Xiaowen Zhang from the Department of Pharmacology and Pharmacy, The University of Hong Kong. It aimed to clarify the long-debated relationship between calcium supplement use and cardiovascular outcomes, particularly in individuals already diagnosed with major cardiovascular conditions.</div><div>For this purpose, the researchers conducted a large population-based retrospective cohort study involving individuals aged 40 years or older who were newly diagnosed with CVD between 2006 and 2015. Patients prescribed calcium supplements were compared with those who had never received such prescriptions. Using propensity score matching to ensure comparable baseline characteristics, the study included 17,720 patients in each group. Statistical analysis was performed using Cox proportional hazard models to estimate the risk of recurrent cardiovascular events.    </div><div>The following were the key findings:</div><ul><li>Calcium supplementation was associated with a modest but statistically significant increase in the risk of recurrent cardiovascular events.</li><li>Patients using calcium supplements had a higher likelihood of CVD-related hospitalizations or emergency department visits.</li><li>The increased risk was more pronounced with calcium-only supplementation.</li><li>No similar increase in risk was observed when calcium was combined with vitamin D.</li><li>The association between calcium supplementation and recurrent cardiovascular events was stronger in men than in women.</li></ul><div>These findings indicate potential sex-based differences in cardiovascular risk related to supplement use.</div><div>The study adds to growing evidence suggesting that calcium supplementation, particularly when used without vitamin D, may not be as safe as previously assumed in high-risk populations. While calcium is commonly prescribed for bone health, especially in older adults, its potential cardiovascular implications warrant careful consideration.</div><div>The authors emphasized that clinicians should exercise caution when recommending calcium supplements to patients with established cardiovascular disease. The combination of calcium with vitamin D may represent a safer alternative, although further research is needed to confirm this observation.</div><div>Overall, the study highlights the importance of individualized treatment decisions, particularly in patients with pre-existing cardiovascular conditions. It also highlights the need for clinicians to balance the benefits of calcium supplementation for bone health against its potential risks for cardiovascular outcomes.</div><div>Reference: https://doi.org/10.1161/JAHA.125.047455</div></div>]]> </content:encoded>
</item>

<item>
<title>Jabalpur Health Dept cancels registration of 5 hospitals, 121 clinics</title>
<link>https://edusehat.com/en/jabalpur-health-dept-cancels-registration-of-5-hospitals-121-clinics</link>
<guid>https://edusehat.com/en/jabalpur-health-dept-cancels-registration-of-5-hospitals-121-clinics</guid>
<description><![CDATA[ Jabalpur: The Health Department has initiated a major crackdown on private healthcare facilities in Jabalpur, cancelling the registrations of 5 private hospitals and 121 clinics for failing to comply with mandatory renewal norms and directing them to cease operations immediately.  Officials said that under existing rules, private hospitals and clinics are granted registration for a period of three years, after which annual renewal is mandatory between January and February. Inspections are conducted in March, and renewal is approved only if all prescribed standards and documentation requirements are met.Also Read:Pune: 37 Private Hospitals get notices over regulatory violationsDuring the review process, officials identified irregularities among 55 hospitals in the district. Two hospitals had applied for closure, one failed to apply for renewal, another submitted incorrect documents, and one was found without staff during inspection. As a result, the registration of five hospitals was cancelled, and they have been barred from admitting or treating patients.Included in the list of cancelled registrations are Batalia Eye Hospital, Namdev Nursing Home, SC Memorial Hospital and Research Centre, Sankalp Hospital, and Government Hospital, reports Raj Express.
The crackdown extended to private clinics as well. Out of 240 clinics in the district, 89 did not apply for renewal, while 32 submitted incomplete or incorrect documentation. Consequently, the registrations of 121 clinics were cancelled for failing to meet regulatory requirements.
The Health Department has issued strict instructions to all affected institutions. They have been directed not to admit new patients, to discharge existing patients after completing their treatment, and to shut down operations immediately. Authorities have also ordered the removal of signboards from such facilities.
Speaking to the Hitavada, CMHO Dr Navin Kothari stated that any hospital found operating without a valid registration will face strict legal action under the MP Nursing Home Act.
The move is part of a broader effort to enforce regulatory compliance and ensure patient safety.Also Read:Maha Health Minister urges officials to submit Health Policy proposal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/20/328625-hospital-sealed.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jabalpur, Health, Dept, cancels, registration, hospitals, 121, clinics</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/20/328625-hospital-sealed.webp"><p><b>Jabalpur:</b> The Health Department has initiated a major crackdown on<a href="https://medicaldialogues.in/topics/private-practice"> private healthcare </a>facilities in Jabalpur, cancelling the <a href="https://medicaldialogues.in/topics/hospital-registration">registrations </a>of 5 private hospitals and 121 clinics for failing to comply with mandatory renewal norms and directing them to cease operations immediately.  </p><p>Officials said that under existing rules, <a href="https://medicaldialogues.in/topics/private-hospitals">private hospitals </a>and clinics are granted registration for a period of three years, after which annual renewal is mandatory between January and February. Inspections are conducted in March, and renewal is approved only if all prescribed standards and documentation requirements are met.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/pune-37-private-hospitals-get-notices-over-regulatory-violations-162244"><b>Also Read:Pune: 37 Private Hospitals get notices over regulatory violations</b></a></p><p>During the review process, officials identified irregularities among 55 hospitals in the district. Two hospitals had applied for closure, one failed to apply for renewal, another submitted incorrect documents, and one was found without staff during inspection. As a result, the registration of five hospitals was cancelled, and they have been barred from admitting or treating patients.</p><p>Included in the list of cancelled registrations are Batalia Eye Hospital, Namdev Nursing Home, SC Memorial Hospital and Research Centre, Sankalp Hospital, and Government Hospital, reports <a href="https://www.rajexpress.com/en/mp-cgnews/jabalpur-health-department-cancels-registration-5-private-hospitals-121-clinics-closed" rel="nofollow">Raj Express</a>.
</p><p>The crackdown extended to private clinics as well. Out of 240 clinics in the district, 89 did not apply for renewal, while 32 submitted incomplete or incorrect documentation. Consequently, the registrations of 121 clinics were cancelled for failing to meet regulatory requirements.
</p><p>The Health Department has issued strict instructions to all affected institutions. They have been directed not to admit new patients, to discharge existing patients after completing their treatment, and to shut down operations immediately. Authorities have also ordered the removal of signboards from such facilities.
</p><p>Speaking to the <a href="https://www.thehitavada.com/Encyc/2026/4/12/health-deptt-cancels-registrations-of-121-private-clinics-5-private-hospitals-in-distt.html" rel="nofollow">Hitavada</a>, CMHO Dr Navin Kothari stated that any hospital found operating without a valid registration will face strict legal action under the MP Nursing Home Act.
</p><p>The move is part of a broader effort to enforce regulatory compliance and ensure patient safety.</p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/maha-health-minister-urges-officials-to-submit-health-policy-proposal-148661">Also Read:Maha Health Minister urges officials to submit Health Policy proposal</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Hyderabad doctor caught with flip number plate on BMW in drunk driving check</title>
<link>https://edusehat.com/en/hyderabad-doctor-caught-with-flip-number-plate-on-bmw-in-drunk-driving-check</link>
<guid>https://edusehat.com/en/hyderabad-doctor-caught-with-flip-number-plate-on-bmw-in-drunk-driving-check</guid>
<description><![CDATA[ Hyderabad: In a shocking incident, a 30-year-old doctor was caught allegedly driving his high-end car in an &#039;&#039;inebriated&#039;&#039; state and found using a flip mechanism to switch between two number plates, police said on Monday. According to the recent PTI report, the matter came to light on April 10 after the man was found driving &quot;drunk&quot; during a check in Jubilee Hills, and the car, which was seized, was driven to a police station when a constable inadvertently pressed a button near the driver&#039;s seat.After the button was pressed, the police noticed that the number plate on the car flip displayed two different registration numbers, one a Delhi registration and the other a Telangana registration.Also Read:Cooper Hospital: Female intern kicked by intoxicated patient during examinationThe doctor had purchased the high-end car in Delhi but had not changed its registration, an official at Jubilee Hills Police Station said, adding he bought the flip number plate system that could change the car&#039;s number plates online and had installed it on his car around two years ago through a technician in the city.During further investigation, it was revealed that a similar car model and make was registered with the Telangana registration number, which belonged to a relative of the doctor. He was allegedly using both the Delhi and Telangana registration numbers through the flip number plate system on his vehicle, police said.Officials further added that the technician who installed the device will also be questioned as part of the investigation.Based on preliminary investigation, police suspect that the accused resorted to the act to evade road tax, though the exact motive is under investigation.A case was registered against the doctor on charges of impersonation and cheating, besides under the Motor Vehicles Act for drunk driving, and a notice was issued to him, police added. Also Read:AIIMS Bhopal doctors&#039; alleged drunken altercation with police goes viral; probe launched ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/14/341529-drunk-drive.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Hyderabad, doctor, caught, with, flip, number, plate, BMW, drunk, driving, check</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/14/341529-drunk-drive.webp"><div class="pasted-from-word-wrapper"><p><span>Hyderabad: In a shocking incident, a </span><span>30-year-old doctor was caught allegedly driving his high-end car in an ''inebriated'' state and found using a flip mechanism to switch between two number plates,</span> <span>police said on Monday. </span></p><p>According to the recent PTI report, the matter came to light on April 10 after the man was found driving "drunk" during a check in Jubilee Hills, and the car, which was seized, was driven to a police station when a constable inadvertently pressed a button near the driver's seat.</p><p>After the button was pressed, the police noticed that the number plate on the car flip displayed two different registration numbers, one a Delhi registration and the other a Telangana registration.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/cooper-hospital-female-intern-kicked-by-intoxicated-patient-during-examination-162282"><b>Also Read:Cooper Hospital: Female intern kicked by intoxicated patient during examination</b></a></p><p>The doctor had purchased the high-end car in Delhi but had not changed its registration, an official at Jubilee Hills Police Station said, adding he bought the flip number plate system that could change the car's number plates online and had installed it on his car around two years ago through a technician in the city.</p><p>During further investigation, it was revealed that a similar car model and make was registered with the Telangana registration number, which belonged to a relative of the doctor. </p><p>He was allegedly using both the Delhi and Telangana registration numbers through the flip number plate system on his vehicle, police said.</p><p>Officials further added that the technician who installed the device will also be questioned as part of the investigation.</p><p>Based on preliminary investigation, police suspect that the accused resorted to the act to evade road tax, though the exact motive is under investigation.</p><p>A case was registered against the doctor on charges of impersonation and cheating, besides under the Motor Vehicles Act for drunk driving, and a notice was issued to him, police added. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/aiims-bhopal-doctors-alleged-drunken-altercation-with-police-goes-viral-probe-launched-157703"><b>Also Read:AIIMS Bhopal doctors' alleged drunken altercation with police goes viral; probe launched</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Maharashtra expands cashless treatment, covers surgeries above Rs 5 lakh</title>
<link>https://edusehat.com/en/maharashtra-expands-cashless-treatment-covers-surgeries-above-rs-5-lakh</link>
<guid>https://edusehat.com/en/maharashtra-expands-cashless-treatment-covers-surgeries-above-rs-5-lakh</guid>
<description><![CDATA[ Mumbai: The Maharashtra government has expanded the coverage of its public healthcare schemes, announcing that it will now cover the full cost of major surgeries exceeding Rs 5 lakh. The move has been formalised through a Government Resolution issued by the Public Health Department.According to an UNI report, under the expanded framework of the Mahatma Jyotirao Phule Jan Arogya Yojana and the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana, several high-end procedures will now be covered. These include complex surgeries such as heart, liver, and lung transplants, bone marrow transplants, and heart valve implantations, making them accessible to economically weaker sections either free of cost or through full government support.Also Read:Maharashtra, AIIMS Nagpur ink MoU to address rising NCDs in ChildrenThe revised system also simplifies the process for patients. Instead of visiting multiple offices, hospitals will now be responsible for submitting proposals and required documents on behalf of beneficiaries. While the process is currently offline, authorities have indicated plans to shift it to a fully online system to improve efficiency. To qualify for the scheme, applicants must be residents of Maharashtra and furnish essential identification documents, including a ration card and an Aadhaar card. The entire process has been made cashless, ensuring that neither patients nor their families are required to make any payments. Once approved, the funds will be directly transferred to the hospital’s bank account.  To be transparent and speed up approvals, the government has set up dedicated committees. A Medical and Fund Approval Committee will convene every Friday to review and sanction proposals promptly.Public Health Minister Prakash Abitkar said that beneficiaries under both schemes would now be eligible for treatments costing above ₹5 lakh. He emphasised that a structured procedure has been put in place to ensure that no underprivileged patient is denied critical medical care due to financial constraints, reports UNI. Also Read:Mumbai: BMC to launch real-time bed availability dashboard, streamline procurement ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341302-medical-treatment.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Maharashtra, expands, cashless, treatment, covers, surgeries, above, lakh</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341302-medical-treatment.webp"><div class="pasted-from-word-wrapper"><p><span>Mumbai: </span><span>The Maharashtra government has expanded the coverage of its public healthcare schemes, announcing that it will now cover the full cost of major surgeries exceeding Rs 5 lakh. </span></p><p>The move has been formalised through a Government Resolution issued by the Public Health Department.</p><p>According to an UNI report, under the expanded framework of the Mahatma Jyotirao Phule Jan Arogya Yojana and the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana, several high-end procedures will now be covered. These include complex surgeries such as heart, liver, and lung transplants, bone marrow transplants, and heart valve implantations, making them accessible to economically weaker sections either free of cost or through full government support.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/maharashtra-aiims-nagpur-ink-mou-to-address-rising-ncds-in-children-168424"><b>Also Read:Maharashtra, AIIMS Nagpur ink MoU to address rising NCDs in Children</b></a></p><p>The revised system also simplifies the process for patients. Instead of visiting multiple offices, hospitals will now be responsible for submitting proposals and required documents on behalf of beneficiaries. While the process is currently offline, authorities have indicated plans to shift it to a fully online system to improve efficiency. </p><p>To qualify for the scheme, applicants must be residents of Maharashtra and furnish essential identification documents, including a ration card and an Aadhaar card. The entire process has been made cashless, ensuring that neither patients nor their families are required to make any payments. Once approved, the funds will be directly transferred to the hospital’s bank account.  </p><p>To be transparent and speed up approvals, the government has set up dedicated committees. A Medical and Fund Approval Committee will convene every Friday to review and sanction proposals promptly.</p><p>Public Health Minister Prakash Abitkar said that beneficiaries under both schemes would now be eligible for treatments costing above ₹5 lakh. He emphasised that a structured procedure has been put in place to ensure that no underprivileged patient is denied critical medical care due to financial constraints, reports UNI. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/mumbai-bmc-to-launch-real-time-bed-availability-dashboard-streamline-procurement-168414"><b>Also Read:Mumbai: BMC to launch real-time bed availability dashboard, streamline procurement</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Chandigarh allocates 4.8 acres for AYUSH Institute in Sector 48</title>
<link>https://edusehat.com/en/chandigarh-allocates-48-acres-for-ayush-institute-in-sector-48</link>
<guid>https://edusehat.com/en/chandigarh-allocates-48-acres-for-ayush-institute-in-sector-48</guid>
<description><![CDATA[ Chandigarh: The Chandigarh Administration has allocated 4.8 acres of land in Sector-48 for setting up a Government AYUSH Institute, which will function as a Centre of Excellence.  Bharatiya Janata Party (BJP) Chandigarh State President Jitendra Pal Malhotra stated that the long-pending project has finally materialized due to continuous efforts by the party, guidance from the Central Government, and support from the Chandigarh Administration, reports Dailyhunt. The development is being seen as an important move to promote India’s traditional systems of medicine.The proposed institute will focus on education, research, and development in the fields of Ayurveda and Homoeopathy, along with continuous efforts to integrate these traditional systems with modern healthcare practices. Officials believe that this initiative closely aligns with the vision of Prime Minister Narendra Modi to strengthen, promote, and globally expand traditional systems of medicine in a structured and sustainable manner.Also Read:Chandigarh set to expand AYUSH services with hospitals in Sector 34 and 11Malhotra said that the institute will offer affordable AYUSH education at minimal government fees, thereby making it easily accessible to a larger number of students, particularly those belonging to economically weaker sections of society. He further stated that the facility is expected to include advanced and well-equipped research laboratories, specialized training centres, outpatient department (OPD) services, and various public awareness programmes related to traditional medicine and healthcare practices.The project is also expected to significantly enhance Chandigarh’s status as an emerging hub for Ayurveda and Homeopathy education, research, and professional training. It is anticipated that the institute will attract students, researchers, and healthcare professionals not only from the region but also from other parts of the country. The foundation stone of the institute is likely to be laid soon by the Union Health Minister or another senior central government leader. Once completed, the institute is expected to generate new educational and employment opportunities while contributing to the steady growth and development of the AYUSH sector in the country.Also Read:Now, AYUSH Health services at Railway hospitals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341415-ayush-institute.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chandigarh, allocates, 4.8, acres, for, AYUSH, Institute, Sector</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341415-ayush-institute.webp"><div class="pasted-from-word-wrapper"><p>Chandigarh: The Chandigarh Administration has allocated 4.8 acres of land in Sector-48 for setting up a Government <a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a> Institute, which will function as a Centre of Excellence.  </p><p>Bharatiya Janata Party (<a href="https://medicaldialogues.in/topics/BJP" target="_blank">BJP</a>) Chandigarh State President Jitendra Pal Malhotra stated that the long-pending project has finally materialized due to continuous efforts by the party, guidance from the Central Government, and support from the Chandigarh Administration, reports<i> <a href="https://m.dailyhunt.in/news/india/english/hindusthan+samachar+english-epaper-hinsamen/48+acres+of+land+allocated+for+ayush+institute+in+chandigarh-newsid-n708111530" target="_blank">Dailyhunt</a></i>. The development is being seen as an important move to promote India’s traditional systems of medicine.</p><p>The proposed institute will focus on education, research, and development in the fields of Ayurveda and Homoeopathy, along with continuous efforts to integrate these traditional systems with modern healthcare practices. Officials believe that this initiative closely aligns with the vision of Prime Minister Narendra Modi to strengthen, promote, and globally expand traditional systems of medicine in a structured and sustainable manner.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/chandigarh-set-to-expand-ayush-services-with-hospitals-in-sector-34-and-11-168360">Also Read:Chandigarh set to expand AYUSH services with hospitals in Sector 34 and 11</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Malhotra said that the institute will offer affordable AYUSH education at minimal government fees, thereby making it easily accessible to a larger number of students, particularly those belonging to economically weaker sections of society. He further stated that the facility is expected to include advanced and well-equipped research laboratories, specialized training centres, outpatient department (OPD) services, and various public awareness programmes related to traditional medicine and healthcare practices.</p><p>The project is also expected to significantly enhance Chandigarh’s status as an emerging hub for Ayurveda and Homeopathy education, research, and professional training. It is anticipated that the institute will attract students, researchers, and healthcare professionals not only from the region but also from other parts of the country. </p><p>The foundation stone of the institute is likely to be laid soon by the Union Health Minister or another senior central government leader. Once completed, the institute is expected to generate new educational and employment opportunities while contributing to the steady growth and development of the AYUSH sector in the country.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/now-ayush-health-services-at-railway-hospitals">Also Read:Now, AYUSH Health services at Railway hospitals</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Baramati doctor duped of Rs 92.5 lakh after bank accounts hacked</title>
<link>https://edusehat.com/en/baramati-doctor-duped-of-rs-925-lakh-after-bank-accounts-hacked</link>
<guid>https://edusehat.com/en/baramati-doctor-duped-of-rs-925-lakh-after-bank-accounts-hacked</guid>
<description><![CDATA[ Pune: In a shocking cyber fraud case, fraudsters allegedly siphoned off Rs 92.5 lakh from a doctor cum General Manager of a hospital in Baramati, Maharashtra, by hacking into two bank accounts on April 6.   Following the incident, the victim lodged a complaint with the Baramati City Police. According to the complaint, on April 6, he discovered that ₹48 lakh had been transferred from the hospital&#039;s private bank account, and ₹44.5 lakh had been transferred from his savings bank account on the same day.  Also Read: Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case   When the hospital manager inquired at the bank, they discovered that the amount had been transferred to an account at a private bank in Ranchi, Jharkhand.Additionally, upon examining the bank statements, it was found that ₹44.5 lakh had been transferred from the medical practitioner&#039;s bank account through four transactions, and ₹48 lakh from the hospital&#039;s bank account through three transactions.   However, the doctor or hospital officials were unaware of how the money had been transferred, according to TOI.  Therefore, based on the complaint, an officer from the Baramati City Police stated that an investigation into this matter is currently underway to determine how exactly the fraudsters gained access to these bank accounts.   &quot;We have launched an investigation into the case. We have also sought the details of the transactions from the bank,&quot; the officer said.  Medical Dialogues had recently reported that a former student of Gajra Raja Medical College has alleged that MBBS degrees were issued to some candidates in exchange for Rs 16 lakh, despite them not appearing for examinations, not meeting academic criteria, and being previously expelled in connection with the Vyapam scam.   Also Read: Rs 16 lakh for MBBS degrees? Vyapam-linked fraud alleged at Gwalior&#039;s medical college ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341313-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 14:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Baramati, doctor, duped, 92.5, lakh, after, bank, accounts, hacked</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341313-fraud.webp"><p><b>Pune:</b> In a shocking cyber fraud case, fraudsters allegedly siphoned off Rs 92.5 lakh from a doctor cum General Manager of a hospital in Baramati, Maharashtra, by hacking into two bank accounts on April 6.   </p><div class="pasted-from-word-wrapper"><p dir="ltr">Following the incident, the victim lodged a complaint with the Baramati City Police. According to the complaint, on April 6, he discovered that ₹48 lakh had been transferred from the hospital's private bank account, and ₹44.5 lakh had been transferred from his savings bank account on the same day.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case-168444"><b>Also Read: </b>Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case</a>   </div><div class="pasted-from-word-wrapper"><p dir="ltr">When the hospital manager inquired at the bank, they discovered that the amount had been transferred to an account at a private bank in Ranchi, Jharkhand.</p><p dir="ltr">Additionally, upon examining the bank statements, it was found that ₹44.5 lakh had been transferred from the medical practitioner's bank account through four transactions, and ₹48 lakh from the hospital's bank account through three transactions.   </p><p dir="ltr">However, the doctor or hospital officials were unaware of how the money had been transferred, according to <a href="https://timesofindia.indiatimes.com/city/pune/crooks-siphon-off-93l-from-baramati-based-medical-practitioners-accounts/articleshow/130219185.cms" target="_blank" rel="nofollow">TOI</a>.  </p><p dir="ltr">Therefore, based on the complaint, an officer from the Baramati City Police stated that an investigation into this matter is currently underway to determine how exactly the fraudsters gained access to these bank accounts.   </p><p dir="ltr">"We have launched an investigation into the case. We have also sought the details of the transactions from the bank," the officer said.  </p><p dir="ltr">Medical Dialogues had recently reported that a former student of <a href="https://medicaldialogues.in/topics/gajra-raja-medical-college" target="_blank">Gajra Raja Medical College</a> has alleged that <a href="https://medicaldialogues.in/topics/mbbs-degree" target="_blank">MBBS degrees</a> were issued to some candidates in exchange for Rs 16 lakh, despite them not appearing for examinations, not meeting academic criteria, and being previously expelled in connection with the Vyapam scam.   </p></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/madhya-pradesh/rs-16-lakh-for-mbbs-degrees-vyapam-linked-fraud-alleged-at-gwaliors-medical-college-168432"><b>Also Read: </b>Rs 16 lakh for MBBS degrees? Vyapam-linked fraud alleged at Gwalior's medical college</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Diabetes Literacy Gap: Only 26 Percent of Patients Aware of Long&#45;Term Risks, Study</title>
<link>https://edusehat.com/en/diabetes-literacy-gap-only-26-percent-of-patients-aware-of-long-term-risks-study</link>
<guid>https://edusehat.com/en/diabetes-literacy-gap-only-26-percent-of-patients-aware-of-long-term-risks-study</guid>
<description><![CDATA[ A recent study published in the Journal of Pharmacy and Bioallied Sciences in December 2025 highlights a significant gap in patient literacy concerning Type 2 Diabetes Mellitus (T2DM) and its systemic risks, with a low mean awareness score of 4.38 ± 1.84 and the discovery that only 26.67% of individuals recognize the threat of chronic complications (the eyes, kidneys, and heart).As India confronts a staggering 11.4% prevalence of diabetes mellitus (DM) and a global projection of 350 million cases by 2030, a profound clinical gap persists where nearly a quarter of patients remain undiagnosed and many more lack the necessary awareness to manage the disease effectively. To address this lack of knowledge, Dr. Abhivyakti Solanki from the Department of General Medicine at Maharaja Agrasen Medical College, along with colleagues, initiated this research to evaluate the level of awareness regarding Type 2 Diabetes Mellitus (T2DM) and its multisystem complications within a tertiary care setting in North India.Therefore, the hospital-based cross-sectional study was conducted over a twelve-month period between December 2022 and November 2023 at Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences (Pt. B.D. Sharma PGIMS) in Rohtak. The investigation involved 300 adult patients who had been receiving treatment for T2DM for at least one year, utilizing a native-language questionnaire to assess knowledge across various clinical domains while excluding pregnant women, minors, and individuals with mental disabilities. Researchers employed Microsoft Excel for data organization and utilized statistical tools such as the independent t-test and analysis of variance (ANOVA) to determine the significance of variables.Key Clinical Findings of the research Include:Etiological Knowledge: The study found that while a high proportion of 93.67% recognized the underlying causes of their condition, this basic understanding did not extend to the recognition of long-term health risks.Complication Awareness: Only 26.67% of the cohort understood that the disease could lead to further complications, highlighting a significant educational void regarding the systemic nature of the illness.Gender Disparity: A significant difference in literacy was observed between genders, with male patients achieving a higher mean awareness score of 4.95 ± 1.81 compared to 3.56 ± 1.58 for females, a finding the study attributed to potentially higher levels of social interaction among men.Socioeconomic Factors: Statistical analysis revealed that higher educational attainment and active employment were significantly linked to better knowledge scores, whereas age and the duration of the disease showed no such correlation.Organ-Specific Risks: Recognition of specific damage was alarmingly low, as the study noted that only 11.67% were aware of eye complications, 12.33% knew of foot problems, and a mere 5% and 6% identified kidney and heart risks, respectively.The results suggest that overall awareness remains suboptimal at 54.71%, with more than 43% of the participants failing to demonstrate even basic knowledge of the disease. These findings indicate that medical professionals should prioritize comprehensive patient education during consultations to bridge the knowledge gap and improve self-care.The primary limitation of this research was its cross-sectional design, which prevented long-term follow-up of patient outcomes, and there is a recognized need for future investigations to account for the impact of different primary consultation settings on patient literacy.ReferenceSingh J, Solanki A, Raidass S. A cross-sectional study of awareness about diabetes mellitus and its complications among Indian patients with type 2 diabetes mellitus. J Pharm Bioall Sci 2025;17:S2980-2. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340797-diabetes-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 10:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Diabetes, Literacy, Gap:, Only, Percent, Patients, Aware, Long-Term, Risks, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340797-diabetes-3.webp"><p>A recent study published in the <i>Journal of Pharmacy and Bioallied Sciences</i> in December 2025 highlights a significant gap in patient literacy concerning <a href="https://medicaldialogues.in/diabetes-endocrinology/perspective/uncontrolled-t2dm-in-india-and-application-of-trusted-molecules-empagliflozin-sitagliptin-and-metformin-coming-together-dr-sunil-m-jain-160331">Type 2 Diabetes Mellitus</a> (T2DM) and its systemic risks, with a low mean awareness score of 4.38 ± 1.84 and the discovery that only 26.67% of individuals recognize the threat of chronic complications (the eyes, kidneys, and heart).</p><div class="pasted-from-word-wrapper"><p dir="ltr">As India confronts a staggering 11.4% prevalence of <a href="https://medicaldialogues.in/medical-courses/dm-clinical-haematology-admissions-medical-colleges-fees-eligibility-criteria-details-107901">diabetes mellitus</a> (DM) and a global projection of 350 million cases by 2030, a profound clinical gap persists where nearly a quarter of patients remain undiagnosed and many more lack the necessary awareness to manage the disease effectively. To address this lack of knowledge, Dr. Abhivyakti Solanki from the <i>Department of General Medicine at Maharaja Agrasen Medical College,</i> along with colleagues, initiated this research to evaluate the level of awareness regarding Type 2 Diabetes Mellitus (T2DM) and its multisystem complications within a tertiary care setting in North India.</p><p dir="ltr">Therefore, the hospital-based cross-sectional study was conducted over a twelve-month period between December 2022 and November 2023 at Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences (Pt. B.D. Sharma PGIMS) in Rohtak. The investigation involved 300 adult patients who had been receiving treatment for T2DM for at least one year, utilizing a native-language questionnaire to assess knowledge across various clinical domains while excluding pregnant women, minors, and individuals with mental disabilities. Researchers employed Microsoft Excel for data organization and utilized statistical tools such as the independent t-test and analysis of variance (ANOVA) to determine the significance of variables.</p><p dir="ltr"><b>Key Clinical Findings of the research Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Etiological Knowledge: </b>The study found that while a high proportion of 93.67% recognized the underlying causes of their condition, this basic understanding did not extend to the recognition of long-term health risks.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Complication Awareness:</b> Only 26.67% of the cohort understood that the disease could lead to further complications, highlighting a significant educational void regarding the systemic nature of the illness.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Gender Disparity: </b>A significant difference in literacy was observed between genders, with male patients achieving a higher mean awareness score of 4.95 ± 1.81 compared to 3.56 ± 1.58 for females, a finding the study attributed to potentially higher levels of social interaction among men.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Socioeconomic Factors:</b> Statistical analysis revealed that higher educational attainment and active employment were significantly linked to better knowledge scores, whereas age and the duration of the disease showed no such correlation.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Organ-Specific Risks:</b> Recognition of specific damage was alarmingly low, as the study noted that only 11.67% were aware of <a href="https://medicaldialogues.in/health-dialogues/caring-for-your-vision-simple-habits-for-healthy-eyes-dr-dinshaw-dastoor-118713">eye</a> complications, 12.33% knew of foot problems, and a mere 5% and 6% identified kidney and heart risks, respectively.</p></li></ul><p dir="ltr">The results suggest that overall awareness remains suboptimal at 54.71%, with more than 43% of the participants failing to demonstrate even basic knowledge of the disease. </p><p dir="ltr">These findings indicate that medical professionals should prioritize comprehensive patient education during consultations to bridge the knowledge gap and improve self-care.</p><p dir="ltr">The primary limitation of this research was its cross-sectional design, which prevented long-term follow-up of patient outcomes, and there is a recognized need for future investigations to account for the impact of different primary consultation settings on patient literacy.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Singh J, Solanki A, Raidass S. A cross-sectional study of awareness about diabetes mellitus and its complications among Indian patients with type 2 diabetes mellitus. J Pharm Bioall Sci 2025;17:S2980-2.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Patna HC Grants Bail in NDPS Case, Says Phenothiazine, Promethazine Not Covered Under Law</title>
<link>https://edusehat.com/en/patna-hc-grants-bail-in-ndps-case-says-phenothiazine-promethazine-not-covered-under-law</link>
<guid>https://edusehat.com/en/patna-hc-grants-bail-in-ndps-case-says-phenothiazine-promethazine-not-covered-under-law</guid>
<description><![CDATA[ New Delhi: In a significant ruling, the Patna High Court granted bail to three appellants convicted under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, observing that the seized substances, later identified as Phenothiazine and Promethazine, do not fall within the ambit of narcotic drugs or psychotropic substances under the law.The judgment was delivered by a Division Bench comprising Justice Mohit Kumar Shah and Justice Arun Kumar Jha while hearing Criminal Appeal (DB) Nos. 285, 291, and 657 of 2025 filed by Vijay Kumar, Dharmendra Kumar, and Ravindra Kumar against the State of Bihar.The case stems from an incident dated June 26, 2022, when police officials on patrol in Bodh Gaya received information about three individuals transporting heroin on motorcycles. Acting on the tip-off, the police intercepted the accused near a hotel on NH-83. Upon search conducted in the presence of a Magistrate, the police recovered over 2 kg of a suspected heroin-like substance from the appellants along with mobile phones and motorcycles. A case was subsequently registered under Sections 8, 21(c), 25, and 29 of the NDPS Act, and after investigation and trial, the appellants were convicted and sentenced to 15 years of rigorous imprisonment along with a fine of Rs. 1.5 lakh.Also Read: Delhi Tramadol Premix Interception Leads Police to Illegal Drug Unit in BiharCounsel for the appellants, Ajay Kumar Thakur, challenged the conviction, arguing that the Forensic Science Laboratory (FSL) report clearly indicated that the seized substance was “Phenothiazine along with Promethazine,” which are neither classified as narcotic drugs nor psychotropic substances under the NDPS Act. It was further contended that these substances are covered under the Drugs and Cosmetics Act, 1940, appearing in Schedule H and Schedule G of the Drugs Rules, 1945, and are commonly used in medicines for their antihistamine and antipsychotic properties.The counsel emphasized that since these substances are not listed in the Schedule of the NDPS Act nor notified by the Central Government, the conviction under NDPS provisions is legally unsustainable. Reliance was also placed on previous cases where similar substances were held not to fall under the NDPS Act.On the other hand, the State of Bihar, represented by APP Shashi Bala Verma, conceded that the substances were not listed under the NDPS Act but argued that they are commonly used as “cutting agents” in narcotics to enhance bulk, reduce purity, and modify pharmacological effects. The State contended that the NDPS Act should be interpreted broadly to curb drug trafficking and that a narrow interpretation would defeat the object of the legislation.After examining the submissions and the statutory framework, the Court observed in detail that Phenothiazine and Promethazine are not included in the list of narcotic drugs or psychotropic substances under the NDPS Act or its Schedule. The Court further noted that although these substances are regulated under the Drugs and Cosmetics Act, violations relating to them are punishable under that Act and not under the NDPS Act. The Bench also referred to legal precedents and clarified that offenses under the Drugs and Cosmetics Act cannot be prosecuted through police FIRs but require complaints by authorized Drug Inspectors.The Court concluded that the conviction of the appellants under the NDPS Act appeared prima facie unsustainable, observing that the substances recovered do not meet the statutory definition required for such offenses.In the final judgement, the court held,&quot;Accordingly, we direct suspension of order of sentence dated 08.01.2025 qua the appellants above-named as also direct to release them on bail, during the pendency of their respective appeals, on furnishing bail bonds of Rs.10,000/-(Ten Thousand) each with two sureties of the like amount each to the satisfaction of learned Additional Sessions Judge-II-cum-the Special Judge (NDPS Act), Gaya, in connection with NDPS Case No. 39/2022, arising out of Bodh Gaya P.S. Case No. 379 of 2022.&quot;To view the official order, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/13/nsmyodujmjaynsmxnino-ak1-ve25pppathc-1775612-341470.pdfAlso Read: Codeine Cough Syrup Prices Hit Rs 1,000 in MP After Crackdown Disrupts Illegal Trade ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/03/325212-patna-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 14 Apr 2026 03:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patna, Grants, Bail, NDPS, Case, Says, Phenothiazine, Promethazine, Not, Covered, Under, Law</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/03/325212-patna-high-court.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> In a significant ruling, the Patna High Court granted bail to three appellants convicted under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, observing that the seized substances, later identified as Phenothiazine and Promethazine, do not fall within the ambit of narcotic drugs or psychotropic substances under the law.</p></div><div class="pasted-from-word-wrapper"><p>The judgment was delivered by a Division Bench comprising Justice Mohit Kumar Shah and Justice Arun Kumar Jha while hearing Criminal Appeal (DB) Nos. 285, 291, and 657 of 2025 filed by Vijay Kumar, Dharmendra Kumar, and Ravindra Kumar against the State of Bihar.</p><p>The case stems from an incident dated June 26, 2022, when police officials on patrol in Bodh Gaya received information about three individuals transporting heroin on motorcycles. Acting on the tip-off, the police intercepted the accused near a hotel on NH-83. Upon search conducted in the presence of a Magistrate, the police recovered over 2 kg of a suspected heroin-like substance from the appellants along with mobile phones and motorcycles. A case was subsequently registered under Sections 8, 21(c), 25, and 29 of the NDPS Act, and after investigation and trial, the appellants were convicted and sentenced to 15 years of rigorous imprisonment along with a fine of Rs. 1.5 lakh.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/delhi-tramadol-premix-interception-leads-police-to-illegal-drug-unit-in-bihar-166240">Also Read: Delhi Tramadol Premix Interception Leads Police to Illegal Drug Unit in Bihar</a></div><p>Counsel for the appellants, Ajay Kumar Thakur, challenged the conviction, arguing that the Forensic Science Laboratory (FSL) report clearly indicated that the seized substance was “Phenothiazine along with Promethazine,” which are neither classified as narcotic drugs nor psychotropic substances under the NDPS Act. It was further contended that these substances are covered under the Drugs and Cosmetics Act, 1940, appearing in Schedule H and Schedule G of the Drugs Rules, 1945, and are commonly used in medicines for their antihistamine and antipsychotic properties.</p><p>The counsel emphasized that since these substances are not listed in the Schedule of the NDPS Act nor notified by the Central Government, the conviction under NDPS provisions is legally unsustainable. Reliance was also placed on previous cases where similar substances were held not to fall under the NDPS Act.</p><p>On the other hand, the State of Bihar, represented by APP Shashi Bala Verma, conceded that the substances were not listed under the NDPS Act but argued that they are commonly used as “cutting agents” in narcotics to enhance bulk, reduce purity, and modify pharmacological effects. The State contended that the NDPS Act should be interpreted broadly to curb drug trafficking and that a narrow interpretation would defeat the object of the legislation.</p><p>After examining the submissions and the statutory framework, the Court observed in detail that Phenothiazine and Promethazine are not included in the list of narcotic drugs or psychotropic substances under the NDPS Act or its Schedule. The Court further noted that although these substances are regulated under the Drugs and Cosmetics Act, violations relating to them are punishable under that Act and not under the NDPS Act. The Bench also referred to legal precedents and clarified that offenses under the Drugs and Cosmetics Act cannot be prosecuted through police FIRs but require complaints by authorized Drug Inspectors.</p><p>The Court concluded that the conviction of the appellants under the NDPS Act appeared prima facie unsustainable, observing that the substances recovered do not meet the statutory definition required for such offenses.</p><p>In the final judgement, the court held,</p><p>"Accordingly, we direct suspension of order of sentence dated 08.01.2025 qua the appellants above-named as also direct to release them on bail, during the pendency of their respective appeals, on furnishing bail bonds of Rs.10,000/-(Ten Thousand) each with two sureties of the like amount each to the satisfaction of learned Additional Sessions Judge-II-cum-the Special Judge (NDPS Act), Gaya, in connection with NDPS Case No. 39/2022, arising out of Bodh Gaya P.S. Case No. 379 of 2022."</p><p><b><i>To view the official order, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/13/nsmyodujmjaynsmxnino-ak1-ve25pppathc-1775612-341470.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/13/nsmyodujmjaynsmxnino-ak1-ve25pppathc-1775612-341470.pdf</a></div><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/codeine-cough-syrup-prices-hit-rs-1000-in-mp-after-crackdown-disrupts-illegal-trade-168565">Also Read: Codeine Cough Syrup Prices Hit Rs 1,000 in MP After Crackdown Disrupts Illegal Trade</a></p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Electroconvulsive Therapy: Cornerstone of Indian Psychiatry, Systematic Review</title>
<link>https://edusehat.com/en/electroconvulsive-therapy-cornerstone-of-indian-psychiatry-systematic-review</link>
<guid>https://edusehat.com/en/electroconvulsive-therapy-cornerstone-of-indian-psychiatry-systematic-review</guid>
<description><![CDATA[ A recent systematic review published in the Indian Journal of Psychiatry in March 2026 reveals that Electroconvulsive Therapy (ECT) remains a high-performance cornerstone of psychiatric care, demonstrating robust efficacy across schizophrenia and depression while confirming that neurocognitive side effects are overwhelmingly transient.Although ECT is recognized as one of the most powerful tools in psychiatry, its global use is paradoxically declining due to procedural variability and enduring social stigma. Previous research in India has been extensive but historically fragmented across five decades, leading Harsh Pathak and colleagues from the National Institute of Mental Health and Neurosciences (NIMHANS) and Fortis Hospitals to conduct this review to bridge the clinical gap and systematically map the diverse landscape of national literature.Therefore, the scoping review utilized the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) framework to evaluate literature across four major global databases and multiple Indian psychiatric journals up to August 2025. The authors examined a wide range of study designs focused on efficacy and procedural parameters, excluding animal research and non-original commentaries to ensure a clinical focus on primary and secondary outcomes related to patient safety and treatment response.Key Clinical Findings of the Study Include:Clinical Success: The evidence highlights that treatment remains a high-yield intervention, particularly in bipolar disorder, where response rates were observed in approximately 90% of patients.Technical Optimization: Comparative data on electrode placement suggests bitemporal methods may be less effective than bifrontal approaches, which achieved a 95% response rate compared to 79% in specific clinical trials.Neurocognitive Recovery: Safety investigations provide reassurance that while acute memory issues may occur, these deficits are generally transient and tend to resolve entirely within roughly three months.Anesthetic Stability: Research into modern induction agents has identified that etomidate and propofol can effectively optimize seizure duration and maintain cardiovascular stability during the procedure.Perception Improvement: Findings indicate that knowledge gaps and social stigma can be successfully mitigated through targeted educational modules lasting just 15 to 60 minutes.The results suggest that Indian research has significantly matured, moving from early efficacy trials to complex inquiries into neurobiology and procedural safety involving a diverse methodological base. The synthesized data confirms that modified treatment, when supported by modern anesthesia and precise stimulus dosing, offers a favorable risk-benefit profile for severe mental illnesses.These findings imply that clinicians should actively integrate structured cognitive monitoring and brief educational interventions into routine practice to optimize patient outcomes and reduce the barriers to treatment acceptance.A limitation of the current evidence base is the scarcity of long-term follow-up data regarding cost-effectiveness and relapse patterns, highlighting a mild need for future qualitative research into patient lived experiences and comparative studies with magnetic seizure therapy (MST) to further refine neuromodulation standards.ReferencePathak H, Baliga SP, Shibu A, Thirthalli J. Electroconvulsive therapy research in India: A scoping review. Indian J Psychiatry 2026;68:218-54. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/30/239685-bipolar-depression-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Electroconvulsive, Therapy:, Cornerstone, Indian, Psychiatry, Systematic, Review</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/30/239685-bipolar-depression-50.webp"><p>A recent systematic review published in the <i>Indian Journal of Psychiatry</i> in March 2026 reveals tha<a href="https://medicaldialogues.in/psychiatry/news/electroconvulsive-therapy-safe-for-treatment-of-mental-conditions-suggests-large-scale-study-84942">t Electroconvulsive Therapy</a> (ECT) remains a high-performance cornerstone of psychiatric care, demonstrating robust efficacy across <a href="https://medicaldialogues.in/mdtv/psychiatry/videos/link-between-schizophrenia-and-vascular-alterations-in-the-brain-uncovered-in-study-105980">schizophrenia</a> and <a href="https://speciality.medicaldialogues.in/non-surgical-brain-stimulation-an-alternative-treatment-for-severe-depression">depression</a> while confirming that neurocognitive side effects are overwhelmingly transient.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Although ECT is recognized as one of the most powerful tools in psychiatry, its global use is paradoxically declining due to procedural variability and enduring social stigma. Previous research in India has been extensive but historically fragmented across five decades, leading Harsh Pathak and colleagues from the <i>National Institute of Mental Health and Neurosciences (NIMHANS) and Fortis Hospitals</i> to conduct this review to bridge the clinical gap and systematically map the diverse landscape of national literature.</p><p dir="ltr">Therefore, the scoping review utilized the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) framework to evaluate literature across four major global databases and multiple Indian psychiatric journals up to August 2025. The authors examined a wide range of study designs focused on efficacy and procedural parameters, excluding animal research and non-original commentaries to ensure a clinical focus on primary and secondary outcomes related to patient safety and treatment response.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Clinical Success: </b>The evidence highlights that treatment remains a high-yield intervention, particularly in bipolar disorder, where response rates were observed in approximately 90% of patients.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Technical Optimization:</b> Comparative data on electrode placement suggests bitemporal methods may be less effective than bifrontal approaches, which achieved a 95% response rate compared to 79% in specific clinical trials.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Neurocognitive Recovery:</b> Safety investigations provide reassurance that while acute memory issues may occur, these deficits are generally transient and tend to resolve entirely within roughly three months.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Anesthetic Stability:</b> Research into modern induction agents has identified that etomidate and propofol can effectively optimize seizure duration and maintain cardiovascular stability during the procedure.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Perception Improvement:</b> Findings indicate that knowledge gaps and social stigma can be successfully mitigated through targeted educational modules lasting just 15 to 60 minutes.</p></li></ul><p dir="ltr">The results suggest that Indian research has significantly matured, moving from early efficacy trials to complex inquiries into neurobiology and procedural safety involving a diverse methodological base. The synthesized data confirms that modified treatment, when supported by modern anesthesia and precise stimulus dosing, offers a favorable risk-benefit profile for severe mental illnesses.</p><p dir="ltr">These findings imply that clinicians should actively integrate structured cognitive monitoring and brief educational interventions into routine practice to optimize patient outcomes and reduce the barriers to treatment acceptance.</p><p dir="ltr">A limitation of the current evidence base is the scarcity of long-term follow-up data regarding cost-effectiveness and relapse patterns, highlighting a mild need for future qualitative research into patient lived experiences and comparative studies with magnetic seizure therapy (MST) to further refine neuromodulation standards.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Pathak H, Baliga SP, Shibu A, Thirthalli J. Electroconvulsive therapy research in India: A scoping review. Indian J Psychiatry 2026;68:218-54.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Serum Neurofilament Light Chain useful CV Risk Biomarker in AF,  Suggests Research</title>
<link>https://edusehat.com/en/serum-neurofilament-light-chain-useful-cv-risk-biomarker-in-af-suggests-research</link>
<guid>https://edusehat.com/en/serum-neurofilament-light-chain-useful-cv-risk-biomarker-in-af-suggests-research</guid>
<description><![CDATA[ Researchers have found in a new study that higher serum neurofilament light chain (sNfL) levels were significantly associated with an increased risk of adverse cardiovascular events and mortality in patients with atrial fibrillation. These findings suggest that serum neurofilament light chain may serve as a useful biomarker for predicting cardiovascular risk in this population.These findings are published in JAMA Cardiology in March 2026.Atrial fibrillation (AF) remains a significant driver of adverse cardiovascular outcomes, and while previous research linked neurofilament levels to subclinical neurological damage, a clinical gap persisted regarding its predictive value in modern populations receiving contemporary anticoagulation therapy; consequently, Geethan Baskaran and associates from the Swiss Atrial Fibrillation Cohort (SWISS-AF) aimed to determine if this biomarker could provide novel insights into systemic vascular risk beyond traditional cardiac factors.The Swiss Atrial Fibrillation Cohort (SWISS-AF) conducted a prospective, multicenter, observational analysis of 2,311 patients across 14 Swiss secondary and tertiary care centers over a median 8-year follow-up period to evaluate how serum neurofilament light chain relates to primary outcomes like major vascular events (MVEs)—a composite of cardiovascular death, nonfatal stroke, and nonfatal myocardial infarction. The study excluded individuals lacking baseline blood samples or follow-up data and assessed secondary endpoints including heart failure hospitalizations and all-cause mortality using multivariable Cox regression models adjusted for various clinical comorbidities.Key Clinical Findings of the Study Include:Primary Event Risk: The analysis demonstrated that healthcare providers should observe a 35% increase in major vascular events for each doubling of the biomarker concentration (adjusted hazard ratio [aHR], 1.35; 95% CI, 1.22-1.50).Stroke Risk Prediction: The investigation found that elevated baseline concentrations were associated with a 31% higher hazard of nonfatal stroke (aHR, 1.31; 95% CI, 1.09-1.57).Mortality Hazard Assessment: The research highlighted that increasing levels were tied to a 41% rise in all-cause mortality (aHR, 1.41; 95% CI, 1.27-1.56).Heart Failure Hospitalization: The study revealed that doubling the marker concentration correlated with a 25% higher risk of heart failure-related admissions (aHR, 1.25; 95% CI, 1.11-1.41).Cardiovascular Death Indicators: The finding indicated that every doubling of the biomarker was linked to a 36% increased risk of cardiovascular-related death (aHR, 1.36; 95% CI, 1.20-1.54).The results suggest that increasing levels of serum neurofilament light chain are independently associated with a broad array of negative cardiovascular outcomes, including a 35% higher hazard for major vascular events per concentration doubling and significantly increased all-cause mortality in patients with atrial fibrillation.Thus, the study concludes clinicians may find this neuronal damage marker useful for refining the identification of patients at high cardiovascular risk beyond what traditional cardiac risk factors currently provide.While the investigation was limited by its observational nature and a lack of racial diversity within the Swiss cohort, future research could explore the underlying mechanistic pathways and the potential for biomarker-guided treatment strategies to enhance long-term patient care.ReferenceBaskaran G, Krisai P, Kühne M, et al. Serum neurofilament light chain and cardiovascular outcomes in patients with atrial fibrillation. JAMA Cardiol. Published online March 29, 2026. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/05/296838-atrial-fibrillation-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Serum, Neurofilament, Light, Chain, useful, Risk, Biomarker, AF, Suggests, Research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/05/296838-atrial-fibrillation-2.webp"><p>Researchers have found in a new study that higher <a href="https://medicaldialogues.in/neurology-neurosurgery/news/nfl-a-new-serum-biomarker-may-help-diagnose-mild-cognitive-decline-in-elderly-study-81500">serum neurofilament light chain </a>(sNfL) levels were significantly associated with an increased risk of adverse cardiovascular events and mortality in patients with <a href="https://medicaldialogues.in/cardiology-ctvs/news/atrial-fibrillation-linked-to-fourfold-rise-in-cardiac-arrest-risk-among-hfpef-patients-study-shows-149598">atrial fibrillation</a>. These findings suggest that serum neurofilament light chain may serve as a useful biomarker for predicting cardiovascular risk in this population.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings are published in <i>JAMA Cardiology</i> in March 2026.</p><p dir="ltr">Atrial fibrillation (AF) remains a significant driver of adverse cardiovascular outcomes, and while previous research linked neurofilament levels to subclinical neurological damage, a clinical gap persisted regarding its predictive value in modern populations receiving contemporary anticoagulation therapy; consequently, Geethan Baskaran and associates from the <i>Swiss Atrial Fibrillation Cohort (SWISS-AF)</i> aimed to determine if this biomarker could provide novel insights into systemic vascular risk beyond traditional cardiac factors.</p><p dir="ltr">The Swiss Atrial Fibrillation Cohort (SWISS-AF) conducted a prospective, multicenter, observational analysis of 2,311 patients across 14 Swiss secondary and tertiary care centers over a median 8-year follow-up period to evaluate how serum neurofilament light chain relates to primary outcomes like major vascular events (MVEs)—a composite of cardiovascular death, nonfatal stroke, and nonfatal myocardial infarction. The study excluded individuals lacking baseline blood samples or follow-up data and assessed secondary endpoints including heart failure hospitalizations and all-cause mortality using multivariable Cox regression models adjusted for various clinical comorbidities.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Primary Event Risk: </b>The analysis demonstrated that healthcare providers should observe a 35% increase in major vascular events for each doubling of the biomarker concentration (adjusted hazard ratio [aHR], 1.35; 95% CI, 1.22-1.50).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Stroke Risk Prediction: </b>The investigation found that elevated baseline concentrations were associated with a 31% higher hazard of <a href="https://medicaldialogues.in/cardiology-ctvs/perspective/aspirin-in-primary-prevention-of-stroke-review-of-evidence-through-the-needs-of-indian-clinical-settings-dr-rahul-r-patil-151245">nonfatal stroke</a> (aHR, 1.31; 95% CI, 1.09-1.57).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Mortality Hazard Assessment:</b> The research highlighted that increasing levels were tied to a 41% rise in all-cause mortality (aHR, 1.41; 95% CI, 1.27-1.56).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Heart Failure Hospitalization: </b>The study revealed that doubling the marker concentration correlated with a 25% higher risk of heart failure-related admissions (aHR, 1.25; 95% CI, 1.11-1.41).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Cardiovascular Death Indicators: </b>The finding indicated that every doubling of the biomarker was linked to a 36% increased risk of cardiovascular-related death (aHR, 1.36; 95% CI, 1.20-1.54).</p></li></ul><p dir="ltr">The results suggest that increasing levels of serum neurofilament light chain are independently associated with a broad array of negative cardiovascular outcomes, including a 35% higher hazard for major vascular events per concentration doubling and significantly increased all-cause mortality in patients with atrial fibrillation.</p><p dir="ltr">Thus, the study concludes clinicians may find this neuronal damage marker useful for refining the identification of patients at high cardiovascular risk beyond what traditional cardiac risk factors currently provide.</p><p dir="ltr">While the investigation was limited by its observational nature and a lack of racial diversity within the Swiss cohort, future research could explore the underlying mechanistic pathways and the potential for biomarker-guided treatment strategies to enhance long-term patient care.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Baskaran G, Krisai P, Kühne M, et al. Serum neurofilament light chain and cardiovascular outcomes in patients with atrial fibrillation. JAMA Cardiol. Published online March 29, 2026.</p></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Why Ovaries May Stop Working Early: Insights from a Major Research Review</title>
<link>https://edusehat.com/en/why-ovaries-may-stop-working-early-insights-from-a-major-research-review</link>
<guid>https://edusehat.com/en/why-ovaries-may-stop-working-early-insights-from-a-major-research-review</guid>
<description><![CDATA[ Premature ovarian insufficiency (POI) is a life-changing condition affecting women under 40, marked by diminished ovarian function, irregular menstruation, and early infertility. While the causes of POI are diverse and often mysterious, a recent systematic review and meta-analysis published in the Journal of Obstetrics and Gynaecology sheds new light on the modifiable and non-modifiable factors that elevate risk, offering hope for prevention and early intervention.
The diagnostic criteria for POI are amenorrhoea or oligomenorrhea lasting at least 4months and elevated follicle-stimulating hormone (FSH) levels exceeding 25U/L on two separate tests, spaced 4weeks apart. The global incidence of POI is reported to range from 1% to 4%, with a prevalence of 3.7%.
The meta-analysis included participants who were patients with disorders related to ovarian function decline, such as premature ovarian failure, POI, or diminished ovarian reserve.
The metaanalysis included a total of 38 studies. All included studies were case-control studies. A total of 4,968 cases and 5,158 control subjects were involved across the studies. The results as reflected by the given systematic review and meta‐analysis showed the following:
The findings reveal a multifactorial etiology, with both lifestyle and hereditary elements playing substantial roles:
1.	Lifestyle Hazards:
o	Chemical Exposure &amp; Hair Dyeing: Regular exposure to chemicals, especially in certain professions (e.g., hairdressing), and frequent hair dye use significantly increased POI risk (OR up to 4.7).
o	Smoking &amp; Sleep Deprivation: Both active and passive smoking, along with chronic sleep deprivation (less than 6 hours per night), were found to nearly triple or quadruple the risk.
o	Negative Emotional States: Type A personalities, chronic stress, and persistent bad moods were among the strongest predictors, with Type A behavior increasing risk sixfold.
2.	Medical and Surgical Histories:
o	Family History &amp; Infections: Women with a family history of POI were four times more likely to develop the condition. A history of mumps, particularly in childhood, was also a strong risk factor.
o	Gynecological Surgeries &amp; Abortions: Past pelvic surgeries and multiple induced abortions were consistently associated with heightened POI risk.
Protective Factors: 
Certain habits can help safeguard ovarian health:
•	Physical Exercise: Regular, moderate activity emerged as a significant protective factor, reducing POI risk by as much as 70%.
•	Vegetable Intake: Diets rich in vegetables and plant-based nutrients offered additional protection, thanks to their antioxidant and anti-inflammatory effects.
The meta-analysis also emphasizes the role of the gut microbiome in POI.
These results highlight the multifactorial nature of POI and underscore the importance of considering a wide range of risk factors in both clinical practice and public health strategies. 
Clinical and Public Health Implications
Early screening of high-risk population, combined with the initiatives like public health strategies including educating the public on smoking cessation, stress management and healthy nutrition along with implementing workplace measures to reduce chemical exposure and support mental well-being can help improve outcomes for individuals at risk of POI.
BULLET POINTS:
•	POI is related with abnormal menstruation, hair dyeing, chemical exposure, Type A personality, survival stress, sleep deprivation, bad mood, smoking history, family history of POI, history of mumps, number of abortions, and history of pelvic surgery.
•	Physical exercise and vegetable intake may provide protection against the development of POI.
•	The findings underscore the importance of managing lifestyle factors and stress to reduce the risk of premature ovarian insufficiency.
•	Early screening for high-risk groups and the initiatives like public health strategies may help preserve fertility.REFERENCE: Shuling Lin, Shanyan Chen &amp; Qin Zhang (2025) Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis, Journal of Obstetrics and Gynaecology, 45:1, 2469331, DOI: 10.1080/01443615.2025.2469331
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/22/322816-premature-ovarian-insufficiency.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Why, Ovaries, May, Stop, Working, Early:, Insights, from, Major, Research, Review</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/22/322816-premature-ovarian-insufficiency.webp"><p>Premature ovarian insufficiency (POI) is a life-changing condition affecting women under 40, marked by diminished ovarian function, irregular menstruation, and early infertility. While the causes of POI are diverse and often mysterious, a recent systematic review and meta-analysis published in the Journal of Obstetrics and Gynaecology sheds new light on the modifiable and non-modifiable factors that elevate risk, offering hope for prevention and early intervention.
</p><p>The diagnostic criteria for POI are amenorrhoea or oligomenorrhea lasting at least 4months and elevated follicle-stimulating hormone (FSH) levels exceeding 25U/L on two separate tests, spaced 4weeks apart. The global incidence of POI is reported to range from 1% to 4%, with a prevalence of 3.7%.
</p><p>The meta-analysis included participants who were patients with disorders related to ovarian function decline, such as premature ovarian failure, POI, or diminished ovarian reserve.
</p><p>The metaanalysis included a total of 38 studies. All included studies were case-control studies. A total of 4,968 cases and 5,158 control subjects were involved across the studies. The results as reflected by the given systematic review and meta‐analysis showed the following:
</p><p>The findings reveal a multifactorial etiology, with both lifestyle and hereditary elements playing substantial roles:
</p><p>1.	Lifestyle Hazards:
</p><p>o	Chemical Exposure & Hair Dyeing: Regular exposure to chemicals, especially in certain professions (e.g., hairdressing), and frequent hair dye use significantly increased POI risk (OR up to 4.7).
</p><p>o	Smoking & Sleep Deprivation: Both active and passive smoking, along with chronic sleep deprivation (less than 6 hours per night), were found to nearly triple or quadruple the risk.
</p><p>o	Negative Emotional States: Type A personalities, chronic stress, and persistent bad moods were among the strongest predictors, with Type A behavior increasing risk sixfold.
</p><p>2.	Medical and Surgical Histories:
</p><p>o	Family History & Infections: Women with a family history of POI were four times more likely to develop the condition. A history of mumps, particularly in childhood, was also a strong risk factor.
</p><p>o	Gynecological Surgeries & Abortions: Past pelvic surgeries and multiple induced abortions were consistently associated with heightened POI risk.
</p><p>Protective Factors: 
</p><p>Certain habits can help safeguard ovarian health:
</p><p>•	Physical Exercise: Regular, moderate activity emerged as a significant protective factor, reducing POI risk by as much as 70%.
</p><p>•	Vegetable Intake: Diets rich in vegetables and plant-based nutrients offered additional protection, thanks to their antioxidant and anti-inflammatory effects.
</p><p>The meta-analysis also emphasizes the role of the gut microbiome in POI.
</p><p>These results highlight the multifactorial nature of POI and underscore the importance of considering a wide range of risk factors in both clinical practice and public health strategies. 
</p><p>Clinical and Public Health Implications
</p><p>Early screening of high-risk population, combined with the initiatives like public health strategies including educating the public on smoking cessation, stress management and healthy nutrition along with implementing workplace measures to reduce chemical exposure and support mental well-being can help improve outcomes for individuals at risk of POI.
</p><p>BULLET POINTS:
</p><p>•	POI is related with abnormal menstruation, hair dyeing, chemical exposure, Type A personality, survival stress, sleep deprivation, bad mood, smoking history, family history of POI, history of mumps, number of abortions, and history of pelvic surgery.
</p><p>•	Physical exercise and vegetable intake may provide protection against the development of POI.
</p><p>•	The findings underscore the importance of managing lifestyle factors and stress to reduce the risk of premature ovarian insufficiency.
</p><p>•	Early screening for high-risk groups and the initiatives like public health strategies may help preserve fertility.</p><p>REFERENCE: Shuling Lin, Shanyan Chen & Qin Zhang (2025) Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis, Journal of Obstetrics and Gynaecology, 45:1, 2469331, DOI: 10.1080/01443615.2025.2469331
</p><p></p>]]> </content:encoded>
</item>

<item>
<title>12&#45;hour duty norms &amp;apos;only on paper&amp;apos;! PGI Chandigarh resident doctors flag overwork, burnout</title>
<link>https://edusehat.com/en/12-hour-duty-norms-only-on-paper-pgi-chandigarh-resident-doctors-flag-overwork-burnout</link>
<guid>https://edusehat.com/en/12-hour-duty-norms-only-on-paper-pgi-chandigarh-resident-doctors-flag-overwork-burnout</guid>
<description><![CDATA[ Chandigarh: The duty hours of resident doctors at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, continue to remain demanding and overburdened, with doctors alleging extreme work pressure, exhaustion, and mental health issues due to staff shortage.Despite the institutional guidelines promising a 12-hour duty schedule and a mandatory weekly off, residents working in wards and emergency services allege that they continue to face overwork and extended shifts, claiming that the norms exist only on paper.Resident doctors, speaking on condition of anonymity to TOI, said heavy patient load, staffing shortages and the inability to leave patients unattended routinely force them to exceed prescribed work hours.In January 2026, residents at PGI Chandigarh alleged that they were working for up to 30 days at a stretch without any weekly off. They had also claimed that emergency duties frequently extended beyond 12 hours depending on case severity.Also read- Maharashtra caps resident doctors&#039; duty hours at 48 per week, enforces 1992 residency schemeAccording to the latest TOI report, the situation remains unchanged, with doctors reiterating that duty hour norms are largely not implemented on the ground.In September 2025, PGI Director Dr Vivek Lal had issued a circular to all departmental heads and asked them to optimise the duty hours of resident doctors. The HoDs were also directed to ensure that the residents get at least one weekly off. These directions were issued to make sure that the resident doctors did not face any undue mental or physical stress. However, the doctors claimed that no steps have been taken for the implementation of the norms. The Ministry of Health and Family Welfare implemented the Residency Scheme on June 5, 1992, following directions from the Supreme Court, which clearly limits resident doctors’ duty hours to a maximum of 12 hours per day and 48 hours per week. However, this remains a dream for doctors across the nation. Claiming the PGI guidelines remain confined on paper, a resident doctor said, &quot;We are told patients cannot be left unattended, and because there are simply not enough doctors to manage the workload, the 12-hour limit is the first thing to be ignored.&quot;The institute has over 600 junior residents and a similar number of senior residents each year. While most complete their training, many do so under intense physical and psychological pressure, residents said.Previously, United Doctors Front (UDF) termed the practice as &quot;exploitation&quot; of doctors and questioned when they would be allowed to work under normal duty hours with proper rest and mental well-being. Doctors have called for urgent intervention that goes beyond policy announcements to include increased staffing, better workload distribution and strict enforcement of recovery time between shifts.Recently, the Parliamentary Standing Committee on Health and Family Welfare, headed by MP Prof. Ram Gopal Yadav, submitted its report on 18.03.2026. Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, the Parliamentary Health Committee expressed concern about the excessive workload of doctors.In this 172nd report, the panel highlighted the possibility of clinical errors and burnout resulting in compromised patient safety and recommended formulated and strictly enforcing a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods and monitored rosters.Welcoming the Parliamentary Health Committee&#039;s recommendations for &#039;Pilot-like Duty Hours&#039; for resident doctors, UDF Chairperson Dr. Lakshya Mittal wrote to the Union Health Minister, Shri J P Nadda, seeking urgent implementation of the same.Explaining how the long working hours often take a toll on the personal life and health of doctors, a resident doctor told TOI, &quot;The relentless workload is taking a toll on doctors&#039; health. There is no time to sleep or rest. I feel constantly sleep-deprived, which affects my focus and attention. There is also no time to eat proper meals.&quot;Another resident doctor also highlighted workplace challenges. The doctor said, &quot;We deal with interpersonal conflicts, face the looming threat of violence from patient attendants, and struggle to balance family expectations and financial pressures.&quot;Sources told TOI that the PGI administration is aware of the concerns and may raise the matter with the Union Health Ministry. Discussions are also underway to increase MD and DM seats to bring in more resident doctors and reduce workload.Also read- Doctors&#039; burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/09/04/299842-duty-hours1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>12-hour, duty, norms, only, paper, PGI, Chandigarh, resident, doctors, flag, overwork, burnout</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/09/04/299842-duty-hours1.webp"><div><b>Chandigarh: </b><span>The <a href="https://medicaldialogues.in/topics/duty-hours" target="_blank">duty hours</a> of resident doctors at <a href="https://medicaldialogues.in/topics/pgimer" target="_blank">Postgraduate Institute of Medical Education and Research</a> (PGIMER), Chandigarh, continue to remain demanding and overburdened, with doctors alleging extreme work pressure, exhaustion, and mental health issues due to staff shortage.</span></div><div><span>Despite the institutional guidelines promising a 12-hour duty schedule and a mandatory weekly off, residents working in wards and emergency services allege that they continue to face overwork and extended shifts, claiming that the norms exist only on paper.</span></div><div><div><span>Resident doctors, speaking on condition of anonymity to TOI, said heavy patient load, staffing shortages and the inability to leave patients unattended routinely force them to exceed prescribed work hours.</span></div><div><p>In January 2026, residents at PGI Chandigarh alleged that they were working for up to 30 days at a stretch without any weekly off. They had also claimed that emergency duties frequently extended beyond 12 hours depending on case severity.</p><p><b>Also read-<a href="https://medicaldialogues.in/news/health/doctors/maharashtra-caps-resident-doctors-duty-hours-at-48-per-week-enforces-1992-residency-scheme-167796" target="_blank"> </a><a href="https://medicaldialogues.in/news/health/doctors/maharashtra-caps-resident-doctors-duty-hours-at-48-per-week-enforces-1992-residency-scheme-167796" target="_blank">Maharashtra caps resident doctors' duty hours at 48 per week, enforces 1992 residency scheme</a></b></p><p>According to the latest <a href="https://timesofindia.indiatimes.com/city/chandigarh/overworked-understaffed-pgi-faces-silent-crisis/articleshow/130179124.cms" target="_blank" rel="nofollow">TOI </a>report, the situation remains unchanged, with doctors reiterating that duty hour norms are largely not implemented on the ground.</p><p>In September 2025, PGI Director Dr Vivek Lal had issued a circular to all departmental heads and asked them to optimise the duty hours of resident doctors. The HoDs were also directed to ensure that the residents get at least one weekly off. These directions were issued to make sure that the resident doctors did not face any undue mental or physical stress. </p><p>However, the doctors claimed that no steps have been taken for the implementation of the norms. </p><p>The Ministry of Health and Family Welfare implemented the Residency Scheme on June 5, 1992, following directions from the Supreme Court, which clearly limits resident doctors’ duty hours to a maximum of 12 hours per day and 48 hours per week. However, this remains a dream for doctors across the nation. </p><p>Claiming the PGI guidelines remain confined on paper, a resident doctor said, "We are told patients cannot be left unattended, and because there are simply not enough doctors to manage the workload, the 12-hour limit is the first thing to be ignored."</p><p>The institute has over 600 junior residents and a similar number of senior residents each year. While most complete their training, many do so under intense physical and psychological pressure, residents said.</p><p>Previously, United Doctors Front (UDF) termed the practice as "exploitation" of doctors and questioned when they would be allowed to work under normal duty hours with proper rest and mental well-being. Doctors have called for urgent intervention that goes beyond policy announcements to include increased staffing, better workload distribution and strict enforcement of recovery time between shifts.</p><p>Recently, the Parliamentary Standing Committee on Health and Family Welfare, headed by MP Prof. Ram Gopal Yadav, submitted its report on 18.03.2026. Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, the Parliamentary Health Committee expressed concern about the excessive workload of doctors.</p><p>In this 172nd report, the panel highlighted the possibility of clinical errors and burnout resulting in compromised patient safety and recommended formulated and strictly enforcing a "Clinical Duty Hours Regulation" policy with mandatory rest periods and monitored rosters.</p><p>Welcoming the Parliamentary Health Committee's recommendations for 'Pilot-like Duty Hours' for resident doctors, UDF Chairperson Dr. Lakshya Mittal wrote to the Union Health Minister, Shri J P Nadda, seeking urgent implementation of the same.</p><p>Explaining how the long working hours often take a toll on the personal life and health of doctors, a resident doctor told TOI, "The relentless workload is taking a toll on doctors' health. There is no time to sleep or rest. I feel constantly sleep-deprived, which affects my focus and attention. There is also no time to eat proper meals."</p><p>Another resident doctor also highlighted workplace challenges. The doctor said, "We deal with interpersonal conflicts, face the looming threat of violence from patient attendants, and struggle to balance family expectations and financial pressures."</p><p>Sources told TOI that the PGI administration is aware of the concerns and may raise the matter with the Union Health Ministry. Discussions are also underway to increase MD and DM seats to bring in more resident doctors and reduce workload.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters-167982" target="_blank">Doctors' burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters</a></b></p></div></div>]]> </content:encoded>
</item>

<item>
<title>American Academy of Dermatology Issues First Pediatric Atopic Dermatitis Guidelines Highlighting Prevention and Expanded Therapies</title>
<link>https://edusehat.com/en/american-academy-of-dermatology-issues-first-pediatric-atopic-dermatitis-guidelines-highlighting-prevention-and-expanded-therapies</link>
<guid>https://edusehat.com/en/american-academy-of-dermatology-issues-first-pediatric-atopic-dermatitis-guidelines-highlighting-prevention-and-expanded-therapies</guid>
<description><![CDATA[ The American Academy of Dermatology’s first pediatric atopic dermatitis guidelines note limited evidence for most preventive interventions, with early moisturizer use conditionally recommended in infants. Core treatment includes moisturizers, topical corticosteroids, and calcineurin inhibitors, while newer options like PDE-4 inhibitors, topical JAK inhibitors, and tapinarof broaden anti-inflammatory therapy choices.For the first time in its history, the American Academy of Dermatology (AAD) has published guidelines of care for both the prevention and management of atopic dermatitis (commonly known as eczema) in pediatric patients. While pediatric and adult eczema share similarities, these guidelines recognize the unique safety, dosing, and patient-caregiver-clinician interactions of individuals under the age of 18.The most common pediatric skin disease, eczema affects up to 25% of children worldwide. It is a long-lasting inflammatory skin disease often marked by itchy skin, dry patches, rashes, and rough bumps.“Eczema is extremely common in children, though it doesn’t always look or behave the same way it does in adults,” said AAD President and board-certified dermatologist Murad Alam, MD, FAAD. “Because eczema can decrease the quality of life of children and their families, we need dedicated guidelines just for children to ensure their best care.”The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric patients. The guidelines were developed by a working group of 14 experts, including 11 board-certified dermatologists and one pediatric allergist.PreventionBecause eczema is so common and can significantly affect a child’s health, there is strong interest in identifying ways to help prevent it. However, current research shows that supplemental therapies like special diets or skipping baths aren’t proven to prevent eczema.Moisturizers were the only treatment to receive a conditional recommendation for use to reduce the occurrence of eczema in children aged 6 months to 3 years.Conditional recommendations reflect an intervention whose benefits are closely balanced with risks and burdens. These recommendations apply to most patients, but the most appropriate action may differ depending on the patient and presentation.The guidelines find insufficient evidence or no benefit to dietary or environmental interventions, including early food introduction, human milk consumption, probiotic or vitamin D supplementation, water softening, and dust mite avoidance.TreatmentThere are more treatments for eczema than ever before, though standard treatments like regular moisturizing remain effective in managing eczema in children.The guidelines provide 26 evidence-based recommendations for topical therapies (prescription and non-prescription), phototherapy, and systemic therapies based on the treatment&#039;s reduction of eczema symptoms and itch severity, inclusive of the below.Strong recommendations reflect treatments in which benefits clearly outweigh the risks and burdens. These recommendations apply to most children with eczema in most circumstances. Strong recommendations were made for the use of the following:Moisturizers to reduce the severity of patients’ dry, itchy skin.Topical calcineurin inhibitors (pimecrolimus 1% cream and tacrolimus 0.03% or 0.1% ointment) to manage patients’ flares when their dry, itchy skin worsens and as intermittent maintenance therapy.Topical corticosteroids (steroid creams), considered a first-line treatment in most cases due to affordability and accessibility, to manage patients’ flares and as maintenance therapy.Phosphodiesterate-4 inhibitors (crisaborole ointment and roflumilast cream) to reduce patients’ itchiness and decrease the frequency of flares. When used proactively, roflumilast can keep skin clearer more consistently.Topical JAK inhibitors (ruxolitinib cream) to decrease the severity of the dry, itchy skin in patients with mild to moderate eczema.Topical aryl hydrocarbon receptor (AhR) agonists (tapinarof cream) to reduce inflammation, improve skin barrier function, and decrease the severity of dry, itchy skin in patients with mild, moderate and severe eczema.Monoclonal antibodies (dupilumab, tralokinumab, and lebrikizumab) to decrease the severity of eczema symptoms, reduce flares and improve itching in patients with moderate to severe eczema.JAK inhibitors (upadacitinib, abrocitinib, and baricitnib) to decrease the severity of eczema symptoms and improve itching in patients with moderate to severe eczema.Conditional recommendations were made for the use of treatments inclusive of the following:Bathing for treatment and maintenance for pediatric patients, followed by a moisturizer as standard care.Wet wrap therapy, under the guidance of a healthcare professional skilled in eczema management, are typically encouraged for patients during eczema flares.Phototherapy (light therapy) at a dermatologist’s office can be usedto treat patients with severe cases of eczema involving many body sites.Strong recommendations were made against systemic corticosteroids, which should be reserved exclusively for patients with sudden, severe flares and as short-term bridge therapy. Conditional recommendations were made against the use of topical antimicrobials and PUVA phototherapy for children with eczema.“These guidelines were developed to educate and empower patients, caregivers, and the medical community so children with eczema receive the best care possible. Early, proactive intervention allows improvement in symptoms and quality of life for patients and their families,” said board-certified dermatologist Dawn Davis, MD, FAAD, co-chair of the AAD’s Atopic Dermatitis Guideline Workgroup. “Since 2014, the landscape for eczema care has been transformed by the approval of new therapies for adults. Our goal was to review how these advancements relate to the pediatric population so children also receive optimal, individualized care.”“Many children’s eczema cases can be improved with a treatment plan made specially just for their needs, and starting treatment early can help keep the problem from getting worse,” said Dr. Alam. “Please partner with a board-certified dermatologist to get expert care for your child’s eczema.&quot;Reference:Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis. JAAD. 2026. doi:10.1016/j.jaad.2026.02.114. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341305-atopic-dermatitis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>American, Academy, Dermatology, Issues, First, Pediatric, Atopic, Dermatitis, Guidelines, Highlighting, Prevention, and, Expanded, Therapies</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341305-atopic-dermatitis.webp"><div class="pasted-from-word-wrapper"><p>The American Academy of Dermatology’s first pediatric atopic dermatitis guidelines note limited evidence for most preventive interventions, with early moisturizer use conditionally recommended in infants. Core treatment includes moisturizers, topical corticosteroids, and calcineurin inhibitors, while newer options like PDE-4 inhibitors, topical JAK inhibitors, and tapinarof broaden anti-inflammatory therapy choices.</p><p>For the first time in its history, the American Academy of Dermatology (AAD) has published guidelines of care for both the prevention and management of<a href="https://medicaldialogues.in/topics/atopic-dermatitis"> atopic dermatitis</a> (commonly known as eczema) in pediatric patients. While pediatric and adult <a href="https://medicaldialogues.in/topics/eczema">eczema </a>share similarities, these guidelines recognize the unique safety, dosing, and patient-caregiver-clinician interactions of individuals under the age of 18.</p><p>The most common pediatric skin disease, eczema affects up to 25% of children worldwide. It is a long-lasting inflammatory<a href="https://medicaldialogues.in/topics/skin-disease"> skin disease</a> often marked by itchy skin, dry patches, rashes, and rough bumps.</p><p>“Eczema is extremely common in children, though it doesn’t always look or behave the same way it does in adults,” said AAD President and board-certified dermatologist Murad Alam, MD, FAAD. “Because eczema can decrease the quality of life of children and their families, we need dedicated guidelines just for children to ensure their best care.”</p><p>The new guidelines, published in the <i>Journal of the American Academy of Dermatology </i>(JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric patients. The guidelines were developed by a working group of 14 experts, including 11 board-certified dermatologists and one pediatric allergist.</p><h2>Prevention</h2><p>Because eczema is so common and can significantly affect a child’s health, there is strong interest in identifying ways to help prevent it. However, current research shows that supplemental therapies like special diets or skipping baths aren’t proven to prevent eczema.</p><p>Moisturizers were the only treatment to receive a conditional recommendation for use to reduce the occurrence of eczema in children aged 6 months to 3 years.</p><p>Conditional recommendations reflect an intervention whose benefits are closely balanced with risks and burdens. These recommendations apply to most patients, but the most appropriate action may differ depending on the patient and presentation.</p><p>The guidelines find insufficient evidence or no benefit to dietary or environmental interventions, including early food introduction, human milk consumption, probiotic or vitamin D supplementation, water softening, and dust mite avoidance.</p><h2>Treatment</h2><p>There are more treatments for eczema than ever before, though standard treatments like regular moisturizing remain effective in managing eczema in children.</p><p>The guidelines provide 26 evidence-based recommendations for topical therapies (prescription and non-prescription), phototherapy, and systemic therapies based on the treatment's reduction of eczema symptoms and itch severity, inclusive of the below.</p><p>Strong recommendations reflect treatments in which benefits clearly outweigh the risks and burdens. These recommendations apply to most children with eczema in most circumstances. Strong recommendations were made for the use of the following:</p><ul><li><p>Moisturizers to reduce the severity of patients’ dry, itchy skin.</p></li><li><p>Topical calcineurin inhibitors (pimecrolimus 1% cream and tacrolimus 0.03% or 0.1% ointment) to manage patients’ flares when their dry, itchy skin worsens and as intermittent maintenance therapy.</p></li><li><p>Topical corticosteroids (steroid creams), considered a first-line treatment in most cases due to affordability and accessibility, to manage patients’ flares and as maintenance therapy.</p></li><li><p>Phosphodiesterate-4 inhibitors (crisaborole ointment and roflumilast cream) to reduce patients’ itchiness and decrease the frequency of flares. When used proactively, roflumilast can keep skin clearer more consistently.</p></li><li><p>Topical JAK inhibitors (ruxolitinib cream) to decrease the severity of the dry, itchy skin in patients with mild to moderate eczema.</p></li><li><p>Topical aryl hydrocarbon receptor (AhR) agonists (tapinarof cream) to reduce inflammation, improve skin barrier function, and decrease the severity of dry, itchy skin in patients with mild, moderate and severe eczema.</p></li><li><p>Monoclonal antibodies (dupilumab, tralokinumab, and lebrikizumab) to decrease the severity of eczema symptoms, reduce flares and improve itching in patients with moderate to severe eczema.</p></li><li><p>JAK inhibitors (upadacitinib, abrocitinib, and baricitnib) to decrease the severity of eczema symptoms and improve itching in patients with moderate to severe eczema.</p></li></ul><p>Conditional recommendations were made for the use of treatments inclusive of the following:</p><ul><li><p>Bathing for treatment and maintenance for pediatric patients, followed by a moisturizer as standard care.</p></li><li><p>Wet wrap therapy, under the guidance of a healthcare professional skilled in eczema management, are typically encouraged for patients during eczema flares.</p></li><li><p>Phototherapy (light therapy) at a dermatologist’s office can be usedto treat patients with severe cases of eczema involving many body sites.</p></li></ul><p>Strong recommendations were made against systemic corticosteroids, which should be reserved exclusively for patients with sudden, severe flares and as short-term bridge therapy. Conditional recommendations were made against the use of topical antimicrobials and PUVA phototherapy for children with eczema.</p><p>“These guidelines were developed to educate and empower patients, caregivers, and the medical community so children with eczema receive the best care possible. Early, proactive intervention allows improvement in symptoms and quality of life for patients and their families,” said board-certified dermatologist Dawn Davis, MD, FAAD, co-chair of the AAD’s Atopic Dermatitis Guideline Workgroup. “Since 2014, the landscape for eczema care has been transformed by the approval of new therapies for adults. Our goal was to review how these advancements relate to the pediatric population so children also receive optimal, individualized care.”</p><p>“Many children’s eczema cases can be improved with a treatment plan made specially just for their needs, and starting treatment early can help keep the problem from getting worse,” said Dr. Alam. “Please partner with a board-certified dermatologist to get expert care for your child’s eczema."</p><p>Reference:</p><p>Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis. JAAD. 2026. doi:10.1016/j.jaad.2026.02.114.</p></div>]]> </content:encoded>
</item>

<item>
<title>Aminophylline in Neonatal HIE has Potential Renal Benefit with Neurological Risk, suggests study</title>
<link>https://edusehat.com/en/aminophylline-in-neonatal-hie-has-potential-renal-benefit-with-neurological-risk-suggests-study</link>
<guid>https://edusehat.com/en/aminophylline-in-neonatal-hie-has-potential-renal-benefit-with-neurological-risk-suggests-study</guid>
<description><![CDATA[ Administration of aminophylline at the initiation of therapeutic hypothermia (TH) in neonates with hypoxic-ischemic encephalopathy (HIE) was associated with a greater decline in serum creatinine, suggesting a possible renoprotective effect. However, the increased incidence of convulsions highlights the importance of close neurological monitoring. Further research is required to determine optimal dosing and to balance potential renal benefits against neurological risks.A study was done to evaluate the renal effects and safety of adjunct aminophylline therapy in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). This retrospective cohort study included neonates ≥36 weeks and &gt;2000 g diagnosed with HIE and treated with TH between May 2018 and January 2025. Infants were classified into two groups: those receiving TH alone (TH group) and those given a single intravenous 8 mg/kg dose of aminophylline at the initiation of cooling (TH+A group). Demographic, perinatal, and laboratory characteristics were collected, and serial serum creatinine (sCr) measurements at 24, 48, 72, and 96 hours were analyzed to compare renal and clinical outcomes. A total of 297 infants were included (TH: 210; TH+A: 87). Baseline demographic and clinical characteristics were similar between groups. While sCr values at each fixed time point did not significantly differ, repeated-measures analysis demonstrated a significantly steeper decline in sCr over time in the TH+A group (p &lt; 0.001). Convulsions were more frequent in the TH+A group (23.0% vs. 10.5%, p = 0.005), whereas mortality and other major clinical outcomes were comparable.Aminophylline administration at the start of TH was associated with a steeper decline in serum creatinine, suggesting a potential renoprotective effect in neonates with HIE. However, the higher frequency of convulsions emphasizes the need for careful neurological monitoring. Further studies are needed to clarify optimal dosing and the balance between potential renal benefits and neurological risks.Reference:Baştuğ, Osman, et al. &quot;Renal Effects of Aminophylline in Cooled Neonates With Hypoxic-Ischemic Encephalopathy.&quot; American Journal of Perinatology, 2026.KeywordS:Aminophylline, Neonatal,  HIE, Potential, Renal,  Benefit, Neurological Risk, suggests,  study, Baştuğ, Osman ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341142-images-2026-04-11t150827183.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aminophylline, Neonatal, HIE, has, Potential, Renal, Benefit, with, Neurological, Risk, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341142-images-2026-04-11t150827183.webp"><p>Administration of aminophylline at the initiation of therapeutic hypothermia (TH) in neonates with hypoxic-ischemic encephalopathy (HIE) was associated with a greater decline in serum creatinine, suggesting a possible renoprotective effect. However, the increased incidence of convulsions highlights the importance of close neurological monitoring. Further research is required to determine optimal dosing and to balance potential renal benefits against neurological risks.</p><div class="pasted-from-word-wrapper"><p dir="ltr">A study was done to evaluate the renal effects and safety of adjunct aminophylline therapy in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH). This retrospective cohort study included neonates ≥36 weeks and >2000 g diagnosed with HIE and treated with TH between May 2018 and January 2025. Infants were classified into two groups: those receiving TH alone (TH group) and those given a single intravenous 8 mg/kg dose of aminophylline at the initiation of cooling (TH+A group). Demographic, perinatal, and laboratory characteristics were collected, and serial serum creatinine (sCr) measurements at 24, 48, 72, and 96 hours were analyzed to compare renal and clinical outcomes. A total of 297 infants were included (TH: 210; TH+A: 87). Baseline demographic and clinical characteristics were similar between groups. While sCr values at each fixed time point did not significantly differ, repeated-measures analysis demonstrated a significantly steeper decline in sCr over time in the TH+A group (p < 0.001). Convulsions were more frequent in the TH+A group (23.0% vs. 10.5%, p = 0.005), whereas mortality and other major clinical outcomes were comparable.</p><p dir="ltr">Aminophylline administration at the start of TH was associated with a steeper decline in serum creatinine, suggesting a potential renoprotective effect in neonates with HIE. However, the higher frequency of convulsions emphasizes the need for careful neurological monitoring. Further studies are needed to clarify optimal dosing and the balance between potential renal benefits and neurological risks.</p><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Baştuğ, Osman, et al. "Renal Effects of Aminophylline in Cooled Neonates With Hypoxic-Ischemic Encephalopathy." American Journal of Perinatology, 2026.</p><p dir="ltr">KeywordS:</p><p dir="ltr">Aminophylline, Neonatal,  HIE, Potential, Renal,  Benefit, Neurological Risk, suggests,  study, Baştuğ, Osman</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Piramal Pharma Closes USFDA Inspection at Lexington Facility with VAI Status</title>
<link>https://edusehat.com/en/piramal-pharma-closes-usfda-inspection-at-lexington-facility-with-vai-status</link>
<guid>https://edusehat.com/en/piramal-pharma-closes-usfda-inspection-at-lexington-facility-with-vai-status</guid>
<description><![CDATA[ New Delhi: Piramal Pharma Limited has successfully closed the USFDA inspection at its Lexington, Kentucky manufacturing facility following the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status, marking completion of the regulatory review process.The company informed that the United States Food and Drug Administration (USFDA) issued the EIR for the facility, confirming the closure of the inspection that had been previously initiated and disclosed in December 2025.The VAI classification indicates that while certain observations may have been noted during the inspection, they do not warrant regulatory enforcement action, allowing the facility to continue operations.Also Read: Piramal Pharma Solutions Grangemouth facility gets updated MHRA GMP certificatesPiramal Pharma stated that the receipt of the EIR represents a successful conclusion of the inspection process for its Lexington-based manufacturing site in the United States.The Lexington facility is an important part of Piramal Pharma’s global manufacturing network, supporting its presence in regulated markets including the United States.Also Read: Piramal Pharma Solutions, NewAmsterdam Pharma open dedicated oral solid dosage form suite at Piramal Sellersville facility ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/10/14/187904-piramal-pharma-new.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Piramal, Pharma, Closes, USFDA, Inspection, Lexington, Facility, with, VAI, Status</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/10/14/187904-piramal-pharma-new.webp"><p><b>New Delhi: </b>Piramal Pharma Limited has successfully closed the USFDA inspection at its Lexington, Kentucky manufacturing facility following the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status, marking completion of the regulatory review process.</p><div class="pasted-from-word-wrapper"><p>The company informed that the United States Food and Drug Administration (USFDA) issued the EIR for the facility, confirming the closure of the inspection that had been previously initiated and disclosed in December 2025.</p><p>The VAI classification indicates that while certain observations may have been noted during the inspection, they do not warrant regulatory enforcement action, allowing the facility to continue operations.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/piramal-pharma-solutions-grangemouth-facility-gets-updated-mhra-gmp-certificates-159046">Also Read: Piramal Pharma Solutions Grangemouth facility gets updated MHRA GMP certificates</a></div></div><p>Piramal Pharma stated that the receipt of the EIR represents a successful conclusion of the inspection process for its Lexington-based manufacturing site in the United States.</p><p>The Lexington facility is an important part of Piramal Pharma’s global manufacturing network, supporting its presence in regulated markets including the United States.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/piramal-pharma-solutions-newamsterdam-pharma-open-dedicated-oral-solid-dosage-form-suite-at-piramal-sellersville-facility-153920">Also Read: Piramal Pharma Solutions, NewAmsterdam Pharma open dedicated oral solid dosage form suite at Piramal Sellersville facility</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Codeine Cough Syrup Prices Hit Rs 1,000 in MP After Crackdown Disrupts Illegal Trade</title>
<link>https://edusehat.com/en/codeine-cough-syrup-prices-hit-rs-1000-in-mp-after-crackdown-disrupts-illegal-trade</link>
<guid>https://edusehat.com/en/codeine-cough-syrup-prices-hit-rs-1000-in-mp-after-crackdown-disrupts-illegal-trade</guid>
<description><![CDATA[ New Delhi: Codeine-based cough syrups are being sold at black market prices of up to Rs 1,000 per bottle in parts of Madhya Pradesh&#039;s Vindhya region following an intensified police crackdown under &quot;Operation Prahaar&quot;, which has led to over 700 NDPS cases, more than 1,100 arrests, and seizure of over 75,000 bottles, significantly disrupting illegal supply chains and driving prices sharply higher.The large-scale enforcement drive, carried out between January 2025 and March 2026, resulted in the registration of 705 cases under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and the arrest of 1,142 individuals involved in the illegal trade. Authorities also seized 2,773 kg of ganja, more than 4 lakh intoxicant tablets and capsules, along with opium, heroin, and other narcotics collectively valued at over ₹5.38 crore.Of the total seizures, codeine-based cough syrups and intoxicant tablets accounted for nearly one-third of the value, estimated at around ₹1.71 crore, highlighting the scale of misuse of prescription medicines in the region.Also Read: After Auditing 90% of Cough Syrup Units, CDSCO Tightens GMP Net, 850 CAPA Notices ServedOfficials stated that the crackdown has reduced the availability of such cough syrups by more than 80%, making them scarce in illegal markets. As supply chains have been disrupted, prices have surged and consumption patterns have started shifting.Experts from de-addiction centres reported that despite reduced availability, addiction remains a serious concern, with an average of around 10 patients seeking treatment every month. They noted that due to stricter enforcement, many users are now turning to alternative narcotic substances.Medical professionals also highlighted the severe health risks associated with such addiction, stating that most users are below 35 years of age and prolonged abuse can significantly reduce life expectancy. In many cases, addicts reportedly consume three to four bottles of cough syrup daily, according to a recent media report in The Economic Times.Authorities have emphasised that the illegal diversion of prescription medicines for substance abuse reflects a deeply entrenched network, and enforcement efforts will continue until the menace is fully controlled.Also Read:Varanasi: 5 held for supplying cough syrup by creating fake pharma cos ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/02/312152-202512023594082.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Codeine, Cough, Syrup, Prices, Hit, 1, 000, After, Crackdown, Disrupts, Illegal, Trade</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/02/312152-202512023594082.webp"><p><b>New Delhi: </b>Codeine-based cough syrups are being sold at black market prices of up to Rs 1,000 per bottle in parts of Madhya Pradesh's Vindhya region following an intensified police crackdown under "Operation Prahaar", which has led to over 700 NDPS cases, more than 1,100 arrests, and seizure of over 75,000 bottles, significantly disrupting illegal supply chains and driving prices sharply higher.</p><div class="pasted-from-word-wrapper"><p>The large-scale enforcement drive, carried out between January 2025 and March 2026, resulted in the registration of 705 cases under the Narcotic Drugs and Psychotropic Substances (NDPS) Act and the arrest of 1,142 individuals involved in the illegal trade. Authorities also seized 2,773 kg of ganja, more than 4 lakh intoxicant tablets and capsules, along with opium, heroin, and other narcotics collectively valued at over ₹5.38 crore.</p><p>Of the total seizures, codeine-based cough syrups and intoxicant tablets accounted for nearly one-third of the value, estimated at around ₹1.71 crore, highlighting the scale of misuse of prescription medicines in the region.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/after-auditing-90-of-cough-syrup-units-cdsco-tightens-gmp-net-850-capa-notices-served-165371">Also Read: After Auditing 90% of Cough Syrup Units, CDSCO Tightens GMP Net, 850 CAPA Notices Served</a></div></div><p>Officials stated that the crackdown has reduced the availability of such cough syrups by more than 80%, making them scarce in illegal markets. As supply chains have been disrupted, prices have surged and consumption patterns have started shifting.</p><p>Experts from de-addiction centres reported that despite reduced availability, addiction remains a serious concern, with an average of around 10 patients seeking treatment every month. They noted that due to stricter enforcement, many users are now turning to alternative narcotic substances.</p><p>Medical professionals also highlighted the severe health risks associated with such addiction, stating that most users are below 35 years of age and prolonged abuse can significantly reduce life expectancy. In many cases, addicts reportedly consume three to four bottles of cough syrup daily, according to a recent media report in <a href="https://pharma.economictimes.indiatimes.com/news/pharma-industry/codeine-based-cough-syrup-selling-for-rs-1000-a-bottle-in-parts-of-mp/130203719" rel="nofollow">The Economic Times</a>.</p><p>Authorities have emphasised that the illegal diversion of prescription medicines for substance abuse reflects a deeply entrenched network, and enforcement efforts will continue until the menace is fully controlled.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/varanasi-5-held-for-supplying-cough-syrup-by-creating-fake-pharma-cos-161564">Also Read:Varanasi: 5 held for supplying cough syrup by creating fake pharma cos</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>NMC says few private medical colleges under PPP linked to district hospitals, no list maintained: Govt</title>
<link>https://edusehat.com/en/nmc-says-few-private-medical-colleges-under-ppp-linked-to-district-hospitals-no-list-maintained-govt</link>
<guid>https://edusehat.com/en/nmc-says-few-private-medical-colleges-under-ppp-linked-to-district-hospitals-no-list-maintained-govt</guid>
<description><![CDATA[ New Delhi: Only a few private medical colleges in the country are currently linked with district hospitals under a Public Private Partnership (PPP) model, and no list of such colleges is maintained by the Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC), the Union Minister of State for Health, Smt Anupriya Patel, informed the Lok Sabha.Replying to a question in the Lok Sabha, Patel informed that, as per the Medical Assessment and Rating Board (MARB) of the National Medical Commission, a few private medical colleges are operating in association with district hospitals under the PPP model.However, she clarified that MARB does not maintain details or a list of these colleges.The information was shared in response to queries raised by a Member of Parliament who sought to know whether the Government proposes to link the private medical colleges with local district hospitals to improve and maintain the quality of medical education in the country, if so, the details thereof, and the names of the private medical colleges linked with district hospitals so far.In response, Patel said, &quot;The Medical Assessment and Rating Board (MARB) of the National Medical Commission has informed that there are a few private medical colleges in the country, operating under the Public Private Partnership (PPP) model, which are linked to district hospitals. However, the details of such colleges are not maintained by the MARB.&quot;Medical Dialogues had earlier reported that, endorsing the public-private partnership model, the Chairman of the National Medical Commission (NMC), Dr Abhijat Sheth, termed it &quot;the way forward&quot; to reshape India&#039;s medical education landscape. Dr Sheth made this observation during his maiden visit to Hyderabad. Referring to Gujarat&#039;s Brownfield Medical College Policy, Dr Sheth called it a game-changer that transformed the struggling district hospitals into thriving education hubs and encouraged the involvement of the private sector in the medical education sector.Also read- PPP model is the way forward to reshape medical education in India: NMC Chairman ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/10/304071-ppp-model.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, says, few, private, medical, colleges, under, PPP, linked, district, hospitals, list, maintained:, Govt</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/10/304071-ppp-model.webp"><p><b>New Delhi: </b>Only a few private medical colleges in the country are currently linked with district hospitals under a <a href="https://medicaldialogues.in/topics/public-private-partnerships" target="_blank">Public Private Partnership</a> (PPP) model, and no list of such colleges is maintained by the Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC), the Union Minister of State for Health, Smt Anupriya Patel, informed the <a href="https://medicaldialogues.in/topics/lok-sabha" target="_blank">Lok Sabha</a>.</p><p>Replying to a question in the Lok Sabha, Patel informed that, as per the Medical Assessment and Rating Board (MARB) of the National Medical Commission, a few private medical colleges are operating in association with district hospitals under the PPP model.</p><p>However, she clarified that MARB does not maintain details or a list of these colleges.</p><p>The information was shared in response to queries raised by a Member of Parliament who sought to know whether the Government proposes to link the private medical colleges with local district hospitals to improve and maintain the quality of medical education in the country, if so, the details thereof, and the names of the private medical colleges linked with district hospitals so far.</p><p>In response, Patel said, <i>"The Medical Assessment and Rating Board (MARB) of the National Medical Commission has informed that there are a few private medical colleges in the country, operating under the Public Private Partnership (PPP) model, which are linked to district hospitals. However, the details of such colleges are not maintained by the MARB."</i></p><p>Medical Dialogues had earlier reported that, endorsing the public-private partnership model, the Chairman of the National Medical Commission (NMC), Dr Abhijat Sheth, termed it "the way forward" to reshape India's medical education landscape. Dr Sheth made this observation during his maiden visit to Hyderabad. Referring to Gujarat's Brownfield Medical College Policy, Dr Sheth called it a game-changer that transformed the struggling district hospitals into thriving education hubs and encouraged the involvement of the private sector in the medical education sector.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/ppp-model-is-the-way-forward-to-reshape-medical-education-in-india-nmc-chairman-156714" target="_blank">PPP model is the way forward to reshape medical education in India: NMC Chairman</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Hearing loss makes it harder for cognitively impaired older adults to walk and think simultaneously: Study</title>
<link>https://edusehat.com/en/hearing-loss-makes-it-harder-for-cognitively-impaired-older-adults-to-walk-and-think-simultaneously-study</link>
<guid>https://edusehat.com/en/hearing-loss-makes-it-harder-for-cognitively-impaired-older-adults-to-walk-and-think-simultaneously-study</guid>
<description><![CDATA[ Cognitive and physical training can help older adults with mild cognitive impairment (MCI) maintain or improve their ability to move and think simultaneously, but hearing ability and sex influence outcomes, according to a new Concordia-led study.The researchers used data from the SYNERGIC clinical trial, a multi-institutional study of how exercise and brain training can improve cognition, mobility and falls in older adults. Their study followed 75 adults between the ages of 60 and 85 with mild cognitive impairment before and after a 20-week intervention involving physical training and cognitive exercises.The researchers specifically looked at how hearing loss affected dual-task performance — walking while performing mental activities like counting backwards or naming animals. Hearing loss was self-reported and objectively assessed following a following a common test of hearing acuity.The team found that poor hearing was strongly linked to worse dual-task performance. Participants with poor hearing were found to walk more slowly, have less stable gait and have more difficulty walking and carrying out cognitive tasks simultaneously.The effects were even more pronounced in individuals who reported poor hearing and had lower cognitive performance. They scored worst on dual-task measures.“We already know that males tend to get hearing loss earlier in life and it tends to be more severe than in females,” says lead author Rachel Downey (PhD 25). “But this is the first documented study to demonstrate this relationship between hearing loss and dual-task performance in male participants.”
“The study is especially novel because it looks at this within a sample of people with MCI,” adds supervising author Karen Li, a professor in the Department of Psychology and director of the Laboratory for Adult Development and Cognitive Aging.“Even for individuals in the pre-dementia stage — and not everyone who has MCI will progress to dementia — we see that the severity of cognitive impairment plays a role in their dual-task gait.”
The study was published in the journal Frontiers in Aging Neuroscience.Sex and hearing loss type shape key differencesThe paper also demonstrates that targeted physical and computerized cognitive training can noticeably improve dual-task performance.Participants completed one of the following interventions:exercise (aerobic and resistance-training) and a sham cognitive training (watching videos, performing simple Internet searches)both exercise and cognitive traininga placebo (toning and stretching exercises with sham cognitive training).“The intensity of the exercise increased every four weeks, so it was about more than just maintaining aerobic-resistance capacity,” notes Berkley Petersen, co-author and PhD candidate.After the 20-week intervention period, the researchers found that participants in the exercise and cognitive training group showed the greatest improvement in walking stability while performing cognitive tasks. The biggest improvement was found among males with higher levels of objective hearing loss.However, among females, those with self-reported hearing loss showed the most improvement. The researchers note that while the relationship in males between self-reported and objective hearing loss was strong, it was weaker among females— suggesting that they may be more worried about hearing loss and over-reporting it, or vice versa.Participants in the placebo group showed little to no improvements or exhibited declines in performance following the study period.Declines and risks are treatable“This study shows that even if an individual has poor hearing and poor cognitive performance, their brain is still plastic enough to benefit from this kind of training,” Downey says.“The risk of falling grows with aging. When you add on hearing loss and cognitive impairment, it gets even higher,” Li says. “There are a lot of practical health care implications for this kind of work because it’s all non-pharmacological and involves exercises that can be done at home.”Reference:Downey RI, Petersen BJ, Mohanathas N, Campos JL, Montero-Odasso M, Bherer L, Pichora-Fuller MK, Bray NW, Burhan AM, Camicioli R, Fraser S, Liu-Ambrose T, Lussier M, Middleton LE, Pieruccini-Faria F, Phillips NA and Li KZH (2026) The effect of hearing ability on dual-task performance following multi-domain training in older adults with mild cognitive impairment: findings from the SYNERGIC trial. Front. Aging Neurosci. 17:1716733. doi: 10.3389/fnagi.2025.1716733 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/02/14/201617-hearing-loss.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Hearing, loss, makes, harder, for, cognitively, impaired, older, adults, walk, and, think, simultaneously:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/02/14/201617-hearing-loss.webp"><div class="pasted-from-word-wrapper"><p>Cognitive and physical training can help older adults with mild <a href="https://medicaldialogues.in/topics/cognitive-impairment">cognitive impairment </a>(MCI) maintain or improve their ability to move and think simultaneously, but hearing ability and sex influence outcomes, according to a new Concordia-led study.</p><p>The researchers used data from the SYNERGIC clinical trial, a multi-institutional study of how <a href="https://medicaldialogues.in/topics/exercise">exercise </a>and brain training can improve cognition, mobility and falls in older adults. Their study followed 75 adults between the ages of 60 and 85 with mild cognitive impairment before and after a 20-week intervention involving physical training and cognitive exercises.</p><p>The researchers specifically looked at how hearing loss affected dual-task performance — walking while performing mental activities like counting backwards or naming animals. <a href="https://medicaldialogues.in/topics/hearing-loss">Hearing loss</a> was self-reported and objectively assessed following a following a common test of hearing acuity.</p><p>The team found that poor hearing was strongly linked to worse dual-task performance. Participants with poor hearing were found to walk more slowly, have less stable gait and have more difficulty walking and carrying out cognitive tasks simultaneously.</p><p>The effects were even more pronounced in individuals who reported poor hearing and had lower cognitive performance. They scored worst on dual-task measures.</p><p>“We already know that males tend to get hearing loss earlier in life and it tends to be more severe than in females,” says lead author Rachel Downey (PhD 25). “But this is the first documented study to demonstrate this relationship between hearing loss and dual-task performance in male participants.”
</p><p>“The study is especially novel because it looks at this within a sample of people with MCI,” adds supervising author Karen Li, a professor in the Department of Psychology and director of the Laboratory for Adult Development and Cognitive Aging.</p><p>“Even for individuals in the pre-dementia stage — and not everyone who has MCI will progress to dementia — we see that the severity of cognitive impairment plays a role in their dual-task gait.”
</p><p>The study was published in the journal Frontiers in Aging Neuroscience.</p><h3>Sex and hearing loss type shape key differences</h3><p>The paper also demonstrates that targeted physical and computerized cognitive training can noticeably improve dual-task performance.</p><p>Participants completed one of the following interventions:</p><ul><li>exercise (aerobic and resistance-training) and a sham cognitive training (watching videos, performing simple Internet searches)</li><li>both exercise and cognitive training</li><li>a placebo (toning and stretching exercises with sham cognitive training).</li></ul><p>“The intensity of the exercise increased every four weeks, so it was about more than just maintaining aerobic-resistance capacity,” notes Berkley Petersen, co-author and PhD candidate.</p><p>After the 20-week intervention period, the researchers found that participants in the exercise and cognitive training group showed the greatest improvement in walking stability while performing cognitive tasks. The biggest improvement was found among males with higher levels of <em>objective hearing loss</em>.</p><p>However, among females, those with <em>self-reported hearing loss</em> showed the most improvement. The researchers note that while the relationship in males between self-reported and objective hearing loss was strong, it was weaker among females— suggesting that they may be more worried about hearing loss and over-reporting it, or vice versa.</p><p>Participants in the placebo group showed little to no improvements or exhibited declines in performance following the study period.</p><h3>Declines and risks are treatable</h3><p>“This study shows that even if an individual has poor hearing and poor cognitive performance, their brain is still plastic enough to benefit from this kind of training,” Downey says.</p><p>“The risk of falling grows with aging. When you add on hearing loss and cognitive impairment, it gets even higher,” Li says. “There are a lot of practical health care implications for this kind of work because it’s all non-pharmacological and involves exercises that can be done at home.”</p><p>Reference:</p><p>Downey RI, Petersen BJ, Mohanathas N, Campos JL, Montero-Odasso M, Bherer L, Pichora-Fuller MK, Bray NW, Burhan AM, Camicioli R, Fraser S, Liu-Ambrose T, Lussier M, Middleton LE, Pieruccini-Faria F, Phillips NA and Li KZH (2026) The effect of hearing ability on dual-task performance following multi-domain training in older adults with mild cognitive impairment: findings from the SYNERGIC trial. Front. Aging Neurosci. 17:1716733. doi: 10.3389/fnagi.2025.1716733</p></div>]]> </content:encoded>
</item>

<item>
<title>Liraglutide Reduces Sleep Apnea Severity in Obese COPD Patients: Study</title>
<link>https://edusehat.com/en/liraglutide-reduces-sleep-apnea-severity-in-obese-copd-patients-study</link>
<guid>https://edusehat.com/en/liraglutide-reduces-sleep-apnea-severity-in-obese-copd-patients-study</guid>
<description><![CDATA[ Denmark: A recent exploratory analysis published in Clinical Obesity has found that liraglutide, a GLP-1 receptor agonist commonly used for weight management, may significantly reduce the severity of obstructive sleep apnea (OSA) and improve certain aspects of quality of life in individuals with obesity and chronic obstructive pulmonary disease (COPD).The study led by Sofie Krogh Wolsing from the University of Southern Denmark suggests that liraglutide may have a therapeutic role in patients with coexisting respiratory and metabolic disorders.Obstructive sleep apnea commonly occurs alongside obesity and COPD, forming a high-risk combination linked to increased morbidity, mortality, and reduced quality of life. Although weight-loss therapies are known to improve OSA, their effectiveness in patients with concurrent COPD has been unclear. To explore this, researchers performed a secondary exploratory analysis of a randomized controlled trial conducted at two Danish hospitals.The study enrolled 40 participants aged 40–70 years with a BMI above 27 and diagnosed with COPD. They were randomly assigned to receive either liraglutide (up to 3.0 mg subcutaneously) or placebo for 40 weeks. OSA prevalence and severity were assessed at baseline and study completion using overnight cardiorespiratory monitoring, measuring apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). Daytime sleepiness and quality of life were evaluated using validated questionnaires.   The researchers reported the following findings:At baseline, obstructive sleep apnea was highly prevalent, affecting 84% of the participants.After 40 weeks, liraglutide treatment led to a significant reduction in OSA severity compared to placebo.There was an average reduction of nearly 10 events per hour in both the apnea-hypopnea index and oxygen desaturation index.These improvements indicate better nighttime breathing and fewer oxygen desaturation episodes.No significant difference was observed in daytime sleepiness between the liraglutide and placebo groups.Liraglutide treatment was associated with improvements in certain domains of health-related quality of life.Participants reported better general health perception following treatment.Improvement was also seen in physical role functioning, reflecting a positive impact on daily activities and overall well-being.The authors noted that coexisting OSA and COPD pose significant management challenges with limited treatment options. Their findings indicate that liraglutide may be a useful adjunct therapy in this group, given its benefits on both weight and respiratory parameters.The study adds to evidence supporting the wider clinical role of GLP-1 receptor agonists beyond glycemic control and weight loss. However, the small sample size warrants cautious interpretation, and larger trials are needed to validate these findings and clarify liraglutide’s role in patients with overlapping obesity, COPD, and OSA.Overall, the results highlight the need for integrated management strategies in complex comorbid conditions and highlight the potential of pharmacological interventions to improve clinical outcomes and quality of life.Reference:Wolsing, S. K., Altintas Dogan, A. D., Juhl, C. B., Hess, S., Jensen, T. T., Bladbjerg, E. M., &amp; Hilberg, O. (2026). Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health-Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial. Clinical Obesity, 16(2), e70079. https://doi.org/10.1111/cob.70079 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/12/209486-obstructive-sleep-apnea-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Liraglutide, Reduces, Sleep, Apnea, Severity, Obese, COPD, Patients:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/12/209486-obstructive-sleep-apnea-1.webp"><p><span>Denmark: A recent exploratory analysis published in <i>Clinical Obesity </i>has found that <a href="https://medicaldialogues.in/topics/liraglutide">liraglutide</a>, a GLP-1 receptor agonist commonly used for weight management, may significantly reduce the severity of<a href="https://medicaldialogues.in/topics/obstructive-sleep-apnea"> obstructive sleep apnea (OSA) </a>and improve certain aspects of quality of life in individuals with obesity and <a href="https://medicaldialogues.in/topics/chronic-obstructive-pulmonary-disease">chronic obstructive pulmonary disease (COPD)</a>.</span></p><div class="pasted-from-word-wrapper"><div>The study led by Sofie Krogh Wolsing from the University of Southern Denmark suggests that liraglutide may have a therapeutic role in patients with coexisting respiratory and metabolic disorders.</div><div>Obstructive sleep apnea commonly occurs alongside obesity and COPD, forming a high-risk combination linked to increased morbidity, mortality, and reduced quality of life. Although weight-loss therapies are known to improve OSA, their effectiveness in patients with concurrent COPD has been unclear. To explore this, researchers performed a secondary exploratory analysis of a randomized controlled trial conducted at two Danish hospitals.</div><div>The study enrolled 40 participants aged 40–70 years with a BMI above 27 and diagnosed with COPD. They were randomly assigned to receive either liraglutide (up to 3.0 mg subcutaneously) or placebo for 40 weeks. OSA prevalence and severity were assessed at baseline and study completion using overnight cardiorespiratory monitoring, measuring apnea-hypopnea index (AHI) and oxygen desaturation index (ODI). Daytime sleepiness and quality of life were evaluated using validated questionnaires.   </div><div>The researchers reported the following findings:</div><ul><li>At baseline, obstructive sleep apnea was highly prevalent, affecting 84% of the participants.</li><li>After 40 weeks, liraglutide treatment led to a significant reduction in OSA severity compared to placebo.</li><li>There was an average reduction of nearly 10 events per hour in both the apnea-hypopnea index and oxygen desaturation index.</li><li>These improvements indicate better nighttime breathing and fewer oxygen desaturation episodes.</li><li>No significant difference was observed in daytime sleepiness between the liraglutide and placebo groups.</li><li>Liraglutide treatment was associated with improvements in certain domains of health-related quality of life.</li><li>Participants reported better general health perception following treatment.</li><li>Improvement was also seen in physical role functioning, reflecting a positive impact on daily activities and overall well-being.</li></ul><div>The authors noted that coexisting OSA and COPD pose significant management challenges with limited treatment options. Their findings indicate that liraglutide may be a useful adjunct therapy in this group, given its benefits on both weight and respiratory parameters.</div><div>The study adds to evidence supporting the wider clinical role of GLP-1 receptor agonists beyond glycemic control and weight loss. However, the small sample size warrants cautious interpretation, and larger trials are needed to validate these findings and clarify liraglutide’s role in patients with overlapping obesity, COPD, and OSA.</div><div>Overall, the results highlight the need for integrated management strategies in complex comorbid conditions and highlight the potential of pharmacological interventions to improve clinical outcomes and quality of life.</div><div>Reference:</div><div>Wolsing, S. K., Altintas Dogan, A. D., Juhl, C. B., Hess, S., Jensen, T. T., Bladbjerg, E. M., & Hilberg, O. (2026). Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health-Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial. Clinical Obesity, 16(2), e70079. https://doi.org/10.1111/cob.70079</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Decline in Long&#45;Term Opioid Use but Rise in Gabapentinoid Co&#45;Prescribing, Reveals Research</title>
<link>https://edusehat.com/en/decline-in-long-term-opioid-use-but-rise-in-gabapentinoid-co-prescribing-reveals-research</link>
<guid>https://edusehat.com/en/decline-in-long-term-opioid-use-but-rise-in-gabapentinoid-co-prescribing-reveals-research</guid>
<description><![CDATA[ USA: A recent research letter published in JAMA reports a considerable decline in long-term opioid use alongside a rise in gabapentinoid co-prescribing. Between 2015 and 2023, the number of individuals in the United States receiving long-term opioid therapy dropped from 5.6 million to 4.2 million, marking a 24.3% reduction. Despite this decline, co-prescribing of opioids with gabapentinoids increased significantly, rising from 47% to 58.7% over the same period. In contrast, benzodiazepine co-prescribing decreased, while stimulant use showed a slight uptick.The patient population receiving long-term opioid therapy has also aged over time, with the mean age increasing from 52.5 to 60.5 years. In addition, there has been a notable shift in insurance coverage, with Medicare emerging as the primary payer by 2023, replacing commercial insurance. These changes highlight evolving prescribing patterns and highlight the need for careful monitoring of combination therapies, particularly in an older population.Long-term opioid therapy, defined as opioid use for 90 days or more, is commonly prescribed for chronic pain but carries well-documented risks such as misuse, dependence, and overdose. In recent years, regulatory measures and updated clinical guidelines in the US have aimed to curb inappropriate opioid use, contributing to a broader decline in prescribing. However, less is known about how these changes have influenced long-term opioid therapy patterns.To address this, researchers led by Thuy D. Nguyen from the University of Michigan School of Public Health analysed national prescription data from the IQVIA Longitudinal Prescription Database, which captures the majority of retail pharmacy prescriptions in the US. The study examined opioid prescriptions dispensed between 2012 and 2023, identifying long-term therapy episodes based on duration and frequency of opioid dispensing.   Key Findings:The analysis included over 16 million long-term opioid therapy episodes among more than 13 million patients.Women constituted the majority of the study population.By 2023, patients on long-term opioid therapy accounted for 11.5% of all individuals receiving any opioid prescriptions.Despite an overall decline in use, a substantial number of patients continued on long-term opioid therapy.The average opioid dosage decreased over time, with reductions in daily morphine milligram equivalents.Overall, co-prescribing with other medications increased from 68.5% in 2015 to 72.3% in 2023.Co-prescribing with benzodiazepines declined during the study period.Co-prescribing with gabapentinoids increased notably.Use of stimulants alongside opioids also showed a slight increase.The authors suggest these trends likely reflect ongoing opioid stewardship efforts and increased awareness of opioid-related risks. However, they raise concerns about the safety of rising polypharmacy, particularly in older adults who are more susceptible to adverse drug events.The study has limitations, including the absence of detailed clinical data such as prescribing indications, comorbidities, and prescriber characteristics. It also does not capture all opioid prescriptions, including those from Veterans Affairs pharmacies.Overall, the findings indicate a shift in US prescribing patterns, with fewer patients on long-term opioids but greater exposure to combination therapies. The authors stress the need for continued vigilance to ensure safe prescribing, given that millions still remain on long-term opioid treatment.Reference:Nguyen TD, Chua K, Jiao A, Bicket MC, Bohnert A, Lagisetty P. US Trends in Long-Term Opioid Therapy. JAMA. Published online April 08, 2026. doi:10.1001/jama.2026.3241 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/08/313238-opioid-overdose.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Decline, Long-Term, Opioid, Use, but, Rise, Gabapentinoid, Co-Prescribing, Reveals, Research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/08/313238-opioid-overdose.webp"><p><span>USA: A recent research letter published in <i>JAMA </i>reports a considerable decline in long-term<a href="https://medicaldialogues.in/topics/opioid-use"> opioid use</a> alongside a rise in <a href="https://medicaldialogues.in/topics/gabapentinoids">gabapentinoid </a>co-prescribing. Between 2015 and 2023, the number of individuals in the United States receiving long-term opioid therapy dropped from 5.6 million to 4.2 million, marking a 24.3% reduction. Despite this decline, co-prescribing of opioids with gabapentinoids increased significantly, rising from 47% to 58.7% over the same period. In contrast, <a href="https://medicaldialogues.in/topics/benzodiazepines">benzodiazepine </a>co-prescribing decreased, while stimulant use showed a slight uptick.</span></p><div class="pasted-from-word-wrapper"><div>The patient population receiving long-term opioid therapy has also aged over time, with the mean age increasing from 52.5 to 60.5 years. In addition, there has been a notable shift in insurance coverage, with Medicare emerging as the primary payer by 2023, replacing commercial insurance. These changes highlight evolving prescribing patterns and highlight the need for careful monitoring of combination therapies, particularly in an older population.</div><div>Long-term opioid therapy, defined as opioid use for 90 days or more, is commonly prescribed for chronic pain but carries well-documented risks such as misuse, dependence, and overdose. In recent years, regulatory measures and updated clinical guidelines in the US have aimed to curb inappropriate opioid use, contributing to a broader decline in prescribing. However, less is known about how these changes have influenced long-term opioid therapy patterns.</div><div>To address this, researchers led by Thuy D. Nguyen from the University of Michigan School of Public Health analysed national prescription data from the IQVIA Longitudinal Prescription Database, which captures the majority of retail pharmacy prescriptions in the US. The study examined opioid prescriptions dispensed between 2012 and 2023, identifying long-term therapy episodes based on duration and frequency of opioid dispensing.   </div><div>Key Findings:</div><ul><li>The analysis included over 16 million long-term opioid therapy episodes among more than 13 million patients.</li><li>Women constituted the majority of the study population.</li><li>By 2023, patients on long-term opioid therapy accounted for 11.5% of all individuals receiving any opioid prescriptions.</li><li>Despite an overall decline in use, a substantial number of patients continued on long-term opioid therapy.</li><li>The average opioid dosage decreased over time, with reductions in daily morphine milligram equivalents.</li><li>Overall, co-prescribing with other medications increased from 68.5% in 2015 to 72.3% in 2023.</li><li>Co-prescribing with benzodiazepines declined during the study period.</li><li>Co-prescribing with gabapentinoids increased notably.</li><li>Use of stimulants alongside opioids also showed a slight increase.</li></ul><div>The authors suggest these trends likely reflect ongoing opioid stewardship efforts and increased awareness of opioid-related risks. However, they raise concerns about the safety of rising polypharmacy, particularly in older adults who are more susceptible to adverse drug events.</div><div>The study has limitations, including the absence of detailed clinical data such as prescribing indications, comorbidities, and prescriber characteristics. It also does not capture all opioid prescriptions, including those from Veterans Affairs pharmacies.</div><div>Overall, the findings indicate a shift in US prescribing patterns, with fewer patients on long-term opioids but greater exposure to combination therapies. The authors stress the need for continued vigilance to ensure safe prescribing, given that millions still remain on long-term opioid treatment.</div><div>Reference:</div><div>Nguyen TD, Chua K, Jiao A, Bicket MC, Bohnert A, Lagisetty P. US Trends in Long-Term Opioid Therapy. JAMA. Published online April 08, 2026. doi:10.1001/jama.2026.3241</div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>People who can’t afford dental care may be at higher risk of developing cardiovascular disease, dementia</title>
<link>https://edusehat.com/en/people-who-cant-afford-dental-care-may-be-at-higher-risk-of-developing-cardiovascular-disease-dementia</link>
<guid>https://edusehat.com/en/people-who-cant-afford-dental-care-may-be-at-higher-risk-of-developing-cardiovascular-disease-dementia</guid>
<description><![CDATA[ Being unable to afford dental care may increase a person’s risk of developing cardiovascular disease or dementia, according to a new study led by researchers at Boston University School of Public Health (BUSPH).
Published in The Journals of Gerontology, Series A, the study found that older people who forego necessary dental procedures because of financial barriers may be more likely to experience heart failure, a heart attack, a stroke, or dementia.
Poor oral health has been previously linked to cardiovascular and neurological conditions, but the prior research was mostly limited to specific oral health issues, such as periodontitis or tooth loss. Being unable to pay for dental care is a modifiable problem that, if addressed, could potentially lower people’s chances of developing more serious or fatal health conditions.
“Cost is one of the main barriers to dental care,” says study lead author Ms. Mabeline Velez, an instructor of health policy and health services research at BUSPH and a PhD candidate at Boston University’s Henry M. Goldman School of Dental Medicine. “As a result, people often delay critical care or they accept the coverage available, which may be more drastic measures—such as getting a tooth pulled than is clinically indicated. Tooth loss, especially early in life, can cause a whole set of health problems later in life including increased mortality. Finding ways to make dental care more accessible and affordable for everyone is a preventative measure that we can take to improve health outcomes down the line.”
For the study, Velez and colleagues from BUSPH and the University of California, San Francisco utilized survey data among participants ages 55 and older in the All of Us study, an initiative that the National Institutes of Health launched in 2017 to develop a diverse database on a variety of health conditions. Analyzing electronic health records and survey responses, the team examined the associations of unmet dental care needs due to cost with new diagnoses of heart failure, heart attacks, strokes, and all-cause dementia. A total of 88,496 people were analyzed for incident heart attacks, 86,593 people for heart failure, 88,410 people for strokes, and 92,272 people for dementia.
They found that people who skipped dental checkups and procedures because they could not afford them had higher incidence of all of the above conditions. On a population level, eliminating the financial barriers that prevented people from receiving dental care could prevent 2-4 percent of each outcome among older adults. With the exception of strokes, the associations were reduced after the researchers accounted for socioeconomic, behavioral, and clinical factors. 
The researchers note that this weakened relationship signals that further data is needed to understand and address the underlying or systemic drivers of chronic diseases.
“Multiple studies have evaluated pieces of this puzzle, but this is the first time we can point to  financial barriers to care as being linked with the incidence of cardiovascular disease and dementia: two leading causes of disability and death among older adults,” says study senior author Dr. Kendra Sims, assistant professor of epidemiology at BUSPH. “This study serves as an indicator that if we alleviate upstream factors such as financial constraints, we can prevent chronic disease.”
Fewer than 30 percent of US adults 65 and older have dental insurance and nearly 8 percent say they are unable to afford necessary dental care. Medicare and Medicaid do provide dental coverage, but that coverage is limited and often excludes preventive services. Medicaid dental coverage also varies widely by state, and in some instances, only covers emergency care. 
Policies that facilitate access to preventive dental care could widely reduce poor oral health outcomes, with benefits that extend to cardiovascular and cognitive outcomes, the researchers say. For example, states that extended dental care under the Affordable Care Act reported an increase in dental visits, fewer missing teeth, and better overall oral functioning. 
These dental visits also present an opportunity to conduct other health screenings.
“People who can access and afford routine dental care typically visit the dentist twice a year,” Dr. Sims says. “What if insurance could cover screening for cardiovascular risk factors like diabetes or hypertension when a patient is in the chair?” 
For her dissertation, Ms. Velez is exploring how periodontitis, a condition where plaque built up on the gums causes inflammation and infection, can eventually lead to cardiovascular issues. 
“Periodontitis is very common, but it is a treatable disease,” she says. “I hope this new insight will encourage doctors to integrate dental care into general practice.”Reference:Mabeline Velez, Peter T Buto, Anna M Pederson, Jennifer Weuve, Audrey R Murchland, Jingxuan Wang, M Maria Glymour, Kendra D Sims, Associations of unmet dental care needs due to cost with incident cardiovascular disease and dementia: a prospective study in the All of Us cohort, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag023, https://doi.org/10.1093/gerona/glag023
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>People, who, can’t, afford, dental, care, may, higher, risk, developing, cardiovascular, disease, dementia</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.webp"><p>Being unable to afford dental care may increase a person’s risk of developing <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease</a> or <a href="https://medicaldialogues.in/topics/dementia">dementia</a>, according to a new study led by researchers at Boston University School of Public Health (BUSPH).
</p><p>Published in <i>The Journals of Gerontology</i>, Series A, the study found that older people who forego necessary dental procedures because of financial barriers may be more likely to experience <a href="https://medicaldialogues.in/topics/heart-failure">heart failure</a>, a<a href="https://medicaldialogues.in/topics/heart-attack"> heart attack</a>, a stroke, or dementia.
</p><p>Poor oral health has been previously linked to cardiovascular and neurological conditions, but the prior research was mostly limited to specific oral health issues, such as periodontitis or tooth loss. Being unable to pay for dental care is a modifiable problem that, if addressed, could potentially lower people’s chances of developing more serious or fatal health conditions.
</p><p>“Cost is one of the main barriers to dental care,” says study lead author Ms. Mabeline Velez, an instructor of health policy and health services research at BUSPH and a PhD candidate at Boston University’s Henry M. Goldman School of Dental Medicine. “As a result, people often delay critical care or they accept the coverage available, which may be more drastic measures—such as getting a tooth pulled than is clinically indicated. Tooth loss, especially early in life, can cause a whole set of health problems later in life including increased mortality. Finding ways to make dental care more accessible and affordable for everyone is a preventative measure that we can take to improve health outcomes down the line.”
</p><p>For the study, Velez and colleagues from BUSPH and the University of California, San Francisco utilized survey data among participants ages 55 and older in the All of Us study, an initiative that the National Institutes of Health launched in 2017 to develop a diverse database on a variety of health conditions. Analyzing electronic health records and survey responses, the team examined the associations of unmet dental care needs due to cost with new diagnoses of heart failure, heart attacks, strokes, and all-cause dementia. A total of 88,496 people were analyzed for incident heart attacks, 86,593 people for heart failure, 88,410 people for strokes, and 92,272 people for dementia.
</p><p>They found that people who skipped dental checkups and procedures because they could not afford them had higher incidence of all of the above conditions. On a population level, eliminating the financial barriers that prevented people from receiving dental care could prevent 2-4 percent of each outcome among older adults. With the exception of strokes, the associations were reduced after the researchers accounted for socioeconomic, behavioral, and clinical factors. 
</p><p>The researchers note that this weakened relationship signals that further data is needed to understand and address the underlying or systemic drivers of chronic diseases.
</p><p>“Multiple studies have evaluated pieces of this puzzle, but this is the first time we can point to  financial barriers to care as being linked with the incidence of cardiovascular disease and dementia: two leading causes of disability and death among older adults,” says study senior author Dr. Kendra Sims, assistant professor of epidemiology at BUSPH. “This study serves as an indicator that if we alleviate upstream factors such as financial constraints, we can prevent chronic disease.”
</p><p>Fewer than 30 percent of US adults 65 and older have dental insurance and nearly 8 percent say they are unable to afford necessary dental care. Medicare and Medicaid do provide dental coverage, but that coverage is limited and often excludes preventive services. Medicaid dental coverage also varies widely by state, and in some instances, only covers emergency care. 
</p><p>Policies that facilitate access to preventive dental care could widely reduce poor oral health outcomes, with benefits that extend to cardiovascular and cognitive outcomes, the researchers say. For example, states that extended dental care under the Affordable Care Act reported an increase in dental visits, fewer missing teeth, and better overall oral functioning. 
</p><p>These dental visits also present an opportunity to conduct other health screenings.
</p><p>“People who can access and afford routine dental care typically visit the dentist twice a year,” Dr. Sims says. “What if insurance could cover screening for cardiovascular risk factors like diabetes or hypertension when a patient is in the chair?” 
</p><p>For her dissertation, Ms. Velez is exploring how periodontitis, a condition where plaque built up on the gums causes inflammation and infection, can eventually lead to cardiovascular issues. 
</p><p>“Periodontitis is very common, but it is a treatable disease,” she says. “I hope this new insight will encourage doctors to integrate dental care into general practice.”</p><p>Reference:</p><p>Mabeline Velez, Peter T Buto, Anna M Pederson, Jennifer Weuve, Audrey R Murchland, Jingxuan Wang, M Maria Glymour, Kendra D Sims, Associations of unmet dental care needs due to cost with incident cardiovascular disease and dementia: a prospective study in the All of Us cohort, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag023, https://doi.org/10.1093/gerona/glag023
</p><p></p>]]> </content:encoded>
</item>

<item>
<title>Extended Trochanteric Osteotomy may Raise Stem Subsidence Risk in Revision THA: Study</title>
<link>https://edusehat.com/en/extended-trochanteric-osteotomy-may-raise-stem-subsidence-risk-in-revision-tha-study</link>
<guid>https://edusehat.com/en/extended-trochanteric-osteotomy-may-raise-stem-subsidence-risk-in-revision-tha-study</guid>
<description><![CDATA[ Tapered splined titanium stems (TSTSs) are the most frequently used femoral stem design in revision total hip arthroplasty. Despite encouraging and favorable results with TSTS, complications including femoral stem subsidence persist and subsidence &gt;5 mm has been associated with implant failures and the need for aseptic re revision surgery.Josef E. Jolissaint et al conducted a study to investigate whether an extended trochanteric osteotomy (ETO) at the time of TSTS insertion increased mean subsidence and whether the amount of cortical contact was associated with subsidence, failure, and revision. The article has been published in ‘JBJS Open access’
It was a single-center retrospective cohort study of a prospectively collected database including all patients who received a TSTS from 2016 to 2020. Data collected include surgery type, presence of an ETO, and stem specifications. Radiographs were reviewed to analyze cortical contact and postoperative subsidence. Pearson’s correlation coefficient was used to determine the association between contact length and subsidence.
The key findings of the study were:
•	This cohort consisted of 299 hips, and 66 hips necessitated an ETO at the time of TSTS. 
•	Patients who required an ETO were more likely to subside (2.5 ± 0.2 mm vs 5.0 ± 0.7 mm, p &lt; 0.001) and were more likely to subside &gt;5 mm (32.3% vs 14.5%, p = 0.001).
•	After controlling for other variables, an ETO was an independent risk factor for significant subsidence (adjusted OR: 3.4, p = 0.02).
•	Contact length below the ETO was inversely related to stem subsidence (correlation coefficient of 20.26; p = 0.037), and multivariable logistic regression demonstrated bicortical contact &gt; 30 mm to be a protective factor for significant subsidence (adjusted OR: 0.12, p &lt; 0.001). 
•	Patients who received an ETO had a higher aseptic rerevision rate than patients who had a TSTS implanted without an ETO (16.1% vs 6.6%, p = 0.018).
The authors concluded – “Patients who receive an ETO during revision hip arthroplasty have a higher mean subsidence and 3-fold increase in odds for subsiding &gt;5 mm. However, bicortical contact of 30 mm or greater below the ETO was protective against significant TSTS subsidence. Although not all patients with &gt;5 mm of subsidence were revised, the aseptic rerevision rate was significantly higher in patients who received an ETO.”
The authors also commented – “An extended trochanteric osteotomy is an excellent technique to gain direct visualization of the femoral canal. However, it is not without its associated morbidity and postoperative complications, specifically stem subsidence. The results of this study suggest that when preparing for a TSTS after an ETO, careful consideration should be taken to confirm 3 cm of cortical engagement below the transverse limb of the ETO. The scaffolding technique, which prioritizes stem preparation followed by ETO closure, facilitates achieving sufficient cortical contact in the intact canal below the ETO segment. Consideration for intraoperative radiographs to confirm appropriate contact length and location may ensure sufficient fixation that will minimize the risk of postoperative stem subsidence.”
Level of Evidence: Level III. For further details on the article refer to:
Extended Trochanteric Osteotomy Increases the Risk of Tapered Splined Stem Subsidence in Revision Total Hip Arthroplasty
Josef E. Jolissaint et al
JBJS Open Access 2025:e25.00110
http://dx.doi.org/10.2106/JBJS.OA.25.00110 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340750-thr-bilateral.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Extended, Trochanteric, Osteotomy, may, Raise, Stem, Subsidence, Risk, Revision, THA:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340750-thr-bilateral.webp"><p>Tapered splined titanium stems (TSTSs) are the most frequently used femoral stem design in revision total hip arthroplasty. Despite encouraging and favorable results with TSTS, complications including femoral stem subsidence persist and subsidence >5 mm has been associated with implant failures and the need for aseptic re revision surgery.</p><p>Josef E. Jolissaint et al conducted a study to investigate whether an extended trochanteric osteotomy (ETO) at the time of TSTS insertion increased mean subsidence and whether the amount of cortical contact was associated with subsidence, failure, and revision. The article has been published in ‘JBJS Open access’
</p><p>It was a single-center retrospective cohort study of a prospectively collected database including all patients who received a TSTS from 2016 to 2020. Data collected include surgery type, presence of an ETO, and stem specifications. Radiographs were reviewed to analyze cortical contact and postoperative subsidence. Pearson’s correlation coefficient was used to determine the association between contact length and subsidence.
</p><p>The key findings of the study were:
</p><p>•	This cohort consisted of 299 hips, and 66 hips necessitated an ETO at the time of TSTS. 
</p><p>•	Patients who required an ETO were more likely to subside (2.5 ± 0.2 mm vs 5.0 ± 0.7 mm, p < 0.001) and were more likely to subside >5 mm (32.3% vs 14.5%, p = 0.001).
</p><p>•	After controlling for other variables, an ETO was an independent risk factor for significant subsidence (adjusted OR: 3.4, p = 0.02).
</p><p>•	Contact length below the ETO was inversely related to stem subsidence (correlation coefficient of 20.26; p = 0.037), and multivariable logistic regression demonstrated bicortical contact > 30 mm to be a protective factor for significant subsidence (adjusted OR: 0.12, p < 0.001). 
</p><p>•	Patients who received an ETO had a higher aseptic rerevision rate than patients who had a TSTS implanted without an ETO (16.1% vs 6.6%, p = 0.018).
</p><p>The authors concluded – “Patients who receive an ETO during revision hip arthroplasty have a higher mean subsidence and 3-fold increase in odds for subsiding >5 mm. However, bicortical contact of 30 mm or greater below the ETO was protective against significant TSTS subsidence. Although not all patients with >5 mm of subsidence were revised, the aseptic rerevision rate was significantly higher in patients who received an ETO.”
</p><p>The authors also commented – “An extended trochanteric osteotomy is an excellent technique to gain direct visualization of the femoral canal. However, it is not without its associated morbidity and postoperative complications, specifically stem subsidence. The results of this study suggest that when preparing for a TSTS after an ETO, careful consideration should be taken to confirm 3 cm of cortical engagement below the transverse limb of the ETO. The scaffolding technique, which prioritizes stem preparation followed by ETO closure, facilitates achieving sufficient cortical contact in the intact canal below the ETO segment. Consideration for intraoperative radiographs to confirm appropriate contact length and location may ensure sufficient fixation that will minimize the risk of postoperative stem subsidence.”
</p><p>Level of Evidence: Level III. </p><p>For further details on the article refer to:
</p><p>Extended Trochanteric Osteotomy Increases the Risk of Tapered Splined Stem Subsidence in Revision Total Hip Arthroplasty
</p><p>Josef E. Jolissaint et al
</p><p>JBJS Open Access 2025:e25.00110
</p><p>http://dx.doi.org/10.2106/JBJS.OA.25.00110</p>]]> </content:encoded>
</item>

<item>
<title>Facial Age Predicts Survival Better Than Chronological Age in NSCLC undergoing radiotherapy: JAMA</title>
<link>https://edusehat.com/en/facial-age-predicts-survival-better-than-chronological-age-in-nsclc-undergoing-radiotherapy-jama</link>
<guid>https://edusehat.com/en/facial-age-predicts-survival-better-than-chronological-age-in-nsclc-undergoing-radiotherapy-jama</guid>
<description><![CDATA[ A recent study published in the Journal of the American Medical Association revealed that among  patients with early-stage non-small cell lung cancer (NSCLC) undergoing stereotactic body radiotherapy (SBRT), facial (biological) age which assessed using deep learning was associated with overall survival and early mortality, unlike chronological age. A facial age ≥85 years significantly increased early mortality risk. Facial age and lung age provided complementary, independent information, supporting their role as novel biomarkers for risk stratification.The study focused on patients aged 60 and older diagnosed with early-stage NSCLC and treated with SBRT. Accurately gauging physiological fitness and life expectancy in this population has long posed a challenge, as chronological age often fails to reflect true biological health.Thus, this research evaluated two innovative, noninvasive biomarkers, the &quot;face age,” which is estimated using a deep learning algorithm analyzing patient photographs, and the “lung age,” which is derived from spirometry-based pulmonary function tests. The study determined whether these measures could better predict overall survival and early mortality when compared to traditional age metrics.The retrospective cohort study included a total of 670 patients treated from 2009 to 2023 across 6 radiation oncology clinics affiliated with a cancer center. With a median follow-up of nearly 4 years, the findings revealed that the face age of a patients was significantly associated with survival outcomes, while their chronological age was not.For every additional decade in face age, the risk of death increased by 39%, even after adjusting for key clinical factors such as cancer stage, smoking history, and performance status. The patients whose face age was estimated at 85 or older also had a significantly higher risk of dying within two years. Also, being 85 or older by actual age did not show the same predictive value.Lung age showed minimal correlation with face age, which suggests that each metric captures different aspects of biological aging. Also, face age remained a strong independent predictor of survival even when lung age was taken into account. Overall, these findings highlight the potential of AI-driven tools to enhance clinical decision-making. A simple photograph could provide valuable insight into the biological resilience of patients.Reference:Lee, G., Haugg, F., Bontempi, D., He, J., Bitterman, D. S., Pai, S., Guthier, C., Fitzgerald, K. J., Kozono, D. E., Kann, B. H., Aerts, H. J. W. L., &amp; Mak, R. H. (2026). Multimodal assessment of biological age following radiation therapy among patients with early-stage NSCLC. JAMA Network Open, 9(4), e264872. https://doi.org/10.1001/jamanetworkopen.2026.4872 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/09/30/254767-cranial-radiation-therapy-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Facial, Age, Predicts, Survival, Better, Than, Chronological, Age, NSCLC, undergoing, radiotherapy:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/09/30/254767-cranial-radiation-therapy-50.webp"><p>A recent study published in the <i>Journal of the American Medical Association</i> revealed that among  patients with early-stage non-small cell lung cancer (NSCLC) undergoing stereotactic body radiotherapy (SBRT), facial (biological) age which assessed using deep learning was associated with overall survival and early mortality, unlike chronological age. A facial age ≥85 years significantly increased early mortality risk. Facial age and lung age provided complementary, independent information, supporting their role as novel biomarkers for risk stratification.</p><p>The study focused on patients aged 60 and older diagnosed with early-stage NSCLC and treated with SBRT. Accurately gauging physiological fitness and life expectancy in this population has long posed a challenge, as chronological age often fails to reflect true biological health.</p><p>Thus, this research evaluated two innovative, noninvasive biomarkers, the "face age,” which is estimated using a deep learning algorithm analyzing patient photographs, and the “lung age,” which is derived from spirometry-based pulmonary function tests. The study determined whether these measures could better predict overall survival and early mortality when compared to traditional age metrics.</p><p>The retrospective cohort study included a total of 670 patients treated from 2009 to 2023 across 6 radiation oncology clinics affiliated with a cancer center. With a median follow-up of nearly 4 years, the findings revealed that the face age of a patients was significantly associated with survival outcomes, while their chronological age was not.</p><p>For every additional decade in face age, the risk of death increased by 39%, even after adjusting for key clinical factors such as cancer stage, smoking history, and performance status. The patients whose face age was estimated at 85 or older also had a significantly higher risk of dying within two years. Also, being 85 or older by actual age did not show the same predictive value.</p><p>Lung age showed minimal correlation with face age, which suggests that each metric captures different aspects of biological aging. Also, face age remained a strong independent predictor of survival even when lung age was taken into account. Overall, these findings highlight the potential of AI-driven tools to enhance clinical decision-making. A simple photograph could provide valuable insight into the biological resilience of patients.</p><p>Reference:</p><p>Lee, G., Haugg, F., Bontempi, D., He, J., Bitterman, D. S., Pai, S., Guthier, C., Fitzgerald, K. J., Kozono, D. E., Kann, B. H., Aerts, H. J. W. L., & Mak, R. H. (2026). Multimodal assessment of biological age following radiation therapy among patients with early-stage NSCLC. JAMA Network Open, 9(4), e264872. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2847516?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=040926" rel="nofollow">https://doi.org/10.1001/jamanetworkopen.2026.4872</a></p>]]> </content:encoded>
</item>

<item>
<title>Mannitol reliable Alternative Clearance Marker in CKD, suggests research</title>
<link>https://edusehat.com/en/mannitol-reliable-alternative-clearance-marker-in-ckd-suggests-research</link>
<guid>https://edusehat.com/en/mannitol-reliable-alternative-clearance-marker-in-ckd-suggests-research</guid>
<description><![CDATA[ A new study published in the journal of Clinical Physiology and Functional Imaging showed that Mannitol demonstrated reliable performance as a clearance marker in patients with chronic kidney disease (CKD) stages 3–4 and may be considered a useful alternative when standard markers such as iohexol or isotopes. However, larger studies are needed to validate its clinical utility.This research evaluated mannitol as a clearance marker for determining glomerular filtration rate (GFR). Traditionally, GFR is measured using markers such as iohexol or radioactive isotopes, which may not always be suitable for all patients due to contraindications or limited availability. This study explored whether mannitol could offer a simpler and equally accurate option.The trial involved 20 outpatients diagnosed with stage 3–4 CKD. Each participant received simultaneous bolus injections of both mannitol and iohexol, the latter serving as the reference standard. Blood samples were collected at 3, 5, and 22 hours after injection, and analyzed using advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS). This research then applied the Bröchner–Mortensen multi-sample model to calculate GFR for both substances.When comparing multi-sample clearance methods, mannitol demonstrated a very small average bias of just 0.95 mL/min/1.73 m² relative to iohexol, with an error rate of 10%. Also, accuracy reached 100% within both P30 and P10 thresholds which indicated how closely the results align with the reference method. This level of agreement suggests that mannitol performs nearly identically to iohexol under multi-sample conditions.The study also assessed a simplified approach using a one-sample method based on the Jacobsson equation, which was applied to blood samples taken at 5 and 22 hours. Despite being less precise, the accuracy remained high, with up to 100% within P30 and 80% within P10 at certain time points, though variability and error rates were higher when compared to the multi-sample method.Overall, the findings indicate that mannitol is a dependable marker for GFR measurement in patients with CKD stages 3–4, particularly when using a multi-sample approach. Its performance closely mirrors that of iohexol, which makes it a potential alternative in clinical situations where these markers cannot be used. Larger-scale investigations are required to confirm the reliability of mannitol across broader patient populations and clinical settings.Source:Kiss, K., Saeed, A., Ricksten, S.-E., &amp; Bragadottir, G. (2026). Clearance of mannitol for assessment of glomerular filtration rate in chronic kidney disease: A validation against iohexol clearance. Clinical Physiology and Functional Imaging, 46(3), e70059. https://doi.org/10.1111/cpf.70059 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/04/18/283500-ckd.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mannitol, reliable, Alternative, Clearance, Marker, CKD, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/04/18/283500-ckd.webp"><p>A new study published in the journal of <i>Clinical Physiology and Functional Imaging</i> showed that Mannitol demonstrated reliable performance as a clearance marker in patients with chronic kidney disease (CKD) stages 3–4 and may be considered a useful alternative when standard markers such as iohexol or isotopes. However, larger studies are needed to validate its clinical utility.</p><p>This research evaluated mannitol as a clearance marker for determining glomerular filtration rate (GFR). Traditionally, GFR is measured using markers such as iohexol or radioactive isotopes, which may not always be suitable for all patients due to contraindications or limited availability. This study explored whether mannitol could offer a simpler and equally accurate option.</p><p>The trial involved 20 outpatients diagnosed with stage 3–4 CKD. Each participant received simultaneous bolus injections of both mannitol and iohexol, the latter serving as the reference standard. Blood samples were collected at 3, 5, and 22 hours after injection, and analyzed using advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS). This research then applied the Bröchner–Mortensen multi-sample model to calculate GFR for both substances.</p><p>When comparing multi-sample clearance methods, mannitol demonstrated a very small average bias of just 0.95 mL/min/1.73 m² relative to iohexol, with an error rate of 10%. Also, accuracy reached 100% within both P30 and P10 thresholds which indicated how closely the results align with the reference method. This level of agreement suggests that mannitol performs nearly identically to iohexol under multi-sample conditions.</p><p>The study also assessed a simplified approach using a one-sample method based on the Jacobsson equation, which was applied to blood samples taken at 5 and 22 hours. Despite being less precise, the accuracy remained high, with up to 100% within P30 and 80% within P10 at certain time points, though variability and error rates were higher when compared to the multi-sample method.</p><p>Overall, the findings indicate that mannitol is a dependable marker for GFR measurement in patients with CKD stages 3–4, particularly when using a multi-sample approach. Its performance closely mirrors that of iohexol, which makes it a potential alternative in clinical situations where these markers cannot be used. Larger-scale investigations are required to confirm the reliability of mannitol across broader patient populations and clinical settings.</p><p>Source:</p><p>Kiss, K., Saeed, A., Ricksten, S.-E., & Bragadottir, G. (2026). Clearance of mannitol for assessment of glomerular filtration rate in chronic kidney disease: A validation against iohexol clearance. Clinical Physiology and Functional Imaging, 46(3), e70059. <a href="https://onlinelibrary.wiley.com/doi/10.1111/cpf.70059" rel="nofollow">https://doi.org/10.1111/cpf.70059</a></p>]]> </content:encoded>
</item>

<item>
<title>4&#45;week Vancomycin pulse and taper regimen reduces C. difficile recurrence, finds study</title>
<link>https://edusehat.com/en/4-week-vancomycin-pulse-and-taper-regimen-reduces-c-difficile-recurrence-finds-study</link>
<guid>https://edusehat.com/en/4-week-vancomycin-pulse-and-taper-regimen-reduces-c-difficile-recurrence-finds-study</guid>
<description><![CDATA[ A new study published in the Journal of the American Medical Association revealed that a 4-week vancomycin pulse and taper regimen was more effective than a 2-week regimen in reducing Clostridioides difficile recurrence by day 56. However, some recurrences were delayed rather than completely prevented, which suggests the longer regimen may help postpone relapse while remaining a safe and effective strategy.Clostridioides difficile infection (CDI) remains a major health concern in hospital settings, where it is linked to significant illness and death. Recurrence is common, with many patients experiencing repeat infections even after initial recovery. Thus, this randomized, double-blind clinical trial conducted across 12 hospitals in Canada, examined whether a longer, tapered dosing schedule of vancomycin could outperform the standard shorter regimen in preventing recurrent CDI (rCDI).This study enrolled a total of 265 adult patients who had either a first episode or a first recurrence of CDI. All participants initially received a standard 2-week course of vancomycin. After showing improvement by day 10, they were randomly assigned to either a group receiving an additional 2-week tapering dose of vancomycin, or the other receiving a placebo.By day 56, recurrence occurred in 14.8% of patients in the extended-treatment group, when compared to 17.7% in the standard-treatment group. While this difference did not meet strong statistical certainty, the extended regimen demonstrated a 73.8% probability of being more effective.By day 38, only 6.7% of patients receiving the extended taper experienced recurrence, when compared to 15.4% in the control group. This translates to a significantly lower risk, with a 99% probability that the longer regimen is superior in preventing early relapse.Also, both treatment strategies were found to be safe, with very few adverse effects reported in either group. This reinforces the feasibility of adopting a longer tapering approach without increasing patient risk. This trial was stopped early due to recruitment challenges, which may limit the strength of long-term conclusions. While the extended vancomycin regimen may not completely eliminate recurrence, it appears to delay or reduce early relapse, which can be clinically significant. Overall, the study highlighted the accessible strategy for managing CDI. Reference:McDonald, E. G., Butler-Laporte, G., Brophy, J. M., Elsayed, S., Frenette, C., Huseen, I., Loo, V. G., Moran, K., Coburn, B., Hota, S. S., Longtin, Y., Kong, L. Y., Muller, M. P., Steiner, T. S., Valiquette, L., Daneman, N., Daley, P., Nott, C., MacFadden, D. R., … TAPER-V Team. (2026). Initial vancomycin taper for the prevention of recurrent Clostridioides difficile infection: A randomized clinical trial: A randomized clinical trial. JAMA Network Open, 9(2), e2560495. https://doi.org/10.1001/jamanetworkopen.2025.60495 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>4-week, Vancomycin, pulse, and, taper, regimen, reduces, difficile, recurrence, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.webp"><p>A new study published in the <i>Journal of the American Medical Association</i> revealed that a 4-week vancomycin pulse and taper regimen was more effective than a 2-week regimen in reducing Clostridioides difficile recurrence by day 56. However, some recurrences were delayed rather than completely prevented, which suggests the longer regimen may help postpone relapse while remaining a safe and effective strategy.</p><p>Clostridioides difficile infection (CDI) remains a major health concern in hospital settings, where it is linked to significant illness and death. Recurrence is common, with many patients experiencing repeat infections even after initial recovery. Thus, this randomized, double-blind clinical trial conducted across 12 hospitals in Canada, examined whether a longer, tapered dosing schedule of vancomycin could outperform the standard shorter regimen in preventing recurrent CDI (rCDI).</p><p>This study enrolled a total of 265 adult patients who had either a first episode or a first recurrence of CDI. All participants initially received a standard 2-week course of vancomycin. After showing improvement by day 10, they were randomly assigned to either a group receiving an additional 2-week tapering dose of vancomycin, or the other receiving a placebo.</p><p>By day 56, recurrence occurred in 14.8% of patients in the extended-treatment group, when compared to 17.7% in the standard-treatment group. While this difference did not meet strong statistical certainty, the extended regimen demonstrated a 73.8% probability of being more effective.</p><p>By day 38, only 6.7% of patients receiving the extended taper experienced recurrence, when compared to 15.4% in the control group. This translates to a significantly lower risk, with a 99% probability that the longer regimen is superior in preventing early relapse.</p><p>Also, both treatment strategies were found to be safe, with very few adverse effects reported in either group. This reinforces the feasibility of adopting a longer tapering approach without increasing patient risk. This trial was stopped early due to recruitment challenges, which may limit the strength of long-term conclusions. </p><p>While the extended vancomycin regimen may not completely eliminate recurrence, it appears to delay or reduce early relapse, which can be clinically significant. Overall, the study highlighted the accessible strategy for managing CDI. </p><p>Reference:</p><p>McDonald, E. G., Butler-Laporte, G., Brophy, J. M., Elsayed, S., Frenette, C., Huseen, I., Loo, V. G., Moran, K., Coburn, B., Hota, S. S., Longtin, Y., Kong, L. Y., Muller, M. P., Steiner, T. S., Valiquette, L., Daneman, N., Daley, P., Nott, C., MacFadden, D. R., … TAPER-V Team. (2026). Initial vancomycin taper for the prevention of recurrent Clostridioides difficile infection: A randomized clinical trial: A randomized clinical trial. JAMA Network Open, 9(2), e2560495. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845599?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=041026" rel="nofollow">https://doi.org/10.1001/jamanetworkopen.2025.60495</a></p>]]> </content:encoded>
</item>

<item>
<title>Toric Lenses Preferred Over Spherical Lenses in Astigmatism, suggests study</title>
<link>https://edusehat.com/en/toric-lenses-preferred-over-spherical-lenses-in-astigmatism-suggests-study</link>
<guid>https://edusehat.com/en/toric-lenses-preferred-over-spherical-lenses-in-astigmatism-suggests-study</guid>
<description><![CDATA[ A new clinical study published in the journal of Contact Lens and Anterior Eye showed that patients with astigmatism of at least –0.75 diopters achieve better visual acuity with toric lenses when compared to spherical lenses and also tend to prefer them. These findings suggest that clinicians should consider toric lenses as a primary option for correcting astigmatism to improve both vision quality and patient satisfaction.This randomized, crossover clinical trial involved 53 habitual soft contact lens wearers between the ages of 20 and 40, and analyzed 84 eyes in total. Participants were grouped based on their level of astigmatism, which ranged from none (0.00 DC) to −1.50 diopters cylinder (DC), increasing in increments of 0.25 DC. Each eye was tested using three types of correction as spherical soft contact lenses, custom toric soft contact lenses, and full-correction spectacles.The Pupil-Controlled Vision Testing System (PUCS) dynamically adjusted lighting conditions to simulate different pupil sizes—2.5 mm, 4.0 mm, 5.5 mm, as well as each participant’s natural minimum and maximum pupil diameters, which allowed the research to assess visual acuity in more realistic conditions than standard testing methods.Visual acuity decreased as pupil size increased across all types of vision correction, confirming that larger pupils can reduce clarity. However, toric lenses consistently delivered better visual performance than spherical lenses once astigmatism reached −0.75 DC or higher. This improvement was statistically significant across all pupil sizes.On average, toric lenses improved visual acuity by about 0.06 logMAR (roughly three letters on an eye chart) at −0.75 DC, and by 0.12 logMAR (about six letters) at −1.50 DC. Also, toric lenses performed on par with full-correction spectacles, long considered the gold standard for astigmatism correction.The participants increasingly favored toric lenses as astigmatism levels rose. From −0.75 DC onward, toric lenses were the preferred choice, and at −1.25 DC or higher, no participants preferred spherical lenses at all. Toric lenses demonstrated excellent rotational stability in maintaining consistent visual clarity.Overall, the study suggests that toric soft contact lenses should be routinely prescribed for individuals with astigmatism of −0.75 DC or greater. The benefits are not only measurable in clinical terms but also strongly felt by patients in everyday vision quality.Source:Read, M., Morgan, P., Maldonado-Codina, C., Orsborn, G., Vega, J., &amp; Navascues-Cornago, M. (2025). Evaluating the visual benefits of toric soft contact lenses using a novel pupil-controlled vision testing system. Contact Lens &amp; Anterior Eye: The Journal of the British Contact Lens Association, 49(2), 102604. https://doi.org/10.1016/j.clae.2025.102604 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/17/269530-contact-lens.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Toric, Lenses, Preferred, Over, Spherical, Lenses, Astigmatism, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/17/269530-contact-lens.webp"><p>A new clinical study published in the journal of <i>Contact Lens and Anterior Eye</i> showed that patients with astigmatism of at least –0.75 diopters achieve better visual acuity with toric lenses when compared to spherical lenses and also tend to prefer them. These findings suggest that clinicians should consider toric lenses as a primary option for correcting astigmatism to improve both vision quality and patient satisfaction.</p><p>This randomized, crossover clinical trial involved 53 habitual soft contact lens wearers between the ages of 20 and 40, and analyzed 84 eyes in total. Participants were grouped based on their level of astigmatism, which ranged from none (0.00 DC) to −1.50 diopters cylinder (DC), increasing in increments of 0.25 DC. Each eye was tested using three types of correction as spherical soft contact lenses, custom toric soft contact lenses, and full-correction spectacles.</p><p>The Pupil-Controlled Vision Testing System (PUCS) dynamically adjusted lighting conditions to simulate different pupil sizes—2.5 mm, 4.0 mm, 5.5 mm, as well as each participant’s natural minimum and maximum pupil diameters, which allowed the research to assess visual acuity in more realistic conditions than standard testing methods.</p><p>Visual acuity decreased as pupil size increased across all types of vision correction, confirming that larger pupils can reduce clarity. However, toric lenses consistently delivered better visual performance than spherical lenses once astigmatism reached −0.75 DC or higher. This improvement was statistically significant across all pupil sizes.</p><p>On average, toric lenses improved visual acuity by about 0.06 logMAR (roughly three letters on an eye chart) at −0.75 DC, and by 0.12 logMAR (about six letters) at −1.50 DC. Also, toric lenses performed on par with full-correction spectacles, long considered the gold standard for astigmatism correction.</p><p>The participants increasingly favored toric lenses as astigmatism levels rose. From −0.75 DC onward, toric lenses were the preferred choice, and at −1.25 DC or higher, no participants preferred spherical lenses at all. Toric lenses demonstrated excellent rotational stability in maintaining consistent visual clarity.</p><p>Overall, the study suggests that toric soft contact lenses should be routinely prescribed for individuals with astigmatism of −0.75 DC or greater. The benefits are not only measurable in clinical terms but also strongly felt by patients in everyday vision quality.</p><p>Source:</p><p>Read, M., Morgan, P., Maldonado-Codina, C., Orsborn, G., Vega, J., & Navascues-Cornago, M. (2025). Evaluating the visual benefits of toric soft contact lenses using a novel pupil-controlled vision testing system. Contact Lens & Anterior Eye: The Journal of the British Contact Lens Association, 49(2), 102604. <a href="https://www.contactlensjournal.com/article/S1367-0484%2825%2900238-3/fulltext" rel="nofollow">https://doi.org/10.1016/j.clae.2025.102604</a></p>]]> </content:encoded>
</item>

<item>
<title>Daytime Liver Transplants Safe After Prolonged Machine Perfusion: JAMA</title>
<link>https://edusehat.com/en/daytime-liver-transplants-safe-after-prolonged-machine-perfusion-jama</link>
<guid>https://edusehat.com/en/daytime-liver-transplants-safe-after-prolonged-machine-perfusion-jama</guid>
<description><![CDATA[ Prospective data from the Netherlands, published in JAMA Network Open, have revealed that liver transplants performed during the daytime remain safe even after prolonged dual hypothermic oxygenated machine perfusion of donor livers. This approach may improve transplant logistics without compromising patient outcomes. The study was conducted by Silke B. and colleagues.Until now, liver transplantation has traditionally been an around the clock surgery procedure, where surgical teams had to perform operations in night shifts, due to which the fatigue among surgeons and disutility among patients was quite high. Recently, an observational study performed at a renowned university hospital in the Netherlands showed that performing DHOPE-PRO on a routine basis results in an immense number of liver transplants being done in the day shift with optimized surgical logistics.The study was conducted from January 1, 2021, to December 31, 2024, using 330 liver transplantations on both adults and children. The researchers studied 175 transplants that occurred from the years 2023–2024 (after the regular use of DHOPE-PRO) as opposed to the control group of 155 transplants conducted in 2021–2022. The average age of participants was 45 years, and 186 of them (56.4%) were male. Grafts used in the study were acquired through DBD, DCD, and living donor methods. The criterion of effectiveness for this study was the number of &quot;daytime&quot; operations; these were procedures that started at or after 8 am and involved reperfusion at 8 pm or before.Key findings:First, the percentage of daytime transplants according to reperfusion time improved from 48.4% (75 of 155) in the control group to 84.6% (148 of 175) in the DHOPE-PRO group (P ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/10/03/255148-liver-transplantation.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 23:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Daytime, Liver, Transplants, Safe, After, Prolonged, Machine, Perfusion:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/10/03/255148-liver-transplantation.webp"><p>Prospective data from the Netherlands, published in <i>JAMA Network Open</i>, have revealed that liver transplants performed during the daytime remain safe even after prolonged dual hypothermic oxygenated machine perfusion of donor livers. This approach may improve transplant logistics without compromising patient outcomes. The study was conducted by Silke B. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Until now, liver transplantation has traditionally been an around the clock surgery procedure, where surgical teams had to perform operations in night shifts, due to which the fatigue among surgeons and disutility among patients was quite high. Recently, an observational study performed at a renowned university hospital in the Netherlands showed that performing DHOPE-PRO on a routine basis results in an immense number of liver transplants being done in the day shift with optimized surgical logistics.</p><p dir="ltr">The study was conducted from January 1, 2021, to December 31, 2024, using 330 liver transplantations on both adults and children. The researchers studied 175 transplants that occurred from the years 2023–2024 (after the regular use of DHOPE-PRO) as opposed to the control group of 155 transplants conducted in 2021–2022. The average age of participants was 45 years, and 186 of them (56.4%) were male. Grafts used in the study were acquired through DBD, DCD, and living donor methods. The criterion of effectiveness for this study was the number of "daytime" operations; these were procedures that started at or after 8 am and involved reperfusion at 8 pm or before.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">First, the percentage of daytime transplants according to reperfusion time improved from 48.4% (75 of 155) in the control group to 84.6% (148 of 175) in the DHOPE-PRO group (P<0.001). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Daytime transplants, according to completion time, saw percentages improve from 53.5% (83 of 155) to 89.1% (156 of 175) (P<0.001). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Median time of machine perfusion improved significantly from 2.1 to 10.2 hours (P<0.001). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Most notably, total preservation time was safely prolonged to 31.4 hours in the study, creating a broad time span for planning purposes not available with conventional cold storage or short-time perfusions. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">DHOPE-PRO utilization had no significant relation to higher postoperative complications; for instance, the chance of developing new-onset acute kidney injury demonstrated an odds ratio of 0.64 (95% CI, 0.37-1.07; P = 0.09). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">One-year patient survival was surprisingly good, surpassing 90% in each subgroup of the study participants. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">According to the data obtained through statistical evaluation, there was no link between DHOPE-PRO and reduced survival of grafts (hazard ratio, 1.28 [95% CI, 0.59-2.74]; P=0.53) or patient survival (hazard ratio, 2.05 [95% CI, 0.75-5.59]; P = 0.16).</p></li></ul><p dir="ltr">This prospective study demonstrates strong evidence of DHOPE-PRO as a revolutionary instrument in current liver transplantation surgery. It is achieved through maximizing the number of daytime procedures up to 90% from the existing 50%. Above all, the study has demonstrated that prolonged preservation does not have an effect on the high level of survival rate, which remains above 90%.</p><p dir="ltr">Reference:</p><p dir="ltr">Bodewes SB, Woltjes LC, Thorne AM, et al. Prolonged Dual Hypothermic Oxygenated Machine Perfusion for Daytime Liver Transplant. JAMA Netw Open. 2026;9(4):e265039. doi:10.1001/jamanetworkopen.2026.5039 </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>NMC regulatory architecture suffers amid vacancies, zero whole&#45;time members: Parliamentary panel calls for time&#45;bound recruitment</title>
<link>https://edusehat.com/en/nmc-regulatory-architecture-suffers-amid-vacancies-zero-whole-time-members-parliamentary-panel-calls-for-time-bound-recruitment</link>
<guid>https://edusehat.com/en/nmc-regulatory-architecture-suffers-amid-vacancies-zero-whole-time-members-parliamentary-panel-calls-for-time-bound-recruitment</guid>
<description><![CDATA[ New Delhi: Expressing serious concern over the vacant posts at the National Medical Commission (NMC), a Parliamentary Standing Committee on Health has recommended initiating an urgent time-bound recruitment process to fill all statutory, ex officio, and encadred vacancies.Further, taking note of the number of contractual staff members, the Parliamentary Health Panel observed that consequent heavy reliance on such outsourced and contractual staff ultimately compromises institutional accountability, dilutes a sense of belongingness, and raises the risk of unethical practices to secure continued engagement.These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.Huge Vacancies in Statutory &amp; Encadred Posts: The panel noted that a total of 17 statutory and 36 encadred posts were vacant at the Apex Medical Commission. It was observed by the panel that the posts of 2 out of 10 ex officio members and 3 out of 22 part-time members were lying vacant in the Commission.Shockingly, all 8 posts of Whole-time members in the Autonomous Boards and 4 out of 8 Part-time members in the Boards were also unfilled. Further, 11 CSS Cadred and 25 CSSS cadred posts were also vacant.Sl No.PositionPost NameSanctioned StrengthIn position StrengthVacant Strength1Statutory PostsChairman1102Ex-officio members10823Part-time Members in NMC221934Whole-Time Members in Autonomous Boards8085Part-time Members in Autonomous Boards8446Secretary1107EncadredPostsCSS Cadre Posts4534118CSSS Cadre Posts603525 Apart from these, the panel noted that 66 consultants and 170 DEOs, MTS &amp; Drivers have been outsourced on a contractual basis.Urgent, Time-Bound Recruitment Required: The panel observed that while on the one hand, NMC has successfully overseen a massive expansion of medical education capacity, which has now reached 818 medical colleges, its own regulatory architecture is suffering from an acute deficit of personnel.Accordingly, the panel has recommended the Department to initiate a time-bound recruitment process to fill up all statutory, ex-officio and encadred vacancies.&quot;The Committee observes that while the National Medical Commission (NMC) has successfully overseen a massive expansion of medical education capacity, reaching 818 colleges, its own regulatory architecture is suffering from acute personnel deficits. The Committee notes with serious concern the absolute vacancy in the crucial category of Whole-Time Members in Autonomous Boards, with 0 out of 8 sanctioned posts filled, alongside significant vacancies in encadred administrative posts,&quot; observed the panel.&quot;The Committee believes that the consequent heavy reliance on 236 outsourced and contractual staff members compromises institutional accountability, dilutes a sense of belongingness, and raises the risk of unethical practices to secure continued engagement. The Committee, therefore, recommends that the Department urgently initiate a timebound recruitment process to fill all statutory, ex-officio, and encadred vacancies,&quot; it recommended.Medical Dialogues had previously reported that earlier this year, the Union Health and Family Welfare Minister Anupriya Patel in the Rajya Sabha stated that nearly one-third of the approved positions in the National Medical Commission (NMC) were lying vacant.  The total sanctioned strength across the apex medical regulator and its autonomous boards is 54 posts, of which 35 are filled, while 19 remain vacant, the Minister had informed. These vacant posts included the posts of Presidents of the Undergraduate Medical Education Board (UGMEB) and the Ethics and Medical Registration Board (EMRB). Besides, the posts of two whole-time and two part-time members of the NMC UG board and two whole-time and one part-time members of the PG Board, along with two whole-time and one part-time members of the Medical Assessment and Rating Board and two whole-time and two part-time members of the Ethics &amp; Medical Registration Board, reportedly were also lying vacant.According to the details provided by the Ministry earlier this year, the Commission itself has 33 sanctioned posts, with 28 in position and 5 vacant. The Undergraduate Medical Education Board (UGMEB) has 5 sanctioned posts, but only 1 member was in position, leaving 4 vacancies.Similarly, the Postgraduate Medical Education Board (PGMEB) has 5 sanctioned posts, of which 2 were filled, and 3 were vacant. The Medical Assessment and Rating Board (MARB) also has 5 sanctioned posts, with 2 in position and 3 vacant. The Ethics and Medical Registration Board (EMRB) has 5 sanctioned posts, but only 1 member was in position, leaving 4 vacancies.Also Read: 19 of 54 NMC posts vacant: Health Minister tells Parliament ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/19/279190-vacant-posts.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, regulatory, architecture, suffers, amid, vacancies, zero, whole-time, members:, Parliamentary, panel, calls, for, time-bound, recruitment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/19/279190-vacant-posts.webp"><p><b>New Delhi:</b> Expressing serious concern over the <a href="https://medicaldialogues.in/topics/vacant-posts">vacant posts</a> at the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>), a Parliamentary Standing Committee on Health has recommended initiating an urgent time-bound recruitment process to fill all statutory, ex officio, and encadred vacancies.</p><p>Further, taking note of the number of contractual staff members, the Parliamentary Health Panel observed that consequent heavy reliance on such outsourced and contractual staff ultimately compromises institutional accountability, dilutes a sense of belongingness, and raises the risk of unethical practices to secure continued engagement.</p><p>These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.</p><p><b>Huge Vacancies in Statutory & Encadred Posts:</b> </p><p>The panel noted that a total of 17 statutory and 36 encadred posts were vacant at the Apex Medical Commission. It was observed by the panel that the posts of 2 out of 10 ex officio members and 3 out of 22 part-time members were lying vacant in the Commission.</p><p>Shockingly, all 8 posts of Whole-time members in the Autonomous Boards and 4 out of 8 Part-time members in the Boards were also unfilled. Further, 11 CSS Cadred and 25 CSSS cadred posts were also vacant.</p><div class="pasted-from-word-wrapper"><table border="1" cellspacing="0"><tbody><tr><td width="26" valign="top"><p class="16">Sl No.</p></td><td width="62" valign="top"><p class="16">Position</p></td><td width="152" valign="top"><p class="16">Post Name</p></td><td width="78" valign="top"><p class="16">Sanctioned Strength</p></td><td width="72" valign="top"><p class="16">In position Strength</p></td><td width="62" valign="top"><p class="16">Vacant Strength</p></td></tr><tr><td width="26" valign="top"><p class="16">1</p></td><td width="62" valign="top" rowspan="6"><p class="16">Statutory Posts</p></td><td width="152" valign="top"><p class="16">Chairman</p></td><td width="78" valign="top"><p class="16">1</p></td><td width="72" valign="top"><p class="16">1</p></td><td width="62" valign="top"><p class="16">0</p></td></tr><tr><td width="26" valign="top"><p class="16">2</p></td><td width="152" valign="top"><p class="16">Ex-officio members</p></td><td width="78" valign="top"><p class="16">10</p></td><td width="72" valign="top"><p class="16">8</p></td><td width="62" valign="top"><p class="16">2</p></td></tr><tr><td width="26" valign="top"><p class="16">3</p></td><td width="152" valign="top"><p class="16">Part-time Members in NMC</p></td><td width="78" valign="top"><p class="16">22</p></td><td width="72" valign="top"><p class="16">19</p></td><td width="62" valign="top"><p class="16">3</p></td></tr><tr><td width="26" valign="top"><p class="16">4</p></td><td width="152" valign="top"><p class="16">Whole-Time Members in Autonomous Boards</p></td><td width="78" valign="top"><p class="16">8</p></td><td width="72" valign="top"><p class="16">0</p></td><td width="62" valign="top"><p class="16">8</p></td></tr><tr><td width="26" valign="top"><p class="16">5</p></td><td width="152" valign="top"><p class="16">Part-time Members in Autonomous Boards</p></td><td width="78" valign="top"><p class="16">8</p></td><td width="72" valign="top"><p class="16">4</p></td><td width="62" valign="top"><p class="16">4</p></td></tr><tr><td width="26" valign="top"><p class="16">6</p></td><td width="152" valign="top"><p class="16">Secretary</p></td><td width="78" valign="top"><p class="16">1</p></td><td width="72" valign="top"><p class="16">1</p></td><td width="62" valign="top"><p class="16">0</p></td></tr><tr><td width="26" valign="top"><p class="16">7</p></td><td width="62" valign="top" rowspan="2"><p class="16">Encadred</p><p class="16">Posts</p></td><td width="152" valign="top"><p class="16">CSS Cadre Posts</p></td><td width="78" valign="top"><p class="16">45</p></td><td width="72" valign="top"><p class="16">34</p></td><td width="62" valign="top"><p class="16">11</p></td></tr><tr><td width="26" valign="top"><p class="16">8</p></td><td width="152" valign="top"><p class="16">CSSS Cadre Posts</p></td><td width="78" valign="top"><p class="16">60</p></td><td width="72" valign="top"><p class="16">35</p></td><td width="62" valign="top"><p class="16">25</p></td></tr></tbody></table><p><b> </b></p><p>Apart from these, the panel noted that 66 consultants and 170 DEOs, MTS & Drivers have been outsourced on a contractual basis.</p><p><b>Urgent, Time-Bound Recruitment Required:</b> </p><p>The panel observed that while on the one hand, NMC has successfully overseen a massive expansion of medical education capacity, which has now reached 818 medical colleges, its own regulatory architecture is suffering from an acute deficit of personnel.</p><p>Accordingly, the panel has recommended the Department to initiate a time-bound recruitment process to fill up all statutory, ex-officio and encadred vacancies.</p></div><p><i>"The Committee observes that while the National Medical Commission (NMC) has successfully overseen a massive expansion of medical education capacity, reaching 818 colleges, its own regulatory architecture is suffering from acute personnel deficits. The Committee notes with serious concern the absolute vacancy in the crucial category of Whole-Time Members in Autonomous Boards, with 0 out of 8 sanctioned posts filled, alongside significant vacancies in encadred administrative posts," </i>observed the panel.</p><p><i>"The Committee believes that the consequent heavy reliance on 236 outsourced and contractual staff members compromises institutional accountability, dilutes a sense of belongingness, and raises the risk of unethical practices to secure continued engagement. The Committee, therefore, recommends that the Department urgently initiate a timebound recruitment process to fill all statutory, ex-officio, and encadred vacancies,"</i> it recommended.</p><p>Medical Dialogues had previously reported that earlier this year, the Union Health and Family Welfare Minister Anupriya Patel in the <a href="https://medicaldialogues.in/topics/rajya-sabha" target="_blank">Rajya Sabha</a> stated that nearly one-third of the approved positions in the National Medical Commission (NMC) were lying vacant. </p><p> The total sanctioned strength across the apex medical regulator and its autonomous boards is 54 posts, of which 35 are filled, while 19 remain vacant, the Minister had informed.</p><div class="pasted-from-word-wrapper"><p> These vacant posts included the posts of Presidents of the <a href="https://medicaldialogues.in/topics/ugmeb">Undergraduate Medical Education Board (UGMEB</a>) and the Ethics and Medical Registration Board (EMRB). Besides, the posts of two whole-time and two part-time members of the NMC UG board and two whole-time and one part-time members of the PG Board, along with two whole-time and one part-time members of the Medical Assessment and Rating Board and two whole-time and two part-time members of the Ethics & Medical Registration Board, reportedly were also lying vacant.</p><p>According to the details provided by the Ministry earlier this year, the Commission itself has 33 sanctioned posts, with 28 in position and 5 vacant. The <a href="https://medicaldialogues.in/topics/UGMEB">Undergraduate Medical Education Board (UGMEB)</a> has 5 sanctioned posts, but only 1 member was in position, leaving 4 vacancies.</p></div><p>Similarly, the Postgraduate Medical Education Board (PGMEB) has 5 sanctioned posts, of which 2 were filled, and 3 were vacant. The Medical Assessment and Rating Board (MARB) also has 5 sanctioned posts, with 2 in position and 3 vacant. The Ethics and Medical Registration Board (EMRB) has 5 sanctioned posts, but only 1 member was in position, leaving 4 vacancies.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/19-of-54-nmc-posts-vacant-health-minister-tells-parliament-164583"><b><i>Also Read: 19 of 54 NMC posts vacant: Health Minister tells Parliament</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 13/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-13april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-13april2026</guid>
<description><![CDATA[ Here are the top medical news for today:New Study Reveals Hidden Drainage System Within the Human Brain
Your brain is constantly cleaning itself—but scientists have just discovered a hidden “drainage switch” that controls how it happens.
A new study published in iScience by researchers at the Medical University of South Carolina (MUSC) has identified a previously unknown control point in the brain’s waste clearance system. The discovery centers on the middle meningeal artery (MMA), a structure now believed to play a crucial role in draining fluids and metabolic waste from the brain.
The brain relies on a specialized lymphatic system to remove toxins and maintain healthy function. Until recently, scientists had limited understanding of how this system operates in humans. Using advanced real-time MRI technology—developed through a collaboration with NASA—researchers were able to observe fluid movement in unprecedented detail.
In the study, scientists tracked cerebrospinal and interstitial fluid flow in five healthy individuals over a six-hour period. Surprisingly, the fluid traveling along the MMA did not behave like blood, which moves rapidly through arteries. Instead, it flowed slowly and steadily, resembling a drainage system. This provided the first direct evidence that the MMA is involved in lymphatic function rather than just blood circulation.
These finding challenges long-standing assumptions about the brain’s isolation from the rest of the body. The brain is protected by layers called the meninges, which were once thought to act as barriers. However, emerging research shows that these layers contain lymphatic vessels that connect the brain to the body’s immune and waste removal systems.
By identifying the MMA as a key control point, scientists now have a clearer picture of how the brain clears harmful substances. This could have major implications for conditions such as Alzheimer’s disease and other neurological disorders, where waste buildup is a known factor.
The discovery opens new avenues for research, potentially leading to therapies that enhance the brain’s natural cleaning processes and improve long-term brain health.
REFERENCE: Mehmet Albayram, Sutton B. Richmond, Kaan Yagmurlu, Ibrahim S. Tuna, Eda Karakaya, Hiranmayi Ravichandran, Fatih Tufan, Emal Lesha, Melike Mut, Filiz Bunyak, Yashar.S. Kalani, Adviye Ergul, Rachael D. Seidler, Onder Albayram. Meningeal lymphatic architecture and drainage dynamics surrounding the human middle meningeal artery. iScience, 2025; 28 (11): 113693 DOI: 10.1016/j.isci.2025.113693
Creatine Alone Not Enough for Muscle Gain, Resistance Training Key, Study Suggests
Creatine may boost performance—but its real power depends on how you train.
A new systematic review and meta-analysis published in Frontiers in Nutrition reveals that the benefits of creatine supplementation are strongly influenced by training context, particularly resistance training. Researchers analyzed 39 randomized controlled trials involving healthy men aged 18 to 30 to understand how creatine affects strength, anaerobic performance, and body composition.
Creatine is widely known for enhancing the phosphocreatine system, which helps rapidly regenerate ATP—the body’s primary energy source during short, high-intensity activities. This makes it a popular supplement among athletes and gym-goers aiming to improve performance.
The study found that creatine significantly improved squat strength (1RM) and anaerobic power, including peak and mean performance in Wingate cycling tests. These benefits were observed across both resistance-trained (RT) and non-resistance-trained (non-RT) individuals, suggesting that creatine can enhance explosive performance regardless of training background.
However, when it came to body composition, the effects were more selective. Increases in lean body mass (1.61 kg) and fat-free mass (2.32 kg) were seen only in participants engaged in resistance training. This supports the idea that creatine works best as a “training amplifier,” enhancing the adaptations triggered by structured strength training rather than independently building muscle.
Interestingly, improvements in jump performance were modest and inconsistent, becoming significant mainly in longer studies (eight weeks or more) and among competitive athletes. No meaningful differences were found between daily and non-daily supplementation strategies.
The findings also highlight variability across studies due to differences in training protocols, participant fitness levels, and supplementation methods. Importantly, some of the early gains in lean mass may reflect increased water retention in muscles rather than true muscle growth.
Overall, the research underscores a key takeaway: while creatine can enhance strength and power broadly, pairing it with resistance training is essential for meaningful muscle gains.
REFERENCE: Gu, J. et al. (2026). Creatine supplementation in young men under resistance versus non-resistance training: A systematic review and meta-analysis of strength, performance, and lean mass. Frontiers in Nutrition. 13, 1800546. DOI: https://doi.org/10.3389/fnut.2026.1800546. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1800546/full
Research Shows Breastfeeding Linked to Better Long-Term Weight Outcomes for Mothers
Breastfeeding may shape your health decades later—not just in the months after childbirth.
A new study from the University of Oslo suggests that women who breastfeed for at least three months gain significantly less weight later in life. Published in the American Journal of Clinical Nutrition, the research followed over 170,000 participants from the long-running Women and Health Study in Norway, tracking weight changes from early adulthood into middle age.
The findings reveal a clear long-term benefit. Women who breastfed each child for three to 15 months gained up to 6.5 kilograms less over time compared to those who breastfed for shorter durations. The effect was most pronounced among women who were already overweight or obese before pregnancy. Among women with normal weight, the difference was smaller but still notable—up to 3 kilograms less weight gain over the years.
Researchers say breastfeeding likely contributes to this effect by increasing energy expenditure, as the body uses additional calories to produce milk. However, the relationship is not straightforward. Increased appetite during breastfeeding may offset some of the calorie burn, meaning outcomes can vary between individuals.
Interestingly, the association between breastfeeding and lower long-term weight was strongest among women who had children after 1980. This group is considered more reflective of modern lifestyles, including diet and breastfeeding practices, making the findings especially relevant today.
Beyond individual benefits, the study highlights broader public health implications. Supporting breastfeeding could play a role in reducing long-term weight gain and associated risks such as cardiovascular disease. At the same time, researchers emphasize the importance of personalized care, noting that women—especially those with overweight or obesity—may need additional support after childbirth.
Overall, the study reinforces that breastfeeding is not just beneficial for infants, but may also offer lasting health advantages for mothers well into later life.
REFERENCE: Skammelsrud, T. B., et al. (2026). Breastfeeding duration and maternal weight change through adulthood in a population-based cohort study. The American Journal of Clinical Nutrition. DOI: 10.1016/j.ajcnut.2025.101134. https://ajcn.nutrition.org/article/S0002-9165(25)00726-9/fulltext
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341295-top-medical-2026-04-13t113558157.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 13April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341295-top-medical-2026-04-13t113558157.webp"><p><b>Here are the top medical news for today:</b></p><p><b>New Study Reveals Hidden Drainage System Within the Human Brain
</b></p><p>Your brain is constantly cleaning itself—but scientists have just discovered a hidden “drainage switch” that controls how it happens.
</p><p>A new study published in iScience by researchers at the Medical University of South Carolina (MUSC) has identified a previously unknown control point in the brain’s waste clearance system. The discovery centers on the middle meningeal artery (MMA), a structure now believed to play a crucial role in draining fluids and metabolic waste from the brain.
</p><p>The brain relies on a specialized lymphatic system to remove toxins and maintain healthy function. Until recently, scientists had limited understanding of how this system operates in humans. Using advanced real-time MRI technology—developed through a collaboration with NASA—researchers were able to observe fluid movement in unprecedented detail.
</p><p>In the study, scientists tracked cerebrospinal and interstitial fluid flow in five healthy individuals over a six-hour period. Surprisingly, the fluid traveling along the MMA did not behave like blood, which moves rapidly through arteries. Instead, it flowed slowly and steadily, resembling a drainage system. This provided the first direct evidence that the MMA is involved in lymphatic function rather than just blood circulation.
</p><p>These finding challenges long-standing assumptions about the brain’s isolation from the rest of the body. The brain is protected by layers called the meninges, which were once thought to act as barriers. However, emerging research shows that these layers contain lymphatic vessels that connect the brain to the body’s immune and waste removal systems.
</p><p>By identifying the MMA as a key control point, scientists now have a clearer picture of how the brain clears harmful substances. This could have major implications for conditions such as Alzheimer’s disease and other neurological disorders, where waste buildup is a known factor.
</p><p>The discovery opens new avenues for research, potentially leading to therapies that enhance the brain’s natural cleaning processes and improve long-term brain health.
</p><p><b>REFERENCE: </b>Mehmet Albayram, Sutton B. Richmond, Kaan Yagmurlu, Ibrahim S. Tuna, Eda Karakaya, Hiranmayi Ravichandran, Fatih Tufan, Emal Lesha, Melike Mut, Filiz Bunyak, Yashar.S. Kalani, Adviye Ergul, Rachael D. Seidler, Onder Albayram. Meningeal lymphatic architecture and drainage dynamics surrounding the human middle meningeal artery. iScience, 2025; 28 (11): 113693 DOI: 10.1016/j.isci.2025.113693
</p><p><b><br></b></p><p><b>Creatine Alone Not Enough for Muscle Gain, Resistance Training Key, Study Suggests
</b></p><p>Creatine may boost performance—but its real power depends on how you train.
</p><p>A new systematic review and meta-analysis published in Frontiers in Nutrition reveals that the benefits of creatine supplementation are strongly influenced by training context, particularly resistance training. Researchers analyzed 39 randomized controlled trials involving healthy men aged 18 to 30 to understand how creatine affects strength, anaerobic performance, and body composition.
</p><p>Creatine is widely known for enhancing the phosphocreatine system, which helps rapidly regenerate ATP—the body’s primary energy source during short, high-intensity activities. This makes it a popular supplement among athletes and gym-goers aiming to improve performance.
</p><p>The study found that creatine significantly improved squat strength (1RM) and anaerobic power, including peak and mean performance in Wingate cycling tests. These benefits were observed across both resistance-trained (RT) and non-resistance-trained (non-RT) individuals, suggesting that creatine can enhance explosive performance regardless of training background.
</p><p>However, when it came to body composition, the effects were more selective. Increases in lean body mass (1.61 kg) and fat-free mass (2.32 kg) were seen only in participants engaged in resistance training. This supports the idea that creatine works best as a “training amplifier,” enhancing the adaptations triggered by structured strength training rather than independently building muscle.
</p><p>Interestingly, improvements in jump performance were modest and inconsistent, becoming significant mainly in longer studies (eight weeks or more) and among competitive athletes. No meaningful differences were found between daily and non-daily supplementation strategies.
</p><p>The findings also highlight variability across studies due to differences in training protocols, participant fitness levels, and supplementation methods. Importantly, some of the early gains in lean mass may reflect increased water retention in muscles rather than true muscle growth.
</p><p>Overall, the research underscores a key takeaway: while creatine can enhance strength and power broadly, pairing it with resistance training is essential for meaningful muscle gains.
</p><p><b>REFERENCE:</b> Gu, J. et al. (2026). Creatine supplementation in young men under resistance versus non-resistance training: A systematic review and meta-analysis of strength, performance, and lean mass. Frontiers in Nutrition. 13, 1800546. DOI: https://doi.org/10.3389/fnut.2026.1800546. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1800546/full
</p><p><b><br></b></p><p><b>Research Shows Breastfeeding Linked to Better Long-Term Weight Outcomes for Mothers
</b></p><p>Breastfeeding may shape your health decades later—not just in the months after childbirth.
</p><p>A new study from the University of Oslo suggests that women who breastfeed for at least three months gain significantly less weight later in life. Published in the American Journal of Clinical Nutrition, the research followed over 170,000 participants from the long-running Women and Health Study in Norway, tracking weight changes from early adulthood into middle age.
</p><p>The findings reveal a clear long-term benefit. Women who breastfed each child for three to 15 months gained up to 6.5 kilograms less over time compared to those who breastfed for shorter durations. The effect was most pronounced among women who were already overweight or obese before pregnancy. Among women with normal weight, the difference was smaller but still notable—up to 3 kilograms less weight gain over the years.
</p><p>Researchers say breastfeeding likely contributes to this effect by increasing energy expenditure, as the body uses additional calories to produce milk. However, the relationship is not straightforward. Increased appetite during breastfeeding may offset some of the calorie burn, meaning outcomes can vary between individuals.
</p><p>Interestingly, the association between breastfeeding and lower long-term weight was strongest among women who had children after 1980. This group is considered more reflective of modern lifestyles, including diet and breastfeeding practices, making the findings especially relevant today.
</p><p>Beyond individual benefits, the study highlights broader public health implications. Supporting breastfeeding could play a role in reducing long-term weight gain and associated risks such as cardiovascular disease. At the same time, researchers emphasize the importance of personalized care, noting that women—especially those with overweight or obesity—may need additional support after childbirth.
</p><p>Overall, the study reinforces that breastfeeding is not just beneficial for infants, but may also offer lasting health advantages for mothers well into later life.
</p><p><b>REFERENCE: </b>Skammelsrud, T. B., et al. (2026). Breastfeeding duration and maternal weight change through adulthood in a population-based cohort study. The American Journal of Clinical Nutrition. DOI: 10.1016/j.ajcnut.2025.101134. https://ajcn.nutrition.org/article/S0002-9165(25)00726-9/fulltext
</p>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 13/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-13april2026</link>
<guid>https://edusehat.com/en/health-bulletin-13april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:NBE Releases Tentative 2026 Exam Schedule for FMGE, DNB, DrNB and Diploma CoursesThe National Board of Examinations in Medical Sciences (NBEMS) has released the tentative schedule for upcoming key examinations, including DNB, DrNB, NBE Diploma, and FMGE, for the 2026-2027 academic cycle.As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with NEET-PG 2026 tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.For more details, check out the full story on the link below:FMGE, DNB, DrNB, Diploma: NBE releases tentative schedule of upcoming 2026 exams, detailsMedical Seats Must Not Go Vacant, Says Supreme Court in NEET UG CaseWhile upholding the admission of a NEET UG candidate, the Supreme Court observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court&#039;s direction, the same decision was challenged before the Supreme Court.For more details, check out the full story on the link below:Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud caseForeign Object Left in Patient, No Consent for Procedure; TN Hospitals Ordered to Pay Rs 7 Lakh CompensationThe District Consumer Disputes Redressal Commission, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh compensation to a city resident.According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.For more details, check out the full story on the link below:Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensationAIIMS Expert Warns Semaglutide Cannot Replace Lifestyle ChangesA doctor from the All India Institute of Medical Sciences has cautioned that lifestyle changes cannot be replaced by Semaglutide, highlighting growing misuse of the drug through online pharmacies and wellness clinics in India. Hey noted that while semaglutide is effective for managing type 2 diabetes and weight loss, it requires strict medical supervision. With the drug becoming more affordable after patent expiry, its wider availability has raised concerns about unsupervised consumption and rising health risks.Experts warned that improper use may lead to serious complications such as gastrointestinal issues, pancreatitis, kidney problems, dehydration, and nutritional deficiencies, reports The Hindu.They also flagged misuse for cosmetic weight loss and the risk of temporary results followed by rebound weight gain. Emphasising that diet and exercise remain essential, they stressed the need for stricter enforcement of prescription norms along with better monitoring systems and public awareness to ensure safe and responsible use. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341389-health-bulletin-12.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 13April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341389-health-bulletin-12.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>NBE Releases Tentative 2026 Exam Schedule for FMGE, DNB, DrNB and Diploma Courses</b></p><p>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/NBEMS">NBEMS</a>) has released the tentative <a href="https://medicaldialogues.in/topics/schedule">schedule</a> for upcoming key examinations, including <a href="https://medicaldialogues.in/topics/DNB">DNB</a>, DrNB, <a href="https://medicaldialogues.in/topics/NBEMS-Diploma">NBE Diploma</a>, and FMGE, for the 2026-2027 academic cycle.<b></b></p><div class="pasted-from-word-wrapper"><p>As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with <a href="https://medicaldialogues.in/topics/NEET-PG-2026">NEET-PG 2026</a> tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/nbems-releases-tentative-schedule-for-dnb-drnb-diploma-exams-2026-27-168429"><i><b>FMGE, DNB, DrNB, Diploma: NBE releases tentative schedule of upcoming 2026 exams, details</b></i></a></p><p><b></b></p><p><b>Medical Seats Must Not Go Vacant, Says Supreme Court in NEET UG Case</b></p><p>While upholding the admission of a <a href="https://medicaldialogues.in/topics/NEET-UG">NEET UG</a> candidate, the <a href="https://medicaldialogues.in/topics/Supreme-Court">Supreme Court</a> observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.</p><p>The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court's direction, the same decision was challenged before the Supreme Court.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case-168444"><i><b>Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case</b></i></a></p><p><b></b></p><p><b>Foreign Object Left in Patient, No Consent for Procedure; TN Hospitals Ordered to Pay Rs 7 Lakh Compensation</b></p><p>The <a href="https://medicaldialogues.in/topics/DCDRC">District Consumer Disputes Redressal Commission</a>, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh <a href="https://medicaldialogues.in/topics/compensation">compensation</a> to a city resident.</p><p>According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/foreign-object-inside-patient-during-root-canal-endoscopic-procedure-without-consent-tn-hospitals-slapped-rs-7-lakh-compensation-168455"><i><b>Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensation</b></i></a></p><p><b></b></p><p><b>AIIMS Expert Warns Semaglutide Cannot Replace Lifestyle Changes</b></p><p>A doctor from the All India Institute of Medical Sciences has cautioned that lifestyle changes cannot be replaced by Semaglutide, highlighting growing misuse of the drug through online pharmacies and wellness clinics in India. Hey noted that while semaglutide is effective for managing type 2 diabetes and weight loss, it requires strict medical supervision. With the drug becoming more affordable after patent expiry, its wider availability has raised concerns about unsupervised consumption and rising health risks.</p><p>Experts warned that improper use may lead to serious complications such as gastrointestinal issues, pancreatitis, kidney problems, dehydration, and nutritional deficiencies, reports The Hindu.</p><p>They also flagged misuse for cosmetic weight loss and the risk of temporary results followed by rebound weight gain. Emphasising that diet and exercise remain essential, they stressed the need for stricter enforcement of prescription norms along with better monitoring systems and public awareness to ensure safe and responsible use.</p></div>]]> </content:encoded>
</item>

<item>
<title>NCAHP releases curriculum for 17 allied health courses, mandatory from 2026&#45;27</title>
<link>https://edusehat.com/en/ncahp-releases-curriculum-for-17-allied-health-courses-mandatory-from-2026-27</link>
<guid>https://edusehat.com/en/ncahp-releases-curriculum-for-17-allied-health-courses-mandatory-from-2026-27</guid>
<description><![CDATA[ Mangaluru: The National Commission for Allied and Healthcare Professions (NCAHP) has released curricula for 17 allied health courses and directed institutions to implement them mandatorily from the 2026-27 academic year.Sharing the update, NCAHP Chairperson Yagna Unmesh Shukla said the courses include Occupational Therapy, Respiratory Technology, Medical Physics and Nuclear Medicine Technology. She added that the Commission will soon notify minimum standards for institutions offering allied health programmes.Dr Shukla announced this while speaking at the inauguration of Mangalore Physiocon, an international physiotherapy conference organised by the South Canara Physiotherapy Teachers’ Association in Mangaluru on April 10.She emphasised that all healthcare institutions must adopt the prescribed curriculum for these 17 courses from the 2026–27 session.Saying that the registration of allied and healthcare professions will start soon, she said as reported by TOI, &quot;The regulations for institutions and minimum standards for institutions will be notified, and the big reform is going to come, and we all must be ready. It is our duty to ensure its implementation. So it will be the state&#039;s responsibility to ensure implementation.&quot;&quot;I am very sure that Karnataka will be the first state to implement the curriculum. So many meetings were held, and I do get updates. I am really happy that the Karnataka State Allied &amp; Healthcare Professions Council is doing wonderful. I must say that NCAHP is working tirelessly on standardisation, research promotion, innovation, adoption and equitable access to rehabilitation services,&quot; she said.&quot;The NCAHP Act, 2021, has brought a big reform. It is a big game changer in healthcare in India. Physiotherapy is one of the scheduled professions of Allied and Healthcare Commission, she said.She said that &quot;Physiotherapy was in the frontline to reduce hospital stay, preventing complications, and helping patients to reclaim their lives. Future of physiotherapy was being reshaped by ground-breaking innovation. Quality care is now accessible in the remotest areas. New technology is helping physiotherapist deliver evidence-based efficient patient centric care.&quot;&quot;In India, non-communicable diseases, cardiovascular conditions and musculoskeletal disorders are on the rise, and the ageing population demands greater focus on geriatric care. We all know physiotherapy plays a pivotal role. We all know post-Covid-19, the world witnessed how critical and important rehabilitation is. From restoring lung capacity and mobility in acute care to managing long-term post-Covid viral fatigue and neurological complications, physiotherapists were on the front lines, reducing hospital stays, preventing complications and helping patients reclaim their lives,&quot; she said, adding that the future of physiotherapy is being reshaped by groundbreaking innovations.Karnataka’s Health and Family Welfare Minister Dinesh Gundu Rao told The Hindu, &quot;There is great scope for physiotherapy. Those who practice physiotherapy will have a stable career. The government of Karnataka is committed to make the course more effective and useful to everybody.&quot;Growing demand for Allied health fieldsWith more countries facing a shortage of healthcare workers, allied health courses like nursing, physiotherapy and pharmacy are emerging as strong career options for students, especially those who fail to clear NEET.Speaking at The Hindu Education Plus Career Counselling Fair 2026, E. Theranirajan, Additional Director of Medical Education, Tamil Nadu, said these courses did not require students to appear for the National Eligibility cum Entrance Test (NEET).Medical Dialogues had previously reported that the National Commission for Allied and Healthcare Professions (NCAHP) has announced that appearing in the National Eligibility-Entrance Test (NEET UG) will not be mandatory for admission to Bachelor of Physiotherapy (BPT) and Bachelor of Occupational Therapy (BOT) undergraduate programmes for the academic year 2026-27. In a letter issued to the University Grants Commission (UGC) on March 2nd, the Commission informed that the earlier decision to conduct admissions to these courses through NEET has been deferred to the next academic year 2027–28.Advising students on kind of courses they can pursue in furture, Dr Theranirajan said, &quot;In the backdrop of surging demand for nursing professionals in Europe and other countries, the government of Tamil Nadu was going to start the B.Sc Nursing course in 11 government colleges. Similarly, Physiotherapy was growing in scope both within the country and abroad, while Occupational Therapy was an emerging field in India, but already in high demand abroad. Also, certain diploma courses like Cardio Perfusion Technology were in high demand that could be pursued.&quot;&quot;Occupational Therapy is in high demand abroad and has its uses in the care of children with special needs to make them ambulant. Allied sciences like Forensic Science and Embryology were gaining ground as well,&quot; he added. Speaking about the foreign medical graduates waiting for internship in Tamil Nadu, he said, &quot;Over 600 students have applied for internships in Tamil Nadu and have been on the wait. The portal would be opened up soon for students to be able to choose colleges.&quot;Recalling his time as the Dean of Madras Medical College (MMC) when the COVID-19 pandemic hit, Dr. Theranirajan said &quot;Tamil Nadu became a pioneer in managing the spread of the pandemic, banking primarily on its history of research and publication. We searched the literature and finally arrived at protocols on mild, moderate, or severe cases, and how to go about managing severe cases.&quot;The MMC treated 88,000 COVID-19-affected patients and cured 96 per cent of them. MMC, he added, was ranked 10th in NIRF rankings in 2024 due to its excellence in research, publication, patient care, and academics and diversity of students.Also read- NEET NOT Mandatory for Physiotherapy, occupational therapy admissions this year, requirement deferred to 2027-28 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/09/264157-national-commission-for-allied-and-healthcare-professions.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NCAHP, releases, curriculum, for, allied, health, courses, mandatory, from, 2026-27</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/09/264157-national-commission-for-allied-and-healthcare-professions.webp"><p><b>Mangaluru: </b>The <a href="https://medicaldialogues.in/topics/national-commission-for-allied-and-healthcare-professions" target="_blank">National Commission for Allied and Healthcare Professions (NCAHP</a>) has released curricula for 17 allied health courses and directed institutions to implement them mandatorily from the 2026-27 academic year.</p><p>Sharing the update, NCAHP Chairperson Yagna Unmesh Shukla said the courses include Occupational Therapy, Respiratory Technology, Medical Physics and Nuclear Medicine Technology. She added that the Commission will soon notify minimum standards for institutions offering allied health programmes.</p><p>Dr Shukla announced this while speaking at the inauguration of Mangalore Physiocon, an international <a href="https://medicaldialogues.in/topics/physiotherapy" target="_blank" rel="nofollow">physiotherapy </a>conference organised by the South Canara Physiotherapy Teachers’ Association in Mangaluru on April 10.</p><p>She emphasised that all healthcare institutions must adopt the prescribed curriculum for these 17 courses from the 2026–27 session.</p><p>Saying that the registration of allied and healthcare professions will start soon, she said as reported by <a href="https://timesofindia.indiatimes.com/city/mangaluru/states-should-be-ready-to-implement-regulations-ncahp/articleshow/130177176.cms" target="_blank" rel="nofollow">TOI</a>, "The regulations for institutions and minimum standards for institutions will be notified, and the big reform is going to come, and we all must be ready. It is our duty to ensure its implementation. So it will be the state's responsibility to ensure implementation."</p><p>"I am very sure that Karnataka will be the first state to implement the curriculum. So many meetings were held, and I do get updates. I am really happy that the Karnataka State Allied & Healthcare Professions Council is doing wonderful. I must say that NCAHP is working tirelessly on standardisation, research promotion, innovation, adoption and equitable access to rehabilitation services," she said.</p><p>"The NCAHP Act, 2021, has brought a big reform. It is a big game changer in healthcare in India. Physiotherapy is one of the scheduled professions of Allied and Healthcare Commission, she said.</p><p>She said that "Physiotherapy was in the frontline to reduce hospital stay, preventing complications, and helping patients to reclaim their lives. Future of physiotherapy was being reshaped by ground-breaking innovation. Quality care is now accessible in the remotest areas. New technology is helping physiotherapist deliver evidence-based efficient patient centric care."</p><p>"In India, non-communicable diseases, cardiovascular conditions and musculoskeletal disorders are on the rise, and the ageing population demands greater focus on geriatric care. We all know physiotherapy plays a pivotal role. We all know post-Covid-19, the world witnessed how critical and important rehabilitation is. From restoring lung capacity and mobility in acute care to managing long-term post-Covid viral fatigue and neurological complications, physiotherapists were on the front lines, reducing hospital stays, preventing complications and helping patients reclaim their lives," she said, adding that the future of physiotherapy is being reshaped by groundbreaking innovations.</p><p>Karnataka’s Health and Family Welfare Minister Dinesh Gundu Rao told <a href="https://www.thehindu.com/news/cities/Mangalore/mandatory-to-implement-ncahp-prescribed-curriculum-for-17-allied-health-courses-from-this-year-yagna-unmesh-shukla/article70846348.ece" target="_blank" rel="nofollow">The Hindu,</a> "There is great scope for physiotherapy. Those who practice physiotherapy will have a stable career. The government of Karnataka is committed to make the course more effective and useful to everybody."</p><p><b>Growing demand for Allied health fields</b></p><p>With more countries facing a shortage of healthcare workers, allied health courses like nursing, physiotherapy and pharmacy are emerging as strong career options for students, especially those who fail to clear NEET.</p><p>Speaking at <a href="https://www.thehindu.com/news/national/tamil-nadu/allied-health-fields-do-not-require-neet-and-are-growing-in-scope-with-rising-demand-additional-director-of-medical/article70851253.ece" target="_blank" rel="nofollow">The Hindu</a> Education Plus Career Counselling Fair 2026, E. Theranirajan, Additional Director of Medical Education, Tamil Nadu, said these courses did not require students to appear for the National Eligibility cum Entrance Test (NEET).</p><p>Medical Dialogues had previously reported that the National Commission for Allied and Healthcare Professions (NCAHP) has announced that appearing in the National Eligibility-Entrance Test (NEET UG) will not be mandatory for admission to Bachelor of Physiotherapy (BPT) and Bachelor of Occupational Therapy (BOT) undergraduate programmes for the academic year 2026-27. In a letter issued to the University Grants Commission (UGC) on March 2nd, the Commission informed that the earlier decision to conduct admissions to these courses through NEET has been deferred to the next academic year 2027–28.</p><p>Advising students on kind of courses they can pursue in furture, Dr Theranirajan said, "In the backdrop of surging demand for nursing professionals in Europe and other countries, the government of Tamil Nadu was going to start the B.Sc Nursing course in 11 government colleges. Similarly, Physiotherapy was growing in scope both within the country and abroad, while Occupational Therapy was an emerging field in India, but already in high demand abroad. Also, certain diploma courses like Cardio Perfusion Technology were in high demand that could be pursued."</p><p>"Occupational Therapy is in high demand abroad and has its uses in the care of children with special needs to make them ambulant. Allied sciences like Forensic Science and Embryology were gaining ground as well," he added. </p><p>Speaking about the foreign medical graduates waiting for internship in Tamil Nadu, he said, "Over 600 students have applied for internships in Tamil Nadu and have been on the wait. The portal would be opened up soon for students to be able to choose colleges."</p><p>Recalling his time as the Dean of Madras Medical College (MMC) when the COVID-19 pandemic hit, Dr. Theranirajan said "Tamil Nadu became a pioneer in managing the spread of the pandemic, banking primarily on its history of research and publication. We searched the literature and finally arrived at protocols on mild, moderate, or severe cases, and how to go about managing severe cases."</p><p>The MMC treated 88,000 COVID-19-affected patients and cured 96 per cent of them. MMC, he added, was ranked 10th in NIRF rankings in 2024 due to its excellence in research, publication, patient care, and academics and diversity of students.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-admissions/neet-not-mandatory-for-physiotherapy-occupational-therapy-admissions-this-year-requirement-deferred-to-2027-28-165924" target="_blank">NEET NOT Mandatory for Physiotherapy, occupational therapy admissions this year, requirement deferred to 2027-28</a></b></p>]]> </content:encoded>
</item>

<item>
<title>AIIMS notifies 2779 vacancies for NORCET 10</title>
<link>https://edusehat.com/en/aiims-notifies-2779-vacancies-for-norcet-10</link>
<guid>https://edusehat.com/en/aiims-notifies-2779-vacancies-for-norcet-10</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS) has released the detailed vacancy list for Nursing Officer Recruitment Common Eligibility Test (NORCET) 10, giving candidates a clearer picture of available seats across various institutes.As per the notice issued on April 10, 2026, vacancies have been announced in multiple AIIMS institutions and other participating centres such as JIPMER Puducherry and ESIC hospitals.NORCET 10 VACANT SEATS GIVEN BELOW-
 
 
 
 
  S.No.
  Institute Name
  vacancy position
 
 
  1
  AIIMS BATHINDA
  72
 
 
  2
  AIIMS BHOPAL
  76
 
 
  3
  AIIMS BHUBANESWAR
  55
 
 
  4
  AIIMS DEOGHAR
  104
 
 
  5
  AIIMS GORAKHPUR
  203
 
 
  6
  AIIMS GUWAHATI
  78
 
 
  7
  AIIMS KALYANI
  205
 
 
  8
  AIIMS MANGALAGIRI
  192
 
 
  9
  AIIMS NAGPUR
  80
 
 
  10
  AIIMS RAEBARELI
  86
 
 
  11
  AIIMS NEW DELHI
  282
 
 
  12
  AIIMS PATNA
  168
 
 
  13
  AIIMS RISHIKESH
  64
 
 
  14
  AIIMS, RAIPUR
  43
 
 
  15
  AIIMS VIJAYPUR, JAMMU
  54
 
 
  16
  AIIMS, Madurai
  30
 
 
  17
  CAPFIMS, Maidangarhi
  32
 
 
  18
  NITRD
  5
 
 
  19
  AIIPMR, Mumbai
  2
 
 
  20
  CIP, Ranchi
  13
 
 
  21
  JIPMER, Puducherry
  88
 
 
  22
  JIPMER, Yanam
  7
 
 
  23
  JIPMER, Karaikal
  383
 
 
  24
  SJH, Hospital**
  140
 
 
  25
  Dr. RML, Hospital**
  24
 
 
  26
  KSCH, Hospital
  2
 
 
  27
  LHMC &amp; SSKH
  72
 
 
  28
  ESIC, New Delhi
  219
 
 
  Grand Total
  2779
 The first phase of the computer-based examination for NORCET 10 was held on April 11. While the second phase of the examination will be conducted on April 30. This competitive examination will be held to fill a total of 2,551 posts for Nursing Officers across AIIMS institutions and their associated healthcare centres throughout India.The AIIMS NORCET 10 selection process comprises Phase 1 (Written Examination), Phase 2 Examination, Document Verification, and Medical Examination.To view the official vacancy position released, click the link mentioned below-https://medicaldialogues.in/pdf_upload/2026/04/13/1775897590161-228671941-341318.pdfPreparation of List of Qualified Candidates for Stage IIi. Candidates qualifying as per the scheme of examination in Stage I equal to 5 times the total seats in each category (UR, OBC, SC, ST, EWS) will be called for Stage II subject to the following additional points:1. All qualified PWBD candidates will be called for Stage II.2. All tie cases from the qualified candidates with the last candidate in the list of candidates called for Stage II will also be called for Stage II.3. There may be a situation where a candidate is qualified but not called for Stage II examination.Stage II: NORCET Main.a. Scheme of Examinationi. The duration of the examination shall be 180 minutes.ii. 160 MCQs of 160 marks with four alternatives for each question related to the subject covering the entire syllabus of Nursing courses being taught at the essential qualification level focused towards case scenario-based questions for testing nursing skills competency.iii. There will be a negative marking of 1/3 marks for each wrong answer.iv. Question paper will be divided in 4 sections of 45 minutes each containing 40 questions.v. There will be sequence in which each section, which will be enabled to view/answer questions. Access to visible/active part to view/answer will be disabled after the set duration expires and next section will be automatically activated/ visible and so on.vi. Examination will be submitted automatically after 180 minutes. Each section will appear one by one during180 minutes’ duration at one time only for the set section duration. You will be allowed only to attempt questions in the currently active section which will remain enable for set time and it will never come back again for any action after moved to next section.vii. You will not be allowed to view or answer any questions section rather than currently active/visible section. Hence attempt all possible question during the given time period including review of any skipped question or question marked for review etc.viii. The qualifying (percentage) marks in the NORCET Examination will be 50% for UR/EWS, 45% for OBC and 40% for SC &amp; ST.For PWBD, an additional 5% relaxation will be given irrespective of the category. Accordingly, qualifying marks for PWBD will be as follows UR/EWS-PWBD-45%, OBC-PWBD-40% and SC/ST-PWBD-35%). As per DOPT office memorandum No. No.36035/02/2017-Estt (Res) dated 15.01.2018, the same relaxed standard should be applied for all the candidates with Benchmark Disabilities whether they belong to Unreserved/SC/ST/OBC. No further relaxation of standards will be considered or admissible in favour of any candidate from any category whatsoever.ix. If a CBT examination is conducted in multiple shifts, the respective normalisation procedure at AIIMS published vide Notice No. 35/2023 dated 20.01.2023 shall be applicable.b. Resolution of Tie CasesIn cases where more than one candidate secures equal MARKS, tie will be resolved;(i) First, by using date of birth with older candidates placed higher;(ii) If not resolved by (i), the number of wrong answers / negative marks will be used, wherein those with fewer wrong answers / negative marks will be placed higher; Merit will be reflected accordingly in the NORCET Score.a. SyllabusThe syllabus will be in accordance with education qualification and experience as mentioned in the Eligibility Section/Advertisement.b. Preparation of Merit List &amp; Allocation of Seats (Based on Stage II NORCET Mains)a) Merit List of qualified candidates shall be prepared based on performance in CBT as per qualifying criteria in Stage II NORCET Mains only. If a CBT examination is conducted in multiple shifts, the respective normalisation procedure at AIIMS published vide Notice No. 35/2023 dated 20.01.2023 shall be applicable.b) There may be a situation where a candidate is qualified but not eligible for any or all participating Institute/Hospital.c) Choices will be invited only from qualified, eligible candidates as per applicable eligibility criteria.d) There will only be one round of allocation of seats in general.e) Allocation of seats will be made in order of merit out of choices made by the candidate in order of preference.f) A candidate to whom a seat has been allocated out of any choice filled is mandatorily required to join the allocated seat subject to eligibility as applicable. Hence candidates are advised to fill in only those choices where they will join, as failure to join an allocated seat for any reason(s) shall lead to mandatory cancellation of candidature for that NORCET.g) There will not be any waiting list for NORCET to fill any remaining advertised vacancy from the pool of remaining candidates in the merit list, as NORCET has been planned to be conducted twice in a year.h) Detail Information on the allocation process will be published with the invitation of choices after the declaration of a list of qualified candidates.i) AIIMS reserves the right to invite choices at any time during the process of recruitment.Also Read:AIIMS NORCET 10 registrations begin, check complete details HERE! ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341316-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-68.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, notifies, 2779, vacancies, for, NORCET</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341316-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-68.webp"><div class="pasted-from-word-wrapper"><strong data-start="0" data-end="14">New Delhi: </strong>The All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/AIIMS">AIIMS)</a> has released the detailed vacancy list for Nursing Officer Recruitment Common Eligibility Test (<a href="https://medicaldialogues.in/topics/norcet">NORCET</a>) 10, giving candidates a clearer picture of available seats across various institutes.</div><div class="pasted-from-word-wrapper">As per the notice issued on April 10, 2026, vacancies have been announced in multiple AIIMS institutions and other participating centres such as JIPMER Puducherry and ESIC hospitals.</div><div class="pasted-from-word-wrapper"><b>NORCET 10 VACANT SEATS GIVEN BELOW-</b></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="312">
 <colgroup><col width="74">
 <col width="109">
 <col width="129">
 </colgroup><tbody><tr height="18">
  <td height="18" class="xl69" width="74"><b>S.No.</b></td>
  <td class="xl64" width="109"><b>Institute Name</b></td>
  <td class="xl63" width="129"><b>vacancy position</b></td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">1</td>
  <td class="xl66" width="109">AIIMS BATHINDA</td>
  <td class="xl65" width="129">72</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">2</td>
  <td class="xl66" width="109">AIIMS BHOPAL</td>
  <td class="xl65" width="129">76</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">3</td>
  <td class="xl66" width="109">AIIMS BHUBANESWAR</td>
  <td class="xl65" width="129">55</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">4</td>
  <td class="xl66" width="109">AIIMS DEOGHAR</td>
  <td class="xl65" width="129">104</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">5</td>
  <td class="xl66" width="109">AIIMS GORAKHPUR</td>
  <td class="xl65" width="129">203</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">6</td>
  <td class="xl66" width="109">AIIMS GUWAHATI</td>
  <td class="xl65" width="129">78</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">7</td>
  <td class="xl66" width="109">AIIMS KALYANI</td>
  <td class="xl65" width="129">205</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">8</td>
  <td class="xl66" width="109">AIIMS MANGALAGIRI</td>
  <td class="xl65" width="129">192</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">9</td>
  <td class="xl66" width="109">AIIMS NAGPUR</td>
  <td class="xl65" width="129">80</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">10</td>
  <td class="xl66" width="109">AIIMS RAEBARELI</td>
  <td class="xl65" width="129">86</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">11</td>
  <td class="xl66" width="109">AIIMS NEW DELHI</td>
  <td class="xl65" width="129">282</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">12</td>
  <td class="xl66" width="109">AIIMS PATNA</td>
  <td class="xl65" width="129">168</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">13</td>
  <td class="xl66" width="109">AIIMS RISHIKESH</td>
  <td class="xl65" width="129">64</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">14</td>
  <td class="xl66" width="109">AIIMS, RAIPUR</td>
  <td class="xl65" width="129">43</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">15</td>
  <td class="xl66" width="109">AIIMS VIJAYPUR, JAMMU</td>
  <td class="xl65" width="129">54</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">16</td>
  <td class="xl66" width="109">AIIMS, Madurai</td>
  <td class="xl65" width="129">30</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">17</td>
  <td class="xl66" width="109">CAPFIMS, Maidangarhi</td>
  <td class="xl65" width="129">32</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">18</td>
  <td class="xl66" width="109">NITRD</td>
  <td class="xl65" width="129">5</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">19</td>
  <td class="xl66" width="109">AIIPMR, Mumbai</td>
  <td class="xl65" width="129">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">20</td>
  <td class="xl66" width="109">CIP, Ranchi</td>
  <td class="xl65" width="129">13</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">21</td>
  <td class="xl66" width="109">JIPMER, Puducherry</td>
  <td class="xl65" width="129">88</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">22</td>
  <td class="xl66" width="109">JIPMER, Yanam</td>
  <td class="xl65" width="129">7</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">23</td>
  <td class="xl66" width="109">JIPMER, Karaikal</td>
  <td class="xl65" width="129">383</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">24</td>
  <td class="xl66" width="109">SJH, Hospital**</td>
  <td class="xl65" width="129">140</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">25</td>
  <td class="xl66" width="109">Dr. RML, Hospital**</td>
  <td class="xl65" width="129">24</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">26</td>
  <td class="xl66" width="109">KSCH, Hospital</td>
  <td class="xl65" width="129">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">27</td>
  <td class="xl66" width="109">LHMC & SSKH</td>
  <td class="xl65" width="129">72</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="74">28</td>
  <td class="xl68" width="109">ESIC, New Delhi</td>
  <td class="xl65" width="129">219</td>
 </tr>
 <tr height="18">
  <td colspan="2" height="18" class="xl71" width="183"><b>Grand Total</b></td>
  <td class="xl67" width="129"><b>2779</b></td>
 </tr></tbody></table></div><div class="pasted-from-word-wrapper"><span>The first phase of the computer-based examination for NORCET 10 was held on April 11. While the second phase of the examination will be conducted on April 30. This competitive examination will be held to fill a total of 2,551 posts for Nursing Officers across AIIMS institutions and their associated healthcare centres throughout India.</span></div><p>The AIIMS NORCET 10 selection process comprises Phase 1 (Written Examination), Phase 2 Examination, Document Verification, and Medical Examination.</p><p><b><i>To view the official vacancy position released, click the link mentioned below-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/13/1775897590161-228671941-341318.pdf">https://medicaldialogues.in/pdf_upload/2026/04/13/1775897590161-228671941-341318.pdf</a><a href="https://medicaldialogues.in/pdf_upload/2026/04/13/1775897590161-228671941-341318.pdf" target="_blank"><b><i></i></b></a></p><p>Preparation of List of Qualified Candidates for Stage II</p><div class="pasted-from-word-wrapper"><p>i. Candidates qualifying as per the scheme of examination in Stage I equal to 5 times the total seats in each category (UR, OBC, SC, ST, EWS) will be called for Stage II subject to the following additional points:</p><p>1. All qualified PWBD candidates will be called for Stage II.</p><p>2. All tie cases from the qualified candidates with the last candidate in the list of candidates called for Stage II will also be called for Stage II.</p><p>3. There may be a situation where a candidate is qualified but not called for Stage II examination.</p><p>Stage II: NORCET Main.</p><p>a. Scheme of Examination</p><p>i. The duration of the examination shall be 180 minutes.</p><p>ii. 160 MCQs of 160 marks with four alternatives for each question related to the subject covering the entire syllabus of Nursing courses being taught at the essential qualification level focused towards case scenario-based questions for testing nursing skills competency.</p><p>iii. There will be a negative marking of 1/3 marks for each wrong answer.</p><p>iv. Question paper will be divided in 4 sections of 45 minutes each containing 40 questions.</p><p>v. There will be sequence in which each section, which will be enabled to view/answer questions. Access to visible/active part to view/answer will be disabled after the set duration expires and next section will be automatically activated/ visible and so on.</p><p>vi. Examination will be submitted automatically after 180 minutes. Each section will appear one by one during180 minutes’ duration at one time only for the set section duration. You will be allowed only to attempt questions in the currently active section which will remain enable for set time and it will never come back again for any action after moved to next section.</p><p>vii. You will not be allowed to view or answer any questions section rather than currently active/visible section. Hence attempt all possible question during the given time period including review of any skipped question or question marked for review etc.</p><p>viii. The qualifying (percentage) marks in the NORCET Examination will be 50% for UR/EWS, 45% for OBC and 40% for SC & ST.</p><p>For PWBD, an additional 5% relaxation will be given irrespective of the category. Accordingly, qualifying marks for PWBD will be as follows UR/EWS-PWBD-45%, OBC-PWBD-40% and SC/ST-PWBD-35%). As per DOPT office memorandum No. No.36035/02/2017-Estt (Res) dated 15.01.2018, the same relaxed standard should be applied for all the candidates with Benchmark Disabilities whether they belong to Unreserved/SC/ST/OBC. No further relaxation of standards will be considered or admissible in favour of any candidate from any category whatsoever.</p><p>ix. If a CBT examination is conducted in multiple shifts, the respective normalisation procedure at AIIMS published vide Notice No. 35/2023 dated 20.01.2023 shall be applicable.</p><p>b. Resolution of Tie Cases</p><p>In cases where more than one candidate secures equal MARKS, tie will be resolved;</p><p>(i) First, by using date of birth with older candidates placed higher;</p><p>(ii) If not resolved by (i), the number of wrong answers / negative marks will be used, wherein those with fewer wrong answers / negative marks will be placed higher; Merit will be reflected accordingly in the NORCET Score.</p><p>a. Syllabus</p><p>The syllabus will be in accordance with education qualification and experience as mentioned in the Eligibility Section/Advertisement.</p><p>b. Preparation of Merit List & Allocation of Seats (Based on Stage II NORCET Mains)</p><p>a) Merit List of qualified candidates shall be prepared based on performance in CBT as per qualifying criteria in Stage II NORCET Mains only. If a CBT examination is conducted in multiple shifts, the respective normalisation procedure at AIIMS published vide Notice No. 35/2023 dated 20.01.2023 shall be applicable.</p><p>b) There may be a situation where a candidate is qualified but not eligible for any or all participating Institute/Hospital.</p><p>c) Choices will be invited only from qualified, eligible candidates as per applicable eligibility criteria.</p><p>d) There will only be one round of allocation of seats in general.</p><p>e) Allocation of seats will be made in order of merit out of choices made by the candidate in order of preference.</p><p>f) A candidate to whom a seat has been allocated out of any choice filled is mandatorily required to join the allocated seat subject to eligibility as applicable. Hence candidates are advised to fill in only those choices where they will join, as failure to join an allocated seat for any reason(s) shall lead to mandatory cancellation of candidature for that NORCET.</p><p>g) There will not be any waiting list for NORCET to fill any remaining advertised vacancy from the pool of remaining candidates in the merit list, as NORCET has been planned to be conducted twice in a year.</p><p>h) Detail Information on the allocation process will be published with the invitation of choices after the declaration of a list of qualified candidates.</p><p>i) AIIMS reserves the right to invite choices at any time during the process of recruitment.</p></div><p><br></p><p><br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-registrations-begin-check-complete-details-here-165416"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/02/25/329590-education-2026-02-25t145408482.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-registrations-begin-check-complete-details-here-165416"><span class="read-this-also">Also Read:</span>AIIMS NORCET 10 registrations begin, check complete details HERE!</a><div></div></div></div><p><br></p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"></div></div>]]> </content:encoded>
</item>

<item>
<title>Foreign Object Left in Patient, No Consent for Procedure; TN Hospitals Ordered to Pay Rs 7 Lakh Compensation</title>
<link>https://edusehat.com/en/foreign-object-left-in-patient-no-consent-for-procedure-tn-hospitals-ordered-to-pay-rs-7-lakh-compensation</link>
<guid>https://edusehat.com/en/foreign-object-left-in-patient-no-consent-for-procedure-tn-hospitals-ordered-to-pay-rs-7-lakh-compensation</guid>
<description><![CDATA[ The District Consumer Disputes Redressal Commission, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh compensation to a city resident.According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.For
more details, check out the full story on the link below:Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensation ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341376-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-72.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Foreign, Object, Left, Patient, Consent, for, Procedure, Hospitals, Ordered, Pay, Lakh, Compensation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341376-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-72.webp"><div class="pasted-from-word-wrapper"><p>The <a href="https://medicaldialogues.in/topics/DCDRC">District Consumer Disputes Redressal Commission</a>, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh <a href="https://medicaldialogues.in/topics/compensation">compensation</a> to a city resident.</p><p>According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.</p><p><b><i>For
more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/foreign-object-inside-patient-during-root-canal-endoscopic-procedure-without-consent-tn-hospitals-slapped-rs-7-lakh-compensation-168455"><b><i>Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensation</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Nagpur doctor arrested for abetting suicide of 28&#45;year&#45;old air hostess</title>
<link>https://edusehat.com/en/nagpur-doctor-arrested-for-abetting-suicide-of-28-year-old-air-hostess</link>
<guid>https://edusehat.com/en/nagpur-doctor-arrested-for-abetting-suicide-of-28-year-old-air-hostess</guid>
<description><![CDATA[ Nagpur: A doctor from Umred has been arrested on charges of abetting the suicide
of his girlfriend, a 28-year-old air hostess, police said. The air hostess allegedly died by suicide following a heated phone argument with him.According to
investigators, the woman and the doctor, both 28 years old, were in a relationship. Authorities have taken the doctor into custody as part of the probe into the circumstances
surrounding her death. Also Read:BDS student dies after fall in Kannur, Harassment allegations surface, 2 faculty suspendedPolice confirmed that the
couple was in a serious relationship and was planning to
get married soon. They had reportedly informed their family members about the relationship and sought
their approval, which was given.

According to The Times of India, on April 3, the deceased’s family members travelled to Bhandara to
attend a family function. Meanwhile, she called the doctor on his mobile at around 2 am and got into a heated argument with him. Police said that
the situation escalated, and she reportedly threatened her partner with taking her own life
before disconnecting the call. The doctor got scared and rushed to her
residence. He tried to secure a response by knocking on the door repeatedly.
However, there was no response.

 The doctor informed the local police and her
family members. Police came and forced the door open and found her hanging. Her
family members returned from Bhandara only to find her dead body hanging. Initially, the Lakadganj police registered an accidental death case. However, during the
investigation, police came to know that instead of handling the situation, the
doctor seemed to escalate the quarrel, which might have forced the deceased to
take the drastic step. Hence, a case of abetment has been registered against
the doctor. Also Read:AIIMS Rajkot MBBS suicide case: HC seeks state reply after 5 accused students appeal to quash abetment charge ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Nagpur, doctor, arrested, for, abetting, suicide, 28-year-old, air, hostess</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.webp"><p>Nagpur: A doctor from Umred has been arrested on charges of abetting the <a href="https://medicaldialogues.in/topics/suicide" target="_blank">suicide</a>
of his girlfriend, a 28-year-old air hostess, police said. The air hostess allegedly died by suicide following a heated phone argument with him.</p><p>According to
investigators, the woman and the doctor, both 28 years old, were in a relationship. Authorities have taken the doctor into custody as part of the probe into the circumstances
surrounding her death. <br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/kerala/bds-student-dies-after-fall-in-kannur-harassment-allegations-surface-2-faculty-suspended-168526"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/03/30/338444-dead.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/kerala/bds-student-dies-after-fall-in-kannur-harassment-allegations-surface-2-faculty-suspended-168526"><span class="read-this-also">Also Read:</span>BDS student dies after fall in Kannur, Harassment allegations surface, 2 faculty suspended</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>Police confirmed that the
couple was in a serious relationship and was planning to
get married soon. They had reportedly informed their family members about the relationship and sought
their approval, which was given.</p>

<p>According to The <a href="https://timesofindia.indiatimes.com/city/nagpur/air-hostess-dies-by-suicide-doctor-arrested-for-abetment/articleshow/130198823.cms" target="_blank" rel="nofollow">Times of India</a>, on April 3, the deceased’s family members travelled to Bhandara to
attend a family function. Meanwhile, she called the doctor on his mobile at around 2 am and got into a heated argument with him. Police said that
the situation escalated, and she reportedly threatened her partner with taking her own life
before disconnecting the call. The doctor got scared and rushed to her
residence. He tried to secure a response by knocking on the door repeatedly.
However, there was no response.</p>

<p> The doctor informed the local police and her
family members. Police came and forced the door open and found her hanging. Her
family members returned from Bhandara only to find her dead body hanging. </p><p>Initially, the Lakadganj police registered an accidental death case. However, during the
investigation, police came to know that instead of handling the situation, the
doctor seemed to escalate the quarrel, which might have forced the deceased to
take the drastic step. Hence, a case of abetment has been registered against
the doctor. </p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/gujarat/aiims-rajkot-mbbs-suicide-case-hc-seeks-state-reply-after-5-accused-students-appeal-to-quash-abetment-charge-168400"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2020/05/26/129368-hc-gujarat.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/gujarat/aiims-rajkot-mbbs-suicide-case-hc-seeks-state-reply-after-5-accused-students-appeal-to-quash-abetment-charge-168400"><span class="read-this-also">Also Read:</span>AIIMS Rajkot MBBS suicide case: HC seeks state reply after 5 accused students appeal to quash abetment charge</a></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS Expert Warns Semaglutide Cannot Replace Lifestyle Changes</title>
<link>https://edusehat.com/en/aiims-expert-warns-semaglutide-cannot-replace-lifestyle-changes</link>
<guid>https://edusehat.com/en/aiims-expert-warns-semaglutide-cannot-replace-lifestyle-changes</guid>
<description><![CDATA[ A doctor from the All India Institute of Medical Sciences has cautioned that lifestyle changes cannot be replaced by Semaglutide, highlighting growing misuse of the drug through online pharmacies and wellness clinics in India. Hey noted that while semaglutide is effective for managing type 2 diabetes and weight loss, it requires strict medical supervision. With the drug becoming more affordable after patent expiry, its wider availability has raised concerns about unsupervised consumption and rising health risks.Experts warned that improper use may lead to serious complications such as gastrointestinal issues, pancreatitis, kidney problems, dehydration, and nutritional deficiencies, reports The Hindu.They also flagged misuse for cosmetic weight loss and the risk of temporary results followed by rebound weight gain. Emphasising that diet and exercise remain essential, they stressed the need for stricter enforcement of prescription norms along with better monitoring systems and public awareness to ensure safe and responsible use. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341387-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-73.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Expert, Warns, Semaglutide, Cannot, Replace, Lifestyle, Changes</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341387-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-73.webp"><p>A doctor from the All India Institute of Medical Sciences has cautioned that lifestyle changes cannot be replaced by Semaglutide, highlighting growing misuse of the drug through online pharmacies and wellness clinics in India. Hey noted that while semaglutide is effective for managing type 2 diabetes and weight loss, it requires strict medical supervision. With the drug becoming more affordable after patent expiry, its wider availability has raised concerns about unsupervised consumption and rising health risks.</p><p>Experts warned that improper use may lead to serious complications such as gastrointestinal issues, pancreatitis, kidney problems, dehydration, and nutritional deficiencies, reports The Hindu.</p><p>They also flagged misuse for cosmetic weight loss and the risk of temporary results followed by rebound weight gain. Emphasising that diet and exercise remain essential, they stressed the need for stricter enforcement of prescription norms along with better monitoring systems and public awareness to ensure safe and responsible use.</p>]]> </content:encoded>
</item>

<item>
<title>Deoria clinic dispute over prescription goes viral, patient alleges assault</title>
<link>https://edusehat.com/en/deoria-clinic-dispute-over-prescription-goes-viral-patient-alleges-assault</link>
<guid>https://edusehat.com/en/deoria-clinic-dispute-over-prescription-goes-viral-patient-alleges-assault</guid>
<description><![CDATA[ Deoria: A dispute at a private clinic in Deoria, Uttar Pradesh, has sparked controversy after allegations of patient assault and misconduct surfaced, with a video of the incident circulating widely on social media. According to news reports, the incident occurred at a dermatologist&#039;s clinic, where a patient reportedly sought the names of the medicines listed in his prescription, claiming that the handwriting was unclear. He further alleged that even the pharmacists at a Pradhan Mantri Jan Aushadhi Yojana centre were unable to decipher them.Also Read:AIOCD Flags AI-Generated Fake Prescriptions, Writes to PM Seeking Shutdown of Unregulated E-PharmaciesThe patient further alleged that when he requested clarification, clinic staff refused to disclose the names of the medicines, leading to an argument. The situation reportedly escalated when the dermatologist’s husband, also a doctor, pushed the patient out of the clinic.वायरल वीडियो के अनुसार डॉ दीप्ति तिवारी क्लिनिक देवरिया जहां मरीज के साथ मारपीट होती है उनको इलाज में दी जाने वाली मेडिसिन के बारे मे नही बताया जाता है क्या पेशेंट को हक नहीं है दवाई जानने का, कहीं प्रतिबंधित दवाई तो नहीं है, क्लीनिक मान्यता और डॉक्टर की डिग्री रद्द करनी चाहिए pic.twitter.com/AvheeVOMBp— Mukesh kumar (@Mk6401) April 10, 2026 The patient has also alleged that additional individuals were called in during the confrontation, and that he was verbally abused, threatened, and physically assaultedThe victim questioned the incident, saying that if patients are not informed about the medication they are receiving, how can government programs aimed at providing affordable and accessible medicines be successful? He expressed concern that patients are being forced to purchase their medication from private clinics, reports Bhaskar English.
The incident has triggered debate over patient rights, prescription transparency, and conduct within private healthcare facilities.
As of now, there has been no official response from the doctor or the clinic regarding the allegations. Police and health department officials are expected to take further action if a formal complaint is filed and an investigation is initiated.Also Read:AIIMS Delhi doctors told to use Hindi in prescriptions, sparks debate ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/09/11/252008-prescription.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Deoria, clinic, dispute, over, prescription, goes, viral, patient, alleges, assault</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/09/11/252008-prescription.webp"><p><b>Deoria: </b>A dispute at a <a href="https://medicaldialogues.in/topics/private-practice">private clinic</a> in Deoria, Uttar Pradesh, has sparked controversy after allegations of patient <a href="https://medicaldialogues.in/topics/assault" rel="nofollow">assault </a>and misconduct surfaced, with a video of the incident circulating widely on social media. </p><p>According to news reports, the incident occurred at a dermatologist's clinic, where a patient reportedly sought the names of the medicines listed in his prescription, claiming that the handwriting was unclear. He further alleged that even the pharmacists at a <a href="https://medicaldialogues.in/topics/jan-aushadhi-kendra">Pradhan Mantri Jan Aushadhi Yojana</a> centre were unable to decipher them.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/industry-perspective/aiocd-flags-ai-generated-fake-prescriptions-writes-to-pm-seeking-shutdown-of-unregulated-e-pharmacies-165150"><b>Also Read:AIOCD Flags AI-Generated Fake Prescriptions, Writes to PM Seeking Shutdown of Unregulated E-Pharmacies</b></a></p><p>The patient further alleged that when he requested clarification, clinic staff refused to disclose the names of the medicines, leading to an argument. The situation reportedly escalated when the dermatologist’s husband, also a doctor, pushed the patient out of the clinic.</p><div class="hocal-draggable" draggable="true"><div class="h-embed" contenteditable="false"><div class="h-embed-wrapper"><blockquote contenteditable="false" class="twitter-tweet"><p lang="hi" dir="ltr">वायरल वीडियो के अनुसार डॉ दीप्ति तिवारी क्लिनिक देवरिया जहां मरीज के साथ मारपीट होती है उनको इलाज में दी जाने वाली मेडिसिन के बारे मे नही बताया जाता है क्या पेशेंट को हक नहीं है दवाई जानने का, कहीं प्रतिबंधित दवाई तो नहीं है, क्लीनिक मान्यता और डॉक्टर की डिग्री रद्द करनी चाहिए <a href="https://t.co/AvheeVOMBp">pic.twitter.com/AvheeVOMBp</a></p>— Mukesh kumar (@Mk6401) <a href="https://twitter.com/Mk6401/status/2042555454837182800?ref_src=twsrc%5Etfw">April 10, 2026</a></blockquote> </div></div></div><p>The patient has also alleged that additional individuals were called in during the confrontation, and that he was verbally abused, threatened, and physically assaulted</p><p>The victim questioned the incident, saying that if patients are not informed about the medication they are receiving, how can government programs aimed at providing affordable and accessible medicines be successful? He expressed concern that patients are being forced to purchase their medication from private clinics, reports <a href="https://www.bhaskar.com/local/uttar-pradesh/deoria/news/devriya-doctor-assault-video-viral-137669114.html" rel="nofollow">Bhaskar English</a>.
</p><p>The incident has triggered debate over patient rights, prescription transparency, and conduct within private healthcare facilities.
</p><p>As of now, there has been no official response from the doctor or the clinic regarding the allegations. Police and health department officials are expected to take further action if a formal complaint is filed and an investigation is initiated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/aiims-delhi-doctors-told-to-use-hindi-in-prescriptions-sparks-debate-158069"><b>Also Read:AIIMS Delhi doctors told to use Hindi in prescriptions, sparks debate</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Elderly medical officer duped of Rs 2 Crore in digital arrest scam</title>
<link>https://edusehat.com/en/elderly-medical-officer-duped-of-rs-2-crore-in-digital-arrest-scam</link>
<guid>https://edusehat.com/en/elderly-medical-officer-duped-of-rs-2-crore-in-digital-arrest-scam</guid>
<description><![CDATA[ Nagpur: In a major case of cyber fraud, a 76-year-old retired medical officer from Laxmi Nagar, Maharashtra, was allegedly swindled out of Rs 2 crore through a &#039;digital arrest&#039; scam. The fraudsters who perpetrated this fraud claimed that his bank account was linked to terrorist activities.  The fraudsters posed as officials from the Supreme Court, the ED, the Mumbai Police, and the RBI; the accused allegedly sent fake documents bearing official government seals via WhatsApp and instructed the elderly citizen to transfer money online from their bank accounts.  Also Read: Digital Arrest Fraud: Bihar doctor duped of Rs 19 lakh; accused arrestedFollowing the incident, the victim lodged a complaint at the Cyber ​​Police Station on Saturday, based on which an FIR was registered. According to the complaint, the complainant received threatening messages on his mobile number between March 23 and April 3.However, the police have invoked relevant sections of the BNS, including 318(4), 319(2), 336(2), 340(1), 204, and 61(2), as well as Section 66 of the Information Technology Act. No arrests have been made so far, reports TOI. Meanwhile, Cyber ​​experts have warned citizens, particularly senior citizens, not to share their personal information or transfer money in response to calls claiming a &quot;digital arrest&quot; or a fake warrant.Medical Dialogues had earlier reported that a 90-year-old retired Air Force doctor in Gwalior, Madhya Pradesh, was allegedly duped of approximately Rs 2.5 crore after being kept under “digital arrest” for nearly 25 days by cyber fraudsters. According to the complaint, the doctor received a phone call on January 25 from an individual claiming to be associated with an investigating agency. The caller alleged that the doctor’s official documents had been misused in illegal activities and warned him of imminent arrest and legal consequences. Also Read: 90-year-old retired Air Force doctor loses Rs 2.5 crore in digital arrest ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/11/09/259989-digital-arrest.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Elderly, medical, officer, duped, Crore, digital, arrest, scam</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/11/09/259989-digital-arrest.webp"><p>Nagpur: In a major case of <a href="https://medicaldialogues.in/topics/cyber-fraud" target="_blank">cyber fraud</a>, a 76-year-old retired medical officer from Laxmi Nagar, Maharashtra, was allegedly swindled out of Rs 2 crore through a '<a href="https://medicaldialogues.in/topics/digital-arrest" target="_blank">digital arrest</a>' scam. The fraudsters who perpetrated this fraud claimed that his bank account was linked to terrorist activities.  </p><div class="pasted-from-word-wrapper"><p dir="ltr">The fraudsters posed as officials from the Supreme Court, the ED, the Mumbai Police, and the RBI; the accused allegedly sent fake documents bearing official government seals via WhatsApp and instructed the elderly citizen to transfer money online from their bank accounts.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/digital-arrest-fraud-bihar-doctor-duped-of-rs-19-lakh-accused-arrested-165406"><b>Also Read: </b>Digital Arrest Fraud: Bihar doctor duped of Rs 19 lakh; accused arrested</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Following the incident, the victim lodged a complaint at the Cyber ​​Police Station on Saturday, based on which an FIR was registered. According to the complaint, the complainant received threatening messages on his mobile number between March 23 and April 3.</p><p dir="ltr">However, the police have invoked relevant sections of the BNS, including 318(4), 319(2), 336(2), 340(1), 204, and 61(2), as well as Section 66 of the Information Technology Act. No arrests have been made so far, reports <a href="https://timesofindia.indiatimes.com/city/nagpur/retd-medical-officer-in-digital-arrest-duped-of-rs2cr/articleshow/130216533.cms" target="_blank" rel="nofollow">TOI</a>. </p><p dir="ltr">Meanwhile, Cyber ​​experts have warned citizens, particularly senior citizens, not to share their personal information or transfer money in response to calls claiming a "digital arrest" or a fake warrant.</p><p dir="ltr">Medical Dialogues had earlier reported that a 90-year-old retired Air Force doctor in Gwalior, Madhya Pradesh, was allegedly duped of approximately Rs 2.5 crore after being kept under “digital arrest” for nearly 25 days by cyber fraudsters. According to the complaint, the doctor received a phone call on January 25 from an individual claiming to be associated with an investigating agency. The caller alleged that the doctor’s official documents had been misused in illegal activities and warned him of imminent arrest and legal consequences. </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/90-year-old-retired-air-force-doctor-loses-rs-25-crore-in-digital-arrest-165399"><b>Also Read: </b>90-year-old retired Air Force doctor loses Rs 2.5 crore in digital arrest</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Renowned Neurosurgeon Prof Dr Sureswar Mohanty passes away at 83</title>
<link>https://edusehat.com/en/renowned-neurosurgeon-prof-dr-sureswar-mohanty-passes-away-at-83</link>
<guid>https://edusehat.com/en/renowned-neurosurgeon-prof-dr-sureswar-mohanty-passes-away-at-83</guid>
<description><![CDATA[ Bhubaneswar: In a tragic loss to the medical fraternity, eminent neurosurgeon and academician Prof. (Dr.) Sureswar Mohanty passed away in Bhubaneswar at the age of 83. According to the news reports, he had been ailing for some time and breathed his last while undergoing treatment at IMS and SUM Hospital. Prof. Mohanty, regarded as one of India’s most respected neurosurgeons, is survived by his daughter.Also Read:Dr Seshagiri Rao Mallampati, Pioneer of Mallampati Score, Passes Away at 85Dr Mohanty completed his MBBS from S.C.B. Medical College, Cuttack, and obtained his M.Ch in Neurosurgery from the All India Institute of Medical Sciences (AIIMS), New Delhi. He went on to serve as Professor and Head of the Department of Neurosurgery at the Institute of Medical Sciences, Banaras Hindu University (BHU), where he later also served as Director. During his distinguished career, he received advanced neurosurgical training at leading global centres, including institutes in London, Moscow’s Burdenko Institute, and the Cleveland Clinic in the United States, which helped him bring modern neurosurgical techniques to India. After retiring from IMS-BHU, he returned to Odisha and played a key role in establishing the Institute of Medical Sciences and SUM Hospital, where he served as the first Principal and Dean. Prof. Mohanty has published nearly 150 research papers in reputed national and international medical journals. He was honoured by several national bodies, including the Indian Council of Medical Research (ICMR), Medical Council of India (MCI), and Neurological Society of India (NSI). He was also a Fellow of the National Academy of Medical Sciences (NAMS) and a recipient of the Dr. B.C. Roy Award, India’s highest medical honour.
Throughout his career, he held several leadership positions, including President of the Uttar Pradesh Neurosciences Society and President of the Neurotrauma Society of India. He was widely regarded as a pioneer in advancing modern neurosurgery in eastern India and played a key role in building high-level neurosurgical training programs, bridging global medical practices with Indian healthcare systems.
The Neurological Society of India deeply mourned the passing of Prof. (Dr.) Mohanty describes him as a highly accomplished professional, dedicated clinician, and mentor. Several leading healthcare professionals, including Prof. (Dr.) Ashok Mahapatra, eminent neurosurgeon, former Vice-Chancellor of SOA Deemed to be University, former Head of Department of Neurosurgery, AIIMS, New Delhi, and Founding Director of AIIMS, Bhubaneswar, Prof. (Dr.) Sanghamitra Mishra, Dean of IMS and SUM Hospital, Prof. (Dr.) Pusparaj Samantasinghar, Medical Superintendent of IMS and SUM Hospital, senior professors, and others have mourned the passing away of Prof. (Dr.) Mohanty. A guard of honour was presented to the departed soul at the hospital, reports Daily Hunt.
Also Read:90-year-old doctor, known for affordable healthcare, passes away ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341329-prof-sureswar-mohanty.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Renowned, Neurosurgeon, Prof, Sureswar, Mohanty, passes, away</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341329-prof-sureswar-mohanty.webp"><p><b>Bhubaneswar: </b>In a tragic loss to the medical fraternity, eminent <a href="https://medicaldialogues.in/topics/neurosurgeon">neurosurgeon</a> and academician Prof. (Dr.) Sureswar Mohanty passed away in Bhubaneswar at the age of 83. </p><p>According to the news reports, he had been ailing for some time and breathed his last while undergoing treatment at IMS and SUM Hospital. Prof. Mohanty, regarded as one of India’s most respected neurosurgeons, is survived by his daughter.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/dr-seshagiri-rao-mallampati-pioneer-of-mallampati-score-passes-away-at-85-165168"><b>Also Read:Dr Seshagiri Rao Mallampati, Pioneer of Mallampati Score, Passes Away at 85</b></a></p><p>Dr Mohanty completed his MBBS from <a href="https://medicaldialogues.in/topics/scb-medical-college-hospital">S.C.B. Medical College</a>, Cuttack, and obtained his M.Ch in Neurosurgery from the All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/aiims-delhi">AIIMS</a>), New Delhi. He went on to serve as Professor and Head of the Department of Neurosurgery at the Institute of Medical Sciences, Banaras Hindu University (BHU), where he later also served as Director. </p><p>During his distinguished career, he received advanced neurosurgical training at leading global centres, including institutes in London, Moscow’s Burdenko Institute, and the Cleveland Clinic in the United States, which helped him bring modern neurosurgical techniques to India. </p><p>After retiring from IMS-BHU, he returned to Odisha and played a key role in establishing the Institute of Medical Sciences and SUM Hospital, where he served as the first Principal and Dean. </p><p>Prof. Mohanty has published nearly 150 research papers in reputed national and international medical journals. He was honoured by several national bodies, including the Indian Council of Medical Research (ICMR), Medical Council of India (MCI), and Neurological Society of India (NSI). He was also a Fellow of the National Academy of Medical Sciences (NAMS) and a recipient of the Dr. B.C. Roy Award, India’s highest medical honour.
</p><p>Throughout his career, he held several leadership positions, including President of the Uttar Pradesh Neurosciences Society and President of the Neurotrauma Society of India. He was widely regarded as a pioneer in advancing modern neurosurgery in eastern India and played a key role in building high-level neurosurgical training programs, bridging global medical practices with Indian healthcare systems.
</p><p>The Neurological Society of India deeply mourned the passing of Prof. (Dr.) Mohanty describes him as a highly accomplished professional, dedicated clinician, and mentor. Several leading healthcare professionals, including Prof. (Dr.) Ashok Mahapatra, eminent neurosurgeon, former Vice-Chancellor of SOA Deemed to be University, former Head of Department of Neurosurgery, AIIMS, New Delhi, and Founding Director of AIIMS, Bhubaneswar, Prof. (Dr.) Sanghamitra Mishra, Dean of IMS and SUM Hospital, Prof. (Dr.) Pusparaj Samantasinghar, Medical Superintendent of IMS and SUM Hospital, senior professors, and others have mourned the passing away of Prof. (Dr.) Mohanty. A guard of honour was presented to the departed soul at the hospital, reports <a href="https://m.dailyhunt.in/news/india/english/update+odisha-epaper-upodish/eminent+neurosurgeon+sureswar+mohanty+passes+away-newsid-n708010731" rel="nofollow">Daily Hunt</a>.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/90-year-old-doctor-known-for-affordable-healthcare-passes-away-164756"><b>Also Read:90-year-old doctor, known for affordable healthcare, passes away</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Medical Seats Must Not Go Vacant, Says Supreme Court in NEET UG Case</title>
<link>https://edusehat.com/en/medical-seats-must-not-go-vacant-says-supreme-court-in-neet-ug-case</link>
<guid>https://edusehat.com/en/medical-seats-must-not-go-vacant-says-supreme-court-in-neet-ug-case</guid>
<description><![CDATA[ While upholding the admission of a NEET UG candidate, the Supreme Court observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court&#039;s direction, the same decision was challenged before the Supreme Court.For more details, check out the full story on the link below:Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341374-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-71.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Seats, Must, Not, Vacant, Says, Supreme, Court, NEET, Case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341374-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-71.webp"><div class="pasted-from-word-wrapper"><p>While upholding the admission of a <a href="https://medicaldialogues.in/topics/NEET-UG">NEET UG</a> candidate, the <a href="https://medicaldialogues.in/topics/Supreme-Court">Supreme Court</a> observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.</p><p>The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court's direction, the same decision was challenged before the Supreme Court.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case-168444"><b><i>Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>NBE Releases Tentative 2026 Exam Schedule for FMGE, DNB, DrNB and Diploma Courses</title>
<link>https://edusehat.com/en/nbe-releases-tentative-2026-exam-schedule-for-fmge-dnb-drnb-and-diploma-courses</link>
<guid>https://edusehat.com/en/nbe-releases-tentative-2026-exam-schedule-for-fmge-dnb-drnb-and-diploma-courses</guid>
<description><![CDATA[ The National Board of Examinations in Medical Sciences (NBEMS) has released the tentative schedule for upcoming key examinations, including DNB, DrNB, NBE Diploma, and FMGE, for the 2026-2027 academic cycle.As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with NEET-PG 2026 tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.For more details, check out the full story on the link below:FMGE, DNB, DrNB, Diploma: NBE releases tentative schedule of upcoming 2026 exams, details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341370-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-70.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NBE, Releases, Tentative, 2026, Exam, Schedule, for, FMGE, DNB, DrNB, and, Diploma, Courses</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341370-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-70.webp"><div class="pasted-from-word-wrapper"><p>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/NBEMS">NBEMS</a>) has released the tentative <a href="https://medicaldialogues.in/topics/schedule">schedule</a> for upcoming key examinations, including <a href="https://medicaldialogues.in/topics/DNB">DNB</a>, DrNB, <a href="https://medicaldialogues.in/topics/NBEMS-Diploma">NBE Diploma</a>, and FMGE, for the 2026-2027 academic cycle.</p><p>As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with <a href="https://medicaldialogues.in/topics/NEET-PG-2026">NEET-PG 2026</a> tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/nbems-releases-tentative-schedule-for-dnb-drnb-diploma-exams-2026-27-168429"><b><i>FMGE, DNB, DrNB, Diploma: NBE releases tentative schedule of upcoming 2026 exams, details</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Orbicular Pharma, Apotex Secure USFDA Tentative Nod for Generic Ozempic</title>
<link>https://edusehat.com/en/orbicular-pharma-apotex-secure-usfda-tentative-nod-for-generic-ozempic</link>
<guid>https://edusehat.com/en/orbicular-pharma-apotex-secure-usfda-tentative-nod-for-generic-ozempic</guid>
<description><![CDATA[ Hyderabad: Orbicular Pharmaceutical Technologies on Saturday announced that a generic version of Ozempic (semaglutide injection), developed in partnership with Apotex, has received tentative approval from the U.S. Food and Drug Administration (FDA).The product will be marketed and commercialised in the United States by Apotex Corp., the Abbreviated New Drug Application (ANDA) applicant, the Hyderabad based pharma company said in a release here.The tentative approval marks a significant milestone in expanding access to complex peptide-based therapies, which are considered among the most scientifically and regulatorily challenging segments in generic drug development.Also Read: Tata Capital arm injects USD 20 million in Orbicular Pharmaceutical TechnologiesDr. M. S. Mohan, Managing Director of Orbicular Pharmaceutical Technologies, said achieving technical equivalence in complex peptide products requires high scientific precision and disciplined development.He noted that the collaboration combined Orbicular’s development expertise with Apotex’s regulatory leadership, enabling the partners to secure the FDA’s tentative approval.Barry Fishman, Chief Corporate Development Officer at Apotex, acknowledged Orbicular’s contribution, stating that the company’s scientific depth and quality focus were instrumental in advancing the programme.He added that Apotex remains committed to delivering high-quality, affordable peptide therapies and values the partnership that enabled the milestone.Also Read: Strides, Orbicular ink pact to develop range of nasal sprays ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341384-orbic-pharma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Orbicular, Pharma, Apotex, Secure, USFDA, Tentative, Nod, for, Generic, Ozempic</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341384-orbic-pharma.webp"><p><b>Hyderabad</b>: Orbicular Pharmaceutical Technologies on Saturday announced that a generic version of <a href="https://medicaldialogues.in/topics/Ozempic" target="_blank">Ozempic</a> (semaglutide injection), developed in partnership with Apotex, has received tentative approval from the U.S. Food and Drug Administration (FDA).</p><div class="pasted-from-word-wrapper"><p>The product will be marketed and commercialised in the United States by Apotex Corp., the Abbreviated New Drug Application (ANDA) applicant, the Hyderabad based pharma company said in a release here.</p><p>The tentative approval marks a significant milestone in expanding access to complex peptide-based therapies, which are considered among the most scientifically and regulatorily challenging segments in generic drug development.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/tata-capital-arm-injects-usd-20-million-in-orbicular-pharmaceutical-technologies-129498">Also Read: Tata Capital arm injects USD 20 million in Orbicular Pharmaceutical Technologies</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Dr. M. S. Mohan, Managing Director of Orbicular Pharmaceutical Technologies, said achieving technical equivalence in complex peptide products requires high scientific precision and disciplined development.</p><p>He noted that the collaboration combined Orbicular’s development expertise with Apotex’s regulatory leadership, enabling the partners to secure the FDA’s tentative approval.</p><p>Barry Fishman, Chief Corporate Development Officer at Apotex, acknowledged Orbicular’s contribution, stating that the company’s scientific depth and quality focus were instrumental in advancing the programme.</p><p>He added that Apotex remains committed to delivering high-quality, affordable peptide therapies and values the partnership that enabled the milestone.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/strides-orbicular-ink-pact-to-develop-range-of-nasal-sprays-110905">Also Read: Strides, Orbicular ink pact to develop range of nasal sprays</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities</title>
<link>https://edusehat.com/en/pharma-healthcare-firms-set-for-11-growth-in-q4-margins-under-pressure-hdfc-securities</link>
<guid>https://edusehat.com/en/pharma-healthcare-firms-set-for-11-growth-in-q4-margins-under-pressure-hdfc-securities</guid>
<description><![CDATA[ Mumbai: The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securities.&quot;We project sales/EBITDA growth of 11%/6% YoY for our coverage universe,&quot; the brokerage added.The pharmaceutical companies are expected to see 10% YoY sales growth, driven by a 15% YoY increase in the India business. However, this growth will be offsby a 5% QoQ decline in the US formulations due to pricing pressures and the absence of gRevlimid sales. &quot;EBITDA margins for the pharma segment are expected to come down (-110bps YoY), with an increase in input cost, price erosion in the US, absence of gRevlimid, steady R&amp;D, and higher SG&amp;A,&quot; said the report.The hospital business is projected to grow by 15% YoY during the reporting quarter, driven by steady occupancy and ARPOBs and bed capacity addition. The diagnostics segment is expected to post 15% YoY sales growth, driven by volume increases leading to moderate margin expansion. The retail pharmacy business is expected to see strong growth, with Medplus expected to see 22% YoY growth and Apollo HealthCo expected to see steady 20% YoY growth.Also Read: Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report&quot;The US generics market is likely to decline QoQ due to the absence of gRevlimid sales and pricing pressures in the base business,&quot; said the report. However, there is expected to be some traction in key products such as gJynarque, gSpiriva,The Indian pharma market is expected to have seen steady growth of 12% in Jan/Feb&#039;26, led by strong 16% growth in the chronic segment and ~9% growth in the acute segment. &quot;We expect our coverage universe to see 15% YoY growth in India business on the back of traction in the speciality portfolio and chronic,&quot; the brokerage said in its report.The research report by HDFC Securities noted that margins will remain under check due to an increase in input costs, pricing pressures in the US business, absence of high margin gRevlimid, steady research and development, and higher selling, general, and administrative expenses. The Contract Research, Development, and Manufacturing Organisation business is expected to sustain its margins as new capacities mature, while the hospital business could see some pressure on lower international payor mix and new bed additions.Also Read: Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11% ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/10/28/258521-medicine-7.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pharma, Healthcare, Firms, Set, for, 11, Growth, Q4, Margins, Under, Pressure:, HDFC, Securities</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/10/28/258521-medicine-7.webp"><p><b>Mumbai</b>: The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securities.</p><div class="pasted-from-word-wrapper"><p>"We project sales/EBITDA growth of 11%/6% YoY for our coverage universe," the brokerage added.</p><p>The pharmaceutical companies are expected to see 10% YoY sales growth, driven by a 15% YoY increase in the India business. However, this growth will be offsby a 5% QoQ decline in the US formulations due to pricing pressures and the absence of gRevlimid sales. "EBITDA margins for the pharma segment are expected to come down (-110bps YoY), with an increase in input cost, price erosion in the US, absence of gRevlimid, steady R&D, and higher SG&A," said the report.</p><p>The hospital business is projected to grow by 15% YoY during the reporting quarter, driven by steady occupancy and ARPOBs and bed capacity addition. The diagnostics segment is expected to post 15% YoY sales growth, driven by volume increases leading to moderate margin expansion. The retail pharmacy business is expected to see strong growth, with Medplus expected to see 22% YoY growth and Apollo HealthCo expected to see steady 20% YoY growth.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/domestic-pharma-growth-strong-us-market-drag-to-weigh-on-q4fy26-earnings-report-168405">Also Read: Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>"The US generics market is likely to decline QoQ due to the absence of gRevlimid sales and pricing pressures in the base business," said the report. However, there is expected to be some traction in key products such as gJynarque, gSpiriva,</p><p>The Indian pharma market is expected to have seen steady growth of 12% in Jan/Feb'26, led by strong 16% growth in the chronic segment and ~9% growth in the acute segment. "We expect our coverage universe to see 15% YoY growth in India business on the back of traction in the speciality portfolio and chronic," the brokerage said in its report.</p><p>The research report by HDFC Securities noted that margins will remain under check due to an increase in input costs, pricing pressures in the US business, absence of high margin gRevlimid, steady research and development, and higher selling, general, and administrative expenses. The Contract Research, Development, and Manufacturing Organisation business is expected to sustain its margins as new capacities mature, while the hospital business could see some pressure on lower international payor mix and new bed additions.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-q3-fy26-profit-slips-to-rs-133-cr-after-one-time-labour-code-provision-revenue-up-11-164253">Also Read: Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11%</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Assam Man Arrested in Arunachal for Fake Pharmacy Licence Fraud</title>
<link>https://edusehat.com/en/assam-man-arrested-in-arunachal-for-fake-pharmacy-licence-fraud</link>
<guid>https://edusehat.com/en/assam-man-arrested-in-arunachal-for-fake-pharmacy-licence-fraud</guid>
<description><![CDATA[ New Delhi: A 33-year-old man from Assam has been arrested by Arunachal Pradesh Police for allegedly duping multiple individuals by promising to arrange pharmacy and business licences, collecting money under false pretences, with several cases registered against him across the Itanagar Capital Region and investigations revealing he had been absconding since 2023.The accused, identified as Debojit Sharma, a resident of Bihpuria in Assam, was apprehended from North Lakhimpur district after a prolonged search operation. Police tracked him down to Pithaguri in Mazgaon and arrested him on April 10 following sustained surveillance.According to officials, Sharma allegedly targeted individuals in areas such as Doimukh and Naharlagun, where he collected money by falsely assuring them of facilitating pharmacy licences and other business permits. Victims were reportedly misled into believing he had the authority and connections to secure approvals.Also Read: Fake pharmacy registration racket busted, Delhi Pharmacy Council former employee, 46 others arrestedPolice stated that multiple complaints had been filed against him at different police stations in the Itanagar Capital Region, including Naharlagun and Yupia, indicating a wider network of fraud cases linked to the accused.Following his arrest, Sharma was produced before a court in Naharlagun, which remanded him to judicial custody. A case has been registered under relevant provisions of the Bharatiya Nyaya Sanhita dealing with cheating and fraud.Authorities have urged the public to exercise caution and verify credentials before engaging in any transactions related to licences or regulatory approvals, warning against falling prey to such fraudulent schemes, reports Northeast Today.Also Read: Fake Pharmacy Certificates Scam: Nine Chemists, 2 Ex-Registrars, 1 superintendent of Punjab State Pharmacy Council arrested ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 20:15:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Assam, Man, Arrested, Arunachal, for, Fake, Pharmacy, Licence, Fraud</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.webp"><p><b>New Delhi: </b>A 33-year-old man from Assam has been arrested by Arunachal Pradesh Police for allegedly duping multiple individuals by promising to arrange pharmacy and business licences, collecting money under false pretences, with several cases registered against him across the Itanagar Capital Region and investigations revealing he had been absconding since 2023.</p><div class="pasted-from-word-wrapper"><p>The accused, identified as Debojit Sharma, a resident of Bihpuria in Assam, was apprehended from North Lakhimpur district after a prolonged search operation. Police tracked him down to Pithaguri in Mazgaon and arrested him on April 10 following sustained surveillance.</p><p>According to officials, Sharma allegedly targeted individuals in areas such as Doimukh and Naharlagun, where he collected money by falsely assuring them of facilitating pharmacy licences and other business permits. Victims were reportedly misled into believing he had the authority and connections to secure approvals.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/fake-pharmacy-registration-racket-busted-delhi-pharmacy-council-former-employee-46-others-arrested-146057">Also Read: Fake pharmacy registration racket busted, Delhi Pharmacy Council former employee, 46 others arrested</a></div></div><p>Police stated that multiple complaints had been filed against him at different police stations in the Itanagar Capital Region, including Naharlagun and Yupia, indicating a wider network of fraud cases linked to the accused.</p><p>Following his arrest, Sharma was produced before a court in Naharlagun, which remanded him to judicial custody. A case has been registered under relevant provisions of the Bharatiya Nyaya Sanhita dealing with cheating and fraud.</p><p>Authorities have urged the public to exercise caution and verify credentials before engaging in any transactions related to licences or regulatory approvals, warning against falling prey to such fraudulent schemes, reports <a href="https://northeasttoday.in/northeast/arunachal-pradesh/assam-man-arrested-in-arunachal-for-alleged-fraud-over-fake-pharmacy-licences/" rel="nofollow">Northeast Today.</a></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/punjab/fake-pharmacy-certificates-scam-nine-chemists-2-ex-registrars-1-superintendent-of-punjab-state-pharmacy-council-arrested-121655">Also Read: Fake Pharmacy Certificates Scam: Nine Chemists, 2 Ex-Registrars, 1 superintendent of Punjab State Pharmacy Council arrested</a></p></div>]]> </content:encoded>
</item>

<item>
<title>Case Profile of Anemia Associated with Myelodysplastic Syndrome (MDS) Treated with Darbepoetin alfa &#45; Dr. Rishu Vidhatri</title>
<link>https://edusehat.com/en/case-profile-of-anemia-associated-with-myelodysplastic-syndrome-mds-treated-with-darbepoetin-alfa-dr-rishu-vidhatri</link>
<guid>https://edusehat.com/en/case-profile-of-anemia-associated-with-myelodysplastic-syndrome-mds-treated-with-darbepoetin-alfa-dr-rishu-vidhatri</guid>
<description><![CDATA[ This case discusses a 62-year-old male diagnosed with Myelodysplastic Syndrome (MDS) presenting with severe anemia and transfusion dependence. Despite regular transfusions, the patient continued to experience fatigue and dyspnea, significantly impacting quality of life.With a serum erythropoietin level  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341300-darbepoetin-alfa-featured-image-jpg.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Case, Profile, Anemia, Associated, with, Myelodysplastic, Syndrome, MDS, Treated, with, Darbepoetin, alfa, Dr., Rishu, Vidhatri</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341300-darbepoetin-alfa-featured-image-jpg.webp"><p>This case discusses a 62-year-old male diagnosed with Myelodysplastic Syndrome (MDS) presenting with severe anemia and transfusion dependence. Despite regular transfusions, the patient continued to experience fatigue and dyspnea, significantly impacting quality of life.</p><p>With a serum erythropoietin level <750 mIU/mL, treatment with darbepoetin alfa was initiated, leading to a clinically meaningful hemoglobin rise from 5.6 g/dL to 9 g/dL and notable symptomatic improvement.</p><p>This case highlights the importance of early ESA therapy, patient selection based on EPO levels, and targeted management in intermediate-risk MDS to reduce transfusion burden and improve outcomes.</p><p>Watch to understand:</p><p>• When to initiate ESA in MDS</p><p>• Role of darbepoetin alfa in anemia management</p><p>• Practical insights for improving patient quality of life</p>]]> </content:encoded>
</item>

<item>
<title>CARI Bengaluru becomes first CCRAS institute to secure ISO Accreditation</title>
<link>https://edusehat.com/en/cari-bengaluru-becomes-first-ccras-institute-to-secure-iso-accreditation</link>
<guid>https://edusehat.com/en/cari-bengaluru-becomes-first-ccras-institute-to-secure-iso-accreditation</guid>
<description><![CDATA[ Bengaluru: Central Ayurveda Research Institute (CARI), Bengaluru, has achieved a significant milestone in quality healthcare after its clinical laboratory received ISO 15189:2022 accreditation for both Biochemistry and Haematology under the Ministry of Ayush. With this recognition, it has become the first institute under the Central Council for Research in Ayurvedic Sciences (CCRAS) to secure this international standard certification.According to the Ayush Ministry, the accreditation ensures that the laboratory provides accurate, reliable and safe diagnostic results in line with globally accepted quality standards, reports Asianet News. The development marks a major transition for the laboratory, which has progressed from an entry-level NABL-certified facility to a fully accredited centre of excellence, strengthening the credibility of AYUSH-based diagnostics.Also Read:CCRAS-CARI Bengaluru to host International Conference to tackle obesity and metabolic syndromeMinister of State (Independent Charge), Ministry of Ayush, Prataprao Jadhav, said that international accreditation plays a crucial role in ensuring precision in diagnostics, which directly impacts treatment outcomes and patient care. He added that the achievement reflects the Ministry’s continued efforts to upgrade AYUSH institutions to meet global benchmarks.Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha, described the milestone as an important step towards integrating high-quality diagnostic services with traditional systems of medicine. He emphasized that it reinforces the focus on research, evidence-based practices and patient-centric healthcare delivery.Director General of CCRAS, Prof. Rabinarayan Acharya, noted that the institute’s earlier NABH and NABL certifications, along with its role as an Ayurveda Science Incubation Centre, have helped elevate its standards further.CARI Head Dr. Sulochana Bhat described the achievement a proud moment, crediting the dedicated efforts of the team, including Dr. Vidyashree Anchan and laboratory staff.During 2025–26, the laboratory conducted over 1.52 lakh investigations, benefiting more than 9,300 patients while offering faster and accessible digital reporting services, highlighting its growing capacity and commitment to quality care. Also Read:Safdarjung Hospital partners with Central Ayurveda Research Institute to boost menopause care ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341085-iso-certification-for-ayush-lab.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>CARI, Bengaluru, becomes, first, CCRAS, institute, secure, ISO, Accreditation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341085-iso-certification-for-ayush-lab.webp"><div class="pasted-from-word-wrapper"><p>Bengaluru: Central Ayurveda Research Institute (CARI), Bengaluru, has achieved a significant milestone in quality healthcare after its clinical laboratory received ISO 15189:2022 accreditation for both Biochemistry and Haematology under the <a href="https://medicaldialogues.in/topics/ministry%20of%20ayush" target="_blank">Ministry of Ayush</a>. With this recognition, it has become the first institute under the Central Council for Research in Ayurvedic Sciences (CCRAS) to secure this international standard certification.</p><p>According to the Ayush Ministry, the accreditation ensures that the laboratory provides accurate, reliable and safe diagnostic results in line with globally accepted quality standards, reports A<i><a href="https://newsable.asianetnews.com/india/ayush-ministrys-cari-bengaluru-lab-gets-key-iso-quality-accreditation-articleshow-x932g9g" target="_blank">sianet News</a></i>. The development marks a major transition for the laboratory, which has progressed from an entry-level NABL-certified facility to a fully accredited centre of excellence, strengthening the credibility of AYUSH-based diagnostics.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/ccras-cari-bengaluru-to-host-international-conference-to-tackle-obesity-and-metabolic-syndrome-159794">Also Read:CCRAS-CARI Bengaluru to host International Conference to tackle obesity and metabolic syndrome</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Minister of State (Independent Charge), Ministry of Ayush, Prataprao Jadhav, said that international accreditation plays a crucial role in ensuring precision in diagnostics, which directly impacts treatment outcomes and patient care. He added that the achievement reflects the Ministry’s continued efforts to upgrade AYUSH institutions to meet global benchmarks.</p><p>Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha, described the milestone as an important step towards integrating high-quality diagnostic services with traditional systems of medicine. He emphasized that it reinforces the focus on research, evidence-based practices and patient-centric healthcare delivery.</p><p>Director General of CCRAS, Prof. Rabinarayan Acharya, noted that the institute’s earlier NABH and NABL certifications, along with its role as an Ayurveda Science Incubation Centre, have helped elevate its standards further.</p><p>CARI Head Dr. Sulochana Bhat described the achievement a proud moment, crediting the dedicated efforts of the team, including Dr. Vidyashree Anchan and laboratory staff.</p><p>During 2025–26, the laboratory conducted over 1.52 lakh investigations, benefiting more than 9,300 patients while offering faster and accessible digital reporting services, highlighting its growing capacity and commitment to quality care. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/safdarjung-hospital-partners-with-central-ayurveda-research-institute-to-boost-menopause-care-159070">Also Read:Safdarjung Hospital partners with Central Ayurveda Research Institute to boost menopause care</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>NEET 2026: NTA releases city intimation slip, exam on may 3</title>
<link>https://edusehat.com/en/neet-2026-nta-releases-city-intimation-slip-exam-on-may-3</link>
<guid>https://edusehat.com/en/neet-2026-nta-releases-city-intimation-slip-exam-on-may-3</guid>
<description><![CDATA[ New Delhi: The National Testing Agency (NTA) has issued the advance intimation of examination city for candidates appearing in the National Eligibility and Entrance Test Undergraduate (NEET UG) exam for the academic year 2026. The announcement was made through a public notice.The NEET UG 2026 is scheduled to be held on May 3, 2026 across 552 cities in India and 14 cities abroad, in pen-and-paper mode from 2:00 PM to 5:00 PM.Also Read: NTA to Release NEET 2026 City Intimation Slip SoonAs per the notice, the advance city intimation slip is now available for candidates to download using their application number and date of birth.The NTA has clarified that this city intimation slip is not the admit card, but only provides advance information regarding the city where the examination centre will be located. The official admit cards will be released separately at a later stage.Candidates have been advised to download and check their city intimation slips to make necessary travel arrangements in advance. In case of any difficulty in accessing the slip, candidates can contact the NTA helpline numbers or reach out via email for assistance.To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/13/nta-341289.pdfSTEPS TO DOWNLOAD THE NEET 2026 EXAM CITY INTIMATION SLIPSTEP 1- Visit the official NTA NEET.STEP 2- Click on the designated link for &quot;NEET 2026 City Intimation Slip.&quot;STEP 3- Enter your application number, date of birth, and security pin in the provided fields.STEP 4- The NEET exam city slip 2026 will appear on your screen.STEP 5- Download and save a copy for your records. It is advisable to print it out.Candidates should carefully check all details. The City Intimation Slip contains the necessary preliminary information. This City Slip will provide candidates with information regarding their allotted examination city.Also Read: NTA opens NEET 2026 application correction window, complete details HERE! ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341285-exam-city-slip.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, 2026:, NTA, releases, city, intimation, slip, exam, may</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341285-exam-city-slip.webp"><p><b>New Delhi: </b>The National Testing Agency (<a href="https://medicaldialogues.in/topics/nta" target="_blank">NTA</a>) has issued the advance intimation of examination city for candidates appearing in the National Eligibility and Entrance Test Undergraduate (NEET UG) exam for the academic year 2026. The announcement was made through a public notice.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The <a href="https://medicaldialogues.in/topics/neet-ug-2026" target="_blank">NEET UG 2026</a> is scheduled to be held on May 3, 2026 across 552 cities in India and 14 cities abroad, in pen-and-paper mode from 2:00 PM to 5:00 PM.</p><div></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/nta-to-release-neet-2026-city-intimation-slip-soon-167068"><b>Also Read: </b>NTA to Release NEET 2026 City Intimation Slip Soon</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">As per the notice, the advance city intimation slip is now available for candidates to download using their application number and date of birth.</p><p dir="ltr">The NTA has clarified that this city intimation slip is not the admit card, but only provides advance information regarding the city where the examination centre will be located. The official admit cards will be released separately at a later stage.</p><p dir="ltr">Candidates have been advised to download and check their city intimation slips to make necessary travel arrangements in advance. In case of any difficulty in accessing the slip, candidates can contact the NTA helpline numbers or reach out via email for assistance.</p><p dir="ltr"><u><b><i>To view the notice, click the link below</i></b></u></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/13/nta-341289.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/13/nta-341289.pdf</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr"><u><b>STEPS TO DOWNLOAD THE NEET 2026 EXAM CITY INTIMATION SLIP</b></u></p><p dir="ltr"><b>STEP 1-</b> Visit the official NTA NEET.</p><p dir="ltr"><b>STEP 2-</b> Click on the designated link for "NEET 2026 City Intimation Slip."</p><p dir="ltr"><b>STEP 3-</b> Enter your application number, date of birth, and security pin in the provided fields.</p><p dir="ltr"><b>STEP 4- </b>The NEET exam city slip 2026 will appear on your screen.</p><p dir="ltr"><b>STEP 5-</b> Download and save a copy for your records. It is advisable to print it out.</p><p dir="ltr">Candidates should carefully check all details. The City Intimation Slip contains the necessary preliminary information. This City Slip will provide candidates with information regarding their allotted examination city.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/nta-opens-neet-2026-application-correction-window-complete-details-here-166330"><b>Also Read: </b>NTA opens NEET 2026 application correction window, complete details HERE!</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Research Shows Breastfeeding Linked to Better Long&#45;Term Weight Outcomes for Mothers</title>
<link>https://edusehat.com/en/research-shows-breastfeeding-linked-to-better-long-term-weight-outcomes-for-mothers</link>
<guid>https://edusehat.com/en/research-shows-breastfeeding-linked-to-better-long-term-weight-outcomes-for-mothers</guid>
<description><![CDATA[ Breastfeeding may shape your health decades later-not just in the months after childbirth.
A new study from the University of Oslo suggests that women who breastfeed for at least three months gain significantly less weight later in life. Published in the American Journal of Clinical Nutrition, the research followed over 170,000 participants from the long-running Women and Health Study in Norway, tracking weight changes from early adulthood into middle age.
The findings reveal a clear long-term benefit. Women who breastfed each child for three to 15 months gained up to 6.5 kilograms less over time compared to those who breastfed for shorter durations. The effect was most pronounced among women who were already overweight or obese before pregnancy. Among women with normal weight, the difference was smaller but still notable—up to 3 kilograms less weight gain over the years.
Researchers say breastfeeding likely contributes to this effect by increasing energy expenditure, as the body uses additional calories to produce milk. However, the relationship is not straightforward. Increased appetite during breastfeeding may offset some of the calorie burn, meaning outcomes can vary between individuals.
Interestingly, the association between breastfeeding and lower long-term weight was strongest among women who had children after 1980. This group is considered more reflective of modern lifestyles, including diet and breastfeeding practices, making the findings especially relevant today.
Beyond individual benefits, the study highlights broader public health implications. Supporting breastfeeding could play a role in reducing long-term weight gain and associated risks such as cardiovascular disease. At the same time, researchers emphasize the importance of personalized care, noting that women—especially those with overweight or obesity—may need additional support after childbirth.
Overall, the study reinforces that breastfeeding is not just beneficial for infants, but may also offer lasting health advantages for mothers well into later life.
REFERENCE: Skammelsrud, T. B., et al. (2026). Breastfeeding duration and maternal weight change through adulthood in a population-based cohort study. The American Journal of Clinical Nutrition. DOI: 10.1016/j.ajcnut.2025.101134. https://ajcn.nutrition.org/article/S0002-9165(25)00726-9/fulltext
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341294-research-shows-breastfeeding-linked-to-better-long-term-weight-outcomes-for-mothers.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Research, Shows, Breastfeeding, Linked, Better, Long-Term, Weight, Outcomes, for, Mothers</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341294-research-shows-breastfeeding-linked-to-better-long-term-weight-outcomes-for-mothers.webp"><p>Breastfeeding may shape your health decades later-not just in the months after childbirth.
</p><p>A new study from the University of Oslo suggests that women who breastfeed for at least three months gain significantly less weight later in life. Published in the <i>American Journal of Clinical Nutrition, </i>the research followed over 170,000 participants from the long-running Women and Health Study in Norway, tracking weight changes from early adulthood into middle age.
</p><p>The findings reveal a clear long-term benefit. Women who breastfed each child for three to 15 months gained up to 6.5 kilograms less over time compared to those who breastfed for shorter durations. The effect was most pronounced among women who were already overweight or obese before pregnancy. Among women with normal weight, the difference was smaller but still notable—up to 3 kilograms less weight gain over the years.
</p><p>Researchers say breastfeeding likely contributes to this effect by increasing energy expenditure, as the body uses additional calories to produce milk. However, the relationship is not straightforward. Increased appetite during breastfeeding may offset some of the calorie burn, meaning outcomes can vary between individuals.
</p><p>Interestingly, the association between breastfeeding and lower long-term weight was strongest among women who had children after 1980. This group is considered more reflective of modern lifestyles, including diet and breastfeeding practices, making the findings especially relevant today.
</p><p>Beyond individual benefits, the study highlights broader public health implications. Supporting breastfeeding could play a role in reducing long-term weight gain and associated risks such as cardiovascular disease. At the same time, researchers emphasize the importance of personalized care, noting that women—especially those with overweight or obesity—may need additional support after childbirth.
</p><p>Overall, the study reinforces that breastfeeding is not just beneficial for infants, but may also offer lasting health advantages for mothers well into later life.
</p><p><b>REFERENCE: </b>Skammelsrud, T. B., et al. (2026). Breastfeeding duration and maternal weight change through adulthood in a population-based cohort study. The American Journal of Clinical Nutrition. DOI: 10.1016/j.ajcnut.2025.101134. https://ajcn.nutrition.org/article/S0002-9165(25)00726-9/fulltext
</p>]]> </content:encoded>
</item>

<item>
<title>Creatine Alone Not Enough for Muscle Gain, Resistance Training Key, Study Suggests</title>
<link>https://edusehat.com/en/creatine-alone-not-enough-for-muscle-gain-resistance-training-key-study-suggests</link>
<guid>https://edusehat.com/en/creatine-alone-not-enough-for-muscle-gain-resistance-training-key-study-suggests</guid>
<description><![CDATA[ Creatine may boost performance-but its real power depends on how you train.
A new systematic review and meta-analysis published in Frontiers in Nutrition reveals that the benefits of creatine supplementation are strongly influenced by training context, particularly resistance training. Researchers analyzed 39 randomized controlled trials involving healthy men aged 18 to 30 to understand how creatine affects strength, anaerobic performance, and body composition.
Creatine is widely known for enhancing the phosphocreatine system, which helps rapidly regenerate ATP—the body’s primary energy source during short, high-intensity activities. This makes it a popular supplement among athletes and gym-goers aiming to improve performance.
The study found that creatine significantly improved squat strength (1RM) and anaerobic power, including peak and mean performance in Wingate cycling tests. These benefits were observed across both resistance-trained (RT) and non-resistance-trained (non-RT) individuals, suggesting that creatine can enhance explosive performance regardless of training background.
However, when it came to body composition, the effects were more selective. Increases in lean body mass (1.61 kg) and fat-free mass (2.32 kg) were seen only in participants engaged in resistance training. This supports the idea that creatine works best as a “training amplifier,” enhancing the adaptations triggered by structured strength training rather than independently building muscle.
Interestingly, improvements in jump performance were modest and inconsistent, becoming significant mainly in longer studies (eight weeks or more) and among competitive athletes. No meaningful differences were found between daily and non-daily supplementation strategies.
The findings also highlight variability across studies due to differences in training protocols, participant fitness levels, and supplementation methods. Importantly, some of the early gains in lean mass may reflect increased water retention in muscles rather than true muscle growth.
Overall, the research underscores a key takeaway: while creatine can enhance strength and power broadly, pairing it with resistance training is essential for meaningful muscle gains.
REFERENCE: Gu, J. et al. (2026). Creatine supplementation in young men under resistance versus non-resistance training: A systematic review and meta-analysis of strength, performance, and lean mass. Frontiers in Nutrition. 13, 1800546. DOI: https://doi.org/10.3389/fnut.2026.1800546. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1800546/full
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341291-creatine-alone-not-enough-for-muscle-gain-resistance-training-key-study-suggests.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Creatine, Alone, Not, Enough, for, Muscle, Gain, Resistance, Training, Key, Study, Suggests</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341291-creatine-alone-not-enough-for-muscle-gain-resistance-training-key-study-suggests.webp"><p>Creatine may boost performance-but its real power depends on how you train.
</p><p>A new systematic review and meta-analysis published in <i>Frontiers in Nutrition</i> reveals that the benefits of creatine supplementation are strongly influenced by training context, particularly resistance training. Researchers analyzed 39 randomized controlled trials involving healthy men aged 18 to 30 to understand how creatine affects strength, anaerobic performance, and body composition.
</p><p>Creatine is widely known for enhancing the phosphocreatine system, which helps rapidly regenerate ATP—the body’s primary energy source during short, high-intensity activities. This makes it a popular supplement among athletes and gym-goers aiming to improve performance.
</p><p>The study found that creatine significantly improved squat strength (1RM) and anaerobic power, including peak and mean performance in Wingate cycling tests. These benefits were observed across both resistance-trained (RT) and non-resistance-trained (non-RT) individuals, suggesting that creatine can enhance explosive performance regardless of training background.
</p><p>However, when it came to body composition, the effects were more selective. Increases in lean body mass (1.61 kg) and fat-free mass (2.32 kg) were seen only in participants engaged in resistance training. This supports the idea that creatine works best as a “training amplifier,” enhancing the adaptations triggered by structured strength training rather than independently building muscle.
</p><p>Interestingly, improvements in jump performance were modest and inconsistent, becoming significant mainly in longer studies (eight weeks or more) and among competitive athletes. No meaningful differences were found between daily and non-daily supplementation strategies.
</p><p>The findings also highlight variability across studies due to differences in training protocols, participant fitness levels, and supplementation methods. Importantly, some of the early gains in lean mass may reflect increased water retention in muscles rather than true muscle growth.
</p><p>Overall, the research underscores a key takeaway: while creatine can enhance strength and power broadly, pairing it with resistance training is essential for meaningful muscle gains.
</p><p><b>REFERENCE:</b> Gu, J. et al. (2026). Creatine supplementation in young men under resistance versus non-resistance training: A systematic review and meta-analysis of strength, performance, and lean mass. Frontiers in Nutrition. 13, 1800546. DOI: https://doi.org/10.3389/fnut.2026.1800546. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1800546/full
</p>]]> </content:encoded>
</item>

<item>
<title>New Study Reveals Hidden Drainage System Within the Human Brain</title>
<link>https://edusehat.com/en/new-study-reveals-hidden-drainage-system-within-the-human-brain</link>
<guid>https://edusehat.com/en/new-study-reveals-hidden-drainage-system-within-the-human-brain</guid>
<description><![CDATA[ Your brain is constantly cleaning itself-but scientists have just discovered a hidden &quot;drainage switch&quot; that controls how it happens.
A new study published in iScience by researchers at the Medical University of South Carolina (MUSC) has identified a previously unknown control point in the brain’s waste clearance system. The discovery centers on the middle meningeal artery (MMA), a structure now believed to play a crucial role in draining fluids and metabolic waste from the brain.
The brain relies on a specialized lymphatic system to remove toxins and maintain healthy function. Until recently, scientists had limited understanding of how this system operates in humans. Using advanced real-time MRI technology—developed through a collaboration with NASA—researchers were able to observe fluid movement in unprecedented detail.
In the study, scientists tracked cerebrospinal and interstitial fluid flow in five healthy individuals over a six-hour period. Surprisingly, the fluid traveling along the MMA did not behave like blood, which moves rapidly through arteries. Instead, it flowed slowly and steadily, resembling a drainage system. This provided the first direct evidence that the MMA is involved in lymphatic function rather than just blood circulation.
These finding challenges long-standing assumptions about the brain’s isolation from the rest of the body. The brain is protected by layers called the meninges, which were once thought to act as barriers. However, emerging research shows that these layers contain lymphatic vessels that connect the brain to the body’s immune and waste removal systems.
By identifying the MMA as a key control point, scientists now have a clearer picture of how the brain clears harmful substances. This could have major implications for conditions such as Alzheimer’s disease and other neurological disorders, where waste buildup is a known factor.
The discovery opens new avenues for research, potentially leading to therapies that enhance the brain’s natural cleaning processes and improve long-term brain health.
REFERENCE: Mehmet Albayram, Sutton B. Richmond, Kaan Yagmurlu, Ibrahim S. Tuna, Eda Karakaya, Hiranmayi Ravichandran, Fatih Tufan, Emal Lesha, Melike Mut, Filiz Bunyak, Yashar.S. Kalani, Adviye Ergul, Rachael D. Seidler, Onder Albayram. Meningeal lymphatic architecture and drainage dynamics surrounding the human middle meningeal artery. iScience, 2025; 28 (11): 113693 DOI: 10.1016/j.isci.2025.113693
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341290-new-study-reveals-hidden-drainage-system-within-the-human-brain.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Study, Reveals, Hidden, Drainage, System, Within, the, Human, Brain</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341290-new-study-reveals-hidden-drainage-system-within-the-human-brain.webp"><p>Your brain is constantly cleaning itself-but scientists have just discovered a hidden "drainage switch" that controls how it happens.
</p><p>A new study published in<i> iScience </i>by researchers at the Medical University of South Carolina (MUSC) has identified a previously unknown control point in the brain’s waste clearance system. The discovery centers on the middle meningeal artery (MMA), a structure now believed to play a crucial role in draining fluids and metabolic waste from the brain.
</p><p>The brain relies on a specialized lymphatic system to remove toxins and maintain healthy function. Until recently, scientists had limited understanding of how this system operates in humans. Using advanced real-time MRI technology—developed through a collaboration with NASA—researchers were able to observe fluid movement in unprecedented detail.
</p><p>In the study, scientists tracked cerebrospinal and interstitial fluid flow in five healthy individuals over a six-hour period. Surprisingly, the fluid traveling along the MMA did not behave like blood, which moves rapidly through arteries. Instead, it flowed slowly and steadily, resembling a drainage system. This provided the first direct evidence that the MMA is involved in lymphatic function rather than just blood circulation.
</p><p>These finding challenges long-standing assumptions about the brain’s isolation from the rest of the body. The brain is protected by layers called the meninges, which were once thought to act as barriers. However, emerging research shows that these layers contain lymphatic vessels that connect the brain to the body’s immune and waste removal systems.
</p><p>By identifying the MMA as a key control point, scientists now have a clearer picture of how the brain clears harmful substances. This could have major implications for conditions such as Alzheimer’s disease and other neurological disorders, where waste buildup is a known factor.
</p><p>The discovery opens new avenues for research, potentially leading to therapies that enhance the brain’s natural cleaning processes and improve long-term brain health.
</p><p><b>REFERENCE: </b>Mehmet Albayram, Sutton B. Richmond, Kaan Yagmurlu, Ibrahim S. Tuna, Eda Karakaya, Hiranmayi Ravichandran, Fatih Tufan, Emal Lesha, Melike Mut, Filiz Bunyak, Yashar.S. Kalani, Adviye Ergul, Rachael D. Seidler, Onder Albayram. Meningeal lymphatic architecture and drainage dynamics surrounding the human middle meningeal artery. iScience, 2025; 28 (11): 113693 DOI: 10.1016/j.isci.2025.113693
</p>]]> </content:encoded>
</item>

<item>
<title>Iatrogenic Alzheimer&amp;apos;s disease Shows Typical AD Pathology with Prominent Language Impairment: JAMA</title>
<link>https://edusehat.com/en/iatrogenic-alzheimers-disease-shows-typical-ad-pathology-with-prominent-language-impairment-jama-9735</link>
<guid>https://edusehat.com/en/iatrogenic-alzheimers-disease-shows-typical-ad-pathology-with-prominent-language-impairment-jama-9735</guid>
<description><![CDATA[ A new study published in the Journal of the American Medical Association revealed that patients with iatrogenic Alzheimer&#039;s disease (iAD) can exhibit histopathological features similar to sporadic Alzheimer’s disease, with notable language impairment emerging as a key clinical characteristic of this subtype.This case series have documented four men who developed what is now being termed iatrogenic Alzheimer disease (iAD) which is associated with exposure to contaminated medical products. All four individuals had received cadaveric pituitary–derived human growth hormone (c-hGH) during childhood, a treatment used decades ago before synthetic alternatives became available.Based on patients referred to the UK National Prion Clinic between 2024 and 2025, this study suggests that these treatments may have inadvertently introduced amyloid-β (Aβ) “seeds” into the brain. These seeds are known to play a crucial role in Alzheimer disease by promoting the buildup of amyloid plaques.What made these findings particularly significant were the growing evidence that Aβ pathology may spread in a “prion-like” manner, where misfolded proteins can trigger similar misfolding in healthy proteins, which propagates the disease over time. This mechanism has previously been linked to iatrogenic cerebral amyloid angiopathy, but its role in full Alzheimer disease has only recently come into focus.The four patients described in the report developed symptoms between the ages of 47 and 60, which was earlier than is typical for sporadic Alzheimer disease. Also, their cognitive decline was marked by prominent language impairments, rather than the more commonly recognized memory loss seen in most Alzheimer cases.One patient, who began showing symptoms at age 47 and died at 57 and underwent a postmortem brain examination. The analysis revealed extensive amyloid plaque deposition and severe tau pathology inside neurons.The other three patients exhibited similar clinical patterns, particularly difficulties with language, illuminating that this may be a distinguishing feature of iatrogenic Alzheimer disease. This findings could help clinicians identify and differentiate iAD from more typical forms of the condition.Despite the use of c-hGH was discontinued decades ago, the long incubation period observed in these cases highlights the long lasting impact of past medical practices. It also raises queries on how protein-based pathologies may be transmitted and develop over time.The findings of this series press on the need for continued vigilance in medical procedures and a deeper understanding of how neurodegenerative diseases can arise. Overall, the study reinforces that iatrogenic Alzheimer disease mirrors the biological characteristics of sporadic Alzheimer’s, while potentially presenting with language impairments.Reference:Banerjee, G., Mok, T. H., Hyare, H., Cousins, O., Jaunmuktane, Z., Mead, S., &amp; Collinge, J. (2026). High-Level Alzheimer disease neuropathological change following iatrogenic exposure. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.0437 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277388-alzheimers-disease-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Iatrogenic, Alzheimers, disease, Shows, Typical, Pathology, with, Prominent, Language, Impairment:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277388-alzheimers-disease-2.webp"><p>A new study published in the <i>Journal of the American Medical Association</i> revealed that patients with iatrogenic Alzheimer's disease (iAD) can exhibit histopathological features similar to sporadic Alzheimer’s disease, with notable language impairment emerging as a key clinical characteristic of this subtype.</p><p>This case series have documented four men who developed what is now being termed iatrogenic Alzheimer disease (iAD) which is associated with exposure to contaminated medical products. All four individuals had received cadaveric pituitary–derived human growth hormone (c-hGH) during childhood, a treatment used decades ago before synthetic alternatives became available.</p><p>Based on patients referred to the UK National Prion Clinic between 2024 and 2025, this study suggests that these treatments may have inadvertently introduced amyloid-β (Aβ) “seeds” into the brain. These seeds are known to play a crucial role in Alzheimer disease by promoting the buildup of amyloid plaques.</p><p>What made these findings particularly significant were the growing evidence that Aβ pathology may spread in a “prion-like” manner, where misfolded proteins can trigger similar misfolding in healthy proteins, which propagates the disease over time. This mechanism has previously been linked to iatrogenic cerebral amyloid angiopathy, but its role in full Alzheimer disease has only recently come into focus.</p><p>The four patients described in the report developed symptoms between the ages of 47 and 60, which was earlier than is typical for sporadic Alzheimer disease. Also, their cognitive decline was marked by prominent language impairments, rather than the more commonly recognized memory loss seen in most Alzheimer cases.</p><p>One patient, who began showing symptoms at age 47 and died at 57 and underwent a postmortem brain examination. The analysis revealed extensive amyloid plaque deposition and severe tau pathology inside neurons.</p><p>The other three patients exhibited similar clinical patterns, particularly difficulties with language, illuminating that this may be a distinguishing feature of iatrogenic Alzheimer disease. This findings could help clinicians identify and differentiate iAD from more typical forms of the condition.</p><p>Despite the use of c-hGH was discontinued decades ago, the long incubation period observed in these cases highlights the long lasting impact of past medical practices. It also raises queries on how protein-based pathologies may be transmitted and develop over time.</p><p>The findings of this series press on the need for continued vigilance in medical procedures and a deeper understanding of how neurodegenerative diseases can arise. Overall, the study reinforces that iatrogenic Alzheimer disease mirrors the biological characteristics of sporadic Alzheimer’s, while potentially presenting with language impairments.</p><p>Reference:</p><p>Banerjee, G., Mok, T. H., Hyare, H., Cousins, O., Jaunmuktane, Z., Mead, S., & Collinge, J. (2026). High-Level Alzheimer disease neuropathological change following iatrogenic exposure. JAMA Neurology. <a href="https://jamanetwork.com/journals/jamaneurology/fullarticle/2847009?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=033126" rel="nofollow">https://doi.org/10.1001/jamaneurol.2026.0437</a></p>]]> </content:encoded>
</item>

<item>
<title>BDS student dies after fall in Kannur, Harassment allegations surface, 2 faculty suspended</title>
<link>https://edusehat.com/en/bds-student-dies-after-fall-in-kannur-harassment-allegations-surface-2-faculty-suspended</link>
<guid>https://edusehat.com/en/bds-student-dies-after-fall-in-kannur-harassment-allegations-surface-2-faculty-suspended</guid>
<description><![CDATA[ Kannur: In an unfortunate incident, a first-year BDS student at Anjarakandy Dental College died after falling from a college building under suspicious circumstances. While Police suspect suicide, the student’s parents have dismissed the possibility alleging that he was murdered and had been subjected to emotional and mental harassment by faculty members. According to the family, he was pushed from the third floor of the six-storey building, but the police said the preliminary findings point to suicide.The family told the media that his son was emotionally and &quot;verbally harassed&quot; by teachers over his dark complexion and poor family background. They claimed that not only did the faculty members make racist remarks, but also called him &#039;slum dog&#039; and &#039;rabid dog&#039;.While an inquiry has been launched into the case, the institution has suspended two professors - the Head of the Dental Anatomy department, and an associate professor, over allegations of mentally harassing the student.Police have also launched a probe against faculty members after registering a case under Section 194 (unnatural death) of the Bharatiya Nyaya Sanhita (BNS). An investigation is underway. As per PTI report, the student has been identified as 22 year old native of Uzhamalackal, Puthukulangara, Thiruvananthapuram who belonged to the Scheduled Caste (SC) community.According to police, the student was found critically injured near the medical college block after falling from the building on the afternoon of April 10. He was found lying on a stone-paved area between the administrative block and the hospital building on the campus at around 1.30 pm.  Though he was rushed to the medical college and given treatment, he later succumbed to his injuries.Viral audio clipPolice said that the student had sent an audio message to his friends alleging harassment by faculty members, including threats of physical assault and academic repercussions such as reducing his marks in examinations.As reported by HT, the student in the clip was heard telling his friend that one of the teachers threatened to chop his hands off if he stepped out of the college gates and that he would be forced to walk around like an invalid.The audio clip, which has been marked authentic by his parents, captured him saying, &quot;He called me an idiot. I said ‘same to you’. You have no idea what they said to me in the staff room. They threatened to chop my hands and feet off if I stepped outside the gates. He said he wanted to see me walk around without limbs. I said I would like to see him try. Teachers like Dr *** just stood and watched.&quot;He further heard saying as reported by The News Minute, &quot;I tolerated the insult as far as I could. They insulted my mother and her surgery. My answer sheet was distributed among students, pointing out my spelling mistakes.&quot;Following the clip&#039;s circulation, the college initiated an internal inquiry and, on Saturday, suspended the two professors. Meanwhile, the police booked the two professors under under Section 3(1)(r) of the Scheduled Castes and Scheduled Tribes (Prevention of Atrocities) Act and Section 108 (abetment of suicide) of the Bharatiya Nyaya Sanhita (BNS). Officials at Chakkarakkal police station said a detailed probe is underway into the incident, with digital evidence being collected. Also, statements by the student&#039;s classmates, college authorities and family members will be recorded soon, police added.Mental harassment, racist remarksThe deceased&#039;s father told reporters that his son was emotionally and &quot;verbally harassed&quot; by teachers over his dark complexion and poor family background.&quot;He worked hard without any support to secure admission on a merit seat in the dental college. But he was harassed by faculty over his caste and colour. They also threatened to harm him academically,&quot; he claimed.&quot;He was mocked by teachers for his dark skin, ridiculed for our work as daily wage labourers and targeted because he belonged to a Scheduled Caste,&quot; he told South First. His father further alleged that the head of the department repeatedly insulted him in front of his classmates and maintained a hostile attitude despite his academic performance.His sister told local media on Sunday, &quot;Prof ** has always targeted him and even called him a rabid dog. He was abused based on his dark skin and caste. In class, when he insults a student, he wants other students to laugh. And when certain students don’t laugh, he hits them.”&quot;We had complained earlier to the principal of the college, but he denied it. If the call records can be obtained by the cyber cell, everything will become clear. My younger brother would not commit suicide and was likely pushed off the building. He had video-called me on Thursday, too, and he seemed fine,&quot; she said.The father said that they have lodged a complaint against the faculty members with the police and are expecting a fair probe into the death of his son.His sister claimed that he had filed a complaint with the college principal, but no action was taken. &quot;He used to tell us about such discrimination and harassment regularly. He was once called to the staff room where he was severely harassed,&quot; she alleged.The sister also claimed that the student was once called a &quot;slum dog&quot; in the classroom in front of other students by a faculty member. &quot;Once, when the harassment became unbearable, he reacted, after which the verbal abuse intensified,&quot; she added.When contacted, college authorities told PTI that two faculty members had been suspended and that they were cooperating with the police investigation. &quot;We will fully cooperate with the investigation and share all details. Further action will be taken based on the outcome of the police probe,&quot; an official said.The body of the student was brought to his residence in Thiruvananthapuram on Sunday, and the cremation is expected to be held in the afternoon.Kerala State Human Rights Commission seeks a report in a weekMeanwhile, the Kerala State Human Rights Commission on Sunday directed the police to conduct a detailed probe into the death of the student and submit a report within a week. The Commission took a case on its own based on media reports.Commission Judicial member K Baijunath issued directions to the Kannur City Police Commissioner to investigate the allegations surrounding the incident and file a report within the stipulated time, according to a statement.Loan app angleDuring the investigation, the Kannur police found that he had taken a loan through a mobile application between December and January. The matter is under probe and a cyber FIR has been registered at the Cyber Police Station.According to Kannur City Police Commissioner, the student received repeated calls from the lenders. The loan agency had also contacted a teacher at his college regarding the repayment and the teacher reportedly received multiple calls in connection with the dues.Commenting on this, the student&#039;s father said the loan was taken with the family’s knowledge for his mother’s treatment. &quot;My wife had been undergoing treatment for over a month, and we needed money to meet the medical expenses. That is why he took the loan,&quot; he told Onmanorama. &quot;Since he had been spending most of his time at the hospital, he was unable to work, which led to a delay in repayment. He could have informed me if the loan had become a problem. The father also alleged that the college authorities had never informed the family about issues related to the loan, including instances where a teacher was reportedly contacted by the lending agency.
“They have my phone number. Then why didn’t they call me even once to inform me about it?” he asked.A senior police officer told HT, “We are currently treating it as a case of suicide. We have not found evidence yet of him being pushed off the building by anyone. We have not recovered a suicide note either. The doctor who conducted the autopsy said the death resulted from injuries during the course of the fall. The final report is still awaited.”Also read- Bengaluru Dental student suicide: 6 oral medicine and radiology faculty suspended ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/30/338444-dead.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>BDS, student, dies, after, fall, Kannur, Harassment, allegations, surface, faculty, suspended</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/30/338444-dead.webp"><p><b>Kannur: </b>In an unfortunate incident, a first-year <a href="https://medicaldialogues.in/topics/bds" target="_blank">BDS </a>student at Anjarakandy Dental College died after falling from a college building under suspicious circumstances. </p><p>While Police suspect suicide, the student’s parents have dismissed the possibility alleging that he was murdered and had been subjected to emotional and mental harassment by faculty members. According to the family, he was pushed from the third floor of the six-storey building, but the police said the preliminary findings point to suicide.</p><p>The family told the media that his son was emotionally and "verbally harassed" by teachers over his dark complexion and poor family background. They claimed that not only did the faculty members make racist remarks, but also called him 'slum dog' and 'rabid dog'.</p><p>While an inquiry has been launched into the case, the institution has suspended two professors - the Head of the Dental Anatomy department, and an associate professor, over allegations of mentally harassing the student.</p><p>Police have also launched a probe against faculty members after registering a case under Section 194 (unnatural death) of the Bharatiya Nyaya Sanhita (BNS). An investigation is underway. </p><p>As per PTI report, the student has been identified as 22 year old native of Uzhamalackal, Puthukulangara, Thiruvananthapuram who belonged to the Scheduled Caste (SC) community.</p><p>According to police, the student was found critically injured near the medical college block after falling from the building on the afternoon of April 10. He was found lying on a stone-paved area between the administrative block and the hospital building on the campus at around 1.30 pm.  Though he was rushed to the medical college and given treatment, he later succumbed to his injuries.</p><p><b>Viral audio clip</b></p><p>Police said that the student had sent an audio message to his friends alleging harassment by faculty members, including threats of physical assault and academic repercussions such as reducing his marks in examinations.</p><p>As reported by <a href="https://www.hindustantimes.com/india-news/kerala-bds-student-s-death-family-alleges-murder-says-casteist-slurs-used-101776022527840.html" target="_blank" rel="nofollow">HT</a>, the student in the clip was heard telling his friend that one of the teachers threatened to chop his hands off if he stepped out of the college gates and that he would be forced to walk around like an invalid.</p><p>The audio clip, which has been marked authentic by his parents, captured him saying, "He called me an idiot. I said ‘same to you’. You have no idea what they said to me in the staff room. They threatened to chop my hands and feet off if I stepped outside the gates. He said he wanted to see me walk around without limbs. I said I would like to see him try. Teachers like Dr *** just stood and watched."</p><p>He further heard saying as reported by <a href="https://www.thenewsminute.com/kerala/caste-harassment-alleged-after-kannur-dental-students-death-2-teachers-suspended" target="_blank" rel="nofollow">The News Minute</a>, "I tolerated the insult as far as I could. They insulted my mother and her surgery. My answer sheet was distributed among students, pointing out my spelling mistakes."</p><p>Following the clip's circulation, the college initiated an internal inquiry and, on Saturday, suspended the two professors. Meanwhile, the police booked the two professors under under Section 3(1)(r) of the Scheduled Castes and Scheduled Tribes (Prevention of Atrocities) Act and Section 108 (abetment of suicide) of the Bharatiya Nyaya Sanhita (BNS). </p><p>Officials at Chakkarakkal police station said a detailed probe is underway into the incident, with digital evidence being collected. Also, statements by the student's classmates, college authorities and family members will be recorded soon, police added.</p><p><b>Mental harassment, racist remarks</b></p><p>The deceased's father told reporters that his son was emotionally and "verbally harassed" by teachers over his dark complexion and poor family background.</p><p>"He worked hard without any support to secure admission on a merit seat in the dental college. But he was harassed by faculty over his caste and colour. They also threatened to harm him academically," he claimed.</p><p>"He was mocked by teachers for his dark skin, ridiculed for our work as daily wage labourers and targeted because he belonged to a Scheduled Caste," he told South First. </p><p>His father further alleged that the head of the department repeatedly insulted him in front of his classmates and maintained a hostile attitude despite his academic performance.</p><p>His sister told local media on Sunday, "Prof ** has always targeted him and even called him a rabid dog. He was abused based on his dark skin and caste. In class, when he insults a student, he wants other students to laugh. And when certain students don’t laugh, he hits them.”</p><p>"We had complained earlier to the principal of the college, but he denied it. If the call records can be obtained by the cyber cell, everything will become clear. My younger brother would not commit suicide and was likely pushed off the building. He had video-called me on Thursday, too, and he seemed fine," she said.</p><p>The father said that they have lodged a complaint against the faculty members with the police and are expecting a fair probe into the death of his son.</p><p>His sister claimed that he had filed a complaint with the college principal, but no action was taken. "He used to tell us about such discrimination and harassment regularly. He was once called to the staff room where he was severely harassed," she alleged.</p><p>The sister also claimed that the student was once called a "slum dog" in the classroom in front of other students by a faculty member. "Once, when the harassment became unbearable, he reacted, after which the verbal abuse intensified," she added.</p><p>When contacted, college authorities told PTI that two faculty members had been suspended and that they were cooperating with the police investigation. "We will fully cooperate with the investigation and share all details. Further action will be taken based on the outcome of the police probe," an official said.</p><p>The body of the student was brought to his residence in Thiruvananthapuram on Sunday, and the cremation is expected to be held in the afternoon.</p><p><b>Kerala State Human Rights Commission seeks a report in a week</b></p><p>Meanwhile, the Kerala State Human Rights Commission on Sunday directed the police to conduct a detailed probe into the death of the student and submit a report within a week. The Commission took a case on its own based on media reports.</p><p>Commission Judicial member K Baijunath issued directions to the Kannur City Police Commissioner to investigate the allegations surrounding the incident and file a report within the stipulated time, according to a statement.</p><p><b>Loan app angle</b></p><p>During the investigation, the Kannur police found that he had taken a loan through a mobile application between December and January. The matter is under probe and a cyber FIR has been registered at the Cyber Police Station.</p><p>According to Kannur City Police Commissioner, the student received repeated calls from the lenders. The loan agency had also contacted a teacher at his college regarding the repayment and the teacher reportedly received multiple calls in connection with the dues.</p><p>Commenting on this, the student's father said the loan was taken with the family’s knowledge for his mother’s treatment. "My wife had been undergoing treatment for over a month, and we needed money to meet the medical expenses. That is why he took the loan," he told <a href="https://www.onmanorama.com/news/kerala/2026/04/13/kannur-student-death-loan-mother-treatment.html" target="_blank" rel="nofollow">Onmanorama</a>. </p><p>"Since he had been spending most of his time at the hospital, he was unable to work, which led to a delay in repayment. He could have informed me if the loan had become a problem. </p><p>The father also alleged that the college authorities had never informed the family about issues related to the loan, including instances where a teacher was reportedly contacted by the lending agency.
</p><p>“They have my phone number. Then why didn’t they call me even once to inform me about it?” he asked.</p><p>A senior police officer told HT, “We are currently treating it as a case of suicide. We have not found evidence yet of him being pushed off the building by anyone. We have not recovered a suicide note either. The doctor who conducted the autopsy said the death resulted from injuries during the course of the fall. The final report is still awaited.”</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-colleges/bengaluru-dental-student-suicide-6-oral-medicine-and-radiology-faculty-suspended-162594" target="_blank">Bengaluru Dental student suicide: 6 oral medicine and radiology faculty suspended</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Jaipur Hospital operator arrested over alleged RGHS fraud</title>
<link>https://edusehat.com/en/jaipur-hospital-operator-arrested-over-alleged-rghs-fraud</link>
<guid>https://edusehat.com/en/jaipur-hospital-operator-arrested-over-alleged-rghs-fraud</guid>
<description><![CDATA[ Jaipur: A private hospital operator in Jaipur was arrested on Sunday for allegedly submitting forged and fabricated documents under the Rajasthan Government Health Scheme (RGHS). According to news reports, the case stems from a complaint filed on September 29, 2025, by Jitendra Kumar Sharma at a local police station. He alleged serious irregularities during the treatment of his mother at a private hospital in the Mansarovar area.Also Read:Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensationThe complaint states that the hospital collected substantial amounts of cash without issuing any bills or receipts, raising suspicions of financial malpractice. The complainant further claimed that hospital authorities failed to inform the family about the deterioration of his mother’s condition, and they were later abruptly told of her death. When he demanded medical records and billing details, hospital staff allegedly refused to cooperate and even intimidated him by involving outsiders.Given the gravity of the allegations, Jaipur Police constituted a Special Investigation Team (SIT) to probe the matter thoroughly. As part of the investigation, a medical board comprising eight doctors from SMS Hospital reviewed the treatment records. 
The board found no evidence of medical negligence in the care provided to the patient. However, the investigation uncovered discrepancies in the hospital’s administrative practices. 
DCP South Rajarshi Raj stated that no action has been taken against the hospital for medical negligence. The action was taken for document fraud. The department had also filed a complaint regarding the fraud. Following an investigation, the private hospital operator was arrested, reports Patrika.
Speaking to TOI, Officials said the hospital management allegedly showed the patient as discharged and readmitted multiple times and tampered with a consent form by altering dates before uploading it online. The RGHS authorities also found irregularities during their inquiry, and a forensic science laboratory report confirmed tampering of documents, police said.
Following his arrest, the accused doctor reportedly experienced anxiety and a decline in health. He was admitted to SMS Hospital for medical care. Station House Officer Lakhan Singh Khatana confirmed that the doctor complained of severe stress.
The arrest has sparked a strong reaction from the private healthcare sector. Vijay Kapoor, President of the Private Hospitals and Nursing Homes Association, criticized the move, calling it contrary to established government standard operating procedures (SOPs).
According to Patrika, he alleged that this move, taken under pressure from lawyers, would have serious long-term consequences. He said that private hospitals would hesitate to admit and treat critical patients. Serious patients would face difficulties in accessing treatment in private hospitals, ultimately borne by the public. He said that in the event of a patient&#039;s death during treatment, there is a clear and specific system and guidelines for further investigation and action, which must be followed.
Also Read:Bengaluru Man Arrested for Submitting Fake Medical Bills to Claim CM Relief Fund ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/05/312744-education-2025-12-05t124058275.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jaipur, Hospital, operator, arrested, over, alleged, RGHS, fraud</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/05/312744-education-2025-12-05t124058275.webp"><p><b>Jaipur: </b>A <a href="https://medicaldialogues.in/topics/private-hospital">private hospital </a>operator in Jaipur was arrested on Sunday for allegedly submitting forged and <a href="https://medicaldialogues.in/topics/forged-documents">fabricated documents</a> under the Rajasthan Government Health Scheme (<a href="https://medicaldialogues.in/topics/rghs">RGHS</a>). </p><p>According to news reports, the case stems from a complaint filed on September 29, 2025, by Jitendra Kumar Sharma at a local police station. He alleged serious irregularities during the treatment of his mother at a private hospital in the Mansarovar area.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/medico-legal/foreign-object-inside-patient-during-root-canal-endoscopic-procedure-without-consent-tn-hospitals-slapped-rs-7-lakh-compensation-168455"><b>Also Read:Foreign object inside patient during root canal, endoscopic procedure without consent- TN Hospitals slapped Rs 7 lakh compensation</b></a></p><p>The complaint states that the hospital collected substantial amounts of cash without issuing any bills or receipts, raising suspicions of financial malpractice. The complainant further claimed that hospital authorities failed to inform the family about the deterioration of his mother’s condition, and they were later abruptly told of her death. When he demanded medical records and billing details, hospital staff allegedly refused to cooperate and even intimidated him by involving outsiders.</p><p>Given the gravity of the allegations, Jaipur Police constituted a Special Investigation Team (SIT) to probe the matter thoroughly. As part of the investigation, a medical board comprising eight doctors from SMS Hospital reviewed the treatment records. 
</p><p>The board found no evidence of medical negligence in the care provided to the patient. However, the investigation uncovered discrepancies in the hospital’s administrative practices. 
</p><p>DCP South Rajarshi Raj stated that no action has been taken against the hospital for medical negligence. The action was taken for document fraud. The department had also filed a complaint regarding the fraud. Following an investigation, the private hospital operator was arrested, reports <a href="https://www.patrika.com/jaipur-news/major-scam-exposed-through-fake-documents-on-rghs-portal-private-hospital-operator-arrested-20496064" rel="nofollow">Patrika</a>.
</p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/jaipur/pvt-hospital-operator-held-for-forging-rghs-documents-probe-on/articleshow/130219978.cms" rel="nofollow">TOI</a>, Officials said the hospital management allegedly showed the patient as discharged and readmitted multiple times and tampered with a consent form by altering dates before uploading it online. The RGHS authorities also found irregularities during their inquiry, and a forensic science laboratory report confirmed tampering of documents, police said.
</p><p>Following his arrest, the accused doctor reportedly experienced anxiety and a decline in health. He was admitted to SMS Hospital for medical care. Station House Officer Lakhan Singh Khatana confirmed that the doctor complained of severe stress.
</p><p>The arrest has sparked a strong reaction from the private healthcare sector. Vijay Kapoor, President of the Private Hospitals and Nursing Homes Association, criticized the move, calling it contrary to established government standard operating procedures (SOPs).
</p><p>According to Patrika, he alleged that this move, taken under pressure from lawyers, would have serious long-term consequences. He said that private hospitals would hesitate to admit and treat critical patients. Serious patients would face difficulties in accessing treatment in private hospitals, ultimately borne by the public. He said that in the event of a patient's death during treatment, there is a clear and specific system and guidelines for further investigation and action, which must be followed.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/bengaluru-man-arrested-for-submitting-fake-medical-bills-to-claim-cm-relief-fund-158471"><b>Also Read:Bengaluru Man Arrested for Submitting Fake Medical Bills to Claim CM Relief Fund</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Bengaluru doctor booked after woman employee alleges sexual harassment</title>
<link>https://edusehat.com/en/bengaluru-doctor-booked-after-woman-employee-alleges-sexual-harassment</link>
<guid>https://edusehat.com/en/bengaluru-doctor-booked-after-woman-employee-alleges-sexual-harassment</guid>
<description><![CDATA[ Bengaluru: In a shocking incident in Bengaluru, a doctor heading a private multi-specialty hospital in Bengaluru has been booked by police for allegedly sexually harassing a woman employee who later resigned, citing repeated inappropriate behaviour.According to a senior police officer, the 29-year-old complainant, who had been working as an accountant at the private Hospital since July 2025, alleged that the hospital head repeatedly made inappropriate remarks about her appearance during office hours. She further claimed that he would stare at her while she was in uniform and comment on her attire despite her objections. Also Read:Bengaluru medical college assistant professor booked for sexual harassment after alleged proposal to student in classroomThe complainant stated that she had repeatedly warned him to stop such behaviour, but the alleged harassment continued.She also alleged that the harassment reportedly continued beyond the workplace, claiming that the doctor sent her objectionable messages on WhatsApp and later contacted her via phone call, during which he allegedly made inappropriate remarks about her appearance.The situation reportedly escalated at her home when her husband overheard one of the calls, leading to a dispute and further distress. Following repeated incidents, the woman resigned from her job and approached the police. Based on a complaint, a case has been registered at the HSR Layout police station, and the accused doctor is currently out of station. “Once he returns, we will initiate legal action,” the police officer said, reports Deccan Herald.  Medical dialogues had previously reported that a senior Ayurvedic doctor posted at the AYUSH wing of the District Medical College Hospital in Korba was accused of molesting a trainee doctor by allegedly pretending to examine her against her will. Following her complaint, the police have registered a case and launched an investigation into the matter.    Also Read:Ayurveda doctor booked for allegedly sexually harassing trainee doctor ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/30/306157-booked-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bengaluru, doctor, booked, after, woman, employee, alleges, sexual, harassment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/30/306157-booked-2.webp"><p><b>Bengaluru:</b> In a shocking incident in Bengaluru, a <a href="https://medicaldialogues.in/topics/doctors">doctor</a> heading a private <a href="https://medicaldialogues.in/topics/multi-speciality-hospitals">multi-specialty hospital</a> in Bengaluru has been booked by police for allegedly s<a href="https://medicaldialogues.in/topics/sexual-harassment">exually harassing</a> a woman employee who later resigned, citing repeated inappropriate behaviour.</p><p>According to a senior police officer, the 29-year-old complainant, who had been working as an accountant at the private Hospital since July 2025, alleged that the hospital head repeatedly made inappropriate remarks about her appearance during office hours. She further claimed that he would stare at her while she was in uniform and comment on her attire despite her objections. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/bengaluru-medical-college-assistant-professor-booked-for-sexual-harassment-after-alleged-proposal-to-student-in-classroom-167473"><b>Also Read:Bengaluru medical college assistant professor booked for sexual harassment after alleged proposal to student in classroom</b></a></p><p>The complainant stated that she had repeatedly warned him to stop such behaviour, but the alleged harassment continued.</p><p>She also alleged that the harassment reportedly continued beyond the workplace, claiming that the doctor sent her objectionable messages on WhatsApp and later contacted her via phone call, during which he allegedly made inappropriate remarks about her appearance.</p><p>The situation reportedly escalated at her home when her husband overheard one of the calls, leading to a dispute and further distress. Following repeated incidents, the woman resigned from her job and approached the police. </p><p>Based on a complaint, a case has been registered at the HSR Layout police station, and the accused doctor is currently out of station. “Once he returns, we will initiate legal action,” the police officer said, reports <a href="https://www.deccanherald.com/india/karnataka/bengaluru/doctor-booked-for-harassing-woman-employee-in-bengaluru-3964893" rel="nofollow">Deccan Herald</a>.  </p><p>Medical dialogues had previously reported that a senior Ayurvedic doctor posted at the AYUSH wing of the District Medical College Hospital in Korba was accused of molesting a trainee doctor by allegedly pretending to examine her against her will. Following her complaint, the police have registered a case and launched an investigation into the matter.    </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ayurveda-doctor-booked-for-allegedly-sexually-harassing-trainee-doctor-156664"><b>Also Read:Ayurveda doctor booked for allegedly sexually harassing trainee doctor</b></a></p>]]> </content:encoded>
</item>

<item>
<title>MBBS student alleges ragging at Doon medical college</title>
<link>https://edusehat.com/en/mbbs-student-alleges-ragging-at-doon-medical-college</link>
<guid>https://edusehat.com/en/mbbs-student-alleges-ragging-at-doon-medical-college</guid>
<description><![CDATA[ Dehradun: In a shocking ragging allegation surfaced from Government Doon Medical College in Dehradun, an MBBS student has claimed that seniors forced him to shave his beard and get a haircut.The complaint was submitted anonymously, and the anti-ragging committee has taken up the matter for investigation, Principal Dr Geeta Jain confirmed.Meanwhile, a senior doctor at the college indicated that the administration may soon address the issue publicly.Also read- Bijnor&#039;s medical college 11 MBBS students suspended over raggingSpeaking to TOI, Dr Jain said, &quot;The committee is looking into all the aspects of the complaint as the complainant is anonymous and has not revealed the identity of the seniors.&quot;Similarly, the student said, &quot;The college is likely to hold a press conference to address the media regarding the complaint. It is imperative to know the victim as well as the perpetrators, to initiate any kind of action.&quot;The fresh complaint comes three months after Medical Dialogues reported that the administration had fined 24 students for indiscipline following a ragging incident. In that case, a first-year MBBS student alleged that seniors had taken him outside the campus and beaten him with a belt, leaving him “shaken and terrified.”The student from the 2025 batch of Government Doon Medical College stated in a written complaint that he had been mentally disturbed and living in fear since the incident.Taking disciplinary action, the administration suspended nine MBBS students and expelled them from the hostel. Of them, two students were suspended from classes for two months, expelled from the hostel and internship for the entire course duration, and fined Rs 50,000 each. The remaining seven students were suspended from classes for one month and expelled from the hostel for three months.Also read- Doon medical college 9 MBBS students suspended, expelled for ragging ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/02/24/275778-ragging.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MBBS, student, alleges, ragging, Doon, medical, college</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/02/24/275778-ragging.webp"><p><b>Dehradun: </b>In a shocking <a href="https://medicaldialogues.in/topics/ragging" target="_blank">ragging </a>allegation surfaced from <a href="https://medicaldialogues.in/topics/doon-medical-college" target="_blank">Government Doon Medical College</a> in Dehradun, an MBBS student has claimed that seniors forced him to shave his beard and get a haircut.</p><p>The complaint was submitted anonymously, and the anti-ragging committee has taken up the matter for investigation, Principal Dr Geeta Jain confirmed.</p><p>Meanwhile, a senior doctor at the college indicated that the administration may soon address the issue publicly.</p><p><b>Also read-<a href="https://medicaldialogues.in/news/education/medical-colleges/bijnors-medical-college-11-mbbs-students-suspended-over-ragging-168362" target="_blank"> Bijnor's medical college 11 MBBS students suspended over ragging</a></b></p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/dehradun/fresh-ragging-complaint-at-doon-med-college-mbbs-student-alleges-pressure-to-shave-beard/articleshow/130140418.cms" target="_blank" rel="nofollow">TOI</a>, Dr Jain said, "The committee is looking into all the aspects of the complaint as the complainant is anonymous and has not revealed the identity of the seniors."</p><p>Similarly, the student said, "The college is likely to hold a press conference to address the media regarding the complaint. It is imperative to know the victim as well as the perpetrators, to initiate any kind of action."</p><p>The fresh complaint comes three months after Medical Dialogues reported that the administration had fined 24 students for indiscipline following a ragging incident. In that case, a first-year MBBS student alleged that seniors had taken him outside the campus and beaten him with a belt, leaving him “shaken and terrified.”</p><p>The student from the 2025 batch of Government Doon Medical College stated in a written complaint that he had been mentally disturbed and living in fear since the incident.</p><p>Taking disciplinary action, the administration suspended nine MBBS students and expelled them from the hostel. Of them, two students were suspended from classes for two months, expelled from the hostel and internship for the entire course duration, and fined Rs 50,000 each. The remaining seven students were suspended from classes for one month and expelled from the hostel for three months.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-colleges/doon-medical-college-9-mbbs-students-suspended-expelled-for-ragging-162978" target="_blank">Doon medical college 9 MBBS students suspended, expelled for ragging</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Margoa doctor robbed at knifepoint at home, Rs 1.5 lakh looted</title>
<link>https://edusehat.com/en/margoa-doctor-robbed-at-knifepoint-at-home-rs-15-lakh-looted</link>
<guid>https://edusehat.com/en/margoa-doctor-robbed-at-knifepoint-at-home-rs-15-lakh-looted</guid>
<description><![CDATA[ Margoa: In a shocking incident, a doctor from Margao, Goa, was allegedly robbed at knifepoint at his residence in Benaulim on April 6. Following the incident, he lodged a complaint with the police.According to the complaint, the doctor said that as he was opening the door, an unidentified individual, who was short in height, dark-complexioned, and wearing a light-colored, full-sleeved T-shirt, suddenly entered his property.  Also Read: Bombay HC Upholds FDA Action in Spurious Anti-Venom Case Against Aarav PharmaThe doctor alleged that after entering the house, the man pushed him to the ground, threatened him with a knife, and snatched his gold chain.According to TheGoan media news report, he also stated that the accused took his shorts, along with a wallet worth approximately ₹4,000, car keys, keys to two houses, and essential documents such as a DDSSY card, MDI card, Aadhaar card, and bank cards and items worth about Rs ₹1,50,000.The complainant further stated that after taking all the belongings, the individual locked him inside the house and then fled the scene.Meanwhile, the Colva Police have registered an FIR under sections 329(3), 115(2), 351(3), 309(4), and 127(2) of the BNS.Medical Dialogues had earlier reported that a group of five to seven masked dacoits broke into the residence of a doctor in Mapusa’s densely populated Ganeshpuri areas. The assailants held four family members hostage for over two hours, looted cash and gold worth more than Rs 35 lakh, and fled in the family’s car, which was later found abandoned in Panaji. The incident occurred between 3 AM and 5 AM at the home of the 49-year-old, Dr Mahendra Kamat Ghanekar. Armed with iron rods and a large knife, the gang entered the house by cutting through a window grill. Also Read: Illegal tenure row: Bombay HC hears plea against Goa dental college dean&#039;s post-retirement continuance  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341327-doctor-robbed.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Margoa, doctor, robbed, knifepoint, home, 1.5, lakh, looted</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341327-doctor-robbed.webp"><p><b>Margoa: </b>In a shocking incident, a doctor from Margao, Goa, was allegedly robbed at knifepoint at his residence in Benaulim on April 6. Following the incident, he lodged a complaint with the police.</p><div class="pasted-from-word-wrapper"><p dir="ltr">According to the complaint, the doctor said that as he was opening the door, an unidentified individual, who was short in height, dark-complexioned, and wearing a light-colored, full-sleeved T-shirt, suddenly entered his property.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/bombay-hc-upholds-fda-action-in-spurious-anti-venom-case-against-aarav-pharma-168486"><b>Also Read: </b>Bombay HC Upholds FDA Action in Spurious Anti-Venom Case Against Aarav Pharma</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The doctor alleged that after entering the house, the man pushed him to the ground, threatened him with a knife, and snatched his gold chain.</p><p dir="ltr">According to <a href="https://www.thegoan.net/goa-news/margao-doctor-robbed-at-knife-point-in-benaulim-home/146353.html" target="_blank" rel="nofollow">TheGoan </a>media news report, he also stated that the accused took his shorts, along with a wallet worth approximately ₹4,000, car keys, keys to two houses, and essential documents such as a DDSSY card, MDI card, Aadhaar card, and bank cards and items worth about Rs ₹1,50,000.</p><p dir="ltr">The complainant further stated that after taking all the belongings, the individual locked him inside the house and then fled the scene.</p><p dir="ltr">Meanwhile, the Colva Police have registered an FIR under sections 329(3), 115(2), 351(3), 309(4), and 127(2) of the BNS.</p><p dir="ltr">Medical Dialogues had earlier reported that a group of five to seven masked dacoits broke into the residence of a doctor in Mapusa’s densely populated Ganeshpuri areas. The assailants held four family members hostage for over two hours, looted cash and gold worth more than Rs 35 lakh, and fled in the family’s car, which was later found abandoned in Panaji. The incident occurred between 3 AM and 5 AM at the home of the 49-year-old, Dr Mahendra Kamat Ghanekar. Armed with iron rods and a large knife, the gang entered the house by cutting through a window grill. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/illegal-tenure-row-bombay-hc-hears-plea-against-goa-dental-college-deans-post-retirement-continuance-167526"><b>Also Read: </b>Illegal tenure row: Bombay HC hears plea against Goa dental college dean's post-retirement continuance</a> </p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Rs 573 crore infrastructure boost for MAMC&#45; Delhi Govt approves new hostels for medical students</title>
<link>https://edusehat.com/en/rs-573-crore-infrastructure-boost-for-mamc-delhi-govt-approves-new-hostels-for-medical-students</link>
<guid>https://edusehat.com/en/rs-573-crore-infrastructure-boost-for-mamc-delhi-govt-approves-new-hostels-for-medical-students</guid>
<description><![CDATA[ New Delhi: Strengthening student infrastructure in government medical institutions, the Delhi government has approved two new hostel complexes at Maulana Azad Medical College (MAMC) at a cost of Rs 573.41 crore.The project comes in response to growing demand for accommodation and the deteriorating condition of decades-old hostel buildings.According to UNI report, the decision was cleared at a meeting of the Expenditure Finance Committee (EFC) chaired by Chief Minister Rekha Gupta.The project includes separate hostel buildings for male and female students within the MAMC campus and is expected to be completed within a 36-month timeframe.Also Read:Delhi University temporarily bans protests, rallies, public gatherings- MAMC issues orderDescribing the move as a major step towards student welfare, the Chief Minister said, “Under the guidance of Prime Minister Narendra Modi, and in line with the vision of ‘Sabka Saath, Sabka Vikas’, the Delhi government is working to ensure that students in government institutions have access to world-class facilities.”Highlighting the urgent need for expanded accommodation, Gupta noted that the annual student intake at MAMC has increased significantly over the years. “The intake has risen from 150 to 250 students, placing considerable pressure on the existing hostel infrastructure. Many students are forced to share rooms, while some are unable to secure hostel accommodation altogether,” she said.She further pointed out that the current hostel buildings, constructed between 1965 and 1982, have aged considerably. “This project addresses a long-pending requirement and reflects our commitment to modernising essential infrastructure in medical education,” the Chief Minister added.According to official details, the girls’ hostel will be developed at Site A with an estimated cost of Rs 269.19 crore, while the boys’ hostel will be constructed at Site B at a cost of Rs 304.22 crore. Both facilities will include basement and superstructure components along with comprehensive civil and electrical works.Emphasising the non-commercial nature of the initiative, Gupta said, “This project is not commercial in nature. It has been conceived purely with a social objective, to improve students’ living conditions and support their academic growth.”She also confirmed that land for the project is readily available and construction will begin within six months after administrative and financial approvals are finalised. The timeline includes six months for planning and 30 months for construction.Reiterating the government’s broader focus, Gupta said, “Expanding infrastructure in education and healthcare remains a top priority for the Delhi government. Long-pending needs are being addressed on priority to ensure time-bound and meaningful outcomes.”Expressing confidence in the initiative, she added that the new hostels would further strengthen MAMC’s standing. “This move will help Maulana Azad Medical College emerge even stronger as one of the country’s leading medical institutions in the years ahead,” she said, quotes UNIAlso Read:Rekha Gupta inaugurates Department of Medical Genetics at MAMC ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341297-rekha.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 16:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>573, crore, infrastructure, boost, for, MAMC-, Delhi, Govt, approves, new, hostels, for, medical, students</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341297-rekha.webp"><div class="pasted-from-word-wrapper"><p><span>New Delhi: </span>Strengthening student infrastructure in government medical institutions, the Delhi government has approved two new hostel complexes at Maulana Azad Medical College (MAMC) at a cost of Rs 573.41 crore.</p><p>The project comes in response to growing demand for accommodation and the deteriorating condition of decades-old hostel buildings.</p><p><span>According to UNI report, t</span><span>he decision was cleared at a meeting of the Expenditure Finance Committee (EFC) chaired by Chief Minister </span><a href="https://medicaldialogues.in/topics/rekha-gupta" target="_blank">Rekha Gupta</a><span>.</span></p><p>The project includes separate hostel buildings for male and female students within the <a href="https://medicaldialogues.in/topics/MAMC" target="_blank">MAMC </a>campus and is expected to be completed within a 36-month timeframe.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/delhi-university-temporarily-bans-protests-rallies-public-gatherings-mamc-issues-order-165433"><b>Also Read:Delhi University temporarily bans protests, rallies, public gatherings- MAMC issues order</b></a></p><p>Describing the move as a major step towards student welfare, the Chief Minister said, “Under the guidance of Prime Minister Narendra Modi, and in line with the vision of ‘Sabka Saath, Sabka Vikas’, the Delhi government is working to ensure that students in government institutions have access to world-class facilities.”</p><p>Highlighting the urgent need for expanded accommodation, Gupta noted that the annual student intake at <a href="https://medicaldialogues.in/topics/MAMC" target="_blank">MAMC </a>has increased significantly over the years. “The intake has risen from 150 to 250 students, placing considerable pressure on the existing hostel infrastructure. Many students are forced to share rooms, while some are unable to secure hostel accommodation altogether,” she said.</p><p>She further pointed out that the current hostel buildings, constructed between 1965 and 1982, have aged considerably. “This project addresses a long-pending requirement and reflects our commitment to modernising essential infrastructure in medical education,” the Chief Minister added.</p><p>According to official details, the girls’ hostel will be developed at Site A with an estimated cost of Rs 269.19 crore, while the boys’ hostel will be constructed at Site B at a cost of Rs 304.22 crore. Both facilities will include basement and superstructure components along with comprehensive civil and electrical works.</p><p>Emphasising the non-commercial nature of the initiative, Gupta said, “This project is not commercial in nature. It has been conceived purely with a social objective, to improve students’ living conditions and support their academic growth.”</p><p>She also confirmed that land for the project is readily available and construction will begin within six months after administrative and financial approvals are finalised. The timeline includes six months for planning and 30 months for construction.</p><p>Reiterating the government’s broader focus, Gupta said, “Expanding infrastructure in education and healthcare remains a top priority for the Delhi government. Long-pending needs are being addressed on priority to ensure time-bound and meaningful outcomes.”</p><p>Expressing confidence in the initiative, she added that the new hostels would further strengthen MAMC’s standing. “This move will help Maulana Azad Medical College emerge even stronger as one of the country’s leading medical institutions in the years ahead,” she said, quotes UNI</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/rekha-gupta-inaugurates-department-of-medical-genetics-at-mamc-163268"><b>Also Read:Rekha Gupta inaugurates Department of Medical Genetics at MAMC</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Food Supplementation after HF feasible but may not reduce hospitalization or ED visits: JAMA</title>
<link>https://edusehat.com/en/food-supplementation-after-hf-feasible-but-may-not-reduce-hospitalization-or-ed-visits-jama</link>
<guid>https://edusehat.com/en/food-supplementation-after-hf-feasible-but-may-not-reduce-hospitalization-or-ed-visits-jama</guid>
<description><![CDATA[ A pilot randomized trial showed that food supplementation after hospitalization for heart failure (HF) is feasible, with fresh produce being more acceptable and better adhered to than medically tailored meals. However, it did not reduce HF hospitalizations or emergency visits. These findings support the need for larger trials to evaluate its clinical impact.Low-quality dietary intake is associated with adverse heart failure (HF) outcomes, yet evidence evaluating food-as-medicine interventions that supply high-quality dietary content is limited. A study was done to determine the feasibility of providing food supplementation with medically tailored meals or fresh produce and explore the association of food supplementation vs usual care with clinical outcomes in patients recently hospitalized with HF and whether it differs by conditioning food supplementation to health care engagement. This open-label factorial randomized clinical trial was conducted between April 2024 and October 2025 at 2 hospitals in Dallas, Texas. The study included patients who were hospitalized for HF and enrolled within 14 days of discharge, excluding those with prior heart transplant, a left ventricular assist device, or inotropic support at discharge; current enrollment in meal delivery programs; and inability to receive home deliveries. Participants were followed up with for 12 weeks. Of 150 participants enrolled, 2 were withdrawn due to clinical deterioration, 1 died, and 6 were lost to follow-up; all were included in the intention-to-treat analysis.Participants were randomized 1:1:1 to medically tailored meals, fresh produce, or usual care. Those receiving food supplementation underwent secondary 1:1 randomization to conditional (linked to clinic attendance and medication fills) vs unconditional delivery. Implementation outcomes included delivery completion, adherence, and acceptability and exploratory clinical outcomes. The primary clinical outcome was defined as readmission for HF or emergency department (ED) visits for HF over 90-day follow-up. Secondary clinical outcomes included a win-ratio–based hierarchical composite (all-cause death, total HF hospitalizations or ED visits, and ≥10-point Kansas City Cardiomyopathy Questionnaire-Clinical Summary Score [KCCQ-CSS] improvement). Results  Among 150 participants (median [IQR] age, 59.5 [52.0-66.0] years; 91 [60.7%] male), the baseline median (IQR) left ventricular ejection fraction was 35% (25.0-54.0), the baseline median (IQR) KCCQ-CSS was 56.6 (36.8-72.9), and 79 (52.7%) had food insecurity. Food delivery completion was 93.6% with a mean (SD) reported consumption adherence of 4.7 (2.4) days per week (medically tailored meals) and 5.5 (2.3) days per week (fresh produce), with high retention (96.0%). Fresh produce demonstrated superior acceptability compared with medically tailored meals (Net Promoter Score: 8.6 vs 7.3; P = .02). There was no significant difference in the primary clinical outcome (HF readmission or ED visit) between food supplementation (23 events among 100 participants) vs usual care (9 events among 50 participants) (adjusted rate ratio, 1.09; 95% CI, 0.49-2.43; P = .83). The hierarchical composite favored food supplementation vs usual care (win ratio, 1.21; 95% CI, 1.14-1.29; P  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341137-b2edac12a5bfcb1a4a492ddbf2c42244eee1c1b1-5000x2998.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 13:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Food, Supplementation, after, feasible, but, may, not, reduce, hospitalization, visits:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341137-b2edac12a5bfcb1a4a492ddbf2c42244eee1c1b1-5000x2998.webp"><p>A pilot randomized trial showed that food supplementation after hospitalization for heart failure (HF) is feasible, with fresh produce being more acceptable and better adhered to than medically tailored meals. However, it did not reduce HF hospitalizations or emergency visits. These findings support the need for larger trials to evaluate its clinical impact.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Low-quality dietary intake is associated with adverse heart failure (HF) outcomes, yet evidence evaluating food-as-medicine interventions that supply high-quality dietary content is limited. A study was done to determine the feasibility of providing food supplementation with medically tailored meals or fresh produce and explore the association of food supplementation vs usual care with clinical outcomes in patients recently hospitalized with HF and whether it differs by conditioning food supplementation to health care engagement. This open-label factorial randomized clinical trial was conducted between April 2024 and October 2025 at 2 hospitals in Dallas, Texas. The study included patients who were hospitalized for HF and enrolled within 14 days of discharge, excluding those with prior heart transplant, a left ventricular assist device, or inotropic support at discharge; current enrollment in meal delivery programs; and inability to receive home deliveries. Participants were followed up with for 12 weeks. Of 150 participants enrolled, 2 were withdrawn due to clinical deterioration, 1 died, and 6 were lost to follow-up; all were included in the intention-to-treat analysis.</p><p dir="ltr">Participants were randomized 1:1:1 to medically tailored meals, fresh produce, or usual care. Those receiving food supplementation underwent secondary 1:1 randomization to conditional (linked to clinic attendance and medication fills) vs unconditional delivery. Implementation outcomes included delivery completion, adherence, and acceptability and exploratory clinical outcomes. The primary clinical outcome was defined as readmission for HF or emergency department (ED) visits for HF over 90-day follow-up. Secondary clinical outcomes included a win-ratio–based hierarchical composite (all-cause death, total HF hospitalizations or ED visits, and ≥10-point Kansas City Cardiomyopathy Questionnaire-Clinical Summary Score [KCCQ-CSS] improvement). Results  Among 150 participants (median [IQR] age, 59.5 [52.0-66.0] years; 91 [60.7%] male), the baseline median (IQR) left ventricular ejection fraction was 35% (25.0-54.0), the baseline median (IQR) KCCQ-CSS was 56.6 (36.8-72.9), and 79 (52.7%) had food insecurity. Food delivery completion was 93.6% with a mean (SD) reported consumption adherence of 4.7 (2.4) days per week (medically tailored meals) and 5.5 (2.3) days per week (fresh produce), with high retention (96.0%). Fresh produce demonstrated superior acceptability compared with medically tailored meals (Net Promoter Score: 8.6 vs 7.3; P = .02). There was no significant difference in the primary clinical outcome (HF readmission or ED visit) between food supplementation (23 events among 100 participants) vs usual care (9 events among 50 participants) (adjusted rate ratio, 1.09; 95% CI, 0.49-2.43; P = .83). The hierarchical composite favored food supplementation vs usual care (win ratio, 1.21; 95% CI, 1.14-1.29; P < .001). Among participants receiving food supplementation, conditional delivery (vs unconditional) was not associated with risk of HF events. In this randomized clinical trial, 90-day food supplementation was feasible and well accepted in individuals with recent HF. Food supplementation was not associated with an improvement in the primary clinical outcome and there was no difference when conditioning food supplementation on health care engagement.</p><div><br></div><div><br></div><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Pandey A, Keshvani N, Coellar JD, et al. Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial. JAMA Cardiol. Published online April 08, 2026. doi:10.1001/jamacardio.2026.0435</p><p dir="ltr">Keywords:</p><p dir="ltr">Food Supplementation, HF,  feasible, reduce,  hospitalization, ED visits, JAMA, Pandey A, Keshvani N, Coellar JD</p><div><br></div><div><br></div><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>90&#45;year&#45;old doctor moves  Bombay HC to adopt caretaker as son; Centre, State asked to respond</title>
<link>https://edusehat.com/en/90-year-old-doctor-moves-bombay-hc-to-adopt-caretaker-as-son-centre-state-asked-to-respond</link>
<guid>https://edusehat.com/en/90-year-old-doctor-moves-bombay-hc-to-adopt-caretaker-as-son-centre-state-asked-to-respond</guid>
<description><![CDATA[ Mumbai: The Bombay High Court on Tuesday sought responses from the Centre and the state government on a
petition filed in 2025 by a 90-year-old retired professor and gynaecologist, who has requested permission to legally adopt his 43-year-old caretaker as his son to “carry
forward the name and fame.”

The petitioner, a resident of Opera House and owner of a bungalow, several plots of land, and a BMW, has
requested the court to direct the registration of an adoption deed naming his
Hindu caretaker as his son.Also Read:Kerala HC Rules Failure to Conduct Pre-Anaesthetic Check-Up Gross Negligence, Denies Relief to AnaesthetistAccording to Economic Times, he has sought the court’s intervention to secure permission for the registration of the adoption deed and to declare his “right to adopt an adult
person of his choice having a long association with him.” His advocate Suresh
Mane said he is a “well-known medical practitioner” and is physically and
mentally fit.

He was not married and had
no legal heir. He has only one sister who passed away, leaving her children
behind. His lawyer told the court, “Now at the fag end of his life… he would
like to adopt an adult person as his own son.” The petition states that the
caretaker, who follows the Hindu faith, has been living with and caring for the
petitioner since 1999. The case highlights a gap in India’s adoption laws,
which primarily address child adoption and do not provide provisions for
adopting adults. The counsel for the petitioner pointed out the problem with
the current legal framework related to the adoption law, which is child-centric
and has no provision for adult adoption, reports The Daily.

 “There is a legislative vacuum in India
regarding adult adoption,” he stated. He also mentioned other countries like
the US, Canada, Japan, Germany, and Switzerland all have provisions for adult
adoption. “The existing legal regime is child-centric and does not cover adult
adoption… Whether he should suffer because of the deficiency of the law?” the counsel
argued. During the hearing, the court questioned the need for adoption since the
petitioner had already secured the caretaker’s future by making a will in his
favour, granting him power of attorney, and handing over key documents.Also Read:Bombay HC refuses to quash criminal proceedings against doctor in patient data leak caseAccording to The Daily,
the case reached the court after the registrar refused to register the adoption
deed in August 2025, prompting the petitioner to seek judicial intervention to
recognise his right to adopt an adult and direct the registrar to accept the
deed. The state also raised concerns about his assets, noting that he owns
several properties mentioned in his will and that legal clarity is necessary
before permitting such an adoption.

Responding to the
statement, the counsel for the petitioner stated, “The petitioner has a right
to dispose of his properties.” The court also stated that the petitioner’s
nephew executed the will, and he should be included in the case. The petitioner is
a Parsi but wants to adopt a Hindu adult. He has appealed to the judgment of
the bench by mentioning constitutional secularism and sought permission to
choose his legal heir. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/03/330682-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 13:05:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>90-year-old, doctor, moves, Bombay, adopt, caretaker, son, Centre, State, asked, respond</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/03/330682-court.webp"><p>Mumbai: The <a href="https://medicaldialogues.in/topics/bombay-high-court" target="_blank">Bombay High Court</a> on Tuesday sought responses from the Centre and the state government on a
petition filed in 2025 by a 90-year-old retired professor and gynaecologist, who has requested permission to legally adopt his 43-year-old caretaker as his son to “carry
forward the name and fame.”<br></p><div class="pasted-from-word-wrapper">

<p>The petitioner, a resident of Opera House and owner of a bungalow, several plots of land, and a BMW, has
requested the court to direct the registration of an adoption deed naming his
Hindu caretaker as his son.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/mdtv/top-videos/kerala-hc-rules-failure-to-conduct-pre-anaesthetic-check-up-gross-negligence-denies-relief-to-anaesthetist-168447"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/04/11/341060-mbbs-19.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/top-videos/kerala-hc-rules-failure-to-conduct-pre-anaesthetic-check-up-gross-negligence-denies-relief-to-anaesthetist-168447"><span class="read-this-also">Also Read:</span>Kerala HC Rules Failure to Conduct Pre-Anaesthetic Check-Up Gross Negligence, Denies Relief to Anaesthetist</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>According to <a href="https://economictimes.indiatimes.com/news/new-updates/90-year-old-doctor-moves-hc-to-adopt-43-year-old-opens-debate-on-why-india-doesnt-allow-adult-adoption/articleshow/130107949.cms?from=mdr" target="_blank" rel="nofollow">Economic Times</a>, he has sought the court’s intervention to secure permission for the registration of the adoption deed and to declare his “right to adopt an adult
person of his choice having a long association with him.” His advocate Suresh
Mane said he is a “well-known medical practitioner” and is physically and
mentally fit.</p>

<p>He was not married and had
no legal heir. He has only one sister who passed away, leaving her children
behind. His lawyer told the court, “Now at the fag end of his life… he would
like to adopt an adult person as his own son.” The petition states that the
caretaker, who follows the Hindu faith, has been living with and caring for the
petitioner since 1999. The case highlights a gap in India’s adoption laws,
which primarily address child adoption and do not provide provisions for
adopting adults. The counsel for the petitioner pointed out the problem with
the current legal framework related to the adoption law, which is child-centric
and has no provision for adult adoption, reports The Daily.</p>

<p> “There is a legislative vacuum in India
regarding adult adoption,” he stated. He also mentioned other countries like
the US, Canada, Japan, Germany, and Switzerland all have provisions for adult
adoption. “The existing legal regime is child-centric and does not cover adult
adoption… Whether he should suffer because of the deficiency of the law?” the counsel
argued. During the hearing, the court questioned the need for adoption since the
petitioner had already secured the caretaker’s future by making a will in his
favour, granting him power of attorney, and handing over key documents.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/doctors/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case-167978"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/01/31/324777-bombay-high-court.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case-167978"><span class="read-this-also">Also Read:</span>Bombay HC refuses to quash criminal proceedings against doctor in patient data leak case</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>According to The Daily,
the case reached the court after the registrar refused to register the adoption
deed in August 2025, prompting the petitioner to seek judicial intervention to
recognise his right to adopt an adult and direct the registrar to accept the
deed. The state also raised concerns about his assets, noting that he owns
several properties mentioned in his will and that legal clarity is necessary
before permitting such an adoption.</p>

<p>Responding to the
statement, the counsel for the petitioner stated, “The petitioner has a right
to dispose of his properties.” The court also stated that the petitioner’s
nephew executed the will, and he should be included in the case. The petitioner is
a Parsi but wants to adopt a Hindu adult. He has appealed to the judgment of
the bench by mentioning constitutional secularism and sought permission to
choose his legal heir.</p></div>]]> </content:encoded>
</item>

<item>
<title>IMA Kerala flags concern over mixopathy in 2026 election manifestos</title>
<link>https://edusehat.com/en/ima-kerala-flags-concern-over-mixopathy-in-2026-election-manifestos</link>
<guid>https://edusehat.com/en/ima-kerala-flags-concern-over-mixopathy-in-2026-election-manifestos</guid>
<description><![CDATA[ Thiruvananthapuram: The
Indian Medical Association (IMA) unit in Kerala has raised concerns after some
political parties reportedly included support for “mixopathy” in their
manifestos ahead of the upcoming 2026 Assembly elections.Also Read:IMA Kerala raises concern over Clinical Establishments Act, small hospitals at riskThe association said that
endorsing mixopathy contradicts the spirit of World Health Day 2026, which is
being observed under the theme “Unite for Health, Stand with Science.” According to the IMA, the
theme emphasises the importance of scientific evidence and evidence-based medical
practice in healthcare. The IMA noted that while World Health Day highlights
the need for science-based treatment approaches, the promotion of mixopathy
runs counter to this message.

Speaking to Medical
Dialogues, Dr. N. Sulphi, the convener of the Indian Medical Association’s  national action committee and the former
president of IMA Kerala, stated, “It takes years of research and clinical trials
to decide on any form of modern medication. There are some standards that the
doctors should follow to ensure patient safety and treatment. Mixing modern
medication techniques with Ayush and traditional medicine is highly risky and
compromises patient safety. In China, some people are also mixing traditional
Acupuncture with modern medicines, but such experiments never bear good
outcomes.”

The doctor also pointed
out that Article 51A(h) of the Indian Constitution places importance on developing
a scientific temper, humanism, and a spirit of inquiry in every human being.
Hence, promoting mixopathy does not support the spirit of the Constitution. Applying
two systems of medicine without any scientific explanation is dangerous. Before
making any policy decision or making any comment on a political manifesto, one
must first determine if that is in the best interest of the patient.Also Read:1,306 clinics shut, as private hospitals rise in Kerala; IMA expresses concern“One must protect
scientific integrity in healthcare. I am not against promoting traditional
means of treatment like Ayush. However, it must not be mixed with allopathy.
Both mediums of treatment could not be more different, and mixing them, without
any scientific proof of their efficiency, is too much of a risk. The IMA will
stand against any such step that occurs without scientific evidence and compromises
patient safety. Using such phrases in a political party’s manifesto is shocking,”
Dr. N. Sulphi further stated. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/07/185150-mixopathy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 13:05:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>IMA, Kerala, flags, concern, over, mixopathy, 2026, election, manifestos</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/07/185150-mixopathy.webp"><p>Thiruvananthapuram: The
<a href="https://medicaldialogues.in/topics/indian-medical-association-kerala" target="_blank">Indian Medical Association</a> (IMA) unit in Kerala has raised concerns after some
political parties reportedly included support for “<a href="https://medicaldialogues.in/topics/mixopathy" target="_blank">mixopathy</a>” in their
manifestos ahead of the upcoming 2026 Assembly elections.<br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/ima-kerala-raises-concern-over-clinical-establishments-act-small-hospitals-at-risk-164437"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/02/10/326801-doctor-14.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/ima-kerala-raises-concern-over-clinical-establishments-act-small-hospitals-at-risk-164437"><span class="read-this-also">Also Read:</span>IMA Kerala raises concern over Clinical Establishments Act, small hospitals at risk</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>The association said that
endorsing mixopathy contradicts the spirit of World Health Day 2026, which is
being observed under the theme “Unite for Health, Stand with Science.” According to the IMA, the
theme emphasises the importance of scientific evidence and evidence-based medical
practice in healthcare. The IMA noted that while World Health Day highlights
the need for science-based treatment approaches, the promotion of mixopathy
runs counter to this message.</p>

<p>Speaking to Medical
Dialogues, Dr. N. Sulphi, the convener of the Indian Medical Association’s  national action committee and the former
president of IMA Kerala, stated, “It takes years of research and clinical trials
to decide on any form of modern medication. There are some standards that the
doctors should follow to ensure patient safety and treatment. Mixing modern
medication techniques with Ayush and traditional medicine is highly risky and
compromises patient safety. In China, some people are also mixing traditional
Acupuncture with modern medicines, but such experiments never bear good
outcomes.”</p>

<p>The doctor also pointed
out that Article 51A(h) of the Indian Constitution places importance on developing
a scientific temper, humanism, and a spirit of inquiry in every human being.
Hence, promoting mixopathy does not support the spirit of the Constitution. Applying
two systems of medicine without any scientific explanation is dangerous. Before
making any policy decision or making any comment on a political manifesto, one
must first determine if that is in the best interest of the patient.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/1306-clinics-shut-as-private-hospitals-rise-in-kerala-ima-expresses-concern-164665"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/01/16/321712-andhra-pradesh-1.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/1306-clinics-shut-as-private-hospitals-rise-in-kerala-ima-expresses-concern-164665"><span class="read-this-also">Also Read:</span>1,306 clinics shut, as private hospitals rise in Kerala; IMA expresses concern</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>“One must protect
scientific integrity in healthcare. I am not against promoting traditional
means of treatment like Ayush. However, it must not be mixed with allopathy.
Both mediums of treatment could not be more different, and mixing them, without
any scientific proof of their efficiency, is too much of a risk. The IMA will
stand against any such step that occurs without scientific evidence and compromises
patient safety. Using such phrases in a political party’s manifesto is shocking,”
Dr. N. Sulphi further stated.</p></div>]]> </content:encoded>
</item>

<item>
<title>Trapeziectomy with ECRL Ligament Reconstruction Improves Outcomes in Thumb CMC Osteoarthritis: Study</title>
<link>https://edusehat.com/en/trapeziectomy-with-ecrl-ligament-reconstruction-improves-outcomes-in-thumb-cmc-osteoarthritis-study</link>
<guid>https://edusehat.com/en/trapeziectomy-with-ecrl-ligament-reconstruction-improves-outcomes-in-thumb-cmc-osteoarthritis-study</guid>
<description><![CDATA[ Carpometacarpal (CM) joint osteoarthritis of the thumb is characterized by pain and impaired thumb function in terms of pinch and range of motion. Teiji Kato et al newly adopted a trapeziectomy with a graft-augmented ligament reconstruction procedure, in which the reconstructed ligament is reinforced using a half-slip extensor carpi radialis longus (ECRL) tendon. The article was published in “JBJS Open Access.”101 hands of 95 patients with CM joint osteoarthritis of the thumb underwent trapeziectomy with graft-augmented ligament reconstruction using the half-slip ECRL tendon to reconstruct the ligament. The reconstructed ligament was reinforced by wrapping 3 times with the half-slip ECRL tendon. All patients underwent a 1-year assessment, and 29 hands of 26 patients were followed up for &gt;4 years postoperatively. 
The key findings of the study were:
•	Motion pain, as assessed by visual analogue scale, was significantly improved from 56.9 ± 20.6 preoperatively to 4.2 ± 10.1 at the 1-year assessment (p &lt; 0.001).
•	Radial and palmar abduction also increased significantly from 46.0  ± 11.0  and 49.7  ± 8.8 preoperatively, respectively, to 58.4  ± 6.4  (p &lt; 0.001) and 59.5  ± 6.3  (p &lt; 0.001), respectively, at 12 months postoperatively. 
•	Both male and female tip pinch increased significantly from 4.2 ± 1.8 and 3.0 ± 1.4 preoperatively, respectively, to 6.1 ± 1.9 (p = 0.002) and 4.3 ± 1.4 (p &lt; 0.001) at the 1-year postoperative evaluation. 
•	The authors observed no impingement of the first metacarpal and scaphoid bones due to sinking of the first metacarpal bone, and repeat surgery due to rupture of the reconstructed ligament or fractures at the bone hole, was not needed for the 101 hands followed for approximately 1 year and the 29 hands followed over 4 years. 
The authors concluded – “Trapeziectomy combined with graft-augmented ligament reconstruction, using a reinforced half-slip ECRL tendon wrapped 3 times, may serve as an effective treatment option for primary thumb carpometacarpal osteoarthritis. This approach offers significant pain relief, improved range of motion and pinch strength, and prevents postoperative impingement of the first metacarpal across all Eaton stages in the short medium term.” 
Level of Evidence: Therapeutic Level Ⅳ. For further details on the article refer to:
Trapeziectomy and Ligament Reconstruction Using a Reinforced Half-Slip of the Extensor Carpi Radialis Longus Tendon for Thumb Carpometacarpal Osteoarthritis
Teiji Kato et al
JBJS Open Access 2025:e25.00147
http://dx.doi.org/10.2106/JBJS.OA.25.00147 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/13/341276-hand-old-woman.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 13:05:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Trapeziectomy, with, ECRL, Ligament, Reconstruction, Improves, Outcomes, Thumb, CMC, Osteoarthritis:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/13/341276-hand-old-woman.webp"><p>Carpometacarpal (CM) joint osteoarthritis of the thumb is characterized by pain and impaired thumb function in terms of pinch and range of motion. Teiji Kato et al newly adopted a trapeziectomy with a graft-augmented ligament reconstruction procedure, in which the reconstructed ligament is reinforced using a half-slip extensor carpi radialis longus (ECRL) tendon. The article was published in “JBJS Open Access.”</p><p>101 hands of 95 patients with CM joint osteoarthritis of the thumb underwent trapeziectomy with graft-augmented ligament reconstruction using the half-slip ECRL tendon to reconstruct the ligament. The reconstructed ligament was reinforced by wrapping 3 times with the half-slip ECRL tendon. All patients underwent a 1-year assessment, and 29 hands of 26 patients were followed up for >4 years postoperatively. 
</p><p>The key findings of the study were:
</p><p>•	Motion pain, as assessed by visual analogue scale, was significantly improved from 56.9 ± 20.6 preoperatively to 4.2 ± 10.1 at the 1-year assessment (p < 0.001).
</p><p>•	Radial and palmar abduction also increased significantly from 46.0  ± 11.0  and 49.7  ± 8.8 preoperatively, respectively, to 58.4  ± 6.4  (p < 0.001) and 59.5  ± 6.3  (p < 0.001), respectively, at 12 months postoperatively. 
</p><p>•	Both male and female tip pinch increased significantly from 4.2 ± 1.8 and 3.0 ± 1.4 preoperatively, respectively, to 6.1 ± 1.9 (p = 0.002) and 4.3 ± 1.4 (p < 0.001) at the 1-year postoperative evaluation. 
</p><p>•	The authors observed no impingement of the first metacarpal and scaphoid bones due to sinking of the first metacarpal bone, and repeat surgery due to rupture of the reconstructed ligament or fractures at the bone hole, was not needed for the 101 hands followed for approximately 1 year and the 29 hands followed over 4 years. 
</p><p>The authors concluded – “Trapeziectomy combined with graft-augmented ligament reconstruction, using a reinforced half-slip ECRL tendon wrapped 3 times, may serve as an effective treatment option for primary thumb carpometacarpal osteoarthritis. This approach offers significant pain relief, improved range of motion and pinch strength, and prevents postoperative impingement of the first metacarpal across all Eaton stages in the short medium term.” 
</p><p>Level of Evidence: Therapeutic Level Ⅳ. </p><p>For further details on the article refer to:
</p><p>Trapeziectomy and Ligament Reconstruction Using a Reinforced Half-Slip of the Extensor Carpi Radialis Longus Tendon for Thumb Carpometacarpal Osteoarthritis
</p><p>Teiji Kato et al
</p><p>JBJS Open Access 2025:e25.00147
</p><p>http://dx.doi.org/10.2106/JBJS.OA.25.00147</p>]]> </content:encoded>
</item>

<item>
<title>Add on Dapagliflozin to Insulin Pump Superior to add on Metformin for Glycemic Control in Diabetes: Study</title>
<link>https://edusehat.com/en/add-on-dapagliflozin-to-insulin-pump-superior-to-add-on-metformin-for-glycemic-control-in-diabetes-study</link>
<guid>https://edusehat.com/en/add-on-dapagliflozin-to-insulin-pump-superior-to-add-on-metformin-for-glycemic-control-in-diabetes-study</guid>
<description><![CDATA[ Researchers have found in a new study that dapagliflozin combined with intensive insulin pump therapy provides better glycemic control than metformin in patients with type 2 diabetes, indicating a more effective treatment strategy for clinical practice. The study was published in the Journal of Diabetes Research by Miaoguan P. and colleagues.In the present study, a total of 110 subjects suffering from severe hyperglycemia at the time of their diagnosis were included in the trial. The inclusion criteria of the study required participants to have an HbA1c level greater than 9%, a blood glucose level above 11.1 mmol/L, or obvious symptoms of hyperglycemia. Recently diagnosed was described as being diagnosed within the year of the start of the experiment, and all patients involved in the study were treatment-naïve or had been on treatment for less than two weeks. Of the total number of subjects, 81 participants (73.6%) gave complete information for analysis purposes. The subjects were divided into three different groups for treatment:Group 1: Insulin pump therapy only had 25 subjects,Group 2: Insulin, along with Dapagliflozin, had 20 subjects, andGroup 3: Insulin, along with Metformin, had 36 subjects.Key findings:The authors primarily concentrated on three clinical outcomes: time taken to achieve glycaemic control targets, total dose of insulin at the end of the intensive period, and its overall effects on the functioning of the pancreas. The key finding was associated with fluctuations in fasting insulin in all groups throughout the experiment period. It was found that the greatest decrease in fasting insulin was noted in the insulin pump therapy alone and insulin pump therapy with Dapagliflozin groups. At the same time, the insulin pump therapy with the Metformin group registered a smaller decrease. By evaluating the selected parameters, it was established that the use of the Dapagliflozin drug facilitated a more effective physiological shift during the intensive period compared with the conventional Metformin treatment.Conclusively, this experimental research clearly highlights an important revolution within the clinical practices regarding intensive glucose control strategies. The addition of Dapagliflozin treatment to the insulin pump therapy is considered a much more appropriate strategy compared to the combination of Metformin to achieve glycemic goals and insulin levels. This research can be seen as a great opportunity for clinicians who deal with patients suffering from newly diagnosed T2DM in order to intensify their treatment more efficiently.Reference:Peng, Miaoguan, Xie, Yijuan, Liang, Naifeng, Wen, Shiyun, Zhai, Yaojie, Xie, Yingjun, Chen, Yuyi, The Impact of Different Oral Antidiabetic Drugs on Insulin Pump Intensive Therapy in Type 2 Diabetes Patients: A Clinical Study, Journal of Diabetes Research, 2026, 9957473, 8 pages, 2026. https://doi.org/10.1155/jdr/9957473 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/06/07/289904-diabetes.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 13:05:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Add, Dapagliflozin, Insulin, Pump, Superior, add, Metformin, for, Glycemic, Control, Diabetes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/06/07/289904-diabetes.webp"><p>Researchers have found in a new study that dapagliflozin combined with intensive insulin pump therapy provides better glycemic control than metformin in patients with type 2 diabetes, indicating a more effective treatment strategy for clinical practice. The study was published in the <i>Journal of Diabetes Research</i> by Miaoguan P. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">In the present study, a total of 110 subjects suffering from severe hyperglycemia at the time of their diagnosis were included in the trial. The inclusion criteria of the study required participants to have an HbA1c level greater than 9%, a blood glucose level above 11.1 mmol/L, or obvious symptoms of hyperglycemia. Recently diagnosed was described as being diagnosed within the year of the start of the experiment, and all patients involved in the study were treatment-naïve or had been on treatment for less than two weeks. Of the total number of subjects, 81 participants (73.6%) gave complete information for analysis purposes. The subjects were divided into three different groups for treatment:</p><p dir="ltr">Group 1: Insulin pump therapy only had 25 subjects,</p><p dir="ltr">Group 2: Insulin, along with Dapagliflozin, had 20 subjects, and</p><p dir="ltr">Group 3: Insulin, along with Metformin, had 36 subjects.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The authors primarily concentrated on three clinical outcomes: time taken to achieve glycaemic control targets, total dose of insulin at the end of the intensive period, and its overall effects on the functioning of the pancreas. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The key finding was associated with fluctuations in fasting insulin in all groups throughout the experiment period. It was found that the greatest decrease in fasting insulin was noted in the insulin pump therapy alone and insulin pump therapy with Dapagliflozin groups. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">At the same time, the insulin pump therapy with the Metformin group registered a smaller decrease. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">By evaluating the selected parameters, it was established that the use of the Dapagliflozin drug facilitated a more effective physiological shift during the intensive period compared with the conventional Metformin treatment.</p></li></ul><p dir="ltr">Conclusively, this experimental research clearly highlights an important revolution within the clinical practices regarding intensive glucose control strategies. The addition of Dapagliflozin treatment to the insulin pump therapy is considered a much more appropriate strategy compared to the combination of Metformin to achieve glycemic goals and insulin levels. </p><p dir="ltr">This research can be seen as a great opportunity for clinicians who deal with patients suffering from newly diagnosed T2DM in order to intensify their treatment more efficiently.</p><p dir="ltr">Reference:</p><p dir="ltr">Peng, Miaoguan, Xie, Yijuan, Liang, Naifeng, Wen, Shiyun, Zhai, Yaojie, Xie, Yingjun, Chen, Yuyi, The Impact of Different Oral Antidiabetic Drugs on Insulin Pump Intensive Therapy in Type 2 Diabetes Patients: A Clinical Study, Journal of Diabetes Research, 2026, 9957473, 8 pages, 2026. <a href="https://doi.org/10.1155/jdr/9957473">https://doi.org/10.1155/jdr/9957473</a></p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>NPPA Revises Prices of Piperacillin&#45;Tazobactam Injections, Sets Ceiling at Rs 470 per Bag</title>
<link>https://edusehat.com/en/nppa-revises-prices-of-piperacillin-tazobactam-injections-sets-ceiling-at-rs-470-per-bag</link>
<guid>https://edusehat.com/en/nppa-revises-prices-of-piperacillin-tazobactam-injections-sets-ceiling-at-rs-470-per-bag</guid>
<description><![CDATA[ New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has revised the ceiling prices of Piperacillin plus Tazobactam injections in dual chamber bags based on the annual Wholesale Price Index (WPI) for 2025.The price revision reflects a marginal increase of 0.64956% over the previous year (2024), and will come into effect from April 1, 2026.The revised ceiling prices apply to Piperacillin + Tazobactam injections in dual chamber bags with special features.As per the notification, the ceiling price for Piperacillin 2 g + Tazobactam 250 mg injection has been fixed at Rs. 225.56 per dual chamber bag, while Piperacillin 4 g + Tazobactam 500 mg injection has been revised to Rs. 470.34 per dual chamber bag.The formulations covered under this notification include products manufactured by M/s Gufic Biosciences Limited under the brand name Tazofic Injection (DCB).Also Read: Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg TabletsIn exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11, 14 and 16 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. No. 1475(E) dated 27.03.2025 in so far as it relate to formulation packs mentioned in the Table A below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, has revised the price based on Wholesale price index (WPI) of 2025 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:Table A: Price Revision as per Annual Wholesale Price Index (WPI) @ 0.64956% increaseSl. No.MedicinesDosage form and StrengthUnitCeiling price (w.e.f. 1.4.2026 with WPI @ 0.64956%) (in Rs.)1Piperacillin (A) + Tazobactam (B)Powder for Injection 2 g (A) + 250 mg (B)Per Dual chamber bag with special feature225.562Piperacillin (A) + Tazobactam (B)Powder for Injection 4 g (A) + 500 mg (B)Per Dual chamber bag with special feature470.34Table BSl. No.Name of ManufacturerProduct / Brand Name1M/s Gufic Biosciences LimitedTazofic Injection (DCB)The notification further clarified(a) The ceiling prices are applicable with effect from 1.4.2026 (ceiling prices are inclusive of Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024).(b) The manufacturers of scheduled formulations, selling above said products/brands of scheduled formulations at price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above Table A plus Goods and Services Tax as applicable, if any.(c) The manufacturers of above-mentioned scheduled formulations having MRP lower than the ceiling price notified vide S.O. No. 1475(E) dated 27.03.2025 (plus Goods and Services Tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 0.64956% for year 2025 over 2024 in accordance with paragraph 16(2) of DPCO, 2013.(d) The manufacturers may add Goods and Services Tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said Table A.(e) Any other manufacturer claiming separate ceiling price for Piperacillin (A) + Tazobactam (B) Injection (i) Powder for injection 2g (A) + 250mg (B) (ii) 4g (A) + 500mg (B) Per Dual chamber bag having special features shall apply to NPPA for separate ceiling price approval.(f) Information about the revision, if carried out, shall be forwarded to the Government in either electronic or physical form in Form-II within a period of fifteen days of such revision and non-submission of information under this subparagraph shall be construed as non-revision of maximum retail price (MRP) and the concerned manufacturer shall be liable to deposit the amount charged over and above the pre-revised maximum retail price (MRP), along with interest thereon from the date of overcharging.(g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above Table A as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.(h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.(i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above Table A launches a new drug as per paragraph 2 (1) (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.(j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.(k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above Table A in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.To view the official notice, click the link below:https://medicaldialogues.in/pdf_upload/2026/03/31/49d9a23b3ec2dfa91cfa83ea27609700-338761.pdfAlso Read: NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/07/240441-nppa.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NPPA, Revises, Prices, Piperacillin-Tazobactam, Injections, Sets, Ceiling, 470, per, Bag</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/07/240441-nppa.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has revised the ceiling prices of Piperacillin plus Tazobactam injections in dual chamber bags based on the annual Wholesale Price Index (WPI) for 2025.</p></div><div class="pasted-from-word-wrapper"><p>The price revision reflects a marginal increase of 0.64956% over the previous year (2024), and will come into effect from April 1, 2026.</p><p>The revised ceiling prices apply to Piperacillin + Tazobactam injections in dual chamber bags with special features.</p><p>As per the notification, the ceiling price for Piperacillin 2 g + Tazobactam 250 mg injection has been fixed at Rs. 225.56 per dual chamber bag, while Piperacillin 4 g + Tazobactam 500 mg injection has been revised to Rs. 470.34 per dual chamber bag.</p><p>The formulations covered under this notification include products manufactured by M/s Gufic Biosciences Limited under the brand name Tazofic Injection (DCB).</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/wockhardt-gets-5-year-nppa-price-control-exemption-for-nafithromycin-400-mg-tablets-167632">Also Read: Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg Tablets</a></div><p>In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11, 14 and 16 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. No. 1475(E) dated 27.03.2025 in so far as it relate to formulation packs mentioned in the Table A below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, has revised the price based on Wholesale price index (WPI) of 2025 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:</p><p>Table A: Price Revision as per Annual Wholesale Price Index (WPI) @ 0.64956% increase</p><div class="pasted-from-word-wrapper"><table><thead><tr><th>Sl. No.</th><th>Medicines</th><th>Dosage form and Strength</th><th>Unit</th><th>Ceiling price (w.e.f. 1.4.2026 with WPI @ 0.64956%) (in Rs.)</th></tr></thead><tbody><tr><td>1</td><td>Piperacillin (A) + Tazobactam (B)</td><td>Powder for Injection 2 g (A) + 250 mg (B)</td><td>Per Dual chamber bag with special feature</td><td>225.56</td></tr><tr><td>2</td><td>Piperacillin (A) + Tazobactam (B)</td><td>Powder for Injection 4 g (A) + 500 mg (B)</td><td>Per Dual chamber bag with special feature</td><td>470.34</td></tr></tbody></table></div><p>Table B</p><div class="pasted-from-word-wrapper"><table><thead><tr><th>Sl. No.</th><th>Name of Manufacturer</th><th>Product / Brand Name</th></tr></thead><tbody><tr><td>1</td><td>M/s Gufic Biosciences Limited</td><td>Tazofic Injection (DCB)</td></tr></tbody></table></div><p>The notification further clarified</p><p>(a) The ceiling prices are applicable with effect from 1.4.2026 (ceiling prices are inclusive of Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024).</p><p>(b) The manufacturers of scheduled formulations, selling above said products/brands of scheduled formulations at price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above Table A plus Goods and Services Tax as applicable, if any.</p><p>(c) The manufacturers of above-mentioned scheduled formulations having MRP lower than the ceiling price notified vide S.O. No. 1475(E) dated 27.03.2025 (plus Goods and Services Tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 0.64956% for year 2025 over 2024 in accordance with paragraph 16(2) of DPCO, 2013.</p><p>(d) The manufacturers may add Goods and Services Tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said Table A.</p><p>(e) Any other manufacturer claiming separate ceiling price for Piperacillin (A) + Tazobactam (B) Injection (i) Powder for injection 2g (A) + 250mg (B) (ii) 4g (A) + 500mg (B) Per Dual chamber bag having special features shall apply to NPPA for separate ceiling price approval.</p><p>(f) Information about the revision, if carried out, shall be forwarded to the Government in either electronic or physical form in Form-II within a period of fifteen days of such revision and non-submission of information under this subparagraph shall be construed as non-revision of maximum retail price (MRP) and the concerned manufacturer shall be liable to deposit the amount charged over and above the pre-revised maximum retail price (MRP), along with interest thereon from the date of overcharging.</p><p>(g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above Table A as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.</p><p>(h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.</p><p>(i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above Table A launches a new drug as per paragraph 2 (1) (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.</p><p>(j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.</p><p>(k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above Table A in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.</p><p><b><i>To view the official notice, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/03/31/49d9a23b3ec2dfa91cfa83ea27609700-338761.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/03/31/49d9a23b3ec2dfa91cfa83ea27609700-338761.pdf</a></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/nppa-fixes-retail-prices-of-31-drug-formulations-including-atorvastatin-empagliflozin-details-167522">Also Read: NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details</a></div></div><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/03/31/49d9a23b3ec2dfa91cfa83ea27609700-338761.pdf" target="_blank"></a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Sanofi&amp;apos;s Thyrotropin Alfa Label Update: CDSCO Panel Recommends New Prescription Warning, Limits Sale to Specialists Only</title>
<link>https://edusehat.com/en/sanofis-thyrotropin-alfa-label-update-cdsco-panel-recommends-new-prescription-warning-limits-sale-to-specialists-only</link>
<guid>https://edusehat.com/en/sanofis-thyrotropin-alfa-label-update-cdsco-panel-recommends-new-prescription-warning-limits-sale-to-specialists-only</guid>
<description><![CDATA[ New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has approved an amendment in the warning statement of Thyrotropin Alfa lyophilized powder for solution for injection 0.9 mg/mL, manufactured by Sanofi Healthcare India, after detailed deliberations.The firm had presented a proposal seeking revision of the existing warning statement of the drug from “To be sold by retail on the prescription of a registered Oncologist only” to “To be prescribed by Oncologist, Nuclear Medicine Physicians, Endocrinologists and ENT/Endocrine surgeons”.Also Read: Dr Reddy&#039;s Labs Gets SEC Nod to Manufacture, Market Oral Semaglutide TabletsThe proposal was examined by the committee in detail, taking into account the therapeutic use of the drug and the specialties involved in its administration. Following deliberations, the SEC recommended a modified approval, partially accepting the proposal.Thyrotropin alfa is a recombinant form of thyroid-stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue.Also Read: Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K BaraneedharanThyrotropin Alfa binds to the thyrotropin receptors found on any residual thyroid cells or tissues. This stimulates radioactive iodine uptake for better radiodiagnostic imaging.After detailed deliberation, the committee recommended approval for the following warning statement:“To be sold by retail on the prescription of Oncologist, Nuclear Medicine Physician and Endocrinologist Only” ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/10/197328-sanofi-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sanofis, Thyrotropin, Alfa, Label, Update:, CDSCO, Panel, Recommends, New, Prescription, Warning, Limits, Sale, Specialists, Only</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/10/197328-sanofi-3.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has approved an amendment in the warning statement of Thyrotropin Alfa lyophilized powder for solution for injection 0.9 mg/mL, manufactured by Sanofi Healthcare India, after detailed deliberations.</p></div><div class="pasted-from-word-wrapper"><p>The firm had presented a proposal seeking revision of the existing warning statement of the drug from “To be sold by retail on the prescription of a registered Oncologist only” to “To be prescribed by Oncologist, Nuclear Medicine Physicians, Endocrinologists and ENT/Endocrine surgeons”.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/dr-reddys-laboratories-gets-cdsco-panel-nod-to-manufacture-and-market-oral-semaglutide-tablets-167285"><b><i>Also Read: Dr Reddy's Labs Gets SEC Nod to Manufacture, Market Oral Semaglutide Tablets</i></b></a></div><p>The proposal was examined by the committee in detail, taking into account the therapeutic use of the drug and the specialties involved in its administration. Following deliberations, the SEC recommended a modified approval, partially accepting the proposal.</p><p>Thyrotropin alfa is a recombinant form of thyroid-stimulating hormone used in diagnostic testing for thyroid cancer and alongside radioactive agents to destroy thyroid tissue.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/diabetes-endocrinology/perspective/dapagliflozin-sitagliptin-fixed-dose-combination-in-india-t2d-5-point-clinicians-may-like-to-know-dr-k-baraneedharan-168296"><b><i>Also Read: Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K Baraneedharan</i></b></a></div><p>Thyrotropin Alfa binds to the thyrotropin receptors found on any residual thyroid cells or tissues. This stimulates radioactive iodine uptake for better radiodiagnostic imaging.</p><p>After detailed deliberation, the committee recommended approval for the following warning statement:</p><blockquote><p>“To be sold by retail on the prescription of Oncologist, Nuclear Medicine Physician and Endocrinologist Only”</p></blockquote></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Iatrogenic Alzheimer’s disease Shows Typical AD Pathology with Prominent Language Impairment: JAMA</title>
<link>https://edusehat.com/en/iatrogenic-alzheimers-disease-shows-typical-ad-pathology-with-prominent-language-impairment-jama</link>
<guid>https://edusehat.com/en/iatrogenic-alzheimers-disease-shows-typical-ad-pathology-with-prominent-language-impairment-jama</guid>
<description><![CDATA[ A new study published in the Journal of the American Medical Association revealed that patients with iatrogenic Alzheimer’s disease (iAD) can exhibit histopathological features similar to sporadic Alzheimer’s disease, with notable language impairment emerging as a key clinical characteristic of this subtype.This case series have documented four men who developed what is now being termed iatrogenic Alzheimer disease (iAD) which is associated with exposure to contaminated medical products. All four individuals had received cadaveric pituitary–derived human growth hormone (c-hGH) during childhood, a treatment used decades ago before synthetic alternatives became available.Based on patients referred to the UK National Prion Clinic between 2024 and 2025, this study suggests that these treatments may have inadvertently introduced amyloid-β (Aβ) “seeds” into the brain. These seeds are known to play a crucial role in Alzheimer disease by promoting the buildup of amyloid plaques.What made these findings particularly significant were the growing evidence that Aβ pathology may spread in a “prion-like” manner, where misfolded proteins can trigger similar misfolding in healthy proteins, which propagates the disease over time. This mechanism has previously been linked to iatrogenic cerebral amyloid angiopathy, but its role in full Alzheimer disease has only recently come into focus.The four patients described in the report developed symptoms between the ages of 47 and 60, which was earlier than is typical for sporadic Alzheimer disease. Also, their cognitive decline was marked by prominent language impairments, rather than the more commonly recognized memory loss seen in most Alzheimer cases.One patient, who began showing symptoms at age 47 and died at 57 and underwent a postmortem brain examination. The analysis revealed extensive amyloid plaque deposition and severe tau pathology inside neurons.The other three patients exhibited similar clinical patterns, particularly difficulties with language, illuminating that this may be a distinguishing feature of iatrogenic Alzheimer disease. This findings could help clinicians identify and differentiate iAD from more typical forms of the condition.Despite the use of c-hGH was discontinued decades ago, the long incubation period observed in these cases highlights the long lasting impact of past medical practices. It also raises queries on how protein-based pathologies may be transmitted and develop over time.The findings of this series press on the need for continued vigilance in medical procedures and a deeper understanding of how neurodegenerative diseases can arise. Overall, the study reinforces that iatrogenic Alzheimer disease mirrors the biological characteristics of sporadic Alzheimer’s, while potentially presenting with language impairments.Reference:Banerjee, G., Mok, T. H., Hyare, H., Cousins, O., Jaunmuktane, Z., Mead, S., &amp; Collinge, J. (2026). High-Level Alzheimer disease neuropathological change following iatrogenic exposure. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.0437 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277388-alzheimers-disease-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Iatrogenic, Alzheimer’s, disease, Shows, Typical, Pathology, with, Prominent, Language, Impairment:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277388-alzheimers-disease-2.webp"><p>A new study published in the <i>Journal of the American Medical Association</i> revealed that patients with iatrogenic Alzheimer’s disease (iAD) can exhibit histopathological features similar to sporadic Alzheimer’s disease, with notable language impairment emerging as a key clinical characteristic of this subtype.</p><p>This case series have documented four men who developed what is now being termed iatrogenic Alzheimer disease (iAD) which is associated with exposure to contaminated medical products. All four individuals had received cadaveric pituitary–derived human growth hormone (c-hGH) during childhood, a treatment used decades ago before synthetic alternatives became available.</p><p>Based on patients referred to the UK National Prion Clinic between 2024 and 2025, this study suggests that these treatments may have inadvertently introduced amyloid-β (Aβ) “seeds” into the brain. These seeds are known to play a crucial role in Alzheimer disease by promoting the buildup of amyloid plaques.</p><p>What made these findings particularly significant were the growing evidence that Aβ pathology may spread in a “prion-like” manner, where misfolded proteins can trigger similar misfolding in healthy proteins, which propagates the disease over time. This mechanism has previously been linked to iatrogenic cerebral amyloid angiopathy, but its role in full Alzheimer disease has only recently come into focus.</p><p>The four patients described in the report developed symptoms between the ages of 47 and 60, which was earlier than is typical for sporadic Alzheimer disease. Also, their cognitive decline was marked by prominent language impairments, rather than the more commonly recognized memory loss seen in most Alzheimer cases.</p><p>One patient, who began showing symptoms at age 47 and died at 57 and underwent a postmortem brain examination. The analysis revealed extensive amyloid plaque deposition and severe tau pathology inside neurons.</p><p>The other three patients exhibited similar clinical patterns, particularly difficulties with language, illuminating that this may be a distinguishing feature of iatrogenic Alzheimer disease. This findings could help clinicians identify and differentiate iAD from more typical forms of the condition.</p><p>Despite the use of c-hGH was discontinued decades ago, the long incubation period observed in these cases highlights the long lasting impact of past medical practices. It also raises queries on how protein-based pathologies may be transmitted and develop over time.</p><p>The findings of this series press on the need for continued vigilance in medical procedures and a deeper understanding of how neurodegenerative diseases can arise. Overall, the study reinforces that iatrogenic Alzheimer disease mirrors the biological characteristics of sporadic Alzheimer’s, while potentially presenting with language impairments.</p><p>Reference:</p><p>Banerjee, G., Mok, T. H., Hyare, H., Cousins, O., Jaunmuktane, Z., Mead, S., & Collinge, J. (2026). High-Level Alzheimer disease neuropathological change following iatrogenic exposure. JAMA Neurology. <a href="https://jamanetwork.com/journals/jamaneurology/fullarticle/2847009?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=033126" rel="nofollow">https://doi.org/10.1001/jamaneurol.2026.0437</a></p>]]> </content:encoded>
</item>

<item>
<title>Bombay HC Upholds FDA Action in Spurious Anti&#45;Venom Case Against Aarav Pharma</title>
<link>https://edusehat.com/en/bombay-hc-upholds-fda-action-in-spurious-anti-venom-case-against-aarav-pharma</link>
<guid>https://edusehat.com/en/bombay-hc-upholds-fda-action-in-spurious-anti-venom-case-against-aarav-pharma</guid>
<description><![CDATA[ New Delhi: In a significant reaffirmation of regulatory authority in matters of public health and drug safety, the Bombay High Court has dismissed a petition filed by Aarav Pharma challenging a show-cause notice issued by the Food and Drugs Administration (FDA) over the alleged supply of spurious snake anti-venom vials to Goa&#039;s health authorities.The High Court has directed the FDA to grant the pharma firm a personal hearing and pass an appropriate order within eight weeks, according to a recent media report by The Times of India.As earlier reported by the Medical Dialogues Team, the petition was filed by the firm’s proprietor, Upendra Kumar Singh, who questioned the validity of the notice issued in connection with supplies made to the Directorate of Health Services (DHS).The FDA’s show-cause notice alleges that the company supplied spurious snake anti-venom vials to the DHS and has asked the firm to explain why its drug licence should not be cancelled and why penal action should not be initiated.Also Read: Rajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active IngredientSingh contended before the court that the notice was premature and issued without jurisdiction, and sought protection from coercive action.Opposing the plea, the state government argued that Singh had approached the court without first responding to the show-cause notice, stressing that no final decision had yet been taken by the authorities. It maintained that the writ petition was therefore premature—a contention the court took into account.Earlier, during the proceedings, the High Court had directed the petitioner to submit a reply to the notice and had declined to grant interim relief.Meanwhile, a lower court is also hearing an anticipatory bail application filed by Singh in connection with the same case, reports TOI.Also Read: Granules India&#039;s US Arm Gets 4 USFDA Observations ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/11/02/189703-bombay-high.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bombay, Upholds, FDA, Action, Spurious, Anti-Venom, Case, Against, Aarav, Pharma</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/11/02/189703-bombay-high.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>In a significant reaffirmation of regulatory authority in matters of public health and drug safety, the Bombay High Court has dismissed a petition filed by Aarav Pharma challenging a show-cause notice issued by the Food and Drugs Administration (FDA) over the alleged supply of spurious snake anti-venom vials to Goa's health authorities.</p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The High Court has directed the FDA to grant the pharma firm a personal hearing and pass an appropriate order within eight weeks, according to a recent media report by The Times of India.</p><p>As earlier reported by the <a href="https://medicaldialogues.in/news/industry/pharma/bombay-hc-refuses-interim-shield-to-pharma-firm-in-snake-anti-venom-case-165821" rel="nofollow">Medical Dialogues Team</a>, the petition was filed by the firm’s proprietor, Upendra Kumar Singh, who questioned the validity of the notice issued in connection with supplies made to the Directorate of Health Services (DHS).</p><p>The FDA’s show-cause notice alleges that the company supplied spurious snake anti-venom vials to the DHS and has asked the firm to explain why its drug licence should not be cancelled and why penal action should not be initiated.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/rajasthan-flags-spurious-antibiotic-qcepod-200-after-tests-find-no-active-ingredient-168189">Also Read: Rajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active Ingredient</a></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Singh contended before the court that the notice was premature and issued without jurisdiction, and sought protection from coercive action.</p><p>Opposing the plea, the state government argued that Singh had approached the court without first responding to the show-cause notice, stressing that no final decision had yet been taken by the authorities. It maintained that the writ petition was therefore premature—a contention the court took into account.</p><p>Earlier, during the proceedings, the High Court had directed the petitioner to submit a reply to the notice and had declined to grant interim relief.</p><p>Meanwhile, a lower court is also hearing an anticipatory bail application filed by Singh in connection with the same case, reports <a href="https://timesofindia.indiatimes.com/city/goa/anti-venom-case-hc-dismisses-plea-against-fda-notice/articleshow/130095444.cms" rel="nofollow">TOI</a>.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/granules-indias-us-arm-gets-4-usfda-observations-168191">Also Read: Granules India's US Arm Gets 4 USFDA Observations</a></div></div></div><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Indian Pharma Market Grows 10.1% to Rs 20,012 Cr in March: Report</title>
<link>https://edusehat.com/en/indian-pharma-market-grows-101-to-rs-20012-cr-in-march-report</link>
<guid>https://edusehat.com/en/indian-pharma-market-grows-101-to-rs-20012-cr-in-march-report</guid>
<description><![CDATA[ New Delhi: The Indian Pharmaceutical Market (IPM) registered a value growth of 10.1% in March 2026, reaching Rs 20,012 crore, according to the latest PharmaTrac industry report by Pharmarack.On a moving annual total (MAT) basis, the market stood at Rs 245943 crore, reflecting 8.6% growth. In unit terms, the market recorded marginal growth of 0.1% for the month and 0.6% on a MAT basis, indicating that growth continued to be largely value-driven.Therapy-wise, cardiac therapies recorded strong growth of 14.6%, while anti-diabetic therapies grew 15.5% during the month. Respiratory therapies expanded by 10.7%, and vitamins and minerals registered 10.9% growth. Neuro/CNS therapies grew by 11.6%, dermatology by 9.5%, and pain/analgesics by 8.7%. Gastrointestinal and anti-infective segments showed relatively moderate growth at 4.3% and 4.0%, respectively. Among specialty segments, anti-neoplastics grew 12.4%, urology 12.8%, and vaccines posted a robust growth of 22.7%, emerging as one of the fastest-growing therapies in March.Also Read: Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTracAt the corporate level, Sun Pharma retained its leadership position with monthly sales of ₹1,703 crore, followed by Cipla with ₹1,191 crore and Abbott with ₹1,158 crore. Mankind Pharma and Torrent Pharma also remained among the top performers. Other major companies including Alkem, Intas, Lupin, Dr. Reddy’s, and Zydus recorded steady growth, with most top players showing encouraging value expansion during the month.At the brand level, Mounjaro emerged as the top-selling brand, maintaining its leading position both on MAT and monthly basis. Augmentin and Glycomet GP secured the second and third positions, respectively. Other leading brands included Foracort, Pan, Mixtard, Liv.52, Zerodol SP, Clavam, and Thyronorm. Several brands such as Cilacar, Telma, and Ecosprin AV also demonstrated strong growth momentum, reflecting sustained demand across chronic and acute therapy segments.Also Read: Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTracThe report highlighted that all three growth drivers—new products, price, and volume—remained positive during March 2026, with price growth continuing to be a key contributor. Additionally, the increasing impact of GLP-1 therapies, particularly semaglutide generics, is expected to further shape market dynamics in the coming months, with more aggressive launches anticipated.To view the report, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/10/ipm-performance-pharmatrac-mat-mar-2026-1-340944.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/10/277890-202410103240544.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Indian, Pharma, Market, Grows, 10.1, 20, 012, March:, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/10/277890-202410103240544.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> The Indian Pharmaceutical Market (IPM) registered a value growth of 10.1% in March 2026, reaching Rs 20,012 crore, according to the latest PharmaTrac industry report by Pharmarack.</p></div><div class="pasted-from-word-wrapper"><p>On a moving annual total (MAT) basis, the market stood at Rs 245943 crore, reflecting 8.6% growth. In unit terms, the market recorded marginal growth of 0.1% for the month and 0.6% on a MAT basis, indicating that growth continued to be largely value-driven.</p><p>Therapy-wise, cardiac therapies recorded strong growth of 14.6%, while anti-diabetic therapies grew 15.5% during the month. Respiratory therapies expanded by 10.7%, and vitamins and minerals registered 10.9% growth. Neuro/CNS therapies grew by 11.6%, dermatology by 9.5%, and pain/analgesics by 8.7%. Gastrointestinal and anti-infective segments showed relatively moderate growth at 4.3% and 4.0%, respectively. Among specialty segments, anti-neoplastics grew 12.4%, urology 12.8%, and vaccines posted a robust growth of 22.7%, emerging as one of the fastest-growing therapies in March.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/indian-pharma-market-posts-9-surge-in-november-even-as-volumes-stay-flat-pharmatrac-160370">Also Read: Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac</a></div><p>At the corporate level, Sun Pharma retained its leadership position with monthly sales of ₹1,703 crore, followed by Cipla with ₹1,191 crore and Abbott with ₹1,158 crore. Mankind Pharma and Torrent Pharma also remained among the top performers. Other major companies including Alkem, Intas, Lupin, Dr. Reddy’s, and Zydus recorded steady growth, with most top players showing encouraging value expansion during the month.</p><p>At the brand level, Mounjaro emerged as the top-selling brand, maintaining its leading position both on MAT and monthly basis. Augmentin and Glycomet GP secured the second and third positions, respectively. Other leading brands included Foracort, Pan, Mixtard, Liv.52, Zerodol SP, Clavam, and Thyronorm. Several brands such as Cilacar, Telma, and Ecosprin AV also demonstrated strong growth momentum, reflecting sustained demand across chronic and acute therapy segments.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/indian-pharma-market-kicks-off-2026-with-10-growth-in-january-pharmatrac-164564">Also Read: Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac</a></div><p>The report highlighted that all three growth drivers—new products, price, and volume—remained positive during March 2026, with price growth continuing to be a key contributor. Additionally, the increasing impact of GLP-1 therapies, particularly semaglutide generics, is expected to further shape market dynamics in the coming months, with more aggressive launches anticipated.</p><p><b><i>To view the report, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/10/ipm-performance-pharmatrac-mat-mar-2026-1-340944.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/10/ipm-performance-pharmatrac-mat-mar-2026-1-340944.pdf</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Gland Pharma Reappoints Naina Lal Kidwai as Independent Director for Second Term</title>
<link>https://edusehat.com/en/gland-pharma-reappoints-naina-lal-kidwai-as-independent-director-for-second-term</link>
<guid>https://edusehat.com/en/gland-pharma-reappoints-naina-lal-kidwai-as-independent-director-for-second-term</guid>
<description><![CDATA[ New Delhi: Gland Pharma Limited has approved the re-appointment of Naina Lal Kidwai as an Independent Director for a second term of five consecutive years from May 17, 2026 to May 16, 2031.The decision was taken by the Board of Directors at its meeting held on April 9, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Kidwai had earlier been appointed as an Independent Director for a five-year term from May 17, 2021 to May 16, 2026, and her re-appointment ensures continuity in leadership and governance at the company.A seasoned industry leader, Ms. Kidwai currently serves as Chairman of Rothschild &amp; Co India and holds advisory roles with Advent Private Equity, TPG Rise Climate, and Lightspeed Venture Partners. She is also a Non-Executive Director on the boards of multiple leading companies including Holcim, Gland Pharma, UPL, and Biocon, and is a former President of FICCI.Also Read: Gland Pharma Faces Rs 6.29 Cr GST Demand, Plans to Challenge Tax OrderShe previously served as Executive Director on the Board of HSBC Asia Pacific and Chairman of HSBC India until her retirement in 2015, and later stepped down from the global board of Nestle in 2018.Kidwai is associated with several prestigious institutions, including the Indo-ASEAN Business Council, Harvard Business School’s South Asia Advisory Board, and Standard Chartered Bank’s International Advisory Council.An MBA graduate from Harvard Business School, she has been honoured with the Padma Shri for her contribution to trade and industry. She has also authored books such as “30 Women in Power: Their Voices, Their Stories” and “Survive Or Sink: An Action Agenda for Sanitation, Water, Pollution, and Green Finance.”Her work spans key areas such as sustainability, water, sanitation, and women empowerment. She currently chairs FICCI’s Water Mission and Sustainability Council and is the Founder and Chair of the India Sanitation Coalition, along with being associated with multiple global environmental and policy initiatives.The company clarified that there are no inter-se relationships between the director and other board members and no additional disclosures are required under relevant SEBI circulars.Also Read: Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/10/197311-gland-pharma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gland, Pharma, Reappoints, Naina, Lal, Kidwai, Independent, Director, for, Second, Term</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/10/197311-gland-pharma.webp"><p><b>New Delhi: </b>Gland Pharma Limited has approved the re-appointment of Naina Lal Kidwai as an Independent Director for a second term of five consecutive years from May 17, 2026 to May 16, 2031.</p><div class="pasted-from-word-wrapper"><p>The decision was taken by the Board of Directors at its meeting held on April 9, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.</p><p>Kidwai had earlier been appointed as an Independent Director for a five-year term from May 17, 2021 to May 16, 2026, and her re-appointment ensures continuity in leadership and governance at the company.</p><p>A seasoned industry leader, Ms. Kidwai currently serves as Chairman of Rothschild & Co India and holds advisory roles with Advent Private Equity, TPG Rise Climate, and Lightspeed Venture Partners. She is also a Non-Executive Director on the boards of multiple leading companies including Holcim, Gland Pharma, UPL, and Biocon, and is a former President of FICCI.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gland-pharma-faces-rs-629-cr-gst-demand-plans-to-challenge-tax-order-166165">Also Read: Gland Pharma Faces Rs 6.29 Cr GST Demand, Plans to Challenge Tax Order</a></div></div><p>She previously served as Executive Director on the Board of HSBC Asia Pacific and Chairman of HSBC India until her retirement in 2015, and later stepped down from the global board of Nestle in 2018.Kidwai is associated with several prestigious institutions, including the Indo-ASEAN Business Council, Harvard Business School’s South Asia Advisory Board, and Standard Chartered Bank’s International Advisory Council.</p><p>An MBA graduate from Harvard Business School, she has been honoured with the Padma Shri for her contribution to trade and industry. She has also authored books such as “30 Women in Power: Their Voices, Their Stories” and “Survive Or Sink: An Action Agenda for Sanitation, Water, Pollution, and Green Finance.”</p><p>Her work spans key areas such as sustainability, water, sanitation, and women empowerment. She currently chairs FICCI’s Water Mission and Sustainability Council and is the Founder and Chair of the India Sanitation Coalition, along with being associated with multiple global environmental and policy initiatives.</p><p>The company clarified that there are no inter-se relationships between the director and other board members and no additional disclosures are required under relevant SEBI circulars.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gland-pharma-gets-usfda-approval-for-olopatadine-ophthalmic-solution-162290">Also Read: Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>C4 Therapeutics, Roche Ink USD 1 Billion Cancer Drug Deal for Novel DAC Therapies</title>
<link>https://edusehat.com/en/c4-therapeutics-roche-ink-usd-1-billion-cancer-drug-deal-for-novel-dac-therapies</link>
<guid>https://edusehat.com/en/c4-therapeutics-roche-ink-usd-1-billion-cancer-drug-deal-for-novel-dac-therapies</guid>
<description><![CDATA[ New Delhi: C4 Therapeutics, opens new tab said on Thursday it has entered into a deal ​focused on research and development of ‌a type of cancer drug with Swiss drugmaker Roche, opens new tab that could be worth more ​than USD 1 billion.The companies will collaborate on ​two programs to develop degrader-antibody conjugates ⁠against undisclosed oncology targets exclusive to ​the agreement.Degrader-antibody conjugates (DAC) are an emerging ​class of cancer therapies that combine antibody-drug conjugation with targeted protein degradation technology.Roche will be ​responsible for advancing DAC candidates through ​preclinical and clinical development as well as commercialization.C4T ‌will ⁠receive a $20 million upfront payment for the two programs. If Roche exercises its option for a third target, C4T ​will receive ​an additional ⁠payment.C4T is also eligible to receive over $1 billion in discovery, ​regulatory and commercial milestone payments, ​and ⁠entitled to tiered royalties on future sales.The agreement marks the third collaboration between ⁠the ​two companies and extends ​a relationship that began in 2016.Also Read:Roche Drops Muscle Disease Drug After Trial Failure ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/20/230600-roche-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 13 Apr 2026 02:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Therapeutics, Roche, Ink, USD, Billion, Cancer, Drug, Deal, for, Novel, DAC, Therapies</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/20/230600-roche-50.webp"><p><b>New Delhi: </b>C4 Therapeutics, opens new tab said on Thursday it has entered into a deal ​focused on research and development of ‌a type of cancer drug with Swiss drugmaker Roche, opens new tab that could be worth more ​than USD 1 billion.</p><div class="pasted-from-word-wrapper"><ul><li>The companies will collaborate on ​two programs to develop degrader-antibody conjugates ⁠against undisclosed oncology targets exclusive to ​the agreement.</li><li>Degrader-antibody conjugates (DAC) are an emerging ​class of cancer therapies that combine antibody-drug conjugation with targeted protein degradation technology.</li><li>Roche will be ​responsible for advancing DAC candidates through ​preclinical and clinical development as well as commercialization.</li><li>C4T ‌will ⁠receive a $20 million upfront payment for the two programs. If Roche exercises its option for a third target, C4T ​will receive ​an additional ⁠payment.</li><li>C4T is also eligible to receive over $1 billion in discovery, ​regulatory and commercial milestone payments, ​and ⁠entitled to tiered royalties on future sales.</li><li>The agreement marks the third collaboration between ⁠the ​two companies and extends ​a relationship that began in 2016.</li></ul><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/roche-drops-muscle-disease-drug-after-trial-failure-167133">Also Read:Roche Drops Muscle Disease Drug After Trial Failure</a></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Advanced CT scan analysis may help identify different forms of sarcoidosis: Study</title>
<link>https://edusehat.com/en/advanced-ct-scan-analysis-may-help-identify-different-forms-of-sarcoidosis-study</link>
<guid>https://edusehat.com/en/advanced-ct-scan-analysis-may-help-identify-different-forms-of-sarcoidosis-study</guid>
<description><![CDATA[ Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of sarcoidosis, a complex inflammatory lung disease that affects more than 150,000 people in the United States. In a new study published in Scientific Reports, scientists at National Jewish Health and colleagues used a computer-based imaging technique known as radiomics to analyze subtle patterns in lung scans from 320 people with sarcoidosis. The approach identified four distinct imaging profiles that were linked to differences in lung function and disease severity and gave insight into potential uses of radiomics to advance diagnosis and patient care.
Sarcoidosis most commonly affects the lungs and can lead to inflammation, scarring and breathing difficulties. Doctors typically assess lung involvement by visually reviewing imaging scans, but interpretations can vary among specialists.
Radiomics offers a more objective approach by using advanced algorithms to measure hundreds of quantitative features from medical images, capturing subtle patterns that may not be readily visible to the human eye.
“We found that radiomic analysis of CT scans can reveal distinct patterns of lung abnormalities in sarcoidosis,” said Tasha Fingerlin, PhD, vice chair of the Department of Immunology and Genomic Medicine at National Jewish Health and co-senior author of the study. “These patterns were associated with differences in lung function, suggesting that this approach may help us better understand how the disease varies from patient to patient.”
“Using radiomic analysis could allow providers to evaluate patients’ pulmonary status and radiographs in an automated way,” said Lisa Maier, MD, chief of the Division of Environmental and Occupational Health Sciences, head of the World Association of Sarcoidosis and Granulomatous Disease (WASOG) Sarcoidosis Center of Excellence at National Jewish Health and co-senior author of the study.
The research team analyzed previous high-resolution CT scans from participants in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study, one of the largest and most comprehensive sarcoidosis research cohorts in the United States. Using machine-learning clustering techniques, the investigators identified four patient groups based on their features seen in the images. Some patients showed relatively few abnormalities, while others showed patterns consistent with more extensive inflammation or fibrosis. Importantly, the radiomic groups accounted for differences in lung function even after adjusting for traditional imaging assessments used in clinical practice.
“Current staging systems are helpful, but they don’t always capture the full complexity of what we see in the lungs of people with sarcoidosis,” Dr. Fingerlin said. “Radiomics allows us to quantify those patterns in a more detailed and reproducible way.”
Because the radiomics analysis can be performed quickly and automatically using open-source software, the researchers say it could eventually help clinicians analyze large numbers of scans and better track disease patterns over time.
“Radiomics has the potential to complement the expertise of radiologists by providing objective measurements of lung abnormalities, identifying disease subtypes, monitoring progression and potentially guiding more personalized treatment strategies,” said Dr. Fingerlin.
The researchers note that further studies are needed to determine how radiomic analysis could be used in routine clinical care.
“There is promise for significant impact on patient care, especially in regions where there is no expert in sarcoidosis radiology, which is much of the country and certainly most areas in the Far West,” said Dr. Maier. “Radiomics could also expedite care in clinics with rapid turnaround for patients at specialized centers and revolutionize the way we interpret CT scans for research and clinical trials.”Reference:Carlson, N.E., Lippitt, W.L., Ryan, S.M. et al. Radiomic profiling of chest CT in a cohort of sarcoidosis cases. Sci Rep 16, 9695 (2026). https://doi.org/10.1038/s41598-026-39384-9
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340808-sarcoidosis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Advanced, scan, analysis, may, help, identify, different, forms, sarcoidosis:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340808-sarcoidosis.webp"><p>Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of <a href="https://medicaldialogues.in/topics/sarcoidosis">sarcoidosis</a>, a complex inflammatory lung disease that affects more than 150,000 people in the United States. In a new study published in <i>Scientific Reports</i>, scientists at National Jewish Health and colleagues used a computer-based imaging technique known as radiomics to analyze subtle patterns in lung scans from 320 people with sarcoidosis. The approach identified four distinct imaging profiles that were linked to differences in <a href="https://medicaldialogues.in/topics/lung-function">lung function</a> and disease severity and gave insight into potential uses of radiomics to advance diagnosis and patient care.
</p><p>Sarcoidosis most commonly affects the lungs and can lead to inflammation, scarring and breathing difficulties. Doctors typically assess lung involvement by visually reviewing imaging scans, but interpretations can vary among specialists.
</p><p>Radiomics offers a more objective approach by using advanced algorithms to measure hundreds of quantitative features from medical images, capturing subtle patterns that may not be readily visible to the human eye.
</p><p>“We found that radiomic analysis of CT scans can reveal distinct patterns of lung abnormalities in sarcoidosis,” said Tasha Fingerlin, PhD, vice chair of the Department of Immunology and Genomic Medicine at National Jewish Health and co-senior author of the study. “These patterns were associated with differences in lung function, suggesting that this approach may help us better understand how the disease varies from patient to patient.”
</p><p>“Using radiomic analysis could allow providers to evaluate patients’ pulmonary status and radiographs in an automated way,” said Lisa Maier, MD, chief of the Division of Environmental and Occupational Health Sciences, head of the World Association of Sarcoidosis and Granulomatous Disease (WASOG) Sarcoidosis Center of Excellence at National Jewish Health and co-senior author of the study.
</p><p>The research team analyzed previous high-resolution CT scans from participants in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study, one of the largest and most comprehensive sarcoidosis research cohorts in the United States. Using machine-learning clustering techniques, the investigators identified four patient groups based on their features seen in the images. Some patients showed relatively few abnormalities, while others showed patterns consistent with more extensive inflammation or fibrosis. Importantly, the radiomic groups accounted for differences in lung function even after adjusting for traditional imaging assessments used in clinical practice.
</p><p>“Current staging systems are helpful, but they don’t always capture the full complexity of what we see in the lungs of people with sarcoidosis,” Dr. Fingerlin said. “Radiomics allows us to quantify those patterns in a more detailed and reproducible way.”
</p><p>Because the radiomics analysis can be performed quickly and automatically using open-source software, the researchers say it could eventually help clinicians analyze large numbers of scans and better track disease patterns over time.
</p><p>“Radiomics has the potential to complement the expertise of radiologists by providing objective measurements of lung abnormalities, identifying disease subtypes, monitoring progression and potentially guiding more personalized treatment strategies,” said Dr. Fingerlin.
</p><p>The researchers note that further studies are needed to determine how radiomic analysis could be used in routine clinical care.
</p><p>“There is promise for significant impact on patient care, especially in regions where there is no expert in sarcoidosis radiology, which is much of the country and certainly most areas in the Far West,” said Dr. Maier. “Radiomics could also expedite care in clinics with rapid turnaround for patients at specialized centers and revolutionize the way we interpret CT scans for research and clinical trials.”</p><p>Reference:</p><p>Carlson, N.E., Lippitt, W.L., Ryan, S.M. et al. Radiomic profiling of chest CT in a cohort of sarcoidosis cases. Sci Rep 16, 9695 (2026). https://doi.org/10.1038/s41598-026-39384-9
</p>]]> </content:encoded>
</item>

<item>
<title>Ultra&#45;processed foods are linked to reduced fertility and embryonic development,  finds study</title>
<link>https://edusehat.com/en/ultra-processed-foods-are-linked-to-reduced-fertility-and-embryonic-development-finds-study</link>
<guid>https://edusehat.com/en/ultra-processed-foods-are-linked-to-reduced-fertility-and-embryonic-development-finds-study</guid>
<description><![CDATA[ Eating large amounts of ultra-processed food (UPF) is linked not only to reduced fertility in men, but also to slower growth in early embryos, and smaller yolk sacs, which are essential for early embryonic development, according to new research.
The authors of the study, which is published today (Tuesday) in Human Reproduction , one of the world’s leading reproductive medicine journals, say their findings suggest that reducing the consumption of UPFs, especially around the time of conception and pregnancy, is better for both parents and embryos.
Although maternal and paternal health are known to influence reproductive success and the development and health of offspring, until now no study has investigated the combined impact of mothers’ and fathers’ UPF consumption on the length of time it takes to conceive and early embryonic development.
Consumption of UPFs has been growing rapidly. They are highly processed foods, typically high in added sugars, salt, saturated and trans fats, and additives, and low in fibre, whole foods and other essential nutrients; they are usually designed for convenience and mass production rather than nutritional value. In some high-income countries, UPF now account for up to 50-60% of food eaten each day.
“Even though UPFs are so common in our diets, very little is known about their potential relationship with fertility outcomes, and early human development,” said Dr Romy Gaillard, a paediatrician and associate professor of developmental epidemiology at Erasmus University Medical Center, Rotterdam, The Netherlands, who led the study.
Dr Gaillard and colleagues analysed findings from 831 women and 651 male partners enrolled in a population-based, prospective study that has been following parents from before conception onwards and into their offspring’s childhood – the Generation R Study Next Programme. Couples were included during the pre-conception period or during pregnancy between 2017 and 2021.
The researchers assessed the parents’ diet with a questionnaire during early pregnancy around 12 weeks. The different foods were classified as either non-UPFs or UPFs, and UPF intake was expressed as a percentage of total food intake in grams per day. All the women were pregnant at the time of this questionnaire. The average (median) consumption of UPF was 22% and 25%, respectively, of women’s and men’s total food intake. A questionnaire also provided information on time to pregnancy, fecundability (the probability of conceiving within one month) and subfertility (a time to pregnancy of 12 months or more, or the use of assisted reproductive technology).
The distance between the embryo’s head and its buttocks (crown rump length or CRL), which is an indication of its size and development, and the volume of the yolk sac were measured by transvaginal ultrasound at seven, nine and 11 weeks of gestation.
The first author of the study, Celine Lin, a Phd student at Erasmus University Medical Center, said: “We observed that UPFs consumption in women was not consistently related to the risk of subfertility and time to pregnancy, but was associated with slightly smaller embryonic growth and yolk sac size by the seventh week of pregnancy. These differences in early human development were small, but are important from a research perspective and at population level, as we showed for the first time that UPF consumption is not only important for health of the mother, but may also be related to development of the offspring.
“In men, we observed that higher UPF consumption was related to a higher risk of subfertility and a longer duration until pregnancy was achieved, but not with early embryo development. This association may be explained by the sensitivity of sperm to dietary composition, whereas maternal UPF consumption may directly influence the environment in the womb in which the embryo develops from the start of life onwards.”
Dr Gaillard said: “Our findings suggest that a diet low in UPFs would be best for both partners, not only for their own health, but also for their chances of pregnancy and the health of their unborn child.”
Other studies have shown that slower embryonic growth in the first trimester is associated with an increased risk of adverse birth outcomes, including premature birth (birth before 37 weeks), low birth weight, and an increased risk of heart and blood vessel problems in childhood. Impaired yolk sac development is associated with an increased risk of miscarriage and premature birth.
Dr Gaillard continued: “Our study shows for the first time that UPF consumption in men and women is associated with fertility outcomes and early human development, but also has limitations. Importantly, as this is an observational study, our study shows associations, but cannot prove direct causal effects of UPF consumption on these early life outcomes.
“More research is needed to replicate our findings, in diverse populations, and to study the potential biological mechanisms underlying this effect. For instance, are these differences driven by the low nutritional value of UPFs or by the increased exposure to additives or microplastics? We also want to study whether these early differences have consequences for birth outcomes, growth and development of offspring throughout childhood.
“Finally, our research shows that we should think more broadly about fertility and early pregnancy. We should move away from the idea that only the health and lifestyle of mothers-to-be is important for pregnancy and offspring outcomes, and recognise that the health and lifestyle of both the mother- and father-to-be play an important role. Our results highlight the need to pay more attention to male health in the preconception period, which has traditionally been overlooked.”Reference:Celine H X Lin, Romy Gaillard, Annemarie G M G J Mulders, Vincent W V Jaddoe, Mireille C Schipper, Periconceptional ultra-processed food consumption in women and men, fertility, and early embryonic development, Human Reproduction, 2026;, deag023, https://doi.org/10.1093/humrep/deag023
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/21/232708-ultra-processed-foods-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Ultra-processed, foods, are, linked, reduced, fertility, and, embryonic, development, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/21/232708-ultra-processed-foods-50.webp"><p>Eating large amounts of <a href="https://medicaldialogues.in/topics/ultra-processed-food">ultra-processed food</a> (UPF) is linked not only to reduced <a href="https://medicaldialogues.in/topics/Fertility">fertility</a> in men, but also to slower growth in early <a href="https://medicaldialogues.in/topics/embryos">embryos</a>, and smaller yolk sacs, which are essential for early embryonic development, according to new research.
</p><p>The authors of the study, which is published today (Tuesday) in <i>Human Reproduction</i> , one of the world’s leading reproductive medicine journals, say their findings suggest that reducing the consumption of UPFs, especially around the time of conception and pregnancy, is better for both parents and embryos.
</p><p>Although maternal and paternal health are known to influence reproductive success and the development and health of offspring, until now no study has investigated the combined impact of mothers’ and fathers’ UPF consumption on the length of time it takes to conceive and early embryonic development.
</p><p>Consumption of UPFs has been growing rapidly. They are highly processed foods, typically high in added sugars, salt, saturated and trans fats, and additives, and low in fibre, whole foods and other essential nutrients; they are usually designed for convenience and mass production rather than nutritional value. In some high-income countries, UPF now account for up to 50-60% of food eaten each day.
</p><p>“Even though UPFs are so common in our diets, very little is known about their potential relationship with fertility outcomes, and early human development,” said Dr Romy Gaillard, a paediatrician and associate professor of developmental epidemiology at Erasmus University Medical Center, Rotterdam, The Netherlands, who led the study.
</p><p>Dr Gaillard and colleagues analysed findings from 831 women and 651 male partners enrolled in a population-based, prospective study that has been following parents from before conception onwards and into their offspring’s childhood – the Generation R Study Next Programme. Couples were included during the pre-conception period or during pregnancy between 2017 and 2021.
</p><p>The researchers assessed the parents’ diet with a questionnaire during early pregnancy around 12 weeks. The different foods were classified as either non-UPFs or UPFs, and UPF intake was expressed as a percentage of total food intake in grams per day. All the women were pregnant at the time of this questionnaire. The average (median) consumption of UPF was 22% and 25%, respectively, of women’s and men’s total food intake. </p><p>A questionnaire also provided information on time to pregnancy, fecundability (the probability of conceiving within one month) and subfertility (a time to pregnancy of 12 months or more, or the use of assisted reproductive technology).
</p><p>The distance between the embryo’s head and its buttocks (crown rump length or CRL), which is an indication of its size and development, and the volume of the yolk sac were measured by transvaginal ultrasound at seven, nine and 11 weeks of gestation.
</p><p>The first author of the study, Celine Lin, a Phd student at Erasmus University Medical Center, said: “We observed that UPFs consumption in women was not consistently related to the risk of subfertility and time to pregnancy, but was associated with slightly smaller embryonic growth and yolk sac size by the seventh week of pregnancy. These differences in early human development were small, but are important from a research perspective and at population level, as we showed for the first time that UPF consumption is not only important for health of the mother, but may also be related to development of the offspring.
</p><p>“In men, we observed that higher UPF consumption was related to a higher risk of subfertility and a longer duration until pregnancy was achieved, but not with early embryo development. This association may be explained by the sensitivity of sperm to dietary composition, whereas maternal UPF consumption may directly influence the environment in the womb in which the embryo develops from the start of life onwards.”
</p><p>Dr Gaillard said: “Our findings suggest that a diet low in UPFs would be best for both partners, not only for their own health, but also for their chances of pregnancy and the health of their unborn child.”
</p><p>Other studies have shown that slower embryonic growth in the first trimester is associated with an increased risk of adverse birth outcomes, including premature birth (birth before 37 weeks), low birth weight, and an increased risk of heart and blood vessel problems in childhood. Impaired yolk sac development is associated with an increased risk of miscarriage and premature birth.
</p><p>Dr Gaillard continued: “Our study shows for the first time that UPF consumption in men and women is associated with fertility outcomes and early human development, but also has limitations. Importantly, as this is an observational study, our study shows associations, but cannot prove direct causal effects of UPF consumption on these early life outcomes.
</p><p>“More research is needed to replicate our findings, in diverse populations, and to study the potential biological mechanisms underlying this effect. For instance, are these differences driven by the low nutritional value of UPFs or by the increased exposure to additives or microplastics? We also want to study whether these early differences have consequences for birth outcomes, growth and development of offspring throughout childhood.
</p><p>“Finally, our research shows that we should think more broadly about fertility and early pregnancy. We should move away from the idea that only the health and lifestyle of mothers-to-be is important for pregnancy and offspring outcomes, and recognise that the health and lifestyle of both the mother- and father-to-be play an important role. Our results highlight the need to pay more attention to male health in the preconception period, which has traditionally been overlooked.”</p><p>Reference:</p><p>Celine H X Lin, Romy Gaillard, Annemarie G M G J Mulders, Vincent W V Jaddoe, Mireille C Schipper, Periconceptional ultra-processed food consumption in women and men, fertility, and early embryonic development, Human Reproduction, 2026;, deag023, https://doi.org/10.1093/humrep/deag023
</p>]]> </content:encoded>
</item>

<item>
<title>Antioxidant Breakthrough: A New Era in Multi&#45;Modal Melasma Management, Systematic Review</title>
<link>https://edusehat.com/en/antioxidant-breakthrough-a-new-era-in-multi-modal-melasma-management-systematic-review</link>
<guid>https://edusehat.com/en/antioxidant-breakthrough-a-new-era-in-multi-modal-melasma-management-systematic-review</guid>
<description><![CDATA[ A systematic review published in the Indian Journal of Dermatology in June 2025 reveals that integrating diverse antioxidants like vitamin C and cysteamine into clinical protocols can achieve a superior 81.1% reduction in melasma severity scores, demonstrating that these agents offer a safer, more effective alternative or adjuvant to traditional depigmenting therapies.Melasma is a persistent facial hyperpigmentation disorder driven by a complex interplay of genetics, hormones, and environmental triggers, yet a critical clinical gap exists in understanding how to effectively balance the oxidative stress that promotes inflammation and cellular damage in these patients. Consequently, Rashmi Sarkar and Anjali Sahu from the Department of Dermatology at Lady Hardinge Medical College conducted this systematic review to thoroughly investigate the potential of various exogenous and endogenous antioxidants as safe and effective alternatives or adjuvants in current clinical management protocols.Therefore, the systematic review utilized a comprehensive search of the PubMed database for English-language peer-reviewed articles published over the last decade until January 31, 2024, focusing on study designs such as Randomized Controlled Trials (RCTs) and observational studies involving human populations while excluding animal models and conference abstracts. The investigators assessed the impact of several key antioxidant interventions on clinical outcomes like the Melasma Area and Severity Index (MASI) score by evaluating thirty specific articles to identify optimal therapeutic combinations that enhance patient well-being.Key Clinical Findings of the Study Include:Optimized Peeling Regimens: Research demonstrated that combining a 20% Trichloroacetic Acid (TCA) peel with a 5% topical Magnesium Ascorbyl Phosphate (MAP) cream resulted in a statistically significant 81.1% reduction in MASI scores compared to only 66.2% for those receiving the peel alone.Cysteamine Efficacy: Investigations revealed that 5% cysteamine cream is significantly more effective than the Modified Kligman’s Formula (MKF) in reducing pigmentation, providing a safe and well-tolerated option for patients who need to rotate off hydroquinone(HQ).Silymarin Performance: Evidence showed that silymarin cream at concentrations of 0.7% and 1.4% provides clinical results equivalent to 4% hydroquinone but with a notable absence of the significant adverse effects often associated with traditional depigmenting agents.Glutathione Synergy: Data highlighted that adding glutathione to microneedling or mesotherapy cocktails significantly accelerates the treatment response and leads to more substantial reductions in the hemi-Modified Melasma  Area and Severity Index (hemi-mMASI) scores than standard therapies alone.   Zinc Sulfate Comparison: Findings established that although 10% topical zinc sulfate reduces melasma severity, its potency is markedly lower than hydroquinone, showing only an 18.6% improvement compared to the 43.5% reduction seen with the standard treatment.The results suggest that incorporating these antioxidants into routine care can safely enhance efficacy, with data showing that combined approaches, such as using oral lycopene from tomato extract as an adjuvant, significantly boost serum Superoxide Dismutase (SOD) levels while improving skin appearance. These diverse agents demonstrate a clear potential to serve as safe, effective, and sometimes synergistic components of a modern, multi-modal dermatological strategy.Thus, the study concludes clinicians may find value in adopting these antioxidant therapies as part of a comprehensive management plan to improve patient outcomes and minimize treatment-related side effects.While the current evidence is encouraging, the lack of statistical significance for certain agents like melatonin and the small sample sizes in some split-face trials indicate a need for larger, long-term prospective studies to fully validate these findings and optimize treatment strategies.ReferenceSarkar R, Sahu A. Role of antioxidants in melasma: A systematic review. Indian J Dermatol 2025;70:125-34. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/27/210581-melasma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Antioxidant, Breakthrough:, New, Era, Multi-Modal, Melasma, Management, Systematic, Review</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/27/210581-melasma.webp"><p>A systematic review published in the <i>Indian Journal of Dermatology</i> in June 2025 reveals that integrating diverse <a href="https://speciality.medicaldialogues.in/antioxidant-supplement-cost-saving-and-effective-in-macular-degeneration-bmj">antioxidants</a> like vitamin C and <a href="https://medicaldialogues.in/generics/cysteamine-2723401">cysteamine</a> into clinical protocols can achieve a superior 81.1% reduction in melasma severity scores, demonstrating that these agents offer a safer, more effective alternative or adjuvant to traditional depigmenting therapies.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Melasma is a persistent facial <a href="https://medicaldialogues.in/fact-check/fact-check-can-moringa-remove-10-15-year-old-pigmentation-quickly-150314">hyperpigmentation</a> disorder driven by a complex interplay of genetics, hormones, and environmental triggers, yet a critical clinical gap exists in understanding how to effectively balance the oxidative stress that promotes inflammation and cellular damage in these patients. Consequently, Rashmi Sarkar and Anjali Sahu from the <i>Department of Dermatology at Lady Hardinge Medical College</i> conducted this systematic review to thoroughly investigate the potential of various exogenous and endogenous antioxidants as safe and effective alternatives or adjuvants in current clinical management protocols.</p><p dir="ltr">Therefore, the systematic review utilized a comprehensive search of the PubMed database for English-language peer-reviewed articles published over the last decade until January 31, 2024, focusing on study designs such as Randomized Controlled Trials (RCTs) and observational studies involving human populations while excluding animal models and conference abstracts. The investigators assessed the impact of several key antioxidant interventions on clinical outcomes like the Melasma Area and Severity Index (MASI) score by evaluating thirty specific articles to identify optimal therapeutic combinations that enhance patient well-being.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Optimized Peeling Regimens:</b> Research demonstrated that combining a 20% Trichloroacetic Acid (TCA) peel with a 5% topical Magnesium Ascorbyl Phosphate (MAP) cream resulted in a statistically significant 81.1% reduction in MASI scores compared to only 66.2% for those receiving the peel alone.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Cysteamine Efficacy:</b> Investigations revealed that 5% cysteamine cream is significantly more effective than the Modified Kligman’s Formula (MKF) in reducing pigmentation, providing a safe and well-tolerated option for patients who need to rotate off hydroquinone(HQ).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Silymarin Performance: </b>Evidence showed that silymarin cream at concentrations of 0.7% and 1.4% provides clinical results equivalent to 4% hydroquinone but with a notable absence of the significant adverse effects often associated with traditional depigmenting agents.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Glutathione Synergy:</b> Data highlighted that adding glutathione to microneedling or mesotherapy cocktails significantly accelerates the treatment response and leads to more substantial reductions in the hemi-Modified Melasma  Area and Severity Index (hemi-mMASI) scores than standard therapies alone.   </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Zinc Sulfate Comparison: </b>Findings established that although 10% topical zinc sulfate reduces melasma severity, its potency is markedly lower than hydroquinone, showing only an 18.6% improvement compared to the 43.5% reduction seen with the standard treatment.</p></li></ul><p dir="ltr">The results suggest that incorporating these antioxidants into routine care can safely enhance efficacy, with data showing that combined approaches, such as using oral lycopene from tomato extract as an adjuvant, significantly boost serum Superoxide Dismutase (SOD) levels while improving skin appearance. These diverse agents demonstrate a clear potential to serve as safe, effective, and sometimes synergistic components of a modern, multi-modal dermatological strategy.</p><p dir="ltr">Thus, the study concludes clinicians may find value in adopting these antioxidant therapies as part of a comprehensive management plan to improve patient outcomes and minimize treatment-related side effects.</p><p dir="ltr">While the current evidence is encouraging, the lack of statistical significance for certain agents like melatonin and the small sample sizes in some split-face trials indicate a need for larger, long-term prospective studies to fully validate these findings and optimize treatment strategies.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Sarkar R, Sahu A. Role of antioxidants in melasma: A systematic review. Indian J Dermatol 2025;70:125-34.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>New study finds common blood pressure drug boosts cancer treatment</title>
<link>https://edusehat.com/en/new-study-finds-common-blood-pressure-drug-boosts-cancer-treatment</link>
<guid>https://edusehat.com/en/new-study-finds-common-blood-pressure-drug-boosts-cancer-treatment</guid>
<description><![CDATA[ In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can significantly enhance the cancer-killing activity of the targeted therapy olaparib, potentially expanding its use to many more patients. The findings are newly published in The Journal for ImmunoTherapy of Cancer.
“This study shows that a common, safe, tolerable, convenient, and inexpensive drug may significantly improve how well an important class of cancer therapies works,” said Curiel, the study’s senior and lead author.
Expanding the reach of PARP inhibitors
PARP inhibitors such as olaparib work by exploiting weaknesses in how some cancer cells repair damaged DNA. They are particularly effective in tumors with defective homologous recombination DNA damage repair, such as those with gene mutations in BRCA. However, many tumors lack these defects, limiting the number of patients who can benefit from PARP inhibitors. In addition, most cancers eventually develop resistance to PARP inhibitors.
Curiel’s team discovered that telmisartan can make tumors more vulnerable to PARP inhibitors, even when they lack the specific DNA repair defects that usually make PARP inhibitors effective.
In preclinical studies, telmisartan increased DNA damage in tumor cells when used with olaparib and triggered powerful immune-stimulating signals. Specifically, the combination boosted production of type I interferons—molecules that help the immune system recognize and attack cancer.
“This immune activation appears to be a key reason the combination works so well,” Curiel said.
A unique effect among blood pressure drugs
Telmisartan belongs to the angiotensin II receptor blocker (ARB) class of medications, commonly prescribed to treat hypertension. The DCC study found that the cancer-enhancing effects were unique to telmisartan among all the ARBs tested.
The drug also reduced levels of PD-L1 inside tumor cells-a protein that cancers use to evade immune attack—further increasing its therapeutic potential.
“Telmisartan has several distinct anticancer effects that, together with targeted therapy, could make tumors more responsive to distinct types of treatments,” Curiel said. “We showed the improved efficacy with PARP inhibitors in this study, but we also have good data showing that telmisartan improves efficacy of distinct chemotherapy classes and immunotherapies in many other cancer types through related mechanisms.”
Moving quickly to clinical trials
Telmisartan is orally bioavailable, safe, and well-tolerated, including by individuals without hypertension, making it an ideal candidate for clinical translation. Curiel and colleagues at DCC are already testing the strategy in patients through two ongoing clinical trials.
One trial is evaluating the combination in men with metastatic, castration-resistant prostate cancer. The first patient enrolled in the study experienced what Curiel described as an exceptional response to treatment. The second trial is in platinum-resistant ovarian cancer, which just enrolled its first patient.
“We are encouraged by what we are seeing so far,” Curiel said. “Our goal is to determine whether this combination approach can help more patients benefit from greater effectiveness of PARP inhibitors and other cancer treatment classes and potentially overcome resistance to these drugs.”
Support from the Guyre fund and Gmelich fund at DCC were instrumental in getting these studies completed and the clinical trials launched.Reference:Murray CE, Ontiveros CO, Wentworth J, Blinkiewicz P, Leung B, Bai H, et al. Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production. Journal for ImmunoTherapy of Cancer. 2026;14:e012426. https://doi.org/10.1136/jitc-2025-012426
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/26/335139-cancer-7.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, study, finds, common, blood, pressure, drug, boosts, cancer, treatment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/26/335139-cancer-7.webp"><p>In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug <a href="https://medicaldialogues.in/topics/telmisartan">telmisartan </a>can significantly enhance the <a href="https://medicaldialogues.in/topics/cancer">cancer</a>-killing activity of the targeted therapy olaparib, potentially expanding its use to many more patients. The findings are newly published in The <i>Journal for ImmunoTherapy of Cancer.
</i></p><p>“This study shows that a common, safe, tolerable, convenient, and inexpensive drug may significantly improve how well an important class of cancer therapies works,” said Curiel, the study’s senior and lead author.
</p><h3>Expanding the reach of PARP inhibitors
</h3><p>PARP inhibitors such as olaparib work by exploiting weaknesses in how some cancer cells repair damaged DNA. They are particularly effective in tumors with defective homologous recombination DNA damage repair, such as those with gene mutations in BRCA. However, many tumors lack these defects, limiting the number of patients who can benefit from PARP inhibitors. In addition, most cancers eventually develop resistance to PARP inhibitors.
</p><p>Curiel’s team discovered that telmisartan can make tumors more vulnerable to PARP inhibitors, even when they lack the specific DNA repair defects that usually make PARP inhibitors effective.
</p><p>In preclinical studies, telmisartan increased DNA damage in tumor cells when used with olaparib and triggered powerful immune-stimulating signals. Specifically, the combination boosted production of type I interferons—molecules that help the immune system recognize and attack cancer.
</p><p>“This immune activation appears to be a key reason the combination works so well,” Curiel said.
</p><h3>A unique effect among blood pressure drugs
</h3><p>Telmisartan belongs to the angiotensin II receptor blocker (ARB) class of medications, commonly prescribed to treat hypertension. The DCC study found that the cancer-enhancing effects were unique to telmisartan among all the ARBs tested.
</p><p>The drug also reduced levels of PD-L1 inside tumor cells-a protein that cancers use to evade immune attack—further increasing its therapeutic potential.
</p><p>“Telmisartan has several distinct anticancer effects that, together with targeted therapy, could make tumors more responsive to distinct types of treatments,” Curiel said. “We showed the improved efficacy with PARP inhibitors in this study, but we also have good data showing that telmisartan improves efficacy of distinct chemotherapy classes and immunotherapies in many other cancer types through related mechanisms.”
</p><h3>Moving quickly to clinical trials
</h3><p>Telmisartan is orally bioavailable, safe, and well-tolerated, including by individuals without hypertension, making it an ideal candidate for clinical translation. Curiel and colleagues at DCC are already testing the strategy in patients through two ongoing clinical trials.
</p><p>One trial is evaluating the combination in men with metastatic, castration-resistant prostate cancer. The first patient enrolled in the study experienced what Curiel described as an exceptional response to treatment. The second trial is in platinum-resistant ovarian cancer, which just enrolled its first patient.
</p><p>“We are encouraged by what we are seeing so far,” Curiel said. “Our goal is to determine whether this combination approach can help more patients benefit from greater effectiveness of PARP inhibitors and other cancer treatment classes and potentially overcome resistance to these drugs.”
</p><p>Support from the Guyre fund and Gmelich fund at DCC were instrumental in getting these studies completed and the clinical trials launched.</p><p>Reference:</p><p>Murray CE, Ontiveros CO, Wentworth J, Blinkiewicz P, Leung B, Bai H, et al. Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production. Journal for ImmunoTherapy of Cancer. 2026;14:e012426. https://doi.org/10.1136/jitc-2025-012426
</p>]]> </content:encoded>
</item>

<item>
<title>Cannabis use disorder among young people linked to diagnosis of psychiatric disorders, suggests study</title>
<link>https://edusehat.com/en/cannabis-use-disorder-among-young-people-linked-to-diagnosis-of-psychiatric-disorders-suggests-study</link>
<guid>https://edusehat.com/en/cannabis-use-disorder-among-young-people-linked-to-diagnosis-of-psychiatric-disorders-suggests-study</guid>
<description><![CDATA[ A new study led by Johns Hopkins researchers found that young people with cannabis use disorder were more likely than young people with other substance use disorders to later be diagnosed with a psychiatric disorder. In contrast, adults with cannabis use disorder were significantly less likely to develop psychiatric disorders, compared to adults with other substance use disorders.
The study found that the relative risk of young people age 17 and under with cannabis use disorder was 52% higher for schizophrenia, 30% higher for recurrent major depression, and 21% higher for anxiety disorders, compared to young people with other substance use disorders. Adults with cannabis use disorder had lower relative risks for being diagnosed with a psychiatric disorder.    
The findings highlight the question of whether excessive cannabis use, perhaps more than other substances, might alter brain development of young people, predisposing them to developing a psychiatric disorder.
The study was published online March 5 in the American Journal of Psychiatry.
“Is cannabis use a unique risk factor compared to the use of other substances such as alcohol, opioids, or cocaine? That’s the question we addressed in this study, and our findings suggest that that relative risk depends on the user’s age,” says study co-author Johannes Thrul, PhD, associate professor in the Department of Mental Health at the Bloomberg School.
Products made from the Cannabis sativa plant have been used recreationally in the U.S. since at least the 1800s. Their popularity increased during alcohol prohibition in the 1920s and the counterculture movement in the 1960s. Today, cannabis use by adults age 21 and older is legal in 24 U.S. states and the District of Columbia. Surveys suggest daily use of cannabis is higher than alcohol consumption.
“Much of our interest in this came from the recent legalization of recreational cannabis in Maryland, in 2023, and other states,” says Ryan Nicholson, MD, resident at Johns Hopkins University School of Medicine. “We wanted to understand cannabis-related psychotic disorders clinicians are seeing in the context of other substance-related psychotic disorders.&quot;
The link between cannabis and psychosis first appeared in medical literature in the early twentieth century. In 1987, a study of more than 45,000 Swedish army recruits found that the use of cannabis at the time of conscription was associated with large increases in the risk of subsequent schizophrenia, especially when the cannabis use was heavy. Other studies since then have found similar associations.
For the study, the researchers analyzed nearly 700,000 U.S. medical records from a large commercial database. They identified patients who had been diagnosed with cannabis use disorder—a condition that implies relatively heavy cannabis use—but had not been diagnosed with other psychiatric disorders. They then matched these patients on measures such as age, sex, ethnicity, and income level, with patients who had been diagnosed with other, non-cannabis substance use disorders and did not have other psychiatric conditions. The researchers compared the rates of subsequent schizophrenia and other psychiatric diagnoses in these two patient groups—adults age 18 and older (691,806 patients) and one for those age 17 and under (49,586 patients).
The median age among patients with cannabis use disorder was 16 versus 15 among patients with other substance use disorders. About 10% of patients in the cohort of all substance use disorders were under age 12. The authors note that this aligns with reports from adult patients being treated for substance use disorder: 10.2% reported starting substance use at age 11 or younger.
Adults in the cannabis use disorder group had a 19% lower risk (0.34% vs. 0.42%) of subsequent schizophrenia compared to the group with other substance use disorders. Risks of subsequent psychosis, recurrent major depression, and suicide attempts were also lower in the cannabis-use group.
The results are consistent with the idea that heavy cannabis use predisposes young people to subsequent schizophrenia and some other psychiatric disorders that they might not develop otherwise. Thrul notes that this acceleration effect could make these illnesses seem less likely at later ages, thus appearing to lower the risk in adults, at least in relation to other recreational drugs.
Thrul cautions, however, that the causation might point in the other direction, with individuals who are innately more likely to develop certain psychiatric disorders to also have a greater tendency to self-medicate with cannabis, even before their mental health issues have become evident.
“There are still many unknowns on that question, but I would never recommend that teenagers use cannabis, especially not the high-potency cannabis products that are on the market now,” he says.
One of the paper’s limitations is that the database the researchers used relied on International Classification of Diseases ICD-10 coding by other physicians, so the researchers may not know the exact patient history that led to the diagnosis. Reference:Ryan C. Nicholson, Una E. Choi, Ramin Mojtabai, Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis, American Journal of Psychiatry, https://doi.org/10.1176/appi.ajp.20250336 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/16/232375-cannabis-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Cannabis, use, disorder, among, young, people, linked, diagnosis, psychiatric, disorders, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/16/232375-cannabis-50.webp"><p>A new study led by Johns Hopkins researchers found that young people with cannabis use disorder were more likely than young people with other substance use disorders to later be diagnosed with a psychiatric disorder. In contrast, adults with cannabis use disorder were significantly less likely to develop psychiatric disorders, compared to adults with other substance use disorders.
</p><p>The study found that the relative risk of young people age 17 and under with cannabis use disorder was 52% higher for schizophrenia, 30% higher for recurrent major depression, and 21% higher for anxiety disorders, compared to young people with other substance use disorders. Adults with cannabis use disorder had lower relative risks for being diagnosed with a psychiatric disorder.    
</p><p>The findings highlight the question of whether excessive cannabis use, perhaps more than other substances, might alter brain development of young people, predisposing them to developing a psychiatric disorder.
</p><p>The study was published online March 5 in the <i>American Journal of Psychiatry</i>.
</p><p>“Is cannabis use a unique risk factor compared to the use of other substances such as alcohol, opioids, or cocaine? That’s the question we addressed in this study, and our findings suggest that that relative risk depends on the user’s age,” says study co-author Johannes Thrul, PhD, associate professor in the Department of Mental Health at the Bloomberg School.
</p><p>Products made from the Cannabis sativa plant have been used recreationally in the U.S. since at least the 1800s. Their popularity increased during alcohol prohibition in the 1920s and the counterculture movement in the 1960s. Today, cannabis use by adults age 21 and older is legal in 24 U.S. states and the District of Columbia. Surveys suggest daily use of cannabis is higher than alcohol consumption.
</p><p>“Much of our interest in this came from the recent legalization of recreational cannabis in Maryland, in 2023, and other states,” says Ryan Nicholson, MD, resident at Johns Hopkins University School of Medicine. “We wanted to understand cannabis-related psychotic disorders clinicians are seeing in the context of other substance-related psychotic disorders."
</p><p>The link between cannabis and psychosis first appeared in medical literature in the early twentieth century. In 1987, a study of more than 45,000 Swedish army recruits found that the use of cannabis at the time of conscription was associated with large increases in the risk of subsequent schizophrenia, especially when the cannabis use was heavy. Other studies since then have found similar associations.
</p><p>For the study, the researchers analyzed nearly 700,000 U.S. medical records from a large commercial database. They identified patients who had been diagnosed with cannabis use disorder—a condition that implies relatively heavy cannabis use—but had not been diagnosed with other psychiatric disorders. They then matched these patients on measures such as age, sex, ethnicity, and income level, with patients who had been diagnosed with other, non-cannabis substance use disorders and did not have other psychiatric conditions. The researchers compared the rates of subsequent schizophrenia and other psychiatric diagnoses in these two patient groups—adults age 18 and older (691,806 patients) and one for those age 17 and under (49,586 patients).
</p><p>The median age among patients with cannabis use disorder was 16 versus 15 among patients with other substance use disorders. About 10% of patients in the cohort of all substance use disorders were under age 12. The authors note that this aligns with reports from adult patients being treated for substance use disorder: 10.2% reported starting substance use at age 11 or younger.
</p><p>Adults in the cannabis use disorder group had a 19% lower risk (0.34% vs. 0.42%) of subsequent schizophrenia compared to the group with other substance use disorders. Risks of subsequent psychosis, recurrent major depression, and suicide attempts were also lower in the cannabis-use group.
</p><p>The results are consistent with the idea that heavy cannabis use predisposes young people to subsequent schizophrenia and some other psychiatric disorders that they might not develop otherwise. Thrul notes that this acceleration effect could make these illnesses seem less likely at later ages, thus appearing to lower the risk in adults, at least in relation to other recreational drugs.
</p><p>Thrul cautions, however, that the causation might point in the other direction, with individuals who are innately more likely to develop certain psychiatric disorders to also have a greater tendency to self-medicate with cannabis, even before their mental health issues have become evident.
</p><p>“There are still many unknowns on that question, but I would never recommend that teenagers use cannabis, especially not the high-potency cannabis products that are on the market now,” he says.
</p><p>One of the paper’s limitations is that the database the researchers used relied on International Classification of Diseases ICD-10 coding by other physicians, so the researchers may not know the exact patient history that led to the diagnosis. </p><p>Reference:</p><p>Ryan C. Nicholson, Una E. Choi, Ramin Mojtabai, Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis, American Journal of Psychiatry, https://doi.org/10.1176/appi.ajp.20250336</p>]]> </content:encoded>
</item>

<item>
<title>Study details technique to Preserve Peri&#45;Implant Papilla After Reconstructive Surgery</title>
<link>https://edusehat.com/en/study-details-technique-to-preserve-peri-implant-papilla-after-reconstructive-surgery</link>
<guid>https://edusehat.com/en/study-details-technique-to-preserve-peri-implant-papilla-after-reconstructive-surgery</guid>
<description><![CDATA[ Researchers have found in a new research that using an internally beveled vestibular incision combined with multilayer suturing helps preserve peri-implant papillary integrity. This approach promotes predictable primary intention healing following reconstructive peri-implantitis surgery and is particularly beneficial in esthetically sensitive areas.As the outcome of reconstructive peri-implantitis surgery is highly dependent on complication-free healing with focus on primary intention healing, clinicians should take into account that the wound healing capacity at peri-implant sites is compromised due to fundamental structural biological differences when compared to periodontal tissues. In this context, tunneling flap techniques that avoid superficial incisions in the interproximal soft tissues, specifically between adjacent implants, where the papillary region constitutes a critical weak point, can be a key strategy. When employed together with vestibular access flaps, precise multilayer closure techniques may be applied to stabilize the wound within the highly movable alveolar mucosa and in this way improve predictable primary wound healing.An internally beveled vestibular incision in the alveolar mucosa is introduced and described in this article. After flap preparation and implant surface decontamination, defects were reconstructed using autogenous tuberosity bone. Executing the initial bevel from coronal to apical (internal) created an additional tissue wedge that was incorporated into the coronal flap margin, increasing its surface area and facilitating closure in four distinct layers. The modified approach resulted in primary wound healing in these cases and was associated with substantial reconstructive outcomes at 1 year. Preserving peri-implant papillary integrity by an internally beveled vestibular incision together with multilayer suturing may be beneficial to attain predictable healing by primary intention after reconstructive peri-implantitis surgery, which is also relevant in esthetic areas.Reference:E. Gülnergiz, S. M. Abraha, M. Hürzeler, and O. Zuhr, “ Reconstructive Peri-Implantitis Surgery Using an Internally Beveled Vestibular Incision for Multilayer Wound Closure,” Journal of Esthetic and Restorative Dentistry (2026): 1–10, https://doi.org/10.1111/jerd.70124.Keywords:Study,  details,  technique, Preserve,  Peri-Implant, Papilla,  After,  Reconstructive Surgery, E. Gülnergiz, S. M. Abraha, M. Hürzeler, and O. Zuhr ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/25/329747-413682012articlebfijos201225fig1html.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, details, technique, Preserve, Peri-Implant, Papilla, After, Reconstructive, Surgery</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/25/329747-413682012articlebfijos201225fig1html.webp"><p>Researchers have found in a new research that using an internally beveled vestibular incision combined with multilayer suturing helps preserve peri-implant papillary integrity. This approach promotes predictable primary intention healing following reconstructive peri-implantitis surgery and is particularly beneficial in esthetically sensitive areas.</p><div class="pasted-from-word-wrapper"><div><span>As the outcome of reconstructive peri-implantitis surgery is highly dependent on complication-free healing with focus on primary intention healing, clinicians should take into account that the wound healing capacity at peri-implant sites is compromised due to fundamental structural biological differences when compared to periodontal tissues. In this context, tunneling flap techniques that avoid superficial incisions in the interproximal soft tissues, specifically between adjacent implants, where the papillary region constitutes a critical weak point, can be a key strategy. When employed together with vestibular access flaps, precise multilayer closure techniques may be applied to stabilize the wound within the highly movable alveolar mucosa and in this way improve predictable primary wound healing.</span></div><div><span>An internally beveled vestibular incision in the alveolar mucosa is introduced and described in this article. After flap preparation and implant surface decontamination, defects were reconstructed using autogenous tuberosity bone. Executing the initial bevel from coronal to apical (internal) created an additional tissue wedge that was incorporated into the coronal flap margin, increasing its surface area and facilitating closure in four distinct layers. The modified approach resulted in primary wound healing in these cases and was associated with substantial reconstructive outcomes at 1 year. Preserving peri-implant papillary integrity by an internally beveled vestibular incision together with multilayer suturing may be beneficial to attain predictable healing by primary intention after reconstructive peri-implantitis surgery, which is also relevant in esthetic areas.</span></div><div><span>Reference:</span></div><p dir="ltr">E. Gülnergiz, S. M. Abraha, M. Hürzeler, and O. Zuhr, “ Reconstructive Peri-Implantitis Surgery Using an Internally Beveled Vestibular Incision for Multilayer Wound Closure,” Journal of Esthetic and Restorative Dentistry (2026): 1–10, <a href="https://doi.org/10.1111/jerd.70124">https://doi.org/10.1111/jerd.70124</a>.</p><div><span>Keywords:</span></div><p dir="ltr">Study,  details,  technique, Preserve,  Peri-Implant, Papilla,  After,  Reconstructive Surgery, E. Gülnergiz, S. M. Abraha, M. Hürzeler, and O. Zuhr</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Statins Not Linked to Increased Breast Cancer Risk, reveals research</title>
<link>https://edusehat.com/en/statins-not-linked-to-increased-breast-cancer-risk-reveals-research</link>
<guid>https://edusehat.com/en/statins-not-linked-to-increased-breast-cancer-risk-reveals-research</guid>
<description><![CDATA[ Researchers have found in a new study that Statin use in postmenopausal women was not associated with an increased risk of breast cancer. While primarily used for cardiovascular prevention, their potential role in breast cancer prevention remains uncertain due to mixed evidence.A study was done to study the incidence and subtype of breast cancer in relation to incident and prevalent statin use in a contemporary Swedish prospective cohort, The Karolinska Mammography Project for Risk Prediction of Breast Cancer, KARMA. A total of 35,315 postmenopausal women attending mammography and included in the KARMA cohort (Jan 2011–March 2013) with data on statin use and potential confounders were studied. During eight years of follow-up, 785 incident invasive breast cancer cases were identified.A total of 16% of women were prevalent statin users (prior to study inclusion) and 9% were incident statin users (following study inclusion). In multivariable Cox regression analyses, there was no significant association between incident or prevalent statin use and risk of incident breast cancer (HRadj 1.24, 95% CI 0.89–1.72, and HRadj 0.90, 95% CI 0.73–1.11, respectively). Similarly, no significant association was found for incident or prevalent statin use and subtype-specific risk of breast cancer. This prospective population-based study performed in a modern screening population with a substantial number of statin users, concurs with previous publications showing no evidence of an association between statin use and risk of postmenopausal breast cancer.Reference:Klintman, M., Rosendahl, A.H., Johannesen, B.R. et al. Statins and postmenopausal breast cancer risk; results from the KARMA cohort. Cancer Causes Control 37, 72 (2026). https://doi.org/10.1007/s10552-026-02156-xKeywords:Statins, Linked, Increased,  Breast Cancer Risk, reveals,  research, Klintman, M., Rosendahl, A.H., Johannesen, B.R,  Statins, Overweight, Obesity, BMI, Breast cancer risk, Breast cancer subtypes ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341135-images-23.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Statins, Not, Linked, Increased, Breast, Cancer, Risk, reveals, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341135-images-23.webp"><p>Researchers have found in a new study that Statin use in postmenopausal women was not associated with an increased risk of breast cancer. While primarily used for cardiovascular prevention, their potential role in breast cancer prevention remains uncertain due to mixed evidence.</p><div class="pasted-from-word-wrapper"><p dir="ltr">A study was done to study the incidence and subtype of breast cancer in relation to incident and prevalent statin use in a contemporary Swedish prospective cohort, The Karolinska Mammography Project for Risk Prediction of Breast Cancer, KARMA. A total of 35,315 postmenopausal women attending mammography and included in the KARMA cohort (Jan 2011–March 2013) with data on statin use and potential confounders were studied. During eight years of follow-up, 785 incident invasive breast cancer cases were identified.</p><p dir="ltr">A total of 16% of women were prevalent statin users (prior to study inclusion) and 9% were incident statin users (following study inclusion). In multivariable Cox regression analyses, there was no significant association between incident or prevalent statin use and risk of incident breast cancer (HRadj 1.24, 95% CI 0.89–1.72, and HRadj 0.90, 95% CI 0.73–1.11, respectively). Similarly, no significant association was found for incident or prevalent statin use and subtype-specific risk of breast cancer. This prospective population-based study performed in a modern screening population with a substantial number of statin users, concurs with previous publications showing no evidence of an association between statin use and risk of postmenopausal breast cancer.</p><p dir="ltr">Reference:</p><p dir="ltr">Klintman, M., Rosendahl, A.H., Johannesen, B.R. et al. Statins and postmenopausal breast cancer risk; results from the KARMA cohort. Cancer Causes Control 37, 72 (2026). <a href="https://doi.org/10.1007/s10552-026-02156-x">https://doi.org/10.1007/s10552-026-02156-x</a></p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Statins, Linked, Increased,  Breast Cancer Risk, reveals,  research, Klintman, M., Rosendahl, A.H., Johannesen, B.R,  Statins, Overweight, Obesity, BMI, Breast cancer risk, Breast cancer subtypes</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>AI&#45;Estimated Accelerated Biological Aging on Chest X&#45;ray Predicts Mortality: Study</title>
<link>https://edusehat.com/en/ai-estimated-accelerated-biological-aging-on-chest-x-ray-predicts-mortality-study</link>
<guid>https://edusehat.com/en/ai-estimated-accelerated-biological-aging-on-chest-x-ray-predicts-mortality-study</guid>
<description><![CDATA[ A large Korean study published in the journal of Radiology Artificial Intelligence found that accelerated biological aging, as estimated from chest X-rays using a deep-learning model, is significantly associated with increased patient mortality, which suggests its potential role as a prognostic marker.This research analyzed chest X-rays from more than 421,000 Korean adults collected between 2006 and 2020 to determine whether “radiographic age” (AI-derived estimate) could predict mortality. Using a deep learning model known as AgeNet, which was trained on healthy individuals, this study compared the radiographic age of each person with their actual chronological age.The results suggest that when the body appears older than its actual age on imaging, it may signal significantly higher health risks. The participants whose radiographic age exceeded their chronological age by 5 or more years were classified as experiencing “accelerated aging.” Across the median follow-up period of 8.5 years, over 6,500 deaths were recorded, which included those from cardiovascular disease, cancer, and respiratory illness.Accelerated aging was strongly associated with increased mortality across all causes and this effect was more pronounced in women. Men with accelerated aging had a 26% increased risk of death, while women faced a 52% higher risk, which highlighted the potential sex-based differences in how aging impacts health.This study also examined how quickly radiographic age (aging velocity) changes over time. Among nearly 180,000 individuals who had at least 3 chest X-rays, those with faster increases in radiographic age underwent significantly higher mortality risks, regardless of their initial health status.Each standard deviation increase in aging velocity corresponded to a 24% rise in mortality risk for men and 35% for women. Slower aging rates were linked to better outcomes, where women with decelerated aging velocity (1.5 years) were at markedly higher risk of death. Mortality rates rose by 51% in men and 71% in women within this group. Overall, the study found that both accelerated radiographic aging and rapid aging velocity independently predict mortality risk. These findings suggest that AI-enhanced analysis of routine chest X-rays could become a valuable tool in preventive medicine.Reference:Chang, Y., Kim, H., Lee, S., Lee, H., Yoon, S. H., &amp; Ryu, S. (2026). Accelerated aging and aging velocity from deep learning-based chest radiograph-derived age for predicting cause-specific mortality. Radiology. Artificial Intelligence, e250609, e250609. https://doi.org/10.1148/ryai.250609 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/21/328779-artificial-intelligence.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AI-Estimated, Accelerated, Biological, Aging, Chest, X-ray, Predicts, Mortality:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/21/328779-artificial-intelligence.webp"><p>A large Korean study published in the journal of <i>Radiology Artificial Intelligence</i> found that accelerated biological aging, as estimated from chest X-rays using a deep-learning model, is significantly associated with increased patient mortality, which suggests its potential role as a prognostic marker.</p><p>This research analyzed chest X-rays from more than 421,000 Korean adults collected between 2006 and 2020 to determine whether “radiographic age” (AI-derived estimate) could predict mortality. Using a deep learning model known as AgeNet, which was trained on healthy individuals, this study compared the radiographic age of each person with their actual chronological age.</p><p>The results suggest that when the body appears older than its actual age on imaging, it may signal significantly higher health risks. The participants whose radiographic age exceeded their chronological age by 5 or more years were classified as experiencing “accelerated aging.” Across the median follow-up period of 8.5 years, over 6,500 deaths were recorded, which included those from cardiovascular disease, cancer, and respiratory illness.</p><p>Accelerated aging was strongly associated with increased mortality across all causes and this effect was more pronounced in women. Men with accelerated aging had a 26% increased risk of death, while women faced a 52% higher risk, which highlighted the potential sex-based differences in how aging impacts health.</p><p>This study also examined how quickly radiographic age (aging velocity) changes over time. Among nearly 180,000 individuals who had at least 3 chest X-rays, those with faster increases in radiographic age underwent significantly higher mortality risks, regardless of their initial health status.</p><p>Each standard deviation increase in aging velocity corresponded to a 24% rise in mortality risk for men and 35% for women. Slower aging rates were linked to better outcomes, where women with decelerated aging velocity (<0.5 years of radiographic aging per year) experienced around 50% reduction in mortality risk.</p><p>The individuals whose radiographic age increased rapidly (>1.5 years) were at markedly higher risk of death. Mortality rates rose by 51% in men and 71% in women within this group. Overall, the study found that both accelerated radiographic aging and rapid aging velocity independently predict mortality risk. These findings suggest that AI-enhanced analysis of routine chest X-rays could become a valuable tool in preventive medicine.</p><p>Reference:</p><p>Chang, Y., Kim, H., Lee, S., Lee, H., Yoon, S. H., & Ryu, S. (2026). Accelerated aging and aging velocity from deep learning-based chest radiograph-derived age for predicting cause-specific mortality. Radiology. Artificial Intelligence, e250609, e250609. <a href="https://pubs.rsna.org/doi/10.1148/ryai.250609" rel="nofollow">https://doi.org/10.1148/ryai.250609</a></p>]]> </content:encoded>
</item>

<item>
<title>In Advanced CKD Cases, Women Have Higher Symptom Burden but Progression of Disease Faster in Men: Study</title>
<link>https://edusehat.com/en/in-advanced-ckd-cases-women-have-higher-symptom-burden-but-progression-of-disease-faster-in-men-study</link>
<guid>https://edusehat.com/en/in-advanced-ckd-cases-women-have-higher-symptom-burden-but-progression-of-disease-faster-in-men-study</guid>
<description><![CDATA[ Netherlands: Among older adults with advanced chronic kidney disease (CKD), women experienced a greater overall symptom burden than men; however, men demonstrated a more rapid worsening of symptoms over time and with declining kidney function.The study published in Nephrology Dialysis Transplantation by Nicholas C. Chesnaye and colleagues from Amsterdam UMC sheds light on how symptom burden changes over time in older adults with advanced chronic kidney disease, highlighting key sex-based differences with implications for patient-centered care.The researchers conducted a prospective cohort analysis within the European QUALity (EQUAL) study, including 1,135 adults aged 65 years or older with newly diagnosed advanced CKD (eGFR  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340981-chronic-kidney-disease-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Advanced, CKD, Cases, Women, Have, Higher, Symptom, Burden, but, Progression, Disease, Faster, Men:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340981-chronic-kidney-disease-2.webp"><p><span>Netherlands: Among older adults with advanced<a href="https://medicaldialogues.in/topics/chronic-kidney-disease"> chronic kidney disease (CKD)</a>, women experienced a greater overall symptom burden than men; however, men demonstrated a more rapid worsening of symptoms over time and with declining <a href="https://medicaldialogues.in/topics/kidney-function">kidney function</a>.</span></p><div class="pasted-from-word-wrapper"><div>The study published in <i><a href="https://medicaldialogues.in/topics/nephrology-dialysis-transplantation">Nephrology Dialysis Transplantation </a></i>by Nicholas C. Chesnaye and colleagues from Amsterdam UMC sheds light on how symptom burden changes over time in older adults with advanced chronic kidney disease, highlighting key sex-based differences with implications for patient-centered care.</div><div>The researchers conducted a prospective cohort analysis within the European QUALity (EQUAL) study, including 1,135 adults aged 65 years or older with newly diagnosed advanced CKD (eGFR <20 mL/min/1.73 m²), none of whom were on dialysis at baseline. Of these, 775 were men. Participants were followed for up to 5 years or until the initiation of kidney replacement therapy, whichever occurred first.</div><div>Symptom burden was assessed using the Dialysis Symptom Index, a validated patient-reported outcome measure covering 30 symptoms. Data were collected every 3 to 6 months, along with clinical and laboratory parameters.</div><div>During follow-up, 4,730 symptom assessments were recorded. Overall, symptom progression was gradual, with the number of symptoms increasing by an average of 0.47 per year. Symptom burden also rose with worsening kidney function, increasing by 0.75 symptoms for every 5 mL/min/1.73 m² decline in eGFR.</div><div>The study led to the following findings:</div><ul><li>Women reported a higher number of symptoms than men at baseline and throughout follow-up, with average counts of 13.6 compared to 10.9.</li><li>The rate of increase in symptom burden over time was faster in men than in women.</li><li>Men experienced an average increase of 0.58 symptoms per year.</li><li>Women showed a slower increase, with an average of 0.24 symptoms per year.</li><li>Symptom burden increased with declining kidney function in both sexes.</li><li>In men, symptom burden rose by nearly one additional symptom for every 5 mL/min/1.73 m² decrease in eGFR.</li><li>In women, the increase in symptom burden with declining eGFR was smaller.</li><li>The relationship between worsening kidney function and symptom burden was non-linear.</li><li>A sharper rise in symptom number and severity was observed at lower eGFR levels, especially in men.</li></ul><div>The authors emphasize that while women tend to report a higher overall symptom load, men may require closer monitoring due to the faster pace of symptom progression. They also highlight the variability in individual symptom experiences, underscoring the importance of routinely incorporating patient-reported outcome measures into nephrology practice.</div><div>These findings reinforce the need for personalized care strategies and improved communication between patients and clinicians, particularly as CKD advances and symptom burden intensifies.</div><div>Reference:</div><div>Chesnaye, N. C., Wrackefeldt, J., Caskey, F. J., Dekker, F. W., Torino, C., Szymczak, M., Drechsler, C., Wanner, C., Vilasi, A., Meuleman, Y., Pippias, M., Stel, V. S., Jager, K. J., Evans, M., Schneider, A., Torp, A., Iwig, B., Perras, B., Marx, C., . . . Kuan, Y. The evolution of symptom burden in older men and women with advanced CKD. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag045</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Mezagitamab Improves Platelet Counts in Chronic ITP in Phase 2 Trial</title>
<link>https://edusehat.com/en/mezagitamab-improves-platelet-counts-in-chronic-itp-in-phase-2-trial</link>
<guid>https://edusehat.com/en/mezagitamab-improves-platelet-counts-in-chronic-itp-in-phase-2-trial</guid>
<description><![CDATA[ USA: A Phase 2 trial has revealed that treatment with mezagitamab increased platelet counts in patients with persistent or chronic immune thrombocytopenia (ITP), with a safety profile comparable to placebo.A study published in the New England Journal of Medicine (NEJM) highlights the potential of mezagitamab, a novel anti-CD38 monoclonal antibody, as a therapeutic option for patients with difficult-to-treat ITP. This autoimmune condition is characterized by accelerated platelet destruction and impaired platelet production, leading to an elevated risk of bleeding and reduced quality of life. Notably, a significant proportion of patients do not achieve adequate responses with currently available treatments.Led by David J. Kuter and colleagues, the multicenter, double-blind, randomized, placebo-controlled trial evaluated the safety and efficacy of mezagitamab administered subcutaneously once weekly for eight weeks. Adults with persistent or chronic ITP and a mean platelet count below 30,000 per microliter were enrolled. Participants were randomized to receive mezagitamab at doses of 100 mg, 300 mg, or 600 mg or a placebo.The primary endpoint focused on safety, while a key secondary endpoint assessed platelet response. A response was defined as achieving a platelet count of at least 50,000 per microliter with an increase of at least 20,000 per microliter from baseline on at least two occasions within 16 weeks.The study included 28 participants in the mezagitamab group and 13 in the placebo group. Patients had a history of multiple prior therapies, reflecting a population with treatment-resistant disease. Baseline platelet counts were low across both groups, highlighting the severity of the condition.   Key Findings:Safety outcomes were comparable between the mezagitamab and placebo groups.Adverse events were reported in approximately two-thirds of participants in both groups.Rates of severe (grade ≥3) and serious adverse events were similar, indicating no additional safety risk with mezagitamab.Mezagitamab significantly improved platelet counts, with the greatest effect seen at higher doses.In the 600 mg group, 91% of participants achieved a platelet response compared to 23% in the placebo group.The findings demonstrate a clear dose-dependent response.Targeting CD38-expressing cells appears to be a promising approach for improving platelet levels in ITP patients.Overall, the trial provides encouraging evidence that mezagitamab may offer a new treatment avenue for patients with persistent or chronic ITP, especially those who have not responded to existing therapies. While the results are promising, larger trials will be necessary to confirm these findings and to better define the long-term safety and durability of response.“Treatment with mezagitamab improved platelet counts while demonstrating a safety profile comparable to placebo in patients with persistent or chronic immune thrombocytopenia,” the authors concluded.Reference:DOI: 10.1056/NEJMoa2513120 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/06/208986-immune-thrombocytopenia-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mezagitamab, Improves, Platelet, Counts, Chronic, ITP, Phase, Trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/06/208986-immune-thrombocytopenia-2.webp"><p><span>USA: A Phase 2 trial has revealed that treatment with mezagitamab increased platelet counts in patients with persistent or<a href="https://medicaldialogues.in/topics/immune-thrombocytopenia"> chronic immune thrombocytopenia (ITP)</a>, with a safety profile comparable to placebo.</span></p><div class="pasted-from-word-wrapper"><div>A study published in the <i><a href="https://medicaldialogues.in/topics/new-england-journal-of-medicine">New England Journal of Medicine </a></i><a href="https://medicaldialogues.in/topics/new-england-journal-of-medicine">(NEJM) </a>highlights the potential of mezagitamab, a novel anti-CD38 <a href="https://medicaldialogues.in/topics/monoclonal-antibodies">monoclonal antibody</a>, as a therapeutic option for patients with difficult-to-treat ITP. This autoimmune condition is characterized by accelerated platelet destruction and impaired platelet production, leading to an elevated risk of bleeding and reduced quality of life. Notably, a significant proportion of patients do not achieve adequate responses with currently available treatments.</div><div>Led by David J. Kuter and colleagues, the multicenter, double-blind, randomized, placebo-controlled trial evaluated the safety and efficacy of mezagitamab administered subcutaneously once weekly for eight weeks. Adults with persistent or chronic ITP and a mean platelet count below 30,000 per microliter were enrolled. Participants were randomized to receive mezagitamab at doses of 100 mg, 300 mg, or 600 mg or a placebo.</div><div>The primary endpoint focused on safety, while a key secondary endpoint assessed platelet response. A response was defined as achieving a platelet count of at least 50,000 per microliter with an increase of at least 20,000 per microliter from baseline on at least two occasions within 16 weeks.</div><div>The study included 28 participants in the mezagitamab group and 13 in the placebo group. Patients had a history of multiple prior therapies, reflecting a population with treatment-resistant disease. Baseline platelet counts were low across both groups, highlighting the severity of the condition.   </div><div>Key Findings:</div><ul><li>Safety outcomes were comparable between the mezagitamab and placebo groups.</li><li>Adverse events were reported in approximately two-thirds of participants in both groups.</li><li>Rates of severe (grade ≥3) and serious adverse events were similar, indicating no additional safety risk with mezagitamab.</li><li>Mezagitamab significantly improved platelet counts, with the greatest effect seen at higher doses.</li><li>In the 600 mg group, 91% of participants achieved a platelet response compared to 23% in the placebo group.</li><li>The findings demonstrate a clear dose-dependent response.</li><li>Targeting CD38-expressing cells appears to be a promising approach for improving platelet levels in ITP patients.</li></ul><div>Overall, the trial provides encouraging evidence that mezagitamab may offer a new treatment avenue for patients with persistent or chronic ITP, especially those who have not responded to existing therapies. While the results are promising, larger trials will be necessary to confirm these findings and to better define the long-term safety and durability of response.</div><div><p>“Treatment with mezagitamab improved platelet counts while demonstrating a safety profile comparable to placebo in patients with persistent or chronic immune thrombocytopenia,” the authors concluded.</p></div><div>Reference:</div><div>DOI: 10.1056/NEJMoa2513120</div></div>]]> </content:encoded>
</item>

<item>
<title>Intraoperative use of Indocyanine Green Fluorescence Reduces Anastomotic Leaks during colorectal surgery: Study</title>
<link>https://edusehat.com/en/intraoperative-use-of-indocyanine-green-fluorescence-reduces-anastomotic-leaks-during-colorectal-surgery-study</link>
<guid>https://edusehat.com/en/intraoperative-use-of-indocyanine-green-fluorescence-reduces-anastomotic-leaks-during-colorectal-surgery-study</guid>
<description><![CDATA[ A recent systematic review and meta-analysis published in The Lancet Gastroenterology &amp; Hepatology found that intraoperative use of indocyanine green (ICG) fluorescence angiography during colorectal surgery is associated with a reduced risk of anastomotic leaks, particularly in rectal and left-sided resections. Surgical connection between two sections of the bowel could fail, which leads to leakage of intestinal contents. This complication can result in severe infection, prolonged hospitalization, and even death. Traditionally, surgeons rely on visual inspection and clinical judgment to assess blood flow to the bowel before completing the connection. However, ICGFA offers a more objective, real-time method by using fluorescent dye to visualize tissue perfusion intraoperatively.This research analyzed data exclusively from randomized controlled trials and included 9 trials involving a total of 4,754 patients undergoing colorectal resection with primary anastomosis. Databases such as PubMed, Embase, and the Cochrane Library were searched up to July 2025, following rigorous PRISMA guidelines.The patients whose surgeries incorporated the imaging technique experienced a 34% reduction in overall anastomotic leak rates when compared to those assessed with standard methods alone. The number needed to treat (NNT) revealed that for every 24 patients treated with ICGFA, one leak could be prevented.Further analysis showed that ICGFA reduced both severe leaks requiring intervention and less severe leaks not requiring additional procedures. The benefits were especially pronounced in left-sided colorectal surgeries, rectal resections, and low anterior resections, the procedures which were traditionally associated with higher leak risks. Here, the NNT dropped as low as 13, which indicated even greater clinical impact.This study found no significant benefit for right-sided resections. Also, a meta-regression analysis identified patient body mass index (BMI) as a key factor influencing outcomes. The protective effect of ICGFA increased with higher BMI, highlighting that patients with obesity may benefit most from the technology.Through trial sequential analysis, this study was confirmed to be robust with sufficient data to draw firm conclusions. Overall, this study suggest that the routine use of ICGFA in left-sided and rectal colorectal surgeries should now be strongly considered. Further research on proving benefit and more on optimizing implementation and identifying specific patient groups who stand to gain the most is needed.Source:Ryan, É. J., Ryan, O. K., Corrigan, N., Ainsworth, G., Hilling, D. E., Vahrmeijer, A. L., Kössi, J., Watanabe, J., Jayne, D., &amp; Cahill, R. A. (2026). Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analyses. The Lancet. Gastroenterology &amp; Hepatology. https://doi.org/10.1016/S2468-1253(25)00373-5 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/12/08/227313-colorectal-cancer.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Intraoperative, use, Indocyanine, Green, Fluorescence, Reduces, Anastomotic, Leaks, during, colorectal, surgery:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/12/08/227313-colorectal-cancer.webp"><p>A recent systematic review and meta-analysis published in <i>The Lancet Gastroenterology & Hepatology</i> found that intraoperative use of indocyanine green (ICG) fluorescence angiography during colorectal surgery is associated with a reduced risk of anastomotic leaks, particularly in rectal and left-sided resections. </p><p>Surgical connection between two sections of the bowel could fail, which leads to leakage of intestinal contents. This complication can result in severe infection, prolonged hospitalization, and even death. Traditionally, surgeons rely on visual inspection and clinical judgment to assess blood flow to the bowel before completing the connection. However, ICGFA offers a more objective, real-time method by using fluorescent dye to visualize tissue perfusion intraoperatively.</p><p>This research analyzed data exclusively from randomized controlled trials and included 9 trials involving a total of 4,754 patients undergoing colorectal resection with primary anastomosis. Databases such as PubMed, Embase, and the Cochrane Library were searched up to July 2025, following rigorous PRISMA guidelines.</p><p>The patients whose surgeries incorporated the imaging technique experienced a 34% reduction in overall anastomotic leak rates when compared to those assessed with standard methods alone. The number needed to treat (NNT) revealed that for every 24 patients treated with ICGFA, one leak could be prevented.</p><p>Further analysis showed that ICGFA reduced both severe leaks requiring intervention and less severe leaks not requiring additional procedures. The benefits were especially pronounced in left-sided colorectal surgeries, rectal resections, and low anterior resections, the procedures which were traditionally associated with higher leak risks. Here, the NNT dropped as low as 13, which indicated even greater clinical impact.</p><p>This study found no significant benefit for right-sided resections. Also, a meta-regression analysis identified patient body mass index (BMI) as a key factor influencing outcomes. The protective effect of ICGFA increased with higher BMI, highlighting that patients with obesity may benefit most from the technology.</p><p>Through trial sequential analysis, this study was confirmed to be robust with sufficient data to draw firm conclusions. Overall, this study suggest that the routine use of ICGFA in left-sided and rectal colorectal surgeries should now be strongly considered. Further research on proving benefit and more on optimizing implementation and identifying specific patient groups who stand to gain the most is needed.</p><p>Source:</p><p>Ryan, É. J., Ryan, O. K., Corrigan, N., Ainsworth, G., Hilling, D. E., Vahrmeijer, A. L., Kössi, J., Watanabe, J., Jayne, D., & Cahill, R. A. (2026). Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analyses. The Lancet. Gastroenterology & Hepatology. <a href="https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00373-5/abstract" rel="nofollow">https://doi.org/10.1016/S2468-1253(25)00373-5</a></p>]]> </content:encoded>
</item>

<item>
<title>Children with IBD may face higher risk of VTE: Study</title>
<link>https://edusehat.com/en/children-with-ibd-may-face-higher-risk-of-vte-study</link>
<guid>https://edusehat.com/en/children-with-ibd-may-face-higher-risk-of-vte-study</guid>
<description><![CDATA[ Children and adolescents with inflammatory bowel disease (IBD) have a significantly higher risk of developing venous thromboembolism (VTE), highlighting the need.The increased risk of venous thromboembolism (VTE) in adults with inflammatory bowel disease (IBD) is well known, but we know less about the VTE risk of IBD in children and teenagers. We evaluated the risk of VTE in children and teenagers through systematic review and meta-analysis. A systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science for studies from the establishment of these databases to February 10, 2026, to find relevant research on the risk of VTE in children and teenagers with IBD (PROSPERO, ID: CRD420251081653). Random-effects and fixed-effects models were used to estimate the relative risk (RR) and the corresponding 95% confidence interval (CI). The quality of the included studies was evaluated using the Newcastle-Ottawa Scale.Seven cohort studies were included in this systematic review, involving 101,253 children and teenagers with IBD and 19,651,587 non-IBD controls. Compared with non-IBD children and teenagers, the overall RR of VTE in children and teenagers with IBD was 6.94 (95% CI [1.87-25.69], P = 0.004). The risk of deep vein thrombosis (DVT) in children and teenagers with IBD was increased (RR = 6.25, 95% CI [1.13-34.69], P = 0.036); the risk of pulmonary thromboembolism (PE) in children and teenagers with IBD was also increased, but there was no statistically significant difference (RR = 3.13, 95% CI [0.96-10.19], P = 0.058). Children and teenagers with ulcerative colitis (UC) have a higher risk of VTE (RR = 7.53, 95% CI [2.97-19.10], P &lt; 0.001) than those with Crohn&#039;s disease (CD) (RR = 3.69, 95% CI [1.67-8.17], P = 0.001). The unadjusted VTE risk in children and teenagers with IBD (RR = 8.19, 95% CI [2.29-29.32], P = 0.001) was higher than the adjusted VTE risk for confounding factors (RR = 4.53, 95% CI [1.91-10.77], P = 0.001).Children and teenagers with IBD are at a significantly increased risk of developing VTE. Therefore, VTE prevention strategies should be emphasized in this population as well as in adults.Reference:Shen, Yuezhong, et al. &quot;Increased Risk of Venous Thromboembolism in Children and Teenagers With Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.&quot; PeerJ, vol. 14, 2026, pp. e21056.KeywordS:Children, IBD, face,  higher risk, VTE, Study, Shen, Yuezhong, PeerJ  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341140-images-2026-04-11t150703620.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Children, with, IBD, may, face, higher, risk, VTE:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341140-images-2026-04-11t150703620.webp"><p>Children and adolescents with inflammatory bowel disease (IBD) have a significantly higher risk of developing venous thromboembolism (VTE), highlighting the need.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The increased risk of venous thromboembolism (VTE) in adults with inflammatory bowel disease (IBD) is well known, but we know less about the VTE risk of IBD in children and teenagers. We evaluated the risk of VTE in children and teenagers through systematic review and meta-analysis. A systematic search was conducted in PubMed, Embase, Cochrane Library, Web of Science for studies from the establishment of these databases to February 10, 2026, to find relevant research on the risk of VTE in children and teenagers with IBD (PROSPERO, ID: CRD420251081653). Random-effects and fixed-effects models were used to estimate the relative risk (RR) and the corresponding 95% confidence interval (CI). The quality of the included studies was evaluated using the Newcastle-Ottawa Scale.</p><p dir="ltr">Seven cohort studies were included in this systematic review, involving 101,253 children and teenagers with IBD and 19,651,587 non-IBD controls. Compared with non-IBD children and teenagers, the overall RR of VTE in children and teenagers with IBD was 6.94 (95% CI [1.87-25.69], P = 0.004). The risk of deep vein thrombosis (DVT) in children and teenagers with IBD was increased (RR = 6.25, 95% CI [1.13-34.69], P = 0.036); the risk of pulmonary thromboembolism (PE) in children and teenagers with IBD was also increased, but there was no statistically significant difference (RR = 3.13, 95% CI [0.96-10.19], P = 0.058). Children and teenagers with ulcerative colitis (UC) have a higher risk of VTE (RR = 7.53, 95% CI [2.97-19.10], P < 0.001) than those with Crohn's disease (CD) (RR = 3.69, 95% CI [1.67-8.17], P = 0.001). The unadjusted VTE risk in children and teenagers with IBD (RR = 8.19, 95% CI [2.29-29.32], P = 0.001) was higher than the adjusted VTE risk for confounding factors (RR = 4.53, 95% CI [1.91-10.77], P = 0.001).</p><p dir="ltr">Children and teenagers with IBD are at a significantly increased risk of developing VTE. Therefore, VTE prevention strategies should be emphasized in this population as well as in adults.</p><p dir="ltr">Reference:</p><p dir="ltr">Shen, Yuezhong, et al. "Increased Risk of Venous Thromboembolism in Children and Teenagers With Inflammatory Bowel Disease: a Systematic Review and Meta-analysis." PeerJ, vol. 14, 2026, pp. e21056.</p><div><br></div><p dir="ltr">KeywordS:</p><p dir="ltr">Children, IBD, face,  higher risk, VTE, Study, Shen, Yuezhong, PeerJ </p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Study reports worsening of symptoms of obsessive&#45;compulsive disorders in premenstrual period</title>
<link>https://edusehat.com/en/study-reports-worsening-of-symptoms-of-obsessive-compulsive-disorders-in-premenstrual-period</link>
<guid>https://edusehat.com/en/study-reports-worsening-of-symptoms-of-obsessive-compulsive-disorders-in-premenstrual-period</guid>
<description><![CDATA[ Preliminary evidence suggests that obsessive-compulsive and related disorder (OCRD) symptoms fluctuate across the menstrual cycle, with consistent premenstrual worsening reported. However, significant research gaps remain, and longitudinal studies with reliable tools are needed to better understand the role of female sex hormones.Anecdotal evidence suggests that the menstrual cycle influences symptoms of Obsessive-Compulsive and Related Disorders (OCRD), although scientific literature investigating this effect is scarce. The premenstrual phase has been associated with the exacerbation of certain psychiatric conditions, with some reports showing premenstrual worsening of OCD. This scoping review aimed to systematically synthesize the evidence on the effect of the menstrual cycle on OCRD symptoms. Systematic searches were conducted on MEDLINE, EMBASE, APA PsycINFO, Cochrane Database of Systematic Reviews, and Web of Science for peer-reviewed studies investigating the menstrual cycle and OCRD. Data examining study methodology, participant demographics, OCRD symptoms, and menstrual cycles were extracted and analyzed.The systematic search identified 12 studies, where ten studies examined OCD symptoms across the menstrual cycle, one examined trichotillomania, and one examined both OCD and trichotillomania. Eight retrospective cross-sectional studies, one longitudinal study were included. Three case reports were identified but not included in the results. Symptom fluctuations were predominantly assessed through self-reports, except for the longitudinal study, which used the Yale-Brown Obsessive Compulsive Scale. In all the studies participants reported worsening OCRD symptoms during the premenstrual phase.Preliminary research suggests OCRD symptoms fluctuate across the menstrual cycle, with premenstrual worsening of OCRD being reported in all studies. Significant gaps exist in the literature emphasizing the need for longitudinal study designs and reliable instruments to improve reliability and clarify the potential relationship between female sex hormones and OCD symptoms.Reference:Juliette S. Mojgani, Anna M. Rzepka, Yejin Kang, Hashim Al-Bya, Beth Patterson, Michael Van Ameringen. The effect of the menstrual cycle on obsessive-compulsive and related disorders: A scoping review, Comprehensive Psychiatry, Volume 147,2026, 152696, ISSN 0010-440X, https://doi.org/10.1016/j.comppsych.2026.152696.(https://www.sciencedirect.com/science/article/pii/S0010440X26000350)Keywords:Study,  reports, worsening, symptoms, obsessive-compulsive, disorders , premenstrual, period, Menstrual cycle, Female sex hormones, Premenstrual exacerbations, Obsessive-compulsive disorders, Obsessive-compulsive disorder, Trichotillomania ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341130-images-2026-04-11t143933312.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 22:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, reports, worsening, symptoms, obsessive-compulsive, disorders, premenstrual, period</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341130-images-2026-04-11t143933312.webp"><p>Preliminary evidence suggests that obsessive-compulsive and related disorder (OCRD) symptoms fluctuate across the menstrual cycle, with consistent premenstrual worsening reported. However, significant research gaps remain, and longitudinal studies with reliable tools are needed to better understand the role of female sex hormones.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Anecdotal evidence suggests that the menstrual cycle influences symptoms of Obsessive-Compulsive and Related Disorders (OCRD), although scientific literature investigating this effect is scarce. The premenstrual phase has been associated with the exacerbation of certain psychiatric conditions, with some reports showing premenstrual worsening of OCD. This scoping review aimed to systematically synthesize the evidence on the effect of the menstrual cycle on OCRD symptoms. Systematic searches were conducted on MEDLINE, EMBASE, APA PsycINFO, Cochrane Database of Systematic Reviews, and Web of Science for peer-reviewed studies investigating the menstrual cycle and OCRD. Data examining study methodology, participant demographics, OCRD symptoms, and menstrual cycles were extracted and analyzed.</p><p dir="ltr">The systematic search identified 12 studies, where ten studies examined OCD symptoms across the menstrual cycle, one examined trichotillomania, and one examined both OCD and trichotillomania. Eight retrospective cross-sectional studies, one longitudinal study were included. Three case reports were identified but not included in the results. Symptom fluctuations were predominantly assessed through self-reports, except for the longitudinal study, which used the Yale-Brown Obsessive Compulsive Scale. In all the studies participants reported worsening OCRD symptoms during the premenstrual phase.</p><p dir="ltr">Preliminary research suggests OCRD symptoms fluctuate across the menstrual cycle, with premenstrual worsening of OCRD being reported in all studies. Significant gaps exist in the literature emphasizing the need for longitudinal study designs and reliable instruments to improve reliability and clarify the potential relationship between female sex hormones and OCD symptoms.</p><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Juliette S. Mojgani, Anna M. Rzepka, Yejin Kang, Hashim Al-Bya, Beth Patterson, Michael Van Ameringen. The effect of the menstrual cycle on obsessive-compulsive and related disorders: A scoping review, Comprehensive Psychiatry, Volume 147,</p><p dir="ltr">2026, 152696, ISSN 0010-440X, https://doi.org/10.1016/j.comppsych.2026.152696.</p><p dir="ltr">(https://www.sciencedirect.com/science/article/pii/S0010440X26000350)</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Study,  reports, worsening, symptoms, obsessive-compulsive, disorders , premenstrual, period, Menstrual cycle, Female sex hormones, Premenstrual exacerbations, Obsessive-compulsive disorders, Obsessive-compulsive disorder, Trichotillomania</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Punjab Health Minister warns of action as nurses continue indefinite strike</title>
<link>https://edusehat.com/en/punjab-health-minister-warns-of-action-as-nurses-continue-indefinite-strike</link>
<guid>https://edusehat.com/en/punjab-health-minister-warns-of-action-as-nurses-continue-indefinite-strike</guid>
<description><![CDATA[ Patiala: The nursing staff at three government medical colleges and hospitals in Punjab have been on an indefinite strike for the past 15 days. Health Minister Dr Balbir Singh on Thursday warned the striking nurses to resume their duties, failing which strict action would be taken.The nurses have been protesting against the state government&#039;s decision to invoke the &#039;Essential Services Maintenance Act&#039; (ESMA) and are demanding the restoration of the ₹4,600 grade pay.Also Read: Ludhiana doctor&#039;s plea: HC orders review of passports in multiple criminal casesThe Minister called the strike &#039;illegal&#039; and also said that the nurses would not be paid for the duration of the strike, as they had already violated ESMA. He also added that the nursing students had to be enlisted to ensure that patient care remained unaffected during the strike.“It had come to my notice that protesting nurses attempted to shut down an operating theatre (OT). If any patient dies because of such actions, an FIR will be registered. Around 5,000 nursing students who come to government hospitals for training will be deployed. They will work without remuneration. Patient care will not be affected at all”, he said, HT quoted.  The minister refuted the nursing staff&#039;s claims and stated that the students were qualified to care for patients. “These students are qualified and degree holders. They have already completed the General Nursing and Midwifery (GNM) course,” he added. This statement by the Minister came two days after the All-India Government Nurses Federation (AIGNF) wrote a letter to Union Health Minister JP Nadda.Meanwhile, terming the existing salary structure as discriminatory, the nurses&#039; organisation argued that it does not reflect the workload and responsibilities handled by the staff in tertiary care hospitals.This protest by regular nurses centres on a long-standing salary anomaly affecting nurses recruited on or after July 17, 2020. Union leaders claim that approximately 1,500 nurses are currently receiving a monthly salary of around ₹29,000 under a Grade Pay of ₹2,800. They are demanding an upgrade to a Grade Pay of ₹4,600, which would raise their monthly salary to approximately ₹44,900; additionally, they are seeking the reclassification of their posts from Grade C to Grade B.Also Read: Guru Gobind Singh medical college 2 MBBS students critically injured, elderly man killed in road accident ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341036-striking.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 19:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Punjab, Health, Minister, warns, action, nurses, continue, indefinite, strike</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341036-striking.webp"><p>Patiala: The nursing staff at three <a href="https://medicaldialogues.in/topics/government-medical-colleges" target="_blank">government medical colleges</a> and hospitals in Punjab have been on an indefinite strike for the past 15 days. Health Minister Dr Balbir Singh on Thursday warned the striking nurses to resume their duties, failing which strict action would be taken.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The nurses have been protesting against the state government's decision to invoke the 'Essential Services Maintenance Act' (<a href="https://medicaldialogues.in/topics/esma" target="_blank">ESMA</a>) and are demanding the restoration of the ₹4,600 grade pay.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ludhiana-doctors-plea-hc-orders-review-of-passports-in-multiple-criminal-cases-168411"><b>Also Read: </b>Ludhiana doctor's plea: HC orders review of passports in multiple criminal cases</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The Minister called the strike 'illegal' and also said that the nurses would not be paid for the duration of the strike, as they had already violated ESMA. He also added that the nursing students had to be enlisted to ensure that patient care remained unaffected during the strike.</p><p dir="ltr">“It had come to my notice that protesting nurses attempted to shut down an operating theatre (OT). If any patient dies because of such actions, an FIR will be registered. Around 5,000 nursing students who come to government hospitals for training will be deployed. They will work without remuneration. Patient care will not be affected at all”, he said, <a href="https://www.hindustantimes.com/cities/chandigarh-news/no-work-no-pay-for-striking-nurses-says-punjab-health-minister-101775762697178.html" target="_blank" rel="nofollow">HT </a>quoted.  </p><p dir="ltr">The minister refuted the nursing staff's claims and stated that the students were qualified to care for patients. “These students are qualified and degree holders. They have already completed the General Nursing and Midwifery (<a href="https://medicaldialogues.in/topics/gnm" target="_blank">GNM</a>) course,” he added. </p><p dir="ltr">This statement by the Minister came two days after the All-India Government Nurses Federation (AIGNF) wrote a letter to Union Health Minister JP Nadda.</p><p dir="ltr">Meanwhile, terming the existing salary structure as discriminatory, the nurses' organisation argued that it does not reflect the workload and responsibilities handled by the staff in tertiary care hospitals.</p><p dir="ltr">This protest by regular nurses centres on a long-standing salary anomaly affecting nurses recruited on or after July 17, 2020. Union leaders claim that approximately 1,500 nurses are currently receiving a monthly salary of around ₹29,000 under a Grade Pay of ₹2,800. They are demanding an upgrade to a Grade Pay of ₹4,600, which would raise their monthly salary to approximately ₹44,900; additionally, they are seeking the reclassification of their posts from Grade C to Grade B.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/punjab/guru-gobind-singh-medical-college-2-mbbs-students-critically-injured-elderly-man-killed-in-road-accident-168363"><b>Also Read: </b>Guru Gobind Singh medical college 2 MBBS students critically injured, elderly man killed in road accident</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Jind: Health and AYUSH Department clash over polyclinic space</title>
<link>https://edusehat.com/en/jind-health-and-ayush-department-clash-over-polyclinic-space</link>
<guid>https://edusehat.com/en/jind-health-and-ayush-department-clash-over-polyclinic-space</guid>
<description><![CDATA[ Jind: A dispute has emerged between the Health Department and the AYUSH Department in Jind over the use of space in the Sector-8 polyclinic, with both departments reportedly asserting competing needs for limited space.  The issue prompted a high-level inspection on Friday, when an AYUSH team visited the Civil Hospital to assess the situation and review existing arrangements, reports Amar Ujala. According to news reports, the inspection team included Additional Directors Vijender Hudda and Sushma Nain, along with Hisar District Ayurvedic Officer Dr. Dharampal Punia and officials Dr. Shashikant and Dr. Chandan Dua. During the visit, the team inspected both the Panchkarma centre operating from the polyclinic and the AYUSH OPD functioning in a separate building within the Civil Hospital premises.Also Read:Himachal HC slams State over infrastructure delays at AIMSS ChamianaThe dispute is centred on the Panchkarma centre, an Ayurvedic facility focused on detoxification and rejuvenation through specialized therapies, which is currently operating from rooms in the polyclinic under the Health Department. The Health Department has reportedly sought to have these rooms vacated to establish a Cath Lab, a move aimed at strengthening and expanding cardiac care services in the district. Officials believe that setting up the Cath lab is essential to improving access to advanced heart-related diagnosis and treatment. However, the AYUSH Department has opposed the move, citing the absence of adequate and suitable space within the Civil Hospital premises to relocate the Panchkarma facility without disrupting its services. Speaking on the issue, Additional Director Vijender Hudda stated that there is currently no sufficient space available to shift the centre. He clarified that until proper infrastructure and arrangements are in place, relocating the facility would not be feasible. He further added that the Panchkarma unit will continue to operate from the polyclinic for the time being, and that efforts are actively underway to identify and arrange an appropriate alternative location as early as possible.The situation has been further complicated by administrative issues following recent duty reallocations by the Civil Surgeon. As part of these changes, some Panchkarma staff members have been assigned duties at the Civil Hospital, while others continue to work at the centre. This division of staff has led to attendance discrepancies, gaps in coordination, and operational challenges at both locations, affecting overall efficiency and workflow management.Also Read:Maha: Gadchiroli district hospital lacks MRI machine, doctor expresses concern ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340999-health-ayush-in-dispute-over-space-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 19:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jind:, Health, and, AYUSH, Department, clash, over, polyclinic, space</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340999-health-ayush-in-dispute-over-space-1.webp"><div class="pasted-from-word-wrapper"><p>Jind: A dispute has emerged between the Health Department and the <a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a> Department in Jind over the use of space in the Sector-8 polyclinic, with both departments reportedly asserting competing needs for limited space.  </p><p>The issue prompted a high-level inspection on Friday, when an AYUSH team visited the Civil Hospital to assess the situation and review existing arrangements, reports<i><a href="https://www.amarujala.com/haryana/jind/turf-war-between-health-and-ayush-departments-over-building-jind-news-c-199-1-sroh1006-151405-2026-04-11" target="_blank"> Amar Ujala</a></i>. </p><p>According to news reports, the inspection team included Additional Directors Vijender Hudda and Sushma Nain, along with Hisar District Ayurvedic Officer Dr. Dharampal Punia and officials Dr. Shashikant and Dr. Chandan Dua. During the visit, the team inspected both the Panchkarma centre operating from the polyclinic and the AYUSH OPD functioning in a separate building within the Civil Hospital premises.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/himachal-hc-slams-state-over-infrastructure-delays-at-aimss-chamiana-162429">Also Read:Himachal HC slams State over infrastructure delays at AIMSS Chamiana</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>The dispute is centred on the Panchkarma centre, an Ayurvedic facility focused on detoxification and rejuvenation through specialized therapies, which is currently operating from rooms in the polyclinic under the Health Department. The Health Department has reportedly sought to have these rooms vacated to establish a Cath Lab, a move aimed at strengthening and expanding cardiac care services in the district. </p><p>Officials believe that setting up the Cath lab is essential to improving access to advanced heart-related diagnosis and treatment. However, the AYUSH Department has opposed the move, citing the absence of adequate and suitable space within the Civil Hospital premises to relocate the Panchkarma facility without disrupting its services. </p><p>Speaking on the issue, Additional Director Vijender Hudda stated that there is currently no sufficient space available to shift the centre. He clarified that until proper infrastructure and arrangements are in place, relocating the facility would not be feasible. He further added that the Panchkarma unit will continue to operate from the polyclinic for the time being, and that efforts are actively underway to identify and arrange an appropriate alternative location as early as possible.</p><p>The situation has been further complicated by administrative issues following recent duty reallocations by the Civil Surgeon. As part of these changes, some Panchkarma staff members have been assigned duties at the Civil Hospital, while others continue to work at the centre. This division of staff has led to attendance discrepancies, gaps in coordination, and operational challenges at both locations, affecting overall efficiency and workflow management.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/maha-gadchiroli-district-hospital-lacks-mri-machine-doctor-expresses-concern-107045">Also Read:Maha: Gadchiroli district hospital lacks MRI machine, doctor expresses concern</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Chhattisgarh to add 5 new medical colleges, MBBS seats to rise by 250</title>
<link>https://edusehat.com/en/chhattisgarh-to-add-5-new-medical-colleges-mbbs-seats-to-rise-by-250</link>
<guid>https://edusehat.com/en/chhattisgarh-to-add-5-new-medical-colleges-mbbs-seats-to-rise-by-250</guid>
<description><![CDATA[ Chhattisgarh: To provide new strength to health education in Chhattisgarh, the State Government has decided to establish five new medical colleges across the state. This initiative will also lead to a significant expansion in the number of seats available for medical education.These new medical colleges will be established in five districts, including Manendragarh, Kabirdham, Janjgir-Champa, Gidam (Dantewada), and Kunkuri (Jashpur). CM Sai himself shared this information on his X handle.Also Read: 265 of 443 Medical College Applications Approved by NMC, Government Informs ParliamentCM Sai took to his social media handle, &#039;X&#039;, and wrote to state that this initiative will not only train future physicians but also serve as a significant step toward ensuring improved healthcare facilities in every region of the state; simultaneously, it will bolster the availability of quality healthcare services at the local level. Following the establishment of five new medical colleges, the number of MBBS seats will increase. The number of seats is set to rise from 1,430 to 1,680. Additionally, the total number of medical colleges in the state will also increase from 10 to 15.According to the Zeenews media news report, there will be 50 MBBS seats in each college. As a result, the number of seats in Chhattisgarh&#039;s government medical colleges will increase by 250.Currently, there are 10 government medical colleges in the state, with a total of 1,430 MBBS seats available.This decision will benefit lakhs of medical students across the entire state. This step will ensure that students no longer have to look elsewhere in search of colleges. This initiative will provide convenience to students and promote the expansion of medical education within the state.Meanwhile, construction work is underway at the colleges currently being established across the state. The construction of the medical college buildings has already commenced.Additionally, 125 Assistant Professors are being recruited through the CG PSC, and the process of appointing faculty members for colleges is also underway.Also Read: NMC approved 265 of 443 medical college applications in 5 years, 43 in 2025-26: Govt tells Parliament ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340767-new-medical-college-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 19:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chhattisgarh, add, new, medical, colleges, MBBS, seats, rise, 250</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340767-new-medical-college-1.webp"><p><b>Chhattisgarh: </b>To provide new strength to health education in Chhattisgarh, the State Government has decided to establish five new medical colleges across the state. This initiative will also lead to a significant expansion in the number of seats available for medical education.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These new medical colleges will be established in five districts, including Manendragarh, Kabirdham, Janjgir-Champa, Gidam (Dantewada), and Kunkuri (Jashpur). CM Sai himself shared this information on his X handle.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/top-videos/265-of-443-medical-college-applications-approved-by-nmc-government-informs-parliament-167826"><b>Also Read: </b>265 of 443 Medical College Applications Approved by NMC, Government Informs Parliament</a></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p dir="ltr">CM Sai took to his social media handle, 'X', and wrote to state that this initiative will not only train future physicians but also serve as a significant step toward ensuring improved healthcare facilities in every region of the state; simultaneously, it will bolster the availability of quality healthcare services at the local level. </p><p dir="ltr">Following the establishment of five <a href="https://medicaldialogues.in/topics/new-medical-college" target="_blank">new medical colleges</a>, the number of MBBS seats will increase. The number of seats is set to rise from 1,430 to 1,680. Additionally, the total number of medical colleges in the state will also increase from 10 to 15.</p><p dir="ltr">According to the <a href="https://zeenews.india.com/hindi/india/chhattisgarh/cm-sai-announces-chhattisgarh-receives-5-new-medical-colleges-increasing-250-mbbs-seats-to-1680/3170838" target="_blank" rel="nofollow">Zeenews </a>media news report, there will be 50 MBBS seats in each college. As a result, the number of seats in Chhattisgarh's <a href="https://medicaldialogues.in/topics/government-medical-colleges" target="_blank">government medical colleges</a> will increase by 250.</p><p dir="ltr">Currently, there are 10 government medical colleges in the state, with a total of 1,430 <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>seats available.</p><p dir="ltr">This decision will benefit lakhs of medical students across the entire state. This step will ensure that students no longer have to look elsewhere in search of colleges. This initiative will provide convenience to students and promote the expansion of medical education within the state.</p><p dir="ltr">Meanwhile, construction work is underway at the colleges currently being established across the state. The construction of the medical college buildings has already commenced.</p><p dir="ltr">Additionally, 125 Assistant Professors are being recruited through the CG PSC, and the process of appointing faculty members for colleges is also underway.</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nmc-approved-265-of-443-medical-college-applications-in-5-years-43-in-2025-26-govt-tells-parliament-167765"><b>Also Read: </b>NMC approved 265 of 443 medical college applications in 5 years, 43 in 2025-26: Govt tells Parliament</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Maharashtra, AIIMS Nagpur ink MoU to address rising NCDs in Children</title>
<link>https://edusehat.com/en/maharashtra-aiims-nagpur-ink-mou-to-address-rising-ncds-in-children</link>
<guid>https://edusehat.com/en/maharashtra-aiims-nagpur-ink-mou-to-address-rising-ncds-in-children</guid>
<description><![CDATA[ Nagpur: To address the growing burden of non-communicable diseases (NCDs) among children, the Maharashtra government has inked a memorandum of understanding (MoU) with the All India Institute of Medical Sciences (AIIMS), Nagpur, according to an official statement.The initiative will see the state public health department and AIIMS Nagpur work jointly on the early identification, diagnosis, treatment and long-term management of childhood NCDs.Officials noted that the initiative will target conditions such as diabetes, asthma, congenital heart disorders, sickle cell disease, obesity and mental health issues, which are increasingly being reported among children in the state, news agency UNI reported.Also Read:AIIMS Nagpur awarded Full NABH AccreditationThe programme also aims to enhance the existing healthcare system by focusing on capacity building, training of medical personnel and improving access to essential healthcare services at the district level.  Authorities emphasised that the initiative will prioritise preventive healthcare and early intervention, highlighting that many diseases in adulthood stem from risk factors developed during childhood, including poor diet, sedentary habits and unhealthy lifestyles.The collaboration will also involve community-based outreach, awareness drives and data-led strategies to identify at-risk children and ensure timely medical support.Experts have flagged childhood NCDs as a rising public health concern in Maharashtra, underlining the need for coordinated efforts between government bodies and premier medical institutions to effectively tackle the issue. Medical Dialogues had earlier reported that the All India Institute of Medical Sciences (AIIMS) Patna has been recognised for securing the top position in service delivery, especially in Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY).Congratulating AIIMS for the achievement, Bihar Health Minister Mangal Pandey said that over 41.6 million cards issued in Bihar are ensuring timely, cashless care for millions. Highlighting the role of AIIMS Patna, he said the institution has become a symbol of trust for patients, delivering advanced medical care with empathy, efficiency, and accountability.  Also Read:AIIMS Nagpur inaugurates ART Centre, ID-NAT Lab and Blood Irradiator Unit ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340980-aiims-raipur-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 19:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Maharashtra, AIIMS, Nagpur, ink, MoU, address, rising, NCDs, Children</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340980-aiims-raipur-2.webp"><div class="pasted-from-word-wrapper"><p><span>Nagpur: To address the growing burden of non-communicable diseases (NCDs) among children, the Maharashtra government has inked a memorandum of understanding (MoU) with the All India Institute of Medical Sciences (AIIMS), Nagpur, according to an official statement.</span></p><p>The initiative will see the state public health department and <a href="https://medicaldialogues.in/topics/AIIMS-Nagpur" target="_blank">AIIMS Nagpur</a> work jointly on the early identification, diagnosis, treatment and long-term management of childhood NCDs.</p><p>Officials noted that the initiative will target conditions such as diabetes, asthma, congenital heart disorders, sickle cell disease, <a href="https://medicaldialogues.in/topics/obesity" target="_blank">obesity </a>and mental health issues, which are increasingly being reported among children in the state, news agency UNI reported.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-nagpur-awarded-full-nabh-accreditation-164753"><b>Also Read:AIIMS Nagpur awarded Full NABH Accreditation</b></a></p><p>The programme also aims to enhance the existing healthcare system by focusing on capacity building, training of medical personnel and improving access to essential healthcare services at the district level.  </p><p>Authorities emphasised that the initiative will prioritise preventive healthcare and early intervention, highlighting that many diseases in adulthood stem from risk factors developed during childhood, including poor diet, sedentary habits and unhealthy lifestyles.</p><p>The collaboration will also involve community-based outreach, awareness drives and data-led strategies to identify at-risk children and ensure timely medical support.</p><p>Experts have flagged childhood NCDs as a rising public health concern in Maharashtra, underlining the need for coordinated efforts between government bodies and premier medical institutions to effectively tackle the issue. </p><p>Medical Dialogues had earlier reported that the All India Institute of Medical Sciences (AIIMS) Patna has been recognised for securing the top position in service delivery, especially in Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY).</p><p>Congratulating AIIMS for the achievement, Bihar Health Minister Mangal Pandey said that over 41.6 million cards issued in Bihar are ensuring timely, cashless care for millions. Highlighting the role of AIIMS Patna, he said the institution has become a symbol of trust for patients, delivering advanced medical care with empathy, efficiency, and accountability.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-nagpur-inaugurates-art-centre-id-nat-lab-and-blood-irradiator-unit-158216"><b>Also Read:AIIMS Nagpur inaugurates ART Centre, ID-NAT Lab and Blood Irradiator Unit</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS INI CET July 2026 application process to end soon</title>
<link>https://edusehat.com/en/aiims-ini-cet-july-2026-application-process-to-end-soon</link>
<guid>https://edusehat.com/en/aiims-ini-cet-july-2026-application-process-to-end-soon</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS), New Delhi, is soon going to close the online application process for the Institute of National Importance Combined Entrance Test (INI CET) July for the 2026 session for admission to various postgraduate medical courses.According to the notice, the entrance examination will be conducted for admission to MD, MS, MCh (6 years), DM (6 years), MDS, and MD (Hospital Administration) courses across AIIMS New Delhi and other participating Institutes of National Importance, including JIPMER Puducherry, NIMHANS Bengaluru, PGIMER Chandigarh, and SCTIMST Thiruvananthapuram. The examination will be held in cities across India.Also Read: AIIMS INI CET January 2026 open round results declared, reporting deadline February 28thAs per the schedule provided in the notice, the last date to apply is April 25, 2026, till 5:00 PM. Meanwhile, the status of the registration &amp; correction window is April 30 to May 2, 2026, till 5:00 PM. Following this, the final status &amp; admit card will be released on May 9, 2026.To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/10/aiims-opens-ini-cet-july-2026-applications-deadline-april-25-340830.pdfAPPLICATION FEEThe application fee is Rs 4000/- (Rs 3200/- for SC/ST/EWS applicants). It can be paid online through Debit Card/ Credit Card/Net banking. Persons with Benchmark Disabilities are exempted from payment of Examination fees.Applicant must possess a recognised MBBS degree for admission to MD/ MS/ DM-6yrs/ MCh-6yrs/ MD (Hospital Administration), and BDS degree for admission to MDS courses, securing 50% marks in aggregate in case of SC/ST Categories and 55% marks in aggregate for all other categories. Earlier this month, Medical Dialogues had reported that the AIIMS, New Delhi, issued a Corrigendum introducing key changes to the eligibility criteria for the INI CET July 2026 session, specifically for PGIMER Chandigarh.Also Read: INI CET July 2026: AIIMS revises eligibility for MD Hospital administration course at PGIMER, check details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340832-ini-cet-july-2026.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 19:10:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, INI, CET, July, 2026, application, process, end, soon</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340832-ini-cet-july-2026.webp"><p><b>New Delhi: </b>The All India Institute of Medical Sciences (AIIMS), New Delhi, is soon going to close the online application process for the Institute of National Importance Combined Entrance Test (INI CET) July for the 2026 session for admission to various postgraduate medical courses.</p><div class="pasted-from-word-wrapper"><p dir="ltr">According to the notice, the entrance examination will be conducted for admission to MD, MS, MCh (6 years), DM (6 years), MDS, and MD (Hospital Administration) courses across AIIMS New Delhi and other participating Institutes of National Importance, including <a href="https://medicaldialogues.in/topics/jipmer" target="_blank">JIPMER </a>Puducherry, NIMHANS Bengaluru, PGIMER Chandigarh, and SCTIMST Thiruvananthapuram. </p><p dir="ltr">The examination will be held in cities across India.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/aiims-ini-cet-january-2026-open-round-results-declared-reporting-deadline-february-28th-165312"><b>Also Read: </b>AIIMS INI CET January 2026 open round results declared, reporting deadline February 28th</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">As per the schedule provided in the notice, the last date to apply is April 25, 2026, till 5:00 PM. Meanwhile, the status of the registration & correction window is April 30 to May 2, 2026, till 5:00 PM. Following this, the final status & admit card will be released on May 9, 2026.</p><p dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/10/aiims-opens-ini-cet-july-2026-applications-deadline-april-25-340830.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/10/aiims-opens-ini-cet-july-2026-applications-deadline-april-25-340830.pdf</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>APPLICATION FEE</u></b></p><p dir="ltr">The application fee is Rs 4000/- (Rs 3200/- for SC/ST/EWS applicants). It can be paid online through Debit Card/ Credit Card/Net banking. Persons with Benchmark Disabilities are exempted from payment of Examination fees.</p><p dir="ltr">Applicant must possess a recognised MBBS degree for admission to MD/ MS/ DM-6yrs/ MCh-6yrs/ MD (Hospital Administration), and BDS degree for admission to MDS courses, securing 50% marks in aggregate in case of SC/ST Categories and 55% marks in aggregate for all other categories. </p><p dir="ltr">Earlier this month, Medical Dialogues had reported that the <a href="https://medicaldialogues.in/topics/AIIMS">AIIMS</a>, New Delhi, issued a Corrigendum introducing key changes to the eligibility criteria for the <a href="https://medicaldialogues.in/topics/ini-cet-july-2026" target="_blank">INI CET July 2026</a> session, specifically for PGIMER Chandigarh.</p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/ini-cet-july-2026-aiims-revises-eligibility-for-md-hospital-administration-course-at-pgimer-check-details-167692"><b>Also Read: </b>INI CET July 2026: AIIMS revises eligibility for MD Hospital administration course at PGIMER, check details</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Mumbai: BMC to launch real&#45;time bed availability dashboard, streamline procurement</title>
<link>https://edusehat.com/en/mumbai-bmc-to-launch-real-time-bed-availability-dashboard-streamline-procurement</link>
<guid>https://edusehat.com/en/mumbai-bmc-to-launch-real-time-bed-availability-dashboard-streamline-procurement</guid>
<description><![CDATA[ Mumbai: The Brihanmumbai Municipal Corporation (BMC) is set to launch an online dashboard that will display bed availability across its hospitals in Maharashtra. The dashboard will include details of general beds, ICU beds, and 24/7 facilities, and is expected to be ready by next month. In addition, the BMC has decided to conduct all health-related procurements through the Government e-Marketplace portal. This step will enhance transparency in civic healthcare services and streamline the delivery of patient care.   Also Read: DMER Maharashtra releases selection list for winter 2025 super speciality bond service allotmentThe decisions were taken during a meeting held on Tuesday in the presence of Mumbai BJP President and MLA Amit Satam, Mayor Ritu Tawade, Health Committee Chairman Harish Bhandirge, and Additional Municipal Commissioner Vipin Sharma.  According to the Free Press Journal media news report, Satam stated that a decision has been taken to conduct all health-related procurement, including medicines and equipment available on the GeM portal, exclusively through that platform. This will ensure transparency and eliminate corruption.He also stated that, since the BMC will add a capacity of 2,000 more beds over the next few years, it is necessary to recruit both medical and support staff to ensure the full utilisation of these additional beds.  “It has also been decided that an online dashboard displaying real-time data on all available beds in BMC hospitals will be ready within one month. This will ensure that Mumbaikars have easy access to information on bed availability at their fingertips. It will also eliminate the need to run from pillar to post to find it,” Satam further added. Medical Dialogues had earlier reported that BMC-run Dr RN Cooper Hospital is set to appoint a new acting dean within the next week, marking the second such change in recent months. The decision comes in the wake of the assault on three duty doctors in the hospital’s casualty department.  Also Read: After harassment complaints, Maharashtra plans to shift private medical college admission process to govt institutes ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340871-bmc.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 15:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mumbai:, BMC, launch, real-time, bed, availability, dashboard, streamline, procurement</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340871-bmc.webp"><p><b>Mumbai: </b>The Brihanmumbai Municipal Corporation (<a href="https://medicaldialogues.in/topics/bmc" target="_blank">BMC) </a>is set to launch an online dashboard that will display bed availability across its hospitals in Maharashtra. The dashboard will include details of general beds, ICU beds, and 24/7 facilities, and is expected to be ready by next month. </p><div class="pasted-from-word-wrapper"><p dir="ltr">In addition, the BMC has decided to conduct all health-related procurements through the Government e-Marketplace portal. This step will enhance transparency in civic healthcare services and streamline the delivery of patient care.   </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/dmer-maharashtra-releases-selection-list-for-winter-2025-super-speciality-bond-service-allotment-168326"><b>Also Read: </b>DMER Maharashtra releases selection list for winter 2025 super speciality bond service allotment</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The decisions were taken during a meeting held on Tuesday in the presence of Mumbai BJP President and MLA Amit Satam, Mayor Ritu Tawade, Health Committee Chairman Harish Bhandirge, and Additional Municipal Commissioner Vipin Sharma.  <br></p><p dir="ltr">According to the <a href="https://www.freepressjournal.in/mumbai/mumbai-news-bmc-to-launch-real-time-hospital-bed-dashboard-shift-health-purchases-to-gem-portal-for-transparency" target="_blank" rel="nofollow">Free Press Journal </a>media news report, Satam stated that a decision has been taken to conduct all health-related procurement, including medicines and equipment available on the GeM portal, exclusively through that platform. This will ensure transparency and eliminate corruption.</p><p dir="ltr">He also stated that, since the BMC will add a capacity of 2,000 more beds over the next few years, it is necessary to recruit both medical and support staff to ensure the full utilisation of these additional beds.  </p><p dir="ltr">“It has also been decided that an online dashboard displaying real-time data on all available beds in BMC hospitals will be ready within one month. This will ensure that Mumbaikars have easy access to information on bed availability at their fingertips. It will also eliminate the need to run from pillar to post to find it,” Satam further added. </p><p dir="ltr">Medical Dialogues had earlier reported that BMC-run Dr RN <a href="https://medicaldialogues.in/topics/cooper-hospital" target="_blank">Cooper Hospital</a> is set to appoint a new acting dean within the next week, marking the second such change in recent months. The decision comes in the wake of the assault on three duty doctors in the hospital’s <a href="https://medicaldialogues.in/news/health/doctors/another-assault-at-ddu-hospital-leaves-doctor-security-staff-traumatised-158664">casualty department</a>.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/after-harassment-complaints-maharashtra-plans-to-shift-private-medical-college-admission-process-to-govt-institutes-168327"><b>Also Read: </b>After harassment complaints, Maharashtra plans to shift private medical college admission process to govt institutes</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>PGIMER reschedules 39th convocation to April 30</title>
<link>https://edusehat.com/en/pgimer-reschedules-39th-convocation-to-april-30</link>
<guid>https://edusehat.com/en/pgimer-reschedules-39th-convocation-to-april-30</guid>
<description><![CDATA[ Chandigarh: The Postgraduate Institute of Medical Education and Research (PGIMER) has rescheduled its upcoming 39th convocation ceremony to April 30, 2026, to be held at the Bhargava Auditorium of the institute.As per the official notice, candidates wishing to receive their degrees in person must attend a compulsory rehearsal scheduled for April 29, 2026, from 9:00 AM onwards in Bhargava Auditorium of
PGIMER, Chandigarh. All the candidates desirous of receiving the degrees in person, are
required to be present at the rehearsal and Convocation on the date, time and place
mentioned above. Those who do not attend the rehearsal will not be admitted to the
Convocation.The candidates are requested to confirm their attendance before 15th April,
2026 through google form link so that necessary arrangements are
made accordingly. While confirming participation, details of the acompanying person may
also be given.The recipients of degrees will attend the function in convocation dress. The
sash/stole will be available on hire basis on the day of rehearsal @ Rs.500/- at the counter in
Zakir Hall from 9:00 AM onwards.The entry of only one accompanying guest per candidate is allowed. Due
to space constraint the guest will be allowed entry in separate area where proceedings
of convocation will be televised.No mobile phone/personal camera hand bag or any electronic gadgets are allowed in the Auditorium.To view the full official notice, click the link mentioned below-https://medicaldialogues.in/pdf_upload/2026/04/11/notice-xxxix-convocation-2026-00110apr2026152649-341032.pdfThe Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, recently implemented comprehensive changes to its procurement process following a high-profile scam linked to the Ayushman Bharat scheme, where funds were allegedly misappropriated through the use of forged bills and records of deceased patients.The institute has decided to eliminate third-party vendors from the procurement chain for implants and medical consumables.Also Read: International Patients&#039; Union Conference 2026 brings patients, doctors, policymakers together for healthcare dialogueUnder the new system, all transactions related to surgeries and specialised treatments under cashless schemes will be conducted directly between the hospital and authorized manufacturers or in-house pharmacies, leaving no scope for private intermediaries to interact with the medical staff.Also Read:After Ayushman Bharat fraud, PGI Chandigarh revamps procurement system ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341035-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-67.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 15:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>PGIMER, reschedules, 39th, convocation, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341035-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-67.webp"><p><b>Chandigarh: </b>The Postgraduate Institute of Medical Education and Research (<a href="https://medicaldialogues.in/topics/PGIMER">PGIMER</a>) has rescheduled its upcoming 39th convocation ceremony to April 30, 2026, to be held at the Bhargava Auditorium of the institute.</p><p>As per the official notice, candidates wishing to receive their degrees in person must attend a compulsory rehearsal scheduled for April 29, 2026, <span>from 9:00 AM onwards in Bhargava Auditorium of
PGIMER, Chandigarh. All the candidates desirous of receiving the degrees in person, are
required to be present at the rehearsal and Convocation on the date, time and place
mentioned above. Those who do not attend the rehearsal will not be admitted to the
Convocation.</span></p><p><span>The candidates are requested to confirm their attendance before 15th April,
2026 through google form link so that necessary arrangements are
made accordingly. While confirming participation, details of the acompanying person may
also be given.</span></p><p><span>The recipients of degrees will attend the function in convocation dress. The
sash/stole will be available on hire basis on the day of rehearsal @ Rs.500/- at the counter in
Zakir Hall from 9:00 AM onwards.</span></p><p><span>The entry of only one accompanying guest per candidate is allowed. Due
to space constraint the guest will be allowed entry in separate area where proceedings
of convocation will be televised.</span><span></span></p><p>No mobile phone/personal camera hand bag or any electronic gadgets are allowed in the Auditorium.</p><p><b><i>To view the full official notice, click the link mentioned below-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/notice-xxxix-convocation-2026-00110apr2026152649-341032.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/11/notice-xxxix-convocation-2026-00110apr2026152649-341032.pdf</i></b></a></p><div class="pasted-from-word-wrapper"><p>The Postgraduate Institute of Medical Education and Research (<a href="https://medicaldialogues.in/topics/pgimer" target="_blank">PGIMER</a>), Chandigarh, recently implemented comprehensive changes to its procurement process following a high-profile scam linked to the Ayushman Bharat scheme, where funds were allegedly misappropriated through the use of forged bills and records of deceased patients.</p><div></div><div class="pasted-from-word-wrapper"><p dir="ltr">The institute has decided to eliminate third-party vendors from the procurement chain for implants and medical consumables.</p><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/international-patients-union-conference-2026-brings-patients-doctors-policymakers-together-for-healthcare-dialogue-167936">Also Read: International Patients' Union Conference 2026 brings patients, doctors, policymakers together for healthcare dialogue</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Under the new system, all transactions related to surgeries and specialised treatments under cashless schemes will be conducted directly between the hospital and authorized manufacturers or in-house pharmacies, leaving no scope for private intermediaries to interact with the medical staff.</p></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/after-ayushman-bharat-fraud-pgi-chandigarh-revamps-procurement-system-168065"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/04/06/339913-pgi-1.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/after-ayushman-bharat-fraud-pgi-chandigarh-revamps-procurement-system-168065"><span class="read-this-also">Also Read:</span>After Ayushman Bharat fraud, PGI Chandigarh revamps procurement system</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Gorakhpur AYUSH University to introduce two Health ATMs for diagnostic upgrade</title>
<link>https://edusehat.com/en/gorakhpur-ayush-university-to-introduce-two-health-atms-for-diagnostic-upgrade</link>
<guid>https://edusehat.com/en/gorakhpur-ayush-university-to-introduce-two-health-atms-for-diagnostic-upgrade</guid>
<description><![CDATA[ Gorakhpur: Mahayogi Guru Gorakhnath AYUSH University in Gorakhpur is set to install two Health ATMs soon, aiming to significantly upgrade its diagnostic facilities and provide patients with faster, automated health check-up services. The initiative is expected to improve patient convenience and reduce the burden on existing laboratory services within the campus, reports Dainik Bhaskar. According to university officials, the Health ATMs will be capable of conducting more than 60 health parameter tests in a single session. These include essential diagnostic indicators such as blood pressure, blood sugar levels, ECG, oxygen saturation, body mass index (BMI), body temperature, and pulse rate. The automated systems are designed to complete all tests within approximately 20 minutes, offering a quick and efficient alternative to conventional testing methods. Also Read: Gorakhpur AYUSH University Pharmacy expands production to supply Govt HospitalsOne of the key features of the system will be the digital delivery of reports. Once testing is completed, the results will be sent directly to patients via WhatsApp, eliminating the need for physical reports and reducing waiting time significantly. Authorities believe this will streamline patient flow and enhance overall efficiency in the hospital’s outpatient services. The university already operates a modern pathology-based diagnostic centre equipped with advanced medical equipment. In addition to the Health ATM installation, the institution is also planning to introduce HBA1C testing facilities in the near future. This will benefit diabetic patients by providing three-month average blood sugar reports, which are currently only available through external diagnostic laboratories.  Further expansion of diagnostic infrastructure is also underway, with ultrasound and X-ray machines being procured for the university. Officials have confirmed that recruitment processes for the required technical and support staff have already begun to ensure the smooth operation of the upcoming facilities. These developments will be implemented once final approval is granted by the state government.Authorities stated that the introduction of Health ATMs and additional diagnostic services will modernize patient care at the university, reduce dependency on external labs, and provide faster, more accessible healthcare services under one roof.Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH University ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340135-untitled-design-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 15:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gorakhpur, AYUSH, University, introduce, two, Health, ATMs, for, diagnostic, upgrade</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340135-untitled-design-3.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>Gorakhpur: Mahayogi Guru Gorakhnath<a href="https://medicaldialogues.in/topics/ayush%20university" target="_blank"> AYUSH University</a> in Gorakhpur is set to install two Health ATMs soon, aiming to significantly upgrade its diagnostic facilities and provide patients with faster, automated health check-up services. </p><p>The initiative is expected to improve patient convenience and reduce the burden on existing laboratory services within the campus, reports <i><a href="https://www.bhaskar.com/local/uttar-pradesh/gorakhpur/bhathat/news/ayush-university-health-atm-facility-gorakhnath-137655085.html" target="_blank">Dainik Bhaskar</a></i>. </p><p>According to university officials, the Health ATMs will be capable of conducting more than 60 health parameter tests in a single session. These include essential diagnostic indicators such as blood pressure, blood sugar levels, ECG, oxygen saturation, body mass index (BMI), body temperature, and pulse rate. </p><p>The automated systems are designed to complete all tests within approximately 20 minutes, offering a quick and efficient alternative to conventional testing methods. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/gorakhpur-ayush-university-pharmacy-expands-production-to-supply-govt-hospitals-168349">Also Read: Gorakhpur AYUSH University Pharmacy expands production to supply Govt Hospitals</a></p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p>One of the key features of the system will be the digital delivery of reports. Once testing is completed, the results will be sent directly to patients via WhatsApp, eliminating the need for physical reports and reducing waiting time significantly. Authorities believe this will streamline patient flow and enhance overall efficiency in the hospital’s outpatient services. </p><p>The university already operates a modern pathology-based diagnostic centre equipped with advanced medical equipment. In addition to the Health ATM installation, the institution is also planning to introduce HBA1C testing facilities in the near future. This will benefit diabetic patients by providing three-month average blood sugar reports, which are currently only available through external diagnostic laboratories.  </p><p>Further expansion of diagnostic infrastructure is also underway, with ultrasound and X-ray machines being procured for the university. Officials have confirmed that recruitment processes for the required technical and support staff have already begun to ensure the smooth operation of the upcoming facilities. These developments will be implemented once final approval is granted by the state government.</p><p>Authorities stated that the introduction of Health ATMs and additional diagnostic services will modernize patient care at the university, reduce dependency on external labs, and provide faster, more accessible healthcare services under one roof.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/medicine-distribution-delay-triggers-uproar-at-gorakhpur-ayush-university-168195">Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH University</a><div></div></div></div><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Foreign object inside patient during root canal, endoscopic procedure without consent&#45; TN Hospitals slapped Rs 7 lakh compensation</title>
<link>https://edusehat.com/en/foreign-object-inside-patient-during-root-canal-endoscopic-procedure-without-consent-tn-hospitals-slapped-rs-7-lakh-compensation</link>
<guid>https://edusehat.com/en/foreign-object-inside-patient-during-root-canal-endoscopic-procedure-without-consent-tn-hospitals-slapped-rs-7-lakh-compensation</guid>
<description><![CDATA[ Chennai: The District Consumer Disputes Redressal Commission, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh compensation to a city resident.According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.The matter goes back to August 2025, when the husband of the complainant underwent a root canal procedure. Allegedly, due to the failure in adhering to the standard safety protocols, including the non-use of a rubber dam, a sharp dental instrument slipped into the patient’s digestive tract during the procedure. Further, it was alleged that no informed consent was taken. A consumer court bench comprising President D. Gopinath and members Kavitha Kannan and TR Sivakumar observed that the complainant had established a clear case of negligence in treatment administered to her husband.&quot;The material on record substantiates that a foreign object entered the patient’s body during the procedure,&quot; observed the consumer court. &quot;The hospitals failed to rebut the allegations and are set ex parte,&quot; it further noted.Apart from this, the DCDRC further held that the medical intervention, including an endoscopic procedure, which was conducted at the second hospital lacked the required valid consent or adequate preparation. It was observed by the Commission that the acts of the hospitals amounted to gross deficiency in medical service under the Consumer Protection Act, 2019.Also Read: Surgery delay: WB medical council finds surgeon guilty of medical negligence, issues noticeAs per the latest media report by DT Next, the Commission invoked the legal principle of res ipsa loquitor and ruled that the very nature of the incident indicated negligence.Observing that the hospitals had failed to prove due care, the consumer court noted, &quot;The complainant’s version remains unchallenged and is accepted.&quot;Further, the Commission also took note of continued medical complications, mental trauma, and financial losses suffered by the patient, as well as the failure of the hospitals to furnish complete medical records despite repeated requests.Accordingly, the consumer panel allowed the complaint and directed the two institutions to jointly pay Rs 5 lakh as compensation for medical negligence and Rs 2 lakh as punitive damages. An additional Rs 10,000 was awarded to the complainant towards litigation costs.Apart from paying the compensation, the hospitals have also been directed to provide complete medical records, including consent forms and procedural details within 45 days.In its order, the Commission mentioned that the failure to comply within 60 days will attract 9% annual interest on the amount of compensation awarded to the complainant from the date of filing of the complaint. Also Read: Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/27/305772-197176-medical-negligence-13.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 15:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Foreign, object, inside, patient, during, root, canal, endoscopic, procedure, without, consent-, Hospitals, slapped, lakh, compensation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/27/305772-197176-medical-negligence-13.webp"><p><b>Chennai: </b>The <a href="https://medicaldialogues.in/topics/DCDRC">District Consumer Disputes Redressal Commission</a>, Chennai (North), recently held Saveetha Dental College Hospital and Saveetha Medical College Hospital guilty of medical negligence and deficiency in service and directed them to pay Rs 7 lakh <a href="https://medicaldialogues.in/topics/compensation">compensation</a> to a city resident.</p><p>According to DT Next report, the bench observed that a foreign object entered the body of the patient during a dental procedure, and the subsequent endoscopic procedure performed on the patient lacked valid consent.</p><p>The matter goes back to August 2025, when the husband of the complainant underwent a root canal procedure. Allegedly, due to the failure in adhering to the standard safety protocols, including the non-use of a rubber dam, a sharp dental instrument slipped into the patient’s digestive tract during the procedure. Further, it was alleged that no informed consent was taken. </p><p>A consumer court bench comprising President D. Gopinath and members Kavitha Kannan and TR Sivakumar observed that the complainant had established a clear case of negligence in treatment administered to her husband.</p><p>"The material on record substantiates that a foreign object entered the patient’s body during the procedure," observed the consumer court. "The hospitals failed to rebut the allegations and are set ex parte," it further noted.</p><p>Apart from this, the DCDRC further held that the medical intervention, including an endoscopic procedure, which was conducted at the second hospital lacked the required valid consent or adequate preparation. It was observed by the Commission that the acts of the hospitals amounted to gross deficiency in medical service under the <a href="https://medicaldialogues.in/topics/consumer-protection-Act">Consumer Protection Act, 2019</a>.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/surgery-delay-wb-medical-council-finds-surgeon-guilty-of-medical-negligence-167944"><b><i>Also Read: Surgery delay: WB medical council finds surgeon guilty of medical negligence, issues notice</i></b></a></p><p>As per the latest media report by <a href="https://www.dtnext.in/news/chennai/consumer-panel-holds-hospital-group-liable-for-negligence-awards-rs-7-lakh-compensation" rel="nofollow">DT Next</a>, the Commission invoked the legal principle of res ipsa loquitor and ruled that the very nature of the incident indicated negligence.</p><p>Observing that the hospitals had failed to prove due care, the consumer court noted, "The complainant’s version remains unchallenged and is accepted."</p><p>Further, the Commission also took note of continued medical complications, mental trauma, and financial losses suffered by the patient, as well as the failure of the hospitals to furnish complete medical records despite repeated requests.</p><p>Accordingly, the consumer panel allowed the complaint and directed the two institutions to jointly pay Rs 5 lakh as compensation for medical negligence and Rs 2 lakh as punitive damages. An additional Rs 10,000 was awarded to the complainant towards litigation costs.</p><p>Apart from paying the compensation, the hospitals have also been directed to provide complete medical records, including consent forms and procedural details within 45 days.</p><p>In its order, the Commission mentioned that the failure to comply within 60 days will attract 9% annual interest on the amount of compensation awarded to the complainant from the date of filing of the complaint. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/medico-legal/failure-to-conduct-pre-anaesthetic-check-up-is-gross-negligence-hc-refuses-relief-to-anaesthetist-booked-under-ipc-304a-168399"><b><i>Also Read: Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Rajasthan HC protects NEET PG admission of doctor on maternity leave</title>
<link>https://edusehat.com/en/rajasthan-hc-protects-neet-pg-admission-of-doctor-on-maternity-leave</link>
<guid>https://edusehat.com/en/rajasthan-hc-protects-neet-pg-admission-of-doctor-on-maternity-leave</guid>
<description><![CDATA[ Jaipur: Clarifying that a woman doctor is entitled to continue her sanctioned maternity leave, the Rajasthan High Court granted interim relief to a NEET PG candidate in her postnatal recovery phase, whose request for extension of the joining date for her Post MBBS Diploma in Ophthalmology was rejected by the State.Restraining the State from taking any coercive or adverse action against the petitioner, Single Bench Justice Anuroop Singhi allowed her to continue her officially sanctioned maternity leave, while permitting her to submit her joining before the allotted medical college, S.K. Medical College and Hospital.The bench also granted two weeks time to the State to file its reply and listed the matter for further hearing on April 29, 2026.Also read- NEET PG: Rajasthan HC relief to doctor denied admission over permanent registration certificateAs per Live Law report, the petitioner is currently posted as a Medical Officer in Sikar. She had cleared NEET-PG and was allotted a Post MBBS Diploma seat, for which she had already deposited the tuition fee and security amount.However, during this period, she gave birth and was granted maternity leave till July 19, 2026. Meanwhile, the State had fixed April 9, 2026, as the last date for joining, warning that failure to do so would lead to cancellation of the allotted seat.Since she was in the postnatal recovery phase, the doctor sought an extension of the joining deadline. The State rejected her request, following which she moved the High Court.Taking note of these circumstances, the Court granted two weeks’ time to the State to file its reply. In the meantime, it ensured protection to the petitioner by allowing her to retain both her admission and her maternity leave, making it clear that no adverse action should be taken against her.&quot;The petitioner was granted maternity leave for the period 21.01.2026 to 19.07.2026 .. issued by Chief Medical Officer, Kudan (Sikar), it is directed that while the petitioner may submit her joining before respondent No.5 – S.K. Medical College and Hospital for her Post MBBS Diploma of Ophthamology, she would be entitled to continue with her said maternity leave for the period already granted to her vide order dated 21.01.2026 and the respondents are restrained from taking any coercive or adverse action against the petitioner,&quot; said the court. To view the court order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/10/rhcorderjudgement08042026-666770-340876.pdfAlso read- NEET SS: Rajasthan HC scraps Rs 25 lakh bank guarantee rule for DM, MCh admissions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/16/265116-rajasthan-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 15:35:03 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Rajasthan, protects, NEET, admission, doctor, maternity, leave</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/16/265116-rajasthan-high-court.webp"><p><b>Jaipur: </b>Clarifying that a woman doctor is entitled to continue her sanctioned maternity leave, the <a href="https://medicaldialogues.in/topics/rajasthan-high-court" target="_blank">Rajasthan High Court</a> granted interim relief to a <a href="https://medicaldialogues.in/topics/neet-pg" target="_blank">NEET PG</a> candidate in her postnatal recovery phase, whose request for extension of the joining date for her Post MBBS Diploma in Ophthalmology was rejected by the State.</p><p>Restraining the State from taking any coercive or adverse action against the petitioner, Single Bench Justice Anuroop Singhi allowed her to continue her officially sanctioned maternity leave, while permitting her to submit her joining before the allotted medical college, S.K. Medical College and Hospital.</p><p>The bench also granted two weeks time to the State to file its reply and listed the matter for further hearing on April 29, 2026.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/neet-pg-rajasthan-hc-relief-to-doctor-denied-admission-over-permanent-registration-certificate-167955" target="_blank">NEET PG: Rajasthan HC relief to doctor denied admission over permanent registration certificate</a></b></p><p>As per<a href="https://www.livelaw.in/high-court/rajasthan-high-court/rajasthan-high-court-interim-relief-neetpg-doctor-maternity-leave-529753" target="_blank" rel="nofollow"> Live Law</a> report, the petitioner is currently posted as a Medical Officer in Sikar. She had cleared NEET-PG and was allotted a Post MBBS Diploma seat, for which she had already deposited the tuition fee and security amount.</p><p>However, during this period, she gave birth and was granted maternity leave till July 19, 2026. Meanwhile, the State had fixed April 9, 2026, as the last date for joining, warning that failure to do so would lead to cancellation of the allotted seat.</p><p>Since she was in the postnatal recovery phase, the doctor sought an extension of the joining deadline. The State rejected her request, following which she moved the High Court.</p><p>Taking note of these circumstances, the Court granted two weeks’ time to the State to file its reply. In the meantime, it ensured protection to the petitioner by allowing her to retain both her admission and her maternity leave, making it clear that no adverse action should be taken against her.</p><p><i>"The petitioner was granted maternity leave for the period 21.01.2026 to 19.07.2026 .. issued by Chief Medical Officer, Kudan (Sikar), it is directed that while the petitioner may submit her joining before respondent No.5 – S.K. Medical College and Hospital for her Post MBBS Diploma of Ophthamology, she would be entitled to continue with her said maternity leave for the period already granted to her vide order dated 21.01.2026 and the respondents are restrained from taking any coercive or adverse action against the petitioner,"</i> said the court. </p><p><b>To view the court order, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/10/rhcorderjudgement08042026-666770-340876.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/10/rhcorderjudgement08042026-666770-340876.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/education/neet-ss-rajasthan-hc-scraps-rs-25-lakh-bank-guarantee-rule-for-dm-mch-admissions-167677" target="_blank">NEET SS: Rajasthan HC scraps Rs 25 lakh bank guarantee rule for DM, MCh admissions</a></b></p>]]> </content:encoded>
</item>

<item>
<title>UT Health Secretary mandates display of service rates at clinical establishments</title>
<link>https://edusehat.com/en/ut-health-secretary-mandates-display-of-service-rates-at-clinical-establishments</link>
<guid>https://edusehat.com/en/ut-health-secretary-mandates-display-of-service-rates-at-clinical-establishments</guid>
<description><![CDATA[ Chandigarh: UT Health Secretary Mandeep Singh Brar, while presiding over a meeting of the Chandigarh Council for Clinical Establishments, issued directives to clinical institutions to display rates for various services in the local language and English.    The meeting was attended by the Director of AYUSH, the President of the Indian Medical Association (IMA), a representative of the Bharat Vikas Parishad, the Registrars of the Dental and Pharmacy Councils, and other members of the Chandigarh-based Clinical Establishments Council.      Also Read: Centre&#039;s law to regulate clinical establishments, Delhi HC lauds move  Brar further directed that the registration under the &#039;Clinical Establishments Act, 2010&#039; be made mandatory for all private and public healthcare facilities operating under any recognised system of medicine within the jurisdiction of the UT, including clinics, laboratories, diagnostic centres, hospitals, and nursing homes, reports The Daily.However, Dr Suman Singh, Director of Health and Family Welfare at the Government Multi-Specialty Hospital (GMSH-16), gave a detailed presentation on the status of the implementation of the Clinical Establishments (Registration and Regulation) Act, 2010.     According to the Tribune media news report, the &#039;Action Taken Report&#039; regarding the previous meeting held on September 5, 2025, was reviewed during the meeting.  Last year, Medical Dialogues had reported that to improve regulation, accountability, and quality standards across hospitals and clinics, the Telangana government had reconstituted the State Council for Clinical Establishments under the Clinical Establishments (Registration and Regulation) Act, 2010. Doctors have welcomed the move and praised the government for this step, but have urged more practical rules for small and medium-sized hospitals.    The council will be responsible for maintaining and updating the State Register of Clinical Establishments, submitting monthly reports to the National Register, and representing Telangana at the National Council.      Also Read: Telangana reconstitutes State Council for Clinical Establishments, doctors seek practical rules  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340823-vitamin.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 12:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Secretary, mandates, display, service, rates, clinical, establishments</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340823-vitamin.webp"><p><b>Chandigarh:</b> UT Health Secretary Mandeep Singh Brar, while presiding over a meeting of the Chandigarh Council for Clinical Establishments, issued directives to clinical institutions to display rates for various services in the local language and English.    </p><p>The meeting was attended by the Director of <a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a>, the President of the Indian Medical Association (IMA), a representative of the Bharat Vikas Parishad, the Registrars of the Dental and Pharmacy Councils, and other members of the Chandigarh-based Clinical Establishments Council.      </p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/centres-law-to-regulate-clinical-establishments-delhi-hc-lauds-move-126751"><b>Also Read: </b>Centre's law to regulate clinical establishments, Delhi HC lauds move</a>  </div><div class="pasted-from-word-wrapper"><p dir="ltr">Brar further directed that the registration under the 'Clinical Establishments Act, 2010' be made mandatory for all private and public healthcare facilities operating under any recognised system of medicine within the jurisdiction of the UT, including clinics, laboratories, diagnostic centres, hospitals, and nursing homes, reports The Daily.</p><p dir="ltr">However, Dr Suman Singh, Director of Health and Family Welfare at the Government Multi-Specialty Hospital (GMSH-16), gave a detailed presentation on the status of the implementation of the Clinical Establishments (Registration and Regulation) Act, 2010.     </p><p dir="ltr">According to the Tribune media news report, the 'Action Taken Report' regarding the previous meeting held on September 5, 2025, was reviewed during the meeting.  </p><p dir="ltr">Last year, Medical Dialogues had reported that to improve regulation, accountability, and quality standards across hospitals and clinics, the <a href="https://medicaldialogues.in/topics/telangana-government">Telangana government</a> had reconstituted the State Council for <a href="https://medicaldialogues.in/topics/clinical-establishments">Clinical Establishments</a> under the Clinical Establishments (Registration and Regulation) Act, 2010. Doctors have welcomed the move and praised the government for this step, but have urged more practical rules for small and medium-sized hospitals.    </p><p dir="ltr">The council will be responsible for maintaining and updating the State Register of Clinical Establishments, submitting monthly reports to the National Register, and representing Telangana at the National Council.      </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/telangana-reconstitutes-state-council-for-clinical-establishments-doctors-seek-practical-rules-158163"><b>Also Read: </b>Telangana reconstitutes State Council for Clinical Establishments, doctors seek practical rules</a> </p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>NMC revises rules for PDCC, post doctoral fellowship admissions in medical colleges</title>
<link>https://edusehat.com/en/nmc-revises-rules-for-pdcc-post-doctoral-fellowship-admissions-in-medical-colleges</link>
<guid>https://edusehat.com/en/nmc-revises-rules-for-pdcc-post-doctoral-fellowship-admissions-in-medical-colleges</guid>
<description><![CDATA[ New Delhi: The National Medical Commission (NMC) has revised the rules regarding admission of Post-Doctoral students in medical colleges.The National Medical Commission (NMC) has specified that a medical college can admit either one Post Doctoral Certificate Course (PDCC) student or one Post Doctoral Fellowship (PDF) student every year in a unit, and this will be over and above the already sanctioned or eligible seats in that unit.The commission further stated that in departments where a unit structure does not exist, medical colleges can still admit either one PDCC or one PDF student every year for every five sanctioned or eligible seats in that department.These conditions have been specified by the Postgraduate Medical Education Board (PGMEB) of the Commission in the recently released revised Post Graduate Medical Education Regulations (PGMSR) 2023. The Commission asked all medical colleges and institutions across the country to comply with the updated rules with immediate effect.Issuing a public notice on 11.03.2026, the PGMEB informed that the standards for running postgraduate medical courses have now been amended as of February 20, 2026. These norms define the minimum requirements that institutions must meet to start and run PG medical programmes in the country.The document included the mandatory requirements for a PG medical institute to start a PG medical course, the clinical material/investigation workload required for post-graduate, the ratio of eligible post-graduate faculty to the number of students, the number of minimum and maximum beds in a Unit, the faculty and senior resident requirements for the number of PG seats in different specialities, and the list of functional departments mandatory in a specific medical college etc.Earlier, the PGMSR 2023 regulations stated that one PDCC or PDF student could be admitted over and above the sanctioned or eligible seat in a unit. In departments without a unit structure, one additional seat could be permitted for every five sanctioned or eligible seats. If there is any vacancy, then the remaining number of PDCC or PDF candidates can be admitted. However, under the amended PGMSR 2023, the Commission has clarified, &quot;Either one Post-Doctoral Certificate Course (PDCC) or one Post-Doctoral Fellowship (PDF) student can be admitted every year over and above the sanctioned/eligible seat in a Unit. In a department where a unit structure is not there, either One Post-Doctoral Certificate Course (PDCC) or one Post-Doctoral Fellowship (PDF) student can be admitted every year, up to every five sanctioned/eligible seats.&quot;To view the PGMSR 2023 notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/03/16/nmc-minimum-standards-of-requirements-for-post-graduate-courses-2023-pgmsr-2023-amended-as-on-20022026-333173.pdfAlso read- NMC amends Minimum Standard Requirements for running PG medical courses, here are key takeaways ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/05/263639-admission.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 12:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, revises, rules, for, PDCC, post, doctoral, fellowship, admissions, medical, colleges</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/05/263639-admission.webp"><p><b>New Delhi:</b> The National Medical Commission (NMC) has revised the rules regarding admission of Post-Doctoral students in medical colleges.</p><p>The National Medical Commission (NMC) has specified that a medical college can admit either one <a href="https://medicaldialogues.in/topics/post-doctoral-certificate-courses" target="_blank">Post Doctoral Certificate Course</a> (PDCC) student or one <a href="https://medicaldialogues.in/topics/post-doctoral-fellowship" target="_blank">Post Doctoral Fellowship</a> (PDF) student every year in a unit, and this will be over and above the already sanctioned or eligible seats in that unit.</p><p>The commission further stated that in departments where a unit structure does not exist, medical colleges can still admit either one PDCC or one PDF student every year for every five sanctioned or eligible seats in that department.</p><p>These conditions have been specified by the Postgraduate Medical Education Board (PGMEB) of the Commission in the recently released revised Post Graduate Medical Education Regulations (PGMSR) 2023. The Commission asked all medical colleges and institutions across the country to comply with the updated rules with immediate effect.</p><p>Issuing a public notice on 11.03.2026, the PGMEB informed that the standards for running postgraduate medical courses have now been amended as of February 20, 2026. These norms define the minimum requirements that institutions must meet to start and run PG medical programmes in the country.</p><p>The document included the mandatory requirements for a PG medical institute to start a PG medical course, the clinical material/investigation workload required for post-graduate, the ratio of eligible post-graduate faculty to the number of students, the number of minimum and maximum beds in a Unit, the faculty and senior resident requirements for the number of PG seats in different specialities, and the list of functional departments mandatory in a specific medical college etc.</p><p>Earlier, the PGMSR 2023 regulations stated that one PDCC or PDF student could be admitted over and above the sanctioned or eligible seat in a unit. In departments without a unit structure, one additional seat could be permitted for every five sanctioned or eligible seats. If there is any vacancy, then the remaining number of PDCC or PDF candidates can be admitted. </p><p>However, under the amended PGMSR 2023, the Commission has clarified, <i>"Either one Post-Doctoral Certificate Course (PDCC) or one Post-Doctoral Fellowship (PDF) student can be admitted every year over and above the sanctioned/eligible seat in a Unit. In a department where a unit structure is not there, either One Post-Doctoral Certificate Course (PDCC) or one Post-Doctoral Fellowship (PDF) student can be admitted every year, up to every five sanctioned/eligible seats."</i></p><p><b>To view the PGMSR 2023 notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/03/16/nmc-minimum-standards-of-requirements-for-post-graduate-courses-2023-pgmsr-2023-amended-as-on-20022026-333173.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/03/16/nmc-minimum-standards-of-requirements-for-post-graduate-courses-2023-pgmsr-2023-amended-as-on-20022026-333173.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/health-news/nmc/nmc-amends-minimum-standard-requirements-for-running-pg-medical-courses-here-are-key-takeaways-166476" target="_blank">NMC amends Minimum Standard Requirements for running PG medical courses, here are key takeaways</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Pharmacies Deny Loose Tablets: Govt Mulls Exact Prescription Quantity Drug Dispensing, AIOCD Raises Concerns</title>
<link>https://edusehat.com/en/pharmacies-deny-loose-tablets-govt-mulls-exact-prescription-quantity-drug-dispensing-aiocd-raises-concerns</link>
<guid>https://edusehat.com/en/pharmacies-deny-loose-tablets-govt-mulls-exact-prescription-quantity-drug-dispensing-aiocd-raises-concerns</guid>
<description><![CDATA[ New Delhi: The All India Organisation of Chemists and Druggists Association (AIOCD) has raised concerns regarding the proposal on dispensing exact prescription quantities of strip-packed medicines placed before the Drugs Consultative Committee (DCC), stating that the measures could lead to operational challenges for pharmacies, financial losses, and potential risks related to drug safety and traceability.The issue came up during a recent DCC meeting, where the DCC was apprised about a public grievance received highlighting refusal of pharmacies to dispense cut/loose strips (e.g., 5 tablets when prescribed, but strips contain 10-15), forcing patients to buy excess and incur unnecessary costs (Rs. 5-100 per strip).DCC deliberated the matter and recommended referring the matter to the sub-committee already constituted in the 66th meeting of DCC dated 17.06.2025 to examine the matters of labelling.Responding to the above, the All India Organisation of Chemists and Druggists (AIOCD) has raised serious concerns over the proposal placed before the Drugs Consultative Committee (DCC) regarding the dispensing of exact prescription quantities of strip-packed medicines, cautioning that the move, in its current form, may lead to significant operational, financial, and regulatory challenges for pharmacies.In its representation submitted on behalf of the chemist fraternity, the AIOCD stated that pharmacists and chemists across the country remain fully committed to patient welfare and affordability and acknowledged that patients should not be compelled to purchase medicines beyond their prescribed requirement. However, the association emphasized that while the intent of the proposal is appreciated, several practical challenges need to be addressed before implementation.Also Read:Medicines Cannot Be Treated Like Agro-Chemicals: AIOCD Opposes PACS Drug Licence ProposalHowever, while supporting the intent of the proposal, the AIOCD addressed certain practical and regulatory challenges.1. Impact on Dispensation from Pharmacies: This may lead to operational, legal, and inventory management challenges at the retail level.2. Risk of Wastage of medicines that is a national loss and financial losses to the retailers:Dispensing loose tablets will inevitably result in unsold partial strips, which cannot be reused efficiently.These cut strips cannot be returned to stockists or manufacturers, leading to direct financial loss for chemists.Given that medicine prices and margins are already fixed by the Government, retailers operate on very limited margins and cannot absorb such losses.3. Consultation with stakeholders: -To the best of our knowledge, such a significant operational change has not been discussed in detail with trade bodies like the AIOCD prior to this proposal.Since chemists are the primary stakeholders responsible for implementation, it is essential that:Trade bodies are taken into confidence.Practical ground-level challenges are incorporated into policy decisions.4. Issue of Batch Number &amp; Expiry Visibility: One of the most critical concerns is related to drug safety and traceability.Cutting strips often results in loss of batch number and expiry date visibility.This creates serious issues in Patient safety Drug recall situations, and Complaint redressal.It also exposes chemists to legal and regulatory risks.Additionally:Patients must have access to batch and expiry details.Retaining unidentified loose tablets at the pharmacy is not compliant with good dispensing practices.5. Inventory &amp; Return ChallengesCut strips cannot be taken back by distributors or companies. Pharmacies cannot maintain unidentifiable or incomplete stock • There is currently no reverse supply chain mechanism for such partially used strips.6. Suggestions &amp; Way ForwardWhile supporting patient interest, AIOCD requested that the following measures be considered before implementing any such rule:1. Manufacturer-Level Intervention:Pharmaceutical companies should produce variable pack sizes aligned with common prescription durations.2. Mandatory Printing on Each Tablet/Blister:Ensure batch number and expiry date are printed more than one place one unit/blister segment3. Return Policy for Cut Strips:Companies/distributors should establish a mechanism to accept and compensate for unsold partial strips4. Revision of Trade MarginsGovernment may consider increasing minimum margins to offset operational losses arising from such practices5. Clear Legal &amp; Operational GuidelinesStandard Operating Procedures (SOPs) must be issued to ensure: Proper labelling Traceability AccountabilityOptional / Voluntary DispensingChemists cannot give medicine. Suo Moto must be allowed to dispense loose quantities where feasible, rather than making it mandatory.Concluding its representation, the AIOCD reiterated that while reducing patient burden is a welcome objective, the proposal in its present form may lead to unintended consequences. The association urged that any policy decision be taken only after detailed consultation with stakeholders, assuring its full cooperation in developing a balanced, practical, and patient-friendly solution.Also Read:Chemist Body Opposes DTAB Proposals on Drug Ads, Nicotine Gum OTC, Pushes for Regulated TradeTo view the official communication, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/11/dispensing-exact-prescription-quantities-of-strip-packed-medicines-341115.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/09/326373-medicine.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 04:50:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pharmacies, Deny, Loose, Tablets:, Govt, Mulls, Exact, Prescription, Quantity, Drug, Dispensing, AIOCD, Raises, Concerns</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/09/326373-medicine.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>The All India Organisation of Chemists and Druggists Association (AIOCD) has raised concerns regarding the proposal on dispensing exact prescription quantities of strip-packed medicines placed before the Drugs Consultative Committee (DCC), stating that the measures could lead to operational challenges for pharmacies, financial losses, and potential risks related to drug safety and traceability.</p></div><div class="pasted-from-word-wrapper"><p>The issue came up during a recent DCC meeting, where the DCC was apprised about a public grievance received highlighting refusal of pharmacies to dispense cut/loose strips (e.g., 5 tablets when prescribed, but strips contain 10-15), forcing patients to buy excess and incur unnecessary costs (Rs. 5-100 per strip).</p><p>DCC deliberated the matter and recommended referring the matter to the sub-committee already constituted in the 66th meeting of DCC dated 17.06.2025 to examine the matters of labelling.</p><p>Responding to the above, the All India Organisation of Chemists and Druggists (AIOCD) has raised serious concerns over the proposal placed before the Drugs Consultative Committee (DCC) regarding the dispensing of exact prescription quantities of strip-packed medicines, cautioning that the move, in its current form, may lead to significant operational, financial, and regulatory challenges for pharmacies.</p><p>In its representation submitted on behalf of the chemist fraternity, the AIOCD stated that pharmacists and chemists across the country remain fully committed to patient welfare and affordability and acknowledged that patients should not be compelled to purchase medicines beyond their prescribed requirement. However, the association emphasized that while the intent of the proposal is appreciated, several practical challenges need to be addressed before implementation.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/industry-perspective/medicines-cannot-be-treated-like-agro-chemicals-aiocd-opposes-pacs-drug-licence-proposal-166168">Also Read:Medicines Cannot Be Treated Like Agro-Chemicals: AIOCD Opposes PACS Drug Licence Proposal</a></div><p>However, while supporting the intent of the proposal, the AIOCD addressed certain practical and regulatory challenges.</p><p>1. Impact on Dispensation from Pharmacies: This may lead to operational, legal, and inventory management challenges at the retail level.</p><p>2. Risk of Wastage of medicines that is a national loss and financial losses to the retailers:</p><ul class="hocalwire-editor-list"><li>Dispensing loose tablets will inevitably result in unsold partial strips, which cannot be reused efficiently.</li><li>These cut strips cannot be returned to stockists or manufacturers, leading to direct financial loss for chemists.</li><li>Given that medicine prices and margins are already fixed by the Government, retailers operate on very limited margins and cannot absorb such losses.</li></ul><p>3. Consultation with stakeholders: -</p><p>To the best of our knowledge, such a significant operational change has not been discussed in detail with trade bodies like the AIOCD prior to this proposal.</p><p>Since chemists are the primary stakeholders responsible for implementation, it is essential that:</p><ul class="hocalwire-editor-list"><li>Trade bodies are taken into confidence.</li><li>Practical ground-level challenges are incorporated into policy decisions.</li></ul><p>4. Issue of Batch Number & Expiry Visibility:</p><ul class="hocalwire-editor-list"><li> One of the most critical concerns is related to drug safety and traceability.</li><li>Cutting strips often results in loss of batch number and expiry date visibility.</li><li>This creates serious issues in Patient safety Drug recall situations, and Complaint redressal.</li><li>It also exposes chemists to legal and regulatory risks.</li></ul><p>Additionally:</p><p>Patients must have access to batch and expiry details.</p><p>Retaining unidentified loose tablets at the pharmacy is not compliant with good dispensing practices.</p><p>5. Inventory & Return Challenges</p><p>Cut strips cannot be taken back by distributors or companies. Pharmacies cannot maintain unidentifiable or incomplete stock • There is currently no reverse supply chain mechanism for such partially used strips.</p><p>6. Suggestions & Way Forward</p><p>While supporting patient interest, AIOCD requested that the following measures be considered before implementing any such rule:</p><p>1. Manufacturer-Level Intervention:</p><p>Pharmaceutical companies should produce variable pack sizes aligned with common prescription durations.</p><p>2. Mandatory Printing on Each Tablet/Blister:</p><p>Ensure batch number and expiry date are printed more than one place one unit/blister segment</p><p>3. Return Policy for Cut Strips:</p><p>Companies/distributors should establish a mechanism to accept and compensate for unsold partial strips</p><p>4. Revision of Trade Margins</p><p>Government may consider increasing minimum margins to offset operational losses arising from such practices</p><p>5. Clear Legal & Operational Guidelines</p><p>Standard Operating Procedures (SOPs) must be issued to ensure:</p><ul class="hocalwire-editor-list"><li> Proper labelling</li><li> Traceability Accountability</li><li>Optional / Voluntary Dispensing</li><li>Chemists cannot give medicine. Suo Moto must be allowed to dispense loose quantities where feasible, rather than making it mandatory.</li></ul><p>Concluding its representation, the AIOCD reiterated that while reducing patient burden is a welcome objective, the proposal in its present form may lead to unintended consequences. The association urged that any policy decision be taken only after detailed consultation with stakeholders, assuring its full cooperation in developing a balanced, practical, and patient-friendly solution.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/industry-perspective/chemist-body-opposes-dtab-proposals-on-drug-ads-nicotine-gum-otc-pushes-for-regulated-trade-167956">Also Read:Chemist Body Opposes DTAB Proposals on Drug Ads, Nicotine Gum OTC, Pushes for Regulated Trade</a></div><p><b><i>To view the official communication, click the link below:</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/dispensing-exact-prescription-quantities-of-strip-packed-medicines-341115.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/11/dispensing-exact-prescription-quantities-of-strip-packed-medicines-341115.pdf</a></p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>China Approves Amgen&amp;apos;s Tarlatamab (Imdelltra) for Advanced Small Cell Lung Cancer</title>
<link>https://edusehat.com/en/china-approves-amgens-tarlatamab-imdelltra-for-advanced-small-cell-lung-cancer</link>
<guid>https://edusehat.com/en/china-approves-amgens-tarlatamab-imdelltra-for-advanced-small-cell-lung-cancer</guid>
<description><![CDATA[ Shanghai: Amgen&#039;s lung cancer drug tarlatamab has won approval from ​China&#039;s National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.The drug ​is a targeted immunotherapy ​for adults in the extensive-stage of ⁠hard-to-treat small cell lung cancer ​that has worsened despite chemotherapy.The ​U.S. drugmaker sells tarlatamab in its home market under the name Imdelltra. It is ​part of Amgen&#039;s pipeline of ​bispecific antibodies designed to attach to a ‌cancer ⁠cell and an immune cell, bringing them together so that the body&#039;s immune system can kill ​the cancer.Also Read: USFDA Raises Safety Alert on Amgen&#039;s Tavneos After Liver Injury, Death Cases SurfaceAmgen ​and Hong ⁠Kong-listed BeOne did not respond to requests for ​comment on launch date ​or ⁠pricing for the Chinese market.Some Wall Street analysts have said tarlatamab ⁠could represent ​an annual sales opportunity ​for Amgen of more than $2 billion. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/22/230681-amgen-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 01:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>China, Approves, Amgens, Tarlatamab, Imdelltra, for, Advanced, Small, Cell, Lung, Cancer</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/22/230681-amgen-50.webp"><p><b>Shanghai</b>: Amgen's lung cancer drug tarlatamab has won approval from ​China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.</p><div class="pasted-from-word-wrapper"><p>The drug ​is a targeted immunotherapy ​for adults in the extensive-stage of ⁠hard-to-treat small cell lung cancer ​that has worsened despite chemotherapy.</p><p>The ​U.S. drugmaker sells tarlatamab in its home market under the name Imdelltra. It is ​part of <a href="https://medicaldialogues.in/topics/Amgen" target="_blank">Amgen</a>'s pipeline of ​bispecific antibodies designed to attach to a ‌cancer ⁠cell and an immune cell, bringing them together so that the body's immune system can kill ​the cancer.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/usfda-raises-safety-alert-on-amgens-tavneos-after-liver-injury-death-cases-surface-167949">Also Read: USFDA Raises Safety Alert on Amgen's Tavneos After Liver Injury, Death Cases Surface</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Amgen ​and Hong ⁠Kong-listed BeOne did not respond to requests for ​comment on launch date ​or ⁠pricing for the Chinese market.</p><p>Some Wall Street analysts have said tarlatamab ⁠could represent ​an annual sales opportunity ​for Amgen of more than $2 billion.</p></div>]]> </content:encoded>
</item>

<item>
<title>USFDA Rejects Replimune&amp;apos;s RP1 for Advanced Melanoma, Flags Insufficient Data</title>
<link>https://edusehat.com/en/usfda-rejects-replimunes-rp1-for-advanced-melanoma-flags-insufficient-data</link>
<guid>https://edusehat.com/en/usfda-rejects-replimunes-rp1-for-advanced-melanoma-flags-insufficient-data</guid>
<description><![CDATA[ Bengaluru: The U.S. ​Food and Drug Administration ​on Friday declined to approve Replimune&#039;s drug for ​advanced skin cancer citing insufficient data from studies, a letter from the regulator showed.This marks the second consecutive setback ‌for Replimune, ⁠which was ⁠seeking approval for its drug RP1 to treat the ​most advanced form of the condition, dealing a blow to the ​drug developer&#039;s efforts to introduce its first marketed product.The U.S. regulator had also declined to approve ​the drug last year, citing issues ⁠in clinical ‌trials and inadequate evidence of effectiveness. Replimune&#039;s ​shares were ​halted in morning trading.Also Read: Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US MarketThe FDA&#039;s latest ⁠so-called complete response letter said that data from two studies were not strong enough to support approval of the treatment in combination with Bristol Myers Squibb&#039;s Opdivo for adults with advanced melanoma.Advanced melanoma is a serious form of skin cancer that rapidly spreads to other parts of ‌the body, making it harder to treat. The drug&#039;s previous rejection was during the ​tenure of ​the FDA&#039;s then biologics ⁠unit chief Vinay Prasad, who departed the agency for the second time in February following internal tussles. The recent ​high-profile dispute over the review of Moderna&#039;s influenza shot also unfolded when Prasad was at the agency.Replimune did not immediately respond to a Reuters request for comment.Also Read: FDA Approves dermal filler Radiesse for Wrinkles in neck and chest area Despite Imaging Concerns ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/11/13/260536-usfda.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 01:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>USFDA, Rejects, Replimunes, RP1, for, Advanced, Melanoma, Flags, Insufficient, Data</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/11/13/260536-usfda.webp"><p><b>Bengaluru:</b> The U.S. ​Food and Drug Administration ​on Friday declined to approve Replimune's <a href="https://medicaldialogues.in/topics/drug" target="_blank">drug</a> for ​advanced skin cancer citing insufficient data from studies, a letter from the regulator showed.</p><div class="pasted-from-word-wrapper"><p>This marks the second consecutive setback ‌for Replimune, ⁠which was ⁠seeking approval for its drug RP1 to treat the ​most advanced form of the condition, dealing a blow to the ​drug developer's efforts to introduce its first marketed product.</p><p>The U.S. regulator had also declined to approve ​the drug last year, citing issues ⁠in clinical ‌trials and inadequate evidence of effectiveness. Replimune's ​shares were ​halted in morning trading.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/glenmark-secures-usfda-nod-for-progesterone-vaginal-inserts-targets-usd-59-million-us-market-168408">Also Read: Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>The <a href="https://medicaldialogues.in/topics/fda" target="_blank">FDA</a>'s latest ⁠so-called complete response letter said that data from two studies were not strong enough to support approval of the treatment in combination with Bristol Myers Squibb's Opdivo for adults with advanced melanoma.</p><p>Advanced melanoma is a serious form of skin cancer that rapidly spreads to other parts of ‌the body, making it harder to treat. The drug's previous rejection was during the ​tenure of ​the FDA's then biologics ⁠unit chief Vinay Prasad, who departed the agency for the second time in February following internal tussles. The recent ​high-profile dispute over the review of Moderna's influenza shot also unfolded when Prasad was at the agency.</p><p>Replimune did not immediately respond to a Reuters request for comment.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/dermatology/news/fda-approves-dermal-filler-radiesse-for-wrinkles-in-neck-and-chest-area-despite-imaging-concerns-168371">Also Read: FDA Approves dermal filler Radiesse for Wrinkles in neck and chest area Despite Imaging Concerns</a></p></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>McKinsey to Pay USD 125 Million in Purdue Opioid Settlement Over OxyContin Sales Advice</title>
<link>https://edusehat.com/en/mckinsey-to-pay-usd-125-million-in-purdue-opioid-settlement-over-oxycontin-sales-advice</link>
<guid>https://edusehat.com/en/mckinsey-to-pay-usd-125-million-in-purdue-opioid-settlement-over-oxycontin-sales-advice</guid>
<description><![CDATA[ New York: Consulting firm McKinsey &amp; Co has ​agreed to contribute USD 125 million to Purdue Pharma&#039;s bankruptcy settlement, resolving potential legal ​claims over advice it provided to Purdue on how to &quot;turbocharge&quot; sales of its addictive painkiller OxyContin, according to a court filing submitted late Wednesday.Purdue, which received bankruptcy court approval of a $7.4 billion restructuring plan in November, will use ‌the money ⁠to pay creditors ⁠who accused the company of fueling the U.S. opioid epidemic through its aggressive sales tactics for OxyContin.The broader bankruptcy ​settlement had left open the possibility that Purdue could pursue legal claims against McKinsey over marketing advice that ​contributed to the company&#039;s downfall. McKinsey&#039;s contribution resolves those potential claims, without any admission of wrongdoing from the consulting firm.Purdue did not immediately respond to a request for comment. McKinsey declined to comment.Also Read: J&amp;J talc bankruptcy stays in Texas despite &#039;forum-shopping&#039; oppositionMcKinsey previously agreed to pay $1.6 billion in settlements with the U.S. Department ⁠of Justice, ‌states and local governments over its role in the opioid crisis.McKinsey, which ​ceased advising ​clients on opioid-related businesses in 2019, has previously said that it was &quot;deeply sorry&quot; ⁠for its advice on boosting opioid sales, and that its work for ​opioid manufacturers &quot;will always be a source of profound regret for our ​firm.&quot;The McKinsey settlement will add $50 million to the expected recovery for individuals harmed by the opioid crisis, a group that had been previously expected to get about $865 million, according to court documents.Most of the Purdue settlement money will go to states and local governments, which have agreed to use the money for opioid abatement efforts such as addiction treatment. Purdue&#039;s owners, members of ‌the Sackler family, are contributing at least $6.5 billion to fund the bankruptcy settlement.Purdue twice pleaded guilty to federal criminal charges of falsely marketing the drug, acknowledging ​it misled regulators, doctors ​and patients about addiction ⁠risks and engaged in illegal practices to boost opioid sales. The company is scheduled to be sentenced over its second guilty plea on April 21.Also Read: JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcyAfter the bankruptcy, Purdue will be converted into a nonprofit ​called Knoa Pharma, which will focus on developing and distributing opioid overdose reversal and addiction treatment medications.The settlement must be approved by a U.S. bankruptcy judge before it becomes final. Purdue will seek approval of the agreement at an April 30 court hearing in White Plains, New York.If the settlement is approved, McKinsey will pay $65 million next month and the remaining $60 million in 2027. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341040-mckinsey.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 01:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>McKinsey, Pay, USD, 125, Million, Purdue, Opioid, Settlement, Over, OxyContin, Sales, Advice</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341040-mckinsey.webp"><p><b>New York: </b>Consulting firm McKinsey & Co has ​agreed to contribute USD 125 million to Purdue Pharma's bankruptcy settlement, resolving potential legal ​claims over advice it provided to Purdue on how to "turbocharge" sales of its addictive painkiller OxyContin, according to a court filing submitted late Wednesday.</p><div class="pasted-from-word-wrapper"><p>Purdue, which received bankruptcy court approval of a $7.4 billion restructuring plan in November, will use ‌the money ⁠to pay creditors ⁠who accused the company of fueling the U.S. opioid epidemic through its aggressive sales tactics for OxyContin.</p><p>The broader bankruptcy ​settlement had left open the possibility that Purdue could pursue legal claims against McKinsey over marketing advice that ​contributed to the company's downfall. McKinsey's contribution resolves those potential claims, without any admission of wrongdoing from the consulting firm.</p><p>Purdue did not immediately respond to a request for comment. McKinsey declined to comment.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/jj-talc-bankruptcy-stays-in-texas-despite-forum-shopping-opposition-136293">Also Read: J&J talc bankruptcy stays in Texas despite 'forum-shopping' opposition</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>McKinsey previously agreed to pay $1.6 billion in settlements with the U.S. Department ⁠of Justice, ‌states and local governments over its role in the opioid crisis.</p><p>McKinsey, which ​ceased advising ​clients on opioid-related businesses in 2019, has previously said that it was "deeply sorry" ⁠for its advice on boosting opioid sales, and that its work for ​opioid manufacturers "will always be a source of profound regret for our ​firm."</p><p>The McKinsey settlement will add $50 million to the expected recovery for individuals harmed by the opioid crisis, a group that had been previously expected to get about $865 million, according to court documents.</p><p>Most of the Purdue settlement money will go to states and local governments, which have agreed to use the money for opioid abatement efforts such as addiction treatment. Purdue's owners, members of ‌the Sackler family, are contributing at least $6.5 billion to fund the bankruptcy settlement.</p><p>Purdue twice pleaded guilty to federal criminal charges of falsely marketing the drug, acknowledging ​it misled regulators, doctors ​and patients about addiction ⁠risks and engaged in illegal practices to boost opioid sales. The company is scheduled to be sentenced over its second guilty plea on April 21.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/jnj-faces-18-talc-cancer-trials-prompting-it-again-to-consider-bankruptcy-119399">Also Read: JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcy</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>After the bankruptcy, Purdue will be converted into a nonprofit ​called Knoa Pharma, which will focus on developing and distributing opioid overdose reversal and addiction treatment medications.</p><p>The settlement must be approved by a U.S. bankruptcy judge before it becomes final. Purdue will seek approval of the agreement at an April 30 court hearing in White Plains, New York.</p><p>If the settlement is approved, McKinsey will pay $65 million next month and the remaining $60 million in 2027.</p></div>]]> </content:encoded>
</item>

<item>
<title>Torrent Pharma Gets Zero USFDA Observations for Bileshwarpura Oncology Facility</title>
<link>https://edusehat.com/en/torrent-pharma-gets-zero-usfda-observations-for-bileshwarpura-oncology-facility</link>
<guid>https://edusehat.com/en/torrent-pharma-gets-zero-usfda-observations-for-bileshwarpura-oncology-facility</guid>
<description><![CDATA[ New Delhi: Torrent Pharmaceuticals Limited has successfully completed a USFDA inspection at its Bileshwarpura oncology manufacturing facility with zero observations, indicating full compliance with regulatory standards during the inspection conducted from April 6 to April 10, 2026.The inspection was carried out by the United States Food and Drug Administration (USFDA) at the company’s oncology-focused plant located in Bileshwarpura. The regulatory review concluded without any Form 483 observations, reflecting adherence to quality and manufacturing norms.The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the outcome of the inspection.Also Read: Torrent Pharma Completes JB Chemicals Acquisition, Becomes Promoter with 46.39% StakeA zero-observation outcome is considered a positive regulatory milestone for pharmaceutical manufacturers, as it demonstrates strong compliance with current Good Manufacturing Practices (cGMP) and strengthens the company’s standing in regulated markets such as the United States.The Bileshwarpura facility plays a key role in Torrent Pharma’s oncology portfolio, and the successful inspection is expected to support its ongoing and future business operations in global markets.Also Read: Torrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD Issue ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/11/197479-torrent-pharma-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 01:15:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Torrent, Pharma, Gets, Zero, USFDA, Observations, for, Bileshwarpura, Oncology, Facility</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/11/197479-torrent-pharma-3.webp"><p><b>New Delhi:</b> Torrent Pharmaceuticals Limited has successfully completed a USFDA inspection at its Bileshwarpura oncology manufacturing facility with zero observations, indicating full compliance with regulatory standards during the inspection conducted from April 6 to April 10, 2026.</p><div class="pasted-from-word-wrapper"><p>The inspection was carried out by the United States Food and Drug Administration (USFDA) at the company’s oncology-focused plant located in Bileshwarpura. The regulatory review concluded without any Form 483 observations, reflecting adherence to quality and manufacturing norms.</p><p>The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the outcome of the inspection.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/health-investments/torrent-pharma-completes-jb-chemicals-acquisition-becomes-promoter-with-4639-stake-163220">Also Read: Torrent Pharma Completes JB Chemicals Acquisition, Becomes Promoter with 46.39% Stake</a></div></div><p>A zero-observation outcome is considered a positive regulatory milestone for pharmaceutical manufacturers, as it demonstrates strong compliance with current Good Manufacturing Practices (cGMP) and strengthens the company’s standing in regulated markets such as the United States.</p><p>The Bileshwarpura facility plays a key role in Torrent Pharma’s oncology portfolio, and the successful inspection is expected to support its ongoing and future business operations in global markets.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/torrent-pharma-plans-rs-12500-cr-fund-raise-through-secured-ncd-issue-162094">Also Read: Torrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD Issue</a></p></div>]]> </content:encoded>
</item>

<item>
<title>WBJEE 2026 Correction Window Opens for BPharm Applicants, Edit Forms Till April 12</title>
<link>https://edusehat.com/en/wbjee-2026-correction-window-opens-for-bpharm-applicants-edit-forms-till-april-12</link>
<guid>https://edusehat.com/en/wbjee-2026-correction-window-opens-for-bpharm-applicants-edit-forms-till-april-12</guid>
<description><![CDATA[ New Delhi: The West Bengal Joint Entrance Examinations Board (WBJEEB) has opened the application correction window for WBJEE 2026, allowing candidates seeking admission to pharmacy courses (BPharm) to edit their submitted application forms until April 12 through the official website.Registered candidates can log in using their application number and password to make necessary corrections in their WBJEE 2026 application forms. The correction facility, which began on April 10, is a one-time opportunity and will close on April 12, after which no further changes will be permitted.The board has clarified that certain key personal details such as candidate’s name, parents’ names, domicile, and date of birth cannot be modified during the correction process. Applicants are advised to carefully review and update the editable fields before final submission.Also Read: B.Pharm Student Found Dead in Private College Hostel in AndhraWBJEE is a state-level entrance examination conducted for admission into undergraduate pharmacy programmes. Candidates appearing for Paper 2 (Physics and Chemistry) are eligible for BPharm courses.The WBJEE 2026 examination is scheduled to be held on May 24, with admit cards expected to be released on May 15. The exam will be conducted in two shifts, with Paper 2 covering subjects relevant for pharmacy aspirants, reports Careers360.Candidates are advised to utilise the correction window carefully, as no further opportunity for modification will be provided after the deadline.Also Read: GPAT 2026 Results Declared, General Cut-Off at 96.25 Percentile, NBEMS Releases Rank Details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/19/333846-admission.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 12 Apr 2026 01:15:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>WBJEE, 2026, Correction, Window, Opens, for, BPharm, Applicants, Edit, Forms, Till, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/19/333846-admission.webp"><p><b>New Delhi: </b>The West Bengal Joint Entrance Examinations Board (WBJEEB) has opened the application correction window for WBJEE 2026, allowing candidates seeking admission to pharmacy courses (BPharm) to edit their submitted application forms until April 12 through the official website.</p><div class="pasted-from-word-wrapper"><p>Registered candidates can log in using their application number and password to make necessary corrections in their WBJEE 2026 application forms. The correction facility, which began on April 10, is a one-time opportunity and will close on April 12, after which no further changes will be permitted.</p><p>The board has clarified that certain key personal details such as candidate’s name, parents’ names, domicile, and date of birth cannot be modified during the correction process. Applicants are advised to carefully review and update the editable fields before final submission.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/bpharm-student-found-dead-in-private-college-hostel-in-andhra-168409">Also Read: B.Pharm Student Found Dead in Private College Hostel in Andhra</a></div></div><p>WBJEE is a state-level entrance examination conducted for admission into undergraduate pharmacy programmes. Candidates appearing for Paper 2 (Physics and Chemistry) are eligible for BPharm courses.</p><p>The WBJEE 2026 examination is scheduled to be held on May 24, with admit cards expected to be released on May 15. The exam will be conducted in two shifts, with Paper 2 covering subjects relevant for pharmacy aspirants, reports <a href="https://news.careers360.com/wbjee-2026-application-correction-window-opens-for-btech-bpharm-edit-by-april-12-engineering-pharmacy-wbjeeb-nic-in" rel="nofollow">Careers360</a>.</p><p>Candidates are advised to utilise the correction window carefully, as no further opportunity for modification will be provided after the deadline.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/gpat-2026-results-declared-general-cut-off-at-9625-percentile-nbems-releases-rank-details-168325">Also Read: GPAT 2026 Results Declared, General Cut-Off at 96.25 Percentile, NBEMS Releases Rank Details</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 11/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-11april2026</link>
<guid>https://edusehat.com/en/health-bulletin-11april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:
FMGs Urge NMC for One-Time FMGL Exemption, Seek Prospective Application From 2022 BatchHighlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the National Medical Commission (NMC) to grant a one-time exemption from its strict applicability.In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.For more details, check out the full story on the link below:Grant one-time exemption from FMGL regulations, apply prospectively from 2022 batch: FMGs urge NMCSix Attempts for MBBS First Professional Exams, Ten-Year Course Limit; Suggests Parliamentary PanelPointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission.For more details, check out the full story on the link below:Parliamentary panel suggests 6 attempts to clear MBBS 1st professional exams, 10 years to complete courseKerala HC Rules Failure to Conduct Pre-Anaesthetic Check-Up Gross Negligence, Denies Relief to AnaesthetistObserving that failure to conduct a pre-anaesthetic check-up amounts to gross negligence, the Kerala High Court recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, &quot;...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner.&quot;For more details, check out the full story on the link below:Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304ATelangana Medical Council Bars Doctor for Two Years Over Fake MD Claim, Invalid RegistrationTaking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the Telangana Medical Council has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.For more details, check out the full story on the link below:Misrepresentation as MD Radiodiagnosis, no valid registration: Telangana medical council bars doctor for 2 years, censures another ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341063-health-bulletin-81.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 11April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341063-health-bulletin-81.webp"><p><b>Here are the top health stories for the day:
</b></p><p><b>FMGs Urge NMC for One-Time FMGL Exemption, Seek Prospective Application From 2022 Batch</b></p><div class="pasted-from-word-wrapper"><p>Highlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC) </a>to grant a one-time exemption from its strict applicability.</p><div></div><p>In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://admin.medicaldialogues.in/Grant%20one-time%20exemption%20from%20FMGL%20regulations,%20apply%20prospectively%20from%202022%20batch:%20FMGs%20urge%20NMC" target="_blank"><i><b>Grant one-time exemption from FMGL regulations, apply prospectively from 2022 batch: FMGs urge NMC</b></i></a></p></div><p><br></p><p><b>Six Attempts for MBBS First Professional Exams, Ten-Year Course Limit; Suggests Parliamentary Panel</b></p><div class="pasted-from-word-wrapper"><p>Pointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.</p><div></div><p>However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/parliamentary-panel-suggests-6-attempts-to-clear-mbbs-1st-professional-exams-10-years-to-complete-course-168295" target="_blank"><i><b>Parliamentary panel suggests 6 attempts to clear MBBS 1st professional exams, 10 years to complete course</b></i></a></p></div><p><br></p><p><b>Kerala HC Rules Failure to Conduct Pre-Anaesthetic Check-Up Gross Negligence, Denies Relief to Anaesthetist</b></p><div class="pasted-from-word-wrapper"><p>Observing that failure to conduct a pre-anaesthetic check-up amounts to gross <a href="https://medicaldialogues.in/topics/medical-negligence">negligence</a>, the <a href="https://medicaldialogues.in/topics/kerala-high-court">Kerala High Court</a> recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).</p><div></div><p>Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, <i>"...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner."</i></p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/failure-to-conduct-pre-anaesthetic-check-up-is-gross-negligence-hc-refuses-relief-to-anaesthetist-booked-under-ipc-304a-168399" target="_blank"><i><b>Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A</b></i></a></p></div><p><br></p><p><b>Telangana Medical Council Bars Doctor for Two Years Over Fake MD Claim, Invalid Registration</b></p><div class="pasted-from-word-wrapper"><p>Taking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the <a href="https://medicaldialogues.in/topics/telangana-medical-council" target="_blank">Telangana Medical Council </a>has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.</p><div></div><p>The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/doctors/misrepresentation-as-md-radiodiagnosis-no-valid-registration-telangana-medical-council-bars-doctor-for-2-years-censures-another-168369" target="_blank"><i><b>Misrepresentation as MD Radiodiagnosis, no valid registration: Telangana medical council bars doctor for 2 years, censures another</b></i></a></p></div>]]> </content:encoded>
</item>

<item>
<title>5 children die in Rajasthan&amp;apos;s Salumbar; viral encephalitis suspected</title>
<link>https://edusehat.com/en/5-children-die-in-rajasthans-salumbar-viral-encephalitis-suspected</link>
<guid>https://edusehat.com/en/5-children-die-in-rajasthans-salumbar-viral-encephalitis-suspected</guid>
<description><![CDATA[ Salumbar: In a tragic series of events, the deaths of five young children in Rajasthan’s Salumbar district have sparked fears of suspected viral encephalitis and prompted an intensive surveillance and outbreak control operation across affected villages. Over the past few days, five children from Ghata and Lalpura villages have reportedly died under what officials described as “mysterious circumstances.” The deceased include a 3-year-old and his younger brother from Lalpura, another 4-year-old from Lalpura, and two children aged 4 and 2 from Ghata village.Also Read:Karnataka issues guidelines for Sabarimala Pilgrims amid brain-eating amoeba casesSpeaking to the Indian Express, Salumbar District Collector Muhammad Junaid said that the deceased children had common symptoms, including vomiting, unconsciousness, and altered sensorium. “These point to some kind of encephalitis. In the opinion of the team from Udaipur Medical College, it is a suspected case of viral encephalitis. One suspicion is that it could be a variant, ‘Chandipura’ virus, although the final word is awaited from the National Institute of Virology (NIV), Pune, where the samples have been sent.”Family members said the children first developed fever and vomiting, after which they were taken to nearby health centres and then referred to larger hospitals in Dhariyawad, Pratapgarh, and Udaipur. In several cases, the children died while being shifted for treatment, reports NDTV Profit.
According to the news reports, one relative said a child fell ill on March 31 and died on April 1 during referral to Udaipur. Another child developed similar symptoms on April 5 and died en route to treatment. In another case, a child with sudden fever and vomiting died the same evening despite being shifted between hospitals. Officials noted that the remote location of the villages may have contributed to delays in receiving advanced care. They also said some families initially sought help from unauthorised practitioners, which may have affected outcomes.The deaths have created widespread panic across the region. In response, the district administration has launched a large-scale door-to-door survey and surveillance drive.
Hundreds of teams have combed through Ghata Gram Panchayat, which has three revenue villages — Ghata (2,504 persons/ 408 families), Lalpura (169 persons/ 29 families), and Karnagarh (667 persons/ 124 families) for a total of 561 families. Six schools, with 659 students, and three Anganwadis, with 144 children, have also been covered by the teams, which have collected various samples. Of the 561 families, 528 families have been surveyed, with 9 blood samples being collected on Wednesday, anti-larval activity being conducted at 51 places, and 20 samples being sent for analysis, reports the Indian Express.
The Medical and Health Department said outbreak control activities have been intensified across the seven districts of the Udaipur division, including Salumbar. According to official data, 6,167 field teams have surveyed over 1.2 lakh households across the division, identifying 1,470 symptomatic individuals. Of these, 924 patients were treated on the spot, while 85 were referred to higher medical facilities for advanced care. Public awareness campaigns have been conducted at over 13,000 locations, alongside anti-larval drives at more than 5,500 sites to curb potential mosquito-borne disease spread.
Also Read:Kerala reports 104 Amoebic meningoencephalitis cases, 23 deaths: Health Minister ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/02/22/275452-encephalitis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>children, die, Rajasthans, Salumbar, viral, encephalitis, suspected</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/02/22/275452-encephalitis.webp"><p><b>Salumbar: </b>In a tragic series of events, the deaths of five young children in <a href="https://medicaldialogues.in/state-news/rajasthan">Rajasthan’s</a> Salumbar district have sparked fears of suspected viral <a href="https://speciality.medicaldialogues.in/topics/encephalitis">encephalitis</a> and prompted an intensive<a href="https://medicaldialogues.in/topics/integrated-disease-surveillance-programme"> surveillance</a> and outbreak control operation across affected villages. </p><p>Over the past few days, five children from Ghata and Lalpura villages have reportedly died under what officials described as “mysterious circumstances.” The deceased include a 3-year-old and his younger brother from Lalpura, another 4-year-old from Lalpura, and two children aged 4 and 2 from Ghata village.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/karnataka/karnataka-issues-guidelines-for-sabarimala-pilgrims-amid-brain-eating-amoeba-cases-159103"><b>Also Read:Karnataka issues guidelines for Sabarimala Pilgrims amid brain-eating amoeba cases</b></a></p><p>Speaking to the<a href="https://indianexpress.com/article/india/5-children-dead-of-suspected-encephalitis-in-rajasthan-district-health-dept-on-alert-10626613/" rel="nofollow"> Indian Express</a>, Salumbar District Collector Muhammad Junaid said that the deceased children had common symptoms, including vomiting, unconsciousness, and altered sensorium. “These point to some kind of encephalitis. In the opinion of the team from Udaipur Medical College, it is a suspected case of viral encephalitis. One suspicion is that it could be a variant, ‘Chandipura’ virus, although the final word is awaited from the National Institute of Virology (NIV), Pune, where the samples have been sent.”</p><p>Family members said the children first developed fever and vomiting, after which they were taken to nearby health centres and then referred to larger hospitals in Dhariyawad, Pratapgarh, and Udaipur. In several cases, the children died while being shifted for treatment, reports <a href="https://www.ndtvprofit.com/india/5-children-die-of-suspected-encephalitis-in-rajasthan-health-teams-on-alert-11332900" rel="nofollow">NDTV Profit</a>.
</p><p>According to the news reports, one relative said a child fell ill on March 31 and died on April 1 during referral to Udaipur. Another child developed similar symptoms on April 5 and died en route to treatment. In another case, a child with sudden fever and vomiting died the same evening despite being shifted between hospitals. </p><p>Officials noted that the remote location of the villages may have contributed to delays in receiving advanced care. They also said some families initially sought help from unauthorised practitioners, which may have affected outcomes.</p><p>The deaths have created widespread panic across the region. In response, the district administration has launched a large-scale door-to-door survey and surveillance drive.
</p><p>Hundreds of teams have combed through Ghata Gram Panchayat, which has three revenue villages — Ghata (2,504 persons/ 408 families), Lalpura (169 persons/ 29 families), and Karnagarh (667 persons/ 124 families) for a total of 561 families. Six schools, with 659 students, and three Anganwadis, with 144 children, have also been covered by the teams, which have collected various samples. Of the 561 families, 528 families have been surveyed, with 9 blood samples being collected on Wednesday, anti-larval activity being conducted at 51 places, and 20 samples being sent for analysis, reports the Indian Express.
</p><p>The Medical and Health Department said outbreak control activities have been intensified across the seven districts of the Udaipur division, including Salumbar. According to official data, 6,167 field teams have surveyed over 1.2 lakh households across the division, identifying 1,470 symptomatic individuals. Of these, 924 patients were treated on the spot, while 85 were referred to higher medical facilities for advanced care. Public awareness campaigns have been conducted at over 13,000 locations, alongside anti-larval drives at more than 5,500 sites to curb potential mosquito-borne disease spread.
</p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/kerala/kerala-reports-104-amoebic-meningoencephalitis-cases-23-deaths-health-minister-156883">Also Read:Kerala reports 104 Amoebic meningoencephalitis cases, 23 deaths: Health Minister</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case</title>
<link>https://edusehat.com/en/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case</link>
<guid>https://edusehat.com/en/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case</guid>
<description><![CDATA[ New Delhi: While upholding the admission of a NEET UG candidate, the Supreme Court observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court&#039;s direction, the same decision was challenged before the Supreme Court.The concerned student appeared in the NEET UG exam in 2022 and secured 508 marks in the General Category. During the second round of counselling, which took place between 07.11.2022 and 18.11.2022, two other students were initially granted admission to Pt. Jawahar Lal Nehru Govt. Medical College and Indira Gandhi Medical College, Shimla, respectively.Subsequently, it was revealed that the scorecards of two candidates were forged, and therefore, their admission was cancelled since the documents submitted by them did not match the available information on the NMC portal. Consequently, one undergraduate MBBS seat became vacant in each of those two colleges.The concerned student submitted that before the commencement of the admission counselling process and the verification of relevant documents, the said fact was not detected, and it only came to light on January 17, 2023. Atal Medical &amp; Research University, Himachal Pradesh, on 17.01.2023, informed the NMC secretary that, as a consequence of admissions granted based on forged documents and the resultant action taken against the concerned students, one seat had fallen vacant in each of the two colleges. Accordingly, permission was sought to fill the said vacant seats at the earliest.After a considerable delay of approximately five months, NMC on 19.06.2023 conveyed that since the counselling schedule had already been notificated in accordance with the directions of the Supreme Court, no admission beyond the schedule date i.e., 29.12.2022, would be permissible for Under Graduate courses under any circumstances.Meanwhile, immediately after getting to know about such vacant seats, the concerned student submitted a representation to the medical college as well as to the University. Not getting any response, the student filed a plea on 28.01.2023 seeking direction to consider the admission for MBBS admission during the academic year 2022- 2023 on the said vacant post. Permission was further sought to allow the concerned student to join the additional classes. A prayer for being condoned for any shortage of attendance was also made.Relying on the judgment in the case of Asha v. Pt. B.D. Sharma University of Health Sciences and Others and also the judgment of S. Krishna Sradha v. State of Andhra Pradesh &amp; Others, the HC bench allowed the petition and issued directions to grant the petitioner student admission to Pt. Jawahar Lal Nehru Govt. Medical College, Chamba, Himachal Pradesh, during the academic year 2023-2024.Further, the Court had directed NMC and Atal Medical &amp; Research University to pay Rs 2 lakh compensation along with Rs 10,000 cost because of the delay caused, due to which the concerned student (petitioner before the HC) could not get admitted in the academic year 2022-2023.The High Court&#039;s order was challenged by the National Medical Commission (NMC) before the Supreme Court. The counsel for NMC relied on the Supreme Court&#039;s order dated 20.09.2021 in National Medical Commission v. Sourabh Kumar Jeengar &amp; Ors, contending that the admission as directed by the High Court cannot be allowed in the subsequent year by creating additional seats. It was also contended that once the schedule had been notified pursuant to the directions of the Apex Court dated 21.10.2022 in Ashish Ranjan v. Union of India &amp; Ors, as modified on 08.05.2023, the same could not be overlooked by giving admission to the student. It was further argued that, as held in the Ashish Ranjan (Supra) case, the NMC does not have the authority to permit the University/College for admission as directed. It was also urged that on receiving the letter dated 17.01.2023, oral communications were made to the University with respect to the intent as communicated in the letter by them on 19.06.2023, and therefore, there was no delay in such communication.Meanwhile, the counsel for the student urged with vehemence that if a seat is occupied by an ineligible candidate, prioritizing by playing fraud upon the authorities, though allegedly above in merit, would not defeat her right of admission since she is the next meritorious candidate in the merit list being wait listed. It was also suggested that the process of document verification of the candidate who could get admission in second counselling ought to have been made immediately, and if such exercise was not done with promptness, as is the case in hand, next candidate i.e. the concerned student, placed in the merit list should be offered admission sustaining her merit.Observations by the Supreme Court: Taking note of the submissions, the Supreme Court bench observed that the High Court rightly analysed the entirety of facts and circumstances and found that the University as well as NMC, remained silent and allowed those seats to go vacant.&quot;Therefore, the ratio of the judgment of Asha as well as S. Krishna Sradha is rightly made applicable and the direction is issued to grant admission to Respondent No.1 student in Respondent No. 6-College in the MBBS course for the academic year 2022-2023 by creating one additional seat in the next year 2023-2024. In the peculiar facts and circumstances of the case which have been brought before us, the direction as issued by the High Court is completely justified and because of the said peculiarity, will not be in teeth of the schedule as prescribed by this Court in Ashish Ranjan (Supra),&quot; observed the Apex Court.Highlighting how medical seats in government institutes are a national resource, the bench observed that if such a seat remains vacant, the authorities must allot the same to the next eligible candidate.&quot;It cannot be sufficiently underscored that a medical seat in a Government Institution is not merely an individual gain for a private candidate, but is also a precious resource for our nation that is held in public trust by the regulatory authorities. In an eventuality, when such a seat is rendered vacant through fraud, an obligation is cast upon the authorities to restore that seat to the next eligible candidate as per the merit list,&quot; noted the Apex Court.&quot;To allow a seat to remain wasted due to administrative inaction or lethargy, is a subversion of the very purpose of the NEET-UG examination that was to facilitate systematic organization of admissions in government medical institutions,&quot; it further observed. Addressing NMC&#039;s contention regarding adherence to the schedule fixed by the court in Ashish Ranjan (Supra), the top court bench observed, &quot;it must be borne in mind of the authorities that the said schedule is a servant of the admission process, provided by this Court to facilitate the timely induction of doctors without delay, not a master that can lead to sacrifice of a meritorious student’s career, that too without having any fault of such candidate. In this regard, we are guided by the principle enunciated in S. Krishna Sradha (Supra) that in exceptional cases where a candidate has been prompt in approaching authorities and delay is entirely attributable to the failure of the authorities to detect fraud, irregularity or respond to queries, as is the situation in present case, equity requires that admission be granted to such a candidate in next academic year possible.&quot;Accordingly, the bench held that the High Court&#039;s order was justified. It noted, &quot;In view of the foregoing, we are of the considered opinion that the High Court was completely justified and in fact, because of the vexatious litigation of Appellant, the matter has been stalled before this Court for more than three years. Nonetheless, since we have arrived at a conclusion that the order passed by the High Court is justified, in exercise of jurisdiction under Article 142 of the Constitution of India, we modify the direction as issued by the High Court for grant of admission for the year 2026-2027 instead of 2023-2024 while not interfering with other terms and conditions as directed by the High Court.&quot;To view the order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/07/supreme-court-neet-seats-340190.pdfAlso Read: HC comes to rescue of MBBS candidate denied admission, NMC, University told to pay Rs 4 lakh compensation ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/13/304308-supreme-court-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, seats, are, national, resource, cannot, left, vacant:, Supreme, Court, NEET, fraud, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/13/304308-supreme-court-1.webp"><p><b>New Delhi: </b>While upholding the admission of a <a href="https://medicaldialogues.in/topics/NEET-UG">NEET UG</a> candidate, the <a href="https://medicaldialogues.in/topics/Supreme-Court">Supreme Court</a> observed that medical seats in government medical institutes are a precious resource, and if such a seat becomes vacant, it is the responsibility of the authorities to allot the same to the next eligible candidates.</p><p>The Apex Court bench comprising Justices J.K.Maheshwari and Atul S. Chandurkar made this observation while considering a case where two seats in two medical colleges in Himachal Pradesh had become vacant because the students had submitted forged mark sheets. When one of those seats was granted to a student who appealed, based on the High Court's direction, the same decision was challenged before the Supreme Court.</p><p><span>The concerned student appeared in the NEET UG exam in 2022 and secured 508 marks in the General Category. During the second round of counselling, which took place between 07.11.2022 and 18.11.2022, two other students were initially granted admission to Pt. Jawahar Lal Nehru Govt. Medical College and Indira Gandhi Medical College, Shimla, respectively.</span></p><p>Subsequently, it was revealed that the scorecards of two candidates were forged, and therefore, their admission was cancelled since the documents submitted by them did not match the available information on the <a href="https://medicaldialogues.in/topics/NMC">NMC</a> portal. Consequently, one undergraduate MBBS seat became vacant in each of those two colleges.</p><p>The concerned student submitted that before the commencement of the admission counselling process and the verification of relevant documents, the said fact was not detected, and it only came to light on January 17, 2023. </p><p>Atal Medical & Research University, Himachal Pradesh, on 17.01.2023, informed the NMC secretary that, as a consequence of admissions granted based on forged documents and the resultant action taken against the concerned students, one seat had fallen vacant in each of the two colleges. Accordingly, permission was sought to fill the said vacant seats at the earliest.</p><p>After a considerable delay of approximately five months, NMC on 19.06.2023 conveyed that since the counselling schedule had already been notificated in accordance with the directions of the Supreme Court, no admission beyond the schedule date i.e., 29.12.2022, would be permissible for Under Graduate courses under any circumstances.</p><p>Meanwhile, immediately after getting to know about such vacant seats, the concerned student submitted a representation to the medical college as well as to the University. Not getting any response, the student filed a plea on 28.01.2023 seeking direction to consider the admission for MBBS admission during the academic year 2022- 2023 on the said vacant post. Permission was further sought to allow the concerned student to join the additional classes. A prayer for being condoned for any shortage of attendance was also made.</p><p>Relying on the judgment in the case of Asha v. Pt. B.D. Sharma University of Health Sciences and Others and also the judgment of S. Krishna Sradha v. State of Andhra Pradesh & Others, the HC bench allowed the petition and issued directions to grant the petitioner student admission to Pt. Jawahar Lal Nehru Govt. Medical College, Chamba, Himachal Pradesh, during the academic year 2023-2024.</p><p>Further, the Court had directed NMC and Atal Medical & Research University to pay Rs 2 lakh compensation along with Rs 10,000 cost because of the delay caused, due to which the concerned student (petitioner before the HC) could not get admitted in the academic year 2022-2023.</p><p>The High Court's order was challenged by the National Medical Commission (NMC) before the Supreme Court. The counsel for NMC relied on the Supreme Court's order dated 20.09.2021 in National Medical Commission v. Sourabh Kumar Jeengar & Ors, contending that the admission as directed by the High Court cannot be allowed in the subsequent year by creating additional seats. It was also contended that once the schedule had been notified pursuant to the directions of the Apex Court dated 21.10.2022 in Ashish Ranjan v. Union of India & Ors, as modified on 08.05.2023, the same could not be overlooked by giving admission to the student. </p><p>It was further argued that, as held in the Ashish Ranjan (Supra) case, the NMC does not have the authority to permit the University/College for admission as directed. It was also urged that on receiving the letter dated 17.01.2023, oral communications were made to the University with respect to the intent as communicated in the letter by them on 19.06.2023, and therefore, there was no delay in such communication.</p><p>Meanwhile, the counsel for the student urged with vehemence that if a seat is occupied by an ineligible candidate, prioritizing by playing fraud upon the authorities, though allegedly above in merit, would not defeat her right of admission since she is the next meritorious candidate in the merit list being wait listed. It was also suggested that the process of document verification of the candidate who could get admission in second counselling ought to have been made immediately, and if such exercise was not done with promptness, as is the case in hand, next candidate i.e. the concerned student, placed in the merit list should be offered admission sustaining her merit.</p><p><b>Observations by the Supreme Court:</b> </p><p>Taking note of the submissions, the Supreme Court bench observed that the High Court rightly analysed the entirety of facts and circumstances and found that the University as well as NMC, remained silent and allowed those seats to go vacant.</p><p><i>"Therefore, the ratio of the judgment of Asha as well as S. Krishna Sradha is rightly made applicable and the direction is issued to grant admission to Respondent No.1 student in Respondent No. 6-College in the MBBS course for the academic year 2022-2023 by creating one additional seat in the next year 2023-2024. In the peculiar facts and circumstances of the case which have been brought before us, the direction as issued by the High Court is completely justified and because of the said peculiarity, will not be in teeth of the schedule as prescribed by this Court in Ashish Ranjan (Supra),"</i> observed the Apex Court.</p><p>Highlighting how medical seats in government institutes are a national resource, the bench observed that if such a seat remains vacant, the authorities must allot the same to the next eligible candidate.</p><blockquote><i>"It cannot be sufficiently underscored that a medical seat in a Government Institution is not merely an individual gain for a private candidate, but is also a precious resource for our nation that is held in public trust by the regulatory authorities. In an eventuality, when such a seat is rendered vacant through fraud, an obligation is cast upon the authorities to restore that seat to the next eligible candidate as per the merit list,"</i> noted the Apex Court.</blockquote><blockquote><i>"To allow a seat to remain wasted due to administrative inaction or lethargy, is a subversion of the very purpose of the NEET-UG examination that was to facilitate systematic organization of admissions in government medical institutions,"</i> it further observed. </blockquote><p>Addressing NMC's contention regarding adherence to the schedule fixed by the court in Ashish Ranjan (Supra), the top court bench observed, <i>"it must be borne in mind of the authorities that the said schedule is a servant of the admission process, provided by this Court to facilitate the timely induction of doctors without delay, not a master that can lead to sacrifice of a meritorious student’s career, that too without having any fault of such candidate. In this regard, we are guided by the principle enunciated in S. Krishna Sradha (Supra) that in exceptional cases where a candidate has been prompt in approaching authorities and delay is entirely attributable to the failure of the authorities to detect fraud, irregularity or respond to queries, as is the situation in present case, equity requires that admission be granted to such a candidate in next academic year possible."</i></p><p>Accordingly, the bench held that the High Court's order was justified. It noted, <i>"In view of the foregoing, we are of the considered opinion that the High Court was completely justified and in fact, because of the vexatious litigation of Appellant, the matter has been stalled before this Court for more than three years. Nonetheless, since we have arrived at a conclusion that the order passed by the High Court is justified, in exercise of jurisdiction under Article 142 of the Constitution of India, we modify the direction as issued by the High Court for grant of admission for the year 2026-2027 instead of 2023-2024 while not interfering with other terms and conditions as directed by the High Court."</i></p><p><b><i>To view the order, click on the link below:</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/supreme-court-neet-seats-340190.pdf"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/07/supreme-court-neet-seats-340190.pdf</i></b></a></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/hc-comes-to-rescue-of-mbbs-candidate-denied-admission-nmc-university-told-to-pay-rs-4-lakh-compensation-114474"><b><i>Also Read: HC comes to rescue of MBBS candidate denied admission, NMC, University told to pay Rs 4 lakh compensation</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>On&#45;duty paediatrician shot dead: Rs 1 crore compensation stands, pension needs governor&amp;apos;s nod&#45; Supreme Court</title>
<link>https://edusehat.com/en/on-duty-paediatrician-shot-dead-rs-1-crore-compensation-stands-pension-needs-governors-nod-supreme-court</link>
<guid>https://edusehat.com/en/on-duty-paediatrician-shot-dead-rs-1-crore-compensation-stands-pension-needs-governors-nod-supreme-court</guid>
<description><![CDATA[ New Delhi: Setting aside a Uttarakhand High Court&#039;s direction that granted an extraordinary pension to the widow of a paediatrician who was shot dead while on duty, the Supreme Court has recently held that such a benefit can be awarded only after due consideration under the Uttar Pradesh Civil Services (Extraordinary Pension) Rules, 1981 and with the sanction of the Governor. In its order, the apex court upheld the Rs 1 crore compensation to the kin.The Division Bench comprising J K Maheshwari and Atul S Chandurkar made these observations while hearing an appeal filed by the State of Uttarakhand challenging the High Court’s order. The issue before the Apex Court was whether the respondent was entitled to an extraordinary pension and whether the High Court was justified in granting it directly without the mandatory sanction of the Governor under the 1981 Rules.Partially modifying the high court&#039;s order, the bench accepted the state’s argument that the grant of such an extraordinary pension required the mandatory sanction of the Governor under the Uttar Pradesh Civil Services (Extraordinary Pension) Rules, 1981, as adopted by the State of Uttarakhand. The bench also directed that the Rs 1 crore extraordinary pension already paid to the kin shall be treated as final compensation and will not be recovered.The Bench held, &quot;On a complete reading of the Rules of 1981, it is clear that in the matter of award of extraordinary pension, the sanction of the Hon’ble Governor is necessary. Such sanction is expected to be granted by the Hon’ble Governor after examining all relevant aspects referred to in the Rules of 1981.&quot;It further clarified that &quot;the claim for an extraordinary pension shall be considered and decided on its own merits without being influenced by any observations made either in the judgment of the High Court impugned herein or any observations made in this judgment.&quot;BackgroundThe State of Uttarakhand has challenged a 2018 High Court judgment directing it to pay Rs 1.99 crore compensation with 7.5% interest and grant an extraordinary pension with 8.5% interest on arrears to the widow of Dr Singh.The doctor was appointed as a Medical Officer on an ad hoc basis in the State of Uttar Pradesh on 22.08.1992. Following the enactment of the Uttar Pradesh Reorganisation Act, 2000, he opted to serve in Uttar Pradesh. However, since he was working in the newly formed State of Uttarakhand, he was not relieved from his duties there.On 20.04.2016, while serving as a Pediatrician at CHC Jaspur, the doctor was shot dead during the discharge of his duties. Claiming that his death occurred in the line of duty, his widow (the first respondent) submitted a representation to the Chief Secretary, Ministry of Health, with a copy to the Chief Minister of Uttarakhand, seeking an extraordinary pension under the 1981 Rules.Although a proposal was made to grant Rs 50 lakh compensation, a job to his son, and accommodation, the family alleged that only Rs 1 lakh compensation and a contractual job for the son were provided.The first respondent filed a writ petition before the Uttarakhand High Court seeking implementation of the Rs 50 lakh compensation proposal, enhanced compensation of Rs 4.18 crore, and grant of an extraordinary pension along with family pension.The State opposed the plea, arguing that a doctor’s work does not qualify as hazardous for an extraordinary pension. It stated that Rs 10.65 lakh salary arrears, Rs 1 lakh ex gratia, government housing, and a contractual job for the son had already been provided, and no further relief was due.However, the High Court found that despite approval of Rs 50 lakh, only Rs 1 lakh was paid. Holding that the doctor died in the line of duty, it declared the widow entitled to an extraordinary pension. The Court calculated Rs 1.89 crore as compensation using salary, age, and future prospects, and added Rs 10 lakh for loss of consortium. It directed payment with 7.5% interest, along with extraordinary pension and arrears carrying 8.5% interest, and ordered strict enforcement of the Uttarakhand Medicare Act, 2013.Appearing for the State, Additional Advocate General Gaurav Bhatia challenged the High Court’s directions, particularly the grant of an extraordinary pension. He argued that such a pension is subject to conditions under the 1981 Rules and requires the Governor’s sanction. He contended that the respondent did not meet the criteria under Rule 3, and given the circumstances of his death, the case did not qualify for an extraordinary pension.He emphasised that sanctions by the Governor under Rule 4 are mandatory and discretionary, guided by the Rules. He therefore argued that since Rs 1 crore compensation has already been paid, no further relief should be granted, and the direction for extraordinary pension should be set aside.Meanwhile, Senior Advocate Vijay Hansaria, for the respondent, supported the High Court’s ruling, arguing that the doctor died while on duty and his case qualified for extraordinary pension under Rule 3 of the 1981 Rules, including provisions on &quot;risk&quot; and &quot;violence.&quot;Observation by Supreme CourtAfter hearing both sides, the Court noted that the 1981 Rules constitute a complete code, laying down both the conditions and procedure for grant of extraordinary pension. It observed that under Rule 4, such pension can be awarded only with the sanction of the Governor, who exercises administrative discretion in the matter.Examining the High Court’s reasoning, the Supreme Court held:&quot;The Division Bench of the High Court proceeded on the premise that the husband of the first respondent died while discharging his official duties. It appears that the aspect that though the Hon’ble Chief Minister had agreed to pay compensation of ₹50,00,000/- but only an amount of ₹1,00,000/- was paid to her has heavily weighed with the High Court. In this background, the High Court proceeded to determine the amount of monetary compensation and also held the first respondent entitled to an extraordinary pension. The factual adjudication as required under the Rules of 1981 preceding the grant of extraordinary pension has not been undertaken.&quot;The Court further noted that although the respondent could have been guided to apply in the prescribed manner under the Rules, this was not done. Given the requirement of the Governor’s sanction and the discretion vested under the Rules, the Court held that the claim for extraordinary pension must be considered strictly in accordance with the 1981 Rules.The Bench emphasised that the power to grant an extraordinary pension is administrative and discretionary in nature and it is for the competent authority, i.e., the Governor, to take such a decision after evaluating all relevant factors. Judicial interference, the Court clarified, is warranted only in cases of inaction or arbitrariness. It observed:&quot;In such a scenario, the Court would be slow to itself take such decision especially when the authority on whom the power has been conferred to take such decision has had no occasion to examine the matter and exercise its discretion in accordance with law. It would be a different matter if such authority has either refused to take any decision for a reasonable period of time or the decision taken is found to be wholly arbitrary or suffering from non-application of mind. Even in such situations, normally, a direction to the authority concerned to take a decision afresh would follow. Ordinarily, the Court would not substitute its decision in place of the decision required to be taken by the concerned authority in exercise of its discretion.&quot;Applying these principles, the Court noted that the Governor had no occasion to consider the kin;s claim, as her application dated 20.01.2017 was still pending when she approached the High Court.The Court held that the High Court, without first directing the competent authority to decide the claim, proceeded to grant an extraordinary pension itself. This approach, the bench found as unwarranted, as the High Court exercised jurisdiction without allowing the statutory authority to apply its discretion under the Rules.Accordingly, the Court set aside the High Court&#039;s direction granting an extraordinary pension. However, considering that the respondent has already received Rs 1 crore as compensation, along with other benefits such as compassionate appointment to her son, government accommodation, salary arrears, and family pension, the Court permitted her to apply afresh for an extraordinary pension under the 1981 Rules.The Court partly modified the High Court’s judgment with the following directions:(a) The direction to pay an extraordinary pension to the first respondent is set aside.(b) The first respondent is permitted to make an application for the grant of an extraordinary pension under the Rules of 1981 within the period of four weeks from today. If such an application is duly made, the Competent Authority shall consider the same in accordance with the Rules of 1981 and determine the entitlement of the first respondent to receive an extraordinary pension. This to be done after giving due opportunity to the first respondent. The decision in this regard be taken within a period of twelve weeks from the date of receipt of such application, and the outcome thereof to be communicated to the first respondent. (c) It is clarified that the claim for an extraordinary pension shall be considered and decided on its own merits without being influenced by any observations made either in the judgment of the High Court impugned herein or any observations made in this judgment.(d) The amount of monetary compensation of ₹1,00,00,000/- paid to the first respondent pursuant to the interim orders passed in these proceedings shall be the amount of monetary compensation to which she is entitled. The same shall not be recovered from her.To view the court order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/11/2193720213150269876judgement09-apr-2026-341084.pdfAlso read- Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/09/24/302091-supreme-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>On-duty, paediatrician, shot, dead:, crore, compensation, stands, pension, needs, governors, nod-, Supreme, Court</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/09/24/302091-supreme-court.webp"><p><b>New Delhi:</b><span> Setting aside a Uttarakhand High Court's direction that granted an extraordinary pension to the widow of a </span><a href="https://medicaldialogues.in/topics/pediatrician" target="_blank">paediatricia</a><span>n who was shot dead while on duty, the </span><a href="https://medicaldialogues.in/topics/supreme-court" target="_blank">Supreme Court</a><span> has recently held that such a benefit can be awarded only after due consideration under the Uttar Pradesh Civil Services (Extraordinary Pension) Rules, 1981 and with the sanction of the Governor. In its order, the apex court upheld the Rs 1 crore compensation to the kin.</span></p><p>The Division Bench comprising J K Maheshwari and Atul S Chandurkar made these observations while hearing an appeal filed by the State of Uttarakhand challenging the High Court’s order. The issue before the Apex Court was whether the respondent was entitled to an extraordinary pension and whether the High Court was justified in granting it directly without the mandatory sanction of the Governor under the 1981 Rules.</p><div>Partially modifying the high court's order, the bench accepted the state’s argument that the grant of such an extraordinary pension required the mandatory sanction of the Governor under the Uttar Pradesh Civil Services (Extraordinary Pension) Rules, 1981, as adopted by the State of Uttarakhand. </div><div>The bench also directed that the Rs 1 crore extraordinary pension already paid to the kin shall be treated as final compensation and will not be recovered.</div><p>The Bench held, </p><blockquote>"On a complete reading of the Rules of 1981, it is clear that in the matter of award of extraordinary pension, the sanction of the Hon’ble Governor is necessary. Such sanction is expected to be granted by the Hon’ble Governor after examining all relevant aspects referred to in the Rules of 1981."</blockquote><p>It further clarified that <i>"the claim for an extraordinary pension shall be considered and decided on its own merits without being influenced by any observations made either in the judgment of the High Court impugned herein or any observations made in this judgment."</i></p><p><b>Background</b></p><p>The State of Uttarakhand has challenged a 2018 High Court judgment directing it to pay Rs 1.99 crore compensation with 7.5% interest and grant an extraordinary pension with 8.5% interest on arrears to the widow of Dr Singh.</p><p>The doctor was appointed as a Medical Officer on an ad hoc basis in the State of Uttar Pradesh on 22.08.1992. Following the enactment of the Uttar Pradesh Reorganisation Act, 2000, he opted to serve in Uttar Pradesh. However, since he was working in the newly formed State of Uttarakhand, he was not relieved from his duties there.</p><p>On 20.04.2016, while serving as a Pediatrician at CHC Jaspur, the doctor was shot dead during the discharge of his duties. Claiming that his death occurred in the line of duty, his widow (the first respondent) submitted a representation to the Chief Secretary, Ministry of Health, with a copy to the Chief Minister of Uttarakhand, seeking an extraordinary pension under the 1981 Rules.</p><p>Although a proposal was made to grant Rs 50 lakh compensation, a job to his son, and accommodation, the family alleged that only Rs 1 lakh compensation and a contractual job for the son were provided.</p><p>The first respondent filed a writ petition before the Uttarakhand High Court seeking implementation of the Rs 50 lakh compensation proposal, enhanced compensation of Rs 4.18 crore, and grant of an extraordinary pension along with family pension.</p><p>The State opposed the plea, arguing that a doctor’s work does not qualify as hazardous for an extraordinary pension. It stated that Rs 10.65 lakh salary arrears, Rs 1 lakh ex gratia, government housing, and a contractual job for the son had already been provided, and no further relief was due.</p><p>However, the High Court found that despite approval of Rs 50 lakh, only Rs 1 lakh was paid. Holding that the doctor died in the line of duty, it declared the widow entitled to an extraordinary pension. The Court calculated Rs 1.89 crore as compensation using salary, age, and future prospects, and added Rs 10 lakh for loss of consortium. It directed payment with 7.5% interest, along with extraordinary pension and arrears carrying 8.5% interest, and ordered strict enforcement of the Uttarakhand Medicare Act, 2013.</p><p>Appearing for the State, Additional Advocate General Gaurav Bhatia challenged the High Court’s directions, particularly the grant of an extraordinary pension. He argued that such a pension is subject to conditions under the 1981 Rules and requires the Governor’s sanction. He contended that the respondent did not meet the criteria under Rule 3, and given the circumstances of his death, the case did not qualify for an extraordinary pension.</p><p>He emphasised that sanctions by the Governor under Rule 4 are mandatory and discretionary, guided by the Rules. He therefore argued that since Rs 1 crore compensation has already been paid, no further relief should be granted, and the direction for extraordinary pension should be set aside.</p><p>Meanwhile, Senior Advocate Vijay Hansaria, for the respondent, supported the High Court’s ruling, arguing that the doctor died while on duty and his case qualified for extraordinary pension under Rule 3 of the 1981 Rules, including provisions on "risk" and "violence."</p><p><b>Observation by Supreme Court</b></p><p>After hearing both sides, the Court noted that the 1981 Rules constitute a complete code, laying down both the conditions and procedure for grant of extraordinary pension. It observed that under Rule 4, such pension can be awarded only with the sanction of the Governor, who exercises administrative discretion in the matter.</p><p>Examining the High Court’s reasoning, the Supreme Court held:</p><blockquote>"The Division Bench of the High Court proceeded on the premise that the husband of the first respondent died while discharging his official duties. It appears that the aspect that though the Hon’ble Chief Minister had agreed to pay compensation of ₹50,00,000/- but only an amount of ₹1,00,000/- was paid to her has heavily weighed with the High Court. In this background, the High Court proceeded to determine the amount of monetary compensation and also held the first respondent entitled to an extraordinary pension. The factual adjudication as required under the Rules of 1981 preceding the grant of extraordinary pension has not been undertaken."</blockquote><p>The Court further noted that although the respondent could have been guided to apply in the prescribed manner under the Rules, this was not done. Given the requirement of the Governor’s sanction and the discretion vested under the Rules, the Court held that the claim for extraordinary pension must be considered strictly in accordance with the 1981 Rules.</p><p>The Bench emphasised that the power to grant an extraordinary pension is administrative and discretionary in nature and it is for the competent authority, i.e., the Governor, to take such a decision after evaluating all relevant factors. </p><p>Judicial interference, the Court clarified, is warranted only in cases of inaction or arbitrariness. It observed:</p><blockquote>"In such a scenario, the Court would be slow to itself take such decision especially when the authority on whom the power has been conferred to take such decision has had no occasion to examine the matter and exercise its discretion in accordance with law. It would be a different matter if such authority has either refused to take any decision for a reasonable period of time or the decision taken is found to be wholly arbitrary or suffering from non-application of mind. Even in such situations, normally, a direction to the authority concerned to take a decision afresh would follow. Ordinarily, the Court would not substitute its decision in place of the decision required to be taken by the concerned authority in exercise of its discretion."</blockquote><p>Applying these principles, the Court noted that the Governor had no occasion to consider the kin;s claim, as her application dated 20.01.2017 was still pending when she approached the High Court.</p><p>The Court held that the High Court, without first directing the competent authority to decide the claim, proceeded to grant an extraordinary pension itself. This approach, the bench found as unwarranted, as the High Court exercised jurisdiction without allowing the statutory authority to apply its discretion under the Rules.</p><p>Accordingly, the Court set aside the High Court's direction granting an extraordinary pension. However, considering that the respondent has already received Rs 1 crore as compensation, along with other benefits such as compassionate appointment to her son, government accommodation, salary arrears, and family pension, the Court permitted her to apply afresh for an extraordinary pension under the 1981 Rules.</p><p>The Court partly modified the High Court’s judgment with the following directions:</p><p>(a) The direction to pay an extraordinary pension to the first respondent is set aside.</p><p>(b) The first respondent is permitted to make an application for the grant of an extraordinary pension under the Rules of 1981 within the period of four weeks from today. If such an application is duly made, the Competent Authority shall consider the same in accordance with the Rules of 1981 and determine the entitlement of the first respondent to receive an extraordinary pension. This to be done after giving due opportunity to the first respondent. The decision in this regard be taken within a period of twelve weeks from the date of receipt of such application, and the outcome thereof to be communicated to the first respondent. </p><p>(c) It is clarified that the claim for an extraordinary pension shall be considered and decided on its own merits without being influenced by any observations made either in the judgment of the High Court impugned herein or any observations made in this judgment.</p><p>(d) The amount of monetary compensation of ₹1,00,00,000/- paid to the first respondent pursuant to the interim orders passed in these proceedings shall be the amount of monetary compensation to which she is entitled. The same shall not be recovered from her.</p><p><b>To view the court order, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/2193720213150269876judgement09-apr-2026-341084.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/11/2193720213150269876judgement09-apr-2026-341084.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-seats-are-national-resource-cannot-be-left-vacant-supreme-court-on-neet-fraud-case-168444" target="_blank">Medical seats are national resource, cannot be left vacant: Supreme Court on NEET fraud case</a></b></p>]]> </content:encoded>
</item>

<item>
<title>RML hospital Delhi, ABVIMS releases reporting schedule for DM, MCh, DrNB admissions 2025</title>
<link>https://edusehat.com/en/rml-hospital-delhi-abvims-releases-reporting-schedule-for-dm-mch-drnb-admissions-2025</link>
<guid>https://edusehat.com/en/rml-hospital-delhi-abvims-releases-reporting-schedule-for-dm-mch-drnb-admissions-2025</guid>
<description><![CDATA[ New Delhi: Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr Ram Manohar Lohia Hospital recently released the reporting schedule for candidates allotted seats in DM/MCh and DrNB courses under Round 2 of counselling for the academic year 2025-26.As per the official notice, all selected candidates must report in person between April 8 and April 16, 2026, at the designated venues within the institute, carrying all original documents along with self-attested copies to complete the admission process within the stipulated timeline.Reporting scheduled dates given below-
 
 
 
 
  Quota
  Date of Reporting
  Courses
 
 
  All lndia Ouota
  08.04.2026 (Wednesday)
  DM (Cardiology) DM
  (Cardiac Anaesthesia) M.Ch (CTVS) DM (Nephrology) DM (Neurology) M.Ch
  (Neuro-surgery) DM (Neonatology) M.Ch (Urology) M.Ch (Paediatrlcs Surgery)
  M.Ch (Plastic Reconstructive Surgery) DM (Critical Care Medicine) DM
  Peadiatrics Cardiology DrNB Gastroenterology DrNB Endocrinology
    
    
    
 
 
  09.04.2026
  (Thursday)
 
 
  10.04.2026
  (Friday)
 
 
  11.04.2026
  (Saturday)
 
 
  12.04.2026
  (Sunday)
 
 
  13.04.2026
  (Monday)
 
 
  14.04.2026
  (Tuesday)
 
 
  1
  5.04.2026 (Wednesday)
 
 
  16.04.2026
  (Thursday)
  Address for reporting date 08/04/2026 to PG Cell, Room no. 212 and 09/04/2026 to 16/04/2026 to LT -5, Room no.413, Admin Block, ABVIMS &amp; Dr. RML Hospital. Time for reporting: 10:00 AM.The total fee amounting to Rs. 54,5oo/. (Rupees Fifty Four Thousand Five Hundred only) (as per details mentioned below) to be remitted through Internet Payment Gateway software uploaded on Dr. RML Hospital website in download link. The students after making the payment should submit a hard copy of receipt in Accounts section of this institute (Room No. 303, 3&#039;d Floor Academic Block.)
 
 
 
 
  S.No.
  Details
  Amount (ln Rs.)
 
 
  1
  ABVIMS Share
  Rs. 15,000/-
 
 
  2
  GGSIP University Share
  Rs.28,500/-
 
 
  3
  Security Money (Refundable)
  Rs. 10,000/-
 
 
  4
  Student Activity Fund
  Rs. 1,000/-
 
 
  TOTAL
  Rs. 54,500/-
 List of document required for admission:-1. Fee Receipt Rs. 54,500/- (Rupees Fifty Four Thousand Five Hundred only),2. Passport size Photograph - 063. Seat Allotment Letter issued by MCC.4. Admit Card issued by NBE.5. Rank Letter/Score Card issued by NBE6. High School Certificate/Date of Birth Certificate for verification of date of birth.7. Senior Secondary Certificate8. MSBS Mark sheets of,1st, 2nd &amp; 3rd professional Examinations.9. MBBS Degree Certificate/provisional Certificate.10. Internship Completion Certificate11. PG Degree and Mark Sheet12. Medical Registration Certificate f.om Medical Council of India/State Medical Council for MBBS and PG Degree.13. Copy of ldentification proof (ID proof) i.e. Aadhar Card/ Driving License/Voter lD/passport.14. Character Certificate from the head of the institutional from where the qualifying examination was passed.15. Declaration (Annexure - 2),16. The Surety Bond of Rs. 10, 00,000/- {Rupees ten lakhs only) on No. Judicial Stamp paper of Rs. 100/- (only
on Delhi stamp paper and notarized by Delhi notary only) filled and signed by two sureties either by the
Gazetted Officer of Class-1 or Class-2 Rank, or the person who regularly files the tnco.ne Tax Return and
having annual income about Rs. 10 Lakh (other than Parents/ resident doctors/retired officers) along with
the copies of Pan card &amp; lT returns of both sureties for last two years (Annexure - 1).To view the official notice, click the link mentioned below- https://medicaldialogues.in/pdf_upload/2026/04/11/copy1769d6a8668-786a-451e-8063-cafbf6de1f36-341003.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339372-schedule-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>RML, hospital, Delhi, ABVIMS, releases, reporting, schedule, for, DM, MCh, DrNB, admissions, 2025</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339372-schedule-1.webp"><p><b>New Delhi: </b>Atal Bihari Vajpayee Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/ABVIMS">ABVIMS</a>) and Dr Ram Manohar Lohia Hospital recently released the reporting schedule for candidates allotted seats in DM/MCh and <a href="https://medicaldialogues.in/topics/DrNB">DrNB</a> courses under Round 2 of counselling for the academic year 2025-26.</p><p>As per the official notice, all selected candidates must report in person between April 8 and April 16, 2026, at the designated venues within the institute, carrying all original documents along with self-attested copies to complete the admission process within the stipulated timeline.</p><p><b>Reporting scheduled dates given below-</b></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="476">
 <colgroup><col width="64">
 <col width="174">
 <col width="238">
 </colgroup><tbody><tr height="18">
  <td height="18" class="xl65" width="64"><b>Quota</b></td>
  <td class="xl65" width="174"><b>Date of Reporting</b></td>
  <td class="xl65" width="238"><b>Courses</b></td>
 </tr>
 <tr height="28">
  <td rowspan="9" height="172" class="xl67" width="64">All lndia Ouota</td>
  <td class="xl65" width="174">08.04.2026 (Wednesday)</td>
  <td rowspan="9" class="xl66" width="238">DM (Cardiology) DM
  (Cardiac Anaesthesia) M.Ch (CTVS) DM (Nephrology) DM (Neurology) M.Ch
  (Neuro-surgery) DM (Neonatology) M.Ch (Urology) M.Ch (Paediatrlcs Surgery)
  M.Ch (Plastic Reconstructive Surgery) DM (Critical Care Medicine) DM
  Peadiatrics Cardiology DrNB Gastroenterology DrNB Endocrinology
    
    
    </td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">09.04.2026
  (Thursday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">10.04.2026
  (Friday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">11.04.2026
  (Saturday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">12.04.2026
  (Sunday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">13.04.2026
  (Monday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">14.04.2026
  (Tuesday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">1
  5.04.2026 (Wednesday)</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="174">16.04.2026
  (Thursday)</td>
 </tr></tbody></table><div> </div></div><div class="pasted-from-word-wrapper"><p>Address for reporting date 08/04/2026 to PG Cell, Room no. 212 and 09/04/2026 to 16/04/2026 to LT -5, Room no.413, Admin Block, ABVIMS & Dr. RML Hospital. Time for reporting: 10:00 AM.</p><p>The total fee amounting to Rs. 54,5oo/. (Rupees Fifty Four Thousand Five Hundred only) (as per details mentioned below) to be remitted through Internet Payment Gateway software uploaded on Dr. RML Hospital website in download link. The students after making the payment should submit a hard copy of receipt in Accounts section of this institute (Room No. 303, 3'd Floor Academic Block.)</p></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="338">
 <colgroup><col width="64">
 <col width="170">
 <col width="104">
 </colgroup><tbody><tr height="35">
  <td height="35" class="xl65" width="64"><b>S.No.</b></td>
  <td class="xl65" width="170"><b>Details</b></td>
  <td class="xl65" width="104"><b>Amount (ln Rs.)</b></td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="64">1</td>
  <td class="xl65" width="170">ABVIMS Share</td>
  <td class="xl65" width="104">Rs. 15,000/-</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="64">2</td>
  <td class="xl65" width="170">GGSIP University Share</td>
  <td class="xl65" width="104">Rs.28,500/-</td>
 </tr>
 <tr height="20">
  <td height="20" class="xl65" width="64">3</td>
  <td class="xl65" width="170">Security Money (Refundable)</td>
  <td class="xl65" width="104">Rs. 10,000/-</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65" width="64">4</td>
  <td class="xl65" width="170">Student Activity Fund</td>
  <td class="xl65" width="104">Rs. 1,000/-</td>
 </tr>
 <tr height="18">
  <td colspan="2" height="18" class="xl66" width="234"><b>TOTAL</b></td>
  <td class="xl65" width="104"><b>Rs. 54,500/-</b></td>
 </tr></tbody></table></div><div class="pasted-from-word-wrapper"><p><b>List of document required for admission:-</b></p><p><span>1. Fee Receipt Rs. 54,500/- (Rupees Fifty Four Thousand Five Hundred only),</span></p></div><div class="pasted-from-word-wrapper"><div>2. Passport size Photograph - 06</div><div>3. Seat Allotment Letter issued by MCC.</div><div>4. Admit Card issued by NBE.</div><div>5. Rank Letter/Score Card issued by NBE</div><div>6. High School Certificate/Date of Birth Certificate for verification of date of birth.</div><div>7. Senior Secondary Certificate</div><div>8. MSBS Mark sheets of,1st, 2nd & 3rd professional Examinations.</div><div>9. MBBS Degree Certificate/provisional Certificate.</div><div>10. Internship Completion Certificate</div><div>11. PG Degree and Mark Sheet</div><div>12. Medical Registration Certificate f.om Medical Council of India/State Medical Council for MBBS and PG Degree.</div><div>13. Copy of ldentification proof (ID proof) i.e. Aadhar Card/ Driving License/Voter lD/passport.</div><div>14. Character Certificate from the head of the institutional from where the qualifying examination was passed.</div><div>15. Declaration (Annexure - 2),</div><div>16. The Surety Bond of Rs. 10, 00,000/- {Rupees ten lakhs only) on No. Judicial Stamp paper of Rs. 100/- (only
on Delhi stamp paper and notarized by Delhi notary only) filled and signed by two sureties either by the
Gazetted Officer of Class-1 or Class-2 Rank, or the person who regularly files the tnco.ne Tax Return and
having annual income about Rs. 10 Lakh (other than Parents/ resident doctors/retired officers) along with
the copies of Pan card & lT returns of both sureties for last two years (Annexure - 1).</div><div><b><i>To view the official notice, click the link mentioned below- </i></b></div><div><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/copy1769d6a8668-786a-451e-8063-cafbf6de1f36-341003.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/11/copy1769d6a8668-786a-451e-8063-cafbf6de1f36-341003.pdf</i></b></a></div></div><div class="pasted-from-word-wrapper"></div>]]> </content:encoded>
</item>

<item>
<title>Six Attempts for MBBS First Professional Exams, Ten&#45;Year Course Limit; Suggests Parliamentary Panel</title>
<link>https://edusehat.com/en/six-attempts-for-mbbs-first-professional-exams-ten-year-course-limit-suggests-parliamentary-panel</link>
<guid>https://edusehat.com/en/six-attempts-for-mbbs-first-professional-exams-ten-year-course-limit-suggests-parliamentary-panel</guid>
<description><![CDATA[ Pointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission.For more details, check out the full story on the link below:
Parliamentary panel suggests 6 attempts to clear MBBS 1st professional exams, 10 years to complete course ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341059-mbbs-21.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Six, Attempts, for, MBBS, First, Professional, Exams, Ten-Year, Course, Limit, Suggests, Parliamentary, Panel</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341059-mbbs-21.webp"><div class="pasted-from-word-wrapper"><p>Pointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.</p><div></div><p>However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/education/parliamentary-panel-suggests-6-attempts-to-clear-mbbs-1st-professional-exams-10-years-to-complete-course-168295" target="_blank"><b><i>Parliamentary panel suggests 6 attempts to clear MBBS 1st professional exams, 10 years to complete course</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Belagavi Ayurvedic Doctor Death Case: Wife among two arrested</title>
<link>https://edusehat.com/en/belagavi-ayurvedic-doctor-death-case-wife-among-two-arrested</link>
<guid>https://edusehat.com/en/belagavi-ayurvedic-doctor-death-case-wife-among-two-arrested</guid>
<description><![CDATA[ Belagavi: In a major breakthrough, police have arrested two people, including the wife of a 40-year-old Ayurvedic doctor, in connection with his death, which was initially suspected to be accidental. According to the news reports, the doctor was found dead inside his clinic in Anagol, Belagavi, on March 5. At first, authorities and family members suspected that he may have slipped and fallen, leading to his death. Also Read:Bengaluru Dermatologist Murder Case: Husband denied bail, chats suggest cover-upHowever, doubts were later raised by the victim’s mother, who alleged possible foul play and lodged a complaint with the police, prompting a deeper investigation into the matter.Speaking to PTI, Belagavi Police Commissioner Bhushan Borase said that from the beginning, the statements of the deceased’s wife were inconsistent and lacked clarity. “If it had been an accidental fall, there might have been one injury. However, there were four injury marks on the head,” he said. During the post-mortem, doctors also found internal injury to the heart, which strengthened suspicion, he added. 
He said that the forensic team, including scene-of-crime officers, conducted bloodstain pattern and luminol analyses at the scene. The wife’s version did not match the evidence found at the spot. Based on these scientific findings, the suspicions were confirmed. 
During the investigation, the accused confessed to the offence. The police produced them before the court, which remanded them in judicial custody, reports the Hindu.
Police said both accused had planned the murder together. As per the investigation, the man allegedly attacked the doctor using a gas cylinder at the clinic, while the wife was reportedly not present at the scene. Investigators believe the motive was an illicit relationship, with the husband seen as an obstacle. 
The police commissioner added that the accused initially attempted to mislead investigators by claiming the doctor had low blood sugar and fell, hitting his head on a table.
Police officials have stated that further investigation is ongoing to establish all aspects of the crime.
Also Read:Two armed men shoot 38-year-old patient at Aligarh hospital ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/04/325448-death-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Belagavi, Ayurvedic, Doctor, Death, Case:, Wife, among, two, arrested</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/04/325448-death-2.webp"><p><b>Belagavi:</b> In a major breakthrough, police have arrested two people, including the wife of a 40-year-old <a href="https://medicaldialogues.in/topics/ayurvedic-doctor">Ayurvedic doctor</a>, in connection with his death, which was initially suspected to be accidental. </p><p>According to the news reports, the doctor was found <a href="https://medicaldialogues.in/topics/doctor-dead">dead</a> inside his <a href="https://medicaldialogues.in/topics/clinical-establishments">clinic</a> in Anagol, Belagavi, on March 5. At first, authorities and family members suspected that he may have slipped and fallen, leading to his death. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/bengaluru-dermatologist-murder-case-husband-denied-bail-chats-suggest-cover-up-168289"><b>Also Read:Bengaluru Dermatologist Murder Case: Husband denied bail, chats suggest cover-up</b></a></p><p>However, doubts were later raised by the victim’s mother, who alleged possible foul play and lodged a complaint with the police, prompting a deeper investigation into the matter.</p><p>Speaking to PTI, Belagavi Police Commissioner Bhushan Borase said that from the beginning, the statements of the deceased’s wife were inconsistent and lacked clarity. “If it had been an accidental fall, there might have been one injury. However, there were four injury marks on the head,” he said. During the post-mortem, doctors also found internal injury to the heart, which strengthened suspicion, he added. 
</p><p>He said that the forensic team, including scene-of-crime officers, conducted bloodstain pattern and luminol analyses at the scene. The wife’s version did not match the evidence found at the spot. Based on these scientific findings, the suspicions were confirmed. 
</p><p>During the investigation, the accused confessed to the offence. The police produced them before the court, which remanded them in judicial custody, reports the<a href="https://www.thehindu.com/news/national/karnataka/two-arrested-for-murdering-doctor/article70847053.ece" rel="nofollow"> Hindu</a>.
</p><p>Police said both accused had planned the murder together. As per the investigation, the man allegedly attacked the doctor using a gas cylinder at the clinic, while the wife was reportedly not present at the scene. Investigators believe the motive was an illicit relationship, with the husband seen as an obstacle. 
</p><p>The police commissioner added that the accused initially attempted to mislead investigators by claiming the doctor had low blood sugar and fell, hitting his head on a table.
</p><p>Police officials have stated that further investigation is ongoing to establish all aspects of the crime.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/two-armed-men-shoot-38-year-old-patient-at-aligarh-hospital-166797"><b>Also Read:Two armed men shoot 38-year-old patient at Aligarh hospital</b></a></p>]]> </content:encoded>
</item>

<item>
<title>FMGs Urge NMC for One&#45;Time FMGL Exemption, Seek Prospective Application From 2022 Batch</title>
<link>https://edusehat.com/en/fmgs-urge-nmc-for-one-time-fmgl-exemption-seek-prospective-application-from-2022-batch</link>
<guid>https://edusehat.com/en/fmgs-urge-nmc-for-one-time-fmgl-exemption-seek-prospective-application-from-2022-batch</guid>
<description><![CDATA[ Highlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the National Medical Commission (NMC) to grant a one-time exemption from its strict applicability.In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.For more details, check out the full story on the link below:
Grant one-time exemption from FMGL regulations, apply prospectively from 2022 batch: FMGs urge NMC ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341057-mbbs-18.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>FMGs, Urge, NMC, for, One-Time, FMGL, Exemption, Seek, Prospective, Application, From, 2022, Batch</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341057-mbbs-18.webp"><div class="pasted-from-word-wrapper"><p>Highlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC) </a>to grant a one-time exemption from its strict applicability.</p><div></div><p>In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/mdtv/healthshorts/fmgs-urge-nmc-for-one-time-fmgl-exemption-seek-prospective-application-from-2022-batch-168450" target="_blank"><b><i>Grant one-time exemption from FMGL regulations, apply prospectively from 2022 batch: FMGs urge NMC</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Telangana Medical Council Bars Doctor for Two Years Over Fake MD Claim, Invalid Registration</title>
<link>https://edusehat.com/en/telangana-medical-council-bars-doctor-for-two-years-over-fake-md-claim-invalid-registration</link>
<guid>https://edusehat.com/en/telangana-medical-council-bars-doctor-for-two-years-over-fake-md-claim-invalid-registration</guid>
<description><![CDATA[ Taking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the Telangana Medical Council has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.For more details, check out the full story on the link below:
Misrepresentation as MD Radiodiagnosis, no valid registration: Telangana medical council bars doctor for 2 years, censures another ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341061-mbbs-20.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Telangana, Medical, Council, Bars, Doctor, for, Two, Years, Over, Fake, Claim, Invalid, Registration</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341061-mbbs-20.webp"><div class="pasted-from-word-wrapper"><p>Taking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the <a href="https://medicaldialogues.in/topics/telangana-medical-council" target="_blank">Telangana Medical Council </a>has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.</p><div></div><p>The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/health/doctors/misrepresentation-as-md-radiodiagnosis-no-valid-registration-telangana-medical-council-bars-doctor-for-2-years-censures-another-168369" target="_blank"><b><i>Misrepresentation as MD Radiodiagnosis, no valid registration: Telangana medical council bars doctor for 2 years, censures another</i></b></a></p><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div>]]> </content:encoded>
</item>

<item>
<title>Kerala HC Rules Failure to Conduct Pre&#45;Anaesthetic Check&#45;Up Gross Negligence, Denies Relief to Anaesthetist</title>
<link>https://edusehat.com/en/kerala-hc-rules-failure-to-conduct-pre-anaesthetic-check-up-gross-negligence-denies-relief-to-anaesthetist</link>
<guid>https://edusehat.com/en/kerala-hc-rules-failure-to-conduct-pre-anaesthetic-check-up-gross-negligence-denies-relief-to-anaesthetist</guid>
<description><![CDATA[ Observing that failure to conduct a pre-anaesthetic check-up amounts to gross negligence, the Kerala High Court recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, &quot;...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner.&quot;For more details, check out the full story on the link below:
Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341060-mbbs-19.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kerala, Rules, Failure, Conduct, Pre-Anaesthetic, Check-Up, Gross, Negligence, Denies, Relief, Anaesthetist</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341060-mbbs-19.webp"><div class="pasted-from-word-wrapper"><p>Observing that failure to conduct a pre-anaesthetic check-up amounts to gross <a href="https://medicaldialogues.in/topics/medical-negligence">negligence</a>, the <a href="https://medicaldialogues.in/topics/kerala-high-court">Kerala High Court</a> recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).</p><div></div><p>Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, <i>"...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner."</i></p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/failure-to-conduct-pre-anaesthetic-check-up-is-gross-negligence-hc-refuses-relief-to-anaesthetist-booked-under-ipc-304a-168399" target="_blank"><b><i>Failure to conduct pre-anaesthetic check-up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Inquiry ordered in MBBS, PG exams question paper leak row at IGIMS Patna</title>
<link>https://edusehat.com/en/inquiry-ordered-in-mbbs-pg-exams-question-paper-leak-row-at-igims-patna</link>
<guid>https://edusehat.com/en/inquiry-ordered-in-mbbs-pg-exams-question-paper-leak-row-at-igims-patna</guid>
<description><![CDATA[ Patna: Nearly a month after serious allegations of exam malpractice surfaced, the Indira Gandhi Institute of Medical Sciences (IGIMS), Patna has finally set up an inquiry committee to investigate the allegations of question paper leaks and answer sheet manipulation in MBBS and postgraduate final-year exams,The controversy began on March 13, when an anonymous email flagged irregularities in the examination process. Despite the allegations, no immediate action was taken, as reported by Patna Press. It was only after about 28 days that the acting director-cum-Dean (Academics), Dr Om Kumar, constituted a four-member panel. The committee has been formed under the leadership of acting director-cum-Dean (Academics), Dr Om Kumar. The panel is headed by Dr Sanjay Kumar, Head of the PSM department, with Dr Gyan Bhaskar and Dr Ashwini as members. The panel has been given seven working days to submit its report, following which action will be taken. Also read- NEET 2025 Aftermath: 10 arrested for duping aspirants with Paper leaks, ProxiesAccording to the Daily&#039;s sources, the alleged malpractice involved large sums of money, with separate rates reportedly fixed for leaking question papers and manipulating answer sheets, and for getting answer sheets written externally and later adjusted within the system.Preliminary inputs suggest that CCTV footage from the examination branch has captured suspicious activities, including unusual movement of candidates at odd hours. However, these claims are yet to be officially confirmed.Sources indicate that an initial inquiry had earlier found signs of irregularities, but no concrete action was taken at the time. Meanwhile, the institute administration has come under further scrutiny after Dr Ranjit Guha, the Principal of IGIMS, was excluded from the enquiry process. He said he was neither invited to meetings nor informed about discussions, despite the matter directly involving MBBS and PG students under his charge.Speaking to Patna Press, He said, &quot;Four meetings have been held since March 13 regarding the issue, but I was not informed about any of them. Even internal committee discussions were conducted without me.&quot;Dr Guha added that practical examinations are currently underway and said he plans to directly interact with students after their completion to gather more information.Also read- IGIMS Patna&#039;s 1,200-Bed Super-Speciality Hospital to open by 2026 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/03/276860-question-paper-leak.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 21:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Inquiry, ordered, MBBS, exams, question, paper, leak, row, IGIMS, Patna</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/03/276860-question-paper-leak.webp"><p><b>Patna:</b> Nearly a month after serious allegations of exam malpractice surfaced, the <a href="https://medicaldialogues.in/topics/igims-patna" target="_blank">Indira Gandhi Institute of Medical Sciences (IGIMS), Patna</a> has finally set up an inquiry committee to investigate the allegations of question <a href="https://medicaldialogues.in/topics/neet-paper-leak" target="_blank">paper leaks</a> and answer sheet manipulation in MBBS and postgraduate final-year exams,</p><p>The controversy began on March 13, when an anonymous email flagged irregularities in the examination process. Despite the allegations, no immediate action was taken, as reported by Patna Press. </p><p>It was only after about 28 days that the acting director-cum-Dean (Academics), Dr Om Kumar, constituted a four-member panel. The committee has been formed under the leadership of acting director-cum-Dean (Academics), Dr Om Kumar. The panel is headed by Dr Sanjay Kumar, Head of the PSM department, with Dr Gyan Bhaskar and Dr Ashwini as members. The panel has been given seven working days to submit its report, following which action will be taken. </p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-admissions/neet-2025-aftermath-10-arrested-for-duping-aspirants-with-paper-leaks-proxies-147756" target="_blank">NEET 2025 Aftermath: 10 arrested for duping aspirants with Paper leaks, Proxies</a></b></p><p>According to the Daily's sources, the alleged malpractice involved large sums of money, with separate rates reportedly fixed for leaking question papers and manipulating answer sheets, and for getting answer sheets written externally and later adjusted within the system.</p><p>Preliminary inputs suggest that CCTV footage from the examination branch has captured suspicious activities, including unusual movement of candidates at odd hours. However, these claims are yet to be officially confirmed.</p><p>Sources indicate that an initial inquiry had earlier found signs of irregularities, but no concrete action was taken at the time. </p><p>Meanwhile, the institute administration has come under further scrutiny after Dr Ranjit Guha, the Principal of IGIMS, was excluded from the enquiry process. He said he was neither invited to meetings nor informed about discussions, despite the matter directly involving MBBS and PG students under his charge.</p><p>Speaking to <a href="https://patnapress.com/patna-igims-controversy-alleged-mbbs-exam-fraud-paper-leak-sparks-investigation/" target="_blank" rel="nofollow">Patna Press</a>, He said, "Four meetings have been held since March 13 regarding the issue, but I was not informed about any of them. Even internal committee discussions were conducted without me."</p><p>Dr Guha added that practical examinations are currently underway and said he plans to directly interact with students after their completion to gather more information.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/igims-patnas-1200-bed-super-speciality-hospital-to-open-by-2026-165113" target="_blank">IGIMS Patna's 1,200-Bed Super-Speciality Hospital to open by 2026</a></b></p>]]> </content:encoded>
</item>

<item>
<title>FMGE, DNB, DrNB, Diploma: NBE releases tentative schedule of upcoming 2026 exams, details</title>
<link>https://edusehat.com/en/fmge-dnb-drnb-diploma-nbe-releases-tentative-schedule-of-upcoming-2026-exams-details</link>
<guid>https://edusehat.com/en/fmge-dnb-drnb-diploma-nbe-releases-tentative-schedule-of-upcoming-2026-exams-details</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has released the tentative schedule for upcoming key examinations, including DNB, DrNB, NBE Diploma, and FMGE, for the 2026-2027 academic cycle.As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with NEET-PG 2026 tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.Tentative schedule of forthcoming NBEMS Examinations.Name of ExaminationExam DateExam DayCourseAdmission SessionCut-off Date for
  Completion of Training for Eligibility to appear in the ExaminationDrNB Final Examination August 202631-07-202601-08-202602-08-2026Friday Saturday SundayDrNB Super Specialty2023 Admission Session17-02-2027Post MBBS
  Part-12024 Admission Session30-04-2027Post MBBS
  Part-2No fresh Batch Scheduled31-12-2026DrNB Final Examination February 202719-02-202720-02-202721-02-2027Friday Saturday SundayDrNB Super SpecialtyNo fresh Batch Scheduled31-05-2027Post MBBS
  Part-1No fresh Batch Scheduled31-05-2027Post MBBS
  Part-22021 Admission Session31-05-2027NBEMS Diploma Final Theory ExaminationJune 202614-05-202615-05-202616-05-2026Thursday Friday SaturdayNBEMS DiplomaNo fresh Batch Scheduled31-12-2026NBEMS Diploma Final Examination September202611-09-202612-09-202613-09-2026Friday Saturday SundayNBEMS Diploma2024 Admission Session16-04-2027DNB Final Examination June 202618-06-202619-06-202620-06-202621-06-2026Thursday Friday Saturday
  Sunday Post MBBS2023 Admission Session31-12-2026Post Diploma2024 Admission Session31-01-2027DNB Final Examination November 202619-11-202620-11-202621-11-202622-11-2026Thursday Friday Saturday
  SundayPost MBBSNo fresh Batch Scheduled15-05-2027Post DiplomaNo fresh Batch ScheduledThe tentative schedule for FMGE
December 2026 is as follows:-
 
 
 
 
  Name of Examination
    
  Exam Date
  Exam Day
 
 
  FMGE December 2026
  09-01-2027
  Saturday
 As notified on 22.01.2026, the tentative date for conduct of NEET-PG 2026 is 30.08.2026 (Sunday).The tentative schedule for NEET-SS 2026 will be notified separately.Please note that the above schedule of forthcoming examinations is purely tentative. The exact dates of exams will be indicated in the Information Bulletin which will be notified on NBEMS website in due course.Candidates are advised to regularly visit the NBEMS website for Information Bulletins and online Application Forms of these examinations, as and when notified.For any queries, clarifications, or assistance, candidates are requested to contact NBEMS ONLY through its Communication Web Portal.Please note that queries or representations submitted through any other mode may not be considered and may lead to a delay in response.To view the official notice, click the link mentioned below- https://medicaldialogues.in/pdf_upload/2026/04/11/nbe-tentative-schedule-of-forthcoming-nbems-examinations-340982.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/02/318754-tentative-schedule.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>FMGE, DNB, DrNB, Diploma:, NBE, releases, tentative, schedule, upcoming, 2026, exams, details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/02/318754-tentative-schedule.webp"><p><b>New Delhi: </b>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/NBEMS">NBEMS</a>) has released the tentative <a href="https://medicaldialogues.in/topics/schedule">schedule</a> for upcoming key examinations, including <a href="https://medicaldialogues.in/topics/DNB">DNB</a>, DrNB, <a href="https://medicaldialogues.in/topics/NBEMS-Diploma">NBE Diploma</a>, and FMGE, for the 2026-2027 academic cycle.</p><p>As per the notification, the exams will be conducted across multiple dates between May 2026 and February 2027, with <a href="https://medicaldialogues.in/topics/NEET-PG-2026">NEET-PG 2026</a> tentatively scheduled for August 30, 2026, while candidates have been advised to regularly check the official website for detailed information and updates.</p><p><b>Tentative schedule of forthcoming NBEMS Examinations.</b></p><table border="0" cellpadding="0" cellspacing="0" width="1015"><colgroup><col width="194"><col width="110"><col width="92"><col width="132"><col width="177"><col width="310"></colgroup><tbody><tr height="64"><td height="64" class="xl73" width="194"><b>Name of Examination</b></td><td class="xl74" width="110"><div><b>Exam Date</b></div></td><td class="xl74" width="92"><div><b>Exam Day</b></div></td><td class="xl75" width="132"><div><b>Course</b></div></td><td class="xl73" width="177"><b>Admission Session</b></td><td class="xl73" width="310"><b>Cut-off Date for
  Completion of Training for Eligibility to appear in the Examination</b></td></tr><tr height="18"><td rowspan="3" height="91" class="xl81" width="194">DrNB Final Examination August 2026</td><td rowspan="3" class="xl81" width="110"><div><span>31-07-2026</span></div><div><span>01-08-2026</span></div><div><span>02-08-2026</span></div></td><td rowspan="3" class="xl65" width="92">Friday Saturday Sunday</td><td class="xl76" width="132">DrNB Super Specialty</td><td class="xl80" width="177"><div><span>2023 </span><span>Admission Session</span></div></td><td class="xl94" width="310">17-02-2027</td></tr><tr height="55"><td height="55" class="xl77" width="132">Post MBBS
  Part-1</td><td class="xl79" width="177"><div><span>2024 </span><span>Admission Session</span></div></td><td class="xl95" width="310">30-04-2027</td></tr><tr height="18"><td height="18" class="xl77" width="132">Post MBBS
  Part-2</td><td class="xl79" width="177"><div><span>No fresh </span><span>Batch Scheduled</span></div></td><td class="xl94" width="310">31-12-2026</td></tr><tr height="18"><td rowspan="3" height="54" class="xl84" width="194">DrNB Final Examination February 2027</td><td rowspan="3" class="xl81" width="110"><div><span>19-02-2027</span></div><div><span>20-02-2027</span></div><div><span>21-02-2027</span></div></td><td rowspan="3" class="xl68" width="92">Friday Saturday Sunday</td><td class="xl78" width="132">DrNB Super Specialty</td><td class="xl77" width="177">No fresh Batch Scheduled</td><td class="xl95" width="310">31-05-2027</td></tr><tr height="18"><td height="18" class="xl77" width="132">Post MBBS
  Part-1</td><td class="xl79" width="177"><div><span>No fresh Batch </span><span>Scheduled</span></div></td><td class="xl94" width="310">31-05-2027</td></tr><tr height="18"><td height="18" class="xl77" width="132">Post MBBS
  Part-2</td><td class="xl79" width="177"><div><span>2021 </span><span>Admission Session</span></div></td><td class="xl95" width="310">31-05-2027</td></tr><tr height="54"><td height="54" class="xl93" width="194"><div>NBEMS Diploma Final Theory Examination</div><div><span>June 2026</span></div></td><td class="xl79" width="110"><div><span>14-05-2026</span></div><div><span>15-05-2026</span></div><div><span>16-05-2026</span></div></td><td class="xl77" width="92">Thursday Friday Saturday</td><td class="xl79" width="132"><div><span>NBEMS </span><span>Diploma</span></div></td><td class="xl77" width="177">No fresh Batch Scheduled</td><td class="xl95" width="310">31-12-2026</td></tr><tr height="62"><td height="62" class="xl93" width="194"><div>NBEMS Diploma Final Examination September</div><div><span>2026</span></div></td><td class="xl80" width="110"><div><span>11-09-2026</span></div><div><span>12-09-2026</span></div><div><span>13-09-2026</span></div></td><td class="xl76" width="92">Friday Saturday Sunday</td><td class="xl80" width="132"><div><span>NBEMS </span><span>Diploma</span></div></td><td class="xl79" width="177"><div><span>2024 </span><span>Admission Session</span></div></td><td class="xl95" width="310">16-04-2027</td></tr><tr height="46"><td rowspan="2" height="92" class="xl88" width="194">DNB Final Examination June 2026</td><td rowspan="2" class="xl90" width="110"><div><span>18-06-2026</span></div><div><span>19-06-2026</span></div><div><span>20-06-2026</span></div><div><span>21-06-2026</span></div></td><td rowspan="2" class="xl71" width="92">Thursday Friday Saturday
  Sunday</td><td class="xl87" width="132"> Post MBBS</td><td class="xl80" width="177"><div><span>2023 </span><span>Admission Session</span></div></td><td class="xl94" width="310">31-12-2026</td></tr><tr height="46"><td height="46" class="xl76" width="132">Post Diploma</td><td class="xl80" width="177"><div><span>2024 </span><span>Admission Session</span></div></td><td class="xl95" width="310">31-01-2027</td></tr><tr height="18"><td rowspan="2" height="38" class="xl88" width="194">DNB Final Examination November 2026</td><td rowspan="2" class="xl90" width="110"><div><span>19-11-2026</span></div><div><span>20-11-2026</span></div><div><span>21-11-2026</span></div><div><span>22-11-2026</span></div></td><td rowspan="2" class="xl71" width="92">Thursday Friday Saturday
  Sunday</td><td class="xl87" width="132">Post MBBS</td><td class="xl80" width="177"><div><span>No fresh Batch </span><span>Scheduled</span></div></td><td rowspan="2" class="xl96" width="310">15-05-2027</td></tr><tr height="20"><td height="20" class="xl92" width="132">Post Diploma</td><td class="xl80" width="177"><div><span>No fresh </span><span>Batch Scheduled</span></div></td></tr></tbody></table><p><span><b>The tentative schedule for FMGE
December 2026 is as follows:-</b></span></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="298">
 <colgroup><col width="110">
 <col width="102">
 <col width="86">
 </colgroup><tbody><tr height="67">
  <td height="67" class="xl65" width="110"><b><div><span>Name of Examination</span></div>
    </b></td>
  <td class="xl65" width="102"><div><span><b>Exam Date</b></span></div></td>
  <td class="xl65" width="86"><div><span><b>Exam Day</b></span></div></td>
 </tr>
 <tr height="61">
  <td height="61" class="xl66" width="110">FMGE December 2026</td>
  <td class="xl67">09-01-2027</td>
  <td class="xl68" width="86">Saturday</td>
 </tr></tbody></table></div><p>As notified on 22.01.2026, the tentative date for conduct of NEET-PG 2026 is 30.08.2026 (Sunday).</p><p>The tentative schedule for NEET-SS 2026 will be notified separately.</p><p>Please note that the above schedule of forthcoming examinations is purely tentative. The exact dates of exams will be indicated in the Information Bulletin which will be notified on NBEMS website in due course.</p><p>Candidates are advised to regularly visit the NBEMS website for Information Bulletins and online Application Forms of these examinations, as and when notified.</p><p>For any queries, clarifications, or assistance, candidates are requested to contact NBEMS ONLY through its Communication Web Portal.</p><p>Please note that queries or representations submitted through any other mode may not be considered and may lead to a delay in response.</p><p><b><i>To view the official notice, click the link mentioned below- </i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/nbe-tentative-schedule-of-forthcoming-nbems-examinations-340982.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/11/nbe-tentative-schedule-of-forthcoming-nbems-examinations-340982.pdf</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Scientists Discover Brain Mechanism That Signals the Body to Stop Eating</title>
<link>https://edusehat.com/en/scientists-discover-brain-mechanism-that-signals-the-body-to-stop-eating</link>
<guid>https://edusehat.com/en/scientists-discover-brain-mechanism-that-signals-the-body-to-stop-eating</guid>
<description><![CDATA[ What if the key to feeling full isn&#039;t just in your neurons-but in overlooked brain cells working behind the scenes?
A new study published in Proceedings of the National Academy of Sciences is reshaping how scientists understand appetite control, revealing that astrocytes—once thought to be mere support cells-play an active role in telling the brain when to stop eating. 
The research, led by teams from the University of Concepción and the University of Maryland, uncovers a previously unknown communication pathway in the hypothalamus, the brain’s hunger-regulating center.
Traditionally, neurons were considered the main players in signaling hunger and fullness. However, this study shows a more complex chain of events involving multiple cell types. After a meal, rising glucose levels are detected by specialized cells called tanycytes. These cells convert glucose into lactate, which then acts as a signaling molecule.
Instead of communicating directly with neurons, lactate first activates nearby astrocytes through a receptor known as HCAR1. Once activated, astrocytes release glutamate, a neurotransmitter that signals appetite-suppressing neurons, ultimately creating the sensation of fullness. In simple terms, tanycytes “talk” to astrocytes, and astrocytes “talk” to neurons.
Researchers also found that this signaling can spread across networks of astrocytes, amplifying the brain’s response to food intake. Interestingly, lactate may have a dual role—indirectly activating fullness signals while also potentially suppressing hunger signals through other pathways.
Scientists are now exploring whether manipulating the HCAR1 receptor could influence eating behavior. If successful, this pathway could complement existing treatments like Ozempic, offering a new frontier in metabolic health.
REFERENCE: S. López,R. Elizondo-Vega,V. Azócar,V. Sepúlveda,V. Opazo-Mellado,W. Vásquez,J.C. Sáez,R.C. Araneda, &amp; M.D.L.Á. García-Robles,  Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability, Proc. Natl. Acad. Sci. U.S.A. 123 (15) e2537810123, https://doi.org/10.1073/pnas.2537810123 (2026).
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340998-scientists-discover-brain-mechanism-that-signals-the-body-to-stop-eating.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Scientists, Discover, Brain, Mechanism, That, Signals, the, Body, Stop, Eating</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340998-scientists-discover-brain-mechanism-that-signals-the-body-to-stop-eating.webp"><p>What if the key to feeling full isn't just in your neurons-but in overlooked brain cells working behind the scenes?
</p><p>A new study published in <i>Proceedings of the National Academy of Sciences</i> is reshaping how scientists understand appetite control, revealing that astrocytes—once thought to be mere support cells-play an active role in telling the brain when to stop eating. 
</p><p>The research, led by teams from the University of Concepción and the University of Maryland, uncovers a previously unknown communication pathway in the hypothalamus, the brain’s hunger-regulating center.
</p><p>Traditionally, neurons were considered the main players in signaling hunger and fullness. However, this study shows a more complex chain of events involving multiple cell types. After a meal, rising glucose levels are detected by specialized cells called tanycytes. These cells convert glucose into lactate, which then acts as a signaling molecule.
</p><p>Instead of communicating directly with neurons, lactate first activates nearby astrocytes through a receptor known as HCAR1. Once activated, astrocytes release glutamate, a neurotransmitter that signals appetite-suppressing neurons, ultimately creating the sensation of fullness. In simple terms, tanycytes “talk” to astrocytes, and astrocytes “talk” to neurons.
</p><p>Researchers also found that this signaling can spread across networks of astrocytes, amplifying the brain’s response to food intake. Interestingly, lactate may have a dual role—indirectly activating fullness signals while also potentially suppressing hunger signals through other pathways.
</p><p>Scientists are now exploring whether manipulating the HCAR1 receptor could influence eating behavior. If successful, this pathway could complement existing treatments like Ozempic, offering a new frontier in metabolic health.
</p><p><b>REFERENCE:</b> S. López,R. Elizondo-Vega,V. Azócar,V. Sepúlveda,V. Opazo-Mellado,W. Vásquez,J.C. Sáez,R.C. Araneda, & M.D.L.Á. García-Robles,  Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability, Proc. Natl. Acad. Sci. U.S.A. 123 (15) e2537810123, https://doi.org/10.1073/pnas.2537810123 (2026).
</p>]]> </content:encoded>
</item>

<item>
<title>Non&#45;Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study</title>
<link>https://edusehat.com/en/non-invasive-urine-test-improves-prediction-of-bladder-cancer-treatment-outcomes-study</link>
<guid>https://edusehat.com/en/non-invasive-urine-test-improves-prediction-of-bladder-cancer-treatment-outcomes-study</guid>
<description><![CDATA[ A simple urine sample may soon reveal whether bladder cancer will return before scans can even detect it.
Bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC), is one of the most commonly diagnosed cancers and is notorious for coming back even after early treatment. Patients typically undergo tumor removal followed by immunotherapy using BCG. However, doctors have long lacked a reliable way to predict who will benefit from this therapy and who will relapse.
Now, a new study published in Cell by researchers at Stanford University offers a promising solution: a highly sensitive, non-invasive urine test that can detect microscopic traces of tumor DNA and predict recurrence risk with remarkable accuracy.
The innovation lies in overcoming a major challenge in liquid biopsy testing. Scientists discovered that even healthy bladder cells can carry mutations—termed “clonal cystopoiesis”—which can lead to false positives. To address this, the team developed a statistical method to filter out these background mutations, allowing the test to distinguish real cancer signals from harmless genetic noise.
When tested in patients undergoing surgery and BCG therapy, the results were striking. Individuals with detectable tumor DNA after treatment had an almost certain risk of recurrence, while those whose tumor DNA disappeared showed excellent outcomes. In many cases, the test identified relapse risk even before standard cystoscopy exams showed abnormalities.
Researchers also identified three response patterns: patients cured by surgery alone, those who responded to BCG, and those who did not respond to either. This insight could help doctors tailor treatment strategies more precisely.
If validated in larger trials, this approach could transform bladder cancer care—reducing unnecessary treatments, prioritizing high-risk patients, and enabling earlier intervention. Ultimately, it moves the field closer to truly personalized cancer therapy, guided by a simple urine test.
REFERENCE: Shi, W. Y., et al. (2026). Field-effect-informed urine liquid biopsy for bladder cancer. Cell. DOI: 10.1016/j.cell.2025.12.054. https://www.cell.com/cell/abstract/S0092-8674(25)01503-X
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340788-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-59.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Non-Invasive, Urine, Test, Improves, Prediction, Bladder, Cancer, Treatment, Outcomes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340788-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-59.webp"><p>A simple urine sample may soon reveal whether bladder cancer will return before scans can even detect it.
</p><p>Bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC), is one of the most commonly diagnosed cancers and is notorious for coming back even after early treatment. Patients typically undergo tumor removal followed by immunotherapy using BCG. However, doctors have long lacked a reliable way to predict who will benefit from this therapy and who will relapse.
</p><p>Now, a new study published in <i>Cell </i>by researchers at Stanford University offers a promising solution: a highly sensitive, non-invasive urine test that can detect microscopic traces of tumor DNA and predict recurrence risk with remarkable accuracy.
</p><p>The innovation lies in overcoming a major challenge in liquid biopsy testing. Scientists discovered that even healthy bladder cells can carry mutations—termed “clonal cystopoiesis”—which can lead to false positives. To address this, the team developed a statistical method to filter out these background mutations, allowing the test to distinguish real cancer signals from harmless genetic noise.
</p><p>When tested in patients undergoing surgery and BCG therapy, the results were striking. Individuals with detectable tumor DNA after treatment had an almost certain risk of recurrence, while those whose tumor DNA disappeared showed excellent outcomes. In many cases, the test identified relapse risk even before standard cystoscopy exams showed abnormalities.
</p><p>Researchers also identified three response patterns: patients cured by surgery alone, those who responded to BCG, and those who did not respond to either. This insight could help doctors tailor treatment strategies more precisely.
</p><p>If validated in larger trials, this approach could transform bladder cancer care—reducing unnecessary treatments, prioritizing high-risk patients, and enabling earlier intervention. Ultimately, it moves the field closer to truly personalized cancer therapy, guided by a simple urine test.
</p><p><b>REFERENCE:</b> Shi, W. Y., et al. (2026). Field-effect-informed urine liquid biopsy for bladder cancer. Cell. DOI: 10.1016/j.cell.2025.12.054. https://www.cell.com/cell/abstract/S0092-8674(25)01503-X
</p>]]> </content:encoded>
</item>

<item>
<title>New Study Highlights Brain Benefits of High&#45;Quality Plant&#45;Based Diets</title>
<link>https://edusehat.com/en/new-study-highlights-brain-benefits-of-high-quality-plant-based-diets</link>
<guid>https://edusehat.com/en/new-study-highlights-brain-benefits-of-high-quality-plant-based-diets</guid>
<description><![CDATA[ Not all plant-based diets are healthy-and your brain may know the difference.
A new study published in Neurology journal finds that the quality of plant-based foods you eat could significantly influence your risk of Alzheimer’s disease and other dementias. While plant-based eating is often seen as beneficial, researchers say it’s not just about eating plants—but choosing the right ones.
The study, led by scientists from University of Hawaii at Manoa, followed 92,849 adults with an average age of 59 over 11 years. During this time, more than 21,000 participants developed dementia. Researchers analyzed dietary patterns by categorizing them into three types: an overall plant-based diet, a healthful plant-based diet, and an unhealthful plant-based diet.
The healthful version emphasized whole grains, fruits, vegetables, nuts, legumes, and healthy oils. In contrast, the unhealthful version included refined grains, sugary foods, fruit juices, and processed plant-based items.
Results showed that participants who consumed the highest amount of plant foods overall had a 12% lower risk of dementia compared to those who consumed the least. Those following a healthful plant-based diet had a 7% lower risk. However, people consuming the unhealthiest plant-based foods had a 6% higher risk of developing dementia.
Long-term changes in diet also mattered. Among participants tracked over time, those who shifted toward unhealthful plant-based diets had a 25% higher risk of dementia. Conversely, those who moved away from unhealthy choices reduced their risk by 11%.
The findings highlight a key message: simply avoiding animal products is not enough. Diet quality plays a crucial role in brain health. While the study is observational and does not prove cause and effect, it suggests that choosing nutrient-rich, minimally processed plant foods may support cognitive health as we age.
REFERENCE: Song-Yi Park, Veronica Wendy Setiawan, Eileen M. Crimmins, et al.; Plant-Based Dietary Patterns and Risk of Alzheimer Disease and Related Dementias in the Multiethnic Cohort Study; Neurology, The American Academy of Neurology; https://doi.org/10.1212/WNL.0000000000214916
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340782-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-58.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Study, Highlights, Brain, Benefits, High-Quality, Plant-Based, Diets</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340782-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-58.webp"><p>Not all plant-based diets are healthy-and your brain may know the difference.
</p><p>A new study published in Neurology journal finds that the quality of plant-based foods you eat could significantly influence your risk of Alzheimer’s disease and other dementias. While plant-based eating is often seen as beneficial, researchers say it’s not just about eating plants—but choosing the right ones.
</p><p>The study, led by scientists from University of Hawaii at Manoa, followed 92,849 adults with an average age of 59 over 11 years. During this time, more than 21,000 participants developed dementia. Researchers analyzed dietary patterns by categorizing them into three types: an overall plant-based diet, a healthful plant-based diet, and an unhealthful plant-based diet.
</p><p>The healthful version emphasized whole grains, fruits, vegetables, nuts, legumes, and healthy oils. In contrast, the unhealthful version included refined grains, sugary foods, fruit juices, and processed plant-based items.
</p><p>Results showed that participants who consumed the highest amount of plant foods overall had a 12% lower risk of dementia compared to those who consumed the least. Those following a healthful plant-based diet had a 7% lower risk. However, people consuming the unhealthiest plant-based foods had a 6% higher risk of developing dementia.
</p><p>Long-term changes in diet also mattered. Among participants tracked over time, those who shifted toward unhealthful plant-based diets had a 25% higher risk of dementia. Conversely, those who moved away from unhealthy choices reduced their risk by 11%.
</p><p>The findings highlight a key message: simply avoiding animal products is not enough. Diet quality plays a crucial role in brain health. While the study is observational and does not prove cause and effect, it suggests that choosing nutrient-rich, minimally processed plant foods may support cognitive health as we age.
</p><p><b>REFERENCE: </b>Song-Yi Park, Veronica Wendy Setiawan, Eileen M. Crimmins, et al.; Plant-Based Dietary Patterns and Risk of Alzheimer Disease and Related Dementias in the Multiethnic Cohort Study; Neurology, The American Academy of Neurology; https://doi.org/10.1212/WNL.0000000000214916
</p>]]> </content:encoded>
</item>

<item>
<title>PG training, teaching experience from unrecognised departments Invalid: NMC</title>
<link>https://edusehat.com/en/pg-training-teaching-experience-from-unrecognised-departments-invalid-nmc</link>
<guid>https://edusehat.com/en/pg-training-teaching-experience-from-unrecognised-departments-invalid-nmc</guid>
<description><![CDATA[ New Delhi: Observing that in some cases, teaching experience certificates and postgraduate training were being claimed from unrecognised departments, the Post Graduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) has reiterated that such experience will neither be considered valid nor counted for academic or professional purposes.The Apex Medical Regulatory body stressed that postgraduate medical education and training must strictly follow its notified regulations, including the Postgraduate Medical Education Regulations, 2023 and the Medical Institutions (Qualifications of Faculty) Regulations, 2025.According to the Commission, these regulations clearly stipulate that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records.Writing to the Vice-Chancellors, DGHS officials, heads of medical colleges and Ministry of Health &amp; Family Welfare, the PGMEB clarified that any teaching or training experience gained in departments or units not recognized by the Commission will not be counted for academic or professional purposes.This comes after the Commission noted that some faculty members were submitting experience certificates based on departments that are not approved for postgraduate medical education. It made it clear that such practices are not valid under existing regulations.&quot;The National Medical Commission (NMC) has observed, in certain instances, that teaching experience certificates and postgraduate training experience are being claimed by the faculty or certified by the universities/institutions on the basis of departments or units that are not recognized or permitted by the Commission for conducting postgraduate medical education.It is reiterated that postgraduate medical education and training must strictly conform to the provisions of the regulations notified by the Commission from time to time, including the Postgraduate Medical Education Regulations, 2023 and the Medical Institutions (Qualifications of Faculty) Regulations, 2025. These regulations clearly stipulate that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records,&quot; the letter read. In light of the above, NMC has issued the following clarifications for strict compliance:(i) Non-counting of training/experienceAny postgraduate training or teaching experience obtained in a department or unit, that is not recognized or approved by the National Medical Commission for conducting postgraduate medical education, shall not be counted for the purpose of:a. Eligibility for appearing in postgraduate examinations;
b. Recognition as a postgraduate teacher/guide;
c. Appointment or promotion to faculty positions;
d. Determination of teaching experience for regulatory, academic, or administrative purposes.(ii) Invalidation of experience certificates
Any teaching experience certificate issued on the basis of service rendered in an unrecognized department/unit shall be treated as invalid for determining eligibility, appointment, promotion, or recognition under the applicable regulations of the Commission.(iii) Responsibility of Universities and Institutions
All Medical Colleges/Institutions and affiliating Universities shall ensure that:
a. Teaching experience certificates are issued only after verification of the recognition status of the concerned department/unit as per NMC records;b. No teaching experience certificate is issued for experience gained in departments/units not recognized or permitted by the Commission .&quot;All concerned are requested to ensure strict compliance with the above directions and disseminate this advisory to all affiliated institutions and departments under their jurisdiction,&quot; it added.Referring to the PGMEB letter, the NMC secretary, Dr Raghav Langer, wrote to the concerned stakeholders informing them that postgraduate training or teaching experience obtained from unrecognized departments will not be counted, and any experience certificates issued on such basis will be treated as invalid.&quot;Please find enclosed herewith an Advisory No. NMC-23(1)(161)/2022/Med/PG dated 09-04-2026 on the subject matter as issued by Post Graduate Medical Education Board (PGMEB) of National Medical Commission being self- explanatory and reiterating that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records in due conformity with various regulations as notified by the National Medical Commission. The Advisory inter-alia provides certain instructions and clarifications and all concerned are requested to take note of and ensure strict compliance of the same,&quot; mentioned the notice. To view the notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/11/nmc-non-counting-of-postgraduate-training-teaching-experience-obtained-in-unrecognized-departments-and-invalidation-of-teaching-experience-certificates-issued-on-such-basis-341048.pdfAlso read- Teaching experience before medical college&#039;s recognition not valid for faculty appointment eligibility: HC ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340199-mbbs-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>training, teaching, experience, from, unrecognised, departments, Invalid:, NMC</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340199-mbbs-3.webp"><p><b>New Delhi:</b> Observing that in some cases, teaching experience certificates and <a href="https://medicaldialogues.in/topics/pg-medical" target="_blank">postgraduate </a>training were being claimed from unrecognised departments, the Post Graduate Medical Education Board (PGMEB) of the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC) has reiterated that such experience will neither be considered valid nor counted for academic or professional purposes.</p><p>The Apex Medical Regulatory body stressed that postgraduate medical education and training must strictly follow its notified regulations, including the Postgraduate Medical Education Regulations, 2023 and the Medical Institutions (Qualifications of Faculty) Regulations, 2025.</p><p>According to the Commission, these regulations clearly stipulate that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records.</p><p>Writing to the Vice-Chancellors, DGHS officials, heads of medical colleges and Ministry of Health & Family Welfare, the PGMEB clarified that any teaching or training experience gained in departments or units not recognized by the Commission will not be counted for academic or professional purposes.</p><p>This comes after the Commission noted that some faculty members were submitting experience certificates based on departments that are not approved for postgraduate medical education. It made it clear that such practices are not valid under existing regulations.</p><p><i>"The National Medical Commission (NMC) has observed, in certain instances, that teaching experience certificates and postgraduate training experience are being claimed by the faculty or certified by the universities/institutions on the basis of departments or units that are not recognized or permitted by the Commission for conducting postgraduate medical education.</i></p><p><i>It is reiterated that postgraduate medical education and training must strictly conform to the provisions of the regulations notified by the Commission from time to time, including the Postgraduate Medical Education Regulations, 2023 and the Medical Institutions (Qualifications of Faculty) Regulations, 2025. These regulations clearly stipulate that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records," </i>the letter read. </p><p>In light of the above, NMC has issued the following clarifications for strict compliance:</p><p><b>(i) Non-counting of training/experience</b></p><p>Any postgraduate training or teaching experience obtained in a department or unit, that is not recognized or approved by the National Medical Commission for conducting postgraduate medical education, shall not be counted for the purpose of:</p><p>a. Eligibility for appearing in postgraduate examinations;
</p><p>b. Recognition as a postgraduate teacher/guide;
</p><p>c. Appointment or promotion to faculty positions;
</p><p>d. Determination of teaching experience for regulatory, academic, or administrative purposes.</p><p><b>(ii) Invalidation of experience certificates
</b></p><p>Any teaching experience certificate issued on the basis of service rendered in an unrecognized department/unit shall be treated as invalid for determining eligibility, appointment, promotion, or recognition under the applicable regulations of the Commission.</p><p><b>(iii) Responsibility of Universities and Institutions
</b></p><p>All Medical Colleges/Institutions and affiliating Universities shall ensure that:
</p><p>a. Teaching experience certificates are issued only after verification of the recognition status of the concerned department/unit as per NMC records;</p><p>b. No teaching experience certificate is issued for experience gained in departments/units not recognized or permitted by the Commission .</p><p>"All concerned are requested to ensure strict compliance with the above directions and disseminate this advisory to all affiliated institutions and departments under their jurisdiction," it added.</p><p>Referring to the PGMEB letter, the NMC secretary, Dr Raghav Langer, wrote to the concerned stakeholders informing them that postgraduate training or teaching experience obtained from unrecognized departments will not be counted, and any experience certificates issued on such basis will be treated as invalid.</p><p><i>"Please find enclosed herewith an Advisory No. NMC-23(1)(161)/2022/Med/PG dated 09-04-2026 on the subject matter as issued by Post Graduate Medical Education Board (PGMEB) of National Medical Commission being self- explanatory and reiterating that teaching experience for appointment to faculty positions or for recognition as a postgraduate teacher must be obtained only from recognized medical colleges and duly recognized teaching departments with approved infrastructure, faculty strength, and permitted postgraduate seats as per NMC records in due conformity with various regulations as notified by the National Medical Commission. The Advisory inter-alia provides certain instructions and clarifications and all concerned are requested to take note of and ensure strict compliance of the same,"</i> mentioned the notice. </p><p><b>To view the notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/nmc-non-counting-of-postgraduate-training-teaching-experience-obtained-in-unrecognized-departments-and-invalidation-of-teaching-experience-certificates-issued-on-such-basis-341048.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/11/nmc-non-counting-of-postgraduate-training-teaching-experience-obtained-in-unrecognized-departments-and-invalidation-of-teaching-experience-certificates-issued-on-such-basis-341048.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/teaching-experience-before-medical-colleges-recognition-not-valid-for-faculty-appointment-eligibility-hc-150393" target="_blank">Teaching experience before medical college's recognition not valid for faculty appointment eligibility: HC</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 11/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-11april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-11april2026</guid>
<description><![CDATA[ Here are the top medical news for today:New Study Highlights Brain Benefits of High-Quality Plant-Based Diets
Not all plant-based diets are healthy—and your brain may know the difference.
A new study published in Neurology journal finds that the quality of plant-based foods you eat could significantly influence your risk of Alzheimer’s disease and other dementias. While plant-based eating is often seen as beneficial, researchers say it’s not just about eating plants—but choosing the right ones.
The study, led by scientists from University of Hawaii at Manoa, followed 92,849 adults with an average age of 59 over 11 years. During this time, more than 21,000 participants developed dementia. Researchers analyzed dietary patterns by categorizing them into three types: an overall plant-based diet, a healthful plant-based diet, and an unhealthful plant-based diet.
The healthful version emphasized whole grains, fruits, vegetables, nuts, legumes, and healthy oils. In contrast, the unhealthful version included refined grains, sugary foods, fruit juices, and processed plant-based items.
Results showed that participants who consumed the highest amount of plant foods overall had a 12% lower risk of dementia compared to those who consumed the least. Those following a healthful plant-based diet had a 7% lower risk. However, people consuming the unhealthiest plant-based foods had a 6% higher risk of developing dementia.
Long-term changes in diet also mattered. Among participants tracked over time, those who shifted toward unhealthful plant-based diets had a 25% higher risk of dementia. Conversely, those who moved away from unhealthy choices reduced their risk by 11%.
The findings highlight a key message: simply avoiding animal products is not enough. Diet quality plays a crucial role in brain health. While the study is observational and does not prove cause and effect, it suggests that choosing nutrient-rich, minimally processed plant foods may support cognitive health as we age.
REFERENCE: Song-Yi Park, Veronica Wendy Setiawan, Eileen M. Crimmins, et al.; Plant-Based Dietary Patterns and Risk of Alzheimer Disease and Related Dementias in the Multiethnic Cohort Study; Neurology, The American Academy of Neurology; https://doi.org/10.1212/WNL.0000000000214916
Non-Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study
A simple urine sample may soon reveal whether bladder cancer will return—before scans can even detect it.
Bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC), is one of the most commonly diagnosed cancers and is notorious for coming back even after early treatment. Patients typically undergo tumor removal followed by immunotherapy using BCG. However, doctors have long lacked a reliable way to predict who will benefit from this therapy and who will relapse.
Now, a new study published in Cell by researchers at Stanford University offers a promising solution: a highly sensitive, non-invasive urine test that can detect microscopic traces of tumor DNA and predict recurrence risk with remarkable accuracy.
The innovation lies in overcoming a major challenge in liquid biopsy testing. Scientists discovered that even healthy bladder cells can carry mutations—termed “clonal cystopoiesis”—which can lead to false positives. To address this, the team developed a statistical method to filter out these background mutations, allowing the test to distinguish real cancer signals from harmless genetic noise.
When tested in patients undergoing surgery and BCG therapy, the results were striking. Individuals with detectable tumor DNA after treatment had an almost certain risk of recurrence, while those whose tumor DNA disappeared showed excellent outcomes. In many cases, the test identified relapse risk even before standard cystoscopy exams showed abnormalities.
Researchers also identified three response patterns: patients cured by surgery alone, those who responded to BCG, and those who did not respond to either. This insight could help doctors tailor treatment strategies more precisely.
If validated in larger trials, this approach could transform bladder cancer care—reducing unnecessary treatments, prioritizing high-risk patients, and enabling earlier intervention. Ultimately, it moves the field closer to truly personalized cancer therapy, guided by a simple urine test.
REFERENCE: Shi, W. Y., et al. (2026). Field-effect-informed urine liquid biopsy for bladder cancer. Cell. DOI: 10.1016/j.cell.2025.12.054. https://www.cell.com/cell/abstract/S0092-8674(25)01503-X
Scientists Discover Brain Mechanism That Signals the Body to Stop Eating
What if the key to feeling full isn’t just in your neurons—but in overlooked brain cells working behind the scenes?
A new study published in Proceedings of the National Academy of Sciences is reshaping how scientists understand appetite control, revealing that astrocytes—once thought to be mere support cells—play an active role in telling the brain when to stop eating. 
The research, led by teams from the University of Concepción and the University of Maryland, uncovers a previously unknown communication pathway in the hypothalamus, the brain’s hunger-regulating center.
Traditionally, neurons were considered the main players in signaling hunger and fullness. However, this study shows a more complex chain of events involving multiple cell types. After a meal, rising glucose levels are detected by specialized cells called tanycytes. These cells convert glucose into lactate, which then acts as a signaling molecule.
Instead of communicating directly with neurons, lactate first activates nearby astrocytes through a receptor known as HCAR1. Once activated, astrocytes release glutamate, a neurotransmitter that signals appetite-suppressing neurons, ultimately creating the sensation of fullness. In simple terms, tanycytes “talk” to astrocytes, and astrocytes “talk” to neurons.
Researchers also found that this signaling can spread across networks of astrocytes, amplifying the brain’s response to food intake. Interestingly, lactate may have a dual role—indirectly activating fullness signals while also potentially suppressing hunger signals through other pathways.
Scientists are now exploring whether manipulating the HCAR1 receptor could influence eating behavior. If successful, this pathway could complement existing treatments like Ozempic, offering a new frontier in metabolic health.
REFERENCE: S. López,R. Elizondo-Vega,V. Azócar,V. Sepúlveda,V. Opazo-Mellado,W. Vásquez,J.C. Sáez,R.C. Araneda, &amp; M.D.L.Á. García-Robles,  Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability, Proc. Natl. Acad. Sci. U.S.A. 123 (15) e2537810123, https://doi.org/10.1073/pnas.2537810123 (2026).
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/341002-top-medical-2026-04-11t124318613.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 11April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/341002-top-medical-2026-04-11t124318613.webp"><p><b>Here are the top medical news for today:</b></p><p><b>New Study Highlights Brain Benefits of High-Quality Plant-Based Diets
</b></p><p>Not all plant-based diets are healthy—and your brain may know the difference.
</p><p>A new study published in Neurology journal finds that the quality of plant-based foods you eat could significantly influence your risk of Alzheimer’s disease and other dementias. While plant-based eating is often seen as beneficial, researchers say it’s not just about eating plants—but choosing the right ones.
</p><p>The study, led by scientists from University of Hawaii at Manoa, followed 92,849 adults with an average age of 59 over 11 years. During this time, more than 21,000 participants developed dementia. Researchers analyzed dietary patterns by categorizing them into three types: an overall plant-based diet, a healthful plant-based diet, and an unhealthful plant-based diet.
</p><p>The healthful version emphasized whole grains, fruits, vegetables, nuts, legumes, and healthy oils. In contrast, the unhealthful version included refined grains, sugary foods, fruit juices, and processed plant-based items.
</p><p>Results showed that participants who consumed the highest amount of plant foods overall had a 12% lower risk of dementia compared to those who consumed the least. Those following a healthful plant-based diet had a 7% lower risk. However, people consuming the unhealthiest plant-based foods had a 6% higher risk of developing dementia.
</p><p>Long-term changes in diet also mattered. Among participants tracked over time, those who shifted toward unhealthful plant-based diets had a 25% higher risk of dementia. Conversely, those who moved away from unhealthy choices reduced their risk by 11%.
</p><p>The findings highlight a key message: simply avoiding animal products is not enough. Diet quality plays a crucial role in brain health. While the study is observational and does not prove cause and effect, it suggests that choosing nutrient-rich, minimally processed plant foods may support cognitive health as we age.
</p><p><b>REFERENCE: </b>Song-Yi Park, Veronica Wendy Setiawan, Eileen M. Crimmins, et al.; Plant-Based Dietary Patterns and Risk of Alzheimer Disease and Related Dementias in the Multiethnic Cohort Study; Neurology, The American Academy of Neurology; https://doi.org/10.1212/WNL.0000000000214916
</p><p><b><br></b></p><p><b>Non-Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study
</b></p><p>A simple urine sample may soon reveal whether bladder cancer will return—before scans can even detect it.
</p><p>Bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC), is one of the most commonly diagnosed cancers and is notorious for coming back even after early treatment. Patients typically undergo tumor removal followed by immunotherapy using BCG. However, doctors have long lacked a reliable way to predict who will benefit from this therapy and who will relapse.
</p><p>Now, a new study published in Cell by researchers at Stanford University offers a promising solution: a highly sensitive, non-invasive urine test that can detect microscopic traces of tumor DNA and predict recurrence risk with remarkable accuracy.
</p><p>The innovation lies in overcoming a major challenge in liquid biopsy testing. Scientists discovered that even healthy bladder cells can carry mutations—termed “clonal cystopoiesis”—which can lead to false positives. To address this, the team developed a statistical method to filter out these background mutations, allowing the test to distinguish real cancer signals from harmless genetic noise.
</p><p>When tested in patients undergoing surgery and BCG therapy, the results were striking. Individuals with detectable tumor DNA after treatment had an almost certain risk of recurrence, while those whose tumor DNA disappeared showed excellent outcomes. In many cases, the test identified relapse risk even before standard cystoscopy exams showed abnormalities.
</p><p>Researchers also identified three response patterns: patients cured by surgery alone, those who responded to BCG, and those who did not respond to either. This insight could help doctors tailor treatment strategies more precisely.
</p><p>If validated in larger trials, this approach could transform bladder cancer care—reducing unnecessary treatments, prioritizing high-risk patients, and enabling earlier intervention. Ultimately, it moves the field closer to truly personalized cancer therapy, guided by a simple urine test.
</p><p><b>REFERENCE: </b>Shi, W. Y., et al. (2026). Field-effect-informed urine liquid biopsy for bladder cancer. Cell. DOI: 10.1016/j.cell.2025.12.054. https://www.cell.com/cell/abstract/S0092-8674(25)01503-X
</p><p><b><br></b></p><p><b>Scientists Discover Brain Mechanism That Signals the Body to Stop Eating
</b></p><p>What if the key to feeling full isn’t just in your neurons—but in overlooked brain cells working behind the scenes?
</p><p>A new study published in Proceedings of the National Academy of Sciences is reshaping how scientists understand appetite control, revealing that astrocytes—once thought to be mere support cells—play an active role in telling the brain when to stop eating. 
</p><p>The research, led by teams from the University of Concepción and the University of Maryland, uncovers a previously unknown communication pathway in the hypothalamus, the brain’s hunger-regulating center.
</p><p>Traditionally, neurons were considered the main players in signaling hunger and fullness. However, this study shows a more complex chain of events involving multiple cell types. After a meal, rising glucose levels are detected by specialized cells called tanycytes. These cells convert glucose into lactate, which then acts as a signaling molecule.
</p><p>Instead of communicating directly with neurons, lactate first activates nearby astrocytes through a receptor known as HCAR1. Once activated, astrocytes release glutamate, a neurotransmitter that signals appetite-suppressing neurons, ultimately creating the sensation of fullness. In simple terms, tanycytes “talk” to astrocytes, and astrocytes “talk” to neurons.
</p><p>Researchers also found that this signaling can spread across networks of astrocytes, amplifying the brain’s response to food intake. Interestingly, lactate may have a dual role—indirectly activating fullness signals while also potentially suppressing hunger signals through other pathways.
</p><p>Scientists are now exploring whether manipulating the HCAR1 receptor could influence eating behavior. If successful, this pathway could complement existing treatments like Ozempic, offering a new frontier in metabolic health.
</p><p><b>REFERENCE: </b>S. López,R. Elizondo-Vega,V. Azócar,V. Sepúlveda,V. Opazo-Mellado,W. Vásquez,J.C. Sáez,R.C. Araneda, & M.D.L.Á. García-Robles,  Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability, Proc. Natl. Acad. Sci. U.S.A. 123 (15) e2537810123, https://doi.org/10.1073/pnas.2537810123 (2026).
</p>]]> </content:encoded>
</item>

<item>
<title>X&#45;Ray Film Shortage Row: KMC Hospital asks patients to use mobile photos</title>
<link>https://edusehat.com/en/x-ray-film-shortage-row-kmc-hospital-asks-patients-to-use-mobile-photos</link>
<guid>https://edusehat.com/en/x-ray-film-shortage-row-kmc-hospital-asks-patients-to-use-mobile-photos</guid>
<description><![CDATA[ Chennai: Amid a shortage of X-ray films, Kilpauk Medical College (KMC) Hospital has reportedly advised patients to take photos of their X-rays on mobile phones and show them to doctors for consultation.The move has raised serious concerns, as poor image quality can lead to misinterpretation and misdiagnosis, potentially putting the lives of thousands of daily patients at risk.The development has also sparked questions regarding accessibility. What happens if a patient does not have a smartphone? How will elderly patients manage in such situations? Also Read: 31-year-old Anaesthesiologist found dead in Chennai amid marriage disputeWhen DTNext media news report sought clarification regarding the matter, the Dean of KMC Hospital stated that the hospital has an adequate supply of X-ray sheets and that they would look into the matter with the Radiology Department.Additionally, Dr S Perumal Pillai, President of the Government Doctors&#039; Association, stated that the shortage of X-ray sheets is a statewide crisis, and most government hospitals are currently grappling with this issue.Perumal warned that if doctors are compelled to diagnose patients based on photographs viewed on their mobile phones, it could lead to misdiagnosis and endanger people&#039;s lives. He stated that physical X-ray sheets remain the most reliable method for accurately interpreting a patient&#039;s condition and making a diagnosis.Meanwhile, the Indian Council of Medical Research (ICMR) and the National Medical Commission (NMC) provide specific frameworks for doctors who use digital images for diagnosis.Under the Telemedicine Practice Guidelines, diagnosing a patient using smartphone images of X-rays is legally valid. However, it entails significant professional responsibilities and technical risks. Medical Dialogues had earlier reported that members of the Healthcare Beneficiaries Welfare Committee of the Coimbatore District Government Headquarters Hospital, along with residents, have urged the state authorities to post key specialists at the Pollachi government hospital, noting that although it has 462 inpatient beds, it lacks experts in cardiothoracic surgery, neurology and dermatology. Also Read: Infant dies after alleged wrong injection at Chennai Hospital, family protests ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/26/210551-lung-cancer-in-chest-x-ray.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>X-Ray, Film, Shortage, Row:, KMC, Hospital, asks, patients, use, mobile, photos</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/26/210551-lung-cancer-in-chest-x-ray.webp"><p><b>Chennai: </b>Amid a shortage of X-ray films, Kilpauk Medical College (KMC) Hospital has reportedly advised patients to take photos of their X-rays on mobile phones and show them to doctors for consultation.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The move has raised serious concerns, as poor image quality can lead to misinterpretation and misdiagnosis, potentially putting the lives of thousands of daily patients at risk.</p><p dir="ltr">The development has also sparked questions regarding accessibility. What happens if a patient does not have a smartphone? How will elderly patients manage in such situations? </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/31-year-old-anaesthesiologist-found-dead-in-chennai-amid-marriage-dispute-168043"><b>Also Read: </b>31-year-old Anaesthesiologist found dead in Chennai amid marriage dispute</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">When <a href="https://www.dtnext.in/news/tamilnadu/diagnosis-in-danger-out-of-films-kilpauk-med-college-asks-patients-to-click-pic-of-x-ray-image-2" target="_blank" rel="nofollow">DTNext </a>media news report sought clarification regarding the matter, the Dean of KMC Hospital stated that the hospital has an adequate supply of X-ray sheets and that they would look into the matter with the Radiology Department.</p><p dir="ltr">Additionally, Dr S Perumal Pillai, President of the Government Doctors' Association, stated that the shortage of X-ray sheets is a statewide crisis, and most government hospitals are currently grappling with this issue.</p><p dir="ltr">Perumal warned that if doctors are compelled to diagnose patients based on photographs viewed on their mobile phones, it could lead to misdiagnosis and endanger people's lives. He stated that physical X-ray sheets remain the most reliable method for accurately interpreting a patient's condition and making a diagnosis.</p><p dir="ltr">Meanwhile, the Indian Council of Medical Research (<a href="https://medicaldialogues.in/topics/icmr" target="_blank">ICMR</a>) and the National Medical Commission (<a href="https://medicaldialogues.in/topics/nmc" target="_blank">NMC</a>) provide specific frameworks for doctors who use digital images for diagnosis.</p><p dir="ltr">Under the Telemedicine Practice Guidelines, diagnosing a patient using smartphone images of X-rays is legally valid. However, it entails significant professional responsibilities and technical risks. </p><p dir="ltr">Medical Dialogues had earlier reported that members of the Healthcare Beneficiaries Welfare Committee of the Coimbatore District Government Headquarters Hospital, along with residents, have urged the state authorities to post key specialists at the Pollachi government hospital, noting that although it has 462 inpatient beds, it lacks experts in cardiothoracic surgery, neurology and dermatology. </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/infant-dies-after-alleged-wrong-injection-at-chennai-hospital-family-protests-167658"><b>Also Read: </b>Infant dies after alleged wrong injection at Chennai Hospital, family protests</a></div>]]> </content:encoded>
</item>

<item>
<title>Nursing Association President at AIIMS Bhubaneswar assaulted, critical condition</title>
<link>https://edusehat.com/en/nursing-association-president-at-aiims-bhubaneswar-assaulted-critical-condition</link>
<guid>https://edusehat.com/en/nursing-association-president-at-aiims-bhubaneswar-assaulted-critical-condition</guid>
<description><![CDATA[ Bhubaneswar: A shocking incident of violence has left the medical community in Bhubaneswar deeply disturbed after the president of the All India Institute of Medical Sciences (AIIMS Bhubaneswar) Nursing Association was critically injured in a brutal attack on Friday.  According to news reports, the attack took place near the Patrapada bus stop in Bhubaneswar, where approximately six individuals reportedly assaulted a nursing leader. The motive behind the violent act remains unknown, and authorities have yet to identify those responsible.    Also Read:Woman doctor, staff assaulted by patient attendants at Chamba HospitalThe victim sustained severe injuries in what is being described as a life-threatening assault. He was immediately rushed to AIIMS Bhubaneswar, where he is currently undergoing treatment in the critical care unit.Following the attack, members of the Nursing Association filed a formal complaint at the Khandagiri police station, demanding swift action against those responsible. Police have launched an investigation and are working to identify and apprehend the attackers.   The incident triggered strong reactions across the hospital campus, with nursing staff and association members organizing a candlelight rally to express solidarity and to condemn the act of violence.  Speaking to Odisha TV, a nursing staff member said, &quot;We are not aware of the individuals involved in the attack at this stage. The details will become clear only after a thorough police investigation. It is essential that the police conduct a proper inquiry. Additionally, ensuring the safety and protection of all our nursing staff is of utmost importance.&quot;  The incident has raised serious concerns about the safety of healthcare professionals.
Medical Dialogues had previously reported that, demanding that the management fulfil their long-pending demands, the nursing officers at the Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, staged a protest on Monday by organising a one-hour rally on the hospital premises.   Also Read:NIMS nursing officers protest over long pending demands ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/02/05/272894-aki-in-icu-patients.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Nursing, Association, President, AIIMS, Bhubaneswar, assaulted, critical, condition</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/02/05/272894-aki-in-icu-patients.webp"><p><b>Bhubaneswar: </b>A shocking incident of <a href="https://medicaldialogues.in/topics/violence-against-doctors">violence </a>has left the medical community in Bhubaneswar deeply disturbed after the president of the All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/aiims-bhubaneswar">AIIMS Bhubaneswar) </a>Nursing Association was critically injured in a brutal attack on Friday.  </p><p>According to news reports, the attack took place near the Patrapada bus stop in Bhubaneswar, where approximately six individuals reportedly assaulted a <a href="https://medicaldialogues.in/topics/nursing">nursing</a> leader. The motive behind the violent act remains unknown, and authorities have yet to identify those responsible.    </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/woman-doctor-staff-assaulted-by-patient-attendants-at-chamba-hospital-168354"><b>Also Read:Woman doctor, staff assaulted by patient attendants at Chamba Hospital</b></a></p><p>The victim sustained severe injuries in what is being described as a life-threatening assault. He was immediately rushed to AIIMS Bhubaneswar, where he is currently undergoing treatment in the critical care unit.</p><p>Following the attack, members of the Nursing Association filed a formal complaint at the Khandagiri police station, demanding swift action against those responsible. Police have launched an investigation and are working to identify and apprehend the attackers.   </p><p>The incident triggered strong reactions across the hospital campus, with nursing staff and association members organizing a candlelight rally to express solidarity and to condemn the act of violence.  </p><p>Speaking to <a href="https://odishatv.in/odisha/aiims-bhubaneswar-nursing-association-president-critically-injured-in-brutal-attack-11713585" rel="nofollow">Odisha TV</a>, a nursing staff member said, "We are not aware of the individuals involved in the attack at this stage. The details will become clear only after a thorough police investigation. It is essential that the police conduct a proper inquiry. Additionally, ensuring the safety and protection of all our nursing staff is of utmost importance."  </p><p>The incident has raised serious concerns about the safety of healthcare professionals.
</p><p>Medical Dialogues had previously reported that, demanding that the management fulfil their long-pending demands, the nursing officers at the Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, staged a protest on Monday by organising a one-hour rally on the hospital premises.   </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/nims-nursing-officers-protest-over-long-pending-demands-160763"><b>Also Read:NIMS nursing officers protest over long pending demands</b></a></p>]]> </content:encoded>
</item>

<item>
<title>33 percent MBBS seats to be reserved for Haryana students at Shri Sheetla Mata Devi medical college: CM Saini</title>
<link>https://edusehat.com/en/33-percent-mbbs-seats-to-be-reserved-for-haryana-students-at-shri-sheetla-mata-devi-medical-college-cm-saini</link>
<guid>https://edusehat.com/en/33-percent-mbbs-seats-to-be-reserved-for-haryana-students-at-shri-sheetla-mata-devi-medical-college-cm-saini</guid>
<description><![CDATA[ Gurugram: Haryana Chief Minister Nayab Singh Saini recently directed that 33 percent of the MBBS seats and hospital beds at the upcoming Shri Sheetla Mata Devi Medical College and Hospital in Gurugram be reserved for residents of Haryana.This means that one-third of the 150 MBBS seats and 850 hospital beds will be reserved for students and patients from Haryana. However, the fees for these reserved seats will be aligned with the government medical colleges in order to ensure affordable education for local students, as per PTI report.Also Read: Sheetla Medical College to start OPD services from Sep 23, says CM Khattar Shri Sheetla Mata Devi Medical College and Hospital in Gurugram is being developed under the PPP model. This project spans 30.75 acres and is expected to be completed by August 2026. Officials stated that out of the total project cost of ₹679.08 crore, approximately ₹500 crore has already been spent.Meanwhile, a meeting of the Cabinet Sub-committee was recently held, presided over by Nayab Singh Saini. During the meeting, Saini emphasised that patients admitted to reserved beds should receive benefits under the Ayushman Bharat scheme, in order to ensure access to quality healthcare for economically weaker sections.Chief Minister Nayab Singh Saini has directed officials to reserve 33 per cent each of the 150 MBBS seats and 850 beds at the under-construction Shri Sheetla Mata Devi Medical College and Hospital in Gurugram for students and residents of Haryana. He also said the fees for the reserved seats should be fixed in line with other government medical colleges so that students of Haryana have access to affordable medical education, reports PTIShri Sheetla Mata Devi Medical College and Hospital will be developed in accordance with international standards, and it will significantly strengthen the healthcare infrastructure in this region.Furthermore, the Chief Minister also directed officials to explore the feasibility of establishing 3–4 additional hospitals with 100–150 beds each to meet the growing demand for healthcare services in Gurugram.Meanwhile, Medical Dialogues had earlier reported that Haryana Health, AYUSH, and Medical Education Minister Aarti Singh Rao inspected the ongoing construction of the Shri Mata Sheetla Devi Medical College and Civil Hospital in Gurugram.Following her inspection, she chaired her first meeting with officials from the Health Department and the GMDA in Gurugram.Also Read: Haryana CM highlights Ayurveda&#039;s role in managing lifestyle diseases ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340992-haryana-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>percent, MBBS, seats, reserved, for, Haryana, students, Shri, Sheetla, Mata, Devi, medical, college:, Saini</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340992-haryana-1.webp"><p><b>Gurugram:</b> Haryana Chief Minister <a href="https://medicaldialogues.in/topics/nayab-singh-saini" target="_blank">Nayab Singh Saini</a> recently directed that 33 percent of the MBBS seats and hospital beds at the upcoming Shri Sheetla Mata Devi Medical College and Hospital in Gurugram be reserved for residents of Haryana.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This means that one-third of the 150 <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>seats and 850 hospital beds will be reserved for students and patients from Haryana. However, the fees for these reserved seats will be aligned with the government medical colleges in order to ensure affordable education for local students, as per PTI report.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/sheetla-medical-college-to-start-opd-services-from-sep-23-says-cm-khattar-88922"><b>Also Read: </b>Sheetla Medical College to start OPD services from Sep 23, says CM Khattar</a></div><div class="pasted-from-word-wrapper"><p dir="ltr"> Shri Sheetla Mata Devi Medical College and Hospital in Gurugram is being developed under the PPP model. This project spans 30.75 acres and is expected to be completed by August 2026. Officials stated that out of the total project cost of ₹679.08 crore, approximately ₹500 crore has already been spent.</p><p dir="ltr">Meanwhile, a meeting of the Cabinet Sub-committee was recently held, presided over by Nayab Singh Saini. During the meeting, Saini emphasised that patients admitted to reserved beds should receive benefits under the Ayushman Bharat scheme, in order to ensure access to quality healthcare for economically weaker sections.</p><p>Chief Minister Nayab Singh Saini has directed officials to reserve 33 per cent each of the 150 MBBS seats and 850 beds at the under-construction Shri Sheetla Mata Devi Medical College and Hospital in Gurugram for students and residents of Haryana. He also said the fees for the reserved seats should be fixed in line with other government medical colleges so that students of Haryana have access to affordable medical education, reports PTI</p><p dir="ltr">Shri Sheetla Mata Devi Medical College and Hospital will be developed in accordance with international standards, and it will significantly strengthen the healthcare infrastructure in this region.</p><p dir="ltr">Furthermore, the Chief Minister also directed officials to explore the feasibility of establishing 3–4 additional hospitals with 100–150 beds each to meet the growing demand for healthcare services in Gurugram.</p><p dir="ltr">Meanwhile, Medical Dialogues had earlier reported that Haryana Health, <a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a>, and Medical Education Minister Aarti Singh Rao inspected the ongoing construction of the Shri Mata Sheetla Devi Medical College and Civil Hospital in Gurugram.</p><p dir="ltr">Following her inspection, she chaired her first meeting with officials from the Health Department and the GMDA in Gurugram.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/haryana-cm-highlights-ayurvedas-role-in-managing-lifestyle-diseases-167793"><b>Also Read: </b>Haryana CM highlights Ayurveda's role in managing lifestyle diseases</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>72&#45;year&#45;old cardiologist falls victim to cyber fraud, loses Rs 10 lakh</title>
<link>https://edusehat.com/en/72-year-old-cardiologist-falls-victim-to-cyber-fraud-loses-rs-10-lakh</link>
<guid>https://edusehat.com/en/72-year-old-cardiologist-falls-victim-to-cyber-fraud-loses-rs-10-lakh</guid>
<description><![CDATA[ Mumbai: In a recent case of cyber fraud, a 72-year-old cardiologist from Chembur was allegedly cheated of Rs 10 lakh by cyber criminals posing as Mahanagar Gas Limited personnel, a police official said on Friday.   The victim received a call claiming that he had not paid his gas bill and that supply to his residence would be discontinued, the Chembur police station official said.Also Read:75-year-old Pune doctor scammed of Rs 12.3 crore in share trading fraud&quot;The caller asked him to download a file to complete the bill payment online. After he downloaded the link, the accused got access to his bank account. They transferred Rs 10 lakh from it to another account,&quot; the official said, news agency PTI reported.  According to the complaint, the doctor received a WhatsApp message on April 8 from a mobile number claiming to be from Mahanagar Gas, stating that his February 2026 gas bill was pending and warning that his gas connection would be disconnected by 9:00 PM if the payment was not made, reports Free Press Journal.  Shortly after, he started receiving repeated calls from another number. When he informed the caller that he had already paid the bill, the accused insisted that certain updates were required and then sent him a file via WhatsApp.  Upon checking his bank account, he found that six unauthorised transactions had been made without his consent, reports The Daily.  Based on his complaint, a case was lodged on Friday under the Bharatiya Nyaya Sanhita and Information Technology Act, he said.  Medical Dialogues had earlier reported that in a shocking cyber fraud case in Hadapsar, Pune, a 75-year-old doctor reportedly lost Rs 12.31 crore to online fraudsters who promised high returns through share trading.  Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 months ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/09/197115-cyber-fraud-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>72-year-old, cardiologist, falls, victim, cyber, fraud, loses, lakh</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/09/197115-cyber-fraud-3.webp"><div class="pasted-from-word-wrapper"><p><span>Mumbai: In a recent case of cyber fraud, a 72-year-old cardiologist from Chembur was allegedly cheated of Rs 10 lakh by <a href="https://medicaldialogues.in/topics/cyber-crime" target="_blank">cyber </a>criminals posing as Mahanagar Gas Limited personnel, a police official said on Friday.   </span></p><p>The victim received a call claiming that he had not paid his gas bill and that supply to his residence would be discontinued, the Chembur police station official said.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/75-year-old-pune-doctor-scammed-of-rs-123-crore-in-share-trading-fraud-168213"><b>Also Read:75-year-old Pune doctor scammed of Rs 12.3 crore in share trading fraud</b></a></p><p>"The caller asked him to download a file to complete the bill payment online. After he downloaded the link, the accused got access to his bank account. They transferred Rs 10 lakh from it to another account," the official said, news agency PTI reported.  </p><p>According to the complaint, the doctor received a WhatsApp message on April 8 from a mobile number claiming to be from Mahanagar Gas, stating that his February 2026 gas bill was pending and warning that his gas connection would be disconnected by 9:00 PM if the payment was not made, reports <a href="https://www.freepressjournal.in/mumbai/mumbai-cyber-fraud-72-year-old-cardiologist-duped-of-949-lakh-in-fake-gas-bill-scam-via-whatsapp-apk-case-registered" rel="nofollow">Free Press Journal</a>.  </p><p>Shortly after, he started receiving repeated calls from another number. When he informed the caller that he had already paid the bill, the accused insisted that certain updates were required and then sent him a file via WhatsApp.  </p><p>Upon checking his bank account, he found that six unauthorised transactions had been made without his consent, reports The Daily.  </p><p>Based on his complaint, a case was lodged on Friday under the Bharatiya Nyaya Sanhita and Information Technology Act, he said.  </p><p>Medical Dialogues had earlier reported that in a shocking cyber fraud case in Hadapsar, Pune, a 75-year-old doctor reportedly lost Rs 12.31 crore to online fraudsters who promised high returns through share trading.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ahmedabad-doctor-loses-rs-1-lakh-in-cyber-fraud-fir-registered-after-2-months-167408"><b>Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 months</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Rs 16 lakh for MBBS degrees? Vyapam&#45;linked fraud alleged at Gwalior&amp;apos;s medical college</title>
<link>https://edusehat.com/en/rs-16-lakh-for-mbbs-degrees-vyapam-linked-fraud-alleged-at-gwaliors-medical-college</link>
<guid>https://edusehat.com/en/rs-16-lakh-for-mbbs-degrees-vyapam-linked-fraud-alleged-at-gwaliors-medical-college</guid>
<description><![CDATA[ Gwalior: In a concerning development, a former student of Gajra Raja Medical College has alleged that MBBS degrees were issued to some candidates in exchange for Rs 16 lakh, despite them not appearing for examinations, not meeting academic criteria, and being previously expelled in connection with the Vyapam scam.In a written complaint to the Governor and the college dean, the former student alleged that several expelled students were granted degrees without reinstatement, attendance or examinations, as per Bhaskar.He stated that around 150 students were booked in the Vyapam case, out of which more than 30 MBBS students were expelled, including himself. According to him, none of these students has been formally reinstated or granted relief by any committee so far; yet he claimed degrees have allegedly been issued to some, which amounts to fraud and corruption.Also read- MP HC seeks Govt response on Vyapam whistleblower&#039;s allegationsAs per the latest media report by Bhaskar, the complainant accused the UG branch in charge and his assistant of issuing degrees without due process. He has also alleged involvement of officials from Jiwaji University and the college’s confidential branch.The matter reportedly came to light through an audio clip of a conversation between the former student and the assistant. The complainant claimed to have additional audio and video evidence to expose the scam.When contacted, Dr RKS Dhakad, Dean of the Gwalior Medical College, told Bhaskar that many complaints were received and that he was not specifically aware of this one. However, he confirmed that the matter has been assigned for investigation to Dr Chhabania.Recently, the Madhya Pradesh High Court has stepped into the ongoing dispute involving Vyapam whistleblower and the Gwalior police, seeking responses from the state government and senior officials regarding serious allegations of police misconduct and medical irregularities. The whistleblower and key witness in several Vyapam cases, has accused the police of abuse of power. He made allegations against the police, like collusion with a specific hospital, fake medical records and procedural violations.Also read- Gwalior&#039;s medical college suspends 34 students after hostel clash ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/02/20/275099-scam.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>lakh, for, MBBS, degrees, Vyapam-linked, fraud, alleged, Gwaliors, medical, college</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/02/20/275099-scam.webp"><p><b>Gwalior: </b>In a concerning development, a former student of <a href="https://medicaldialogues.in/topics/gajra-raja-medical-college" target="_blank">Gajra Raja Medical College</a> has alleged that <a href="https://medicaldialogues.in/topics/mbbs-degree" target="_blank">MBBS degrees</a> were issued to some candidates in exchange for Rs 16 lakh, despite them not appearing for examinations, not meeting academic criteria, and being previously expelled in connection with the Vyapam scam.</p><p>In a written complaint to the Governor and the college dean, the former student alleged that several expelled students were granted degrees without reinstatement, attendance or examinations, as per Bhaskar.</p><p>He stated that around 150 students were booked in the Vyapam case, out of which more than 30 MBBS students were expelled, including himself. According to him, none of these students has been formally reinstated or granted relief by any committee so far; yet he claimed degrees have allegedly been issued to some, which amounts to fraud and corruption.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/mp-hc-seeks-govt-response-on-vyapam-whistleblowers-allegations-155815" target="_blank">MP HC seeks Govt response on Vyapam whistleblower's allegations</a></b></p><p>As per the latest media report by <a href="https://www.bhaskarenglish.in/local/mp/gwalior/news/gwalior-vyapam-students-mbbs-degrees-without-exams-137659774.html" target="_blank" rel="nofollow">Bhaskar</a>, the complainant accused the UG branch in charge and his assistant of issuing degrees without due process. He has also alleged involvement of officials from Jiwaji University and the college’s confidential branch.</p><p>The matter reportedly came to light through an audio clip of a conversation between the former student and the assistant. The complainant claimed to have additional audio and video evidence to expose the scam.</p><p>When contacted, Dr RKS Dhakad, Dean of the Gwalior Medical College, told Bhaskar that many complaints were received and that he was not specifically aware of this one. However, he confirmed that the matter has been assigned for investigation to Dr Chhabania.</p><p>Recently, the Madhya Pradesh High Court has stepped into the ongoing dispute involving Vyapam whistleblower and the Gwalior police, seeking responses from the state government and senior officials regarding serious allegations of police misconduct and medical irregularities. The whistleblower and key witness in several Vyapam cases, has accused the police of abuse of power. He made allegations against the police, like collusion with a specific hospital, fake medical records and procedural violations.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-colleges/gwaliors-medical-college-suspends-34-students-after-hostel-clash-156162" target="_blank">Gwalior's medical college suspends 34 students after hostel clash</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Badaun anaesthesiologist found dead at residence</title>
<link>https://edusehat.com/en/badaun-anaesthesiologist-found-dead-at-residence</link>
<guid>https://edusehat.com/en/badaun-anaesthesiologist-found-dead-at-residence</guid>
<description><![CDATA[ Badaun: In a shocking incident, a doctor working in the department of anaesthesiology at the district hospital in Badaun was found dead at his residence under suspicious circumstances.The deceased, who was originally from the Mainpuri district, had his family residing in Moradabad.  According to preliminary information, the doctor is believed to have suffered a heart attack while bathing, after which he collapsed in the bathroom. Concern arose when his colleagues visited his home and found him lying unresponsive in the bathroom. They immediately informed the police, reports UNI.The bathroom door was locked from the inside, the police said.Also Read:Anaesthesiologist found dead at residence in NarsampetAccording to Dainik Bhaskar media report, the family members reported that they had been calling his number for quite some time, but the calls were not being answered.   He was an anesthesiologist and had suffered two heart attacks. He was receiving treatment at AIIMS, Delhi. Upon receiving the information, the local Kotwali police reached the spot, conducted an initial inspection, and began an investigation. The body has been sent for postmortem examination to ascertain the exact cause of death. Medical Dialogues had earlier reported that in a tragic incident, a 31-year-old woman doctor in Chennai allegedly died by suicide after facing prolonged opposition from her family over her choice of marriage partner. According to the news reports, the deceased doctor had been working as an anaesthesiologist at the hospital for the past year. She lost her parents during her college days and was raised by her elder brother, a doctor based in Chengalpattu.  Also Read:ENT doctor found dead at Jagjivan Ram Hospital ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/09/320259-suicide.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 18:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Badaun, anaesthesiologist, found, dead, residence</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/09/320259-suicide.webp"><div class="pasted-from-word-wrapper"><p><span>Badaun: In a shocking incident, a doctor working in the department of anaesthesiology at the district hospital in Badaun was found dead at his residence under suspicious circumstances.</span></p><p>The deceased, who was originally from the Mainpuri district, had his family residing in Moradabad.  </p><p>According to preliminary information, the doctor is believed to have suffered a <a href="https://medicaldialogues.in/topics/heart-attack" target="_blank">heart attack</a> while bathing, after which he collapsed in the bathroom. </p><p>Concern arose when his colleagues visited his home and found him lying unresponsive in the bathroom. They immediately informed the police, reports UNI.</p><p>The bathroom door was locked from the inside, the police said.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/anaesthesiologist-found-dead-at-residence-in-narsampet-166745"><b>Also Read:Anaesthesiologist found dead at residence in Narsampet</b></a></p><p>According to <a href="https://www.bhaskar.com/local/uttar-pradesh/badaun/news/budayun-doctor-death-govt-quarters-bath-room-137660182.html" rel="nofollow">Dainik Bhaskar</a> media report, the family members reported that they had been calling his number for quite some time, but the calls were not being answered.   </p><p>He was an anesthesiologist and had suffered two heart attacks. He was receiving treatment at AIIMS, Delhi. </p><p>Upon receiving the information, the local Kotwali police reached the spot, conducted an initial inspection, and began an investigation. The body has been sent for postmortem examination to ascertain the exact cause of death. </p><p>Medical Dialogues had earlier reported that in a tragic incident, a 31-year-old woman doctor in Chennai allegedly died by suicide after facing prolonged opposition from her family over her choice of marriage partner. According to the news reports, the deceased doctor had been working as an anaesthesiologist at the hospital for the past year. She lost her parents during her college days and was raised by her elder brother, a doctor based in Chengalpattu.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ent-doctor-found-dead-at-jagjivan-ram-hospital-166420"><b>Also Read:ENT doctor found dead at Jagjivan Ram Hospital</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>More sleep and physical activity may prevent Type 2 diabetes in teens, suggests research</title>
<link>https://edusehat.com/en/more-sleep-and-physical-activity-may-prevent-type-2-diabetes-in-teens-suggests-research</link>
<guid>https://edusehat.com/en/more-sleep-and-physical-activity-may-prevent-type-2-diabetes-in-teens-suggests-research</guid>
<description><![CDATA[ Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17-20, 2026, and offers the latest epidemiological science on prevention, lifestyle and cardiometabolic health.
“I was happily surprised with the strength of the association of replacing 30 minutes of sedentary time with moderate-to-vigorous physical activity—a 15% lower insulin resistance is quite a big change,” said Soren Harnois-Leblanc, Ph.D., R.D., lead author of the study and a postdoctoral researcher in the department of population medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School, both in Boston. “Our findings mean that switching from sedentary behaviors to moderate-to-vigorous physical activity or sleep, even if it is only a few minutes per day to start, was beneficial for health.”To assess the impact of typical daily activities on the development of insulin resistance in teenagers, investigators examined health data from Project Viva, an ongoing health study of children born between 1999-2002 and their mothers. Insulin resistance was measured using Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), a test that estimates insulin resistance based on fasting blood glucose and insulin levels. In early adolescence, at an average of nearly 13 years old, 802 participants kept sleep logs and wore an accelerometer (a sensor that quantifies movement accelerations, from which researchers can derive the intensity and duration of physical activity) constantly for 7-10 days, providing a breakdown of the movement activities they engaged in over a typical 24 hours.By far, the highest percentage of daily time, 48% or 11.5 hours per day, was spent in sedentary activities. Examples of sedentary time may include sitting in class, doing homework, commuting and downtime in the evening, which often comes with screen time on an electronic device or watching TV.Other daily activities, reported over a 24-hour period, included sleep (33%), low-intensity physical activity (such as casual walking, 17%), and moderate-vigorous physical activity (such as running, swimming or playing basketball, 2%).The researchers then calculated how much a shift of just 30 minutes from sedentary activity to various types of physical activity or sleep could have impacted estimated insulin resistance levels in 394 of the study participants.Among the study findings:Adolescents who replaced 30 minutes of sedentary time with moderate-vigorous physical activity could lower a measurement of insulin resistance, or lowering their HOMA IR score, by nearly 15%;Participants who exchanged 30 minutes of sedentary time with sleep could lower insulin resistance by nearly 5%;Shifting 30 minutes of sedentary time to low-intensity physical activity did not have a significant change in insulin resistance levels.While activity composition was associated with insulin resistance, it was not associated with levels of adiponectin (a hormone produced by fat cells) or fasting glucose levels (a measure used to diagnose prediabetes and Type 2 diabetes).“This study shows that young adolescents spend a lot of their day being sedentary and only a small amount of time being physically active,” said Kershaw Patel, M.D., an American Heart Association volunteer and chair elect of the Association’s Council on Epidemiology and Prevention. “Interestingly, teens who had more moderate to vigorous physical activity early in adolescence showed signs of lower insulin resistance later on. The big takeaway is being active early in life can really make a difference for long‑term health.” Patel, who was not involved in this study, is an assistant professor of cardiology at Houston Methodist Hospital’s DeBakey Heart &amp; Vascular Institute in Houston.The American Heart Association’s Life’s Essential 8 metrics for optimal cardiovascular health includes strategies for incorporating healthy lifestyle into daily life. For example, dimming lights before bedtime, creating a nighttime routine that doesn’t include electronic devices with screens and putting the phone on “do not disturb” (or leaving it outside the bedroom while sleeping) can help to improve quality and quantity of sleep. Integrating physical activities with social time with friends, to clear your mind or reduce stress can make hikes or other exercise more appealing than sedentary activities.While the study did not find an association between more time spent in light physical activity and lower insulin resistance, the investigators urge additional research on this topic.                                  “More time spent in light physical activity may be beneficial to prevent cardiometabolic disease in adults. Light physical activity is an interesting target because it is likely easier to integrate into everyday routines,” said Harnois-Leblanc.The current study had some limitations, including that insulin resistance information in late adolescence was available for only 49% of participants who had accelerometer data collected in early adolescence. Additionally, cause-and-effect for daily activities and insulin resistance cannot be proven by this data analysis.Study details, background and design:The study included health information for 802 participants, ages 12-17, who were born between 1999-2002 in Eastern Massachusetts, and who were enrolled in Project Viva, an ongoing study aimed at improving the health of children and their mothers.52% of participants were female, 64% were self-identified as non-Hispanic white, 15% self-identified as non-Hispanic Black and 9% self-identified as Hispanic.Participants in early adolescence (median age of 12.9 years) wore a wrist accelerometer for 7-10 consecutive days and completed sleep logs, allowing researchers to calculate the average number of minutes in each 24-hour period were spent sleeping vs. sedentary time vs. light physical activity vs. moderate to vigorous physical activity.In late adolescence (median age of 17.5 years), 394 participants with accelerometer data had fasting blood level tests collected to measure levels of adiponectin (a hormone produced by fat cells), glucose (sugar) and insulin. Fasting glucose and fasting insulin levels were used to calculate HOMA-IR, a measure of insulin resistance that informs on the risk of progressing to Type 2 diabetes.Investigators used a statistical method called compositional data analysis to examine the distribution of 4 types of physical activities within a 24-hour period. They then used modeling to estimate how 30-minute substitutions from one behavior to another could affect test results in later adolescence. Results were adjusted for age, sex, the season in which the participants wore the acceleromAeter, mother’s educational level and family income.Reference:More sleep and physical activity may prevent Type 2 diabetes in teens, American Heart Association, Meeting:AHA Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2026 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/04/24/236774-type-2-diabetes-50-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>More, sleep, and, physical, activity, may, prevent, Type, diabetes, teens, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/04/24/236774-type-2-diabetes-50-1.webp"><div class="pasted-from-word-wrapper"><p>Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous <a href="https://medicaldialogues.in/topics/physical-activity">physical activity</a> or sleep may lower their<a href="https://medicaldialogues.in/topics/Insulin-resistance"> insulin resistance</a>, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17-20, 2026, and offers the latest epidemiological science on prevention, lifestyle and cardiometabolic health.
</p><p>“I was happily surprised with the strength of the association of replacing 30 minutes of sedentary time with moderate-to-vigorous physical activity—a 15% lower insulin resistance is quite a big change,” said Soren Harnois-Leblanc, Ph.D., R.D., lead author of the study and a postdoctoral researcher in the department of population medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School, both in Boston. “Our findings mean that switching from sedentary behaviors to moderate-to-vigorous physical activity or sleep, even if it is only a few minutes per day to start, was beneficial for health.”</p><p>To assess the impact of typical daily activities on the development of insulin resistance in teenagers, investigators examined health data from Project Viva, an ongoing health study of children born between 1999-2002 and their mothers. Insulin resistance was measured using Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), a test that estimates insulin resistance based on fasting blood glucose and insulin levels. In early adolescence, at an average of nearly 13 years old, 802 participants kept sleep logs and wore an accelerometer (a sensor that quantifies movement accelerations, from which researchers can derive the intensity and duration of physical activity) constantly for 7-10 days, providing a breakdown of the movement activities they engaged in over a typical 24 hours.</p><p>By far, the highest percentage of daily time, 48% or 11.5 hours per day, was spent in sedentary activities. Examples of sedentary time may include sitting in class, doing homework, commuting and downtime in the evening, which often comes with screen time on an electronic device or watching TV.</p><p>Other daily activities, reported over a 24-hour period, included sleep (33%), low-intensity physical activity (such as casual walking, 17%), and moderate-vigorous physical activity (such as running, swimming or playing basketball, 2%).</p><p>The researchers then calculated how much a shift of just 30 minutes from sedentary activity to various types of physical activity or sleep could have impacted estimated insulin resistance levels in 394 of the study participants.</p><p>Among the study findings:</p><ul><li>Adolescents who replaced 30 minutes of sedentary time with moderate-vigorous physical activity could lower a measurement of insulin resistance, or lowering their HOMA IR score, by nearly 15%;</li><li>Participants who exchanged 30 minutes of sedentary time with sleep could lower insulin resistance by nearly 5%;</li><li>Shifting 30 minutes of sedentary time to low-intensity physical activity did not have a significant change in insulin resistance levels.</li><li>While activity composition was associated with insulin resistance, it was not associated with levels of adiponectin (a hormone produced by fat cells) or fasting glucose levels (a measure used to diagnose prediabetes and Type 2 diabetes).</li></ul><p>“This study shows that young adolescents spend a lot of their day being sedentary and only a small amount of time being physically active,” said Kershaw Patel, M.D., an American Heart Association volunteer and chair elect of the Association’s Council on Epidemiology and Prevention. “Interestingly, teens who had more moderate to vigorous physical activity early in adolescence showed signs of lower insulin resistance later on. The big takeaway is being active early in life can really make a difference for long‑term health.” Patel, who was not involved in this study, is an assistant professor of cardiology at Houston Methodist Hospital’s DeBakey Heart & Vascular Institute in Houston.</p><p>The American Heart Association’s Life’s Essential 8 metrics for optimal cardiovascular health includes strategies for incorporating healthy lifestyle into daily life. For example, dimming lights before bedtime, creating a nighttime routine that doesn’t include electronic devices with screens and putting the phone on “do not disturb” (or leaving it outside the bedroom while sleeping) can help to improve quality and quantity of sleep. Integrating physical activities with social time with friends, to clear your mind or reduce stress can make hikes or other exercise more appealing than sedentary activities.</p><p>While the study did not find an association between more time spent in light physical activity and lower insulin resistance, the investigators urge additional research on this topic.                                  </p><p>“More time spent in light physical activity may be beneficial to prevent cardiometabolic disease in adults. Light physical activity is an interesting target because it is likely easier to integrate into everyday routines,” said Harnois-Leblanc.</p><p>The current study had some limitations, including that insulin resistance information in late adolescence was available for only 49% of participants who had accelerometer data collected in early adolescence. Additionally, cause-and-effect for daily activities and insulin resistance cannot be proven by this data analysis.</p><p>Study details, background and design:</p><ul><li>The study included health information for 802 participants, ages 12-17, who were born between 1999-2002 in Eastern Massachusetts, and who were enrolled in Project Viva, an ongoing study aimed at improving the health of children and their mothers.</li><li>52% of participants were female, 64% were self-identified as non-Hispanic white, 15% self-identified as non-Hispanic Black and 9% self-identified as Hispanic.</li><li>Participants in early adolescence (median age of 12.9 years) wore a wrist accelerometer for 7-10 consecutive days and completed sleep logs, allowing researchers to calculate the average number of minutes in each 24-hour period were spent sleeping vs. sedentary time vs. light physical activity vs. moderate to vigorous physical activity.</li><li>In late adolescence (median age of 17.5 years), 394 participants with accelerometer data had fasting blood level tests collected to measure levels of adiponectin (a hormone produced by fat cells), glucose (sugar) and insulin. Fasting glucose and fasting insulin levels were used to calculate HOMA-IR, a measure of insulin resistance that informs on the risk of progressing to Type 2 diabetes.</li><li>Investigators used a statistical method called compositional data analysis to examine the distribution of 4 types of physical activities within a 24-hour period. They then used modeling to estimate how 30-minute substitutions from one behavior to another could affect test results in later adolescence. Results were adjusted for age, sex, the season in which the participants wore the acceleromAeter, mother’s educational level and family income.</li></ul><p>Reference:</p><p>More sleep and physical activity may prevent Type 2 diabetes in teens, American Heart Association, Meeting:AHA Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2026</p></div>]]> </content:encoded>
</item>

<item>
<title>Digoxin Improves Outcomes in Patients With Rheumatic Heart Disease: Study</title>
<link>https://edusehat.com/en/digoxin-improves-outcomes-in-patients-with-rheumatic-heart-disease-study</link>
<guid>https://edusehat.com/en/digoxin-improves-outcomes-in-patients-with-rheumatic-heart-disease-study</guid>
<description><![CDATA[ Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
Rheumatic heart disease, which results from heart valve damage caused by rheumatic fever, affects an estimated 55 million people worldwide, and about 360,000 people die from it each year, most in low- and middle-income countries, according to the World Health Organization. Rheumatic fever is triggered by an abnormal immune response to strep throat, usually in childhood, and the resulting heart disease often appears in early adulthood, where it can lead to heart failure and early death.
While valve damage caused by rheumatic heart disease can be surgically repaired, such procedures are unavailable or inaccessible in many poorer countries where the disease is most common, leaving millions of patients with limited options. This study is the first randomized trial to show that digoxin, which is often given to slow the heart rate of patients with severe rheumatic heart disease symptoms, can benefit patients with the disease.
“Our findings suggest that these patients have a reduction in new-onset or worsening heart failure and relatively few events of digoxin toxicity,” said Ganesan Karthikeyan, MD, professor of cardiology at All India Institute of Medical Sciences in New Delhi and the study’s senior author. “It shows that digoxin is probably safe to use in young patients with rheumatic heart disease and provides some benefit in terms of improvement in heart failure symptoms.”
The trial included 1,769 patients treated for symptomatic rheumatic heart disease at 12 sites in India between 2022-2025. The trial’s all-comer enrollment excluded only patients in whom digoxin would not normally be given; 34% were already taking digoxin before enrolling in the study. Participants were young adults—with an average age of 46 years—and 72% were women, consistent with the typical patient population affected by this disease.
Half of the participants were prescribed digoxin, and half were given a placebo, with the dosing and administration strategy left to the discretion of the treating clinician. At a median of 2.1 years of follow-up, those taking digoxin showed an 18% lower rate of the trial’s combined primary endpoint of death from any cause or new-onset or worsening heart failure, a significant benefit in favor of digoxin. Analyzing the components of the primary endpoint separately, researchers found that the difference in outcomes was driven by a reduction in new-onset or worsening heart failure, with no significant difference in mortality between groups. The study also showed an 18% reduction in the composite secondary endpoint of death related to heart failure and new-onset or worsening heart failure.
Digoxin can cause side effects including gastrointestinal problems, vision changes and irregular heartbeat, including some severe reactions that can be life-threatening. Overall, the trial reported a low rate of such effects with 1% of participants experiencing toxicities. Most side effects were minor, and there were no toxicity-related hospitalizations or deaths.
The study findings offer reassurance that digoxin is a generally safe and effective treatment for rheumatic heart disease, researchers said. The results showed no differences in outcomes by sex or body mass index. Patients with atrial fibrillation appeared to benefit from digoxin to a greater degree than those without atrial fibrillation, although the study was not powered to definitively assess this association.
“Digoxin is used in about 30%-40% of rheumatic heart disease cases currently, but it’s based on the physician’s gut feeling and there’s always a concern that it will worsen things,” Karthikeyan said. “With the publication of this trial, I think people will be a little more confident about using digoxin. We have few other drugs to benefit these patients-and this is the first drug which has evidence of benefit from a randomized trial—so I think its use will increase.”
Although the trial was conducted only in India, researchers said that it should be generalizable to patients in many developing low- and middle-income countries since its pragmatic design and all-comer population reflects the patients who typically come to the hospital for rheumatic heart disease in such regions. Karthikeyan said the metric used in the trial to assess worsening heart failure, which included adding or increasing diuretic treatment or the administration of intravenous diuretics with or without hospitalization, is different from the metric that is conventionally used in developed countries, heart failure hospitalization, since it is rare for patients in developing countries to be admitted to the hospital for heart failure symptoms.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/02/339057-rheumatic-heart-disease.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Digoxin, Improves, Outcomes, Patients, With, Rheumatic, Heart, Disease:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/02/339057-rheumatic-heart-disease.webp"><p>Patients with <a href="https://medicaldialogues.in/topics/rheumatic-heart-disease">rheumatic heart disease</a> who took the <a href="https://medicaldialogues.in/topics/heart-failure">heart failure</a> drug <a href="https://medicaldialogues.in/topics/digoxin">digoxin</a> were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
</p><p>Rheumatic heart disease, which results from heart valve damage caused by rheumatic fever, affects an estimated 55 million people worldwide, and about 360,000 people die from it each year, most in low- and middle-income countries, according to the World Health Organization. Rheumatic fever is triggered by an abnormal immune response to strep throat, usually in childhood, and the resulting heart disease often appears in early adulthood, where it can lead to heart failure and early death.
</p><p>While valve damage caused by rheumatic heart disease can be surgically repaired, such procedures are unavailable or inaccessible in many poorer countries where the disease is most common, leaving millions of patients with limited options. This study is the first randomized trial to show that digoxin, which is often given to slow the heart rate of patients with severe rheumatic heart disease symptoms, can benefit patients with the disease.
</p><p>“Our findings suggest that these patients have a reduction in new-onset or worsening heart failure and relatively few events of digoxin toxicity,” said Ganesan Karthikeyan, MD, professor of cardiology at All India Institute of Medical Sciences in New Delhi and the study’s senior author. “It shows that digoxin is probably safe to use in young patients with rheumatic heart disease and provides some benefit in terms of improvement in heart failure symptoms.”
</p><p>The trial included 1,769 patients treated for symptomatic rheumatic heart disease at 12 sites in India between 2022-2025. The trial’s all-comer enrollment excluded only patients in whom digoxin would not normally be given; 34% were already taking digoxin before enrolling in the study. Participants were young adults—with an average age of 46 years—and 72% were women, consistent with the typical patient population affected by this disease.
</p><p>Half of the participants were prescribed digoxin, and half were given a placebo, with the dosing and administration strategy left to the discretion of the treating clinician. At a median of 2.1 years of follow-up, those taking digoxin showed an 18% lower rate of the trial’s combined primary endpoint of death from any cause or new-onset or worsening heart failure, a significant benefit in favor of digoxin. Analyzing the components of the primary endpoint separately, researchers found that the difference in outcomes was driven by a reduction in new-onset or worsening heart failure, with no significant difference in mortality between groups. The study also showed an 18% reduction in the composite secondary endpoint of death related to heart failure and new-onset or worsening heart failure.
</p><p>Digoxin can cause side effects including gastrointestinal problems, vision changes and irregular heartbeat, including some severe reactions that can be life-threatening. Overall, the trial reported a low rate of such effects with 1% of participants experiencing toxicities. Most side effects were minor, and there were no toxicity-related hospitalizations or deaths.
</p><p>The study findings offer reassurance that digoxin is a generally safe and effective treatment for rheumatic heart disease, researchers said. The results showed no differences in outcomes by sex or body mass index. Patients with atrial fibrillation appeared to benefit from digoxin to a greater degree than those without atrial fibrillation, although the study was not powered to definitively assess this association.
</p><p>“Digoxin is used in about 30%-40% of rheumatic heart disease cases currently, but it’s based on the physician’s gut feeling and there’s always a concern that it will worsen things,” Karthikeyan said. “With the publication of this trial, I think people will be a little more confident about using digoxin. We have few other drugs to benefit these patients-and this is the first drug which has evidence of benefit from a randomized trial—so I think its use will increase.”
</p><p>Although the trial was conducted only in India, researchers said that it should be generalizable to patients in many developing low- and middle-income countries since its pragmatic design and all-comer population reflects the patients who typically come to the hospital for rheumatic heart disease in such regions. Karthikeyan said the metric used in the trial to assess worsening heart failure, which included adding or increasing diuretic treatment or the administration of intravenous diuretics with or without hospitalization, is different from the metric that is conventionally used in developed countries, heart failure hospitalization, since it is rare for patients in developing countries to be admitted to the hospital for heart failure symptoms. </p>]]> </content:encoded>
</item>

<item>
<title>AIIMS Raipur recognised for excellence in paediatric emergency care</title>
<link>https://edusehat.com/en/aiims-raipur-recognised-for-excellence-in-paediatric-emergency-care</link>
<guid>https://edusehat.com/en/aiims-raipur-recognised-for-excellence-in-paediatric-emergency-care</guid>
<description><![CDATA[ Raipur: The All India Institute of Medical Sciences (AIIMS) Raipur has achieved national recognition for its excellence in paediatric emergency care, training, and academic leadership at the 17th National Assembly of Paediatric Emergency Medicine (NAPEM) 2026 and the 4th Indian Academy of Pediatrics-Paediatric Emergency Medicine National Conference held in Hyderabad on March 28-29, 2026.The conference organised by KIMS Cuddles Hospital at the Footwear Design and Development Institute (FDDI), Hyderabad, brought together leading experts, clinicians, and trainees from across the country to deliberate on advancements in paediatric emergency medicine.In the run-up to the conference, the Paediatric Emergency Medicine Division of AIIMS Raipur conducted a comprehensive pre-conference workshop on Paediatric Triage and Paediatric Emergency Advanced Resuscitation Learning – Simulation Based (PEARLS) on March 27, 2026, at Malla Reddy Medical College for Women. The workshop was led by Dr. Anil K. Goel, Head of the Department of Paediatrics and In-Charge of the Paediatric Emergency Medicine Division, who also served as the National Coordinator. The programme was coordinated by Dr. Jovin Chris Antony, the PIB stated.Also Read:AIIMS Raipur conducts Sickle Cell Disease screening campThe workshop witnessed participation from 35 delegates from across India and focused on hands-on training in paediatric triage, advanced airway management, vascular access, point-of-care ultrasound, and trauma care. Simulation-based clinical scenarios formed a key component of the training, which was widely appreciated for its practical relevance and interactive delivery.At the main conference, AIIMS Raipur recorded one of the largest institutional representations, comprising faculty members, senior residents, and junior residents, reflecting its growing prominence in the field of paediatric emergency medicine.During the inaugural ceremony, Dr. Anil K. Goel was honoured for his pioneering contribution in establishing India’s first Doctorate of Medicine programme in Paediatric Emergency Medicine and for his leadership as Founder General Secretary and National Chairperson (2025–2026) of the Indian Academy of Pediatrics–Paediatric Emergency Medicine Chapter. Dr. Jovin Chris Antony was also felicitated for his academic contributions, particularly in coordinating the Doctorate of Indian Academy of Pediatrics Webinar Series.The institute also secured notable academic distinctions. Dr. Bipin Bihari Rout won the First Prize in the Oral Paper Presentation category for his research on paediatric sepsis assessment. In the National Paediatric Emergency Medicine Residents Quiz, the team of Dr. Jovin Chris Antony and Dr. Asha Jyothi Penugonda secured the Runners-up position, while Dr. Himmat Ram Siyag and Dr. Mohit Devendra Jaiswal were awarded the Second Runners-up position.Lt. Gen. Ashok Jindal (Retired), Executive Director and Chief Executive Officer of AIIMS Raipur, congratulated the team for their outstanding achievements and reaffirmed the institute’s commitment to advancing paediatric emergency medicine through sustained academic excellence, capacity building, and high-quality training initiatives.Also Read:AIIMS Raipur launches Central India&#039;s first robotic surgery facility ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340804-aiims-raipur-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Raipur, recognised, for, excellence, paediatric, emergency, care</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340804-aiims-raipur-1.webp"><div class="pasted-from-word-wrapper"><p><span>Raipur: The All India Institute of Medical Sciences (AIIMS) Raipur has achieved national recognition for its excellence in paediatric emergency care, training, and academic leadership at the 17th National Assembly of Paediatric Emergency Medicine (NAPEM) 2026 and the 4th Indian Academy of Pediatrics-Paediatric Emergency Medicine National Conference held in Hyderabad on March 28-29, 2026.</span></p><p>The conference organised by KIMS Cuddles Hospital at the Footwear Design and Development Institute (FDDI), Hyderabad, brought together leading experts, clinicians, and trainees from across the country to deliberate on advancements in paediatric emergency medicine.</p><p>In the run-up to the conference, the Paediatric Emergency Medicine Division of <a href="https://medicaldialogues.in/topics/AIIMS-Raipur" target="_blank">AIIMS Raipur</a> conducted a comprehensive pre-conference workshop on Paediatric Triage and Paediatric Emergency Advanced Resuscitation Learning – Simulation Based (PEARLS) on March 27, 2026, at Malla Reddy Medical College for Women. The workshop was led by Dr. Anil K. Goel, Head of the Department of Paediatrics and In-Charge of the Paediatric Emergency Medicine Division, who also served as the National Coordinator. The programme was coordinated by Dr. Jovin Chris Antony, the PIB stated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-raipur-conducts-sickle-cell-disease-screening-camp-156159"><b>Also Read:AIIMS Raipur conducts Sickle Cell Disease screening camp</b></a></p><p>The workshop witnessed participation from 35 delegates from across India and focused on hands-on training in paediatric triage, advanced airway management, vascular access, point-of-care ultrasound, and trauma care. Simulation-based clinical scenarios formed a key component of the training, which was widely appreciated for its practical relevance and interactive delivery.</p><p>At the main conference, <a href="https://medicaldialogues.in/topics/AIIMS-Raipur" target="_blank">AIIMS Raipur</a> recorded one of the largest institutional representations, comprising faculty members, senior residents, and junior residents, reflecting its growing prominence in the field of paediatric emergency medicine.</p><p>During the inaugural ceremony, Dr. Anil K. Goel was honoured for his pioneering contribution in establishing India’s first Doctorate of Medicine programme in Paediatric Emergency Medicine and for his leadership as Founder General Secretary and National Chairperson (2025–2026) of the Indian Academy of Pediatrics–Paediatric Emergency Medicine Chapter. Dr. Jovin Chris Antony was also felicitated for his academic contributions, particularly in coordinating the Doctorate of Indian Academy of Pediatrics Webinar Series.</p><p>The institute also secured notable academic distinctions. Dr. Bipin Bihari Rout won the First Prize in the Oral Paper Presentation category for his research on paediatric sepsis assessment. In the National Paediatric Emergency Medicine Residents Quiz, the team of Dr. Jovin Chris Antony and Dr. Asha Jyothi Penugonda secured the Runners-up position, while Dr. Himmat Ram Siyag and Dr. Mohit Devendra Jaiswal were awarded the Second Runners-up position.</p><p>Lt. Gen. Ashok Jindal (Retired), Executive Director and Chief Executive Officer of AIIMS Raipur, congratulated the team for their outstanding achievements and reaffirmed the institute’s commitment to advancing paediatric emergency medicine through sustained academic excellence, capacity building, and high-quality training initiatives.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-raipur-launches-central-indias-first-robotic-surgery-facility-154823"><b>Also Read:AIIMS Raipur launches Central India's first robotic surgery facility</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>NEET SS 2025 Counselling: MCC adds 9 seats in round 2, choice filling extended</title>
<link>https://edusehat.com/en/neet-ss-2025-counselling-mcc-adds-9-seats-in-round-2-choice-filling-extended</link>
<guid>https://edusehat.com/en/neet-ss-2025-counselling-mcc-adds-9-seats-in-round-2-choice-filling-extended</guid>
<description><![CDATA[ New Delhi: The Medical Counselling Committee (MCC), under the Directorate General of Health Services (DGHS), has announced an extension of the choice filling process and addition of more seats for Round 2 of the National Eligibility and Entrance Test Super Speciality (NEET SS) Counselling for the academic year 2025.As per the notice, the choice filling window for Round 2 has been extended till further orders, providing additional time for candidates to review and update their preferences.Also Read: MCC extends NEET SS round 2 choice filling till further ordersIn a significant update, MCC has informed that candidates will be given the option to ‘unlock’ their previously filled choices. This move comes in light of new seats being added to the Round 2 seat matrix, allowing candidates to make fresh selections or modify existing preferences accordingly.Candidates who wish to revise their choices can do so after unlocking their earlier submissions, ensuring flexibility in the counselling process.To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/11/notice-340978.pdfAlong with this, the MCC under the DGHS has announced the addition of new seats in the Round 2 seat matrix of NEET SS Counselling 2025, allowing candidates to exercise fresh choices for the newly available seats.As per the notice issued by the MCC in this regard, the additional seats have been incorporated based on inputs received from participating institutes, and candidates can now update their preferences accordingly.According to the updated seat matrix, a total of 9 seats have been newly approved in several institutes and specialities. All these seats have been added as newly approved seats communicated by the respective institutes.The addition of seats is expected to provide more opportunities for candidates in the ongoing super-speciality counselling process while ensuring real-time accuracy in seat availability.ADDITION OF SEATS The following seats are added in the seat matrix of Round II-S.NOSTATEINSTITUTE NAME AND ADDRESSSPECIALITYSEATSREASON FOR ADDITION/WITHDRAWAL1PunjabDayanand Medical College and HospitalM.CH. Urology1 Seats have been added as per information received from the Institute (Newly approved seats) 2Madhya Pradesh L.N. MedicalÂ College &amp; Research Centre, Bhopal M.CH. Neuro Surgery 1 Seats have been added as per information received from the Institute (Newly approved seats) 3Madhya PradeshNETAJI SUBHASH CHANDRA BOSE MEDICAL COLLEGED. M. Cardiology 2Seats have been added as per information received from the Institute (Newly approved seats) 4UttarakhandHIMALAYAN INSTITUTE OF MEDICAL SCIENCES, DEHRADUND.M. Neurology  2 Seats have been added as per information received from the Institute (Newly approved seats) 5MaharashtraDR. ULHAS PATIL MEDICAL COLLEGE &amp; HOSPITAL, JALGAOND.M. NEPHROLOGY 1 Seats have been added as per information received from the Institute (Newly approved seats) 6GujaratDr M. K. Shah Medical College and Research Centre, Smt. S.M.S. MultiSpeciality HospitalM.CH. Urology 2 Seats have been added as per information received from the Institute (Newly approved seats) TOTAL9To view the seat matrix, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/11/seat-matrix-340977.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/11/340975-neet-ss-2025-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, 2025, Counselling:, MCC, adds, seats, round, choice, filling, extended</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/11/340975-neet-ss-2025-1.webp"><p><b>New Delhi:</b> The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/mcc" target="_blank">MCC</a>), under the Directorate General of Health Services (DGHS), has announced an extension of the choice filling process and addition of more seats for Round 2 of the National Eligibility and Entrance Test Super Speciality (NEET SS) Counselling for the academic year 2025.</p><div class="pasted-from-word-wrapper"><p dir="ltr">As per the notice, the choice filling window for Round 2 has been extended till further orders, providing additional time for candidates to review and update their preferences.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/mcc-extends-neet-ss-round-2-choice-filling-till-further-orders-168352"><b>Also Read: </b>MCC extends NEET SS round 2 choice filling till further orders</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">In a significant update, MCC has informed that candidates will be given the option to ‘unlock’ their previously filled choices. This move comes in light of new seats being added to the Round 2 seat matrix, allowing candidates to make fresh selections or modify existing preferences accordingly.</p><p dir="ltr">Candidates who wish to revise their choices can do so after unlocking their earlier submissions, ensuring flexibility in the counselling process.</p><p dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/notice-340978.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/11/notice-340978.pdf</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Along with this, the MCC under the <a href="https://medicaldialogues.in/topics/dghs" target="_blank">DGHS </a>has announced the addition of new seats in the Round 2 seat matrix of <a href="https://medicaldialogues.in/topics/neet-ss" target="_blank">NEET SS</a> Counselling 2025, allowing candidates to exercise fresh choices for the newly available seats.</p><p dir="ltr">As per the notice issued by the MCC in this regard, the additional seats have been incorporated based on inputs received from participating institutes, and candidates can now update their preferences accordingly.</p><p dir="ltr">According to the updated seat matrix, a total of 9 seats have been newly approved in several institutes and specialities. All these seats have been added as newly approved seats communicated by the respective institutes.</p><p dir="ltr">The addition of seats is expected to provide more opportunities for candidates in the ongoing super-speciality counselling process while ensuring real-time accuracy in seat availability.</p><p dir="ltr"><b><u>ADDITION OF SEATS </u></b></p><p dir="ltr"><b><i>The following seats are added in the seat matrix of Round II-</i></b></p></div><div class="pasted-from-word-wrapper"><div dir="ltr"><table><colgroup><col width="46"><col width="60"><col width="182"><col width="124"><col width="72"><col width="139"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>STATE</b></p></td><td><p dir="ltr"><b>INSTITUTE NAME AND ADDRESS</b></p></td><td><p dir="ltr"><b>SPECIALITY</b></p></td><td><p dir="ltr"><b>SEATS</b></p></td><td><p dir="ltr"><b>REASON FOR ADDITION/WITHDRAWAL</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Punjab</p></td><td><p dir="ltr">Dayanand Medical College and Hospital</p></td><td><p dir="ltr">M.CH. Urology</p></td><td><p dir="ltr">1 </p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Madhya Pradesh </p></td><td><p dir="ltr">L.N. MedicalÂ College & Research Centre, Bhopal </p></td><td><p dir="ltr">M.CH. Neuro Surgery </p></td><td><p dir="ltr">1 </p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Madhya Pradesh</p></td><td><p dir="ltr">NETAJI SUBHASH CHANDRA BOSE MEDICAL COLLEGE</p></td><td><p dir="ltr">D. M. Cardiology </p></td><td><p dir="ltr">2</p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Uttarakhand</p></td><td><p dir="ltr">HIMALAYAN INSTITUTE OF MEDICAL SCIENCES, DEHRADUN</p></td><td><p dir="ltr">D.M. Neurology  </p></td><td><p dir="ltr">2 </p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">Maharashtra</p></td><td><p dir="ltr">DR. ULHAS PATIL MEDICAL COLLEGE & HOSPITAL, JALGAON</p></td><td><p dir="ltr">D.M. NEPHROLOGY </p></td><td><p dir="ltr">1 </p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Gujarat</p></td><td><p dir="ltr">Dr M. K. Shah Medical College and Research Centre, Smt. S.M.S. MultiSpeciality Hospital</p></td><td><p dir="ltr">M.CH. Urology </p></td><td><p dir="ltr">2 </p></td><td><p dir="ltr">Seats have been added as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td colspan="4"><p dir="ltr"><b>TOTAL</b></p></td><td><p dir="ltr"><b>9</b></p></td><td></td></tr></tbody></table></div></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u><i>To view the seat matrix, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/11/seat-matrix-340977.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/11/seat-matrix-340977.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Ludhiana doctor&amp;apos;s plea: HC orders review of passports in multiple criminal cases</title>
<link>https://edusehat.com/en/ludhiana-doctors-plea-hc-orders-review-of-passports-in-multiple-criminal-cases</link>
<guid>https://edusehat.com/en/ludhiana-doctors-plea-hc-orders-review-of-passports-in-multiple-criminal-cases</guid>
<description><![CDATA[ Ludhiana:  In response to a petition filed by a Ludhiana-based doctor, the Punjab and Haryana High Court has directed passport authorities to examine whether travel documents issued to individuals facing multiple criminal cases should be cancelled. The court has asked the Regional Passport Officer (RPO) in Chandigarh to issue a “reasoned order” within a month.  The plea alleges that the doctor’s legal rivals secured valid passports by concealing their involvement in multiple FIRs registered across Punjab, Himachal Pradesh, and Uttar Pradesh. The dispute is linked to a 22-year-old property conflict in Ludhiana’s Threeke village.Also Read:Punjab and Haryana HC dismisses orthopaedic surgeon&#039;s plea; no absolute right to appear in personAccording to TOI, the petitioner claimed that the group managed to bypass mandatory background checks despite facing FIRs (First Information Reports) in Punjab, Himachal Pradesh, and Uttar Pradesh. The petitioner claim the accused face charges including financial crimes (forgery, cheating, and impersonation), violent offences (multiple criminal cases related to the long-standing property feud), and legal violations (alleged breach of Section 6(2)(f) of the Passport Act, which restricts the issuance of passports to those facing active criminal proceedings without explicit court permission).The petitioner further alleged that the accused, whom he described as politically influential, managed to obtain the documents through forged affidavits and false declarations. He also claimed that one of the individuals has already fled to Canada, while others may be preparing to leave the country to avoid prosecution.
In his plea, the doctor sought immediate cancellation of the passports and demanded action not only against the accused but also against any officials who may have facilitated the issuance.
Dismissing the petition at the initial stage, the high court refrained from ruling on the merits of the allegations but placed a strict timeline on the RPO. &quot;The competent authority must consider the petitioner&#039;s representation dated Oct 10, 2025, and pass a reasoned order within four weeks, strictly in accordance with the law,&quot; the court observed, reports TOI.
By issuing this directive, the court ensured that the Regional Passport Office in Chandigarh is legally bound to examine the claims and determine whether the passports were obtained fraudulently.
The case revolves around provisions of the Passport Act, 1967. Section 6(2)(f) prohibits issuing a passport to individuals with pending criminal cases unless permitted by a court, while Section 12(1)(b) prescribes penalties for providing false information or suppressing material facts to obtain a passport.Also Read:Punjab and Haryana HC stays Human Rights panel&#039;s summons to doctors in body-withholding case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/338845-doctor-6.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Ludhiana, doctors, plea:, orders, review, passports, multiple, criminal, cases</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/338845-doctor-6.webp"><p><b>Ludhiana: </b> In response to a <a href="https://medicaldialogues.in/topics/petition">petition</a> filed by a Ludhiana-based <a href="https://medicaldialogues.in/news/health/doctors">doctor</a>, the <a href="https://medicaldialogues.in/topics/punjab-and-haryana-high-court">Punjab and Haryana High Court</a> has directed passport authorities to examine whether travel documents issued to individuals facing multiple criminal cases should be cancelled. The court has asked the Regional Passport Officer (RPO) in Chandigarh to issue a “reasoned order” within a month.  </p><p>The plea alleges that the doctor’s legal rivals secured valid passports by concealing their involvement in multiple FIRs registered across <a href="https://medicaldialogues.in/state-news/punjab">Punjab</a>, Himachal Pradesh, and Uttar Pradesh. The dispute is linked to a 22-year-old property conflict in Ludhiana’s Threeke village.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/punjab-and-haryana-hc-dismisses-orthopaedic-surgeons-plea-no-absolute-right-to-appear-in-person-164615"><b>Also Read:Punjab and Haryana HC dismisses orthopaedic surgeon's plea; no absolute right to appear in person</b></a></p><p>According to TOI, the petitioner claimed that the group managed to bypass mandatory background checks despite facing FIRs (First Information Reports) in Punjab, Himachal Pradesh, and Uttar Pradesh. The petitioner claim the accused face charges including financial crimes (forgery, cheating, and impersonation), violent offences (multiple criminal cases related to the long-standing property feud), and legal violations (alleged breach of Section 6(2)(f) of the Passport Act, which restricts the issuance of passports to those facing active criminal proceedings without explicit court permission).</p><p>The petitioner further alleged that the accused, whom he described as politically influential, managed to obtain the documents through forged affidavits and false declarations. He also claimed that one of the individuals has already fled to Canada, while others may be preparing to leave the country to avoid prosecution.
</p><p>In his plea, the doctor sought immediate cancellation of the passports and demanded action not only against the accused but also against any officials who may have facilitated the issuance.
</p><p>Dismissing the petition at the initial stage, the high court refrained from ruling on the merits of the allegations but placed a strict timeline on the RPO. "The competent authority must consider the petitioner's representation dated Oct 10, 2025, and pass a reasoned order within four weeks, strictly in accordance with the law," the court observed, reports <a href="https://timesofindia.indiatimes.com/city/ludhiana/high-court-flags-flight-risk-on-ludhiana-doctors-plea-/articleshow/130158302.cms" rel="nofollow">TOI</a>.
</p><p>By issuing this directive, the court ensured that the Regional Passport Office in Chandigarh is legally bound to examine the claims and determine whether the passports were obtained fraudulently.
</p><p>The case revolves around provisions of the Passport Act, 1967. Section 6(2)(f) prohibits issuing a passport to individuals with pending criminal cases unless permitted by a court, while Section 12(1)(b) prescribes penalties for providing false information or suppressing material facts to obtain a passport.</p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/punjab-and-haryana-hc-stays-human-rights-panels-summons-to-doctors-in-body-withholding-case-164545">Also Read:Punjab and Haryana HC stays Human Rights panel's summons to doctors in body-withholding case</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Chandigarh set to expand AYUSH services with hospitals in Sector 34 and 11</title>
<link>https://edusehat.com/en/chandigarh-set-to-expand-ayush-services-with-hospitals-in-sector-34-and-11</link>
<guid>https://edusehat.com/en/chandigarh-set-to-expand-ayush-services-with-hospitals-in-sector-34-and-11</guid>
<description><![CDATA[ Chandigarh: The AYUSH hospitals in Chandigarh, located in Sector 34 and Sector 11, are set to become operational soon, marking a key boost to the city&#039;s traditional healthcare system. The announcement comes as the administration moves closer to completing final preparations at both facilities aimed at strengthening integrated healthcare services. Home-cum-Health Secretary Mandip Singh Brar recently visited both hospital sites to review ongoing arrangements and assess readiness, reports Amar Ujala. During the inspection, he directed officials to expedite pending work and ensure that all necessary infrastructure and services are in place so that the hospitals can begin functioning without further delay.According to officials, both hospitals have been developed as integrated AYUSH centres equipped with modern infrastructure. They are expected to offer a wide range of healthcare services, including Ayurveda, Homoeopathy, and Panchakarma therapies. The facilities will also include outpatient departments (OPDs), diagnostic services, and dedicated pharmacy units to support patient care. In addition, provision for integrated healthcare delivery, including basic allopathic dispensing support, has also been incorporated.Also Read:Lok Nayak Hospital Opens Delhi&#039;s First Model Treatment Centre for HepatitisDuring his visit, the Health Secretary inspected various sections of the hospitals, including treatment rooms, laboratories, pharmacy areas, and patient care units. He also interacted with doctors and staff members to review operational preparedness and understand ground-level requirements. Officials briefed him that staffing and equipment installation are in their final stages, and services will be started once formal approvals are completed.Brar emphasized the importance of maintaining cleanliness, ensuring efficient management, and providing high-quality healthcare services to patients. He instructed concerned departments to ensure that all operational requirements, including manpower deployment, equipment readiness, and service coordination, are completed before the facilities are opened to the public.Authorities said the hospitals are in the final phase of preparation and are expected to begin services soon after completing the remaining formalities. Once operational, they are expected to significantly improve access to AYUSH-based treatment in Chandigarh and provide residents with expanded healthcare options under one roof.Also Read:Bihar expands AYUSH healthcare with seven new 50-bed hospitals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340809-ayush-hospitals.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chandigarh, set, expand, AYUSH, services, with, hospitals, Sector, and</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340809-ayush-hospitals.webp"><div class="pasted-from-word-wrapper"><p>Chandigarh: The <a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a> hospitals in Chandigarh, located in Sector 34 and Sector 11, are set to become operational soon, marking a key boost to the city's traditional healthcare system. The announcement comes as the administration moves closer to completing final preparations at both facilities aimed at strengthening integrated healthcare services. </p><p>Home-cum-Health Secretary Mandip Singh Brar recently visited both hospital sites to review ongoing arrangements and assess readiness, reports<i> <a href="https://www.amarujala.com/chandigarh/ayush-hospitals-in-sector-34-and-11-will-be-operational-soon-health-secretary-reviews-preparations-chandigarh-news-c-16-pkl1049-991623-2026-04-10" target="_blank">Amar Ujala</a></i>. During the inspection, he directed officials to expedite pending work and ensure that all necessary infrastructure and services are in place so that the hospitals can begin functioning without further delay.</p><p>According to officials, both hospitals have been developed as integrated AYUSH centres equipped with modern infrastructure. They are expected to offer a wide range of healthcare services, including Ayurveda, Homoeopathy, and Panchakarma therapies. The facilities will also include outpatient departments (OPDs), diagnostic services, and dedicated pharmacy units to support patient care. In addition, provision for integrated healthcare delivery, including basic allopathic dispensing support, has also been incorporated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/lok-nayak-hospital-opens-delhis-first-model-treatment-centre-for-hepatitis-160441">Also Read:Lok Nayak Hospital Opens Delhi's First Model Treatment Centre for Hepatitis</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>During his visit, the Health Secretary inspected various sections of the hospitals, including treatment rooms, laboratories, pharmacy areas, and patient care units. He also interacted with doctors and staff members to review operational preparedness and understand ground-level requirements. Officials briefed him that staffing and equipment installation are in their final stages, and services will be started once formal approvals are completed.</p><p>Brar emphasized the importance of maintaining cleanliness, ensuring efficient management, and providing high-quality healthcare services to patients. He instructed concerned departments to ensure that all operational requirements, including manpower deployment, equipment readiness, and service coordination, are completed before the facilities are opened to the public.</p><p>Authorities said the hospitals are in the final phase of preparation and are expected to begin services soon after completing the remaining formalities. Once operational, they are expected to significantly improve access to AYUSH-based treatment in Chandigarh and provide residents with expanded healthcare options under one roof.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/bihar-expands-ayush-healthcare-with-seven-new-50-bed-hospitals-163985">Also Read:Bihar expands AYUSH healthcare with seven new 50-bed hospitals</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>vFFR&#45;Guided Strategy Noninferior to Standard FFR in Coronary Lesions: NEJM</title>
<link>https://edusehat.com/en/vffr-guided-strategy-noninferior-to-standard-ffr-in-coronary-lesions-nejm</link>
<guid>https://edusehat.com/en/vffr-guided-strategy-noninferior-to-standard-ffr-in-coronary-lesions-nejm</guid>
<description><![CDATA[ Netherlands: A study in the New England Journal of Medicine has revealed that angiography-derived fractional flow reserve (vFFR) is an effective alternative for assessing intermediate coronary lesions. vFFR-guided revascularization was noninferior to standard FFR-guided treatment in terms of death, myocardial infarction, or repeat revascularization at 1 year.The findings are from an international, open-label randomized trial led by Joost Daemen and colleagues, conducted across 37 centers in Europe. The study addressed an important clinical question, as current guidelines recommend physiological assessment of intermediate coronary artery lesions, but conventional fractional flow reserve (FFR) requires a pressure wire and pharmacological agents to induce hyperemia, which can increase procedural complexity.In contrast, vessel fractional flow reserve (vFFR) is derived from three-dimensional quantitative coronary angiography and does not require additional instrumentation or hyperemic drugs. This makes it a potentially simpler and less invasive option for guiding revascularization decisions in routine practice.The trial enrolled patients with intermediate coronary artery stenosis, defined as 30% to 80% narrowing, who presented with either chronic coronary syndromes or acute coronary syndromes. Participants were randomly assigned to undergo revascularization guided by either vFFR or standard pressure wire–based FFR.A total of over 2,200 patients were included in the analysis, with 1,116 in the vFFR group and 1,095 in the FFR group. The average age of participants was 67 years, with women accounting for nearly one-quarter of the cohort. Additionally, a significant proportion had comorbid conditions, including diabetes, and close to one-fifth presented with acute coronary syndromes.    Key Findings:At 1-year follow-up, the primary composite endpoint—comprising death from any cause, myocardial infarction, or repeat revascularization—occurred at identical rates of 7.5% in both the vFFR-guided and FFR-guided groups.These comparable event rates demonstrate that vFFR-guided revascularization successfully met the predefined criteria for noninferiority when compared with the standard pressure wire–based FFR-guided approach.The overall safety profile of vFFR-guided treatment was found to be similar to that of the conventional FFR-guided strategy.Rates of serious adverse events were comparable between the two groups, indicating no additional safety concerns with the use of vFFR.These findings suggest that vFFR provides a less invasive, more streamlined alternative for guiding revascularization decisions without compromising clinical outcomes or patient safety.The results indicate that vFFR can serve as a reliable alternative to traditional FFR in guiding coronary revascularization decisions. By eliminating the need for pressure wires and hyperemic agents, vFFR has the potential to streamline procedures and improve patient comfort without sacrificing clinical outcomes.Overall, the study supports the integration of angiography-based physiological assessment into clinical practice, particularly for patients with intermediate coronary lesions, where accurate evaluation is essential for optimal treatment planning.Reference:DOI: 10.1056/NEJMoa2601841 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/11/08/259835-revascularization.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 14:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>vFFR-Guided, Strategy, Noninferior, Standard, FFR, Coronary, Lesions:, NEJM</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/11/08/259835-revascularization.webp"><p><span>Netherlands: A study in the<i> New England Journal of Medicine </i>has revealed that <a href="https://medicaldialogues.in/topics/angiography">angiography</a>-derived fractional flow reserve (vFFR) is an effective alternative for assessing intermediate<a href="https://medicaldialogues.in/topics/coronary-lesions"> coronary lesions</a>. vFFR-guided revascularization was noninferior to standard FFR-guided treatment in terms of death, <a href="https://medicaldialogues.in/topics/myocardial-infarction">myocardial infarction</a>, or repeat <a href="https://medicaldialogues.in/topics/revascularization">revascularization </a>at 1 year.</span></p><div class="pasted-from-word-wrapper"><div>The findings are from an international, open-label randomized trial led by Joost Daemen and colleagues, conducted across 37 centers in Europe. The study addressed an important clinical question, as current guidelines recommend physiological assessment of intermediate coronary artery lesions, but conventional fractional flow reserve (FFR) requires a pressure wire and pharmacological agents to induce hyperemia, which can increase procedural complexity.</div><div>In contrast, vessel fractional flow reserve (vFFR) is derived from three-dimensional quantitative coronary angiography and does not require additional instrumentation or hyperemic drugs. This makes it a potentially simpler and less invasive option for guiding revascularization decisions in routine practice.</div><div>The trial enrolled patients with intermediate coronary artery stenosis, defined as 30% to 80% narrowing, who presented with either chronic coronary syndromes or acute coronary syndromes. Participants were randomly assigned to undergo revascularization guided by either vFFR or standard pressure wire–based FFR.</div><div>A total of over 2,200 patients were included in the analysis, with 1,116 in the vFFR group and 1,095 in the FFR group. The average age of participants was 67 years, with women accounting for nearly one-quarter of the cohort. Additionally, a significant proportion had comorbid conditions, including diabetes, and close to one-fifth presented with acute coronary syndromes.    </div><div>Key Findings:</div><ul><li>At 1-year follow-up, the primary composite endpoint—comprising death from any cause, myocardial infarction, or repeat revascularization—occurred at identical rates of 7.5% in both the vFFR-guided and FFR-guided groups.</li><li>These comparable event rates demonstrate that vFFR-guided revascularization successfully met the predefined criteria for noninferiority when compared with the standard pressure wire–based FFR-guided approach.</li><li>The overall safety profile of vFFR-guided treatment was found to be similar to that of the conventional FFR-guided strategy.</li><li>Rates of serious adverse events were comparable between the two groups, indicating no additional safety concerns with the use of vFFR.</li><li>These findings suggest that vFFR provides a less invasive, more streamlined alternative for guiding revascularization decisions without compromising clinical outcomes or patient safety.</li></ul><div>The results indicate that vFFR can serve as a reliable alternative to traditional FFR in guiding coronary revascularization decisions. By eliminating the need for pressure wires and hyperemic agents, vFFR has the potential to streamline procedures and improve patient comfort without sacrificing clinical outcomes.</div><div>Overall, the study supports the integration of angiography-based physiological assessment into clinical practice, particularly for patients with intermediate coronary lesions, where accurate evaluation is essential for optimal treatment planning.</div><div>Reference:</div><div>DOI: 10.1056/NEJMoa2601841</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Digoxin Improves Outcomes in Patients With Rheumatic Heart Disease</title>
<link>https://edusehat.com/en/digoxin-improves-outcomes-in-patients-with-rheumatic-heart-disease</link>
<guid>https://edusehat.com/en/digoxin-improves-outcomes-in-patients-with-rheumatic-heart-disease</guid>
<description><![CDATA[ Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
Rheumatic heart disease, which results from heart valve damage caused by rheumatic fever, affects an estimated 55 million people worldwide, and about 360,000 people die from it each year, most in low- and middle-income countries, according to the World Health Organization. Rheumatic fever is triggered by an abnormal immune response to strep throat, usually in childhood, and the resulting heart disease often appears in early adulthood, where it can lead to heart failure and early death.
While valve damage caused by rheumatic heart disease can be surgically repaired, such procedures are unavailable or inaccessible in many poorer countries where the disease is most common, leaving millions of patients with limited options. This study is the first randomized trial to show that digoxin, which is often given to slow the heart rate of patients with severe rheumatic heart disease symptoms, can benefit patients with the disease.
“Our findings suggest that these patients have a reduction in new-onset or worsening heart failure and relatively few events of digoxin toxicity,” said Ganesan Karthikeyan, MD, professor of cardiology at All India Institute of Medical Sciences in New Delhi and the study’s senior author. “It shows that digoxin is probably safe to use in young patients with rheumatic heart disease and provides some benefit in terms of improvement in heart failure symptoms.”
The trial included 1,769 patients treated for symptomatic rheumatic heart disease at 12 sites in India between 2022-2025. The trial’s all-comer enrollment excluded only patients in whom digoxin would not normally be given; 34% were already taking digoxin before enrolling in the study. Participants were young adults—with an average age of 46 years—and 72% were women, consistent with the typical patient population affected by this disease.
Half of the participants were prescribed digoxin, and half were given a placebo, with the dosing and administration strategy left to the discretion of the treating clinician. At a median of 2.1 years of follow-up, those taking digoxin showed an 18% lower rate of the trial’s combined primary endpoint of death from any cause or new-onset or worsening heart failure, a significant benefit in favor of digoxin. Analyzing the components of the primary endpoint separately, researchers found that the difference in outcomes was driven by a reduction in new-onset or worsening heart failure, with no significant difference in mortality between groups. The study also showed an 18% reduction in the composite secondary endpoint of death related to heart failure and new-onset or worsening heart failure.
Digoxin can cause side effects including gastrointestinal problems, vision changes and irregular heartbeat, including some severe reactions that can be life-threatening. Overall, the trial reported a low rate of such effects with 1% of participants experiencing toxicities. Most side effects were minor, and there were no toxicity-related hospitalizations or deaths.
The study findings offer reassurance that digoxin is a generally safe and effective treatment for rheumatic heart disease, researchers said. The results showed no differences in outcomes by sex or body mass index. Patients with atrial fibrillation appeared to benefit from digoxin to a greater degree than those without atrial fibrillation, although the study was not powered to definitively assess this association.
“Digoxin is used in about 30%-40% of rheumatic heart disease cases currently, but it’s based on the physician’s gut feeling and there’s always a concern that it will worsen things,” Karthikeyan said. “With the publication of this trial, I think people will be a little more confident about using digoxin. We have few other drugs to benefit these patients-and this is the first drug which has evidence of benefit from a randomized trial—so I think its use will increase.”
Although the trial was conducted only in India, researchers said that it should be generalizable to patients in many developing low- and middle-income countries since its pragmatic design and all-comer population reflects the patients who typically come to the hospital for rheumatic heart disease in such regions. Karthikeyan said the metric used in the trial to assess worsening heart failure, which included adding or increasing diuretic treatment or the administration of intravenous diuretics with or without hospitalization, is different from the metric that is conventionally used in developed countries, heart failure hospitalization, since it is rare for patients in developing countries to be admitted to the hospital for heart failure symptoms.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/02/339057-rheumatic-heart-disease.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 10:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Digoxin, Improves, Outcomes, Patients, With, Rheumatic, Heart, Disease</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/02/339057-rheumatic-heart-disease.webp"><p>Patients with <a href="https://medicaldialogues.in/topics/rheumatic-heart-disease">rheumatic heart disease</a> who took the <a href="https://medicaldialogues.in/topics/heart-failure">heart failure</a> drug <a href="https://medicaldialogues.in/topics/digoxin">digoxin</a> were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
</p><p>Rheumatic heart disease, which results from heart valve damage caused by rheumatic fever, affects an estimated 55 million people worldwide, and about 360,000 people die from it each year, most in low- and middle-income countries, according to the World Health Organization. Rheumatic fever is triggered by an abnormal immune response to strep throat, usually in childhood, and the resulting heart disease often appears in early adulthood, where it can lead to heart failure and early death.
</p><p>While valve damage caused by rheumatic heart disease can be surgically repaired, such procedures are unavailable or inaccessible in many poorer countries where the disease is most common, leaving millions of patients with limited options. This study is the first randomized trial to show that digoxin, which is often given to slow the heart rate of patients with severe rheumatic heart disease symptoms, can benefit patients with the disease.
</p><p>“Our findings suggest that these patients have a reduction in new-onset or worsening heart failure and relatively few events of digoxin toxicity,” said Ganesan Karthikeyan, MD, professor of cardiology at All India Institute of Medical Sciences in New Delhi and the study’s senior author. “It shows that digoxin is probably safe to use in young patients with rheumatic heart disease and provides some benefit in terms of improvement in heart failure symptoms.”
</p><p>The trial included 1,769 patients treated for symptomatic rheumatic heart disease at 12 sites in India between 2022-2025. The trial’s all-comer enrollment excluded only patients in whom digoxin would not normally be given; 34% were already taking digoxin before enrolling in the study. Participants were young adults—with an average age of 46 years—and 72% were women, consistent with the typical patient population affected by this disease.
</p><p>Half of the participants were prescribed digoxin, and half were given a placebo, with the dosing and administration strategy left to the discretion of the treating clinician. At a median of 2.1 years of follow-up, those taking digoxin showed an 18% lower rate of the trial’s combined primary endpoint of death from any cause or new-onset or worsening heart failure, a significant benefit in favor of digoxin. Analyzing the components of the primary endpoint separately, researchers found that the difference in outcomes was driven by a reduction in new-onset or worsening heart failure, with no significant difference in mortality between groups. The study also showed an 18% reduction in the composite secondary endpoint of death related to heart failure and new-onset or worsening heart failure.
</p><p>Digoxin can cause side effects including gastrointestinal problems, vision changes and irregular heartbeat, including some severe reactions that can be life-threatening. Overall, the trial reported a low rate of such effects with 1% of participants experiencing toxicities. Most side effects were minor, and there were no toxicity-related hospitalizations or deaths.
</p><p>The study findings offer reassurance that digoxin is a generally safe and effective treatment for rheumatic heart disease, researchers said. The results showed no differences in outcomes by sex or body mass index. Patients with atrial fibrillation appeared to benefit from digoxin to a greater degree than those without atrial fibrillation, although the study was not powered to definitively assess this association.
</p><p>“Digoxin is used in about 30%-40% of rheumatic heart disease cases currently, but it’s based on the physician’s gut feeling and there’s always a concern that it will worsen things,” Karthikeyan said. “With the publication of this trial, I think people will be a little more confident about using digoxin. We have few other drugs to benefit these patients-and this is the first drug which has evidence of benefit from a randomized trial—so I think its use will increase.”
</p><p>Although the trial was conducted only in India, researchers said that it should be generalizable to patients in many developing low- and middle-income countries since its pragmatic design and all-comer population reflects the patients who typically come to the hospital for rheumatic heart disease in such regions. Karthikeyan said the metric used in the trial to assess worsening heart failure, which included adding or increasing diuretic treatment or the administration of intravenous diuretics with or without hospitalization, is different from the metric that is conventionally used in developed countries, heart failure hospitalization, since it is rare for patients in developing countries to be admitted to the hospital for heart failure symptoms. </p>]]> </content:encoded>
</item>

<item>
<title>Dual&#45;Antigen Targeting Yields 79 Percent Response in Drug&#45;Resistant True extramedullary myeloma, suggests study</title>
<link>https://edusehat.com/en/dual-antigen-targeting-yields-79-percent-response-in-drug-resistant-true-extramedullary-myeloma-suggests-study</link>
<guid>https://edusehat.com/en/dual-antigen-targeting-yields-79-percent-response-in-drug-resistant-true-extramedullary-myeloma-suggests-study</guid>
<description><![CDATA[ A remarkable clinical response was achieved in 79% of patients battling drug-resistant, true extramedullary myeloma (EMM) through an innovative dual-antigen targeting approach, as a recent study published in the New England Journal of Medicine in December 2025 has shown.Patients with plasmacytomas noncontiguous with bone marrow face exceptionally high risks of disease relapse; following the promising initial efficacy shown in the phase 1 portion of this research, Dr. Shaji Kumar from the RedirecTT-1 Investigators Study Group led the phase 2 trial to address the current therapeutic gap for triple-class–exposed individuals by evaluating the dual targeting of G protein–coupled receptor family C group 5 member D (GPRC5D) and B-cell maturation antigen (BCMA).Therefore, the phase 2 multicenter study exclusively enrolled 90 patients suffering from drug-resistant EMM to evaluate the combination therapy over a median follow-up period of 12.6 months, utilizing functional imaging to assess the primary endpoint of overall response while excluding patients who did not meet strict resistance criteria and monitoring secondary endpoints such as the duration of response, progression-free survival (PFS), and overall survival (OS).Key Clinical Findngs of the study Include:Robust Clinical Efficacy: The RedirecTT-1 trial demonstrated that a significant 79% (95% confidence interval [CI], 69 to 87) of participants achieved an overall response, proving the strength of dual-targeting in these refractory cases.Durable Remission Data: Among the responders, RedirecTT-1 showed that 64% (95% CI, 48 to 76) maintained their response for at least 12 months, highlighting the potential for long-term disease control.Key Survival Outcomes: Survival data from RedirecTT-1 revealed a 12-month PFS rate of 61% (95% CI, 50 to 71) and a 12-month OS rate of 74% (95% CI, 63 to 83) for this high-risk population.Safety and Toxicity Profile: High-grade adverse events (AEs) recorded by RedirecTT-1 occurred in 76% of patients, a frequency which was notably consistent with the established safety profiles of these therapeutic agents when administered individually as monotherapies.Regimen Continuity Trends: Despite cytokine release syndrome (CRS) appearing in 78% of the cohort and oral symptoms in 87%, RedirecTT-1 indicated that nonfatal AEs led to the permanent discontinuation of treatment in only 6% of participants.The results suggest that the majority of patients with drug-resistant, true EMM can achieve a meaningful clinical response with the combination of talquetamab and teclistamab, although the 76% incidence of grade 3 or higher AEs remains a critical clinical consideration.Thus, the study concludes clinicians may consider this dual-antigen regimen as a potent intervention for aggressive extramedullary disease while ensuring rigorous surveillance for severe infections and hematologic toxicities.Although the high frequency of severe AEs and the occurrence of treatment-related deaths serve as limitations to the current findings, future research is necessary to optimize dosing and supportive care to enhance the safety of this promising combination therapy.ReferenceKumar S, Mateos MV, Ye JC, et al. Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab. N Engl J Med 2026;394:51-61. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/03/10/172017-multiple-myeloma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dual-Antigen, Targeting, Yields, Percent, Response, Drug-Resistant, True, extramedullary, myeloma, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/03/10/172017-multiple-myeloma.webp"><p>A remarkable clinical response was achieved in 79% of patients battling drug-resistant, true extramedullary <a href="https://medicaldialogues.in/oncology/news/why-are-men-more-likely-to-develop-multiple-myeloma-than-women-162960">myeloma</a> (EMM) through an innovative dual-antigen targeting approach, as a recent study published in the <i>New England Journal of Medicine</i> in December 2025 has shown.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Patients with <a href="https://medicaldialogues.in/medical-courses/curriculum/dnb-dermatology-venereology-and-leprosy-in-india-check-out-nbe-released-curriculum-100975">plasmacytomas</a> noncontiguous with <a href="https://medicaldialogues.in/mdtv/medicine/videos/study-highlights-possible-treatment-strategy-for-bone-marrow-failure-syndrome-107969">bone marrow</a> face exceptionally high risks of disease relapse; following the promising initial efficacy shown in the phase 1 portion of this research, Dr. Shaji Kumar from the RedirecTT-1 Investigators Study Group led the phase 2 trial to address the current therapeutic gap for triple-class–exposed individuals by evaluating the dual targeting of G protein–coupled receptor family C group 5 member D (GPRC5D) and B-cell maturation antigen (BCMA).</p><p dir="ltr">Therefore, the phase 2 multicenter study exclusively enrolled 90 patients suffering from drug-resistant EMM to evaluate the combination therapy over a median follow-up period of 12.6 months, utilizing functional imaging to assess the primary endpoint of overall response while excluding patients who did not meet strict resistance criteria and monitoring secondary endpoints such as the duration of response, progression-free survival (PFS), and overall survival (OS).</p><b><div><b>Key Clinical Findngs of the study Include:</b></div></b><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Robust Clinical Efficacy: </b>The RedirecTT-1 trial demonstrated that a significant 79% (95% confidence interval [CI], 69 to 87) of participants achieved an overall response, proving the strength of dual-targeting in these refractory cases.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Durable Remission Data: </b>Among the responders, RedirecTT-1 showed that 64% (95% CI, 48 to 76) maintained their response for at least 12 months, highlighting the potential for long-term disease control.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Key Survival Outcomes: </b>Survival data from RedirecTT-1 revealed a 12-month PFS rate of 61% (95% CI, 50 to 71) and a 12-month OS rate of 74% (95% CI, 63 to 83) for this high-risk population.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Safety and Toxicity Profile: </b>High-grade adverse events (AEs) recorded by RedirecTT-1 occurred in 76% of patients, a frequency which was notably consistent with the established safety profiles of these therapeutic agents when administered individually as monotherapies.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Regimen Continuity Trends: </b>Despite cytokine release syndrome (CRS) appearing in 78% of the cohort and oral symptoms in 87%, RedirecTT-1 indicated that nonfatal AEs led to the permanent discontinuation of treatment in only 6% of participants.</p></li></ul><p dir="ltr">The results suggest that the majority of patients with drug-resistant, true EMM can achieve a meaningful clinical response with the combination of talquetamab and teclistamab, although the 76% incidence of grade 3 or higher AEs remains a critical clinical consideration.</p><p dir="ltr">Thus, the study concludes clinicians may consider this dual-antigen regimen as a potent intervention for aggressive extramedullary disease while ensuring rigorous surveillance for severe infections and hematologic toxicities.</p><p dir="ltr">Although the high frequency of severe AEs and the occurrence of treatment-related deaths serve as limitations to the current findings, future research is necessary to optimize dosing and supportive care to enhance the safety of this promising combination therapy.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Kumar S, Mateos MV, Ye JC, et al. Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab. N Engl J Med 2026;394:51-61.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>GLP&#45;1RAs Expanding Clinical Scope Beyond Glycemic Control: Review Suggests</title>
<link>https://edusehat.com/en/glp-1ras-expanding-clinical-scope-beyond-glycemic-control-review-suggests</link>
<guid>https://edusehat.com/en/glp-1ras-expanding-clinical-scope-beyond-glycemic-control-review-suggests</guid>
<description><![CDATA[ Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have remarkably transitioned from specialized diabetes treatments to versatile therapeutic agents capable of achieving a 55% reduction in apnea-hypopnea index (AHI) and promoting a 14.9% mean weight loss in non-diabetic populations, as shown in a recent study published in the Current Atherosclerosis Reports in January 2025.While these medications were originally synthesized to mimic incretin hormones for managing type 2 diabetes mellitus (T2DM) by enhancing glucose-dependent insulin secretion, the discovery of their pleiotropic effects across the cardiovascular, renal, and skeletal systems identified a critical clinical gap in addressing obesity-driven conditions that traditional glucose-lowering therapies often exacerbated through weight gain; consequently, Elizabeth M. Vaughan, and her colleagues from the University of Texas Medical Branch investigated these diverse applications to provide clinicians with an updated therapeutic roadmap.Therefore, the comprehensive clinical review synthesizes evidence from numerous large-scale cardiovascular and kidney outcome trials, as well as multiple randomized-controlled trials involving thousands of participants with obesity, cardiovascular disease, and chronic kidney disease to evaluate primary efficacy endpoints such as major adverse cardiovascular events (MACE) and liver histologic resolution. The analysis focused on summarizing clinical efficacy while noting specific exclusions and safety profiles to provide a robust, evidence-based framework for medical practitioners managing diverse metabolic disorders.Key Clinical Findings of the review Include:Substantial Weight Management: The investigation highlighted that non-diabetic adults with obesity achieved a 14.9% mean weight reduction when utilizing semaglutide 2.4 mg alongside lifestyle modifications, compared to significantly lower results in control groups.Robust Cardiovascular Risk Reduction: A landmark analysis confirmed that semaglutide therapy significantly lowers the risk of MACE, including non-fatal stroke and myocardial infarction, in overweight patients with established cardiovascular disease regardless of their diabetic status.Management of Obstructive Sleep Apnea: Recent clinical trials demonstrated that tirzepatide treatment leads to a substantial 55% decrease in the AHI for patients suffering from moderate to severe obstructive sleep apnea.Resolution of Metabolic Liver Disease: Targeted research revealed that 63.9% of patients with metabolic dysfunction-associated steatohepatitis achieved histologic resolution of the condition without any progression of fibrosis while on a high-dose weekly semaglutide regimen.Decisive Renal Protection: Dedicated studies found that semaglutide reduces the risk of composite kidney outcomes by 24% in patients with chronic kidney disease, highlighting its potent nephroprotective capabilities beyond its glycemic effects.The results suggest that the therapeutic reach of these agents has fundamentally shifted the paradigm of metabolic care, with findings showing they effectively treat obesity, cardiovascular risk, and sleep-related breathing disorders through multi-organ protective mechanisms. Broader adoption is anticipated as data continue to support their utility in stabilizing renal function and addressing inflammatory conditions in populations both with and without diabetes.Thus, the study concludes clinicians may find it highly beneficial to integrate these therapies into comprehensive treatment plans for patients at high risk of multi-organ complications, moving beyond a singular focus on blood glucose management to leverage their broad physiological benefits.While these findings are promising, the high cost of treatment and disparities in medication initiation among racially and ethnically diverse populations remain significant challenges, suggesting a mild need for future research to focus on strategies that enhance accessibility and evaluate long-term outcomes in real-world settings.ReferenceSheth K, Kim S, Porterfield L, Virani SS, Wadhwani S, Vaughan EM. The expanding scope of GLP-1 receptor agonists: Six uses beyond diabetes. Curr Atheroscler Rep. 2025; 27(1): 76. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/12/20/228276-oral-glp-1-receptor-agonist.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GLP-1RAs, Expanding, Clinical, Scope, Beyond, Glycemic, Control:, Review, Suggests</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/12/20/228276-oral-glp-1-receptor-agonist.webp"><p><a href="https://medicaldialogues.in/diabetes-endocrinology/news/glp-1-receptor-agonists-and-sglt2-inhibitors-reduce-liver-related-risks-and-hcc-in-type-2-diabetes-study-164076">Glucagon-like peptide-1 receptor agonists</a> (GLP-1RAs) have remarkably transitioned from specialized <a href="https://medicaldialogues.in/diabetes-endocrinology/understanding-diabetes-and-its-types-dr-a-k-manchanda-123147">diabetes</a> treatments to versatile therapeutic agents capable of achieving a 55% reduction in <a href="https://speciality.medicaldialogues.in/sleep-disordered-breathing-standard-treatment-guidelines">apnea-hypopnea index </a>(AHI) and promoting a 14.9% mean weight loss in non-diabetic populations, as shown in a recent study published in the <i>Current Atherosclerosis Reports</i> in January 2025.</p><div class="pasted-from-word-wrapper"><p dir="ltr">While these medications were originally synthesized to mimic incretin hormones for managing type 2 diabetes mellitus (T2DM) by enhancing glucose-dependent insulin secretion, the discovery of their pleiotropic effects across the cardiovascular, renal, and skeletal systems identified a critical clinical gap in addressing obesity-driven conditions that traditional glucose-lowering therapies often exacerbated through weight gain; consequently, Elizabeth M. Vaughan, and her colleagues from the<i> University of Texas</i> Medical Branch investigated these diverse applications to provide clinicians with an updated therapeutic roadmap.</p><p dir="ltr">Therefore, the comprehensive clinical review synthesizes evidence from numerous large-scale cardiovascular and kidney outcome trials, as well as multiple randomized-controlled trials involving thousands of participants with obesity, cardiovascular disease, and chronic kidney disease to evaluate primary efficacy endpoints such as major adverse cardiovascular events (MACE) and liver histologic resolution. The analysis focused on summarizing clinical efficacy while noting specific exclusions and safety profiles to provide a robust, evidence-based framework for medical practitioners managing diverse metabolic disorders.</p><p dir="ltr"><b>Key Clinical Findings of the review Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Substantial Weight Management:</b> The investigation highlighted that non-diabetic adults with obesity achieved a 14.9% mean weight reduction when utilizing semaglutide 2.4 mg alongside lifestyle modifications, compared to significantly lower results in control groups.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Robust Cardiovascular Risk Reduction:</b> A landmark analysis confirmed that semaglutide therapy significantly lowers the risk of MACE, including non-fatal stroke and myocardial infarction, in overweight patients with established cardiovascular disease regardless of their diabetic status.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Management of Obstructive Sleep Apnea: Recent clinical trials demonstrated that tirzepatide treatment leads to a substantial 55% decrease in the AHI for patients suffering from moderate to severe obstructive sleep apnea.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Resolution of Metabolic Liver Disease:</b> Targeted research revealed that 63.9% of patients with metabolic dysfunction-associated steatohepatitis achieved histologic resolution of the condition without any progression of fibrosis while on a high-dose weekly semaglutide regimen.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Decisive Renal Protection:</b> Dedicated studies found that semaglutide reduces the risk of composite kidney outcomes by 24% in patients with chronic kidney disease, highlighting its potent nephroprotective capabilities beyond its glycemic effects.</p></li></ul><p dir="ltr">The results suggest that the therapeutic reach of these agents has fundamentally shifted the paradigm of metabolic care, with findings showing they effectively treat obesity, cardiovascular risk, and sleep-related breathing disorders through multi-organ protective mechanisms. Broader adoption is anticipated as data continue to support their utility in stabilizing renal function and addressing inflammatory conditions in populations both with and without diabetes.</p><p dir="ltr">Thus, the study concludes clinicians may find it highly beneficial to integrate these therapies into comprehensive treatment plans for patients at high risk of multi-organ complications, moving beyond a singular focus on blood glucose management to leverage their broad physiological benefits.</p><p dir="ltr">While these findings are promising, the high cost of treatment and disparities in medication initiation among racially and ethnically diverse populations remain significant challenges, suggesting a mild need for future research to focus on strategies that enhance accessibility and evaluate long-term outcomes in real-world settings.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Sheth K, Kim S, Porterfield L, Virani SS, Wadhwani S, Vaughan EM. The expanding scope of GLP-1 receptor agonists: Six uses beyond diabetes. Curr Atheroscler Rep. 2025; 27(1): 76.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Psychosis Metabolic Risk Calculator may Predict Cardiometabolic Risk in Young Adults with Psychosis: Study</title>
<link>https://edusehat.com/en/psychosis-metabolic-risk-calculator-may-predict-cardiometabolic-risk-in-young-adults-with-psychosis-study</link>
<guid>https://edusehat.com/en/psychosis-metabolic-risk-calculator-may-predict-cardiometabolic-risk-in-young-adults-with-psychosis-study</guid>
<description><![CDATA[ A web-based tool, Psychosis Metabolic Risk Calculator 2.0 (PsyMetRiC2), can help predict cardiometabolic risks in young adults with psychosis. Using data from over 25,000 individuals aged 16–35, it accurately forecasted one-year weight gain, six-year metabolic syndrome risk, and 10-year risk of type 2 diabetes. The study was published in The Lancet Psychiatry by Benjamin P. and colleagues.This retrospective, multicohort clinical prediction study utilized large-scale primary care datasets, including the Clinical Practice Research Datalink and QResearch, along with secondary care data from the South London and Maudsley NHS Foundation Trust. Participants were aged 16–35 years at first diagnosis of a psychosis-spectrum disorder between January 1, 2005, and December 31, 2015, with follow-up extending to December 31, 2020, in primary care cohorts. Secondary care participants were enrolled between January 1, 2012, and December 31, 2024.The models developed by PsyMetRiC were revised and updated to increase the accuracy of prediction with the addition of more relevant variables, namely family history of cardiometabolic disease, antidepressant use, systolic blood pressure, and HbA1c levels. Three key outcomes were also modeled, namely, the development of metabolic syndrome in 1 to 6 years using logistic regression, type 2 diabetes in 10 years using Weibull regression, and significant weight gain in 1 year using logistic regression. Full models with biochemical predictors and partial models without biochemical predictors were developed to increase the applicability of the models in different settings.Key findings:The participants were 25,850 in number, comprising 13,614 males (52.7%) and 12,236 females (47.3%). Their mean age was 26.7 ± 5.4 years. In terms of ethnicity, 16,445 participants (63.6%) were White European ethnicity, while 9,405 participants (36.3%) were of Black African/Caribbean, South Asian, mixed, East Asian, or other ethnicity. The results obtained using the PsyMetRiC2 model were excellent in terms of discriminative ability. In terms of the model for metabolic syndrome, external validation gave a C-statistic of 0.81 (95% CI, 0.77–0.84) for the full model and 0.79 (95% CI, 0.76–0.83) for the partial model. In terms of type 2 diabetes prediction, internal validation gave a C-statistic of 0.86 (95% CI, 0.76–0.95) for the full model. External validation gave a C-statistic of 0.81 (95% CI, 0.71–0.88) for the full model. In terms of clinically significant weight gain, internal validation gave a C-statistic of 0.78 (95% CI, 0.73–0.82) for the full model and 0.77 (95% CI, 0.72–0.80) for the partial model.Calibration plots were acceptable across all models, and decision curve analyses indicated clinical usefulness at all plausible risk thresholds.The PsyMetRiC models facilitate the accurate and clinically useful prediction of cardiometabolic risk in young people with psychosis and promote the development of preventive, personalized, and integrated care.Reference:Perry, B. I., Osimo, E. F., Si, S., Hitchins, K. V. B., Lewis, C., Laws, B., Griffin, S. J., Khandaker, G. M., Murray, G. K., Shiers, D., Chew-Graham, C. A., Jones, P. B., Denniston, A. K., Bardus, M., Jowett, S., Walsh, A. E. L., Arshad, S., Formanek, T., Pillinger, T., McCutcheon, R. A., … PsyMetRiC Network (2026). Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study. The lancet. Psychiatry, 13(4), 291–303. https://doi.org/10.1016/S2215-0366(25)00398-0  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/10/231954-psychosis-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Psychosis, Metabolic, Risk, Calculator, may, Predict, Cardiometabolic, Risk, Young, Adults, with, Psychosis:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/10/231954-psychosis-50.webp"><p>A web-based tool, Psychosis Metabolic Risk Calculator 2.0 (PsyMetRiC2), can help predict cardiometabolic risks in young adults with psychosis. Using data from over 25,000 individuals aged 16–35, it accurately forecasted one-year weight gain, six-year metabolic syndrome risk, and 10-year risk of type 2 diabetes. The study was published in <i>The Lancet Psychiatry</i> by Benjamin P. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This retrospective, multicohort clinical prediction study utilized large-scale primary care datasets, including the Clinical Practice Research Datalink and QResearch, along with secondary care data from the South London and Maudsley NHS Foundation Trust. Participants were aged 16–35 years at first diagnosis of a psychosis-spectrum disorder between January 1, 2005, and December 31, 2015, with follow-up extending to December 31, 2020, in primary care cohorts. Secondary care participants were enrolled between January 1, 2012, and December 31, 2024.</p><p dir="ltr">The models developed by PsyMetRiC were revised and updated to increase the accuracy of prediction with the addition of more relevant variables, namely family history of cardiometabolic disease, antidepressant use, systolic blood pressure, and HbA1c levels. Three key outcomes were also modeled, namely, the development of metabolic syndrome in 1 to 6 years using logistic regression, type 2 diabetes in 10 years using Weibull regression, and significant weight gain in 1 year using logistic regression. Full models with biochemical predictors and partial models without biochemical predictors were developed to increase the applicability of the models in different settings.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The participants were 25,850 in number, comprising 13,614 males (52.7%) and 12,236 females (47.3%). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Their mean age was 26.7 ± 5.4 years. In terms of ethnicity, 16,445 participants (63.6%) were White European ethnicity, while 9,405 participants (36.3%) were of Black African/Caribbean, South Asian, mixed, East Asian, or other ethnicity. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The results obtained using the PsyMetRiC2 model were excellent in terms of discriminative ability. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In terms of the model for metabolic syndrome, external validation gave a C-statistic of 0.81 (95% CI, 0.77–0.84) for the full model and 0.79 (95% CI, 0.76–0.83) for the partial model. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In terms of type 2 diabetes prediction, internal validation gave a C-statistic of 0.86 (95% CI, 0.76–0.95) for the full model. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">External validation gave a C-statistic of 0.81 (95% CI, 0.71–0.88) for the full model. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In terms of clinically significant weight gain, internal validation gave a C-statistic of 0.78 (95% CI, 0.73–0.82) for the full model and 0.77 (95% CI, 0.72–0.80) for the partial model.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Calibration plots were acceptable across all models, and decision curve analyses indicated clinical usefulness at all plausible risk thresholds.</p></li></ul><p dir="ltr">The PsyMetRiC models facilitate the accurate and clinically useful prediction of cardiometabolic risk in young people with psychosis and promote the development of preventive, personalized, and integrated care.</p><p dir="ltr">Reference:</p><p dir="ltr">Perry, B. I., Osimo, E. F., Si, S., Hitchins, K. V. B., Lewis, C., Laws, B., Griffin, S. J., Khandaker, G. M., Murray, G. K., Shiers, D., Chew-Graham, C. A., Jones, P. B., Denniston, A. K., Bardus, M., Jowett, S., Walsh, A. E. L., Arshad, S., Formanek, T., Pillinger, T., McCutcheon, R. A., … PsyMetRiC Network (2026). Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study. The lancet. Psychiatry, 13(4), 291–303. <a href="https://doi.org/10.1016/S2215-0366(25)00398-0">https://doi.org/10.1016/S2215-0366(25)00398-0</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Prone Positioning Appears Safe for Cerebral Blood Flow During Spine Surgery, Study Finds</title>
<link>https://edusehat.com/en/prone-positioning-appears-safe-for-cerebral-blood-flow-during-spine-surgery-study-finds</link>
<guid>https://edusehat.com/en/prone-positioning-appears-safe-for-cerebral-blood-flow-during-spine-surgery-study-finds</guid>
<description><![CDATA[ Why Cerebral Hemodynamics Matter in Spine SurgeryIn spine surgeries, the prone (face-down) position is commonly used to give surgeons optimal access. However, this position, along with anesthesia and ventilation strategies, is thought to potentially affect cardiovascular and brain blood flow dynamics. Concerns especially arise about whether prone positioning might elevate intracranial pressure (ICP) or disturb cerebral perfusion, possibly resulting in neurological complications. A recent prospective observational study published in BMC Anesthesiology investigates this by using the non-invasive transcranial Doppler (TCD) technique to monitor cerebral hemodynamics during spine operations.Study Design: Tracking Brain Blood Flow in Real TimeThe research involved 33 adult patients (aged 18–65) undergoing thoracolumbar or lumbosacral spine surgeries under general anesthesia in the prone position. Baseline readings were taken in the supine (lying on back) position before and after anesthesia, then at multiple intervals (up to 60 minutes) after patients were turned prone. Key parameters recorded included heart rate, blood pressure, TCD measurements (peak systolic velocity, mean flow velocity, pulsatility index, and resistivity index), and a calculated non-invasive ICP (nICP).Key Findings: Prone Position Does Not Significantly Alter Cerebral HemodynamicsWhile the study did observe statistically significant decreases in heart rate and blood pressure during the prone position, these changes were not clinically significant (all within 20% of baseline). Importantly, the core cerebral hemodynamic parameters—peak systolic velocity, mean flow velocity, pulsatility index, resistivity index, and nICP—remained stable throughout all time points in the prone position.This suggests that, for patients without significant comorbidities and with well-managed anesthesia and fluid balance, the prone position does not adversely impact cerebral blood flow or increase intracranial pressure.What Sets This Study Apart?The findings align with some previous research but differ from studies reporting mild increases in pulsatility index or ICP—differences that may be due to patient age or higher levels of positive end-expiratory pressure (PEEP) used elsewhere. This study’s younger average patient age and consistent use of physiological (modest) PEEP may explain the lack of significant hemodynamic shifts. Adequate fluid management, careful positioning, and maintaining normothermia and ventilation targets were critical to these results.Limitations and Clinical ImplicationsThe study’s main limitations include a modest sample size and exclusion of higher-risk (ASA 3–5) patients, so results may not extend to older or more medically complex populations. Nonetheless, the research suggests that with proper perioperative care, prone positioning for spine surgery is unlikely to compromise brain perfusion or pressure in most adult patients.Key Takeaways:Prone positioning during spine surgery did not alter key cerebral hemodynamic variables or non-invasive ICP.Modest decreases in heart rate and blood pressure were observed but were not clinically significant.Careful anesthesia, fluid, and ventilation management are essential for maintaining cerebral stability.Findings support the safety of the prone position for most healthy adult patients undergoing spine surgery.Further research is needed in older or higher-risk populations.Citation:Taj Y, Samagh N, Paliwal SU, Ganesh V, Dey A, Aggarwal V. Effect of prone position on cerebral hemodynamics and noninvasive intracranial pressure assessed using transcranial Doppler in patients undergoing spine surgeries: a prospective observational study. BMC Anesthesiology. 2025;25:242. https://doi.org/10.1186/s12871-025-03116-9 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/11/313775-awake-prone-positioning.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Prone, Positioning, Appears, Safe, for, Cerebral, Blood, Flow, During, Spine, Surgery, Study, Finds</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/11/313775-awake-prone-positioning.webp"><p align="justify">Why Cerebral Hemodynamics Matter in Spine Surgery</p><p align="justify">In spine surgeries, the prone (face-down) position is commonly used to give surgeons optimal access. However, this position, along with anesthesia and ventilation strategies, is thought to potentially affect cardiovascular and brain blood flow dynamics. Concerns especially arise about whether prone positioning might elevate intracranial pressure (ICP) or disturb cerebral perfusion, possibly resulting in neurological complications. A recent prospective observational study published in BMC Anesthesiology investigates this by using the non-invasive transcranial Doppler (TCD) technique to monitor cerebral hemodynamics during spine operations.</p><p align="justify">Study Design: Tracking Brain Blood Flow in Real Time</p><p align="justify">The research involved 33 adult patients (aged 18–65) undergoing thoracolumbar or lumbosacral spine surgeries under general anesthesia in the prone position. Baseline readings were taken in the supine (lying on back) position before and after anesthesia, then at multiple intervals (up to 60 minutes) after patients were turned prone. Key parameters recorded included heart rate, blood pressure, TCD measurements (peak systolic velocity, mean flow velocity, pulsatility index, and resistivity index), and a calculated non-invasive ICP (nICP).</p><p align="justify">Key Findings: Prone Position Does Not Significantly Alter Cerebral Hemodynamics</p><p align="justify">While the study did observe statistically significant decreases in heart rate and blood pressure during the prone position, these changes were not clinically significant (all within 20% of baseline). Importantly, the core cerebral hemodynamic parameters—peak systolic velocity, mean flow velocity, pulsatility index, resistivity index, and nICP—remained stable throughout all time points in the prone position.</p><p align="justify">This suggests that, for patients without significant comorbidities and with well-managed anesthesia and fluid balance, the prone position does not adversely impact cerebral blood flow or increase intracranial pressure.</p><p align="justify">What Sets This Study Apart?</p><p align="justify">The findings align with some previous research but differ from studies reporting mild increases in pulsatility index or ICP—differences that may be due to patient age or higher levels of positive end-expiratory pressure (PEEP) used elsewhere. This study’s younger average patient age and consistent use of physiological (modest) PEEP may explain the lack of significant hemodynamic shifts. Adequate fluid management, careful positioning, and maintaining normothermia and ventilation targets were critical to these results.</p><p align="justify">Limitations and Clinical Implications</p><p align="justify">The study’s main limitations include a modest sample size and exclusion of higher-risk (ASA 3–5) patients, so results may not extend to older or more medically complex populations. Nonetheless, the research suggests that with proper perioperative care, prone positioning for spine surgery is unlikely to compromise brain perfusion or pressure in most adult patients.</p><p align="justify">Key Takeaways:</p><p align="justify">Prone positioning during spine surgery did not alter key cerebral hemodynamic variables or non-invasive ICP.</p><p align="justify">Modest decreases in heart rate and blood pressure were observed but were not clinically significant.</p><p align="justify">Careful anesthesia, fluid, and ventilation management are essential for maintaining cerebral stability.</p><p align="justify">Findings support the safety of the prone position for most healthy adult patients undergoing spine surgery.</p><p align="justify">Further research is needed in older or higher-risk populations.</p><p align="justify">Citation:</p><p align="justify">Taj Y, Samagh N, Paliwal SU, Ganesh V, Dey A, Aggarwal V. Effect of prone position on cerebral hemodynamics and noninvasive intracranial pressure assessed using transcranial Doppler in patients undergoing spine surgeries: a prospective observational study. BMC Anesthesiology. 2025;25:242. https://doi.org/10.1186/s12871-025-03116-9</p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>Novel Plasma Biomarkers Identified for Venous Thromboembolism in a New Study</title>
<link>https://edusehat.com/en/novel-plasma-biomarkers-identified-for-venous-thromboembolism-in-a-new-study</link>
<guid>https://edusehat.com/en/novel-plasma-biomarkers-identified-for-venous-thromboembolism-in-a-new-study</guid>
<description><![CDATA[ USA: A new large-scale proteomics study has discovered several new plasma protein biomarkers associated with venous thromboembolism (VTE), with evidence suggesting that some may play a causal role in disease development. These findings enhance understanding of VTE biology and may improve risk prediction. Additionally, they open new avenues for preventive strategies and targeted therapeutic interventions.       The study, published in Circulation, was led by Weihong Tang from the Division of Epidemiology &amp; Community Health at the University of Minnesota School of Public Health and involved multiple international cohorts. Although VTE remains one of the most common cardiovascular conditions, its underlying mechanisms are not fully understood, particularly in cases that occur without cancer or obvious triggers.Researchers analyzed data from four large prospective cohorts: ARIC (Atherosclerosis Risk in Communities), CHS (Cardiovascular Health Study), MESA (Multi-Ethnic Study of Atherosclerosis), and the HUNT study (Trøndelag Health Study). The analysis included 20,737 participants, among whom 1,371 developed incident noncancer VTE over follow-up periods ranging from 10 to 29 years.Baseline plasma samples were assessed using the SomaScan platform, an aptamer-based high-throughput proteomics technology capable of measuring approximately 5,000 to 7,000 proteins simultaneously. Investigators examined the prospective association between circulating protein levels and future VTE risk using Cox proportional hazards models. Top findings were subsequently tested in an external replication cohort from the UK Biobank, which included 783 additional VTE cases among 39,097 participants and used the Olink proteomics platform.In the discovery analysis, 23 proteins met stringent statistical thresholds and were successfully replicated. Of these, 15 had not previously been linked to VTE. Three novel proteins—TAGLN, SVEP1, and TIMP4—remained significant after conservative correction for multiple testing in the HUNT cohort. Among 16 proteins available for validation in the UK Biobank dataset, 11 were independently confirmed.To explore whether these associations might reflect causal relationships rather than correlation alone, the team conducted Mendelian randomization analyses. This approach supported a potential causal role for TIMD4 in VTE risk, with additional suggestive evidence for TIMP4 and CST3. Interestingly, for some proteins, the direction of association in genetic analyses differed from observational findings, highlighting the complexity of underlying biological pathways.The identified proteins were linked to processes extending beyond traditional coagulation pathways. These included extracellular matrix regulation, immune responses, interactions between immune cells and vascular endothelium, vascular aging, and fibrosis. Notably, some proteins such as COL6A3 and EPHA4 have been considered therapeutic targets in other diseases, raising the possibility of drug repurposing.Although the study had limitations—including reliance on single baseline protein measurements and variations in VTE ascertainment across cohorts—the findings consistently demonstrated that incorporating proteomic markers improved VTE risk prediction beyond established clinical factors.Overall, the study broadens insight into the biological mechanisms driving VTE and identifies promising biomarkers that could refine risk stratification and guide safer, more targeted prevention and treatment strategies.Reference:Tang W, Li A, Austin TR, Brækkan SK, Nøst TH, Li X, Deo R, Dubin R, Ganz P, Guan W, Cao R, Hansen JB, Hveem K, Hoogeveen RC, Jonasson C, Rotter JI, Matsushita K, Liu G, Pankow JS, Pankratz N, Psaty BM, Taylor KD, Thibord F, Boerwinkle E, Smith NL, Cushman M, Folsom AR. Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism. Circulation. 2026 Feb 16. doi: 10.1161/CIRCULATIONAHA.125.074493. Epub ahead of print. PMID: 41693575. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/14/198202-venous-thromboembolism.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Novel, Plasma, Biomarkers, Identified, for, Venous, Thromboembolism, New, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/14/198202-venous-thromboembolism.webp"><p><span>USA: A new large-scale proteomics study has discovered several new plasma <a href="https://medicaldialogues.in/topics/protein-biomarkers">protein biomarkers</a> associated with <a href="https://medicaldialogues.in/topics/venous-thromboembolism">venous thromboembolism (VTE)</a>, with evidence suggesting that some may play a causal role in disease development. These findings enhance understanding of VTE biology and may improve<a href="https://medicaldialogues.in/topics/risk-stratification"> risk prediction</a>. Additionally, they open new avenues for preventive strategies and targeted therapeutic interventions.       </span></p><div class="pasted-from-word-wrapper"><div>The study, published in <i>Circulation</i>, was led by Weihong Tang from the Division of Epidemiology & Community Health at the University of Minnesota School of Public Health and involved multiple international cohorts. Although VTE remains one of the most common cardiovascular conditions, its underlying mechanisms are not fully understood, particularly in cases that occur without cancer or obvious triggers.</div><div>Researchers analyzed data from four large prospective cohorts: ARIC (Atherosclerosis Risk in Communities), CHS (Cardiovascular Health Study), MESA (Multi-Ethnic Study of Atherosclerosis), and the HUNT study (Trøndelag Health Study). The analysis included 20,737 participants, among whom 1,371 developed incident noncancer VTE over follow-up periods ranging from 10 to 29 years.</div><div>Baseline plasma samples were assessed using the SomaScan platform, an aptamer-based high-throughput proteomics technology capable of measuring approximately 5,000 to 7,000 proteins simultaneously. Investigators examined the prospective association between circulating protein levels and future VTE risk using Cox proportional hazards models. Top findings were subsequently tested in an external replication cohort from the UK Biobank, which included 783 additional VTE cases among 39,097 participants and used the Olink proteomics platform.</div><div>In the discovery analysis, 23 proteins met stringent statistical thresholds and were successfully replicated. Of these, 15 had not previously been linked to VTE. Three novel proteins—TAGLN, SVEP1, and TIMP4—remained significant after conservative correction for multiple testing in the HUNT cohort. Among 16 proteins available for validation in the UK Biobank dataset, 11 were independently confirmed.</div><div>To explore whether these associations might reflect causal relationships rather than correlation alone, the team conducted Mendelian randomization analyses. This approach supported a potential causal role for TIMD4 in VTE risk, with additional suggestive evidence for TIMP4 and CST3. Interestingly, for some proteins, the direction of association in genetic analyses differed from observational findings, highlighting the complexity of underlying biological pathways.</div><div>The identified proteins were linked to processes extending beyond traditional coagulation pathways. These included extracellular matrix regulation, immune responses, interactions between immune cells and vascular endothelium, vascular aging, and fibrosis. Notably, some proteins such as COL6A3 and EPHA4 have been considered therapeutic targets in other diseases, raising the possibility of drug repurposing.</div><div>Although the study had limitations—including reliance on single baseline protein measurements and variations in VTE ascertainment across cohorts—the findings consistently demonstrated that incorporating proteomic markers improved VTE risk prediction beyond established clinical factors.</div><div>Overall, the study broadens insight into the biological mechanisms driving VTE and identifies promising biomarkers that could refine risk stratification and guide safer, more targeted prevention and treatment strategies.</div><div>Reference:</div><div>Tang W, Li A, Austin TR, Brækkan SK, Nøst TH, Li X, Deo R, Dubin R, Ganz P, Guan W, Cao R, Hansen JB, Hveem K, Hoogeveen RC, Jonasson C, Rotter JI, Matsushita K, Liu G, Pankow JS, Pankratz N, Psaty BM, Taylor KD, Thibord F, Boerwinkle E, Smith NL, Cushman M, Folsom AR. Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism. Circulation. 2026 Feb 16. doi: 10.1161/CIRCULATIONAHA.125.074493. Epub ahead of print. PMID: 41693575.</div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Failure to conduct pre&#45;anaesthetic check&#45;up is gross negligence: HC refuses relief to anaesthetist booked under IPC 304A</title>
<link>https://edusehat.com/en/failure-to-conduct-pre-anaesthetic-check-up-is-gross-negligence-hc-refuses-relief-to-anaesthetist-booked-under-ipc-304a</link>
<guid>https://edusehat.com/en/failure-to-conduct-pre-anaesthetic-check-up-is-gross-negligence-hc-refuses-relief-to-anaesthetist-booked-under-ipc-304a</guid>
<description><![CDATA[ New Delhi: Observing that failure to conduct a pre-anaesthetic check-up amounts to gross negligence, the Kerala High Court recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, &quot;...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner.&quot;The accused doctor filed the plea before the HC bench, challenging the order dated 21.03.2019 of the Additional Assistant Sessions Court, Palakkad, framing charges against him under Section 304A I.P.C, and forwarding the case to the Judicial First Class Magistrate Court-III, Palakkad, under Section 228 Cr.P.C for trial.The petitioner doctor is an Anaesthetist in a private hospital. A 23-year-old patient, who delivered a baby on 11.09.2014, had undergone Post-Partum Sterilization (PPS) surgery in that hospital on 13.09.2014. The petitioner was the Anesthetist who attended her during that time.After the surgery was performed, the concerned patient died due to peripartum cardiomyopathy caused by primary pulmonary hypertension. Initially, an F.I.R was registered under Section 174 Cr.P.C in connection with the aforesaid death.Later, the treating gynaecologist and anaesthetist were booked under Section 304 IPC. After considering the report of the District Level Expert Committee of Doctors, the Investigating Officer laid the final report against the petitioner alone, for the commission of offence under Section 304 I.P.C., in connection with the aforesaid death of that lady after PPS surgery. It was alleged that the petitioner had failed to conduct pre-anaesthetic check-up and it resulted in the complications leading to the death of the patient.The petitioner filed plea before the learned Additional Assistant Sessions Judge, seeking discharge from criminal prosecution. After hearing both sides, the learned Additional Assistant Sessions Judge concluded that the offence under Section 304 I.P.C was not attracted, in the facts and circumstances of the case. However, it was found that there were prima facie materials to proceed against the petitioner for the commission of offence under Section 304 A I.P.C. Accordingly, the learned Additional Assistant Sessions Judge framed charges under the aforesaid Section, and passed the order under Section 228 Cr.P.C forwarding the case to the Judicial First Class Magistrate concerned for proceeding with the trial. This order was challenged by the accused doctor before the High Court.While considering the matter, the HC bench noted that gross negligence in administering treatment was attributed to the petitioner, stating the reason that he gave anesthesia to the deceased lady, without conducting pre-anesthetic check-up, prior to her PPS surgery. According to the prosecution, the said omission was the cause of death of that 23-year-old lady, who delivered a female child without any medical complications, two days prior to her death. The prosecution relied on the report of the District Level Expert Committee consisting of five Senior Medical Officers including Specialists in Gynaecology and Paediatrics and the D.M.O. Further, the prosecution also referred to the findings in the postmortem report to contend that the petitioner displayed gross negligence by his failure to conduct pre-anaesthetic check-up upon the deceased lady before proceeding with the process of anaesthesia.Strongly disputing the allegation about his failure to conduct a pre-anaesthetic check-up upon the lady, who lost her life due to peripartum cardiomyopathy after the PPS procedures, the petitioner submitted that the hospital records would reveal that he had conducted the aforesaid check-up. Taking note of the submissions, the HC bench observed that the matter mainly concerned a dispute of fact as to whether the petitioner had conducted pre-anaesthetic check-up upon the deceased, before proceeding with the process of giving anaesthesia to her.The Court also took note of the report of the expert panel consisting of the District Medical Officer and four other Specialist Doctors of Gynaecology, Paediatrics, Surgery and Forensic Medicine. In the aforesaid report, it has been stated in unequivocal terms that the hospital case records and the postmortem report would disclose that pre-anesthesia check-up, which is the essential part before a surgery, was not done upon the deceased lady. For this reason, the panel of expert doctors unanimously found that the Anesthetist was negligent in that respect. At this outset, the HC bench observed, &quot;As matters stand now, the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner.&quot;&quot;The question whether the complaints of primary pulmonary hypertension leading to peripartum cardiomyopathy could have been detected in a pre-anesthetic check-up, is a different aspect. What could be understood from authoritative medical text books is that a pre-anesthesia check-up can raise suspicion or detect it if symptoms or signs of the aforesaid complaints were present in the patient. If such a medical condition could have been detected from any symptoms or signs of the patient, then definitely adequate precautionary measures could have been taken to save the life of the patient. When viewed in the above perspective, the failure to conduct pre-anesthetic check-up would definitely amount to gross negligence, even though such a check-up could have averted casualty only in such cases where the primary pulmonary hypertension and peripartum cardiomyopathy were symptomatic in the patient. The question whether the deceased lady had any such symptoms indicative of the aforesaid ailments could be ascertained only after the examination of the medical officers concerned who had the occasion to observe that lady prior to the delivery and also immediately after delivery. Thus, the aforesaid factual aspect is also a matter to be looked into by the Trial Court at the stage of evidence,&quot; it further noted.Accordingly, the Court denied relief to the accused doctor and refused to discharge him from the criminal prosecution. It noted, &quot;At any rate, it is not possible for this Court to invoke the revisional powers to terminate the prosecution proceedings against the petitioner, since the documents on record point to the failure of the petitioner to conduct pre-anesthetic check-up upon the deceased lady before giving anesthesia. As a conclusion to the above discussion, I find that the prayer of the petitioner to discharge him from the criminal prosecution for the commission of offence under Section 304A I.P.C, cannot be allowed.&quot;To view the order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/10/kerala-hc-section-304a-340875.pdfAlso Read: How to deal with medical negligence complaints received against doctors under IPC 304A: TN DGP issues guidelines, check out details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/11/19/191432-kerala-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Failure, conduct, pre-anaesthetic, check-up, gross, negligence:, refuses, relief, anaesthetist, booked, under, IPC, 304A</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/11/19/191432-kerala-high-court.webp"><p><b>New Delhi:</b> Observing that failure to conduct a pre-anaesthetic check-up amounts to gross <a href="https://medicaldialogues.in/topics/medical-negligence">negligence</a>, the <a href="https://medicaldialogues.in/topics/kerala-high-court">Kerala High Court</a> recently denied relief to an anaesthetist booked under Section 304 A of the Indian Penal Code (IPC).</p><p>Referring to the findings of the post-mortem report and the expert panel, the HC bench comprising Justice G. Girish observed, <i>"...the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner."</i></p><p>The accused doctor filed the plea before the HC bench, challenging the order dated 21.03.2019 of the Additional Assistant Sessions Court, Palakkad, framing charges against him under<a href="https://medicaldialogues.in/topics/section-304-A"> Section 304A I.P.C</a>, and forwarding the case to the Judicial First Class Magistrate Court-III, Palakkad, under Section 228 Cr.P.C for trial.</p><p>The petitioner doctor is an Anaesthetist in a private hospital. A 23-year-old patient, who delivered a baby on 11.09.2014, had undergone Post-Partum Sterilization (PPS) surgery in that hospital on 13.09.2014. The petitioner was the Anesthetist who attended her during that time.</p><p>After the surgery was performed, the concerned patient died due to peripartum cardiomyopathy caused by primary pulmonary hypertension. Initially, an F.I.R was registered under Section 174 Cr.P.C in connection with the aforesaid death.</p><p>Later, the treating gynaecologist and anaesthetist were booked under Section 304 IPC. After considering the report of the District Level Expert Committee of Doctors, the Investigating Officer laid the final report against the petitioner alone, for the commission of offence under Section 304 I.P.C., in connection with the aforesaid death of that lady after PPS surgery. It was alleged that the petitioner had failed to conduct pre-anaesthetic check-up and it resulted in the complications leading to the death of the patient.</p><p>The petitioner filed plea before the learned Additional Assistant Sessions Judge, seeking discharge from criminal prosecution. After hearing both sides, the learned Additional Assistant Sessions Judge concluded that the offence under Section 304 I.P.C was not attracted, in the facts and circumstances of the case. However, it was found that there were prima facie materials to proceed against the petitioner for the commission of offence under Section 304 A I.P.C. Accordingly, the learned Additional Assistant Sessions Judge framed charges under the aforesaid Section, and passed the order under Section 228 Cr.P.C forwarding the case to the Judicial First Class Magistrate concerned for proceeding with the trial. This order was challenged by the accused doctor before the High Court.</p><p>While considering the matter, the HC bench noted that gross negligence in administering treatment was attributed to the petitioner, stating the reason that he gave anesthesia to the deceased lady, without conducting pre-anesthetic check-up, prior to her PPS surgery. According to the prosecution, the said omission was the cause of death of that 23-year-old lady, who delivered a female child without any medical complications, two days prior to her death. </p><p>The prosecution relied on the report of the District Level Expert Committee consisting of five Senior Medical Officers including Specialists in Gynaecology and Paediatrics and the D.M.O. Further, the prosecution also referred to the findings in the postmortem report to contend that the petitioner displayed gross negligence by his failure to conduct pre-anaesthetic check-up upon the deceased lady before proceeding with the process of anaesthesia.</p><p>Strongly disputing the allegation about his failure to conduct a pre-anaesthetic check-up upon the lady, who lost her life due to peripartum cardiomyopathy after the PPS procedures, the petitioner submitted that the hospital records would reveal that he had conducted the aforesaid check-up. </p><p>Taking note of the submissions, the HC bench observed that the matter mainly concerned a dispute of fact as to whether the petitioner had conducted pre-anaesthetic check-up upon the deceased, before proceeding with the process of giving anaesthesia to her.</p><p>The Court also took note of the report of the expert panel consisting of the District Medical Officer and four other Specialist Doctors of Gynaecology, Paediatrics, Surgery and Forensic Medicine. In the aforesaid report, it has been stated in unequivocal terms that the hospital case records and the postmortem report would disclose that pre-anesthesia check-up, which is the essential part before a surgery, was not done upon the deceased lady. For this reason, the panel of expert doctors unanimously found that the <a href="https://medicaldialogues.in/topics/anaesthetist">Anesthetist</a> was negligent in that respect. </p><p>At this outset, the HC bench observed, </p><blockquote><i>"As matters stand now, the findings in the postmortem report, as well as the report of the expert panel, are to the effect that the surgery of the deceased lady was conducted without pre-anesthetic check-up which the petitioner was bound to conduct before proceeding with the application of anesthesia upon her. If it is found that no pre-anesthetic check-up was done upon the deceased lady, it would definitely point to gross negligence on the part of the petitioner."</i></blockquote><p><i>"The question whether the complaints of primary pulmonary hypertension leading to peripartum cardiomyopathy could have been detected in a pre-anesthetic check-up, is a different aspect. What could be understood from authoritative medical text books is that a pre-anesthesia check-up can raise suspicion or detect it if symptoms or signs of the aforesaid complaints were present in the patient. If such a medical condition could have been detected from any symptoms or signs of the patient, then definitely adequate precautionary measures could have been taken to save the life of the patient. When viewed in the above perspective, the failure to conduct pre-anesthetic check-up would definitely amount to gross negligence, even though such a check-up could have averted casualty only in such cases where the primary pulmonary hypertension and peripartum cardiomyopathy were symptomatic in the patient. The question whether the deceased lady had any such symptoms indicative of the aforesaid ailments could be ascertained only after the examination of the medical officers concerned who had the occasion to observe that lady prior to the delivery and also immediately after delivery. Thus, the aforesaid factual aspect is also a matter to be looked into by the Trial Court at the stage of evidence,"</i> it further noted.</p><p>Accordingly, the Court denied relief to the accused doctor and refused to discharge him from the criminal prosecution. It noted,</p><blockquote><i> "At any rate, it is not possible for this Court to invoke the revisional powers to terminate the prosecution proceedings against the petitioner, since the documents on record point to the failure of the petitioner to conduct pre-anesthetic check-up upon the deceased lady before giving anesthesia. As a conclusion to the above discussion, I find that the prayer of the petitioner to discharge him from the criminal prosecution for the commission of offence under Section 304A I.P.C, cannot be allowed."</i></blockquote><p><b><i>To view the order, click on the link below:</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/10/kerala-hc-section-304a-340875.pdf"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/10/kerala-hc-section-304a-340875.pdf</i></b></a></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/how-to-deal-with-medical-negligence-complaints-received-against-doctors-under-ipc-304a-tn-dgp-issues-guidelines-check-out-details-113363"><b><i>Also Read: How to deal with medical negligence complaints received against doctors under IPC 304A: TN DGP issues guidelines, check out details</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Ultra&#45;Processed Food Intake Linked to Clinical Weakness in Hemodialysis Patients: Study</title>
<link>https://edusehat.com/en/ultra-processed-food-intake-linked-to-clinical-weakness-in-hemodialysis-patients-study</link>
<guid>https://edusehat.com/en/ultra-processed-food-intake-linked-to-clinical-weakness-in-hemodialysis-patients-study</guid>
<description><![CDATA[ Researchers have found in a new study that higher consumption of ultra-processed foods (UPFs) was significantly associated with an increased risk of clinical weakness in hemodialysis (HD) patients. However, it showed no significant association with malnutrition. The study was published in BMC Nephrology by Ramazan M. and colleagues.The nutritional problems of hemodialysis patients are distinctive in the fact that they have to adhere to a restrictive diet while simultaneously consuming increased amounts of protein necessary to cope with muscle atrophy. While conventional dietary recommendations tend to focus on potassium, phosphorus, and protein levels, little is known about the effects of industrially processed foods.For the study, the researchers performed a cross-sectional analysis of 90 patients, collecting a number of variables pertaining to sociodemographics, anthropometrics, and lab results. Dietary behaviors were studied using a validated questionnaire based on the NOVA criteria of classifying foods. In particular, foods were identified depending on how much they had been processed by industrial means, thus allowing the authors to separate the patients into two groups: M1 with low consumption of UPFs and M2 with high consumption. Clinical weakness was quantified using the HGS Index, while malnutrition was measured with NRI.Key findings:The most important results are reflected in the results of strength tests. The Hand Grip Strength (HGS) test was statistically greater in the M1 group (89.6 ± 24.1) compared to the M2 group (77.7 ± 23.9). Based on the simple statistical analysis model, the odds ratio of clinically defined weakness was 3.70-fold greater in the UPF intake group (95% CI 1.41–9.70, p-value = 0.008). The effect proved to be consistent even when adjusted for potential confounders during multiple regression analyses. Even in the multivariate logistic regression analysis, the OR for odds in Model 2 was significantly higher, ranging from 1.30 to 11.77 (p-value = 0.015), while in Model 3 the OR range was 1.28 to 12.08 (p-value = 0.017). However, despite all the evidence of physical weakness, there is no correlation between the odds of malnutrition in any of the adjusted or unadjusted models.The study reveals that the more UPF consumed by an individual, the greater the chances of having clinical weakness. However, the findings do not support any association between the high consumption of UPF and malnutrition in HD patients. Even though the diet may seem satisfactory in terms of providing sufficient calories and proteins, the heavy food processing is causing a loss of energy and stamina. In light of the ongoing research and development regarding diets in chronic kidney disease, this study supports the adoption of a &quot;whole foods&quot; diet to minimize clinical weakness in HD patients.Reference:Atan, R., Yılmaz, H.Ö. Ultra-processed food consumption and the prevalence of malnutrition and clinical weakness among hemodialysis patients: a single-center cross-sectional study. BMC Nephrol (2026). https://doi.org/10.1186/s12882-026-04935-9  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/04/13/207377-hemodialysis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Ultra-Processed, Food, Intake, Linked, Clinical, Weakness, Hemodialysis, Patients:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/04/13/207377-hemodialysis.webp"><p>Researchers have found in a new study that higher consumption of ultra-processed foods (UPFs) was significantly associated with an increased risk of clinical weakness in hemodialysis (HD) patients. However, it showed no significant association with malnutrition. The study was published in <i>BMC Nephrology</i> by Ramazan M. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The nutritional problems of hemodialysis patients are distinctive in the fact that they have to adhere to a restrictive diet while simultaneously consuming increased amounts of protein necessary to cope with muscle atrophy. While conventional dietary recommendations tend to focus on potassium, phosphorus, and protein levels, little is known about the effects of industrially processed foods.</p><p dir="ltr">For the study, the researchers performed a cross-sectional analysis of 90 patients, collecting a number of variables pertaining to sociodemographics, anthropometrics, and lab results. Dietary behaviors were studied using a validated questionnaire based on the NOVA criteria of classifying foods. In particular, foods were identified depending on how much they had been processed by industrial means, thus allowing the authors to separate the patients into two groups: M1 with low consumption of UPFs and M2 with high consumption. Clinical weakness was quantified using the HGS Index, while malnutrition was measured with NRI.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The most important results are reflected in the results of strength tests. The Hand Grip Strength (HGS) test was statistically greater in the M1 group (89.6 ± 24.1) compared to the M2 group (77.7 ± 23.9). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Based on the simple statistical analysis model, the odds ratio of clinically defined weakness was 3.70-fold greater in the UPF intake group (95% CI 1.41–9.70, p-value = 0.008). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The effect proved to be consistent even when adjusted for potential confounders during multiple regression analyses. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Even in the multivariate logistic regression analysis, the OR for odds in Model 2 was significantly higher, ranging from 1.30 to 11.77 (p-value = 0.015), while in Model 3 the OR range was 1.28 to 12.08 (p-value = 0.017). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">However, despite all the evidence of physical weakness, there is no correlation between the odds of malnutrition in any of the adjusted or unadjusted models.</p></li></ul><p dir="ltr">The study reveals that the more UPF consumed by an individual, the greater the chances of having clinical weakness. However, the findings do not support any association between the high consumption of UPF and malnutrition in HD patients. Even though the diet may seem satisfactory in terms of providing sufficient calories and proteins, the heavy food processing is causing a loss of energy and stamina. In light of the ongoing research and development regarding diets in chronic kidney disease, this study supports the adoption of a "whole foods" diet to minimize clinical weakness in HD patients.</p><p dir="ltr">Reference:</p><p dir="ltr">Atan, R., Yılmaz, H.Ö. Ultra-processed food consumption and the prevalence of malnutrition and clinical weakness among hemodialysis patients: a single-center cross-sectional study. BMC Nephrol (2026). <a href="https://doi.org/10.1186/s12882-026-04935-9">https://doi.org/10.1186/s12882-026-04935-9</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Topical Epinephrine Comparable to Oxymetazoline in Pediatric Sinus Surgery: Study</title>
<link>https://edusehat.com/en/topical-epinephrine-comparable-to-oxymetazoline-in-pediatric-sinus-surgery-study</link>
<guid>https://edusehat.com/en/topical-epinephrine-comparable-to-oxymetazoline-in-pediatric-sinus-surgery-study</guid>
<description><![CDATA[ According to a new research,Topical epinephrine and oxymetazoline demonstrate similar safety and risk profiles in pediatric functional endoscopic sinus surgery. However further prospective studies are needed to better evaluate the efficacy of topical epinephrine and confirm its safety.A study was done to assess the safety of topical epinephrine during pediatric functional endoscopic sinus surgery (FESS). After obtaining IRB approval, electronic medical records of patients aged 0 to 14 undergoing FESS in 2021 were retrospectively reviewed and divided into 2 cohorts based on the topical vasoconstrictive agent utilized during the case: oxymetazoline or epinephrine. Patients without documentation of vasoconstrictor utilization or those who received both or neither vasoconstrictive agent were excluded. Outcome variables consisted of preoperative and maximum intraoperative heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, as well as administration of intraoperative propofol, fluids, and antihypertensive medications. Patients without documented preoperative HR, SBP, and DBP were additionally excluded from the study. Mean differences and adjusted mean differences were estimated using linear models adjusted for baseline.Among a total cohort of 123 FESS patients, 57 met inclusion criteria and were primarily male (63%, n = 36) with a median age at procedure of 10.94 years (IQR 7.66, 13.31). Oxymetazoline was administered to 71.93% (n = 41) of the cohort, while 28.07% (n = 16) received epinephrine. The unadjusted and adjusted mean differences between all preoperative and intraoperative hemodynamic parameters were not significantly different between cohorts (P &gt; .05 in all cases). No intraoperative antihypertensives were administered to patients in the study.Topical epinephrine and oxymetazoline have similar risk profiles in pediatric functional endoscopic sinus surgery. A prospective study should be developed to evaluate the efficacy of topical epinephrine and to further assess its safety profile.Reference:Quinn N, Schafer A, McNutt M, Kistler I, Elmaraghy CA. Safety of Topical Epinephrine Compared with Oxymetazoline in Pediatric Functional Endoscopic Sinus Surgery: A Retrospective Cohort Study. Annals of Otology, Rhinology &amp; Laryngology. 2026;0(0). doi:10.1177/00034894261431903Keywords:Topical, Epinephrine,  Comparable, Oxymetazoline, Pediatric Sinus Surgery, Study , Quinn N, Schafer A, McNutt M, Kistler I, Elmaraghy CA. Safety, Topical Epinephrine  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/339012-images-2026-04-01t193731625.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Topical, Epinephrine, Comparable, Oxymetazoline, Pediatric, Sinus, Surgery:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/339012-images-2026-04-01t193731625.webp"><p>According to a new research,Topical epinephrine and oxymetazoline demonstrate similar safety and risk profiles in pediatric functional endoscopic sinus surgery. However further prospective studies are needed to better evaluate the efficacy of topical epinephrine and confirm its safety.</p><div class="pasted-from-word-wrapper"><p dir="ltr">A study was done to assess the safety of topical epinephrine during pediatric functional endoscopic sinus surgery (FESS). After obtaining IRB approval, electronic medical records of patients aged 0 to 14 undergoing FESS in 2021 were retrospectively reviewed and divided into 2 cohorts based on the topical vasoconstrictive agent utilized during the case: oxymetazoline or epinephrine. Patients without documentation of vasoconstrictor utilization or those who received both or neither vasoconstrictive agent were excluded. Outcome variables consisted of preoperative and maximum intraoperative heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, as well as administration of intraoperative propofol, fluids, and antihypertensive medications. Patients without documented preoperative HR, SBP, and DBP were additionally excluded from the study. Mean differences and adjusted mean differences were estimated using linear models adjusted for baseline.</p><p dir="ltr">Among a total cohort of 123 FESS patients, 57 met inclusion criteria and were primarily male (63%, n = 36) with a median age at procedure of 10.94 years (IQR 7.66, 13.31). Oxymetazoline was administered to 71.93% (n = 41) of the cohort, while 28.07% (n = 16) received epinephrine. The unadjusted and adjusted mean differences between all preoperative and intraoperative hemodynamic parameters were not significantly different between cohorts (P > .05 in all cases). No intraoperative antihypertensives were administered to patients in the study.</p><p dir="ltr">Topical epinephrine and oxymetazoline have similar risk profiles in pediatric functional endoscopic sinus surgery. A prospective study should be developed to evaluate the efficacy of topical epinephrine and to further assess its safety profile.</p><p dir="ltr">Reference:</p><p dir="ltr">Quinn N, Schafer A, McNutt M, Kistler I, Elmaraghy CA. Safety of Topical Epinephrine Compared with Oxymetazoline in Pediatric Functional Endoscopic Sinus Surgery: A Retrospective Cohort Study. Annals of Otology, Rhinology & Laryngology. 2026;0(0). doi:10.1177/00034894261431903</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Topical, Epinephrine,  Comparable, Oxymetazoline, Pediatric Sinus Surgery, Study , Quinn N, Schafer A, McNutt M, Kistler I, Elmaraghy CA. Safety, Topical Epinephrine </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>FDA Approves dermal filler Radiesse for Wrinkles in neck and chest area Despite Imaging Concerns</title>
<link>https://edusehat.com/en/fda-approves-dermal-filler-radiesse-for-wrinkles-in-neck-and-chest-area-despite-imaging-concerns</link>
<guid>https://edusehat.com/en/fda-approves-dermal-filler-radiesse-for-wrinkles-in-neck-and-chest-area-despite-imaging-concerns</guid>
<description><![CDATA[ The FDA has approved the subdermal implant Radiesse for treating wrinkles and adding volume in the décolleté area (neck and upper chest) in adults aged 22 and above. While effective, the filler contains hydroxylapatite microspheres that can appear on X-rays and CT scans, potentially interfering with breast imaging-an issue that prompted prior FDA advisory review.RADIESSE® is a regenerative biostimulator designed to firm and tighten the skin by addressing the visible signs of aging at their source. Using an ingredient that is also naturally found in the body, RADIESSE® helps stimulate the production of collagen, elastin, and other essential proteins-supporting healthier looking skin with results that can last up to two years. Backed by two decades of scientific research and clinical experience, RADIESSE® is the #1 most researched biostimulator in regenerative aesthetics, with more than 250 scientific publications, 20+ million syringes shipped globally, and availability in over 85 countries. It also boasts a 98% patient satisfaction rate, highlighting consumer trust and demand.“The décolleté is one of the most visible-and earliest-areas to show signs of aging,” says Samantha Kerr, Chief Scientific Officer at Merz Aesthetics. “Because it’s often overlooked in skincare routines and aesthetic care, this delicate area can benefit from RADIESSE® to help improve the appearance of wrinkles.”
“Collagen and elastin decline is a major driver of aging skin,” says board-certified cosmetic dermatologist Dr. Jeremy Green, who was part of clinical studies conducted by Merz Aesthetics. “Patients love RADIESSE® because it jump-starts the skin’s regenerative process, giving them firmer, smoother, more radiant-looking results without surgery.”
In the last few years, there has been an increase in consumers wanting to improve the look of both the face and body. According to data referencing the ISAPS Global Survey, there has been a 39% increase in demand for non-invasive skin lifting treatments (in the face and body).16 Data supporting the décolleté approval demonstrated significant evidence of RADIESSE®’s effectiveness:• More than 80% of RADIESSE® patients felt satisfied with skin tightness.• 83% of patients reported they were likely to get RADIESSE® treatment again, over a year after their initial treatment.• 90% of healthcare providers reported RADIESSE® patients with visible improvements by 4 months.• 93% of patients were interested in other RADIESSE® treatments.“The new décolleté indication helps address increasing patient demand as today’s aesthetics market evolves towards regenerative biostimulation, or ‘reversing visible signs of aging from within’,” says Patrick Urban, President, North America, Merz Aesthetics. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340811-wrinkles-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>FDA, Approves, dermal, filler, Radiesse, for, Wrinkles, neck, and, chest, area, Despite, Imaging, Concerns</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340811-wrinkles-1.webp"><p>The FDA has approved the subdermal implant Radiesse for treating wrinkles and adding volume in the décolleté area (neck and upper chest) in adults aged 22 and above. While effective, the filler contains hydroxylapatite microspheres that can appear on X-rays and CT scans, potentially interfering with breast imaging-an issue that prompted prior FDA advisory review.</p><p>RADIESSE® is a regenerative biostimulator designed to firm and tighten the skin by addressing the visible signs of aging at their source. Using an ingredient that is also naturally found in the body, RADIESSE® helps stimulate the production of collagen, elastin, and other essential proteins-supporting healthier looking skin with results that can last up to two years. Backed by two decades of scientific research and clinical experience, RADIESSE® is the #1 most researched biostimulator in regenerative aesthetics, with more than 250 scientific publications, 20+ million syringes shipped globally, and availability in over 85 countries. It also boasts a 98% patient satisfaction rate, highlighting consumer trust and demand.</p><p>“The décolleté is one of the most visible-and earliest-areas to show signs of aging,” says Samantha Kerr, Chief Scientific Officer at Merz Aesthetics. “Because it’s often overlooked in skincare routines and aesthetic care, this delicate area can benefit from RADIESSE® to help improve the appearance of wrinkles.”
</p><p>“Collagen and elastin decline is a major driver of aging skin,” says board-certified cosmetic dermatologist Dr. Jeremy Green, who was part of clinical studies conducted by Merz Aesthetics. “Patients love RADIESSE® because it jump-starts the skin’s regenerative process, giving them firmer, smoother, more radiant-looking results without surgery.”
</p><p>In the last few years, there has been an increase in consumers wanting to improve the look of both the face and body. According to data referencing the ISAPS Global Survey, there has been a 39% increase in demand for non-invasive skin lifting treatments (in the face and body).16 Data supporting the décolleté approval demonstrated significant evidence of RADIESSE®’s effectiveness:</p><p><span>• </span>More than 80% of RADIESSE® patients felt satisfied with skin tightness.</p><p>• 83% of patients reported they were likely to get RADIESSE® treatment again, over a year after their initial treatment.</p><p>• 90% of healthcare providers reported RADIESSE® patients with visible improvements by 4 months.</p><p>• 93% of patients were interested in other RADIESSE® treatments.</p><p>“The new décolleté indication helps address increasing patient demand as today’s aesthetics market evolves towards regenerative biostimulation, or ‘reversing visible signs of aging from within’,” says Patrick Urban, President, North America, Merz Aesthetics.</p>]]> </content:encoded>
</item>

<item>
<title>High prenatal exposure to PFAS may increase the risk of childhood asthma,finds research</title>
<link>https://edusehat.com/en/high-prenatal-exposure-to-pfas-may-increase-the-risk-of-childhood-asthmafinds-research</link>
<guid>https://edusehat.com/en/high-prenatal-exposure-to-pfas-may-increase-the-risk-of-childhood-asthmafinds-research</guid>
<description><![CDATA[ Asthma can lead to childhood hospitalizations, missed school days, missed workdays for caregivers, and a lower quality of life for both children and their caregivers. The global prevalence of asthma has increased over the past fifty years. A study published April 9th in the open-access journal PLOS Medicine by Annelise Blomberg at Lund University, Lund, Sweden and colleagues suggests that high prenatal PFAS exposure is associated with a higher incidence of asthma in childhood.
PFAS (Perfluoroalkyl substances) are widespread synthetic chemicals that impact the immune system and may play a role in the development of asthma. Previous epidemiological studies of PFAS and asthma only investigated low exposure levels and had inconclusive results. Due to decades-long contamination of a municipal waterworks in Ronneby, Sweden, researchers were able to study the impacts of high PFAS exposure. They accessed a register-based open cohort of all children born in Blekinge County between 2006 and 2013, including Ronneby. The researchers then linked maternal addresses during the exposure period to water distribution records to estimate prenatal exposure, and used asthma diagnosis data from the National Patient Register to assess individual asthma outcomes and prenatal exposure levels.
The researchers found that very high prenatal PFAS exposure was associated with a higher incidence of asthma in childhood. Future studies are needed to better understand exposure-response relationships and to address potential confounding variables, such as exposure beyond the prenatal period into early-childhood, exposure to other environmental contaminants or smoking among household members.
According to the authors, “PFAS contamination is a major source of high environmental exposure globally, and evidence from Ronneby offers important insights into the potential health effects of such contamination in affected communities. These results point to a substantial and previously unrecognized public health consequence of PFAS contamination.”
Blomberg adds, “We found that children whose mothers were exposed to very high levels of PFAS during pregnancy had a substantially higher incidence of clinically diagnosed asthma. The association was not observed at lower exposure levels, which may help explain why previous studies in general populations have reported mixed results.”
“Most previous research has examined populations exposed only to background levels of PFAS. In Ronneby, drinking water contamination resulted in exposure levels hundreds of times higher than the general population. This allowed us to evaluate potential health effects across a much broader exposure range.”
“Communities around the world have been affected by PFAS contamination from aqueous film-forming foams and other industrial sources. Our findings suggest that very high prenatal exposure may have lasting consequences for children’s respiratory health. At the same time, replication in other highly exposed populations will be important to confirm these results.”Reference:Annelise J. Blomberg ,Christel Nielsen,Beata Borgström Bolmsjö,Marie-Abèle Bind,Linda Hartman,Anna Saxne Jöud, Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden, PLOS Medicine, https://doi.org/10.1371/journal.pmed.1004659 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/16/327867-asthma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>High, prenatal, exposure, PFAS, may, increase, the, risk, childhood, asthma, finds, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/16/327867-asthma.webp"><p><a href="https://medicaldialogues.in/topics/asthma">Asthma</a> can lead to childhood hospitalizations, missed school days, missed workdays for caregivers, and a lower quality of life for both children and their caregivers. The global prevalence of asthma has increased over the past fifty years. A study published April 9th in the open-access journal <i>PLOS Medicine</i> by Annelise Blomberg at Lund University, Lund, Sweden and colleagues suggests that high prenatal PFAS exposure is associated with a higher incidence of asthma in childhood.
</p><p>PFAS (<a href="https://medicaldialogues.in/topics/Perfluoroalkyl-substances">Perfluoroalkyl substances</a>) are widespread synthetic chemicals that impact the immune system and may play a role in the development of asthma. Previous epidemiological studies of PFAS and asthma only investigated low exposure levels and had inconclusive results. Due to decades-long contamination of a municipal waterworks in Ronneby, Sweden, researchers were able to study the impacts of high PFAS exposure. They accessed a register-based open cohort of all children born in Blekinge County between 2006 and 2013, including Ronneby. The researchers then linked maternal addresses during the exposure period to water distribution records to estimate prenatal exposure, and used asthma diagnosis data from the National Patient Register to assess individual asthma outcomes and prenatal exposure levels.
</p><p>The researchers found that very high prenatal PFAS exposure was associated with a higher incidence of asthma in childhood. Future studies are needed to better understand exposure-response relationships and to address potential confounding variables, such as exposure beyond the prenatal period into early-childhood, exposure to other environmental contaminants or smoking among household members.
</p><p>According to the authors, “PFAS contamination is a major source of high environmental exposure globally, and evidence from Ronneby offers important insights into the potential health effects of such contamination in affected communities. These results point to a substantial and previously unrecognized public health consequence of PFAS contamination.”
</p><p>Blomberg adds, “We found that children whose mothers were exposed to very high levels of PFAS during pregnancy had a substantially higher incidence of clinically diagnosed asthma. The association was not observed at lower exposure levels, which may help explain why previous studies in general populations have reported mixed results.”
</p><p>“Most previous research has examined populations exposed only to background levels of PFAS. In Ronneby, drinking water contamination resulted in exposure levels hundreds of times higher than the general population. This allowed us to evaluate potential health effects across a much broader exposure range.”
</p><p>“Communities around the world have been affected by PFAS contamination from aqueous film-forming foams and other industrial sources. Our findings suggest that very high prenatal exposure may have lasting consequences for children’s respiratory health. At the same time, replication in other highly exposed populations will be important to confirm these results.”</p><p>Reference:</p><p>Annelise J. Blomberg ,Christel Nielsen,Beata Borgström Bolmsjö,Marie-Abèle Bind,Linda Hartman,Anna Saxne Jöud, Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden, PLOS Medicine, https://doi.org/10.1371/journal.pmed.1004659</p>]]> </content:encoded>
</item>

<item>
<title>Sauna bathing may boost immune responses, suggests study</title>
<link>https://edusehat.com/en/sauna-bathing-may-boost-immune-responses-suggests-study</link>
<guid>https://edusehat.com/en/sauna-bathing-may-boost-immune-responses-suggests-study</guid>
<description><![CDATA[ Sauna bathing releases white blood cells into the bloodstream, a new study from Finland shows. Circulating white blood cells play a key role in the body’s defence against various pathogens and diseases.
A 30-minute sauna session, with a brief cooling period under a cold shower midway through, increased the number of all circulating white blood cells. Neutrophils and lymphocytes, which are central to immune defence, returned to baseline within half an hour.
“This may indicate that sauna bathing mobilises additional white blood cells into the bloodstream from tissues, where they are then redeposited after the session. This kind of periodic release of white blood cells into the bloodstream is beneficial, as once they leave their storage sites, they are better able to patrol the body and respond to pathogens,” says Ilkka Heinonen, an Academy Research Fellow at the University of Turku.
The release of white blood cells into the bloodstream, which also occurs, for example, during physical exercise, is the body’s way of enhancing immune surveillance by white blood cells throughout the body, and boosting its immune defence.
In addition to immune cells, the researchers also measured the levels of numerous cytokines, which act as mediators in immune defence. On average, sauna bathing had little effect on circulating cytokine levels.
“Interestingly, however, the levels of several cytokines changed in relation to how much body temperature rose during sauna bathing. No similar association was observed between white blood cell counts and changes in body temperature,” says Professor Jari Laukkanen, who led the study at the University of Eastern Finland.
Regular sauna bathing has been associated with several beneficial health effects, and the new findings may, in part, help explain how these effects develop in the body. However, the researchers emphasise that the study was limited to a single sauna session and its immediate effects. Therefore, no definite conclusions can be drawn about the development of longer-term health effects.
The study involved 51 adults with a mean age of 50 years. The results were published in the scientific journal Temperature, which focuses on the medical physiology of body temperature regulation.Reference:Heinonen, I. H. A., Koivula, T., Hollmén, M., Immonen, J., Kunutsor, S. K., Jalkanen, S., &amp; Laukkanen, J. A. (2026). Acute Finnish sauna heat exposure induces stronger immune cell than cytokine responses. Temperature, 1–14. https://doi.org/10.1080/23328940.2026.2645467
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340791-untitled-design-2026-04-10t115256310.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sauna, bathing, may, boost, immune, responses, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340791-untitled-design-2026-04-10t115256310.webp"><p>Sauna bathing releases white blood cells into the bloodstream, a new study from Finland shows. Circulating white blood cells play a key role in the body’s defence against various pathogens and diseases.
</p><p>A 30-minute sauna session, with a brief cooling period under a cold shower midway through, increased the number of all circulating white blood cells. Neutrophils and lymphocytes, which are central to immune defence, returned to baseline within half an hour.
</p><p>“This may indicate that sauna bathing mobilises additional white blood cells into the bloodstream from tissues, where they are then redeposited after the session. This kind of periodic release of white blood cells into the bloodstream is beneficial, as once they leave their storage sites, they are better able to patrol the body and respond to pathogens,” says Ilkka Heinonen, an Academy Research Fellow at the University of Turku.
</p><p>The release of white blood cells into the bloodstream, which also occurs, for example, during physical exercise, is the body’s way of enhancing immune surveillance by white blood cells throughout the body, and boosting its immune defence.
</p><p>In addition to immune cells, the researchers also measured the levels of numerous cytokines, which act as mediators in immune defence. On average, sauna bathing had little effect on circulating cytokine levels.
</p><p>“Interestingly, however, the levels of several cytokines changed in relation to how much body temperature rose during sauna bathing. No similar association was observed between white blood cell counts and changes in body temperature,” says Professor Jari Laukkanen, who led the study at the University of Eastern Finland.
</p><p>Regular sauna bathing has been associated with several beneficial health effects, and the new findings may, in part, help explain how these effects develop in the body. However, the researchers emphasise that the study was limited to a single sauna session and its immediate effects. Therefore, no definite conclusions can be drawn about the development of longer-term health effects.
</p><p>The study involved 51 adults with a mean age of 50 years. The results were published in the scientific journal Temperature, which focuses on the medical physiology of body temperature regulation.</p><p>Reference:</p><p>Heinonen, I. H. A., Koivula, T., Hollmén, M., Immonen, J., Kunutsor, S. K., Jalkanen, S., & Laukkanen, J. A. (2026). Acute Finnish sauna heat exposure induces stronger immune cell than cytokine responses. Temperature, 1–14. https://doi.org/10.1080/23328940.2026.2645467
</p>]]> </content:encoded>
</item>

<item>
<title>Extended&#45;Release Buprenorphine Effective for Opioid Use Disorder in Pregnancy: JAMA</title>
<link>https://edusehat.com/en/extended-release-buprenorphine-effective-for-opioid-use-disorder-in-pregnancy-jama</link>
<guid>https://edusehat.com/en/extended-release-buprenorphine-effective-for-opioid-use-disorder-in-pregnancy-jama</guid>
<description><![CDATA[ A recent study published in the Journal of the American Medical Association revealed that extended-release buprenorphine given as a weekly injection led to higher rates of illicit opioid abstinence in pregnant women with opioid use disorder (OUD) when compared to daily sublingual buprenorphine. The rates of neonatal opioid withdrawal syndrome (NOWS) and maternal adverse events were similar between the injectable and sublingual treatments, indicating comparable safety for both mothers and newborns. Treating OUD during pregnancy is critical for both maternal and infant health. Sublingual buprenorphine, taken daily under the tongue, is currently considered an evidence-based standard treatment. However, daily dosing can present challenges, including adherence issues, medication diversion risks, and the need for frequent clinic visits. This clinical trial from July 2020 to October 2024, enrolled 140 pregnant adults with OUD across 13 outpatient cross-disciplinary peripartum treatment sites. Participants were between 6 and 30 weeks pregnant at enrollment and were randomly assigned to receive either sublingual buprenorphine or an extended-release version administered weekly during pregnancy. After delivery, participants in the extended-release group had the option to switch to a monthly formulation if they were not breastfeeding.This study primarily evaluated illicit opioid abstinence during pregnancy and the postpartum period. Abstinence was measured using weekly urine samples tested for illicit opioids. Secondary outcomes included infant health measures like the need for treatment of NOWS and the duration of such treatment.The results showed elevated rates of illicit opioid abstinence during pregnancy among participants receiving extended-release buprenorphine. Approximately 82.5% of their weekly urine samples tested negative for illicit opioids when compared to 72.6% in the sublingual group, which represented a statistically significant improvement.When compared to those taking sublingual buprenorphine, the participants receiving the long-acting medication experienced fewer serious adverse events during pregnancy and after delivery. While nonserious adverse events occurred at similar rates overall, medication-related side effects were reported more often among extended-release users during pregnancy.About 30% of infants exposed to extended-release buprenorphine required opioid treatment for NOWS, similar to the 26.5% rate among infants exposed to sublingual buprenorphine. The average duration of treatment for withdrawal symptoms also did not significantly differ.Infants exposed to the extended-release medication had slightly larger average head circumferences, though the clinical significance of this finding remains uncertain. Overall, the study supports weekly extended-release buprenorphine as an effective and safe treatment option for OUD during pregnancy.Reference:Winhusen, T. J., Lofwall, M. R., Kropp, F., Lewis, D., Smid, M. C., Young, J. L., Hodgkins, C., Krans, E. E., Hansen, Z., Wachman, E. M., Schiff, D. M., Guille, C., Rudolf, V., Chowdhury, T., Leeman, L., Lewis, M., Matthews, A. G., Cochran, G., King, J., … Rosa, C. (2026). Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: A randomized clinical trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.0057 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/03/31/206612-buprenorphine.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Extended-Release, Buprenorphine, Effective, for, Opioid, Use, Disorder, Pregnancy:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/03/31/206612-buprenorphine.webp"><p>A recent study published in the <i>Journal of the American Medical Association</i> revealed that extended-release buprenorphine given as a weekly injection led to higher rates of illicit opioid abstinence in pregnant women with opioid use disorder (OUD) when compared to daily sublingual buprenorphine. The rates of neonatal opioid withdrawal syndrome (NOWS) and maternal adverse events were similar between the injectable and sublingual treatments, indicating comparable safety for both mothers and newborns. </p><p>Treating OUD during pregnancy is critical for both maternal and infant health. Sublingual buprenorphine, taken daily under the tongue, is currently considered an evidence-based standard treatment. However, daily dosing can present challenges, including adherence issues, medication diversion risks, and the need for frequent clinic visits. </p><p>This clinical trial from July 2020 to October 2024, enrolled 140 pregnant adults with OUD across 13 outpatient cross-disciplinary peripartum treatment sites. Participants were between 6 and 30 weeks pregnant at enrollment and were randomly assigned to receive either sublingual buprenorphine or an extended-release version administered weekly during pregnancy. After delivery, participants in the extended-release group had the option to switch to a monthly formulation if they were not breastfeeding.</p><p>This study primarily evaluated illicit opioid abstinence during pregnancy and the postpartum period. Abstinence was measured using weekly urine samples tested for illicit opioids. Secondary outcomes included infant health measures like the need for treatment of NOWS and the duration of such treatment.</p><p>The results showed elevated rates of illicit opioid abstinence during pregnancy among participants receiving extended-release buprenorphine. Approximately 82.5% of their weekly urine samples tested negative for illicit opioids when compared to 72.6% in the sublingual group, which represented a statistically significant improvement.</p><p>When compared to those taking sublingual buprenorphine, the participants receiving the long-acting medication experienced fewer serious adverse events during pregnancy and after delivery. While nonserious adverse events occurred at similar rates overall, medication-related side effects were reported more often among extended-release users during pregnancy.</p><p>About 30% of infants exposed to extended-release buprenorphine required opioid treatment for NOWS, similar to the 26.5% rate among infants exposed to sublingual buprenorphine. The average duration of treatment for withdrawal symptoms also did not significantly differ.</p><p>Infants exposed to the extended-release medication had slightly larger average head circumferences, though the clinical significance of this finding remains uncertain. Overall, the study supports weekly extended-release buprenorphine as an effective and safe treatment option for OUD during pregnancy.</p><p>Reference:</p><p>Winhusen, T. J., Lofwall, M. R., Kropp, F., Lewis, D., Smid, M. C., Young, J. L., Hodgkins, C., Krans, E. E., Hansen, Z., Wachman, E. M., Schiff, D. M., Guille, C., Rudolf, V., Chowdhury, T., Leeman, L., Lewis, M., Matthews, A. G., Cochran, G., King, J., … Rosa, C. (2026). Extended-release vs sublingual buprenorphine in pregnancy through 12 months post partum: A randomized clinical trial. JAMA Internal Medicine. <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846277" rel="nofollow">https://doi.org/10.1001/jamainternmed.2026.0057</a></p>]]> </content:encoded>
</item>

<item>
<title>Early surgery within 24 hours in Patients with Hip Fracture on DOAC safe and beneficial: study</title>
<link>https://edusehat.com/en/early-surgery-within-24-hours-in-patients-with-hip-fracture-on-doac-safe-and-beneficial-study</link>
<guid>https://edusehat.com/en/early-surgery-within-24-hours-in-patients-with-hip-fracture-on-doac-safe-and-beneficial-study</guid>
<description><![CDATA[ Surgery in patients with hip fracture on direct oral anticoagulants (DOACs) is frequently delayed because of concerns about bleeding risk. However, evidence supporting such delays remains limited, and institutional practices vary widely.Schiepers et al conducted a study to determine whether early surgery within 24 hours is associated with a greater perioperative hemoglobin decrease compared with delayed surgery after 24 hours or more in patients with hip fracture on DOACs. The article has been published in ‘JBJS open access.’
This multicenter retrospective cohort study included patients with hip fracture aged more than70 years on DOACs at admission across 5 hospitals. Patients were stratified by time to surgery: 24 hours (delayed surgery). The primary outcome was hemoglobin decrease in mmol/L. Secondary outcomes included a hemoglobin decrease of more than 2 mmol/L, preoperative and postoperative blood transfusion, packed red blood cells administered, postoperative anemia, hospital length of stay, and in-hospital and 30-day mortality. Multiple linear regression and multiple imputation were applied.
The key findings of the study were:
•	Among the 875 patients included, 504 underwent early surgery and 371 underwent delayed surgery.
•	Early surgery was associated with a lower median decrease in hemoglobin levels (0.6 vs. 0.9 mmol/L, p &lt; 0.001); with an adjusted mean difference of -0.25 mmol/L (95% CI, 20.37 to 20.13, p &lt; 0.001).
•	No significant differences were observed in a hemoglobin decrease of more than 2 mmol/L, blood transfusion rates, postoperative anemia, or in-hospital and 30-day mortality.
•	Early surgery was associated with a shorter hospital length of stay median 2 days (95% CI, 2-3; p &lt; 0.001).
Conclusions: Early surgery within 24 hours was associated with a modestly smaller hemoglobin decrease and a shorter hospital length of stay, without an increased blood transfusion rate or mortality rates compared with delayed surgery. These findings suggest that early surgery in patients with hip fracture on DOACs may be safe and potentially beneficial in reducing hospital length of stay.
Level of Evidence: Level III. For further details on the article refer to:
Impact of Early (24 Hours) Surgery on Hemoglobin Decrease in Patients with Hip Fracture on Direct Oral Anticoagulants
Schiepers et al
JBJS Open Access 2026:e25.00334. 
http://dx.doi.org/10.2106/JBJS.OA.25.00334 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/22/334440-hip2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Early, surgery, within, hours, Patients, with, Hip, Fracture, DOAC, safe, and, beneficial:, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/22/334440-hip2.webp"><p>Surgery in patients with hip fracture on direct oral anticoagulants (DOACs) is frequently delayed because of concerns about bleeding risk. However, evidence supporting such delays remains limited, and institutional practices vary widely.</p><p>Schiepers et al conducted a study to determine whether early surgery within 24 hours is associated with a greater perioperative hemoglobin decrease compared with delayed surgery after 24 hours or more in patients with hip fracture on DOACs. The article has been published in ‘JBJS open access.’
</p><p>This multicenter retrospective cohort study included patients with hip fracture aged more than70 years on DOACs at admission across 5 hospitals. Patients were stratified by time to surgery: <24 hours (early surgery) versus >24 hours (delayed surgery). The primary outcome was hemoglobin decrease in mmol/L. Secondary outcomes included a hemoglobin decrease of more than 2 mmol/L, preoperative and postoperative blood transfusion, packed red blood cells administered, postoperative anemia, hospital length of stay, and in-hospital and 30-day mortality. Multiple linear regression and multiple imputation were applied.
</p><p>The key findings of the study were:
</p><p>•	Among the 875 patients included, 504 underwent early surgery and 371 underwent delayed surgery.
</p><p>•	Early surgery was associated with a lower median decrease in hemoglobin levels (0.6 vs. 0.9 mmol/L, p < 0.001); with an adjusted mean difference of -0.25 mmol/L (95% CI, 20.37 to 20.13, p < 0.001).
</p><p>•	No significant differences were observed in a hemoglobin decrease of more than 2 mmol/L, blood transfusion rates, postoperative anemia, or in-hospital and 30-day mortality.
</p><p>•	Early surgery was associated with a shorter hospital length of stay median 2 days (95% CI, 2-3; p < 0.001).
</p><p>Conclusions: Early surgery within 24 hours was associated with a modestly smaller hemoglobin decrease and a shorter hospital length of stay, without an increased blood transfusion rate or mortality rates compared with delayed surgery. These findings suggest that early surgery in patients with hip fracture on DOACs may be safe and potentially beneficial in reducing hospital length of stay.
</p><p>Level of Evidence: Level III. </p><p>For further details on the article refer to:
</p><p>Impact of Early (<24 Hours) vs. Delayed (>24 Hours) Surgery on Hemoglobin Decrease in Patients with Hip Fracture on Direct Oral Anticoagulants
</p><p>Schiepers et al
</p><p>JBJS Open Access 2026:e25.00334. 
</p><p>http://dx.doi.org/10.2106/JBJS.OA.25.00334</p>]]> </content:encoded>
</item>

<item>
<title>AIIMS Rajkot MBBS suicide case: HC seeks state reply after 5 accused students appeal to quash abetment charge</title>
<link>https://edusehat.com/en/aiims-rajkot-mbbs-suicide-case-hc-seeks-state-reply-after-5-accused-students-appeal-to-quash-abetment-charge</link>
<guid>https://edusehat.com/en/aiims-rajkot-mbbs-suicide-case-hc-seeks-state-reply-after-5-accused-students-appeal-to-quash-abetment-charge</guid>
<description><![CDATA[ Ahmedabad: The Gujarat High Court has issued a notice to the state government in a case involving five MBBS students of AIIMS Rajkot who have been booked for abetment to suicide after a fellow student&#039;s suicide case.The matter came up after the accused students approached the High Court seeking the quashing of the FIR registered against them. They were earlier arrested under provisions of the BNS and the SC/ST (Prevention of Atrocities) Act, and later released on bail.The case is related to the death of a final-year MBBS student who died by suicide on March 14. Medical Dialogues had reported that the 25-year-old MBBS medico committed suicide after allegedly being assaulted and harassed by classmates, leaving behind a 17-page note. His body was found on a railway track between Ghanteshwar and Para Pipaliya. He was struck by a train, and his laptop, mobile phones, medical files and ID card were found near the tracks along with a 17-page note that accused his classmates of assaulting him.Also read- 5 accused classmates in AIIMS Rajkot MBBS medico&#039;s suicide case get bailIn the note, he mentioned that the accused students allegedly assaulted him inside a hostel room and recorded his video and audio. He mentioned that his classmates had been repeatedly harassing him since January this year, over suspicion regarding his relationship with a girl.Weeks later, when the matter came up before the Rajkot Sessions Court, the court granted bail to the five accused students on the grounds that keeping them in judicial custody until the trial concludes would amount to &quot;pre-trial punishment.&quot;During the hearing before the Gujarat High Court as reported by TOI, senior advocate Mitesh Amin, appearing for the students, informed the court that the deceased had written three separate suicide notes on different dates.He said the first was circulated on social media on Jan 27 when he first attempted suicide. This note was addressed to the institute&#039;s faculty members. The second note, also to the faculty members, came after he was taken home. The third was found from a bag lying near his body at a railway track on March 14. It was submitted to the court that the accused had stopped talking to the student since his first suicide attempt.It was also submitted that the deceased student was undergoing treatment for schizophrenia, and one of the notes mentioned a girl. His earlier statement to police reportedly indicated that he had not been in contact with the five students for about a month.Opposing the plea, the state government argued that the FIR is based on the first suicide note, in which he had alleged that he was assaulted by the accused a day before his initial attempt.After hearing both sides, Justice M R Mengdey issued notice to the state government as well as the deceased student&#039;s father, who had filed the complaint. The court has scheduled the next hearing for June 22.Also read- AIIMS Rajkot MBBS student suicide: Probe continues 2 weeks on amid harassment allegations ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/05/26/129368-hc-gujarat.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Rajkot, MBBS, suicide, case:, seeks, state, reply, after, accused, students, appeal, quash, abetment, charge</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/05/26/129368-hc-gujarat.webp"><p><b>Ahmedabad: </b>The <a href="https://medicaldialogues.in/topics/gujarat-high-court" target="_blank">Gujarat High Court</a> has issued a notice to the state government in a case involving five MBBS students of <a href="https://medicaldialogues.in/topics/aiims-rajkot" target="_blank">AIIMS Rajkot</a> who have been booked for abetment to suicide after a fellow student's suicide case.</p><p>The matter came up after the accused students approached the High Court seeking the quashing of the FIR registered against them. They were earlier arrested under provisions of the BNS and the SC/ST (Prevention of Atrocities) Act, and later released on bail.</p><p>The case is related to the death of a final-year MBBS student who died by suicide on March 14. Medical Dialogues had reported that the 25-year-old MBBS medico committed suicide after allegedly being assaulted and harassed by classmates, leaving behind a 17-page note. </p><p>His body was found on a railway track between Ghanteshwar and Para Pipaliya. He was struck by a train, and his laptop, mobile phones, medical files and ID card were found near the tracks along with a 17-page note that accused his classmates of assaulting him.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/gujarat/5-accused-classmates-in-aiims-rajkot-mbbs-medicos-suicide-case-get-bail-167983" target="_blank">5 accused classmates in AIIMS Rajkot MBBS medico's suicide case get bail</a></b></p><p>In the note, he mentioned that the accused students allegedly assaulted him inside a hostel room and recorded his video and audio. He mentioned that his classmates had been repeatedly harassing him since January this year, over suspicion regarding his relationship with a girl.</p><p>Weeks later, when the matter came up before the Rajkot Sessions Court, the court granted bail to the five accused students on the grounds that keeping them in judicial custody until the trial concludes would amount to "pre-trial punishment."</p><p>During the hearing before the Gujarat High Court as reported by <a href="https://timesofindia.indiatimes.com/city/ahmedabad/aiims-suicide-accused-seek-quashing-of-abetment-charge/articleshow/130152144.cms" target="_blank" rel="nofollow">TOI</a>, senior advocate Mitesh Amin, appearing for the students, informed the court that the deceased had written three separate suicide notes on different dates.</p><p><span>He said the first was circulated on social media on Jan 27 when he first attempted suicide. This note was addressed to the institute's faculty members. The second note, also to the faculty members, came after he was taken home. The third was found from a bag lying near his body at a railway track on March 14. It was submitted to the court that the accused had stopped talking to the student since his first suicide attempt.</span></p><p>It was also submitted that the deceased student was undergoing treatment for schizophrenia, and one of the notes mentioned a girl. His earlier statement to police reportedly indicated that he had not been in contact with the five students for about a month.</p><p>Opposing the plea, the state government argued that the FIR is based on the first suicide note, in which he had alleged that he was assaulted by the accused a day before his initial attempt.</p><p>After hearing both sides, Justice M R Mengdey issued notice to the state government as well as the deceased student's father, who had filed the complaint. </p><p>The court has scheduled the next hearing for June 22.</p><p><b>Also read- <a href="https://medicaldialogues.in/topics/gujarat-high-court" target="_blank">AIIMS Rajkot MBBS student suicide: Probe continues 2 weeks on amid harassment allegations</a></b></p>]]> </content:encoded>
</item>

<item>
<title>B.Pharm Student Found Dead in Private College Hostel in Andhra</title>
<link>https://edusehat.com/en/bpharm-student-found-dead-in-private-college-hostel-in-andhra</link>
<guid>https://edusehat.com/en/bpharm-student-found-dead-in-private-college-hostel-in-andhra</guid>
<description><![CDATA[ Amaravati: A pharmacy student was found dead in her hostel room in Andhra Pradesh, triggering a police investigation into the circumstances surrounding her death, with initial findings pointing toward a suspected suicide while authorities continue to examine all possible angles.The deceased was a B.Pharmacy student studying at a private college in Eluru district and was residing in the college hostel at the time of the incident.According to preliminary information, the incident took place late at night after a college-related event. The student was discovered unresponsive within the hostel premises, following which the college authorities alerted the police. She was immediately taken to a nearby hospital for treatment but succumbed to her injuries. Reports suggest that she had spoken to her family shortly before the incident.Also Read: B.Pharm Student Killed After Speeding Trailer Rams Motorcycle in IndoreInvestigators indicated that the student may have been experiencing emotional distress, though the exact cause behind the incident has not yet been confirmed.Based on a complaint filed by her family, police have registered a case and initiated a detailed probe. Officials stated that all possible factors, including personal and institutional aspects, are being examined to establish the sequence of events, reports The Hindu.The incident has raised concerns regarding student safety and mental health in educational institutions, with further updates expected as the investigation progresses. Also Read: B.Pharm Student Found Hanging in Bengaluru PG, Police Probe Underway ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/05/325747-death-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>B.Pharm, Student, Found, Dead, Private, College, Hostel, Andhra</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/05/325747-death-3.webp"><p><b>Amaravati</b>: A pharmacy student was found dead in her hostel room in Andhra Pradesh, triggering a police investigation into the circumstances surrounding her death, with initial findings pointing toward a suspected suicide while authorities continue to examine all possible angles.</p><div class="pasted-from-word-wrapper"><p>The deceased was a B.Pharmacy student studying at a private college in Eluru district and was residing in the college hostel at the time of the incident.</p><p>According to preliminary information, the incident took place late at night after a college-related event. The student was discovered unresponsive within the hostel premises, following which the college authorities alerted the police. She was immediately taken to a nearby hospital for treatment but succumbed to her injuries. Reports suggest that she had spoken to her family shortly before the incident.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/bpharm-student-killed-after-speeding-trailer-rams-motorcycle-in-indore-165819">Also Read: B.Pharm Student Killed After Speeding Trailer Rams Motorcycle in Indore</a></div></div><p>Investigators indicated that the student may have been experiencing emotional distress, though the exact cause behind the incident has not yet been confirmed.</p><p>Based on a complaint filed by her family, police have registered a case and initiated a detailed probe. Officials stated that all possible factors, including personal and institutional aspects, are being examined to establish the sequence of events, reports <a href="https://www.thehindu.com/news/national/andhra-pradesh/pharmacy-student-found-dead-in-hostel-room/article70843516.ece" rel="nofollow">The Hindu</a>.</p><p>The incident has raised concerns regarding student safety and mental health in educational institutions, with further updates expected as the investigation progresses. </p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/bpharm-student-found-hanging-in-bengaluru-pg-police-probe-underway-159813">Also Read: B.Pharm Student Found Hanging in Bengaluru PG, Police Probe Underway</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market</title>
<link>https://edusehat.com/en/glenmark-secures-usfda-nod-for-progesterone-vaginal-inserts-targets-usd-59-million-us-market</link>
<guid>https://edusehat.com/en/glenmark-secures-usfda-nod-for-progesterone-vaginal-inserts-targets-usd-59-million-us-market</guid>
<description><![CDATA[ New Delhi: Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone Vaginal Inserts, 100 mg, which are therapeutically and bioequivalent to the reference listed drug Endometrin, 100 mg, with the product set to be marketed in the United States through Glenmark Pharmaceuticals Inc., USA, targeting a market with annual sales of about USD 59.2 million.The approved product is a generic version of Endometrin Vaginal Inserts, 100 mg, originally developed by Ferring Pharmaceuticals Inc. The USFDA has confirmed that Glenmark’s product meets the required standards of bioequivalence and therapeutic equivalence.According to IQVIA data for the 12-month period ending February 2026, the Endometrin Vaginal Inserts market recorded annual sales of approximately $59.2 million, indicating a significant commercial opportunity for Glenmark in the US market.Also Read: Glenmark Appoints Former Mankind Pharma Leader Kamlesh Gupta as Business HeadCommenting on the development, Marc Kikuchi, President and Business Head, North America, stated that the approval marks an important addition to the company’s portfolio and reflects its continued focus on expanding access to high-quality and affordable medicines, particularly in the women’s healthcare segment.The company noted that the approved product will be marketed only for the indications listed in its approved label and not for all indications of the reference listed drug.Glenmark Pharmaceuticals is a global, research-driven pharmaceutical company with a presence in over 80 countries. It operates 11 manufacturing facilities across four continents and is supported by six R&amp;D centres. The company has a diversified portfolio spanning branded, generics, innovative, and consumer healthcare products, with key focus areas including respiratory, dermatology, and oncology.Also Read: Intas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/11/02/189709-glenmark-new-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Glenmark, Secures, USFDA, Nod, for, Progesterone, Vaginal, Inserts, Targets, USD, Million, Market</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/11/02/189709-glenmark-new-1.webp"><p><b>New Delhi:</b> Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone Vaginal Inserts, 100 mg, which are therapeutically and bioequivalent to the reference listed drug Endometrin, 100 mg, with the product set to be marketed in the United States through Glenmark Pharmaceuticals Inc., USA, targeting a market with annual sales of about USD 59.2 million.</p><div class="pasted-from-word-wrapper"><p>The approved product is a generic version of Endometrin Vaginal Inserts, 100 mg, originally developed by Ferring Pharmaceuticals Inc. The USFDA has confirmed that Glenmark’s product meets the required standards of bioequivalence and therapeutic equivalence.</p><p>According to IQVIA data for the 12-month period ending February 2026, the Endometrin Vaginal Inserts market recorded annual sales of approximately $59.2 million, indicating a significant commercial opportunity for Glenmark in the US market.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/glenmark-appoints-former-mankind-pharma-leader-kamlesh-gupta-as-business-head-166550">Also Read: Glenmark Appoints Former Mankind Pharma Leader Kamlesh Gupta as Business Head</a></div></div><p>Commenting on the development, Marc Kikuchi, President and Business Head, North America, stated that the approval marks an important addition to the company’s portfolio and reflects its continued focus on expanding access to high-quality and affordable medicines, particularly in the women’s healthcare segment.</p><p>The company noted that the approved product will be marketed only for the indications listed in its approved label and not for all indications of the reference listed drug.</p><p>Glenmark Pharmaceuticals is a global, research-driven pharmaceutical company with a presence in over 80 countries. It operates 11 manufacturing facilities across four continents and is supported by six R&D centres. The company has a diversified portfolio spanning branded, generics, innovative, and consumer healthcare products, with key focus areas including respiratory, dermatology, and oncology.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/intas-pharma-appoints-umesh-gupta-as-associate-executive-vice-president-manufacturing-operations-152606">Also Read: Intas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations</a></p></div>]]> </content:encoded>
</item>

<item>
<title>Optimism Linked to Lower Dementia Risk in Older Adults: Study</title>
<link>https://edusehat.com/en/optimism-linked-to-lower-dementia-risk-in-older-adults-study</link>
<guid>https://edusehat.com/en/optimism-linked-to-lower-dementia-risk-in-older-adults-study</guid>
<description><![CDATA[ Researchers have found in a new study that higher levels of optimism in older adults were associated with a 15% reduced risk of developing dementia. This relationship was consistent across both White and Black participants and remained significant after adjusting for health factors, supporting the role of a positive outlook in healthy aging. The study was published in the Journal of the American Geriatrics Society by Sade S. and colleagues.With aging being one of the global population trends, the investigation of potentially modifiable risk factors for dementia is becoming a key concern for public health researchers. While some studies conducted on a smaller scale have suggested a possible link between mental state and the brain&#039;s resistance, evidence based on nationally-representative sample sizes was limited. This particular study analyzed data collected from 9,071 individuals free of any cognitive impairments within a considerable follow-up window reaching 14 years.The levels of optimism were assessed with the help of the Life Orientation Test-Revised tool, and the cases of dementia were detected using a specially-designed algorithm to work accurately regardless of race or ethnicity. Data was gathered during eight waves, taking place between 2006 and 2020, which enabled the researchers to track the changes occurring over time, rather than basing their conclusions on only one data point. The precision of results was checked through Cox proportional hazard models and several sensitivity analyses, including the exclusion of data obtained within the first two years to avoid potential bias caused by reverse causality.Key findings:These results show the strength of a positive attitude in relation to its ability to be protective. It was found that for each 1 standard deviation increase in levels of optimism, the risk of dementia was reduced, with a hazard ratio of 0.85 (Confidence interval: 0.82 - 0.88). For each one-point increase in the level of optimism in an individual, the risk of getting dementia is reduced by around 15%. None of these findings changed much after including behavioral characteristics of health in the model or excluding people with poor psychological health. That this correlation was consistent even after 14 years suggests the potential of psychological factors in impacting brain health.Higher optimism levels were linked with a lower prevalence of dementia and, consequently, proved to be a valuable psychological resource for the elderly. The findings from this study suggest that a positive outlook does not necessarily result from good health conditions, but is rather a factor that affects the latter.Through the provision of a measure of the link between optimism and health via a 15% decrease in dementia risk for each standard deviation of optimism level, researchers have provided another benchmark for geriatrics. Looking ahead at what the future may bring in terms of healthy aging, optimism can potentially become an efficient method of combatting dementia.Reference:S.Stenlund, H. K.Koga, P.James, et al., “The Bright Side of Life: Optimism and Risk of Dementia,” Journal of the American Geriatrics Society (2026): 1–9, https://doi.org/10.1111/jgs.70392. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Optimism, Linked, Lower, Dementia, Risk, Older, Adults:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/31/272115-dementia-50-2.webp"><p>Researchers have found in a new study that higher levels of optimism in older adults were associated with a 15% reduced risk of developing dementia. This relationship was consistent across both White and Black participants and remained significant after adjusting for health factors, supporting the role of a positive outlook in healthy aging. The study was published in the <i>Journal of the American Geriatrics Society</i> by Sade S. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">With aging being one of the global population trends, the investigation of potentially modifiable risk factors for dementia is becoming a key concern for public health researchers. While some studies conducted on a smaller scale have suggested a possible link between mental state and the brain's resistance, evidence based on nationally-representative sample sizes was limited. This particular study analyzed data collected from 9,071 individuals free of any cognitive impairments within a considerable follow-up window reaching 14 years.</p><p dir="ltr">The levels of optimism were assessed with the help of the Life Orientation Test-Revised tool, and the cases of dementia were detected using a specially-designed algorithm to work accurately regardless of race or ethnicity. Data was gathered during eight waves, taking place between 2006 and 2020, which enabled the researchers to track the changes occurring over time, rather than basing their conclusions on only one data point. The precision of results was checked through Cox proportional hazard models and several sensitivity analyses, including the exclusion of data obtained within the first two years to avoid potential bias caused by reverse causality.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">These results show the strength of a positive attitude in relation to its ability to be protective. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">It was found that for each 1 standard deviation increase in levels of optimism, the risk of dementia was reduced, with a hazard ratio of 0.85 (Confidence interval: 0.82 - 0.88). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">For each one-point increase in the level of optimism in an individual, the risk of getting dementia is reduced by around 15%. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">None of these findings changed much after including behavioral characteristics of health in the model or excluding people with poor psychological health. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">That this correlation was consistent even after 14 years suggests the potential of psychological factors in impacting brain health.</p></li></ul><p dir="ltr">Higher optimism levels were linked with a lower prevalence of dementia and, consequently, proved to be a valuable psychological resource for the elderly. The findings from this study suggest that a positive outlook does not necessarily result from good health conditions, but is rather a factor that affects the latter.</p><p dir="ltr">Through the provision of a measure of the link between optimism and health via a 15% decrease in dementia risk for each standard deviation of optimism level, researchers have provided another benchmark for geriatrics. Looking ahead at what the future may bring in terms of healthy aging, optimism can potentially become an efficient method of combatting dementia.</p><p dir="ltr">Reference:</p><p dir="ltr">S.Stenlund, H. K.Koga, P.James, et al., “The Bright Side of Life: Optimism and Risk of Dementia,” Journal of the American Geriatrics Society (2026): 1–9, <a href="https://doi.org/10.1111/jgs.70392">https://doi.org/10.1111/jgs.70392</a>.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin&#45;Metformin Tablets</title>
<link>https://edusehat.com/en/lupin-gets-usfda-approval-for-xigduo-xr-generic-dapagliflozin-metformin-tablets</link>
<guid>https://edusehat.com/en/lupin-gets-usfda-approval-for-xigduo-xr-generic-dapagliflozin-metformin-tablets</guid>
<description><![CDATA[ New Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in multiple strengths, strengthening its portfolio in the anti-diabetic segment.The approval has been granted for strengths of 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg under the company’s Abbreviated New Drug Application (ANDA). In addition, Lupin has also received tentative approval for the 2.5 mg/1000 mg strength of the combination drug.The approved product is bioequivalent to the reference listed drug Xigduo XR, developed by AstraZeneca, and will be marketed in the United States for the approved indications.Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets are used as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, combining the benefits of an SGLT2 inhibitor and a widely used first-line anti-diabetic agent.Also Read: Lupin Gets USFDA Tentative Nod for Generic Pitolisant Tablets for Sleep DisorderLupin stated that the approval marks an important addition to its diabetes portfolio in the US market, where demand for combination therapies continues to grow.Lupin Limited, headquartered in Mumbai, is a global pharmaceutical company with a presence in over 100 markets. The company offers a broad range of products including generics, complex generics, biotechnology products, and active pharmaceutical ingredients across key therapeutic areas such as cardiovascular, respiratory, anti-diabetic, and central nervous system disorders.Also Read: Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/24/279928-lupin-50-4.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Lupin, Gets, USFDA, Approval, for, Xigduo, Generic, Dapagliflozin-Metformin, Tablets</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/24/279928-lupin-50-4.webp"><p><b>New Delhi:</b> Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in multiple strengths, strengthening its portfolio in the anti-diabetic segment.</p><div class="pasted-from-word-wrapper"><p>The approval has been granted for strengths of 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg under the company’s Abbreviated New Drug Application (ANDA). In addition, Lupin has also received tentative approval for the 2.5 mg/1000 mg strength of the combination drug.</p><p>The approved product is bioequivalent to the reference listed drug Xigduo XR, developed by AstraZeneca, and will be marketed in the United States for the approved indications.</p><p>Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets are used as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, combining the benefits of an SGLT2 inhibitor and a widely used first-line anti-diabetic agent.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/lupin-gets-usfda-tentative-nod-for-generic-pitolisant-tablets-for-sleep-disorder-167629">Also Read: Lupin Gets USFDA Tentative Nod for Generic Pitolisant Tablets for Sleep Disorder</a></div></div><p>Lupin stated that the approval marks an important addition to its diabetes portfolio in the US market, where demand for combination therapies continues to grow.</p><p>Lupin Limited, headquartered in Mumbai, is a global pharmaceutical company with a presence in over 100 markets. The company offers a broad range of products including generics, complex generics, biotechnology products, and active pharmaceutical ingredients across key therapeutic areas such as cardiovascular, respiratory, anti-diabetic, and central nervous system disorders.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/lupin-expands-glp-1-portfolio-with-galenicum-semaglutide-deal-163123">Also Read: Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Aurobindo Arm CuraTeQ Reports Positive Phase 3 Results for Xolair Biosimilar BP11</title>
<link>https://edusehat.com/en/aurobindo-arm-curateq-reports-positive-phase-3-results-for-xolair-biosimilar-bp11</link>
<guid>https://edusehat.com/en/aurobindo-arm-curateq-reports-positive-phase-3-results-for-xolair-biosimilar-bp11</guid>
<description><![CDATA[ New Delhi: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced positive top-line results from its Phase 3 clinical study of BP11, an investigational biosimilar to Xolair (omalizumab). The Phase 3 study successfully met all primary endpoints, demonstrating high comparability with the reference product in patients suffering from chronic spontaneous urticaria (CSU) at the 300 mg dose.The trial involved 608 patients across nearly 80 clinical sites spanning seven European countries and India. The primary endpoint evaluated was the change from baseline in ISS7 (7-point Itch Severity Score) at Week 12, a key parameter for both USFDA and EMA approvals. The results showed precise equivalence, with confidence intervals well within the predefined margins of -2.5 to 2.0.Additionally, the co-primary endpoint assessing relative potency—based on changes in ISS7 using a 4-point assay—was also successfully achieved. The findings demonstrated parallelism between BP11 and the reference product Xolair across different dose levels, indicating strong efficacy alignment and robust data consistency.Also Read: Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day ExclusivityBased on these outcomes, CuraTeQ stated that the data supports future regulatory submissions for multiple indications, including chronic spontaneous urticaria, allergic asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP).Commenting on the development, Dr. Arpitkumar Prajapati, Head of Clinical Development, said that the Phase 3 results with narrow confidence intervals validate the company’s clinical strategy and execution. He added that detailed results will be submitted for regulatory review and presented at upcoming medical conferences.Dr Disha Dadke, Head of R&amp;D and Regulatory Sciences, noted that BP11 has demonstrated comparable efficacy and safety to Xolair, potentially improving access to more affordable treatment options. She further stated that the company plans to complete regulatory filings with both the USFDA and EMA by the end of Q2 2026.Aurobindo Pharma Limited, headquartered in Hyderabad, is a global pharmaceutical company operating in over 150 countries. It manufactures and markets a wide range of generic pharmaceuticals, specialty products, and active pharmaceutical ingredients, supported by a strong research and development infrastructure.Also Read: Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/05/16/128890-aurobindo-pharma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aurobindo, Arm, CuraTeQ, Reports, Positive, Phase, Results, for, Xolair, Biosimilar, BP11</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/05/16/128890-aurobindo-pharma.webp"><p><b>New Delhi:</b> CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced positive top-line results from its Phase 3 clinical study of BP11, an investigational biosimilar to Xolair (omalizumab). The Phase 3 study successfully met all primary endpoints, demonstrating high comparability with the reference product in patients suffering from chronic spontaneous urticaria (CSU) at the 300 mg dose.</p><div class="pasted-from-word-wrapper"><p>The trial involved 608 patients across nearly 80 clinical sites spanning seven European countries and India. The primary endpoint evaluated was the change from baseline in ISS7 (7-point Itch Severity Score) at Week 12, a key parameter for both USFDA and EMA approvals. The results showed precise equivalence, with confidence intervals well within the predefined margins of -2.5 to 2.0.</p><p>Additionally, the co-primary endpoint assessing relative potency—based on changes in ISS7 using a 4-point assay—was also successfully achieved. The findings demonstrated parallelism between BP11 and the reference product Xolair across different dose levels, indicating strong efficacy alignment and robust data consistency.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-secures-usfda-nod-for-dapagliflozin-metformin-xr-gains-180-day-exclusivity-168272">Also Read: Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity</a></div></div><p>Based on these outcomes, CuraTeQ stated that the data supports future regulatory submissions for multiple indications, including chronic spontaneous urticaria, allergic asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP).</p><p>Commenting on the development, Dr. Arpitkumar Prajapati, Head of Clinical Development, said that the Phase 3 results with narrow confidence intervals validate the company’s clinical strategy and execution. He added that detailed results will be submitted for regulatory review and presented at upcoming medical conferences.</p><p>Dr Disha Dadke, Head of R&D and Regulatory Sciences, noted that BP11 has demonstrated comparable efficacy and safety to Xolair, potentially improving access to more affordable treatment options. She further stated that the company plans to complete regulatory filings with both the USFDA and EMA by the end of Q2 2026.</p><p>Aurobindo Pharma Limited, headquartered in Hyderabad, is a global pharmaceutical company operating in over 150 countries. It manufactures and markets a wide range of generic pharmaceuticals, specialty products, and active pharmaceutical ingredients, supported by a strong research and development infrastructure.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-arm-curateq-partners-stada-arzneimittel-ag-to-commercialise-biosimilars-in-europe-167361">Also Read: Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report</title>
<link>https://edusehat.com/en/domestic-pharma-growth-strong-us-market-drag-to-weigh-on-q4fy26-earnings-report</link>
<guid>https://edusehat.com/en/domestic-pharma-growth-strong-us-market-drag-to-weigh-on-q4fy26-earnings-report</guid>
<description><![CDATA[ New Delhi: India&#039;s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by Nuvama Institutional Equities.The report noted that while the domestic business remains robust, overall profitability is expected to be impacted by margin pressures and weakness in exports.&quot;We reckon revenue/EBITDA/PAT of our coverage universe shall grow 10%/3%/-6% YoY,&quot; the report said, adding that &quot;the aggregate EBITDA margin stands at 23.1% (-178bp YoY).&quot; Domestic demand is expected to remain a key growth driver, supported by strong performance across therapies such as cardiac, anti-diabetic and oncology.&quot;Domestic business to expand 12% YoY led by strong Cardiac and Anti-diabetic therapy performance,&quot; the report highlighted.It further added that the Indian Pharmaceutical Market (IPM) recorded a strong 12 per cent YoY expansion, led by robust performance across key therapies, Oncology (33 per cent), Cardiac (16 per cent), Anti-diabetic (16 per cent).Also Read: Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11%However, the US market is expected to remain a drag on overall growth, particularly due to pricing pressures and the decline in sales of key drugs.&quot;As gRevlimid is undergoing high price erosion, companies... are set to post a decrease in their US revenue,&quot; the report said.It also flagged additional challenges for select companies, noting that Cipla is also set to face a dual impact from the end of gRevlimid and Lanreotide-related issues. Among major firms, companies such as Sun Pharma, Dr Reddy&#039;s, Zydus and Ajanta are expected to lead domestic growth, while others may face earnings pressure due to export headwinds and cost factors.The report also pointed to margin pressures across the sector, stating that EBITDA margins are expected to decline both year-on-year and sequentially due to factors such as pricing erosion, product mix and higher operating costs.Overall, the sector outlook remains mixed, with strong domestic demand partially offsetting global challenges, particularly in the US generics market.Also Read: Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on Deleveraging ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/10/28/258521-medicine-7.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Domestic, Pharma, Growth, Strong, Market, Drag, Weigh, Q4FY26, Earnings:, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/10/28/258521-medicine-7.webp"><p><b>New Delhi: </b>India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by Nuvama Institutional Equities.</p><div class="pasted-from-word-wrapper"><p>The report noted that while the domestic business remains robust, overall profitability is expected to be impacted by margin pressures and weakness in exports.</p><p>"We reckon revenue/EBITDA/PAT of our coverage universe shall grow 10%/3%/-6% YoY," the report said, adding that "the aggregate EBITDA margin stands at 23.1% (-178bp YoY)." Domestic demand is expected to remain a key growth driver, supported by strong performance across therapies such as cardiac, anti-diabetic and oncology.</p><p>"Domestic business to expand 12% YoY led by strong Cardiac and Anti-diabetic therapy performance," the report highlighted.</p><p>It further added that the Indian Pharmaceutical Market (IPM) recorded a strong 12 per cent YoY expansion, led by robust performance across key therapies, Oncology (33 per cent), Cardiac (16 per cent), Anti-diabetic (16 per cent).</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-q3-fy26-profit-slips-to-rs-133-cr-after-one-time-labour-code-provision-revenue-up-11-164253">Also Read: Alembic Pharma Q3 FY26 Profit Slips to Rs 133 Cr After One-Time Labour Code Provision, Revenue Up 11%</a></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>However, the US market is expected to remain a drag on overall growth, particularly due to pricing pressures and the decline in sales of key drugs.</p><p>"As gRevlimid is undergoing high price erosion, companies... are set to post a decrease in their US revenue," the report said.</p><p>It also flagged additional challenges for select companies, noting that Cipla is also set to face a dual impact from the end of gRevlimid and Lanreotide-related issues. Among major firms, companies such as Sun Pharma, Dr Reddy's, Zydus and Ajanta are expected to lead domestic growth, while others may face earnings pressure due to export headwinds and cost factors.</p><p>The report also pointed to margin pressures across the sector, stating that EBITDA margins are expected to decline both year-on-year and sequentially due to factors such as pricing erosion, product mix and higher operating costs.</p><p>Overall, the sector outlook remains mixed, with strong domestic demand partially offsetting global challenges, particularly in the US generics market.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/solara-active-pharma-swings-to-rs-101-crore-loss-in-q2-fy26-amid-shutdown-impact-focuses-on-deleveraging-158164">Also Read: Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on Deleveraging</a></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Kissing Poses Minimal Gluten Risk in Celiac Disease: Study</title>
<link>https://edusehat.com/en/kissing-poses-minimal-gluten-risk-in-celiac-disease-study</link>
<guid>https://edusehat.com/en/kissing-poses-minimal-gluten-risk-in-celiac-disease-study</guid>
<description><![CDATA[ Researchers have found in a new study that, despite concerns, kissing appears to carry a very low risk of gluten transfer for people with celiac disease. Only a small number of exposures showed detectable gluten levels, and none exceeded safety limits when the non-celiac partner drank water beforehand. This suggests kissing is generally safe with simple precautions. The study was published in the Gastroenterology journal by Anne R. and colleagues.The treatment for Celiac disease is currently reliant on the adoption of a strict gluten-free diet, as even the slightest amount of &quot;cross-contact&quot; may result in an immune reaction and damage to the lining of the small intestine. While many people with CeD report feeling worried about the risks of gluten transfer through kissing, there was a notable lack of clinical evidence to back up this belief. For this reason, researchers developed a study focused on assessing the exact mechanics involved in the transfer of gluten.To do that, some couples, where only one individual suffered from CeD, were selected for participation. The non-CeD participant consumed a meal called &quot;gluten load,&quot; which consisted of 10 crackers containing 59,107 ppm (about 590 mg) of gluten. Two different scenarios took place: in one case, the non-CeD partner had to wait for 5 minutes after finishing his or her meal, while in the other case, he/she was required to drink 4 ounces of water and then kiss his/her partner. Saliva of the partner suffering from CeD was collected and analyzed using R-5 enzyme-linked immunosorbent assay (ELISA).Key findings:Based on the findings of the 20 gluten trials performed, it is evident that the risk of accidental ingestion of gluten via kisses is extremely low. The tests conducted revealed that out of the 20 tests, there were only two instances where the concentration of gluten exceeded 20 ppm, and both instances were only found in the test that involved no consumption of water. Moreover, the study concluded that taking 4 oz of water before engaging in the act of kissing lowered the risks to almost none at all. Additionally, there was no significant amount of gluten detected in the urine samples of the patients with CeD.This study shows that there was no greater risk of gluten exposure by kissing for those with Celiac Disease. Although there may be a fear of cross-contamination, which is certainly a legitimate concern in relation to having an autoimmune disease, the risks associated with this activity appear to be negligible and can easily be prevented. Ingesting 4 ounces of water before kissing also eliminates the risk, thereby maintaining the amount of gluten at less than 20 ppm, the international safety guideline. These findings should dictate our clinical practices, and we should relay these findings to our patients so as to decrease the difficulty of their diets.Reference:Lee, A. R., Chen, Z., Jossen, J., Lebovits, J., Lebwohl, B., Lewis, S. K., Krishnareddy, S., Wolf, R. L., Emerson, L., &amp; Green, P. H. R. (2026). A prospective study of gluten transfer through kissing in celiac-discordant couples. Gastroenterology. https://doi.org/10.1053/j.gastro.2026.01.024  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/03/02/125105-celiac-disease.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kissing, Poses, Minimal, Gluten, Risk, Celiac, Disease:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/03/02/125105-celiac-disease.webp"><p>Researchers have found in a new study that, despite concerns, kissing appears to carry a very low risk of gluten transfer for people with celiac disease. Only a small number of exposures showed detectable gluten levels, and none exceeded safety limits when the non-celiac partner drank water beforehand. This suggests kissing is generally safe with simple precautions. The study was published in the <i>Gastroenterology</i> journal by Anne R. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The treatment for Celiac disease is currently reliant on the adoption of a strict gluten-free diet, as even the slightest amount of "cross-contact" may result in an immune reaction and damage to the lining of the small intestine. While many people with CeD report feeling worried about the risks of gluten transfer through kissing, there was a notable lack of clinical evidence to back up this belief. For this reason, researchers developed a study focused on assessing the exact mechanics involved in the transfer of gluten.</p><p dir="ltr">To do that, some couples, where only one individual suffered from CeD, were selected for participation. The non-CeD participant consumed a meal called "gluten load," which consisted of 10 crackers containing 59,107 ppm (about 590 mg) of gluten. Two different scenarios took place: in one case, the non-CeD partner had to wait for 5 minutes after finishing his or her meal, while in the other case, he/she was required to drink 4 ounces of water and then kiss his/her partner. Saliva of the partner suffering from CeD was collected and analyzed using R-5 enzyme-linked immunosorbent assay (ELISA).</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Based on the findings of the 20 gluten trials performed, it is evident that the risk of accidental ingestion of gluten via kisses is extremely low. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The tests conducted revealed that out of the 20 tests, there were only two instances where the concentration of gluten exceeded 20 ppm, and both instances were only found in the test that involved no consumption of water. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Moreover, the study concluded that taking 4 oz of water before engaging in the act of kissing lowered the risks to almost none at all. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Additionally, there was no significant amount of gluten detected in the urine samples of the patients with CeD.</p></li></ul><p dir="ltr">This study shows that there was no greater risk of gluten exposure by kissing for those with Celiac Disease. Although there may be a fear of cross-contamination, which is certainly a legitimate concern in relation to having an autoimmune disease, the risks associated with this activity appear to be negligible and can easily be prevented. Ingesting 4 ounces of water before kissing also eliminates the risk, thereby maintaining the amount of gluten at less than 20 ppm, the international safety guideline. These findings should dictate our clinical practices, and we should relay these findings to our patients so as to decrease the difficulty of their diets.</p><p dir="ltr">Reference:</p><p dir="ltr">Lee, A. R., Chen, Z., Jossen, J., Lebovits, J., Lebwohl, B., Lewis, S. K., Krishnareddy, S., Wolf, R. L., Emerson, L., & Green, P. H. R. (2026). A prospective study of gluten transfer through kissing in celiac-discordant couples. Gastroenterology. <a href="https://doi.org/10.1053/j.gastro.2026.01.024">https://doi.org/10.1053/j.gastro.2026.01.024</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Dental dedicated MRI: A Reliable Radiation&#45;Free Tool for Orthodontic Landmark Identification</title>
<link>https://edusehat.com/en/dental-dedicated-mri-a-reliable-radiation-free-tool-for-orthodontic-landmark-identification</link>
<guid>https://edusehat.com/en/dental-dedicated-mri-a-reliable-radiation-free-tool-for-orthodontic-landmark-identification</guid>
<description><![CDATA[ A new study published in the journal of Imaging Science in Dentistry revealed that 5T dental-dedicated magnetic resonance imaging (ddMRI) is a feasible imaging modality for 2D orthodontic landmark identification, which demonstrates high intra- and inter-rater reliability. This offers a dependable, radiation-free alternative for orthodontic diagnosis and treatment planning.Lateral cephalograms have long been the standard imaging method for identifying anatomical landmarks and conducting cephalometric analysis in orthodontics. However, their reliance on ionizing radiation raises ongoing concerns in younger patients and those requiring repeated imaging. Thus, studies have been exploring MRI as a safer alternative capable of visualizing both hard and soft tissues without radiation exposure.This study evaluated whether ddMRI could reliably replicate the landmark identification typically performed on cephalograms. 13 adult volunteers (7 men and 6 women) with an average age of 33 years underwent ddMRI scans. Using specialized imaging software, 3 independent raters were tasked with identifying and annotating key orthodontic landmarks on two separate occasions.The analysis focused on both intra-rater consistency (how consistent each rater was with themselves over time) and inter-rater agreement (how closely different raters aligned with one another). These results were highly promising, where intra-rater reliability scores ranged from 0.909 to 0.999, and inter-rater scores ranged from 0.988 to 0.999. These findings indicate that ddMRI can produce highly consistent and reproducible landmark identifications.This research measured the differences in annotated landmark positions using linear distances in millimeters which helps further in assessing accuracy. Bland-Altman plots were employed to visualize agreement and detect any systematic bias between measurements. The results showed minimal variation, which reinforced the reliability of this method.Overall, this study demonstrates that ddMRI can reliably identify cephalometric landmarks in two dimensions and this opens options to safer imaging protocols in orthodontics. This is certainly relevant for patients who require multiple imaging sessions over time, like adolescents who undergo long-term treatment. Future research will be imperative to confirm these findings across more diverse populations and explore how ddMRI performs in routine clinical workflows.Source:Srivastav, S., Stoustrup, P. B., Liu, J., Federici, M. I., Christensen, J., &amp; Spin-Neto, R. (2026). Reliability of dental-dedicated magnetic resonance imaging for 2-dimensional orthodontic diagnosis: A pilot study of landmark identification. Imaging Science in Dentistry, 56(1), 36–44. https://doi.org/10.5624/isd.20250201 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/26/317227-dental-age-of-children.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dental, dedicated, MRI:, Reliable, Radiation-Free, Tool, for, Orthodontic, Landmark, Identification</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/26/317227-dental-age-of-children.webp"><p>A new study published in the journal of <i>Imaging Science in Dentistry</i> revealed that 5T dental-dedicated magnetic resonance imaging (ddMRI) is a feasible imaging modality for 2D orthodontic landmark identification, which demonstrates high intra- and inter-rater reliability. This offers a dependable, radiation-free alternative for orthodontic diagnosis and treatment planning.</p><p>Lateral cephalograms have long been the standard imaging method for identifying anatomical landmarks and conducting cephalometric analysis in orthodontics. However, their reliance on ionizing radiation raises ongoing concerns in younger patients and those requiring repeated imaging. Thus, studies have been exploring MRI as a safer alternative capable of visualizing both hard and soft tissues without radiation exposure.</p><p>This study evaluated whether ddMRI could reliably replicate the landmark identification typically performed on cephalograms. 13 adult volunteers (7 men and 6 women) with an average age of 33 years underwent ddMRI scans. Using specialized imaging software, 3 independent raters were tasked with identifying and annotating key orthodontic landmarks on two separate occasions.</p><p>The analysis focused on both intra-rater consistency (how consistent each rater was with themselves over time) and inter-rater agreement (how closely different raters aligned with one another). These results were highly promising, where intra-rater reliability scores ranged from 0.909 to 0.999, and inter-rater scores ranged from 0.988 to 0.999. These findings indicate that ddMRI can produce highly consistent and reproducible landmark identifications.</p><p>This research measured the differences in annotated landmark positions using linear distances in millimeters which helps further in assessing accuracy. Bland-Altman plots were employed to visualize agreement and detect any systematic bias between measurements. The results showed minimal variation, which reinforced the reliability of this method.</p><p>Overall, this study demonstrates that ddMRI can reliably identify cephalometric landmarks in two dimensions and this opens options to safer imaging protocols in orthodontics. This is certainly relevant for patients who require multiple imaging sessions over time, like adolescents who undergo long-term treatment. Future research will be imperative to confirm these findings across more diverse populations and explore how ddMRI performs in routine clinical workflows.</p><p>Source:</p><p>Srivastav, S., Stoustrup, P. B., Liu, J., Federici, M. I., Christensen, J., & Spin-Neto, R. (2026). Reliability of dental-dedicated magnetic resonance imaging for 2-dimensional orthodontic diagnosis: A pilot study of landmark identification. Imaging Science in Dentistry, 56(1), 36–44. <a href="https://isdent.org/search.php?where=aview&id=10.5624/isd.20250201&code=2080ISD&vmode=FULL" rel="nofollow">https://doi.org/10.5624/isd.20250201</a></p>]]> </content:encoded>
</item>

<item>
<title>Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report</title>
<link>https://edusehat.com/en/sun-pharma-plans-usd-12-billion-organon-acquisition-prepares-binding-bid-report</link>
<guid>https://edusehat.com/en/sun-pharma-plans-usd-12-billion-organon-acquisition-prepares-binding-bid-report</guid>
<description><![CDATA[ Mumbai: Sun Pharmaceutical Industries is preparing to submit a binding offer of around USD 12 billion to acquire Organon &amp; Co., in what could become the largest overseas acquisition by an Indian pharmaceutical company, as it completes due diligence, arranges financing with global banks, and moves toward finalising an all-cash bid amid competition from other investors, according to a recent media report in The Economic Times.The Mumbai-based drugmaker, led by Dilip Shanghvi, has spent over three months conducting detailed due diligence after initially submitting a non-binding offer in January. The company is now in advanced stages of securing funds, with at least three global banks reportedly mandated to support the transaction.If successful, the acquisition would mark a significant strategic shift for Sun Pharma, strengthening its position in branded and innovative medicines while reducing reliance on generics. The move aligns with the company’s long-term focus on specialty and research-driven segments.Organon, which was spun off from Merck Sharp &amp; Dohme (MSD) in 2021, operates in women’s health, biosimilars, and established medicines. However, the company has been grappling with financial challenges, including a substantial debt burden that stood at around $8 billion in 2025 despite some reduction.Also Read: Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology AdvancesThe US-based firm has a diverse portfolio spanning cardiovascular, respiratory, dermatology, bone health, and non-opioid pain therapies, along with its core women’s health offerings. Its key contraceptive brand Nexplanon reported a decline in 2025 sales, partly due to reduced government funding and other pressures, although growth is expected in emerging markets such as Latin America.Organon has also been restructuring operations, including divesting certain assets to sharpen its focus on women’s health biopharma. At the same time, it continues to face pricing pressures and competition in the generics segment.Sun Pharma, on the other hand, maintains a strong balance sheet with net cash reserves, enabling it to pursue large-scale acquisitions. The company reported revenues of around Rs 52,000 crore in FY26, with significant contributions from both domestic and US markets. It has also been expanding its specialty pipeline, including through acquisitions such as Checkpoint Therapeutics, which strengthened its oncology portfolio.While discussions around the deal have seen fluctuations due to global market volatility, recent developments indicate renewed momentum, reports The Economic Times.Also Read: Sun Pharma Names Former PwC India COO Satyavati Berera as Independent Director ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/04/240154-sun-pharma-new-50-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 11 Apr 2026 00:10:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sun, Pharma, Plans, USD, Billion, Organon, Acquisition, Prepares, Binding, Bid:, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/04/240154-sun-pharma-new-50-1.webp"><p><b>Mumbai:</b> Sun Pharmaceutical Industries is preparing to submit a binding offer of around USD 12 billion to acquire Organon & Co., in what could become the largest overseas acquisition by an Indian pharmaceutical company, as it completes due diligence, arranges financing with global banks, and moves toward finalising an all-cash bid amid competition from other investors, according to a recent media report in The Economic Times.</p><div class="pasted-from-word-wrapper"><p>The Mumbai-based drugmaker, led by Dilip Shanghvi, has spent over three months conducting detailed due diligence after initially submitting a non-binding offer in January. The company is now in advanced stages of securing funds, with at least three global banks reportedly mandated to support the transaction.</p><p>If successful, the acquisition would mark a significant strategic shift for Sun Pharma, strengthening its position in branded and innovative medicines while reducing reliance on generics. The move aligns with the company’s long-term focus on specialty and research-driven segments.</p><p>Organon, which was spun off from Merck Sharp & Dohme (MSD) in 2021, operates in women’s health, biosimilars, and established medicines. However, the company has been grappling with financial challenges, including a substantial debt burden that stood at around $8 billion in 2025 despite some reduction.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/sun-pharma-to-present-ilumya-leqselvi-winlevi-data-at-aad-2026-showcases-dermatology-advances-167532">Also Read: Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances</a></div></div><p>The US-based firm has a diverse portfolio spanning cardiovascular, respiratory, dermatology, bone health, and non-opioid pain therapies, along with its core women’s health offerings. Its key contraceptive brand Nexplanon reported a decline in 2025 sales, partly due to reduced government funding and other pressures, although growth is expected in emerging markets such as Latin America.</p><p>Organon has also been restructuring operations, including divesting certain assets to sharpen its focus on women’s health biopharma. At the same time, it continues to face pricing pressures and competition in the generics segment.</p><p>Sun Pharma, on the other hand, maintains a strong balance sheet with net cash reserves, enabling it to pursue large-scale acquisitions. The company reported revenues of around Rs 52,000 crore in FY26, with significant contributions from both domestic and US markets. It has also been expanding its specialty pipeline, including through acquisitions such as Checkpoint Therapeutics, which strengthened its oncology portfolio.</p><p>While discussions around the deal have seen fluctuations due to global market volatility, recent developments indicate renewed momentum, reports <a href="https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-preps-for-12-billion-organon-bid-in-biggest-overseas-pharma-ma-by-indian-co/articleshow/130152812.cms" rel="nofollow">The Economic Times</a>.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/sun-pharma-names-former-pwc-india-coo-satyavati-berera-as-independent-director-168109">Also Read: Sun Pharma Names Former PwC India COO Satyavati Berera as Independent Director</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 10/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-10april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-10april2026</guid>
<description><![CDATA[ Here are the top medical news for today:Breakthrough Male Contraceptive May Temporarily Stop Sperm Production
A birth control breakthrough for men may finally be on the horizon.Researchers at Cornell University have made a significant breakthrough in the search for a safe, reversible, and long-acting nonhormonal male contraceptive—an innovation long considered the “holy grail” of reproductive health. In a proof-of-principle study conducted in mice and published in Proceedings of the National Academy of Sciences, scientists demonstrated that temporarily interrupting a critical step in sperm production can effectively halt fertility without causing permanent damage.
The team focused on meiosis, the specialized cell division process that produces sperm. Using a small molecule called JQ1 inhibitor, originally developed for cancer research, they disrupted a key stage known as prophase 1. This intervention caused developing sperm cells to stop maturing, effectively shutting down sperm production during treatment.
Importantly, the effect was reversible. Male mice received JQ1 for three weeks, after which sperm production ceased entirely. However, within six weeks of stopping the treatment, normal sperm development resumed. The mice were able to reproduce successfully, and their offspring were healthy, indicating no lasting genetic or reproductive harm.
Unlike hormonal approaches, which can carry side effects and affect broader physiological systems, this method targets the testis directly while preserving spermatogonial stem cells—the foundation of long-term fertility. This ensures that fertility can be restored once treatment stops, addressing a major concern in male contraception research.
Currently, male contraceptive options are limited to condoms and vasectomy, the latter often seen as permanent despite possible reversals. A nonhormonal, reversible method could dramatically expand choices and shift the burden of contraception more evenly.
While JQ1 itself is not suitable for human use due to potential neurological side effects, the study provides a crucial roadmap for developing safer alternatives. Future versions could be delivered as periodic injections or patches, offering men a reliable and convenient contraceptive option.
REFERENCE: Stephanie Tanis, Leah E. Simon, Adriana K. Alexander, Tegan S. Horan, Maria de las Mercedes Carro, Samantha Jane Bonnett, Audrey Xie, Roni Ben-Shlomo, Connor E. Owens, Charles G. Danko, Jelena Lujic, Paula E. Cohen. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1. Proceedings of the National Academy of Sciences, 2026; 123 (15) DOI: 10.1073/pnas.2517498123
Study Explores Whether Midlife Vitamin D Levels May Protect Against Early Alzheimer’s Risk
Could your vitamin D levels in your 30s shape your brain health decades later?A new study published in Neurology journal suggests that vitamin D levels in early midlife may play a role in shaping future brain health and dementia risk. While previous research has linked low vitamin D in older adults to cognitive decline, this study shifts the focus earlier in life—when preventive strategies may be more effective.
Researchers analyzed data from 793 dementia-free participants in the Framingham Heart Study Generation 3 cohort. Vitamin D levels were measured at an average age of 39, and participants later underwent advanced brain scans (PET imaging) roughly 16 years afterward to detect early markers of Alzheimer’s disease, including amyloid and tau protein buildup.
The findings revealed that individuals with higher circulating vitamin D levels in early midlife had lower levels of tau deposition in the brain. Tau accumulation is considered a key early marker of Alzheimer’s disease and is closely linked to cognitive decline. Interestingly, no association was found between vitamin D levels and amyloid buildup, another hallmark of the disease.
The relationship remained significant even after adjusting for multiple factors such as age, lifestyle, and vascular health. Exploratory analyses also hinted at a dose-response effect, with the highest vitamin D levels linked to the lowest tau burden, though these results require further confirmation.
Biologically, vitamin D supports brain health through several mechanisms. It helps regulate inflammation, enhances antioxidant defenses, and supports neuronal function. It may also reduce abnormal tau phosphorylation, a process that contributes to toxic protein buildup in the brain.
Despite these promising findings, the study is observational and does not prove causation. Limitations include a largely homogeneous population and lack of repeated vitamin D measurements over time.
Overall, the research highlights vitamin D as a potentially modifiable factor in early dementia prevention. Maintaining adequate levels in midlife—through safe sun exposure, diet, or supplementation—could support long-term brain health, though further clinical trials are needed to confirm its protective role.
REFERENCE: Mulligan, M. D., Scott, M. R., Yang, Q., et al. (2026). Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology. DOI: https://doi.org/10.1212/WN9.0000000000000057. https://www.neurology.org/doi/pdf/10.1212/WN9.0000000000000057
Even Occasional Binge Drinking Linked to Higher Risk of Liver Damage: Study
That occasional “weekend binge” may be doing far more harm to your liver than you think.A new study from Keck Medicine of USC, published in Clinical Gastroenterology and Hepatology, challenges a common belief about alcohol consumption: that occasional binge drinking is harmless if overall intake is moderate. The findings show that even infrequent episodes of heavy drinking can significantly increase the risk of serious liver damage—especially in people with underlying metabolic conditions.
The research focused on individuals with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting roughly one in three adults and commonly linked to obesity, Type 2 diabetes, and high cholesterol. Using data from over 8,000 participants in the National Health and Nutrition Examination Survey (2017–2023), researchers examined how drinking patterns—not just total alcohol intake—affect liver health.
Episodic heavy drinking, defined as consuming four or more drinks for women or five or more for men in a single day at least once a month, was associated with a nearly threefold increase in the risk of advanced liver fibrosis. Fibrosis refers to the buildup of scar tissue in the liver, which can impair function and lead to long-term complications.
Importantly, this elevated risk was observed even when total weekly alcohol consumption was similar. In other words, spreading alcohol intake across multiple days appeared far less harmful than consuming the same amount in a single session. Younger adults and men were more likely to engage in such binge patterns, and higher quantities per occasion were linked to more severe liver damage.
The findings suggest that the liver may be overwhelmed by large, concentrated doses of alcohol, triggering inflammation and accelerating scarring. For individuals with MASLD, whose livers are already vulnerable, this effect can be particularly damaging.
Overall, the study highlights the need to rethink how alcohol-related risks are assessed. It is not just how much you drink, but how you drink that matters. Avoiding binge patterns may be a crucial step in protecting long-term liver health.
REFERENCE: Yinan Su, Jennifer L. Dodge, Brian P. Lee. Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study. Clinical Gastroenterology and Hepatology, 2026; DOI: 10.1016/j.cgh.2026.03.004
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340816-top-medical-18.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 10April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340816-top-medical-18.webp"><p><b>Here are the top medical news for today:</b></p><p><b>Breakthrough Male Contraceptive May Temporarily Stop Sperm Production
</b></p><p>A birth control breakthrough for men may finally be on the horizon.</p><p>Researchers at Cornell University have made a significant breakthrough in the search for a safe, reversible, and long-acting nonhormonal male contraceptive—an innovation long considered the “holy grail” of reproductive health. In a proof-of-principle study conducted in mice and published in Proceedings of the National Academy of Sciences, scientists demonstrated that temporarily interrupting a critical step in sperm production can effectively halt fertility without causing permanent damage.
</p><p>The team focused on meiosis, the specialized cell division process that produces sperm. Using a small molecule called JQ1 inhibitor, originally developed for cancer research, they disrupted a key stage known as prophase 1. This intervention caused developing sperm cells to stop maturing, effectively shutting down sperm production during treatment.
</p><p>Importantly, the effect was reversible. Male mice received JQ1 for three weeks, after which sperm production ceased entirely. However, within six weeks of stopping the treatment, normal sperm development resumed. The mice were able to reproduce successfully, and their offspring were healthy, indicating no lasting genetic or reproductive harm.
</p><p>Unlike hormonal approaches, which can carry side effects and affect broader physiological systems, this method targets the testis directly while preserving spermatogonial stem cells—the foundation of long-term fertility. This ensures that fertility can be restored once treatment stops, addressing a major concern in male contraception research.
</p><p>Currently, male contraceptive options are limited to condoms and vasectomy, the latter often seen as permanent despite possible reversals. A nonhormonal, reversible method could dramatically expand choices and shift the burden of contraception more evenly.
</p><p>While JQ1 itself is not suitable for human use due to potential neurological side effects, the study provides a crucial roadmap for developing safer alternatives. Future versions could be delivered as periodic injections or patches, offering men a reliable and convenient contraceptive option.
</p><p><b>REFERENCE:</b> Stephanie Tanis, Leah E. Simon, Adriana K. Alexander, Tegan S. Horan, Maria de las Mercedes Carro, Samantha Jane Bonnett, Audrey Xie, Roni Ben-Shlomo, Connor E. Owens, Charles G. Danko, Jelena Lujic, Paula E. Cohen. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1. Proceedings of the National Academy of Sciences, 2026; 123 (15) DOI: 10.1073/pnas.2517498123
</p><p><b></b></p><p><b>Study Explores Whether Midlife Vitamin D Levels May Protect Against Early Alzheimer’s Risk
</b></p><p>Could your vitamin D levels in your 30s shape your brain health decades later?</p><p>A new study published in Neurology journal suggests that vitamin D levels in early midlife may play a role in shaping future brain health and dementia risk. While previous research has linked low vitamin D in older adults to cognitive decline, this study shifts the focus earlier in life—when preventive strategies may be more effective.
</p><p>Researchers analyzed data from 793 dementia-free participants in the Framingham Heart Study Generation 3 cohort. Vitamin D levels were measured at an average age of 39, and participants later underwent advanced brain scans (PET imaging) roughly 16 years afterward to detect early markers of Alzheimer’s disease, including amyloid and tau protein buildup.
</p><p>The findings revealed that individuals with higher circulating vitamin D levels in early midlife had lower levels of tau deposition in the brain. Tau accumulation is considered a key early marker of Alzheimer’s disease and is closely linked to cognitive decline. Interestingly, no association was found between vitamin D levels and amyloid buildup, another hallmark of the disease.
</p><p>The relationship remained significant even after adjusting for multiple factors such as age, lifestyle, and vascular health. Exploratory analyses also hinted at a dose-response effect, with the highest vitamin D levels linked to the lowest tau burden, though these results require further confirmation.
</p><p>Biologically, vitamin D supports brain health through several mechanisms. It helps regulate inflammation, enhances antioxidant defenses, and supports neuronal function. It may also reduce abnormal tau phosphorylation, a process that contributes to toxic protein buildup in the brain.
</p><p>Despite these promising findings, the study is observational and does not prove causation. Limitations include a largely homogeneous population and lack of repeated vitamin D measurements over time.
</p><p>Overall, the research highlights vitamin D as a potentially modifiable factor in early dementia prevention. Maintaining adequate levels in midlife—through safe sun exposure, diet, or supplementation—could support long-term brain health, though further clinical trials are needed to confirm its protective role.
</p><p><b>REFERENCE:</b> Mulligan, M. D., Scott, M. R., Yang, Q., et al. (2026). Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology. DOI: https://doi.org/10.1212/WN9.0000000000000057. https://www.neurology.org/doi/pdf/10.1212/WN9.0000000000000057
</p><p><b></b></p><p><b>Even Occasional Binge Drinking Linked to Higher Risk of Liver Damage: Study
</b></p><p>That occasional “weekend binge” may be doing far more harm to your liver than you think.</p><p>A new study from Keck Medicine of USC, published in Clinical Gastroenterology and Hepatology, challenges a common belief about alcohol consumption: that occasional binge drinking is harmless if overall intake is moderate. The findings show that even infrequent episodes of heavy drinking can significantly increase the risk of serious liver damage—especially in people with underlying metabolic conditions.
</p><p>The research focused on individuals with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting roughly one in three adults and commonly linked to obesity, Type 2 diabetes, and high cholesterol. Using data from over 8,000 participants in the National Health and Nutrition Examination Survey (2017–2023), researchers examined how drinking patterns—not just total alcohol intake—affect liver health.
</p><p>Episodic heavy drinking, defined as consuming four or more drinks for women or five or more for men in a single day at least once a month, was associated with a nearly threefold increase in the risk of advanced liver fibrosis. Fibrosis refers to the buildup of scar tissue in the liver, which can impair function and lead to long-term complications.
</p><p>Importantly, this elevated risk was observed even when total weekly alcohol consumption was similar. In other words, spreading alcohol intake across multiple days appeared far less harmful than consuming the same amount in a single session. Younger adults and men were more likely to engage in such binge patterns, and higher quantities per occasion were linked to more severe liver damage.
</p><p>The findings suggest that the liver may be overwhelmed by large, concentrated doses of alcohol, triggering inflammation and accelerating scarring. For individuals with MASLD, whose livers are already vulnerable, this effect can be particularly damaging.
</p><p>Overall, the study highlights the need to rethink how alcohol-related risks are assessed. It is not just how much you drink, but how you drink that matters. Avoiding binge patterns may be a crucial step in protecting long-term liver health.
</p><p><b>REFERENCE: </b>Yinan Su, Jennifer L. Dodge, Brian P. Lee. Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study. Clinical Gastroenterology and Hepatology, 2026; DOI: 10.1016/j.cgh.2026.03.004
</p>]]> </content:encoded>
</item>

<item>
<title>AIIMS Delhi hosts global collaboration to bridge gap between medicine and technology</title>
<link>https://edusehat.com/en/aiims-delhi-hosts-global-collaboration-to-bridge-gap-between-medicine-and-technology</link>
<guid>https://edusehat.com/en/aiims-delhi-hosts-global-collaboration-to-bridge-gap-between-medicine-and-technology</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS) Delhi has brought together engineers and clinicians from leading global institutions, including IIT Delhi and the Massachusetts Institute of Technology (MIT), to jointly develop innovative solutions for pressing healthcare challenges. The initiative also brings together researchers from UiT The Arctic University of Norway, the University of Oslo, the University of Southampton, and SINTEF, reflecting a growing international push to combine medical expertise with cutting-edge engineering research for improved patient care, diagnosis, and treatment.Also Read:Doctors, faculty call for immediate rollout of NExT exam for MBBS studentsSpeaking to Tribune India, Dr Vivek Tandon from AIIMS’s Department of Neurosurgery said, “The aim of organising this workshop is to bring engineers and doctors together and create engineering innovations that would actually help the doctors.”  He emphasised that clinical needs must guide technological design. “If I want a specific camera to perform a neurosurgery, then it should be a doctor who sits with an engineer to explain what sort of need the camera must fulfil,” Dr Tandon said. He added that such an approach allows both sides to identify and build targeted healthcare technologies.The workshop is being organised under the chairmanship of IIT Delhi’s DS Mehta, while Dr Balpreet Singh Ahluwalia from UiT The Arctic University of Norway is co-chairing the programme. From MIT, Professor Peter So, an expert in biological engineering and multiphoton microscopy, is among the key international participants.
The discussions opened with a fundamental concern in clinical care. Dr Dipak Sapkota, a researcher from the University of Oslo, highlighted that the most important question patients ask is not what disease they have, but how long they are going to survive, pointing to a gap that continues to challenge modern medicine.
He highlighted challenges in managing oral leukoplakia, a potentially cancerous condition that is difficult to predict and often requires repeated biopsies. “We don’t know what to do; at times in oral cancer, we just wait until the patient dies,” he said, underscoring the urgent need for better predictive tools.
Dr Sapkota stressed that no single technology could solve such complex problems. Instead, he advocated combining clinical data with optical spectral analysis, AI-based imaging, and advanced approaches like single-cell and spatial omics to better identify high-risk patients.
Similar gaps are being addressed through AI in dermatology. Dr Somesh Gupta from AIIMS’s dermatology department said skin diseases generate the highest number of health-related queries globally, yet nearly three billion people lack access to specialists. “There are countries with only two or three specialists,” he said. He pointed out that most datasets used to train AI models are skewed towards lighter skin tones, while a larger share of the global population has darker or Asian skin, reports Tribune India.
To address this, his team is developing India-specific AI models in collaboration with partners, including Google Health, aimed at helping frontline healthcare workers identify and triage skin diseases more effectively.
The ophthalmology department at AIIMS showcased an AI-powered system called MadhuNetraAI, designed to detect and grade diabetic retinopathy. The tool can be deployed in community settings and used by trained health workers to identify patients needing urgent referral.
With a reported sensitivity of 98% and specificity of 96%, the system helps reduce unnecessary hospital visits while ensuring timely treatment for high-risk patients.Experts also discussed public health issues, noting that tobacco warning labels have limited behavioural impact, while indirect advertising continues to influence consumption patterns in subtle ways.The discussions are part of the ongoing ‘Photonics 4 Clinics’ workshop at AIIMS, which focuses on the use of light-based technologies combined with artificial intelligence to detect biological changes and improve clinical decision-making.
Also Read:World&#039;s Best Hospitals 2026: Medanta, AIIMS Delhi, PGI Chandigarh, CMC Vellore in global top 250, 97 Indian hospitals ranked ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/14/308448-aiims-delhi-16.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Delhi, hosts, global, collaboration, bridge, gap, between, medicine, and, technology</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/14/308448-aiims-delhi-16.webp"><p><b>New Delhi: </b>The All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/aiims-new-delhi">AIIMS) Delhi </a>has brought together engineers and clinicians from leading global institutions, including IIT <a href="https://medicaldialogues.in/state-news/delhi">Delhi </a>and the Massachusetts Institute of Technology (MIT), to jointly develop innovative solutions for pressing healthcare challenges. </p><p>The initiative also brings together researchers from UiT The Arctic University of Norway, the University of Oslo, the University of Southampton, and SINTEF, reflecting a growing international push to combine medical expertise with cutting-edge engineering research for improved <a href="https://medicaldialogues.in/topics/patient-care">patient care</a>, <a href="https://medicaldialogues.in/topics/medical-diagnosis">diagnosis</a>, and treatment.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/doctors-faculty-call-for-immediate-rollout-of-next-exam-for-mbbs-students-168096"><b>Also Read:Doctors, faculty call for immediate rollout of NExT exam for MBBS students</b></a></p><p>Speaking to Tribune India, Dr Vivek Tandon from AIIMS’s Department of Neurosurgery said, “The aim of organising this workshop is to bring engineers and doctors together and create engineering innovations that would actually help the doctors.”  He emphasised that clinical needs must guide technological design. “If I want a specific camera to perform a neurosurgery, then it should be a doctor who sits with an engineer to explain what sort of need the camera must fulfil,” Dr Tandon said. He added that such an approach allows both sides to identify and build targeted healthcare technologies.</p><p>The workshop is being organised under the chairmanship of IIT Delhi’s DS Mehta, while Dr Balpreet Singh Ahluwalia from UiT The Arctic University of Norway is co-chairing the programme. From MIT, Professor Peter So, an expert in biological engineering and multiphoton microscopy, is among the key international participants.
</p><p>The discussions opened with a fundamental concern in clinical care. Dr Dipak Sapkota, a researcher from the University of Oslo, highlighted that the most important question patients ask is not what disease they have, but how long they are going to survive, pointing to a gap that continues to challenge modern medicine.
</p><p>He highlighted challenges in managing oral leukoplakia, a potentially cancerous condition that is difficult to predict and often requires repeated biopsies. “We don’t know what to do; at times in oral cancer, we just wait until the patient dies,” he said, underscoring the urgent need for better predictive tools.
</p><p>Dr Sapkota stressed that no single technology could solve such complex problems. Instead, he advocated combining clinical data with optical spectral analysis, AI-based imaging, and advanced approaches like single-cell and spatial omics to better identify high-risk patients.
</p><p>Similar gaps are being addressed through AI in dermatology. Dr Somesh Gupta from AIIMS’s dermatology department said skin diseases generate the highest number of health-related queries globally, yet nearly three billion people lack access to specialists. “There are countries with only two or three specialists,” he said. He pointed out that most datasets used to train AI models are skewed towards lighter skin tones, while a larger share of the global population has darker or Asian skin, reports Tribune India.
</p><p>To address this, his team is developing India-specific AI models in collaboration with partners, including Google Health, aimed at helping frontline healthcare workers identify and triage skin diseases more effectively.
</p><p>The ophthalmology department at AIIMS showcased an AI-powered system called MadhuNetraAI, designed to detect and grade diabetic retinopathy. The tool can be deployed in community settings and used by trained health workers to identify patients needing urgent referral.
</p><p>With a reported sensitivity of 98% and specificity of 96%, the system helps reduce unnecessary hospital visits while ensuring timely treatment for high-risk patients.</p><p>Experts also discussed public health issues, noting that tobacco warning labels have limited behavioural impact, while indirect advertising continues to influence consumption patterns in subtle ways.</p><p>The discussions are part of the ongoing ‘Photonics 4 Clinics’ workshop at AIIMS, which focuses on the use of light-based technologies combined with artificial intelligence to detect biological changes and improve clinical decision-making.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/worlds-best-hospitals-2026-medanta-aiims-delhi-pgi-chandigarh-cmc-vellore-in-global-top-250-97-indian-hospitals-ranked-165726"><b>Also Read:World's Best Hospitals 2026: Medanta, AIIMS Delhi, PGI Chandigarh, CMC Vellore in global top 250, 97 Indian hospitals ranked</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Cyber Fraud Case: Delhi Court Rejects Bail Plea of NEET Aspirant</title>
<link>https://edusehat.com/en/cyber-fraud-case-delhi-court-rejects-bail-plea-of-neet-aspirant</link>
<guid>https://edusehat.com/en/cyber-fraud-case-delhi-court-rejects-bail-plea-of-neet-aspirant</guid>
<description><![CDATA[ Granting no relief, a Delhi court has denied bail to an 18 year old NEET aspirant who was allegedly active in large scale organised cyber fraud.The court said that his role is not simply &quot;peripheral&quot; in light of the recovery of substantial proof against him.According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.For more details, check out the full story on the link below:NEET aspirant denied bail in cyber fraud case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340866-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-66.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Cyber, Fraud, Case:, Delhi, Court, Rejects, Bail, Plea, NEET, Aspirant</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340866-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-66.webp"><div class="pasted-from-word-wrapper"><p>Granting no relief, a Delhi court has denied bail to an 18 year old <a href="https://medicaldialogues.in/topics/NEET-aspirant">NEET aspirant</a> who was allegedly active in large scale organised <a href="https://medicaldialogues.in/topics/cyber-fraud">cyber fraud</a>.</p><p>The court said that his role is not simply "peripheral" in light of the recovery of substantial proof against him.</p><p>According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/state-news/delhi/neet-aspirant-denied-bail-in-cyber-fraud-case-168280"><i><b>NEET aspirant denied bail in cyber fraud case</b></i></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Fake Disability Certificates Row: 12 Booked in Shahjahanpur</title>
<link>https://edusehat.com/en/fake-disability-certificates-row-12-booked-in-shahjahanpur</link>
<guid>https://edusehat.com/en/fake-disability-certificates-row-12-booked-in-shahjahanpur</guid>
<description><![CDATA[ In a major fraud case in Uttar Pradesh’s Shahjahanpur, police have booked 12 health department employees for allegedly issuing fake disability certificates to 14 people without any medical examination. According to officials, the scam came to light after a complaint by a local resident, which led to an inquiry. The investigation revealed that individuals who were neither disabled nor examined were given certificates and identity cards through the official portal, allowing them to wrongly avail government benefits meant for persons with disabilities.Based on a complaint by the Chief Medical Officer’s office, an FIR has been registered under charges of cheating and the Prevention of Corruption Act, according to a PTI report.In a separate case, another FIR has been filed against 12 retired health department employees for allegedly siphoning off around ₹30 lakh using fake hospital bills for medical reimbursements. Police have started investigations in both cases and are working to identify the full extent of the fraud and those involved.
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340865-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-64.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fake, Disability, Certificates, Row:, Booked, Shahjahanpur</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340865-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-64.webp"><p>In a major fraud case in Uttar Pradesh’s Shahjahanpur, police have booked 12 health department employees for allegedly issuing fake disability certificates to 14 people without any medical examination. According to officials, the scam came to light after a complaint by a local resident, which led to an inquiry. The investigation revealed that individuals who were neither disabled nor examined were given certificates and identity cards through the official portal, allowing them to wrongly avail government benefits meant for persons with disabilities.</p><p>Based on a complaint by the Chief Medical Officer’s office, an FIR has been registered under charges of cheating and the Prevention of Corruption Act, according to a PTI report.</p><p>In a separate case, another FIR has been filed against 12 retired health department employees for allegedly siphoning off around ₹30 lakh using fake hospital bills for medical reimbursements. Police have started investigations in both cases and are working to identify the full extent of the fraud and those involved.
</p>]]> </content:encoded>
</item>

<item>
<title>Karnataka High Court Rules Compulsory MBBS Bond Service Does Not Amount to Forced Labour</title>
<link>https://edusehat.com/en/karnataka-high-court-rules-compulsory-mbbs-bond-service-does-not-amount-to-forced-labour</link>
<guid>https://edusehat.com/en/karnataka-high-court-rules-compulsory-mbbs-bond-service-does-not-amount-to-forced-labour</guid>
<description><![CDATA[ In the matter of MBBS bond service, the Karnataka High Court recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.It noted that MBBS students who agreed to compulsory service bonds at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.For more details, check out the full story on the link below:Medicos cannot challenge bond service after availing subsidised MBBS education: Karnataka HC ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340851-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-63.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Karnataka, High, Court, Rules, Compulsory, MBBS, Bond, Service, Does, Not, Amount, Forced, Labour</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340851-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-63.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p>In the matter of MBBS bond service, the <a href="https://medicaldialogues.in/topics/karnataka-high-court" target="_blank">Karnataka High Court</a> recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.</p><p>It noted that MBBS students who agreed to compulsory <a href="https://medicaldialogues.in/topics/service-bond" target="_blank">service bonds</a> at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/medicos-cannot-challenge-bond-service-after-availing-subsidised-mbbs-education-karnataka-hc-168314"><b><i>Medicos cannot challenge bond service after availing subsidised MBBS education: Karnataka HC</i></b></a></p></div><div class="pasted-from-word-wrapper"></div>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 10/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-10april2026</link>
<guid>https://edusehat.com/en/health-bulletin-10april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:Karnataka High Court Rules Compulsory MBBS Bond Service Does Not Amount to Forced LabourIn the matter of MBBS bond service, the Karnataka High Court recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.It noted that MBBS students who agreed to compulsory service bonds at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.For more details, check out the full story on the link below:Medicos cannot challenge bond service after availing subsidised MBBS education: Karnataka HCFake Disability Certificates Row: 12 Booked in ShahjahanpurIn a major fraud case in Uttar Pradesh’s Shahjahanpur, police have booked 12 health department employees for allegedly issuing fake disability certificates to 14 people without any medical examination. According to officials, the scam came to light after a complaint by a local resident, which led to an inquiry. The investigation revealed that individuals who were neither disabled nor examined were given certificates and identity cards through the official portal, allowing them to wrongly avail government benefits meant for persons with disabilities.Based on a complaint by the Chief Medical Officer’s office, an FIR has been registered under charges of cheating and the Prevention of Corruption Act, according to a PTI report.In a separate case, another FIR has been filed against 12 retired health department employees for allegedly siphoning off around ₹30 lakh using fake hospital bills for medical reimbursements. Police have started investigations in both cases and are working to identify the full extent of the fraud and those involved.Cyber Fraud Case: Delhi Court Rejects Bail Plea of NEET AspirantGranting no relief, a Delhi court has denied bail to an 18 year old NEET aspirant who was allegedly active in large scale organised cyber fraud.The court said that his role is not simply &quot;peripheral&quot; in light of the recovery of substantial proof against him.According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.For more details, check out the full story on the link below:NEET aspirant denied bail in cyber fraud case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340868-health-bulletin-11.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 10April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340868-health-bulletin-11.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>Karnataka High Court Rules Compulsory MBBS Bond Service Does Not Amount to Forced Labour</b></p><p>In the matter of MBBS bond service, the <a href="https://medicaldialogues.in/topics/karnataka-high-court" target="_blank">Karnataka High Court</a> recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.</p><div class="pasted-from-word-wrapper"><div><p>It noted that MBBS students who agreed to compulsory <a href="https://medicaldialogues.in/topics/service-bond" target="_blank">service bonds</a> at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/medicos-cannot-challenge-bond-service-after-availing-subsidised-mbbs-education-karnataka-hc-168314"><i><b>Medicos cannot challenge bond service after availing subsidised MBBS education: Karnataka HC</b></i></a></p></div></div><p><b></b></p><p><b>Fake Disability Certificates Row: 12 Booked in Shahjahanpur</b></p><p>In a major fraud case in Uttar Pradesh’s Shahjahanpur, police have booked 12 health department employees for allegedly issuing fake disability certificates to 14 people without any medical examination. According to officials, the scam came to light after a complaint by a local resident, which led to an inquiry. The investigation revealed that individuals who were neither disabled nor examined were given certificates and identity cards through the official portal, allowing them to wrongly avail government benefits meant for persons with disabilities.</p><p>Based on a complaint by the Chief Medical Officer’s office, an FIR has been registered under charges of cheating and the Prevention of Corruption Act, according to a PTI report.</p><p>In a separate case, another FIR has been filed against 12 retired health department employees for allegedly siphoning off around ₹30 lakh using fake hospital bills for medical reimbursements. Police have started investigations in both cases and are working to identify the full extent of the fraud and those involved.</p><p><b></b></p><p><b>Cyber Fraud Case: Delhi Court Rejects Bail Plea of NEET Aspirant</b></p><div class="pasted-from-word-wrapper"><p>Granting no relief, a Delhi court has denied bail to an 18 year old <a href="https://medicaldialogues.in/topics/NEET-aspirant">NEET aspirant</a> who was allegedly active in large scale organised <a href="https://medicaldialogues.in/topics/cyber-fraud">cyber fraud</a>.</p><p>The court said that his role is not simply "peripheral" in light of the recovery of substantial proof against him.</p><p>According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/state-news/delhi/neet-aspirant-denied-bail-in-cyber-fraud-case-168280"><i><b>NEET aspirant denied bail in cyber fraud case</b></i></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Kanpur illegal Kidney transplant racket spans 9 hospitals across 4 cities</title>
<link>https://edusehat.com/en/kanpur-illegal-kidney-transplant-racket-spans-9-hospitals-across-4-cities</link>
<guid>https://edusehat.com/en/kanpur-illegal-kidney-transplant-racket-spans-9-hospitals-across-4-cities</guid>
<description><![CDATA[ Kanpur: As authorities dig deeper into a major illegal kidney transplant racket, shocking details have emerged from a Private Hospital, revealing a well-organised network that allegedly operated across nine hospitals in four cities of Uttar Pradesh. Investigators said that more than 50 illegal kidney transplants were conducted, with patients charged between Rs 50 lakh and Rs 2.5 crore per procedure. The case came to light after a Bihar-based victim complained that he was underpaid after donating his kidney. Acting on the complaint, police launched a detailed investigation, which soon exposed a wider interstate network involving agents, doctors, technicians, and hospital administrators.Also Read:Kanpur Kidney Racket: Recovered audio reveals operations across UPInvestigators allege that the network targeted poor and vulnerable individuals through social media and messaging platforms, offering Rs 5–10 lakh for kidney donations. The surgeries were reportedly carried out in extreme secrecy, often between 3 am and 4 am, with hospital staff kept away and CCTV cameras switched off to avoid detection. According to police sources, teams associated with the racket travelled by air to Kanpur, performed the surgeries, collected payments, and left immediately using different routes to avoid identification. The operations were described as highly coordinated and clinically precise.
Police sources further stated that the probe has expanded across multiple cities, including Delhi, Ghaziabad, Noida, and Meerut, to trace absconding suspects. Authorities are examining financial records, hospital documentation, and communication data linked to the network.
Investigators have also reportedly recovered a crucial audio recording from the mobile phone of the alleged mastermind, which is believed to provide insight into the gang’s operations.
Medical dialogues had previously reported that following a breakthrough in the Kanpur kidney transplant scam, police have recovered a crucial audio recording from the mobile phone of the alleged mastermind, shedding light on the gang’s operations and its network across multiple cities in Uttar Pradesh.
“Of the total 15 accused, nine have been arrested so far. This includes doctors, hospital owners, and administrative personnel,&quot; said a police officer. Six suspects, among them several doctors, are still on the run, reports TNIE.
The case has raised serious concerns about regulatory failures in monitoring private healthcare institutions and the alleged involvement of trained medical professionals in illegal organ trade. 
Police are continuing raids to arrest absconding accused and trace financial links. Authorities are also examining whether more hospitals and medical professionals were involved, reports Bhaskar English.
Also Read:Meerut Hospital under probe for alleged links to kidney transplant racket ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/24/270925-kidney-transplantation-racket.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 20:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kanpur, illegal, Kidney, transplant, racket, spans, hospitals, across, cities</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/24/270925-kidney-transplantation-racket.webp"><p><b>Kanpur:</b> As authorities dig deeper into a major illegal <a href="https://medicaldialogues.in/topics/kidney-transplant-racket">kidney transplant racket</a>, shocking details have emerged from a<a href="https://medicaldialogues.in/topics/private-hospital"> Private Hospital</a>, revealing a well-organised network that allegedly operated across nine hospitals in four cities of <a href="https://medicaldialogues.in/state-news/uttar-pradesh">Uttar Pradesh</a>. Investigators said that more than 50 illegal kidney transplants were conducted, with patients charged between Rs 50 lakh and Rs 2.5 crore per procedure. </p><p>The case came to light after a <a href="https://medicaldialogues.in/state-news/bihar">Bihar</a>-based victim complained that he was underpaid after donating his kidney. Acting on the complaint, police launched a detailed investigation, which soon exposed a wider interstate network involving agents, doctors, technicians, and hospital administrators.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/kanpur-kidney-racket-recovered-audio-reveals-operations-across-up-168059"><b>Also Read:Kanpur Kidney Racket: Recovered audio reveals operations across UP</b></a></p><p>Investigators allege that the network targeted poor and vulnerable individuals through social media and messaging platforms, offering Rs 5–10 lakh for kidney donations. The surgeries were reportedly carried out in extreme secrecy, often between 3 am and 4 am, with hospital staff kept away and CCTV cameras switched off to avoid detection. </p><p>According to police sources, teams associated with the racket travelled by air to Kanpur, performed the surgeries, collected payments, and left immediately using different routes to avoid identification. The operations were described as highly coordinated and clinically precise.
</p><p>Police sources further stated that the probe has expanded across multiple cities, including Delhi, Ghaziabad, Noida, and Meerut, to trace absconding suspects. Authorities are examining financial records, hospital documentation, and communication data linked to the network.
</p><p>Investigators have also reportedly recovered a crucial audio recording from the mobile phone of the alleged mastermind, which is believed to provide insight into the gang’s operations.
</p><p>Medical dialogues had previously reported that following a breakthrough in the Kanpur kidney transplant scam, police have recovered a crucial audio recording from the mobile phone of the alleged mastermind, shedding light on the gang’s operations and its network across multiple cities in Uttar Pradesh.
</p><p>“Of the total 15 accused, nine have been arrested so far. This includes doctors, hospital owners, and administrative personnel," said a police officer. Six suspects, among them several doctors, are still on the run, reports <a href="https://www.newindianexpress.com/states/uttar-pradesh/2026/Apr/09/midnight-flying-surgeons-ran-covert-kidney-transplant-racket-across-four-up-cities-nine-arrestedhttps://www.newindianexpress.com/states/uttar-pradesh/2026/Apr/09/midnight-flying-surgeons-ran-covert-kidney-transplant-racket-across-four-up-cities-nine-arrested" rel="nofollow">TNIE</a>.
</p><p>The case has raised serious concerns about regulatory failures in monitoring private healthcare institutions and the alleged involvement of trained medical professionals in illegal organ trade. 
</p><p>Police are continuing raids to arrest absconding accused and trace financial links. Authorities are also examining whether more hospitals and medical professionals were involved, reports <a href="https://www.bhaskarenglish.in/local/uttar-pradesh/news/kanpur-kidney-racket-dr-rohit-dr-ahuja-operation-uttar-pradesh-137650635.html" rel="nofollow">Bhaskar English</a>.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/meerut-hospital-under-probe-for-alleged-links-to-kidney-transplant-racket-167891"><b>Also Read:Meerut Hospital under probe for alleged links to kidney transplant racket</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Pre&#45;pregnancy parental obesity linked to next generation&amp;apos;s heightened fatty liver disease risk: Study</title>
<link>https://edusehat.com/en/pre-pregnancy-parental-obesity-linked-to-next-generations-heightened-fatty-liver-disease-risk-study-9580</link>
<guid>https://edusehat.com/en/pre-pregnancy-parental-obesity-linked-to-next-generations-heightened-fatty-liver-disease-risk-study-9580</guid>
<description><![CDATA[ Pre-pregnancy parental overweight and obesity is linked to the next generation&#039;s heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.
If both parents are overweight or obese before they conceive, that child’s subsequent odds of developing MASLD by the age of 24 are more than 3 times higher, most of which is influenced by cumulative excess weight (BMI) during childhood, the findings indicate.
Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction associated steatotic liver disease, or MASLD for short, is the most common chronic liver disease worldwide, affecting an estimated 15% of children and more than 30% of adults, note the researchers.
Previously published research has emphasised the role of maternal obesity in future generations’ MASLD risk, but it’s not clear what role paternal obesity might have and if childhood overweight might also influence this risk.
To find out, the researchers assessed the associations between parental weight (BMI) before pregnancy and the odds of developing MASLD by the age of 24 in 1933 children from the UK Avon Longitudinal Study of Parents and Children (ALSPAC).
MASLD was defined as high levels of fat in the liver and at least 1 cardiometabolic risk factor, such as high cholesterol or high fasting glucose.
Both parents provided information on height, weight, calculated BMI and waist circumference, and they completed regular questionnaires on potentially influential health and lifestyle factors throughout pregnancy and after the birth.
These included information on age at delivery, smoking during the first 3 months of pregnancy, typical weekly alcohol consumption before pregnancy, employment status, and educational attainment.
The mums also reported their physical activity levels and whether they had ever been diagnosed with diabetes or high blood pressure at the time of study enrolment.
Information on the children included early life factors: sex; mode of delivery; gestational age and birthweight; antibiotic exposure within the first 6 months of life; and length of breastfeeding.
And it included repeated measures of BMI and waist circumference when they were aged 7–9, 10–12, and 13–17, plus alcohol and tobacco use as a young adult.
By the age of 24, one in 10 of these children (201) had MASLD; the other 1732 had a normal liver. Those with MASLD were more likely to be male and to have a higher BMI.
Maternal and paternal overweight and obesity were independently associated with increased odds of their children subsequently developing MASLD, after accounting for potentially influential factors.
Each additional kg of maternal BMI increased the odds of MASLD by 10%, while the equivalent increase in paternal BMI raised the odds by 9%.
Overweight or obesity in both parents was associated with more than 3 times the odds of their child developing MASLD as a young adult compared with those whose parents had a normal pre-pregnancy BMI.
Two thirds (67%) of this association was influenced by cumulative excess BMI between the ages of 7 and 17.
Further analysis, accounting for mothers’ and children’s sugar consumption, plus genetic predisposition to MASLD, generated similar findings.
This is an observational study, and as such, no firm conclusions can be drawn about cause and effect, added to which the researchers acknowledge various limitations to their findings.References: Tica, Stefani and Luo, Chongliang and Ren, Duo and Zong, Xiaoyu and Thompson, Michael D and Stoll, Janis and DeBosch, Brian Jesse and Tarr, Phillip I and Cao, Yin, Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study Gut Published Online First: 24 February 2026. doi: 10.1136/gutjnl-2025-336165 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/25/329520-education-2026-02-25t113218767.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pre-pregnancy, parental, obesity, linked, next, generations, heightened, fatty, liver, disease, risk:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/25/329520-education-2026-02-25t113218767.webp"><p>Pre-pregnancy parental overweight and <a href="https://medicaldialogues.in/topics/obesity">obesity</a> is linked to the next generation's heightened risk of developing <a href="https://medicaldialogues.in/topics/fatty-liver">fatty liver</a> disease, a potential precursor to <a href="https://medicaldialogues.in/topics/cirrhosis">cirrhosis</a> and liver failure, suggests research published online in the journal <i>Gut</i>.
</p><p>If both parents are overweight or obese before they conceive, that child’s subsequent odds of developing <a href="https://medicaldialogues.in/topics/MASLD">MASLD</a> by the age of 24 are more than 3 times higher, most of which is influenced by cumulative excess weight (BMI) during childhood, the findings indicate.
</p><p>Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction associated steatotic liver disease, or MASLD for short, is the most common chronic liver disease worldwide, affecting an estimated 15% of children and more than 30% of adults, note the researchers.
</p><p>Previously published research has emphasised the role of maternal obesity in future generations’ MASLD risk, but it’s not clear what role paternal obesity might have and if childhood overweight might also influence this risk.
</p><p>To find out, the researchers assessed the associations between parental weight (BMI) before pregnancy and the odds of developing MASLD by the age of 24 in 1933 children from the UK Avon Longitudinal Study of Parents and Children (ALSPAC).
</p><p>MASLD was defined as high levels of fat in the liver and at least 1 cardiometabolic risk factor, such as high cholesterol or high fasting glucose.
</p><p>Both parents provided information on height, weight, calculated BMI and waist circumference, and they completed regular questionnaires on potentially influential health and lifestyle factors throughout pregnancy and after the birth.
</p><p>These included information on age at delivery, smoking during the first 3 months of pregnancy, typical weekly alcohol consumption before pregnancy, employment status, and educational attainment.
</p><p>The mums also reported their physical activity levels and whether they had ever been diagnosed with diabetes or high blood pressure at the time of study enrolment.
</p><p>Information on the children included early life factors: sex; mode of delivery; gestational age and birthweight; antibiotic exposure within the first 6 months of life; and length of breastfeeding.
</p><p>And it included repeated measures of BMI and waist circumference when they were aged 7–9, 10–12, and 13–17, plus alcohol and tobacco use as a young adult.
</p><p>By the age of 24, one in 10 of these children (201) had MASLD; the other 1732 had a normal liver. Those with MASLD were more likely to be male and to have a higher BMI.
</p><p>Maternal and paternal overweight and obesity were independently associated with increased odds of their children subsequently developing MASLD, after accounting for potentially influential factors.
</p><p>Each additional kg of maternal BMI increased the odds of MASLD by 10%, while the equivalent increase in paternal BMI raised the odds by 9%.
</p><p>Overweight or obesity in both parents was associated with more than 3 times the odds of their child developing MASLD as a young adult compared with those whose parents had a normal pre-pregnancy BMI.
</p><p>Two thirds (67%) of this association was influenced by cumulative excess BMI between the ages of 7 and 17.
</p><p>Further analysis, accounting for mothers’ and children’s sugar consumption, plus genetic predisposition to MASLD, generated similar findings.
</p><p>This is an observational study, and as such, no firm conclusions can be drawn about cause and effect, added to which the researchers acknowledge various limitations to their findings.</p><p><b>References: </b>Tica, Stefani and Luo, Chongliang and Ren, Duo and Zong, Xiaoyu and Thompson, Michael D and Stoll, Janis and DeBosch, Brian Jesse and Tarr, Phillip I and Cao, Yin, Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study Gut Published Online First: 24 February 2026. doi: 10.1136/gutjnl-2025-336165</p>]]> </content:encoded>
</item>

<item>
<title>Even Occasional Binge Drinking Linked to Higher Risk of Liver Damage: Study</title>
<link>https://edusehat.com/en/even-occasional-binge-drinking-linked-to-higher-risk-of-liver-damage-study</link>
<guid>https://edusehat.com/en/even-occasional-binge-drinking-linked-to-higher-risk-of-liver-damage-study</guid>
<description><![CDATA[ That occasional &quot;weekend binge&quot; may be doing far more harm to your liver than you think. 
A new study from Keck Medicine of USC, published in Clinical Gastroenterology and Hepatology, challenges a common belief about alcohol consumption: that occasional binge drinking is harmless if overall intake is moderate. The findings show that even infrequent episodes of heavy drinking can significantly increase the risk of serious liver damage—especially in people with underlying metabolic conditions.
The research focused on individuals with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting roughly one in three adults and commonly linked to obesity, Type 2 diabetes, and high cholesterol. Using data from over 8,000 participants in the National Health and Nutrition Examination Survey (2017–2023), researchers examined how drinking patterns—not just total alcohol intake—affect liver health.
Episodic heavy drinking, defined as consuming four or more drinks for women or five or more for men in a single day at least once a month, was associated with a nearly threefold increase in the risk of advanced liver fibrosis. Fibrosis refers to the buildup of scar tissue in the liver, which can impair function and lead to long-term complications.
Importantly, this elevated risk was observed even when total weekly alcohol consumption was similar. In other words, spreading alcohol intake across multiple days appeared far less harmful than consuming the same amount in a single session. Younger adults and men were more likely to engage in such binge patterns, and higher quantities per occasion were linked to more severe liver damage.
The findings suggest that the liver may be overwhelmed by large, concentrated doses of alcohol, triggering inflammation and accelerating scarring. For individuals with MASLD, whose livers are already vulnerable, this effect can be particularly damaging.
Overall, the study highlights the need to rethink how alcohol-related risks are assessed. It is not just how much you drink, but how you drink that matters. Avoiding binge patterns may be a crucial step in protecting long-term liver health.
REFERENCE: Yinan Su, Jennifer L. Dodge, Brian P. Lee. Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study. Clinical Gastroenterology and Hepatology, 2026; DOI: 10.1016/j.cgh.2026.03.004
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340805-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-62.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Even, Occasional, Binge, Drinking, Linked, Higher, Risk, Liver, Damage:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340805-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-62.webp"><p>That occasional "weekend binge" may be doing far more harm to your liver than you think. 
</p><p>A new study from Keck Medicine of USC, published in<i> Clinical Gastroenterology and Hepatology, </i>challenges a common belief about alcohol consumption: that occasional binge drinking is harmless if overall intake is moderate. The findings show that even infrequent episodes of heavy drinking can significantly increase the risk of serious liver damage—especially in people with underlying metabolic conditions.
</p><p>The research focused on individuals with metabolic dysfunction–associated steatotic liver disease (MASLD), a condition affecting roughly one in three adults and commonly linked to obesity, Type 2 diabetes, and high cholesterol. Using data from over 8,000 participants in the National Health and Nutrition Examination Survey (2017–2023), researchers examined how drinking patterns—not just total alcohol intake—affect liver health.
</p><p>Episodic heavy drinking, defined as consuming four or more drinks for women or five or more for men in a single day at least once a month, was associated with a nearly threefold increase in the risk of advanced liver fibrosis. Fibrosis refers to the buildup of scar tissue in the liver, which can impair function and lead to long-term complications.
</p><p>Importantly, this elevated risk was observed even when total weekly alcohol consumption was similar. In other words, spreading alcohol intake across multiple days appeared far less harmful than consuming the same amount in a single session. Younger adults and men were more likely to engage in such binge patterns, and higher quantities per occasion were linked to more severe liver damage.
</p><p>The findings suggest that the liver may be overwhelmed by large, concentrated doses of alcohol, triggering inflammation and accelerating scarring. For individuals with MASLD, whose livers are already vulnerable, this effect can be particularly damaging.
</p><p>Overall, the study highlights the need to rethink how alcohol-related risks are assessed. It is not just how much you drink, but how you drink that matters. Avoiding binge patterns may be a crucial step in protecting long-term liver health.
</p><p><b>REFERENCE: </b>Yinan Su, Jennifer L. Dodge, Brian P. Lee. Episodic Heavy Drinking and Implications for Steatotic Liver Disease Nomenclature: A National Cross-Sectional Study. Clinical Gastroenterology and Hepatology, 2026; DOI: 10.1016/j.cgh.2026.03.004
</p>]]> </content:encoded>
</item>

<item>
<title>Study Explores Whether Midlife Vitamin D Levels May Protect Against Early Alzheimer&amp;apos;s Risk</title>
<link>https://edusehat.com/en/study-explores-whether-midlife-vitamin-d-levels-may-protect-against-early-alzheimers-risk</link>
<guid>https://edusehat.com/en/study-explores-whether-midlife-vitamin-d-levels-may-protect-against-early-alzheimers-risk</guid>
<description><![CDATA[ Could your vitamin D levels in your 30s shape your brain health decades later?A new study published in the Neurology journal suggests that vitamin D levels in early midlife may play a role in shaping future brain health and dementia risk. While previous research has linked low vitamin D in older adults to cognitive decline, this study shifts the focus earlier in life—when preventive strategies may be more effective. Researchers analyzed data from 793 dementia-free participants in the Framingham Heart Study Generation 3 cohort. Vitamin D levels were measured at an average age of 39, and participants later underwent advanced brain scans (PET imaging) roughly 16 years afterward to detect early markers of Alzheimer’s disease, including amyloid and tau protein buildup.
The findings revealed that individuals with higher circulating vitamin D levels in early midlife had lower levels of tau deposition in the brain. Tau accumulation is considered a key early marker of Alzheimer’s disease and is closely linked to cognitive decline. Interestingly, no association was found between vitamin D levels and amyloid buildup, another hallmark of the disease.
The relationship remained significant even after adjusting for multiple factors such as age, lifestyle, and vascular health. Exploratory analyses also hinted at a dose-response effect, with the highest vitamin D levels linked to the lowest tau burden, though these results require further confirmation.
Biologically, vitamin D supports brain health through several mechanisms. It helps regulate inflammation, enhances antioxidant defenses, and supports neuronal function. It may also reduce abnormal tau phosphorylation, a process that contributes to toxic protein buildup in the brain.
Despite these promising findings, the study is observational and does not prove causation. Limitations include a largely homogeneous population and lack of repeated vitamin D measurements over time.
Overall, the research highlights vitamin D as a potentially modifiable factor in early dementia prevention. Maintaining adequate levels in midlife—through safe sun exposure, diet, or supplementation—could support long-term brain health, though further clinical trials are needed to confirm its protective role.
REFERENCE: Mulligan, M. D., Scott, M. R., Yang, Q., et al. (2026). Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology. DOI: https://doi.org/10.1212/WN9.0000000000000057. https://www.neurology.org/doi/pdf/10.1212/WN9.0000000000000057
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340801-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-61.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Explores, Whether, Midlife, Vitamin, Levels, May, Protect, Against, Early, Alzheimers, Risk</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340801-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-61.webp"><p>Could your vitamin D levels in your 30s shape your brain health decades later?</p><p>A new study published in the <i>Neurology </i>journal suggests that vitamin D levels in early midlife may play a role in shaping future brain health and dementia risk. While previous research has linked low vitamin D in older adults to cognitive decline, this study shifts the focus earlier in life—when preventive strategies may be more effective. </p><p>Researchers analyzed data from 793 dementia-free participants in the Framingham Heart Study Generation 3 cohort. Vitamin D levels were measured at an average age of 39, and participants later underwent advanced brain scans (PET imaging) roughly 16 years afterward to detect early markers of Alzheimer’s disease, including amyloid and tau protein buildup.
</p><p>The findings revealed that individuals with higher circulating vitamin D levels in early midlife had lower levels of tau deposition in the brain. Tau accumulation is considered a key early marker of Alzheimer’s disease and is closely linked to cognitive decline. Interestingly, no association was found between vitamin D levels and amyloid buildup, another hallmark of the disease.
</p><p>The relationship remained significant even after adjusting for multiple factors such as age, lifestyle, and vascular health. Exploratory analyses also hinted at a dose-response effect, with the highest vitamin D levels linked to the lowest tau burden, though these results require further confirmation.
</p><p>Biologically, vitamin D supports brain health through several mechanisms. It helps regulate inflammation, enhances antioxidant defenses, and supports neuronal function. It may also reduce abnormal tau phosphorylation, a process that contributes to toxic protein buildup in the brain.
</p><p>Despite these promising findings, the study is observational and does not prove causation. Limitations include a largely homogeneous population and lack of repeated vitamin D measurements over time.
</p><p>Overall, the research highlights vitamin D as a potentially modifiable factor in early dementia prevention. Maintaining adequate levels in midlife—through safe sun exposure, diet, or supplementation—could support long-term brain health, though further clinical trials are needed to confirm its protective role.
</p><p><b>REFERENCE:</b> Mulligan, M. D., Scott, M. R., Yang, Q., et al. (2026). Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology. DOI: https://doi.org/10.1212/WN9.0000000000000057. https://www.neurology.org/doi/pdf/10.1212/WN9.0000000000000057
</p>]]> </content:encoded>
</item>

<item>
<title>Breakthrough Male Contraceptive May Temporarily Stop Sperm Production: Research Shows</title>
<link>https://edusehat.com/en/breakthrough-male-contraceptive-may-temporarily-stop-sperm-production-research-shows</link>
<guid>https://edusehat.com/en/breakthrough-male-contraceptive-may-temporarily-stop-sperm-production-research-shows</guid>
<description><![CDATA[ A birth control breakthrough for men may finally be on the horizon.
Researchers at Cornell University have made a significant breakthrough in the search for a safe, reversible, and long-acting nonhormonal male contraceptive—an innovation long considered the “holy grail” of reproductive health. In a proof-of-principle study conducted in mice and published in Proceedings of the National Academy of Sciences, scientists demonstrated that temporarily interrupting a critical step in sperm production can effectively halt fertility without causing permanent damage.
The team focused on meiosis, the specialized cell division process that produces sperm. Using a small molecule called JQ1 inhibitor, originally developed for cancer research, they disrupted a key stage known as prophase 1. This intervention caused developing sperm cells to stop maturing, effectively shutting down sperm production during treatment.
Importantly, the effect was reversible. Male mice received JQ1 for three weeks, after which sperm production ceased entirely. However, within six weeks of stopping the treatment, normal sperm development resumed. The mice were able to reproduce successfully, and their offspring were healthy, indicating no lasting genetic or reproductive harm.
Unlike hormonal approaches, which can carry side effects and affect broader physiological systems, this method targets the testis directly while preserving spermatogonial stem cells—the foundation of long-term fertility. This ensures that fertility can be restored once treatment stops, addressing a major concern in male contraception research.
Currently, male contraceptive options are limited to condoms and vasectomy, the latter often seen as permanent despite possible reversals. A nonhormonal, reversible method could dramatically expand choices and shift the burden of contraception more evenly.
While JQ1 itself is not suitable for human use due to potential neurological side effects, the study provides a crucial roadmap for developing safer alternatives. Future versions could be delivered as periodic injections or patches, offering men a reliable and convenient contraceptive option.
REFERENCE: Stephanie Tanis, Leah E. Simon, Adriana K. Alexander, Tegan S. Horan, Maria de las Mercedes Carro, Samantha Jane Bonnett, Audrey Xie, Roni Ben-Shlomo, Connor E. Owens, Charles G. Danko, Jelena Lujic, Paula E. Cohen. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1. Proceedings of the National Academy of Sciences, 2026; 123 (15) DOI: 10.1073/pnas.2517498123
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340794-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-60.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Breakthrough, Male, Contraceptive, May, Temporarily, Stop, Sperm, Production:, Research, Shows</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340794-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-60.webp"><p>A birth control breakthrough for men may finally be on the horizon.
</p><p>Researchers at Cornell University have made a significant breakthrough in the search for a safe, reversible, and long-acting nonhormonal male contraceptive—an innovation long considered the “holy grail” of reproductive health. In a proof-of-principle study conducted in mice and published in <i>Proceedings of the National Academy of Sciences, </i>scientists demonstrated that temporarily interrupting a critical step in sperm production can effectively halt fertility without causing permanent damage.
</p><p>The team focused on meiosis, the specialized cell division process that produces sperm. Using a small molecule called JQ1 inhibitor, originally developed for cancer research, they disrupted a key stage known as prophase 1. This intervention caused developing sperm cells to stop maturing, effectively shutting down sperm production during treatment.
</p><p>Importantly, the effect was reversible. Male mice received JQ1 for three weeks, after which sperm production ceased entirely. However, within six weeks of stopping the treatment, normal sperm development resumed. The mice were able to reproduce successfully, and their offspring were healthy, indicating no lasting genetic or reproductive harm.
</p><p>Unlike hormonal approaches, which can carry side effects and affect broader physiological systems, this method targets the testis directly while preserving spermatogonial stem cells—the foundation of long-term fertility. This ensures that fertility can be restored once treatment stops, addressing a major concern in male contraception research.
</p><p>Currently, male contraceptive options are limited to condoms and vasectomy, the latter often seen as permanent despite possible reversals. A nonhormonal, reversible method could dramatically expand choices and shift the burden of contraception more evenly.
</p><p>While JQ1 itself is not suitable for human use due to potential neurological side effects, the study provides a crucial roadmap for developing safer alternatives. Future versions could be delivered as periodic injections or patches, offering men a reliable and convenient contraceptive option.
</p><p><b>REFERENCE:</b> Stephanie Tanis, Leah E. Simon, Adriana K. Alexander, Tegan S. Horan, Maria de las Mercedes Carro, Samantha Jane Bonnett, Audrey Xie, Roni Ben-Shlomo, Connor E. Owens, Charles G. Danko, Jelena Lujic, Paula E. Cohen. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1. Proceedings of the National Academy of Sciences, 2026; 123 (15) DOI: 10.1073/pnas.2517498123
</p>]]> </content:encoded>
</item>

<item>
<title>Misrepresentation as MD Radiodiagnosis, no valid registration: Telangana medical council bars doctor for 2 years, censures another</title>
<link>https://edusehat.com/en/misrepresentation-as-md-radiodiagnosis-no-valid-registration-telangana-medical-council-bars-doctor-for-2-years-censures-another</link>
<guid>https://edusehat.com/en/misrepresentation-as-md-radiodiagnosis-no-valid-registration-telangana-medical-council-bars-doctor-for-2-years-censures-another</guid>
<description><![CDATA[ Hyderabad: Taking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the Telangana Medical Council has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.On the other hand, Dr Ali was found to have been practising without a valid Telangana Medical Council registration.An order issued by the council mentioned that the case surfaced after the Chairman took suo motu cognisance and constituted an inspection team comprising Dr. V. Naresh Kumar (TGMC Member), Dr. Rajeev Naik, and Dr. Arundathi (Co-opted members) to examine alleged unethical practices in clinics and diagnostic centres across Suryapet and Nalgonda districts, including involvement of unqualified practitioners and non-modern system doctors prescribing allopathic drugs. Acting on credible inputs, the team inspected Apple Scan Centre, Suryapet, on April 24, 2025.Also read- Telangana Medical Council cracks down on 8 eye clinics, technicians performing surgeriesFake Qualification, Expired RegistrationDuring the inspection, the doctor was found practising as a Consultant Radiologist without holding a recognised postgraduate qualification in Radiodiagnosis and with an expired registration, which had lapsed on March 26, 2022 at the Suryapet diagnosis centre. As per the order, the Council noted that he had been using the title “MD (Radio Diagnosis)” and presenting himself as a Consultant Radiologist in hospital signage, name boards, and reports, despite not possessing a recognised qualification approved by the National Medical Commission.It was also found that his registration with the Telangana Medical Council had expired on March 26, 2022, and had not been renewed. A photocopy of the registration certificate allegedly in his name was submitted during inspection, which was found to be fabricated upon verification.Based on this, the Council issued show-cause notices dated 26.04.2025 to him seeking explanations. In response to the notice, the doctor submitted his explanation. He admitted that he was practising as a Consultant Sonologist under the provisions of PCPNDT Rule 3(3)(1)(b), that he had applied for renewal of registration on 10.10.2023, and that he was not aware of any fabricated certificate allegedly submitted during inspection.After considering his explanations, notices were issued to the doctor directing him to appear before the Ethics Committee on 12.07.2025, 27.09.2025, and 29.11.2025. He was charged with violation of Regulation 7.20 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, submission of a fabricated certificate and for alleged infamous conduct in a professional respectDuring proceedings, the doctor admitted that he had displayed &quot;MD (Radio Diagnosis)&quot; and falsely described himself as a Consultant Radiologist on the name board, hospital signage and scanning reports issued to patients. He further admitted that he does not possess a recognised MD (Radio Diagnosis) qualification and that the qualification relied upon by him is not recognised by the National Medical Commission.When confronted with the forged registration certificate purportedly issued by the Maharashtra Medical Council, he stated that although the signature appeared to be his, the certificate might have been submitted by hospital staff. He reportedly failed to submit documents as directed by the Committee.Practising without valid registrationMeanwhile, a doctor was found working as a Consultant Radiologist without valid registration with the Telangana Medical Council at the Suryapet diagnosis centre. He later admitted that he was unaware of the requirement for separate registration with the Telangana Medical Council and sought leniency, stating that he had obtained a No Objection Certificate from his parent State Medical Council.He was charged of violation of Regulation 1.1.3 of the said Regulations, for practicing without valid medical council registration, submission of fabricated certificate, and for alleged infamous conduct in a professional respect.Appearing before the Ethics Committee after being issued notice, he admitted violation of Regulation 1.1.3 and further admitted that he submitted the fabricated registration certificate of concerned sonologist to the inspection team on 24.04.2025.Final decisionAfter examining the oral submissions, documentary evidence, and relevant provisions of the Telangana Medical Practitioners Registration Act, 1968 and the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, the Ethics Committee recommended removal of the name of the sonologist from the Medical Register of the Council for a period of two (2) years under Sections 15(4) and 17 of the Telangana Medical Practitioners Registration Act, 1968 and Regulation 8.2 of the Indian Medical Council Regulations, 2002 and recommended that the other doctor be censured under the aforesaid statutory provisions.&quot;The recommendations of the Ethics Committee were placed before the General Body of the Council. After detailed deliberation, the General Body unanimously approved the recommendations. Accordingly, in exercise of powers under Section 17(2) r/w Section 15(4) of the Telangana Medical Practitioners Registration Act, 1968 and Regulation 8.2 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, the name of Dr Soma (Reg. No. ***) is hereby removed from the Medical Register of the Telangana Medical Council for a period of two (2) years with effect from the date of receipt of this order.  Dr Soma is directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten (10) days from the date of receipt of this order, failing which his name shall be permanently removed from the Medical Register of the Council. Dr Ali (Reg. No. ***) is hereby censured,&quot; mentioned the order. It further mentioned, &quot;Both practitioners are informed that they may prefer an appeal before the National Medical Commission within sixty (60) days from the date of receipt of this order under Regulation 8.8 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 and Section 30(3) of the National Medical Commission Act, 2019.&quot;Also read- Doctors seek medical council action against Telangana pathologist for signing lab reports in Maharashtra sans registration ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/06/19/291307-doctors-8.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Misrepresentation, Radiodiagnosis, valid, registration:, Telangana, medical, council, bars, doctor, for, years, censures, another</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/06/19/291307-doctors-8.webp"><p><b>Hyderabad:</b> Taking note of alleged unethical practices, professional misconduct, use of fake medical qualifications, and expired registration certificates, the <a href="https://medicaldialogues.in/topics/telangana-medical-council" target="_blank">Telangana Medical Council </a>has removed the name of a doctor from its medical register for two years and censured another for their alleged illegal practices at a diagnostic centre in Suryapet.</p><p>The Council found that Dr Soma, a registered sonologist, was practising as a Consultant Radiologist with a fake MD degree and with an expired registration since March 26, 2022. He has been directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten days, failing which his name will be permanently removed from the Medical Register.</p><p>On the other hand, Dr Ali was found to have been practising without a valid Telangana Medical Council registration.</p><p>An order issued by the council mentioned that the case surfaced after the Chairman took suo motu cognisance and constituted an inspection team comprising Dr. V. Naresh Kumar (TGMC Member), Dr. Rajeev Naik, and Dr. Arundathi (Co-opted members) to examine alleged unethical practices in clinics and diagnostic centres across Suryapet and Nalgonda districts, including involvement of unqualified practitioners and non-modern system doctors prescribing allopathic drugs. Acting on credible inputs, the team inspected Apple Scan Centre, Suryapet, on April 24, 2025.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/telangana-medical-council-cracks-down-on-8-eye-clinics-technicians-performing-surgeries-165535" target="_blank">Telangana Medical Council cracks down on 8 eye clinics, technicians performing surgeries</a></b></p><p><b>Fake Qualification, Expired Registration</b></p><p>During the inspection, the doctor was found practising as a Consultant Radiologist without holding a recognised postgraduate qualification in Radiodiagnosis and with an expired registration, which had lapsed on March 26, 2022 at the Suryapet diagnosis centre. </p><p>As per the order, the Council noted that he had been using the title “MD (Radio Diagnosis)” and presenting himself as a Consultant Radiologist in hospital signage, name boards, and reports, despite not possessing a recognised qualification approved by the National Medical Commission.</p><p>It was also found that his registration with the Telangana Medical Council had expired on March 26, 2022, and had not been renewed. A photocopy of the registration certificate allegedly in his name was submitted during inspection, which was found to be fabricated upon verification.</p><p>Based on this, the Council issued show-cause notices dated 26.04.2025 to him seeking explanations. In response to the notice, the doctor submitted his explanation. </p><p>He admitted that he was practising as a Consultant Sonologist under the provisions of PCPNDT Rule 3(3)(1)(b), that he had applied for renewal of registration on 10.10.2023, and that he was not aware of any fabricated certificate allegedly submitted during inspection.</p><p>After considering his explanations, notices were issued to the doctor directing him to appear before the Ethics Committee on 12.07.2025, 27.09.2025, and 29.11.2025. He was charged with violation of Regulation 7.20 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, submission of a fabricated certificate and for alleged infamous conduct in a professional respect</p><p>During proceedings, the doctor admitted that he had displayed "MD (Radio Diagnosis)" and falsely described himself as a Consultant Radiologist on the name board, hospital signage and scanning reports issued to patients. He further admitted that he does not possess a recognised MD (Radio Diagnosis) qualification and that the qualification relied upon by him is not recognised by the National Medical Commission.</p><p>When confronted with the forged registration certificate purportedly issued by the Maharashtra Medical Council, he stated that although the signature appeared to be his, the certificate might have been submitted by hospital staff. He reportedly failed to submit documents as directed by the Committee.</p><p><b>Practising without valid registration</b></p><p>Meanwhile, a doctor was found working as a Consultant Radiologist without valid registration with the Telangana Medical Council at the Suryapet diagnosis centre. He later admitted that he was unaware of the requirement for separate registration with the Telangana Medical Council and sought leniency, stating that he had obtained a No Objection Certificate from his parent State Medical Council.</p><p>He was charged of violation of Regulation 1.1.3 of the said Regulations, for practicing without valid medical council registration, submission of fabricated certificate, and for alleged infamous conduct in a professional respect.</p><p>Appearing before the Ethics Committee after being issued notice, he admitted violation of Regulation 1.1.3 and further admitted that he submitted the fabricated registration certificate of concerned sonologist to the inspection team on 24.04.2025.</p><p><b>Final decision</b></p><p>After examining the oral submissions, documentary evidence, and relevant provisions of the Telangana Medical Practitioners Registration Act, 1968 and the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, the Ethics Committee recommended removal of the name of the sonologist from the Medical Register of the Council for a period of two (2) years under Sections 15(4) and 17 of the Telangana Medical Practitioners Registration Act, 1968 and Regulation 8.2 of the Indian Medical Council Regulations, 2002 and recommended that the other doctor be censured under the aforesaid statutory provisions.</p><p><i>"The recommendations of the Ethics Committee were placed before the General Body of the Council. After detailed deliberation, the General Body unanimously approved the recommendations. Accordingly, in exercise of powers under Section 17(2) r/w Section 15(4) of the Telangana Medical Practitioners Registration Act, 1968 and Regulation 8.2 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, the name of Dr Soma (Reg. No. ***) is hereby removed from the Medical Register of the Telangana Medical Council for a period of two (2) years with effect from the date of receipt of this order.  Dr Soma is directed to surrender his Permanent Registration Certificate and Renewal Certificate within ten (10) days from the date of receipt of this order, failing which his name shall be permanently removed from the Medical Register of the Council. Dr Ali (Reg. No. ***) is hereby censured,"</i> mentioned the order. </p><p>It further mentioned, <i>"Both practitioners are informed that they may prefer an appeal before the National Medical Commission within sixty (60) days from the date of receipt of this order under Regulation 8.8 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 and Section 30(3) of the National Medical Commission Act, 2019."</i></p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/doctors-seek-medical-council-action-against-telangana-pathologist-for-signing-lab-reports-in-maharashtra-sans-registration-163835" target="_blank">Doctors seek medical council action against Telangana pathologist for signing lab reports in Maharashtra sans registration</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Grant one&#45;time exemption from FMGL regulations, apply prospectively from 2022 batch: FMGs urge NMC</title>
<link>https://edusehat.com/en/grant-one-time-exemption-from-fmgl-regulations-apply-prospectively-from-2022-batch-fmgs-urge-nmc</link>
<guid>https://edusehat.com/en/grant-one-time-exemption-from-fmgl-regulations-apply-prospectively-from-2022-batch-fmgs-urge-nmc</guid>
<description><![CDATA[ New Delhi: Highlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the National Medical Commission (NMC) to grant a one-time exemption from its strict applicability.In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.Referring to different issues faced by the medical graduates from abroad, representatives from the All FMGs Association (AFA) and All India Medical Students&#039; Association Foreign Medical Students&#039; Wing (AIMSA-FMSW) met with the National Medical Commission&#039;s officials yesterday.The medical graduates from abroad also highlighted the issue of State Medical Councils not following the NMC guidelines and the notice dated 18 March 2026. Other matters, such as the shortage of Preventive and Social Medicine seats and the three-year internship issue, were also raised before the Apex Medical Commission.&quot;Today, AFA (@official_afa_)along with AIMSA-FMSW(@aimsa_fmsw) representatives met with NMC (@NMC_BHARAT) officials regarding the non‑uniformity in the FMGL‑21 regulation affecting the 2021 batch of the 2021‑22 session. We further discussed the issue of state medical councils not following the NMC guidelines and the notice dated 18 March 2026. Other matters raised included the shortage of PSM seats in Delhi and the three‑year internship issue faced by FMGs. We are truly thankful to the @NMC_BHARAT officials who patiently heard our concerns and assured us of prompt action on these matters. We are truly grateful to our representatives — Dr. Kanishka, Dr. Shubham, Dr. Gaurav and National convenor Dr Apurv &amp; National Vice president Dr Samar for doing such a commendable job,&quot; All FMGs Association mentioned in an X post.In its representation, submitted to NMC, AIMSA-FMSW referred to the meeting held on 17 March 2026 regarding the grievances arising out of the implementation of the Foreign Medical Graduate Licentiate (FMGL)- 2021 Regulations.&quot;At the outset it is respectfully submitted that the batch of students admitted during the academic cycle of 2021-2022 was subjected to extraordinary and unprecedented disruptions caused by the COVID-19 pandemic. Notably. NEST-UG 2021 was conducted in September 1021 instead of its usual schedule in May. leading to substantial delays in the counselling and admission process. Consequently. a large number of students were unable to join their respective foreign medical institutions within the prescribed timelines,&quot; the letter addressed to NMC Secretary mentioned.&quot;It is further submitted that. despite belonging to the same academic batch. certain students were able to commence their courses earlier. while others--due to circumstances entirely beyond their control-faced delayed admissions and travel restrictions. The rigid application of the FAAGL -2021 Regulations in such a scenario has resulted in an arbitrary and discriminatory outcome within the same cohort. Such differential treatment among similarly placed students is contrary to the principles of equality and fairness enshrined under Article 14 of the Constitution of India. which mandates equal treatment under the law. The present situation, therefore, warrants urgent reconsideration to prevent manifest injustice to the affected student,&quot; AIMSA FMSW further mentioned in the letter.The association, on behalf of the aggrieved FMGs, has urged the Apex Medical Commission to grant a one-time exemption from the strict applicability of the FMGL-2021 Regulations for the affected 2021 batch of the 2021-2022 session, ensure that the said regulations are implemented prospectively and uniformly from the academic year 2022 onwards, to maintain consistency, fairness, and legal certainty.Speaking to Medical Dialogues, Dr. Kaushal from AFA said, &quot;Representatives of the All FMGs Association (AFA) and AIMSA-FMSW held an important meeting with officials of the National Medical Commission (NMC) today to discuss pressing issues affecting Foreign Medical Graduates (FMGs), particularly the 2021 batch. The delegation highlighted the non-uniform implementation of the FMGL-21 regulations, which has created significant hardships for students from the 2021-22 academic session. They pointed out inconsistencies in how different states and medical councils are interpreting and applying the guidelines, leading to uncertainty and delays in licensing and practice for many FMGs.&quot;&quot;During the meeting, the representatives also raised concerns over several state medical councils failing to adhere to NMC guidelines and the official notice issued on 18 March 2026. This non-compliance has reportedly exacerbated difficulties for FMG students seeking permanent registration. Other critical issues discussed included an acute shortage of PSM (Preventive and Social Medicine) seats in Delhi, affecting FMGs who require these compulsory postings, and the three-year internship mandate being faced by many Foreign Medical Graduates, which has become a major bottleneck in their professional journey. According to the representative, NMC officials listened patiently to all the concerns raised and assured prompt, positive action to resolve the issues at the earliest,&quot; he addedThe team of foreign medical graduates who led the delegation included Dr. Kanishka Kalra, Dr. Shubham Singh, Dr. Gaurav, AIMSA FMSW National Convenor Dr. Apurv Dalvi, and National Vice President Dr. Samar Kumar.Medical Dialogues had earlier reported that in a notice dated March 06, 2026, the Undergraduate Medical Education Board (UGMEB) of NMC had stated that FMGs who took admission on or before Nov 18, 2021 and have already compensated for online classes and completed internship abroad will be governed by the old rules (Screening Test Regulations). Those admitted after Nov 18, 2021, will follow FMGL 2021 and must do a 1-year mandatory internship in India (CRMI).This triggered protests and opposition from FMGs, who argued that the notice was unfair, as they had attended online classes due to the COVID-19 pandemic and should not be required to undergo additional training again in India. Several representations from associations like AIMSA, AFA, and Tamil Nadu Medical Students Association&#039;s Foreign Medical Graduates Wing, Democratic Medical Association (DMA India) were submitted to the NMC for a rollback.In response, NMC withdrew its earlier notice dated March 6, 2026, and the Undergraduate Medical Education Board (UGMEB) of the Commission issued a fresh clarification on physical onsite compensation for online studies undertaken by FMGs on 18.03.2026.Issuing the new notice, the National Medical Commission (NMC) clarified that the medicos will not be required to undergo additional training in India if they have already completed the required compensation abroad.The Commission also stated that FMGs who had to attend online classes during their MBBS course abroad due to the COVID-19 pandemic or war will not be required to undergo additional clerkship in India if they have already completed the required compensation through physical classes at their parent foreign medical institution.As per the Apex Medical Body, such candidates must produce a valid compensatory certificate issued by their foreign medical institute, confirming that the online portion of their course has been duly covered through physical training, additional classes, or extended course duration. Once verified, these FMGs will be considered eligible for registration in India.Also Read: No extra clerkship if compensated abroad: NMC issues fresh clarification on FMG online classes compensation ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/09/11/218858-mbbs-abroad-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Grant, one-time, exemption, from, FMGL, regulations, apply, prospectively, from, 2022, batch:, FMGs, urge, NMC</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/09/11/218858-mbbs-abroad-1.webp"><p><b>New Delhi:</b> Highlighting the non-uniform implementation of the Foreign Medical Graduates Licentiate (FMGL) 2021 Regulations across States, the medical graduates from abroad have requested the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC) </a>to grant a one-time exemption from its strict applicability.</p><p>In the representation submitted before the Apex Medical Commission, the FMGs have requested NMC to ensure that the 2021 Regulations are implemented prospectively and uniformly from the 2022 batch onwards.</p><p>Referring to different issues faced by the medical graduates from abroad, representatives from the <a href="https://medicaldialogues.in/topics/All-FMGs-Association">All FMGs Association (AFA)</a> and <a href="https://medicaldialogues.in/topics/Aimsa">All India Medical Students' Association Foreign Medical Students' Wing (AIMSA-FMSW)</a> met with the National Medical Commission's officials yesterday.</p><p>The medical graduates from abroad also highlighted the issue of State Medical Councils not following the NMC guidelines and the notice dated 18 March 2026. Other matters, such as the shortage of Preventive and Social Medicine seats and the three-year internship issue, were also raised before the Apex Medical Commission.</p><p>"Today, AFA (@official_afa_)along with AIMSA-FMSW(@aimsa_fmsw) representatives met with NMC (@NMC_BHARAT) officials regarding the non‑uniformity in the FMGL‑21 regulation affecting the 2021 batch of the 2021‑22 session. We further discussed the issue of state medical councils not following the NMC guidelines and the notice dated 18 March 2026. Other matters raised included the shortage of PSM seats in Delhi and the three‑year internship issue faced by FMGs. We are truly thankful to the @NMC_BHARAT officials who patiently heard our concerns and assured us of prompt action on these matters. We are truly grateful to our representatives — Dr. Kanishka, Dr. Shubham, Dr. Gaurav and National convenor Dr Apurv & National Vice president Dr Samar for doing such a commendable job," All FMGs Association mentioned in an X post.</p><p>In its representation, submitted to NMC, AIMSA-FMSW referred to the meeting held on 17 March 2026 regarding the grievances arising out of the implementation of the <a href="https://medicaldialogues.in/topics/FMGL">Foreign Medical Graduate Licentiate (FMGL)- 2021 Regulations.</a></p><p>"At the outset it is respectfully submitted that the batch of students admitted during the academic cycle of 2021-2022 was subjected to extraordinary and unprecedented disruptions caused by the COVID-19 pandemic. Notably. NEST-UG 2021 was conducted in September 1021 instead of its usual schedule in May. leading to substantial delays in the counselling and admission process. Consequently. a large number of students were unable to join their respective foreign medical institutions within the prescribed timelines," the letter addressed to NMC Secretary mentioned.</p><p>"It is further submitted that. despite belonging to the same academic batch. certain students were able to commence their courses earlier. while others--due to circumstances entirely beyond their control-faced delayed admissions and travel restrictions. The rigid application of the FAAGL -2021 Regulations in such a scenario has resulted in an arbitrary and discriminatory outcome within the same cohort. Such differential treatment among similarly placed students is contrary to the principles of equality and fairness enshrined under Article 14 of the Constitution of India. which mandates equal treatment under the law. The present situation, therefore, warrants urgent reconsideration to prevent manifest injustice to the affected student," AIMSA FMSW further mentioned in the letter.</p><p>The association, on behalf of the aggrieved FMGs, has urged the Apex Medical Commission to grant a one-time exemption from the strict applicability of the FMGL-2021 Regulations for the affected 2021 batch of the 2021-2022 session, ensure that the said regulations are implemented prospectively and uniformly from the academic year 2022 onwards, to maintain consistency, fairness, and legal certainty.</p><p>Speaking to Medical Dialogues, Dr. Kaushal from AFA said, "Representatives of the All FMGs Association (AFA) and AIMSA-FMSW held an important meeting with officials of the National Medical Commission (NMC) today to discuss pressing issues affecting Foreign Medical Graduates (FMGs), particularly the 2021 batch. The delegation highlighted the non-uniform implementation of the FMGL-21 regulations, which has created significant hardships for students from the 2021-22 academic session. They pointed out inconsistencies in how different states and medical councils are interpreting and applying the guidelines, leading to uncertainty and delays in licensing and practice for many FMGs."</p><p>"During the meeting, the representatives also raised concerns over several state medical councils failing to adhere to NMC guidelines and the official notice issued on 18 March 2026. This non-compliance has reportedly exacerbated difficulties for FMG students seeking permanent registration. Other critical issues discussed included an acute shortage of PSM (Preventive and Social Medicine) seats in Delhi, affecting FMGs who require these compulsory postings, and the three-year internship mandate being faced by many Foreign Medical Graduates, which has become a major bottleneck in their professional journey. According to the representative, NMC officials listened patiently to all the concerns raised and assured prompt, positive action to resolve the issues at the earliest," he added</p><p>The team of foreign medical graduates who led the delegation included Dr. Kanishka Kalra, Dr. Shubham Singh, Dr. Gaurav, AIMSA FMSW National Convenor Dr. Apurv Dalvi, and National Vice President Dr. Samar Kumar.</p><p>Medical Dialogues had earlier reported that in a notice dated March 06, 2026, the Undergraduate Medical Education Board (UGMEB) of NMC had stated that FMGs who took admission on or before Nov 18, 2021 and have already compensated for online classes and completed internship abroad will be governed by the old rules (Screening Test Regulations). Those admitted after Nov 18, 2021, will follow FMGL 2021 and must do a 1-year mandatory internship in India (CRMI).</p><p>This triggered protests and opposition from FMGs, who argued that the notice was unfair, as they had attended online classes due to the COVID-19 pandemic and should not be required to undergo additional training again in India. Several representations from associations like AIMSA, AFA, and Tamil Nadu Medical Students Association's Foreign Medical Graduates Wing, Democratic Medical Association (DMA India) were submitted to the NMC for a rollback.</p><p>In response, NMC withdrew its earlier notice dated March 6, 2026, and the Undergraduate Medical Education Board (UGMEB) of the Commission issued a fresh clarification on physical onsite compensation for online studies undertaken by FMGs on 18.03.2026.</p><p>Issuing the new notice, the <a href="https://medicaldialogues.in/topics/national-medical-commission" target="_blank">National Medical Commission</a> (NMC) clarified that the medicos will not be required to undergo additional training in India if they have already completed the required compensation abroad.</p><div class="pasted-from-word-wrapper"><div></div><p>The Commission also stated that FMGs who had to attend online classes during their MBBS course abroad due to the COVID-19 pandemic or war will not be required to undergo additional clerkship in India if they have already completed the required compensation through physical classes at their parent foreign medical institution.</p><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div><p>As per the Apex Medical Body, such candidates must produce a valid compensatory certificate issued by their foreign medical institute, confirming that the online portion of their course has been duly covered through physical training, additional classes, or extended course duration. Once verified, these FMGs will be considered eligible for registration in India.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/study-abroad/no-extra-clerkship-if-compensated-abroad-nmc-issues-fresh-clarification-on-fmg-online-classes-compensation-166820"><b><i>Also Read: No extra clerkship if compensated abroad: NMC issues fresh clarification on FMG online classes compensation</i></b></a></div>]]> </content:encoded>
</item>

<item>
<title>Guru Gobind Singh medical college 2 MBBS students critically injured, elderly man killed in road accident</title>
<link>https://edusehat.com/en/guru-gobind-singh-medical-college-2-mbbs-students-critically-injured-elderly-man-killed-in-road-accident</link>
<guid>https://edusehat.com/en/guru-gobind-singh-medical-college-2-mbbs-students-critically-injured-elderly-man-killed-in-road-accident</guid>
<description><![CDATA[ Faridkot: In a tragic incident, two final-year MBBS students of Guru Gobind Singh (GGS) Medical College sustained severe injuries after a speeding car rammed into their two-wheeler near the college campus.According to Tribune report, the accident not only left the two students with multiple compound fractures in their thighs and legs, with one also suffering a severely broken jaw, but also claimed the life of an unidentified elderly man.The injured students were riding an Activa on Sadiq Road when a speeding car hit them from behind near the medical college gate on Wednesday evening. ​Now, both students are currently receiving medical care at GGS Medical College and Hospital.Also read- Govt Siddhartha medical college 1st year MBBS student dies in bike accidentThe Tribune reported that the driver of the car first slammed into the students, according to eyewitnesses.  After hitting the students, the car driver allegedly tried to flee the scene. In the process, he lost control of the vehicle and crashed into another motorcycle a short distance away. The second victim, an unidentified elderly man, was rushed to the hospital but was declared dead on arrival.​The rampage only ended when a tyre on the car burst, rendering the vehicle immovable. Bystanders quickly surrounded the car, apprehended the driver, and handed him over to the local police.DSP Tarlochan Singh told The Tribune, &quot;This is a grave incident involving extreme recklessness. We have seized the vehicle and are investigating the circumstances of the multiple hits. Legal action is being initiated against the driver.&quot;Medical Dialogues had reported that a tragic car accident claimed the life of a 24-year-old MBBS intern at a Government Medical College in Chennai and injured three of her friends after the car they were travelling in overturned near Villupuram.Also read- MBBS intern dies after car overturns in Villupuram, 3 injured ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/16/333200-accident-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Guru, Gobind, Singh, medical, college, MBBS, students, critically, injured, elderly, man, killed, road, accident</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/16/333200-accident-1.webp"><p><b>Faridkot:</b> In a tragic incident, two final-year MBBS students of <a href="https://medicaldialogues.in/topics/guru-gobind-singh-medical-college" target="_blank">Guru Gobind Singh (GGS) Medical College</a> sustained severe injuries after a speeding car rammed into their two-wheeler near the college campus.</p><p>According to Tribune report, the <a href="https://medicaldialogues.in/topics/accident" target="_blank">accident </a>not only left the two students with multiple compound fractures in their thighs and legs, with one also suffering a severely broken jaw, but also claimed the life of an unidentified elderly man.</p><p>The injured students were riding an Activa on Sadiq Road when a speeding car hit them from behind near the medical college gate on Wednesday evening. ​Now, both students are currently receiving medical care at GGS Medical College and Hospital.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/andhra-pradesh/govt-siddhartha-medical-college-1st-year-mbbs-student-dies-in-bike-accident-166628" target="_blank">Govt Siddhartha medical college 1st year MBBS student dies in bike accident</a></b></p><p>The Tribune reported that the driver of the car first slammed into the students, according to eyewitnesses.  After hitting the students, the car driver allegedly tried to flee the scene. In the process, he lost control of the vehicle and crashed into another motorcycle a short distance away. The second victim, an unidentified elderly man, was rushed to the hospital but was declared dead on arrival.</p><p>​The rampage only ended when a tyre on the car burst, rendering the vehicle immovable. Bystanders quickly surrounded the car, apprehended the driver, and handed him over to the local police.</p><p>DSP Tarlochan Singh told The Tribune, "This is a grave incident involving extreme recklessness. We have seized the vehicle and are investigating the circumstances of the multiple hits. Legal action is being initiated against the driver."</p><p>Medical Dialogues had reported that a tragic car accident claimed the life of a 24-year-old MBBS intern at a Government Medical College in Chennai and injured three of her friends after the car they were travelling in overturned near Villupuram.</p><p><b>Also read-<a href="https://medicaldialogues.in/state-news/tamil-nadu/mbbs-intern-dies-after-car-overturns-in-villupuram-3-injured-168037" target="_blank"> MBBS intern dies after car overturns in Villupuram, 3 injured</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Bijnor&amp;apos;s medical college 11 MBBS students suspended over ragging</title>
<link>https://edusehat.com/en/bijnors-medical-college-11-mbbs-students-suspended-over-ragging</link>
<guid>https://edusehat.com/en/bijnors-medical-college-11-mbbs-students-suspended-over-ragging</guid>
<description><![CDATA[ Bijnor: A ragging incident at Mahatma Vidur Autonomous State Medical College (MVASMC) has led to the suspension of 11 second-year MBBS students with fines following a complaint by a first year student to the anti-ragging helpline of the National Medical Commission (NMC).In his complaint, the student claimed that he was humiliated and beaten by the second-year students. The complaint led to an internal inquiry, following which strict action was taken against 11 second-year students.After an investigation by the anti-ragging committee, 11 students were found guilty. Among them, one student has been fined Rs 10,000 and suspended for six weeks, another fined Rs 10,000 with a four-week suspension, and one student fined Rs 5,000 with a two-week suspension. The remaining eight students have been suspended for two weeks without fine.Also read- MAMC Doctors Decry Meal Payment Tradition for Seniors, Post Goes ViralAs per latest TOI media report, the incident took place six weeks ago. Initially, the college administration tried to handle the issue internally. However, the situation changed after the first year student lodged a complaint with the NMC helpline, forcing the college to initiate disciplinary proceedings.The student is reportedly still struggling with the mental impact of the incident and is in the recovery stage, an official told TOI. He said &quot;Counselling sessions were held to maintain a safe campus.&quot;Meanwhile, some students, speaking on condition of anonymity, alleged that a few of those punished were not directly involved in the ragging and were merely present at the spot.College principal, Dr Tuhin Vashisht, said &quot;The institution follows a zero tolerance policy towards ragging. Action has been taken after our internal inquiry process was complete. Parents of all the students were summoned. The college is now working to ensure a safe environment on campus for first-year students.&quot;Also read- Hassan Institute of medical sciences surgery medico alleges ragging, harassment ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/07/331502-ragging.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bijnors, medical, college, MBBS, students, suspended, over, ragging</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/07/331502-ragging.webp"><p><b>Bijnor: </b>A <a href="https://medicaldialogues.in/topics/ragging" target="_blank">ragging </a>incident at Mahatma Vidur Autonomous State Medical College (MVASMC) has led to the suspension of 11 second-year MBBS students with fines following a complaint by a first year student to the anti-ragging helpline of the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC).</p><p>In his complaint, the student claimed that he was humiliated and beaten by the second-year students. The complaint led to an internal inquiry, following which strict action was taken against 11 second-year students.</p><p>After an investigation by the anti-ragging committee, 11 students were found guilty. Among them, one student has been fined Rs 10,000 and suspended for six weeks, another fined Rs 10,000 with a four-week suspension, and one student fined Rs 5,000 with a two-week suspension. The remaining eight students have been suspended for two weeks without fine.</p><p><b>Also read-<a href="https://medicaldialogues.in/news/health/doctors/mamc-doctors-decry-meal-payment-tradition-for-seniors-post-goes-viral-166995" target="_blank"> MAMC Doctors Decry Meal Payment Tradition for Seniors, Post Goes Viral</a></b></p><p>As per latest <a href="https://timesofindia.indiatimes.com/city/meerut/11-mbbs-students-suspended-in-bijnor-college-ragging-case/amp_articleshow/130152690.cms" target="_blank" rel="nofollow">TOI </a>media report, the incident took place six weeks ago. Initially, the college administration tried to handle the issue internally. However, the situation changed after the first year student lodged a complaint with the NMC helpline, forcing the college to initiate disciplinary proceedings.<br></p><p>The student is reportedly still struggling with the mental impact of the incident and is in the recovery stage, an official told TOI. He said "Counselling sessions were held to maintain a safe campus."</p><p>Meanwhile, some students, speaking on condition of anonymity, alleged that a few of those punished were not directly involved in the ragging and were merely present at the spot.</p><p>College principal, Dr Tuhin Vashisht, said "The institution follows a zero tolerance policy towards ragging. Action has been taken after our internal inquiry process was complete. Parents of all the students were summoned. The college is now working to ensure a safe environment on campus for first-year students."</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/hassan-institute-of-medical-sciences-surgery-medico-alleged-ragging-harassment-165950" target="_blank">Hassan Institute of medical sciences surgery medico alleges ragging, harassment</a></b></p>]]> </content:encoded>
</item>

<item>
<title>18&#45;year&#45;old woman critical after treatment by Quack in Mirzapur</title>
<link>https://edusehat.com/en/18-year-old-woman-critical-after-treatment-by-quack-in-mirzapur</link>
<guid>https://edusehat.com/en/18-year-old-woman-critical-after-treatment-by-quack-in-mirzapur</guid>
<description><![CDATA[ Mirzapur: In a shocking incident, a case from Mirzapur district of Uttar Pradesh has once again raised concerns over the dangers posed by unqualified practitioners, after an 18-year-old woman was allegedly left in a critical condition due to treatment by a quack.   According to the news reports, the woman, a resident of a village in the district, had been suffering from a minor illness for a few days. Her family took her to a nearby private clinic run by an unlicensed practitioner. The family alleged that the so-called doctor prescribed medication without conducting any medical examination or diagnostic tests, and that the medicines given were typically used for psychiatric patients.  Also Read:Crackdown on fake doctors in Ballari, Illegal clinics sealedSoon after taking the medication, the woman reportedly began to feel dizzy, lost her ability to speak properly, and her condition deteriorated rapidly.Alarmed by her deteriorating health, the family rushed her to a nearby hospital. Doctors there, during their initial assessment, indicated that consuming incorrect medication can severely impact the body and may lead to critical complications. As her condition continued to worsen, she was referred to a hospital in another city for advanced treatment, where she remains under close observation.
The incident has sparked outrage among local residents. The victim’s father has lodged a formal complaint with the authorities, alleging that the individual responsible was practising medicine without a valid degree and endangering lives. He has called for a thorough investigation and strict legal action.
Speaking to Asia Net, local residents say that many quack doctors are running clinics openly in rural areas. They claim the health department doesn&#039;t pay attention to them, which is why people are forced to go to them for treatment. 
In the wake of the incident, residents have called for an urgent crackdown on illegal clinics and stricter enforcement of healthcare regulations to prevent similar cases in the future.  Also Read:Fake doctor busted in Surat; illegal clinic exposed ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>18-year-old, woman, critical, after, treatment, Quack, Mirzapur</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.webp"><p><b>Mirzapur:</b> In a shocking incident, a case from Mirzapur district of <a href="https://medicaldialogues.in/state-news/uttar-pradesh">Uttar Pradesh</a> has once again raised concerns over the dangers posed by unqualified practitioners, after an 18-year-old woman was allegedly left in a critical condition due to treatment by a <a href="https://medicaldialogues.in/topics/quack" target="_blank">quack</a>.   </p><p>According to the news reports, the woman, a resident of a village in the district, had been suffering from a minor illness for a few days. Her family took her to a nearby private clinic run by an unlicensed practitioner. The family alleged that the so-called doctor prescribed medication without conducting any medical examination or diagnostic tests, and that the medicines given were typically used for psychiatric patients.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/crackdown-on-fake-doctors-in-ballari-illegal-clinics-sealed-162464"><b>Also Read:Crackdown on fake doctors in Ballari, Illegal clinics sealed</b></a></p><p>Soon after taking the medication, the woman reportedly began to feel dizzy, lost her ability to speak properly, and her condition deteriorated rapidly.</p><p>Alarmed by her deteriorating health, the family rushed her to a nearby hospital. Doctors there, during their initial assessment, indicated that consuming incorrect medication can severely impact the body and may lead to critical complications. As her condition continued to worsen, she was referred to a hospital in another city for advanced treatment, where she remains under close observation.
</p><p>The incident has sparked outrage among local residents. The victim’s father has lodged a formal complaint with the authorities, alleging that the individual responsible was practising medicine without a valid degree and endangering lives. He has called for a thorough investigation and strict legal action.
</p><p>Speaking to <a href="https://newsable.asianetnews.com/india/mirzapur-teen-in-critical-condition-after-quack-doctor-allegedly-prescribes-wrong-medicine-articleshow-h2888ky" rel="nofollow">Asia Net</a>, local residents say that many quack doctors are running clinics openly in rural areas. They claim the health department doesn't pay attention to them, which is why people are forced to go to them for treatment. 
</p><p>In the wake of the incident, residents have called for an urgent crackdown on illegal clinics and stricter enforcement of healthcare regulations to prevent similar cases in the future.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/fake-doctor-busted-in-surat-illegal-clinic-exposed-168129"><b>Also Read:Fake doctor busted in Surat; illegal clinic exposed</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Forced to kneel, abused: 7 Katatiya medical college MBBS students suspended for ragging</title>
<link>https://edusehat.com/en/forced-to-kneel-abused-7-katatiya-medical-college-mbbs-students-suspended-for-ragging</link>
<guid>https://edusehat.com/en/forced-to-kneel-abused-7-katatiya-medical-college-mbbs-students-suspended-for-ragging</guid>
<description><![CDATA[ Hyderabad: Altogether seven third-year MBBS students of Kakatiya Medical College at Warangal have been suspended for six months after being found guilty of allegedly ragging some second-year students.According to media reports, the accused senior students allegedly forced the juniors to kneel on a boys&#039; hostel terrace, and verbally abused them.As a result, the students have now been permanently expelled from the hostel till the completion of their course and suspended from academic activities for six months.Also read- SMS medical college suspends 6 MBBS students over ragging complaint, probe later flags dispute: ReportThe incident took place on March 29, but it came to the notice of the college authorities on April 7 after the affected juniors filed a complaint. As per TNIE media reports, the seniors were unhappy with the behaviour of the juniors and therefore cautioned them.Later, the seniors called them to the terrace of the hostel building, where they were allegedly asked to kneel down as punishment. A PTI report mentioned that the senior students also allegedly abused them. Following this, the juniors filed an online complaint against the seniors with the Union Home Minister, National Medical Commission (NMC), the State University, Kaloji Narayana Rao University of Health Sciences (KNRUHS), Warangal commissioner of police, legal services authority and other medical council authorities and the University Grants Commission’s (UGC) anti-ragging helpline. Acting on the complaint, the college’s anti-ragging committee subsequently initiated a detailed inquiry into the allegations. During the inquiry, the Committee found the seven students, all from the 2023 admission batch guillty of their actions.Speaking to The Hindu, KMC principal Dr Sandhya Sunkaraneni said, &quot;The accused senior students were summoned before the committee and asked to explain the charges levelled against them. A detailed inquiry was conducted, and the accused were found guilty.&quot;Based on the findings, the committee recommended the suspension of the seven third-year MBBS students for six months.Dr Sunkaraneni said, &quot;Following the inquiry, the college imposed strict penalties. The students have been permanently expelled from the hostel and suspended from academic activities for six months.&quot;Also raed- Ragging: 3 MBBS students expelled, suspended at Guwahati medical college ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/19/322181-education-43.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Forced, kneel, abused:, Katatiya, medical, college, MBBS, students, suspended, for, ragging</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/19/322181-education-43.webp"><p><b>Hyderabad: </b>Altogether seven third-year MBBS students of<a href="https://medicaldialogues.in/topics/kakatiya-medical-college" target="_blank"> Kakatiya Medical College</a> at Warangal have been suspended for six months after being found guilty of allegedly <a href="https://medicaldialogues.in/topics/ragging" target="_blank">ragging</a> some second-year students.</p><p>According to media reports, the accused senior students allegedly forced the juniors to kneel on a boys' hostel terrace, and verbally abused them.</p><p>As a result, the students have now been permanently expelled from the hostel till the completion of their course and suspended from academic activities for six months.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-colleges/sms-medical-college-suspends-6-mbbs-students-over-ragging-complaint-probe-later-flags-dispute-report-167238" target="_blank">SMS medical college suspends 6 MBBS students over ragging complaint, probe later flags dispute: Report</a></b></p><p>The incident took place on March 29, but it came to the notice of the college authorities on April 7 after the affected juniors filed a complaint. As per <a href="https://www.newindianexpress.com/states/telangana/2026/Apr/10/kmc-slaps-six-month-suspension-on-seven-mbbs-students-for-ragging" target="_blank" rel="nofollow">TNIE </a>media reports, the seniors were unhappy with the behaviour of the juniors and therefore cautioned them.</p><p>Later, the seniors called them to the terrace of the hostel building, where they were allegedly asked to kneel down as punishment. A PTI report mentioned that the senior students also allegedly abused them. </p><p>Following this, the juniors filed an online complaint against the seniors with the Union Home Minister, National Medical Commission (NMC), the State University, Kaloji Narayana Rao University of Health Sciences (KNRUHS), Warangal commissioner of police, legal services authority and other medical council authorities and the University Grants Commission’s (UGC) anti-ragging helpline. </p><p>Acting on the complaint, the college’s anti-ragging committee subsequently initiated a detailed inquiry into the allegations. During the inquiry, the Committee found the seven students, all from the 2023 admission batch guillty of their actions.</p><p>Speaking to <a href="https://www.thehindu.com/news/national/telangana/seven-kmc-warangal-students-suspended-for-six-months-expelled-from-hostel-for-ragging-juniors/article70843473.ece" target="_blank" rel="nofollow">The Hindu</a>, KMC principal Dr Sandhya Sunkaraneni said, "The accused senior students were summoned before the committee and asked to explain the charges levelled against them. A detailed inquiry was conducted, and the accused were found guilty."</p><p>Based on the findings, the committee recommended the suspension of the seven third-year MBBS students for six months.</p><p>Dr Sunkaraneni said, "Following the inquiry, the college imposed strict penalties. The students have been permanently expelled from the hostel and suspended from academic activities for six months."</p><p><b>Also raed- <a href="https://medicaldialogues.in/state-news/assam/ragging-3-mbbs-students-expelled-suspended-at-guwahati-medical-college-166632" target="_blank">Ragging: 3 MBBS students expelled, suspended at Guwahati medical college</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Woman doctor, staff assaulted by patient attendants at Chamba Hospital</title>
<link>https://edusehat.com/en/woman-doctor-staff-assaulted-by-patient-attendants-at-chamba-hospital</link>
<guid>https://edusehat.com/en/woman-doctor-staff-assaulted-by-patient-attendants-at-chamba-hospital</guid>
<description><![CDATA[ Chamba: In a disturbing incident at Pandit Jawaharlal Nehru Government Medical College in Chamba late Wednesday night, a woman doctor, security guards, and technical staff were allegedly assaulted by attendants after a patient died during treatment, triggering outrage among the medical community.
According to Medical College Faculty Association president Dr Manik Sehgal, the incident took place when a heart attack patient was brought to the emergency ward around midnight in a critical condition. “He had no vitals when he was brought in. The doctor on emergency duty made every possible effort to revive him, but he could not be saved,” Sehgal stated. Also Read:4 arrested in Telangana Paediatrician assault caseSoon after the patient was declared dead, his attendants allegedly became aggressive. They reportedly verbally abused the woman doctor and physically assaulted her. In an attempt to escape, she moved towards the minor operation theatre, but the attackers allegedly followed her and tried to assault her again. Security guards and technical staff who intervened were also beaten during the incident. The entire episode was captured on CCTV cameras installed in the hospital. Condemning the incident, the faculty association termed it “deplorable” and demanded strict legal action against those involved. It also called for stronger security measures to ensure a safe working environment for healthcare professionals.  
As per the news reports by Tribune India, Principal Dr Pankaj Gupta said the issue was serious, noting that incidents of violence and misbehaviour against doctors and staff have occurred earlier as well. “It is essential that the accused are arrested and strict action is taken to prevent such incidents in the future,” he said.
In response to the incident, outsourced employees, along with other hospital staff, staged a sit-in protest outside the medical college campus. Protesters blocked the road, demanding immediate action against the culprits and stronger safety measures. The protest was later called off after the administration assured prompt action and improved security arrangements. Police said an FIR was registered after examination of CCTV footage, and a case was lodged under Sections 132 and 121(3) of the BNS. Hospital staff said they had long been demanding a police post and stronger security arrangements at the medical college, reports TOI. Speaking to Tribune India, Chamba SP Vijay Kumar Saklani said four persons have been detained for questioning, and the investigation is on. “CCTV footage is being examined, and efforts are being made to nab the accused. They will be arrested soon,” he added.
Also Read:Paediatrician attacked by patient attendant at Adilabad hospital, doctors demand action ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/11/26/192043-stop-violence-against-doctors.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Woman, doctor, staff, assaulted, patient, attendants, Chamba, Hospital</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/11/26/192043-stop-violence-against-doctors.webp"><p><b>Chamba: </b>In a disturbing incident at Pandit Jawaharlal Nehru Government Medical College in Chamba late Wednesday night, a <a href="https://medicaldialogues.in/topics/female-doctor">woman doctor</a>, security guards, and technical staff were allegedly <a href="https://medicaldialogues.in/topics/assault">assaulted</a> by attendants after a patient died during treatment, triggering outrage among the medical community.
</p><p>According to Medical College Faculty Association president Dr Manik Sehgal, the incident took place when a heart attack patient was brought to the emergency ward around midnight in a critical condition. </p><p>“He had no vitals when he was brought in. The doctor on emergency duty made every possible effort to revive him, but he could not be saved,” Sehgal stated. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/4-arrested-in-telangana-paediatrician-assault-case-167623"><b>Also Read:4 arrested in Telangana Paediatrician assault case</b></a></p><p>Soon after the patient was declared dead, his attendants allegedly became aggressive. They reportedly verbally abused the woman doctor and physically assaulted her. In an attempt to escape, she moved towards the minor operation theatre, but the attackers allegedly followed her and tried to assault her again. Security guards and technical staff who intervened were also beaten during the incident. The entire episode was captured on CCTV cameras installed in the hospital. </p><p>Condemning the incident, the faculty association termed it “deplorable” and demanded strict legal action against those involved. It also called for stronger security measures to ensure a safe working environment for healthcare professionals.  
</p><p>As per the news reports by Tribune India, Principal Dr Pankaj Gupta said the issue was serious, noting that incidents of violence and misbehaviour against doctors and staff have occurred earlier as well. “It is essential that the accused are arrested and strict action is taken to prevent such incidents in the future,” he said.
</p><p>In response to the incident, outsourced employees, along with other hospital staff, staged a sit-in protest outside the medical college campus. Protesters blocked the road, demanding immediate action against the culprits and stronger safety measures. The protest was later called off after the administration assured prompt action and improved security arrangements. </p><p>Police said an FIR was registered after examination of CCTV footage, and a case was lodged under Sections 132 and 121(3) of the BNS. Hospital staff said they had long been demanding a police post and stronger security arrangements at the medical college, reports <a href="https://timesofindia.indiatimes.com/city/chandigarh/hospital-staff-protest-after-doctor-guards-assaulted-in-chamba/articleshow/130148169.cms" rel="nofollow">TOI</a>. </p><p>Speaking to Tribune India, Chamba SP Vijay Kumar Saklani said four persons have been detained for questioning, and the investigation is on. “CCTV footage is being examined, and efforts are being made to nab the accused. They will be arrested soon,” he added.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/paediatrician-attacked-by-patient-attendant-at-adilabad-hospital-doctors-demand-action-167402"><b>Also Read:Paediatrician attacked by patient attendant at Adilabad hospital, doctors demand action</b></a></p>]]> </content:encoded>
</item>

<item>
<title>MCC extends NEET SS round 2 choice filling till further orders</title>
<link>https://edusehat.com/en/mcc-extends-neet-ss-round-2-choice-filling-till-further-orders</link>
<guid>https://edusehat.com/en/mcc-extends-neet-ss-round-2-choice-filling-till-further-orders</guid>
<description><![CDATA[ New Delhi: The Medical Counselling Committee (MCC) has further extended the choice filling process for Round 2 of the National Eligibility and Entrance Test Super Speciality (NEET SS) counselling for the academic year 2025.The MCC has notified &quot;all candidates participating in Round-2 of SS Counselling 2025 that the Choice Filling for Round 2 of NEET SS Counselling 2025 has been extended till further orders.&quot;&quot;As per the schedule, the academic session for the year 2025 for Super Specialty courses was to start from 10th April, 2026. In this regard, it is informed that those candidates who do not wish to participate in Round-2 for upgradation may join their respective departments at the allotted institutes. Candidates who want to avail upgradation facility in Round-2 may join their duty at the time of reporting itself, once the result of Round-2 is declared,&quot; the MCC stated.Medical dialogues had earlier reported the steps for Neet SS round 2 choice fillingSTEP 1- Visit the official MCC portal and select the &quot;Super Speciality&quot; tab.STEP 2- Use your NEET SS roll number and password.STEP 3- New candidates or those who didn&#039;t join R1 must pay registration fees.STEP 4- Select preferred courses and colleges. Seat matrix includes newly added (133), clear (1,858), and virtual (4,600) seats.STEP 5- Lock choices before the deadline (11:55 PM, April 7).However, according to the official schedule released by the MCC, the choice filling and locking process for Round 2 of the NEET SS 2025 Counselling was scheduled to conclude today.Thereafter, the processing of seat allotment was to be done from 5th April, 2026 and the result declaration on 7th April, 2026.Below is the schedule as earlier released by the MCC on its official website-2nd ROUND (now extended)VERIFICATION OF SEAT MATRIX BY INSTITUTESREGISTRATION/PAYMENT FACILITYCHOICE FILLING/LOCKINGPROCESSING OF SEAT ALLOTMENTRESULTRESPORTING26 and 27 March, 2026Registration Facility will be available from 28 March, 2026 up to 12:00 NOON of 3 April, 2026( as per Server Time)Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 20265 April, 2026 to 6 April, 20267 April, 20268 April, 2026 to 16 April, 2026 (till 11:00 pm)Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server TimeChoice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026DAYS(7-Days)(7-Days)(2-Days)(1-Day)(9- Days)To view the official notice, click the link mentioned below- https://medicaldialogues.in/pdf_upload/2026/04/10/mcc-neet-ss-notice-for-start-of-ss-academic-session-2025-340813.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/30/324568-extend.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MCC, extends, NEET, round, choice, filling, till, further, orders</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/30/324568-extend.webp"><p><b>New Delhi:</b> The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/MCC">MCC</a>) has further extended the choice filling process for Round 2 of the National Eligibility and Entrance Test Super Speciality (<a href="https://medicaldialogues.in/topics/neet-ss">NEET SS</a>) counselling for the academic year 2025.</p><p>The MCC has notified "all candidates participating in Round-2 of SS Counselling 2025 that the Choice Filling for Round 2 of NEET SS Counselling 2025 has been extended till further orders."</p><p>"As per the schedule, the academic session for the year 2025 for Super Specialty courses was to start from 10th April, 2026. In this regard, it is informed that those candidates who do not wish to participate in Round-2 for upgradation may join their respective departments at the allotted institutes. Candidates who want to avail upgradation facility in Round-2 may join their duty at the time of reporting itself, once the result of Round-2 is declared," the MCC stated.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>Medical dialogues had earlier reported the steps for Neet SS round 2 choice filling</u></b></p><p dir="ltr"><b>STEP 1-</b> Visit the official MCC portal and select the "Super Speciality" tab.</p><p dir="ltr"><b>STEP 2-</b> Use your NEET SS roll number and password.</p><p dir="ltr"><b>STEP 3-</b> New candidates or those who didn't join R1 must pay registration fees.</p><p dir="ltr"><b>STEP 4-</b> Select preferred courses and colleges. Seat matrix includes newly added (133), clear (1,858), and virtual (4,600) seats.</p><p dir="ltr"><b>STEP 5-</b> Lock choices before the deadline (11:55 PM, April 7).</p><div class="inside-post-ad-2 inside-post-ad ads_common_inside_post"></div><p dir="ltr">However, according to the official schedule released by the MCC, the choice filling and locking process for Round 2 of the NEET SS 2025 Counselling was scheduled to conclude today.</p><p dir="ltr">Thereafter, the processing of seat allotment was to be done from 5th April, 2026 and the result declaration on 7th April, 2026.</p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div>Below is the schedule as earlier released by the MCC on its official website-</div></div></div></div><table><tbody><tr><td colspan="6"><p dir="ltr"><b>2nd ROUND (now extended)</b></p></td></tr><tr><td><p dir="ltr"><b>VERIFICATION OF SEAT MATRIX BY INSTITUTES</b></p></td><td><p dir="ltr"><b>REGISTRATION/PAYMENT FACILITY</b></p></td><td><p dir="ltr"><b>CHOICE FILLING/LOCKING</b></p></td><td><p dir="ltr"><b>PROCESSING OF SEAT ALLOTMENT</b></p></td><td><p dir="ltr"><b>RESULT</b></p></td><td><p dir="ltr"><b>RESPORTING</b></p></td></tr><tr><td><p dir="ltr">26 and 27 March, 2026</p></td><td><p dir="ltr">Registration Facility will be available from 28 March, 2026 up to 12:00 NOON of 3 April, 2026( as per Server Time)</p></td><td><p dir="ltr">Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 2026</p></td><td><p dir="ltr">5 April, 2026 to 6 April, 2026</p></td><td><p dir="ltr">7 April, 2026</p></td><td><p dir="ltr">8 April, 2026 to 16 April, 2026 (till 11:00 pm)</p></td></tr><tr><td></td><td><p dir="ltr">Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server Time</p></td><td><p dir="ltr">Choice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026</p></td><td></td><td></td><td></td></tr><tr><td><p dir="ltr">DAYS</p></td><td><p dir="ltr">(7-Days)</p></td><td><p dir="ltr">(7-Days)</p></td><td><p dir="ltr">(2-Days)</p></td><td><p dir="ltr">(1-Day)</p></td><td><p dir="ltr">(9- Days)</p></td></tr></tbody></table><p><b><i>To view the official notice, click the link mentioned below- </i></b></p><p><b><i><a href="https://medicaldialogues.in/pdf_upload/2026/04/10/mcc-neet-ss-notice-for-start-of-ss-academic-session-2025-340813.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/10/mcc-neet-ss-notice-for-start-of-ss-academic-session-2025-340813.pdf</a></i></b></p>]]> </content:encoded>
</item>

<item>
<title>4 students arrested for alleged assault in Tiruvallur MBBS student suicide case</title>
<link>https://edusehat.com/en/4-students-arrested-for-alleged-assault-in-tiruvallur-mbbs-student-suicide-case</link>
<guid>https://edusehat.com/en/4-students-arrested-for-alleged-assault-in-tiruvallur-mbbs-student-suicide-case</guid>
<description><![CDATA[ Tamil Nadu: In a tragic suicide case of an MBBS student, the police have recently arrested four students accused of assault.The deceased has been identified as a resident of Muthiapuram in the Thoothukudi district. He was a second-year MBBS student at a private medical college located in Pandur, near Tiruvallur.Also Read: 31-year-old Anaesthesiologist found dead in Chennai amid marriage disputeAccording to the Daily Thanthi media news report, a row erupted after objectionable messages and videos were allegedly circulated using a fake ID during an online class. It is reported that the accused physically assaulted the medico inside the classroom.Distressed by this incident, the daily reported that the student jumped from the fifth floor of the college building on Tuesday, April 7. He sustained severe injuries following the incident and was initially admitted to the Tiruvallur Government Medical College Hospital.However, he was later shifted to a private hospital in Porur for better treatment, but he passed away.Following this incident, the deceased&#039;s father filed a complaint. Based on the complaint, the police have registered a case, and further investigation is underway. The incident has caused a stir in the area.Meanwhile, Medical Dialogues had recently reported that in a tragic incident, a second-year MBBS student from a private medical college near Tiruvallur died after allegedly jumping from the fifth floor of his hostel building on campus. The deceased has been identified as a 20-year-old student from the Thoothukudi district. He was staying in the college hostel located in Pandur village while pursuing his medical studies.Also Read: 2nd year MBBS student dies after allegedly jumping from hostel buildingPreviously, a medical student allegedly committed suicide by jumping from the 12th floor of an apartment building. The incident was reported on Friday in Attavar, Karnataka. The deceased has been identified as a student at Kasturba Medical College (KMC).The incident occurred at an apartment complex located in Attavar. It is reported that the medico had gone there to meet a friend. After signing the visitor register at the security desk, he directly proceeded to the 12th floor of the building. Before jumping, he placed his mobile phone on the ground. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340790-suicide.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>students, arrested, for, alleged, assault, Tiruvallur, MBBS, student, suicide, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340790-suicide.webp"><p><b>Tamil Nadu:</b> In a tragic <a href="https://medicaldialogues.in/topics/suicide" target="_blank">suicide</a> case of an MBBS student, the police have recently arrested four students accused of assault.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The deceased has been identified as a resident of Muthiapuram in the Thoothukudi district. He was a second-year MBBS student at a private medical college located in Pandur, near Tiruvallur.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/31-year-old-anaesthesiologist-found-dead-in-chennai-amid-marriage-dispute-168043"><b>Also Read: </b>31-year-old Anaesthesiologist found dead in Chennai amid marriage dispute</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">According to the <a href="https://www.dailythanthi.com/news/tamilnadu/medical-college-student-suicide-case-near-tiruvallur-case-registered-against-four-people" target="_blank">Daily Thanthi</a> media news report, a row erupted after objectionable messages and videos were allegedly circulated using a fake ID during an online class. It is reported that the accused physically assaulted the medico inside the classroom.</p><p dir="ltr">Distressed by this incident, the daily reported that the student jumped from the fifth floor of the college building on Tuesday, April 7. He sustained severe injuries following the incident and was initially admitted to the Tiruvallur Government Medical College Hospital.</p><p dir="ltr">However, he was later shifted to a private hospital in Porur for better treatment, but he passed away.</p><p dir="ltr">Following this incident, the deceased's father filed a complaint. Based on the complaint, the police have registered a case, and further investigation is underway. The incident has caused a stir in the area.</p><p dir="ltr">Meanwhile, Medical Dialogues had recently reported that in a tragic incident, a second-year <a href="https://medicaldialogues.in/topics/mbbs-student">MBBS student</a> from a <a href="https://medicaldialogues.in/topics/private-medical-colleges">private medical college </a>near Tiruvallur died after allegedly jumping from the fifth floor of his hostel building on campus. The deceased has been identified as a 20-year-old student from the Thoothukudi district. He was staying in the college hostel located in Pandur village while pursuing his medical studies.</p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/tamil-nadu/2nd-year-mbbs-student-dies-after-allegedly-jumping-from-hostel-building-168285"><b>Also Read: </b>2nd year MBBS student dies after allegedly jumping from hostel building</a></p><p>Previously, a medical student allegedly committed suicide by jumping from the 12th floor of an apartment building. The incident was reported on Friday in Attavar, Karnataka. The deceased has been identified as a student at Kasturba Medical College (KMC).</p><p>The incident occurred at an apartment complex located in Attavar. It is reported that the medico had gone there to meet a friend. After signing the visitor register at the security desk, he directly proceeded to the 12th floor of the building. Before jumping, he placed his mobile phone on the ground.</p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Gorakhpur AYUSH University Pharmacy expands production to supply Govt Hospitals</title>
<link>https://edusehat.com/en/gorakhpur-ayush-university-pharmacy-expands-production-to-supply-govt-hospitals</link>
<guid>https://edusehat.com/en/gorakhpur-ayush-university-pharmacy-expands-production-to-supply-govt-hospitals</guid>
<description><![CDATA[ Gorakhpur: Mahayogi Guru Gorakhnath AYUSH University, Gorakhpur in Uttar Pradesh, has been directed to supply Ayurvedic medicines to state-run Ayurvedic hospitals.The university administration has stepped up preparations to ensure that medicines produced on campus are delivered efficiently to government hospitals across the state.The pharmacy produces a wide range of essential Ayurvedic medicines, including Madhumehari, which is specifically used for diabetes management, Ashwagandha, Arjun bark, Triphala, Haritaki, and Vibhitaki powders, reports Dainik Bhaskar. These medicines are widely recognised for their natural healing properties and are used in treating various health conditions, such as metabolic disorders, heart problems, digestive issues, and general wellness maintenance.Production of Madhumehari has seen a substantial increase, rising from 60 kilograms to nearly 12 quintals to meet the growing demand in government hospitals. The university has prioritized Madhumehari for initial supply, ensuring that patients suffering from diabetes in public Ayurvedic hospitals receive timely access to this important medicine. Following this first phase, other herbal powders and Ayurvedic formulations produced at the pharmacy will be systematically supplied to hospitals across the state, expanding the availability of essential traditional medicines for a wide range of treatments.Also Read:UP Govt steps in to expedite pending construction at AYUSH UniversitySpeaking to The Daily, Vice-Chancellor Dr. K. Ramchandra Reddy stated that the production process uses modern automated machinery and that strict quality checks are in place to maintain high standards. He added that the initiative will ensure the regular availability of Ayurvedic medicines at government hospitals, providing patients with safe and natural treatment options.The expansion of the pharmacy also supports the cultivation of medicinal plants in the region and creates employment opportunities for trained AYUSH practitioners. By supplying essential medicines directly to hospitals, the initiative is expected to improve healthcare delivery in rural and remote areas where access to medical facilities is limited.Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH University ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/18/333649-ayush-medicines.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gorakhpur, AYUSH, University, Pharmacy, expands, production, supply, Govt, Hospitals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/18/333649-ayush-medicines.webp"><div class="pasted-from-word-wrapper"><p>Gorakhpur: Mahayogi Guru Gorakhnath<a href="https://medicaldialogues.in/topics/ayush%20university" target="_blank"> AYUSH University</a>, Gorakhpur in Uttar Pradesh, has been directed to supply Ayurvedic medicines to state-run Ayurvedic hospitals.</p><p>The university administration has stepped up preparations to ensure that medicines produced on campus are delivered efficiently to <a href="https://medicaldialogues.in/topics/government-hospital" target="_blank">government hospitals</a> across the state.</p><p>The pharmacy produces a wide range of essential Ayurvedic medicines, including Madhumehari, which is specifically used for diabetes management, Ashwagandha, Arjun bark, Triphala, Haritaki, and Vibhitaki powders, reports <i><a href="https://www.bhaskar.com/local/uttar-pradesh/gorakhpur/bhathat/news/ayush-university-supplies-medicines-govt-hospitals-137646082.html" target="_blank">Dainik Bhaskar</a></i>. These medicines are widely recognised for their natural healing properties and are used in treating various health conditions, such as metabolic disorders, heart problems, digestive issues, and general wellness maintenance.</p><p>Production of Madhumehari has seen a substantial increase, rising from 60 kilograms to nearly 12 quintals to meet the growing demand in government hospitals. The university has prioritized Madhumehari for initial supply, ensuring that patients suffering from diabetes in public Ayurvedic hospitals receive timely access to this important medicine. </p><p>Following this first phase, other herbal powders and Ayurvedic formulations produced at the pharmacy will be systematically supplied to hospitals across the state, expanding the availability of essential traditional medicines for a wide range of treatments.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/up-govt-steps-in-to-expedite-pending-construction-at-ayush-university-168287">Also Read:UP Govt steps in to expedite pending construction at AYUSH University</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Speaking to The Daily, Vice-Chancellor Dr. K. Ramchandra Reddy stated that the production process uses modern automated machinery and that strict quality checks are in place to maintain high standards. He added that the initiative will ensure the regular availability of Ayurvedic medicines at government hospitals, providing patients with safe and natural treatment options.</p><p>The expansion of the pharmacy also supports the cultivation of medicinal plants in the region and creates employment opportunities for trained AYUSH practitioners. By supplying essential medicines directly to hospitals, the initiative is expected to improve healthcare delivery in rural and remote areas where access to medical facilities is limited.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/medicine-distribution-delay-triggers-uproar-at-gorakhpur-ayush-university-168195">Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH University</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Medical officer arrested in Thane for taking Rs 2,000 bribe</title>
<link>https://edusehat.com/en/medical-officer-arrested-in-thane-for-taking-rs-2000-bribe</link>
<guid>https://edusehat.com/en/medical-officer-arrested-in-thane-for-taking-rs-2000-bribe</guid>
<description><![CDATA[ Thane: The Anti-Corruption Bureau (ACB) has arrested a medical officer from Maharashtra&#039;s Thane district for allegedly accepting a bribe of Rs 2,000 for issuing a medical certificate required for the renewal of a gun licence, an official said here Friday.The accused has been identified as a medical officer, posted at Murbad Rural Hospital, said the Thane unit of the Anti-Corruption Bureau (ACB).As per the complaint, a man had approached the Murbad hospital seeking a medical certificate required for renewal of his father’s revolver licence.Also Read:CBI arrests medical officer, Noida hospital executive in Rs 3 lakh bribery case“An ambulance driver allegedly demanded Rs 3,000 on behalf of the medical officer for getting the certificate issued. The amount was later negotiated down to Rs 2,000,” said inspector Rupali Pol from ACB, news agency PTI reported.Following the complaint, the ACB laid a trap on the hospital premises and arrested the medical officer, allegedly while accepting the bribe on Thursday.  “Our team caught the medical officer red-handed while accepting the bribe amount. The ambulance driver is currently absconding, and a search is underway to trace him,” Pol said. The ACB has launched an investigation to ascertain if more persons are involved and to verify if similar illegal demands were made from other applicants, she said, adding that the accused has been booked under the Prevention of Corruption Act.  Medical Dialogues had earlier reported that in a shocking case raising serious questions about financial irregularities at a premier health institution, an alleged embezzlement of nearly Rs 50 lakh has been uncovered at the All India Institute of Medical Sciences (AIIMS), Patna. The irregularities came to light during an internal audit, prompting swift administrative action. Following the audit findings, AIIMS Patna has suspended the Chief Cashier with immediate effect and initiated a departmental inquiry into the matter.Also Read:SCB Medical College Doctor detained, Rs 2.63 lakh cash seized ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/13/297615-arrested-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, officer, arrested, Thane, for, taking, 2, 000, bribe</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/13/297615-arrested-1.webp"><div class="pasted-from-word-wrapper"><p><span>Thane: </span><span>The </span>Anti-Corruption Bureau (ACB) has <a href="https://medicaldialogues.in/topics/arrested" target="_blank">arrested</a> a medical officer from Maharashtra's Thane district for allegedly <span>accepting a </span><a href="https://medicaldialogues.in/topics/bribe" target="_blank">bribe </a><span>of Rs 2,000 for issuing a medical certificate required for the renewal of a gun licence, an official said here Friday.</span></p></div><div class="pasted-from-word-wrapper"><p>The accused has been identified as a medical officer, posted at Murbad Rural Hospital, said the Thane unit of the Anti-Corruption Bureau (ACB).</p><p>As per the complaint, a man had approached the Murbad hospital seeking a medical certificate required for renewal of his father’s revolver licence.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/cbi-arrests-medical-officer-noida-hospital-executive-in-rs-3-lakh-bribery-case-166768"><b>Also Read:CBI arrests medical officer, Noida hospital executive in Rs 3 lakh bribery case</b></a></p><p>“An ambulance driver allegedly demanded Rs 3,000 on behalf of the medical officer for getting the certificate issued. The amount was later negotiated down to Rs 2,000,” said inspector Rupali Pol from ACB, news agency PTI reported.</p><p>Following the complaint, the ACB laid a trap on the hospital premises and arrested the medical officer, allegedly while accepting the bribe on Thursday.  </p><p>“Our team caught the medical officer red-handed while accepting the bribe amount. The ambulance driver is currently absconding, and a search is underway to trace him,” Pol said. <br></p><p>The ACB has launched an investigation to ascertain if more persons are involved and to verify if similar illegal demands were made from other applicants, she said, adding that the accused has been booked under the Prevention of Corruption Act.  </p><p>Medical Dialogues had earlier reported that in a shocking case raising serious questions about financial irregularities at a premier health institution, an alleged embezzlement of nearly Rs 50 lakh has been uncovered at the All India Institute of Medical Sciences (AIIMS), Patna. The irregularities came to light during an internal audit, prompting swift administrative action. Following the audit findings, AIIMS Patna has suspended the Chief Cashier with immediate effect and initiated a departmental inquiry into the matter.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/scb-medical-college-doctor-detained-rs-263-lakh-cash-seized-163865"><b>Also Read:SCB Medical College Doctor detained, Rs 2.63 lakh cash seized</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Pune Civic Hospitals continue to face financial irregularities amid manual billing systems</title>
<link>https://edusehat.com/en/pune-civic-hospitals-continue-to-face-financial-irregularities-amid-manual-billing-systems</link>
<guid>https://edusehat.com/en/pune-civic-hospitals-continue-to-face-financial-irregularities-amid-manual-billing-systems</guid>
<description><![CDATA[ Pune: The
Pimpri-Chinchwad Municipal Corporation (PCMC) has continued to depend on contractual
employees and manual billing systems at its civic hospitals, even as at
least four major instances of financial irregularities have been reported in hospital billing sections over the past three years.

Reports indicate that several
financial discrepancies have surfaced at billing counters in recent years. Despite
repeated assurances from the civic body about introducing digital systems, the
transition has moved slowly.Also Read:Four Pimpri-Chinchwad Hospital staff accused of siphoning Rs 9.25 lakhThe continued use of
offline billing methods has reportedly created loopholes that some staff
members have allegedly used to alter records and divert public money. The delay
in digitising operations has therefore drawn attention to vulnerabilities in
the current system at municipal healthcare facilities. Officials suggested that
relying on an online billing system and regular monitoring might be a solution to
the problem, reports The Times of India.

Medical
Dialogues had earlier reported that four staff members at a Pimpri-Chinchwad Municipal
Corporation-run hospital were accused of manipulating billing records and
siphoning off lakhs of rupees. Preliminary findings indicate that one permanent
employee and three contractual staff were involved, siphoning off around Rs
9.25 lakh over a period of time. Among the four staff, there were three
contractual employees and one permanent billing clerk at Prabhakar Malharrao
Kute Hospital in Akurdi.  Following the discovery, PCMC authorities
conducted inspections at other civic hospitals and found a similar pattern of
suspected financial misconduct at a hospital in Bhosari, where two employees
were allegedly involved in misappropriating nearly Rs 10 lakh.

Investigators found that
staff manipulated billing records by collecting the full payment from patients
but reporting a lower amount in official documents. For instance, while a
patient might be charged Rs. 100, the copy submitted to the civic authorities
would show only Rs. 25, allowing the staff to keep the remaining Rs. 75, reports     The Daily.

Dr Laxman Gophane, chief
medical health officer of PCMC, pointed out that an investigation is underway.
&quot;We have written to the police seeking an FIR against four individuals in
one case. A second FIR against two more individuals in a separate incident will
be proposed soon,&quot; he said. Dr Gophane also added that senior officials are
also being investigated to check accountability. However, an official FIR is
yet to be registered in either matter.Also Read:Woman Duped of Rs 23 Lakh in Fake Hospital Pharmacy Deal, Three BookedMany officials pointed
out that this has been a recurring problem. In December 2024, staff at Jijamata
Hospital were found to be involved in a fraud where a significant portion of
patient payments was not deposited in official accounts. Similarly, in November
2023, a contractual employee at Yashwantrao Chavan Memorial Hospital used
fabricated receipts to misappropriate funds by underreporting collections. A
senior health department official attributed the continued dependence on
third-party staff to a shortage of permanent personnel.  &quot;Clerical
work requires a large volume of staff to work round-the-clock, and PCMC
currently lacks that internal strength,&quot; he explained. 

Officials said that
introducing a fully digital billing system with real-time monitoring is the
only sustainable solution. At present, most of the nine hospitals run by the
Pimpri Chinchwad Municipal Corporation still rely on offline systems, though
the city’s largest facility, Yashwantrao Chavan Memorial Hospital, has shifted
almost all its billing counters to an online system in the past three months.

“We are in the process of
making online billing mandatory across all hospitals within the next 45 days,”
Dr Gophane told The Daily. Sayali Kiran Nadhe, president of the Congress city unit&#039;s
women&#039;s wings, also pointed out that handwritten bills become a medium of fraud.
“Shifting to a fully online system would significantly reduce the scope for
manipulation,” Nadhe said. She further demanded that to uphold an unbiased
investigation, these cases should be dealt with by the police rather than the internal
administration. “In previous instances, the civic body allowed those involved
to continue working after they returned the misappropriated amount. This cycle
must stop. Those involved must be suspended and face strict legal action to
deter others,” she added. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/24/279914-money.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 17:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pune, Civic, Hospitals, continue, face, financial, irregularities, amid, manual, billing, systems</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/24/279914-money.webp"><p>Pune: The
Pimpri-Chinchwad Municipal Corporation (PCMC) has continued to depend on contractual
employees and manual <a href="https://medicaldialogues.in/topics/hospital-bill" target="_blank">billing</a> systems at its civic hospitals, even as at
least four major instances of financial irregularities have been reported in hospital billing sections over the past three years.<br></p><div class="pasted-from-word-wrapper">

<p>Reports indicate that several
financial discrepancies have surfaced at billing counters in recent years. Despite
repeated assurances from the civic body about introducing digital systems, the
transition has moved slowly.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/four-pimpri-chinchwad-hospital-staff-accused-of-siphoning-rs-925-lakh-166840"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/07/21/295225-fraud-1.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/four-pimpri-chinchwad-hospital-staff-accused-of-siphoning-rs-925-lakh-166840"><span class="read-this-also">Also Read:</span>Four Pimpri-Chinchwad Hospital staff accused of siphoning Rs 9.25 lakh</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>The continued use of
offline billing methods has reportedly created loopholes that some staff
members have allegedly used to alter records and divert public money. The delay
in digitising operations has therefore drawn attention to vulnerabilities in
the current system at municipal healthcare facilities. Officials suggested that
relying on an online billing system and regular monitoring might be a solution to
the problem, reports The <a href="https://timesofindia.indiatimes.com/city/pune/four-billing-scams-at-civic-hospitals-in-3-years-pcmc-yet-to-fix-system-flaws/articleshow/130095268.cms" target="_blank" rel="nofollow">Times of India</a>.</p></div><div class="pasted-from-word-wrapper">

<p>Medical
Dialogues had earlier reported that four staff members at a Pimpri-Chinchwad Municipal
Corporation-run hospital were accused of manipulating billing records and
siphoning off lakhs of rupees. Preliminary findings indicate that one permanent
employee and three contractual staff were involved, siphoning off around Rs
9.25 lakh over a period of time. Among the four staff, there were three
contractual employees and one permanent billing clerk at Prabhakar Malharrao
Kute Hospital in Akurdi.  Following the discovery, PCMC authorities
conducted inspections at other civic hospitals and found a similar pattern of
suspected financial misconduct at a hospital in Bhosari, where two employees
were allegedly involved in misappropriating nearly Rs 10 lakh.</p>

<p>Investigators found that
staff manipulated billing records by collecting the full payment from patients
but reporting a lower amount in official documents. For instance, while a
patient might be charged Rs. 100, the copy submitted to the civic authorities
would show only Rs. 25, allowing the staff to keep the remaining Rs. 75, reports     The Daily.</p>

<p>Dr Laxman Gophane, chief
medical health officer of PCMC, pointed out that an investigation is underway.
"We have written to the police seeking an FIR against four individuals in
one case. A second FIR against two more individuals in a separate incident will
be proposed soon," he said. Dr Gophane also added that senior officials are
also being investigated to check accountability. However, an official FIR is
yet to be registered in either matter.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/industry/pharma/woman-duped-of-rs-23-lakh-in-fake-hospital-pharmacy-deal-three-booked-166715"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/07/10/294129-scam.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/woman-duped-of-rs-23-lakh-in-fake-hospital-pharmacy-deal-three-booked-166715"><span class="read-this-also">Also Read:</span>Woman Duped of Rs 23 Lakh in Fake Hospital Pharmacy Deal, Three Booked</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>Many officials pointed
out that this has been a recurring problem. In December 2024, staff at Jijamata
Hospital were found to be involved in a fraud where a significant portion of
patient payments was not deposited in official accounts. Similarly, in November
2023, a contractual employee at Yashwantrao Chavan Memorial Hospital used
fabricated receipts to misappropriate funds by underreporting collections. A
senior health department official attributed the continued dependence on
third-party staff to a shortage of permanent personnel.  "Clerical
work requires a large volume of staff to work round-the-clock, and PCMC
currently lacks that internal strength," he explained. </p>

<p>Officials said that
introducing a fully digital billing system with real-time monitoring is the
only sustainable solution. At present, most of the nine hospitals run by the
Pimpri Chinchwad Municipal Corporation still rely on offline systems, though
the city’s largest facility, Yashwantrao Chavan Memorial Hospital, has shifted
almost all its billing counters to an online system in the past three months.</p>

<p>“We are in the process of
making online billing mandatory across all hospitals within the next 45 days,”
Dr Gophane told The Daily. Sayali Kiran Nadhe, president of the Congress city unit's
women's wings, also pointed out that handwritten bills become a medium of fraud.
“Shifting to a fully online system would significantly reduce the scope for
manipulation,” Nadhe said. She further demanded that to uphold an unbiased
investigation, these cases should be dealt with by the police rather than the internal
administration. “In previous instances, the civic body allowed those involved
to continue working after they returned the misappropriated amount. This cycle
must stop. Those involved must be suspended and face strict legal action to
deter others,” she added.</p></div>]]> </content:encoded>
</item>

<item>
<title>Punya Salila Srivastava reviews cleanliness measures at AIIMS Mangalagiri</title>
<link>https://edusehat.com/en/punya-salila-srivastava-reviews-cleanliness-measures-at-aiims-mangalagiri</link>
<guid>https://edusehat.com/en/punya-salila-srivastava-reviews-cleanliness-measures-at-aiims-mangalagiri</guid>
<description><![CDATA[ Mangalagiri: The Ministry of Health and Family Welfare is observing Swachhata Pakhwada 2026 from 1st April to 15th April 2026 across all its hospitals and institutes, in accordance with the calendar issued by the Cabinet Secretariat. As part of the initiative, the Union Health Secretary, Smt. Punya Salila Srivastava visited the All India Institute of Medical Sciences (AIIMS), Mangalagiri, to review the ongoing activities under Swachhata Pakhwada and to dedicate the newly constructed Undergraduate Girls’ Hostel to the institute.During the visit, the Union Health Secretary undertook a comprehensive review of the cleanliness and sanitation initiatives being implemented as part of the campaign. The review covered key areas including hospital premises, patient care facilities, waste management systems, and public utility spaces. The Secretary commended the efforts of the institute in promoting cleanliness, waste segregation, and awareness among staff, students, and patients, the PIB stated.Also Read:Doctors carry hopes of millions- MoS Health at AIIMS Manglagiri convocationIt was observed that AIIMS Mangalagiri has undertaken several activities during the Pakhwada, including cleanliness drives, awareness campaigns, and initiatives aimed at strengthening biomedical waste management and infection control practices.An interaction session was subsequently held at the institute auditorium, where the Secretary engaged with Heads of Departments, faculty members, staff, and students. Addressing the gathering, the Union Health Secretary stated that “Swachhata Pakhwada is being implemented in alignment with the Hon’ble Prime Minister’s vision of Swachh Bharat, emphasizing cleanliness as a fundamental pillar of national development. Under the guidance of the Hon’ble Union Health Minister, the initiative focuses on strengthening the preventive and promotive aspects of healthcare.”She emphasized that cleanliness and sanitation are critical enablers of preventive healthcare and contribute significantly to reducing disease burden and improving public health outcomes. The Secretary also appreciated AIIMS Mangalagiri for its proactive role in delivering inclusive, accessible, and quality healthcare services, particularly in the domain of super-speciality care.The Secretary also reviewed an exhibition of Information, Education and Communication (IEC) materials prepared on Swachhata Pakhwada and appreciated the efforts made towards promoting awareness and behavioural change.As part of the visit, the Secretary reviewed the ‘Waste to Art’ campaign gallery, where innovative models created by students using recycled materials were displayed. She appreciated the creativity reflected in various exhibits as well as canvas paintings, slogan cards, and pot paintings developed on the theme of Swachhata Pakhwada. The Secretary also signed the Swachhata pledge banner as part of the ongoing signature campaign.On the occasion, awards were presented to students for outstanding performance in Swachhata-themed competitions. The Secretary also felicitated sanitary workers, security personnel, and staff members for their contribution to maintaining a clean, safe, and patient-friendly hospital environment during the campaign.As part of the institutional review, the Secretary visited key hospital facilities, including the ABHA registration area, Outpatient Department (OPD), radiology services such as mammography, X-ray and ultrasound units, and the Radiation Oncology unit equipped with advanced cancer care facilities, including Linear Accelerator (LINAC) and brachytherapy. Inpatient wards and Trauma &amp; Emergency/Casualty services were also reviewed.During the visit, the Union Health Secretary dedicated the Undergraduate Girls’ Hostel Block, a G+9-storied residential facility aimed at enhancing accommodation capacity and providing a safe and conducive living environment for female undergraduate students.The visit also included interactions with faculty members, students, and administrative staff, wherein various aspects related to institutional development, academic excellence, and patient care services were discussed. The Secretary appreciated the dedication of healthcare professionals and reiterated the need for continued focus on quality service delivery. The visit commenced with a plantation drive in the campus, reflecting the Ministry’s commitment to environmental sustainability alongside cleanliness.Senior officials of the Ministry of Health and Family Welfare, along with the Executive Director, faculty members, and staff of AIIMS Mangalagiri, were present during the visit.Also Read:AIIMS Mangalagiri to launch Bone Marrow Transplants ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/10/340781-ayush-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 13:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Punya, Salila, Srivastava, reviews, cleanliness, measures, AIIMS, Mangalagiri</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/10/340781-ayush-2.webp"><div class="pasted-from-word-wrapper"><p><span>Mangalagiri: The Ministry of Health and Family Welfare is observing Swachhata Pakhwada 2026 from 1st April to 15th April 2026 across all its hospitals and institutes, in accordance with the calendar issued by the Cabinet Secretariat. </span></p><p>As part of the initiative, the Union Health Secretary, Smt. Punya Salila Srivastava visited the All India Institute of Medical Sciences (AIIMS), Mangalagiri, to review the ongoing activities under Swachhata Pakhwada and to dedicate the newly constructed Undergraduate Girls’ Hostel to the institute.</p><p>During the visit, the Union Health Secretary undertook a comprehensive review of the cleanliness and sanitation initiatives being implemented as part of the campaign. The review covered key areas including hospital premises, patient care facilities, waste management systems, and public utility spaces. The Secretary commended the efforts of the institute in promoting cleanliness, waste segregation, and awareness among staff, students, and patients, the PIB stated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/doctors-carry-hopes-of-millions-mos-health-at-aiims-manglagiri-convocation-164916"><b>Also Read:Doctors carry hopes of millions- MoS Health at AIIMS Manglagiri convocation</b></a></p><p>It was observed that <a href="https://medicaldialogues.in/topics/AIIMS-Mangalagiri" target="_blank">AIIMS Mangalagiri</a> has undertaken several activities during the Pakhwada, including cleanliness drives, awareness campaigns, and initiatives aimed at strengthening biomedical waste management and infection control practices.</p><p>An interaction session was subsequently held at the institute auditorium, where the Secretary engaged with Heads of Departments, faculty members, staff, and students. Addressing the gathering, the Union Health Secretary stated that “Swachhata Pakhwada is being implemented in alignment with the Hon’ble Prime Minister’s vision of Swachh Bharat, emphasizing cleanliness as a fundamental pillar of national development. Under the guidance of the Hon’ble Union Health Minister, the initiative focuses on strengthening the preventive and promotive aspects of healthcare.”</p><p>She emphasized that cleanliness and sanitation are critical enablers of preventive healthcare and contribute significantly to reducing disease burden and improving public health outcomes. The Secretary also appreciated <a href="https://medicaldialogues.in/topics/AIIMS-Mangalagiri" target="_blank">AIIMS Mangalagiri</a> for its proactive role in delivering inclusive, accessible, and quality healthcare services, particularly in the domain of super-speciality care.</p><p>The Secretary also reviewed an exhibition of Information, Education and Communication (IEC) materials prepared on Swachhata Pakhwada and appreciated the efforts made towards promoting awareness and behavioural change.</p><p>As part of the visit, the Secretary reviewed the ‘Waste to Art’ campaign gallery, where innovative models created by students using recycled materials were displayed. She appreciated the creativity reflected in various exhibits as well as canvas paintings, slogan cards, and pot paintings developed on the theme of Swachhata Pakhwada. The Secretary also signed the Swachhata pledge banner as part of the ongoing signature campaign.</p><p>On the occasion, awards were presented to students for outstanding performance in Swachhata-themed competitions. The Secretary also felicitated sanitary workers, security personnel, and staff members for their contribution to maintaining a clean, safe, and patient-friendly hospital environment during the campaign.</p><p>As part of the institutional review, the Secretary visited key hospital facilities, including the ABHA registration area, Outpatient Department (OPD), radiology services such as mammography, X-ray and ultrasound units, and the Radiation Oncology unit equipped with advanced cancer care facilities, including Linear Accelerator (LINAC) and brachytherapy. Inpatient wards and Trauma & Emergency/Casualty services were also reviewed.</p><p>During the visit, the Union Health Secretary dedicated the Undergraduate Girls’ Hostel Block, a G+9-storied residential facility aimed at enhancing accommodation capacity and providing a safe and conducive living environment for female undergraduate students.</p><p>The visit also included interactions with faculty members, students, and administrative staff, wherein various aspects related to institutional development, academic excellence, and patient care services were discussed. The Secretary appreciated the dedication of healthcare professionals and reiterated the need for continued focus on quality service delivery. The visit commenced with a plantation drive in the campus, reflecting the Ministry’s commitment to environmental sustainability alongside cleanliness.</p><p>Senior officials of the Ministry of Health and Family Welfare, along with the Executive Director, faculty members, and staff of AIIMS Mangalagiri, were present during the visit.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-mangalagiri-to-launch-bone-marrow-transplants-149490"><b>Also Read:AIIMS Mangalagiri to launch Bone Marrow Transplants</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>COMBINE&#45;Angina Study Explained: Expert Insights from Dr Abhishek Shukla</title>
<link>https://edusehat.com/en/combine-angina-study-explained-expert-insights-from-dr-abhishek-shukla</link>
<guid>https://edusehat.com/en/combine-angina-study-explained-expert-insights-from-dr-abhishek-shukla</guid>
<description><![CDATA[ In this video, Dr Abhishek Shukla, Consultant Cardiologist at Ajanta Hospital, Lucknow, shares key insights from the COMBINE-Angina study - an international, prospective study evaluating the early addition of trimetazidine in patients with stable angina who remain symptomatic despite first-line hemodynamic therapy.
The study, published in the International Journal of Cardiology and presented at ESC Congress 2025, highlights the clinical value of combining metabolic and hemodynamic approaches in angina management.

Dr Shukla discusses the real-world relevance of SAQ-7 score improvements, the impact on patients’ daily lives, and the applicability of these findings in Indian clinical practice. He also shares practical takeaways for cardiologists managing symptomatic stable angina. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/30/338362-featured-images-1-28.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 13:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>COMBINE-Angina, Study, Explained:, Expert, Insights, from, Abhishek, Shukla</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/30/338362-featured-images-1-28.webp"><div class="pasted-from-word-wrapper">In this video, Dr Abhishek Shukla, Consultant Cardiologist at Ajanta Hospital, Lucknow, shares key insights from the COMBINE-Angina study - an international, prospective study evaluating the early addition of trimetazidine in patients with stable angina who remain symptomatic despite first-line hemodynamic therapy.</div><div class="pasted-from-word-wrapper">
The study, published in the International Journal of Cardiology and presented at ESC Congress 2025, highlights the clinical value of combining metabolic and hemodynamic approaches in angina management.

Dr Shukla discusses the real-world relevance of SAQ-7 score improvements, the impact on patients’ daily lives, and the applicability of these findings in Indian clinical practice. He also shares practical takeaways for cardiologists managing symptomatic stable angina.</div>]]> </content:encoded>
</item>

<item>
<title>CM Sukhu announces increase in retirement age to address faculty shortage</title>
<link>https://edusehat.com/en/cm-sukhu-announces-increase-in-retirement-age-to-address-faculty-shortage</link>
<guid>https://edusehat.com/en/cm-sukhu-announces-increase-in-retirement-age-to-address-faculty-shortage</guid>
<description><![CDATA[ Shimla: Chief Minister Sukhvinder Singh Sukhu on Wednesday announced that the retirement age for professors in government medical colleges will be increased to 65 years for the next three years, in a bid to address the ongoing shortage of faculty across Himachal Pradesh. The decision is aimed at strengthening medical education, particularly in newer institutions and in addressing the shortage of super-specialists at Tanda Medical College. The Chief Minister also clarified that the move would not impact promotional opportunities for other faculty members.Also Read:CM Sukhu inaugurates nuclear medicine block at IGMC ShimlaTo further strengthen the system, the government will designate assistant and associate professors wherever required. In addition, postgraduate (PG) seats are being significantly increased across medical colleges, including 57 in Tanda, 29 in Mandi, 32 in Nahan, 33 in Chamba, 67 in Hamirpur, and 96 in Indira Gandhi Medical College, Shimla. This expansion is expected to improve institutional efficiency, enhance training capacity, and ultimately lead to better patient care.While chairing a review meeting of the medical education department, Sukhu directed officials to ensure efficient healthcare services across all government medical colleges. He emphasised that strengthening healthcare infrastructure, especially diagnostic services, remains a top priority for the government.
The CM also announced that all vacant nursing posts would be filled by November this year, along with the recruitment of adequate technical staff. The govt has earmarked Rs 192 crore for Phase II of Chamba Medical College and Rs 500 crore for Nahan Medical College, he added. Also, Rs 3,000 crore will be invested in modern medical equipment, alongside efforts to promote health tourism in the state, said Sukhu, reports TOI.
Highlighting the government’s priorities, the Chief Minister emphasised that health and education remain top priorities, assuring that there is no shortage of funds for these sectors.
As per Tribune India, the meeting was attended by Health and Family Welfare Minister Dr (Col) Dhani Ram Shandil, Secretary Health M Sudha Devi, and Director Health Education Dr Rakesh Sharma. Principals of all medical colleges joined the meeting virtually.
Also Read:Himachal Govt strengthens healthcare infrastructure in Una district ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/03/04/203929-sukhvinder-singh-sukhu-new.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 13:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sukhu, announces, increase, retirement, age, address, faculty, shortage</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/03/04/203929-sukhvinder-singh-sukhu-new.webp"><p><b>Shimla: </b>Chief Minister <a href="https://medicaldialogues.in/topics/sukhvinder-singh-sukhu">Sukhvinder Singh Sukhu</a> on Wednesday announced that the retirement age for professors in <a href="https://medicaldialogues.in/topics/government-medical-colleges">government medical colleges</a> will be increased to 65 years for the next three years, in a bid to address the ongoing shortage of faculty across Himachal Pradesh. </p><p>The decision is aimed at strengthening medical education, particularly in newer institutions and in addressing the shortage of super-specialists at Tanda Medical College. The Chief Minister also clarified that the move would not impact promotional opportunities for other faculty members.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/cm-sukhu-inaugurates-nuclear-medicine-block-at-igmc-shimla-167963"><b>Also Read:CM Sukhu inaugurates nuclear medicine block at IGMC Shimla</b></a></p><p>To further strengthen the system, the government will designate assistant and associate professors wherever required. In addition, postgraduate (PG) seats are being significantly increased across medical colleges, including 57 in Tanda, 29 in Mandi, 32 in Nahan, 33 in Chamba, 67 in Hamirpur, and 96 in Indira Gandhi Medical College, Shimla. This expansion is expected to improve institutional efficiency, enhance training capacity, and ultimately lead to better patient care.</p><p>While chairing a review meeting of the medical education department, Sukhu directed officials to ensure efficient healthcare services across all government medical colleges. He emphasised that strengthening healthcare infrastructure, especially diagnostic services, remains a top priority for the government.
</p><p>The CM also announced that all vacant nursing posts would be filled by November this year, along with the recruitment of adequate technical staff. The govt has earmarked Rs 192 crore for Phase II of Chamba Medical College and Rs 500 crore for Nahan Medical College, he added. Also, Rs 3,000 crore will be invested in modern medical equipment, alongside efforts to promote health tourism in the state, said Sukhu, reports <a href="https://timesofindia.indiatimes.com/city/chandigarh/cm-announces-raising-retirement-age-of-medical-profs-to-tackle-shortage/articleshow/130122113.cms" rel="nofollow">TOI.</a>
</p><p>Highlighting the government’s priorities, the Chief Minister emphasised that health and education remain top priorities, assuring that there is no shortage of funds for these sectors.
</p><p>As per Tribune India, the meeting was attended by Health and Family Welfare Minister Dr (Col) Dhani Ram Shandil, Secretary Health M Sudha Devi, and Director Health Education Dr Rakesh Sharma. Principals of all medical colleges joined the meeting virtually.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/himachal-pradesh/himachal-govt-strengthens-healthcare-infrastructure-in-una-district-166117"><b>Also Read:Himachal Govt strengthens healthcare infrastructure in Una district</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Jharkhand to set up health cottages in every panchayat: Irfan Ansari</title>
<link>https://edusehat.com/en/jharkhand-to-set-up-health-cottages-in-every-panchayat-irfan-ansari</link>
<guid>https://edusehat.com/en/jharkhand-to-set-up-health-cottages-in-every-panchayat-irfan-ansari</guid>
<description><![CDATA[ Ranchi: Jharkhand Health Minister Irfan Ansari on Wednesday announced that the state government will soon set up &#039;health cottages&#039; in every panchayat to provide treatment and promote a health-friendly environment.  Addressing a state-level workshop on eSanjeevani telemedicine in Ranchi, Ansari also stated that 747 Abua medical stores are being opened across the state to make medicines more accessible.   &quot;Medicines will be available at Abua medical stores along with information on their use, side effects and method of consumption in simple language,&quot; he added, news agency PTI reported.  Also Read:Jharkhand to launch Liver, Kidney transplant services soonAnsari also said advanced and AI-based technologies would be incorporated into the state&#039;s healthcare system to bring about comprehensive improvements.He also announced that a monitoring cell will soon be established to ensure quality health services.  &quot;A new policy will be implemented to ensure the availability of blood. Blood will be made available through an agency, and a toll-free number will be issued for the convenience of the people,&quot; the minister said.  Civil surgeons from across the state, representatives of eSanjeevani telemedicine and senior health officials participated in the workshop. Thirteen doctors and 12 Community Health Officers (CHO) were felicitated for their outstanding performance on the occasion, reports PTI.  Medical Dialogues had earlier reported that the Jharkhand Government will soon recruit 1,200 doctors to strengthen healthcare services across the state, Health Minister Irfan Ansari said. He said the appointments would be made through the Jharkhand Public Service Commission (JPSC) to address the shortage of medical professionals in government hospitals.    “We will soon recruit over 1,200 doctors through JPSC to improve healthcare facilities in hospitals,” he said while handing appointment letters to 76 newly-recruited contractual doctors at a programme in Ranchi.  Also Read:Jharkhand Govt approves 245 block public health units at Rs 203.35 Crore ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340531-irfan-ansari.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 13:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jharkhand, set, health, cottages, every, panchayat:, Irfan, Ansari</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340531-irfan-ansari.webp"><div class="pasted-from-word-wrapper"><p><span>Ranchi: Jharkhand Health Minister <a href="https://medicaldialogues.in/topics/Irfan-Ansari" target="_blank">Irfan Ansari</a> on Wednesday announced that the state government will soon set up 'health cottages' in every panchayat to provide treatment and promote a health-friendly environment.  </span></p><p>Addressing a state-level workshop on <a href="https://medicaldialogues.in/topics/eSanjeevani-telemedicine" target="_blank">eSanjeevani telemedicine</a> in Ranchi, Ansari also stated that 747 Abua medical stores are being opened across the state to make medicines more accessible.   </p><p>"Medicines will be available at Abua medical stores along with information on their use, side effects and method of consumption in simple language," he added, news agency PTI reported.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jharkhand-to-launch-liver-kidney-transplant-services-soon-164676"><b>Also Read:Jharkhand to launch Liver, Kidney transplant services soon</b></a></p><p>Ansari also said advanced and AI-based technologies would be incorporated into the state's healthcare system to bring about comprehensive improvements.</p><p>He also announced that a monitoring cell will soon be established to ensure quality health services.  </p><p>"A new policy will be implemented to ensure the availability of blood. Blood will be made available through an agency, and a toll-free number will be issued for the convenience of the people," the minister said.  </p><p>Civil surgeons from across the state, representatives of <a href="https://medicaldialogues.in/topics/eSanjeevani-telemedicine" target="_blank">eSanjeevani telemedicine</a> and senior health officials participated in the workshop. Thirteen doctors and 12 Community Health Officers (CHO) were felicitated for their outstanding performance on the occasion, reports PTI.  </p><p>Medical Dialogues had earlier reported that the Jharkhand Government will soon recruit 1,200 doctors to strengthen healthcare services across the state, Health Minister Irfan Ansari said. He said the appointments would be made through the Jharkhand Public Service Commission (JPSC) to address the shortage of medical professionals in government hospitals.    </p><p>“We will soon recruit over 1,200 doctors through JPSC to improve healthcare facilities in hospitals,” he said while handing appointment letters to 76 newly-recruited contractual doctors at a programme in Ranchi.  <br></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/jharkhand-govt-approves-245-block-public-health-units-at-rs-20335-crore-163221"><b>Also Read:Jharkhand Govt approves 245 block public health units at Rs 203.35 Crore</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>DCC Approves Real&#45;Time Digital Portal to Track NDPS&#45;Regulated Pharma Products</title>
<link>https://edusehat.com/en/dcc-approves-real-time-digital-portal-to-track-ndps-regulated-pharma-products</link>
<guid>https://edusehat.com/en/dcc-approves-real-time-digital-portal-to-track-ndps-regulated-pharma-products</guid>
<description><![CDATA[ New Delhi: In a significant move aimed at tightening regulatory oversight over controlled pharmaceutical substances, the Drugs Consultative Committee (DCC) has approved a proposal for the development of a centralized, real-time digital portal to track pharmaceutical products regulated under the Narcotic Drugs and Psychotropic Substances Act (NDPS Act).The matter was discussed at the 68th meeting of the DCC held on March 20, 2026, through virtual mode.The committee was apprised of the urgent need for a centralized, real-time, end-to-end digital tracking mechanism for the manufacture, import/export, sale/distribution, stock, etc., of pharmaceutical Products regulated under the NDPS Act.DCC also deliberated about the proposed scope of the digital portal, key functional features, regulatory and legal considerations, the role of CDSCO and State Drug Regulatory Authorities, Implementation Strategy and its anticipated benefits.After detailed deliberation, DCC approved the proposal.Also Read:Illegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana RaidIt further recommended that the CDSCO hold consultations with the Central Bureau of Narcotics (CBN), which currently operates a portal for manufacturing units dealing with controlled substances.Regarding the above, it opined,&quot;A meeting of CDSCO may be held with CBN on the matter, as CBN presently maintains a portal for the manufacturing units.&quot;Additionally, the DCC also recommended that once this portal is developed, access may be provided to all the concerned agencies for effective surveillance and monitoring.Also Read:Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/07/240457-medicine-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 10 Apr 2026 02:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>DCC, Approves, Real-Time, Digital, Portal, Track, NDPS-Regulated, Pharma, Products</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/07/240457-medicine-2.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> In a significant move aimed at tightening regulatory oversight over controlled pharmaceutical substances, the Drugs Consultative Committee (DCC) has approved a proposal for the development of a centralized, real-time digital portal to track pharmaceutical products regulated under the Narcotic Drugs and Psychotropic Substances Act (NDPS Act).</p><p>The matter was discussed at the 68th meeting of the DCC held on March 20, 2026, through virtual mode.</p><p>The committee was apprised of the urgent need for a centralized, real-time, end-to-end digital tracking mechanism for the manufacture, import/export, sale/distribution, stock, etc., of pharmaceutical Products regulated under the NDPS Act.</p><p>DCC also deliberated about the proposed scope of the digital portal, key functional features, regulatory and legal considerations, the role of CDSCO and State Drug Regulatory Authorities, Implementation Strategy and its anticipated benefits.</p><p>After detailed deliberation, DCC approved the proposal.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/illegal-stockpiling-busted-pregabalin-alprazolam-medicines-seized-in-ludhiana-raid-168310">Also Read:Illegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana Raid</a></div><p>It further recommended that the CDSCO hold consultations with the Central Bureau of Narcotics (CBN), which currently operates a portal for manufacturing units dealing with controlled substances.</p><p>Regarding the above, it opined,</p><blockquote>"A meeting of CDSCO may be held with CBN on the matter, as CBN presently maintains a portal for the manufacturing units."</blockquote><p>Additionally, the DCC also recommended that once this portal is developed, access may be provided to all the concerned agencies for effective surveillance and monitoring.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/delhi-police-bust-rs-2-crore-fake-drug-racket-6-arrested-rs-50-crore-gst-fraud-network-exposed-168187">Also Read:Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed</a></div></div><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Doctors urge health minister to implement panel recommendations for &amp;apos;Pilot&#45;like&amp;apos; duty hours</title>
<link>https://edusehat.com/en/doctors-urge-health-minister-to-implement-panel-recommendations-for-pilot-like-duty-hours</link>
<guid>https://edusehat.com/en/doctors-urge-health-minister-to-implement-panel-recommendations-for-pilot-like-duty-hours</guid>
<description><![CDATA[ New Delhi: Welcoming the Parliamentary Health Committee&#039;s recommendations for &#039;Pilot-like Duty Hours&#039; for resident doctors, a medical association has recently written to the Union Health Minister, Shri J P Nadda, seeking urgent implementation of the same.&quot;We welcome the recommendation of the committee and urge to introduce working hours regulations as per other safety-critical professions like civil aviation to prevent fatigue-induced accidents,&quot; the Chairperson of UDF, Dr. Lakshya Mittal, mentioned in the letter addressed to Minister Nadda.The Parliamentary Standing Committee on Health and Family Welfare, headed by MP Prof. Ram Gopal Yadav, has submitted its report on 18.03.2026. Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, the Parliamentary Health Committee expressed concern about the excessive workload of doctors.In this 172nd report, the panel highlighted the possibility of clinical errors and burnout resulting in compromised patient safety and recommended formulated and strictly enforcing a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods and monitored rosters.&quot;The Committee is concerned about excessive continuous duty hours for Junior and Senior Residents and the risk of clinical errors and burnout, thereby compromising patient safety. The Committee, therefore, recommends that the Department formulate and strictly enforce a &#039;Clinical Duty Hours Regulation&#039; policy with mandatory rest periods, and monitored rosters, drawing a direct analogy from other safety-critical professions like civil aviation to prevent fatigue-induced accidents,&quot; the Committee mentioned in its report.Referring to the Panel&#039;s recommendations, United Doctors Front (UDF) mentioned in the letter addressed to Minister Nadda that as per Civil Aviation duty rules in India, Pilots can&#039;t fly excessive hours. Airlines must ensure proper rest for them.&quot;These rules aim to reduce pilot fatigue and improve flight safety. Resident doctors are also responsible for safeguarding their patients, and prevention of fatigue-induced errors will be in the larger interest of society,&quot; mentioned the letter.The association also referred to the Uniform Residency Scheme 1992 by MoHFW, which caps duty hours at 48 hours per week. Referring to this, the association pointed out how many medical colleges do not comply to these rules and mentioned, &quot;The Uniform Residency Scheme 1992 by MoHFW caps 48 hours a week and not more than 12 hours at a stretch duty. But most medical colleges are not implementing the same as violation of the rules and maintaining forged duty data is also not categorized as any irregularity or crime and no accounatility is fixed.&quot;UDF has requested the immediate implementation of the Uniform Residency Scheme of 1992. It has also requested the Minister to form a high-level committee to further examine appropriate steps to formulate other regulations to improve it as per civil aviation duty hour rules.&quot;Therefore, we request issuance of firm instructions to implement the Uniform Residency Scheme 1992 and to form a high-level committee to further examine appropriate steps to formulate other regulations to improve it as per civil aviation duty hours rules,&quot; the letter stated.Further referring to the report of the National Task Force 2024 on mental health issues of medical students, the letter added, &quot;We also refer to the National Task Force 2024 report on mental health issues of medical students, which is very alarming. The report highlights the urgent need for appropriate measures to address the mental health concerns of medical students.&quot;Speaking to Medical Dialogues, UDF Chairperson Dr. Lakshya Mittal welcomed the recommendations given by the Parliamentary Committee. He said, &quot;We welcome the recommendation of Parliamentary Standing Committee suggesting pilot like duty hour regulations for resident doctors. Both these professions are responsible for saving lives. It cannot be ignored in the Healthcare system. There is already a Uniform Residency Scheme 1992, which mandates 48-hours a week and 12 hours a shift. Unfortunately, it is not followed in most of the institutions. That&#039;s why we have written to the Honourable Union Health Minister for immediate enforcement, strict monitoring and accountability.&quot;&quot;A fatigued doctor is a risk to the patient safety. This is not only about the doctors&#039; wellfare, but also about the lives. That&#039;s why we are urging the Government to act immediately without any further delay,&quot; he added.Also Read: Doctors&#039; burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339651-duty-hours.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Doctors, urge, health, minister, implement, panel, recommendations, for, Pilot-like, duty, hours</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339651-duty-hours.webp"><p><b>New Delhi: </b>Welcoming the <a href="https://medicaldialogues.in/topics/parliamentary-committee-on-health">Parliamentary Health Committee's</a> recommendations for 'Pilot-like Duty Hours' for resident doctors, a medical association has recently written to the Union Health Minister, Shri J P Nadda, seeking urgent implementation of the same.</p><p>"We welcome the recommendation of the committee and urge to introduce working hours regulations as per other safety-critical professions like civil aviation to prevent fatigue-induced accidents," the Chairperson of UDF, Dr. Lakshya Mittal, mentioned in the letter addressed to Minister Nadda.</p><p>The Parliamentary Standing Committee on Health and Family Welfare, headed by MP Prof. Ram Gopal Yadav, has submitted its report on 18.03.2026. Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, the Parliamentary Health Committee expressed concern about the excessive workload of doctors.</p><p>In this 172nd report, the panel highlighted the possibility of clinical errors and burnout resulting in compromised patient safety and recommended formulated and strictly enforcing a "Clinical <a href="https://medicaldialogues.in/topics/duty-hours">Duty Hours</a> Regulation" policy with mandatory rest periods and monitored rosters.</p><p><i>"The Committee is concerned about excessive continuous duty hours for Junior and Senior Residents and the risk of clinical errors and burnout, thereby compromising patient safety. The Committee, therefore, recommends that the Department formulate and strictly enforce a 'Clinical Duty Hours Regulation' policy with mandatory rest periods, and monitored rosters, drawing a direct analogy from other safety-critical professions like civil aviation to prevent fatigue-induced accidents,"</i> the Committee mentioned in its report.</p><p>Referring to the Panel's recommendations, United Doctors Front (UDF) mentioned in the letter addressed to Minister Nadda that as per Civil Aviation duty rules in India, Pilots can't fly excessive hours. Airlines must ensure proper rest for them.</p><p>"These rules aim to reduce pilot fatigue and improve flight safety. Resident doctors are also responsible for safeguarding their patients, and prevention of fatigue-induced errors will be in the larger interest of society," mentioned the letter.</p><p>The association also referred to the <a href="https://medicaldialogues.in/topics/uniform-residency-scheme">Uniform Residency Scheme</a> 1992 by MoHFW, which caps duty hours at 48 hours per week. Referring to this, the association pointed out how many medical colleges do not comply to these rules and mentioned, "The Uniform Residency Scheme 1992 by MoHFW caps 48 hours a week and not more than 12 hours at a stretch duty. But most medical colleges are not implementing the same as violation of the rules and maintaining forged duty data is also not categorized as any irregularity or crime and no accounatility is fixed."</p><p>UDF has requested the immediate implementation of the Uniform Residency Scheme of 1992. It has also requested the Minister to form a high-level committee to further examine appropriate steps to formulate other regulations to improve it as per civil aviation duty hour rules.</p><p>"Therefore, we request issuance of firm instructions to implement the Uniform Residency Scheme 1992 and to form a high-level committee to further examine appropriate steps to formulate other regulations to improve it as per civil aviation duty hours rules," the letter stated.</p><p>Further referring to the report of the National Task Force 2024 on mental health issues of medical students, the letter added, "We also refer to the National Task Force 2024 report on mental health issues of medical students, which is very alarming. The report highlights the urgent need for appropriate measures to address the mental health concerns of medical students."</p><p>Speaking to Medical Dialogues, <a href="https://medicaldialogues.in/topics/udf">UDF</a> Chairperson Dr. Lakshya Mittal welcomed the recommendations given by the Parliamentary Committee. He said, "We welcome the recommendation of Parliamentary Standing Committee suggesting pilot like duty hour regulations for resident doctors. Both these professions are responsible for saving lives. It cannot be ignored in the Healthcare system. There is already a Uniform Residency Scheme 1992, which mandates 48-hours a week and 12 hours a shift. Unfortunately, it is not followed in most of the institutions. That's why we have written to the Honourable Union Health Minister for immediate enforcement, strict monitoring and accountability."</p><p>"A fatigued doctor is a risk to the patient safety. This is not only about the doctors' wellfare, but also about the lives. That's why we are urging the Government to act immediately without any further delay," he added.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters-167982"><b><i>Also Read: Doctors' burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Pre&#45;pregnancy parental obesity linked to next generation’s heightened fatty liver disease risk: Study</title>
<link>https://edusehat.com/en/pre-pregnancy-parental-obesity-linked-to-next-generations-heightened-fatty-liver-disease-risk-study</link>
<guid>https://edusehat.com/en/pre-pregnancy-parental-obesity-linked-to-next-generations-heightened-fatty-liver-disease-risk-study</guid>
<description><![CDATA[ Pre-pregnancy parental overweight and obesity is linked to the next generation’s heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.
If both parents are overweight or obese before they conceive, that child’s subsequent odds of developing MASLD by the age of 24 are more than 3 times higher, most of which is influenced by cumulative excess weight (BMI) during childhood, the findings indicate.
Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction associated steatotic liver disease, or MASLD for short, is the most common chronic liver disease worldwide, affecting an estimated 15% of children and more than 30% of adults, note the researchers.
Previously published research has emphasised the role of maternal obesity in future generations’ MASLD risk, but it’s not clear what role paternal obesity might have and if childhood overweight might also influence this risk.
To find out, the researchers assessed the associations between parental weight (BMI) before pregnancy and the odds of developing MASLD by the age of 24 in 1933 children from the UK Avon Longitudinal Study of Parents and Children (ALSPAC).
MASLD was defined as high levels of fat in the liver and at least 1 cardiometabolic risk factor, such as high cholesterol or high fasting glucose.
Both parents provided information on height, weight, calculated BMI and waist circumference, and they completed regular questionnaires on potentially influential health and lifestyle factors throughout pregnancy and after the birth.
These included information on age at delivery, smoking during the first 3 months of pregnancy, typical weekly alcohol consumption before pregnancy, employment status, and educational attainment.
The mums also reported their physical activity levels and whether they had ever been diagnosed with diabetes or high blood pressure at the time of study enrolment.
Information on the children included early life factors: sex; mode of delivery; gestational age and birthweight; antibiotic exposure within the first 6 months of life; and length of breastfeeding.
And it included repeated measures of BMI and waist circumference when they were aged 7–9, 10–12, and 13–17, plus alcohol and tobacco use as a young adult.
By the age of 24, one in 10 of these children (201) had MASLD; the other 1732 had a normal liver. Those with MASLD were more likely to be male and to have a higher BMI.
Maternal and paternal overweight and obesity were independently associated with increased odds of their children subsequently developing MASLD, after accounting for potentially influential factors.
Each additional kg of maternal BMI increased the odds of MASLD by 10%, while the equivalent increase in paternal BMI raised the odds by 9%.
Overweight or obesity in both parents was associated with more than 3 times the odds of their child developing MASLD as a young adult compared with those whose parents had a normal pre-pregnancy BMI.
Two thirds (67%) of this association was influenced by cumulative excess BMI between the ages of 7 and 17.
Further analysis, accounting for mothers’ and children’s sugar consumption, plus genetic predisposition to MASLD, generated similar findings.
This is an observational study, and as such, no firm conclusions can be drawn about cause and effect, added to which the researchers acknowledge various limitations to their findings.References: Tica, Stefani and Luo, Chongliang and Ren, Duo and Zong, Xiaoyu and Thompson, Michael D and Stoll, Janis and DeBosch, Brian Jesse and Tarr, Phillip I and Cao, Yin, Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study Gut Published Online First: 24 February 2026. doi: 10.1136/gutjnl-2025-336165 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/25/329520-education-2026-02-25t113218767.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pre-pregnancy, parental, obesity, linked, next, generation’s, heightened, fatty, liver, disease, risk:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/25/329520-education-2026-02-25t113218767.webp"><p>Pre-pregnancy parental overweight and <a href="https://medicaldialogues.in/topics/obesity">obesity</a> is linked to the next generation’s heightened risk of developing <a href="https://medicaldialogues.in/topics/fatty-liver">fatty liver</a> disease, a potential precursor to <a href="https://medicaldialogues.in/topics/cirrhosis">cirrhosis</a> and liver failure, suggests research published online in the journal <i>Gut</i>.
</p><p>If both parents are overweight or obese before they conceive, that child’s subsequent odds of developing <a href="https://medicaldialogues.in/topics/MASLD">MASLD</a> by the age of 24 are more than 3 times higher, most of which is influenced by cumulative excess weight (BMI) during childhood, the findings indicate.
</p><p>Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction associated steatotic liver disease, or MASLD for short, is the most common chronic liver disease worldwide, affecting an estimated 15% of children and more than 30% of adults, note the researchers.
</p><p>Previously published research has emphasised the role of maternal obesity in future generations’ MASLD risk, but it’s not clear what role paternal obesity might have and if childhood overweight might also influence this risk.
</p><p>To find out, the researchers assessed the associations between parental weight (BMI) before pregnancy and the odds of developing MASLD by the age of 24 in 1933 children from the UK Avon Longitudinal Study of Parents and Children (ALSPAC).
</p><p>MASLD was defined as high levels of fat in the liver and at least 1 cardiometabolic risk factor, such as high cholesterol or high fasting glucose.
</p><p>Both parents provided information on height, weight, calculated BMI and waist circumference, and they completed regular questionnaires on potentially influential health and lifestyle factors throughout pregnancy and after the birth.
</p><p>These included information on age at delivery, smoking during the first 3 months of pregnancy, typical weekly alcohol consumption before pregnancy, employment status, and educational attainment.
</p><p>The mums also reported their physical activity levels and whether they had ever been diagnosed with diabetes or high blood pressure at the time of study enrolment.
</p><p>Information on the children included early life factors: sex; mode of delivery; gestational age and birthweight; antibiotic exposure within the first 6 months of life; and length of breastfeeding.
</p><p>And it included repeated measures of BMI and waist circumference when they were aged 7–9, 10–12, and 13–17, plus alcohol and tobacco use as a young adult.
</p><p>By the age of 24, one in 10 of these children (201) had MASLD; the other 1732 had a normal liver. Those with MASLD were more likely to be male and to have a higher BMI.
</p><p>Maternal and paternal overweight and obesity were independently associated with increased odds of their children subsequently developing MASLD, after accounting for potentially influential factors.
</p><p>Each additional kg of maternal BMI increased the odds of MASLD by 10%, while the equivalent increase in paternal BMI raised the odds by 9%.
</p><p>Overweight or obesity in both parents was associated with more than 3 times the odds of their child developing MASLD as a young adult compared with those whose parents had a normal pre-pregnancy BMI.
</p><p>Two thirds (67%) of this association was influenced by cumulative excess BMI between the ages of 7 and 17.
</p><p>Further analysis, accounting for mothers’ and children’s sugar consumption, plus genetic predisposition to MASLD, generated similar findings.
</p><p>This is an observational study, and as such, no firm conclusions can be drawn about cause and effect, added to which the researchers acknowledge various limitations to their findings.</p><p><b>References: </b>Tica, Stefani and Luo, Chongliang and Ren, Duo and Zong, Xiaoyu and Thompson, Michael D and Stoll, Janis and DeBosch, Brian Jesse and Tarr, Phillip I and Cao, Yin, Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study Gut Published Online First: 24 February 2026. doi: 10.1136/gutjnl-2025-336165</p>]]> </content:encoded>
</item>

<item>
<title>DMER Maharashtra releases selection list for winter 2025 super speciality bond service allotment</title>
<link>https://edusehat.com/en/dmer-maharashtra-releases-selection-list-for-winter-2025-super-speciality-bond-service-allotment</link>
<guid>https://edusehat.com/en/dmer-maharashtra-releases-selection-list-for-winter-2025-super-speciality-bond-service-allotment</guid>
<description><![CDATA[ Mumbai: The Directorate of Medical Education and Research (DMER), Maharashtra, has released the provisional list of Super Speciality candidates selected for bonded posts for the Winter 2025 batch. As per a notification dated April 7, 2026, the list includes candidates who have completed their super-specialty courses and are now required to serve under the mandatory bond service as per state government norms. These candidates have been allotted postings across various government medical institutions in Maharashtra.To check out the, Provisional selection list for super speciality candidates for bonded posts for winter-2025 batch date 07.04.2026 (2nd list); click the link below-https://medicaldialogues.in/pdf_upload/2026/04/09/super-speciality-candidates-for-bonded-posts-for-winter-2025-batch-date-07042026-340633.pdfMedical Dialogues had earlier reported that The Directorate of Medical Education and Research (DMER), Maharashtra, issued notices detailing the instructions, vacancies and schedule for online application and allotment of Government Bond Service for Super-Speciality degree holders for the Winter-2025 batch.QUAILIFICATIONSuper Speciality Degree Passed during Winter-2025 of MUHS from Govt./Govt. aided institutes.GENERAL INSTRUCTIONS1 Candidates will be allotted seats as per subject merit for posts of Assistant Professor, Super Speciality Medical Officer, Senior Resident on post in Superspeciality based on marks obtained in Superspeciality degree examination. All posts will be allotted on a merit basis in the Open Category.2 All candidates who are eligible for getting bond service as per the list attached must fill online application form.3 If any candidate does not fill online application form, thereby refusing to get allotment of bond service, the said candidate will be deemed not interested in complying with bond service. Hence, for such a candidate, the process of recovery of the bond penalty amount will be initiated.4 Recommendation /Selection will be displayed on the DMER website on 28.03.2026.5 Candidate can download Recommendations letter from DMER website.6 Candidates should take print out of recommendation letter and report to concerned allotted institute with requisite documents within 7 days from the date of recommendation letter.THE CANDIDATE MUST SUBMIT ATTESTED PHOTOCOPY OF REQUISITE DOCUMENTS AT RESPECTIVE INSTITUTE WHERE THEY WILL BE ALLOTTED POST AS PER THE LIST GIVEN BELOW1 SSC Passing Certificate / valid passport (as proof of age).2 Super speciality Degree Mark sheet / Grade Certificate/ Passing Certificate.3 Marksheet of all MBBS, MD/MS examinations.4 MBBS degree / Passing certificate.5 MD/M.S. Degree Passing Certificate.6 Permanent Registration certificate of Maharashtra Medical Council.7 Additional qualification registration (MD/MS) certificate of Maharashtra Medical Council.RULE OF TIE-BREAKERSelection of candidate for the vacant post shall be as per the procedure of preparation of merit list as given below-FIRST LEVEL- The Candidate having Highest Mark in DM/MCH postgraduate examination (Super speciality) will be preferred, if tie persists then.SECOND LEVEL- The Candidate having Highest Mark in final MD / MS will be preferred, if tie persists then.THIRD LEVEL- The Candidate having Highest aggregate Mark in Final MBBS (Part I &amp; II) taken together will be preferred, if tie persists then.FOURTH LEVEL- The older candidate will be preferred.ASSISTANT PROFESSOR FOR SUPER SPECIALITYS.NOINSTITUTEVACANCY1GOVERNMENT MEDICAL COLLEGE AKOLA.92GOVERNMENT MEDICAL COLLEGE NAGPUR.63GOVERNMENT MEDICAL COLLEGE SAMBHAJINAGAR.54GRANT GOVERNMENT MEDICAL COLLEGE MUMBAI.65LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE (LTMMC)AND GENERAL HOSPITAL IN SION, MUMBAI.106SETH GS MEDICAL COLLEGE AND KING EDWARD MEMORIAL (KEM) HOSPITAL, MUMBAI.537SHRI VASANTRAO NAIK GOVERNMENT MEDICAL COLLEGE YAVATMAL.148TOPIWALA NATIONAL MEDICAL COLLEGE AND BAI YAMUNABAI LAXMAN NAIR CHARITABLE HOSPITAL, MUMBAI .149VILASRAO DESHMUKH GOVERNMENT MEDICAL COLLEGE LATUR .6TOTAL123SENIOR RESIDENT FOR SUPER SPECIALITYS.NOINSTITUTEVACANCY1B.J. GOVERNMENT MEDICAL COLLEGE PUNE.122GOVERNMENT MEDICAL COLLEGE AKOLA.193GOVERNMENT MEDICAL COLLEGE NAGPUR.214GOVERNMENT MEDICAL COLLEGE SAMBHAJINAGAR.235SHRI VASANTRAO NAIK GOVERNMENT MEDICAL COLLEGE YAVATMAL.86VILASRAO DESHMUKH GOVERNMENT MEDICAL COLLEGE LATUR.8TOTAL91SUPER SPECIALITY MEDICAL OFFICER FOR SUPER SPECIALITYS.NOINSTITUTEVACANCY1COMPRESSIVE THALASSEMIA CARE BORIVALI, MUMBAI.1TOTAL1 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340638-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-57.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>DMER, Maharashtra, releases, selection, list, for, winter, 2025, super, speciality, bond, service, allotment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340638-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-57.webp"><p><b>Mumbai: </b>The Directorate of Medical Education and Research (<a href="https://medicaldialogues.in/topics/DMER">DMER</a>), Maharashtra, has released the provisional list of <a href="https://medicaldialogues.in/topics/Super-Specialty">Super Speciality</a> candidates selected for bonded posts for the Winter 2025 batch.</p><p> As per a notification dated April 7, 2026, the list includes candidates who have completed their super-specialty courses and are now required to serve under the mandatory bond service as per state government norms. </p><p>These candidates have been allotted postings across various government medical institutions in Maharashtra.</p><p><b><i>To check out the, Provisional selection list for super speciality candidates for bonded posts for winter-2025 batch date 07.04.2026 (2nd list); click the link below-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/09/super-speciality-candidates-for-bonded-posts-for-winter-2025-batch-date-07042026-340633.pdf">https://medicaldialogues.in/pdf_upload/2026/04/09/super-speciality-candidates-for-bonded-posts-for-winter-2025-batch-date-07042026-340633.pdf</a><a href="https://medicaldialogues.in/pdf_upload/2026/04/09/super-speciality-candidates-for-bonded-posts-for-winter-2025-batch-date-07042026-340633.pdf" target="_blank"><b><i></i></b></a></p><p>Medical Dialogues had earlier reported that The Directorate of Medical Education and Research (DMER), Maharashtra, issued notices detailing the instructions, vacancies and schedule for online application and allotment of Government Bond Service for Super-Speciality degree holders for the Winter-2025 batch.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p dir="ltr"><u>QUAILIFICATION</u></p><p dir="ltr">Super Speciality Degree Passed during Winter-2025 of <a href="https://medicaldialogues.in/topics/muhs" target="_blank">MUHS </a>from Govt./Govt. aided institutes.</p></div><div class="pasted-from-word-wrapper"><p dir="ltr"><u>GENERAL INSTRUCTIONS</u></p><p dir="ltr">1 Candidates will be allotted seats as per subject merit for posts of Assistant Professor, Super Speciality Medical Officer, Senior Resident on post in Superspeciality based on marks obtained in Superspeciality degree examination. All posts will be allotted on a merit basis in the Open Category.</p><div class="inside-post-ad-3 inside-post-ad ads_common_inside_post"></div><p dir="ltr">2 All candidates who are eligible for getting bond service as per the list attached must fill online application form.</p><p dir="ltr">3 If any candidate does not fill online application form, thereby refusing to get allotment of bond service, the said candidate will be deemed not interested in complying with bond service. Hence, for such a candidate, the process of recovery of the bond penalty amount will be initiated.</p><p dir="ltr">4 Recommendation /Selection will be displayed on the DMER website on 28.03.2026.</p><p dir="ltr">5 Candidate can download Recommendations letter from DMER website.</p><p dir="ltr">6 Candidates should take print out of recommendation letter and report to concerned allotted institute with requisite documents within 7 days from the date of recommendation letter.</p><p dir="ltr"><u>THE CANDIDATE MUST SUBMIT ATTESTED PHOTOCOPY OF REQUISITE DOCUMENTS AT RESPECTIVE INSTITUTE WHERE THEY WILL BE ALLOTTED POST AS PER THE LIST GIVEN BELOW</u></p><p dir="ltr">1 SSC Passing Certificate / valid passport (as proof of age).</p><p dir="ltr">2 Super speciality Degree Mark sheet / Grade Certificate/ Passing Certificate.</p><p dir="ltr">3 Marksheet of all MBBS, MD/MS examinations.</p><p dir="ltr">4 MBBS degree / Passing certificate.</p><p dir="ltr">5 MD/M.S. Degree Passing Certificate.</p><p dir="ltr">6 Permanent Registration certificate of Maharashtra Medical Council.</p><p dir="ltr">7 Additional qualification registration (MD/MS) certificate of Maharashtra Medical Council.</p><p dir="ltr"><u>RULE OF TIE-BREAKER</u></p><p dir="ltr">Selection of candidate for the vacant post shall be as per the procedure of preparation of merit list as given below-</p><p dir="ltr">FIRST LEVEL- The Candidate having Highest Mark in DM/MCH postgraduate examination (Super speciality) will be preferred, if tie persists then.</p><p dir="ltr">SECOND LEVEL- The Candidate having Highest Mark in final MD / MS will be preferred, if tie persists then.</p><p dir="ltr">THIRD LEVEL- The Candidate having Highest aggregate Mark in Final MBBS (Part I & II) taken together will be preferred, if tie persists then.</p><p dir="ltr">FOURTH LEVEL- The older candidate will be preferred.</p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p dir="ltr"><u>ASSISTANT PROFESSOR FOR SUPER SPECIALITY</u></p></div><div class="pasted-from-word-wrapper"><div dir="ltr"><table><colgroup><col width="51"><col width="365"><col width="208"></colgroup><tbody><tr><td><p dir="ltr">S.NO</p></td><td><p dir="ltr">INSTITUTE</p></td><td><p dir="ltr">VACANCY</p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE AKOLA.</p></td><td><p dir="ltr">9</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE NAGPUR.</p></td><td><p dir="ltr">6</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE SAMBHAJINAGAR.</p></td><td><p dir="ltr">5</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">GRANT GOVERNMENT MEDICAL COLLEGE MUMBAI.</p></td><td><p dir="ltr">6</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE (LTMMC)AND GENERAL HOSPITAL IN SION, MUMBAI.</p></td><td><p dir="ltr">10</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">SETH GS MEDICAL COLLEGE AND KING EDWARD MEMORIAL (KEM) HOSPITAL, MUMBAI.</p></td><td><p dir="ltr">53</p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">SHRI VASANTRAO NAIK GOVERNMENT MEDICAL COLLEGE YAVATMAL.</p></td><td><p dir="ltr">14</p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">TOPIWALA NATIONAL MEDICAL COLLEGE AND BAI YAMUNABAI LAXMAN NAIR CHARITABLE HOSPITAL, MUMBAI .</p></td><td><p dir="ltr">14</p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">VILASRAO DESHMUKH GOVERNMENT MEDICAL COLLEGE LATUR .</p></td><td><p dir="ltr">6</p></td></tr><tr><td colspan="2"><p dir="ltr">TOTAL</p></td><td><p dir="ltr">123</p></td></tr></tbody></table></div><p dir="ltr"><u>SENIOR RESIDENT FOR SUPER SPECIALITY</u></p><div dir="ltr"><table><colgroup><col width="51"><col width="365"><col width="208"></colgroup><tbody><tr><td><p dir="ltr">S.NO</p></td><td><p dir="ltr">INSTITUTE</p></td><td><p dir="ltr">VACANCY</p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">B.J. GOVERNMENT MEDICAL COLLEGE PUNE.</p></td><td><p dir="ltr">12</p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE AKOLA.</p></td><td><p dir="ltr">19</p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE NAGPUR.</p></td><td><p dir="ltr">21</p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">GOVERNMENT MEDICAL COLLEGE SAMBHAJINAGAR.</p></td><td><p dir="ltr">23</p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">SHRI VASANTRAO NAIK GOVERNMENT MEDICAL COLLEGE YAVATMAL.</p></td><td><p dir="ltr">8</p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">VILASRAO DESHMUKH GOVERNMENT MEDICAL COLLEGE LATUR.</p></td><td><p dir="ltr">8</p></td></tr><tr><td colspan="2"><p dir="ltr">TOTAL</p></td><td><p dir="ltr">91</p></td></tr></tbody></table></div><p dir="ltr"><u>SUPER SPECIALITY MEDICAL OFFICER FOR SUPER SPECIALITY</u></p><div dir="ltr"><table><colgroup><col width="51"><col width="365"><col width="208"></colgroup><tbody><tr><td><p dir="ltr">S.NO</p></td><td><p dir="ltr">INSTITUTE</p></td><td><p dir="ltr">VACANCY</p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">COMPRESSIVE THALASSEMIA CARE BORIVALI, MUMBAI.</p></td><td><p dir="ltr">1</p></td></tr><tr><td colspan="2"><p dir="ltr">TOTAL</p></td><td><p dir="ltr">1</p></td></tr></tbody></table></div></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"></div></div>]]> </content:encoded>
</item>

<item>
<title>Prediabetes, Obesity and Low Vitamin Levels: Apollo Report Warns of Alarming Health Trends</title>
<link>https://edusehat.com/en/prediabetes-obesity-and-low-vitamin-levels-apollo-report-warns-of-alarming-health-trends</link>
<guid>https://edusehat.com/en/prediabetes-obesity-and-low-vitamin-levels-apollo-report-warns-of-alarming-health-trends</guid>
<description><![CDATA[ India’s health profile is undergoing a silent but significant shift, with lifestyle-related risks emerging earlier and often going unnoticed. A recent nationwide ‘Health of the Nation 2026’ report by Apollo Hospitals, based on over three million preventive assessments in 2025 highlights that one in five individuals under 30 is already prediabetic, though the condition remains reversible at this stage, according to The Hindu.More than half the population studied was found to be obese and had abnormal cholesterol levels, while nearly 70% were deficient in Vitamin D and almost half had low Vitamin B12 levels.The findings also reveal that younger individuals show declining physical fitness, with two-thirds lacking adequate strength, flexibility, or balance. Among working adults, a majority were overweight, with high rates of prediabetes and hypertension. Women showed distinct risks such as anaemia and earlier onset of breast cancer. Alarmingly, many serious conditions like fatty liver and early atherosclerosis were detected despite normal routine test results, underlining the need for early, preventive, and more comprehensive health screening approaches. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340603-mcc-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Prediabetes, Obesity, and, Low, Vitamin, Levels:, Apollo, Report, Warns, Alarming, Health, Trends</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340603-mcc-3.webp"><p>India’s health profile is undergoing a silent but significant shift, with lifestyle-related risks emerging earlier and often going unnoticed. A recent nationwide ‘Health of the Nation 2026’ report by Apollo Hospitals, based on over three million preventive assessments in 2025 highlights that one in five individuals under 30 is already prediabetic, though the condition remains reversible at this stage, according to The Hindu.</p><p>More than half the population studied was found to be obese and had abnormal cholesterol levels, while nearly 70% were deficient in Vitamin D and almost half had low Vitamin B12 levels.</p><p>The findings also reveal that younger individuals show declining physical fitness, with two-thirds lacking adequate strength, flexibility, or balance. Among working adults, a majority were overweight, with high rates of prediabetes and hypertension. Women showed distinct risks such as anaemia and earlier onset of breast cancer. Alarmingly, many serious conditions like fatty liver and early atherosclerosis were detected despite normal routine test results, underlining the need for early, preventive, and more comprehensive health screening approaches.</p>]]> </content:encoded>
</item>

<item>
<title>NMC Directs Medical Colleges to Charge MBBS Fees Only for 4.5 Years</title>
<link>https://edusehat.com/en/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years</link>
<guid>https://edusehat.com/en/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years</guid>
<description><![CDATA[ Noting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the National Medical Commission (NMC) has strictly directed all medical colleges to charge fees only for the prescribed academic duration of four and a half years.The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.For more details, check out the full story on the link below:
NMC directs medical colleges to charge MBBS fees only for 4.5 years, warns against non-compliance ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340598-mcc-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, Directs, Medical, Colleges, Charge, MBBS, Fees, Only, for, 4.5, Years</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340598-mcc-2.webp"><div class="pasted-from-word-wrapper"><p>Noting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the <a href="https://medicaldialogues.in/topics//nmc" target="_blank">National Medical Commission</a> (NMC) has strictly directed all medical colleges to charge<a href="https://medicaldialogues.in/topics/mbbs-fees" target="_blank"> fees</a> only for the prescribed academic duration of four and a half years.</p><div></div><p>The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/health-news/nmc/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years-warns-against-non-compliance-168206" target="_blank"><b><i>NMC directs medical colleges to charge MBBS fees only for 4.5 years, warns against non-compliance</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Healthy Diet and Lifestyle Linked to Better Periodontal Health: Study</title>
<link>https://edusehat.com/en/healthy-diet-and-lifestyle-linked-to-better-periodontal-health-study</link>
<guid>https://edusehat.com/en/healthy-diet-and-lifestyle-linked-to-better-periodontal-health-study</guid>
<description><![CDATA[ Researchers have found in a new study that among postmenopausal women, a higher Oxidative Balance Score (OBS)—reflecting a healthy diet and lifestyle—is associated with better periodontal health. Conversely, a low Oxidative Balance Score may serve as a potential risk indicator for periodontitis.Menopause is a time of declining reproductive function in women, and hormonal changes can affect oral health and chronic diseases such as periodontitis. The oxidative balance score (OBS) indicates oxidative balance using diet and lifestyle habits. This is the first study to investigate the relationship between the Oxidative Balance Score and periodontitis in postmenopausal women.The study included 16,489 participants from the Korea National Health and Nutrition Examination Survey (KNHANES). Modified Poisson regression was used to examine the effect of the Oxidative Balance Score on periodontitis in postmenopausal women, adjusting for confounders. Results: The Oxidative Balance Score was 17.66 ± 0.13 in the presence of periodontitis and 18.42 ± 0.10 in the absence of periodontitis. In the fully adjusted model, higher Oxidative Balance Score quartiles were associated with a lower prevalence of periodontitis (Q2, prevalence ratio [PR] = 0.899; Q3, PR = 0.941; Q4, PR = 0.800). When divided into components, lifestyle Oxidative Balance Score showed a significant inverse association with periodontitis (PR = 0.786, 95% confidence interval [CI]: 0.638–0.970), whereas dietary Oxidative Balance Score did not (PR = 0.952, 95% CI: 0.804–1.127).In postmenopausal women, an increase in the Oxidative Balance Score due to a healthy diet and lifestyle is associated with periodontal health. A low Oxidative Balance Score may be considered a potential risk indicator for periodontitis.Reference:Seon, J. H., &amp; Chung, K. H. (2026). Oxidative balance score and periodontitis in postmenopausal women: a nationwide study. Climacteric, 1–8. https://doi.org/10.1080/13697137.2026.2631512Keywords:Healthy Diet, Lifestyle, Linked, Better, Periodontal Health,Study,Seon, J. H., &amp; Chung, K. H.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/13/332539-images-2026-03-12t205653017.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Healthy, Diet, and, Lifestyle, Linked, Better, Periodontal, Health:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/13/332539-images-2026-03-12t205653017.webp"><p>Researchers have found in a new study that among postmenopausal women, a higher Oxidative Balance Score (OBS)—reflecting a healthy diet and lifestyle—is associated with better periodontal health. Conversely, a low Oxidative Balance Score may serve as a potential risk indicator for periodontitis.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Menopause is a time of declining reproductive function in women, and hormonal changes can affect oral health and chronic diseases such as periodontitis. The oxidative balance score (OBS) indicates oxidative balance using diet and lifestyle habits. This is the first study to investigate the relationship between the Oxidative Balance Score and periodontitis in postmenopausal women.</p><p dir="ltr">The study included 16,489 participants from the Korea National Health and Nutrition Examination Survey (KNHANES). Modified Poisson regression was used to examine the effect of the Oxidative Balance Score on periodontitis in postmenopausal women, adjusting for confounders. Results: The Oxidative Balance Score was 17.66 ± 0.13 in the presence of periodontitis and 18.42 ± 0.10 in the absence of periodontitis. In the fully adjusted model, higher Oxidative Balance Score quartiles were associated with a lower prevalence of periodontitis (Q2, prevalence ratio [PR] = 0.899; Q3, PR = 0.941; Q4, PR = 0.800). When divided into components, lifestyle Oxidative Balance Score showed a significant inverse association with periodontitis (PR = 0.786, 95% confidence interval [CI]: 0.638–0.970), whereas dietary Oxidative Balance Score did not (PR = 0.952, 95% CI: 0.804–1.127).</p><p dir="ltr">In postmenopausal women, an increase in the Oxidative Balance Score due to a healthy diet and lifestyle is associated with periodontal health. A low Oxidative Balance Score may be considered a potential risk indicator for periodontitis.</p><p dir="ltr">Reference:</p><p dir="ltr">Seon, J. H., & Chung, K. H. (2026). Oxidative balance score and periodontitis in postmenopausal women: a nationwide study. Climacteric, 1–8. <a href="https://doi.org/10.1080/13697137.2026.2631512">https://doi.org/10.1080/13697137.2026.2631512</a></p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Healthy Diet, Lifestyle, Linked, Better, Periodontal Health,Study,Seon, J. H., & Chung, K. H. </p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Late&#45;Pregnancy Albumin/Globulin Ratio May Predict Risk of Neonatal Jaundice Admissions, suggests study</title>
<link>https://edusehat.com/en/late-pregnancy-albuminglobulin-ratio-may-predict-risk-of-neonatal-jaundice-admissions-suggests-study</link>
<guid>https://edusehat.com/en/late-pregnancy-albuminglobulin-ratio-may-predict-risk-of-neonatal-jaundice-admissions-suggests-study</guid>
<description><![CDATA[ Unlocking a Maternal Biomarker for Neonatal HealthA new study published in BMC Pregnancy and Childbirth points to a promising connection between a mother&#039;s late-pregnancy albumin to globulin (A/G) ratio and the risk of her newborn being admitted for neonatal hyperbilirubinemia (NHB)—a condition commonly known as severe neonatal jaundice. NHB is prevalent among both term and preterm infants and can sometimes lead to serious health complications, including neurological damage.Study Overview: Tracking A/G Ratios and Jaundice RiskResearchers at Nanjing Lishui People’s Hospital in China analyzed data from 1,432 mother-newborn pairs, focusing on the mother’s A/G ratio measured late in pregnancy. The goal: to see whether this easily obtained blood measurement could help flag pregnancies at higher risk of newborns requiring admission for NHB.Key Findings: A U-Shaped RelationshipPrevalence: 15.7% of newborns in the study were admitted for NHB.U-Shaped Risk Curve: The study found a U-shaped association between maternal A/G ratio and NHB admission.When the A/G ratio was below 1.29, each 0.1 increase was linked to a 33% lower risk of NHB admission.When the A/G ratio was 1.29 or higher, each 0.1 increase was linked to a 16% higher risk.Risk at Extremes: Both very low (1.40) A/G ratios were associated with increased risk, especially for mothers aged 30 and above.Why Does This Matter?The A/G ratio reflects not only nutritional status but also inflammation and liver function—all important factors for pregnancy and fetal development. This study suggests that routine monitoring of a mother&#039;s A/G ratio could serve as a simple, cost-effective way to identify pregnancies that may need closer neonatal monitoring for jaundice, especially in women over 30.Clinical Implications and Next StepsWhile much remains to be learned about the underlying mechanisms, this research highlights the A/G ratio as an early warning biomarker. The authors recommend further research to refine risk thresholds and to understand how nutritional or medical interventions might optimize outcomes for mothers and babies.5 Key Takeaways:The late-pregnancy A/G ratio is closely linked to the risk of neonatal jaundice admissions.Both low and high extremes of the A/G ratio increase risk, with an optimal range around 1.15–1.40.The association is especially strong in mothers aged 30 and above.Monitoring the A/G ratio could help flag pregnancies needing increased neonatal jaundice surveillance.Further research is needed to confirm these findings and to explore intervention strategies.Citation:Wei H, Chang X, Ji R, Tang Y. Association between late pregnancy A/G ratio and the risk of neonatal admission for neonatal hyperbilirubinemia. BMC Pregnancy and Childbirth. 2025;25:563. https://doi.org/10.1186/s12884-025-07706-w ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/28/311357-blue-light-for-neonatal-jaundice.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Late-Pregnancy, AlbuminGlobulin, Ratio, May, Predict, Risk, Neonatal, Jaundice, Admissions, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/28/311357-blue-light-for-neonatal-jaundice.webp"><p align="justify">Unlocking a Maternal Biomarker for Neonatal Health</p><p align="justify">A new study published in BMC Pregnancy and Childbirth points to a promising connection between a mother's late-pregnancy albumin to globulin (A/G) ratio and the risk of her newborn being admitted for neonatal hyperbilirubinemia (NHB)—a condition commonly known as severe neonatal jaundice. NHB is prevalent among both term and preterm infants and can sometimes lead to serious health complications, including neurological damage.</p><p align="justify">Study Overview: Tracking A/G Ratios and Jaundice Risk</p><p align="justify">Researchers at Nanjing Lishui People’s Hospital in China analyzed data from 1,432 mother-newborn pairs, focusing on the mother’s A/G ratio measured late in pregnancy. The goal: to see whether this easily obtained blood measurement could help flag pregnancies at higher risk of newborns requiring admission for NHB.</p><p align="justify">Key Findings: A U-Shaped Relationship</p><p align="justify">Prevalence: 15.7% of newborns in the study were admitted for NHB.</p><p align="justify">U-Shaped Risk Curve: The study found a U-shaped association between maternal A/G ratio and NHB admission.</p><p align="justify">When the A/G ratio was below 1.29, each 0.1 increase was linked to a 33% lower risk of NHB admission.</p><p align="justify">When the A/G ratio was 1.29 or higher, each 0.1 increase was linked to a 16% higher risk.</p><p align="justify">Risk at Extremes: Both very low (<1.15) and very high (>1.40) A/G ratios were associated with increased risk, especially for mothers aged 30 and above.</p><p align="justify">Why Does This Matter?</p><p align="justify">The A/G ratio reflects not only nutritional status but also inflammation and liver function—all important factors for pregnancy and fetal development. This study suggests that routine monitoring of a mother's A/G ratio could serve as a simple, cost-effective way to identify pregnancies that may need closer neonatal monitoring for jaundice, especially in women over 30.</p><p align="justify">Clinical Implications and Next Steps</p><p align="justify">While much remains to be learned about the underlying mechanisms, this research highlights the A/G ratio as an early warning biomarker. The authors recommend further research to refine risk thresholds and to understand how nutritional or medical interventions might optimize outcomes for mothers and babies.</p><p align="justify">5 Key Takeaways:</p><p align="justify">The late-pregnancy A/G ratio is closely linked to the risk of neonatal jaundice admissions.</p><p align="justify">Both low and high extremes of the A/G ratio increase risk, with an optimal range around 1.15–1.40.</p><p align="justify">The association is especially strong in mothers aged 30 and above.</p><p align="justify">Monitoring the A/G ratio could help flag pregnancies needing increased neonatal jaundice surveillance.</p><p align="justify">Further research is needed to confirm these findings and to explore intervention strategies.</p><p align="justify">Citation:</p><p align="justify">Wei H, Chang X, Ji R, Tang Y. Association between late pregnancy A/G ratio and the risk of neonatal admission for neonatal hyperbilirubinemia. BMC Pregnancy and Childbirth. 2025;25:563. https://doi.org/10.1186/s12884-025-07706-w</p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>Higher Meat Intake Benefits cognitive health in Genetically Defined Subgroup: JAMA</title>
<link>https://edusehat.com/en/higher-meat-intake-benefits-cognitive-health-in-genetically-defined-subgroup-jama</link>
<guid>https://edusehat.com/en/higher-meat-intake-benefits-cognitive-health-in-genetically-defined-subgroup-jama</guid>
<description><![CDATA[ Sweden: Findings of a new study suggest that consuming more meat than typically recommended could provide health benefits for a specific genetically defined group, which makes up about 25% of the global population.The study, published in JAMA Network Open, was led by Jakob Norgren from the Karolinska Institutet, Sweden, and explored how genetic variation in the apolipoprotein E (APOE) gene may influence the relationship between meat intake and cognitive health. The APOE ε4 variant is known to increase the risk of Alzheimer’s disease, prompting interest in whether dietary patterns could modify this risk.To investigate this, researchers analyzed data from 2,157 older adults without dementia enrolled in the Swedish National Study on Aging and Care–Kungsholmen. Participants, aged 60 years and above, were followed for up to 15 years. Dietary intake was assessed using validated food frequency questionnaires, focusing on total meat consumption and the proportion of processed meat. Cognitive performance was tracked over time, and new cases of dementia were recorded.   Key Findings:Approximately 26% of participants had APOE ε3/ε4 or ε4/ε4 genotypes, associated with a higher genetic risk of cognitive decline.In this subgroup, higher meat consumption was linked to slower cognitive decline.Higher meat intake in these individuals was also associated with a reduced risk of developing dementia.This association was not observed in participants with other APOE genotypes, indicating a genotype-specific effect.Significant interactions were found between APOE genotype and meat consumption for global cognition and episodic memory.At higher levels of meat intake, the usual cognitive disadvantage seen in APOE ε4 carriers appeared to lessen.A higher proportion of processed meat intake was associated with an increased risk of dementia, irrespective of genotype.No significant differences were observed between unprocessed red meat and poultry in relation to cognitive outcomes.The researchers also conducted additional analyses suggesting that higher intake of unprocessed meat may be linked to lower overall mortality among APOE ε4 carriers. These findings align with emerging evidence supporting the concept of gene-diet interactions in shaping long-term health outcomes.Despite the robust design and extended follow-up period, the authors acknowledged several limitations. The study population was predominantly of Northern European origin, which may limit the applicability of the findings to more diverse populations. Dietary data were self-reported and may be subject to inaccuracies, and the possibility of residual confounding cannot be excluded. Additionally, survival bias may have influenced the results, as healthier individuals are more likely to remain in long-term studies.The study highlights a potentially important interaction between genetics and diet, suggesting that higher meat consumption may benefit cognitive health in individuals with specific APOE genotypes. These findings highlight the need for more personalized nutritional approaches and further research to better understand how genetic factors can inform dietary recommendations aimed at preventing cognitive decline.Reference:Norgren J, Carballo-Casla A, Grande G, et al. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Netw Open. 2026;9(3):e266489. doi:10.1001/jamanetworkopen.2026.6489 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/14/269000-cognitive-function-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Higher, Meat, Intake, Benefits, cognitive, health, Genetically, Defined, Subgroup:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/14/269000-cognitive-function-50.webp"><p><span>Sweden: Findings of a new study suggest that consuming more <a href="https://medicaldialogues.in/topics/meat-consumption">meat </a>than typically recommended could provide health benefits for a specific genetically defined group, which makes up about 25% of the global population.</span></p><div class="pasted-from-word-wrapper"><div>The study, published in <i><a href="https://medicaldialogues.in/topics/jama-network-open">JAMA Network Open</a>,</i> was led by Jakob Norgren from the Karolinska Institutet, Sweden, and explored how genetic variation in the <a href="https://medicaldialogues.in/topics/apolipoprotein-e">apolipoprotein E (APOE) gene </a>may influence the relationship between meat intake and cognitive health. The APOE ε4 variant is known to increase the risk of<a href="https://medicaldialogues.in/topics/alzheimer%E2%80%99s-disease"> Alzheimer’s disease</a>, prompting interest in whether dietary patterns could modify this risk.</div><div>To investigate this, researchers analyzed data from 2,157 older adults without dementia enrolled in the Swedish National Study on Aging and Care–Kungsholmen. Participants, aged 60 years and above, were followed for up to 15 years. Dietary intake was assessed using validated food frequency questionnaires, focusing on total meat consumption and the proportion of processed meat. Cognitive performance was tracked over time, and new cases of dementia were recorded.   </div><div>Key Findings:</div><ul><li>Approximately 26% of participants had APOE ε3/ε4 or ε4/ε4 genotypes, associated with a higher genetic risk of cognitive decline.</li><li>In this subgroup, higher meat consumption was linked to slower cognitive decline.</li><li>Higher meat intake in these individuals was also associated with a reduced risk of developing dementia.</li><li>This association was not observed in participants with other APOE genotypes, indicating a genotype-specific effect.</li><li>Significant interactions were found between APOE genotype and meat consumption for global cognition and episodic memory.</li><li>At higher levels of meat intake, the usual cognitive disadvantage seen in APOE ε4 carriers appeared to lessen.</li><li>A higher proportion of processed meat intake was associated with an increased risk of dementia, irrespective of genotype.</li><li>No significant differences were observed between unprocessed red meat and poultry in relation to cognitive outcomes.</li></ul><div>The researchers also conducted additional analyses suggesting that higher intake of unprocessed meat may be linked to lower overall mortality among APOE ε4 carriers. These findings align with emerging evidence supporting the concept of gene-diet interactions in shaping long-term health outcomes.</div><div>Despite the robust design and extended follow-up period, the authors acknowledged several limitations. The study population was predominantly of Northern European origin, which may limit the applicability of the findings to more diverse populations. Dietary data were self-reported and may be subject to inaccuracies, and the possibility of residual confounding cannot be excluded. Additionally, survival bias may have influenced the results, as healthier individuals are more likely to remain in long-term studies.</div><div>The study highlights a potentially important interaction between genetics and diet, suggesting that higher meat consumption may benefit cognitive health in individuals with specific APOE genotypes. These findings highlight the need for more personalized nutritional approaches and further research to better understand how genetic factors can inform dietary recommendations aimed at preventing cognitive decline.</div><div>Reference:</div><div>Norgren J, Carballo-Casla A, Grande G, et al. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Netw Open. 2026;9(3):e266489. doi:10.1001/jamanetworkopen.2026.6489</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Transient Vision Loss may Predict Short&#45; and Long&#45;Term CV Events: Study</title>
<link>https://edusehat.com/en/transient-vision-loss-may-predict-short-and-long-term-cv-events-study</link>
<guid>https://edusehat.com/en/transient-vision-loss-may-predict-short-and-long-term-cv-events-study</guid>
<description><![CDATA[ Researchers have found in a new study that patients with transient vision loss have a markedly higher risk of major adverse cardiovascular events—including stroke, myocardial infarction, arrhythmias, and early hospitalization—within 14 days of symptom onset, with this increased risk persisting for up to 10 years.A study was done to evaluate short- and long-term cardiovascular risk following a first diagnosis of transient vision loss (TVL) compared with matched controls using the TriNetX research network. Patients with an incident diagnosis of Transient vision loss were retrospectively identified and 1:1 propensity score-matched to controls with dry eye syndrome. Primary outcomes included major adverse cardiovascular events (MACE), stroke, myocardial infarction (MI), ventricular arrhythmias, venous thromboembolism (VTE), hospitalisation and all-cause mortality. Cox proportional hazards models estimated hazard ratios (HRs) from 14 days to 10 years. Subgroup analyses evaluated patients free of events at 90 days and 1 year.Results After matching, 37 750 patients were included in each cohort. Mean (SD) age was 56.8 (16.8) years in the TVL cohort (59.7% female) and 56.6 (16.3) years in the control cohort (58.9% female). Within 14 days, stroke risk increased over 21-fold (HR 21.7; 95% CI 13.4 to 37.4), major adverse cardiovascular events nearly 10-fold (HR 9.80; 95% CI 7.19 to 13.34), arrhythmia over fourfold (HR 4.01; 95% CI 2.72 to 5.90), MI fivefold (HR 5.00; 95% CI 1.92 to 12.06) and hospitalisation nearly fourfold (HR 3.83; 95% CI, 3.52 to 4.17) compared with controls. Venous thromboembolism risk was modest and transient, with no elevation beyond 5 years, and all-cause mortality was not elevated at any time point. Among patients’ event-free at 90 days or 1 year, elevated long-term risk persisted up to 10 years for major adverse cardiovascular events, stroke, arrhythmiaand hospitalisation. Transient vision loss is associated with increased short- and long-term risks of major adverse cardiovascular events, stroke, MI, arrhythmia and hospitalisation, warranting prompt systemic evaluation and long-term monitoring.Reference:Miller T, Xie JS, Rahat Qureshi A, et alCardiovascular risk following transient vision loss. British Journal of Ophthalmology Published Online First: 09 December 2025. doi: 10.1136/bjo-2025-328605Keywords:Miller T, Xie JS, Rahat,  Qureshi A, Cardiovascular, risk,  following,  transient vision loss, British Journal of Ophthalmology ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/17/328023-images-2026-02-16t213354820.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Transient, Vision, Loss, may, Predict, Short-, and, Long-Term, Events:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/17/328023-images-2026-02-16t213354820.webp"><p>Researchers have found in a new study that patients with transient vision loss have a markedly higher risk of major adverse cardiovascular events—including stroke, myocardial infarction, arrhythmias, and early hospitalization—within 14 days of symptom onset, with this increased risk persisting for up to 10 years.</p><p>A study was done to evaluate short- and long-term cardiovascular risk following a first diagnosis of transient vision loss (TVL) compared with matched controls using the TriNetX research network. Patients with an incident diagnosis of Transient vision loss were retrospectively identified and 1:1 propensity score-matched to controls with dry eye syndrome. Primary outcomes included major adverse cardiovascular events (MACE), stroke, myocardial infarction (MI), ventricular arrhythmias, venous thromboembolism (VTE), hospitalisation and all-cause mortality. Cox proportional hazards models estimated hazard ratios (HRs) from 14 days to 10 years. Subgroup analyses evaluated patients free of events at 90 days and 1 year.</p><p>Results After matching, 37 750 patients were included in each cohort. Mean (SD) age was 56.8 (16.8) years in the TVL cohort (59.7% female) and 56.6 (16.3) years in the control cohort (58.9% female). Within 14 days, stroke risk increased over 21-fold (HR 21.7; 95% CI 13.4 to 37.4), major adverse cardiovascular events nearly 10-fold (HR 9.80; 95% CI 7.19 to 13.34), arrhythmia over fourfold (HR 4.01; 95% CI 2.72 to 5.90), MI fivefold (HR 5.00; 95% CI 1.92 to 12.06) and hospitalisation nearly fourfold (HR 3.83; 95% CI, 3.52 to 4.17) compared with controls. Venous thromboembolism risk was modest and transient, with no elevation beyond 5 years, and all-cause mortality was not elevated at any time point. Among patients’ event-free at 90 days or 1 year, elevated long-term risk persisted up to 10 years for major adverse cardiovascular events, stroke, arrhythmiaand hospitalisation. Transient vision loss is associated with increased short- and long-term risks of major adverse cardiovascular events, stroke, MI, arrhythmia and hospitalisation, warranting prompt systemic evaluation and long-term monitoring.</p><div class="pasted-from-word-wrapper"><div><span>Reference:</span></div><p dir="ltr">Miller T, Xie JS, Rahat Qureshi A, et alCardiovascular risk following transient vision loss. British Journal of Ophthalmology Published Online First: 09 December 2025. doi: 10.1136/bjo-2025-328605</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Miller T, Xie JS, Rahat,  Qureshi A, Cardiovascular, risk,  following,  transient vision loss, British Journal of Ophthalmology</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Preoperative CRP Predicts Surgical Complexity in acute calculous cholecystitis: Study</title>
<link>https://edusehat.com/en/preoperative-crp-predicts-surgical-complexity-in-acute-calculous-cholecystitis-study</link>
<guid>https://edusehat.com/en/preoperative-crp-predicts-surgical-complexity-in-acute-calculous-cholecystitis-study</guid>
<description><![CDATA[ A new study published in the BMC Surgery revealed that elevated preoperative C-reactive protein (CRP) levels are significantly associated with greater surgical complexity and a higher risk of conversion in acute calculous cholecystitis (ACC). CRP can therefore serve as a useful predictor for anticipating technical challenges and improving surgical planning and resource utilization, particularly in resource-limited settings.Acute calculous cholecystitis (ACC) is one of the most common surgical emergencies globally where the standard treatment is Laparoscopic Cholecystectomy. However, in complicated cases surgeons may need to switch to the more invasive Open Cholecystectomy, which can prolong surgery and recovery. Thus, this observational study at Shree Birendra Hospital in Kathmandu, Nepal, examined whether preoperative levels of CRP could predict surgical complexity in ACC cases.The study from April 2024 to March 2025, included 108 patients who underwent emergency laparoscopic gallbladder removal. Patients with other medical conditions known to influence CRP levels were excluded to ensure accurate results. This research defined a “difficult” laparoscopic procedure as one lasting longer than 60 minutes.The results showed a clear relationship between elevated CRP levels and surgical difficulty. Of the 108 patients studied, 71 underwent straightforward laparoscopic procedures, 28 experienced difficult operations, and 9 required conversion to open surgery.Patients who had uncomplicated procedures had a mean CRP level of 18.2 mg/L. In comparison, those who experienced difficult laparoscopic surgeries had an average CRP level of 36 mg/L. The highest levels were observed in patients whose surgeries were converted to open procedures, averaging 50.1 mg/L.Statistical analysis confirmed a significant association between high CRP levels and surgical complexity. The findings also revealed that both the duration of surgery and the length of hospital stay increased as the complexity of the operation rose.Also, demographic factors like age and gender did not show any significant link with surgical difficulty. The study population had a mean age of 49.8 years and a male-to-female ratio of approximately 1:3.5, which reflected higher prevalence of gallbladder disease among women.The research suggest that these findings could have practical implications for surgical teams, particularly in hospitals with limited resources. Overall, the study points that CRP testing is inexpensive and widely available, and it could serve as a useful preoperative indicator for anticipating technical challenges.Source:Rayamajhi, B. B., Shrivastav, A., Karki, G., Ayer, D. B., &amp; Pradhan, S. K. (2026). C-reactive protein as a predicting factor for difficult laparoscopic cholecystectomy or its conversion to open cholecystectomy in acute calculous cholecystitis: an observational study. BMC Surgery. https://doi.org/10.1186/s12893-026-03650-4 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/31/306349-diagnostic-laparoscopy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Preoperative, CRP, Predicts, Surgical, Complexity, acute, calculous, cholecystitis:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/31/306349-diagnostic-laparoscopy.webp"><p>A new study published in the <i>BMC Surgery</i> revealed that elevated preoperative C-reactive protein (CRP) levels are significantly associated with greater surgical complexity and a higher risk of conversion in acute calculous cholecystitis (ACC). CRP can therefore serve as a useful predictor for anticipating technical challenges and improving surgical planning and resource utilization, particularly in resource-limited settings.</p><p>Acute calculous cholecystitis (ACC) is one of the most common surgical emergencies globally where the standard treatment is Laparoscopic Cholecystectomy. However, in complicated cases surgeons may need to switch to the more invasive Open Cholecystectomy, which can prolong surgery and recovery. Thus, this observational study at Shree Birendra Hospital in Kathmandu, Nepal, examined whether preoperative levels of CRP could predict surgical complexity in ACC cases.</p><p>The study from April 2024 to March 2025, included 108 patients who underwent emergency laparoscopic gallbladder removal. Patients with other medical conditions known to influence CRP levels were excluded to ensure accurate results. This research defined a “difficult” laparoscopic procedure as one lasting longer than 60 minutes.</p><p>The results showed a clear relationship between elevated CRP levels and surgical difficulty. Of the 108 patients studied, 71 underwent straightforward laparoscopic procedures, 28 experienced difficult operations, and 9 required conversion to open surgery.</p><p>Patients who had uncomplicated procedures had a mean CRP level of 18.2 mg/L. In comparison, those who experienced difficult laparoscopic surgeries had an average CRP level of 36 mg/L. The highest levels were observed in patients whose surgeries were converted to open procedures, averaging 50.1 mg/L.</p><p>Statistical analysis confirmed a significant association between high CRP levels and surgical complexity. The findings also revealed that both the duration of surgery and the length of hospital stay increased as the complexity of the operation rose.</p><p>Also, demographic factors like age and gender did not show any significant link with surgical difficulty. The study population had a mean age of 49.8 years and a male-to-female ratio of approximately 1:3.5, which reflected higher prevalence of gallbladder disease among women.</p><p>The research suggest that these findings could have practical implications for surgical teams, particularly in hospitals with limited resources. Overall, the study points that CRP testing is inexpensive and widely available, and it could serve as a useful preoperative indicator for anticipating technical challenges.</p><p>Source:</p><p>Rayamajhi, B. B., Shrivastav, A., Karki, G., Ayer, D. B., & Pradhan, S. K. (2026). C-reactive protein as a predicting factor for difficult laparoscopic cholecystectomy or its conversion to open cholecystectomy in acute calculous cholecystitis: an observational study. BMC Surgery. <a href="https://medicaldialogues.in/surgery/news/link.springer.com/article/10.1186/s12893-026-03650-4" rel="nofollow">https://doi.org/10.1186/s12893-026-03650-4</a></p>]]> </content:encoded>
</item>

<item>
<title>Povetacicept Reduces Proteinuria in IgA Nephropathy, suggests trial</title>
<link>https://edusehat.com/en/povetacicept-reduces-proteinuria-in-iga-nephropathy-suggests-trial</link>
<guid>https://edusehat.com/en/povetacicept-reduces-proteinuria-in-iga-nephropathy-suggests-trial</guid>
<description><![CDATA[ Povetacicept, a dual BAFF/APRIL inhibitor, significantly lowered proteinuria in patients with immunoglobulin A nephropathy (IgAN), as demonstrated in the RAINIER trial.The trial met its primary objective. In the interim analysis population, patients treated with povetacicept achieved a 52.0% reduction from baseline in urine protein to creatinine ratio (UPCR) at Week 36, with a statistically significant and clinically meaningful 49.8% UPCR reduction compared to placebo (P ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/09/237764-iga-nephropathy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Povetacicept, Reduces, Proteinuria, IgA, Nephropathy, suggests, trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/09/237764-iga-nephropathy.webp"><p>Povetacicept, a dual BAFF/APRIL inhibitor, significantly lowered proteinuria in patients with immunoglobulin A <a href="https://medicaldialogues.in/topics/nephropathy">nephropathy </a>(IgAN), as demonstrated in the RAINIER trial.</p><p>The trial met its primary objective. In the interim analysis population, patients treated with povetacicept achieved a 52.0% reduction from baseline in urine protein to creatinine ratio (UPCR) at Week 36, with a statistically significant and clinically meaningful 49.8% UPCR reduction compared to placebo (P<0.0001). The reduction in proteinuria was consistent across all pre-specified subgroups.
</p><p>The trial also met its secondary objective. For the first secondary endpoint, patients treated with povetacicept demonstrated a 77.4% reduction from baseline in serum galactose deficient IgA1 (Gd-IgA1) compared to an increase of +9.1% in the placebo group, yielding a reduction of 79.3% compared to placebo (P<0.0001). For the second secondary endpoint, in patients with baseline hematuria, 85.1% achieved hematuria resolution in the povetacicept treatment group compared to 23.4% in the placebo group, resulting in hematuria resolution of 61.7% compared to placebo (P<0.0001).
</p><p>Povetacicept was generally safe and well tolerated. The majority of adverse events (AEs) were mild to moderate. There were no serious adverse events (SAEs) related to povetacicept and no deaths in the trial. There were no opportunistic infections, and no discontinuations due to infections. As expected, anti-drug antibodies (ADAs) were observed; these ADAs had no impact on efficacy or the risk profile.
</p><p>Treatment discontinuations (for any reason) were 8.8% in the placebo group and 3.8% in the povetacicept group, and trial discontinuations (for any reason) were 1.5% in the placebo group and 0.8% in the povetacicept group in this interim analysis population.
</p><p>“The Phase 3 RAINIER 36-week interim analysis results in IgAN are remarkable. With its clinical profile, dosing and administration advantage, and breadth of potential indications, povetacicept demonstrates best-in-class potential and establishes renal medicine as Vertex’s fourth franchise alongside cystic fibrosis, hematology and acute pain,” said Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President of Vertex. “As a nephrologist, I am struck by the rapid, deep and sustained response to povetacicept, as well as the consistency of benefit across all subgroups. These results are important for patients with IgAN and also bring us one step closer to realizing povetacicept’s pipeline-in-a-product promise. We thank the patients and trial investigators for their trust and for making RAINIER the largest and fastest enrolling of any contemporary IgAN trial.”
</p><h3>Trial Design, Population Characteristics and Efficacy Results
</h3><p>RAINIER is a global Phase 3 randomized, double-blind, placebo-controlled pivotal trial of povetacicept 80 mg administered subcutaneously every four weeks versus placebo on top of standard of care.
</p><p>A total of 605 patients were randomized in the trial, N=557 are in the main cohort, of which N=199 are in the interim analysis population, and N=48 patients are in an exploratory cohort. These patients are representative of real world IgAN patients at risk of kidney disease progression. The median time from diagnosis of IgAN to randomization in the main cohort was approximately 3.8 years and the trial patients had high rates of background supportive care, with 97.8% of patients on angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEi/ARBs), and 67.7% of patients on sodium-glucose co-transporter 2 (SGLT2) inhibitors, the latter representing the highest percentage in recently completed IgAN trials.
</p><p>For the interim analysis, the trial’s primary endpoint is percent change from baseline in 24-hour UPCR, and the two alpha-controlled secondary endpoints are percent change from baseline in serum Gd-IgA1 and the proportion of patients to achieve hematuria resolution, all at Week 36. Exploratory endpoints for this interim analysis included the proportion of patients with 24-hour UPCR <0.5 g/g, in line with the most recent Kidney Disease: Improving Global Outcomes (KDIGO) guidelines.</p><div contenteditable="false" data-width="587" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/03/18/333605-image.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="23690HXGJ7uMrMKYEsUeVKEhy90YWV6wLLaJc9853389" data-watermark="false" info-selector="#info_item_1773809854318"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"></div></div><p><b>Figure 1: Pre-specified Subgroup Analysis in Percent Change from Baseline in 24-Hour UPCR at Week 36</b></p><h3>Safety Results
</h3><p>Povetacicept was generally safe and well tolerated. The data below reflect 557 patients in the main cohort with a mean duration of treatment of 33.7 weeks for the povetacicept cohort and 33.4 weeks for placebo.</p><div contenteditable="false" data-width="587" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/03/18/333606-image.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="23690L1q6L6MzQCHBkkJ0sn5HQDeM9fKHw2Wr9925487" data-watermark="false" info-selector="#info_item_1773809926194"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"></div></div><h3>Next Steps
</h3><p>The U.S. Food and Drug Administration (FDA) has granted rolling review of the Biologics License Application (BLA) for povetacicept in IgAN. As such, Vertex has already submitted several modules and will complete the full BLA submission by the end of March for potential accelerated approval. As announced previously, Vertex is using a priority review voucher to expedite the review of the povetacicept BLA from ten months to six months.
</p><p>If povetacicept is approved by the FDA, Vertex plans to launch povetacicept in a low volume (<0.5 mL) subcutaneous auto-injector delivered once every four weeks via at-home administration.
</p><p>The RAINIER Phase 3 trial continues in a blinded manner, and final analysis will occur at two years of treatment, with a primary endpoint of total estimated glomerular filtration rate (eGFR) slope through Week 104. Full enrollment for the RAINIER trial was announced in November 2025.</p>]]> </content:encoded>
</item>

<item>
<title>GPAT 2026 Results Declared, General Cut&#45;Off at 96.25 Percentile, NBEMS Releases Rank Details</title>
<link>https://edusehat.com/en/gpat-2026-results-declared-general-cut-off-at-9625-percentile-nbems-releases-rank-details</link>
<guid>https://edusehat.com/en/gpat-2026-results-declared-general-cut-off-at-9625-percentile-nbems-releases-rank-details</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has declared the Graduate Pharmacy Aptitude Test (GPAT) 2026 results, with the General (Non-PwBD) category cut-off recorded at 96.2586493 percentile, corresponding to a score of 213 and closing rank of 2059.Along with the results, NBEMS has released category-wise cut-off percentiles, scores, and rank details. The cut-off for General (PwBD) stands at 48.9825988 percentile with a score of 104, while the EWS (Non-PwBD) category recorded 90.8238059 percentile with a score of 180. OBC-NCL candidates have a cut-off of 90.0870992 percentile with a score of 177. For reserved categories, the cut-off for SC candidates is 76.4664192 percentile with a score of 142, whereas ST candidates recorded 59.1939124 percentile with a score of 116.Also Read: NBEMS Releases Tentative Exam Schedule for FMGE, GPAT, DNB, DrNB and More, Check DatesThe examination authority also informed that seven questions in GPAT 2026 were found to be technically incorrect, and full marks have been awarded to all candidates for these questions irrespective of attempts. Additionally, four questions had revised answers, and marks for these were awarded only to candidates who selected the corrected responses.Candidates who appeared for the examination can check and download their results, including scorecards and rank details, from the official NBEMS website. The results are crucial for admission into M.Pharm programmes and for eligibility for scholarships for pharmacy graduates.GPAT is a national-level entrance examination that plays a key role in postgraduate pharmacy admissions across India. Candidates are advised to review their results carefully and follow further instructions regarding counselling and admission processes.According to a recent NDTV report, the result announcement includes detailed rank lists and qualifying criteria, helping candidates plan their next steps for higher education.Also Read: Kerala Opens M.Pharm Admission 2025-26, GPAT Score Mandatory, Deadline November 2 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/23/316403-gpat-2026.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GPAT, 2026, Results, Declared, General, Cut-Off, 96.25, Percentile, NBEMS, Releases, Rank, Details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/23/316403-gpat-2026.webp"><p><b>New Delhi: </b>The National Board of Examinations in Medical Sciences (NBEMS) has declared the Graduate Pharmacy Aptitude Test (GPAT) 2026 results, with the General (Non-PwBD) category cut-off recorded at 96.2586493 percentile, corresponding to a score of 213 and closing rank of 2059.</p><div class="pasted-from-word-wrapper"><p>Along with the results, NBEMS has released category-wise cut-off percentiles, scores, and rank details. The cut-off for General (PwBD) stands at 48.9825988 percentile with a score of 104, while the EWS (Non-PwBD) category recorded 90.8238059 percentile with a score of 180. OBC-NCL candidates have a cut-off of 90.0870992 percentile with a score of 177. For reserved categories, the cut-off for SC candidates is 76.4664192 percentile with a score of 142, whereas ST candidates recorded 59.1939124 percentile with a score of 116.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/nbems-releases-tentative-exam-schedule-for-fmge-gpat-dnb-drnb-and-more-check-dates-161768">Also Read: NBEMS Releases Tentative Exam Schedule for FMGE, GPAT, DNB, DrNB and More, Check Dates</a></div></div><p>The examination authority also informed that seven questions in GPAT 2026 were found to be technically incorrect, and full marks have been awarded to all candidates for these questions irrespective of attempts. Additionally, four questions had revised answers, and marks for these were awarded only to candidates who selected the corrected responses.</p><p>Candidates who appeared for the examination can check and download their results, including scorecards and rank details, from the official NBEMS website. The results are crucial for admission into M.Pharm programmes and for eligibility for scholarships for pharmacy graduates.</p><p>GPAT is a national-level entrance examination that plays a key role in postgraduate pharmacy admissions across India. Candidates are advised to review their results carefully and follow further instructions regarding counselling and admission processes.</p><p>According to a recent <a href="https://www.ndtv.com/education/nbems-gpat-result-2026-out-live-heres-direct-link-to-check-cut-off-rank-list-details-11322528" rel="nofollow">NDTV</a> report, the result announcement includes detailed rank lists and qualifying criteria, helping candidates plan their next steps for higher education.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/kerala-opens-mpharm-admission-2025-26-gpat-score-mandatory-deadline-november-2-157838">Also Read: Kerala Opens M.Pharm Admission 2025-26, GPAT Score Mandatory, Deadline November 2</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Acharya Balkrishna receives Vishwa Ayurveda Ratna at Earth Awards 2026</title>
<link>https://edusehat.com/en/acharya-balkrishna-receives-vishwa-ayurveda-ratna-at-earth-awards-2026</link>
<guid>https://edusehat.com/en/acharya-balkrishna-receives-vishwa-ayurveda-ratna-at-earth-awards-2026</guid>
<description><![CDATA[ Haridwar: Acharya Balkrishna has been honoured with the &#039;Vishwa Ayurveda Ratna&#039; award at a ceremony held in New Delhi. The award was presented during the Earth Awards 2026, organised by Net Green Foundation at UNESCO House, recognising his efforts in promoting Ayurveda globally. A renowned Sanskrit scholar, Ayurveda researcher, and author, Balkrishna is widely recognised for his work in promoting traditional Indian medicine. He is the co-founder and managing director of Patanjali Ayurved and Patanjali Yogpeeth Trust, leading initiatives in herbal and Ayurvedic products, wellness, and healthcare.He has been instrumental in establishing healthcare institutions such as the Patanjali Emergency &amp; Critical Care Hospital and continues to advance the practice and global reach of Ayurveda through research, publications, and wellness programs.Also Read:Renowned Ayurvedacharya Dr Harish Patankar conferred International Ayurveda Ratna AwardHe was recognised for his ongoing efforts to bring traditional Ayurvedic knowledge and practices to the international stage and for advancing Indian heritage in holistic healthcare, reports Jagran. While he could not attend the event in person, he dedicated the honour to the ancient Ayurvedic tradition that has contributed to health and wellness for generations.The Earth Awards ceremony was attended by prominent leaders, experts, and policymakers from both India and abroad. The notable guests included Manjinder Singh Sirsa, Minister for Environment, Forest, and Wildlife of the Delhi government, and Dr. Benno Boer, head of UNESCO’s Natural Sciences Unit, along with several other dignitaries and specialists in environmental and healthcare fields. Their presence underscored the growing global interest in promoting traditional medicine systems alongside modern scientific approaches. The Net Green Foundation is an international organisation dedicated to recognising significant efforts in environmental protection, sustainable development, and the preservation of traditional knowledge systems. Through its awards, the foundation aims to encourage initiatives that strengthen the balance between human well-being and nature, foster sustainable practices, and highlight the value of ancient knowledge in addressing contemporary challenges in health and the environment. Also Read:AYUSH Ministry honours 3 distinguished practitioners with National Dhanwantari Ayurveda Awards ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340623-acharya-balkrishna.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Acharya, Balkrishna, receives, Vishwa, Ayurveda, Ratna, Earth, Awards, 2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340623-acharya-balkrishna.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p>Haridwar: Acharya Balkrishna has been honoured with the 'Vishwa Ayurveda Ratna' <a href="https://medicaldialogues.in/topics/awards" target="_blank">award</a> at a ceremony held in New Delhi. The award was presented during the Earth Awards 2026, organised by Net Green Foundation at UNESCO House, recognising his efforts in promoting Ayurveda globally. </p><p>A renowned Sanskrit scholar, Ayurveda researcher, and author, Balkrishna is widely recognised for his work in promoting traditional Indian medicine. He is the co-founder and managing director of Patanjali Ayurved and Patanjali Yogpeeth Trust, leading initiatives in herbal and Ayurvedic products, wellness, and healthcare.</p><p>He has been instrumental in establishing healthcare institutions such as the Patanjali Emergency & Critical Care Hospital and continues to advance the practice and global reach of Ayurveda through research, publications, and wellness programs.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/renowned-ayurvedacharya-dr-harish-patankar-conferred-international-ayurveda-ratna-award-161801">Also Read:Renowned Ayurvedacharya Dr Harish Patankar conferred International Ayurveda Ratna Award</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>He was recognised for his ongoing efforts to bring traditional Ayurvedic knowledge and practices to the international stage and for advancing Indian heritage in holistic healthcare, reports <i><a href="https://www.jagran.com/uttarakhand/haridwar-acharya-balkrishna-honored-with-vishwa-ayurveda-ratna-award-40199031.html" target="_blank">Jagran</a></i>. While he could not attend the event in person, he dedicated the honour to the ancient Ayurvedic tradition that has contributed to health and wellness for generations.</p><div class="pasted-from-word-wrapper"><p>The Earth Awards ceremony was attended by prominent leaders, experts, and policymakers from both India and abroad. The notable guests included Manjinder Singh Sirsa, Minister for Environment, Forest, and Wildlife of the Delhi government, and Dr. Benno Boer, head of UNESCO’s Natural Sciences Unit, along with several other dignitaries and specialists in environmental and healthcare fields. Their presence underscored the growing global interest in promoting traditional medicine systems alongside modern scientific approaches. </p><p>The Net Green Foundation is an international organisation dedicated to recognising significant efforts in environmental protection, sustainable development, and the preservation of traditional knowledge systems. Through its awards, the foundation aims to encourage initiatives that strengthen the balance between human well-being and nature, foster sustainable practices, and highlight the value of ancient knowledge in addressing contemporary challenges in health and the environment. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/ayush-ministry-honours-3-distinguished-practitioners-with-national-dhanwantari-ayurveda-awards-143907">Also Read:AYUSH Ministry honours 3 distinguished practitioners with National Dhanwantari Ayurveda Awards</a></p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"></div></div>]]> </content:encoded>
</item>

<item>
<title>After harassment complaints, Maharashtra plans to shift private medical college admission process to govt institutes</title>
<link>https://edusehat.com/en/after-harassment-complaints-maharashtra-plans-to-shift-private-medical-college-admission-process-to-govt-institutes</link>
<guid>https://edusehat.com/en/after-harassment-complaints-maharashtra-plans-to-shift-private-medical-college-admission-process-to-govt-institutes</guid>
<description><![CDATA[ Mumbai: After repeated complaints from students about harassment during medical admissions, the state CET Cell is planning to shift the admission process for private medical colleges to designated government medical colleges.Instead of asking students to report to private colleges, the CET Cell has proposed that the entire admission process, including document verification and fee payment fixed by the Fee Regulatory Authority, will take place at selected government medical colleges, following which admissions will be confirmed. However, the proposal is under consideration, and discussions are underway. Several meetings have already been held between the CET Cell, the Directorate of Medical Education and Research (DMER), and the state medical education department to work out how the system will function.Also read- No specific central reservation policy for AYUSH graduates seeking MBBS admissions via NEET: MoS HealthThe move comes after serious allegations during the 2025 admission season, during which students reported instances of harassment across private institutions. At present, students allotted seats through the CET Cell&#039;s centralised process are required to report physically to the respective colleges within a stipulated timeframe to submit documents or pay fees to secure their seats, reports TOI. They claimed that each year, they were stopped at the gates of private colleges, coerced into paying full fees despite eligibility for concessions, and asked to pay amounts exceeding those approved by the Fee Regulatory Authority. There have also been allegations of students being confined within campuses until admission deadlines lapse, and even instances where the mobile phones of students and parents were taken away. Such incidents, according to them, led to some deserving candidates losing their seats.If the new system gets approved then students will instead go to designated government medical colleges, submit and verify documents, pay fees as fixed by the Fee Regulatory Authority and complete admission in a monitored environment.While DMER has flagged concerns over staffing requirements, the CET Cell has suggested that private colleges depute their own representatives to these govt centres, thereby avoiding additional burden on public infrastructure.Officials added that representatives from medical education department and the CET Cell will be present to resolve grievances in real time.According to TOI sources, the proposal will first be submitted to the medical education secretary and will then be sent to the law and judiciary department, as changes to the current admission framework may be needed before the 2026 admission cycle.Commenting on this, Former DMER head Dr Pravin Shingare said, &quot;It can mark a decisive shift in how admissions are conducted. For the first time, the entire process will be truly centralised in Maharashtra. If the govt clears this plan, it will send a strong message to students and parents that merit will be protected and any injustice to deserving candidates will not be tolerated.&quot;Also read- Andhra Pradesh: 520 posts approved for Piduguralla Medical College ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/19/333846-admission.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>After, harassment, complaints, Maharashtra, plans, shift, private, medical, college, admission, process, govt, institutes</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/19/333846-admission.webp"><p><b>Mumbai: </b>After repeated complaints from students about harassment during <a href="https://medicaldialogues.in/topics/mbbs-admissions" target="_blank">medical admissions</a>, the state CET Cell is planning to shift the admission process for private medical colleges to designated <a href="https://medicaldialogues.in/topics/government-medical-colleges" target="_blank">government medical colleges</a>.</p><p>Instead of asking students to report to private colleges, the CET Cell has proposed that the entire admission process, including document verification and fee payment fixed by the Fee Regulatory Authority, will take place at selected government medical colleges, following which admissions will be confirmed. </p><p>However, the proposal is under consideration, and discussions are underway. Several meetings have already been held between the CET Cell, the Directorate of Medical Education and Research (DMER), and the state medical education department to work out how the system will function.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/medical-admissions/no-specific-central-reservation-policy-for-ayush-graduates-seeking-mbbs-admissions-via-neet-mos-health-164556" target="_blank">No specific central reservation policy for AYUSH graduates seeking MBBS admissions via NEET: MoS Health</a></b></p><p>The move comes after serious allegations during the 2025 admission season, during which students reported instances of harassment across private institutions. At present, students allotted seats through the CET Cell's centralised process are required to report physically to the respective colleges within a stipulated timeframe to submit documents or pay fees to secure their seats, reports TOI. </p><p>They claimed that each year, they were stopped at the gates of private colleges, coerced into paying full fees despite eligibility for concessions, and asked to pay amounts exceeding those approved by the Fee Regulatory Authority. There have also been allegations of students being confined within campuses until admission deadlines lapse, and even instances where the mobile phones of students and parents were taken away. Such incidents, according to them, led to some deserving candidates losing their seats.</p><p>If the new system gets approved then students will instead go to designated government medical colleges, submit and verify documents, pay fees as fixed by the Fee Regulatory Authority and complete admission in a monitored environment.</p><p>While DMER has flagged concerns over staffing requirements, the CET Cell has suggested that private colleges depute their own representatives to these govt centres, thereby avoiding additional burden on public infrastructure.</p><p>Officials added that representatives from medical education department and the CET Cell will be present to resolve grievances in real time.</p><p>According to <a href="https://timesofindia.indiatimes.com/city/mumbai/govt-may-shift-admissions-for-pvt-med-colleges-to-govt-centres/articleshow/130069370.cms" target="_blank" rel="nofollow">TOI </a>sources, the proposal will first be submitted to the medical education secretary and will then be sent to the law and judiciary department, as changes to the current admission framework may be needed before the 2026 admission cycle.</p><p>Commenting on this, Former DMER head Dr Pravin Shingare said, "It can mark a decisive shift in how admissions are conducted. For the first time, the entire process will be truly centralised in Maharashtra. If the govt clears this plan, it will send a strong message to students and parents that merit will be protected and any injustice to deserving candidates will not be tolerated."</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/andhra-pradesh/andhra-pradesh-520-posts-approved-for-piduguralla-medical-college-167215" target="_blank">Andhra Pradesh: 520 posts approved for Piduguralla Medical College</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Benzalkonium Chloride in Laundry Detergent Misdiagnosed as Eczema: Case Report Highlights Hidden Allergen Risk</title>
<link>https://edusehat.com/en/benzalkonium-chloride-in-laundry-detergent-misdiagnosed-as-eczema-case-report-highlights-hidden-allergen-risk</link>
<guid>https://edusehat.com/en/benzalkonium-chloride-in-laundry-detergent-misdiagnosed-as-eczema-case-report-highlights-hidden-allergen-risk</guid>
<description><![CDATA[ China: A recent case report published in Clinical, Cosmetic and Investigational Dermatology has highlighted how systemic contact dermatitis caused by benzalkonium chloride can be easily misdiagnosed as eczema, delaying appropriate treatment. The study, led by Man Yu from the Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, China, highlights the importance of detailed exposure history in patients with persistent or treatment-resistant dermatitis.Allergic contact dermatitis (ACD) is a common inflammatory skin condition that often mimics other eczematous disorders, making diagnosis challenging. Benzalkonium chloride (BAK), a widely used compound found in disinfectants, preservatives, and household cleaning products, is increasingly recognized as a potential allergen. However, due to its widespread use, it is often overlooked as a trigger in clinical practice.The report describes a 31-year-old woman who presented with a two-month history of worsening skin symptoms, including widespread redness, scaling, intense itching, and localized discomfort. The lesions initially appeared in the lower back region and gradually spread symmetrically to the trunk and thighs. She had no history of fever, joint symptoms, or mucosal involvement.The patient had previously consulted multiple healthcare providers and was diagnosed with eczema and allergic dermatitis. She was treated with oral antihistamines and topical corticosteroids, which provided only temporary relief. Notably, her symptoms recurred quickly after stopping treatment, with each episode becoming more severe. She had no prior history of chronic illness, allergies, or exposure to new personal care products.Clinical examination revealed well-defined, erythematous, scaly plaques distributed mainly in areas in close contact with clothing, such as the waistline and lower torso. Laboratory investigations, including blood tests and autoimmune screening, were unremarkable. A skin biopsy showed features consistent with contact dermatitis, including mild spongiosis and superficial inflammatory infiltrates.A turning point in diagnosis came after a detailed reassessment of the patient’s environmental exposures. The patient reported recently using a new laundry disinfectant introduced approximately eight weeks before symptom onset. Further evaluation confirmed that the product contained benzalkonium chloride. Based on the temporal association, lesion distribution, and exclusion of other causes, a diagnosis of BAK-induced allergic contact dermatitis was established.The patient was treated with appropriate anti-inflammatory therapy and advised to completely avoid the offending product. Significant improvement was observed within two weeks, and complete resolution of symptoms was noted at one-month follow-up, confirming the causal relationship.The authors emphasized that such cases are not uncommon, as BAK-related dermatitis often resembles chronic eczema and may respond only transiently to standard therapies. They highlighted that laundry disinfectants are an underrecognized source of allergen exposure. The case also points to the need for clinicians to consider other similar compounds in household products that may provoke comparable reactions.Overall, the findings reinforce the critical role of thorough history-taking, particularly regarding household and environmental exposures, in patients with persistent dermatitis. Early identification and elimination of the causative allergen can lead to rapid recovery and prevent unnecessary prolonged treatment.Reference:Yu M, Meng F, Tian S. Systemic Contact Dermatitis Triggered by Benzalkonium Chloride in Laundry Detergent: A Case Initially Misdiagnosed as Eczema. Clin Cosmet Investig Dermatol. 2026;19:1-5https://doi.org/10.2147/CCID.S577154 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/23/230746-contact-dermatitis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Benzalkonium, Chloride, Laundry, Detergent, Misdiagnosed, Eczema:, Case, Report, Highlights, Hidden, Allergen, Risk</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/23/230746-contact-dermatitis.webp"><p><span>China: A recent case report published in<i> Clinical, Cosmetic and Investigational Dermatology </i>has highlighted how systemic contact dermatitis caused by benzalkonium chloride can be easily <a href="https://medicaldialogues.in/topics/wrongly-diagnosed">misdiagnosed </a>as <a href="https://medicaldialogues.in/topics/eczema">eczema</a>, delaying appropriate treatment. The study, led by Man Yu from the Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, China, highlights the importance of detailed exposure history in patients with persistent or treatment-resistant dermatitis.</span></p><div class="pasted-from-word-wrapper"><div><a href="https://medicaldialogues.in/topics/allergic-contact-dermatitis">Allergic contact dermatitis (ACD)</a> is a common inflammatory skin condition that often mimics other eczematous disorders, making diagnosis challenging. Benzalkonium chloride (BAK), a widely used compound found in disinfectants, preservatives, and household cleaning products, is increasingly recognized as a potential allergen. However, due to its widespread use, it is often overlooked as a trigger in clinical practice.</div><div>The report describes a 31-year-old woman who presented with a two-month history of worsening skin symptoms, including widespread redness, scaling, intense itching, and localized discomfort. The lesions initially appeared in the lower back region and gradually spread symmetrically to the trunk and thighs. She had no history of fever, joint symptoms, or mucosal involvement.</div><div>The patient had previously consulted multiple healthcare providers and was diagnosed with eczema and allergic dermatitis. She was treated with oral antihistamines and topical corticosteroids, which provided only temporary relief. Notably, her symptoms recurred quickly after stopping treatment, with each episode becoming more severe. She had no prior history of chronic illness, allergies, or exposure to new personal care products.</div><div>Clinical examination revealed well-defined, erythematous, scaly plaques distributed mainly in areas in close contact with clothing, such as the waistline and lower torso. Laboratory investigations, including blood tests and autoimmune screening, were unremarkable. A skin biopsy showed features consistent with contact dermatitis, including mild spongiosis and superficial inflammatory infiltrates.</div><div>A turning point in diagnosis came after a detailed reassessment of the patient’s environmental exposures. The patient reported recently using a new laundry disinfectant introduced approximately eight weeks before symptom onset. Further evaluation confirmed that the product contained benzalkonium chloride. Based on the temporal association, lesion distribution, and exclusion of other causes, a diagnosis of BAK-induced allergic contact dermatitis was established.</div><div>The patient was treated with appropriate anti-inflammatory therapy and advised to completely avoid the offending product. Significant improvement was observed within two weeks, and complete resolution of symptoms was noted at one-month follow-up, confirming the causal relationship.</div><div>The authors emphasized that such cases are not uncommon, as BAK-related dermatitis often resembles chronic eczema and may respond only transiently to standard therapies. They highlighted that laundry disinfectants are an underrecognized source of allergen exposure. The case also points to the need for clinicians to consider other similar compounds in household products that may provoke comparable reactions.</div><div>Overall, the findings reinforce the critical role of thorough history-taking, particularly regarding household and environmental exposures, in patients with persistent dermatitis. Early identification and elimination of the causative allergen can lead to rapid recovery and prevent unnecessary prolonged treatment.</div><div>Reference:</div><div>Yu M, Meng F, Tian S. Systemic Contact Dermatitis Triggered by Benzalkonium Chloride in Laundry Detergent: A Case Initially Misdiagnosed as Eczema. Clin Cosmet Investig Dermatol. 2026;19:1-5https://doi.org/10.2147/CCID.S577154</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>ICS/LABA Not Linked to Increased Oral Food Challenge Reaction Severity: Study</title>
<link>https://edusehat.com/en/icslaba-not-linked-to-increased-oral-food-challenge-reaction-severity-study</link>
<guid>https://edusehat.com/en/icslaba-not-linked-to-increased-oral-food-challenge-reaction-severity-study</guid>
<description><![CDATA[ USA: Current recommendations advise withholding long-acting beta-agonists before conducting an oral food challenge (OFC). However, recent findings of a study show that the severity of OFC reactions in patients using a combination of inhaled corticosteroids and long-acting beta-agonists (ICS/LABA) did not significantly differ from those using inhaled corticosteroids (ICS) alone. The odds of experiencing more severe reactions were similar between both groups, suggesting that ICS/LABA therapy may not increase reaction risk.These results, published in the Annals of Allergy, Asthma &amp; Immunology, provide reassurance regarding the safety profile of ICS/LABA in this context.Oral food challenges are the gold standard for diagnosing IgE-mediated food allergies. Although generally safe, severe reactions can occur, particularly in individuals with poorly controlled asthma, adolescents and young adults, or when reactions happen outside supervised settings.Current guidelines recommend withholding long-acting beta-agonists (LABAs) for at least eight hours before an OFC, but this advice is based on limited evidence. Earlier studies showed that LABAs like salmeterol can produce prolonged bronchodilation for up to 12 hours, raising concerns that they might delay or mask early respiratory symptoms during an allergic reaction.However, this creates a clinical challenge, as good asthma control is crucial for safe and accurate OFC interpretation. For many patients, especially those with moderate to severe asthma, LABAs are essential for maintaining stability. Withholding them before testing may therefore compromise respiratory control and introduce additional risks.To address this gap, the study led by Kyle Robillard and colleagues from the University of Texas Southwestern Medical Center evaluated whether LABA use influences the severity of reactions during OFCs. The researchers compared outcomes between patients receiving ICS/LABA combination therapy and those treated with ICS alone.   The analysis found the following:No significant difference in reaction severity was observed between patients using ICS/LABA and those using ICS alone.The likelihood of experiencing more severe reactions was similar in both groups.LABA use did not worsen or intensify allergic responses during oral food challenges.The findings question the routine practice of withholding LABAs before OFCs.Continuing LABA therapy may not adversely affect the safety of oral food challenges.The results hold practical implications for clinical practice. By demonstrating that LABAs do not appear to increase the severity of OFC reactions, the study provides clinicians with evidence that may help refine existing guidelines. It also highlights the importance of balancing medication adjustments with the need to maintain adequate asthma control.The authors emphasize that a clearer understanding of how asthma therapies interact with allergy testing protocols is essential for improving patient care. Further research may help determine whether current recommendations regarding LABA withholding should be reconsidered, potentially simplifying pre-test preparation while ensuring patient safety.Reference:Robillard K, Crooks JL, Leung D, Hui-Beckman JW, Lanser BJ. Long-acting β-agonist (LABA) use in individuals with asthma is not associated with an increased severity of oral food challenge (OFC) reactions. Ann Allergy Asthma Immunol. 2026 Jan 18:S1081-1206(26)00023-2. doi: 10.1016/j.anai.2026.01.006. Epub ahead of print. PMID: 41558625. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339348-long-acting-agonist-laba.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>ICSLABA, Not, Linked, Increased, Oral, Food, Challenge, Reaction, Severity:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339348-long-acting-agonist-laba.webp"><p><span>USA: Current recommendations advise withholding long-acting <a href="https://medicaldialogues.in/topics/beta-3-agonist">beta-agonists </a>before conducting an<a href="https://medicaldialogues.in/topics/oral-food-challenge-ofc"> oral food challenge (OFC)</a>. However, recent findings of a study show that the severity of OFC reactions in patients using a combination of<a href="https://medicaldialogues.in/topics/inhaled-corticosteroids"> inhaled corticosteroids</a> and long-acting beta-agonists (ICS/LABA) did not significantly differ from those using inhaled corticosteroids (ICS) alone. The odds of experiencing more severe reactions were similar between both groups, suggesting that ICS/LABA therapy may not increase reaction risk.</span></p><div class="pasted-from-word-wrapper"><div>These results, published in the<i> Annals of Allergy, Asthma & Immunology</i>, provide reassurance regarding the safety profile of ICS/LABA in this context.</div><div>Oral food challenges are the gold standard for diagnosing IgE-mediated food allergies. Although generally safe, severe reactions can occur, particularly in individuals with poorly controlled asthma, adolescents and young adults, or when reactions happen outside supervised settings.</div><div>Current guidelines recommend withholding long-acting beta-agonists (LABAs) for at least eight hours before an OFC, but this advice is based on limited evidence. Earlier studies showed that LABAs like salmeterol can produce prolonged bronchodilation for up to 12 hours, raising concerns that they might delay or mask early respiratory symptoms during an allergic reaction.</div><div>However, this creates a clinical challenge, as good asthma control is crucial for safe and accurate OFC interpretation. For many patients, especially those with moderate to severe asthma, LABAs are essential for maintaining stability. Withholding them before testing may therefore compromise respiratory control and introduce additional risks.</div><div>To address this gap, the study led by Kyle Robillard and colleagues from the University of Texas Southwestern Medical Center evaluated whether LABA use influences the severity of reactions during OFCs. The researchers compared outcomes between patients receiving ICS/LABA combination therapy and those treated with ICS alone.   </div><div>The analysis found the following:</div><ul><li>No significant difference in reaction severity was observed between patients using ICS/LABA and those using ICS alone.</li><li>The likelihood of experiencing more severe reactions was similar in both groups.</li><li>LABA use did not worsen or intensify allergic responses during oral food challenges.</li><li>The findings question the routine practice of withholding LABAs before OFCs.</li><li>Continuing LABA therapy may not adversely affect the safety of oral food challenges.</li></ul><div>The results hold practical implications for clinical practice. By demonstrating that LABAs do not appear to increase the severity of OFC reactions, the study provides clinicians with evidence that may help refine existing guidelines. It also highlights the importance of balancing medication adjustments with the need to maintain adequate asthma control.</div><div>The authors emphasize that a clearer understanding of how asthma therapies interact with allergy testing protocols is essential for improving patient care. Further research may help determine whether current recommendations regarding LABA withholding should be reconsidered, potentially simplifying pre-test preparation while ensuring patient safety.</div><div>Reference:</div><div>Robillard K, Crooks JL, Leung D, Hui-Beckman JW, Lanser BJ. Long-acting β-agonist (LABA) use in individuals with asthma is not associated with an increased severity of oral food challenge (OFC) reactions. Ann Allergy Asthma Immunol. 2026 Jan 18:S1081-1206(26)00023-2. doi: 10.1016/j.anai.2026.01.006. Epub ahead of print. PMID: 41558625.</div></div>]]> </content:encoded>
</item>

<item>
<title>Patients of Anaphylaxis with Pre&#45;existing CV Disease Had Worse Outcomes: Study</title>
<link>https://edusehat.com/en/patients-of-anaphylaxis-with-pre-existing-cv-disease-had-worse-outcomes-study</link>
<guid>https://edusehat.com/en/patients-of-anaphylaxis-with-pre-existing-cv-disease-had-worse-outcomes-study</guid>
<description><![CDATA[ Researchers have found in a new study that patients with anaphylaxis and cardiovascular disease experienced a 32% longer hospital stay. In the study, all 115,395 anaphylaxis hospitalizations were analyzed, and out of them, 60.9% of patients had pre-existing cardiovascular disease. It was revealed that overall, outcomes were worse in anaphylaxis patients with underlying cardiovascular conditions. The findings of the study were reported at a major allergy and immunology meeting.These findings are published in the Journal of Allergy and Clinical Immunology in February 2026.Anaphylaxis is defined as a rapid-onset, systemic hypersensitivity reaction necessitating immediate intervention, yet the prognostic impact of pre-existing cardiovascular disease (CVD) on these patients has remained a critically underrecognized area in medicine. To address this clinical gap, Dr. Diala Merheb and a team of clinical researchers from the University of Kansas (KU) School of Medicine evaluated the association between various forms of heart disease and in-hospital outcomes among patients across the United States.The study utilized a retrospective design by analyzing the National Inpatient Sample (NIS) data from 2016 to 2022 to identify a massive cohort of 115,395 weighted adult hospitalizations where anaphylaxis was the primary diagnosis. By excluding pediatric populations and employing multivariable regression models adjusted for age, sex, and the Charlson Comorbidity Index (CCI), the researchers evaluated primary endpoints such as in-hospital mortality and length of stay (LOS), while secondary outcomes focused on acute systemic complications.Key Clinical Findings of the Study Includes:Elevated Mortality: Study identifies that individuals with pre-existing heart conditions face nearly twofold higher mortality compared to those without such comorbidities (adjusted odds ratio [aOR] 1.97, 95% CI 1.60–2.42). Arrhythmia Severity: Evidence indicates that among various cardiovascular subtypes, arrhythmias are the most lethal, associated with a 5.19 times higher risk of in-hospital death. Organ Complications: Research highlights that these patients face a 3.85-fold increase in myocardial infarction (MI) odds and a 27% higher likelihood of developing acute kidney injury (AKI). Respiratory Impact: Data shows a significantly higher pulmonary burden, with a 33% increased risk of respiratory failure (aOR 1.33) and a 41% higher risk of experiencing bronchospasm (aOR 1.41). Prolonged Recovery: Findings demonstrate that the presence of cardiovascular disease is associated with a 32% longer duration of hospitalization.The results suggest that with 60.9% of anaphylaxis hospitalizations involving patients with pre-existing cardiovascular disease, there is a clear and statistically significant link between heart health and the likelihood of surviving a severe allergic event. Specifically, the data confirms that these patients suffer from significantly increased rates of both in-hospital mortality and systemic organ dysfunction.Given the severe impact of these comorbidities, clinicians might consider the implementation of integrated cardiovascular risk assessments and multidisciplinary care strategies to better manage severe allergic reactions in high-risk populations.While the analysis provides vital insights, further investigations distinguishing between various allergic triggers may help researchers understand specific morbidity patterns and potentially modify the medical management of cardiovascular disease for patients who have experienced life-threatening reactions.ReferenceMerheb D, Odai R, Nguyen T, Gierer S. Impact of Cardiovascular Disease on Morbidity and Mortality in Patients Hospitalized for Anaphylaxis. J Allergy Clin Immunol. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/27/337103-telangana.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patients, Anaphylaxis, with, Pre-existing, Disease, Had, Worse, Outcomes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/27/337103-telangana.webp"><p>Researchers have found in a new study that patients with anaphylaxis and <a href="https://medicaldialogues.in/cardiology-ctvs/news/cardiovascular-deaths-to-surge-73-by-2050-despite-medical-advances-finds-study-156450">cardiovascular disease</a> experienced a 32% longer hospital stay. In the study, all 115,395 <a href="https://speciality.medicaldialogues.in/anaphylaxis-management-canadian-2018-guidance">anaphylaxis</a> hospitalizations were analyzed, and out of them, 60.9% of patients had pre-existing cardiovascular disease. It was revealed that overall, outcomes were worse in anaphylaxis patients with underlying cardiovascular conditions. The findings of the study were reported at a major allergy and immunology meeting.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings are published in the <i>Journal of Allergy and Clinical Immunology</i> in February 2026.</p><p dir="ltr">Anaphylaxis is defined as a rapid-onset, systemic <a href="https://medicaldialogues.in/dermatology/news/researchers-propose-identifying-tmp-smx-hypersensitivity-reactions-as-scorch-jama-103182">hypersensitivity</a> reaction necessitating immediate intervention, yet the prognostic impact of pre-existing cardiovascular disease (CVD) on these patients has remained a critically underrecognized area in medicine. To address this clinical gap, Dr. Diala Merheb and a team of clinical researchers from the <i>University of Kansas (KU) School of Medicine</i> evaluated the association between various forms of heart disease and in-hospital outcomes among patients across the United States.</p><p dir="ltr">The study utilized a retrospective design by analyzing the National Inpatient Sample (NIS) data from 2016 to 2022 to identify a massive cohort of 115,395 weighted adult hospitalizations where anaphylaxis was the primary diagnosis. By excluding pediatric populations and employing multivariable regression models adjusted for age, sex, and the Charlson Comorbidity Index (CCI), the researchers evaluated primary endpoints such as in-hospital mortality and length of stay (LOS), while secondary outcomes focused on acute systemic complications.</p><p dir="ltr"><b>Key Clinical Findings of the Study Includes:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Elevated Mortality: </b>Study identifies that individuals with pre-existing heart conditions face nearly twofold higher mortality compared to those without such comorbidities (adjusted odds ratio [aOR] 1.97, 95% CI 1.60–2.42).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b> Arrhythmia Severity:</b> Evidence indicates that among various cardiovascular subtypes, arrhythmias are the most lethal, associated with a 5.19 times higher risk of in-hospital death.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b> Organ Complications:</b> Research highlights that these patients face a 3.85-fold increase in myocardial infarction (MI) odds and a 27% higher likelihood of developing acute kidney injury (AKI).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b> Respiratory Impact:</b> Data shows a significantly higher pulmonary burden, with a 33% increased risk of respiratory failure (aOR 1.33) and a 41% higher risk of experiencing bronchospasm (aOR 1.41).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b> Prolonged Recovery: </b>Findings demonstrate that the presence of cardiovascular disease is associated with a 32% longer duration of hospitalization.</p></li></ul><p dir="ltr">The results suggest that with 60.9% of anaphylaxis hospitalizations involving patients with pre-existing cardiovascular disease, there is a clear and statistically significant link between heart health and the likelihood of surviving a severe allergic event. Specifically, the data confirms that these patients suffer from significantly increased rates of both in-hospital mortality and systemic organ dysfunction.</p><p dir="ltr">Given the severe impact of these comorbidities, clinicians might consider the implementation of integrated cardiovascular risk assessments and multidisciplinary care strategies to better manage severe allergic reactions in high-risk populations.</p><p dir="ltr">While the analysis provides vital insights, further investigations distinguishing between various allergic triggers may help researchers understand specific morbidity patterns and potentially modify the medical management of cardiovascular disease for patients who have experienced life-threatening reactions.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Merheb D, Odai R, Nguyen T, Gierer S. Impact of Cardiovascular Disease on Morbidity and Mortality in Patients Hospitalized for Anaphylaxis. J Allergy Clin Immunol.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>GLP&#45;1 Therapy Interruption Increases Cardiovascular Risk in Type 2 Diabetes: Study</title>
<link>https://edusehat.com/en/glp-1-therapy-interruption-increases-cardiovascular-risk-in-type-2-diabetes-study</link>
<guid>https://edusehat.com/en/glp-1-therapy-interruption-increases-cardiovascular-risk-in-type-2-diabetes-study</guid>
<description><![CDATA[ A target trial emulation study has found that a 6-month break in GLP-1 drug therapy in patients with type 2 diabetes was associated with a higher risk of major adverse cardiovascular events compared to those who continued treatment, emphasizing the importance of consistent therapy adherence. The study was published in BMJ Medicine by Yan Xie and colleagues.In order to draw such findings, the investigators relied on a &quot;target trial emulation&quot; study design, wherein the data were examined between 1 January 2017 and 31 December 2023. The sample size was huge, involving 132,551 new users of GLP-1RAs and 201,136 new users of sulfonylureas, all of whom had type 2 diabetes mellitus. In order to qualify for inclusion into the study, the participants had to make at least two visits to the VA healthcare facility and use the VA pharmacy at least once during the past year before taking the medications under study. The participants were then tracked for three years, and their medication status was switched every six months, creating 16 distinct medication regimens.Key findings:There is a clear relationship between the use of GLP-1 receptor agonists and the reduction in the cumulative risk of major adverse cardiovascular events (MACEs), including myocardial infarction, stroke, or all-cause mortality within a period of three years. Comparing the sulfonylurea reference group to patients using GLP-1RAs, there was no statistically significant decrease in cardiovascular risk when using GLP-1RAs for 0.5, 1, or 1.5 years, where the incidence risk ratios (IRRs) were nearly equal to 1.0. Nevertheless, a reduction in the risk was observed when the GLP-1RAs were used for two years at an IRR of 0.93 (95% CI 0.88 to 0.98), but a slightly greater reduction occurred with the use of these drugs for 2.5 years (IRR 0.85; 95% CI 0). The largest reduction in the risk was recorded among the users who continued to use GLP-1RAs for the full three years, obtaining a statistically significant IRR of 0.82 (95% CI 0.78 to 0.85).In contrast to continued users, discontinuers with 0.5 years of interruption had a higher risk of developing MACE, which had an IRR of 1.04 (95% CI 1.01 to 1.08). Discontinuing use of GLP-1RA drugs for longer periods, however, increased the MACE risk even more rapidly; specifically, one-year and two-year interruptions increased the risks by IRRs of 1.14 (1.09 to 1.18) and 1.22 (1.16 to 1.27), respectively. Short interruptions were also harmful, since a 0.5-year interruption increased risks, while one-year and two-year interruptions yielded IRRs of 1.12 (95% CI 1.06 to 1.19) and 1.16 (1.11 to 1.22), respectively. From these data, it is evident that although the protective effect of GLP-1RAs forms a shield against MACEs, this protection is temporary since discontinuation starts to erode it instantly.In conclusion, the benefits of GLP-1RAs when it comes to cardiovascular protection are difficult to achieve yet easy to lose. The findings of the three-year trial have shown that, whereas consistent use provides for a 18% decrease in the occurrence of major adverse cardiovascular events in comparison to patients on sulfonylureas, this achievement is fragile indeed. Any deviation from the regime can result in loss of these hard-gained benefits and increase the chances of having a myocardial infarction, stroke, or even mortality. Medical practitioners need to understand that GLP-1RAs should not be used cyclically but on a consistent basis.Reference:Xie Y, Choi T, Al-Aly Z. Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation. BMJ Medicine. 2026;5:e002150. https://doi.org/10.1136/bmjmed-2025-002150  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/06/16/130474-glp-1-receptor-agonists.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GLP-1, Therapy, Interruption, Increases, Cardiovascular, Risk, Type, Diabetes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/06/16/130474-glp-1-receptor-agonists.webp"><p>A target trial emulation study has found that a 6-month break in GLP-1 drug therapy in patients with type 2 diabetes was associated with a higher risk of major adverse cardiovascular events compared to those who continued treatment, emphasizing the importance of consistent therapy adherence. The study was published in <i>BMJ Medicine</i> by Yan Xie and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">In order to draw such findings, the investigators relied on a "target trial emulation" study design, wherein the data were examined between 1 January 2017 and 31 December 2023. The sample size was huge, involving 132,551 new users of GLP-1RAs and 201,136 new users of sulfonylureas, all of whom had type 2 diabetes mellitus. In order to qualify for inclusion into the study, the participants had to make at least two visits to the VA healthcare facility and use the VA pharmacy at least once during the past year before taking the medications under study. The participants were then tracked for three years, and their medication status was switched every six months, creating 16 distinct medication regimens.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">There is a clear relationship between the use of GLP-1 receptor agonists and the reduction in the cumulative risk of major adverse cardiovascular events (MACEs), including myocardial infarction, stroke, or all-cause mortality within a period of three years. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Comparing the sulfonylurea reference group to patients using GLP-1RAs, there was no statistically significant decrease in cardiovascular risk when using GLP-1RAs for 0.5, 1, or 1.5 years, where the incidence risk ratios (IRRs) were nearly equal to 1.0. Nevertheless, a reduction in the risk was observed when the GLP-1RAs were used for two years at an IRR of 0.93 (95% CI 0.88 to 0.98), but a slightly greater reduction occurred with the use of these drugs for 2.5 years (IRR 0.85; 95% CI 0). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The largest reduction in the risk was recorded among the users who continued to use GLP-1RAs for the full three years, obtaining a statistically significant IRR of 0.82 (95% CI 0.78 to 0.85).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In contrast to continued users, discontinuers with 0.5 years of interruption had a higher risk of developing MACE, which had an IRR of 1.04 (95% CI 1.01 to 1.08). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Discontinuing use of GLP-1RA drugs for longer periods, however, increased the MACE risk even more rapidly; specifically, one-year and two-year interruptions increased the risks by IRRs of 1.14 (1.09 to 1.18) and 1.22 (1.16 to 1.27), respectively. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Short interruptions were also harmful, since a 0.5-year interruption increased risks, while one-year and two-year interruptions yielded IRRs of 1.12 (95% CI 1.06 to 1.19) and 1.16 (1.11 to 1.22), respectively. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">From these data, it is evident that although the protective effect of GLP-1RAs forms a shield against MACEs, this protection is temporary since discontinuation starts to erode it instantly.</p></li></ul><p dir="ltr">In conclusion, the benefits of GLP-1RAs when it comes to cardiovascular protection are difficult to achieve yet easy to lose. The findings of the three-year trial have shown that, whereas consistent use provides for a 18% decrease in the occurrence of major adverse cardiovascular events in comparison to patients on sulfonylureas, this achievement is fragile indeed. Any deviation from the regime can result in loss of these hard-gained benefits and increase the chances of having a myocardial infarction, stroke, or even mortality. Medical practitioners need to understand that GLP-1RAs should not be used cyclically but on a consistent basis.</p><p dir="ltr">Reference:</p><p dir="ltr">Xie Y, Choi T, Al-Aly Z. Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation. BMJ Medicine. 2026;5:e002150. <a href="https://doi.org/10.1136/bmjmed-2025-002150">https://doi.org/10.1136/bmjmed-2025-002150</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Sotatercept shows promise for uncommon type of pulmonary hypertension linked to HF with preserved ejection fraction: Study</title>
<link>https://edusehat.com/en/sotatercept-shows-promise-for-uncommon-type-of-pulmonary-hypertension-linked-to-hf-with-preserved-ejection-fraction-study</link>
<guid>https://edusehat.com/en/sotatercept-shows-promise-for-uncommon-type-of-pulmonary-hypertension-linked-to-hf-with-preserved-ejection-fraction-study</guid>
<description><![CDATA[ Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and vascular health after taking the drug sotatercept, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
Group 2 pulmonary hypertension is due to left-sided heart abnormalities. The trial is the first to test sotatercept in a specific subset of patients with Group 2 pulmonary hypertension, including HPpEF and severe combined post and precapillary pulmonary hypertension (CpcPH).
CpcPH occurs when high pressure caused by heart problems backs up into the lungs and, over time, damages the lung’s blood vessels—making it harder to breathe and limiting daily activities. HFpEF is a form of heart failure in which the heart’s left ventricle does not relax fully and may be stiff. This reduces its ability to fill properly with blood between each heartbeat, leading to a variety of symptoms including fatigue, shortness of breath and swelling.  
Sotatercept is a first-in-class drug that is designed to reduce abnormal proliferation of cells in blood vessel walls. It is approved for Group 1 pulmonary hypertension, which affects the pulmonary artery and can be caused by genes, toxins and some systemic diseases. While multiple therapies are available for treating Group 1 pulmonary hypertension, no previous drug has been proven effective for Group 2 pulmonary hypertension, including CpcPH-HFpEF.
“Patients and the scientific community have been waiting a long time for a treatment that shows benefit in CpcPH associated with HFpEF, as previous trials have failed and there are no approved therapies,” said Mardi Gomberg, MD, MSc, a cardiologist and professor of medicine at the George Washington School of Medicine and Health Sciences in Washington and the study’s lead author. “We have seen recent improvements in HFpEF therapies but none that are specific to the distinct clinical condition of CpcPH-HFpEF. These patients continue to have severe heart failure symptoms.”
Researchers enrolled 164 patients with CpcPH-HFpEF in the Phase 2 trial. Patients were 75 years old on average, and 70% were female, which is reflective of the typical patient population for CpcPH-HFpEF. The participants were randomly assigned 1:1:1 to receive sotatercept at 0.3 mg/kg, at 0.7 mg/kg or a placebo. At 24 weeks, researchers assessed hemodynamic and clinical outcome measures of pulmonary hypertension.
Sotatercept treatment improved pulmonary arterial pressure with a statistically significant reduction in pulmonary vascular resistance, the primary endpoint. Pulmonary vascular resistance is a measure of how hard it is for blood to flow through the blood vessels in the lungs, which when narrowed, stiff or damaged, results in the heart working harder to move blood through them. Higher resistance means the heart is working under more stress, so a decrease in pulmonary vascular resistance means the strain on the heart is lower. Secondary endpoints also were better in those taking sotatercept, who showed improved six-minute walking distance and right heart function and a lower rate of clinical worsening events.  
“It’s really exciting because we see improvements in heart failure clinical markers as well as biomarkers of heart function in both the right side and the left side,” Gomberg said. “The left atrial volume and left atrial pressure (measured as wedge pressure) improved, features that can put you at risk for a variety of bad outcomes with HFpEF. Seeing these improvements in addition to improvements in the pulmonary vasculature makes this a big deal.”  
Sotatercept showed a favorable safety profile, with rates of adverse events on par with those seen in previous clinical trials. Initial results suggest that the lower dose of sotatercept seems to optimize the benefit-risk in this patient population.
Also of note, the study included some patients who had previously undergone procedures to repair a heart valve at least a year prior to enrolling in the study. Although these patients represented only a small number of participants, the results revealed that this group experienced similar benefits from sotatercept with no indication of increased risk.
As a Phase 2 trial, the study was limited by a relatively small sample size; its 24-week placebo-controlled time period also limits the ability to draw conclusions regarding long-term safety and efficacy. Based on the positive results from the study, the researchers are planning to pursue a Phase 3 study to test sotatercept in CpcPH-HFpEF.
Reference:Mardi Gomberg-Maitland, Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study, Circulation, https://doi.org/10.1161/CIRCULATIONAHA.126.079918  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/03/231468-pulmonary-hypertension.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sotatercept, shows, promise, for, uncommon, type, pulmonary, hypertension, linked, with, preserved, ejection, fraction:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/03/231468-pulmonary-hypertension.webp"><p>Patients who have<a href="https://medicaldialogues.in/topics/heart-failure"> heart failure</a> with preserved ejection fraction (HFpEF) and <a href="https://medicaldialogues.in/topics/high-blood-pressure">high blood pressure</a> in the lungs (<a href="https://medicaldialogues.in/topics/pulmonary-hypertension">pulmonary hypertension</a>) experienced significant improvements in blood pressure and vascular health after taking the drug sotatercept, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
</p><p>Group 2 pulmonary hypertension is due to left-sided heart abnormalities. The trial is the first to test sotatercept in a specific subset of patients with Group 2 pulmonary hypertension, including HPpEF and severe combined post and precapillary pulmonary hypertension (CpcPH).
</p><p>CpcPH occurs when high pressure caused by heart problems backs up into the lungs and, over time, damages the lung’s blood vessels—making it harder to breathe and limiting daily activities. HFpEF is a form of heart failure in which the heart’s left ventricle does not relax fully and may be stiff. This reduces its ability to fill properly with blood between each heartbeat, leading to a variety of symptoms including fatigue, shortness of breath and swelling.  
</p><p>Sotatercept is a first-in-class drug that is designed to reduce abnormal proliferation of cells in blood vessel walls. It is approved for Group 1 pulmonary hypertension, which affects the pulmonary artery and can be caused by genes, toxins and some systemic diseases. While multiple therapies are available for treating Group 1 pulmonary hypertension, no previous drug has been proven effective for Group 2 pulmonary hypertension, including CpcPH-HFpEF.
</p><p>“Patients and the scientific community have been waiting a long time for a treatment that shows benefit in CpcPH associated with HFpEF, as previous trials have failed and there are no approved therapies,” said Mardi Gomberg, MD, MSc, a cardiologist and professor of medicine at the George Washington School of Medicine and Health Sciences in Washington and the study’s lead author. “We have seen recent improvements in HFpEF therapies but none that are specific to the distinct clinical condition of CpcPH-HFpEF. These patients continue to have severe heart failure symptoms.”
</p><p>Researchers enrolled 164 patients with CpcPH-HFpEF in the Phase 2 trial. Patients were 75 years old on average, and 70% were female, which is reflective of the typical patient population for CpcPH-HFpEF. The participants were randomly assigned 1:1:1 to receive sotatercept at 0.3 mg/kg, at 0.7 mg/kg or a placebo. At 24 weeks, researchers assessed hemodynamic and clinical outcome measures of pulmonary hypertension.
</p><p>Sotatercept treatment improved pulmonary arterial pressure with a statistically significant reduction in pulmonary vascular resistance, the primary endpoint. Pulmonary vascular resistance is a measure of how hard it is for blood to flow through the blood vessels in the lungs, which when narrowed, stiff or damaged, results in the heart working harder to move blood through them. Higher resistance means the heart is working under more stress, so a decrease in pulmonary vascular resistance means the strain on the heart is lower. Secondary endpoints also were better in those taking sotatercept, who showed improved six-minute walking distance and right heart function and a lower rate of clinical worsening events.  
</p><p>“It’s really exciting because we see improvements in heart failure clinical markers as well as biomarkers of heart function in both the right side and the left side,” Gomberg said. “The left atrial volume and left atrial pressure (measured as wedge pressure) improved, features that can put you at risk for a variety of bad outcomes with HFpEF. Seeing these improvements in addition to improvements in the pulmonary vasculature makes this a big deal.”  
</p><p>Sotatercept showed a favorable safety profile, with rates of adverse events on par with those seen in previous clinical trials. Initial results suggest that the lower dose of sotatercept seems to optimize the benefit-risk in this patient population.
</p><p>Also of note, the study included some patients who had previously undergone procedures to repair a heart valve at least a year prior to enrolling in the study. Although these patients represented only a small number of participants, the results revealed that this group experienced similar benefits from sotatercept with no indication of increased risk.
</p><p>As a Phase 2 trial, the study was limited by a relatively small sample size; its 24-week placebo-controlled time period also limits the ability to draw conclusions regarding long-term safety and efficacy. Based on the positive results from the study, the researchers are planning to pursue a Phase 3 study to test sotatercept in CpcPH-HFpEF.
</p><p>Reference:</p><p>Mardi Gomberg-Maitland, Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study, Circulation, https://doi.org/10.1161/CIRCULATIONAHA.126.079918 </p>]]> </content:encoded>
</item>

<item>
<title>Simple blood tests may predict response to lymphoma treatment , suggests research</title>
<link>https://edusehat.com/en/simple-blood-tests-may-predict-response-to-lymphoma-treatment-suggests-research</link>
<guid>https://edusehat.com/en/simple-blood-tests-may-predict-response-to-lymphoma-treatment-suggests-research</guid>
<description><![CDATA[ Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy  drugs. However, this treatment regimen fails in about three in 10 patients, and its intense chemotherapy can cause heart damage-a serious risk for older patients, who make up a large share of those diagnosed.  
Despite these risks, clinicians are often reluctant to try newer, potentially less-toxic treatment regimens, because there’s no reliable way to predict whether a patient’s cancer will respond. 
A new study in pet dogs treated with promising novel treatment regimens for the same cancer suggests that immune signatures found in blood samples could help identify poor responders early. The findings, published in Scientific Reports, point toward a future in which blood tests could help guide more personalized treatment decisions in both veterinary and human cancer care. 
For the study, researchers from Cummings School of Veterinary Medicine at Tufts University and UMass Chan Medical School analyzed blood samples collected during a previous clinical trial involving pet dogs being treated for diffuse large B cell lymphoma.  
In that trial, dogs were randomly assigned to one of three new treatment regimens. Each regimen combined a canine antibody equivalent to the one used in human medicine plus a low dose of doxorubicin, one of the four traditional chemotherapy drugs-a gentler version of the gold standard of care-followed by one of three experimental immune-boosting therapies. (Two of those new immunotherapies are now also being tested in humans.) 
Rather than focusing on tumor tissue, the team examined gene activity in immune cells circulating in the dogs’ blood—a noninvasive approach similar to “liquid biopsies” increasingly used in human and veterinary oncology. Blood samples were analyzed at several key points: before treatment with the antibody and chemotherapy began; seven days into the treatment regimen and just before administering the novel immunotherapy; at the end of the chemo-immunotherapy cycle; and, finally, either when the cancer returned or at 400 days post-treatment if the dog stayed cancer-free.  
The researchers then compared gene activity patterns between dogs whose cancer returned quickly and those who survived much longer after treatment. 
“Many of today’s cancer treatments are designed to boost the immune system so it can help eliminate the tumor,” said Jillian Richmond, an assistant professor of comparative pathobiology at Cummings School and one of three senior authors on the study. “What we found was that certain immune-related genes circulating in the blood were linked to either a good or a poor response to treatment.” 
The researchers found that activity in two genes, CD1E and CCL14, was linked to long-term survival. CD1E helps deliver molecular signals that enable T cells to better recognize and attack cancer, while CCL14 acts like a chemical beacon, helping recruit immune cells to where they’re needed. 
Richmond said this suggests the two genes could serve as blood-based markers of a more effective immune response to therapy. The researchers found that it did not seem to matter which immunotherapy the dogs received; instead, outcomes appeared to depend more on whether the immune system was already exhausted before treatment began.  
One of the most surprising findings involved interferon-stimulated genes, which were consistently linked to worse outcomes in the dogs, including shorter survival times and early relapse. “Interferon is a type of cytokine, a protein that immune cells use to talk to each other and coordinate their responses,” Richmond explained. “Historically in oncology, we’ve thought of interferon responses largely as protective, because they tell the immune system to fight cancer.” 
“But our results suggest that in a blood cancer like lymphoma, some interferon-related signals may actually be harmful,” she said. “We suspect that, in this context, they may be helping cancerous blood cells survive or continue to rapidly reproduce.” 
The team also identified three genes-TBHD, NPNT, and ISG20-whose activity just one week into treatment appeared to predict a poor outcome. Co-senior author Heather Gardner, assistant professor and Usen Family Career Development Professor at Cummings School, developed a simple laboratory test that could detect elevated activity among these genes associated with poorer survival. 
The findings suggest that a rapid blood test early in treatment could help flag dogs at higher risk of cancer recurrence, allowing veterinarians to adjust treatment sooner. Co-senior author Cheryl London, Anne Engen and Dusty Professor in Comparative Oncology at Cummings School, plans to evaluate whether using this blood test to guide treatment decisions can ultimately improve survival in dogs with lymphoma. 
“Our long-term goal is to leverage the data we are generating in dogs with lymphoma to develop new diagnostics and therapeutic combinations that can be successfully translated into human lymphoma patients to reduce treatment-related toxicities and improve outcomes,” said London. Reference:Rao, K., Rao, Z., Huang, A. et al. Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL. Sci Rep 16, 9929 (2026). https://doi.org/10.1038/s41598-026-44677-0
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/07/16/180963-lymphoma.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Simple, blood, tests, may, predict, response, lymphoma, treatment, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/07/16/180963-lymphoma.webp"><p>Many people with an aggressive<a href="https://medicaldialogues.in/topics/blood-cancer"> blood cancer </a>called diffuse large B cell <a href="https://medicaldialogues.in/topics/lymphoma">lymphoma</a> are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four <a href="https://medicaldialogues.in/topics/chemotherapy">chemotherapy </a> drugs. However, this treatment regimen fails in about three in 10 patients, and its intense chemotherapy can cause heart damage-a serious risk for older patients, who make up a large share of those diagnosed.  
</p><p>Despite these risks, clinicians are often reluctant to try newer, potentially less-toxic treatment regimens, because there’s no reliable way to predict whether a patient’s cancer will respond. 
</p><p>A new study in pet dogs treated with promising novel treatment regimens for the same cancer suggests that immune signatures found in blood samples could help identify poor responders early. The findings, published in <i>Scientific Reports,</i> point toward a future in which blood tests could help guide more personalized treatment decisions in both veterinary and human cancer care. 
</p><p>For the study, researchers from Cummings School of Veterinary Medicine at Tufts University and UMass Chan Medical School analyzed blood samples collected during a previous clinical trial involving pet dogs being treated for diffuse large B cell lymphoma.  
</p><p>In that trial, dogs were randomly assigned to one of three new treatment regimens. Each regimen combined a canine antibody equivalent to the one used in human medicine plus a low dose of doxorubicin, one of the four traditional chemotherapy drugs-a gentler version of the gold standard of care-followed by one of three experimental immune-boosting therapies. (Two of those new immunotherapies are now also being tested in humans.) 
</p><p>Rather than focusing on tumor tissue, the team examined gene activity in immune cells circulating in the dogs’ blood—a noninvasive approach similar to “liquid biopsies” increasingly used in human and veterinary oncology. Blood samples were analyzed at several key points: before treatment with the antibody and chemotherapy began; seven days into the treatment regimen and just before administering the novel immunotherapy; at the end of the chemo-immunotherapy cycle; and, finally, either when the cancer returned or at 400 days post-treatment if the dog stayed cancer-free.  
</p><p>The researchers then compared gene activity patterns between dogs whose cancer returned quickly and those who survived much longer after treatment. 
</p><p>“Many of today’s cancer treatments are designed to boost the immune system so it can help eliminate the tumor,” said Jillian Richmond, an assistant professor of comparative pathobiology at Cummings School and one of three senior authors on the study. “What we found was that certain immune-related genes circulating in the blood were linked to either a good or a poor response to treatment.” 
</p><p>The researchers found that activity in two genes, CD1E and CCL14, was linked to long-term survival. CD1E helps deliver molecular signals that enable T cells to better recognize and attack cancer, while CCL14 acts like a chemical beacon, helping recruit immune cells to where they’re needed. 
</p><p>Richmond said this suggests the two genes could serve as blood-based markers of a more effective immune response to therapy. The researchers found that it did not seem to matter which immunotherapy the dogs received; instead, outcomes appeared to depend more on whether the immune system was already exhausted before treatment began.  
</p><p>One of the most surprising findings involved interferon-stimulated genes, which were consistently linked to worse outcomes in the dogs, including shorter survival times and early relapse. “Interferon is a type of cytokine, a protein that immune cells use to talk to each other and coordinate their responses,” Richmond explained. “Historically in oncology, we’ve thought of interferon responses largely as protective, because they tell the immune system to fight cancer.” 
</p><p>“But our results suggest that in a blood cancer like lymphoma, some interferon-related signals may actually be harmful,” she said. “We suspect that, in this context, they may be helping cancerous blood cells survive or continue to rapidly reproduce.” 
</p><p>The team also identified three genes-TBHD, NPNT, and ISG20-whose activity just one week into treatment appeared to predict a poor outcome. Co-senior author Heather Gardner, assistant professor and Usen Family Career Development Professor at Cummings School, developed a simple laboratory test that could detect elevated activity among these genes associated with poorer survival. 
</p><p>The findings suggest that a rapid blood test early in treatment could help flag dogs at higher risk of cancer recurrence, allowing veterinarians to adjust treatment sooner. Co-senior author Cheryl London, Anne Engen and Dusty Professor in Comparative Oncology at Cummings School, plans to evaluate whether using this blood test to guide treatment decisions can ultimately improve survival in dogs with lymphoma. 
</p><p>“Our long-term goal is to leverage the data we are generating in dogs with lymphoma to develop new diagnostics and therapeutic combinations that can be successfully translated into human lymphoma patients to reduce treatment-related toxicities and improve outcomes,” said London. </p><p>Reference:</p><p>Rao, K., Rao, Z., Huang, A. et al. Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL. Sci Rep 16, 9929 (2026). https://doi.org/10.1038/s41598-026-44677-0
</p>]]> </content:encoded>
</item>

<item>
<title>Reducing Air Pollution May Help Delay Physical Disability in Older Adult: JAMA</title>
<link>https://edusehat.com/en/reducing-air-pollution-may-help-delay-physical-disability-in-older-adult-jama</link>
<guid>https://edusehat.com/en/reducing-air-pollution-may-help-delay-physical-disability-in-older-adult-jama</guid>
<description><![CDATA[ USA: Researchers have found in a new study that lowering air pollution levels could play a significant role in delaying the onset and progression of physical disability among aging adults. These findings highlight the importance of cleaner air policies as a potential strategy to promote healthier aging and preserve physical function in older populations.The study published in JAMA Network Open contributes to the growing evidence that long-term exposure to common air pollutants may influence the development of physical disability over time in adults aged 50 years and older. Led by Jiaqi Gao from the Department of Epidemiology at the University of Michigan School of Public Health, the study examined whether sustained exposure to air pollution affects transitions between healthy physical function, mobility limitations, and disability in activities of daily living (ADL).The analysis included 29,790 participants from the nationally representative Health and Retirement Study who completed at least two interviews between 2000 and 2016. The average age at baseline was 63 years, and participants were followed for a mean of eight years. Researchers estimated 10-year average exposure to fine particulate matter (PM2.5), coarse particulate matter (PM10-2.5), nitrogen dioxide (NO2), and ozone (O3) at each participant’s residential address using spatiotemporal modeling techniques.Physical function was assessed through self-reported mobility and the ability to perform daily tasks such as bathing, dressing, and eating. To capture the dynamic nature of disability, the investigators used multistate statistical models that accounted for progression, recovery, and death, while adjusting for individual and area-level characteristics.    The key findings of the study were as follows:Higher long-term concentrations of PM2.5, PM10-2.5, and NO2 were linked to an increased risk of moving from no physical limitations to more severe disability states.Each interquartile range (IQR) increase in PM2.5 exposure was associated with a 6% higher risk of developing physical function limitations.Higher PM2.5 levels were also associated with a 4% lower likelihood of recovering from physical limitations back to normal function.Similar associations with worsening disability transitions were observed for PM10-2.5 and NO2.In contrast, higher ozone (O3) concentrations were associated with a lower risk of progressing to physical limitations or activities of daily living (ADL) disability.The researchers noted that the protective association observed with ozone was unexpected and requires further investigation to clarify the underlying mechanisms.The study has limitations. Exposure estimates were based on residential outdoor pollution and did not account for indoor air quality or time spent outside the home. Although statistical methods were used to address attrition and mortality-related bias, some residual bias may remain. Physical disability was measured through self-report rather than clinical diagnosis, and disease-specific modifiers were not examined.Despite these limitations, the findings suggest that reducing long-term exposure to particulate matter and nitrogen dioxide may help delay the onset and progression of disability in older adults. Cleaner air could therefore be an important component of strategies aimed at promoting healthy aging and reducing the burden of disability.Reference:Gao, J., Szpiro, A. A., Weuve, J., Langa, K. M., Hirth, R. A., Bakulski, K. M., Lee, J., Zhang, B., Keller, K. P., Kaufman, J. D., Faul, J., &amp; Adar, S. D. (2026). Air Pollution and the Progression of Physical Function Limitations and Disability in Aging Adults. JAMA Network Open, 9(2), e2558699. https://doi.org/10.1001/jamanetworkopen.2025.58699 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/20/232614-air-pollution-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Reducing, Air, Pollution, May, Help, Delay, Physical, Disability, Older, Adult:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/20/232614-air-pollution-50.webp"><p><span>USA: Researchers have found in a new study that lowering <a href="https://medicaldialogues.in/topics/air-pollution">air pollution </a>levels could play a significant role in delaying the onset and progression of physical <a href="https://medicaldialogues.in/topics/disability">disability </a>among aging adults. These findings highlight the importance of cleaner air policies as a potential strategy to promote healthier aging and preserve <a href="https://medicaldialogues.in/topics/physical-functions">physical function</a> in older populations.</span></p><div class="pasted-from-word-wrapper"><div>The study published in<i> JAMA Network Open </i>contributes to the growing evidence that long-term exposure to common air pollutants may influence the development of physical disability over time in adults aged 50 years and older. Led by Jiaqi Gao from the Department of Epidemiology at the University of Michigan School of Public Health, the study examined whether sustained exposure to air pollution affects transitions between healthy physical function, mobility limitations, and disability in activities of daily living (ADL).</div><div>The analysis included 29,790 participants from the nationally representative Health and Retirement Study who completed at least two interviews between 2000 and 2016. The average age at baseline was 63 years, and participants were followed for a mean of eight years. Researchers estimated 10-year average exposure to fine particulate matter (PM2.5), coarse particulate matter (PM10-2.5), nitrogen dioxide (NO2), and ozone (O3) at each participant’s residential address using spatiotemporal modeling techniques.</div><div>Physical function was assessed through self-reported mobility and the ability to perform daily tasks such as bathing, dressing, and eating. To capture the dynamic nature of disability, the investigators used multistate statistical models that accounted for progression, recovery, and death, while adjusting for individual and area-level characteristics.    </div><div>The key findings of the study were as follows:</div><ul><li>Higher long-term concentrations of PM2.5, PM10-2.5, and NO2 were linked to an increased risk of moving from no physical limitations to more severe disability states.</li><li>Each interquartile range (IQR) increase in PM2.5 exposure was associated with a 6% higher risk of developing physical function limitations.</li><li>Higher PM2.5 levels were also associated with a 4% lower likelihood of recovering from physical limitations back to normal function.</li><li>Similar associations with worsening disability transitions were observed for PM10-2.5 and NO2.</li><li>In contrast, higher ozone (O3) concentrations were associated with a lower risk of progressing to physical limitations or activities of daily living (ADL) disability.</li></ul><div>The researchers noted that the protective association observed with ozone was unexpected and requires further investigation to clarify the underlying mechanisms.</div><div>The study has limitations. Exposure estimates were based on residential outdoor pollution and did not account for indoor air quality or time spent outside the home. Although statistical methods were used to address attrition and mortality-related bias, some residual bias may remain. Physical disability was measured through self-report rather than clinical diagnosis, and disease-specific modifiers were not examined.</div><div>Despite these limitations, the findings suggest that reducing long-term exposure to particulate matter and nitrogen dioxide may help delay the onset and progression of disability in older adults. Cleaner air could therefore be an important component of strategies aimed at promoting healthy aging and reducing the burden of disability.</div><div>Reference:</div><div>Gao, J., Szpiro, A. A., Weuve, J., Langa, K. M., Hirth, R. A., Bakulski, K. M., Lee, J., Zhang, B., Keller, K. P., Kaufman, J. D., Faul, J., & Adar, S. D. (2026). Air Pollution and the Progression of Physical Function Limitations and Disability in Aging Adults. JAMA Network Open, 9(2), e2558699. https://doi.org/10.1001/jamanetworkopen.2025.58699</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Biocon Launches Denosumab Biosimilars Bosaya, Aukelso in US</title>
<link>https://edusehat.com/en/biocon-launches-denosumab-biosimilars-bosaya-aukelso-in-us</link>
<guid>https://edusehat.com/en/biocon-launches-denosumab-biosimilars-bosaya-aukelso-in-us</guid>
<description><![CDATA[ New Delhi: Biocon Limited has announced the commercial launch of its denosumab biosimilars, Bosaya and Aukelso, in the United States, marking a significant expansion of its biosimilars portfolio in oncology and bone health.The two products- Bosaya (biosimilar to Prolia) and Aukelso (biosimilar to Xgeva are now available nationwide by prescription through specialty pharmacies and healthcare providers. Both had earlier received approval from the US Food and Drug Administration (USFDA) in September 2025 along with an interchangeable designation, enabling substitution at the pharmacy level as per state regulations.Denosumab is a monoclonal antibody that targets RANKL, a key factor involved in bone resorption. By inhibiting this pathway, the therapy helps reduce bone loss, increase bone strength, and manage conditions such as osteoporosis and bone complications associated with cancer.The launch addresses a large patient population in the US, where around 10 million adults suffer from osteoporosis, with an additional 44 million at risk due to low bone density. Additionally, more than 330,000 patients annually are affected by bone metastases, a common complication of advanced cancers.Also Read: Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSCBiocon highlighted that denosumab products recorded approximately USD 5 billion in US sales in 2024, underlining the growing demand for cost-effective treatment alternatives. Bosaya is available as a 60 mg/mL prefilled syringe for subcutaneous injection, while Aukelso is offered as a 120 mg/1.7 mL single-dose vial.Commenting on the development, Shreehas Tambe, CEO and Managing Director of Biocon Limited, said the launch represents a strategic milestone in expanding access to affordable, high-quality therapies for patients with serious bone conditions and reinforces the company’s commitment to building a scalable global access platform.Biocon Limited, headquartered in Bengaluru, is a global biopharmaceutical company focused on delivering affordable, life-changing medicines across multiple therapeutic areas including oncology, diabetes, cardiovascular diseases, and immunology. The company operates in over 120 countries with a strong portfolio of biosimilars and generics supported by robust research and manufacturing capabilities.Also Read: Biocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/03/267433-biocon-50-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Biocon, Launches, Denosumab, Biosimilars, Bosaya, Aukelso</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/03/267433-biocon-50-1.webp"><p><b>New Delhi: </b>Biocon Limited has announced the commercial launch of its denosumab biosimilars, Bosaya and Aukelso, in the United States, marking a significant expansion of its biosimilars portfolio in oncology and bone health.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The two products- Bosaya (biosimilar to Prolia) and Aukelso (biosimilar to Xgeva are now available nationwide by prescription through specialty pharmacies and healthcare providers. Both had earlier received approval from the US Food and Drug Administration (USFDA) in September 2025 along with an interchangeable designation, enabling substitution at the pharmacy level as per state regulations.</p><p>Denosumab is a monoclonal antibody that targets RANKL, a key factor involved in bone resorption. By inhibiting this pathway, the therapy helps reduce bone loss, increase bone strength, and manage conditions such as osteoporosis and bone complications associated with cancer.</p><p>The launch addresses a large patient population in the US, where around 10 million adults suffer from osteoporosis, with an additional 44 million at risk due to low bone density. Additionally, more than 330,000 patients annually are affected by bone metastases, a common complication of advanced cancers.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/biocon-gets-usfda-approval-for-everolimus-oral-suspension-in-pediatric-adult-tsc-162540">Also Read: Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC</a></div></div><p>Biocon highlighted that denosumab products recorded approximately USD 5 billion in US sales in 2024, underlining the growing demand for cost-effective treatment alternatives. Bosaya is available as a 60 mg/mL prefilled syringe for subcutaneous injection, while Aukelso is offered as a 120 mg/1.7 mL single-dose vial.</p><p>Commenting on the development, Shreehas Tambe, CEO and Managing Director of Biocon Limited, said the launch represents a strategic milestone in expanding access to affordable, high-quality therapies for patients with serious bone conditions and reinforces the company’s commitment to building a scalable global access platform.</p><p>Biocon Limited, headquartered in Bengaluru, is a global biopharmaceutical company focused on delivering affordable, life-changing medicines across multiple therapeutic areas including oncology, diabetes, cardiovascular diseases, and immunology. The company operates in over 120 countries with a strong portfolio of biosimilars and generics supported by robust research and manufacturing capabilities.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/biocon-strengthens-control-over-biologics-unit-issues-shares-to-mylan-other-investors-162103">Also Read: Biocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors</a></div></div></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Smartphone Overuse Linked to Disordered Eating Behaviors: Study</title>
<link>https://edusehat.com/en/smartphone-overuse-linked-to-disordered-eating-behaviors-study</link>
<guid>https://edusehat.com/en/smartphone-overuse-linked-to-disordered-eating-behaviors-study</guid>
<description><![CDATA[ Excessive smartphone use and increased daily screen time are associated with higher levels of eating disorder psychopathology, according to a study in JMIR Mental Health. Affected individuals showed symptoms such as food addiction, body dissatisfaction, uncontrolled eating, and emotional overeating, highlighting a link between problematic digital habits and unhealthy eating patterns. The study was conducted by Johanna K. and fellow researchers.This systematic review is a preregistered study that has been conducted following the guidelines of the PRISMA protocol and has incorporated studies obtained through the following databases: PubMed, Embase, and Web of Science. This systematic review has focused on studies conducted and published after January 2011 that explored the association between PSU and eating disorder psychopathology and other outcomes.A total of 35 studies met the inclusion criteria of the systematic review, consisting of 52,584 participants who were mostly from nonclinical populations. The mean age of the participants in the studies was 17.0 ± 5.5 years, indicating a significant number of adolescents and young adults. Using the modified Newcastle-Ottawa Scale, the overall quality of the studies was rated as good in 28 studies (78%).Key findings:The majority of these studies found a positive and consistent relationship between PSU and ED psychopathology. In all these studies, different populations and age groups from different regions showed a strong and consistent positive relationship between PSU and ED psychopathology. Higher levels of PSU are associated with more symptoms of eating disorders. It is also noteworthy that more screen time spent using a smartphone screen each day showed a positive and consistent relationship with ED psychopathology. In addition to ED psychopathology, PSU is also associated with a range of behavioral and psychological outcomes. These include food addiction, body discontent, uncontrollable eating habits, and emotional eating.The significant relationship between daily smartphone screen time and ED-related outcomes indicates that it is not only the problematic aspects of smartphone use that may be related to eating behaviors, but it is also the duration of smartphone screen time that may be related to eating behaviors. Social media, body image, and peer comparison may all be factors that contribute to body image concerns and disordered eating. Problematic smartphone use and screen time are consistently related to ED symptoms and related behaviors in nonclinical populations.Reference:Keeler J, Conde Ludtke L, Yang Q, Raschke Rameh V, Ward R, Treasure J, Carter BAssociations of Problematic Smartphone Use and Smartphone Screen Time With Eating Disorder Psychopathology in Non-Clinical Samples: A Systematic ReviewJMIR Ment Health 2026;13:e88572doi: 10.2196/88572PMID: 41813322PMCID: 12980065 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/29/306007-mental-health.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Smartphone, Overuse, Linked, Disordered, Eating, Behaviors:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/29/306007-mental-health.webp"><p>Excessive smartphone use and increased daily screen time are associated with higher levels of eating disorder psychopathology, according to a study in <i>JMIR Mental Health</i>. Affected individuals showed symptoms such as food addiction, body dissatisfaction, uncontrolled eating, and emotional overeating, highlighting a link between problematic digital habits and unhealthy eating patterns. The study was conducted by Johanna K. and fellow researchers.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This systematic review is a preregistered study that has been conducted following the guidelines of the PRISMA protocol and has incorporated studies obtained through the following databases: PubMed, Embase, and Web of Science. This systematic review has focused on studies conducted and published after January 2011 that explored the association between PSU and eating disorder psychopathology and other outcomes.</p><p dir="ltr">A total of 35 studies met the inclusion criteria of the systematic review, consisting of 52,584 participants who were mostly from nonclinical populations. The mean age of the participants in the studies was 17.0 ± 5.5 years, indicating a significant number of adolescents and young adults. Using the modified Newcastle-Ottawa Scale, the overall quality of the studies was rated as good in 28 studies (78%).</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The majority of these studies found a positive and consistent relationship between PSU and ED psychopathology. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In all these studies, different populations and age groups from different regions showed a strong and consistent positive relationship between PSU and ED psychopathology. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Higher levels of PSU are associated with more symptoms of eating disorders. It is also noteworthy that more screen time spent using a smartphone screen each day showed a positive and consistent relationship with ED psychopathology. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In addition to ED psychopathology, PSU is also associated with a range of behavioral and psychological outcomes. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">These include food addiction, body discontent, uncontrollable eating habits, and emotional eating.</p></li></ul><p dir="ltr">The significant relationship between daily smartphone screen time and ED-related outcomes indicates that it is not only the problematic aspects of smartphone use that may be related to eating behaviors, but it is also the duration of smartphone screen time that may be related to eating behaviors. Social media, body image, and peer comparison may all be factors that contribute to body image concerns and disordered eating. Problematic smartphone use and screen time are consistently related to ED symptoms and related behaviors in nonclinical populations.</p><p dir="ltr">Reference:</p><p dir="ltr">Keeler J, Conde Ludtke L, Yang Q, Raschke Rameh V, Ward R, Treasure J, Carter B</p><p dir="ltr">Associations of Problematic Smartphone Use and Smartphone Screen Time With Eating Disorder Psychopathology in Non-Clinical Samples: A Systematic Review</p><p dir="ltr">JMIR Ment Health 2026;13:e88572</p><p dir="ltr">doi: <a href="https://doi.org/10.2196/88572">10.2196/88572</a></p><p dir="ltr">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/41813322">41813322</a></p><p dir="ltr">PMCID: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/12980065">12980065</a></p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Symptomatic Knee Osteoarthritis a Barrier to Glycemic Control in T2DM, suggests study</title>
<link>https://edusehat.com/en/symptomatic-knee-osteoarthritis-a-barrier-to-glycemic-control-in-t2dm-suggests-study</link>
<guid>https://edusehat.com/en/symptomatic-knee-osteoarthritis-a-barrier-to-glycemic-control-in-t2dm-suggests-study</guid>
<description><![CDATA[ A new  cross-sectional study published in the journal of Arthritis Care &amp; Research revealed that  symptomatic knee osteoarthritis (OA) is a barrier to glycemic control in type 2 diabetes mellitus (T2DM). These individuals with an average pain severity of ≥20/100 had lower odds of achieving target glycemic control. The findings suggest that knee OA may act as a clinically relevant and potentially modifiable risk factor contributing to poor diabetes control and increased risk of complications. Knee osteoarthritis is marked by pain, stiffness, and reduced mobility, and is known to be more common among people with T2DM. However, the mechanisms linking the two conditions have remained unclear. This latest cross-sectional study aimed to explore whether symptomatic knee OA is associated with poorer glycemic control in adults with diabetes.The research recruited a total of 351 participants aged 45 and older from three academic centers across Canada. The average age was 66.2 years, and just over half (50.7%) were women. Participants completed detailed online questionnaires covering demographics, medical history, and joint symptoms. This study also collected glycosylated hemoglobin (HbA1c) levels to evaluate long-term blood sugar control.Knee OA was defined using established clinical criteria, while good glycemic control was classified as an HbA1c level of 7.0% or lower. Overall, 28.5% of participants met the criteria for knee OA, and 43.9% achieved target blood sugar levels.Initial findings revealed that individuals with knee OA were less likely to meet glycemic targets when compared to those without the condition. However, after adjusting for factors such as age, gender, education, and body mass index, this association was no longer statistically significant. In knee OA participants experiencing more severe symptoms with moderate to high pain levels (rated at least 20 out of 100), a significant link emerged. These individuals were notably less likely to achieve target glycemic control, despite accounting for other influencing factors.Overall, the findings of this study suggest that pain may play a crucial role in disrupting diabetes management. Reduced mobility, difficulty exercising, and the physiological stress associated with chronic pain could all contribute to poorer blood sugar regulation. The study highlights the need for further research to validate these results and to develop effective strategies for improving knee OA management, which may, in turn, enhance overall diabetes outcomes.Source:King, L. K., Weisman, A., Shah, B. R., Goldberg, R., Parikh, A., Stanaitis, I., Hung, V., Nisenbaum, R., Almodahka, A., Lipscombe, L., &amp; Hawker, G. A. (2025). Association between symptomatic knee osteoarthritis and target glycemic control in individuals with type 2 diabetes. Arthritis Care &amp; Research, acr.70019. https://doi.org/10.1002/acr.70019 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/26/310843-knee-pain-main.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Symptomatic, Knee, Osteoarthritis, Barrier, Glycemic, Control, T2DM, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/26/310843-knee-pain-main.webp"><p>A new  cross-sectional study published in the journal of <i>Arthritis Care & Research</i> revealed that  symptomatic knee osteoarthritis (OA) is a barrier to glycemic control in type 2 diabetes mellitus (T2DM). These individuals with an average pain severity of ≥20/100 had lower odds of achieving target glycemic control. The findings suggest that knee OA may act as a clinically relevant and potentially modifiable risk factor contributing to poor diabetes control and increased risk of complications. </p><p>Knee osteoarthritis is marked by pain, stiffness, and reduced mobility, and is known to be more common among people with T2DM. However, the mechanisms linking the two conditions have remained unclear. This latest cross-sectional study aimed to explore whether symptomatic knee OA is associated with poorer glycemic control in adults with diabetes.</p><p>The research recruited a total of 351 participants aged 45 and older from three academic centers across Canada. The average age was 66.2 years, and just over half (50.7%) were women. Participants completed detailed online questionnaires covering demographics, medical history, and joint symptoms. This study also collected glycosylated hemoglobin (HbA1c) levels to evaluate long-term blood sugar control.</p><p>Knee OA was defined using established clinical criteria, while good glycemic control was classified as an HbA1c level of 7.0% or lower. Overall, 28.5% of participants met the criteria for knee OA, and 43.9% achieved target blood sugar levels.</p><p>Initial findings revealed that individuals with knee OA were less likely to meet glycemic targets when compared to those without the condition. However, after adjusting for factors such as age, gender, education, and body mass index, this association was no longer statistically significant. In knee OA participants experiencing more severe symptoms with moderate to high pain levels (rated at least 20 out of 100), a significant link emerged. These individuals were notably less likely to achieve target glycemic control, despite accounting for other influencing factors.</p><p>Overall, the findings of this study suggest that pain may play a crucial role in disrupting diabetes management. Reduced mobility, difficulty exercising, and the physiological stress associated with chronic pain could all contribute to poorer blood sugar regulation. The study highlights the need for further research to validate these results and to develop effective strategies for improving knee OA management, which may, in turn, enhance overall diabetes outcomes.</p><p>Source:</p><p>King, L. K., Weisman, A., Shah, B. R., Goldberg, R., Parikh, A., Stanaitis, I., Hung, V., Nisenbaum, R., Almodahka, A., Lipscombe, L., & Hawker, G. A. (2025). Association between symptomatic knee osteoarthritis and target glycemic control in individuals with type 2 diabetes. Arthritis Care & Research, acr.70019. <a href="https://acrjournals.onlinelibrary.wiley.com/doi/full/10.1002/acr.70019?campaign=wolearlyview" rel="nofollow">https://doi.org/10.1002/acr.70019</a></p>]]> </content:encoded>
</item>

<item>
<title>High&#45;frequency oscillatory ventilation May Lower BPD Risk in Preterm Infants: JAMA</title>
<link>https://edusehat.com/en/high-frequency-oscillatory-ventilation-may-lower-bpd-risk-in-preterm-infants-jama</link>
<guid>https://edusehat.com/en/high-frequency-oscillatory-ventilation-may-lower-bpd-risk-in-preterm-infants-jama</guid>
<description><![CDATA[ Researchers have found in a new study that high-frequency oscillatory ventilation (HFOV) may reduce the incidence of bronchopulmonary dysplasia (BPD) compared to conventional mechanical ventilation (CMV) in infants born at ≤34 weeks’ gestation with neonatal respiratory distress syndrome (NARDS). The study was published in JAMA Network Open by Jie Li and fellow researchers.The design of this single-center randomized clinical trial was carried out from August 1, 2019, to December 31, 2023, and included preterm infants born between 25 weeks 0 days and 34 weeks 6 days of gestation with a diagnosis of NARDS and initial clinical stability on CMV ventilation. A total of 386 infants were included in this clinical trial, with 181 infants randomized to elective HFOV and 205 infants continuing CMV ventilation. Data analysis was carried out between October and December 2024.The primary outcome of this clinical trial was to examine the rate of BPD, with BPD defined by both a 2001 research-based Eunice Kennedy Shriver NICHD definition and a 2019 research-based definition. Secondary outcomes of this clinical trial included mortality, retinopathy of prematurity &gt; stage 2, necrotizing enterocolitis &gt; stage 2, intraventricular hemorrhage &gt; grade 3, air leak, and hemodynamically significant patent ductus arteriosus. The analyses of this clinical trial included modified Poisson regression, ordinal regression, and Cox proportional hazards models.Key findings:In this study, there were 386 infants enrolled, of which 59.6% (230) were male, and the mean maternal age was 29.9 ± 4.8 years. A total of 154 (39.9%) infants developed BPD based on the 2001 criteria, and 83 (21.5%) infants developed BPD based on the 2019 criteria. Using elective HFOV, there was a significant reduction in BPD compared with CMV ventilation. Using the 2001 criteria, BPD was reduced from 44.9% in the CMV group to 34.3% in the HFOV group, a reduction of 8.0% and a relative risk of 0.92 (95% CI, 0.86 to 0.99). Using the 2019 criteria, BPD was reduced from 25.4% in the CMV group to 17.1% in the HFOV group, a reduction of 32.0% and a relative risk of 0.68 (95% CI, 0.45 to 1.00). There was no statistically significant difference between the HFOV and CMV groups with respect to secondary outcomes, including death, ROP ≥ stage 2, necrotizing enterocolitis ≥ stage 2, grade 3 or higher IVH, air leak, and hemodynamically significant PDA. Sensitivity analyses excluding 44 crossover infants from both groups also supported this study’s findings.The use of elective HFOV reduced the incidence of bronchopulmonary dysplasia in preterm infants with NARDS without increasing adverse outcomes, supporting its potential as a preferred ventilation strategy in this high-risk group.Reference:Li J, Liu K, Yang Q, et al. High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e260268. doi:10.1001/jamanetworkopen.2026.0268  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/06/26/292309-preterm-birth.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 23:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>High-frequency, oscillatory, ventilation, May, Lower, BPD, Risk, Preterm, Infants:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/06/26/292309-preterm-birth.webp"><p>Researchers have found in a new study that high-frequency oscillatory ventilation (HFOV) may reduce the incidence of bronchopulmonary dysplasia (BPD) compared to conventional mechanical ventilation (CMV) in infants born at ≤34 weeks’ gestation with neonatal respiratory distress syndrome (NARDS). The study was published in <i>JAMA Network Open</i> by Jie Li and fellow researchers.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The design of this single-center randomized clinical trial was carried out from August 1, 2019, to December 31, 2023, and included preterm infants born between 25 weeks 0 days and 34 weeks 6 days of gestation with a diagnosis of NARDS and initial clinical stability on CMV ventilation. A total of 386 infants were included in this clinical trial, with 181 infants randomized to elective HFOV and 205 infants continuing CMV ventilation. Data analysis was carried out between October and December 2024.</p><p dir="ltr">The primary outcome of this clinical trial was to examine the rate of BPD, with BPD defined by both a 2001 research-based Eunice Kennedy Shriver NICHD definition and a 2019 research-based definition. Secondary outcomes of this clinical trial included mortality, retinopathy of prematurity > stage 2, necrotizing enterocolitis > stage 2, intraventricular hemorrhage > grade 3, air leak, and hemodynamically significant patent ductus arteriosus. The analyses of this clinical trial included modified Poisson regression, ordinal regression, and Cox proportional hazards models.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In this study, there were 386 infants enrolled, of which 59.6% (230) were male, and the mean maternal age was 29.9 ± 4.8 years. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">A total of 154 (39.9%) infants developed BPD based on the 2001 criteria, and 83 (21.5%) infants developed BPD based on the 2019 criteria. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Using elective HFOV, there was a significant reduction in BPD compared with CMV ventilation. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Using the 2001 criteria, BPD was reduced from 44.9% in the CMV group to 34.3% in the HFOV group, a reduction of 8.0% and a relative risk of 0.92 (95% CI, 0.86 to 0.99). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Using the 2019 criteria, BPD was reduced from 25.4% in the CMV group to 17.1% in the HFOV group, a reduction of 32.0% and a relative risk of 0.68 (95% CI, 0.45 to 1.00). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">There was no statistically significant difference between the HFOV and CMV groups with respect to secondary outcomes, including death, ROP ≥ stage 2, necrotizing enterocolitis ≥ stage 2, grade 3 or higher IVH, air leak, and hemodynamically significant PDA. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Sensitivity analyses excluding 44 crossover infants from both groups also supported this study’s findings.</p></li></ul><p dir="ltr">The use of elective HFOV reduced the incidence of bronchopulmonary dysplasia in preterm infants with NARDS without increasing adverse outcomes, supporting its potential as a preferred ventilation strategy in this high-risk group.</p><p dir="ltr">Reference:</p><p dir="ltr">Li J, Liu K, Yang Q, et al. High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e260268. doi:10.1001/jamanetworkopen.2026.0268 </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>WBUHS extends BSc Nursing registration till April 22</title>
<link>https://edusehat.com/en/wbuhs-extends-bsc-nursing-registration-till-april-22</link>
<guid>https://edusehat.com/en/wbuhs-extends-bsc-nursing-registration-till-april-22</guid>
<description><![CDATA[ Kolkata: The West Bengal University of Health Sciences (WBUHS) has issued a notification announcing the extension of the registration deadline for BSc Nursing students for the 2025-2026 academic batch.The decision aims to provide additional time for students and colleges to complete the registration process.According to the official notice, the registration portal will now remain open till April 22, 2026, with a structured late fee schedule applicable thereafter.Extended Registration Timeline and Fee Structure-Upto 22.04.2026 :- Registration fees - 2500/-23.04.2026 - 02.05.2026 :- Registration fees - 2500/- + Late fees – 500/-03.05.2026 - 20.05.2026:- Registration fees - 2500/- + Late fees – 2500/-Also Read:WBUHS extends BSc Nursing registration deadline for 2025-26 batchThe university has clarified that mere payment of registration fee does not entitle a student to have registration with WBUHS. If all the relevant documents are not in order or if there is any falsification then registration number will not be provided and registration fees and/or late fees will be forfeited.Colleges are instructed to verify the data of newly admitted students within 21.05.2026 so that university registration can be completed in due time.Students and colleges are requested to complete the steps of registration within due time as registration portal will be closed after the stipulated time.Medical dialogues had earlier reported that the West Bengal University of Health Sciences (WBUHS) had issued a notification announcing the extension of the registration deadline for BSc Nursing students for the 2025-2026 academic batch. The registration process was extended till April 09, 2026.To view the full official notice, click the link mentioned-https://medicaldialogues.in/pdf_upload/2026/04/08/date-extension-of-bsc-nursing-registration-portal-2025-2026-07042026-340304.pdfMedical Dialogues had earlier reported that in response to the Lok Sabha question regarding the shortage of medical seats in the country, MoS Health Smt Anupriya Patel informed, &quot;As reported by the National Medical Commission (NMC), the number of Medical Colleges has increased by 111.36 % from 387 in 2013-14 to 818 at present. Further, it has been informed that MBBS seats have increased by 151.18%, from 51,348 before 2013–14 to 1,28,976 at present, thereby contributing to improved accessibility to medical education.&quot;Along with this, the parliament member sought details from the Minister regarding the possibility of a huge shortage in the total number of seats available as compared to the number of candidates appearing in the NEET-UG examination in the country during the current year, whether the students securing high marks are compelled to migrate abroad for medical studies for this reason and whether the Government proposes to take any action to address such migration of students for medical education abroad. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/05/296947-extends.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:10 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>WBUHS, extends, BSc, Nursing, registration, till, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/05/296947-extends.webp"><div class="pasted-from-word-wrapper"><p><b>Kolkata:</b> The West Bengal University of Health Sciences (<a href="https://medicaldialogues.in/topics/wbuhs">WBUH</a>S) has issued a notification announcing the extension of the registration deadline for <a href="https://medicaldialogues.in/topics/BSc-Nursing">BSc Nursing</a> students for the 2025-2026 academic batch.</p><p>The decision aims to provide additional time for students and colleges to complete the registration process.</p><div class="pasted-from-word-wrapper"><p>According to the official notice, the registration portal will now remain open till April 22, 2026, with a structured late fee schedule applicable thereafter.</p><p><b><u>Extended Registration Timeline and Fee Structure</u>-</b></p><p><b>Upto 22.04.2026 :-</b> Registration fees - 2500/-</p><p><b>23.04.2026 - 02.05.2026 :-</b> Registration fees - 2500/- + Late fees – 500/-</p><p><b>03.05.2026 - 20.05.2026:-</b> Registration fees - 2500/- + Late fees – 2500/-</p></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nursing/wbuhs-extends-bsc-nursing-registration-deadline-for-2025-26-batch-167536">Also Read:WBUHS extends BSc Nursing registration deadline for 2025-26 batch</a></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The university has clarified that mere payment of registration fee does not entitle a student to have registration with WBUHS. If all the relevant documents are not in order or if there is any falsification then registration number will not be provided and registration fees and/or late fees will be forfeited.</p></div></div><div class="pasted-from-word-wrapper"><p>Colleges are instructed to verify the data of newly admitted students within 21.05.2026 so that university registration can be completed in due time.</p><p>Students and colleges are requested to complete the steps of registration within due time as registration portal will be closed after the stipulated time.</p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>Medical dialogues had earlier reported that the West Bengal University of Health Sciences (WBUHS) had issued a notification announcing the extension of the registration deadline for BSc Nursing students for the 2025-2026 academic batch. The registration process was extended till April 09, 2026.</p><p><b><i>To view the full official notice, click the link mentioned-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/date-extension-of-bsc-nursing-registration-portal-2025-2026-07042026-340304.pdf">https://medicaldialogues.in/pdf_upload/2026/04/08/date-extension-of-bsc-nursing-registration-portal-2025-2026-07042026-340304.pdf</a><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/date-extension-of-bsc-nursing-registration-portal-2025-2026-07042026-340304.pdf" target="_blank"><b><i></i></b></a></p><p>Medical Dialogues had earlier reported that in response to the Lok Sabha question regarding the shortage of medical seats in the country, MoS Health Smt Anupriya Patel informed, "As reported by the National Medical Commission (NMC), the number of Medical Colleges has increased by 111.36 % from 387 in 2013-14 to 818 at present. Further, it has been informed that MBBS seats have increased by 151.18%, from 51,348 before 2013–14 to 1,28,976 at present, thereby contributing to improved accessibility to medical education."</p><p>Along with this, the parliament member sought details from the Minister regarding the possibility of a huge shortage in the total number of seats available as compared to the number of candidates appearing in the NEET-UG examination in the country during the current year, whether the students securing high marks are compelled to migrate abroad for medical studies for this reason and whether the Government proposes to take any action to address such migration of students for medical education abroad.</p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"></div></div>]]> </content:encoded>
</item>

<item>
<title>New Research Highlights Role of Spice Extracts in Strengthening Bone Implants</title>
<link>https://edusehat.com/en/new-research-highlights-role-of-spice-extracts-in-strengthening-bone-implants</link>
<guid>https://edusehat.com/en/new-research-highlights-role-of-spice-extracts-in-strengthening-bone-implants</guid>
<description><![CDATA[ A new study from Washington State University highlights the potential of natural compounds from turmeric and ginger to improve the performance of bone implants. 
Published in the Journal of the American Ceramic Society, the research suggests these extracts could enhance healing, prevent infections, and even reduce cancer-related risks.
The study focused on coating titanium implants with a slow-release extract containing curcumin and bioactive components from ginger. In early experiments, this combination nearly doubled bone bonding around implants within six weeks, a critical factor for long-term implant success. Poor bonding is a major reason why joint replacements fail, often requiring additional surgeries.
Infection is another serious challenge in orthopedic procedures. Researchers found that the coated implants eliminated more than 90% of bacteria on their surfaces. This is significant, as infections occur in a substantial proportion of failed implants and can lead to implant removal, prolonged treatment, and increased healthcare costs.
Results showed an 11-fold reduction in cancer-causing cells around the implant site compared to untreated controls. This suggests the coating could offer added protection in patients undergoing treatment for bone cancer, where residual cancer cells often remain after surgery.
By integrating natural anti-inflammatory and antioxidant compounds into modern devices, scientists aim to address multiple complications simultaneously—improving bone integration, reducing infection risk, and supporting cancer management.
While these findings are promising, they are based on early-stage laboratory and animal studies. Further clinical research is needed to confirm safety and effectiveness in humans. 
REFERENCE: Bhattacharjee, A., et al. (2026). ZnO‐Hydroxyapatite‐Coated Ti‐6Al‐4V With Curcumin and Ginger Extract for Load‐Bearing Implants. Journal of the American Ceramic Society. DOI: 10.1111/jace.70532. https://ceramics.onlinelibrary.wiley.com/doi/10.1111/jace.70532
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340571-untitled-design-2026-04-09t141456266.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:10 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Research, Highlights, Role, Spice, Extracts, Strengthening, Bone, Implants</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340571-untitled-design-2026-04-09t141456266.webp"><p>A new study from Washington State University highlights the potential of natural compounds from turmeric and ginger to improve the performance of bone implants. 
</p><p>Published in the <i>Journal of the American Ceramic Society</i>, the research suggests these extracts could enhance healing, prevent infections, and even reduce cancer-related risks.
</p><p>The study focused on coating titanium implants with a slow-release extract containing curcumin and bioactive components from ginger. In early experiments, this combination nearly doubled bone bonding around implants within six weeks, a critical factor for long-term implant success. Poor bonding is a major reason why joint replacements fail, often requiring additional surgeries.
</p><p>Infection is another serious challenge in orthopedic procedures. Researchers found that the coated implants eliminated more than 90% of bacteria on their surfaces. This is significant, as infections occur in a substantial proportion of failed implants and can lead to implant removal, prolonged treatment, and increased healthcare costs.
</p><p>Results showed an 11-fold reduction in cancer-causing cells around the implant site compared to untreated controls. This suggests the coating could offer added protection in patients undergoing treatment for bone cancer, where residual cancer cells often remain after surgery.
</p><p>By integrating natural anti-inflammatory and antioxidant compounds into modern devices, scientists aim to address multiple complications simultaneously—improving bone integration, reducing infection risk, and supporting cancer management.
</p><p>While these findings are promising, they are based on early-stage laboratory and animal studies. Further clinical research is needed to confirm safety and effectiveness in humans. 
</p><p><b>REFERENCE:</b> Bhattacharjee, A., et al. (2026). ZnO‐Hydroxyapatite‐Coated Ti‐6Al‐4V With Curcumin and Ginger Extract for Load‐Bearing Implants. Journal of the American Ceramic Society. DOI: 10.1111/jace.70532. https://ceramics.onlinelibrary.wiley.com/doi/10.1111/jace.70532
</p>]]> </content:encoded>
</item>

<item>
<title>Study Questions Effectiveness of Fish Oil Supplements After Mild Brain Injuries</title>
<link>https://edusehat.com/en/study-questions-effectiveness-of-fish-oil-supplements-after-mild-brain-injuries</link>
<guid>https://edusehat.com/en/study-questions-effectiveness-of-fish-oil-supplements-after-mild-brain-injuries</guid>
<description><![CDATA[ A first-of-its-kind study from Medical University of South Carolina suggests that fish oil supplements may not always benefit brain health—particularly in individuals with repetitive mild traumatic brain injury. 
Published in Cell Reports, the research challenges the common belief that omega-3 fatty acids are universally neuroprotective.
The study focused on how fish oil influences recovery after repeated brain injuries. Researchers identified a context-dependent effect, meaning outcomes vary depending on biological conditions. A key finding involved eicosapentaenoic acid, a major component of fish oil. In experimental models, higher levels of EPA in the brain were linked to impaired repair of blood vessels and reduced recovery capacity after injury.
In contrast, another omega-3 fatty acid, docosahexaenoic acid, showed more consistent benefits. DHA is a structural component of brain cells and plays a well-established role in maintaining neuronal integrity. EPA, however, appears to follow a different metabolic pathway, with effects that depend on exposure duration and physiological context.
Using mouse models, researchers observed that long-term fish oil supplementation led to poorer cognitive performance and increased accumulation of tau protein around blood vessels—changes associated with neurodegeneration. Additional experiments in human brain endothelial cells revealed that EPA weakened the ability of blood vessels to repair and maintain their barrier function.
To strengthen their findings, the team analyzed brain tissue from individuals with chronic traumatic encephalopathy. These samples showed similar patterns of disrupted fat metabolism and vascular instability, supporting the experimental results.
Importantly, researchers stress that these findings do not mean fish oil is harmful for everyone. Instead, they highlight the need for “precision nutrition,” where dietary recommendations are tailored to individual health conditions. 
The study underscores that supplements may have different effects depending on context, particularly in complex conditions like brain injury, and calls for more targeted research into long-term omega-3 use.
REFERENCE: Karakaya E, Berber B, Eskiocak O, et al.; Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy; Cell Reports; DOI: 10.1016/j.celrep.2026.117135
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340569-study-questions-effectiveness-of-fish-oil-supplements-after-mild-brain-injuries.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:10 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Questions, Effectiveness, Fish, Oil, Supplements, After, Mild, Brain, Injuries</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340569-study-questions-effectiveness-of-fish-oil-supplements-after-mild-brain-injuries.webp"><p>A first-of-its-kind study from Medical University of South Carolina suggests that fish oil supplements may not always benefit brain health—particularly in individuals with repetitive mild traumatic brain injury. 
</p><p>Published in <i>Cell Reports, </i>the research challenges the common belief that omega-3 fatty acids are universally neuroprotective.
</p><p>The study focused on how fish oil influences recovery after repeated brain injuries. Researchers identified a context-dependent effect, meaning outcomes vary depending on biological conditions. A key finding involved eicosapentaenoic acid, a major component of fish oil. In experimental models, higher levels of EPA in the brain were linked to impaired repair of blood vessels and reduced recovery capacity after injury.
</p><p>In contrast, another omega-3 fatty acid, docosahexaenoic acid, showed more consistent benefits. DHA is a structural component of brain cells and plays a well-established role in maintaining neuronal integrity. EPA, however, appears to follow a different metabolic pathway, with effects that depend on exposure duration and physiological context.
</p><p>Using mouse models, researchers observed that long-term fish oil supplementation led to poorer cognitive performance and increased accumulation of tau protein around blood vessels—changes associated with neurodegeneration. Additional experiments in human brain endothelial cells revealed that EPA weakened the ability of blood vessels to repair and maintain their barrier function.
</p><p>To strengthen their findings, the team analyzed brain tissue from individuals with chronic traumatic encephalopathy. These samples showed similar patterns of disrupted fat metabolism and vascular instability, supporting the experimental results.
</p><p>Importantly, researchers stress that these findings do not mean fish oil is harmful for everyone. Instead, they highlight the need for “precision nutrition,” where dietary recommendations are tailored to individual health conditions. 
</p><p>The study underscores that supplements may have different effects depending on context, particularly in complex conditions like brain injury, and calls for more targeted research into long-term omega-3 use.
</p><p><b>REFERENCE:</b> Karakaya E, Berber B, Eskiocak O, et al.; Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy; Cell Reports; DOI: 10.1016/j.celrep.2026.117135
</p>]]> </content:encoded>
</item>

<item>
<title>Parliamentary panel suggests 6 attempts to clear MBBS 1st professional exams, 10 years to complete course</title>
<link>https://edusehat.com/en/parliamentary-panel-suggests-6-attempts-to-clear-mbbs-1st-professional-exams-10-years-to-complete-course</link>
<guid>https://edusehat.com/en/parliamentary-panel-suggests-6-attempts-to-clear-mbbs-1st-professional-exams-10-years-to-complete-course</guid>
<description><![CDATA[ New Delhi: Pointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission. These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.As per the existing rules prescribed by the National Medical Commission (NMC), MBBS students are given a total of four attempts to clear their first professional examination.Also Read: Altogether 4 Attempts to Clear MBBS 1st prof Exams: NMC GMER 2023Medical Dialogues had earlier reported that setting a limit regarding the number of attempts to clear the MBBS examination, NMC had clarified in GMER 2023, &quot;Provided under no circumstances the student shall be allowed more than four (04) attempts for first year (First Professional MBBS) and no student shall be allowed to continue undergraduate medical course after nine (09) years from the date of admission into the course, mentioned the Regulations.&quot;Back in 2023, the Apex Medical Commission granted one extra attempt to the MBBS batches of 2019 and 2020 to qualify for their first professional exam. NMC took this decision because these batches were affected by COVID.Recommendations by Parliamentary Health Panel: Recently, while addressing the rules regarding the permissible number of attempts to clear the first year professional MBBS exam, the Parliamentary Health Panel has suggested increasing the number of permissible attempts from four to six.&quot;The Committee has been apprised of that under the present regulations of the National Medical Commission, MBBS students are currently permitted a maximum of four attempts to clear the First Professional Examination. Considering the academic intensity of foundational subjects such as anatomy, physiology, and biochemistry, this restriction can be overly stringent for many students adjusting to the demanding nature of medical education. The Committee, therefore, suggested that the permissible limit be increased to six attempts, while ensuring that students complete the entire MBBS course within a maximum period of ten years from the date of admission,&quot; the Committee has recommended.&quot;This balanced approach will maintain academic standards while providing a more humane and student-friendly framework, preventing capable students from being forced to discontinue medical education due to early academic setbacks,&quot; it further mentioned in the report.Earlier this year, the Rajasthan Chapter of the United Doctors Front (UDF) urged the State Medical Education Department to grant one additional Mercy attempt to the MBBS students from the 2021 batch to clear their First Professional Exam, considering the academic disruption caused by the COVID-19 pandemic.The association highlighted that the students of Batch 2021 went through extraordinary and adverse circumstances, which were different from normal academic sessions. Due to the COVID-19 pandemic, the association stated regular classes were disrupted, there were technical difficulties in online teaching, and many families faced health-related crises during the year 2020–21. These circumstances directly affected the academic preparation and performance of students, as a result of which many students could not pass the First Professional Year.Also Read: Doctors&#039; body demands additional exam mercy attempt for MBBS 2021 batch ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/05/21/287626-mbbs-exam.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Parliamentary, panel, suggests, attempts, clear, MBBS, 1st, professional, exams, years, complete, course</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/05/21/287626-mbbs-exam.webp"><p><b>New Delhi:</b> Pointing out that permitting students only four attempts to clear the MBBS first professional examination can be overly stringent for many students adjusting to the demanding nature of medical education, a Parliamentary Standing Committee on Health has suggested increasing the permissible limit to six attempts.</p><p>However, the panel has opined that the students must complete the entire MBBS course within a maximum period of ten years from the date of admission. </p><p>These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.</p><p>As per the existing rules prescribed by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC)</a>, MBBS students are given a total of four attempts to clear their first professional examination.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/altogether-4-attempts-to-clear-mbbs-1st-prof-exams-nmc-gmer-2023-113370"><b><i>Also Read: Altogether 4 Attempts to Clear MBBS 1st prof Exams: NMC GMER 2023</i></b></a></p><p>Medical Dialogues had earlier reported that s<span>etting a limit regarding the number of attempts to clear the MBBS examination, NMC had clarified in GMER 2023, </span><i>"Provided under no circumstances the student shall be allowed more than four (04) attempts for first year (First Professional MBBS) and no student shall be allowed to continue undergraduate medical course after nine (09) years from the date of admission into the course, mentioned the Regulations."</i></p><p>Back in 2023, the Apex Medical Commission granted one extra attempt to the MBBS batches of 2019 and 2020 to qualify for their first professional exam. NMC took this decision because these batches were affected by COVID.</p><p><b>Recommendations by Parliamentary Health Panel:</b> </p><p>Recently, while addressing the rules regarding the permissible number of attempts to clear the first year professional MBBS exam, the Parliamentary Health Panel has suggested increasing the number of permissible attempts from four to six.</p><p><i>"The Committee has been apprised of that under the present regulations of the National Medical Commission, MBBS students are currently permitted a maximum of four attempts to clear the First Professional Examination. Considering the academic intensity of foundational subjects such as anatomy, physiology, and biochemistry, this restriction can be overly stringent for many students adjusting to the demanding nature of medical education. The Committee, therefore, suggested that the permissible limit be increased to six attempts, while ensuring that students complete the entire MBBS course within a maximum period of ten years from the date of admission,"</i> the Committee has recommended.</p><p><i>"This balanced approach will maintain academic standards while providing a more humane and student-friendly framework, preventing capable students from being forced to discontinue medical education due to early academic setbacks,"</i> it further mentioned in the report.</p><p>Earlier this year, the Rajasthan Chapter of the<a href="https://medicaldialogues.in/topics/udf"> United Doctors Front (UDF)</a> urged the State Medical Education Department to grant one additional Mercy attempt to the MBBS students from the 2021 batch to clear their First Professional Exam, considering the academic disruption caused by the <a href="https://medicaldialogues.in/topics/covid-19" target="_blank">COVID-19 pandemic</a>.</p><p>The association highlighted that the students of Batch 2021 went through extraordinary and adverse circumstances, which were different from normal academic sessions. Due to the COVID-19 pandemic, the association stated regular classes were disrupted, there were technical difficulties in online teaching, and many families faced health-related crises during the year 2020–21. These circumstances directly affected the academic preparation and performance of students, as a result of which many students could not pass the First Professional Year.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/doctors-body-demands-additional-exam-mercy-attempt-for-mbbs-2021-batch-164180"><b><i>Also Read: Doctors' body demands additional exam mercy attempt for MBBS 2021 batch</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know &#45; Dr K Baraneedharan</title>
<link>https://edusehat.com/en/dapagliflozin-and-sitagliptin-fdc-in-indian-t2d-5-points-clinicians-may-like-to-know-dr-k-baraneedharan</link>
<guid>https://edusehat.com/en/dapagliflozin-and-sitagliptin-fdc-in-indian-t2d-5-points-clinicians-may-like-to-know-dr-k-baraneedharan</guid>
<description><![CDATA[ The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to ensure durable glycemic control and prevent long-term complications. In the Indian population, marked by higher insulin resistance, reduced beta-cell function, abdominal obesity, and clustering of cardiovascular risk factors, the case for early combination therapy is particularly important. This article reviews five recent data points relevant to clinicians considering the Dapagliflozin (SGLT2 inhibitor) and Sitagliptin (DPP-4 inhibitor) combination in T2DM management.[1]
1. Dapagliflozin &amp; Sitagliptin Combination – Experienced Beta-Cell Independent complementary citing agents coming together: The dapagliflozin (SGLT2i) &amp; sitagliptin (DPP4i) combination targets complementary and mechanistically distinct pathways involved in glucose regulation (Figure 1). Sitagliptin enhances incretin-mediated, glucose-dependent insulin secretion by DPP-4, thereby increasing endogenous incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Dapagliflozin lowers plasma glucose by selectively inhibiting SGLT2 in the proximal renal tubule, promoting urinary glucose excretion independent of insulin secretion and without the hypo-glycaemia or weight gain associated with conventional therapies.[2] Figure 1. Complementary mechanisms of action of SGLT2 inhibitors and DPP-4 inhibitors in glucose regulation. Adapted from: Chadha M, Das AK, Deb P, et al. Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting. Diabetes Therapy. 2022;13:1097–1114. Abbreviations: SGLT2i -Sodium-glucose co-transporter-2 inhibitor, DPP-4i – Dipeptidyl peptidase-4 inhibitor, GLP-1 – Glucagon-like peptide-1, GIP – Glucose-dependent insulinotropic polypeptide, SBP – Systolic blood pressure﻿
2. Dapagliflozin &amp; Sitagliptin Combination in Indian T2D: Evidence of Gluco-Cardio-Metabolic Benefits:
An Indian multi-center real-world study (N=328; 111 centers) evaluated the dapagliflozin–sitagliptin fixed-dose combination (FDC) in patients with type 2 diabetes mellitus (T2DM), many of whom had cardiometabolic comorbidities, including hypertension (71.65%) and dyslipidemia (42.38%). Treatment with the FDC significantly improved glycemic parameters, with HbA1c decreasing by 1.05% (from 8.36% to 7.31%, p ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340580-featured-images-1-18.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dapagliflozin, and, Sitagliptin, FDC, Indian, T2D:, Points, Clinicians, May, Like, Know, Baraneedharan</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340580-featured-images-1-18.webp"><p>The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to ensure durable glycemic control and prevent long-term complications. In the Indian population, marked by higher insulin resistance, reduced beta-cell function, abdominal obesity, and clustering of cardiovascular risk factors, the case for early combination therapy is particularly important. This article reviews five recent data points relevant to clinicians considering the Dapagliflozin (SGLT2 inhibitor) and Sitagliptin (DPP-4 inhibitor) combination in T2DM management.[1]
</p><p><b>1. Dapagliflozin & Sitagliptin Combination </b>– Experienced Beta-Cell Independent complementary citing agents coming together: The dapagliflozin (SGLT2i) & sitagliptin (DPP4i) combination targets complementary and mechanistically distinct pathways involved in glucose regulation (Figure 1). Sitagliptin enhances incretin-mediated, glucose-dependent insulin secretion by DPP-4, thereby increasing endogenous incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Dapagliflozin lowers plasma glucose by selectively inhibiting SGLT2 in the proximal renal tubule, promoting urinary glucose excretion independent of insulin secretion and without the hypo-glycaemia or weight gain associated with conventional therapies.[2]</p><p> </p><div contenteditable="false" data-width="100%" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/04/09/340581-picture1.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="23690rED4vUlPtMi3mMVCn992DYx6YCJLjrFz5306583" data-watermark="false" info-selector="#info_item_1775725308276"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"></div></div><p><span>Figure 1. Complementary mechanisms of action of SGLT2 inhibitors and DPP-4 inhibitors in glucose regulation. Adapted from: Chadha M, Das AK, Deb P, et al. Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting. Diabetes Therapy. 2022;13:1097–1114. Abbreviations: SGLT2i -Sodium-glucose co-transporter-2 inhibitor, DPP-4i – Dipeptidyl peptidase-4 inhibitor, GLP-1 – Glucagon-like peptide-1, GIP – Glucose-dependent insulinotropic polypeptide, SBP – Systolic blood pressure</span><span>﻿</span>
</p><p><b>2. Dapagliflozin & Sitagliptin Combination in Indian T2D: Evidence of Gluco-Cardio-Metabolic Benefits:
</b></p><p>An Indian multi-center real-world study (N=328; 111 centers) evaluated the dapagliflozin–sitagliptin fixed-dose combination (FDC) in patients with type 2 diabetes mellitus (T2DM), many of whom had cardiometabolic comorbidities, including hypertension (71.65%) and dyslipidemia (42.38%). Treatment with the FDC significantly improved glycemic parameters, with HbA1c decreasing by 1.05% (from 8.36% to 7.31%, p<0.0001) over 12 weeks. Fasting plasma glucose declined by 41.70 mg/dL (from 165.52 to 123.82 mg/dL, p<0.0001), while postprandial blood glucose decreased by 71.91 mg/dL (from 242.15 to 170.24 mg/dL, p<0.0001) during follow-up. In addition to glycemic control, the combination demonstrated favorable cardiometabolic effects, with systolic blood pressure decreasing by 14.61 mmHg (from 147.00 to 132.40 mmHg) and diastolic blood pressure by 7.80 mmHg (from 90.32 to 82.52 mmHg). LDL-cholesterol also declined by 18.14 mg/dL (from 121.40 to 103.20 mg/dL, p<0.0001). These findings provide evidence supporting the glycemic and cardiometabolic benefits of the dapagliflozin–sitagliptin FDC in a comorbidity-burdened T2DM population.[3]
</p><p><b>3. Dapagliflozin's Cardiorenal Benefits Maintained When Combined with a DPP-4 Inhibitor:</b> A trial-level meta-analysis of cardiovascular outcome trials (up to 37,687 participants) found that the cardiorenal benefits of SGLT2 inhibitors — including 3-point MACE (N=32,418), cardiovascular death or heart failure hospitalization (N=37,687), heart failure hospitalization alone (N=27,545), cardiovascular death (N=34,565), and renal outcomes (N=25,406) were statistically similar regardless of background DPP-4 inhibitor therapy (P heterogeneity = 0.71, 0.07, 0.87, 0.72, and 0.25, respectively).[4] For clinicians prescribing the dapagliflozin–sitagliptin combination, this provides reassurance that dapagliflozin's established cardiorenal profile, demonstrated in DECLARE-TIMI 58, DAPA-HF, and DAPA-CKD is not attenuated by the addition of sitagliptin.[5] The TECOS trial has also confirmed the cardiovascular safety of sitagliptin, demonstrating no increase in major adverse cardiovascular events or hospitalization for heart failure when added to standard care in patients with T2D and established CVD.[6]
</p><p><b>4. Real-World Indian Clinical Utilization Data Affirm Dapagliflozin & Sitagliptin Combination Adoption Across Diverse T2D Patient Profiles:</b> A recently published multicenter cross-sectional study across 100 Indian clinics analyzed records of 873 T2DM patients prescribed the sitagliptin 100 mg + dapagliflozin 10 mg FDC (mean age 55.26 ± 11.46 years; diabetes duration 7.02 ± 5.86 years). About 36.8% were treatment-naïve, while 62.8% were switched from prior oral therapy due to inadequate glycemic control or comorbidities. Obesity (44.9%), cardiovascular disease (44.8%), and dyslipidemia (33.6%) were prevalent comorbidities, with concomitant antihypertensives (47.8%) and lipid-lowering/antiplatelet agents (32.3%) commonly co-prescribed. These prescribing patterns indicate that Indian clinicians are deploying the dapagliflozin–sitagliptin FDC across a broad cardiometabolic risk spectrum.[1]
</p><p><b>5. Dapagliflozin and Sitagliptin Combination: Where Does Combination Therapy Sit in Latest Guidelines?
</b></p><p>The updated February 2026 NICE NG28 guideline highlighted that SGLT2 inhibitors are now recommended as first-line therapy for newly diagnosed T2DM, and when eGFR declines below 45 mL/min/1.73 m², the guideline advises continuing the SGLT2 inhibitor for cardiorenal protection while adding a DPP-4 inhibitor to maintain glycemic control.[7] The ADA Standards of Care 2026 recommends considering combination therapy as initial treatment to shorten time to glycemic goal attainment, and advises consideration of SGLT2 inhibitors for patients with established or high-risk atherosclerotic cardiovascular disease, heart failure (with reduced or preserved ejection fraction), and for comprehensive cardiorenal risk reduction, irrespective of HbA1c. DPP-4 inhibitors are recognized as weight-neutral add-on agents. [8]
</p><p>Taken together, these findings highlight the clinical relevance of the dapagliflozin sitagliptin FDC in the management of T2DM, particularly in the Indian population marked by needs for beta-cell preservation, and addressing a cluster of cardiovascular risk factors to mitigate the risk of diabetes related complications. Early combination therapy targeting complementary pathways may help ensure durable glycemic control and support use of the dapagliflozin sitagliptin FDC across a broad cardiometabolic risk spectrum in routine Indian T2DM care continuum.
</p><p><span>Abbreviations: ADA, American Diabetes Association; CVD, cardiovascular disease; DAPA-CKD, Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease; DAPA-HF, Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure; DBP, diastolic blood pressure; DECLARE-TIMI 58, Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58; DPP-4, dipeptidyl peptidase-4; eGFR, estimated glomerular filtration rate; FDC, fixed-dose combination; FPG, fasting plasma glucose; GLP-1, glucagon-like peptide-1; HbA1c, glycated haemoglobin; LDL-C, low-density lipoprotein cholesterol; MACE, major adverse cardiovascular events; NICE, National Institute for Health and Care Excellence; NG28, NICE Guideline 28; PPBG, postprandial blood glucose; SBP, systolic blood pressure; SGLT2, sodium-glucose cotransporter-2; SIDAXA, Safety, Clinical Utilization, and Effectiveness of Sitagliptin and Dapagliflozin Combination Therapy in the Treatment of Type 2 Diabetes for Extra Glycaemic Advantages; T2DM, type 2 diabetes mellitus.</span></p>]]> </content:encoded>
</item>

<item>
<title>8 years after hit&#45;and&#45;run, Tribunal grants Rs 98.5 lakh compensation to Nair hospital BDS intern&amp;apos;s family</title>
<link>https://edusehat.com/en/8-years-after-hit-and-run-tribunal-grants-rs-985-lakh-compensation-to-nair-hospital-bds-interns-family</link>
<guid>https://edusehat.com/en/8-years-after-hit-and-run-tribunal-grants-rs-985-lakh-compensation-to-nair-hospital-bds-interns-family</guid>
<description><![CDATA[ Mumbai: Nearly eight years after a 25-year-old BDS intern of Nair Hospital was killed in a road accident, the Motor Accident Claims Tribunal has directed a Mumbai-based teacher, her husband, and an insurance company to jointly pay nearly Rs 98.5 lakh as compensation to the family of the deceased.Passing the order, the tribunal member R R Patwari held the driver solely responsible for the fatal accident for jumping a red signal, rejected claims that the intern&#039;s use of a mobile phone contributed to the accident and fixed the total compensation at around Rs 98.5 lakh, inclusive of interest.Also read- No medical negligence in doctor&#039;s Total Knee Replacement case- Consumer court relief to Medanta Medicity, Orthopaedic surgeonAs per a latest TOI report, the history of the incident dates back to 2018, when the BDS intern was undergoing her internship at Nair Hospital Dental College at the time of the incident. She was on her way to attend her brother’s convocation on March 24, 2018, when the accident took place.According to the case details, she was crossing the road near N S Road signal when a speeding Honda City car driven by the accused allegedly jumped the red signal and hit her. She suffered serious head injuries and died six days later during treatment.During the proceedings, the driver and the insurance company argued that the student was negligent as she was using her mobile phone and had stepped onto the road abruptly. However, the tribunal rejected these claims.The Tribunal relied on the testimony of an independent eyewitness who followed the car after the hit-and-run. The witness confirmed that the pedestrian signal was red for vehicles when the car &quot;came in high speed, broke the signal and struck the said woman&quot;.Based on this, the tribunal clearly held that there was no negligence on the part of the deceased.It observed, &quot;The accused driver was duty-bound to stop the vehicle at the traffic signal until the signal turns green. This clearly shows that there was no negligence on the part of the deceased. Negligence means failure to exercise the required degree of care which is expected of a prudent driver. When a motor vehicle is being driven with reasonable care, it would ordinarily not meet with accident.&quot;The Tribunal further held, &quot;The academic records of the deceased include her marks-memos which show that she had passed her 10th and 12th and graduation in BDS with good marks. She was a brilliant student. AW2 (a witness) has stated that after completion of BDS, there are various govt and private sectors for the students to join. The deceased was aiming to practice as a dentist.&quot;To determine the compensation, the tribunal considered the victim&#039;s high academic standing and the career trajectory of a medical professional. Although she was only earning a stipend of Rs 6,000 at the time, the tribunal set her notional income at Rs 40,000 per month.The tribunal quoted an order in similar case which said, &quot;The deceased was a diligent and outstanding student of medicine who could have pursued her MD after her graduation and reached greater heights. Today, medical practice is one of the most sought after and rewarding professions.&quot;The compensation awarded included Rs 60.48 lakh for loss of dependency, Rs 2.05 lakh for medical expenses incurred during her treatment, and approximately Rs 84,700 for conventional heads like funeral expenses and loss of estate. The amount also includes interest at 7% from 2018, bringing the total payable to approximately Rs 98.5 lakh.During the course of the proceedings, the deceased&#039;s father passed away. Therefore, the major portion of the compensation has been paid to her mother, with smaller portions designated for her siblings, who are both doctors. Also read- Rs 44 lakh relief to SGPGI, paediatric, immunology doctors in cancer treatment negligence case, Rs 6 lakh slapped for not filing records ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/12/28/195325-compensation.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>years, after, hit-and-run, Tribunal, grants, 98.5, lakh, compensation, Nair, hospital, BDS, interns, family</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/12/28/195325-compensation.webp"><p><b>Mumbai:</b> Nearly eight years after a 25-year-old BDS intern of <a href="https://medicaldialogues.in/topics/byl-nair-hospital" target="_blank">Nair Hospital </a>was killed in a road accident, the Motor Accident Claims Tribunal has directed a Mumbai-based teacher, her husband, and an insurance company to jointly pay nearly Rs 98.5 lakh as <a href="https://medicaldialogues.in/topics/compensation" target="_blank">compensation</a> to the family of the deceased.</p><p>Passing the order, the tribunal member R R Patwari held the driver solely responsible for the fatal accident for jumping a red signal, rejected claims that the intern's use of a mobile phone contributed to the accident and fixed the total compensation at around Rs 98.5 lakh, inclusive of interest.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/medico-legal/no-medical-negligence-in-doctors-total-knee-replacement-case-consumer-court-relief-to-medanta-medicity-orthopaedic-surgeon-167509" target="_blank">No medical negligence in doctor's Total Knee Replacement case- Consumer court relief to Medanta Medicity, Orthopaedic surgeon</a></b></p><p>As per a latest <a href="https://timesofindia.indiatimes.com/city/mumbai/mumbai-couple-insurer-to-pay-rs-1-crore-for-hit-run-of-dental-student-in-2018/articleshow/129869161.cms" target="_blank" rel="nofollow">TOI </a>report, the history of the incident dates back to 2018, when the BDS intern was undergoing her internship at Nair Hospital Dental College at the time of the incident. She was on her way to attend her brother’s convocation on March 24, 2018, when the accident took place.</p><p>According to the case details, she was crossing the road near N S Road signal when a speeding Honda City car driven by the accused allegedly jumped the red signal and hit her. She suffered serious head injuries and died six days later during treatment.</p><p>During the proceedings, the driver and the insurance company argued that the student was negligent as she was using her mobile phone and had stepped onto the road abruptly. However, the tribunal rejected these claims.</p><p>The Tribunal relied on the testimony of an independent eyewitness who followed the car after the hit-and-run. The witness confirmed that the pedestrian signal was red for vehicles when the car "came in high speed, broke the signal and struck the said woman".</p><p>Based on this, the tribunal clearly held that there was no negligence on the part of the deceased.</p><p>It observed, "The accused driver was duty-bound to stop the vehicle at the traffic signal until the signal turns green. This clearly shows that there was no negligence on the part of the deceased. Negligence means failure to exercise the required degree of care which is expected of a prudent driver. When a motor vehicle is being driven with reasonable care, it would ordinarily not meet with accident."</p><p>The Tribunal further held, "The academic records of the deceased include her marks-memos which show that she had passed her 10th and 12th and graduation in BDS with good marks. She was a brilliant student. AW2 (a witness) has stated that after completion of BDS, there are various govt and private sectors for the students to join. The deceased was aiming to practice as a dentist."</p><p>To determine the compensation, the tribunal considered the victim's high academic standing and the career trajectory of a medical professional. Although she was only earning a stipend of Rs 6,000 at the time, the tribunal set her notional income at Rs 40,000 per month.</p><p>The tribunal quoted an order in similar case which said, "The deceased was a diligent and outstanding student of medicine who could have pursued her MD after her graduation and reached greater heights. Today, medical practice is one of the most sought after and rewarding professions."</p><p>The compensation awarded included Rs 60.48 lakh for loss of dependency, Rs 2.05 lakh for medical expenses incurred during her treatment, and approximately Rs 84,700 for conventional heads like funeral expenses and loss of estate. The amount also includes interest at 7% from 2018, bringing the total payable to approximately Rs 98.5 lakh.</p><p>During the course of the proceedings, the deceased's father passed away. Therefore, the major portion of the compensation has been paid to her mother, with smaller portions designated for her siblings, who are both doctors. </p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/medico-legal/rs-44-lakh-relief-to-sgpgi-paediatric-immunology-doctors-in-cancer-treatment-negligence-case-rs-6-lakh-slapped-for-not-filing-records-160604" target="_blank">Rs 44 lakh relief to SGPGI, paediatric, immunology doctors in cancer treatment negligence case, Rs 6 lakh slapped for not filing records</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Medicos cannot challenge bond service after availing subsidised MBBS education: Karnataka HC</title>
<link>https://edusehat.com/en/medicos-cannot-challenge-bond-service-after-availing-subsidised-mbbs-education-karnataka-hc</link>
<guid>https://edusehat.com/en/medicos-cannot-challenge-bond-service-after-availing-subsidised-mbbs-education-karnataka-hc</guid>
<description><![CDATA[ Bengaluru: In the matter of MBBS bond service, the Karnataka High Court recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.It noted that MBBS students who agreed to compulsory service bonds at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.Based on this, the Court allowed the appeal filed by Employees’ State Insurance Corporation (ESIC), on mandatory service in its medical institutes, which had challenged the Single Judge’s order quashing the posting orders against the students, restraining enforcement of the service bonds, which was relaxed from 5 years to one year.The period of compulsory service was reduced from five years to one year pursuant to the ESIC memorandum dated 28.07.2020, and if the students fail to render this one-year service, ESIC has fixed the liquidated damages at Rs 5 lakh. The said memorandum was issued after the pronouncement of the impugned Single Judge’s order in this case.Holding that 5-year bond, later converted into a 1-year mandate prospectively from 2020, wouldn&#039;t violate the rights of MBBS students under Article 19(1)(g) [Right to practise a profession of choice] or Article 23 [prohibition against bonded labour], Division Bench of Chief Justice Vibhu Bakhru and Justice C.M Poonacha observed, &quot;The conclusion that executing a service bond as a part of availing education for subsidised rate is bonded labour is without any basis in law. It is common for students to avail themselves of study loans to defer the cost of education.&quot;Setting aside the single-judge&#039;s order that had done away with the compulsory service bonds for medical students and rejecting the single bench reasoning, the division bench said, &quot;Once it is accepted that execution of the service bond is an integral part of the consideration for the education provided to the petitioners, it cannot be stated that availing of the educational services/training unreservedly over a period of over five and a half years to challenge the consideration for the same is a mere technical plea.&quot; The bench also held that &quot;Since the petitioners had accepted the bond condition at the time of admission and did not challenge it then or soon after, they cannot question it later after completing the course.&quot;BackgroundThe petitioners are students who were admitted to the MBBS course at the ESIC Medical College &amp; PGIMSR, Rajajinagar, Bengaluru, for the academic year 2012-13, in the Government quota seats allotted by the Karnataka Examinations Authority (KEA). They had executed service bonds at the time of admission to serve five years at any of the ESIC hospitals across the country, and on failure to do so, are liable to pay an amount of Rs 7,50,000/-.Later, the bond terms of the service bond were subsequently relaxed under the Memorandum dated 28.07.2020 issued by ESIC; the duration of the compulsory service was reduced to one year, and the amount payable on avoiding the bond was reduced to Rs 5,00,000/-. The terms were applied prospectively, i.e., effective from 28.07.2020. Therefore, the benefit was also extended to students who were already serving in ESIC hospitals under the bonds they had executed. Accordingly, if the remaining bond period exceeded one year, it was reduced and capped at one year.The petitioners completed their 4.5-year MBBS course and a 1-year compulsory internship at the teaching hospital by January 2018. Thereafter, the petitioners were required to register with the Karnataka Medical Council, for which the College was required to issue the Certificate of Internship, Study Certificate, and Conduct Certificate. As a result, the petitioners approached the Dean of the College requesting the issuance of the said certificates. However, the College refused to issue the certificates and directed the petitioners to serve in ESIC hospitals as per the service bond.On 22.05.2018, the petitioners, along with similarly placed students, submitted a joint representation to the College Dean seeking the release of their original documents required for registration with KMC. Subsequently, on 03.07.2018, ESIC issued posting orders deploying the petitioners and other MBBS graduates to various ESIC hospitals across the country as Junior Residents under the ESIC Residency Scheme to fulfil the five-year service bond, directing them to join within seven days.However, the petitioners challenged the legality of the service bonds on several fronts. First, they contended that ESIC is not competent to prescribe any condition for personal service as it is beyond the powers conferred under the Employees’ State Insurance Act, 1948, Second, the College does not have any power to enter into a contract providing for a service bond. Third, the requirement of rendering compulsory services offends the right to carry on a profession guaranteed under Article 19(1)(g) of the Constitution of India. Fourth, it violates the provisions of Article 23 of the Constitution of India, as it amounts to Bonded Labour. Fifth, that the service bond is void under Section 27 of the Indian Contract Act 1872. And sixth, the petitioners were compelled to execute the service bond, and the same, being without free consent, is void. They claim that the condition for executing the service bond was not made known to them prior to their opting for admission to the college. Additionally, the petitioners claim that, since they had already executed bonds to serve the State, no additional condition could be imposed on them. Aggrieved by these posting orders and the enforcement of the service bond, the petitioners filed a writ petition before the single bench of this Court in July 2018.After going through the matter, the learned Single Judge allowed the writ petitions by the impugned order and quashed the impugned posting orders; restrained ESIC and its colleges from enforcing the five year service bond against the petitioners; and directed the ESIC to relieve the petitioners from the obligation of compulsory service. The Corporation, being aggrieved by the aforesaid order, has filed the present appeal. Court&#039;s ObservationReferring to the contention that the ESI Act or Rules must provide a specific power to enter into a particular kind of contractual agreement, which entails a student providing a service bond, the Court found no merit in this argument. It observed, &quot;ESIC is fully empowered to enter into contractual arrangements. The petitioners&#039; admission to the College is also a contractual arrangement under which medical education and training is imparted to the petitioners. In consideration of the same, the students are obligated to pay the fees as fixed, as well as to serve ESIC hospitals for a period as agreed in terms of the Service Bond,&quot; The Court further held that the learned Single Judge erred in concluding that ESIC lacked the authority to impose such a bond and that the bond was not a valid contract. This conclusion, based on the absence of proof that the Dean was authorised to execute the bond on behalf of ESIC, was found to be flawed.Emphasising that execution of the bond was a condition of admission, the Court observed that “there is no ground to accept that the bond was not an agreement between the parties.&quot;Clarifying that there is no compulsion for a student to necessarily serve ESIC, as they are free to pay the agreed amount under the bond, the bench said, &quot;It is necessary to note that there is no compulsion for a student to necessarily serve ESIC. However, it is always open for the students to pay the amount as agreed under the service bond. We may note that there is no allegation that a sum of `7,50,000/-, which is mentioned in the bond, is in the nature of a penalty or in terrorem. Undisputedly, the said amount would barely cover the costs of education availed by the students. Thus, we are unable to accept that the terms of the bond violate Article 19(1)(g) of the Constitution of India.&quot;Referring to the Sub-Article (1) of Article 23 of the Constitution raised by the petitioners, which indicates that it prohibits traffic in human beings and forced labour, and other forms of exploitation, the Court held, &quot;The conclusion that executing a service bond as a part of availing education for subsidised rate is bonded labour is without any basis in law. It is common for students to avail themselves of study loans to defer the cost of education. They cannot be heard to state that their obligation to repay the loan after attaining the qualifications is bonded labour, even though a substantial part of their income may used to service the student loan. The agreement to serve a minimum period, as consideration for having received subsidised medical education and being trained, cannot be conflated with human trafficking, forced labour and other kinds of exploitation.&quot;In view of the above, the Court held that &quot;we are unable to accept that the petitioners are not liable to perform the bond executed by them.&quot;Regarding the petitioner&#039;s argument that since they had already executed a one-year bond with the State, imposing an additional five-year service was excessive; that they were unaware of such a condition at admission and that the college could not impose extra terms after surrendering seats to the State, the court said, &quot;As noticed at the outset, ESIC had reduced the requirement for rendering compulsory service to only one year, and it had further reduced the amount payable by the students, if they failed to render the said service to `5,00,000/-. Thus, even if the service required to be rendered by the petitioners to the State Government is taken into consideration, the total period of compulsory service is now confined to only two years. We are unable to accept that the period of two years’ compulsory service or the payment of Rs 5,00,000/- in lieu thereof is in any way onerous, as contended.&quot;Further, the court said, &quot;We may also note that ESIC had, during the proceedings in the writ petition, readily accepted that the period of compulsory service with the State be reduced from the term of five years as stipulated under the bond. This period is further reduced to one year prospectively from the date of the memorandum, that is, from 28.07.2020. Thus, in the case of the petitioners, they are required to serve only one year with the ESIC hospitals as of that date.&quot;Holding that the said issue may not be of much significant, the Court said, &quot;there is no dispute that the petitioners were called upon to furnish the service bond at the material time, and there is no dispute that at the time of the admission, they had done so. Thus, concededly, they had taken admission to the college on furnishing the service bond as required. They had not challenged the same either at the time of taking admission or immediately thereafter.  More importantly, the petitioners had undergone the course at subsidised costs on the basis of a compulsory bond. Plainly, they cannot be permitted to challenge the same after completion of the entire course and after having availed the corresponding benefit of education at subsidized costs, which may not have been available to them, if they had not furnished the service bond. The petitioners cannot now be heard to make a grievance of not being aware of the condition of furnishing a bond at the time of counselling.&quot;The Court further held, &quot;The contention that the ESIC could not impose a condition of service, as the petitioners were admitted against seats released to the State Government, is also not persuasive. ESIC/College is entitled to fix the fees for providing the course and, as noted above, execution of the service bond is a part of the consideration for provision of education and training.&quot;Accordingly, the Court allowed the appeal and set aside the impugned order. It observed that petitioners who are unable to join the ESIC service would be required to pay the reduced bond amount of Rs 5,00,000 with interest. Those seeking time to join may approach ESIC, which should consider such requests sympathetically, including deferment in appropriate cases.Insofar as those petitioners who are willing to render the service (which is now confined to a period of one year), ESIC is at liberty to avail the services of those petitioners at any of the ESIC hospitals. However, ESIC would also consider placing the petitioners in positions commensurate with their experience and further qualifications, the court added.To view the court order, click on the link below: https://medicaldialogues.in/pdf_upload/2026/04/09/employees-state-insurance-corporation-vs-sri-abhishek-choudhari-666381-340587.pdfAlso read- Allow meritorious PG doctors to defer bond service for super-speciality training: Supreme court tells states ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/10/11/187666-karnataka-high-court-new.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medicos, cannot, challenge, bond, service, after, availing, subsidised, MBBS, education:, Karnataka</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/10/11/187666-karnataka-high-court-new.webp"><p><b>Bengaluru:</b> In the matter of MBBS bond service, the <a href="https://medicaldialogues.in/topics/karnataka-high-court" target="_blank">Karnataka High Court</a> recently observed that the medicos cannot be permitted to challenge the obligation after completion of the entire course and after having availed the corresponding benefit of education at subsidised costs, which may not have been available to them, if they had not furnished the service bond.</p><p>It noted that MBBS students who agreed to compulsory <a href="https://medicaldialogues.in/topics/service-bond" target="_blank">service bonds</a> at the time of admission cannot avoid their obligations after availing subsidised education and training, and such bonds cannot be treated as forced labour or exploitation. The Court also observed that there is no compulsion on a student to serve a bond, as they are free to pay the agreed fine under the bond.</p><p>Based on this, the Court allowed the appeal filed by Employees’ State Insurance Corporation (ESIC), on mandatory service in its medical institutes, which had challenged the Single Judge’s order quashing the posting orders against the students, restraining enforcement of the service bonds, which was relaxed from 5 years to one year.</p><p>The period of compulsory service was reduced from five years to one year pursuant to the ESIC memorandum dated 28.07.2020, and if the students fail to render this one-year service, ESIC has fixed the liquidated damages at Rs 5 lakh. The said memorandum was issued after the pronouncement of the impugned Single Judge’s order in this case.</p><p>Holding that 5-year bond, later converted into a 1-year mandate prospectively from 2020, wouldn't violate the rights of MBBS students under Article 19(1)(g) [Right to practise a profession of choice] or Article 23 [prohibition against bonded labour], Division Bench of Chief Justice Vibhu Bakhru and Justice C.M Poonacha observed, </p><blockquote>"The conclusion that executing a service bond as a part of availing education for subsidised rate is bonded labour is without any basis in law. It is common for students to avail themselves of study loans to defer the cost of education."</blockquote><p>Setting aside the single-judge's order that had done away with the compulsory service bonds for medical students and rejecting the single bench reasoning, the division bench said,<i> "Once it is accepted that execution of the service bond is an integral part of the consideration for the education provided to the petitioners, it cannot be stated that availing of the educational services/training unreservedly over a period of over five and a half years to challenge the consideration for the same is a mere technical plea." </i></p><p>The bench also held that "Since the petitioners had accepted the bond condition at the time of admission and did not challenge it then or soon after, they cannot question it later after completing the course."</p><p><b>Background</b></p><p>The petitioners are students who were admitted to the MBBS course at the ESIC Medical College & PGIMSR, Rajajinagar, Bengaluru, for the academic year 2012-13, in the Government quota seats allotted by the Karnataka Examinations Authority (KEA). </p><p>They had executed service bonds at the time of admission to serve five years at any of the ESIC hospitals across the country, and on failure to do so, are liable to pay an amount of Rs 7,50,000/-.</p><p>Later, the bond terms of the service bond were subsequently relaxed under the Memorandum dated 28.07.2020 issued by ESIC; the duration of the compulsory service was reduced to one year, and the amount payable on avoiding the bond was reduced to Rs 5,00,000/-. The terms were applied prospectively, i.e., effective from 28.07.2020. Therefore, the benefit was also extended to students who were already serving in ESIC hospitals under the bonds they had executed. Accordingly, if the remaining bond period exceeded one year, it was reduced and capped at one year.</p><p>The petitioners completed their 4.5-year MBBS course and a 1-year compulsory internship at the teaching hospital by January 2018. Thereafter, the petitioners were required to register with the Karnataka Medical Council, for which the College was required to issue the Certificate of Internship, Study Certificate, and Conduct Certificate. As a result, the petitioners approached the Dean of the College requesting the issuance of the said certificates. However, the College refused to issue the certificates and directed the petitioners to serve in ESIC hospitals as per the service bond.</p><p>On 22.05.2018, the petitioners, along with similarly placed students, submitted a joint representation to the College Dean seeking the release of their original documents required for registration with KMC. </p><p>Subsequently, on 03.07.2018, ESIC issued posting orders deploying the petitioners and other MBBS graduates to various ESIC hospitals across the country as Junior Residents under the ESIC Residency Scheme to fulfil the five-year service bond, directing them to join within seven days.</p><p>However, t<span>he petitioners challenged the legality of the service bonds on several fronts. </span><span>First, they contended that ESIC is not competent to prescribe any condition for personal service as it is beyond the powers conferred under the Employees’ State Insurance Act, 1948, Second, the College does not have any power to enter into a contract providing for a service bond. Third, the requirement of rendering compulsory services offends the right to carry on a profession guaranteed under Article 19(1)(g) of the Constitution of India. </span></p><p>Fourth, it violates the provisions of Article 23 of the Constitution of India, as it amounts to Bonded Labour. Fifth, that the service bond is void under Section 27 of the Indian Contract Act 1872. And sixth, the petitioners were compelled to execute the service bond, and the same, being without free consent, is void. </p><p>They claim that the condition for executing the service bond was not made known to them prior to their opting for admission to the college. Additionally, the petitioners claim that, since they had already executed bonds to serve the State, no additional condition could be imposed on them. </p><p>Aggrieved by these posting orders and the enforcement of the service bond, the petitioners filed a writ petition before the single bench of this Court in July 2018.</p><p>After going through the matter, the learned Single Judge allowed the writ petitions by the impugned order and quashed the impugned posting orders; restrained ESIC and its colleges from enforcing the five year service bond against the petitioners; and directed the ESIC to relieve the petitioners from the obligation of compulsory service. </p><p>The Corporation, being aggrieved by the aforesaid order, has filed the present appeal. </p><p><b>Court's Observation</b></p><p>Referring to the contention that the ESI Act or Rules must provide a specific power to enter into a particular kind of contractual agreement, which entails a student providing a service bond, the Court found no merit in this argument. It observed, <i>"ESIC is fully empowered to enter into contractual arrangements. The petitioners' admission to the College is also a contractual arrangement under which medical education and training is imparted to the petitioners. In consideration of the same, the students are obligated to pay the fees as fixed, as well as to serve ESIC hospitals for a period as agreed in terms of the Service Bond," </i></p><p>The Court further held that the learned Single Judge erred in concluding that ESIC lacked the authority to impose such a bond and that the bond was not a valid contract. This conclusion, based on the absence of proof that the Dean was authorised to execute the bond on behalf of ESIC, was found to be flawed.</p><p>Emphasising that execution of the bond was a condition of admission, the Court observed that “there is no ground to accept that the bond was not an agreement between the parties."</p><p>Clarifying that there is no compulsion for a student to necessarily serve ESIC, as they are free to pay the agreed amount under the bond, the bench said, </p><blockquote>"It is necessary to note that there is no compulsion for a student to necessarily serve ESIC. However, it is always open for the students to pay the amount as agreed under the service bond. We may note that there is no allegation that a sum of `7,50,000/-, which is mentioned in the bond, is in the nature of a penalty or in terrorem. Undisputedly, the said amount would barely cover the costs of education availed by the students. Thus, we are unable to accept that the terms of the bond violate Article 19(1)(g) of the Constitution of India."</blockquote><p>Referring to the Sub-Article (1) of Article 23 of the Constitution raised by the petitioners, which indicates that it prohibits traffic in human beings and forced labour, and other forms of exploitation, the Court held, </p><blockquote>"The conclusion that executing a service bond as a part of availing education for subsidised rate is bonded labour is without any basis in law. It is common for students to avail themselves of study loans to defer the cost of education. They cannot be heard to state that their obligation to repay the loan after attaining the qualifications is bonded labour, even though a substantial part of their income may used to service the student loan. The agreement to serve a minimum period, as consideration for having received subsidised medical education and being trained, cannot be conflated with human trafficking, forced labour and other kinds of exploitation."</blockquote><p>In view of the above, the Court held that "we are unable to accept that the petitioners are not liable to perform the bond executed by them."</p><p>Regarding the petitioner's argument that since they had already executed a one-year bond with the State, imposing an additional five-year service was excessive; that they were unaware of such a condition at admission and that the college could not impose extra terms after surrendering seats to the State, the court said, </p><blockquote>"As noticed at the outset, ESIC had reduced the requirement for rendering compulsory service to only one year, and it had further reduced the amount payable by the students, if they failed to render the said service to `5,00,000/-. Thus, even if the service required to be rendered by the petitioners to the State Government is taken into consideration, the total period of compulsory service is now confined to only two years. We are unable to accept that the period of two years’ compulsory service or the payment of Rs 5,00,000/- in lieu thereof is in any way onerous, as contended."</blockquote><p>Further, the court said, </p><blockquote>"We may also note that ESIC had, during the proceedings in the writ petition, readily accepted that the period of compulsory service with the State be reduced from the term of five years as stipulated under the bond. This period is further reduced to one year prospectively from the date of the memorandum, that is, from 28.07.2020. Thus, in the case of the petitioners, they are required to serve only one year with the ESIC hospitals as of that date."</blockquote><p>Holding that the said issue may not be of much significant, the Court said, <i>"there is no dispute that the petitioners were called upon to furnish the service bond at the material time, and there is no dispute that at the time of the admission, they had done so. Thus, concededly, they had taken admission to the college on furnishing the service bond as required. They had not challenged the same either at the time of taking admission or immediately thereafter.  </i><i>More importantly, the petitioners had undergone the course at subsidised costs on the basis of a compulsory bond. Plainly, they cannot be permitted to challenge the same after completion of the entire course and after having availed the corresponding benefit of education at subsidized costs, which may not have been available to them, if they had not furnished the service bond. The petitioners cannot now be heard to make a grievance of not being aware of the condition of furnishing a bond at the time of counselling."</i></p><p>The Court further held, </p><p><i>"The contention that the ESIC could not impose a condition of service, as the petitioners were admitted against seats released to the State Government, is also not persuasive. ESIC/College is entitled to fix the fees for providing the course and, as noted above, execution of the service bond is a part of the consideration for provision of education and training."</i></p><p>Accordingly, the Court allowed the appeal and set aside the impugned order. It observed that petitioners who are unable to join the ESIC service would be required to pay the reduced bond amount of Rs 5,00,000 with interest. Those seeking time to join may approach ESIC, which should consider such requests sympathetically, including deferment in appropriate cases.</p><p>Insofar as those petitioners who are willing to render the service (which is now confined to a period of one year), ESIC is at liberty to avail the services of those petitioners at any of the ESIC hospitals. However, ESIC would also consider placing the petitioners in positions commensurate with their experience and further qualifications, the court added.</p><p><b>To view the court order, click on the link below: </b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/09/employees-state-insurance-corporation-vs-sri-abhishek-choudhari-666381-340587.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/09/employees-state-insurance-corporation-vs-sri-abhishek-choudhari-666381-340587.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/allow-meritorious-pg-doctors-to-defer-bond-service-for-super-speciality-training-supreme-court-tells-states-163866" target="_blank">Allow meritorious PG doctors to defer bond service for super-speciality training: Supreme court tells states</a></b></p>]]> </content:encoded>
</item>

<item>
<title>IMA UP flags safety risks as many patients turn to Quacks first</title>
<link>https://edusehat.com/en/ima-up-flags-safety-risks-as-many-patients-turn-to-quacks-first</link>
<guid>https://edusehat.com/en/ima-up-flags-safety-risks-as-many-patients-turn-to-quacks-first</guid>
<description><![CDATA[ Lucknow: The Indian Medical Association (IMA), Uttar Pradesh unit, has expressed concerns that many patients in the state
initially seek treatment from unqualified practitioners before consulting registered medical professionals, which compromises patient safety.

Doctors pointed out that the issue is more prominent in
rural areas and among economically weaker sections. Providing accessible as
well as affordable healthcare in those areas might be helpful in reducing their
reliance on quacks for treatment. Also Read:Lucknow: MBBS student dies by suicide allegedly after failing 1st year examsSpeaking to Medical
Dialogues, IMA UP president Dr Rajeev Goel stated that though they have no
official record, almost four out of ten patients still turn to quacks as
their first point of medical care. The proportion is believed to be even higher
in rural and semi-rural regions, particularly in areas on the outskirts of
cities such as Lucknow.

The IMA also urged the
government to take strict measures against medical stores that sell potent
medicines without valid prescriptions, noting that such practices contribute to
unsafe treatment and misuse of drugs. Dr Goel further stated, “The quacks do not
always give prescriptions; sometimes they write the name of a piece of paper, and
the medical shops, relying on the handwriting, sell the medicine to the
patient. This is risky and needs to be stopped. There are laws, but enforcement
is weak because they find out illegal ways of elaborately carrying on the
scheme.”

Most patients are from
rural or semi-rural areas and economically weaker sections, and they are more susceptible
to such frauds. Accessibility and affordability are the main reasons. In many
areas, qualified doctors or govt facilities are far or overcrowded. Quacks are
easily available, charge less initially, and gain people&#039;s trust. They go to
save time and money, but it leads to complications later,&quot; Dr Manoj K
Asthana, president, IMA Lucknow branch, told Times of India. “Most patients come
with aggravated problems. Typhoid patients, for instance, often receive
incomplete or wrong initial treatment, making the infection more severe by the
time they reach a proper facility,&quot; said Dr Shweta Srivastava, secretary,
IMA Lucknow branch.

Doctors pointed out that
previously quacks could easily give treatment to patients without proper
registration because of a lack of a structured system, but then, following the
directions of the apex court, the National Medical Commission has introduced
formal procedures to complete and structure the registration process.Also Read:Maharashtra steps up action against unregistered nursing homes, bogus doctorsHowever, the doctor
pointed out that the process is tedious with repeated documentation and
inspection. Currently, the state government has increased the validity of the
registration to 5 years to ensure a smooth administrative system, and quacks are
taking advantage of the situation. Though the government is conducting raids on
illegal clinics and diagnostic centres, it is not enough to keep up with the
menace of quackery. &quot;Regular drives are being carried out. If anyone has
information, they can contact the health department. Their identity will be
kept confidential,&quot; said Dr AP Singh, additional chief medical officer. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/07/231754-action-against-quacks.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>IMA, flags, safety, risks, many, patients, turn, Quacks, first</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/07/231754-action-against-quacks.webp"><p>Lucknow: The <a href="https://medicaldialogues.in/topics/indian-medical-association" target="_blank">Indian Medical Association</a> (IMA), Uttar Pradesh unit, has expressed concerns that many patients in the state
initially seek treatment from unqualified practitioners before consulting registered medical professionals, which compromises patient safety.<br></p><div class="pasted-from-word-wrapper">

<p>Doctors pointed out that the issue is more prominent in
rural areas and among economically weaker sections. Providing accessible as
well as affordable healthcare in those areas might be helpful in reducing their
reliance on <a href="https://medicaldialogues.in/topics/quack" target="_blank">quacks</a> for treatment. </p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/uttar-pradesh/lucknow-mbbs-student-dies-by-suicide-allegedly-after-failing-1st-year-exams-166429"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/03/13/332703-suicide-5.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/uttar-pradesh/lucknow-mbbs-student-dies-by-suicide-allegedly-after-failing-1st-year-exams-166429"><span class="read-this-also">Also Read:</span>Lucknow: MBBS student dies by suicide allegedly after failing 1st year exams</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>Speaking to Medical
Dialogues, IMA UP president Dr Rajeev Goel stated that though they have no
official record, almost four out of ten patients still turn to quacks as
their first point of medical care. The proportion is believed to be even higher
in rural and semi-rural regions, particularly in areas on the outskirts of
cities such as Lucknow.</p>

<p>The IMA also urged the
government to take strict measures against medical stores that sell potent
medicines without valid prescriptions, noting that such practices contribute to
unsafe treatment and misuse of drugs. Dr Goel further stated, “The quacks do not
always give prescriptions; sometimes they write the name of a piece of paper, and
the medical shops, relying on the handwriting, sell the medicine to the
patient. This is risky and needs to be stopped. There are laws, but enforcement
is weak because they find out illegal ways of elaborately carrying on the
scheme.”</p>

<p>Most patients are from
rural or semi-rural areas and economically weaker sections, and they are more susceptible
to such frauds. Accessibility and affordability are the main reasons. In many
areas, qualified doctors or govt facilities are far or overcrowded. Quacks are
easily available, charge less initially, and gain people's trust. They go to
save time and money, but it leads to complications later," Dr Manoj K
Asthana, president, IMA Lucknow branch, told <a href="https://timesofindia.indiatimes.com/city/lucknow/quacks-remain-first-stop-for-25-patients-in-up-says-ima/articleshow/130046211.cms" target="_blank" rel="nofollow">Times of India</a>. “Most patients come
with aggravated problems. Typhoid patients, for instance, often receive
incomplete or wrong initial treatment, making the infection more severe by the
time they reach a proper facility," said Dr Shweta Srivastava, secretary,
IMA Lucknow branch.</p>

<p>Doctors pointed out that
previously quacks could easily give treatment to patients without proper
registration because of a lack of a structured system, but then, following the
directions of the apex court, the National Medical Commission has introduced
formal procedures to complete and structure the registration process.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/doctors/maharashtra-steps-up-action-against-unregistered-nursing-homes-bogus-doctors-166759"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2025/09/16/301020-fake-2.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/maharashtra-steps-up-action-against-unregistered-nursing-homes-bogus-doctors-166759"><span class="read-this-also">Also Read:</span>Maharashtra steps up action against unregistered nursing homes, bogus doctors</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>However, the doctor
pointed out that the process is tedious with repeated documentation and
inspection. Currently, the state government has increased the validity of the
registration to 5 years to ensure a smooth administrative system, and quacks are
taking advantage of the situation. Though the government is conducting raids on
illegal clinics and diagnostic centres, it is not enough to keep up with the
menace of quackery. "Regular drives are being carried out. If anyone has
information, they can contact the health department. Their identity will be
kept confidential," said Dr AP Singh, additional chief medical officer.</p></div>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 09/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-09april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-09april2026</guid>
<description><![CDATA[ Here are the top medical news for today:Review Finds Mediterranean-Style Diet May Influence Thyroid Disease Risk and Management
A recent review published in the Journal of Endocrinological Investigation highlights how diet plays a critical and often underappreciated role in thyroid health, particularly in autoimmune thyroid diseases. 
While iodine has long been recognized as essential for thyroid hormone production, researchers emphasize that overall nutrition—including micronutrients, dietary patterns, and gut health—significantly influences thyroid function.
The review analyzed studies from major databases between 2005 and 2025, focusing on key nutrients such as iodine, selenium, iron, zinc, vitamin D, and vitamin B12. Findings show that iodine follows a U-shaped relationship with thyroid health: both deficiency and excess can disrupt function. 
Low iodine levels may lead to hypothyroidism and goiter, while excessive intake can trigger hyperthyroidism or autoimmune thyroiditis in susceptible individuals.
Other micronutrients also play vital roles. Selenium supports antioxidant defenses and hormone metabolism, while zinc and iron are essential for enzyme activity involved in hormone production. Deficiencies in these nutrients may increase the risk of thyroid dysfunction. 
Meanwhile, low levels of vitamin D and B12 are commonly observed in individuals with autoimmune thyroid conditions, although supplementation is only beneficial when deficiencies are present.
Dietary patterns further shape thyroid outcomes. The Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and olive oil, is associated with lower inflammation and reduced thyroid autoantibodies. 
In contrast, the Western diet—high in refined sugars, saturated fats, and processed foods—may նպ promote inflammation, oxidative stress, and gut microbiota imbalance, increasing disease risk.
Importantly, restrictive diets such as gluten-free or lactose-free regimens show no clear benefit for thyroid health unless medically indicated and may even cause nutrient deficiencies. 
Overall, the review underscores that balanced, nutrient-rich diets—not extreme restrictions—are key to supporting thyroid function and reducing disease risk.
REFERENCE: Ruggeri, R.M., Virili, C., Mocini, E. Campennì, A., Centanni, M., Rotondi, M., Cannavò, S., Croce, L., &amp; Migliaccio, S. (2026). The role of nutrition on thyroid health and disease: myths and facts. J Endocrinol Invest (2026). DOI: 10.1007/s40618-026-02852-0, https://link.springer.com/article/10.1007/s40618-026-02852-0
Study Questions Effectiveness of Fish Oil Supplements After Mild Brain Injuries
A first-of-its-kind study from Medical University of South Carolina suggests that fish oil supplements may not always benefit brain health—particularly in individuals with repetitive mild traumatic brain injury. 
Published in Cell Reports, the research challenges the common belief that omega-3 fatty acids are universally neuroprotective.
The study focused on how fish oil influences recovery after repeated brain injuries. Researchers identified a context-dependent effect, meaning outcomes vary depending on biological conditions. A key finding involved eicosapentaenoic acid, a major component of fish oil. In experimental models, higher levels of EPA in the brain were linked to impaired repair of blood vessels and reduced recovery capacity after injury.
In contrast, another omega-3 fatty acid, docosahexaenoic acid, showed more consistent benefits. DHA is a structural component of brain cells and plays a well-established role in maintaining neuronal integrity. EPA, however, appears to follow a different metabolic pathway, with effects that depend on exposure duration and physiological context.
Using mouse models, researchers observed that long-term fish oil supplementation led to poorer cognitive performance and increased accumulation of tau protein around blood vessels—changes associated with neurodegeneration. Additional experiments in human brain endothelial cells revealed that EPA weakened the ability of blood vessels to repair and maintain their barrier function.
To strengthen their findings, the team analyzed brain tissue from individuals with chronic traumatic encephalopathy. These samples showed similar patterns of disrupted fat metabolism and vascular instability, supporting the experimental results.
Importantly, researchers stress that these findings do not mean fish oil is harmful for everyone. Instead, they highlight the need for “precision nutrition,” where dietary recommendations are tailored to individual health conditions. 
The study underscores that supplements may have different effects depending on context, particularly in complex conditions like brain injury, and calls for more targeted research into long-term omega-3 use.
REFERENCE: Karakaya E, Berber B, Eskiocak O, et al.; Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy; Cell Reports; DOI: 10.1016/j.celrep.2026.117135
New Research Highlights Role of Spice Extracts in Strengthening Bone Implants
A new study from Washington State University highlights the potential of natural compounds from turmeric and ginger to improve the performance of bone implants. 
Published in the Journal of the American Ceramic Society, the research suggests these extracts could enhance healing, prevent infections, and even reduce cancer-related risks.
The study focused on coating titanium implants with a slow-release extract containing curcumin and bioactive components from ginger. In early experiments, this combination nearly doubled bone bonding around implants within six weeks, a critical factor for long-term implant success. Poor bonding is a major reason why joint replacements fail, often requiring additional surgeries.
Infection is another serious challenge in orthopedic procedures. Researchers found that the coated implants eliminated more than 90% of bacteria on their surfaces. This is significant, as infections occur in a substantial proportion of failed implants and can lead to implant removal, prolonged treatment, and increased healthcare costs.
Results showed an 11-fold reduction in cancer-causing cells around the implant site compared to untreated controls. This suggests the coating could offer added protection in patients undergoing treatment for bone cancer, where residual cancer cells often remain after surgery.
By integrating natural anti-inflammatory and antioxidant compounds into modern devices, scientists aim to address multiple complications simultaneously—improving bone integration, reducing infection risk, and supporting cancer management.
While these findings are promising, they are based on early-stage laboratory and animal studies. Further clinical research is needed to confirm safety and effectiveness in humans. 
REFERENCE: Bhattacharjee, A., et al. (2026). ZnO‐Hydroxyapatite‐Coated Ti‐6Al‐4V With Curcumin and Ginger Extract for Load‐Bearing Implants. Journal of the American Ceramic Society. DOI: 10.1111/jace.70532. https://ceramics.onlinelibrary.wiley.com/doi/10.1111/jace.70532
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340588-top-medical-2026-04-09t144509558.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 09April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340588-top-medical-2026-04-09t144509558.webp"><p><b>Here are the top medical news for today:</b></p><p><b>Review Finds Mediterranean-Style Diet May Influence Thyroid Disease Risk and Management
</b></p><p>A recent review published in the Journal of Endocrinological Investigation highlights how diet plays a critical and often underappreciated role in thyroid health, particularly in autoimmune thyroid diseases. 
</p><p>While iodine has long been recognized as essential for thyroid hormone production, researchers emphasize that overall nutrition—including micronutrients, dietary patterns, and gut health—significantly influences thyroid function.
</p><p>The review analyzed studies from major databases between 2005 and 2025, focusing on key nutrients such as iodine, selenium, iron, zinc, vitamin D, and vitamin B12. Findings show that iodine follows a U-shaped relationship with thyroid health: both deficiency and excess can disrupt function. 
</p><p>Low iodine levels may lead to hypothyroidism and goiter, while excessive intake can trigger hyperthyroidism or autoimmune thyroiditis in susceptible individuals.
</p><p>Other micronutrients also play vital roles. Selenium supports antioxidant defenses and hormone metabolism, while zinc and iron are essential for enzyme activity involved in hormone production. Deficiencies in these nutrients may increase the risk of thyroid dysfunction. 
</p><p>Meanwhile, low levels of vitamin D and B12 are commonly observed in individuals with autoimmune thyroid conditions, although supplementation is only beneficial when deficiencies are present.
</p><p>Dietary patterns further shape thyroid outcomes. The Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and olive oil, is associated with lower inflammation and reduced thyroid autoantibodies. 
</p><p>In contrast, the Western diet—high in refined sugars, saturated fats, and processed foods—may նպ promote inflammation, oxidative stress, and gut microbiota imbalance, increasing disease risk.
</p><p>Importantly, restrictive diets such as gluten-free or lactose-free regimens show no clear benefit for thyroid health unless medically indicated and may even cause nutrient deficiencies. 
</p><p>Overall, the review underscores that balanced, nutrient-rich diets—not extreme restrictions—are key to supporting thyroid function and reducing disease risk.
</p><p><b>REFERENCE: </b>Ruggeri, R.M., Virili, C., Mocini, E. Campennì, A., Centanni, M., Rotondi, M., Cannavò, S., Croce, L., & Migliaccio, S. (2026). The role of nutrition on thyroid health and disease: myths and facts. J Endocrinol Invest (2026). DOI: 10.1007/s40618-026-02852-0, https://link.springer.com/article/10.1007/s40618-026-02852-0
</p><p><b><br></b></p><p><b>Study Questions Effectiveness of Fish Oil Supplements After Mild Brain Injuries
</b></p><p>A first-of-its-kind study from Medical University of South Carolina suggests that fish oil supplements may not always benefit brain health—particularly in individuals with repetitive mild traumatic brain injury. 
</p><p>Published in Cell Reports, the research challenges the common belief that omega-3 fatty acids are universally neuroprotective.
</p><p>The study focused on how fish oil influences recovery after repeated brain injuries. Researchers identified a context-dependent effect, meaning outcomes vary depending on biological conditions. A key finding involved eicosapentaenoic acid, a major component of fish oil. In experimental models, higher levels of EPA in the brain were linked to impaired repair of blood vessels and reduced recovery capacity after injury.
</p><p>In contrast, another omega-3 fatty acid, docosahexaenoic acid, showed more consistent benefits. DHA is a structural component of brain cells and plays a well-established role in maintaining neuronal integrity. EPA, however, appears to follow a different metabolic pathway, with effects that depend on exposure duration and physiological context.
</p><p>Using mouse models, researchers observed that long-term fish oil supplementation led to poorer cognitive performance and increased accumulation of tau protein around blood vessels—changes associated with neurodegeneration. Additional experiments in human brain endothelial cells revealed that EPA weakened the ability of blood vessels to repair and maintain their barrier function.
</p><p>To strengthen their findings, the team analyzed brain tissue from individuals with chronic traumatic encephalopathy. These samples showed similar patterns of disrupted fat metabolism and vascular instability, supporting the experimental results.
</p><p>Importantly, researchers stress that these findings do not mean fish oil is harmful for everyone. Instead, they highlight the need for “precision nutrition,” where dietary recommendations are tailored to individual health conditions. 
</p><p>The study underscores that supplements may have different effects depending on context, particularly in complex conditions like brain injury, and calls for more targeted research into long-term omega-3 use.
</p><p><b>REFERENCE:</b> Karakaya E, Berber B, Eskiocak O, et al.; Eicosapentaenoic acid reprograms cerebrovascular metabolism and impairs repair after brain injury, with relevance to chronic traumatic encephalopathy; Cell Reports; DOI: 10.1016/j.celrep.2026.117135
</p><p><b><br></b></p><p><b>New Research Highlights Role of Spice Extracts in Strengthening Bone Implants
</b></p><p>A new study from Washington State University highlights the potential of natural compounds from turmeric and ginger to improve the performance of bone implants. 
</p><p>Published in the Journal of the American Ceramic Society, the research suggests these extracts could enhance healing, prevent infections, and even reduce cancer-related risks.
</p><p>The study focused on coating titanium implants with a slow-release extract containing curcumin and bioactive components from ginger. In early experiments, this combination nearly doubled bone bonding around implants within six weeks, a critical factor for long-term implant success. Poor bonding is a major reason why joint replacements fail, often requiring additional surgeries.
</p><p>Infection is another serious challenge in orthopedic procedures. Researchers found that the coated implants eliminated more than 90% of bacteria on their surfaces. This is significant, as infections occur in a substantial proportion of failed implants and can lead to implant removal, prolonged treatment, and increased healthcare costs.
</p><p>Results showed an 11-fold reduction in cancer-causing cells around the implant site compared to untreated controls. This suggests the coating could offer added protection in patients undergoing treatment for bone cancer, where residual cancer cells often remain after surgery.
</p><p>By integrating natural anti-inflammatory and antioxidant compounds into modern devices, scientists aim to address multiple complications simultaneously—improving bone integration, reducing infection risk, and supporting cancer management.
</p><p>While these findings are promising, they are based on early-stage laboratory and animal studies. Further clinical research is needed to confirm safety and effectiveness in humans. 
</p><p><b>REFERENCE: </b>Bhattacharjee, A., et al. (2026). ZnO‐Hydroxyapatite‐Coated Ti‐6Al‐4V With Curcumin and Ginger Extract for Load‐Bearing Implants. Journal of the American Ceramic Society. DOI: 10.1111/jace.70532. https://ceramics.onlinelibrary.wiley.com/doi/10.1111/jace.70532
</p>]]> </content:encoded>
</item>

<item>
<title>Jabalpur crime branch busts Rs 1.55 crore gold scam targeting doctors; four arrested</title>
<link>https://edusehat.com/en/jabalpur-crime-branch-busts-rs-155-crore-gold-scam-targeting-doctors-four-arrested</link>
<guid>https://edusehat.com/en/jabalpur-crime-branch-busts-rs-155-crore-gold-scam-targeting-doctors-four-arrested</guid>
<description><![CDATA[ Jabalpur: In a major crackdown, the Crime Branch in Jabalpur, Madhya Pradesh, has uncovered a sophisticated fraud targeting doctors with the lure of “buried gold,” reportedly resulting in losses of approximately Rs 1.55 crore. Four members of the same family from Jhansi have been arrested in connection with the scam.
According to the Crime Branch, the accused are residents of Faridabad, Haryana. Police tracked their location to Jhansi before conducting a raid and apprehending the suspects.  Also Read:75-year-old Pune doctor scammed of Rs 12.3 crore in share trading fraudInvestigators revealed that the gang initially approached doctors under the guise of providing medical treatment. They later posed as labourers claiming to have discovered buried gold during excavation, and claimed they could not sell it themselves. To gain the victims’ trust, the gang first provided 4–5 real gold coins, which were verified as genuine. Once confidence was established, the accused offered gold at Rs 12 lakh per kilogram. Lured by the promise of lucrative returns, the victims agreed to purchase. 
However, after receiving cash payments, the gang would provide fake gold coins or gold biscuits and flee. Subsequent verification revealed the gold was counterfeit.
Police registered cases under sections 318(4) and 3(5) of the Indian Penal Code following three separate complaints:
April 1, 2026: The first complaint involved 7 kg of gold for Rs 10 lakh. The doctor was approached by a man who claimed to have found buried treasure. After receiving 5 real gold coins for verification, the doctor paid Rs 9 lakh upfront for 7 kg of gold, only to later discover that the remainder of the gold was fake. 
April 3, 2026: Another doctor lost Rs 50 lakh in a 5 kg gold transaction. The accused and his family, including his father, mother, and brother, lured the doctor by claiming the gold was part of a buried treasure. After receiving 5 kg of gold and paying Rs 50 lakh, the doctor discovered he had been given fake gold. 
April 4, 2026: The third doctor was cheated of Rs 1 crore in a 12 kg gold deal. Again, the gang presented small amounts of real gold first, which led the doctor to finalise the deal, only to receive counterfeit gold biscuits in exchange for cash. 
After the complaints were received, SP Sampat Upadhyay formed a special team led by Additional Superintendent of Police Jitendra Singh. Using technical evidence, the team traced the gang to Jhansi and conducted arrests.
During questioning, the accused disclosed that they had hidden money in a rented house in the Panagar area. Police recovered Rs 1.55 crore in cash, 84 grams of real gold, around 20 kg of fake gold coins, and 11 mobile phones during the search, reports Bhaskar English.
The gang has reportedly disclosed information about other potential victims, and further. Speaking to ETV Bharat, SP Sampat Upadhyay said, &quot;All of them were taken on remand and interrogated rigorously. On this, all four fraudsters admitted to cheating together and told that they were living in a rented house in Panagar, where they had hidden the money obtained through cheating. On the directions of the accused, while searching the rented house in Panagar, Rs 1 crore 55 lakh cash, 84 grams of real gold coins, 20 kg of fake coins, and 11 mobile phones were seized, and all of them were arrested. They used to buy fake gold coins from Delhi. All of them are being interrogated as to how many more people have been cheated by this gang before this.&quot;He cautioned the public, &quot;Greed is a bad emotion, and anyone can fall prey to it. Many such frauds have been perpetrated in the past, with people claiming to have found buried treasure and spreading the word that the government will confiscate the gold. This time, the fraudsters targeted doctors, selling them fake gold while pretending it was real. We need to be cautious of such people.&quot;Also Read:Haryana doctor among nine arrested in Rs 209 crore online investment scam ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/12/294338-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jabalpur, crime, branch, busts, 1.55, crore, gold, scam, targeting, doctors, four, arrested</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/12/294338-fraud.webp"><p><b>Jabalpur:</b> In a major crackdown, the Crime Branch in Jabalpur, <a href="https://medicaldialogues.in/state-news/madhya-pradesh" rel="nofollow">Madhya Pradesh</a>, has uncovered a sophisticated fraud targeting <a href="https://medicaldialogues.in/topics/doctors">doctors</a> with the lure of “buried gold,” reportedly resulting in losses of approximately Rs 1.55 crore. Four members of the same family from Jhansi have been arrested in connection with the scam.
</p><p>According to the Crime Branch, the accused are residents of Faridabad, Haryana. Police tracked their location to Jhansi before conducting a raid and apprehending the suspects.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/75-year-old-pune-doctor-scammed-of-rs-123-crore-in-share-trading-fraud-168213"><b>Also Read:75-year-old Pune doctor scammed of Rs 12.3 crore in share trading fraud</b></a></p><p>Investigators revealed that the gang initially approached doctors under the guise of providing medical treatment. They later posed as labourers claiming to have discovered buried gold during excavation, and claimed they could not sell it themselves. To gain the victims’ trust, the gang first provided 4–5 real gold coins, which were verified as genuine. </p><p>Once confidence was established, the accused offered gold at Rs 12 lakh per kilogram. Lured by the promise of lucrative returns, the victims agreed to purchase. 
</p><p>However, after receiving cash payments, the gang would provide fake gold coins or gold biscuits and flee. Subsequent verification revealed the gold was counterfeit.
</p><p>Police registered cases under sections 318(4) and 3(5) of the Indian Penal Code following three separate complaints:
</p><p><b>April 1, 2026:</b> The first complaint involved 7 kg of gold for Rs 10 lakh. The doctor was approached by a man who claimed to have found buried treasure. After receiving 5 real gold coins for verification, the doctor paid Rs 9 lakh upfront for 7 kg of gold, only to later discover that the remainder of the gold was fake. 
</p><p><b>April 3, 2026:</b> Another doctor lost Rs 50 lakh in a 5 kg gold transaction. The accused and his family, including his father, mother, and brother, lured the doctor by claiming the gold was part of a buried treasure. After receiving 5 kg of gold and paying Rs 50 lakh, the doctor discovered he had been given fake gold. 
</p><p><b>April 4, 2026: </b>The third doctor was cheated of Rs 1 crore in a 12 kg gold deal. Again, the gang presented small amounts of real gold first, which led the doctor to finalise the deal, only to receive counterfeit gold biscuits in exchange for cash. 
</p><p>After the complaints were received, SP Sampat Upadhyay formed a special team led by Additional Superintendent of Police Jitendra Singh. Using technical evidence, the team traced the gang to Jhansi and conducted arrests.
</p><p>During questioning, the accused disclosed that they had hidden money in a rented house in the Panagar area. Police recovered Rs 1.55 crore in cash, 84 grams of real gold, around 20 kg of fake gold coins, and 11 mobile phones during the search, reports <a href="https://www.bhaskarenglish.in/amp/local/mp/jabalpur/news/jabalpur-doctors-duped-rs-1-55-crore-haryana-gang-caught-jhansi-137629478.html" rel="nofollow">Bhaskar English</a>.
</p><p>The gang has reportedly disclosed information about other potential victims, and further. Speaking to <a href="https://www.etvbharat.com/hi/state/haryana-thug-family-cheated-jabalpur-doctors-name-of-extracting-buried-money-1-crore-60-lakh-rupees-gold-coins-madhya-pradesh-news-mps26040701295" rel="nofollow">ETV Bharat</a>, SP Sampat Upadhyay said, "All of them were taken on remand and interrogated rigorously. On this, all four fraudsters admitted to cheating together and told that they were living in a rented house in Panagar, where they had hidden the money obtained through cheating. On the directions of the accused, while searching the rented house in Panagar, Rs 1 crore 55 lakh cash, 84 grams of real gold coins, 20 kg of fake coins, and 11 mobile phones were seized, and all of them were arrested. They used to buy fake gold coins from Delhi. All of them are being interrogated as to how many more people have been cheated by this gang before this."</p><p>He cautioned the public, "Greed is a bad emotion, and anyone can fall prey to it. Many such frauds have been perpetrated in the past, with people claiming to have found buried treasure and spreading the word that the government will confiscate the gold. This time, the fraudsters targeted doctors, selling them fake gold while pretending it was real. We need to be cautious of such people."</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/haryana-doctor-among-nine-arrested-in-rs-209-crore-online-investment-scam-164853"><b>Also Read:Haryana doctor among nine arrested in Rs 209 crore online investment scam</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Illegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana Raid</title>
<link>https://edusehat.com/en/illegal-stockpiling-busted-pregabalin-alprazolam-medicines-seized-in-ludhiana-raid</link>
<guid>https://edusehat.com/en/illegal-stockpiling-busted-pregabalin-alprazolam-medicines-seized-in-ludhiana-raid</guid>
<description><![CDATA[ Ludhiana: The Drug Control Department (DCD) has intensified its crackdown on illegal pharmaceutical stockpiling, leading to the detection of a firm in Ludhiana found storing nine varieties of allopathic medicines containing Pregabalin and Alprazolam.Acting on a tip-off, officials carried out an inspection at a medical store located in the Kaneja area to verify compliance with the provisions of the Drugs and Cosmetics Act, 1940 and the rules framed under it, TOI reported.The operation was conducted by the Drugs Control Officer (Ludhiana-3). During the inspection, the firm was found stocking nine different allopathic formulations containing Pregabalin and Alprazolam salts; however, it failed to produce the mandatory purchase records for these medicines, in violation of statutory requirements.Also Read: Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action RequiredConsequently, authorities seized the stock on the spot, with the value of the confiscated medicines estimated at around ₹47,640, reports TOI.Navdeep Sandhu stated that stringent action would be taken against such violations and affirmed that enforcement drives would continue to curb illegal drug sales and safeguard public health.Also Read: Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV Facility ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/01/306459-seized.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Illegal, Stockpiling, Busted:, Pregabalin, Alprazolam, Medicines, Seized, Ludhiana, Raid</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/01/306459-seized.webp"><div class="pasted-from-word-wrapper"><p><b>Ludhiana</b>: The Drug Control Department (DCD) has intensified its crackdown on illegal pharmaceutical stockpiling, leading to the detection of a firm in Ludhiana found storing nine varieties of allopathic medicines containing Pregabalin and Alprazolam.</p></div><div class="pasted-from-word-wrapper"><p>Acting on a tip-off, officials carried out an inspection at a medical store located in the Kaneja area to verify compliance with the provisions of the Drugs and Cosmetics Act, 1940 and the rules framed under it, TOI reported.</p><p>The operation was conducted by the Drugs Control Officer (Ludhiana-3). During the inspection, the firm was found stocking nine different allopathic formulations containing Pregabalin and Alprazolam salts; however, it failed to produce the mandatory purchase records for these medicines, in violation of statutory requirements.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/granules-india-arm-gets-usfda-vai-status-for-shamirpet-facility-no-action-required-167757">Also Read: Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action Required</a></div><p>Consequently, authorities seized the stock on the spot, with the value of the confiscated medicines estimated at around ₹47,640, reports <a href="https://timesofindia.indiatimes.com/city/ludhiana/unlicensed-drugs-seized-from-pharmacy/articleshow/130094259.cms" rel="nofollow">TOI</a>.</p><p>Navdeep Sandhu stated that stringent action would be taken against such violations and affirmed that enforcement drives would continue to curb illegal drug sales and safeguard public health.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-gets-5-usfda-observations-for-unit-iv-facility-166369">Also Read: Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV Facility</a></p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline</title>
<link>https://edusehat.com/en/gilead-to-acquire-tubulis-for-usd-5-billion-to-strengthen-cancer-pipeline</link>
<guid>https://edusehat.com/en/gilead-to-acquire-tubulis-for-usd-5-billion-to-strengthen-cancer-pipeline</guid>
<description><![CDATA[ Bengaluru: Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs pipeline.This marks the latest in Gilead&#039;s acquisition spree. The company has been expanding beyond its key areas for growth amid looming ‌patent expiries and ⁠declining ⁠sales of its COVID-19 treatment.In February, the U.S. drugmaker bought partner Arcellx for up to $7.8 billion, ​while last month it agreed to acquire privately held biotech firm Ouro Medicines in ​a deal worth more than $2 billion.With the latest deal, Gilead will get access to Tubulis&#039; experimental drugs, which belong to a class called antibody-drug conjugates (ADC), popularly known as &quot;guided missiles&quot;, that deliver chemotherapy directly to ⁠cancer cells ‌while minimizing harm to healthy tissue.We believe the Tubulis acquisition represents a strategically sound bolt-on that addresses Gilead&#039;s oncology pipeline growth needs, ⁠while securing differentiated next-gen ADC platform capabilities, said RBC Capital Markets analyst Brian Abrahams.Also Read: Gilead to Acquire Ouro Medicines in USD 2 Billion Deal to Boost Immunology PipelineTubulis&#039; lead asset, TUB-040, which binds ​to NaPi2b, a protein found in certain cancer cells, is currently in early-stage development for a type of ovarian cancer and non-small cell lung cancer.Another experimental drug, TUB-030, is being studied across various solid tumor types. &quot;Our drugs in early trials have delivered very competitive data&quot;, said Tubulis CEO ‌Dominik Schumacher.&quot;Now for me, it&#039;s all about how can we get this as quickly as possible to patients. And with ​a partner ​like Gilead, I ⁠think this is really the perfect way to get this vision into reality,&quot; he added.Gilead will acquire all of the outstanding equity of Tubulis for $3.15 billion in ​upfront cash, payable at closing, and up to $1.85 billion in milestone payments.The companies have previously entered into licensing agreements to develop ADCs. Tubulis also has a partnership with Bristol-Myers Squibb After the deal closes, expected in the second quarter, Tubulis will operate as an ADC research organization within Gilead.Also Read: Gilead to Acquire Arcellx in USD 7.8 Billion Deal to Bolster Oncology Pipeline ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/08/231808-gilead-sciences-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gilead, Acquire, Tubulis, for, USD, Billion, Strengthen, Cancer, Pipeline</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/08/231808-gilead-sciences-50.webp"><p><b>Bengaluru:</b><a href="https://medicaldialogues.in/topics/gilead" target="_blank"> Gilead</a> said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs pipeline.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>This marks the latest in Gilead's acquisition spree. The company has been expanding beyond its key areas for growth amid looming ‌patent expiries and ⁠declining ⁠sales of its COVID-19 treatment.</p><p>In February, the U.S. drugmaker bought partner Arcellx for up to $7.8 billion, ​while last month it agreed to acquire privately held biotech firm Ouro Medicines in ​a deal worth more than $2 billion.</p><p>With the latest deal, Gilead will get access to Tubulis' experimental drugs, which belong to a class called antibody-drug conjugates (ADC), popularly known as "guided missiles", that deliver chemotherapy directly to ⁠cancer cells ‌while minimizing harm to healthy tissue.</p><p>We believe the Tubulis acquisition represents a strategically sound bolt-on that addresses Gilead's oncology pipeline growth needs, ⁠while securing differentiated next-gen ADC platform capabilities, said RBC Capital Markets analyst Brian Abrahams.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gilead-to-acquire-ouro-medicines-in-usd-2-billion-deal-to-boost-immunology-pipeline-167200">Also Read: Gilead to Acquire Ouro Medicines in USD 2 Billion Deal to Boost Immunology Pipeline</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>Tubulis' lead asset, TUB-040, which binds ​to NaPi2b, a protein found in certain cancer cells, is currently in early-stage development for a type of ovarian cancer and non-small cell lung cancer.</p><p>Another experimental drug, TUB-030, is being studied across various solid tumor types. "Our drugs in early trials have delivered very competitive data", said Tubulis CEO ‌Dominik Schumacher.</p><p>"Now for me, it's all about how can we get this as quickly as possible to patients. And with ​a partner ​like Gilead, I ⁠think this is really the perfect way to get this vision into reality," he added.</p><p>Gilead will acquire all of the outstanding equity of Tubulis for $3.15 billion in ​upfront cash, payable at closing, and up to $1.85 billion in milestone payments.</p><p>The companies have previously entered into licensing agreements to develop ADCs. Tubulis also has a partnership with Bristol-Myers Squibb After the deal closes, expected in the second quarter, Tubulis will operate as an ADC research organization within Gilead.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gilead-to-acquire-arcellx-in-usd-78-billion-deal-to-bolster-oncology-pipeline-165632">Also Read: Gilead to Acquire Arcellx in USD 7.8 Billion Deal to Bolster Oncology Pipeline</a></div></div></div><div class="pasted-from-word-wrapper"></div>]]> </content:encoded>
</item>

<item>
<title>Gujarat HC approves pregnancy termination for 16&#45;year&#45;old minor rape survivor</title>
<link>https://edusehat.com/en/gujarat-hc-approves-pregnancy-termination-for-16-year-old-minor-rape-survivor</link>
<guid>https://edusehat.com/en/gujarat-hc-approves-pregnancy-termination-for-16-year-old-minor-rape-survivor</guid>
<description><![CDATA[ Ahmedabad: The Gujarat High Court has approved the termination of a 25-week pregnancy of a minor rape survivor, emphasising the trauma, mental agony, and potential social stigma the girl would face.   In an April 6 order, Justice M R Mengdey directed a team of senior doctors to examine the 16-year-old girl and carry out the procedure urgently.Also Read:Hospitals to face legal action for failing to report minor pregnancies: Karnataka GovtThe court referred to the Supreme Court’s established “best interest” principle, which emphasises the welfare and holistic development of children, overriding parental rights or rigid legal frameworks. The High Court noted that every day’s delay in the procedure would exacerbate the survivor’s trauma, and acting swiftly was in her overall well-being.According to the news reports, a medical board at GMERS General Hospital, comprising senior gynaecologists, a psychologist, a physician, and a radiologist, examined the minor. Their report confirmed that the pregnancy was at 25 weeks and 3 days and recommended termination under the Medical Termination of Pregnancy (MTP) Act, 1971, considering the risks to the minor’s physical and mental health.
The court also directed that if the foetus is born alive, the hospital must provide the best possible medical care to ensure healthy development.
Besides, if the victim is not willing to assume the responsibility of the baby, the state and its agencies should assume full responsibility and offer medical support and facilities to the child, keeping in mind the best interest of the child and the statutory provisions in the Juvenile Justice (Care and Protection of Children) Act, 2005. The court also directed the doctors to take the necessary tissue samples for DNA identification by following the scientific practice for the same and handing over the samples to the investigating officer, reports the Indian Express.
As per ETV Bharat reports, Counsel for the petitioner, P.S. Dutta, said the court adopted a humane approach by placing the minor’s physical and psychological condition at the forefront.
The Gujarat High Court’s decision echoes a similar ruling by the Karnataka High Court, where a minor rape survivor’s 26-week pregnancy was terminated to safeguard her dignity and well-being. In that case, Justice R Nataraj emphasised that the court should not hesitate to protect the “honour and dignity” of the minor, recognising the unique vulnerability of teenage survivors in cases of sexual assault.
Also Read:Karnataka HC permits termination of 25-week pregnancy of 13-year-old rape victim subject to Govt doctor&#039;s opinion ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/05/26/129368-hc-gujarat.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gujarat, approves, pregnancy, termination, for, 16-year-old, minor, rape, survivor</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/05/26/129368-hc-gujarat.webp"><p><b>Ahmedabad:</b> The <a href="https://medicaldialogues.in/topics/gujarat-high-court">Gujarat High Court</a> has approved the termination of a 25-week <a href="https://speciality.medicaldialogues.in/topics/pregnancy">pregnancy</a> of a minor rape survivor, emphasising the trauma, mental agony, and potential social stigma the girl would face.   </p><p>In an April 6 order, Justice M R Mengdey directed a team of senior doctors to examine the 16-year-old girl and carry out the procedure urgently.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/hospitals-to-face-legal-action-for-failing-to-report-minor-pregnancies-karnataka-govt-168115"><b>Also Read:Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt</b></a></p><div class="pasted-from-word-wrapper"><div><span>The court referred to the Supreme Court’s established “best interest” principle, which emphasises the welfare and holistic development of children, overriding parental rights or rigid legal frameworks. The High Court noted that every day’s delay in the procedure would exacerbate the survivor’s trauma, and acting swiftly was in her overall well-being.</span></div></div><p>According to the news reports, a medical board at GMERS General Hospital, comprising senior gynaecologists, a psychologist, a physician, and a radiologist, examined the minor. Their report confirmed that the pregnancy was at 25 weeks and 3 days and recommended termination under the Medical Termination of Pregnancy (MTP) Act, 1971, considering the risks to the minor’s physical and mental health.
</p><p>The court also directed that if the foetus is born alive, the hospital must provide the best possible medical care to ensure healthy development.
</p><p>Besides, if the victim is not willing to assume the responsibility of the baby, the state and its agencies should assume full responsibility and offer medical support and facilities to the child, keeping in mind the best interest of the child and the statutory provisions in the Juvenile Justice (Care and Protection of Children) Act, 2005. The court also directed the doctors to take the necessary tissue samples for DNA identification by following the scientific practice for the same and handing over the samples to the investigating officer, reports the <a href="https://indianexpress.com/article/legal-news/gujarat-high-court-25-week-pregnancy-termination-minor-rape-case-10623259/" rel="nofollow">Indian Express</a>.
</p><p>As per <a href="https://www.etvbharat.com/en/state/gujarat-high-court-allows-abortion-for-16-year-old-rape-survivor-at-25-weeks-enn26040707426" rel="nofollow">ETV Bharat </a>reports, Counsel for the petitioner, P.S. Dutta, said the court adopted a humane approach by placing the minor’s physical and psychological condition at the forefront.
</p><p>The Gujarat High Court’s decision echoes a similar ruling by the Karnataka High Court, where a minor rape survivor’s 26-week pregnancy was terminated to safeguard her dignity and well-being. In that case, Justice R Nataraj emphasised that the court should not hesitate to protect the “honour and dignity” of the minor, recognising the unique vulnerability of teenage survivors in cases of sexual assault.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/karnataka-hc-permits-termination-of-25-week-pregnancy-of-13-year-old-rape-victim-subject-to-govt-doctors-opinion-102264"><b>Also Read:Karnataka HC permits termination of 25-week pregnancy of 13-year-old rape victim subject to Govt doctor's opinion</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 09/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-09april2026</link>
<guid>https://edusehat.com/en/health-bulletin-09april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:NEET SS 2025 Counselling Round 2: MCC Adds 18 Seats, Withdraws OneThe Medical Counselling Committee (MCC), under the Directorate General of Health Services (DGHS), has issued a notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (NEET SS) Super Speciality Counselling 2025.As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.For more details, check out the full story on the link below:MCC adds 18 seats, withdraws 1 from round 2 NEET SS counselling 2025NMC Releases Tentative DM, MCh Seat Matrix; 4,689 Total Seats, 616 Added for 2025-26Altogether 616 super speciality seats have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year&#039;s 4073 seats, according to the National Medical Commission (NMC).Releasing the tentative seat matrix for super specialty courses, the Medical Assessment &amp; Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.For more details, check out the full story on the link below:Altogether 4,689 DM, MCh seats, 616 granted in 2025-26: NMC releases tentative seat matrixNMC Directs Medical Colleges to Charge MBBS Fees Only for 4.5 YearsNoting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the National Medical Commission (NMC) has strictly directed all medical colleges to charge fees only for the prescribed academic duration of four and a half years.The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.For more details, check out the full story on the link below:NMC directs medical colleges to charge MBBS fees only for 4.5 years, warns against non-compliancePrediabetes, Obesity and Low Vitamin Levels: Apollo Report Warns of Alarming Health TrendsIndia’s health profile is undergoing a silent but significant shift, with lifestyle-related risks emerging earlier and often going unnoticed. A recent nationwide ‘Health of the Nation 2026’ report by Apollo Hospitals, based on over three million preventive assessments in 2025, highlights that one in five individuals under 30 is already prediabetic, though the condition remains reversible at this stage, according to The Hindu. More than half the population studied was found to be obese and had abnormal cholesterol levels, while nearly 70% were deficient in Vitamin D and almost half had low Vitamin B12 levels.The findings also reveal that younger individuals show declining physical fitness, with two-thirds lacking adequate strength, flexibility, or balance. Among working adults, a majority were overweight, with high rates of prediabetes and hypertension. Women showed distinct risks, such as anaemia and earlier onset of breast cancer. Alarmingly, many serious conditions like fatty liver and early atherosclerosis were detected despite normal routine test results, underlining the need for early, preventive, and more comprehensive health screening approaches. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340608-health-bulletin-80.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 09April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340608-health-bulletin-80.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>NEET SS 2025 Counselling Round 2: MCC Adds 18 Seats, Withdraws One</b></p><div class="pasted-from-word-wrapper"><p>The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/mcc" target="_blank">MCC</a>), under the Directorate General of Health Services (<a href="https://medicaldialogues.in/topics/dghs" target="_blank">DGHS</a>), has issued a notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (<a href="https://medicaldialogues.in/topics/neet" target="_blank">NEET</a> SS) Super Speciality Counselling 2025.</p><div></div><div class="pasted-from-word-wrapper"><p dir="ltr">As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/medical-admissions/mcc-adds-18-seats-withdraws-1-from-round-2-neet-ss-counselling-2025-168200" target="_blank"><i><b>MCC adds 18 seats, withdraws 1 from round 2 NEET SS counselling 2025</b></i></a></p></div></div><p><br></p><p><b>NMC Releases Tentative DM, MCh Seat Matrix; 4,689 Total Seats, 616 Added for 2025-26</b></p><div class="pasted-from-word-wrapper"><p>Altogether 616 super speciality seats have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year's 4073 seats, according to the National Medical Commission (NMC).</p><p>Releasing the tentative seat matrix for super specialty courses, the Medical Assessment & Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/altogether-4689-dm-mch-seats-616-granted-in-2025-26-nmc-releases-tentative-seat-matrix-168240" target="_blank"><i><b>Altogether 4,689 DM, MCh seats, 616 granted in 2025-26: NMC releases tentative seat matrix</b></i></a></p></div><p><br></p><p><b>NMC Directs Medical Colleges to Charge MBBS Fees Only for 4.5 Years</b></p><div class="pasted-from-word-wrapper"><p>Noting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the <a href="https://medicaldialogues.in/topics//nmc" target="_blank">National Medical Commission</a> (NMC) has strictly directed all medical colleges to charge<a href="https://medicaldialogues.in/topics/mbbs-fees" target="_blank"> fees</a> only for the prescribed academic duration of four and a half years.</p><div></div><p>The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/health-news/nmc/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years-warns-against-non-compliance-168206" target="_blank"><i><b>NMC directs medical colleges to charge MBBS fees only for 4.5 years, warns against non-compliance</b></i></a></p></div><p><b><br></b></p><p><b>Prediabetes, Obesity and Low Vitamin Levels: Apollo Report Warns of Alarming Health Trends</b></p><p>India’s health profile is undergoing a silent but significant shift, with lifestyle-related risks emerging earlier and often going unnoticed. A recent nationwide ‘Health of the Nation 2026’ report by Apollo Hospitals, based on over three million preventive assessments in 2025, highlights that one in five individuals under 30 is already prediabetic, though the condition remains reversible at this stage, according to The Hindu.</p><p> More than half the population studied was found to be obese and had abnormal cholesterol levels, while nearly 70% were deficient in Vitamin D and almost half had low Vitamin B12 levels.</p><p>The findings also reveal that younger individuals show declining physical fitness, with two-thirds lacking adequate strength, flexibility, or balance. Among working adults, a majority were overweight, with high rates of prediabetes and hypertension. Women showed distinct risks, such as anaemia and earlier onset of breast cancer. Alarmingly, many serious conditions like fatty liver and early atherosclerosis were detected despite normal routine test results, underlining the need for early, preventive, and more comprehensive health screening approaches.</p>]]> </content:encoded>
</item>

<item>
<title>NEET SS 2025 Counselling Round 2: MCC Adds 18 Seats, Withdraws One</title>
<link>https://edusehat.com/en/neet-ss-2025-counselling-round-2-mcc-adds-18-seats-withdraws-one</link>
<guid>https://edusehat.com/en/neet-ss-2025-counselling-round-2-mcc-adds-18-seats-withdraws-one</guid>
<description><![CDATA[ The Medical Counselling Committee (MCC), under the Directorate General of Health Services (DGHS), has issued an notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (NEET SS) Super Speciality Counselling 2025.As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.For more details, check out the full story on the link below:
MCC adds 18 seats, withdraws 1 from round 2 NEET SS counselling 2025
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340574-mcc.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, 2025, Counselling, Round, MCC, Adds, Seats, Withdraws, One</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340574-mcc.webp"><div class="pasted-from-word-wrapper"><p>The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/mcc" target="_blank">MCC</a>), under the Directorate General of Health Services (<a href="https://medicaldialogues.in/topics/dghs" target="_blank">DGHS</a>), has issued an notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (<a href="https://medicaldialogues.in/topics/neet" target="_blank">NEET</a> SS) Super Speciality Counselling 2025.</p><div></div><div class="pasted-from-word-wrapper"><p dir="ltr">As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/education/medical-admissions/mcc-adds-18-seats-withdraws-1-from-round-2-neet-ss-counselling-2025-168200" target="_blank"><b><i>MCC adds 18 seats, withdraws 1 from round 2 NEET SS counselling 2025</i></b></a></p><p>
</p><p></p><p></p><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Lupin, Zydus Secure USFDA Nod for Dapagliflozin Tablets</title>
<link>https://edusehat.com/en/lupin-zydus-secure-usfda-nod-for-dapagliflozin-tablets</link>
<guid>https://edusehat.com/en/lupin-zydus-secure-usfda-nod-for-dapagliflozin-tablets</guid>
<description><![CDATA[ New Delhi: Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg, strengthening their presence in the anti-diabetic segment in the US market.Lupin announced that it has received approval for its Abbreviated New Drug Application (ANDA) for Dapagliflozin Tablets, which are bioequivalent to the reference listed drug Farxiga of AstraZeneca. The approval enables the company to market the product in the United States for the approved indications.On the other hand, Zydus Lifesciences has received final USFDA approval for the same strengths of Dapagliflozin Tablets. With this approval, Zydus becomes eligible for 180 days of shared generic drug exclusivity, providing a competitive advantage in the US generics market.Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.Also Read: India&#039;s Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full ListHighlighting the market opportunity, Zydus noted that Dapagliflozin tablets recorded annual sales of approximately USD 10.2 billion in the United States for the twelve months ending February 2026, underscoring the strong demand for the drug. The company also stated that the product will be manufactured at its formulation facility located in the Special Economic Zone (SEZ) in Ahmedabad.In terms of regulatory progress, Zydus has received a total of 436 approvals and has filed 505 ANDAs since the start of its filing process in FY 2003-04, reflecting its growing footprint in the global generics space.Lupin, headquartered in Mumbai, is a global pharmaceutical company with operations in over 100 markets and a diverse portfolio spanning generics, complex generics, biotechnology products, and active pharmaceutical ingredients across key therapeutic areas including cardiovascular and anti-diabetic segments.Also Read: Zydus Arm Sentynl Licenses Progeria Drug Progerinin, Strengthens Rare Disease Pipeline ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/07/297167-dapagliflozin.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Lupin, Zydus, Secure, USFDA, Nod, for, Dapagliflozin, Tablets</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/07/297167-dapagliflozin.webp"><p><b>New Delhi:</b> Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg, strengthening their presence in the anti-diabetic segment in the US market.</p><div class="pasted-from-word-wrapper"><p>Lupin announced that it has received approval for its Abbreviated New Drug Application (ANDA) for Dapagliflozin Tablets, which are bioequivalent to the reference listed drug Farxiga of AstraZeneca. The approval enables the company to market the product in the United States for the approved indications.</p><p>On the other hand, Zydus Lifesciences has received final USFDA approval for the same strengths of Dapagliflozin Tablets. With this approval, Zydus becomes eligible for 180 days of shared generic drug exclusivity, providing a competitive advantage in the US generics market.</p><p>Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/indias-semaglutide-market-set-for-generic-boom-as-patents-expire-over-50-brands-lined-up-for-launch-see-full-list-165838">Also Read: India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List</a></div></div><p>Highlighting the market opportunity, Zydus noted that Dapagliflozin tablets recorded annual sales of approximately USD 10.2 billion in the United States for the twelve months ending February 2026, underscoring the strong demand for the drug. The company also stated that the product will be manufactured at its formulation facility located in the Special Economic Zone (SEZ) in Ahmedabad.</p><p>In terms of regulatory progress, Zydus has received a total of 436 approvals and has filed 505 ANDAs since the start of its filing process in FY 2003-04, reflecting its growing footprint in the global generics space.</p><p>Lupin, headquartered in Mumbai, is a global pharmaceutical company with operations in over 100 markets and a diverse portfolio spanning generics, complex generics, biotechnology products, and active pharmaceutical ingredients across key therapeutic areas including cardiovascular and anti-diabetic segments.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-arm-sentynl-licenses-progeria-drug-progerinin-strengthens-rare-disease-pipeline-166781">Also Read: Zydus Arm Sentynl Licenses Progeria Drug Progerinin, Strengthens Rare Disease Pipeline</a></p></div>]]> </content:encoded>
</item>

<item>
<title>Lokayukta Raids Assistant Drug Controller, Unearths Rs 3.37 Crore Disproportionate Assets</title>
<link>https://edusehat.com/en/lokayukta-raids-assistant-drug-controller-unearths-rs-337-crore-disproportionate-assets</link>
<guid>https://edusehat.com/en/lokayukta-raids-assistant-drug-controller-unearths-rs-337-crore-disproportionate-assets</guid>
<description><![CDATA[ Mangaluru: Officials from the Karnataka Lokayukta on Tuesday carried out coordinated raids at the office, residences, and other properties linked to Assistant Drug Controller Babu B N, who is posted at the Regional Deputy Drugs Controller&#039;s Office in Mangaluru, over allegations of holding assets disproportionate to his known sources of income.During the operation, assets worth approximately Rs 3.37 crore were uncovered, according to a recent media report in the Deccan Herald.As per Lokayukta police, search operations were conducted across multiple locations, including Babu’s residence and commercial establishments in Bagepalli town of Chikkaballapur district, his houses and a flat in Bengaluru, his residence in Mangaluru, and his office premises.The raids led to the detection of both movable and immovable assets amounting to ₹3.37 crore. Among these, movable assets worth ₹23.64 lakh—including cash, gold, and silver ornaments—were recovered from his Bengaluru residence, officials said.Also Read: Counterfeit Goods From Toothpaste to Paneer Penetrate Homes, Raids Put Essentials Under ScannerThe action was initiated following credible inputs received at the Lokayukta Police Station in Mangaluru, alleging that the official had amassed wealth beyond his legitimate income.Based on a report filed by Police Inspector Chandrashekhar KN, a case was registered against Babu at the Karnataka Lokayukta Police Station in Mangaluru under the provisions of the Prevention of Corruption Act.Subsequently, raids were conducted at multiple locations under the supervision of Lokayukta Superintendent of Police BP Dinesh Kumar of Dakshina Kannada district, reports Deccan Herald.The operation involved Lokayukta Deputy Superintendents of Police Gana P Kumar and Suresh Kumar, along with Police Inspectors Manjunath, Bharati G, Shivaraj Kumar, Rajendra Nayak, and other personnel who took part in the operation.Also Read: Kanpur: Doctor couple detained as illegal kidney transplant racket busted ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/05/06/285723-raid.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Lokayukta, Raids, Assistant, Drug, Controller, Unearths, 3.37, Crore, Disproportionate, Assets</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/05/06/285723-raid.webp"><div class="pasted-from-word-wrapper"><p><b>Mangaluru</b>: Officials from the Karnataka Lokayukta on Tuesday carried out coordinated raids at the office, residences, and other properties linked to Assistant Drug Controller Babu B N, who is posted at the Regional Deputy Drugs Controller's Office in Mangaluru, over allegations of holding assets disproportionate to his known sources of income.</p></div><div class="pasted-from-word-wrapper"><p>During the operation, assets worth approximately Rs 3.37 crore were uncovered, according to a recent media report in the Deccan Herald.</p><p>As per Lokayukta police, search operations were conducted across multiple locations, including Babu’s residence and commercial establishments in Bagepalli town of Chikkaballapur district, his houses and a flat in Bengaluru, his residence in Mangaluru, and his office premises.</p><p>The raids led to the detection of both movable and immovable assets amounting to ₹3.37 crore. Among these, movable assets worth ₹23.64 lakh—including cash, gold, and silver ornaments—were recovered from his Bengaluru residence, officials said.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/counterfeit-goods-from-toothpaste-to-paneer-penetrate-homes-raids-put-essentials-under-scanner-168086">Also Read: Counterfeit Goods From Toothpaste to Paneer Penetrate Homes, Raids Put Essentials Under Scanner</a></div><p>The action was initiated following credible inputs received at the Lokayukta Police Station in Mangaluru, alleging that the official had amassed wealth beyond his legitimate income.</p><p>Based on a report filed by Police Inspector Chandrashekhar KN, a case was registered against Babu at the Karnataka Lokayukta Police Station in Mangaluru under the provisions of the Prevention of Corruption Act.</p><p>Subsequently, raids were conducted at multiple locations under the supervision of Lokayukta Superintendent of Police BP Dinesh Kumar of Dakshina Kannada district, reports <a href="https://www.deccanherald.com/india/karnataka/mangaluru/lokayukta-conduct-raids-on-properties-linked-to-asst-drug-controller-seizes-assets-worth-rs-337-crore-3959715" rel="nofollow">Deccan Herald</a>.</p><p>The operation involved Lokayukta Deputy Superintendents of Police Gana P Kumar and Suresh Kumar, along with Police Inspectors Manjunath, Bharati G, Shivaraj Kumar, Rajendra Nayak, and other personnel who took part in the operation.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/kanpur-doctor-couple-detained-as-illegal-kidney-transplant-racket-busted-167649">Also Read: Kanpur: Doctor couple detained as illegal kidney transplant racket busted</a></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Gurugram Child Sexual Assault: Max Hospital doctor denies changing medical opinion</title>
<link>https://edusehat.com/en/gurugram-child-sexual-assault-max-hospital-doctor-denies-changing-medical-opinion</link>
<guid>https://edusehat.com/en/gurugram-child-sexual-assault-max-hospital-doctor-denies-changing-medical-opinion</guid>
<description><![CDATA[ New Delhi: In connection with the alleged sexual assault of a 4-year-old girl in Gurugram, the head of the paediatrics department at Max Healthcare, who was issued a show cause notice, has submitted her response to the Supreme Court of India, denying allegations that she changed her medical opinion under pressure.In her affidavit, the doctor clearly stated that her medical findings have remained the same since the beginning and described claims of altering her report as &quot;completely incorrect.&quot; Medical Dialogues had earlier reported that, highlighting the glaring insensitivity, sheer recklessness and irresponsible conduct of the authorities, the Supreme Court issued show-cause notices to Gurugram police Commissioner and other police officials involved in investigating the alleged sexual assault of a 4-year-old child. Also read- Max Healthcare inks MoU with The Learning Lab for healthcare capacity buildingShe stated, as per Live Law media report, &quot;I have not changed my medical opinion in any manner. Any information given by any party in this regard is completely incorrect.&quot;During an earlier hearing, the victim’s counsel had alleged that the doctor completely changed her opinion about one and a half months after the initial examination. He questioned what led the doctor to write a letter to the police later with different statements.Taking note of this, Chief Justice of India Surya Kant had earlier made strong remarks and sought an explanation from the doctor.The doctor told the Court that the child was brought to the hospital on February 2. After speaking to the mother and the child, she prepared a case sheet. As per the child’s statement, a domestic helper took her to a &quot;dirty place&quot; where a man kissed her cheeks, twisted her ears, and hit her on the stomach.The doctor further stated in her affidavit that during the physical examination, no external injuries were found on the child’s body, and her private parts were found to be normal.She also informed the Court that she had advised the parents to approach the police and register a medico-legal case. A few days later, a police officer recorded her statement based on the case sheet, which she signed.Then, 47 days after the incident, two police officers again approached her for information. The doctor stated that she repeated the same details from memory as recorded earlier.Meanwhile, the child’s parents have expressed dissatisfaction with the probe by the Haryana Police and demanded a probe by the CBI or an SIT.Earlier, the Supreme Court had criticised the police handling of the case, calling it “shocking” and insensitive. The Court has now ordered a Special Investigation Team (SIT) probe and removed senior Gurugram police officials, including the police commissioner, from the investigation. Also read- NMC draft amendment proposes single state registration for AFMS doctors ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/338833-blanket.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gurugram, Child, Sexual, Assault:, Max, Hospital, doctor, denies, changing, medical, opinion</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/338833-blanket.webp"><p><b>New Delhi: </b>In connection with the alleged sexual assault of a 4-year-old girl in Gurugram, the head of the paediatrics department at <a href="https://medicaldialogues.in/topics/max-healthcare" target="_blank">Max Healthcare, </a>who was issued a show cause notice, has submitted her response to the Supreme Court of India, denying allegations that she changed her medical opinion under pressure.</p><p>In her affidavit, the <a href="https://medicaldialogues.in/topics/doctors" target="_blank">doctor </a>clearly stated that her medical findings have remained the same since the beginning and described claims of altering her report as "completely incorrect." </p><p>Medical Dialogues had earlier reported that, highlighting the glaring insensitivity, sheer recklessness and irresponsible conduct of the authorities, the Supreme Court issued show-cause notices to Gurugram police Commissioner and other police officials involved in investigating the alleged sexual assault of a 4-year-old child. </p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/max-healthcare-inks-mou-with-the-learning-lab-for-healthcare-capacity-building-162178" target="_blank">Max Healthcare inks MoU with The Learning Lab for healthcare capacity building</a></b></p><p>She stated, as per<a href="https://www.livelaw.in/top-stories/supreme-court-gurugram-4-yr-old-minor-girl-rape-case-max-hospital-doctor-denies-change-in-medical-opinion-due-to-influence-529440" target="_blank"> Live Law</a> media report, "I have not changed my medical opinion in any manner. Any information given by any party in this regard is completely incorrect."</p><p>During an earlier hearing, the victim’s counsel had alleged that the doctor completely changed her opinion about one and a half months after the initial examination. He questioned what led the doctor to write a letter to the police later with different statements.</p><p>Taking note of this, Chief Justice of India Surya Kant had earlier made strong remarks and sought an explanation from the doctor.</p><p>The doctor told the Court that the child was brought to the hospital on February 2. After speaking to the mother and the child, she prepared a case sheet. As per the child’s statement, a domestic helper took her to a "dirty place" where a man kissed her cheeks, twisted her ears, and hit her on the stomach.</p><p>The doctor further stated in her affidavit that during the physical examination, no external injuries were found on the child’s body, and her private parts were found to be normal.</p><p>She also informed the Court that she had advised the parents to approach the police and register a medico-legal case. A few days later, a police officer recorded her statement based on the case sheet, which she signed.</p><p>Then, 47 days after the incident, two police officers again approached her for information. The doctor stated that she repeated the same details from memory as recorded earlier.</p><p>Meanwhile, the child’s parents have expressed dissatisfaction with the probe by the Haryana Police and demanded a probe by the CBI or an SIT.</p><p>Earlier, the Supreme Court had criticised the police handling of the case, calling it “shocking” and insensitive. The Court has now ordered a Special Investigation Team (SIT) probe and removed senior Gurugram police officials, including the police commissioner, from the investigation. </p><p><b>Also read- <a href="https://medicaldialogues.in/health-news/nmc/nmc-draft-amendment-proposes-single-state-registration-for-afms-doctors-168198" target="_blank">NMC draft amendment proposes single state registration for AFMS doctors</a></b></p>]]> </content:encoded>
</item>

<item>
<title>NMC Releases Tentative DM, MCh Seat Matrix; 4,689 Total Seats, 616 Added for 2025&#45;26</title>
<link>https://edusehat.com/en/nmc-releases-tentative-dm-mch-seat-matrix-4689-total-seats-616-added-for-2025-26</link>
<guid>https://edusehat.com/en/nmc-releases-tentative-dm-mch-seat-matrix-4689-total-seats-616-added-for-2025-26</guid>
<description><![CDATA[ Altogether 616 super speciality seats have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year&#039;s 4073 seats, according to the National Medical Commission (NMC).Releasing the tentative seat matrix for super specialty courses, the Medical Assessment &amp; Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.For more details, check out the full story on the link below:Altogether 4,689 DM, MCh seats, 616 granted in 2025-26: NMC releases tentative seat matrix ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340589-mcc-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 19:30:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, Releases, Tentative, DM, MCh, Seat, Matrix, 4, 689, Total, Seats, 616, Added, for, 2025-26</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340589-mcc-1.webp"><div class="pasted-from-word-wrapper"><p>Altogether 616 super speciality seats have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year's 4073 seats, according to the National Medical Commission (NMC).</p><p>Releasing the tentative seat matrix for super specialty courses, the Medical Assessment & Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/altogether-4689-dm-mch-seats-616-granted-in-2025-26-nmc-releases-tentative-seat-matrix-168240" target="_blank"><b><i>Altogether 4,689 DM, MCh seats, 616 granted in 2025-26: NMC releases tentative seat matrix</i></b></a></p><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div>]]> </content:encoded>
</item>

<item>
<title>NEET aspirant denied bail in cyber fraud case</title>
<link>https://edusehat.com/en/neet-aspirant-denied-bail-in-cyber-fraud-case</link>
<guid>https://edusehat.com/en/neet-aspirant-denied-bail-in-cyber-fraud-case</guid>
<description><![CDATA[ New Delhi: Granting no relief, a Delhi court has denied bail to an 18 year old NEET aspirant who was allegedly active in large scale organised cyber fraud.The court said that his role is not simply &quot;peripheral&quot; in light of the recovery of substantial proof against him.
According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.Also Read:AIIMS NORCET 10 admit card released&quot;This court is of the view that the role attributed to the applicant is not peripheral. Economic offences involving organised cyber fraud have serious ramifications on society and financial systems, and are required to be dealt with strictly,&quot; the court said in its order dated April 6, reports PTI&quot;In view of the nature of allegations, the possibility of the applicant influencing witnesses or tampering with evidence cannot be ruled out, this court is not inclined to grant bail to the applicant,&quot; the court added, as it noted that involvement of other persons in the larger conspiracy is yet to be ascertained in the ongoing investigation.
The court took note of the material placed on record as it revealed the recovery of approximately 38 ATM cards, multiple cheque books, passbooks, SIM cards, mobile phones and a laptop.&quot;The applicant was actively involved in arranging bank accounts and routing funds through multiple accounts and converting the same into cryptocurrency, which prima facie reflects a well-organised and systematic activity,&quot; the court said.
The prosecution had also highlighted that the 30-40 bank accounts associated with the accused were linked with multiple complaints on the National Cyber Crime Portal, including for high-value fraud cases.
It also found that the CCTV footage of the accused withdrawing and depositing cash through various ATMs and the magnitude of transactions, including deposits, running into approximately Rs 44 lakh, further strengthened the prosecution&#039;s case opposing the plea.
Earlier, the defence counsel argued that the alleged recovery of evidence had been falsely planted, and no independent recovery had been effected by the police. He also cited the accused&#039;s young age to argue that continued incarceration would adversely affect his education and future prospects.
The court responded that such matters require evidence and cannot be adjudicated at this stage of bail.Also Read:AIIMS New Delhi launches Virtual Reality training centre for medical students ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340536-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-54.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, aspirant, denied, bail, cyber, fraud, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340536-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-54.webp"><p><b>New Delhi: </b>Granting no relief, a Delhi court has denied bail to an 18 year old <a href="https://medicaldialogues.in/topics/NEET-aspirant">NEET aspirant</a> who was allegedly active in large scale organised <a href="https://medicaldialogues.in/topics/cyber-fraud">cyber fraud</a>.</p><p>The court said that his role is not simply "peripheral" in light of the recovery of substantial proof against him.
</p><p>According to PTI report, additional Sessions Judge Vinod Kumar Gautam rejected the bail plea of teenager, who has been accused of committing offences under Sections 318(4) (cheating and dishonestly inducing delivery of property), 112(3) (abetment of offence), 317(2) (receiving stolen property, 61(2) (criminal conspiracy), 49 (abetment of suicide), and 3(5) (common intention) of the BNS, along with Section 66(D) (cyber cheating by personation) of the Information Technology Act.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-admit-card-released-168207">Also Read:AIIMS NORCET 10 admit card released</a></div><p>"This court is of the view that the role attributed to the applicant is not peripheral. Economic offences involving organised cyber fraud have serious ramifications on society and financial systems, and are required to be dealt with strictly," the court said in its order dated April 6, reports PTI</p><p>"In view of the nature of allegations, the possibility of the applicant influencing witnesses or tampering with evidence cannot be ruled out, this court is not inclined to grant bail to the applicant," the court added, as it noted that involvement of other persons in the larger conspiracy is yet to be ascertained in the ongoing investigation.
</p><p>The court took note of the material placed on record as it revealed the recovery of approximately 38 ATM cards, multiple cheque books, passbooks, SIM cards, mobile phones and a laptop.</p><p>"The applicant was actively involved in arranging bank accounts and routing funds through multiple accounts and converting the same into cryptocurrency, which prima facie reflects a well-organised and systematic activity," the court said.
</p><p>The prosecution had also highlighted that the 30-40 bank accounts associated with the accused were linked with multiple complaints on the National Cyber Crime Portal, including for high-value fraud cases.
</p><p>It also found that the CCTV footage of the accused withdrawing and depositing cash through various ATMs and the magnitude of transactions, including deposits, running into approximately Rs 44 lakh, further strengthened the prosecution's case opposing the plea.
</p><p>Earlier, the defence counsel argued that the alleged recovery of evidence had been falsely planted, and no independent recovery had been effected by the police. He also cited the accused's young age to argue that continued incarceration would adversely affect his education and future prospects.
</p><p>The court responded that such matters require evidence and cannot be adjudicated at this stage of bail.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/aiims-new-delhi-launches-virtual-reality-training-centre-for-medical-students-168141">Also Read:AIIMS New Delhi launches Virtual Reality training centre for medical students</a></div><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Maha: Doctor, staff arrested for bribe in free family planning surgery</title>
<link>https://edusehat.com/en/maha-doctor-staff-arrested-for-bribe-in-free-family-planning-surgery</link>
<guid>https://edusehat.com/en/maha-doctor-staff-arrested-for-bribe-in-free-family-planning-surgery</guid>
<description><![CDATA[ Chhatrapati Sambhajinagar: A Medical Superintendent and a sanitation worker at a rural Hospital in Bidkin, Chhatrapati Sambhajinagar district, were caught red-handed by the Anti-Corruption Bureau (ACB) while allegedly accepting a bribe of Rs 1,200 for a free family planning surgery.  According to news reports, both accused were produced before a local court on Tuesday and remanded to police custody for three days.Also Read: Three middlemen arrested for duping patients at SCB Medical CollegeSpeaking to TOI, ACB Inspector Santosh Tigote stated that the accused had demanded ₹6,000 from a patient for a family planning surgery. After negotiations, the 58-year-old doctor agreed to accept ₹1,200 from the patient as an illegal bribe and instructed him to deposit the money with a sanitation worker. However, the procedure was supposed to be performed free of cost.The family was unwilling to pay the bribe; therefore, the female patient&#039;s brother lodged a formal complaint with the ACB. After verifying the demand for the bribe, a trap was laid.&quot;We caught the sanitation worker red-handed while accepting the bribe, and the doctor was subsequently held. The bribe amount was recovered, and the mobile phones of both accused were seized. We also searched the house of the main accused,&quot; Tigote said.Meanwhile, the Bidkin Police have registered a case under the Prevention of Corruption Act, 1988, and have initiated an investigation into the matter.The ACB has appealed to the public that if anyone demands money to get their work done, they should contact them and lodge an official complaint.Medical Dailogues had recently reported that observing that it is immaterial whether a public servant receives, accepts, or attempts to obtain an undue advantage directly or through a third party, the Madhya Pradesh High Court refused to quash an FIR against a government doctor accused of demanding a bribe to allow a centre to continue functioning on the campus of a Community Health Center in Khargapur.Also Read: Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Maha:, Doctor, staff, arrested, for, bribe, free, family, planning, surgery</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340407-arrest-1.webp"><p>Chhatrapati Sambhajinagar: A Medical Superintendent and a sanitation worker at a rural Hospital in Bidkin, Chhatrapati Sambhajinagar district, were caught red-handed <span>by the </span><a href="https://medicaldialogues.in/topics/anti-corruption-bureau" target="_blank">Anti-Corruption Bureau</a><span> (ACB) while allegedly </span>accepting a bribe of Rs 1,200 for a free family planning surgery.  </p><div class="pasted-from-word-wrapper"><p dir="ltr">According to news reports, both accused were produced before a local court on Tuesday and remanded to police custody for three days.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/three-middlemen-arrested-for-duping-patients-at-scb-medical-college-168196"><b>Also Read: </b>Three middlemen arrested for duping patients at SCB Medical College</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Speaking to <a href="https://timesofindia.indiatimes.com/city/aurangabad/medical-superintendent-sanitation-worker-land-in-acb-net-for-accepting-5000/articleshow/130094053.cms" target="_blank" rel="nofollow">TOI</a>, ACB Inspector Santosh Tigote stated that the accused had demanded ₹6,000 from a patient for a family planning surgery. After negotiations, the 58-year-old doctor agreed to accept ₹1,200 from the patient as an illegal bribe and instructed him to deposit the money with a sanitation worker. However, the procedure was supposed to be performed free of cost.</p><p dir="ltr">The family was unwilling to pay the bribe; therefore, the female patient's brother lodged a formal complaint with the ACB. After verifying the demand for the bribe, a trap was laid.</p><p dir="ltr">"We caught the sanitation worker red-handed while accepting the bribe, and the doctor was subsequently held. The bribe amount was recovered, and the mobile phones of both accused were seized. We also searched the house of the main accused," Tigote said.</p><p dir="ltr">Meanwhile, the Bidkin Police have registered a case under the Prevention of Corruption Act, 1988, and have initiated an investigation into the matter.</p><p dir="ltr">The ACB has appealed to the public that if anyone demands money to get their work done, they should contact them and lodge an official complaint.</p><p dir="ltr">Medical Dailogues had recently reported that observing that it is immaterial whether a public servant receives, accepts, or attempts to obtain an undue advantage directly or through a third party, the <a href="https://medicaldialogues.in/topics/madhya-pradesh-high-court">Madhya Pradesh High Court</a> refused to quash an FIR against a government doctor accused of demanding a<a href="https://medicaldialogues.in/topics/bribe"> bribe</a> to allow a centre to continue functioning on the campus of a Community Health Center in Khargapur.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/delhi-police-bust-rs-2-crore-fake-drug-racket-6-arrested-rs-50-crore-gst-fraud-network-exposed-168187"><b>Also Read: </b>Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Review Finds Mediterranean&#45;Style Diet May Influence Thyroid Disease Risk and Management</title>
<link>https://edusehat.com/en/review-finds-mediterranean-style-diet-may-influence-thyroid-disease-risk-and-management</link>
<guid>https://edusehat.com/en/review-finds-mediterranean-style-diet-may-influence-thyroid-disease-risk-and-management</guid>
<description><![CDATA[ A recent review published in the Journal of Endocrinological Investigation highlights how diet plays a critical and often underappreciated role in thyroid health, particularly in autoimmune thyroid diseases. 
While iodine has long been recognized as essential for thyroid hormone production, researchers emphasize that overall nutrition—including micronutrients, dietary patterns, and gut health—significantly influences thyroid function.
The review analyzed studies from major databases between 2005 and 2025, focusing on key nutrients such as iodine, selenium, iron, zinc, vitamin D, and vitamin B12. Findings show that iodine follows a U-shaped relationship with thyroid health: both deficiency and excess can disrupt function. 
Low iodine levels may lead to hypothyroidism and goiter, while excessive intake can trigger hyperthyroidism or autoimmune thyroiditis in susceptible individuals.
Other micronutrients also play vital roles. Selenium supports antioxidant defenses and hormone metabolism, while zinc and iron are essential for enzyme activity involved in hormone production. Deficiencies in these nutrients may increase the risk of thyroid dysfunction. 
Meanwhile, low levels of vitamin D and B12 are commonly observed in individuals with autoimmune thyroid conditions, although supplementation is only beneficial when deficiencies are present.
Dietary patterns further shape thyroid outcomes. The Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and olive oil, is associated with lower inflammation and reduced thyroid autoantibodies. 
In contrast, the Western diet—high in refined sugars, saturated fats, and processed foods—may նպ promote inflammation, oxidative stress, and gut microbiota imbalance, increasing disease risk.
Importantly, restrictive diets such as gluten-free or lactose-free regimens show no clear benefit for thyroid health unless medically indicated and may even cause nutrient deficiencies. 
Overall, the review underscores that balanced, nutrient-rich diets—not extreme restrictions—are key to supporting thyroid function and reducing disease risk.
REFERENCE: Ruggeri, R.M., Virili, C., Mocini, E. Campennì, A., Centanni, M., Rotondi, M., Cannavò, S., Croce, L., &amp; Migliaccio, S. (2026). The role of nutrition on thyroid health and disease: myths and facts. J Endocrinol Invest (2026). DOI: 10.1007/s40618-026-02852-0, https://link.springer.com/article/10.1007/s40618-026-02852-0
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340566-review-finds-mediterranean-style-diet-may-influence-thyroid-disease-risk-and-management.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Review, Finds, Mediterranean-Style, Diet, May, Influence, Thyroid, Disease, Risk, and, Management</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340566-review-finds-mediterranean-style-diet-may-influence-thyroid-disease-risk-and-management.webp"><p>A recent review published in the <i>Journal of Endocrinological Investigation </i>highlights how diet plays a critical and often underappreciated role in thyroid health, particularly in autoimmune thyroid diseases. 
</p><p>While iodine has long been recognized as essential for thyroid hormone production, researchers emphasize that overall nutrition—including micronutrients, dietary patterns, and gut health—significantly influences thyroid function.
</p><p>The review analyzed studies from major databases between 2005 and 2025, focusing on key nutrients such as iodine, selenium, iron, zinc, vitamin D, and vitamin B12. Findings show that iodine follows a U-shaped relationship with thyroid health: both deficiency and excess can disrupt function. 
</p><p>Low iodine levels may lead to hypothyroidism and goiter, while excessive intake can trigger hyperthyroidism or autoimmune thyroiditis in susceptible individuals.
</p><p>Other micronutrients also play vital roles. Selenium supports antioxidant defenses and hormone metabolism, while zinc and iron are essential for enzyme activity involved in hormone production. Deficiencies in these nutrients may increase the risk of thyroid dysfunction. 
</p><p>Meanwhile, low levels of vitamin D and B12 are commonly observed in individuals with autoimmune thyroid conditions, although supplementation is only beneficial when deficiencies are present.
</p><p>Dietary patterns further shape thyroid outcomes. The Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and olive oil, is associated with lower inflammation and reduced thyroid autoantibodies. 
</p><p>In contrast, the Western diet—high in refined sugars, saturated fats, and processed foods—may նպ promote inflammation, oxidative stress, and gut microbiota imbalance, increasing disease risk.
</p><p>Importantly, restrictive diets such as gluten-free or lactose-free regimens show no clear benefit for thyroid health unless medically indicated and may even cause nutrient deficiencies. 
</p><p>Overall, the review underscores that balanced, nutrient-rich diets—not extreme restrictions—are key to supporting thyroid function and reducing disease risk.
</p><p><b>REFERENCE:</b> Ruggeri, R.M., Virili, C., Mocini, E. Campennì, A., Centanni, M., Rotondi, M., Cannavò, S., Croce, L., & Migliaccio, S. (2026). The role of nutrition on thyroid health and disease: myths and facts. J Endocrinol Invest (2026). DOI: 10.1007/s40618-026-02852-0, https://link.springer.com/article/10.1007/s40618-026-02852-0
</p>]]> </content:encoded>
</item>

<item>
<title>Dapagliflozin &amp;amp; Sitagliptin fixed dose combination in India T2D: 5 Point Clinicians May Like to Know&#45;Dr K Baraneedharan</title>
<link>https://edusehat.com/en/dapagliflozin-sitagliptin-fixed-dose-combination-in-india-t2d-5-point-clinicians-may-like-to-know-dr-k-baraneedharan</link>
<guid>https://edusehat.com/en/dapagliflozin-sitagliptin-fixed-dose-combination-in-india-t2d-5-point-clinicians-may-like-to-know-dr-k-baraneedharan</guid>
<description><![CDATA[ The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to ensure durable glycemic control and prevent long-term complications. In the Indian population, marked by higher insulin resistance, reduced beta-cell function, abdominal obesity, and clustering of cardiovascular risk factors, the case for early combination therapy is particularly important. This article reviews five recent data points relevant to clinicians considering the Dapagliflozin (SGLT2 inhibitor) and Sitagliptin (DPP-4 inhibitor) combination in T2DM management.[1] 
1. Dapagliflozin &amp; Sitagliptin Combination – Experienced Beta-Cell Independent complementary citing agents coming together: The dapagliflozin (SGLT2i) &amp; sitagliptin (DPP4i) combination targets complementary and mechanistically distinct pathways involved in glucose regulation (Figure 1). Sitagliptin enhances incretin-mediated, glucose-dependent insulin secretion by DPP-4, thereby increasing endogenous incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Dapagliflozin lowers plasma glucose by selectively inhibiting SGLT2 in the proximal renal tubule, promoting urinary glucose excretion independent of insulin secretion and without the hypo-glycaemia or weight gain associated with conventional therapies.[2]
 Figure 1. Complementary mechanisms of action of SGLT2 inhibitors and DPP-4 inhibitors in glucose regulation. Adapted from: Chadha M, Das AK, Deb P, et al. Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting. Diabetes Therapy. 2022;13:1097–1114. Abbreviations: SGLT2i -Sodium-glucose co-transporter-2 inhibitor, DPP-4i – Dipeptidyl peptidase-4 inhibitor, GLP-1 – Glucagon-like peptide-1, GIP – Glucose-dependent insulinotropic polypeptide, SBP – Systolic blood pressure
2. Dapagliflozin &amp; Sitagliptin Combination in Indian T2D: Evidence of Gluco-Cardio-Metabolic Benefits: 
An Indian multi-center real-world study (N=328; 111 centers) evaluated the dapagliflozin–sitagliptin fixed-dose combination (FDC) in patients with type 2 diabetes mellitus (T2DM), many of whom had cardiometabolic comorbidities, including hypertension (71.65%) and dyslipidemia (42.38%). Treatment with the FDC significantly improved glycemic parameters, with HbA1c decreasing by 1.05% (from 8.36% to 7.31%, p ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/09/340544-featured-images-1-18.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dapagliflozin, Sitagliptin, fixed, dose, combination, India, T2D:, Point, Clinicians, May, Like, Know-Dr, Baraneedharan</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/09/340544-featured-images-1-18.webp"><p>The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to ensure durable glycemic control and prevent long-term complications. In the Indian population, marked by higher insulin resistance, reduced beta-cell function, abdominal obesity, and clustering of cardiovascular risk factors, the case for early combination therapy is particularly important. This article reviews five recent data points relevant to clinicians considering the Dapagliflozin (SGLT2 inhibitor) and Sitagliptin (DPP-4 inhibitor) combination in T2DM management.[1] 
</p><p><b>1. Dapagliflozin & Sitagliptin Combination </b>– Experienced Beta-Cell Independent complementary citing agents coming together: The dapagliflozin (SGLT2i) & sitagliptin (DPP4i) combination targets complementary and mechanistically distinct pathways involved in glucose regulation (Figure 1). Sitagliptin enhances incretin-mediated, glucose-dependent insulin secretion by DPP-4, thereby increasing endogenous incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Dapagliflozin lowers plasma glucose by selectively inhibiting SGLT2 in the proximal renal tubule, promoting urinary glucose excretion independent of insulin secretion and without the hypo-glycaemia or weight gain associated with conventional therapies.[2]
</p><div contenteditable="false" data-width="100%" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/04/09/340509-picture1.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="23690iHxTMD9lFOqsaMh518xJsG3DODsOb1S61404438" data-watermark="false" info-selector="#info_item_1775711404684"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"></div></div><p> </p><p>Figure 1. Complementary mechanisms of action of SGLT2 inhibitors and DPP-4 inhibitors in glucose regulation. Adapted from: Chadha M, Das AK, Deb P, et al. Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting. Diabetes Therapy. 2022;13:1097–1114. Abbreviations: SGLT2i -Sodium-glucose co-transporter-2 inhibitor, DPP-4i – Dipeptidyl peptidase-4 inhibitor, GLP-1 – Glucagon-like peptide-1, GIP – Glucose-dependent insulinotropic polypeptide, SBP – Systolic blood pressure
</p><p><b>2. Dapagliflozin & Sitagliptin Combination in Indian T2D: Evidence of Gluco-Cardio-Metabolic Benefits: 
</b></p><p>An Indian multi-center real-world study (N=328; 111 centers) evaluated the dapagliflozin–sitagliptin fixed-dose combination (FDC) in patients with type 2 diabetes mellitus (T2DM), many of whom had cardiometabolic comorbidities, including hypertension (71.65%) and dyslipidemia (42.38%). Treatment with the FDC significantly improved glycemic parameters, with HbA1c decreasing by 1.05% (from 8.36% to 7.31%, p<0.0001) over 12 weeks. Fasting plasma glucose declined by 41.70 mg/dL (from 165.52 to 123.82 mg/dL, p<0.0001), while postprandial blood glucose decreased by 71.91 mg/dL (from 242.15 to 170.24 mg/dL, p<0.0001) during follow-up. In addition to glycemic control, the combination demonstrated favorable cardiometabolic effects, with systolic blood pressure decreasing by 14.61 mmHg (from 147.00 to 132.40 mmHg) and diastolic blood pressure by 7.80 mmHg (from 90.32 to 82.52 mmHg). LDL-cholesterol also declined by 18.14 mg/dL (from 121.40 to 103.20 mg/dL, p<0.0001). These findings provide evidence supporting the glycemic and cardiometabolic benefits of the dapagliflozin–sitagliptin FDC in a comorbidity-burdened T2DM population.[3]
</p><p><b>3. Dapagliflozin's Cardiorenal Benefits Maintained When Combined with a DPP-4 Inhibitor:</b> A trial-level meta-analysis of cardiovascular outcome trials (up to 37,687 participants) found that the cardiorenal benefits of SGLT2 inhibitors — including 3-point MACE (N=32,418), cardiovascular death or heart failure hospitalization (N=37,687), heart failure hospitalization alone (N=27,545), cardiovascular death (N=34,565), and renal outcomes (N=25,406)  were statistically similar regardless of background DPP-4 inhibitor therapy (P heterogeneity = 0.71, 0.07, 0.87, 0.72, and 0.25, respectively).[4] For clinicians prescribing the dapagliflozin–sitagliptin combination, this provides reassurance that dapagliflozin's established cardiorenal profile, demonstrated in DECLARE-TIMI 58, DAPA-HF, and DAPA-CKD  is not attenuated by the addition of sitagliptin.[5] The TECOS trial has also confirmed the cardiovascular safety of sitagliptin, demonstrating no increase in major adverse cardiovascular events or hospitalization for heart failure when added to standard care in patients with T2D and established CVD.[6]
</p><p><b>4. Real-World Indian Clinical Utilization Data Affirm Dapagliflozin & Sitagliptin Combination Adoption Across Diverse T2D Patient Profiles: </b>A recently published multicenter cross-sectional study across 100 Indian clinics analyzed records of 873 T2DM patients prescribed the sitagliptin 100 mg + dapagliflozin 10 mg FDC (mean age 55.26 ± 11.46 years; diabetes duration 7.02 ± 5.86 years). About 36.8% were treatment-naïve, while 62.8% were switched from prior oral therapy due to inadequate glycemic control or comorbidities. Obesity (44.9%), cardiovascular disease (44.8%), and dyslipidemia (33.6%) were prevalent comorbidities, with concomitant antihypertensives (47.8%) and lipid-lowering/antiplatelet agents (32.3%) commonly co-prescribed. These prescribing patterns indicate that Indian clinicians are deploying the dapagliflozin–sitagliptin FDC across a broad cardiometabolic risk spectrum.[1]
</p><p><b>5. Dapagliflozin and Sitagliptin Combination: Where Does Combination Therapy Sit in Latest Guidelines? 
</b></p><p>The updated February 2026 NICE NG28 guideline highlighted that SGLT2 inhibitors are now recommended as first-line therapy for newly diagnosed T2DM, and when eGFR declines below 45 mL/min/1.73 m², the guideline advises continuing the SGLT2 inhibitor for cardiorenal protection while adding a DPP-4 inhibitor to maintain glycemic control.[7]  The ADA Standards of Care 2026 recommends considering combination therapy as initial treatment to shorten time to glycemic goal attainment, and advises consideration of SGLT2 inhibitors for patients with established or high-risk atherosclerotic cardiovascular disease, heart failure (with reduced or preserved ejection fraction), and for comprehensive cardiorenal risk reduction, irrespective of HbA1c. DPP-4 inhibitors are recognized as weight-neutral add-on agents. [8]  
</p><p>Taken together, these findings highlight the clinical relevance of the dapagliflozin sitagliptin FDC in the management of T2DM, particularly in the Indian population marked by needs for beta-cell preservation, and addressing a cluster of cardiovascular risk factors to mitigate the risk of diabetes related complications. Early combination therapy targeting complementary pathways may help ensure durable glycemic control and support use of the dapagliflozin sitagliptin FDC across a broad cardiometabolic risk spectrum in routine Indian T2DM care continuum.
</p><p><span>Abbreviations: ADA, American Diabetes Association; CVD, cardiovascular disease; DAPA-CKD, Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease; DAPA-HF, Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure; DBP, diastolic blood pressure; DECLARE-TIMI 58, Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58; DPP-4, dipeptidyl peptidase-4; eGFR, estimated glomerular filtration rate; FDC, fixed-dose combination; FPG, fasting plasma glucose; GLP-1, glucagon-like peptide-1; HbA1c, glycated haemoglobin; LDL-C, low-density lipoprotein cholesterol; MACE, major adverse cardiovascular events; NICE, National Institute for Health and Care Excellence; NG28, NICE Guideline 28; PPBG, postprandial blood glucose; SBP, systolic blood pressure; SGLT2, sodium-glucose cotransporter-2; SIDAXA, Safety, Clinical Utilization, and Effectiveness of Sitagliptin and Dapagliflozin Combination Therapy in the Treatment of Type 2 Diabetes for Extra Glycaemic Advantages; T2DM, type 2 diabetes mellitus.</span>
</p>]]> </content:encoded>
</item>

<item>
<title>2nd year MBBS student dies after allegedly jumping from hostel building</title>
<link>https://edusehat.com/en/2nd-year-mbbs-student-dies-after-allegedly-jumping-from-hostel-building</link>
<guid>https://edusehat.com/en/2nd-year-mbbs-student-dies-after-allegedly-jumping-from-hostel-building</guid>
<description><![CDATA[ Chennai: In a tragic incident, a second year MBBS student from a private medical college near Tiruvallur died after allegedly jumping from the fifth floor of his hostel building on campus.The deceased has been identified as a 20-year-old student from the Thoothukudi district. He was staying in the college hostel located in Pandur village while pursuing his medical studies.According to police officials, the incident took place on Wednesday after classes. The student reportedly fell from the fifth floor of the hostel building and suffered serious injuries.Also read- VIMSAR 1st year Paediatrics medico attempts suicide by overdose, excessive work pressure, harassment suspectedHe was immediately rushed to a nearby hospital for treatment. However, despite efforts by doctors, he could not be saved and was declared dead, reports DT Next. The Tiruvallur Taluk Police have registered a case in connection with the incident. Further investigation is currently underway to find out the exact circumstances leading to his death.Medical Dialogues had earlier reported that a medical student allegedly committed suicide by jumping from the 12th floor of an apartment building. The incident was reported on Friday in Attavar, Karnataka. The deceased has been identified as a student at Kasturba Medical College (KMC).The incident occurred at an apartment complex located in Attavar. It is reported that the medico had gone there to meet a friend. After signing the visitor register at the security desk, he directly proceeded to the 12th floor of the building. Before jumping, he placed his mobile phone on the ground.Also read- Kasturba medical college student allegedly commits suicide ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/04/26/284572-jump-off.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>2nd, year, MBBS, student, dies, after, allegedly, jumping, from, hostel, building</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/04/26/284572-jump-off.webp"><p><b>Chennai: </b>In a tragic incident, a second year <a href="https://medicaldialogues.in/topics/mbbs-student" target="_blank">MBBS student</a> from a <a href="https://medicaldialogues.in/topics/private-medical-colleges" target="_blank">private medical college </a>near Tiruvallur died after allegedly jumping from the fifth floor of his hostel building on campus.</p><p>The deceased has been identified as a 20-year-old student from the Thoothukudi district. He was staying in the college hostel located in Pandur village while pursuing his medical studies.</p><p>According to police officials, the incident took place on Wednesday after classes. The student reportedly fell from the fifth floor of the hostel building and suffered serious injuries.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/vimsar-1st-year-paediatrics-medico-attempts-suicide-by-overdose-excessive-work-pressure-harassment-suspected-167549" target="_blank">VIMSAR 1st year Paediatrics medico attempts suicide by overdose, excessive work pressure, harassment suspected</a></b></p><p>He was immediately rushed to a nearby hospital for treatment. However, despite efforts by doctors, he could not be saved and was declared dead, reports<a href="https://www.dtnext.in/news/chennai/tiruvallur-medical-student-jumps-from-5th-floor-dies" target="_blank" rel="nofollow"> DT Next. </a></p><p>The Tiruvallur Taluk Police have registered a case in connection with the incident. Further investigation is currently underway to find out the exact circumstances leading to his death.</p><p>Medical Dialogues had earlier reported that a medical student allegedly committed suicide by jumping from the 12th floor of an apartment building. The incident was reported on Friday in Attavar, Karnataka. The deceased has been identified as a student at Kasturba Medical College (KMC).</p><p>The incident occurred at an apartment complex located in Attavar. It is reported that the medico had gone there to meet a friend. After signing the visitor register at the security desk, he directly proceeded to the 12th floor of the building. Before jumping, he placed his mobile phone on the ground.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/karnataka/kasturba-medical-college-student-allegedly-commits-suicide-167730" target="_blank">Kasturba medical college student allegedly commits suicide</a></b></p>]]> </content:encoded>
</item>

<item>
<title>RML Hospital super speciality block NOC denied over discrepancies</title>
<link>https://edusehat.com/en/rml-hospital-super-speciality-block-noc-denied-over-discrepancies</link>
<guid>https://edusehat.com/en/rml-hospital-super-speciality-block-noc-denied-over-discrepancies</guid>
<description><![CDATA[ New Delhi: The Delhi Urban Arts Commission (DUAC) has refused to issue a completion no objection certificate (NOC) for the new super speciality block at Ram Manohar Lohia (RML) hospital, over concerns regarding lack of parking facilities and “discrepancies” in the project. The commission denied issuing a completion NOC, saying that while a multi-level car parking (MLCP) design scheme had been formally approved by the commission in view of existing and future parking requirements within the hospital campus for doctors, visitors, and other users, it has neither been reflected nor included in the current submission.“Overall, the current submission, received at the completion stage, lacks clarity and has discrepancies. The architect is advised to adhere to all the above and furnish a point-by-point incorporation and response,” the DUAC said, news agency PTI reported.Also Read:Fire safety violations at RML Hospital trauma building, NOC rejectedAccording to the proposal, the building plans for the project were initially approved in September 2015. The new super speciality block at RML hospital has three basements, ground plus 11 floors.   A revised proposal for the super speciality block, along with the proposal for MLCP, was later approved on July 16, 2021, with specific observations.The DUAC further said during the deliberations, the architect informed that “the MLCP has not yet been constructed and is proposed to be taken up at a later stage; however, this assertion has not been substantiated with appropriate documentation.” The commission, therefore, advised the architect to furnish relevant correspondence, reports PTI.  Medical Dialogues had earlier reported that the Delhi High Court has directed the medical superintendent of Ram Manohar Lohia (RML) Hospital to submit an affidavit in response to a petition highlighting the issue of non-availability of proper medical facilities at the institute.  Also Read:HC seeks RML Hospital&#039;s response on plea alleging lack of medical facilities ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/12/12/193561-ram-manohar.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>RML, Hospital, super, speciality, block, NOC, denied, over, discrepancies</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/12/12/193561-ram-manohar.webp"><div class="pasted-from-word-wrapper"><p><span>New Delhi: The Delhi Urban Arts Commission (DUAC) has refused to issue a completion no objection certificate (NOC) for the new super speciality block at Ram Manohar Lohia (RML) hospital, over concerns regarding lack of parking facilities and “discrepancies” in the project. </span></p><p>The commission denied issuing a completion NOC, saying that while a multi-level car parking (MLCP) design scheme had been formally approved by the commission in view of existing and future parking requirements within the hospital campus for doctors, visitors, and other users, it has neither been reflected nor included in the current submission.</p><p>“Overall, the current submission, received at the completion stage, lacks clarity and has discrepancies. The architect is advised to adhere to all the above and furnish a point-by-point incorporation and response,” the DUAC said, news agency PTI reported.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/fire-safety-violations-at-rml-hospital-trauma-building-noc-rejected-160272"><b>Also Read:Fire safety violations at RML Hospital trauma building, NOC rejected</b></a></p><p>According to the proposal, the building plans for the project were initially approved in September 2015. The new super speciality block at <a href="https://medicaldialogues.in/topics/RML-hospital" target="_blank">RML hospital</a> has three basements, ground plus 11 floors.   </p><p>A revised proposal for the super speciality block, along with the proposal for MLCP, was later approved on July 16, 2021, with specific observations.</p><p>The DUAC further said during the deliberations, the architect informed that “the MLCP has not yet been constructed and is proposed to be taken up at a later stage; however, this assertion has not been substantiated with appropriate documentation.” The commission, therefore, advised the architect to furnish relevant correspondence, reports PTI.  </p><p>Medical Dialogues had earlier reported that the Delhi High Court has directed the medical superintendent of Ram Manohar Lohia (RML) Hospital to submit an affidavit in response to a petition highlighting the issue of non-availability of proper medical facilities at the institute. </p><p> <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/hc-seeks-rml-hospitals-response-on-plea-alleging-lack-of-medical-facilities-157970"><b>Also Read:HC seeks RML Hospital's response on plea alleging lack of medical facilities</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>HC seeks action report on HIV&#45;infected blood transfusion at Chaibasa Hospital</title>
<link>https://edusehat.com/en/hc-seeks-action-report-on-hiv-infected-blood-transfusion-at-chaibasa-hospital</link>
<guid>https://edusehat.com/en/hc-seeks-action-report-on-hiv-infected-blood-transfusion-at-chaibasa-hospital</guid>
<description><![CDATA[ Ranchi: The Jharkhand High Court has directed the state government to submit a supplementary affidavit detailing the progress of the investigation and the actions taken so far in connection with the alleged transfusion of HIV-infected blood to five minor thalassemia children at Chaibasa Sadar Hospital.The High Court has taken strong exception to the alleged transfusion of HIV-infected blood to minor children at the blood bank of Chaibasa Sadar Hospital, terming the matter &#039;&#039;extremely serious&#039;&#039;. The court sought a comprehensive status report from the state government on the matter.According to an IANS report, hearing the case on Wednesday, a bench led by Justice Rongan Mukhopadhyay expressed dissatisfaction with the state’s response, observing that merely registering an FIR is not enough in a case of such grave consequences.The court stressed that accountability must be fixed and those responsible for the lapse must be brought to justice.Also Read:Five Children Test HIV-Positive After Blood Transfusion, Jharkhand HC Orders FIRThe petition, filed by Deepika Hembram and others, had sought the registration of an FIR and the setting up of a Special Investigation Team (SIT) to probe the alleged lapse.The court was informed that FIR No. 18/2026 had already been lodged on February 6 this year. However, the state government failed to provide clarity on the progress of the investigation, drawing sharp criticism from the court.Making stern observations, the court stated that the transfusion of HIV-infected blood to young children has had a devastating impact on their lives and future and must not be treated lightly.The court also noted that the affidavit submitted by the state government was limited to confirming the FIR, with no substantive details on the progress of the investigation or steps taken so far.Taking serious cognisance of the lapse, the High Court directed the state government to file a supplementary affidavit detailing the entire course of the investigation and actions taken to date, reports IANS.The case came to light in 2025 after five minor thalassemia patients at Chaibasa Sadar Hospital were allegedly administered HIV-contaminated blood during transfusions. The victims’ families subsequently moved to the High Court seeking justice.The matter is scheduled for further hearing on April 21.Also Read:Jharkhand HC orders FIR after five children test HIV-positive following blood transfusions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/01/306451-hiv.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>seeks, action, report, HIV-infected, blood, transfusion, Chaibasa, Hospital</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/01/306451-hiv.webp"><div class="pasted-from-word-wrapper"><p><span>Ranchi: The </span><a href="https://medicaldialogues.in/topics/jharkhand-high-court" target="_blank">Jharkhand High Court </a>has directed the state government to submit a supplementary affidavit detailing the progress of the investigation and the actions taken so far in connection with the alleged transfusion of HIV-infected blood to five minor thalassemia children at Chaibasa Sadar Hospital.</p><p><span>The High Court has taken strong exception to the alleged transfusion of HIV-infected blood to minor children at the blood bank of Chaibasa Sadar Hospital, terming the matter ''extremely serious''. </span></p><p>The court sought a comprehensive status report from the state government on the matter.</p><p>According to an IANS report, hearing the case on Wednesday, a bench led by Justice Rongan Mukhopadhyay expressed dissatisfaction with the state’s response, observing that merely registering an FIR is not enough in a case of such grave consequences.</p><p>The court stressed that accountability must be fixed and those responsible for the lapse must be brought to justice.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/five-children-test-hiv-positive-after-blood-transfusion-jharkhand-hc-orders-fir-164280"><b>Also Read:Five Children Test HIV-Positive After Blood Transfusion, Jharkhand HC Orders FIR</b></a></p><p>The petition, filed by Deepika Hembram and others, had sought the registration of an FIR and the setting up of a Special Investigation Team (SIT) to probe the alleged lapse.</p><p>The court was informed that FIR No. 18/2026 had already been lodged on February 6 this year. However, the state government failed to provide clarity on the progress of the investigation, drawing sharp criticism from the court.</p><p>Making stern observations, the court stated that the transfusion of <a href="https://medicaldialogues.in/topics/hiv-infection" target="_blank">HIV</a>-infected blood to young children has had a devastating impact on their lives and future and must not be treated lightly.</p><p>The court also noted that the affidavit submitted by the state government was limited to confirming the FIR, with no substantive details on the progress of the investigation or steps taken so far.</p><p>Taking serious cognisance of the lapse, the High Court directed the state government to file a supplementary affidavit detailing the entire course of the investigation and actions taken to date, reports IANS.</p><p>The case came to light in 2025 after five minor <a href="https://medicaldialogues.in/topics/thalassemia" target="_blank">thalassemia </a>patients at Chaibasa Sadar Hospital were allegedly administered HIV-contaminated blood during transfusions. The victims’ families subsequently moved to the High Court seeking justice.</p><p>The matter is scheduled for further hearing on April 21.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jharkhand-hc-orders-fir-after-five-children-test-hiv-positive-following-blood-transfusions-164163"><b>Also Read:Jharkhand HC orders FIR after five children test HIV-positive following blood transfusions</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Bengaluru Dermatologist Murder Case: Husband denied bail, chats suggest cover&#45;up</title>
<link>https://edusehat.com/en/bengaluru-dermatologist-murder-case-husband-denied-bail-chats-suggest-cover-up</link>
<guid>https://edusehat.com/en/bengaluru-dermatologist-murder-case-husband-denied-bail-chats-suggest-cover-up</guid>
<description><![CDATA[ Bengaluru: Following the alleged calculated murder of a Bengaluru-based dermatologist by her husband, a sessions court has denied bail to the general surgeon, citing the seriousness of the charges and the weight of digital and forensic evidence against him.The case revolves around the death of a dermatologist, initially presumed to be natural. However, subsequent forensic findings and a deeper investigation transformed it into a suspected case of foul play. The authorities alleged that her husband orchestrated a calculated killing and attempted to conceal the crime.Also Read:Victoria Hospital Surgeon arrested for killing dermatologist wife with anaesthesia overdoseAccording to the news reports, a key breakthrough in the case came from a series of chat messages recovered by investigators. The messages, reportedly sent by the accused to his girlfriend, reveal attempts to manipulate the narrative and obstruct the investigation.Investigators claim the accused sent instructions to his girlfriend, urging her to distance herself and deny the nature of their relationship if questioned. In one message, he allegedly advised her to describe them as “just friends” and avoid contacting him altogether.
More striking are messages in which the accused appeared to admit guilt. According to investigators, he wrote that he had killed his wife and would eventually face imprisonment, adding that “a killer can never be happy.” 
Medical Dialogues had previously reported that  the general surgeon from Victoria Hospital, who was arrested for allegedly murdering his dermatologist wife by administering propofol, has once again come under media spotlight for reportedly sending cryptic messages like &quot;I killed my wife for you&quot; to four to five women. Among them was a medical professional who had rejected his marriage proposal, made just weeks after his wife’s death.
Police say the digital trail—including chat records and financial application data—has helped reconstruct the sequence of events leading up to the doctor’s death.Speaking to News 18, officials said more than 10.34 lakh digital files have been analysed so far, including 485 chat records from the PhonePe application, along with several deleted messages that were successfully recovered during forensic examination. Investigators believe the recovered digital trail has strengthened the case significantly and helped establish the accused’s movements, communications, and financial activity linked to the incident.
How the Crime Was Allegedly Carried Out
Authorities allege that the murder was carried out using Propofol, a powerful anaesthetic drug typically administered in operating theatres under strict supervision. Both the accused and the victim were employed at Victoria Hospital, which, police say, may have enabled access to the drug.
The incident occurred on April 23, 2025, when the victim collapsed at her father’s residence in Marathahalli, a locality in Bengaluru. Police allege that the accused had visited her in the preceding days and administered injections under the guise of medical treatment. She was later declared dead at a nearby hospital.
It was only after her family raised concerns that the case was re-examined. A forensic report subsequently confirmed the presence of Propofol in her system.Also Read:Bengaluru dermatologist murder case: Surgeon says I killed my wife for you in messagesWith bail denied and the prosecution backed by a combination of forensic and digital evidence, the case is expected to move forward. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/03/330682-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bengaluru, Dermatologist, Murder, Case:, Husband, denied, bail, chats, suggest, cover-up</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/03/330682-court.webp"><p><b>Bengaluru:</b> Following the alleged calculated murder of a Bengaluru-based dermatologist by her husband, a sessions court has denied <a href="https://medicaldialogues.in/topics/bail-plea">bail</a> to the general surgeon, citing the seriousness of the charges and the weight of digital and forensic evidence against him.</p><p>The case revolves around the death of a dermatologist, initially presumed to be natural. However, subsequent forensic findings and a deeper investigation transformed it into a suspected case of foul play. The authorities alleged that her husband orchestrated a calculated killing and attempted to conceal the crime.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/victoria-hospital-surgeon-arrested-for-killing-dermatologist-wife-with-anaesthesia-overdose-157007"><b>Also Read:Victoria Hospital Surgeon arrested for killing dermatologist wife with anaesthesia overdose</b></a></p><div class="pasted-from-word-wrapper"><div><span>According to the news reports, a key breakthrough in the case came from a series of chat messages recovered by investigators. The messages, reportedly sent by the accused to his girlfriend, reveal attempts to manipulate the narrative and obstruct the investigation.</span></div></div><p>Investigators claim the accused sent instructions to his girlfriend, urging her to distance herself and deny the nature of their relationship if questioned. In one message, he allegedly advised her to describe them as “just friends” and avoid contacting him altogether.
</p><p>More striking are messages in which the accused appeared to admit guilt. According to investigators, he wrote that he had killed his wife and would eventually face imprisonment, adding that “a killer can never be happy.” 
</p><p>Medical Dialogues had previously reported that  the general surgeon from Victoria Hospital, who was arrested for allegedly murdering his dermatologist wife by administering propofol, has once again come under media spotlight for reportedly sending cryptic messages like "I killed my wife for you" to four to five women. Among them was a medical professional who had rejected his marriage proposal, made just weeks after his wife’s death.
</p><p>Police say the digital trail—including chat records and financial application data—has helped reconstruct the sequence of events leading up to the doctor’s death.</p><p>Speaking to <a href="https://www.news18.com/india/i-will-go-to-jail-i-killed-kruthika-husbands-chilling-chats-surface-in-bengaluru-doctor-murder-case-ws-l-10022955.html" rel="nofollow">News 18</a>, officials said more than 10.34 lakh digital files have been analysed so far, including 485 chat records from the PhonePe application, along with several deleted messages that were successfully recovered during forensic examination. Investigators believe the recovered digital trail has strengthened the case significantly and helped establish the accused’s movements, communications, and financial activity linked to the incident.
</p><p><b>How the Crime Was Allegedly Carried Out
</b></p><p>Authorities allege that the murder was carried out using Propofol, a powerful anaesthetic drug typically administered in operating theatres under strict supervision. Both the accused and the victim were employed at Victoria Hospital, which, police say, may have enabled access to the drug.
</p><p>The incident occurred on April 23, 2025, when the victim collapsed at her father’s residence in Marathahalli, a locality in Bengaluru. Police allege that the accused had visited her in the preceding days and administered injections under the guise of medical treatment. She was later declared dead at a nearby hospital.
</p><p>It was only after her family raised concerns that the case was re-examined. A forensic report subsequently confirmed the presence of Propofol in her system.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/bengaluru-dermatologist-murder-case-surgeon-says-i-killed-my-wife-for-you-in-messages-158114"><b>Also Read:Bengaluru dermatologist murder case: Surgeon says I killed my wife for you in messages</b></a></p><p>With bail denied and the prosecution backed by a combination of forensic and digital evidence, the case is expected to move forward.</p>]]> </content:encoded>
</item>

<item>
<title>UP Govt steps in to expedite pending construction at AYUSH University</title>
<link>https://edusehat.com/en/up-govt-steps-in-to-expedite-pending-construction-at-ayush-university</link>
<guid>https://edusehat.com/en/up-govt-steps-in-to-expedite-pending-construction-at-ayush-university</guid>
<description><![CDATA[ Gorakhpur: The ongoing Construction at AYUSH University has faced significant delays and lapses, prompting the Uttar Pradesh government to place the project under special supervision.    Following complaints from stakeholders, senior officials have carried out inspections, and major actions are being planned against those responsible to ensure the timely completion of all pending work.   Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH UniversityThe construction of the university auditorium is running far behind schedule, reports Dainik Bhaskar. Several other works, including the kitchen and associated facilities, also remain incomplete. Despite previous inspections by the Commissioner and District Magistrate, the construction company has continued to display negligence, preventing the auditorium from progressing at the expected pace.    Recently, Chief Revenue Officer (CRO) Himanshu Verma, along with Public Works Department (PWD) officials, inspected the ongoing work. Expressing dissatisfaction over the slow pace, he directed that all pending work be completed within the stipulated timeline. Vice-Chancellor Dr K. Ramachandra Reddy and XEN Manish Singh from the PWD also reviewed the progress of the administrative building construction. During the inspection, officials questioned the Project Manager regarding the slow pace in the auditorium and the reduced workforce. They also instructed that pits dug in the garden near the cottages be filled immediately to ensure the safety and site hygiene.    Last week, Commissioner Anil Kumar Dhingra and District Magistrate Deepak Meena had also visited the site and expressed concern over the delays. They had directed that all pending works be completed within the prescribed timeframe. Despite these instructions, limited progress has been observed, leading officials to reprimand the responsible parties.      Project Manager Muneshwar assured that manpower would be increased and all necessary measures taken to complete the remaining work on time, reports The Daily.  Also Read:Haryana To Get First Shri Krishna Ayush University at cost of Rs 500 crore     ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/04/04/173466-ayush-university.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 15:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Govt, steps, expedite, pending, construction, AYUSH, University</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/04/04/173466-ayush-university.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p>Gorakhpur: The ongoing Construction at <a href="https://medicaldialogues.in/topics/ayush%20university" target="_blank">AYUSH University</a> has faced significant delays and lapses, prompting the Uttar Pradesh government to place the project under special supervision.    </p><p>Following complaints from stakeholders, senior officials have carried out inspections, and major actions are being planned against those responsible to ensure the timely completion of all pending work.   </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/medicine-distribution-delay-triggers-uproar-at-gorakhpur-ayush-university-168195">Also Read:Medicine distribution delay triggers uproar at Gorakhpur AYUSH University</a><br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>The construction of the university auditorium is running far behind schedule, reports<a href="https://www.bhaskar.com/local/uttar-pradesh/gorakhpur/bhathat/news/ayush-university-construction-slow-action-ready-137635704.html" target="_blank"> </a><i><a href="https://www.bhaskar.com/local/uttar-pradesh/gorakhpur/bhathat/news/ayush-university-construction-slow-action-ready-137635704.html" target="_blank">Dainik Bhaskar</a></i>. Several other works, including the kitchen and associated facilities, also remain incomplete. Despite previous inspections by the Commissioner and District Magistrate, the construction company has continued to display negligence, preventing the auditorium from progressing at the expected pace.    </p><p>Recently, Chief Revenue Officer (CRO) Himanshu Verma, along with Public Works Department (PWD) officials, inspected the ongoing work. Expressing dissatisfaction over the slow pace, he directed that all pending work be completed within the stipulated timeline. Vice-Chancellor Dr K. Ramachandra Reddy and XEN Manish Singh from the PWD also reviewed the progress of the administrative building construction. </p><p>During the inspection, officials questioned the Project Manager regarding the slow pace in the auditorium and the reduced workforce. They also instructed that pits dug in the garden near the cottages be filled immediately to ensure the safety and site hygiene.    </p><p>Last week, Commissioner Anil Kumar Dhingra and District Magistrate Deepak Meena had also visited the site and expressed concern over the delays. They had directed that all pending works be completed within the prescribed timeframe. Despite these instructions, limited progress has been observed, leading officials to reprimand the responsible parties.      </p><p>Project Manager Muneshwar assured that manpower would be increased and all necessary measures taken to complete the remaining work on time, reports The Daily.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/haryana-to-get-first-shri-krishna-ayush-university-at-cost-of-rs-500-crore-90928">Also Read:Haryana To Get First Shri Krishna Ayush University at cost of Rs 500 crore</a>    </p></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>GLP&#45;1 Receptor Agonists Linked to Higher Depression Risk Than SGLT2 Inhibitors in T2D: Study</title>
<link>https://edusehat.com/en/glp-1-receptor-agonists-linked-to-higher-depression-risk-than-sglt2-inhibitors-in-t2d-study</link>
<guid>https://edusehat.com/en/glp-1-receptor-agonists-linked-to-higher-depression-risk-than-sglt2-inhibitors-in-t2d-study</guid>
<description><![CDATA[ USA: Adults with type 2 diabetes who begin treatment with certain glucose-lowering medications may face differing risks for developing depression, a large real-world study published in Diabetes, Obesity and Metabolism has revealed.The research, led by Stephanie A. Hooker of HealthPartners Institute in Minneapolis, Minnesota, evaluated the comparative safety of four commonly prescribed drug classes and found that sustained use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modestly higher risk of new-onset depression over 2.5 years compared with some alternatives.To investigate the relationship, researchers conducted a retrospective cohort study using electronic health record data from six integrated health systems between January 2014 and December 2022. The team emulated six comparative “target trials,” each examining a pairwise comparison between medication classes: GLP-1 RAs, sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors), dipeptidyl peptidase-4 inhibitors (DPP4 inhibitors), and sulfonylureas (SU).Cohort sizes ranged from 54,773 to 227,414 adults aged 18 years and older. Eligible participants were new users of one of the medications and had no evidence of depression or prior use of the comparator drug in the two years before starting therapy. Medication exposure was determined through pharmacy dispensing and claims records, with treatment periods defined as twice the days supplied. The primary outcome was time to a new diagnosis of depression within 2.5 years of drug initiation, identified using diagnostic codes from inpatient, outpatient, or emergency department visits.   The analysis revealed the following findings:Continuous GLP-1 receptor agonist (RA) use was associated with a higher cumulative risk of incident depression compared with sustained SGLT2 inhibitor use (risk difference [RD] 1.0%).GLP-1 RA use was also linked to a higher risk of depression compared with sulfonylurea use (RD 1.8%).No significant difference in depression risk was observed between GLP-1 RAs and DPP4 inhibitors.SGLT2 inhibitor use was associated with a lower risk of depression compared with DPP4 inhibitor use (RD −0.7%).No meaningful difference in depression risk was found between SGLT2 inhibitors and sulfonylureas.GLP-1 RAs and DPP4 inhibitors showed the highest relative risks for new-onset depression overall.Sulfonylureas demonstrated an intermediate risk profile.SGLT2 inhibitors were associated with the lowest risk of incident depression.After adjusting for time-varying demographic and clinical factors, only the difference between GLP-1 RAs and SGLT2 inhibitors remained statistically significant.The findings suggest that while the absolute differences in risk were small, they may still be clinically relevant in long-term diabetes management. The authors note that decisions regarding glucose-lowering therapy should incorporate these mental health considerations alongside established benefits such as glycemic control, cardiovascular protection, and weight effects. For patients with type 2 diabetes, particularly those with a history of mood vulnerability, individualized treatment discussions may be warranted.Reference:Hooker SA, Neugebauer RS, Schmittdiel JA, An J, Cassidy-Bushrow AE, Dombrowski SK, Oshiro CES, Bergenstal R, Gilliam LK, Nolan MB, Thomas T, Rossom RC, Kaur J, Finertie H, Yassin M, Lin S, Izadian K, O&#039;Connor PJ. Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes. Diabetes Obes Metab. 2026 Mar;28(3):2215-2226. doi: 10.1111/dom.70415. Epub 2026 Jan 2. PMID: 41479367. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/05/240174-intensive-glycemic-control.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 12:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GLP-1, Receptor, Agonists, Linked, Higher, Depression, Risk, Than, SGLT2, Inhibitors, T2D:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/05/240174-intensive-glycemic-control.webp"><p><span>USA: Adults with <a href="https://medicaldialogues.in/topics/type-2-diabetes">type 2 diabetes </a>who begin treatment with certain <a href="https://speciality.medicaldialogues.in/topics/diabetes-drugs">glucose-lowering medications</a> may face differing risks for developing <a href="https://medicaldialogues.in/topics/depression">depression</a>, a large real-world study published in <i>Diabetes, Obesity and Metabolism</i> has revealed.</span></p><div class="pasted-from-word-wrapper"><div>The research, led by Stephanie A. Hooker of HealthPartners Institute in Minneapolis, Minnesota, evaluated the comparative safety of four commonly prescribed drug classes and found that sustained use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modestly higher risk of new-onset depression over 2.5 years compared with some alternatives.</div><div>To investigate the relationship, researchers conducted a retrospective cohort study using electronic health record data from six integrated health systems between January 2014 and December 2022. The team emulated six comparative “target trials,” each examining a pairwise comparison between medication classes: GLP-1 RAs, sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors), dipeptidyl peptidase-4 inhibitors (DPP4 inhibitors), and sulfonylureas (SU).</div><div>Cohort sizes ranged from 54,773 to 227,414 adults aged 18 years and older. Eligible participants were new users of one of the medications and had no evidence of depression or prior use of the comparator drug in the two years before starting therapy. Medication exposure was determined through pharmacy dispensing and claims records, with treatment periods defined as twice the days supplied. </div><div>The primary outcome was time to a new diagnosis of depression within 2.5 years of drug initiation, identified using diagnostic codes from inpatient, outpatient, or emergency department visits.   </div><div>The analysis revealed the following findings:</div><ul><li>Continuous GLP-1 receptor agonist (RA) use was associated with a higher cumulative risk of incident depression compared with sustained SGLT2 inhibitor use (risk difference [RD] 1.0%).</li><li>GLP-1 RA use was also linked to a higher risk of depression compared with sulfonylurea use (RD 1.8%).</li><li>No significant difference in depression risk was observed between GLP-1 RAs and DPP4 inhibitors.</li><li>SGLT2 inhibitor use was associated with a lower risk of depression compared with DPP4 inhibitor use (RD −0.7%).</li><li>No meaningful difference in depression risk was found between SGLT2 inhibitors and sulfonylureas.</li><li>GLP-1 RAs and DPP4 inhibitors showed the highest relative risks for new-onset depression overall.</li><li>Sulfonylureas demonstrated an intermediate risk profile.</li><li>SGLT2 inhibitors were associated with the lowest risk of incident depression.</li><li>After adjusting for time-varying demographic and clinical factors, only the difference between GLP-1 RAs and SGLT2 inhibitors remained statistically significant.</li></ul><div>The findings suggest that while the absolute differences in risk were small, they may still be clinically relevant in long-term diabetes management. The authors note that decisions regarding glucose-lowering therapy should incorporate these mental health considerations alongside established benefits such as glycemic control, cardiovascular protection, and weight effects. For patients with type 2 diabetes, particularly those with a history of mood vulnerability, individualized treatment discussions may be warranted.</div><div>Reference:</div><div>Hooker SA, Neugebauer RS, Schmittdiel JA, An J, Cassidy-Bushrow AE, Dombrowski SK, Oshiro CES, Bergenstal R, Gilliam LK, Nolan MB, Thomas T, Rossom RC, Kaur J, Finertie H, Yassin M, Lin S, Izadian K, O'Connor PJ. Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes. Diabetes Obes Metab. 2026 Mar;28(3):2215-2226. doi: 10.1111/dom.70415. Epub 2026 Jan 2. PMID: 41479367.</div></div>]]> </content:encoded>
</item>

<item>
<title>AP private hospitals call off strike after govt promises Rs 1,000 crore</title>
<link>https://edusehat.com/en/ap-private-hospitals-call-off-strike-after-govt-promises-rs-1000-crore</link>
<guid>https://edusehat.com/en/ap-private-hospitals-call-off-strike-after-govt-promises-rs-1000-crore</guid>
<description><![CDATA[ Vijayawada: Healthcare services under the Dr. NTR Vaidya Seva scheme in Andhra Pradesh are set to resume after a six-day suspension, following a strike by private network hospitals demanding the release of pending dues. The strike, which began earlier this week, had disrupted services at over 500 hospitals across the state.
Medical Dialogues had previously reported that, following pending dues of Rs 3,000 crore, private hospitals under the Andhra Pradesh Speciality Hospital Association (ASHA) have announced that they will suspend free healthcare services for poor patients under the Dr NTR Vaidya Seva Trust scheme starting Wednesday. The payments, meant for cashless treatment services under the scheme, have not been released by the state government despite previous assurances.Also Read:Private hospitals in Andhra Pradesh suspend free services over Rs 3,000 crore unpaid duesAndhra Pradesh Speciality Hospitals Association (ASHA) vice president S.V.L. Narayana Rao said that, unlike previous discussions, the government explicitly mentioned in the official Minutes of Meeting that ₹ 1,000 crore would be paid to private hospitals within 10 days. ASHA members had participated in a virtual meeting with health officials on Monday, April 6.Usually, fund releases under the scheme are shared between private and government hospitals. However, the ₹1,000 crore this time will be used solely to clear dues of around 600 private hospitals. Even after this payment, another ₹1,000 crore in dues will remain. According to ASHA, of the total ₹3,000 crore in pending dues, Rs 2,000 crore is owed to private hospitals, while the remaining ₹1,000 crore pertains to government hospitals. In addition to the initial payment, the government has also agreed to provide ₹150–170 crore monthly to cover ongoing operational expenses. 
The monthly expenses incurred by all 800 network hospitals in the State under the scheme touch ₹350 crore, 60% of which comes from private hospitals. “Despite the monthly payment of ₹150-₹170 crore, ₹40-₹50 crore will keep getting added to the outstanding dues,” Dr. Narayana Rao said, stating that it is, however, a good deal, reports the Hindu.
With the assurance in place, private hospitals are expected to resume all services from April 8. Also Read:AP Govt releases Rs 250 crore pending dues to private hospitals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340115-hospital.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 12:20:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>private, hospitals, call, off, strike, after, govt, promises, 1, 000, crore</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340115-hospital.webp"><p><b>Vijayawada:</b> Healthcare services under the <a href="https://medicaldialogues.in/topics/dr-ntr-vaidya-seva-scheme">Dr. NTR Vaidya Seva </a>scheme in <a href="https://medicaldialogues.in/state-news/andhra-pradesh">Andhra Pradesh</a> are set to resume after a six-day suspension, following a strike by private network hospitals demanding the release of pending dues. The strike, which began earlier this week, had disrupted services at over 500 hospitals across the state.
</p><p>Medical Dialogues had previously reported that, following pending dues of Rs 3,000 crore, private hospitals under the Andhra Pradesh Speciality Hospital Association (ASHA) have announced that they will suspend free healthcare services for poor patients under the Dr NTR Vaidya Seva Trust scheme starting Wednesday. The payments, meant for cashless treatment services under the scheme, have not been released by the state government despite previous assurances.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/private-hospitals-in-andhra-pradesh-suspend-free-services-over-rs-3000-crore-unpaid-dues-167758"><b>Also Read:Private hospitals in Andhra Pradesh suspend free services over Rs 3,000 crore unpaid dues</b></a></p><p>Andhra Pradesh Speciality Hospitals Association (ASHA) vice president S.V.L. Narayana Rao said that, unlike previous discussions, the government explicitly mentioned in the official Minutes of Meeting that ₹ 1,000 crore would be paid to private hospitals within 10 days. ASHA members had participated in a virtual meeting with health officials on Monday, April 6.</p><p>Usually, fund releases under the scheme are shared between private and government hospitals. However, the ₹1,000 crore this time will be used solely to clear dues of around 600 private hospitals. Even after this payment, another ₹1,000 crore in dues will remain. According to ASHA, of the total ₹3,000 crore in pending dues, Rs 2,000 crore is owed to private hospitals, while the remaining ₹1,000 crore pertains to government hospitals. </p><p>In addition to the initial payment, the government has also agreed to provide ₹150–170 crore monthly to cover ongoing operational expenses. 
</p><p>The monthly expenses incurred by all 800 network hospitals in the State under the scheme touch ₹350 crore, 60% of which comes from private hospitals. “Despite the monthly payment of ₹150-₹170 crore, ₹40-₹50 crore will keep getting added to the outstanding dues,” Dr. Narayana Rao said, stating that it is, however, a good deal, reports the <a href="https://www.thehindu.com/news/national/andhra-pradesh/private-network-hospitals-in-ap-call-off-strike-after-government-promises-partial-payments/article70834143.ece" rel="nofollow">Hindu</a>.
</p><p>With the assurance in place, private hospitals are expected to resume all services from April 8. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/ap-govt-releases-rs-250-crore-pending-dues-to-private-hospitals-157353"><b>Also Read:AP Govt releases Rs 250 crore pending dues to private hospitals</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Study finds substantial delay in initiation of quadruple guideline&#45;directed medical therapy in patients with HFrEF: JAMA</title>
<link>https://edusehat.com/en/study-finds-substantial-delay-in-initiation-of-quadruple-guideline-directed-medical-therapy-in-patients-with-hfref-jama</link>
<guid>https://edusehat.com/en/study-finds-substantial-delay-in-initiation-of-quadruple-guideline-directed-medical-therapy-in-patients-with-hfref-jama</guid>
<description><![CDATA[ A new study published in the Journal of the American Medical Association found fewer than 25% (21.2%) of patients—particularly veterans—with heart failure with reduced ejection fraction (HFrEF) to achieve quadruple guideline-directed medical therapy over 2.9 years, with a median time to treatment optimization (TTQ) of 6 months. These results highlight substantial deficiencies in both the adoption and timely initiation of therapy, with medication copays emerging as an important modifiable barrier to better access and improved clinical outcomes.This research analyzed data from over 52,000 U.S. veterans diagnosed with HFrEF between 2020 and 2023. The focus was on “quadruple guideline-directed medical therapy” (GDMT), which is a combination of 4 key drug classes including β-blockers, renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 (SGLT2) inhibitors. These medications, when used together, are considered the gold standard for managing the condition.Only 21.2% of patients achieved this comprehensive therapy during a median follow-up of nearly 3 years. Even among those who did, the median time to quadruple therapy (TTQ) was 197 days (over six months) which highlighted the delays in optimizing care.This study identified Black and Hispanic patients to reach quadruple therapy most likely than White patients, with rates approximately 20% higher after statistical adjustment. The reasons for this disparity remain unclear but may reflect differences in care pathways or targeted clinical efforts within the Veterans Health Administration. However, gender did not significantly impact treatment timelines, with similar rates observed between male and female patients.The patients required to pay copays were 8% less likely to achieve quadruple therapy when compared to those with no out-of-pocket medication costs. This suggests that even relatively modest financial barriers can delay or prevent access to life-saving treatments.The patients diagnosed in outpatient settings were more likely to receive full therapy than those diagnosed during hospitalization. Also, individuals with diabetes had higher treatment rates, while those with chronic kidney disease were less likely to reach quadruple therapy, which could possibly be due to the concerns about drug safety or tolerability. Overall, the study illuminates a significant opportunity to improve care delivery for HFrEF patients. Reference:Jacobs, J. A., Greene, T., Vanneman, M. E., Kean, J., Carter, S. J., Shah, K. S., Pandey, A., Derington, C. G., Zheutlin, A. R., Fang, J., Stehlik, J., Fonarow, G. C., &amp; Bress, A. P. (2026). Time to quadruple therapy after initial diagnosis of heart failure with reduced ejection fraction. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2026.0375 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/21/279502-heart-failure-4.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 12:20:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, finds, substantial, delay, initiation, quadruple, guideline-directed, medical, therapy, patients, with, HFrEF:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/21/279502-heart-failure-4.webp"><p>A new study published in the <i>Journal of the American Medical Association</i> found fewer than 25% (21.2%) of patients—particularly veterans—with heart failure with reduced ejection fraction (HFrEF) to achieve quadruple guideline-directed medical therapy over 2.9 years, with a median time to treatment optimization (TTQ) of 6 months. These results highlight substantial deficiencies in both the adoption and timely initiation of therapy, with medication copays emerging as an important modifiable barrier to better access and improved clinical outcomes.</p><p>This research analyzed data from over 52,000 U.S. veterans diagnosed with HFrEF between 2020 and 2023. The focus was on “quadruple guideline-directed medical therapy” (GDMT), which is a combination of 4 key drug classes including β-blockers, renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 (SGLT2) inhibitors. These medications, when used together, are considered the gold standard for managing the condition.</p><p>Only 21.2% of patients achieved this comprehensive therapy during a median follow-up of nearly 3 years. Even among those who did, the median time to quadruple therapy (TTQ) was 197 days (over six months) which highlighted the delays in optimizing care.</p><p>This study identified Black and Hispanic patients to reach quadruple therapy most likely than White patients, with rates approximately 20% higher after statistical adjustment. The reasons for this disparity remain unclear but may reflect differences in care pathways or targeted clinical efforts within the Veterans Health Administration. However, gender did not significantly impact treatment timelines, with similar rates observed between male and female patients.</p><p>The patients required to pay copays were 8% less likely to achieve quadruple therapy when compared to those with no out-of-pocket medication costs. This suggests that even relatively modest financial barriers can delay or prevent access to life-saving treatments.</p><p>The patients diagnosed in outpatient settings were more likely to receive full therapy than those diagnosed during hospitalization. Also, individuals with diabetes had higher treatment rates, while those with chronic kidney disease were less likely to reach quadruple therapy, which could possibly be due to the concerns about drug safety or tolerability. Overall, the study illuminates a significant opportunity to improve care delivery for HFrEF patients. </p><p>Reference:</p><p>Jacobs, J. A., Greene, T., Vanneman, M. E., Kean, J., Carter, S. J., Shah, K. S., Pandey, A., Derington, C. G., Zheutlin, A. R., Fang, J., Stehlik, J., Fonarow, G. C., & Bress, A. P. (2026). Time to quadruple therapy after initial diagnosis of heart failure with reduced ejection fraction. JAMA Cardiology. <a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2846899?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=040226" rel="nofollow">https://doi.org/10.1001/jamacardio.2026.0375</a></p>]]> </content:encoded>
</item>

<item>
<title>GLP&#45;1 Receptor Agonists linked to modest reduction of risk of Femur Fracture: Study</title>
<link>https://edusehat.com/en/glp-1-receptor-agonists-linked-to-modest-reduction-of-risk-of-femur-fracture-study</link>
<guid>https://edusehat.com/en/glp-1-receptor-agonists-linked-to-modest-reduction-of-risk-of-femur-fracture-study</guid>
<description><![CDATA[ A new study published in the journal of Bone that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modest reduction in femur fracture risk. However, because the study was observational and may involve residual confounding and multiple testing, the findings are exploratory and require confirmation in prospective studies before being applied clinically.People with T2DM face a well-known paradox in bone biology. Despite having normal or even elevated bone mineral density, the patients experience a higher risk of fractures, particularly in weight-bearing bones such as the hip and femur. GLP-1 RAs have attracted attention because of potential beneficial effects on bone metabolism.This large retrospective cohort study used data from the TriNetX US Collaborative Network, which included analysis from over 3.6 million adults with T2DM identified between 2018 and 2022. Using a target trial emulation approach this study compared patients initiating GLP-1 receptor agonists with those starting dipeptidyl peptidase-4 inhibitors (DPP-4is).The study initially identified 491,936 patients who began GLP-1 RA therapy and 345,484 who initiated DPP-4 inhibitors. To minimize bias and ensure comparable groups, this research applied propensity score matching, balancing baseline characteristics such as age, sex, and health status. After matching, each treatment cohort included 172,381 patients with a mean age of 59 years; 51% were men.Participants were followed for up to 5 years, with an average follow-up period of approximately 40 months. During this time, the study monitored the occurrence of femur fractures. Statistical analysis using Cox proportional-hazards models revealed that patients taking GLP-1 receptor agonists experienced a significantly lower risk of femoral fractures when compared to those using DPP-4 inhibitors.GLP-1 RA users had a 9% lower risk of femur fractures, with a hazard ratio of 0.91 and a 95% confidence interval ranging from 0.85 to 0.98. The protective association remained consistent across multiple sensitivity analyses designed to test the robustness of the results. Similar trends were also observed when GLP-1 RAs were compared to several other antidiabetic medications.Since the study relied on observational data rather than a randomized clinical trial, unmeasured confounding factors may still influence the outcome. Also, the analysis involved multiple statistical comparisons, increasing the possibility that some associations may occur by chance. Overall, the study suggests that GLP-1 receptor agonists may offer a modest reduction in femur fracture risk among people with type 2 diabetes.Reference:Chang, Y. J., Fuh, C. S., Chang, J. F., Chen, M. T., &amp; Tsai, M. H. (2026). Association between glucagon-like peptide-1 receptor agonists and femur fracture risk in type 2 diabetes: A large-scale target trial emulation. Bone, 207, 117851. https://doi.org/10.1016/j.bone.2026.117851 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/13/297691-fracture-scaled.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 12:20:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GLP-1, Receptor, Agonists, linked, modest, reduction, risk, Femur, Fracture:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/13/297691-fracture-scaled.webp"><p>A new study published in the journal of <i>Bone</i> that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with a modest reduction in femur fracture risk. However, because the study was observational and may involve residual confounding and multiple testing, the findings are exploratory and require confirmation in prospective studies before being applied clinically.</p><p>People with T2DM face a well-known paradox in bone biology. Despite having normal or even elevated bone mineral density, the patients experience a higher risk of fractures, particularly in weight-bearing bones such as the hip and femur. GLP-1 RAs have attracted attention because of potential beneficial effects on bone metabolism.</p><p>This large retrospective cohort study used data from the TriNetX US Collaborative Network, which included analysis from over 3.6 million adults with T2DM identified between 2018 and 2022. Using a target trial emulation approach this study compared patients initiating GLP-1 receptor agonists with those starting dipeptidyl peptidase-4 inhibitors (DPP-4is).</p><p>The study initially identified 491,936 patients who began GLP-1 RA therapy and 345,484 who initiated DPP-4 inhibitors. To minimize bias and ensure comparable groups, this research applied propensity score matching, balancing baseline characteristics such as age, sex, and health status. After matching, each treatment cohort included 172,381 patients with a mean age of 59 years; 51% were men.</p><p>Participants were followed for up to 5 years, with an average follow-up period of approximately 40 months. During this time, the study monitored the occurrence of femur fractures. Statistical analysis using Cox proportional-hazards models revealed that patients taking GLP-1 receptor agonists experienced a significantly lower risk of femoral fractures when compared to those using DPP-4 inhibitors.</p><p>GLP-1 RA users had a 9% lower risk of femur fractures, with a hazard ratio of 0.91 and a 95% confidence interval ranging from 0.85 to 0.98. The protective association remained consistent across multiple sensitivity analyses designed to test the robustness of the results. Similar trends were also observed when GLP-1 RAs were compared to several other antidiabetic medications.</p><p>Since the study relied on observational data rather than a randomized clinical trial, unmeasured confounding factors may still influence the outcome. Also, the analysis involved multiple statistical comparisons, increasing the possibility that some associations may occur by chance. Overall, the study suggests that GLP-1 receptor agonists may offer a modest reduction in femur fracture risk among people with type 2 diabetes.</p><p>Reference:</p><p>Chang, Y. J., Fuh, C. S., Chang, J. F., Chen, M. T., & Tsai, M. H. (2026). Association between glucagon-like peptide-1 receptor agonists and femur fracture risk in type 2 diabetes: A large-scale target trial emulation. Bone, 207, 117851. <a href="https://www.sciencedirect.com/science/article/pii/S8756328226000773?via%3Dihub" rel="nofollow">https://doi.org/10.1016/j.bone.2026.117851</a></p>]]> </content:encoded>
</item>

<item>
<title>More than 25 percent of Older Adults May Discontinue Levothyroxine Under Supervision: JAMA</title>
<link>https://edusehat.com/en/more-than-25-percent-of-older-adults-may-discontinue-levothyroxine-under-supervision-jama</link>
<guid>https://edusehat.com/en/more-than-25-percent-of-older-adults-may-discontinue-levothyroxine-under-supervision-jama</guid>
<description><![CDATA[ Netherlands: An open-label prospective study has found that approximately 26% of older adults were able to successfully discontinue levothyroxine under physician supervision while maintaining stable thyrotropin (TSH) and free thyroxine levels over one year. Discontinuation was more likely among patients who were on lower baseline doses of levothyroxine.The findings highlight the importance of periodically reassessing thyroid hormone therapy in older adults to prevent overtreatment and its associated risks, suggesting that nearly one-quarter of patients may safely wean off medication with appropriate monitoring.A study published in JAMA by Janneke Ravensberg and colleagues from Leiden University Medical Center, the Netherlands, provides important insights into the necessity of long-term levothyroxine therapy in older adults. Levothyroxine is commonly prescribed for hypothyroidism and is often continued indefinitely, but evidence supporting lifelong use in all patients has remained limited.To address this, researchers conducted a prospective, single-group study in community-dwelling adults aged 60 years and older who had been on a stable levothyroxine dose (≤150 µg/day) for at least one year, with baseline TSH levels below 10 mIU/L. The study was carried out across 58 general practices in the Netherlands, with participants enrolled between January 2020 and July 2022 and followed up until December 2023.Participants underwent a structured, stepwise reduction in levothyroxine, with thyroid function assessed at least six weeks after each dose adjustment. The aim was to determine the proportion of individuals who could discontinue therapy while maintaining adequate thyroid function after one year.Of the 370 participants who initiated the discontinuation protocol, 366 completed the study. The median age was 70 years, and most participants were women. The median baseline dose was 50 µg/day. At one year, 95 participants (25.7%) had successfully discontinued levothyroxine while maintaining TSH levels below 10 mIU/L and normal free thyroxine levels.The following were the key findings:Nearly half of the participants who successfully discontinued levothyroxine achieved TSH levels within a tighter, near-normal range.Higher discontinuation success was observed in individuals who were on lower baseline doses of levothyroxine.Among participants taking 50 µg/day or less, nearly two-thirds were able to stop treatment without affecting thyroid function.Discontinuation of levothyroxine did not negatively impact thyroid-related quality of life.Quality of life remained stable over the one-year follow-up period regardless of whether discontinuation was successful.The findings indicate that supervised and gradual withdrawal of levothyroxine may not lead to worsening symptoms in appropriately selected patients.The study highlights the need for clinicians to periodically evaluate the continued necessity of levothyroxine therapy in older adults. The authors suggest that routine reassessment, particularly in those on lower doses, could help avoid unnecessary long-term treatment and reduce the risk of overtreatment-related complications.Overall, the findings indicate that a substantial proportion of older adults may not require lifelong levothyroxine therapy and could safely discontinue treatment under medical supervision.Reference:Ravensberg J, Gussekloo J, Le Cessie S, Dekkers OM, Mooijaart SP, Poortvliet RKE. Discontinuation of Levothyroxine in Adults Aged 60 Years or Older. JAMA. Published online April 06, 2026. doi:10.1001/jama.2026.2864 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340096-levothyroxine.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>More, than, percent, Older, Adults, May, Discontinue, Levothyroxine, Under, Supervision:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340096-levothyroxine.webp"><p><span>Netherlands: An open-label prospective study has found that approximately 26% of older adults were able to successfully discontinue <a href="https://medicaldialogues.in/topics/levothyroxine">levothyroxine </a>under physician supervision while maintaining stable<a href="https://medicaldialogues.in/topics/thyroid-hormone"> thyrotropin (TSH) </a>and free thyroxine levels over one year. Discontinuation was more likely among patients who were on lower baseline doses of levothyroxine.</span></p><div class="pasted-from-word-wrapper"><div>The findings highlight the importance of periodically reassessing thyroid hormone therapy in older adults to prevent overtreatment and its associated risks, suggesting that nearly one-quarter of patients may safely wean off medication with appropriate monitoring.</div><div>A study published in <i><a href="https://medicaldialogues.in/topics/jama">JAMA </a></i>by Janneke Ravensberg and colleagues from Leiden University Medical Center, the Netherlands, provides important insights into the necessity of long-term levothyroxine therapy in older adults. Levothyroxine is commonly prescribed for hypothyroidism and is often continued indefinitely, but evidence supporting lifelong use in all patients has remained limited.</div><div>To address this, researchers conducted a prospective, single-group study in community-dwelling adults aged 60 years and older who had been on a stable levothyroxine dose (≤150 µg/day) for at least one year, with baseline TSH levels below 10 mIU/L. The study was carried out across 58 general practices in the Netherlands, with participants enrolled between January 2020 and July 2022 and followed up until December 2023.</div><div>Participants underwent a structured, stepwise reduction in levothyroxine, with thyroid function assessed at least six weeks after each dose adjustment. The aim was to determine the proportion of individuals who could discontinue therapy while maintaining adequate thyroid function after one year.</div><div>Of the 370 participants who initiated the discontinuation protocol, 366 completed the study. The median age was 70 years, and most participants were women. The median baseline dose was 50 µg/day. At one year, 95 participants (25.7%) had successfully discontinued levothyroxine while maintaining TSH levels below 10 mIU/L and normal free thyroxine levels.</div><div>The following were the key findings:</div><ul><li>Nearly half of the participants who successfully discontinued levothyroxine achieved TSH levels within a tighter, near-normal range.</li><li>Higher discontinuation success was observed in individuals who were on lower baseline doses of levothyroxine.</li><li>Among participants taking 50 µg/day or less, nearly two-thirds were able to stop treatment without affecting thyroid function.</li><li>Discontinuation of levothyroxine did not negatively impact thyroid-related quality of life.</li><li>Quality of life remained stable over the one-year follow-up period regardless of whether discontinuation was successful.</li><li>The findings indicate that supervised and gradual withdrawal of levothyroxine may not lead to worsening symptoms in appropriately selected patients.</li></ul><div>The study highlights the need for clinicians to periodically evaluate the continued necessity of levothyroxine therapy in older adults. The authors suggest that routine reassessment, particularly in those on lower doses, could help avoid unnecessary long-term treatment and reduce the risk of overtreatment-related complications.</div><div>Overall, the findings indicate that a substantial proportion of older adults may not require lifelong levothyroxine therapy and could safely discontinue treatment under medical supervision.</div><div>Reference:</div><div>Ravensberg J, Gussekloo J, Le Cessie S, Dekkers OM, Mooijaart SP, Poortvliet RKE. Discontinuation of Levothyroxine in Adults Aged 60 Years or Older. JAMA. Published online April 06, 2026. doi:10.1001/jama.2026.2864</div></div>]]> </content:encoded>
</item>

<item>
<title>New biomarker for immunoglobulin a nephropathy identified in new study</title>
<link>https://edusehat.com/en/new-biomarker-for-immunoglobulin-a-nephropathy-identified-in-new-study</link>
<guid>https://edusehat.com/en/new-biomarker-for-immunoglobulin-a-nephropathy-identified-in-new-study</guid>
<description><![CDATA[ Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial cell proliferation, enhanced extracellular matrix production, and variable infiltration of inflammatory cells. Because IgA nephropathy carries a lifelong risk of progression to end-stage kidney disease, optimal therapeutic strategies to halt renal deterioration are needed. 
In accordance with the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for IgA nephropathy and IgA vasculitis, therapeutic strategies are categorized into two groups: one targeting IgAN-specific drivers for nephron loss, and the other addressing the host’s genetic response to IgAN-induced nephron loss. The former is represented by immunosuppressive agents, whereas the latter mainly consists of comprehensive supportive care focused on managing cardiovascular and metabolic risk factors. However, systemic corticosteroid therapy has raised safety concerns and is therefore used only in carefully selected patients who can tolerate its adverse effects. Thus, unraveling the molecular pathogenesis of IgA nephropathy and identifying reliable biomarkers and actionable therapeutic targets are pivotal.
“The key IgA-IC-associated molecules and pathways involved in the development of glomerulonephritis remain unclear,” says Professor Kazuo Takahashi from the Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Japan. To elucidate the molecular components of IgA-ICs and molecules involved in glomerular injury in patients with IgA nephropathy, a proteome study was conducted by a team of researchers led by Prof. Takahashi, along with Senior Assistant Professor Yukako Ohyama and Assistant Professor Yudai Tsuji from the same institute. The team performed proteomic analyses on stored remnant FFPE kidney tissues and on IgA-ICs isolated from patients with IgA nephropathy, as well as on samples obtained from controls. Their findings were made available online on November 26, 2025, and were published in volume 15 of the journal Scientific Reports on December 30, 2025.
The team found that complement pathway proteins, associated with both the classical and alternative, and terminal pathways were overexpressed in the glomeruli of patients with IgA nephropathy compared with normal kidney segments removed due to cancer. These included complement factor H-related protein (CFHR) 1, CFHR2, CFHR3, CFHR5, C1q chains B and C, and properdin. Serum CFHR1 levels and CFHR1 levels within circulating IgA-ICs were also significantly higher in patients than in healthy individuals and disease controls. Furthermore, colocalization of CFHR1 with mesangial IgA deposition was confirmed by double immunofluorescence staining of CFHR1 ad IgA using frozen kidney-biopsy sections.
Longitudinal studies showed that CFHR1 levels in circulating IgA-ICs were significantly reduced after two years of immunosuppressive treatment, whereas no significant change was observed in patients receiving supportive therapy. Interestingly, serum CFHR1 levels remained unchanged in both treatment groups.
What does this mean for the progression of IgA nephropathy? Prof. Takahashi speculates that elevated CFHR1 in circulating IgA-ICs may increase the likelihood of developing the disorder, adding, “Elevated circulating total CFHR1 levels in patients with IgA nephropathy may reflect activation of the alternative complement pathway upon exposure to mucosal microbial antigens bound to IgA.” CFHR1 may thus catalyze the formation of IgA-ICs around abnormal IgA molecules, which eventually get deposited in the kidney and cause inflammation.
These findings indicate that CFHR1 could serve as a new diagnostic marker for IgA nephropathy. “The quantification of CFHR1 within circulating IgA immune complexes holds promise as a novel diagnostic and prognostic biomarker for IgA nephropathy. Notably, several new therapeutic agents with distinct mechanisms of action—including complement-targeting drugs—are currently under development and clinical evaluation for IgA nephropathy. CFHR1 may also serve as a potential companion diagnostic marker to guide these emerging therapies,” remarks Prof. Takahashi. He adds that a better understanding of the mechanism of IgA-IC formation, including the roles played by complement pathway proteins, will lead to optimized patient management and better treatment outcomes.Reference:Tsuji, Y., Ohyama, Y., Saitoh, S. et al. Complement proteins associated with circulatory and glomerular IgA-containing immune complexes in patients with IgA nephropathy. Sci Rep 15, 45375 (2025). https://doi.org/10.1038/s41598-025-29024-z
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/09/237764-iga-nephropathy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, biomarker, for, immunoglobulin, nephropathy, identified, new, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/09/237764-iga-nephropathy.webp"><p>Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial cell proliferation, enhanced extracellular matrix production, and variable infiltration of inflammatory cells. Because IgA nephropathy carries a lifelong risk of progression to end-stage kidney disease, optimal therapeutic strategies to halt renal deterioration are needed. 
</p><p>In accordance with the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for IgA nephropathy and IgA vasculitis, therapeutic strategies are categorized into two groups: one targeting IgAN-specific drivers for nephron loss, and the other addressing the host’s genetic response to IgAN-induced nephron loss. The former is represented by immunosuppressive agents, whereas the latter mainly consists of comprehensive supportive care focused on managing cardiovascular and metabolic risk factors. However, systemic corticosteroid therapy has raised safety concerns and is therefore used only in carefully selected patients who can tolerate its adverse effects. Thus, unraveling the molecular pathogenesis of IgA nephropathy and identifying reliable biomarkers and actionable therapeutic targets are pivotal.
</p><p>“The key IgA-IC-associated molecules and pathways involved in the development of glomerulonephritis remain unclear,” says Professor Kazuo Takahashi from the Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Japan. To elucidate the molecular components of IgA-ICs and molecules involved in glomerular injury in patients with IgA nephropathy, a proteome study was conducted by a team of researchers led by Prof. Takahashi, along with Senior Assistant Professor Yukako Ohyama and Assistant Professor Yudai Tsuji from the same institute. The team performed proteomic analyses on stored remnant FFPE kidney tissues and on IgA-ICs isolated from patients with IgA nephropathy, as well as on samples obtained from controls. Their findings were made available online on November 26, 2025, and were published in volume 15 of the journal Scientific Reports on December 30, 2025.
</p><p>The team found that complement pathway proteins, associated with both the classical and alternative, and terminal pathways were overexpressed in the glomeruli of patients with IgA nephropathy compared with normal kidney segments removed due to cancer. These included complement factor H-related protein (CFHR) 1, CFHR2, CFHR3, CFHR5, C1q chains B and C, and properdin. Serum CFHR1 levels and CFHR1 levels within circulating IgA-ICs were also significantly higher in patients than in healthy individuals and disease controls. Furthermore, colocalization of CFHR1 with mesangial IgA deposition was confirmed by double immunofluorescence staining of CFHR1 ad IgA using frozen kidney-biopsy sections.
</p><p>Longitudinal studies showed that CFHR1 levels in circulating IgA-ICs were significantly reduced after two years of immunosuppressive treatment, whereas no significant change was observed in patients receiving supportive therapy. Interestingly, serum CFHR1 levels remained unchanged in both treatment groups.
</p><p>What does this mean for the progression of IgA nephropathy? Prof. Takahashi speculates that elevated CFHR1 in circulating IgA-ICs may increase the likelihood of developing the disorder, adding, “Elevated circulating total CFHR1 levels in patients with IgA nephropathy may reflect activation of the alternative complement pathway upon exposure to mucosal microbial antigens bound to IgA.” CFHR1 may thus catalyze the formation of IgA-ICs around abnormal IgA molecules, which eventually get deposited in the kidney and cause inflammation.
</p><p>These findings indicate that CFHR1 could serve as a new diagnostic marker for IgA nephropathy. “The quantification of CFHR1 within circulating IgA immune complexes holds promise as a novel diagnostic and prognostic biomarker for IgA nephropathy. Notably, several new therapeutic agents with distinct mechanisms of action—including complement-targeting drugs—are currently under development and clinical evaluation for IgA nephropathy. CFHR1 may also serve as a potential companion diagnostic marker to guide these emerging therapies,” remarks Prof. Takahashi. He adds that a better understanding of the mechanism of IgA-IC formation, including the roles played by complement pathway proteins, will lead to optimized patient management and better treatment outcomes.</p><p>Reference:</p><p>Tsuji, Y., Ohyama, Y., Saitoh, S. et al. Complement proteins associated with circulatory and glomerular IgA-containing immune complexes in patients with IgA nephropathy. Sci Rep 15, 45375 (2025). https://doi.org/10.1038/s41598-025-29024-z
</p>]]> </content:encoded>
</item>

<item>
<title>Blood test predicts dementia in women as many as 25 years before symptoms begin: Study</title>
<link>https://edusehat.com/en/blood-test-predicts-dementia-in-women-as-many-as-25-years-before-symptoms-begin-study</link>
<guid>https://edusehat.com/en/blood-test-predicts-dementia-in-women-as-many-as-25-years-before-symptoms-begin-study</guid>
<description><![CDATA[ Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman’s risk of developing dementia as many as 25 years before symptoms appear. The study, published on March 10, 2026 in JAMA Network Open, shows that higher levels of phosphorylated tau 217 (p-tau217)-a protein linked to the brain changes seen in Alzheimer’s disease — were strongly associated with future mild cognitive impairment and dementia among older women who were cognitively healthy at baseline, meaning at the start of the study before any memory or thinking problems were detected.
“Our study suggests we may be able to identify women at elevated risk for dementia decades before symptoms emerge,” said Aladdin H. Shadyab, PhD, MPH, first author of the study and UC San Diego associate professor of public health and medicine at the Herbert Wertheim School of Public Health and Human Longevity Science and the School of Medicine. “That kind of long lead time opens the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life.”
The findings are based on data from 2,766 participants in the Women’s Health Initiative Memory Study, a large national study that enrolled women ages 65 to 79 in the late 1990s and followed them for up to 25 years. All women were cognitively unimpaired when they entered the study. Blood samples collected at baseline were analyzed years later to measure p-tau217, a form of tau protein that reflects early brain changes associated with Alzheimer’s disease.
Over the years of follow-up, researchers identified women who developed memory or thinking problems, including dementia. Those who had higher levels of p-tau217 in their blood at the start of the study were much more likely to develop dementia later in life. In fact, as levels of this biomarker increased, so did dementia risk. Women with the highest p-tau217 levels faced the greatest likelihood of developing dementia over the long term.
However, the researchers also found that risk of cognitive impairment or dementia associated with higher levels of p-tau217 was not the same for everyone. For example, higher p-tau217 levels were more strongly associated with poorer cognitive outcomes among women over age 70 than those younger than 70 years at baseline and among those with the APOE ε4 genetic risk factor for Alzheimer’s disease. The study also found that p-tau217 was more predictive of dementia among women who had been randomized to estrogen plus progestin hormone therapy versus placebo. The strength of the association also differed between white and Black women, but combining p-tau217 with age improved dementia prediction similarly in both groups.
“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” said Linda K. McEvoy, PhD, senior author of the study, senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health. “This is important for accelerating research into the factors that affect risk of dementia and for evaluating strategies that may reduce risk.” 
Currently, blood-based biomarkers are not recommended for clinical use in people without symptoms of cognitive impairment. The authors note that additional studies are needed to determine how p-tau217 testing might be used in routine clinical care and whether early identification can meaningfully change outcomes. Future research will also explore how factors such as hormone therapy, genetics and age-related health conditions interact with plasma p-tau217 over the course of someone’s life to affect dementia risk.
“Ultimately, the goal is not just prediction,” Shadyab added, “but using that knowledge to delay or prevent dementia altogether.”Reference:Shadyab AH, Zhang B, LaCroix AZ, et al. Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women. JAMA Netw Open. 2026;9(3):e261295. doi:10.1001/jamanetworkopen.2026.1295
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277387-dementia-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Blood, test, predicts, dementia, women, many, years, before, symptoms, begin:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277387-dementia-2.webp"><p>Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman’s risk of developing <a href="https://medicaldialogues.in/topics/dementia">dementia </a>as many as 25 years before symptoms appear. The study, published on March 10, 2026 in <i>JAMA Network Open</i>, shows that higher levels of phosphorylated tau 217 (p-tau217)-a protein linked to the brain changes seen in <a href="https://medicaldialogues.in/topics/Alzheimer%E2%80%99s-disease">Alzheimer’s disease </a>— were strongly associated with future mild <a href="https://medicaldialogues.in/topics/cognitive-impairment">cognitive impairment</a> and dementia among older women who were cognitively healthy at baseline, meaning at the start of the study before any memory or thinking problems were detected.
</p><p>“Our study suggests we may be able to identify women at elevated risk for dementia decades before symptoms emerge,” said Aladdin H. Shadyab, PhD, MPH, first author of the study and UC San Diego associate professor of public health and medicine at the Herbert Wertheim School of Public Health and Human Longevity Science and the School of Medicine. “That kind of long lead time opens the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life.”
</p><p>The findings are based on data from 2,766 participants in the Women’s Health Initiative Memory Study, a large national study that enrolled women ages 65 to 79 in the late 1990s and followed them for up to 25 years. All women were cognitively unimpaired when they entered the study. Blood samples collected at baseline were analyzed years later to measure p-tau217, a form of tau protein that reflects early brain changes associated with Alzheimer’s disease.
</p><p>Over the years of follow-up, researchers identified women who developed memory or thinking problems, including dementia. Those who had higher levels of p-tau217 in their blood at the start of the study were much more likely to develop dementia later in life. In fact, as levels of this biomarker increased, so did dementia risk. Women with the highest p-tau217 levels faced the greatest likelihood of developing dementia over the long term.
</p><p>However, the researchers also found that risk of cognitive impairment or dementia associated with higher levels of p-tau217 was not the same for everyone. For example, higher p-tau217 levels were more strongly associated with poorer cognitive outcomes among women over age 70 than those younger than 70 years at baseline and among those with the APOE ε4 genetic risk factor for Alzheimer’s disease. The study also found that p-tau217 was more predictive of dementia among women who had been randomized to estrogen plus progestin hormone therapy versus placebo. The strength of the association also differed between white and Black women, but combining p-tau217 with age improved dementia prediction similarly in both groups.
</p><p>“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” said Linda K. McEvoy, PhD, senior author of the study, senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health. “This is important for accelerating research into the factors that affect risk of dementia and for evaluating strategies that may reduce risk.” 
</p><p>Currently, blood-based biomarkers are not recommended for clinical use in people without symptoms of cognitive impairment. The authors note that additional studies are needed to determine how p-tau217 testing might be used in routine clinical care and whether early identification can meaningfully change outcomes. Future research will also explore how factors such as hormone therapy, genetics and age-related health conditions interact with plasma p-tau217 over the course of someone’s life to affect dementia risk.
</p><p>“Ultimately, the goal is not just prediction,” Shadyab added, “but using that knowledge to delay or prevent dementia altogether.”</p><p>Reference:</p><p>Shadyab AH, Zhang B, LaCroix AZ, et al. Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women. JAMA Netw Open. 2026;9(3):e261295. doi:10.1001/jamanetworkopen.2026.1295
</p>]]> </content:encoded>
</item>

<item>
<title>Study finds link between sugary drinks and anxiety in young people,  finds study</title>
<link>https://edusehat.com/en/study-finds-link-between-sugary-drinks-and-anxiety-in-young-people-finds-study</link>
<guid>https://edusehat.com/en/study-finds-link-between-sugary-drinks-and-anxiety-in-young-people-finds-study</guid>
<description><![CDATA[ A new study has identified an association between consumption of drinks containing a high amount of sugar and anxiety symptoms in adolescents. 
Researchers at Bournemouth University were part of a team involved in reviewing the findings of multiple studies that have investigated people’s diets and their mental health, to establish common findings. 
Their results have been published in the Journal of Human Nutrition and Dietetics.
“With increasing concern about adolescent nutrition, most public health initiatives have emphasised the physical consequences of poor dietary habits, such as obesity and type-2 diabetes,” said Dr Chloe Casey, Lecturer in Nutrition and co-author of the study. “However, the mental health implications of diet have been underexplored by comparison, particularly for drinks that are energy dense but low in nutrients,” she added.
Anxiety disorders are a leading cause of mental distress among young people, in 2023 it was estimated that one in five children and young people had a mental health disorder, with anxiety one of the most reported conditions. 
The studies investigated by the research team measured sugary drink consumption and mental health of the young people through surveys. Beverages with high amounts of sugar can include fizzy drinks, energy drinks, sugary juices, squashes, sweetened tea and coffee, and flavoured milks.
The results consistently found a link between high levels of sugary drink consumption and anxiety.
The researchers emphasise that because of the nature of the studies they investigated, the findings do not provide evidence that drinking more sugary drinks directly causes anxiety. It is also possible that experiencing symptoms of anxiety leads to some young people consuming more sugary drinks. Or there could be other common factors – for example family life and sleeping disorders – that lead to both increased consumption and symptoms of anxiety. 
“Whilst we may not be able to confirm at this stage what the direct cause is, this study has identified an unhealthy connection between consumption of sugary drinks and anxiety disorders in young people,” Dr Casey said. 
“Anxiety disorders in adolescence have risen sharply in recent years so it is important to identify lifestyle habits which can be changed to reduce the risk of this trend continuing,” she concluded. Reference:Karim Khaled, Nathalie Abdulbaki, Orouba Almilaji, Chloe Casey, Fotini Tsofliou, Sugar-Sweetened Beverage Consumption and Anxiety Disorders in Adolescents: A Systematic Review and Meta-Analysis, Journal of Human Nutrition and Dietetics, https://doi.org/10.1111/jhn.70217 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/06/231649-anxiety-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, finds, link, between, sugary, drinks, and, anxiety, young, people, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/06/231649-anxiety-50.webp"><p>A new study has identified an association between consumption of drinks containing a high amount of sugar and <a href="https://medicaldialogues.in/topics/anxiety">anxiety </a>symptoms in adolescents. 
</p><p>Researchers at Bournemouth University were part of a team involved in reviewing the findings of multiple studies that have investigated people’s diets and their <a href="https://medicaldialogues.in/topics/mental-health">mental health</a>, to establish common findings. 
</p><p>Their results have been published in the<i> Journal of Human Nutrition and Dietetics.
</i></p><p>“With increasing concern about adolescent nutrition, most public health initiatives have emphasised the physical consequences of poor dietary habits, such as <a href="https://medicaldialogues.in/topics/obesity">obesity </a>and <a href="https://medicaldialogues.in/topics/type-2-diabetes">type-2 diabetes</a>,” said Dr Chloe Casey, Lecturer in Nutrition and co-author of the study. “However, the mental health implications of diet have been underexplored by comparison, particularly for drinks that are energy dense but low in nutrients,” she added.
</p><p>Anxiety disorders are a leading cause of mental distress among young people, in 2023 it was estimated that one in five children and young people had a mental health disorder, with anxiety one of the most reported conditions. 
</p><p>The studies investigated by the research team measured sugary drink consumption and mental health of the young people through surveys. Beverages with high amounts of sugar can include fizzy drinks, energy drinks, sugary juices, squashes, sweetened tea and coffee, and flavoured milks.
</p><p>The results consistently found a link between high levels of sugary drink consumption and anxiety.
</p><p>The researchers emphasise that because of the nature of the studies they investigated, the findings do not provide evidence that drinking more sugary drinks directly causes anxiety. It is also possible that experiencing symptoms of anxiety leads to some young people consuming more sugary drinks. Or there could be other common factors – for example family life and sleeping disorders – that lead to both increased consumption and symptoms of anxiety. 
</p><p>“Whilst we may not be able to confirm at this stage what the direct cause is, this study has identified an unhealthy connection between consumption of sugary drinks and anxiety disorders in young people,” Dr Casey said. 
</p><p>“Anxiety disorders in adolescence have risen sharply in recent years so it is important to identify lifestyle habits which can be changed to reduce the risk of this trend continuing,” she concluded. </p><p>Reference:</p><p>Karim Khaled, Nathalie Abdulbaki, Orouba Almilaji, Chloe Casey, Fotini Tsofliou, Sugar-Sweetened Beverage Consumption and Anxiety Disorders in Adolescents: A Systematic Review and Meta-Analysis, Journal of Human Nutrition and Dietetics, https://doi.org/10.1111/jhn.70217</p>]]> </content:encoded>
</item>

<item>
<title>USFDA Approves Alembic&amp;apos;s Dapagliflozin Tablets, Grants 180&#45;Day Exclusivity</title>
<link>https://edusehat.com/en/usfda-approves-alembics-dapagliflozin-tablets-grants-180-day-exclusivity</link>
<guid>https://edusehat.com/en/usfda-approves-alembics-dapagliflozin-tablets-grants-180-day-exclusivity</guid>
<description><![CDATA[ New Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin Tablets in strengths of 5 mg and 10 mg, the company announced in a regulatory filing.The approval has been granted for Alembic’s Abbreviated New Drug Application (ANDA), with the product being therapeutically equivalent to the reference listed drug Farxiga Tablets, 5 mg and 10 mg, developed by AstraZeneca AB.Dapagliflozin belongs to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors. It is indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors. Additionally, it is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Alembic highlighted that it was among the first applicants to submit a substantially complete ANDA with a paragraph IV certification for this product. With the final approval, the company is now eligible for 180 days of shared generic drug exclusivity in the US market.Also Read: Alembic Pharma Sets Up New Subsidiary in Thailand to Expand Global PresenceAccording to IQVIA data, Dapagliflozin tablets in the approved strengths have an estimated market size of US$ 10,487 million for the twelve months ending December 2025, indicating a significant commercial opportunity for the company.With this latest approval, Alembic Pharmaceuticals has further strengthened its US generics portfolio. The company now has a cumulative total of 235 ANDA approvals from the USFDA, comprising 217 final approvals and 18 tentative approvals.Alembic Pharmaceuticals Limited, headquartered in Vadodara, is a vertically integrated research and development-driven pharmaceutical company with a legacy dating back to 1907. The company manufactures and markets generic pharmaceutical products globally and operates state-of-the-art facilities approved by several international regulatory authorities, including the USFDA.Also Read: Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/10/197273-alembic-pharma-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>USFDA, Approves, Alembics, Dapagliflozin, Tablets, Grants, 180-Day, Exclusivity</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/10/197273-alembic-pharma-3.webp"><p><b>New Delhi: </b>Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin Tablets in strengths of 5 mg and 10 mg, the company announced in a regulatory filing.</p><div class="pasted-from-word-wrapper"><p>The approval has been granted for Alembic’s Abbreviated New Drug Application (ANDA), with the product being therapeutically equivalent to the reference listed drug Farxiga Tablets, 5 mg and 10 mg, developed by AstraZeneca AB.</p><p>Dapagliflozin belongs to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors. It is indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors. Additionally, it is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.</p><p>Alembic highlighted that it was among the first applicants to submit a substantially complete ANDA with a paragraph IV certification for this product. With the final approval, the company is now eligible for 180 days of shared generic drug exclusivity in the US market.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-sets-up-new-subsidiary-in-thailand-to-expand-global-presence-166302">Also Read: Alembic Pharma Sets Up New Subsidiary in Thailand to Expand Global Presence</a></div></div><p>According to IQVIA data, Dapagliflozin tablets in the approved strengths have an estimated market size of US$ 10,487 million for the twelve months ending December 2025, indicating a significant commercial opportunity for the company.</p><p>With this latest approval, Alembic Pharmaceuticals has further strengthened its US generics portfolio. The company now has a cumulative total of 235 ANDA approvals from the USFDA, comprising 217 final approvals and 18 tentative approvals.</p><p>Alembic Pharmaceuticals Limited, headquartered in Vadodara, is a vertically integrated research and development-driven pharmaceutical company with a legacy dating back to 1907. The company manufactures and markets generic pharmaceutical products globally and operates state-of-the-art facilities approved by several international regulatory authorities, including the USFDA.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/alembic-pharma-secures-usfda-tentative-approval-for-bosulif-generic-bosutinib-400-mg-162541">Also Read: Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Radiofrequency Ablation Fails to Improve Survival and Worsens Quality of Life in Pancreatic Cancer: JAMA</title>
<link>https://edusehat.com/en/radiofrequency-ablation-fails-to-improve-survival-and-worsens-quality-of-life-in-pancreatic-cancer-jama</link>
<guid>https://edusehat.com/en/radiofrequency-ablation-fails-to-improve-survival-and-worsens-quality-of-life-in-pancreatic-cancer-jama</guid>
<description><![CDATA[ Netherlands: In a randomized clinical trial of patients with locally advanced pancreatic cancer (LAPC) following 2 months of multiagent chemotherapy, the addition of radiofrequency ablation (RFA) did not improve overall survival compared with chemotherapy alone and was associated with a negative impact on patients’ quality of life.The findings, published in JAMA Network Open, are from the PELICAN trial led by Leonard W. F. Seelen from UMC Utrecht Cancer Center and St Antonius Hospital, the Netherlands, along with an international team of researchers. The study was designed to evaluate whether adding local ablative therapy with RFA could enhance outcomes in patients with unresectable LAPC who had achieved at least stable disease after initial chemotherapy.Pancreatic cancer continues to carry a poor prognosis, and treatment options for locally advanced disease remain limited. While systemic chemotherapy is the standard approach, local tumor control strategies such as RFA have been explored as potential adjuncts to improve survival outcomes. However, robust clinical evidence supporting their benefit has been lacking.To address this, investigators conducted an international randomized clinical trial between April 2015 and December 2022, enrolling patients with unresectable LAPC who did not show disease progression after two months of induction chemotherapy. Participants were randomly assigned to receive either RFA in addition to continued chemotherapy or chemotherapy alone. The study included 188 patients, with a median age of 65 years, and a slight predominance of male participants.Before randomization, most patients had received modified FOLFIRINOX regimens, while a smaller proportion were treated with gemcitabine-based therapies. The primary endpoint was overall survival, while secondary outcomes included progression-free survival, adverse events, and patient-reported quality of life assessed using validated cancer-specific questionnaires.The trial revealed the following findings:No significant difference in overall survival was observed between the two groups after a median follow-up of 55 months.Median overall survival was 12.1 months in the RFA plus chemotherapy group versus 11.6 months in the chemotherapy-only group.Progression-free survival was comparable between the groups, with no significant benefit from adding RFA.The RFA group had a higher rate of serious (grade ≥3) adverse events.About 27% of patients in the RFA group experienced severe complications compared to 11% in the chemotherapy-only group.Patients undergoing RFA showed a clinically meaningful decline in quality of life.Global health status scores worsened over time in the RFA group.Quality-of-life measures remained relatively stable in patients receiving chemotherapy alone.The findings suggest that incorporating RFA into the treatment strategy for LAPC after initial chemotherapy does not confer survival benefits and may instead increase treatment-related burden. The authors conclude that these results do not support the routine use of RFA in this patient population and highlight the importance of prioritizing therapies that balance efficacy with quality of life.Reference:Seelen LWF, Brada LJH, Walma MS, et al. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e263861. doi:10.1001/jamanetworkopen.2026.3861 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/02/339073-radiofrequency-ablation.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Radiofrequency, Ablation, Fails, Improve, Survival, and, Worsens, Quality, Life, Pancreatic, Cancer:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/02/339073-radiofrequency-ablation.webp"><p><span>Netherlands: In a randomized clinical trial of patients with locally advanced <a href="https://medicaldialogues.in/topics/pancreatic-cancer">pancreatic cancer </a>(LAPC) following 2 months of multiagent chemotherapy, the addition of<a href="https://medicaldialogues.in/topics/radiofrequency-ablation"> radiofrequency ablation (RFA) </a>did not improve overall survival compared with <a href="https://medicaldialogues.in/topics/chemotherapy">chemotherapy </a>alone and was associated with a negative impact on patients’ quality of life.</span></p><div class="pasted-from-word-wrapper"><div>The findings, published in <i>JAMA Network Open, </i>are from the PELICAN trial led by Leonard W. F. Seelen from UMC Utrecht Cancer Center and St Antonius Hospital, the Netherlands, along with an international team of researchers. The study was designed to evaluate whether adding local ablative therapy with RFA could enhance outcomes in patients with unresectable LAPC who had achieved at least stable disease after initial chemotherapy.</div><div>Pancreatic cancer continues to carry a poor prognosis, and treatment options for locally advanced disease remain limited. While systemic chemotherapy is the standard approach, local tumor control strategies such as RFA have been explored as potential adjuncts to improve survival outcomes. However, robust clinical evidence supporting their benefit has been lacking.</div><div>To address this, investigators conducted an international randomized clinical trial between April 2015 and December 2022, enrolling patients with unresectable LAPC who did not show disease progression after two months of induction chemotherapy. Participants were randomly assigned to receive either RFA in addition to continued chemotherapy or chemotherapy alone. The study included 188 patients, with a median age of 65 years, and a slight predominance of male participants.</div><div>Before randomization, most patients had received modified FOLFIRINOX regimens, while a smaller proportion were treated with gemcitabine-based therapies. The primary endpoint was overall survival, while secondary outcomes included progression-free survival, adverse events, and patient-reported quality of life assessed using validated cancer-specific questionnaires.</div><div>The trial revealed the following findings:</div><ul><li>No significant difference in overall survival was observed between the two groups after a median follow-up of 55 months.</li><li>Median overall survival was 12.1 months in the RFA plus chemotherapy group versus 11.6 months in the chemotherapy-only group.</li><li>Progression-free survival was comparable between the groups, with no significant benefit from adding RFA.</li><li>The RFA group had a higher rate of serious (grade ≥3) adverse events.</li><li>About 27% of patients in the RFA group experienced severe complications compared to 11% in the chemotherapy-only group.</li><li>Patients undergoing RFA showed a clinically meaningful decline in quality of life.</li><li>Global health status scores worsened over time in the RFA group.</li><li>Quality-of-life measures remained relatively stable in patients receiving chemotherapy alone.</li></ul><div>The findings suggest that incorporating RFA into the treatment strategy for LAPC after initial chemotherapy does not confer survival benefits and may instead increase treatment-related burden. The authors conclude that these results do not support the routine use of RFA in this patient population and highlight the importance of prioritizing therapies that balance efficacy with quality of life.</div><div>Reference:</div><div>Seelen LWF, Brada LJH, Walma MS, et al. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e263861. doi:10.1001/jamanetworkopen.2026.3861</div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Study suggests children with ear tubes may safely swim in treated pools</title>
<link>https://edusehat.com/en/study-suggests-children-with-ear-tubes-may-safely-swim-in-treated-pools</link>
<guid>https://edusehat.com/en/study-suggests-children-with-ear-tubes-may-safely-swim-in-treated-pools</guid>
<description><![CDATA[ A new study published in Otolaryngology−Head and Neck Surgery, the peer-reviewed journal of the American Academy of Otolaryngology−Head and Neck Surgery Foundation (AAO-HNSF), finds that children with tympanostomy tubes who swim in treated pools are not at increased risk of ear drainage, while those exposed to untreated or natural bodies of water face significantly higher odds of developing recurrent otorrhea.
Tympanostomy tube placement, commonly known as ear tube surgery, is one of the most frequently performed surgical procedures in children in the United States, typically recommended for those with recurrent ear infections or persistent fluid in the middle ear.
“The role of water precautions in tympanostomy tubes has been extensively debated, yet empirical evidence regarding the impact of water type and otorrhea risk is limited,” said Kavita Dedhia, MD, MSHP, Assistant Professor, Department of Otorhinolaryngology Head &amp; Neck Surgery, Perelman School of Medicine at the University of Pennsylvania. “We identified an association between increased otorrhea episodes and exposure to untreated water. Although this is not a definitive study, it can guide providers to counsel families on when to consider water precautions.” 
These findings are consistent with the AAO-HNSF&#039;s 2022 Clinical Practice Guideline on Tympanostomy Tubes in Children (Update), which are specified in Key Action Statement 15, Clinicians should not encourage routine, prophylactic water precautions (use of earplugs or headbands, avoidance of swimming or water sports) for children with tympanostomy tubes. The CPG notes that water precautions are best reserved for select children rather than applied routinely, with the preferred approach being to allow unrestricted water activity first and introduce precautions only if problems arise. Exceptions include children with recurrent or persistent otorrhea — particularly those with P. aeruginosa or S. aureus in middle ear cultures — those with immune dysfunction, those who experience ear discomfort during swimming, and those exposed to heavily contaminated water or engaging in deep diving.
The authors acknowledge several limitations, including the potential for recall bias among caregivers and the observational nature of the study design, which limits causal conclusions. They call for prospective studies and interventional trials to further clarify the biological mechanisms underlying water-related ear drainage and to identify additional modifiable risk factors. The study also found that younger children were more likely to experience recurrent ear drainage regardless of water exposure type, consistent with prior research on acute otitis media in early childhood.
The authors call for prospective studies and interventional trials to further clarify the biological mechanisms underlying water-related ear drainage and to identify additional modifiable risk factors.Reference:Alexandria L. Irace, Terri Giordano, Ashley Williams, Jillian Karpink, Mimi Kim, Outcomes and Characteristics of Water Exposure in Children with Tympanostomy Tubes, Otolaryngology,https://doi.org/10.1002/ohn.70093 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/31/338583-ear-tubes.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, suggests, children, with, ear, tubes, may, safely, swim, treated, pools</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/31/338583-ear-tubes.webp"><p>A new study published in <i>Otolaryngology−Head and Neck Surgery</i>, the peer-reviewed journal of the American Academy of Otolaryngology−Head and Neck Surgery Foundation (AAO-HNSF), finds that children with tympanostomy tubes who swim in treated pools are not at increased risk of ear drainage, while those exposed to untreated or natural bodies of water face significantly higher odds of developing recurrent otorrhea.
</p><p>Tympanostomy tube placement, commonly known as ear tube surgery, is one of the most frequently performed surgical procedures in children in the United States, typically recommended for those with recurrent ear infections or persistent fluid in the middle ear.
</p><p>“The role of water precautions in tympanostomy tubes has been extensively debated, yet empirical evidence regarding the impact of water type and otorrhea risk is limited,” said Kavita Dedhia, MD, MSHP, Assistant Professor, Department of Otorhinolaryngology Head & Neck Surgery, Perelman School of Medicine at the University of Pennsylvania. “We identified an association between increased otorrhea episodes and exposure to untreated water. Although this is not a definitive study, it can guide providers to counsel families on when to consider water precautions.” 
</p><p>These findings are consistent with the AAO-HNSF's 2022 Clinical Practice Guideline on Tympanostomy Tubes in Children (Update), which are specified in Key Action Statement 15, Clinicians should not encourage routine, prophylactic water precautions (use of earplugs or headbands, avoidance of swimming or water sports) for children with tympanostomy tubes. The CPG notes that water precautions are best reserved for select children rather than applied routinely, with the preferred approach being to allow unrestricted water activity first and introduce precautions only if problems arise. Exceptions include children with recurrent or persistent otorrhea — particularly those with P. aeruginosa or S. aureus in middle ear cultures — those with immune dysfunction, those who experience ear discomfort during swimming, and those exposed to heavily contaminated water or engaging in deep diving.
</p><p>The authors acknowledge several limitations, including the potential for recall bias among caregivers and the observational nature of the study design, which limits causal conclusions. They call for prospective studies and interventional trials to further clarify the biological mechanisms underlying water-related ear drainage and to identify additional modifiable risk factors. The study also found that younger children were more likely to experience recurrent ear drainage regardless of water exposure type, consistent with prior research on acute otitis media in early childhood.
</p><p>The authors call for prospective studies and interventional trials to further clarify the biological mechanisms underlying water-related ear drainage and to identify additional modifiable risk factors.</p><p>Reference:</p><p>Alexandria L. Irace, Terri Giordano, Ashley Williams, Jillian Karpink, Mimi Kim, Outcomes and Characteristics of Water Exposure in Children with Tympanostomy Tubes, Otolaryngology,https://doi.org/10.1002/ohn.70093</p>]]> </content:encoded>
</item>

<item>
<title>New study identifies promising pathway to reverse pulmonary fibrosis</title>
<link>https://edusehat.com/en/new-study-identifies-promising-pathway-to-reverse-pulmonary-fibrosis</link>
<guid>https://edusehat.com/en/new-study-identifies-promising-pathway-to-reverse-pulmonary-fibrosis</guid>
<description><![CDATA[ Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The recent study published in Nature Communications(Opens in a new window) reveals that the protein BCL-2 impedes normal lung repair and that targeting it may restore lung health.
Pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF), is a progressive and often lung disease marked by scarring that limits the lungs’ ability to function. A central challenge in treating the disease has been understanding why scar-forming cells, called fibroblasts, persist rather than die naturally after injury.
In this study, researchers demonstrated that elevated BCL-2 expression allows these fibroblasts to evade cell death, accumulate in the lungs and drive ongoing scarring. Importantly, the team also showed that blocking BCL-2 with a targeted therapy reactivated the body’s natural cell-clearing processes, reduced fibrosis and improved lung structure and function in preclinical models.
“Our findings show that BCL-2 plays a central role in allowing harmful fibroblasts to survive and sustain fibrosis,” said David Riches, PhD, head of the Division of Cell Biology at National Jewish Health and senior author of the study. “By therapeutically inhibiting this pathway, we were able to promote the clearance of these cells and restore key aspects of normal lung architecture. This opens an important new avenue for potential treatment strategies.”
The research also revealed that BCL-2–expressing fibroblasts develop features of cellular aging, or senescence, further contributing to chronic disease progression. Analyses of human lung tissue confirmed the presence of these senescent, BCL-2–positive cells in patients with pulmonary fibrosis, underscoring the translational relevance of the findings.
“This study provides compelling evidence that resistance to cell death and the development of senescence are tightly linked in driving persistent fibrosis,” said Elizabeth Redente, PhD, professor of medicine at National Jewish Health and first author of the study. “Targeting BCL-2 not only addresses fibroblast survival but also helps disrupt the underlying biology that sustains disease progression.”
Notably, treatment with a BCL-2 inhibitor significantly reduced fibrotic burden, improved oxygenation and partially restored normal lung structure in preclinical models, suggesting strong potential for future clinical translation.
These findings represent a significant step forward in understanding and potentially treating pulmonary fibrosis, offering new hope for patients facing this devastating disease.Reference:Redente, E.F., Song, T., Javkhlan, N. et al. Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69865-4
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/08/17/248278-idiopathic-pulmonary-fibrosis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, study, identifies, promising, pathway, reverse, pulmonary, fibrosis</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/08/17/248278-idiopathic-pulmonary-fibrosis.webp"><p>Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent<a href="https://medicaldialogues.in/topics/pulmonary-fibrosis"> pulmonary fibrosis</a> and identified a promising strategy to reverse it. The recent study published in Nature Communications(Opens in a new window) reveals that the protein BCL-2 impedes normal lung repair and that targeting it may restore <a href="https://medicaldialogues.in/topics/lung-health">lung health</a>.
</p><p>Pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF), is a progressive and often <a href="https://medicaldialogues.in/topics/lung-disease">lung disease</a> marked by scarring that limits the lungs’ ability to function. A central challenge in treating the disease has been understanding why scar-forming cells, called fibroblasts, persist rather than die naturally after injury.
</p><p>In this study, researchers demonstrated that elevated BCL-2 expression allows these fibroblasts to evade cell death, accumulate in the lungs and drive ongoing scarring. Importantly, the team also showed that blocking BCL-2 with a targeted therapy reactivated the body’s natural cell-clearing processes, reduced fibrosis and improved lung structure and function in preclinical models.
</p><p>“Our findings show that BCL-2 plays a central role in allowing harmful fibroblasts to survive and sustain fibrosis,” said David Riches, PhD, head of the Division of Cell Biology at National Jewish Health and senior author of the study. “By therapeutically inhibiting this pathway, we were able to promote the clearance of these cells and restore key aspects of normal lung architecture. This opens an important new avenue for potential treatment strategies.”
</p><p>The research also revealed that BCL-2–expressing fibroblasts develop features of cellular aging, or senescence, further contributing to chronic disease progression. Analyses of human lung tissue confirmed the presence of these senescent, BCL-2–positive cells in patients with pulmonary fibrosis, underscoring the translational relevance of the findings.
</p><p>“This study provides compelling evidence that resistance to cell death and the development of senescence are tightly linked in driving persistent fibrosis,” said Elizabeth Redente, PhD, professor of medicine at National Jewish Health and first author of the study. “Targeting BCL-2 not only addresses fibroblast survival but also helps disrupt the underlying biology that sustains disease progression.”
</p><p>Notably, treatment with a BCL-2 inhibitor significantly reduced fibrotic burden, improved oxygenation and partially restored normal lung structure in preclinical models, suggesting strong potential for future clinical translation.
</p><p>These findings represent a significant step forward in understanding and potentially treating pulmonary fibrosis, offering new hope for patients facing this devastating disease.</p><p>Reference:</p><p>Redente, E.F., Song, T., Javkhlan, N. et al. Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69865-4
</p>]]> </content:encoded>
</item>

<item>
<title>Dr Reddy&amp;apos;s Divests Svaas Wellness Stake to Enspirit for Rs 2.23 Crore</title>
<link>https://edusehat.com/en/dr-reddys-divests-svaas-wellness-stake-to-enspirit-for-rs-223-crore</link>
<guid>https://edusehat.com/en/dr-reddys-divests-svaas-wellness-stake-to-enspirit-for-rs-223-crore</guid>
<description><![CDATA[ Hyderabad: Drugmaker Dr. Reddy&#039;s Laboratories Limited has entered into an agreement to sell its entire shareholding in its wholly owned subsidiary, Svaas Wellness Limited, for a consideration of Rs 2.23 crore, as per a regulatory filing.The company informed stock exchanges that the agreement for the sale was executed on April 7, 2026, and the transaction is also expected to be completed on the same day. Following the completion of this deal, Svaas Wellness Limited will cease to be a wholly owned subsidiary of Dr. Reddy’s Laboratories.According to the disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Svaas Wellness Limited reported a turnover of Rs 28.5 crore as per its audited financials for FY 2025. Notably, 100% of this turnover was derived from Dr. Reddy’s Laboratories Limited, contributing approximately 0.09% to the company’s consolidated turnover.Also Read: Dr Reddy&#039;s Slapped Rs 2.19 Crore GST Demand for FY20-22, Plans to Challenge OrdersThe buyer in this transaction is Enspirit Technology Services Private Limited, based in Hyderabad, Telangana. The company clarified that the buyer does not belong to the promoter or promoter group or any group companies of Dr. Reddy’s Laboratories.Further, the company confirmed that the transaction does not qualify as a related party transaction. Enspirit Technology Services Private Limited is not related to Dr. Reddy’s Laboratories or any of its subsidiaries, and the deal has been conducted independently.The disclosure also stated that the transaction does not fall under a scheme of arrangement and is not categorized as a slump sale. Hence, additional regulatory requirements applicable to such cases are not relevant in this instance.Dr. Reddy’s Laboratories, headquartered in Hyderabad, is a leading global pharmaceutical company engaged in providing affordable and innovative medicines. The divestment of Svaas Wellness Limited appears to be part of its strategic business decisions, though specific reasons for the sale were not disclosed in the filing.Also Read: Dr Reddy&#039;s Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer Study ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/20/230651-dr-reddys-new-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Reddys, Divests, Svaas, Wellness, Stake, Enspirit, for, 2.23, Crore</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/20/230651-dr-reddys-new-50.webp"><p><b>Hyderabad</b>: Drugmaker Dr. Reddy's Laboratories Limited has entered into an agreement to sell its entire shareholding in its wholly owned subsidiary, Svaas Wellness Limited, for a consideration of Rs 2.23 crore, as per a regulatory filing.</p><div class="pasted-from-word-wrapper"><p>The company informed stock exchanges that the agreement for the sale was executed on April 7, 2026, and the transaction is also expected to be completed on the same day. Following the completion of this deal, Svaas Wellness Limited will cease to be a wholly owned subsidiary of Dr. Reddy’s Laboratories.</p><p>According to the disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Svaas Wellness Limited reported a turnover of Rs 28.5 crore as per its audited financials for FY 2025. Notably, 100% of this turnover was derived from Dr. Reddy’s Laboratories Limited, contributing approximately 0.09% to the company’s consolidated turnover.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/dr-reddys-slapped-rs-219-crore-gst-demand-for-fy20-22-plans-to-challenge-orders-166865">Also Read: Dr Reddy's Slapped Rs 2.19 Crore GST Demand for FY20-22, Plans to Challenge Orders</a></div></div><p>The buyer in this transaction is Enspirit Technology Services Private Limited, based in Hyderabad, Telangana. The company clarified that the buyer does not belong to the promoter or promoter group or any group companies of Dr. Reddy’s Laboratories.</p><p>Further, the company confirmed that the transaction does not qualify as a related party transaction. Enspirit Technology Services Private Limited is not related to Dr. Reddy’s Laboratories or any of its subsidiaries, and the deal has been conducted independently.</p><p>The disclosure also stated that the transaction does not fall under a scheme of arrangement and is not categorized as a slump sale. Hence, additional regulatory requirements applicable to such cases are not relevant in this instance.</p><p>Dr. Reddy’s Laboratories, headquartered in Hyderabad, is a leading global pharmaceutical company engaged in providing affordable and innovative medicines. The divestment of Svaas Wellness Limited appears to be part of its strategic business decisions, though specific reasons for the sale were not disclosed in the filing.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/dr-reddys-partner-immutep-halts-phase-iii-trial-of-eftilagimod-alfa-in-lung-cancer-study-166520">Also Read: Dr Reddy's Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer Study</a></p></div>]]> </content:encoded>
</item>

<item>
<title>Aurobindo Pharma Secures USFDA Nod for Dapagliflozin&#45;Metformin XR, Gains 180&#45;Day Exclusivity</title>
<link>https://edusehat.com/en/aurobindo-pharma-secures-usfda-nod-for-dapagliflozin-metformin-xr-gains-180-day-exclusivity</link>
<guid>https://edusehat.com/en/aurobindo-pharma-secures-usfda-nod-for-dapagliflozin-metformin-xr-gains-180-day-exclusivity</guid>
<description><![CDATA[ New Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in multiple strengths, the company announced.The approved strengths include 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. The product is bioequivalent and therapeutically equivalent to the reference listed drug Xigduo XR Tablets of AstraZeneca AB.According to the company, the approved formulation will be manufactured at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of Aurobindo Pharma, and the product launch is planned immediately.Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.Also Read: Aurobindo Pharma Transfers Domestic Branded Business to Auropharm for Rs 143.21 CroreAurobindo Pharma stated that it was among the first applicants to file a substantially complete ANDA with a paragraph IV certification for this product. With this approval, the company will be eligible for 180 days of shared generic drug exclusivity in the US market.The company highlighted that the approved product has an estimated market size of approximately US$ 514 million for the twelve months ending February 2026, as per IQVIA data.With this latest approval, Aurobindo Pharma has further expanded its US generics portfolio. As of March 31, 2026, the company has received a total of 579 ANDA approvals from the USFDA, including 554 final approvals and 25 tentative approvals.Aurobindo Pharma Limited, headquartered in Hyderabad, is an integrated global pharmaceutical company with operations in over 150 countries. The company develops, manufactures, and markets a wide range of generic pharmaceuticals, specialty products, and active pharmaceutical ingredients. It operates more than 30 manufacturing and packaging facilities approved by major global regulatory authorities including the USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.Also Read: Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/03/02/233467-aurobindo-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 09 Apr 2026 01:35:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aurobindo, Pharma, Secures, USFDA, Nod, for, Dapagliflozin-Metformin, XR, Gains, 180-Day, Exclusivity</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/03/02/233467-aurobindo-50.webp"><p><b>New Delhi:</b> Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in multiple strengths, the company announced.</p><div class="pasted-from-word-wrapper"><p>The approved strengths include 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. The product is bioequivalent and therapeutically equivalent to the reference listed drug Xigduo XR Tablets of AstraZeneca AB.</p><p>According to the company, the approved formulation will be manufactured at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of Aurobindo Pharma, and the product launch is planned immediately.</p><p>Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-transfers-domestic-branded-business-to-auropharm-for-rs-14321-crore-168110">Also Read: Aurobindo Pharma Transfers Domestic Branded Business to Auropharm for Rs 143.21 Crore</a></div></div><p>Aurobindo Pharma stated that it was among the first applicants to file a substantially complete ANDA with a paragraph IV certification for this product. With this approval, the company will be eligible for 180 days of shared generic drug exclusivity in the US market.</p><p>The company highlighted that the approved product has an estimated market size of approximately US$ 514 million for the twelve months ending February 2026, as per IQVIA data.</p><p>With this latest approval, Aurobindo Pharma has further expanded its US generics portfolio. As of March 31, 2026, the company has received a total of 579 ANDA approvals from the USFDA, including 554 final approvals and 25 tentative approvals.</p><p>Aurobindo Pharma Limited, headquartered in Hyderabad, is an integrated global pharmaceutical company with operations in over 150 countries. The company develops, manufactures, and markets a wide range of generic pharmaceuticals, specialty products, and active pharmaceutical ingredients. It operates more than 30 manufacturing and packaging facilities approved by major global regulatory authorities including the USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-subsidiary-eugia-launches-generic-pomalyst-capsules-in-us-165910">Also Read: Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>NTRUHS announces 29th, 30th convocations, invites applications</title>
<link>https://edusehat.com/en/ntruhs-announces-29th-30th-convocations-invites-applications</link>
<guid>https://edusehat.com/en/ntruhs-announces-29th-30th-convocations-invites-applications</guid>
<description><![CDATA[ Vijayawada: Dr NTR University of Health Sciences (NTRUHS) has announced that its 29th and 30th Annual Convocations will be held in June/July 2026, inviting applications from students who successfully completed their courses in the academic years 2024 and 2025.All the concerned students are advised to take note of the following details:Instructions to apply for degree certificates-1.	All the students declared successful in their respective regular examinations of the year 2024 &amp; 2025 pertaining to Super Specialty Degree, Post Graduate Degree, Post Graduate Diploma and Ph.D. courses are eligible to receive the Degree certificates “IN PERSON” or “IN ABSENTIA”.
2.	All the Under Graduate students declared successful in their respective regular examinations of the year 2024 &amp; 2025 including internship, are eligible to apply for award of Degrees “IN ABSENTIA” of the convocation only. Degrees will not be awarded “IN PERSON” for Under Graduates.
3.	Such of those students for whom compulsory internship is not applicable but have passed their respective regular examination of the year 2024 &amp; 2025 are eligible to receive the Degree Certificates “IN ABSENTIA” only.
4.	The filled-in Application Form should be submitted in person or by post to the Controller of Examinations, Dr. NTR University of Health Sciences, A.P. Vijayawada, so as to reach on or before 21.04.2026 duly enclosing all the required documents and Demand Draft as directed in the instructions / guidelines given in the concerned application form.
5.	Applications received after 21.04.2026 will not be considered.
6.	The exact date, time and venue of the Convocation will be notified separately.
7.	The candidates applying for Degrees “IN PERSON”, for the Ph.D., Super Specialty Courses and Medal/ Prize winners only will be called on to the dais for receiving the Degrees/ Medals/ Prizes. All other candidates (Post Graduates) have to receive the Degrees in their respective seats only and will not be called on to the dais during the Convocation. IN ABSENTIA Degrees will be sent to the candidate’s address by post.Instructions / guidelines to the applicants-1)	USE CAPITAL LETTERS ONLY WHILE FILLING THE APPLICATION FORM.
2)	Applications must be routed through the Principal of the College where the candidate has studied the Super Specialty/ PG Degree/ PG Diploma/ PhD/ Under Graduate Degree Courses.
3)	Full Name:
a.	It should be written as spelt in the Intermediate or its Equivalent Certificate by those who are applying for UG Degree Certificates.
b.	It should be written as spelt in the UG Degree Certificates by those who are applying for Super Specialty/ PG Degree/ PG Diploma/ Ph.D. Certificates.
c.	In case of those who want to obtain Super Specialty/ PG Degree/ PG Diploma/ PhD./ UG Degree Certificates as per the changed Name/ changed Surname, the Full Name must be written as spelt in the AP Gazette, Proceedings of the Dr. NTR University of Health Sciences or any other Competent Educational Authority.
4)	Passport Size Photographs:
a.	One photograph should be affixed on the Application Form duly attested by the Principal of the college where the applicant has studied and passed.
b.	Two photographs should be kept in an envelope and is to be enclosed to the Application.
5)	Fee to be paid through online as detailed below:
Online Payment for degree certificates as detailed below:
 
 
 
 
 
  Sl.
  No.
  Course
  Fee for
  obtaining Degree Certificate
 
 
  In-Person ₹.
  In-absentia ₹.
 
 
  1
  Super Specialty/ Ph.D./ MD/
  MS/ MDS/MD (Ayurveda)/MD (Homoeo)/ MD (Unani) and PG Diploma
  2,000/-
  3,000/-
 
 
  2
  M.Sc (Applied Nutrition)
  2,000/-
  2,500/-
 
 
  3
  M.Sc (N) and MPT
  1,500/-
  2,000/-
 
 
  4
  M.Sc (M)
  1,000/-
  1,500/-
 
 
  5
  All UG Courses
  ----
  1,000/-
 6)	Details of Internship :
It should be filled up by those who are applying for UG Degree Certificate only.7)	Filled in application forms should be sent to the “CONTROLLER OF EXAMINATIONS” Dr. NTR University of Health Sciences, Vijayawada only on or before 21.04.2026. The envelope containing filled in application should be superscribed “29th &amp; 30th Annual Convocations”.
8)	ENCLOSURES:
The following documents are to be enclosed.
a.	Common to all applicants:
1)	Those candidates who want to obtain their Degree Certificates as per the changed Name / changed Surname should submit attested copy of AP Gazette / Proceedings of Dr. NTR University of Health Sciences or any other Educational Authority.
2)	All enclosures must securely be tagged to the application.
3)	Envelope containing two (2) passport size photograph should be kept with the application along with enclosures
4)	Online payment receipt should be enclosed to the application.
5)	There is no need to enclose a self addressed envelope either with stamps or without stamps.
b.	By those who are applying for issue of Super Specialty /PG Degree / PG Diploma / Ph.D. Degree Certificates only:
 
 
 
 
  1
  For Super Speciality
  Attested copy of PG Permanent Degree Certificate
 
 
  2
  For PG Degree/Diploma
  Attested copies of Provisional Certificate of the respective course and
  UG Degree Certificate
 
 
  3
  For Ph.D.
  Attested copy of the qualifying Examination Certificate (previous
  qualification certificate)
 c.	By those who are applying for issue of UG Degree Certificates only :
1)	Attested copy of Intermediate or Equivalent Certificate.
2)	Attested copy of Internship Certificate issued by the Principal of the concerned College.
3)	Attested copy of UG Degree Provisional Certificate
4)	Attested copy of Temporary / Permanent Registration Certificate as proof of having registered themselves with MCI/NMC/DCI/INC etc.,
5)	Attested copy of individual marks memos of First to Final year UG Degree Exams (only if the Official Transcript is not yet been issued by Dr. NTR UHS)
6)	Attested copy of G.O. on transfer of candidate from one college to another college during the Internship period.
7)	Address and Mobile numbers of the candidates shall be written in the following space (two copies)
To view the official notices, click the link mentioned below-https://medicaldialogues.in/pdf_upload/2026/04/08/20260402151302517-340396.pdfhttps://medicaldialogues.in/pdf_upload/2026/04/08/20260402151311210-340397.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340395-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-52.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NTRUHS, announces, 29th, 30th, convocations, invites, applications</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340395-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-52.webp"><p><b>Vijayawada: </b>Dr NTR University of Health Sciences (<a href="https://medicaldialogues.in/topics/NTRUHS">NTRUHS</a>) has announced that its 29th and 30th Annual Convocations will be held in June/July 2026, inviting applications from students who successfully completed their courses in the academic years 2024 and 2025.</p><p>All the concerned students are advised to take note of the following details:</p><p><b>Instructions to apply for degree certificates-</b></p><p>1.	All the students declared successful in their respective regular examinations of the year 2024 & 2025 pertaining to Super Specialty Degree, Post Graduate Degree, Post Graduate Diploma and Ph.D. courses are eligible to receive the Degree certificates “IN PERSON” or “IN ABSENTIA”.
</p><p>2.	All the Under Graduate students declared successful in their respective regular examinations of the year 2024 & 2025 including internship, are eligible to apply for award of Degrees “IN ABSENTIA” of the convocation only. Degrees will not be awarded “IN PERSON” for Under Graduates.
</p><p>3.	Such of those students for whom compulsory internship is not applicable but have passed their respective regular examination of the year 2024 & 2025 are eligible to receive the Degree Certificates “IN ABSENTIA” only.
</p><p>4.	The filled-in Application Form should be submitted in person or by post to the Controller of Examinations, Dr. NTR University of Health Sciences, A.P. Vijayawada, so as to reach on or before 21.04.2026 duly enclosing all the required documents and Demand Draft as directed in the instructions / guidelines given in the concerned application form.
</p><p>5.	Applications received after 21.04.2026 will not be considered.
</p><p>6.	The exact date, time and venue of the Convocation will be notified separately.
</p><p>7.	The candidates applying for Degrees “IN PERSON”, for the Ph.D., Super Specialty Courses and Medal/ Prize winners only will be called on to the dais for receiving the Degrees/ Medals/ Prizes. All other candidates (Post Graduates) have to receive the Degrees in their respective seats only and will not be called on to the dais during the Convocation. IN ABSENTIA Degrees will be sent to the candidate’s address by post.</p><p><b>Instructions / guidelines to the applicants-</b></p><p>1)	USE CAPITAL LETTERS ONLY WHILE FILLING THE APPLICATION FORM.
</p><p>2)	Applications must be routed through the Principal of the College where the candidate has studied the Super Specialty/ PG Degree/ PG Diploma/ PhD/ Under Graduate Degree Courses.
</p><p>3)	<b>Full Name:
</b></p><p>a.	It should be written as spelt in the Intermediate or its Equivalent Certificate by those who are applying for UG Degree Certificates.
</p><p>b.	It should be written as spelt in the UG Degree Certificates by those who are applying for Super Specialty/ PG Degree/ PG Diploma/ Ph.D. Certificates.
</p><p>c.	In case of those who want to obtain Super Specialty/ PG Degree/ PG Diploma/ PhD./ UG Degree Certificates as per the changed Name/ changed Surname, the Full Name must be written as spelt in the AP Gazette, Proceedings of the Dr. NTR University of Health Sciences or any other Competent Educational Authority.
</p><p>4)	<b>Passport Size Photographs:
</b></p><p>a.	One photograph should be affixed on the Application Form duly attested by the Principal of the college where the applicant has studied and passed.
</p><p>b.	Two photographs should be kept in an envelope and is to be enclosed to the Application.
</p><p>5)	<b>Fee to be paid through online as detailed below:
</b></p><p><b>Online Payment for degree certificates as detailed below:</b></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="556">
 <colgroup><col width="55">
 <col width="302">
 <col width="95">
 <col width="104">
 </colgroup><tbody><tr height="93">
  <td rowspan="2" height="140" class="xl68" width="55"><b>Sl.
  No.</b></td>
  <td rowspan="2" class="xl68" width="302"><b>Course</b></td>
  <td colspan="2" class="xl70" width="199"><b>Fee for
  obtaining Degree Certificate</b></td>
 </tr>
 <tr height="47">
  <td height="47" class="xl63" width="95"><b>In-Person ₹.</b></td>
  <td class="xl63" width="104"><b>In-absentia ₹.</b></td>
 </tr>
 <tr height="22">
  <td height="22" class="xl72" width="55">1</td>
  <td class="xl64" width="302">Super Specialty/ Ph.D./ MD/
  MS/ MDS/MD (Ayurveda)/MD (Homoeo)/ MD (Unani) and PG Diploma</td>
  <td class="xl66" width="95">2,000/-</td>
  <td class="xl66" width="104">3,000/-</td>
 </tr>
 <tr height="24">
  <td height="24" class="xl67" width="55">2</td>
  <td class="xl65" width="302">M.Sc (Applied Nutrition)</td>
  <td class="xl66" width="95">2,000/-</td>
  <td class="xl66" width="104">2,500/-</td>
 </tr>
 <tr height="24">
  <td height="24" class="xl67" width="55">3</td>
  <td class="xl65" width="302">M.Sc (N) and MPT</td>
  <td class="xl66" width="95">1,500/-</td>
  <td class="xl66" width="104">2,000/-</td>
 </tr>
 <tr height="24">
  <td height="24" class="xl67" width="55">4</td>
  <td class="xl65" width="302">M.Sc (M)</td>
  <td class="xl66" width="95">1,000/-</td>
  <td class="xl66" width="104">1,500/-</td>
 </tr>
 <tr height="24">
  <td height="24" class="xl67" width="55">5</td>
  <td class="xl65" width="302">All UG Courses</td>
  <td class="xl66" width="95">----</td>
  <td class="xl66" width="104">1,000/-</td>
 </tr></tbody></table></div><p>6)	<b>Details of Internship :
</b></p><p>It should be filled up by those who are applying for UG Degree Certificate only.</p><p>7)	Filled in application forms should be sent to the “CONTROLLER OF EXAMINATIONS” Dr. NTR University of Health Sciences, Vijayawada only on or before 21.04.2026. The envelope containing filled in application should be superscribed “29th & 30th Annual Convocations”.
</p><p>8)	<b>ENCLOSURES:
</b></p><p>The following documents are to be enclosed.
</p><p><b>a.	Common to all applicants:
</b></p><p>1)	Those candidates who want to obtain their Degree Certificates as per the changed Name / changed Surname should submit attested copy of AP Gazette / Proceedings of Dr. NTR University of Health Sciences or any other Educational Authority.
</p><p>2)	All enclosures must securely be tagged to the application.
</p><p>3)	Envelope containing two (2) passport size photograph should be kept with the application along with enclosures
</p><p>4)	Online payment receipt should be enclosed to the application.
</p><p>5)	There is no need to enclose a self addressed envelope either with stamps or without stamps.
</p><p><b>b.	By those who are applying for issue of Super Specialty /PG Degree / PG Diploma / Ph.D. Degree Certificates only:</b></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="441">
 <colgroup><col width="64">
 <col width="147">
 <col width="230">
 </colgroup><tbody><tr height="47">
  <td height="47" class="xl66" width="64">1</td>
  <td class="xl66" width="147">For Super Speciality</td>
  <td class="xl67" width="230">Attested copy of PG Permanent Degree Certificate</td>
 </tr>
 <tr height="94">
  <td height="94" class="xl66" width="64">2</td>
  <td class="xl66" width="147">For PG Degree/Diploma</td>
  <td class="xl65" width="230">Attested copies of Provisional Certificate of the respective course and
  UG Degree Certificate</td>
 </tr>
 <tr height="93">
  <td height="93" class="xl66" width="64">3</td>
  <td class="xl66" width="147">For Ph.D.</td>
  <td class="xl65" width="230">Attested copy of the qualifying Examination Certificate (previous
  qualification certificate)</td>
 </tr></tbody></table></div><p><b>c.	By those who are applying for issue of UG Degree Certificates only :
</b></p><p>1)	Attested copy of Intermediate or Equivalent Certificate.
</p><p>2)	Attested copy of Internship Certificate issued by the Principal of the concerned College.
</p><p>3)	Attested copy of UG Degree Provisional Certificate
</p><p>4)	Attested copy of Temporary / Permanent Registration Certificate as proof of having registered themselves with MCI/NMC/DCI/INC etc.,
</p><p>5)	Attested copy of individual marks memos of First to Final year UG Degree Exams (only if the Official Transcript is not yet been issued by Dr. NTR UHS)
</p><p>6)	Attested copy of G.O. on transfer of candidate from one college to another college during the Internship period.
</p><p>7)	Address and Mobile numbers of the candidates shall be written in the following space (two copies)
</p><p><b><i>To view the official notices, click the link mentioned below-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260402151302517-340396.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260402151302517-340396.pdf</i></b></a></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260402151311210-340397.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260402151311210-340397.pdf</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>BMC resident doctors threaten black ribbon protest over long&#45;pending DA hike</title>
<link>https://edusehat.com/en/bmc-resident-doctors-threaten-black-ribbon-protest-over-long-pending-da-hike</link>
<guid>https://edusehat.com/en/bmc-resident-doctors-threaten-black-ribbon-protest-over-long-pending-da-hike</guid>
<description><![CDATA[ Mumbai: Disappointed over the long-pending implementation of the Dearness Allowance (DA) hike by the Brihanmumbai Municipal Corporation (BMC), despite approval from the state government, thousands of resident doctors from four civil-run hospitals in Maharashtra have announced a black ribbon protest from April 10 without disrupting regular duties.  The doctors under the Maharashtra Association of Resident Doctors (BMC MARD) have warned that if their demands are not addressed within the stipulated time, they will be forced to escalate the protest, which may include mass leave or a strike.BMC MARD, which represents resident doctors working across four BMC-run hospitals, including Cooper Hospital, KEM Hospital, Nair Hospital, and Sion Hospital, has expressed serious concern over the matter.Also read- Maha Senior Resident Doctors flag stipend delays, DA non-implementation in Medical CollegesIn its press release, the association stated that despite the Maharashtra Government issuing Government Resolutions (GRs) for DA hikes effective from July 1, 2024, January 1, 2025, and July 1, 2025, the revised DA has not yet been implemented for resident doctors in BMC hospitals.As per the state government’s revisions, the DA for resident doctors was increased by 12% effective July 1, 2024, then by 11% effective January 1, 2025, and further by 8% effective July 1, 2025. However, resident doctors under BMC claim that they are receiving DA at around 443%, while the government-approved rate has increased to 474%, creating a gap of about 31%. Due to this, arrears have been accumulating for nearly 21 months, leading to financial stress among resident doctors.&quot;BMC MARD has been consistently following up on this issue since July 2025 through multiple letters, meetings, and discussions with senior administrative officials. The matter has also been discussed at the level of the Deputy Municipal Commissioner (Public Health), and instructions have been given to present it in a meeting of all deans for a final decision,&quot; mentioned the press release.On April 6, 2026, BMC MARD submitted a detailed letter to the Municipal Commissioner, Deputy Municipal Commissioner (PH), Additional Municipal Commissioner (WS), Director (MEMH), and all hospital deans.During these representations, Dr. Chinmay Kelkar (President, BMC MARD), Dr. Digvijay Jadhav (Vice President), Dr. Amar Agme (Secretary), Dr. Kaustubh Kokil (Secretary), and Dr. Shubham Solanke (President, KEM MARD) were present. Additionally, BMC MARD representatives met the Deputy Municipal Commissioner (PH) and Additional Municipal Commissioner (WS) in person and held detailed discussions. The Deputy Municipal Commissioner (PH) has scheduled a meeting on April 9 in the afternoon regarding this issue.The association has also met Deputy Mayor Mr. Sanjay Ghadi and discussed the delay in implementing the DA hike. &quot;Resident doctors are the backbone of Mumbai’s public healthcare system and provide continuous 24×7 services. In such a situation, the delay in implementing their rightful and government-approved financial benefits is a serious issue, leading to growing dissatisfaction among them. BMC MARD has clearly informed the administration that they expect an official circular to be issued by Thursday. Failing this, they will be compelled to intensify their protest in phases starting Friday, through democratic means. So far, BMC MARD has shown restraint and chosen dialogue with the administration. However, the association has emphasized that an immediate and concrete decision is now necessary,&quot; said the association. Providing an update to Medical Dialogues, Dr Chinmay Kelkar, President, BMC MARD, said, &quot;We have submitted a detailed representation to Hon’ble MC, DMC (PH), AMC, Director (MEMH), and all Deans, and also met Hon’ble Deputy Mayor Shri Sanjay Ghadi regarding this issue. We are expecting the official circular by Thursday. If not, a token protest from Friday will be held, followed by escalation.&quot;Also read- JnK NHM staff launch 72-Hour strike over demand for regularisation, salary deductions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/09/320248-protest-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>BMC, resident, doctors, threaten, black, ribbon, protest, over, long-pending, hike</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/09/320248-protest-2.webp"><p><b>Mumbai: </b>Disappointed over the long-pending implementation of the Dearness Allowance (DA) hike by the Brihanmumbai Municipal Corporation (BMC), despite approval from the state government, thousands of <a href="https://medicaldialogues.in/topics/resident-doctors" target="_blank">resident doctors</a> from four civil-run hospitals in Maharashtra have announced a black ribbon <a href="https://medicaldialogues.in/topics/protest" target="_blank">protest </a>from April 10 without disrupting regular duties.  </p><p>The doctors under the Maharashtra Association of Resident Doctors (BMC MARD) have warned that if their demands are not addressed within the stipulated time, they will be forced to escalate the protest, which may include mass leave or a strike.</p><p>BMC MARD, which represents resident doctors working across four BMC-run hospitals, including Cooper Hospital, KEM Hospital, Nair Hospital, and Sion Hospital, has expressed serious concern over the matter.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/maha-senior-resident-doctors-flag-stipend-delays-da-non-implementation-in-medical-colleges-166689" target="_blank">Maha Senior Resident Doctors flag stipend delays, DA non-implementation in Medical Colleges</a></b></p><p>In its press release, the association stated that despite the Maharashtra Government issuing Government Resolutions (GRs) for DA hikes effective from July 1, 2024, January 1, 2025, and July 1, 2025, the revised DA has not yet been implemented for resident doctors in BMC hospitals.</p><p>As per the state government’s revisions, the DA for resident doctors was increased by 12% effective July 1, 2024, then by 11% effective January 1, 2025, and further by 8% effective July 1, 2025. </p><p>However, resident doctors under BMC claim that they are receiving DA at around 443%, while the government-approved rate has increased to 474%, creating a gap of about 31%. Due to this, arrears have been accumulating for nearly 21 months, leading to financial stress among resident doctors.</p><p>"BMC MARD has been consistently following up on this issue since July 2025 through multiple letters, meetings, and discussions with senior administrative officials. The matter has also been discussed at the level of the Deputy Municipal Commissioner (Public Health), and instructions have been given to present it in a meeting of all deans for a final decision," mentioned the press release.</p><p>On April 6, 2026, BMC MARD submitted a detailed letter to the Municipal Commissioner, Deputy Municipal Commissioner (PH), Additional Municipal Commissioner (WS), Director (MEMH), and all hospital deans.</p><p>During these representations, Dr. Chinmay Kelkar (President, BMC MARD), Dr. Digvijay Jadhav (Vice President), Dr. Amar Agme (Secretary), Dr. Kaustubh Kokil (Secretary), and Dr. Shubham Solanke (President, KEM MARD) were present. </p><p>Additionally, BMC MARD representatives met the Deputy Municipal Commissioner (PH) and Additional Municipal Commissioner (WS) in person and held detailed discussions. The Deputy Municipal Commissioner (PH) has scheduled a meeting on April 9 in the afternoon regarding this issue.</p><p>The association has also met Deputy Mayor Mr. Sanjay Ghadi and discussed the delay in implementing the DA hike. </p><p><i>"Resident doctors are the backbone of Mumbai’s public healthcare system and provide continuous 24×7 services. In such a situation, the delay in implementing their rightful and government-approved financial benefits is a serious issue, leading to growing dissatisfaction among them. BMC MARD has clearly informed the administration that they expect an official circular to be issued by Thursday. Failing this, they will be compelled to intensify their protest in phases starting Friday, through democratic means. So far, BMC MARD has shown restraint and chosen dialogue with the administration. However, the association has emphasized that an immediate and concrete decision is now necessary," </i>said the association. </p><p>Providing an update to Medical Dialogues, Dr Chinmay Kelkar, President, BMC MARD, said, "We have submitted a detailed representation to Hon’ble MC, DMC (PH), AMC, Director (MEMH), and all Deans, and also met Hon’ble Deputy Mayor Shri Sanjay Ghadi regarding this issue. We are expecting the official circular by Thursday. If not, a token protest from Friday will be held, followed by escalation."</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/jnk-nhm-staff-launch-72-hour-strike-over-demand-for-regularisation-salary-deductions-167895" target="_blank">JnK NHM staff launch 72-Hour strike over demand for regularisation, salary deductions</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 08/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-08april2026</link>
<guid>https://edusehat.com/en/health-bulletin-08april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:Over 2,300 CPS Doctors Face Uncertainty Amid Exam Delays, NMC Urged to ActHighlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors&#039; body has written to the National Medical Commission (NMC), requesting its intervention in the matter.In a letter addressed to the Chairperson of the Apex Medical Commission, the Federation of All India Medical Association (FAIMA) has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year.For more details, check out the full story on the link below:Over 2,300 CPS doctors in limbo as exams delayed, NMC intervention urgedSC Quashes Criminal Proceedings Against Paediatric Surgeon in Toddler&#039;s Orchidectomy CaseGranting relief to a paediatric surgeon who performed an orchidectomy on a toddler, the Supreme Court quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.For more details, check out the full story on the link below:Operating surgeon best judge of procedure- SC quashes criminal proceedings against paediatric surgeon in toddler&#039;s orchidectomy caseVacant Medical Seat Due to Fraud Must Go to Next Eligible Candidate: Supreme CourtThe Supreme Court of India has ruled that medical seats vacated due to fraud must be allotted to the next eligible candidate in the merit list, ensuring no seat goes unused. Delivering the judgment on April 6, 2026, the bench led by Justice J.K. Maheshwari emphasized that medical seats are a “national resource” and cannot be wasted, according to Reliable Study media report. The Court clarified that allowing such seats to remain vacant would unfairly penalize deserving candidates and indirectly benefit fraudulent actions, undermining the integrity of competitive exams like NEET-UG.The ruling places responsibility on counselling authorities, including the Medical Counselling Committee, to promptly reallocate such seats based on merit. It reinforces transparency, discourages malpractice, and ensures optimal utilization of limited medical seats amid ongoing doctor shortages. The decision also highlights the need for stronger fraud detection and efficient counselling coordination, ensuring that deserving students are not deprived of opportunities due to irregularities in the admission process.Karnataka Government Warns Hospitals of Legal Action for Failing to Report Minor PregnanciesTaking a significant step to ensure the safety of minors, the Karnataka Government has issued new directives mandating all hospitals in the state to report cases of pregnancy involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports The Indian Express.For more details, check out the full story on the link below:Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340363-health-bulletin-79.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 08April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340363-health-bulletin-79.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>Over 2,300 CPS Doctors Face Uncertainty Amid Exam Delays, NMC Urged to Act</b></p><div class="pasted-from-word-wrapper"><p>Highlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors' body has written to the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>), requesting its intervention in the matter.</p><div class="pasted-from-word-wrapper"><div></div><p>In a letter addressed to the Chairperson of the Apex Medical Commission, the <a href="https://medicaldialogues.in/topics/FAIMA">Federation of All India Medical Association (FAIMA)</a> has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year.</p></div><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/doctors/over-2300-cps-doctors-in-limbo-as-exams-delayed-nmc-intervention-urged-168181" target="_blank"><i><b>Over 2,300 CPS doctors in limbo as exams delayed, NMC intervention urged</b></i></a></p></div><p><br></p><p><b>SC Quashes Criminal Proceedings Against Paediatric Surgeon in Toddler's Orchidectomy Case</b></p><div class="pasted-from-word-wrapper"><p>Granting relief to a <a href="https://medicaldialogues.in/topics/paediatric-surgeon" target="_blank">paediatric surgeon</a> who performed an orchidectomy on a toddler, the<a href="https://medicaldialogues.in/topics/supreme-court" target="_blank"> Supreme Court</a> quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.</p><div></div><p>The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/operating-surgeon-best-judge-of-procedure-sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case-168154" target="_blank"><i><b>Operating surgeon best judge of procedure- SC quashes criminal proceedings against paediatric surgeon in toddler's orchidectomy case</b></i></a></p></div><p><br></p><p><b>Vacant Medical Seat Due to Fraud Must Go to Next Eligible Candidate: Supreme Court</b></p><p>The Supreme Court of India has ruled that medical seats vacated due to fraud must be allotted to the next eligible candidate in the merit list, ensuring no seat goes unused. Delivering the judgment on April 6, 2026, the bench led by Justice J.K. Maheshwari emphasized that medical seats are a “national resource” and cannot be wasted, according to Reliable Study media report.</p><p> The Court clarified that allowing such seats to remain vacant would unfairly penalize deserving candidates and indirectly benefit fraudulent actions, undermining the integrity of competitive exams like NEET-UG.</p><p>The ruling places responsibility on counselling authorities, including the Medical Counselling Committee, to promptly reallocate such seats based on merit. It reinforces transparency, discourages malpractice, and ensures optimal utilization of limited medical seats amid ongoing doctor shortages. The decision also highlights the need for stronger fraud detection and efficient counselling coordination, ensuring that deserving students are not deprived of opportunities due to irregularities in the admission process.</p><p><br></p><p><b>Karnataka Government Warns Hospitals of Legal Action for Failing to Report Minor Pregnancies</b></p><div class="pasted-from-word-wrapper"><p>Taking a significant step to ensure the safety of minors, the <a href="https://medicaldialogues.in/state-news/karnataka">Karnataka</a> Government has issued new directives mandating all hospitals in the state to report cases of <a href="https://medicaldialogues.in/topics/pregnant">pregnancy</a> involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.</p><div></div><p>As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports <a href="https://indianexpress.com/article/cities/bangalore/report-child-pregnancies-or-face-action-karnataka-issues-stern-mandate-for-all-hospitals-to-initiate-pocso-cases-10616814/" rel="nofollow">The Indian Express</a>.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/hospitals-to-face-legal-action-for-failing-to-report-minor-pregnancies-karnataka-govt-168115" target="_blank"><b><i>Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Altogether 4,689 DM, MCh seats, 616 granted in 2025&#45;26: NMC releases tentative seat matrix</title>
<link>https://edusehat.com/en/altogether-4689-dm-mch-seats-616-granted-in-2025-26-nmc-releases-tentative-seat-matrix</link>
<guid>https://edusehat.com/en/altogether-4689-dm-mch-seats-616-granted-in-2025-26-nmc-releases-tentative-seat-matrix</guid>
<description><![CDATA[ New Delhi: Altogether 616 super speciality seats have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year&#039;s 4073 seats, according to the National Medical Commission (NMC).Releasing the tentative seat matrix for super specialty courses, the Medical Assessment &amp; Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.As per the data, a total of 4,073 PG super specialty seats were available during the academic year 2024-25. With the addition of 616 seats, the total number has increased to 4,689 seats for the academic year 2025-26.&quot;The number of seats available as on 2.4.2026 in various Post-Graduate (Super Specialty) courses in Medical Colleges/Institutions after the inclusion of seats granted on or before 1.4.26 under the purview of the National Medical Commission (NMC) for the Academic Year 2025-26 is attached for the information of all stakeholders,&quot; mentioned the notice issued on April 7, 2026.MARB has further requested medical colleges and institutions to verify and confirm the number of seats available against their respective institutions. In case of any discrepancy, the board asked them to bring the matter to their notice along with supporting documents within 15 days from the date of this notice on the mentioned mail.The notice further warns that if colleges fail to report discrepancies within the given time, it may affect the updating of student details on the NMC Admission Portal.&quot;The LOPs for sanctioned PG seats for AY 2025-26 are in the process of being issued. The counselling authorities need not wait for the LOP&#039;s from institutions to include them in the counselling process. The matrix uploaded on the website shall be considered as valid document for counselling process,&quot; the notice read. Speciality-wise additional seats granted in 2025-26For specialty wise, a total of 77 seats have been added in DM Cardiology, followed by 41 seats in DM Nephrology and 34 seats in DM Critical Care Medicine, 29 seats in DM Neurology, while 20 seats in DM Medical Gastroenterology. Further, 18 seats have been added in DM Cardiac-Anaesthesia, 16 seats in DM Clinical Immunology &amp; Rheumatology, and 12 seats in DM Interventional Radiology, 10 seats in DM Endocrinology, 8 seats in DM Onco Pathology and DM Neuro Anaesthesia, 5 seats in DM Medical Genetics and DM-Medical Gastroenterology, and 4 seats each in DM Clinical Hematology, DM Hepatology, DM Paediatric and Neonatal Anaesthesia, and DM Pediatric Cardiology, 2 seats each in DM Geriatric Mental Health, DM Pulmonary Medicine, DM Pediatrics Gastroenterology, DM Paediatrics Nephrology, DM Endocrinology (separate category), DM Pulmonary Medicine (another category), and Hepato Pancreato Biliary Surgery, 2 seats each in DM Geriatric Mental Health, DM Pulmonary Medicine, DM Pediatrics Gastroenterology, DM Paediatrics Nephrology, DM Endocrinology (separate entry), DM Pulmonary Medicine (another category), and Hepato Pancreato Biliary Surgery, 8 seats in M.Ch Paediatric Surgery (separate entry), 6 seats in M.Ch–Urology, 5 seats in M.Ch Vascular Surgery, and 4 seats in M.Ch Head &amp; Neck Surgery and M.Ch Gynaecological Oncology. Smaller additions include 2 seats each in M.Ch Hepato Pancreato Biliary Surgery, M.Ch Plastic and Reconstructive Surgery (separate category), and related niche courses.
 
 
 
 
 
  Course
  Name
  Sum of Seats
  during AY 2024
  Sum of No. of
  seats granted in AY 25
  Final
  seats
 
 
  DM -
  Cardiac-Anaesthesia
  49
  18
  67
 
 
  DM - Clinical
  Hematology
  32
  4
  36
 
 
  DM - Clinical
  Immunology &amp;
    Rheumatology
  38
  16
  54
 
 
  DM - Critical
  Care Medicine
  103
  34
  137
 
 
  DM -
  Endocrinology
  92
  10
  102
 
 
  DM - Geriatric
  Mental Health
  0
  2
  2
 
 
  DM -
  Hepatology
  29
  4
  33
 
 
  DM -
  Infectious Disease
  17
  0
  17
 
 
  DM -
  Interventional Radiology
  31
  12
  43
 
 
  DM - Medical
  Gastroenterology
  228
  20
  248
 
 
  DM - Medical
  Genetics
  4
  5
  9
 
 
  DM -
  Nephrology
  243
  41
  284
 
 
  DM - Neuro
  Anasthesia
  18
  8
  26
 
 
  DM - Neuro
  Radiology
  1
  0
  1
 
 
  DM - Neurology
  351
  29
  380
 
 
  DM - Onco
  Pathology
  0
  8
  8
 
 
  DM - Organ
  Transplant Anaesthesia &amp;
    Critical Care
  5
  0
  5
 
 
  DM -
  Paediatric and Neonatal Anaesthesia
  0
  4
  4
 
 
  DM -
  Paediatric Cardiology
  2
  0
  2
 
 
  DM -
  Paediatric Hepatology
  3
  0
  3
 
 
  DM -
  Paediatric Neurology
  8
  0
  8
 
 
  DM -
  Paediatric Oncology
  10
  0
  10
 
 
  DM - Pediatric
  Cardiology
  0
  4
  4
 
 
  DM -
  Pediatrics Gastroenterology
  4
  2
  6
 
 
  DM - Pulmonary
  and Critical Care
    medicine
  6
  0
  6
 
 
  DM - Pulmonary
  Medicine
  0
  2
  2
 
 
  DM -
  Rheumatology
  6
  0
  6
 
 
  DM- Cardiology
  508
  77
  585
 
 
  DM- Clinical
  Pharmacology
  9
  0
  9
 
 
  DM-
  Endocrinology
  11
  2
  13
 
 
  DM Geriatic
  Mental Health
  3
  0
  3
 
 
  DM- Medical
  Oncology
  162
  16
  178
 
 
  DM- Onco
  Pathology
  44
  4
  48
 
 
  DM- Paediatric
  and neonatal Anesthesia
  2
  0
  2
 
 
  DM-
  Paediatrics Nephrology
  8
  2
  10
 
 
  DM Paediatrics
  oncology
  10
  0
  10
 
 
  DM- Pulmonary
  Medicine
  42
  5
  47
 
 
  DM-
  Pulmonology
  2
  0
  2
 
 
  DM- Virology
  5
  0
  5
 
 
  DM/M. Ch-
  Reproductive Medicine and
    Surgery
  21
  0
  21
 
 
  DM-Medical
  Gastroenterology
  0
  5
  5
 
 
  DM-Neonatology
  90
  24
  114
 
 
  DM-Onco
  Pathology
  0
  2
  2
 
 
  DM-Paediatric
  Neurology
  2
  0
  2
 
 
  Hepato
  Pancreato Biliary Surgery
  0
  2
  2
 
 
  M Ch. -
  Thorasic Surgery
  2
  0
  2
 
 
  M. Ch - Neuro
  Surgery
  387
  335
  422
 
 
  M. Ch -
  Plastic Surgery
  2
  0
  2
 
 
  M. Ch-
  Gynaecological Oncology
  4
  0
  4
 
 
  M. Ch-
  Pediatric Surgery
  207
  17
  224
 
 
  M.CH -
  Cardiology
  1
  0
  1
 
 
  M.Ch -
  Endocrine Surgery
  11
  0
  11
 
 
  M.Ch -
  Gynaecological Oncology
  26
  2
  28
 
 
  M.Ch - Head
  &amp; Neck Surgery
  31
  4
  35
 
 
  M.Ch - Hepato
  Pancreato Biliary Surgery
  11
  2
  13
 
 
  M.Ch - Medical
  Gastroenterology
  6
  0
  6
 
 
  M.Ch - Neuro
  Surgery(3 years)
  1
  0
  1
 
 
  M.Ch - Neuro
  Surgery(6 years)
  2
  0
  2
 
 
  M.Ch -
  Paediatric Orthopaedics
  10
  0
  10
 
 
  M.Ch -
  Paediatric Surgery
  0
  8
  8
 
 
  M.Ch - Plastic
  Surgery/Plastic &amp; Reconstructive Surgery
  288
  44
  332
 
 
  M.Ch -
  Surgical Gastroenterology
  89
  20
  109
 
 
  M.Ch -
  Surgical Oncology
  180
  40
  220
 
 
  M.Ch -
  Thoracic Surgery/Cardio Thoracic Surgery/Cardio Vascular and thoracic Surgery
  210
  17
  227
 
 
  M.Ch -
  Urology/Genito-Urinary Surgery
  371
  52
  423
 
 
  M.Ch -
  Vascular Surgery
  25
  5
  30
 
 
  M.Ch Pediatric
  2
  0
  2
 
 
  M.Ch. - Hand
  Surgery
  8
  0
  8
 
 
  M.Ch.- Plastic
  and
    Reconstructive Surgery
  0
  2
  2
 
 
  M.Ch–Urology
  0
  6
  6
 
 
  Grand Total
  4073
  616
  4689
 State-wise additional seats granted in 2025-26Among the states, Odisha recorded the highest increase with 71 seats added, followed by Karnataka with 63 seats, Telangana with 62 seats, and Uttar Pradesh with 58 seats, Gujarat with 52 additional seats, while Tamil Nadu with 46 seats and Rajasthan with 43 seats. Maharashtra rwith 39 seats, Punjab with 32 seats being added, Andhra Pradesh and Jammu &amp; Kashmir each with 26 seats, Assam with 20 seats, Madhya Pradesh with 18 seats, Uttarakhand with 17 seats, Kerala with 14 seats, Delhi with 13 seats, Haryana with 6 additional seats, Goa with 3 seats, Bihar with 3 seats, Chhattisgarh and Manipur, with 2 seats each.
 
 
 
  States
  seats during AY
  2024
    25
  seats granted in
  AY 25
    26
  Final seats
 
 
  Andhra Pradesh
  208
  26
  234
 
 
  Assam
  59
  20
  79
 
 
  Bihar
  47
  3
  50
 
 
  Chandigarh
  7
  0
  7
 
 
  Chhatisgarh
  11
  2
  13
 
 
  Delhi
  200
  13
  213
 
 
  Goa
  16
  3
  19
 
 
  Gujarat
  126
  52
  178
 
 
  Haryana
  34
  6
  40
 
 
  Jammu &amp;
  Kashmir
  46
  26
  72
 
 
  Jharkhand
  11
  0
  11
 
 
  Karnataka
  498
  63
  561
 
 
  Kerala
  252
  14
  266
 
 
  Madhya Pradesh
  117
  18
  135
 
 
  Maharashtra
  413
  39
  452
 
 
  Manipur
  5
  2
  7
 
 
  Meghalaya
  4
  0
  4
 
 
  Orissa
  119
  71
  190
 
 
  Pondicherry
  6
  0
  6
 
 
  Punjab
  41
  32
  73
 
 
  Rajasthan
  341
  43
  384
 
 
  Tamil Nadu
  697
  46
  743
 
 
  Telangana
  214
  62
  276
 
 
  Uttar Pradesh
  343
  58
  401
 
 
  Uttarakhand
  37
  17
  54
 
 
  West Bengal
  221
  0
  221
 
 
  Grand Total
  4073
  616
  4689
 Referring to the MARB Notice, NMC Secretary Dr Raghav Langer wrote to the Director/Principal/Dean of all medical colleges under NMC and informed them about tentative seats for Post-Graduate courses in Medical Colleges/ Institutions for the Academic Year (AY) 2025-26.&quot;Kind reference is invited to the Public Notice of even number dated 07-04-2026 (copy enclosed) as issued by Medical Assessment &amp; Rating Board (MARB) of National Medical Commission (NMC) on the subject mentioned above being self-explanatory inter-alia duly enclosing the list of seats available as on 2.4.2026 in various Post-Graduate (Super Specialty) courses in Medical Colleges/Institutions after the inclusion of seats granted on or before 1.4.26 under the purview of the National Medical Commission (NMC) for the Academic Year (AY) 2025-26 and requesting the stakeholders to verify and bring any discrepancy to its notice on the designated mail. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. Accordingly, all concerned stakeholders are requested to take note of the same and the other instructions for compliance and necessary action on their part,&quot; mentioned the letter. To view the NMC notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/08/publicnoticemegedneetpgssseats2426-340364.pdfAlso read- NMC clears 49 additional DM, MCh seats for 2025-26 after appeals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340305-seat-matrix-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Altogether, 4, 689, DM, MCh, seats, 616, granted, 2025-26:, NMC, releases, tentative, seat, matrix</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340305-seat-matrix-1.webp"><p><b>New Delhi: </b>Altogether 616 <a href="https://medicaldialogues.in/topics/super-speciality" target="_blank">super speciality seats</a> have been added in the academic year 2025-26, taking the total DM and MCh seats to 4689 from preivious year's 4073 seats, according to the <a href="https://medicaldialogues.in/topics/NMC" target="_blank">National Medical Commission </a>(NMC).</p><p>Releasing the tentative seat matrix for super specialty courses, the Medical Assessment & Rating Board (MARB) of NMC shared a detailed list of seats available as of April 2, 2026, in various DM and M.Ch courses across medical colleges and institutions in the country. These include all seats that were approved on or before April 1, 2026, under NMC’s purview.</p><p>As per the data, a total of 4,073 PG super specialty seats were available during the academic year 2024-25. With the addition of 616 seats, the total number has increased to 4,689 seats for the academic year 2025-26.</p><p><i>"The number of seats available as on 2.4.2026 in various Post-Graduate (Super Specialty) courses in Medical Colleges/Institutions after the inclusion of seats granted on or before 1.4.26 under the purview of the National Medical Commission (NMC) for the Academic Year 2025-26 is attached for the information of all stakeholders,"</i> mentioned the notice issued on April 7, 2026.</p><p>MARB has further requested medical colleges and institutions to verify and confirm the number of seats available against their respective institutions. In case of any discrepancy, the board asked them to bring the matter to their notice along with supporting documents within 15 days from the date of this notice on the mentioned mail.</p><p>The notice further warns that if colleges fail to report discrepancies within the given time, it may affect the updating of student details on the NMC Admission Portal.</p><p><i>"The LOPs for sanctioned PG seats for AY 2025-26 are in the process of being issued. The counselling authorities need not wait for the LOP's from institutions to include them in the counselling process. The matrix uploaded on the website shall be considered as valid document for counselling process,"</i> the notice read. </p><p><b>Speciality-wise additional seats granted in 2025-26</b></p><p>For specialty wise, a total of 77 seats have been added in DM Cardiology, followed by 41 seats in DM Nephrology and 34 seats in DM Critical Care Medicine, 29 seats in DM Neurology, while 20 seats in DM Medical Gastroenterology. Further, 18 seats have been added in DM Cardiac-Anaesthesia, 16 seats in DM Clinical Immunology & Rheumatology, and 12 seats in DM Interventional Radiology, 10 seats in DM Endocrinology, 8 seats in DM Onco Pathology and DM Neuro Anaesthesia, 5 seats in DM Medical Genetics and DM-Medical Gastroenterology, and 4 seats each in DM Clinical Hematology, DM Hepatology, DM Paediatric and Neonatal Anaesthesia, and DM Pediatric Cardiology, 2 seats each in DM Geriatric Mental Health, DM Pulmonary Medicine, DM Pediatrics Gastroenterology, DM Paediatrics Nephrology, DM Endocrinology (separate category), DM Pulmonary Medicine (another category), and Hepato Pancreato Biliary Surgery, 2 seats each in DM Geriatric Mental Health, DM Pulmonary Medicine, DM Pediatrics Gastroenterology, DM Paediatrics Nephrology, DM Endocrinology (separate entry), DM Pulmonary Medicine (another category), and Hepato Pancreato Biliary Surgery, 8 seats in M.Ch Paediatric Surgery (separate entry), 6 seats in M.Ch–Urology, 5 seats in M.Ch Vascular Surgery, and 4 seats in M.Ch Head & Neck Surgery and M.Ch Gynaecological Oncology. Smaller additions include 2 seats each in M.Ch Hepato Pancreato Biliary Surgery, M.Ch Plastic and Reconstructive Surgery (separate category), and related niche courses.</p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="1014">
 <colgroup><col width="505">
 <col width="182">
 <col width="218">
 <col width="109">
 </colgroup><tbody><tr height="18">
  <td height="18" class="xl65" width="505">Course
  Name</td>
  <td class="xl67" width="182">Sum of Seats
  during AY 2024</td>
  <td class="xl67" width="218">Sum of No. of
  seats granted in AY 25</td>
  <td class="xl67" width="109">Final
  seats</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Cardiac-Anaesthesia</td>
  <td class="xl66">49</td>
  <td class="xl66">18</td>
  <td class="xl66">67</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Clinical
  Hematology</td>
  <td class="xl66">32</td>
  <td class="xl66">4</td>
  <td class="xl66">36</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Clinical
  Immunology &<br>
    Rheumatology</td>
  <td class="xl66">38</td>
  <td class="xl66">16</td>
  <td class="xl66">54</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Critical
  Care Medicine</td>
  <td class="xl66">103</td>
  <td class="xl66">34</td>
  <td class="xl66">137</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Endocrinology</td>
  <td class="xl66">92</td>
  <td class="xl66">10</td>
  <td class="xl66">102</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Geriatric
  Mental Health</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Hepatology</td>
  <td class="xl66">29</td>
  <td class="xl66">4</td>
  <td class="xl66">33</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Infectious Disease</td>
  <td class="xl66">17</td>
  <td class="xl66">0</td>
  <td class="xl66">17</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Interventional Radiology</td>
  <td class="xl66">31</td>
  <td class="xl66">12</td>
  <td class="xl66">43</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Medical
  Gastroenterology</td>
  <td class="xl66">228</td>
  <td class="xl66">20</td>
  <td class="xl66">248</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Medical
  Genetics</td>
  <td class="xl66">4</td>
  <td class="xl66">5</td>
  <td class="xl66">9</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Nephrology</td>
  <td class="xl66">243</td>
  <td class="xl66">41</td>
  <td class="xl66">284</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Neuro
  Anasthesia</td>
  <td class="xl66">18</td>
  <td class="xl66">8</td>
  <td class="xl66">26</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Neuro
  Radiology</td>
  <td class="xl66">1</td>
  <td class="xl66">0</td>
  <td class="xl66">1</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Neurology</td>
  <td class="xl66">351</td>
  <td class="xl66">29</td>
  <td class="xl66">380</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Onco
  Pathology</td>
  <td class="xl66">0</td>
  <td class="xl66">8</td>
  <td class="xl66">8</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Organ
  Transplant Anaesthesia &<br>
    Critical Care</td>
  <td class="xl66">5</td>
  <td class="xl66">0</td>
  <td class="xl66">5</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Paediatric and Neonatal Anaesthesia</td>
  <td class="xl66">0</td>
  <td class="xl66">4</td>
  <td class="xl66">4</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Paediatric Cardiology</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Paediatric Hepatology</td>
  <td class="xl66">3</td>
  <td class="xl66">0</td>
  <td class="xl66">3</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Paediatric Neurology</td>
  <td class="xl66">8</td>
  <td class="xl66">0</td>
  <td class="xl66">8</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Paediatric Oncology</td>
  <td class="xl66">10</td>
  <td class="xl66">0</td>
  <td class="xl66">10</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Pediatric
  Cardiology</td>
  <td class="xl66">0</td>
  <td class="xl66">4</td>
  <td class="xl66">4</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Pediatrics Gastroenterology</td>
  <td class="xl66">4</td>
  <td class="xl66">2</td>
  <td class="xl66">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Pulmonary
  and Critical Care<br>
    medicine</td>
  <td class="xl66">6</td>
  <td class="xl66">0</td>
  <td class="xl66">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM - Pulmonary
  Medicine</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM -
  Rheumatology</td>
  <td class="xl66">6</td>
  <td class="xl66">0</td>
  <td class="xl66">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Cardiology</td>
  <td class="xl66">508</td>
  <td class="xl66">77</td>
  <td class="xl66">585</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Clinical
  Pharmacology</td>
  <td class="xl66">9</td>
  <td class="xl66">0</td>
  <td class="xl66">9</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-
  Endocrinology</td>
  <td class="xl66">11</td>
  <td class="xl66">2</td>
  <td class="xl66">13</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM Geriatic
  Mental Health</td>
  <td class="xl66">3</td>
  <td class="xl66">0</td>
  <td class="xl66">3</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Medical
  Oncology</td>
  <td class="xl66">162</td>
  <td class="xl66">16</td>
  <td class="xl66">178</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Onco
  Pathology</td>
  <td class="xl66">44</td>
  <td class="xl66">4</td>
  <td class="xl66">48</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Paediatric
  and neonatal Anesthesia</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-
  Paediatrics Nephrology</td>
  <td class="xl66">8</td>
  <td class="xl66">2</td>
  <td class="xl66">10</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM Paediatrics
  oncology</td>
  <td class="xl66">10</td>
  <td class="xl66">0</td>
  <td class="xl66">10</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Pulmonary
  Medicine</td>
  <td class="xl66">42</td>
  <td class="xl66">5</td>
  <td class="xl66">47</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-
  Pulmonology</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM- Virology</td>
  <td class="xl66">5</td>
  <td class="xl66">0</td>
  <td class="xl66">5</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM/M. Ch-
  Reproductive Medicine and<br>
    Surgery</td>
  <td class="xl66">21</td>
  <td class="xl66">0</td>
  <td class="xl66">21</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-Medical
  Gastroenterology</td>
  <td class="xl66">0</td>
  <td class="xl66">5</td>
  <td class="xl66">5</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-Neonatology</td>
  <td class="xl66">90</td>
  <td class="xl66">24</td>
  <td class="xl66">114</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-Onco
  Pathology</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">DM-Paediatric
  Neurology</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Hepato
  Pancreato Biliary Surgery</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M Ch. -
  Thorasic Surgery</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M. Ch - Neuro
  Surgery</td>
  <td class="xl66">387</td>
  <td class="xl66">335</td>
  <td class="xl66">422</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M. Ch -
  Plastic Surgery</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M. Ch-
  Gynaecological Oncology</td>
  <td class="xl66">4</td>
  <td class="xl66">0</td>
  <td class="xl66">4</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M. Ch-
  Pediatric Surgery</td>
  <td class="xl66">207</td>
  <td class="xl66">17</td>
  <td class="xl66">224</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.CH -
  Cardiology</td>
  <td class="xl66">1</td>
  <td class="xl66">0</td>
  <td class="xl66">1</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Endocrine Surgery</td>
  <td class="xl66">11</td>
  <td class="xl66">0</td>
  <td class="xl66">11</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Gynaecological Oncology</td>
  <td class="xl66">26</td>
  <td class="xl66">2</td>
  <td class="xl66">28</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Head
  & Neck Surgery</td>
  <td class="xl66">31</td>
  <td class="xl66">4</td>
  <td class="xl66">35</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Hepato
  Pancreato Biliary Surgery</td>
  <td class="xl66">11</td>
  <td class="xl66">2</td>
  <td class="xl66">13</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Medical
  Gastroenterology</td>
  <td class="xl66">6</td>
  <td class="xl66">0</td>
  <td class="xl66">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Neuro
  Surgery(3 years)</td>
  <td class="xl66">1</td>
  <td class="xl66">0</td>
  <td class="xl66">1</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Neuro
  Surgery(6 years)</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Paediatric Orthopaedics</td>
  <td class="xl66">10</td>
  <td class="xl66">0</td>
  <td class="xl66">10</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Paediatric Surgery</td>
  <td class="xl66">0</td>
  <td class="xl66">8</td>
  <td class="xl66">8</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch - Plastic
  Surgery/Plastic & Reconstructive Surgery</td>
  <td class="xl66">288</td>
  <td class="xl66">44</td>
  <td class="xl66">332</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Surgical Gastroenterology</td>
  <td class="xl66">89</td>
  <td class="xl66">20</td>
  <td class="xl66">109</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Surgical Oncology</td>
  <td class="xl66">180</td>
  <td class="xl66">40</td>
  <td class="xl66">220</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Thoracic Surgery/Cardio Thoracic Surgery/Cardio Vascular and thoracic Surgery</td>
  <td class="xl66">210</td>
  <td class="xl66">17</td>
  <td class="xl66">227</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Urology/Genito-Urinary Surgery</td>
  <td class="xl66">371</td>
  <td class="xl66">52</td>
  <td class="xl66">423</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch -
  Vascular Surgery</td>
  <td class="xl66">25</td>
  <td class="xl66">5</td>
  <td class="xl66">30</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch Pediatric</td>
  <td class="xl66">2</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch. - Hand
  Surgery</td>
  <td class="xl66">8</td>
  <td class="xl66">0</td>
  <td class="xl66">8</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch.- Plastic
  and<br>
    Reconstructive Surgery</td>
  <td class="xl66">0</td>
  <td class="xl66">2</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">M.Ch–Urology</td>
  <td class="xl66">0</td>
  <td class="xl66">6</td>
  <td class="xl66">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Grand Total</td>
  <td class="xl66">4073</td>
  <td class="xl66">616</td>
  <td class="xl66">4689</td>
 </tr></tbody></table></div><p><b>State-wise additional seats granted in 2025-26</b></p><p>Among the states, Odisha recorded the highest increase with 71 seats added, followed by Karnataka with 63 seats, Telangana with 62 seats, and Uttar Pradesh with 58 seats, Gujarat with 52 additional seats, while Tamil Nadu with 46 seats and Rajasthan with 43 seats. Maharashtra rwith 39 seats, Punjab with 32 seats being added, Andhra Pradesh and Jammu & Kashmir each with 26 seats, Assam with 20 seats, Madhya Pradesh with 18 seats, Uttarakhand with 17 seats, Kerala with 14 seats, Delhi with 13 seats, Haryana with 6 additional seats, Goa with 3 seats, Bihar with 3 seats, Chhattisgarh and Manipur, with 2 seats each.</p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="302">
 <colgroup><col width="110">
 <col width="64" span="3">
 </colgroup><tbody><tr height="70">
  <td height="70" class="xl65" width="110">States</td>
  <td class="xl66" width="64">seats during AY
  2024<br>
    25</td>
  <td class="xl66" width="64">seats granted in
  AY 25<br>
    26</td>
  <td class="xl65" width="64">Final seats</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Andhra Pradesh</td>
  <td class="xl65">208</td>
  <td class="xl65">26</td>
  <td class="xl65">234</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Assam</td>
  <td class="xl65">59</td>
  <td class="xl65">20</td>
  <td class="xl65">79</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Bihar</td>
  <td class="xl65">47</td>
  <td class="xl65">3</td>
  <td class="xl65">50</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Chandigarh</td>
  <td class="xl65">7</td>
  <td class="xl65">0</td>
  <td class="xl65">7</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Chhatisgarh</td>
  <td class="xl65">11</td>
  <td class="xl65">2</td>
  <td class="xl65">13</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Delhi</td>
  <td class="xl65">200</td>
  <td class="xl65">13</td>
  <td class="xl65">213</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Goa</td>
  <td class="xl65">16</td>
  <td class="xl65">3</td>
  <td class="xl65">19</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Gujarat</td>
  <td class="xl65">126</td>
  <td class="xl65">52</td>
  <td class="xl65">178</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Haryana</td>
  <td class="xl65">34</td>
  <td class="xl65">6</td>
  <td class="xl65">40</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Jammu &
  Kashmir</td>
  <td class="xl65">46</td>
  <td class="xl65">26</td>
  <td class="xl65">72</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Jharkhand</td>
  <td class="xl65">11</td>
  <td class="xl65">0</td>
  <td class="xl65">11</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Karnataka</td>
  <td class="xl65">498</td>
  <td class="xl65">63</td>
  <td class="xl65">561</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Kerala</td>
  <td class="xl65">252</td>
  <td class="xl65">14</td>
  <td class="xl65">266</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Madhya Pradesh</td>
  <td class="xl65">117</td>
  <td class="xl65">18</td>
  <td class="xl65">135</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Maharashtra</td>
  <td class="xl65">413</td>
  <td class="xl65">39</td>
  <td class="xl65">452</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Manipur</td>
  <td class="xl65">5</td>
  <td class="xl65">2</td>
  <td class="xl65">7</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Meghalaya</td>
  <td class="xl65">4</td>
  <td class="xl65">0</td>
  <td class="xl65">4</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Orissa</td>
  <td class="xl65">119</td>
  <td class="xl65">71</td>
  <td class="xl65">190</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Pondicherry</td>
  <td class="xl65">6</td>
  <td class="xl65">0</td>
  <td class="xl65">6</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Punjab</td>
  <td class="xl65">41</td>
  <td class="xl65">32</td>
  <td class="xl65">73</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Rajasthan</td>
  <td class="xl65">341</td>
  <td class="xl65">43</td>
  <td class="xl65">384</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Tamil Nadu</td>
  <td class="xl65">697</td>
  <td class="xl65">46</td>
  <td class="xl65">743</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Telangana</td>
  <td class="xl65">214</td>
  <td class="xl65">62</td>
  <td class="xl65">276</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Uttar Pradesh</td>
  <td class="xl65">343</td>
  <td class="xl65">58</td>
  <td class="xl65">401</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Uttarakhand</td>
  <td class="xl65">37</td>
  <td class="xl65">17</td>
  <td class="xl65">54</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">West Bengal</td>
  <td class="xl65">221</td>
  <td class="xl65">0</td>
  <td class="xl65">221</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl65">Grand Total</td>
  <td class="xl65">4073</td>
  <td class="xl65">616</td>
  <td class="xl65">4689</td>
 </tr></tbody></table></div><p>Referring to the MARB Notice, NMC Secretary Dr Raghav Langer wrote to the Director/Principal/Dean of all medical colleges under NMC and informed them about tentative seats for Post-Graduate courses in Medical Colleges/ Institutions for the Academic Year (AY) 2025-26.</p><p><i>"Kind reference is invited to the Public Notice of even number dated 07-04-2026 (copy enclosed) as issued by Medical Assessment & Rating Board (MARB) of National Medical Commission (NMC) on the subject mentioned above being self-explanatory inter-alia duly enclosing the list of seats available as on 2.4.2026 in various Post-Graduate (Super Specialty) courses in Medical Colleges/Institutions after the inclusion of seats granted on or before 1.4.26 under the purview of the National Medical Commission (NMC) for the Academic Year (AY) 2025-26 and requesting the stakeholders to verify and bring any discrepancy to its notice on the designated mail. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. Accordingly, all concerned stakeholders are requested to take note of the same and the other instructions for compliance and necessary action on their part," </i>mentioned the letter. </p><p><b>To view the NMC notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/publicnoticemegedneetpgssseats2426-340364.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/08/publicnoticemegedneetpgssseats2426-340364.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/health-news/nmc/nmc-clears-49-additional-dm-mch-seats-for-2025-26-after-appeals-167648" target="_blank">NMC clears 49 additional DM, MCh seats for 2025-26 after appeals</a></b></p>]]> </content:encoded>
</item>

<item>
<title>KNRUHS to close round 2 web options for MSc Nursing, MPT courses tomorrow, check details</title>
<link>https://edusehat.com/en/knruhs-to-close-round-2-web-options-for-msc-nursing-mpt-courses-tomorrow-check-details</link>
<guid>https://edusehat.com/en/knruhs-to-close-round-2-web-options-for-msc-nursing-mpt-courses-tomorrow-check-details</guid>
<description><![CDATA[ Telangana: The Kaloji Narayana Rao University of Health Sciences (KNRUHS) has announced the second phase of web-based counselling for admission into MSc Nursing and MPT courses for the academic year 2025-26 under the Competent Authority Quota. As per the official notification, eligible candidates listed in the final merit list can exercise their web options till April 9, 2026, through the university website, marking the next step in the ongoing admission process for affiliated colleges.To check out the list of not joined candidates in M.sc nursing and MPT admissions under competent authority quota- 2025-26 ,click the link below:  https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101454knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-not-joined-candidate-list-340336.pdfCandidates who have not joined after allotment in first phase of counselling shall
not be permitted to exercise web options in second phase of counselling.University Fee:Allotted Candidates have to pay University fee of Rs. 10,000
(Rupees Ten thousand only) through payment gateway by using
online payment Allotted Candidates have to pay University fee of Rs. 10,000
(Rupees Ten thousand only) through payment gateway by using
online payment method (Debit Card / Credit Card / Internet Banking) and download the allotment letter. Candidates who have paid University fee in the first phase need not pay again.Tuition Fee: Tuition fee is to be paid at respective colleges. The tuition fee payable is, as notified by the Government of Telangana.To check out the list of vacant seats for second phase of counselling in M.sc nursing and MPT courses under competent authority quota- 2025-26, click the link below-https://medicaldialogues.in/pdf_upload/2026/04/08/20260407102643knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-vacancies-for-second-phase-of-counselling-340347.pdfIMPORTANT INSTRUCTIONS TO CANDIDATES:1. The details of vacant seats available and seat matrix of newly added colleges for all the courses are notified on the website.2. Candidates can exercise web options through website from home or any other place having
internet facility. Use only system with Internet connection. Do not use Tabs
or Mobiles to exercise web options.3. Candidates can exercise web options to all courses and colleges to which they
are interested to join as per their priority for the course and college.4. Candidates are advised to go through the Prospectus and Rules available on
KNRUHS website before exercising web options.5. Candidates are informed that they have to exercise options to the courses and
colleges in which they are interested to join. In case the candidate does not join
the course/ college after allotment he / she will not be allowed to exercise
web-options in subsequent phases of counseling. 6. Candidates are advised to exercise web options for vacant seats in all
courses/colleges in which they are interested to join irrespective of
available vacant seats shown in seat matrix, as vacancies will arise during
counseling process due to sliding of candidates from allotted seats in first
phase of counseling to other seats as per their web options in the second
phase of counseling.7. If a seat is allotted in this phase of counseling as per web options
exercised by the candidate in this phase of counseling, the seat allotted
in 1st phase of counseling will be automatically cancelled and allotted to
the other candidate. Therefore, candidates are informed to exercise web
options carefully for sliding with awareness of this fact.8. One time password will be sent to the registered mobile number at the time
of exercising web options after saving Options. The password consists of SIX
letter code with English capital A to Z.9. Candidates a r e directed to login to check their allotment status
on website after each phase of counseling without
fail.10. The selected candidates shall download the allotment letter from website
after payment of the University fee by gateway method by using Online
payment method. (Debit Card/Credit Card/Internet Banking)11. The Candidates should take print out of allotment letter, check their
allotment and report to the Principal of allotted college on or before the date
specified on the allotment letter. Selected candidates have to report to the
Principal of the respective college before the last date for joining as specified
on the allotment letter, submit all original certificates, pay the tuition
fee/college fee to complete the process of admission. If the candidate does
not fulfill the above criteria to complete the admission process within
specified date for joining, the admission will be cancelled automatically and
the candidates will not be permitted for subsequent phases of counseling
and admission.12. If the candidate slides to other college during second phase of counseling
in colleges affiliated to KNRUHS, the candidates have to get relieved from
first phase joined college, collect custodian certificate, relieving order
and tuition fee from the principal of the college in which the candidate
has been allotted seat in first phase of counselling and report to the
Principal of allotted college in this phase of counselling before last date
of joining. Candidates who do not join the course at the allotted college in
this phase of counseling are not eligible for further phases of counseling.13. Candidates are hereby informed that final verification of original certificates
will be conducted at the allotted college and in case of any discrepancy,
the provisional allotment will be cancelled and action may be initiated as per
University regulations14. Original certificates will not be returned to candidates unless the
candidate discontinues from the course.15. The University Fee and other fees once paid shall not be refunded under
any circumstances.To view the official notices, click the links given below-https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101001knruhs-admissions-into-msc-nursing-course-second-phase-notification-for-web-options-2025-26-340348.pdfhttps://medicaldialogues.in/pdf_upload/2026/04/08/20260407101029knruhs-admissions-into-mpt-course-second-phase-notification-for-web-options-2025-26-340349.pdf   ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340355-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-51.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>KNRUHS, close, round, web, options, for, MSc, Nursing, MPT, courses, tomorrow, check, details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340355-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-51.webp"><p><b>Telangana: </b>The Kaloji Narayana Rao University of Health Sciences (<a href="https://medicaldialogues.in/topics/KNRUHS">KNRUHS</a>) has announced the second phase of web-based counselling for admission into MSc Nursing and MPT courses for the academic year 2025-26 under the Competent Authority Quota. </p><p>As per the official notification, eligible candidates listed in the final merit list can exercise their web options till April 9, 2026, through the university website, marking the next step in the ongoing admission process for affiliated colleges.</p><p><b><i>To check out the list of not joined candidates in M.sc nursing and MPT admissions under competent authority quota- 2025-26 ,click the link below:  </i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101454knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-not-joined-candidate-list-340336.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101454knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-not-joined-candidate-list-340336.pdf</i></b></a></p><p><span>Candidates who have not joined after allotment in first phase of counselling shall
not be permitted to exercise web options in second phase of counselling.</span></p><p><b><u>University Fee</u>:</b></p><div class="pasted-from-word-wrapper">Allotted Candidates have to pay University fee of Rs. 10,000
(Rupees Ten thousand only) through payment gateway by using
online payment Allotted Candidates have to pay University fee of Rs. 10,000
(Rupees Ten thousand only) through payment gateway by using
online payment <span>method (Debit Card / Credit Card / Internet Banking) and </span><span>download the allotment letter. Candidates who have paid </span><span>University fee in the first phase need not pay again.</span></div><p><b><u>Tuition Fee</u>: </b></p><p>Tuition fee is to be paid at respective colleges. The tuition fee payable is, as notified by the Government of Telangana.</p><p><b>To check out the list of vacant seats for second phase of counselling in M.sc nursing and MPT courses under competent authority quota- 2025-26, click the link below-</b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260407102643knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-vacancies-for-second-phase-of-counselling-340347.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260407102643knruhs-admissions-into-msc-nursing-and-mpt-courses-2025-26-vacancies-for-second-phase-of-counselling-340347.pdf</i></b></a></p><p><b><u>IMPORTANT INSTRUCTIONS TO CANDIDATES</u>:</b></p><p>1. The details of vacant seats available and seat matrix of newly added colleges for all the courses are notified on the website.</p><p><span>2. Candidates can exercise web options through website from home or any other place having
internet facility. Use only system with Internet connection. Do not use Tabs
or Mobiles to exercise web options.</span></p><p><span>3. Candidates can exercise web options to all courses and colleges to which they
are interested to join as per their priority for the course and college.</span></p><div class="pasted-from-word-wrapper"><div>4. Candidates are advised to go through the Prospectus and Rules available on
KNRUHS website before exercising web options.</div><div>5. Candidates are informed that they have to exercise options to the courses and
colleges in which they are interested to join. In case the candidate does not join
the course/ college after allotment he / she will not be allowed to exercise
web-options in subsequent phases of counseling. </div><div>6. Candidates are advised to exercise web options for vacant seats in all
courses/colleges in which they are interested to join irrespective of
available vacant seats shown in seat matrix, as vacancies will arise during
counseling process due to sliding of candidates from allotted seats in first
phase of counseling to other seats as per their web options in the second
phase of counseling.</div><div>7. If a seat is allotted in this phase of counseling as per web options
exercised by the candidate in this phase of counseling, the seat allotted
in 1st phase of counseling will be automatically cancelled and allotted to
the other candidate. Therefore, candidates are informed to exercise web
options carefully for sliding with awareness of this fact.</div><div>8. One time password will be sent to the registered mobile number at the time
of exercising web options after saving Options. The password consists of SIX
letter code with English capital A to Z.</div><div>9. Candidates a r e directed to login to check their allotment status
on website after each phase of counseling without
fail.</div><div>10. The selected candidates shall download the allotment letter from website
after payment of the University fee by gateway method by using Online
payment method. (Debit Card/Credit Card/Internet Banking)</div><div>11. The Candidates should take print out of allotment letter, check their
allotment and report to the Principal of allotted college on or before the date
specified on the allotment letter. Selected candidates have to report to the
Principal of the respective college before the last date for joining as specified
on the allotment letter, submit all original certificates, pay the tuition
fee/college fee to complete the process of admission. If the candidate does
not fulfill the above criteria to complete the admission process within
specified date for joining, the admission will be cancelled automatically and
the candidates will not be permitted for subsequent phases of counseling
and admission.</div><div>12. If the candidate slides to other college during second phase of counseling
in colleges affiliated to KNRUHS, the candidates have to get relieved from
first phase joined college, collect custodian certificate, relieving order
and tuition fee from the principal of the college in which the candidate
has been allotted seat in first phase of counselling and report to the
Principal of allotted college in this phase of counselling before last date
of joining. Candidates who do not join the course at the allotted college in
this phase of counseling are not eligible for further phases of counseling.</div><div>13. Candidates are hereby informed that final verification of original certificates
will be conducted at the allotted college and in case of any discrepancy,
the provisional allotment will be cancelled and action may be initiated as per
University regulations</div><div>14. Original certificates will not be returned to candidates unless the
candidate discontinues from the course.</div><div>15. The University Fee and other fees once paid shall not be refunded under
any circumstances.</div><div><b><i>To view the official notices, click the links given below-</i></b></div><div><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101001knruhs-admissions-into-msc-nursing-course-second-phase-notification-for-web-options-2025-26-340348.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101001knruhs-admissions-into-msc-nursing-course-second-phase-notification-for-web-options-2025-26-340348.pdf</i></b></a></div></div><div class="pasted-from-word-wrapper"><div><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101029knruhs-admissions-into-mpt-course-second-phase-notification-for-web-options-2025-26-340349.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/08/20260407101029knruhs-admissions-into-mpt-course-second-phase-notification-for-web-options-2025-26-340349.pdf</i></b></a></div></div><div class="pasted-from-word-wrapper"><div></div><div> </div><div></div><div> </div></div>]]> </content:encoded>
</item>

<item>
<title>Over 2,300 CPS Doctors Face Uncertainty Amid Exam Delays, NMC Urged to Act</title>
<link>https://edusehat.com/en/over-2300-cps-doctors-face-uncertainty-amid-exam-delays-nmc-urged-to-act</link>
<guid>https://edusehat.com/en/over-2300-cps-doctors-face-uncertainty-amid-exam-delays-nmc-urged-to-act</guid>
<description><![CDATA[ Highlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors&#039; body has written to the National Medical Commission (NMC), requesting its intervention in the matter.In a letter addressed to the Chairperson of the Apex Medical Commission, the Federation of All India Medical Association (FAIMA) has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year.For more details, check out the full story on the link below:
Over 2,300 CPS doctors in limbo as exams delayed, NMC intervention urged ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340351-exam-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Over, 2, 300, CPS, Doctors, Face, Uncertainty, Amid, Exam, Delays, NMC, Urged, Act</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340351-exam-1.webp"><p>Highlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors' body has written to the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>), requesting its intervention in the matter.</p><div class="pasted-from-word-wrapper"><div></div><p>In a letter addressed to the Chairperson of the Apex Medical Commission, the <a href="https://medicaldialogues.in/topics/FAIMA">Federation of All India Medical Association (FAIMA)</a> has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year.</p></div><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/health/doctors/over-2300-cps-doctors-in-limbo-as-exams-delayed-nmc-intervention-urged-168181" target="_blank"><b><i>Over 2,300 CPS doctors in limbo as exams delayed, NMC intervention urged</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market</title>
<link>https://edusehat.com/en/wegovy-hd-rollout-novo-nordisk-introduces-72-mg-dose-in-us-market</link>
<guid>https://edusehat.com/en/wegovy-hd-rollout-novo-nordisk-introduces-72-mg-dose-in-us-market</guid>
<description><![CDATA[ Bengaluru: Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States.The 7.2-milligram dose, ‌branded ⁠as Wegovy ⁠HD, gained approval under the FDA ​Commissioner&#039;s National Priority Review Voucher program last month.Also Read: Oral Weight-Loss Pills Gain Ground as Patients Prefer Cheaper, Needle-Free Options Over InjectionsBefore ​the approval, the highest authorized dose of the injectable Wegovy for ​weight loss was ⁠2.4 mg.The ‌company said the higher-dose Wegovy will be available through ⁠U.S. pharmacies, NovoCare Pharmacy and select telehealth providers.Cash-paying adults prescribed Wegovy HD can expect to pay $399 per month, while commercially insured patients may pay as little as $25 per month using ‌the Wegovy savings offer, Novo said. Last month, Novo said it plans to launch ⁠a discounted subscription plan for U.S. Wegovy patients paying for the drug themselves, offering steep discounts to regain ground ceded to Eli Lilly in the obesity-drug market.Also Read: USFDA Approves Eli Lilly&#039;s Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/25/230934-novo-nordisk-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Wegovy, Rollout:, Novo, Nordisk, Introduces, 7.2, Dose, Market</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/25/230934-novo-nordisk-50.webp"><p><b>Bengaluru:</b> <a href="https://medicaldialogues.in/topics/Novo-Nordisk">Novo Nordisk</a> said on Tuesday that it has made a higher-dose version of its blockbuster <a href="https://medicaldialogues.in/topics/weight-loss">weight-loss</a> drug <a href="https://medicaldialogues.in/topics/Wegovy">Wegovy</a> available across the United States.</p><div class="pasted-from-word-wrapper"><p>The 7.2-milligram dose, ‌branded ⁠as Wegovy ⁠HD, gained approval under the FDA ​Commissioner's National Priority Review Voucher program last month.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/oral-weight-loss-pills-gain-ground-as-patients-prefer-cheaper-needle-free-options-over-injections-168188">Also Read: Oral Weight-Loss Pills Gain Ground as Patients Prefer Cheaper, Needle-Free Options Over Injections</a></div><p>Before ​the approval, the highest authorized dose of the injectable Wegovy for ​weight loss was ⁠2.4 mg.</p><p>The ‌company said the higher-dose Wegovy will be available through ⁠U.S. pharmacies, NovoCare Pharmacy and select telehealth providers.</p><p>Cash-paying adults prescribed Wegovy HD can expect to pay $399 per month, while commercially insured patients may pay as little as $25 per month using ‌the Wegovy savings offer, Novo said. Last month, Novo said it plans to launch ⁠a discounted subscription plan for U.S. Wegovy patients paying for the drug themselves, offering steep discounts to regain ground ceded to Eli Lilly in the obesity-drug market.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/usfda-approves-eli-lillys-weight-loss-pill-foundayo-intensifies-rivalry-with-novo-nordisk-167873">Also Read: USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk</a></div></div><p><br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>SC Quashes Criminal Proceedings Against Paediatric Surgeon in Toddler&amp;apos;s Orchidectomy Case</title>
<link>https://edusehat.com/en/sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case</link>
<guid>https://edusehat.com/en/sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case</guid>
<description><![CDATA[ Granting relief to a paediatric surgeon who performed an orchidectomy on a toddler, the Supreme Court quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.For more details, check out the full story on the link below:
Operating surgeon best judge of procedure- SC quashes criminal proceedings against paediatric surgeon in toddler&#039;s orchidectomy case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340356-exam-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Quashes, Criminal, Proceedings, Against, Paediatric, Surgeon, Toddlers, Orchidectomy, Case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340356-exam-2.webp"><div class="pasted-from-word-wrapper"><p>Granting relief to a <a href="https://medicaldialogues.in/topics/paediatric-surgeon" target="_blank">paediatric surgeon</a> who performed an orchidectomy on a toddler, the<a href="https://medicaldialogues.in/topics/supreme-court" target="_blank"> Supreme Court</a> quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.</p><div></div><p>The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/health/medico-legal/operating-surgeon-best-judge-of-procedure-sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case-168154" target="_blank"><b><i>Operating surgeon best judge of procedure- SC quashes criminal proceedings against paediatric surgeon in toddler's orchidectomy case</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>AstraZeneca&amp;apos;s Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial</title>
<link>https://edusehat.com/en/astrazenecas-imfinzi-combo-shows-strong-survival-benefit-in-liver-cancer-trial</link>
<guid>https://edusehat.com/en/astrazenecas-imfinzi-combo-shows-strong-survival-benefit-in-liver-cancer-trial</guid>
<description><![CDATA[ Bengaluru: AstraZeneca said that a combination treatment with its cancer drug Imfinzi showed significant improvement in how long patients with a common liver cancer lived before their disease worsened, in a late-stage trial.The drugmaker ⁠said Imfinzi, ⁠when given in combination with other cancer treatments Imjudo and lenvatinib, along ​with a standard cancer-targeting procedure for early-stage liver cancer, showed a statistically significant and ​clinically meaningful improvement in the main study goal of progression-free survival.Also Read: AstraZeneca to Set Up Cell Therapy Hub in Shanghai, Expands CAR-T Capabilities in ChinaThis compared with when patients only underwent a procedure called transarterial chemoembolisation (TACE) for unresectable hepatocellular carcinoma (HCC).TACE is a ⁠procedure in ‌which chemotherapy treatments are injected into the liver&#039;s ​tumours, followed ​by the blocking of blood supply to the tumour, ⁠to stave it off.In an interim analysis, ​the Imfinzi combination also showed an improvement in ​patients&#039; overall survival, versus TACE alone, AstraZeneca said.Patients in the investigational arm of the trial were treated with a single shot of Imjudo, followed by regular shots of Imfinzi, a standard early style of treatment. These were given with or without ‌lenvatinib, before TACE, and then alongside TACE.Senior AstraZeneca executive Susan Galbraith said the results so far from the ​trial showed ​that starting the ⁠regimen earlier alongside TACE and lenvatinib could further improve outcomes.Analysts at JP Morgan forecast peak annual sales of $11.3 billion for the Imfinzi + Imjudo ​combination, similar to Citi analysts, and above current market expectations of about $10.6 billion.AstraZeneca last week said its experimental drug reduced flare-ups in patients with a chronic lung disease in late-stage trials, sending its shares up nearly 4%.Also Read: Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/17/241275-astrazeneca-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AstraZenecas, Imfinzi, Combo, Shows, Strong, Survival, Benefit, Liver, Cancer, Trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/17/241275-astrazeneca-50.webp"><p><b>Bengaluru:</b> <a href="https://medicaldialogues.in/topics/AstraZeneca">AstraZeneca</a> said that a combination treatment with its cancer drug <a href="https://medicaldialogues.in/topics/Imfinzi">Imfinzi</a> showed significant improvement in how long patients with a common <a href="https://medicaldialogues.in/topics/liver-cancer">liver cancer</a> lived before their disease worsened, in a late-stage trial.</p><div class="pasted-from-word-wrapper"><p>The drugmaker ⁠said Imfinzi, ⁠when given in combination with other cancer treatments Imjudo and lenvatinib, along ​with a standard cancer-targeting procedure for early-stage liver cancer, showed a statistically significant and ​clinically meaningful improvement in the main study goal of progression-free survival.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/astrazeneca-to-set-up-cell-therapy-hub-in-shanghai-expands-car-t-capabilities-in-china-167035">Also Read: AstraZeneca to Set Up Cell Therapy Hub in Shanghai, Expands CAR-T Capabilities in China</a></div><p>This compared with when patients only underwent a procedure called transarterial chemoembolisation (TACE) for unresectable hepatocellular carcinoma (HCC).</p><p>TACE is a ⁠procedure in ‌which chemotherapy treatments are injected into the liver's ​tumours, followed ​by the blocking of blood supply to the tumour, ⁠to stave it off.</p><p>In an interim analysis, ​the Imfinzi combination also showed an improvement in ​patients' overall survival, versus TACE alone, AstraZeneca said.</p><p>Patients in the investigational arm of the trial were treated with a single shot of Imjudo, followed by regular shots of Imfinzi, a standard early style of treatment. These were given with or without ‌lenvatinib, before TACE, and then alongside TACE.</p><p>Senior AstraZeneca executive Susan Galbraith said the results so far from the ​trial showed ​that starting the ⁠regimen earlier alongside TACE and lenvatinib could further improve outcomes.</p><p>Analysts at JP Morgan forecast peak annual sales of $11.3 billion for the Imfinzi + Imjudo ​combination, similar to Citi analysts, and above current market expectations of about $10.6 billion.</p><p>AstraZeneca last week said its experimental drug reduced flare-ups in patients with a chronic lung disease in late-stage trials, sending its shares up nearly 4%.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/sanofi-replaces-ceo-paul-hudson-amid-vaccine-headwinds-names-belen-garijo-successor-164633">Also Read: Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor</a></p></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Hoshiarpur likely to get new medical college with 100 MBBS seats</title>
<link>https://edusehat.com/en/hoshiarpur-likely-to-get-new-medical-college-with-100-mbbs-seats</link>
<guid>https://edusehat.com/en/hoshiarpur-likely-to-get-new-medical-college-with-100-mbbs-seats</guid>
<description><![CDATA[ Punjab-: Punjab Chief Minister Bhagwant Mann recently announced that a new medical college in Hoshiarpur would be completed within two years.This college will train 100 MBBS doctors annually and will feature a 300-bed hospital, equipped with modern facilities including OPD, MRI, CT scans, and specialised departments, as per HT report.This announcement was made while addressing a gathering, in which he stated that the &#039;Shaheed Udham Singh State Institute of Medical Sciences&#039; would be completed within two years.Also Read: 65 percent MBBS exam failure turn pass after review, BFUHS re-evaluation row sparks concern“The medical college and 300-bed hospital will come up at Hoshiarpur at a cost of ₹268 crore. It will go a long way in imparting quality health services to the people besides emerging the state as a hub of medical education,” CM added.Currently, there are only four government medical colleges in Punjab, while the number of private institutions is seven.According to the HT media news report, the state government announced the establishment of seven medical colleges in March, including two government institutions in Hoshiarpur and Kapurthala. Two minority medical colleges are being set up in Lehra Gaga and Malerkotla, while two additional institutions are being established in SBS Nagar and Sangrur under the Public-Private Partnership (PPP) model.However, the fourth government medical college, Dr B.R. Ambedkar State Institute of Medical Sciences, was established in Mohali in 2021, after nearly five decades.Meanwhile, a private college is also being established in Ludhiana. During its first budget session in 2022, the Aam Aadmi Party (AAP) government announced plans to establish 16 government medical colleges over its five-year tenure. Additionally, there are two centrally administered institutions, AIIMS Bathinda and the ESIC Medical College in Ludhiana.Along with this, the Chief Minister also announced that seven additional Health and Wellness Centres would be established to extend the reach of healthcare services to the last mile within the constituency.Also Read: CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema village ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340320-mann.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Hoshiarpur, likely, get, new, medical, college, with, 100, MBBS, seats</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340320-mann.webp"><p><b>Punjab-: </b>Punjab Chief Minister Bhagwant Mann recently announced that a <a href="https://medicaldialogues.in/topics/new-medical-college" target="_blank">new medical college</a> in Hoshiarpur would be completed within two years.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This college will train 100 <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>doctors annually and will feature a 300-bed hospital, equipped with modern facilities including OPD, MRI, CT scans, and specialised departments, as per HT report.</p><div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">This announcement was made while addressing a gathering, in which he stated that the 'Shaheed Udham Singh State Institute of Medical Sciences' would be completed within two years.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/punjab/65-percent-mbbs-exam-failure-turn-pass-after-review-bfuhs-re-evaluation-row-sparks-concern-167984"><b>Also Read: </b>65 percent MBBS exam failure turn pass after review, BFUHS re-evaluation row sparks concern</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">“The medical college and 300-bed hospital will come up at Hoshiarpur at a cost of ₹268 crore. It will go a long way in imparting quality health services to the people besides emerging the state as a hub of medical education,” CM added.</p><p dir="ltr">Currently, there are only four government medical colleges in Punjab, while the number of private institutions is seven.</p><p dir="ltr">According to the <a href="https://www.hindustantimes.com/cities/chandigarh-news/268cr-med-college-to-come-up-in-hoshiarpur-says-punjab-cm-mann-101775586714949.html" target="_blank" rel="nofollow">HT </a>media news report, the state government announced the establishment of seven medical colleges in March, including two government institutions in Hoshiarpur and Kapurthala. Two minority medical colleges are being set up in Lehra Gaga and Malerkotla, while two additional institutions are being established in SBS Nagar and Sangrur under the Public-Private Partnership (<a href="https://medicaldialogues.in/topics/ppp-model" target="_blank">PPP) model</a>.</p><p dir="ltr">However, the fourth government medical college, Dr B.R. Ambedkar State Institute of Medical Sciences, was established in Mohali in 2021, after nearly five decades.</p><p dir="ltr">Meanwhile, a private college is also being established in Ludhiana. During its first budget session in 2022, the Aam Aadmi Party (AAP) government announced plans to establish 16 government medical colleges over its five-year tenure. Additionally, there are two centrally administered institutions, AIIMS Bathinda and the ESIC Medical College in Ludhiana.</p><p dir="ltr">Along with this, the Chief Minister also announced that seven additional Health and Wellness Centres would be established to extend the reach of healthcare services to the last mile within the constituency.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/cm-mann-inaugurates-sant-attar-singh-ji-maharaj-hospital-in-cheema-village-167863"><b>Also Read: </b>CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema village</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Vacant Medical Seat Due to Fraud Must Go to Next Eligible Candidate: Supreme Court</title>
<link>https://edusehat.com/en/vacant-medical-seat-due-to-fraud-must-go-to-next-eligible-candidate-supreme-court</link>
<guid>https://edusehat.com/en/vacant-medical-seat-due-to-fraud-must-go-to-next-eligible-candidate-supreme-court</guid>
<description><![CDATA[ The Supreme Court of India has ruled that medical seats vacated due to fraud must be allotted to the next eligible candidate in the merit list, ensuring no seat goes unused. Delivering the judgment on April 6, 2026, the bench led by Justice J.K. Maheshwari emphasized that medical seats are a “national resource” and cannot be wasted, according to Reliable Study media report. The Court clarified that allowing such seats to remain vacant would unfairly penalize deserving candidates and indirectly benefit fraudulent actions, undermining the integrity of competitive exams like NEET-UG.The ruling places responsibility on counselling authorities, including the Medical Counselling Committee, to promptly reallocate such seats based on merit. It reinforces transparency, discourages malpractice, and ensures optimal utilization of limited medical seats amid ongoing doctor shortages. The decision also highlights the need for stronger fraud detection and efficient counselling coordination, ensuring that deserving students are not deprived of opportunities due to irregularities in the admission process. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340359-exam-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Vacant, Medical, Seat, Due, Fraud, Must, Next, Eligible, Candidate:, Supreme, Court</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340359-exam-3.webp"><p>The Supreme Court of India has ruled that medical seats vacated due to fraud must be allotted to the next eligible candidate in the merit list, ensuring no seat goes unused. Delivering the judgment on April 6, 2026, the bench led by Justice J.K. Maheshwari emphasized that medical seats are a “national resource” and cannot be wasted, according to Reliable Study media report.</p><p> The Court clarified that allowing such seats to remain vacant would unfairly penalize deserving candidates and indirectly benefit fraudulent actions, undermining the integrity of competitive exams like NEET-UG.</p><p>The ruling places responsibility on counselling authorities, including the Medical Counselling Committee, to promptly reallocate such seats based on merit. It reinforces transparency, discourages malpractice, and ensures optimal utilization of limited medical seats amid ongoing doctor shortages. The decision also highlights the need for stronger fraud detection and efficient counselling coordination, ensuring that deserving students are not deprived of opportunities due to irregularities in the admission process.</p>]]> </content:encoded>
</item>

<item>
<title>Karnataka Government Warns Hospitals of Legal Action for Failing to Report Minor Pregnancies</title>
<link>https://edusehat.com/en/karnataka-government-warns-hospitals-of-legal-action-for-failing-to-report-minor-pregnancies</link>
<guid>https://edusehat.com/en/karnataka-government-warns-hospitals-of-legal-action-for-failing-to-report-minor-pregnancies</guid>
<description><![CDATA[ Taking a significant step to ensure the safety of minors, the Karnataka Government has issued new directives mandating all hospitals in the state to report cases of pregnancy involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports The Indian Express.For more details, check out the full story on the link below:
Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340360-exam-4.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Karnataka, Government, Warns, Hospitals, Legal, Action, for, Failing, Report, Minor, Pregnancies</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340360-exam-4.webp"><div class="pasted-from-word-wrapper"><p>Taking a significant step to ensure the safety of minors, the <a href="https://medicaldialogues.in/state-news/karnataka">Karnataka</a> Government has issued new directives mandating all hospitals in the state to report cases of <a href="https://medicaldialogues.in/topics/pregnant">pregnancy</a> involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.</p><div></div><p>As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports <a href="https://indianexpress.com/article/cities/bangalore/report-child-pregnancies-or-face-action-karnataka-issues-stern-mandate-for-all-hospitals-to-initiate-pocso-cases-10616814/" rel="nofollow">The Indian Express</a>.</p><p><b><i>For more details, check out the full story on the link below:
</i></b></p><p><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/hospitals-to-face-legal-action-for-failing-to-report-minor-pregnancies-karnataka-govt-168115" target="_blank"><b><i>Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt</i></b></a></p><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div>]]> </content:encoded>
</item>

<item>
<title>NBE releases DNB PDCET 2026 admit card, exam on April 12</title>
<link>https://edusehat.com/en/nbe-releases-dnb-pdcet-2026-admit-card-exam-on-april-12</link>
<guid>https://edusehat.com/en/nbe-releases-dnb-pdcet-2026-admit-card-exam-on-april-12</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has released the admit cards for the Diplomate of National Board Post Diploma Centralised Entrance Test (DNB PDCET) 2026.The hall tickets have been released on the official website of the NBE. Therefore, candidates who have registered for the examination must visit the official website to download their hall tickets. Candidates will need to use their User ID and password as their login credentials to download the admit card.Also Read: NBE invites applications for DNB PDCET 2026, exam on April 12The DNB PDCET Hall Ticket is a crucial document that candidates are required to carry with them to the examination center in order to appear for the exam. Additionally, they must also carry a valid photo identity card, such as an Aadhaar Card, Voter ID Card, PAN Card, Driving License, or Passport.The DNB PDCET Admit Card 2026 will contain important information related to the examination and the applicant, such as the candidate&#039;s name, roll number, date of birth, gender, category, the course applied for, the date of the examination, the time of the examination, and details of the examination center.STEPS TO DOWNLOAD THE DNB PDCET ADMIT CARD 2026STEP 1- Visit the official website of NBE.STEP 2- Click on the ‘DNB-PDCET’ tab.STEP 3- Press on ‘Applicant login&quot;.STEP 4- Enter your login using the credentials to submit.STEP 5- DNB PDCET 2026 Admit Card will appear.STEP 6- Review and download the hall ticket for exam reference.Medical Dialogues had earlier reported that, as per the official notice issued by the NBE in this regard, DNB-PDCET 2026 will be conducted on April 12, 2026, on a computer-based platform at various examination centres nationwide. The result will be declared by May 12, 2026. Also Read: NBE releases 2026 tentative exam calendar, check FMGE, GPAT, DNB PDCET, Diploma exams dates here ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340330-admit-card.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NBE, releases, DNB, PDCET, 2026, admit, card, exam, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340330-admit-card.webp"><p><b>New Delhi:</b> The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) has released the admit cards for the Diplomate of National Board Post Diploma Centralised Entrance Test (<a href="https://medicaldialogues.in/topics/dnb-pdcet" target="_blank">DNB PDCET</a>) 2026.</p><p>The hall tickets have been released on the official website of the NBE. Therefore, candidates who have registered for the examination must visit the official website to download their hall tickets. Candidates will need to use their User ID and password as their login credentials to download the admit card.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/nbe-invites-applications-for-dnb-pdcet-2026-exam-on-april-12-164907"><b>Also Read: </b>NBE invites applications for DNB PDCET 2026, exam on April 12</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The DNB PDCET Hall Ticket is a crucial document that candidates are required to carry with them to the examination center in order to appear for the exam. Additionally, they must also carry a valid photo identity card, such as an Aadhaar Card, Voter ID Card, PAN Card, Driving License, or Passport.</p><p dir="ltr">The DNB PDCET Admit Card 2026 will contain important information related to the examination and the applicant, such as the candidate's name, roll number, date of birth, gender, category, the course applied for, the date of the examination, the time of the examination, and details of the examination center.</p><p dir="ltr"><b><u>STEPS TO DOWNLOAD THE DNB PDCET ADMIT CARD 2026</u></b></p><p dir="ltr"><b>STEP 1-</b> Visit the official website of NBE.</p><p dir="ltr"><b>STEP 2- </b>Click on the ‘DNB-PDCET’ tab.</p><p dir="ltr"><b>STEP 3-</b> Press on ‘Applicant login".</p><p dir="ltr"><b>STEP 4- </b>Enter your login using the credentials to submit.</p><p dir="ltr"><b>STEP 5- </b>DNB PDCET 2026 Admit Card will appear.</p><p dir="ltr"><b>STEP 6-</b> Review and download the hall ticket for exam reference.</p><p dir="ltr">Medical Dialogues had earlier reported that, as per the official notice issued by the NBE in this regard, DNB-PDCET 2026 will be conducted on April 12, 2026, on a computer-based platform at various examination centres nationwide. The result will be declared by May 12, 2026. </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nbe-releases-2026-tentative-exam-calendar-check-fmge-gpat-dnb-pdcet-diploma-exams-dates-here-161644"><b>Also Read: </b>NBE releases 2026 tentative exam calendar, check FMGE, GPAT, DNB PDCET, Diploma exams dates here</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>AI&#45;powered ECG could help guide lifelong heart monitoring for patients with repaired tetralogy of fallot</title>
<link>https://edusehat.com/en/ai-powered-ecg-could-help-guide-lifelong-heart-monitoring-for-patients-with-repaired-tetralogy-of-fallot</link>
<guid>https://edusehat.com/en/ai-powered-ecg-could-help-guide-lifelong-heart-monitoring-for-patients-with-repaired-tetralogy-of-fallot</guid>
<description><![CDATA[  Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and validate an artificial intelligence (AI) tool that can analyze a standard electrocardiogram (ECG) to identify patients with repaired tetralogy of Fallot who may be at risk for harmful heart changes typically detected by cardiac MRI. The study, supported by the National Institutes of Health, was published in the European Heart Journal: Digital Health.Tetralogy of Fallot is a congenital heart defect that requires surgical repair in childhood, but patients need lifelong monitoring to detect changes in heart size and function. Cardiac MRI is the gold-standard imaging test for this follow-up care; however, MRI scans are expensive, time-consuming, and not always easily accessible. Many patients miss recommended imaging.In this multicenter study, investigators trained an AI model using ECG and MRI data from patients with repaired tetralogy of Fallot and validated the model across five additional hospitals in North America. The AI learned patterns in ECG signals linked to ventricular remodeling—changes in heart size and pumping function that can signal worsening health.Key findingsAI plus ECG can estimate risk of ventricular remodeling: A quick, widely available test may help identify patients who need MRI sooner.There is potential to improve access and efficiency: The tool could help doctors prioritize MRI scans for higher-risk patients while safely delaying scans for lower-risk patients.Performance varied by hospital: Results highlight the importance of validating AI tools locally before clinical use.“This research shows how artificial intelligence can unlock new value from a routine ECG,” said Son Duong, MD, MS, lead author and Assistant Professor of Pediatrics, and Artificial Intelligence and Human Health at Icahn School of Medicine at Mount Sinai. “Our goal is to make lifelong heart monitoring more accessible and efficient for people born with congenital heart disease.”The researchers emphasize that the model is not intended to replace cardiac MRI. Instead, it could help clinicians decide when imaging is most urgently needed.“As AI becomes more integrated into health care, it is critical to rigorously validate these tools across diverse clinical settings,” said Girish Nadkarni, MD, MPH, co-senior author and Barbara T. Murphy Chair of the Windreich Department of Artificial Intelligence and Human Health, at Mount Sinai Health System. “Our findings show both the promise of AI-enabled screening and the importance of testing performance at each site before real-world implementation.” Dr. Nadkarni is also the Director of the Hasso Plattner Institute for Digital Health and Chief AI Officer, Icahn School of Medicine at Mount Sinai.Why this mattersPatients with congenital heart disease often require lifelong specialized follow-up care. By combining AI with a simple ECG, the researchers hope to:Reduce unnecessary testing and health care costsImprove access to advanced imaging for patients who need it mostPersonalize follow-up care and improve long-term outcomesNext stepsThe research team plans to test the AI-ECG approach in prospective clinical studies and trials and refine the model for younger patients. The long-term goal is to integrate the tool into routine clinical care.Reference:Son Q Duong, Akhil Vaid, Pengfei Jiang, Yuval Bitterman, Yamini Krishnamurthy, I Min Chiu, Joshua Finer, Brian Cleary, Benjamin S Glicksberg, Ruchira Garg, Michael DiLorenzo, Mark Friedberg, Evan Zahn, Matthew Lewis, Michael Satzer, David Ouyang, Pierre Elias, Tal Geva, Sunil Ghelani, Brett R Anderson, Ali Zaidi, Rachel M Wald, Girish N Nadkarni, Joshua Mayourian, Development and multicentre validation of an artificial intelligence electrocardiogram model for ventricular remodeling in repaired tetralogy of Fallot, European Heart Journal - Digital Health, Volume 7, Issue 2, March 2026, ztag015, https://doi.org/10.1093/ehjdh/ztag015
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/04/18/207616-ecg.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AI-powered, ECG, could, help, guide, lifelong, heart, monitoring, for, patients, with, repaired, tetralogy, fallot</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/04/18/207616-ecg.webp"><div class="pasted-from-word-wrapper"><p> Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and validate an <a href="https://medicaldialogues.in/topics/artificial-intelligence">artificial intelligence</a> (AI) tool that can analyze a standard <a href="https://medicaldialogues.in/topics/electrocardiogram">electrocardiogram </a>(ECG) to identify patients with repaired tetralogy of Fallot who may be at risk for harmful heart changes typically detected by cardiac MRI. The study, supported by the National Institutes of Health, was published in the <i>European Heart Journal: Digital Health.</i></p><p>Tetralogy of Fallot is a congenital heart defect that requires surgical repair in childhood, but patients need lifelong monitoring to detect changes in heart size and function. Cardiac MRI is the gold-standard imaging test for this follow-up care; however, MRI scans are expensive, time-consuming, and not always easily accessible. Many patients miss recommended imaging.</p><p>In this multicenter study, investigators trained an AI model using ECG and MRI data from patients with repaired tetralogy of Fallot and validated the model across five additional hospitals in North America. The AI learned patterns in ECG signals linked to ventricular remodeling—changes in heart size and pumping function that can signal worsening health.</p><p>Key findings</p><ul><li><b>AI plus ECG can estimate risk of ventricular remodeling:</b> A quick, widely available test may help identify patients who need MRI sooner.</li><li><b>There is potential to improve access and efficiency:</b> The tool could help doctors prioritize MRI scans for higher-risk patients while safely delaying scans for lower-risk patients.</li><li><b>Performance varied by hospital: </b>Results highlight the importance of validating AI tools locally before clinical use.</li></ul><p>“This research shows how artificial intelligence can unlock new value from a routine ECG,” said Son Duong, MD, MS, lead author and Assistant Professor of Pediatrics, and Artificial Intelligence and Human Health at Icahn School of Medicine at Mount Sinai. “Our goal is to make lifelong heart monitoring more accessible and efficient for people born with congenital heart disease.”</p><p>The researchers emphasize that the model is not intended to replace cardiac MRI. Instead, it could help clinicians decide when imaging is most urgently needed.</p><p>“As AI becomes more integrated into health care, it is critical to rigorously validate these tools across diverse clinical settings,” said Girish Nadkarni, MD, MPH, co-senior author and Barbara T. Murphy Chair of the Windreich Department of Artificial Intelligence and Human Health, at Mount Sinai Health System. “Our findings show both the promise of AI-enabled screening and the importance of testing performance at each site before real-world implementation.” Dr. Nadkarni is also the Director of the Hasso Plattner Institute for Digital Health and Chief AI Officer, Icahn School of Medicine at Mount Sinai.</p><h3>Why this matters</h3><p>Patients with congenital heart disease often require lifelong specialized follow-up care. By combining AI with a simple ECG, the researchers hope to:</p><ul><li>Reduce unnecessary testing and health care costs</li><li>Improve access to advanced imaging for patients who need it most</li><li>Personalize follow-up care and improve long-term outcomes</li></ul><h3>Next steps</h3><p>The research team plans to test the AI-ECG approach in prospective clinical studies and trials and refine the model for younger patients. The long-term goal is to integrate the tool into routine clinical care.</p><p>Reference:</p><p>Son Q Duong, Akhil Vaid, Pengfei Jiang, Yuval Bitterman, Yamini Krishnamurthy, I Min Chiu, Joshua Finer, Brian Cleary, Benjamin S Glicksberg, Ruchira Garg, Michael DiLorenzo, Mark Friedberg, Evan Zahn, Matthew Lewis, Michael Satzer, David Ouyang, Pierre Elias, Tal Geva, Sunil Ghelani, Brett R Anderson, Ali Zaidi, Rachel M Wald, Girish N Nadkarni, Joshua Mayourian, Development and multicentre validation of an artificial intelligence electrocardiogram model for ventricular remodeling in repaired tetralogy of Fallot, European Heart Journal - Digital Health, Volume 7, Issue 2, March 2026, ztag015, https://doi.org/10.1093/ehjdh/ztag015
</p></div>]]> </content:encoded>
</item>

<item>
<title>2.5 Million Jobs by 2030 in Pharma, Healthcare as Sector Shifts to Skill&#45;Led Growth: Report</title>
<link>https://edusehat.com/en/25-million-jobs-by-2030-in-pharma-healthcare-as-sector-shifts-to-skill-led-growth-report</link>
<guid>https://edusehat.com/en/25-million-jobs-by-2030-in-pharma-healthcare-as-sector-shifts-to-skill-led-growth-report</guid>
<description><![CDATA[ Mumbai: India&#039;s healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent of the workforce will likely need reskilling, according to a report released on Monday.The country&#039;s healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specialisation and technology integration across hospitals, AYUSH, home and elder care, pharma, life sciences, diagnostics, telemedicine, clinical research and public health systems, according to a report by Adecco India.Also Read: NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026The insights and numbers presented in the report are derived from data collected from over 100 Adecco clients, supplemented with credible market research sources.As demand continues to grow, the sector is expected to create over 2-2.5 million new jobs by 2030, with nearly 30-35 per cent of the workforce likely to undergo reskilling, reflecting a shift in how roles are defined across care delivery, research, and manufacturing, the report said.This growth is closely linked to the sector&#039;s expanding economic footprint, which stood at 3.3 per cent of GDP in 2022 and is projected to reach 5 per cent by 2030, supported by clinical research activity, digital health adoption, and the continued global outsourcing of pharmaceutical development and manufacturing.Diagnostics, preventive healthcare, and telemedicine are also expected to drive an estimated 20-25 per cent increase in demand for distributed and remote care roles, particularly across tier II and III markets.Hiring for advanced R&amp;D and regulatory roles is expected to increase by 25-30 per cent, aligning with a shift towards complex generics, speciality therapies, and biologics.&quot;Employers are also facing a dual challenge of volume shortages in core healthcare roles and capability gaps in specialised talent, making skill development, retention, and geographic distribution a critical workforce priority,&quot; Adecco India Associate Director and Head of Sales - Permanent Recruitment, Peush Saproo, said.While 65-70 per cent of hiring remains concentrated across Bengaluru, Hyderabad, Mumbai, Chennai, and Delhi-NCR, there is a gradual increase in hiring activity across tier II and III locations, such as Pune, Ahmedabad and Coimbatore, supported by expansion in hospital networks, manufacturing clusters, and distributed delivery models, he added.Saproo further said that over the next 5-7 years, hiring in healthcare and pharma will be shaped by India&#039;s emergence as a global talent supplier, with an estimated 25-30 per cent increase in overseas demand for healthcare professionals across key markets, such as the Middle East, Southeast Asia, the UK, and other developed regions.&quot;As this shift accelerates, demand for hybrid, tech-enabled roles combining clinical and digital capabilities will continue to rise, prompting organisations to adopt more strategic workforce planning with a stronger focus on capability building, retention, and accessing talent beyond traditional metro hubs,&quot; Saproo added.Also Read: Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340297-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>2.5, Million, Jobs, 2030, Pharma, Healthcare, Sector, Shifts, Skill-Led, Growth:, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340297-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-50.webp"><p><b>Mumbai</b>: India's healthcare and <a href="https://medicaldialogues.in/topics/pharmaceutical-sector">pharmaceutical sector </a>is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent of the workforce will likely need reskilling, according to a report released on Monday.</p><div class="pasted-from-word-wrapper"><p>The country's healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specialisation and technology integration across hospitals, AYUSH, home and elder care, pharma, life sciences, diagnostics, telemedicine, clinical research and public health systems, according to a report by Adecco India.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/medical-devices/nppa-revises-coronary-stent-prices-des-at-rs-39186-and-bms-at-rs-10762-from-april-2026-168192">Also Read: NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026</a></div><p>The insights and numbers presented in the report are derived from data collected from over 100 Adecco clients, supplemented with credible market research sources.</p><p>As demand continues to grow, the sector is expected to create over 2-2.5 million new jobs by 2030, with nearly 30-35 per cent of the workforce likely to undergo reskilling, reflecting a shift in how roles are defined across care delivery, research, and manufacturing, the report said.</p><p>This growth is closely linked to the sector's expanding economic footprint, which stood at 3.3 per cent of GDP in 2022 and is projected to reach 5 per cent by 2030, supported by clinical research activity, digital health adoption, and the continued global outsourcing of pharmaceutical development and manufacturing.</p><p>Diagnostics, preventive healthcare, and telemedicine are also expected to drive an estimated 20-25 per cent increase in demand for distributed and remote care roles, particularly across tier II and III markets.</p><p>Hiring for advanced R&D and regulatory roles is expected to increase by 25-30 per cent, aligning with a shift towards complex generics, speciality therapies, and biologics.</p><p>"Employers are also facing a dual challenge of volume shortages in core healthcare roles and capability gaps in specialised talent, making skill development, retention, and geographic distribution a critical workforce priority," Adecco India Associate Director and Head of Sales - Permanent Recruitment, Peush Saproo, said.</p><p>While 65-70 per cent of hiring remains concentrated across Bengaluru, Hyderabad, Mumbai, Chennai, and Delhi-NCR, there is a gradual increase in hiring activity across tier II and III locations, such as Pune, Ahmedabad and Coimbatore, supported by expansion in hospital networks, manufacturing clusters, and distributed delivery models, he added.</p><p>Saproo further said that over the next 5-7 years, hiring in healthcare and pharma will be shaped by India's emergence as a global talent supplier, with an estimated 25-30 per cent increase in overseas demand for healthcare professionals across key markets, such as the Middle East, Southeast Asia, the UK, and other developed regions.</p><p>"As this shift accelerates, demand for hybrid, tech-enabled roles combining clinical and digital capabilities will continue to rise, prompting organisations to adopt more strategic workforce planning with a stronger focus on capability building, retention, and accessing talent beyond traditional metro hubs," Saproo added.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-wellness-arm-faces-eur-19472-vat-penalty-in-spain-plans-to-appeal-168190">Also Read: Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal</a></p></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Regular Oral Care Improves Outcomes in hepatic decompensation and compensated Cirrhosis: Study</title>
<link>https://edusehat.com/en/regular-oral-care-improves-outcomes-in-hepatic-decompensation-and-compensated-cirrhosis-study</link>
<guid>https://edusehat.com/en/regular-oral-care-improves-outcomes-in-hepatic-decompensation-and-compensated-cirrhosis-study</guid>
<description><![CDATA[ A new study published in the journal of JHEP Reports revealed that regular dental prophylaxis and at least annual periodontal maintenance are independently linked to reduced risks of hepatic decompensation, hepatocellular carcinoma (HCC), and hospitalizations in patients with compensated cirrhosis. Integrating routine oral care into cirrhosis management may enhance overall clinical outcomes.Poor oral health has long been associated with systemic inflammation, which can worsen chronic diseases. However, until now, there has been limited data examining whether routine dental services like cleanings and periodontal maintenance which can influence outcomes in cirrhosis. Using a national cohort of U.S. veterans, this study found compelling evidence.The study analyzed data from 47,809 veterans diagnosed with compensated cirrhosis from 2005 to 2023, all of whom were eligible for comprehensive dental care through the Veterans Affairs (VA) system. This research divided participants into a group who received regular dental prophylaxis services (at least one visit per year) and another who did not.Only 17.5% of patients met the criteria for regular dental care. After adjusting for differences between groups using statistical matching techniques, the patients who maintained consistent dental visits experienced significantly lower risks of several major complications within two years.Regular dental care was associated with a 15% reduction in ascites (fluid buildup in the abdomen), a 19% reduction in hepatic encephalopathy (a decline in brain function due to liver disease), and a 27% reduction in the development of HCC. Additionally, these patients had fewer hospitalizations overall and fewer hospital visits directly related to liver complications.The study found no significant difference in rates of variceal bleeding or spontaneous bacterial peritonitis, two other serious cirrhosis complications. This research also observed that the benefit of dental care plateaued at about one visit per year, suggesting that even modest adherence can be impactful.Unlike dental care, colonoscopy adherence did not show the same protective effect, which reinforced the idea that oral health itself plays a unique role in disease progression.Overall, the findings support growing evidence that inflammation originating in the mouth can influence systemic conditions, including liver disease. These results could help reshape clinical practice by incorporating routine dental check-ups into standard care for cirrhosis patients.Source:Bajaj, J. S., Silvey, S., Aljabi, A., Deeb, J. G., &amp; Patel, N. (2026). Dental prophylactic Interventions are Associated with Lower Decompensation-related Hospitalizations over 2 years in Cirrhosis. JHEP Reports: Innovation in Hepatology, 101821, 101821. https://doi.org/10.1016/j.jhepr.2026.101821 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/01/231329-oral-health-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Regular, Oral, Care, Improves, Outcomes, hepatic, decompensation, and, compensated, Cirrhosis:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/01/231329-oral-health-50.webp"><p>A new study published in the journal of <i>JHEP Reports</i> revealed that regular dental prophylaxis and at least annual periodontal maintenance are independently linked to reduced risks of hepatic decompensation, hepatocellular carcinoma (HCC), and hospitalizations in patients with compensated cirrhosis. Integrating routine oral care into cirrhosis management may enhance overall clinical outcomes.</p><p>Poor oral health has long been associated with systemic inflammation, which can worsen chronic diseases. However, until now, there has been limited data examining whether routine dental services like cleanings and periodontal maintenance which can influence outcomes in cirrhosis. Using a national cohort of U.S. veterans, this study found compelling evidence.</p><p>The study analyzed data from 47,809 veterans diagnosed with compensated cirrhosis from 2005 to 2023, all of whom were eligible for comprehensive dental care through the Veterans Affairs (VA) system. This research divided participants into a group who received regular dental prophylaxis services (at least one visit per year) and another who did not.</p><p>Only 17.5% of patients met the criteria for regular dental care. After adjusting for differences between groups using statistical matching techniques, the patients who maintained consistent dental visits experienced significantly lower risks of several major complications within two years.</p><p>Regular dental care was associated with a 15% reduction in ascites (fluid buildup in the abdomen), a 19% reduction in hepatic encephalopathy (a decline in brain function due to liver disease), and a 27% reduction in the development of HCC. Additionally, these patients had fewer hospitalizations overall and fewer hospital visits directly related to liver complications.</p><p>The study found no significant difference in rates of variceal bleeding or spontaneous bacterial peritonitis, two other serious cirrhosis complications. This research also observed that the benefit of dental care plateaued at about one visit per year, suggesting that even modest adherence can be impactful.</p><p>Unlike dental care, colonoscopy adherence did not show the same protective effect, which reinforced the idea that oral health itself plays a unique role in disease progression.</p><p>Overall, the findings support growing evidence that inflammation originating in the mouth can influence systemic conditions, including liver disease. These results could help reshape clinical practice by incorporating routine dental check-ups into standard care for cirrhosis patients.</p><p>Source:</p><p>Bajaj, J. S., Silvey, S., Aljabi, A., Deeb, J. G., & Patel, N. (2026). Dental prophylactic Interventions are Associated with Lower Decompensation-related Hospitalizations over 2 years in Cirrhosis. JHEP Reports: Innovation in Hepatology, 101821, 101821. <a href="https://www.jhep-reports.eu/article/S2589-5559(26)00092-3/fulltext" rel="nofollow">https://doi.org/10.1016/j.jhepr.2026.101821</a></p>]]> </content:encoded>
</item>

<item>
<title>Fluconazole Successfully Treats Dupilumab&#45;Associated Palmar Erythema: Case Report</title>
<link>https://edusehat.com/en/fluconazole-successfully-treats-dupilumab-associated-palmar-erythema-case-report</link>
<guid>https://edusehat.com/en/fluconazole-successfully-treats-dupilumab-associated-palmar-erythema-case-report</guid>
<description><![CDATA[ Australia: A clinical letter published in the Australasian Journal of Dermatology highlights a potential treatment approach for a lesser-known side effect of dupilumab therapy—palmar erythema—using low-dose fluconazole. The report, authored by Katina J. Selvaraj and Geoffrey Lee from Royal Prince Alfred Hospital, Camperdown, Australia, adds to emerging evidence linking dupilumab-associated skin reactions with underlying fungal hypersensitivity.                Dupilumab, a targeted biologic therapy widely used in moderate-to-severe atopic dermatitis, has been associated with certain cutaneous adverse effects, most notably facial redness. This phenomenon has been increasingly linked to a possible immune response to Malassezia, a common skin yeast. While antifungal agents such as itraconazole, fluconazole, and ivermectin have shown benefit in managing facial erythema, reports of similar reactions affecting the palms remain scarce.The authors describe the case of a 31-year-old man with severe, generalized atopic dermatitis who was receiving dupilumab injections every two weeks. After a year of treatment, while his overall skin condition had improved, he developed persistent redness, scaling, and painful fissures on his palms, accompanied by intense itching. The condition significantly interfered with his profession as a guitarist.Extensive evaluation did not suggest contact dermatitis, and patch testing was deemed unnecessary. Microbiological tests showed mixed bacterial growth, while fungal cultures were negative—though this did not rule out Malassezia, which is known to be difficult to culture. Clinically, the presentation did not match other common diagnoses such as psoriasis or dyshidrotic eczema. The patient also had mild facial redness.Initial management with potent topical corticosteroids provided limited benefit. However, the patient reported some improvement with antifungal creams, particularly miconazole. This response, along with an elevated level of Malassezia-specific immunoglobulin E, raised suspicion of a fungal-related mechanism. Based on this, the clinicians initiated oral fluconazole at a low daily dose.Within four weeks, the patient experienced notable improvement in his symptoms. However, symptoms worsened soon after discontinuing the medication, prompting its reintroduction. Continued therapy led to sustained improvement, with reduced redness, scaling, and fissuring of the palms over several weeks. The patient also noted improvement in facial redness. Importantly, long-term use of fluconazole was well tolerated, and the patient was able to resume his professional activities.The authors suggest that fluconazole may work by reducing Malassezia colonization on the skin and through its anti-inflammatory effects. They also note that low-dose fluconazole is relatively affordable and suitable for extended use, making it a practical option in selected cases.This case underscores the need for clinicians to consider fungal hypersensitivity in patients who develop atypical skin reactions during dupilumab therapy. It also highlights the importance of individualized management strategies and careful clinical assessment in cases that do not respond to conventional treatments.Reference:Selvaraj, K. J., &amp; Lee, G. Dupilumab-Associated Palmar Erythema Successfully Treated With Fluconazole. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70089 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/30/338416-palmar-erythema.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fluconazole, Successfully, Treats, Dupilumab-Associated, Palmar, Erythema:, Case, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/30/338416-palmar-erythema.webp"><p><span>Australia: A clinical letter published in the<i> Australasian Journal of Dermatology</i> highlights a potential treatment approach for a lesser-known side effect of <a href="https://medicaldialogues.in/topics/dupilumab">dupilumab </a>therapy—palmar erythema—using low-dose fluconazole. The report, authored by Katina J. Selvaraj and Geoffrey Lee from Royal Prince Alfred Hospital, Camperdown, Australia, adds to emerging evidence linking dupilumab-associated <a href="https://medicaldialogues.in/topics/skin-reaction">skin reactions</a> with underlying fungal <a href="https://medicaldialogues.in/topics/hypersensitivity-disorders">hypersensitivity</a>.                </span></p><div class="pasted-from-word-wrapper"><div>Dupilumab, a targeted biologic therapy widely used in moderate-to-severe atopic dermatitis, has been associated with certain cutaneous adverse effects, most notably facial redness. This phenomenon has been increasingly linked to a possible immune response to Malassezia, a common skin yeast. While antifungal agents such as itraconazole, fluconazole, and ivermectin have shown benefit in managing facial erythema, reports of similar reactions affecting the palms remain scarce.</div><div>The authors describe the case of a 31-year-old man with severe, generalized atopic dermatitis who was receiving dupilumab injections every two weeks. After a year of treatment, while his overall skin condition had improved, he developed persistent redness, scaling, and painful fissures on his palms, accompanied by intense itching. The condition significantly interfered with his profession as a guitarist.</div><div>Extensive evaluation did not suggest contact dermatitis, and patch testing was deemed unnecessary. Microbiological tests showed mixed bacterial growth, while fungal cultures were negative—though this did not rule out Malassezia, which is known to be difficult to culture. Clinically, the presentation did not match other common diagnoses such as psoriasis or dyshidrotic eczema. The patient also had mild facial redness.</div><div>Initial management with potent topical corticosteroids provided limited benefit. However, the patient reported some improvement with antifungal creams, particularly miconazole. This response, along with an elevated level of Malassezia-specific immunoglobulin E, raised suspicion of a fungal-related mechanism. Based on this, the clinicians initiated oral fluconazole at a low daily dose.</div><div>Within four weeks, the patient experienced notable improvement in his symptoms. However, symptoms worsened soon after discontinuing the medication, prompting its reintroduction. Continued therapy led to sustained improvement, with reduced redness, scaling, and fissuring of the palms over several weeks. The patient also noted improvement in facial redness. Importantly, long-term use of fluconazole was well tolerated, and the patient was able to resume his professional activities.</div><div>The authors suggest that fluconazole may work by reducing Malassezia colonization on the skin and through its anti-inflammatory effects. They also note that low-dose fluconazole is relatively affordable and suitable for extended use, making it a practical option in selected cases.</div><div>This case underscores the need for clinicians to consider fungal hypersensitivity in patients who develop atypical skin reactions during dupilumab therapy. It also highlights the importance of individualized management strategies and careful clinical assessment in cases that do not respond to conventional treatments.</div><div>Reference:</div><div>Selvaraj, K. J., & Lee, G. Dupilumab-Associated Palmar Erythema Successfully Treated With Fluconazole. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70089</div></div>]]> </content:encoded>
</item>

<item>
<title>Sivelestat may Reduce ARDS and Mortality After Cardiovascular Surgery: JAMA</title>
<link>https://edusehat.com/en/sivelestat-may-reduce-ards-and-mortality-after-cardiovascular-surgery-jama</link>
<guid>https://edusehat.com/en/sivelestat-may-reduce-ards-and-mortality-after-cardiovascular-surgery-jama</guid>
<description><![CDATA[ A new study published in the Journal of the American Medical Association revealed that the patients undergoing cardiovascular surgery that sivelestat significantly reduced the incidence of acute respiratory distress syndrome (ARDS) and 90-day all-cause mortality. The drug attenuated neutrophil-driven inflammation by suppressing neutrophil elastase and lowering downstream inflammatory biomarkers, suggesting it may be a potential pharmacologic option to prevent ARDS in cardiovascular procedures.ARDS remains one of the most serious complications following heart and vascular surgeries, which contributes to prolonged intensive care stays and higher mortality rates. This study evaluated whether sivelestat could help prevent this complication. This research at a tertiary academic medical center in China enrolled 424 patients scheduled for major cardiovascular procedures from February 2024 to April 2025, with participants followed for 90 days after surgery.The surgeries included a wide range of complex procedures like coronary artery bypass grafting, valve replacement or repair, ascending aortic reconstruction, congenital heart defect correction, combined cardiac procedures, and removal of cardiac tumors. Patients were randomly assigned to receive either continuous intravenous sivelestat or a placebo solution after arriving in the intensive care unit (ICU) following surgery.Those in the treatment group received sivelestat at a dose of 0.2 milligrams per kilogram per hour, administered continuously for up to 7 days or until discharge from the ICU. The control group received a volume-matched saline placebo following the same schedule. Of the 424 participants, 382 completed the study, with an average age of nearly 63 years and about 55% male. The results showed a substantial reduction in ARDS cases among patients who received sivelestat. Only 16.8% of patients in the treatment group developed ARDS compared with 31.2% in the placebo group. The results also found that 90-day mortality rates were lower among patients treated with sivelestat. Just 1.1% of patients in the treatment group died within 3 months after surgery, when compared to 5.2% of those who received the placebo.Levels of neutrophil elastase, interleukin-6, and other inflammatory markers were significantly lower in patients treated with sivelestat, which suggests that the drug effectively dampens the inflammatory processes that contribute to ARDS. Overall, these results provide evidence that targeting neutrophil-driven inflammation could improve outcomes for patients undergoing high-risk heart surgeries.Source:Pan, T., Xu, C., Wang, Y.-P., Wang, H.-L., Su, W.-X., Zhang, H.-T., Zhu, E.-J., Li, Y.-T., Lv, Z.-K., Zhu, T.-T., Xu, Z.-W., Gao, Y., Xu, C.-Z., Shi, J., Ji, W.-J., Duan, Z.-H., Zhang, C., Xu, Z.-J., Li, K.-S., … Wang, Q. (2026). Sivelestat and incidence of acute respiratory distress syndrome after cardiovascular surgery: A randomized clinical trial. JAMA Network Open, 9(3), e260390. https://doi.org/10.1001/jamanetworkopen.2026.0390 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/02/14/124290-acute-respiratory-distress-syndrome.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sivelestat, may, Reduce, ARDS, and, Mortality, After, Cardiovascular, Surgery:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/02/14/124290-acute-respiratory-distress-syndrome.webp"><p>A new study published in the <i>Journal of the American Medical Association</i> revealed that the patients undergoing cardiovascular surgery that sivelestat significantly reduced the incidence of acute respiratory distress syndrome (ARDS) and 90-day all-cause mortality. The drug attenuated neutrophil-driven inflammation by suppressing neutrophil elastase and lowering downstream inflammatory biomarkers, suggesting it may be a potential pharmacologic option to prevent ARDS in cardiovascular procedures.</p><p>ARDS remains one of the most serious complications following heart and vascular surgeries, which contributes to prolonged intensive care stays and higher mortality rates. This study evaluated whether sivelestat could help prevent this complication. This research at a tertiary academic medical center in China enrolled 424 patients scheduled for major cardiovascular procedures from February 2024 to April 2025, with participants followed for 90 days after surgery.</p><p>The surgeries included a wide range of complex procedures like coronary artery bypass grafting, valve replacement or repair, ascending aortic reconstruction, congenital heart defect correction, combined cardiac procedures, and removal of cardiac tumors. Patients were randomly assigned to receive either continuous intravenous sivelestat or a placebo solution after arriving in the intensive care unit (ICU) following surgery.</p><p>Those in the treatment group received sivelestat at a dose of 0.2 milligrams per kilogram per hour, administered continuously for up to 7 days or until discharge from the ICU. The control group received a volume-matched saline placebo following the same schedule. </p><p>Of the 424 participants, 382 completed the study, with an average age of nearly 63 years and about 55% male. The results showed a substantial reduction in ARDS cases among patients who received sivelestat. Only 16.8% of patients in the treatment group developed ARDS compared with 31.2% in the placebo group. </p><p>The results also found that 90-day mortality rates were lower among patients treated with sivelestat. Just 1.1% of patients in the treatment group died within 3 months after surgery, when compared to 5.2% of those who received the placebo.</p><p>Levels of neutrophil elastase, interleukin-6, and other inflammatory markers were significantly lower in patients treated with sivelestat, which suggests that the drug effectively dampens the inflammatory processes that contribute to ARDS. Overall, these results provide evidence that targeting neutrophil-driven inflammation could improve outcomes for patients undergoing high-risk heart surgeries.</p><p>Source:</p><p>Pan, T., Xu, C., Wang, Y.-P., Wang, H.-L., Su, W.-X., Zhang, H.-T., Zhu, E.-J., Li, Y.-T., Lv, Z.-K., Zhu, T.-T., Xu, Z.-W., Gao, Y., Xu, C.-Z., Shi, J., Ji, W.-J., Duan, Z.-H., Zhang, C., Xu, Z.-J., Li, K.-S., … Wang, Q. (2026). Sivelestat and incidence of acute respiratory distress syndrome after cardiovascular surgery: A randomized clinical trial. JAMA Network Open, 9(3), e260390. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846209?guestAccessKey=193d6070-1889-4c79-9fa2-b5aa1aa25628&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jamanetworkopen&utm_content=new_this_week_&utm_term=031126" rel="nofollow">https://doi.org/10.1001/jamanetworkopen.2026.0390</a></p>]]> </content:encoded>
</item>

<item>
<title>Oral Dydrogesterone Shows No Significant Benefit in Preventing Preterm Birth: Meta&#45;Analysis</title>
<link>https://edusehat.com/en/oral-dydrogesterone-shows-no-significant-benefit-in-preventing-preterm-birth-meta-analysis</link>
<guid>https://edusehat.com/en/oral-dydrogesterone-shows-no-significant-benefit-in-preventing-preterm-birth-meta-analysis</guid>
<description><![CDATA[ Egypt: A recent systematic review and meta-analysis published in BMC Pregnancy and Childbirth has found limited evidence supporting the use of oral dydrogesterone in preventing preterm birth, highlighting the need for more robust clinical trials before it can be routinely recommended.Preterm birth continues to be a leading cause of neonatal illness and death globally, prompting ongoing research into preventive therapies. Oral dydrogesterone, a synthetic progestin, has been used in certain clinical settings for this purpose, although its effectiveness remains uncertain.To address this gap, Sohieb Hedawy from the Faculty of Medicine at Al-Azhar Assiut University, Egypt, and colleagues conducted a systematic review and meta-analysis to assess the efficacy and safety of oral dydrogesterone compared to placebo in pregnant women at risk of preterm delivery. The study followed PRISMA guidelines and included only randomized controlled trials, excluding observational and non-randomized studies to ensure methodological rigor.The researchers performed a comprehensive search across major databases, including PubMed, Cochrane Library, Web of Science, and Scopus, covering studies published up to December 2024. The quality of the included trials was evaluated using the Cochrane Risk of Bias tool. Statistical analyses were conducted using a random-effects model, while the certainty of evidence was assessed using the GRADE framework. Additionally, trial sequential analysis (TSA) was applied to determine whether the available data were sufficient to draw firm conclusions.  The following were the key findings:  The analysis included five randomized controlled trials with a total of 436 participants.Oral dydrogesterone showed a slight increase in gestational age at delivery compared to placebo, but this was not statistically significant.A non-significant reduction in NICU admissions was observed in the dydrogesterone group.No meaningful differences were noted between the two groups for other maternal or neonatal outcomes.Most outcomes were supported by low to very low certainty evidence, reflecting substantial uncertainty.Trial sequential analysis indicated that the available evidence is underpowered and insufficient for definitive conclusions.Overall, the observed trends, though somewhat favorable, remain inconclusive and not fully reliable.Overall, the study concludes that oral dydrogesterone does not demonstrate a statistically or clinically significant benefit in preventing preterm birth or improving related maternal and neonatal outcomes when compared to placebo. Given the low certainty of evidence and inconclusive results, the authors emphasize that dydrogesterone should not be recommended for routine clinical use in this context at present.The researchers highlight the urgent need for larger, well-designed randomized controlled trials to better evaluate the role of oral dydrogesterone in preterm birth prevention and to inform future clinical guidelines.Reference:Hedawy, S., Aldalahmeh, S., Labeeb, E.E. et al. Effectiveness of oral dydrogesterone compared to placebo in reducing the risk of preterm birth: a systematic review and meta-analysis. BMC Pregnancy Childbirth 26, 222 (2026). https://doi.org/10.1186/s12884-026-08747-5 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/31/338574-oral-dydrogesterone.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Oral, Dydrogesterone, Shows, Significant, Benefit, Preventing, Preterm, Birth:, Meta-Analysis</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/31/338574-oral-dydrogesterone.webp"><p><span>Egypt: A recent systematic review and meta-analysis published in <i>BMC Pregnancy and Childbirth</i> has found limited evidence supporting the use of <a href="https://medicaldialogues.in/topics/oral-dydrogesterone">oral dydrogesterone</a> in preventing <a href="https://medicaldialogues.in/topics/preterm-birth">preterm birth</a>, highlighting the need for more robust clinical trials before it can be routinely recommended.</span></p><div class="pasted-from-word-wrapper"><div>Preterm birth continues to be a leading cause of <a href="https://medicaldialogues.in/topics/neonatal-illness">neonatal illness</a> and death globally, prompting ongoing research into preventive therapies. Oral dydrogesterone, a synthetic progestin, has been used in certain clinical settings for this purpose, although its effectiveness remains uncertain.</div><div>To address this gap, Sohieb Hedawy from the Faculty of Medicine at Al-Azhar Assiut University, Egypt, and colleagues conducted a systematic review and meta-analysis to assess the efficacy and safety of oral dydrogesterone compared to placebo in pregnant women at risk of preterm delivery. The study followed PRISMA guidelines and included only randomized controlled trials, excluding observational and non-randomized studies to ensure methodological rigor.</div><div>The researchers performed a comprehensive search across major databases, including PubMed, Cochrane Library, Web of Science, and Scopus, covering studies published up to December 2024. The quality of the included trials was evaluated using the Cochrane Risk of Bias tool. Statistical analyses were conducted using a random-effects model, while the certainty of evidence was assessed using the GRADE framework. Additionally, trial sequential analysis (TSA) was applied to determine whether the available data were sufficient to draw firm conclusions.  </div><div>The following were the key findings:  </div><ul><li>The analysis included five randomized controlled trials with a total of 436 participants.</li><li>Oral dydrogesterone showed a slight increase in gestational age at delivery compared to placebo, but this was not statistically significant.</li><li>A non-significant reduction in NICU admissions was observed in the dydrogesterone group.</li><li>No meaningful differences were noted between the two groups for other maternal or neonatal outcomes.</li><li>Most outcomes were supported by low to very low certainty evidence, reflecting substantial uncertainty.</li><li>Trial sequential analysis indicated that the available evidence is underpowered and insufficient for definitive conclusions.</li><li>Overall, the observed trends, though somewhat favorable, remain inconclusive and not fully reliable.</li></ul><div>Overall, the study concludes that oral dydrogesterone does not demonstrate a statistically or clinically significant benefit in preventing preterm birth or improving related maternal and neonatal outcomes when compared to placebo. Given the low certainty of evidence and inconclusive results, the authors emphasize that dydrogesterone should not be recommended for routine clinical use in this context at present.</div><div>The researchers highlight the urgent need for larger, well-designed randomized controlled trials to better evaluate the role of oral dydrogesterone in preterm birth prevention and to inform future clinical guidelines.</div><div>Reference:</div><div>Hedawy, S., Aldalahmeh, S., Labeeb, E.E. et al. Effectiveness of oral dydrogesterone compared to placebo in reducing the risk of preterm birth: a systematic review and meta-analysis. BMC Pregnancy Childbirth 26, 222 (2026). https://doi.org/10.1186/s12884-026-08747-5</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>AI&#45;Assisted ECG Model Speeds Up ACS Detection Across India: Real&#45;World Study</title>
<link>https://edusehat.com/en/ai-assisted-ecg-model-speeds-up-acs-detection-across-india-real-world-study</link>
<guid>https://edusehat.com/en/ai-assisted-ecg-model-speeds-up-acs-detection-across-india-real-world-study</guid>
<description><![CDATA[ India: A recent study published in Cureus highlights the role of artificial intelligence (AI) in improving the early detection of acute coronary syndrome (ACS) in India. Conducted by Praveen Chandra from Medanta - The Medicity and colleagues, the study evaluated an AI-assisted hub-and-spoke model designed to enhance electrocardiogram (ECG) interpretation and reduce diagnostic delays.ACS continues to be a major contributor to morbidity and mortality in India, often worsened by delays in diagnosis and treatment. To address this, the “Heart Beat” project was implemented across multiple healthcare settings. This model connected primary healthcare centers (spokes) with advanced cardiac hospitals (hubs) equipped with catheterization laboratories, enabling rapid transmission and centralized interpretation of ECG data using AI.The study analyzed retrospective, real-world data collected between January 2020 and December 2022. A total of 45,488 ECGs were recorded from 66 spoke centers linked to 10 hub hospitals across six Indian states. AI-enabled 12-lead ECGs performed at the spokes were categorized into six groups: Normal, Abnormal, Borderline, Critical, Otherwise Normal, and Pacemaker. The study led to the following findings:50.53% of ECGs were classified as normal, 42.64% as abnormal, and 6.58% as critical.Most cardiovascular conditions were identified in abnormal and critical ECG categories.Left ventricular hypertrophy was the most commonly detected condition, seen in 8.78% of patients.ST-elevation myocardial infarction (STEMI) was more frequently observed, with 231 cases (0.51%).Non-ST-elevation myocardial infarction (NSTEMI) was comparatively rare, identified in 22 cases (0.05%).The higher prevalence of STEMI highlights the need for rapid diagnosis and timely intervention.The overall mean turnaround time (TAT) for ECG acquisition and diagnosis using AI was 5.12 minutes.Critical ECGs were identified faster, with a mean TAT of 2.91 minutes.The observed TAT is significantly below the recommended 10-minute benchmark for timely ECG evaluation in suspected ACS cases.These findings suggest that AI-assisted ECG analysis can accelerate diagnosis, enabling quicker triage and management of patients. The model also supports efficient resource utilization, particularly in settings with limited access to specialized cardiac care.However, the authors note that the study is observational and does not assess long-term clinical outcomes. Further research is needed to determine whether faster diagnosis translates into improved survival, better treatment adherence, and enhanced quality of life. Future studies comparing AI interpretations with cardiologist assessments will also be important to validate diagnostic accuracy.Overall, the study demonstrates that an AI-enabled hub-and-spoke model can significantly improve the speed and efficiency of ACS diagnosis, with potential to enhance cardiac care delivery across diverse healthcare settings in India.Reference:Chandra P, Batra A, Singh A K, et al. (March 01, 2026) Artificial Intelligence-Assisted ECG in a Hub-and-Spoke Network in India: Real-World Performance in Acute Coronary Syndrome Detection and Diagnostic Turnaround Times. Cureus 18(3): e104518. DOI 10.7759/cureus.104518 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/26/186256-non-st-elevation-acute-coronary-syndrome.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AI-Assisted, ECG, Model, Speeds, ACS, Detection, Across, India:, Real-World, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/26/186256-non-st-elevation-acute-coronary-syndrome.webp"><p><span>India: A recent study published in <i>Cureus </i>highlights the role of artificial intelligence (AI) in improving the early detection of<a href="https://medicaldialogues.in/topics/acute-coronary-syndrome-acs"> acute coronary syndrome (ACS) </a>in India. Conducted by Praveen Chandra from Medanta - The Medicity and colleagues, the study evaluated an AI-assisted hub-and-spoke model designed to enhance<a href="https://medicaldialogues.in/topics/electrocardiogram"> electrocardiogram (ECG) </a>interpretation and reduce diagnostic delays.</span></p><div class="pasted-from-word-wrapper"><div>ACS continues to be a major contributor to morbidity and mortality in India, often worsened by delays in diagnosis and treatment. To address this, the “Heart Beat” project was implemented across multiple healthcare settings. This model connected primary healthcare centers (spokes) with advanced cardiac hospitals (hubs) equipped with catheterization laboratories, enabling rapid transmission and centralized interpretation of ECG data using AI.</div><div>The study analyzed retrospective, real-world data collected between January 2020 and December 2022. A total of 45,488 ECGs were recorded from 66 spoke centers linked to 10 hub hospitals across six Indian states. AI-enabled 12-lead ECGs performed at the spokes were categorized into six groups: Normal, Abnormal, Borderline, Critical, Otherwise Normal, and Pacemaker. </div><div>The study led to the following findings:</div><ul><li>50.53% of ECGs were classified as normal, 42.64% as abnormal, and 6.58% as critical.</li><li>Most cardiovascular conditions were identified in abnormal and critical ECG categories.</li><li>Left ventricular hypertrophy was the most commonly detected condition, seen in 8.78% of patients.</li><li>ST-elevation myocardial infarction (STEMI) was more frequently observed, with 231 cases (0.51%).</li><li>Non-ST-elevation myocardial infarction (NSTEMI) was comparatively rare, identified in 22 cases (0.05%).</li><li>The higher prevalence of STEMI highlights the need for rapid diagnosis and timely intervention.</li><li>The overall mean turnaround time (TAT) for ECG acquisition and diagnosis using AI was 5.12 minutes.</li><li>Critical ECGs were identified faster, with a mean TAT of 2.91 minutes.</li><li>The observed TAT is significantly below the recommended 10-minute benchmark for timely ECG evaluation in suspected ACS cases.</li></ul><div>These findings suggest that AI-assisted ECG analysis can accelerate diagnosis, enabling quicker triage and management of patients. The model also supports efficient resource utilization, particularly in settings with limited access to specialized cardiac care.</div><div>However, the authors note that the study is observational and does not assess long-term clinical outcomes. Further research is needed to determine whether faster diagnosis translates into improved survival, better treatment adherence, and enhanced quality of life. Future studies comparing AI interpretations with cardiologist assessments will also be important to validate diagnostic accuracy.</div><div>Overall, the study demonstrates that an AI-enabled hub-and-spoke model can significantly improve the speed and efficiency of ACS diagnosis, with potential to enhance cardiac care delivery across diverse healthcare settings in India.</div><div>Reference:</div><div>Chandra P, Batra A, Singh A K, et al. (March 01, 2026) Artificial Intelligence-Assisted ECG in a Hub-and-Spoke Network in India: Real-World Performance in Acute Coronary Syndrome Detection and Diagnostic Turnaround Times. Cureus 18(3): e104518. DOI 10.7759/cureus.104518</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Exchange Transfusion Improves Outcomes in Severe Babesiosis, reveals research</title>
<link>https://edusehat.com/en/exchange-transfusion-improves-outcomes-in-severe-babesiosis-reveals-research</link>
<guid>https://edusehat.com/en/exchange-transfusion-improves-outcomes-in-severe-babesiosis-reveals-research</guid>
<description><![CDATA[ A new research published in the Journal of the American Medical Association showed that red blood cell exchange transfusion (ET) is associated with significantly improved clinical outcomes in patients with severe babesiosis.Babesiosis, caused by parasites that infect red blood cells, can lead to life-threatening complications, particularly in older adults or those with weakened immune systems. Severe cases are often marked by high levels of parasites in the blood (parasitemia), organ damage, or significant hemolytic anemia. While ET essentially replaces the infected red blood cells of a patient with healthy donor cells, it has long been used in critical cases where its true effectiveness has remained uncertain due to limited data. With tick populations expanding and cases rising globally, this study was set to justify early and aggressive intervention with ET in the most critically ill patients.This trial emulation used data from 3,233 adults hospitalized with babesiosis between 2010 and 2024 across 82 medical centers in the northeastern US. From this group, 629 patients met criteria for severe disease and were included in the analysis. About one-third (33.2%) received ET within the first 7 days of hospitalization.The patients who underwent ET were initially more severely ill, with significantly higher median parasitemia levels of 14.0% when compared to 7.2% in those who did not receive ET. However, advanced statistical adjustments were applied to balance differences in baseline severity between the groups, which allowed for a more accurate comparison of outcomes.The results found only 3.6% of patients treated with ET to experience a composite of in-hospital death or 30-day readmission which was the primary endpoint when compared to 9.8% of those who did not receive the treatment. After adjustment, this translated to a nearly 5-fold reduction in risk (adjusted odds ratio of 0.22). The findings remained consistent across multiple sensitivity analyses, which reinforced the robustness of the results.While the findings strongly support ET as a beneficial adjunct therapy in severe babesiosis, the study is observational in nature. This means that unmeasured factors could still influence outcomes. Further research is imperative to determine precisely which patients benefit most from the procedure and to refine treatment guidelines.Source:STOP-BABESIOSIS Investigators, Leaf, D. E., Monson, A. E., Dias, J.-A., Marcos, L. A., Wu, U., Rossi, M., Ng, J. H., Patell, R., Hundert, J., El Khoury, M. Y., Higgs, J., Smith, R. P., Ramsaroop, V., Green, A., Abdul Azim, A., Weisenberg, S., Kirkman, L. A., Ingram, D., … Krause, P. J. (2026). Red blood cell exchange transfusion for severe babesiosis. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.0244 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/10/313628-blood-transfusion.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Exchange, Transfusion, Improves, Outcomes, Severe, Babesiosis, reveals, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/10/313628-blood-transfusion.webp"><p>A new research published in the <i>Journal of the American Medical Association</i> showed that red blood cell exchange transfusion (ET) is associated with significantly improved clinical outcomes in patients with severe babesiosis.</p><p>Babesiosis, caused by parasites that infect red blood cells, can lead to life-threatening complications, particularly in older adults or those with weakened immune systems. Severe cases are often marked by high levels of parasites in the blood (parasitemia), organ damage, or significant hemolytic anemia. </p><p>While ET essentially replaces the infected red blood cells of a patient with healthy donor cells, it has long been used in critical cases where its true effectiveness has remained uncertain due to limited data. With tick populations expanding and cases rising globally, this study was set to justify early and aggressive intervention with ET in the most critically ill patients.</p><p>This trial emulation used data from 3,233 adults hospitalized with babesiosis between 2010 and 2024 across 82 medical centers in the northeastern US. From this group, 629 patients met criteria for severe disease and were included in the analysis. About one-third (33.2%) received ET within the first 7 days of hospitalization.</p><p>The patients who underwent ET were initially more severely ill, with significantly higher median parasitemia levels of 14.0% when compared to 7.2% in those who did not receive ET. However, advanced statistical adjustments were applied to balance differences in baseline severity between the groups, which allowed for a more accurate comparison of outcomes.</p><p>The results found only 3.6% of patients treated with ET to experience a composite of in-hospital death or 30-day readmission which was the primary endpoint when compared to 9.8% of those who did not receive the treatment. After adjustment, this translated to a nearly 5-fold reduction in risk (adjusted odds ratio of 0.22). The findings remained consistent across multiple sensitivity analyses, which reinforced the robustness of the results.</p><p>While the findings strongly support ET as a beneficial adjunct therapy in severe babesiosis, the study is observational in nature. This means that unmeasured factors could still influence outcomes. Further research is imperative to determine precisely which patients benefit most from the procedure and to refine treatment guidelines.</p><p>Source:</p><p>STOP-BABESIOSIS Investigators, Leaf, D. E., Monson, A. E., Dias, J.-A., Marcos, L. A., Wu, U., Rossi, M., Ng, J. H., Patell, R., Hundert, J., El Khoury, M. Y., Higgs, J., Smith, R. P., Ramsaroop, V., Green, A., Abdul Azim, A., Weisenberg, S., Kirkman, L. A., Ingram, D., … Krause, P. J. (2026). Red blood cell exchange transfusion for severe babesiosis. JAMA Internal Medicine.<a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2846968?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=033126" rel="nofollow"> https://doi.org/10.1001/jamainternmed.2026.0244</a></p>]]> </content:encoded>
</item>

<item>
<title>Quadriceps Tendon Graft Leads to Stronger Flexion and Weaker Extension of the Knee Than Hamstring Graft Post&#45;ACLR: study</title>
<link>https://edusehat.com/en/quadriceps-tendon-graft-leads-to-stronger-flexion-and-weaker-extension-of-the-knee-than-hamstring-graft-post-aclr-study</link>
<guid>https://edusehat.com/en/quadriceps-tendon-graft-leads-to-stronger-flexion-and-weaker-extension-of-the-knee-than-hamstring-graft-post-aclr-study</guid>
<description><![CDATA[ The optimal autograft for restoring knee strength and expediting return-to-sport following anterior cruciate ligament reconstruction (ACLR) remains debated. Brandon A. Young et al conducted a systematic review and meta-analysis comparing isokinetic strength and patient-reported outcomes after ACLR using quadriceps tendon (QT), hamstring tendon (HT), or bone–patellar tendon–bone (BTB) autografts to determine graft-specific recovery patterns.PubMed, Cochrane Library, EMBASE, and Google Scholar were systematically searched for comparative studies evaluating isokinetic strength following primary ACLR using QT, HT, or BTB autografts. Non-English, unavailable fulltext, animal/cadaveric, and physeal-sparing studies were excluded. MINORS and Detsky evaluated bias risk. Key findings were quantified, and subgroup meta-analyses were performed on limb symmetry index (LSI) values (significance: p &lt; 0.05).
The key findings of the study were:
•	Seventeen studies (1,705 patients: QT = 765, HT = 725, BTB = 215) with follow-ups through 48 months were included. Due to data heterogeneity, four to six studies qualified for each meta-analysis. 
•	Among 13 QT vs. HT studies, QT grafts demonstrated weaker extensor strength in nine (56.3%) and greater flexor strength in six (37.5%). 
•	No differences were reported in extensor or flexor strength in four (25.0%) and seven (43.8%) studies, respectively.
•	For QT vs. BTB, two studies (12.5%) showed similar extensor strength, whereas two reported conflicting results.
•	QT had greater flexor strength in one (6.3%) and similar strength in three (18.8%) studies.
•	Postoperative pain was comparable between QT and HT.
The authors concluded – “Our data supports our hypothesis that ACLR using QT grafts results in greater extensor strength deficits than HT grafts in the first 12 postoperative months. In addition, QT grafts led to similar or better flexor strength results than HT between 4 and 24 months postoperatively, and lower anterior knee pain than BTB. Rehabilitation targeting early strength deficits following QT and HT grafting may decrease the time of return-to-sport. Further research is needed to evaluate postoperative isokinetic strength differences between QT and BTB graft types, as current comparisons are based on limited and inconsistent evidence.”
Level of evidence: IV.Further reading:
Quadriceps Tendon Graft Leads to Stronger Flexion and Weaker Extension of the Knee Than Hamstring Graft Post-ACLR: Systematic Review and Meta-Analysis
Brandon A. Young et al
Indian Journal of Orthopaedics (2025) 59:2026–2038
https://doi.org/10.1007/s43465-025-01545-9 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/12/327055-acl-knee-reconstruction-surgery.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Quadriceps, Tendon, Graft, Leads, Stronger, Flexion, and, Weaker, Extension, the, Knee, Than, Hamstring, Graft, Post-ACLR:, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/12/327055-acl-knee-reconstruction-surgery.webp"><p>The optimal autograft for restoring knee strength and expediting return-to-sport following anterior cruciate ligament reconstruction (ACLR) remains debated. <i>Brandon A. Young et al</i> conducted a systematic review and meta-analysis comparing isokinetic strength and patient-reported outcomes after ACLR using quadriceps tendon (QT), hamstring tendon (HT), or bone–patellar tendon–bone (BTB) autografts to determine graft-specific recovery patterns.</p><p>PubMed, Cochrane Library, EMBASE, and Google Scholar were systematically searched for comparative studies evaluating isokinetic strength following primary ACLR using QT, HT, or BTB autografts. Non-English, unavailable fulltext, animal/cadaveric, and physeal-sparing studies were excluded. MINORS and Detsky evaluated bias risk. Key findings were quantified, and subgroup meta-analyses were performed on limb symmetry index (LSI) values (significance: p < 0.05).
</p><p>The key findings of the study were:
</p><p>•	Seventeen studies (1,705 patients: QT = 765, HT = 725, BTB = 215) with follow-ups through 48 months were included. Due to data heterogeneity, four to six studies qualified for each meta-analysis. 
</p><p>•	Among 13 QT vs. HT studies, QT grafts demonstrated weaker extensor strength in nine (56.3%) and greater flexor strength in six (37.5%). 
</p><p>•	No differences were reported in extensor or flexor strength in four (25.0%) and seven (43.8%) studies, respectively.
</p><p>•	For QT vs. BTB, two studies (12.5%) showed similar extensor strength, whereas two reported conflicting results.
</p><p>•	QT had greater flexor strength in one (6.3%) and similar strength in three (18.8%) studies.
</p><p>•	Postoperative pain was comparable between QT and HT.
</p><p>The authors concluded – “Our data supports our hypothesis that ACLR using QT grafts results in greater extensor strength deficits than HT grafts in the first 12 postoperative months. In addition, QT grafts led to similar or better flexor strength results than HT between 4 and 24 months postoperatively, and lower anterior knee pain than BTB. Rehabilitation targeting early strength deficits following QT and HT grafting may decrease the time of return-to-sport. Further research is needed to evaluate postoperative isokinetic strength differences between QT and BTB graft types, as current comparisons are based on limited and inconsistent evidence.”
</p><p>Level of evidence: IV.</p><p>Further reading:
</p><p>Quadriceps Tendon Graft Leads to Stronger Flexion and Weaker Extension of the Knee Than Hamstring Graft Post-ACLR: Systematic Review and Meta-Analysis
</p><p>Brandon A. Young et al
</p><p>Indian Journal of Orthopaedics (2025) 59:2026–2038
</p><p>https://doi.org/10.1007/s43465-025-01545-9</p>]]> </content:encoded>
</item>

<item>
<title>Nanoparticle Breakthrough: Cerium Oxide Shields the Liver from Sevoflurane&#45;Induced Damage, study finds</title>
<link>https://edusehat.com/en/nanoparticle-breakthrough-cerium-oxide-shields-the-liver-from-sevoflurane-induced-damage-study-finds</link>
<guid>https://edusehat.com/en/nanoparticle-breakthrough-cerium-oxide-shields-the-liver-from-sevoflurane-induced-damage-study-finds</guid>
<description><![CDATA[  The Double-Edged Sword of SevofluraneSevoflurane is a popular inhalational anesthetic, praised for its safety and efficacy in surgeries. However, isolated reports have raised concerns about its potential to cause liver damage—an effect tied to oxidative stress and the generation of harmful metabolites. With the rise of nanomedicine, scientists are turning to innovative agents like cerium oxide nanoparticles (CeO₂), known for their powerful antioxidant properties, to find solutions for drug-induced organ injury.The Study: Testing Cerium Oxide’s Hepatic DefenseRecently published pioneering experimental study, researchers at Ankara Bilkent City Hospital explored whether cerium oxide could protect against sevoflurane-induced liver injury. They divided 24 Wistar rats into four groups:    1. Control: No intervention.    2. Sevoflurane (S): Exposed to sevoflurane.    3. Cerium Oxide (CeO₂): Received cerium oxide.    4. Sevoflurane + Cerium Oxide (S+CeO₂): Received cerium oxide before sevoflurane exposure.Researchers measured liver enzymes (ALT, AST, LDH) and examined liver tissues for signs of cellular damage.Key Findings: Cerium Oxide Reduces Liver Damage    • Histopathology: Rats exposed to sevoflurane alone showed significant liver cell swelling (hydropic degeneration) and neutrophil infiltration—classic signs of liver stress and injury. These effects were markedly reduced in rats that received cerium oxide, either alone or combined with sevoflurane.    • Biochemistry: Sevoflurane exposure raised AST and LDH levels, indicating liver distress. Notably, LDH levels were significantly lower in the S+CeO₂ group than in the sevoflurane-only group, suggesting cerium oxide’s protective effect.    • No Added Toxicity: Cerium oxide alone did not cause liver damage, supporting its safety at the tested dose. A Step Toward Hepatoprotective NanomedicineThe study provides the first experimental evidence that cerium oxide nanoparticles can mitigate sevoflurane-induced liver injury. The antioxidant ability of CeO₂ appears to offset the oxidative stress and cellular infiltration triggered by sevoflurane. While changes in some liver enzymes (especially AST) did not reach statistical significance, the improvements in tissue health are promising.Researchers caution that further studies are needed, especially with different doses, prolonged exposures, and in subjects with pre-existing liver conditions, to optimize safety and efficacy for clinical use.Key Takeaways:    • Sevoflurane can cause oxidative liver damage, even with short-term exposure.    • Cerium oxide nanoparticles significantly reduce liver tissue injury and some enzyme markers.    • This is the first study to show cerium oxide’s protective effects on sevoflurane-induced hepatic injury.    • Further research is needed to validate these findings before clinical application.Citation:Erbay F, Öztürk L, Kıran MM, Gök G, Arslan M. The effect of cerium oxide on liver in sevoflurane-administered rats: an experimental study. BMC Anesthesiology. 2025;25:251. https://doi.org/10.1186/s12871-025-03126-7 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/26/266536-liver-surgery-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Nanoparticle, Breakthrough:, Cerium, Oxide, Shields, the, Liver, from, Sevoflurane-Induced, Damage, study, finds</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/26/266536-liver-surgery-50.webp"><p align="justify"> The Double-Edged Sword of Sevoflurane</p><p align="justify">Sevoflurane is a popular inhalational anesthetic, praised for its safety and efficacy in surgeries. However, isolated reports have raised concerns about its potential to cause liver damage—an effect tied to oxidative stress and the generation of harmful metabolites. With the rise of nanomedicine, scientists are turning to innovative agents like cerium oxide nanoparticles (CeO₂), known for their powerful antioxidant properties, to find solutions for drug-induced organ injury.</p><p align="justify">The Study: Testing Cerium Oxide’s Hepatic Defense</p><p align="justify">Recently published pioneering experimental study, researchers at Ankara Bilkent City Hospital explored whether cerium oxide could protect against sevoflurane-induced liver injury. They divided 24 Wistar rats into four groups:</p><p align="justify">    1. Control: No intervention.</p><p align="justify">    2. Sevoflurane (S): Exposed to sevoflurane.</p><p align="justify">    3. Cerium Oxide (CeO₂): Received cerium oxide.</p><p align="justify">    4. Sevoflurane + Cerium Oxide (S+CeO₂): Received cerium oxide before sevoflurane exposure.</p><p align="justify">Researchers measured liver enzymes (ALT, AST, LDH) and examined liver tissues for signs of cellular damage.</p><p align="justify">Key Findings: Cerium Oxide Reduces Liver Damage</p><p align="justify">    • Histopathology: Rats exposed to sevoflurane alone showed significant liver cell swelling (hydropic degeneration) and neutrophil infiltration—classic signs of liver stress and injury. These effects were markedly reduced in rats that received cerium oxide, either alone or combined with sevoflurane.</p><p align="justify">    • Biochemistry: Sevoflurane exposure raised AST and LDH levels, indicating liver distress. Notably, LDH levels were significantly lower in the S+CeO₂ group than in the sevoflurane-only group, suggesting cerium oxide’s protective effect.</p><p align="justify">    • No Added Toxicity: Cerium oxide alone did not cause liver damage, supporting its safety at the tested dose.</p><p align="justify"> A Step Toward Hepatoprotective Nanomedicine</p><p align="justify">The study provides the first experimental evidence that cerium oxide nanoparticles can mitigate sevoflurane-induced liver injury. The antioxidant ability of CeO₂ appears to offset the oxidative stress and cellular infiltration triggered by sevoflurane. While changes in some liver enzymes (especially AST) did not reach statistical significance, the improvements in tissue health are promising.</p><p align="justify">Researchers caution that further studies are needed, especially with different doses, prolonged exposures, and in subjects with pre-existing liver conditions, to optimize safety and efficacy for clinical use.</p><p align="justify">Key Takeaways:</p><p align="justify">    • Sevoflurane can cause oxidative liver damage, even with short-term exposure.</p><p align="justify">    • Cerium oxide nanoparticles significantly reduce liver tissue injury and some enzyme markers.</p><p align="justify">    • This is the first study to show cerium oxide’s protective effects on sevoflurane-induced hepatic injury.</p><p align="justify">    • Further research is needed to validate these findings before clinical application.</p><p align="justify">Citation:</p><p align="justify">Erbay F, Öztürk L, Kıran MM, Gök G, Arslan M. The effect of cerium oxide on liver in sevoflurane-administered rats: an experimental study. BMC Anesthesiology. 2025;25:251. https://doi.org/10.1186/s12871-025-03126-7</p><p align="justify"><br></p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>UP Fake Degree Scam: 7,000+ Bogus B Pharma Certificates Sold Across Districts</title>
<link>https://edusehat.com/en/up-fake-degree-scam-7000-bogus-b-pharma-certificates-sold-across-districts</link>
<guid>https://edusehat.com/en/up-fake-degree-scam-7000-bogus-b-pharma-certificates-sold-across-districts</guid>
<description><![CDATA[ Lucknow: In a major revelation, an investigation into a fake degree racket has stunned the police, with findings indicating that a significant number of forged B Pharma degrees were circulated across eastern Uttar Pradesh districts over the past five years.As per the recent media report by The Times of India, acting on intelligence inputs, the cyber crime cell of the Prayagraj Police Commissionerate arrested two key accused—Sashi Prakash Rai alias Rajan Sharma and Manish Kumar Rai — both residents of Azamgarh, on March 25. They have been charged with operating a fraudulent website impersonating the Uttar Pradesh Board and producing fake marksheets and degrees from multiple institutions.According to the investigation, the accused had been running the racket since 2014 and are believed to have sold more than 7,000 fake degrees over the past 11 years. A large share of these counterfeit B Pharma certificates was distributed in eastern UP regions such as Prayagraj, Varanasi, Azamgarh, Jaunpur, and Lucknow.Also Read: B.Pharm Graduate Allegedly Dies by Suicide After Consuming PoisonPolice findings further revealed that B Pharma degrees were in particularly high demand, especially among individuals intending to open medical stores or pharmacies. Shockingly, the alleged mastermind, Sashi Prakash Rai, himself reportedly possesses a fake B Pharma degree obtained from a college based in Haridwar.A senior police official stated that authorities are now working to identify individuals who procured these fake qualifications. Out of the total 7,000 degrees circulated, around 2,500 have been confirmed as fake so far.Investigators also uncovered that the accused had established a call centre in Azamgarh under the name “Shri Education.” Through this setup, they created a fake website mimicking the Board of Secondary Education, Uttar Pradesh, and promoted their services on Facebook, offering to manipulate marks and generate counterfeit marksheets.Once contacted by candidates, parents, or even institutions, the racketeers arranged forged seals, holograms, and templates closely resembling those of legitimate universities and boards. They then digitally altered records to produce backdated high school, intermediate, and university certificates, TOI reported.After preparing the documents, the accused sold these forged marksheets and degrees at prices ranging between ₹4,000 and ₹5,000 per document, delivering them via courier. The profits earned from these illegal transactions were shared among the members of the racket.Police sources confirmed that at least seven FIRs have been registered across the state in connection with the case, and further investigation is currently underway, reports TOI.Also Read: PCI Approves Two MPharm Courses with 15 Seats Each at Gorakhpur University from 2026-27 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/09/197148-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 22:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fake, Degree, Scam:, 7, 000, Bogus, Pharma, Certificates, Sold, Across, Districts</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/09/197148-fraud.webp"><div class="pasted-from-word-wrapper"><p><b>Lucknow: </b>In a major revelation, an investigation into a fake degree racket has stunned the police, with findings indicating that a significant number of forged B Pharma degrees were circulated across eastern Uttar Pradesh districts over the past five years.</p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>As per the recent media report by The Times of India, acting on intelligence inputs, the cyber crime cell of the Prayagraj Police Commissionerate arrested two key accused—Sashi Prakash Rai alias Rajan Sharma and Manish Kumar Rai — both residents of Azamgarh, on March 25. They have been charged with operating a fraudulent website impersonating the Uttar Pradesh Board and producing fake marksheets and degrees from multiple institutions.</p><p>According to the investigation, the accused had been running the racket since 2014 and are believed to have sold more than 7,000 fake degrees over the past 11 years. A large share of these counterfeit B Pharma certificates was distributed in eastern UP regions such as Prayagraj, Varanasi, Azamgarh, Jaunpur, and Lucknow.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/bpharm-graduate-allegedly-dies-by-suicide-after-consuming-poison-165640">Also Read: B.Pharm Graduate Allegedly Dies by Suicide After Consuming Poison</a></div><p>Police findings further revealed that B Pharma degrees were in particularly high demand, especially among individuals intending to open medical stores or pharmacies. Shockingly, the alleged mastermind, Sashi Prakash Rai, himself reportedly possesses a fake B Pharma degree obtained from a college based in Haridwar.</p><p>A senior police official stated that authorities are now working to identify individuals who procured these fake qualifications. Out of the total 7,000 degrees circulated, around 2,500 have been confirmed as fake so far.</p><p>Investigators also uncovered that the accused had established a call centre in Azamgarh under the name “Shri Education.” Through this setup, they created a fake website mimicking the Board of Secondary Education, Uttar Pradesh, and promoted their services on Facebook, offering to manipulate marks and generate counterfeit marksheets.</p><p>Once contacted by candidates, parents, or even institutions, the racketeers arranged forged seals, holograms, and templates closely resembling those of legitimate universities and boards. They then digitally altered records to produce backdated high school, intermediate, and university certificates, TOI reported.</p><p>After preparing the documents, the accused sold these forged marksheets and degrees at prices ranging between ₹4,000 and ₹5,000 per document, delivering them via courier. The profits earned from these illegal transactions were shared among the members of the racket.</p><p>Police sources confirmed that at least seven FIRs have been registered across the state in connection with the case, and further investigation is currently underway, reports <a href="https://timesofindia.indiatimes.com/city/allahabad/fake-b-pharma-degrees-flood-eastern-up-probe-on/articleshow/129910452.cms" rel="nofollow">TOI</a>.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/pci-approves-two-mpharm-courses-with-15-seats-each-at-gorakhpur-university-from-2026-27-167913">Also Read: PCI Approves Two MPharm Courses with 15 Seats Each at Gorakhpur University from 2026-27</a></div></div></div><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>JnK hospitals threaten suspension of Ayushman Bharat services over Rs 295 crore dues</title>
<link>https://edusehat.com/en/jnk-hospitals-threaten-suspension-of-ayushman-bharat-services-over-rs-295-crore-dues</link>
<guid>https://edusehat.com/en/jnk-hospitals-threaten-suspension-of-ayushman-bharat-services-over-rs-295-crore-dues</guid>
<description><![CDATA[ Srinagar: Empanelled
hospitals in Jammu and Kashmir have warned that they may suspend treatment under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
(AB-PMJAY)-Sehat Scheme from April 15, citing pending payments of Rs. 295 crore to 135 empanelled health centres. Also Read:Ayushman Bharat Records Over 11.69 Crore Hospital Admissions, Says MoS HealthAccording to the Private Hospitals and Dialysis Centres Association, the amount has remained unpaid for
more than a year. Despite the delay, the hospitals have
continued to treat patients under the scheme, offering services such as
surgeries, cardiac treatments, and dialysis. They stated that their decision
to stop services stems from the Jammu and Kashmir government’s failure to clear
the long-pending dues.

The hospitals further explained
that suppliers of essential medical equipment and other materials have set a
deadline of April 15; beyond this date, supplies may be halted due to the
non-payment of bills. Expressing their inability to continue providing services
in the absence of funds, these suppliers warned that treatment under the
&quot;Golden Card&quot; scheme could be suspended starting April 15—a
suspension that would remain in effect until the outstanding dues are cleared
and the supply chain is restored, reports the Daily.

One of the hospital
owners told ETV Bharat, &quot;Due to the long-pending non-payment of dues, our
vendors have stopped supplying essential medical materials, implants, and
equipment. This has severely impacted our operational capacity, rendering us
completely unable to provide necessary healthcare services to patients.&quot; Citing the surge in the
prices of medical supplies—attributed to the ongoing conflict involving Iran,
the U.S., and Israel—they noted that costs have risen by approximately 18–22%.
This has further exacerbated their financial burden and heightened the urgency
for timely payments. Another hospital owner remarked, &quot;The delays in
payments, combined with this sudden spike in prices, have made the procurement
of supplies even more difficult.&quot;

In a message addressed to
Anant Dwivedi, CEO of the State Health Agency (SHA) for Jammu and Kashmir, the
hospital owners formally informed him that they would discontinue their
services if their outstanding dues were not cleared. In a letter addressed to
the CEO, the Association stated, &quot;We regret to inform you that, due to the
depletion of medical supplies, we will be unable to continue providing
treatment under this scheme after April 15.&quot;

According to The Daily, the association has
stated that if the State Health Agency provides them with the necessary medical
supplies and implants, they will continue to render their services to ensure
that patient care remains uninterrupted. According to the SHA, there are 8.5
million registered Ayushman cardholders in Jammu and Kashmir who avail the
benefits of this scheme, while the total number of beneficiaries is reported to
be 10,104,488. The SHA further notes that out of the 1.3 million claims
submitted, 82 per cent have already been settled.Also Read:J&amp;K Private Hospitals threaten to exit Ayushman Bharat Scheme over surgery reservation proposalMedical
Dialogues had previously reported that private hospitals and dialysis centres across Jammu
and Kashmir announced their decision to withdraw from the  AB-PMJAY-Sehat
scheme last year. This move came in response to several contentious
decisions made during the 9th Governing Council Meeting, which private
healthcare providers believe could have severe repercussions for the sector.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/06/01/210944-ayushman-bharat.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>JnK, hospitals, threaten, suspension, Ayushman, Bharat, services, over, 295, crore, dues</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/06/01/210944-ayushman-bharat.webp"><p>Srinagar: Empanelled
hospitals in Jammu and Kashmir have warned that they may suspend treatment under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
(<a href="https://medicaldialogues.in/topics/ab-pmjay" target="_blank">AB-PMJAY</a>)-Sehat Scheme from April 15, citing pending payments of Rs. 295 crore to 135 empanelled health centres. </p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/mdtv/healthshorts/ayushman-bharat-records-over-1169-crore-hospital-admissions-says-mos-health-167683"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/03/31/338644-nmc-4.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/ayushman-bharat-records-over-1169-crore-hospital-admissions-says-mos-health-167683"><span class="read-this-also">Also Read:</span>Ayushman Bharat Records Over 11.69 Crore Hospital Admissions, Says MoS Health</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>According to the <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/jk-private-hospitals-suspend-ayushman-bharat-services-over-policy-changes-144999" target="_blank">Private Hospitals and Dialysis Centres Association</a>, the amount has remained unpaid for
more than a year. Despite the delay, the hospitals have
continued to treat patients under the scheme, offering services such as
surgeries, cardiac treatments, and dialysis. They stated that their decision
to stop services stems from the Jammu and Kashmir government’s failure to clear
the long-pending dues.</p>

<p>The hospitals further explained
that suppliers of essential medical equipment and other materials have set a
deadline of April 15; beyond this date, supplies may be halted due to the
non-payment of bills. Expressing their inability to continue providing services
in the absence of funds, these suppliers warned that treatment under the
"Golden Card" scheme could be suspended starting April 15—a
suspension that would remain in effect until the outstanding dues are cleared
and the supply chain is restored, reports the Daily.</p>

<p>One of the hospital
owners told <a href="https://www.etvbharat.com/amp/hi/bharat/jammu-kashmir-hospitals-threaten-to-stop-treatment-under-ayushman-bharat-scheme-from-april-15-over-unpaid-bills-hindi-news-hin26040705587" target="_blank" rel="nofollow">ETV Bharat</a>, "Due to the long-pending non-payment of dues, our
vendors have stopped supplying essential medical materials, implants, and
equipment. This has severely impacted our operational capacity, rendering us
completely unable to provide necessary healthcare services to patients." Citing the surge in the
prices of medical supplies—attributed to the ongoing conflict involving Iran,
the U.S., and Israel—they noted that costs have risen by approximately 18–22%.
This has further exacerbated their financial burden and heightened the urgency
for timely payments. Another hospital owner remarked, "The delays in
payments, combined with this sudden spike in prices, have made the procurement
of supplies even more difficult."</p>

<p>In a message addressed to
Anant Dwivedi, CEO of the State Health Agency (SHA) for Jammu and Kashmir, the
hospital owners formally informed him that they would discontinue their
services if their outstanding dues were not cleared. In a letter addressed to
the CEO, the Association stated, "We regret to inform you that, due to the
depletion of medical supplies, we will be unable to continue providing
treatment under this scheme after April 15."</p>

<p>According to The Daily, the association has
stated that if the State Health Agency provides them with the necessary medical
supplies and implants, they will continue to render their services to ensure
that patient care remains uninterrupted. According to the SHA, there are 8.5
million registered Ayushman cardholders in Jammu and Kashmir who avail the
benefits of this scheme, while the total number of beneficiaries is reported to
be 10,104,488. The SHA further notes that out of the 1.3 million claims
submitted, 82 per cent have already been settled.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jk-private-hospitals-threaten-to-exit-ayushman-bharat-scheme-over-surgery-reservation-proposal-142857"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2023/06/01/210944-ayushman-bharat.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jk-private-hospitals-threaten-to-exit-ayushman-bharat-scheme-over-surgery-reservation-proposal-142857"><span class="read-this-also">Also Read:</span>J&K Private Hospitals threaten to exit Ayushman Bharat Scheme over surgery reservation proposal</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>Medical
Dialogues had previously reported that private hospitals and dialysis centres across Jammu
and Kashmir announced their decision to withdraw from the  AB-PMJAY-Sehat
scheme last year. This move came in response to several contentious
decisions made during the 9th Governing Council Meeting, which private
healthcare providers believe could have severe repercussions for the sector. </p></div>]]> </content:encoded>
</item>

<item>
<title>Telangana launches cancer registry to track new cases</title>
<link>https://edusehat.com/en/telangana-launches-cancer-registry-to-track-new-cases</link>
<guid>https://edusehat.com/en/telangana-launches-cancer-registry-to-track-new-cases</guid>
<description><![CDATA[ Hyderabad: Telangana Health Minister C Damodar Rajanarasimha on Tuesday declared cancer a notifiable disease and launched a cancer registry, a step aimed at helping the government develop better plans to control its spread.  The minister noted that about 55,000 to 60,000 new cancer cases are being reported in the state every year. He said every cancer case would be registered with the announcement of cancer as a notifiable disease.   The cancer registry is expected to provide the government with accurate data for preparing better plans to deal with the spread of cancer, he said. Also Read:Uttar Pradesh proposes cancer as a notifiable disease for early diagnosisAccording to the PTI report, observing that the state government has expanded healthcare to treat cancer by establishing Day Care Cancer Centres in district headquarters towns, he said the government is conducting health checks for 46 lakh members of women self-help groups (SHGs).He said the government would start Regional Cancer Centres and take measures to detect diseases like cancer through AI.The minister said this while attending World Health Day celebrations and inaugurated a LINAC (Linear Accelerator) in the cancer block of the state-run Nizam&#039;s Institute of Medical Sciences (NIMS) here, an official release said.The health minister launched several initiatives, including a comprehensive trauma care policy designed to help victims of accidents and other emergencies.The health department entered into an agreement with AstraZeneca for conducting lung cancer screening, using AI in 20 government hospitals.Medical Dialogues had earlier reported that Telangana Chief Minister A Revanth Reddy announced that the completion of multispecialty hospitals in Warangal and the state capital will add 10,000 beds to the state public health system. During the Question Hour in the assembly, Reddy also stated that the health department is developing a website to allow non-resident Telangana doctors to register to volunteer their services to hospitals in the state when they visit home.Also Read:Should Cancer be made a notifiable Disease? SC seeks response of Centre ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/26/335139-cancer-7.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Telangana, launches, cancer, registry, track, new, cases</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/26/335139-cancer-7.webp"><div class="pasted-from-word-wrapper"><p><span>Hyderabad: </span><span>Telangana Health Minister C Damodar Rajanarasimha on Tuesday declared <a href="https://medicaldialogues.in/topics/cancer" target="_blank">cancer</a> a notifiable disease and launched a cancer registry, a step aimed at helping</span> the government develop better plans to control its spread.  </p><p>The minister noted that about 55,000 to 60,000 new <a href="https://medicaldialogues.in/topics/cancer" target="_blank">cancer</a> cases are being reported in the state every year. He said every cancer case would be registered with the announcement of cancer as a notifiable disease.   </p><p>The cancer registry is expected to provide the government with accurate data for preparing better plans to deal with the spread of cancer, he said. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/uttar-pradesh/uttar-pradesh-proposes-cancer-as-a-notifiable-disease-for-early-diagnosis-167716"><b>Also Read:Uttar Pradesh proposes cancer as a notifiable disease for early diagnosis</b></a></p><p>According to the PTI report, observing that the state government has expanded healthcare to treat cancer by establishing Day Care Cancer Centres in district headquarters towns, he said the government is conducting health checks for 46 lakh members of women self-help groups (SHGs).</p><p>He said the government would start Regional <a href="https://medicaldialogues.in/topics/cancer" target="_blank">Cancer</a> Centres and take measures to detect diseases like cancer through AI.</p><p>The minister said this while attending World Health Day celebrations and inaugurated a LINAC (Linear Accelerator) in the cancer block of the state-run Nizam's Institute of Medical Sciences (NIMS) here, an official release said.</p><p>The health minister launched several initiatives, including a comprehensive trauma care policy designed to help victims of accidents and other emergencies.</p><p>The health department entered into an agreement with AstraZeneca for conducting lung cancer screening, using AI in 20 government hospitals.</p><p>Medical Dialogues had earlier reported that Telangana Chief Minister A Revanth Reddy announced that the completion of multispecialty hospitals in Warangal and the state capital will add 10,000 beds to the state public health system. During the Question Hour in the assembly, Reddy also stated that the health department is developing a website to allow non-resident Telangana doctors to register to volunteer their services to hospitals in the state when they visit home.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/should-cancer-be-made-a-notifiable-disease-sc-seeks-response-of-centre-160590"><b>Also Read:Should Cancer be made a notifiable Disease? SC seeks response of Centre</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>NMC extends NEET PG 2025 admission data submission deadline for medical colleges</title>
<link>https://edusehat.com/en/nmc-extends-neet-pg-2025-admission-data-submission-deadline-for-medical-colleges</link>
<guid>https://edusehat.com/en/nmc-extends-neet-pg-2025-admission-data-submission-deadline-for-medical-colleges</guid>
<description><![CDATA[ New Delhi: After several medical colleges reported technical difficulties in uploading admission details on the portal, the National Medical Commission (NMC) has extended the deadline for submission of NEET PG 2025 admission information.Initially, medical colleges and institutions were asked to submit details of admissions made through NEET-PG 2025 for the academic year 2025–26 by April 8, 2026. However, some institutions informed the authorities that they were experiencing issues while uploading the required data to the Admission Monitoring Portal.Taking note of these concerns, the Post Graduate Medical Education Board (PGMEB) under NMC decided to extend the timeline. Now, all concerned institutions can submit the required admission details till April 15, 2026.Medical Dialogues had reported that the National Medical Commission (NMC) directed all medical colleges and institutions to upload details of postgraduate admissions made through NEET PG 2025 on its online portal for the academic year 2025-26. The Commission set April 8, 2026, as the last date to submit the data.However, through a latest notice, issued on April 7, 2026, to the Directorate of Medical Education of all States and all institutions, additional time has been granted to the institutions to upload the data. The notice mentioned, &quot;I am directed to refer to this Board’s letter of even number dated 30.03.2026 vide which the Medical Colleges/Institutions were requested to submit the requisite information related to admissions made through NEETPG 2025 on the NMC admission monitoring portal by 08.04.2026.It is noted that some of the Medical Colleges/Institutions have informed that they are facing technical difficulties while uploading admission details on the NMC portal. The matter has been considered by the PGMEB, and it has been decided with the approval of the competent authority to extend the timelines for submission of admission details till 15.04.2026.&quot;The Board further asked all medical colleges and institutions to ensure that the requisite admission details are uploaded on the portal within the extended timeline without fail.Referring to this notice, the secretary of NMC, Dr Raghav Langer, wrote to the Director/Principal/Dean of all Medical Colleges/Institutions under NMC asking them to take note of the update and comply with the decision. &quot;Kind reference is invited to the Public Notice No. N-P050 (20)/30/2025- PGMEB- NMC dated 07-04-2026 (copy enclosed) issued by the Post Graduate Medical Education Board (PGMEB) of National Medical Commission (NMC) regarding online filling of information relating to admissions made in Medical College/Postgraduate Institutes through NEET-PG-2025 on the Admission Monitoring Portal, which shall now remain open till 15.04.2026. All the concerned institutions are requested to kindly take note of the same for compliance and necessary action,&quot; the letter read. To view the notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/08/neegpgaddmissionpublicnotice-340334.pdfAlso read- NMC sets deadline for NEET PG 2025 admissions data upload by medical colleges, warns of action ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/02/22/275559-deadline-extended.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, extends, NEET, 2025, admission, data, submission, deadline, for, medical, colleges</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/02/22/275559-deadline-extended.webp"><p><b>New Delhi: </b>After several medical colleges reported technical difficulties in uploading admission details on the portal, the <a href="https://medicaldialogues.in/topics/national-medical-commission" target="_blank">National Medical Commission</a> (NMC) has extended the deadline for submission of <a href="https://medicaldialogues.in/topics/neet-pg-2025" target="_blank">NEET PG 2025</a> admission information.</p><p>Initially, medical colleges and institutions were asked to submit details of admissions made through NEET-PG 2025 for the academic year 2025–26 by April 8, 2026. However, some institutions informed the authorities that they were experiencing issues while uploading the required data to the Admission Monitoring Portal.</p><p>Taking note of these concerns, the Post Graduate Medical Education Board (PGMEB) under NMC decided to extend the timeline. Now, all concerned institutions can submit the required admission details till April 15, 2026.</p><p>Medical Dialogues had reported that the National Medical Commission (NMC) directed all medical colleges and institutions to upload details of postgraduate admissions made through NEET PG 2025 on its online portal for the academic year 2025-26. The Commission set April 8, 2026, as the last date to submit the data.</p><p>However, through a latest notice, issued on April 7, 2026, to the Directorate of Medical Education of all States and all institutions, additional time has been granted to the institutions to upload the data. </p><p>The notice mentioned, <i>"I am directed to refer to this Board’s letter of even number dated 30.03.2026 vide which the Medical Colleges/Institutions were requested to submit the requisite information related to admissions made through NEETPG 2025 on the NMC admission monitoring portal by 08.04.2026.</i></p><p><i>It is noted that some of the Medical Colleges/Institutions have informed that they are facing technical difficulties while uploading admission details on the NMC portal. The matter has been considered by the PGMEB, and it has been decided with the approval of the competent authority to extend the timelines for submission of admission details till 15.04.2026."</i></p><p>The Board further asked all medical colleges and institutions to ensure that the requisite admission details are uploaded on the portal within the extended timeline without fail.</p><p>Referring to this notice, the secretary of NMC, Dr Raghav Langer, wrote to the Director/Principal/Dean of all Medical Colleges/Institutions under NMC asking them to take note of the update and comply with the decision. </p><p><i>"Kind reference is invited to the Public Notice No. N-P050 (20)/30/2025- PGMEB- NMC dated 07-04-2026 (copy enclosed) issued by the Post Graduate Medical Education Board (PGMEB) of National Medical Commission (NMC) regarding online filling of information relating to admissions made in Medical College/Postgraduate Institutes through NEET-PG-2025 on the Admission Monitoring Portal, which shall now remain open till 15.04.2026. All the concerned institutions are requested to kindly take note of the same for compliance and necessary action," </i>the letter read. </p><p><b>To view the notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/neegpgaddmissionpublicnotice-340334.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/08/neegpgaddmissionpublicnotice-340334.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/health-news/nmc/nmc-sets-deadline-for-neet-pg-2025-admissions-data-upload-by-medical-colleges-warns-of-action-167801" target="_blank">NMC sets deadline for NEET PG 2025 admissions data upload by medical colleges, warns of action</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 08/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-08april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-08april2026</guid>
<description><![CDATA[ Here are the top medical news for today:Cancer Ranks Tenth in Causes of Death Among Indian Children: Lancet Study
Childhood cancer remains a major public health challenge, ranking among the top ten causes of death in India, according to the Global Burden of Disease Study 2023 published in The Lancet. In 2023 alone, an estimated 17,000 children in India died from cancer, highlighting a significant and often underrecognized burden.
Globally, childhood cancer was the eighth-leading cause of death, surpassing diseases such as measles, tuberculosis, and HIV/AIDS. The study reported approximately 377,000 new cases and 144,000 deaths worldwide in 2023. The most common types included leukemias, brain and central nervous system cancers, and non-Hodgkin lymphoma.
Despite advances in treatment, disparities remain stark. Low- and middle-income countries accounted for 85% of new cases and a striking 94% of deaths and disability-adjusted life years (DALYs). DALYs reflect the total years of healthy life lost due to illness and premature death, underscoring the long-term impact of childhood cancer.
India’s burden may be even higher than reported. Experts estimate that between 50,000 and 75,000 children are diagnosed annually, suggesting underreporting and gaps in surveillance. While survival rates have improved significantly in high-income countries, many children in Low- and middle-income countries face delays in diagnosis, limited access to treatment, and inadequate healthcare infrastructure.
Encouragingly, childhood cancers are often highly treatable, especially when detected early. However, improving outcomes requires systemic changes. These include strengthening referral systems, expanding access to chemotherapy, surgery, and radiotherapy, and improving workforce training and cancer registries.
The findings highlight an urgent need for targeted policy action. Investments in comprehensive cancer care systems, particularly in resource-limited settings, could significantly reduce mortality. Bridging the gap between high- and low-income regions is critical to ensuring that advances in treatment benefit all children equally.
REFERENCE: Force L, Kocarnik J, May M et al.; Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet; DOI: 10.1016/S0140-6736(26)00200-X External Link
Princeton Researchers Identify New Links Between High-Fat Diets and Aggressive Breast Cancer
A new study from Princeton University has uncovered how high-fat diets may make certain breast cancers more aggressive, offering new insight into how nutrition can influence tumour behaviour. 
Published in APL Bioengineering, the research focused on triple-negative breast cancer, a form of cancer that is difficult to treat due to its lack of response to standard therapies.
Using advanced 3D tumour models, scientists simulated different dietary conditions by exposing cancer cells to various nutrients. While most diets showed little effect on tumour structure, those exposed to high levels of fatty acids and cholesterol behaved differently. 
Instead of remaining compact, these tumours developed invasive, finger-like projections—features associated with aggressive cancers that spread into surrounding tissues and potentially metastasize.
Interestingly, tumour growth rates remained similar across all diet types. However, structural changes were significant in high-fat conditions. Cancer cells migrated outward from the tumour core, indicating increased invasive potential. 
Researchers also identified a sharp rise in the activity of a gene called MMP1, which is known to break down collagen in surrounding tissues. This breakdown may create pathways that allow cancer cells to spread more easily.
In contrast, tumours exposed to high insulin, glycerol, ketones, or even a simulated ketogenic diet did not show the same aggressive structural changes. This was unexpected, as ketogenic diets are often thought to have protective effects in cancer. The findings suggest that, at least for this cancer type, fat itself—not just overall metabolism—may play a critical role in tumour invasiveness.
Researchers caution that these results are based on controlled lab models and may not fully replicate the complexity of the human body. However, the study highlights a potential biological link between dietary fat and cancer progression, opening new avenues for targeted therapies and personalized nutrition strategies in oncology.
REFERENCE: Kohram, M., et al. (2026). Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer. APL Bioengineering. DOI: 10.1063/5.0291646. https://pubs.aip.org/aip/apb/article/10/1/016111/3381798/Fat-promotes-growth-and-invasion-in-a-3D
Researchers Warn BMI Fails to Accurately Assess Health in Many Adults
A new study from Italian researchers challenges the reliability of Body Mass Index as a tool for assessing body weight and health. The findings, to be presented at European Congress on Obesity 2026 and published in Nutrients, show that BMI may incorrectly classify more than one-third of adults when compared with more precise body fat measurements.BMI, widely used in clinical and public health settings, estimates weight status based on height and weight but does not directly measure body fat or its distribution. This limitation has raised concerns about its accuracy. 
To investigate further, researchers compared BMI classifications with results from Dual-energy X-ray absorptiometry, considered the gold standard for measuring body fat percentage.
The study analyzed 1,351 adults aged 18 to 98. Based on BMI, about 41% were categorized as overweight or obese. However, DXA-based assessments showed a lower prevalence of 37%, revealing significant discrepancies. 
Among those labeled obese by BMI, 34% were actually overweight according to DXA. Misclassification was even higher in the overweight category, where 53% were placed incorrectly—many of whom were found to have normal body fat levels.
Even individuals considered “normal weight” were not always accurately classified. While BMI and DXA agreed in 78% of such cases, 22% were reassigned to different categories when body fat was directly measured. 
The greatest mismatch occurred in the underweight group, where more than two-thirds were reclassified as normal weight using DXA.
These findings suggest that BMI may overestimate both obesity and underweight prevalence, potentially leading to misleading health assessments. Experts recommend combining BMI with additional tools such as waist-to-height ratio, skinfold measurements, or direct body composition analysis for a more accurate evaluation.
Overall, the study highlights the need to update current guidelines and adopt more comprehensive approaches to assessing body health.
REFERENCE: Chiara Milanese, Leila Itani, Valentina Cavedon, Marwan El Ghoch. The WHO BMI System Misclassifies Weight Status in Adults from the General Population in North Italy: A DXA-Based Assessment Study (18–98 Years). Nutrients, 2025; 17 (13): 2162 DOI: 10.3390/nu17132162
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340327-top-medical-2026-04-08t122616262.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 08April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340327-top-medical-2026-04-08t122616262.webp"><p><b>Here are the top medical news for today:</b></p><p><b>Cancer Ranks Tenth in Causes of Death Among Indian Children: Lancet Study
</b></p><p>Childhood cancer remains a major public health challenge, ranking among the top ten causes of death in India, according to the Global Burden of Disease Study 2023 published in The Lancet. In 2023 alone, an estimated 17,000 children in India died from cancer, highlighting a significant and often underrecognized burden.
</p><p>Globally, childhood cancer was the eighth-leading cause of death, surpassing diseases such as measles, tuberculosis, and HIV/AIDS. The study reported approximately 377,000 new cases and 144,000 deaths worldwide in 2023. The most common types included leukemias, brain and central nervous system cancers, and non-Hodgkin lymphoma.
</p><p>Despite advances in treatment, disparities remain stark. Low- and middle-income countries accounted for 85% of new cases and a striking 94% of deaths and disability-adjusted life years (DALYs). DALYs reflect the total years of healthy life lost due to illness and premature death, underscoring the long-term impact of childhood cancer.
</p><p>India’s burden may be even higher than reported. Experts estimate that between 50,000 and 75,000 children are diagnosed annually, suggesting underreporting and gaps in surveillance. While survival rates have improved significantly in high-income countries, many children in Low- and middle-income countries face delays in diagnosis, limited access to treatment, and inadequate healthcare infrastructure.
</p><p>Encouragingly, childhood cancers are often highly treatable, especially when detected early. However, improving outcomes requires systemic changes. These include strengthening referral systems, expanding access to chemotherapy, surgery, and radiotherapy, and improving workforce training and cancer registries.
</p><p>The findings highlight an urgent need for targeted policy action. Investments in comprehensive cancer care systems, particularly in resource-limited settings, could significantly reduce mortality. Bridging the gap between high- and low-income regions is critical to ensuring that advances in treatment benefit all children equally.
</p><p><b>REFERENCE: </b>Force L, Kocarnik J, May M et al.; Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet; DOI: 10.1016/S0140-6736(26)00200-X External Link
</p><p><b><br></b></p><p><b>Princeton Researchers Identify New Links Between High-Fat Diets and Aggressive Breast Cancer
</b></p><p>A new study from Princeton University has uncovered how high-fat diets may make certain breast cancers more aggressive, offering new insight into how nutrition can influence tumour behaviour. 
</p><p>Published in APL Bioengineering, the research focused on triple-negative breast cancer, a form of cancer that is difficult to treat due to its lack of response to standard therapies.
</p><p>Using advanced 3D tumour models, scientists simulated different dietary conditions by exposing cancer cells to various nutrients. While most diets showed little effect on tumour structure, those exposed to high levels of fatty acids and cholesterol behaved differently. 
</p><p>Instead of remaining compact, these tumours developed invasive, finger-like projections—features associated with aggressive cancers that spread into surrounding tissues and potentially metastasize.
</p><p>Interestingly, tumour growth rates remained similar across all diet types. However, structural changes were significant in high-fat conditions. Cancer cells migrated outward from the tumour core, indicating increased invasive potential. 
</p><p>Researchers also identified a sharp rise in the activity of a gene called MMP1, which is known to break down collagen in surrounding tissues. This breakdown may create pathways that allow cancer cells to spread more easily.
</p><p>In contrast, tumours exposed to high insulin, glycerol, ketones, or even a simulated ketogenic diet did not show the same aggressive structural changes. This was unexpected, as ketogenic diets are often thought to have protective effects in cancer. The findings suggest that, at least for this cancer type, fat itself—not just overall metabolism—may play a critical role in tumour invasiveness.
</p><p>Researchers caution that these results are based on controlled lab models and may not fully replicate the complexity of the human body. However, the study highlights a potential biological link between dietary fat and cancer progression, opening new avenues for targeted therapies and personalized nutrition strategies in oncology.
</p><p><b>REFERENCE: </b>Kohram, M., et al. (2026). Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer. APL Bioengineering. DOI: 10.1063/5.0291646. https://pubs.aip.org/aip/apb/article/10/1/016111/3381798/Fat-promotes-growth-and-invasion-in-a-3D
</p><p><b><br></b></p><p><b>Researchers Warn BMI Fails to Accurately Assess Health in Many Adults
</b></p><p>A new study from Italian researchers challenges the reliability of Body Mass Index as a tool for assessing body weight and health. The findings, to be presented at European Congress on Obesity 2026 and published in Nutrients, show that BMI may incorrectly classify more than one-third of adults when compared with more precise body fat measurements.</p><p>BMI, widely used in clinical and public health settings, estimates weight status based on height and weight but does not directly measure body fat or its distribution. This limitation has raised concerns about its accuracy. 
</p><p>To investigate further, researchers compared BMI classifications with results from Dual-energy X-ray absorptiometry, considered the gold standard for measuring body fat percentage.
</p><p>The study analyzed 1,351 adults aged 18 to 98. Based on BMI, about 41% were categorized as overweight or obese. However, DXA-based assessments showed a lower prevalence of 37%, revealing significant discrepancies. 
</p><p>Among those labeled obese by BMI, 34% were actually overweight according to DXA. Misclassification was even higher in the overweight category, where 53% were placed incorrectly—many of whom were found to have normal body fat levels.
</p><p>Even individuals considered “normal weight” were not always accurately classified. While BMI and DXA agreed in 78% of such cases, 22% were reassigned to different categories when body fat was directly measured. 
</p><p>The greatest mismatch occurred in the underweight group, where more than two-thirds were reclassified as normal weight using DXA.
</p><p>These findings suggest that BMI may overestimate both obesity and underweight prevalence, potentially leading to misleading health assessments. Experts recommend combining BMI with additional tools such as waist-to-height ratio, skinfold measurements, or direct body composition analysis for a more accurate evaluation.
</p><p>Overall, the study highlights the need to update current guidelines and adopt more comprehensive approaches to assessing body health.
</p><p><b>REFERENCE:</b> Chiara Milanese, Leila Itani, Valentina Cavedon, Marwan El Ghoch. The WHO BMI System Misclassifies Weight Status in Adults from the General Population in North Italy: A DXA-Based Assessment Study (18–98 Years). Nutrients, 2025; 17 (13): 2162 DOI: 10.3390/nu17132162
</p>]]> </content:encoded>
</item>

<item>
<title>Odisha: 5 Kodala Hospital staff detained in Medical Arrears Scam</title>
<link>https://edusehat.com/en/odisha-5-kodala-hospital-staff-detained-in-medical-arrears-scam</link>
<guid>https://edusehat.com/en/odisha-5-kodala-hospital-staff-detained-in-medical-arrears-scam</guid>
<description><![CDATA[ Ganjam: A case of alleged financial irregularities involving medical arrears funds has come to light in the Ganjam district of Odisha. As part of the ongoing investigation, five employees of Kodala Hospital have been taken into custody by vigilance officials.  During the initial interrogation, the accused were first taken to the office of the Chief District Medical Officer (CDMO), where they were questioned. They were later moved to an undisclosed location for further questioning.Also Read: Fake FMGE certificate scam in Chhattisgarh? 3,000 doctors under medical council, NMC, DME scannerAccording to the OdishaTV media news report, a total of seven individuals have been found to be involved in this case so far. However, investigators suspect that as the probe progresses, several more individuals, including other key figures, could come under the ambit of the investigation. Meanwhile, the investigation also revealed that the digital signatures of officials had been forged to execute fraudulent transactions. Taking these findings into cognizance, the CDMO had earlier suspended seven employees on charges of alleged involvement.Given the importance of the allegations, the District Health Department has recommended a high-level vigilance inquiry into this matter. Further investigations are underway, and officials have indicated that more revelations may emerge in the coming days. However, detailed information regarding this matter will be shared at a later stage.  Prior to this, an embezzlement of approximately ₹2.5 crore took place at Kodala Hospital. The allegations indicate that additional funds were fraudulently withdrawn in the guise of outstanding dues in the names of other employees and were subsequently misappropriated. Last month, Medical Dialogues had reported that in a fraud case from Raipur involving allegations of cheating of Rs 2.34 crore under the pretext of securing jobs at the post office and fabricating fake medical degrees, the police have arrested another accused.   Also Read: Fake MBBS, BAMS degrees racket: Woman arrested in Rs 2.34 crore Raipur job scam ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340384-fraud-.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Odisha:, Kodala, Hospital, staff, detained, Medical, Arrears, Scam</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340384-fraud-.webp"><p><b>Ganjam: </b>A case of alleged financial irregularities involving medical arrears funds has come to light in the Ganjam district of Odisha. As part of the ongoing investigation, five employees of Kodala Hospital have been taken into custody by vigilance officials.  </p><div class="pasted-from-word-wrapper"><p dir="ltr">During the initial interrogation, the accused were first taken to the office of the Chief District Medical Officer (CDMO), where they were questioned. They were later moved to an undisclosed location for further questioning.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/chattisgarh/fake-fmge-certificate-scam-in-chhattisgarh-3000-doctors-under-medical-council-nmc-dme-scanner-167556"><b>Also Read: </b>Fake FMGE certificate scam in Chhattisgarh? 3,000 doctors under medical council, NMC, DME scanner</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">According to the <a href="https://odishatv.in/odisha/medical-arrear-fraud-in-ganjam-odisha-vigilance-detains-five-probe-deepens-11700546" target="_blank" rel="nofollow">OdishaTV </a>media news report, a total of seven individuals have been found to be involved in this case so far. However, investigators suspect that as the probe progresses, several more individuals, including other key figures, could come under the ambit of the investigation. </p><p dir="ltr">Meanwhile, the investigation also revealed that the digital signatures of officials had been forged to execute fraudulent transactions. Taking these findings into cognizance, the CDMO had earlier suspended seven employees on charges of alleged involvement.</p><p dir="ltr">Given the importance of the allegations, the District Health Department has recommended a high-level vigilance inquiry into this matter. Further investigations are underway, and officials have indicated that more revelations may emerge in the coming days. However, detailed information regarding this matter will be shared at a later stage.  </p><p dir="ltr">Prior to this, an embezzlement of approximately ₹2.5 crore took place at Kodala Hospital. The allegations indicate that additional funds were fraudulently withdrawn in the guise of outstanding dues in the names of other employees and were subsequently misappropriated. </p><p dir="ltr">Last month, Medical Dialogues had reported that in a fraud case from Raipur involving allegations of cheating of Rs 2.34 crore under the pretext of securing jobs at the post office and fabricating fake medical degrees, the police have arrested another accused.   </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/chattisgarh/fake-mbbs-bams-degrees-racket-woman-arrested-in-rs-234-crore-raipur-job-scam-167531"><b>Also Read: </b>Fake MBBS, BAMS degrees racket: Woman arrested in Rs 2.34 crore Raipur job scam</a><br></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Yoga expert Dr K Raghavendra Pai takes charge as VC of Vyasa Bharati Triyoga University, USA</title>
<link>https://edusehat.com/en/yoga-expert-dr-k-raghavendra-pai-takes-charge-as-vc-of-vyasa-bharati-triyoga-university-usa</link>
<guid>https://edusehat.com/en/yoga-expert-dr-k-raghavendra-pai-takes-charge-as-vc-of-vyasa-bharati-triyoga-university-usa</guid>
<description><![CDATA[ Mysuru: Dr. K. Raghavendra Pai, a noted yoga expert from Mysuru, has been appointed as the Vice-Chancellor of Vyasa Bharati Triyoga University (VBTU) in the United States. Vyasa Bharati Triyoga University is a US-based institution focused on integrating ancient Indian wisdom with modern education, with an emphasis on yoga, philosophy, and Indian knowledge systems, and operates within the global VYASA/Yoga Bharati network.  Originally from Karkala, Dr. Pai is widely recognised for his contributions to the promotion of Sanatana Dharma, yoga, and Vedic knowledge traditions, reports STAR OF MYSORE. With the passage of time, he has played a key role in spreading traditional Indian wisdom through structured education and training programmes. He previously served as Yoga Director of the SDM Yoga and Moral Education Project at Dharmasthala, where he contributed to value-based learning initiatives. Also Read:Dr Bhanu Duggal appointed VC of HNB Uttarakhand Medical Education UniversityHe is currently a member of the Yoga Certification Board under the Ministry of AYUSH, and has also served on the National Education Policy (NEP) syllabus committee, contributing to curriculum development and educational reforms in India.  Dr. Pai was a Visiting Professor at the Swami Vivekananda Study Chair in the Department of Philosophy at the University of Mysore. During his tenure, 13 scholars completed their PhD under his guidance, highlighting his role as a mentor and academic guide.He is the founder of Sri Vedavyasa Yoga Pratisthana in Mysuru, where he continues to engage in research and training in yoga and Dasa Sahitya. He has also contributed to important scholarly works such as Gamana Yoga Sutras and Yoga Vishwakosha.A distinguished yoga exponent, Dr. Pai has trained thousands of teachers and students across India and abroad. He is particularly known for developing the concept of “Yogic Walk – Gamana Yoga Sutras” and for promoting yoga as a tool for holistic well-being. He has received several national and international honours. In his new position, he aims to integrate ancient Indian wisdom with modern education systems and promote holistic human development rooted in Bharatiya knowledge traditions.  Also Read:Dr Vikas Bhatia takes charge as VC of Pandit Deen Dayal Upadhyay University of Health Sciences ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340307-drk-raghavendra-pai-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 18:25:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Yoga, expert, Raghavendra, Pai, takes, charge, Vyasa, Bharati, Triyoga, University, USA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340307-drk-raghavendra-pai-1.webp"><div class="pasted-from-word-wrapper"><p>Mysuru: Dr. K. Raghavendra Pai, a noted yoga expert from Mysuru, has been appointed as the <a href="https://medicaldialogues.in/topics/vice%20chancellor" target="_blank">Vice-Chancellor</a> of Vyasa Bharati Triyoga University (VBTU) in the United States. </p><p>Vyasa Bharati Triyoga University is a US-based institution focused on integrating ancient Indian wisdom with modern education, with an emphasis on yoga, philosophy, and Indian knowledge systems, and operates within the global VYASA/Yoga Bharati network.  </p><p>Originally from Karkala, Dr. Pai is widely recognised for his contributions to the promotion of Sanatana Dharma, yoga, and Vedic knowledge traditions, reports <i><a href="https://starofmysore.com/dr-k-raghavendra-pai-appointed-vc-of-vyasa-bharati-triyoga-university-usa/" target="_blank">STAR OF MYSORE</a></i>. With the passage of time, he has played a key role in spreading traditional Indian wisdom through structured education and training programmes. </p><p>He previously served as Yoga Director of the SDM Yoga and Moral Education Project at Dharmasthala, where he contributed to value-based learning initiatives. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/uttrakhand/dr-bhanu-duggal-appointed-vc-of-hnb-uttarakhand-medical-education-university-164457">Also Read:Dr Bhanu Duggal appointed VC of HNB Uttarakhand Medical Education University</a></p><p>He is currently a member of the Yoga Certification Board under the Ministry of AYUSH, and has also served on the National Education Policy (NEP) syllabus committee, contributing to curriculum development and educational reforms in India.  </p><p>Dr. Pai was a Visiting Professor at the Swami Vivekananda Study Chair in the Department of Philosophy at the University of Mysore. During his tenure, 13 scholars completed their PhD under his guidance, highlighting his role as a mentor and academic guide.</p><p>He is the founder of Sri Vedavyasa Yoga Pratisthana in Mysuru, where he continues to engage in research and training in yoga and Dasa Sahitya. He has also contributed to important scholarly works such as Gamana Yoga Sutras and Yoga Vishwakosha.</p><p>A distinguished yoga exponent, Dr. Pai has trained thousands of teachers and students across India and abroad. He is particularly known for developing the concept of “Yogic Walk – Gamana Yoga Sutras” and for promoting yoga as a tool for holistic well-being. </p><p>He has received several national and international honours. In his new position, he aims to integrate ancient Indian wisdom with modern education systems and promote holistic human development rooted in Bharatiya knowledge traditions.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/dr-vikas-bhatia-takes-charge-as-vc-of-pandit-deen-dayal-upadhyay-university-of-health-sciences-158149">Also Read:Dr Vikas Bhatia takes charge as VC of Pandit Deen Dayal Upadhyay University of Health Sciences</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Older adults&amp;apos; driving habits offer window into brain health, cognitive decline: Study</title>
<link>https://edusehat.com/en/older-adults-driving-habits-offer-window-into-brain-health-cognitive-decline-study-9393</link>
<guid>https://edusehat.com/en/older-adults-driving-habits-offer-window-into-brain-health-cognitive-decline-study-9393</guid>
<description><![CDATA[ Older adults&#039; driving habits revealed clues about their brain health and may provide early warning signs of cognitive decline or dementia, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2026. The meeting is in New Orleans, Feb. 4-6, 2026, and is a world premier global event dedicated to advancing stroke and brain health science.
“Driving habits in older adults can reveal early changes in brain health. How often people drive, where they go, and how much they vary their routes may signal underlying damage to the brain’s white matter, which is linked to cognitive decline and dementia,” said study author Chia-Ling Phuah, M.D., M.M.Sc., an associate professor of neurocritical care and co-director of the Neuro Analytics Center at Barrow Neurological Institute in Phoenix. “These findings suggest that even small shifts in daily driving patterns can offer important clues about brain changes — sometimes before traditional memory and thinking symptoms are noticeable.”
According to the American Heart Association 2026 Heart and Stroke Statistics, about 6.9 million (10.9%) – or 1 in 9 - adults 65 years or older in the United States were living with Alzheimer’s disease in 2024.Researchers reviewed driving habits for 220 adult volunteers, ages 65 and older, living independently in St. Louis, Missouri. Detailed cognitive assessments indicated participants were free of dementia at the start of the study. Car sensors were used to track participants’ driving behavior (including speeding, collisions, hard braking or hard cornering) for more than five years. They conducted additional brain imaging studies within the first year of the study to measure changes in the brain’s white matter, specifically white matter hyperintensities — areas of white matter damage caused by reduced blood flow to brain tissue.The analysis found:Older adults who had more white matter hyperintensities tended to drive less and show sharper declines in their willingness or ability to change driving routes and habits.Over more than five years of follow-up, 17% of participants developed cognitive impairment and most of these individuals were later diagnosed with Alzheimer’s disease.Among the 17% of participants who developed cognitive impairment, higher white matter hyperintensity burden on brain imaging was linked to a greater likelihood of unsafe driving practices, such as hard braking, and to more crashes.“Participants with white matter hyperintensities located in the back of the brain — a region responsible for processing what people see and how they move — were at even higher risk of crashes than those with changes in other brain areas, making them more likely to experience unsafe driving episodes and car accidents over time,“ Phuah explained.Participants taking medications to manage high blood pressure, especially angiotensin-converting enzyme (ACE) inhibitors, were less likely to exhibit risky driving when compared with those who were not taking any blood pressure medication.Overall, the study’s findings suggest that monitoring driving behavior with commercial in-vehicle data loggers may help identify older adults at higher risk for unsafe driving, loss of independence and subtle cognitive problems, Phuah noted.“One especially promising finding was that people taking blood pressure medications, particularly ACE inhibitors, tended to maintain safer driving habits even when their brain scans revealed more damage. This effect was observed regardless of whether their blood pressure levels were at target levels,” Phuah said. “This suggests that these medications may help support brain health as we age.”Nada El Husseini, M.D., M.H.Sc., FAHA, chair of the American Heart Association’s 2023 scientific statement, Cognitive Impairment After Ischemic and Hemorrhagic Stroke said, “What’s surprising about these findings is that people taking ACE inhibitors were less likely to have impairment in their driving despite the extent of white matter disease. The impact of ACE inhibitors on cognitive function and driving safety in people with white matter disease requires further investigation. Also, these results suggest cognitive screening and brain imaging might be considered for people with driving difficulties.” El Husseini is an associate professor of neurology at Duke University Medical Center in Durham, North Carolina and was not involved in this study.
Normal blood pressure is less than 120/80, and treatment is recommended for people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension). Recent research confirms that blood pressure affects brain health, including cognitive function and dementia, so early treatment is recommended for people diagnosed with high blood pressure to maintain brain health and cognition, according to the 2025 American Heart Association High Blood Pressure Guideline.Key limitations include a small study size, most participants were white, college-educated adults, so results may not generalize to people from more diverse backgrounds, and medication use was self-reported, which could introduce errors.The next step will be larger studies that include more diverse participants to confirm and extend these findings.Study details, background and design:The study included 220 adults (average age of 73 years; 54% men, 46% women, 88% white and 12% Black) living in St. Louis, Missouri, who did not have dementia when they enrolled in the study.Data was collected over a nine-year period, from 2016 to 2024, as part of the Driving Real-World In-Vehicle Evaluation System (DRIVES) project based at Washington University in St. Louis.Participants were monitored for continuous in-vehicle driving metrics, such as trip frequency, distance and destination, as well as safety events, including time spent speeding, collisions, hard braking or hard cornering.All participants had brain magnetic resonance imaging (MRI) scans to measure white matter hyperintensities at enrollment, which was around the time they started their driving assessments. About half (102 participants) had a second MRI scan at least 12 months after their first scan. Participants also underwent annual clinical and cognitive assessments.Researchers analyzed the relationship between total and regional white matter hyperintensities and driving patterns and safety.Statistical models were used to adjust for demographics, social/economic factors and health factors.Patient perspective: A caregiver’s view of driving and cognitive declineFor Larry Duncan, a retired business owner from Pinehurst, North Carolina, driving was part of his independence. But subtle changes began to appear before his Alzheimer’s diagnosis in 2023. “Larry was fine driving in familiar areas,” recalls his wife and caregiver, Pam Duncan. “But in new places where he had to make quick decisions, he became anxious.”As his cognitive challenges progressed, Duncan’s doctor advised him to stop driving, a decision she describes as heartbreaking but necessary.“In early-stage cognitive impairment, symptoms can be subtle, and driving is one of them,” said Pam Duncan, who now volunteers for the American Stroke Association, a division of the American Heart Association. “Don’t ignore these changes. As caregivers, our role is to support independence while having the courage to make tough decisions. You can live well with dementia, but it starts with awareness and action.”Reference:Older adults’ driving habits offer window into brain health, cognitive decline, American Heart Association, Meeting: ASA International Stroke Conference 2026 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:26 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Older, adults, driving, habits, offer, window, into, brain, health, cognitive, decline:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.webp"><div class="pasted-from-word-wrapper"><p>Older adults' driving habits revealed clues about their <a href="https://medicaldialogues.in/topics/brain-health">brain health </a>and may provide early warning signs of <a href="https://medicaldialogues.in/topics/cognitive-decline">cognitive decline </a>or <a href="https://medicaldialogues.in/topics/dementia">dementia</a>, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2026. The meeting is in New Orleans, Feb. 4-6, 2026, and is a world premier global event dedicated to advancing stroke and brain health science.
</p><p>“Driving habits in older adults can reveal early changes in brain health. How often people drive, where they go, and how much they vary their routes may signal underlying damage to the brain’s white matter, which is linked to cognitive decline and dementia,” said study author Chia-Ling Phuah, M.D., M.M.Sc., an associate professor of neurocritical care and co-director of the Neuro Analytics Center at Barrow Neurological Institute in Phoenix. “These findings suggest that even small shifts in daily driving patterns can offer important clues about brain changes — sometimes before traditional memory and thinking symptoms are noticeable.”
</p><p>According to the American Heart Association 2026 Heart and Stroke Statistics, about 6.9 million (10.9%) – or 1 in 9 - adults 65 years or older in the United States were living with Alzheimer’s disease in 2024.</p><p>Researchers reviewed driving habits for 220 adult volunteers, ages 65 and older, living independently in St. Louis, Missouri. Detailed cognitive assessments indicated participants were free of dementia at the start of the study. Car sensors were used to track participants’ driving behavior (including speeding, collisions, hard braking or hard cornering) for more than five years. They conducted additional brain imaging studies within the first year of the study to measure changes in the brain’s white matter, specifically white matter hyperintensities — areas of white matter damage caused by reduced blood flow to brain tissue.</p><p>The analysis found:</p><ul><li>Older adults who had more white matter hyperintensities tended to drive less and show sharper declines in their willingness or ability to change driving routes and habits.</li><li>Over more than five years of follow-up, 17% of participants developed cognitive impairment and most of these individuals were later diagnosed with Alzheimer’s disease.</li><li>Among the 17% of participants who developed cognitive impairment, higher white matter hyperintensity burden on brain imaging was linked to a greater likelihood of unsafe driving practices, such as hard braking, and to more crashes.</li><li>“Participants with white matter hyperintensities located in the back of the brain — a region responsible for processing what people see and how they move — were at even higher risk of crashes than those with changes in other brain areas, making them more likely to experience unsafe driving episodes and car accidents over time,“ Phuah explained.</li><li><p>Participants taking medications to manage high blood pressure, especially angiotensin-converting enzyme (ACE) inhibitors, were less likely to exhibit risky driving when compared with those who were not taking any blood pressure medication.</p></li></ul><p>Overall, the study’s findings suggest that monitoring driving behavior with commercial in-vehicle data loggers may help identify older adults at higher risk for unsafe driving, loss of independence and subtle cognitive problems, Phuah noted.</p><p>“One especially promising finding was that people taking blood pressure medications, particularly ACE inhibitors, tended to maintain safer driving habits even when their brain scans revealed more damage. This effect was observed regardless of whether their blood pressure levels were at target levels,” Phuah said. “This suggests that these medications may help support brain health as we age.”</p><p>Nada El Husseini, M.D., M.H.Sc., FAHA, chair of the American Heart Association’s 2023 scientific statement, Cognitive Impairment After Ischemic and Hemorrhagic Stroke said, “What’s surprising about these findings is that people taking ACE inhibitors were less likely to have impairment in their driving despite the extent of white matter disease. The impact of ACE inhibitors on cognitive function and driving safety in people with white matter disease requires further investigation. Also, these results suggest cognitive screening and brain imaging might be considered for people with driving difficulties.” El Husseini is an associate professor of neurology at Duke University Medical Center in Durham, North Carolina and was not involved in this study.
</p><p>Normal blood pressure is less than 120/80, and treatment is recommended for people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension). Recent research confirms that blood pressure affects brain health, including cognitive function and dementia, so early treatment is recommended for people diagnosed with high blood pressure to maintain brain health and cognition, according to the 2025 American Heart Association High Blood Pressure Guideline.</p><p>Key limitations include a small study size, most participants were white, college-educated adults, so results may not generalize to people from more diverse backgrounds, and medication use was self-reported, which could introduce errors.</p><p>The next step will be larger studies that include more diverse participants to confirm and extend these findings.</p><p>Study details, background and design:</p><ul><li>The study included 220 adults (average age of 73 years; 54% men, 46% women, 88% white and 12% Black) living in St. Louis, Missouri, who did not have dementia when they enrolled in the study.</li><li>Data was collected over a nine-year period, from 2016 to 2024, as part of the Driving Real-World In-Vehicle Evaluation System (DRIVES) project based at Washington University in St. Louis.</li><li>Participants were monitored for continuous in-vehicle driving metrics, such as trip frequency, distance and destination, as well as safety events, including time spent speeding, collisions, hard braking or hard cornering.</li><li>All participants had brain magnetic resonance imaging (MRI) scans to measure white matter hyperintensities at enrollment, which was around the time they started their driving assessments. About half (102 participants) had a second MRI scan at least 12 months after their first scan. Participants also underwent annual clinical and cognitive assessments.</li><li>Researchers analyzed the relationship between total and regional white matter hyperintensities and driving patterns and safety.</li><li>Statistical models were used to adjust for demographics, social/economic factors and health factors.</li></ul><p>Patient perspective: A caregiver’s view of driving and cognitive decline</p><p>For Larry Duncan, a retired business owner from Pinehurst, North Carolina, driving was part of his independence. But subtle changes began to appear before his Alzheimer’s diagnosis in 2023. “Larry was fine driving in familiar areas,” recalls his wife and caregiver, Pam Duncan. “But in new places where he had to make quick decisions, he became anxious.”</p><p>As his cognitive challenges progressed, Duncan’s doctor advised him to stop driving, a decision she describes as heartbreaking but necessary.</p><p>“In early-stage cognitive impairment, symptoms can be subtle, and driving is one of them,” said Pam Duncan, who now volunteers for the American Stroke Association, a division of the American Heart Association. “Don’t ignore these changes. As caregivers, our role is to support independence while having the courage to make tough decisions. You can live well with dementia, but it starts with awareness and action.”</p><p>Reference:</p><p>Older adults’ driving habits offer window into brain health, cognitive decline, American Heart Association, Meeting: ASA International Stroke Conference 2026</p></div>]]> </content:encoded>
</item>

<item>
<title>Dairy Intake linked to Increased Risk of Parkinson&amp;apos;s Disease, finds study</title>
<link>https://edusehat.com/en/dairy-intake-linked-to-increased-risk-of-parkinsons-disease-finds-study-9392</link>
<guid>https://edusehat.com/en/dairy-intake-linked-to-increased-risk-of-parkinsons-disease-finds-study-9392</guid>
<description><![CDATA[ A new study published in the journal of Public Health found that higher dairy consumption, especially milk, is associated with an increased risk of Parkinson’s disease (PD).Parkinson’s disease affects movement and is characterized by symptoms like tremors, stiffness, and slowed motion. While its exact causes remain unclear, scientists believe a combination of genetic, environmental, and lifestyle factors contributes to its development. In recent years, attention has turned toward diet, especially the potential role of dairy consumption.This systematic review and meta-analysis examined the relationship between dairy intake and PD risk. This research analyzed data from 9 studies (8 cohort studies and one case-control study) across populations in North America, Europe, and Asia. In total, the cohort studies included over 634,000 participants, among whom more than 4,200 cases of Parkinson’s disease were identified.The analysis showed that individuals with high total dairy intake had a statistically significant 21% higher risk of developing Parkinson’s disease when compared to those with lower intake. The association appeared stronger in men, who showed a 28% increased risk, while the effect in women was minimal and not statistically significant.The participants with higher milk intake had a 13% increased risk of Parkinson’s disease, with similar sex-specific patterns as seen in overall dairy consumption. Also, other dairy products (including yogurt, fermented milk, cheese, butter, and ice cream) did not show a meaningful association with PD risk.These findings suggest that the link may be related to biological mechanisms involving the gut–brain axis. One hypothesis was that dairy intake could influence the gut microbiome in ways that promote the accumulation or spread of alpha-synuclein. Despite the findings, this study caution that the evidence is not yet definitive. The included studies were observational, meaning they can identify associations but cannot prove cause and effect. Also, the results varied across populations, and factors such as genetics, lifestyle, and overall diet may influence outcomes.Overall, the findings of this study emphasize the need for further research involving more diverse populations and clearer distinctions between genetic and non-genetic forms of Parkinson’s disease. They also call for deeper investigation into how specific dietary patterns interact with biological pathways linked to neurodegeneration.Source:Yang, D., Nepal, G., Ojha, R., &amp; Tu, Z. (2026). Association between dairy consumption and Parkinson’s disease: A systematic review and meta-analysis. Public Health, 252(106143), 106143. https://doi.org/10.1016/j.puhe.2026.106143 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/17/185765-dairy-products.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:25 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dairy, Intake, linked, Increased, Risk, Parkinsons, Disease, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/17/185765-dairy-products.webp"><p>A new study published in the journal of <i>Public Health</i> found that higher dairy consumption, especially milk, is associated with an increased risk of Parkinson’s disease (PD).</p><p>Parkinson’s disease affects movement and is characterized by symptoms like tremors, stiffness, and slowed motion. While its exact causes remain unclear, scientists believe a combination of genetic, environmental, and lifestyle factors contributes to its development. In recent years, attention has turned toward diet, especially the potential role of dairy consumption.</p><p>This systematic review and meta-analysis examined the relationship between dairy intake and PD risk. This research analyzed data from 9 studies (8 cohort studies and one case-control study) across populations in North America, Europe, and Asia. In total, the cohort studies included over 634,000 participants, among whom more than 4,200 cases of Parkinson’s disease were identified.</p><p>The analysis showed that individuals with high total dairy intake had a statistically significant 21% higher risk of developing Parkinson’s disease when compared to those with lower intake. The association appeared stronger in men, who showed a 28% increased risk, while the effect in women was minimal and not statistically significant.</p><p>The participants with higher milk intake had a 13% increased risk of Parkinson’s disease, with similar sex-specific patterns as seen in overall dairy consumption. Also, other dairy products (including yogurt, fermented milk, cheese, butter, and ice cream) did not show a meaningful association with PD risk.</p><p>These findings suggest that the link may be related to biological mechanisms involving the gut–brain axis. One hypothesis was that dairy intake could influence the gut microbiome in ways that promote the accumulation or spread of alpha-synuclein. </p><p>Despite the findings, this study caution that the evidence is not yet definitive. The included studies were observational, meaning they can identify associations but cannot prove cause and effect. Also, the results varied across populations, and factors such as genetics, lifestyle, and overall diet may influence outcomes.</p><p>Overall, the findings of this study emphasize the need for further research involving more diverse populations and clearer distinctions between genetic and non-genetic forms of Parkinson’s disease. They also call for deeper investigation into how specific dietary patterns interact with biological pathways linked to neurodegeneration.</p><p>Source:</p><p>Yang, D., Nepal, G., Ojha, R., & Tu, Z. (2026). Association between dairy consumption and Parkinson’s disease: A systematic review and meta-analysis. Public Health, 252(106143), 106143. <a href="https://www.sciencedirect.com/science/article/abs/pii/S0033350626000107?via%3Dihub#xd_co_f=OGRmN2QxMmQtMzBjZC00NjkyLWI3YzItNzZhOTg5ZTEwMWFl~" rel="nofollow">https://doi.org/10.1016/j.puhe.2026.106143</a></p>]]> </content:encoded>
</item>

<item>
<title>The health impacts of alcohol depend on what you drink&#45;and how much</title>
<link>https://edusehat.com/en/the-health-impacts-of-alcohol-depend-on-what-you-drink-and-how-much-9391</link>
<guid>https://edusehat.com/en/the-health-impacts-of-alcohol-depend-on-what-you-drink-and-how-much-9391</guid>
<description><![CDATA[ While high alcohol intake has been associated with worse health outcomes regardless of the type of alcohol consumed, the potential impacts of low to moderate alcohol intake appear to vary by beverage type, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
The study of more than 340,000 British adults adds to previous research showing less alcohol consumption is better for health and provides new insights into the impacts of drinking at low and moderate levels.
“These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher,” said Zhangling Chen, MD, PhD, a professor at the Second Xiangya Hospital, Central South University in China and the study’s senior author.
Researchers analyzed alcohol consumption habits and mortality outcomes among 340,924 adults who participated in the UK Biobank study between 2006-2022. Each participant completed a dietary questionnaire when they enrolled in the study and were grouped into four categories based on their alcohol intake, measured in terms of grams of pure alcohol per day and week. For reference, a 12-ounce can of beer, a 5-ounce glass of wine and a 1.5-ounce shot of spirits each contain about 14 grams of pure alcohol. People consuming less than 20 g (about 1.5 standard drinks) per week were classified as never or occasional drinkers. Men consuming between 20 g per week and 20 g per day and women consuming between 20 g per week and 10 g per day were considered to have low alcohol consumption. Daily consumption of 20 g to 40 g (about 1.5 to three standard drinks) for men and 10 g to 20 g for women was considered moderate. Daily consumption of more than 40 g (about three drinks) for men and 20 g (about 1.5 drinks) for women was considered high. Health outcomes were tracked for over 13 years on average.
Compared with never or occasional drinkers, those with high alcohol consumption were 24% more likely to die from any cause, 36% more likely to die from cancer and 14% more likely to die from heart disease. Differences in risk by alcohol type emerged at low and moderate levels of consumption, where drinking spirits, beer or cider was associated with a significantly higher risk of death while the same level of wine consumption was associated with a significantly lower risk of death.
Looking at deaths from cardiovascular disease in particular, researchers found that moderate wine drinkers had a 21% lower risk of dying from cardiovascular disease compared with never or occasional drinkers. By contrast, even low intake of spirits, beer or cider was associated with a 9% higher risk of dying from cardiovascular disease compared with drinking never or occasionally.
“Our findings help clarify previously mixed evidence on low to moderate alcohol consumption,” Chen said. “These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed, but also on the type of beverage. Even low to moderate intake of spirits, beer or cider is linked to higher mortality, while low to moderate intake of wine may carry lower risk.”
Researchers said that several factors may account for the differences by alcohol type. Certain compounds present in red wine, such as polyphenols and antioxidants, may have benefits for cardiovascular health. Wine is also more likely to be consumed with meals and by people who have higher-quality diets and healthier behaviors in general, while spirits, beer and cider are more likely to be consumed outside of meals and were associated with lower overall diet quality and other lifestyle risk factors.
“Taken together, these factors suggest that the type of alcohol, how it is consumed and the associated lifestyle behaviors all contribute to the observed differences in mortality risk,” Chen said.
In their analyses, researchers adjusted the data to account for demographic factors, socioeconomic status, lifestyle factors, cardiometabolic factors and family history of diabetes, cardiovascular disease and cancer. However, they said that the research has inherent limitations as an observational study and suggested that high-quality randomized trials could help to better understand the impacts of alcohol consumption. Alcohol consumption was assessed based on self-reporting at baseline and did not capture changes in drinking patterns over time. In addition, UK Biobank participants are generally healthier than the overall population, which may limit the study’s generalizability.
Despite these limitations, the study’s large sample size and length of follow-up strengthen its statistical power. Researchers said the study provides a more comprehensive and nuanced picture of the health impacts of alcohol consumption than many prior studies, offering a high degree of granularity in terms of the amount and type of alcohol consumed as well as a variety of mortality outcomes.  Reference:The health impacts of alcohol depend on what you drink – and how much, American College of Cardiology, Meeting:American College of Cardiology&#039;s Annual Scientific Session ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/03/01/233379-alcohol-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:23 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>The, health, impacts, alcohol, depend, what, you, drink-and, how, much</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/03/01/233379-alcohol-50.webp"><p>While high alcohol intake has been associated with worse health outcomes regardless of the type of alcohol consumed, the potential impacts of low to moderate alcohol intake appear to vary by beverage type, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
</p><p>The study of more than 340,000 British adults adds to previous research showing less alcohol consumption is better for health and provides new insights into the impacts of drinking at low and moderate levels.
</p><p>“These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher,” said Zhangling Chen, MD, PhD, a professor at the Second Xiangya Hospital, Central South University in China and the study’s senior author.
</p><p>Researchers analyzed alcohol consumption habits and mortality outcomes among 340,924 adults who participated in the UK Biobank study between 2006-2022. Each participant completed a dietary questionnaire when they enrolled in the study and were grouped into four categories based on their alcohol intake, measured in terms of grams of pure alcohol per day and week. For reference, a 12-ounce can of beer, a 5-ounce glass of wine and a 1.5-ounce shot of spirits each contain about 14 grams of pure alcohol. People consuming less than 20 g (about 1.5 standard drinks) per week were classified as never or occasional drinkers. Men consuming between 20 g per week and 20 g per day and women consuming between 20 g per week and 10 g per day were considered to have low alcohol consumption. Daily consumption of 20 g to 40 g (about 1.5 to three standard drinks) for men and 10 g to 20 g for women was considered moderate. Daily consumption of more than 40 g (about three drinks) for men and 20 g (about 1.5 drinks) for women was considered high. Health outcomes were tracked for over 13 years on average.
</p><p>Compared with never or occasional drinkers, those with high alcohol consumption were 24% more likely to die from any cause, 36% more likely to die from cancer and 14% more likely to die from heart disease. Differences in risk by alcohol type emerged at low and moderate levels of consumption, where drinking spirits, beer or cider was associated with a significantly higher risk of death while the same level of wine consumption was associated with a significantly lower risk of death.
</p><p>Looking at deaths from cardiovascular disease in particular, researchers found that moderate wine drinkers had a 21% lower risk of dying from cardiovascular disease compared with never or occasional drinkers. By contrast, even low intake of spirits, beer or cider was associated with a 9% higher risk of dying from cardiovascular disease compared with drinking never or occasionally.
</p><p>“Our findings help clarify previously mixed evidence on low to moderate alcohol consumption,” Chen said. “These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed, but also on the type of beverage. Even low to moderate intake of spirits, beer or cider is linked to higher mortality, while low to moderate intake of wine may carry lower risk.”
</p><p>Researchers said that several factors may account for the differences by alcohol type. Certain compounds present in red wine, such as polyphenols and antioxidants, may have benefits for cardiovascular health. Wine is also more likely to be consumed with meals and by people who have higher-quality diets and healthier behaviors in general, while spirits, beer and cider are more likely to be consumed outside of meals and were associated with lower overall diet quality and other lifestyle risk factors.
</p><p>“Taken together, these factors suggest that the type of alcohol, how it is consumed and the associated lifestyle behaviors all contribute to the observed differences in mortality risk,” Chen said.
</p><p>In their analyses, researchers adjusted the data to account for demographic factors, socioeconomic status, lifestyle factors, cardiometabolic factors and family history of diabetes, cardiovascular disease and cancer. However, they said that the research has inherent limitations as an observational study and suggested that high-quality randomized trials could help to better understand the impacts of alcohol consumption. Alcohol consumption was assessed based on self-reporting at baseline and did not capture changes in drinking patterns over time. In addition, UK Biobank participants are generally healthier than the overall population, which may limit the study’s generalizability.
</p><p>Despite these limitations, the study’s large sample size and length of follow-up strengthen its statistical power. Researchers said the study provides a more comprehensive and nuanced picture of the health impacts of alcohol consumption than many prior studies, offering a high degree of granularity in terms of the amount and type of alcohol consumed as well as a variety of mortality outcomes.  </p><p>Reference:</p><p>The health impacts of alcohol depend on what you drink – and how much, American College of Cardiology, Meeting:American College of Cardiology's Annual Scientific Session</p>]]> </content:encoded>
</item>

<item>
<title>Low Fischer&amp;apos;s Ratio Associated with Increased Mortality in Chronic Kidney Disease: Study</title>
<link>https://edusehat.com/en/low-fischers-ratio-associated-with-increased-mortality-in-chronic-kidney-disease-study-9390</link>
<guid>https://edusehat.com/en/low-fischers-ratio-associated-with-increased-mortality-in-chronic-kidney-disease-study-9390</guid>
<description><![CDATA[ Sweden: Researchers have found in a new study that a lower Fischer&#039;s ratio-a marker reflecting the balance between branched-chain and aromatic amino acids-is linked to a higher risk of death among patients with kidney failure, particularly those with underlying cardiovascular disease.A study published in Scientific Reports by Qianying Zhang and colleagues from Karolinska Institutet, Sweden, sheds light on the prognostic significance of metabolic alterations in individuals initiating dialysis. The findings suggest that disruptions in amino acid balance may serve as an important indicator of survival outcomes in this vulnerable population.Fischer’s ratio (FR), calculated as the ratio of branched-chain amino acids (BCAAs)—valine, isoleucine, and leucine—to aromatic amino acids (AAAs)—phenylalanine and tyrosine—has been previously associated with metabolic health. In kidney failure, metabolic disturbances are common, and the researchers aimed to explore whether FR could predict mortality risk.For this purpose, the researchers analyzed 328 patients with kidney failure who had recently started dialysis. The median age of participants was 54 years, and 60% were men. Plasma concentrations of amino acids were measured using high-performance liquid chromatography (HPLC). The study employed competing-risk regression models, accounting for renal transplantation as a competing event, to assess survival over five years. Additionally, advanced statistical models were used to evaluate continuous relationships between amino acid levels and mortality.   The study led to the following findings:The median follow-up duration was approximately 29 months, during which over half of the patients underwent kidney transplantation and about one-quarter died.Patients with lower Fischer’s ratio (FR), including those in the middle and lowest tertiles, had a significantly higher risk of mortality compared to those with higher FR levels.The risk of death was approximately 74% higher among individuals with reduced FR.Lower FR was associated with increased levels of inflammation.Reduced FR was also linked to protein-energy wasting, a condition known to adversely affect outcomes in chronic kidney disease.These associations indicate that FR may reflect underlying metabolic and nutritional disturbances contributing to disease progression.The relationship between low FR and mortality was particularly pronounced in patients with pre-existing cardiovascular disease.In this subgroup, patients with lower FR had more than a fourfold increased risk of death.The findings suggest a potential interaction between metabolic imbalance and cardiovascular disease in influencing survival outcomes.Overall, the findings indicate that Fischer’s ratio could serve as a useful biomarker for risk stratification in patients with kidney failure. Monitoring amino acid profiles may help clinicians identify high-risk individuals and guide targeted interventions. The authors emphasize that further research is needed to determine whether modifying amino acid balance could improve survival in this population.Reference:Zhang, Q., Suliman, M. E., Qureshi, A. R., Guo, F., Troise, D., Xu, R., Bárány, P., Heimbürger, O., Stenvinkel, P., &amp; Lindholm, B. (2026). Low Fischer’s ratio is associated with increased mortality in patients with kidney failure. Scientific Reports. https://doi.org/10.1038/s41598-026-46326-y ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277384-kidney-failure.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:22 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Low, Fischers, Ratio, Associated, with, Increased, Mortality, Chronic, Kidney, Disease:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277384-kidney-failure.webp"><p><span>Sweden: Researchers have found in a new study that a lower Fischer's ratio-a marker reflecting the balance between branched-chain and aromatic<a href="https://medicaldialogues.in/topics/amino-acid"> amino acids</a>-is linked to a higher risk of death among patients with<a href="https://medicaldialogues.in/topics/kidney-failure"> kidney failure</a>, particularly those with underlying <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease</a>.</span></p><div class="pasted-from-word-wrapper"><div>A study published in <i>Scientific Reports</i> by Qianying Zhang and colleagues from Karolinska Institutet, Sweden, sheds light on the prognostic significance of metabolic alterations in individuals initiating dialysis. The findings suggest that disruptions in amino acid balance may serve as an important indicator of survival outcomes in this vulnerable population.</div><div>Fischer’s ratio (FR), calculated as the ratio of branched-chain amino acids (BCAAs)—valine, isoleucine, and leucine—to aromatic amino acids (AAAs)—phenylalanine and tyrosine—has been previously associated with metabolic health. In kidney failure, metabolic disturbances are common, and the researchers aimed to explore whether FR could predict mortality risk.</div><div>For this purpose, the researchers analyzed 328 patients with kidney failure who had recently started dialysis. The median age of participants was 54 years, and 60% were men. Plasma concentrations of amino acids were measured using high-performance liquid chromatography (HPLC). The study employed competing-risk regression models, accounting for renal transplantation as a competing event, to assess survival over five years. Additionally, advanced statistical models were used to evaluate continuous relationships between amino acid levels and mortality.   </div><div>The study led to the following findings:</div><ul><li>The median follow-up duration was approximately 29 months, during which over half of the patients underwent kidney transplantation and about one-quarter died.</li><li>Patients with lower Fischer’s ratio (FR), including those in the middle and lowest tertiles, had a significantly higher risk of mortality compared to those with higher FR levels.</li><li>The risk of death was approximately 74% higher among individuals with reduced FR.</li><li>Lower FR was associated with increased levels of inflammation.</li><li>Reduced FR was also linked to protein-energy wasting, a condition known to adversely affect outcomes in chronic kidney disease.</li><li>These associations indicate that FR may reflect underlying metabolic and nutritional disturbances contributing to disease progression.</li><li>The relationship between low FR and mortality was particularly pronounced in patients with pre-existing cardiovascular disease.</li><li>In this subgroup, patients with lower FR had more than a fourfold increased risk of death.</li><li>The findings suggest a potential interaction between metabolic imbalance and cardiovascular disease in influencing survival outcomes.</li></ul><div>Overall, the findings indicate that Fischer’s ratio could serve as a useful biomarker for risk stratification in patients with kidney failure. Monitoring amino acid profiles may help clinicians identify high-risk individuals and guide targeted interventions. The authors emphasize that further research is needed to determine whether modifying amino acid balance could improve survival in this population.</div><div>Reference:</div><div>Zhang, Q., Suliman, M. E., Qureshi, A. R., Guo, F., Troise, D., Xu, R., Bárány, P., Heimbürger, O., Stenvinkel, P., & Lindholm, B. (2026). Low Fischer’s ratio is associated with increased mortality in patients with kidney failure. Scientific Reports. https://doi.org/10.1038/s41598-026-46326-y</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Cancer Ranks Tenth in Causes of Death Among Indian Children: Lancet Study</title>
<link>https://edusehat.com/en/cancer-ranks-tenth-in-causes-of-death-among-indian-children-lancet-study</link>
<guid>https://edusehat.com/en/cancer-ranks-tenth-in-causes-of-death-among-indian-children-lancet-study</guid>
<description><![CDATA[ Childhood cancer remains a major public health challenge, ranking among the top ten causes of death in India, according to the Global Burden of Disease Study 2023 published in The Lancet. In 2023 alone, an estimated 17,000 children in India died from cancer, highlighting a significant and often underrecognized burden.
Globally, childhood cancer was the eighth-leading cause of death, surpassing diseases such as measles, tuberculosis, and HIV/AIDS. The study reported approximately 377,000 new cases and 144,000 deaths worldwide in 2023. The most common types included leukemias, brain and central nervous system cancers, and non-Hodgkin lymphoma.
Despite advances in treatment, disparities remain stark. Low- and middle-income countries accounted for 85% of new cases and a striking 94% of deaths and disability-adjusted life years (DALYs). DALYs reflect the total years of healthy life lost due to illness and premature death, underscoring the long-term impact of childhood cancer.
India’s burden may be even higher than reported. Experts estimate that between 50,000 and 75,000 children are diagnosed annually, suggesting underreporting and gaps in surveillance. While survival rates have improved significantly in high-income countries, many children in Low- and middle-income countries face delays in diagnosis, limited access to treatment, and inadequate healthcare infrastructure.
Encouragingly, childhood cancers are often highly treatable, especially when detected early. However, improving outcomes requires systemic changes. These include strengthening referral systems, expanding access to chemotherapy, surgery, and radiotherapy, and improving workforce training and cancer registries.
The findings highlight an urgent need for targeted policy action. Investments in comprehensive cancer care systems, particularly in resource-limited settings, could significantly reduce mortality. Bridging the gap between high- and low-income regions is critical to ensuring that advances in treatment benefit all children equally.
REFERENCE: Force L, Kocarnik J, May M et al.; Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet; DOI: 10.1016/S0140-6736(26)00200-X External Link
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340311-untitled-design-2026-04-08t120335165.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:21 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Cancer, Ranks, Tenth, Causes, Death, Among, Indian, Children:, Lancet, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340311-untitled-design-2026-04-08t120335165.webp"><p>Childhood <a href="https://medicaldialogues.in/topics/cancer">cancer </a>remains a major public health challenge, ranking among the top ten causes of death in India, according to the Global Burden of Disease Study 2023 published in <i>The Lancet</i>. In 2023 alone, an estimated 17,000 children in India died from cancer, highlighting a significant and often underrecognized burden.
</p><p>Globally, childhood cancer was the eighth-leading cause of death, surpassing diseases such as measles, tuberculosis, and HIV/AIDS. The study reported approximately 377,000 new cases and 144,000 deaths worldwide in 2023. The most common types included leukemias, brain and central nervous system cancers, and non-Hodgkin lymphoma.
</p><p>Despite advances in treatment, disparities remain stark. Low- and middle-income countries accounted for 85% of new cases and a striking 94% of deaths and disability-adjusted life years (DALYs). DALYs reflect the total years of healthy life lost due to illness and premature death, underscoring the long-term impact of childhood cancer.
</p><p>India’s burden may be even higher than reported. Experts estimate that between 50,000 and 75,000 children are diagnosed annually, suggesting underreporting and gaps in surveillance. While survival rates have improved significantly in high-income countries, many children in Low- and middle-income countries face delays in diagnosis, limited access to treatment, and inadequate healthcare infrastructure.
</p><p>Encouragingly, childhood cancers are often highly treatable, especially when detected early. However, improving outcomes requires systemic changes. These include strengthening referral systems, expanding access to chemotherapy, surgery, and radiotherapy, and improving workforce training and cancer registries.
</p><p>The findings highlight an urgent need for targeted policy action. Investments in comprehensive cancer care systems, particularly in resource-limited settings, could significantly reduce mortality. Bridging the gap between high- and low-income regions is critical to ensuring that advances in treatment benefit all children equally.
</p><p><b>REFERENCE:</b> Force L, Kocarnik J, May M et al.; Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023; The Lancet; DOI: 10.1016/S0140-6736(26)00200-X External Link
</p>]]> </content:encoded>
</item>

<item>
<title>Princeton Researchers Identify New Links Between High&#45;Fat Diets and Aggressive Breast Cancer</title>
<link>https://edusehat.com/en/princeton-researchers-identify-new-links-between-high-fat-diets-and-aggressive-breast-cancer</link>
<guid>https://edusehat.com/en/princeton-researchers-identify-new-links-between-high-fat-diets-and-aggressive-breast-cancer</guid>
<description><![CDATA[ A new study from Princeton University has uncovered how high-fat diets may make certain breast cancers more aggressive, offering new insight into how nutrition can influence tumour behaviour. 
Published in APL Bioengineering, the research focused on triple-negative breast cancer, a form of cancer that is difficult to treat due to its lack of response to standard therapies.
Using advanced 3D tumour models, scientists simulated different dietary conditions by exposing cancer cells to various nutrients. While most diets showed little effect on tumour structure, those exposed to high levels of fatty acids and cholesterol behaved differently. 
Instead of remaining compact, these tumours developed invasive, finger-like projections—features associated with aggressive cancers that spread into surrounding tissues and potentially metastasize.
Interestingly, tumour growth rates remained similar across all diet types. However, structural changes were significant in high-fat conditions. Cancer cells migrated outward from the tumour core, indicating increased invasive potential. 
Researchers also identified a sharp rise in the activity of a gene called MMP1, which is known to break down collagen in surrounding tissues. This breakdown may create pathways that allow cancer cells to spread more easily.
In contrast, tumours exposed to high insulin, glycerol, ketones, or even a simulated ketogenic diet did not show the same aggressive structural changes. This was unexpected, as ketogenic diets are often thought to have protective effects against cancer. The findings suggest that, at least for this cancer type, fat itself—not just overall metabolism—may play a critical role in tumour invasiveness.
Researchers caution that these results are based on controlled lab models and may not fully replicate the complexity of the human body. However, the study highlights a potential biological link between dietary fat and cancer progression, opening new avenues for targeted therapies and personalized nutrition strategies in oncology.
REFERENCE: Kohram, M., et al. (2026). Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer. APL Bioengineering. DOI: 10.1063/5.0291646. https://pubs.aip.org/aip/apb/article/10/1/016111/3381798/Fat-promotes-growth-and-invasion-in-a-3D
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340312-princeton-researchers-identify-new-links-between-high-fat-diets-and-aggressive-breast-cancer.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:20 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Princeton, Researchers, Identify, New, Links, Between, High-Fat, Diets, and, Aggressive, Breast, Cancer</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340312-princeton-researchers-identify-new-links-between-high-fat-diets-and-aggressive-breast-cancer.webp"><p>A new study from Princeton University has uncovered how high-fat diets may make certain breast cancers more aggressive, offering new insight into how nutrition can influence tumour behaviour. 
</p><p>Published in <i>APL Bioengineering</i>, the research focused on triple-negative breast cancer, a form of cancer that is difficult to treat due to its lack of response to standard therapies.
</p><p>Using advanced 3D tumour models, scientists simulated different dietary conditions by exposing cancer cells to various nutrients. While most diets showed little effect on tumour structure, those exposed to high levels of fatty acids and cholesterol behaved differently. 
</p><p>Instead of remaining compact, these tumours developed invasive, finger-like projections—features associated with aggressive cancers that spread into surrounding tissues and potentially metastasize.
</p><p>Interestingly, tumour growth rates remained similar across all diet types. However, structural changes were significant in high-fat conditions. Cancer cells migrated outward from the tumour core, indicating increased invasive potential. 
</p><p>Researchers also identified a sharp rise in the activity of a gene called MMP1, which is known to break down collagen in surrounding tissues. This breakdown may create pathways that allow cancer cells to spread more easily.
</p><p>In contrast, tumours exposed to high insulin, glycerol, ketones, or even a simulated ketogenic diet did not show the same aggressive structural changes. This was unexpected, as ketogenic diets are often thought to have protective effects against cancer. The findings suggest that, at least for this cancer type, fat itself—not just overall metabolism—may play a critical role in tumour invasiveness.
</p><p>Researchers caution that these results are based on controlled lab models and may not fully replicate the complexity of the human body. However, the study highlights a potential biological link between dietary fat and cancer progression, opening new avenues for targeted therapies and personalized nutrition strategies in oncology.
</p><p><b>REFERENCE: </b>Kohram, M., et al. (2026). Fat promotes growth and invasion in a 3D microfluidic tumor model of triple-negative breast cancer. APL Bioengineering. DOI: 10.1063/5.0291646. https://pubs.aip.org/aip/apb/article/10/1/016111/3381798/Fat-promotes-growth-and-invasion-in-a-3D
</p>]]> </content:encoded>
</item>

<item>
<title>Researchers Warn BMI Fails to Accurately Assess Health in Many Adults</title>
<link>https://edusehat.com/en/researchers-warn-bmi-fails-to-accurately-assess-health-in-many-adults</link>
<guid>https://edusehat.com/en/researchers-warn-bmi-fails-to-accurately-assess-health-in-many-adults</guid>
<description><![CDATA[ A new study from Italian researchers challenges the reliability of Body Mass Index as a tool for assessing body weight and health. The findings, to be presented at the European Congress on Obesity 2026 and published in Nutrients, show that BMI may incorrectly classify more than one-third of adults when compared with more precise body fat measurements.
BMI, widely used in clinical and public health settings, estimates weight status based on height and weight but does not directly measure body fat or its distribution. This limitation has raised concerns about its accuracy. 
To investigate further, researchers compared BMI classifications with results from Dual-energy X-ray absorptiometry, considered the gold standard for measuring body fat percentage.
The study analyzed 1,351 adults aged 18 to 98. Based on BMI, about 41% were categorized as overweight or obese. However, DXA-based assessments showed a lower prevalence of 37%, revealing significant discrepancies. 
Among those labeled obese by BMI, 34% were actually overweight according to DXA. Misclassification was even higher in the overweight category, where 53% were placed incorrectly, many of whom were found to have normal body fat levels.
Even individuals considered “normal weight” were not always accurately classified. While BMI and DXA agreed in 78% of such cases, 22% were reassigned to different categories when body fat was directly measured. 
The greatest mismatch occurred in the underweight group, where more than two-thirds were reclassified as normal weight using DXA.
These findings suggest that BMI may overestimate both obesity and underweight prevalence, potentially leading to misleading health assessments. Experts recommend combining BMI with additional tools such as waist-to-height ratio, skinfold measurements, or direct body composition analysis for a more accurate evaluation.
Overall, the study highlights the need to update current guidelines and adopt more comprehensive approaches to assessing body health.
REFERENCE: Chiara Milanese, Leila Itani, Valentina Cavedon, Marwan El Ghoch. The WHO BMI System Misclassifies Weight Status in Adults from the General Population in North Italy: A DXA-Based Assessment Study (18–98 Years). Nutrients, 2025; 17 (13): 2162 DOI: 10.3390/nu17132162
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340318-researchers-warn-bmi-fails-to-accurately-assess-health-in-many-adults.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:19 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Researchers, Warn, BMI, Fails, Accurately, Assess, Health, Many, Adults</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340318-researchers-warn-bmi-fails-to-accurately-assess-health-in-many-adults.webp"><p>A new study from Italian researchers challenges the reliability of Body Mass Index as a tool for assessing body weight and health. The findings, to be presented at the European Congress on Obesity 2026 and published in <i>Nutrients</i>, show that BMI may incorrectly classify more than one-third of adults when compared with more precise body fat measurements.
</p><p>BMI, widely used in clinical and public health settings, estimates weight status based on height and weight but does not directly measure body fat or its distribution. This limitation has raised concerns about its accuracy. 
</p><p>To investigate further, researchers compared BMI classifications with results from Dual-energy X-ray absorptiometry, considered the gold standard for measuring body fat percentage.
</p><p>The study analyzed 1,351 adults aged 18 to 98. Based on BMI, about 41% were categorized as overweight or obese. However, DXA-based assessments showed a lower prevalence of 37%, revealing significant discrepancies. 
</p><p>Among those labeled obese by BMI, 34% were actually overweight according to DXA. Misclassification was even higher in the overweight category, where 53% were placed incorrectly, many of whom were found to have normal body fat levels.
</p><p>Even individuals considered “normal weight” were not always accurately classified. While BMI and DXA agreed in 78% of such cases, 22% were reassigned to different categories when body fat was directly measured. 
</p><p>The greatest mismatch occurred in the underweight group, where more than two-thirds were reclassified as normal weight using DXA.
</p><p>These findings suggest that BMI may overestimate both obesity and underweight prevalence, potentially leading to misleading health assessments. Experts recommend combining BMI with additional tools such as waist-to-height ratio, skinfold measurements, or direct body composition analysis for a more accurate evaluation.
</p><p>Overall, the study highlights the need to update current guidelines and adopt more comprehensive approaches to assessing body health.
</p><p><b>REFERENCE: </b>Chiara Milanese, Leila Itani, Valentina Cavedon, Marwan El Ghoch. The WHO BMI System Misclassifies Weight Status in Adults from the General Population in North Italy: A DXA-Based Assessment Study (18–98 Years). Nutrients, 2025; 17 (13): 2162 DOI: 10.3390/nu17132162
</p>]]> </content:encoded>
</item>

<item>
<title>AIIMS NORCET 10 admit card released</title>
<link>https://edusehat.com/en/aiims-norcet-10-admit-card-released</link>
<guid>https://edusehat.com/en/aiims-norcet-10-admit-card-released</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS) has released the admit card for NORCET 10 for the academic year 2026. This admit card has been issued on the official website of AIIMS New Delhi. Therefore, registered candidates can download their NORCET 10 examination hall tickets from there using their login credentials, such as their Candidate ID, mobile number, and password.The NORCET 10 admit card includes the candidate&#039;s name, age, father&#039;s name, examination centre address, exam time, reporting time, exam-day guidelines, and other details.Also Read: AIIMS NORCET 10 exam city slip out, admit card to be released on April 8STEPS TO DOWNLOAD THE NORCET 10 ADMIT CARD 2026Candidates can refer to the steps mentioned below to download the AIIMS NORCET 10 Admit Card-STEP 1- Go to the official website of AIIMS New Delhi.STEP 2- On the homepage, click on the AIIMS NORCET 10 admit card link.STEP 3- A login page will open.STEP 4- Enter registration ID or mobile number and password.STEP 5- Press the submit button to view the admit card.STEP 6- Download and take print out of the AIIMS NORCET 10 admit card.The first phase of the computer-based examination for NORCET 10 will be held on April 11. While the second phase of the examination will be conducted on April 30. This competitive examination will be held to fill a total of 2,551 posts for Nursing Officers across AIIMS institutions and their associated healthcare centres throughout India.The AIIMS NORCET 10 selection process comprises Phase 1 (Written Examination), Phase 2 Examination, Document Verification, and Medical Examination. Meanwhile, AIIMS had recently released the Exam City Slip for the Nursing Officer Recruitment Common Eligibility Test (NORCET) 10 Phase I. Students who have already registered for the examination can check their allotted city before their preliminary exam. Also Read: AIIMS NORCET 10 registrations begin, check complete details HERE! ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340317-nursing-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:18 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, NORCET, admit, card, released</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340317-nursing-2.webp"><p><b>New Delhi: </b>The <a href="https://medicaldialogues.in/topics/all-india-institute-of-medical-sciences" target="_blank">All India Institute of Medical Sciences</a> (AIIMS) has released the admit card for <a href="https://medicaldialogues.in/topics/norcet-10" target="_blank">NORCET 10</a> for the academic year 2026.</p><p> This admit card has been issued on the official website of AIIMS New Delhi. Therefore, registered candidates can download their NORCET 10 examination hall tickets from there using their login credentials, such as their Candidate ID, mobile number, and password.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The NORCET 10 admit card includes the candidate's name, age, father's name, examination centre address, exam time, reporting time, exam-day guidelines, and other details.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-exam-city-slip-out-admit-card-to-be-released-on-april-8-168099"><b>Also Read: </b>AIIMS NORCET 10 exam city slip out, admit card to be released on April 8</a></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>STEPS TO DOWNLOAD THE NORCET 10 ADMIT CARD 2026</u></b></p><p dir="ltr"><b><i>Candidates can refer to the steps mentioned below to download the AIIMS NORCET 10 Admit Card-</i></b></p><p dir="ltr"><b>STEP 1-</b> Go to the official website of AIIMS New Delhi.</p><p dir="ltr"><b>STEP 2-</b> On the homepage, click on the AIIMS NORCET 10 admit card link.</p><p dir="ltr"><b>STEP 3-</b> A login page will open.</p><p dir="ltr"><b>STEP 4-</b> Enter registration ID or mobile number and password.</p><p dir="ltr"><b>STEP 5-</b> Press the submit button to view the admit card.</p><p dir="ltr"><b>STEP 6-</b> Download and take print out of the AIIMS NORCET 10 admit card.</p><p dir="ltr">The first phase of the computer-based examination for NORCET 10 will be held on April 11. While the second phase of the examination will be conducted on April 30. This competitive examination will be held to fill a total of 2,551 posts for <a href="https://medicaldialogues.in/topics/nursing" target="_blank">Nursing </a>Officers across AIIMS institutions and their associated healthcare centres throughout India.</p><p dir="ltr">The AIIMS NORCET 10 selection process comprises Phase 1 (Written Examination), Phase 2 Examination, Document Verification, and Medical Examination. </p><p dir="ltr"><span>Meanwhile, AIIMS had recently released the Exam City Slip for the </span><a href="https://medicaldialogues.in/topics/nursing">Nursing </a><span>Officer Recruitment Common Eligibility Test (</span><a href="https://medicaldialogues.in/topics/norcet">NORCET</a><span>) 10 Phase I. Students who have already registered for the examination can check their allotted city before their preliminary exam. </span></p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-registrations-begin-check-complete-details-here-165416"><b>Also Read: </b>AIIMS NORCET 10 registrations begin, check complete details HERE!</a></div>]]> </content:encoded>
</item>

<item>
<title>Woman&amp;apos;s death after childbirth triggers negligence allegations at Salem Hospital</title>
<link>https://edusehat.com/en/womans-death-after-childbirth-triggers-negligence-allegations-at-salem-hospital</link>
<guid>https://edusehat.com/en/womans-death-after-childbirth-triggers-negligence-allegations-at-salem-hospital</guid>
<description><![CDATA[ Salem: A 36-year-old woman tragically passed away shortly after delivering her second child at the Mettur district headquarters hospital, prompting her husband to seek a police investigation into the incident. According to the news reports, the deceased woman, a resident of Chekkanoor in Mettur, was admitted to the hospital on March 31 for delivery and had been under inpatient care since her admission. On April 4, around 8 pm, she went into labor and delivered a baby girl. However, within an hour of delivery, her husband was informed that she had died. The couple has a seven-year-old daughter.Also Read:Four women arrested in Malappuram gynaecologist assault caseHe has alleged medical negligence, claiming that insufficient doctors were present during his wife’s treatment. He filed a formal complaint at the Mettur police station seeking action.Police confirmed that a postmortem examination was conducted, and the body was handed over to the family on Sunday.
Responding to the allegation, Joint Director of Health Services, Salem, Dr SP Nandhini told TNIE, “The absence of doctors cannot be alleged as the full medical team, including the duty doctor, anaesthetist, physicians, and obstetrician, was present with the patient. The delivery took place around 8.30 pm on Saturday, and within 15 minutes, the patient had a postpartum collapse and went into cardiac arrest. The exact cause can be ascertained only after the postmortem report”.The incident has raised concerns about maternal health and hospital preparedness.Medical Dialogues had previously reported that following the death of a 23-year-old pregnant woman at Sawai Man Singh (SMS Hospital) in Jaipur, Rajasthan, an investigating committee has confirmed that she died after being transfused with the wrong blood type. The committee has held five junior staff members responsible, while the senior officials supervising them have been effectively exonerated. Also Read:SMS Hospital: Pregnant woman dies after wrong blood transfusion, 5 staff held responsible ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/04/01/281042-negligence.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:16 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Womans, death, after, childbirth, triggers, negligence, allegations, Salem, Hospital</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/04/01/281042-negligence.webp"><p><b>Salem:</b> A 36-year-old woman tragically passed away shortly after delivering her second child at the Mettur <a href="https://medicaldialogues.in/topics/district-hospital">district headquarters hospital</a>, prompting her husband to seek a police <a href="https://medicaldialogues.in/topics/police-investigation">investigation</a> into the incident. </p><p>According to the news reports, the deceased woman, a resident of Chekkanoor in Mettur, was admitted to the hospital on March 31 for delivery and had been under inpatient care since her admission. On April 4, around 8 pm, she went into labor and delivered a baby girl. However, within an hour of delivery, her husband was informed that she had died. The couple has a seven-year-old daughter.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/four-women-arrested-in-malappuram-gynaecologist-assault-case-167918"><b>Also Read:Four women arrested in Malappuram gynaecologist assault case</b></a></p><p>He has alleged medical negligence, claiming that insufficient doctors were present during his wife’s treatment. He filed a formal complaint at the Mettur police station seeking action.</p><p>Police confirmed that a postmortem examination was conducted, and the body was handed over to the family on Sunday.
</p><p>Responding to the allegation, Joint Director of Health Services, Salem, Dr SP Nandhini told <a href="https://www.newindianexpress.com/states/tamil-nadu/2026/Apr/06/36-year-old-dies-after-delivering-baby-girl-in-salem-hubby-claims-negligence" rel="nofollow">TNIE</a>, “The absence of doctors cannot be alleged as the full medical team, including the duty doctor, anaesthetist, physicians, and obstetrician, was present with the patient. The delivery took place around 8.30 pm on Saturday, and within 15 minutes, the patient had a postpartum collapse and went into cardiac arrest. The exact cause can be ascertained only after the postmortem report”.</p><p>The incident has raised concerns about maternal health and hospital preparedness.</p><p>Medical Dialogues had previously reported that following the death of a 23-year-old pregnant woman at Sawai Man Singh (SMS Hospital) in Jaipur, Rajasthan, an investigating committee has confirmed that she died after being transfused with the wrong blood type. The committee has held five junior staff members responsible, while the senior officials supervising them have been effectively exonerated. </p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/sms-hospital-pregnant-woman-dies-after-wrong-blood-transfusion-5-staff-held-responsible-162639">Also Read:SMS Hospital: Pregnant woman dies after wrong blood transfusion, 5 staff held responsible</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Medicine distribution delay triggers uproar at Gorakhpur AYUSH University</title>
<link>https://edusehat.com/en/medicine-distribution-delay-triggers-uproar-at-gorakhpur-ayush-university</link>
<guid>https://edusehat.com/en/medicine-distribution-delay-triggers-uproar-at-gorakhpur-ayush-university</guid>
<description><![CDATA[ Gorakhpur: A commotion broke out at the medicine distribution counter of Mahayogi Guru Gorakhnath Ayush University, Gorakhpur, on Monday, following allegations of negligence by the staff.The incident took place when Ranjit Chaudhary, Block President of the Pradhan Sangh, and Bhimnath Gupta, a resident of Bhathat, alleged that hundreds of patients were forced to wait for nearly an hour to receive free medicines provided by the university after consulting doctors, while the staff were reportedly absent, according to Dainik Bhaskar.Also Read:4 SRN Hospital staff suspended over mismanagement allegationsIn their defence, the employees stated that their duty had been assigned to organise medicines in the storage room. They added that the staff nurse was responsible for distributing medicine but was reportedly not attending her station.After receiving information about the incident, Vice-Chancellor K. Ramchandra Reddy called the doctors, complainants, and all concerned staff to his office. After hearing all sides, the Vice-Chancellor made it clear that any negligence in services provided to patients would not be tolerated. Complainant expressed satisfaction with the resolution and assured continued cooperation with the university. According to Dainik Bhaskar, the Vice-Chancellor also highlighted that the university is continuously working to improve patient services. As part of these efforts, the OPD is now operational from 8 AM to 8 PM on Sundays, and steps are being taken to extend evening OPD services on regular days as well. He reiterated that the university will always remain committed to public service.Doctors present during the discussion included Dr Ramakant Dwivedi, Dr. Anoop Srivastava, Dr. Manoj Kumar Chaurasia, Dr. Lakshmi Agnihotri, and Dr. Manoj Kumar Gaur.Mahayogi Guru Gorakhnath Ayush University, Gorakhpur, formerly the State Ayush University, Uttar Pradesh, is a state-affiliating university that specialises in Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy (AYUSH).Also Read:UP govt to introduce new policy to boost AYUSH sector in state ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340135-untitled-design-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:15 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medicine, distribution, delay, triggers, uproar, Gorakhpur, AYUSH, University</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340135-untitled-design-3.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>Gorakhpur: A commotion broke out at the medicine distribution counter of <a href="https://medicaldialogues.in/topics/mahayogi-guru-gorakhnath" target="_blank">Mahayogi Guru Gorakhnath Ayush University</a>, Gorakhpur, on Monday, following allegations of negligence by the staff.</p><p>The incident took place when Ranjit Chaudhary, Block President of the Pradhan Sangh, and Bhimnath Gupta, a resident of Bhathat, alleged that hundreds of patients were forced to wait for nearly an hour to receive free medicines provided by the university after consulting doctors, while the staff were reportedly absent, according to Dainik Bhaskar.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/4-srn-hospital-staff-suspended-over-mismanagement-allegations-149366">Also Read:4 SRN Hospital staff suspended over mismanagement allegations</a></p><p>In their defence, the employees stated that their duty had been assigned to organise medicines in the storage room. They added that the staff nurse was responsible for distributing medicine but was reportedly not attending her station.</p><p>After receiving information about the incident, Vice-Chancellor K. Ramchandra Reddy called the doctors, complainants, and all concerned staff to his office. After hearing all sides, the Vice-Chancellor made it clear that any negligence in services provided to patients would not be tolerated. Complainant expressed satisfaction with the resolution and assured continued cooperation with the university. </p><p>According to<a href="https://www.bhaskar.com/local/uttar-pradesh/gorakhpur/bhathat/news/ayush-university-ayodhya-drug-distribution-dispute-resolved-vc-meeting-137628306.html" target="_blank"> Dainik Bhaskar</a>, the Vice-Chancellor also highlighted that the university is continuously working to improve patient services. As part of these efforts, the OPD is now operational from 8 AM to 8 PM on Sundays, and steps are being taken to extend evening OPD services on regular days as well. He reiterated that the university will always remain committed to public service.</p><p>Doctors present during the discussion included Dr Ramakant Dwivedi, Dr. Anoop Srivastava, Dr. Manoj Kumar Chaurasia, Dr. Lakshmi Agnihotri, and Dr. Manoj Kumar Gaur.</p></div><div class="pasted-from-word-wrapper">Mahayogi Guru Gorakhnath Ayush University, Gorakhpur, formerly the State Ayush University, Uttar Pradesh, is a state-affiliating university that specialises in Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy (<a href="https://medicaldialogues.in/topics/ayush" target="_blank">AYUSH</a>).</div><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/ayush/ayurveda/news/up-govt-to-introduce-new-policy-to-boost-ayush-sector-in-state-160594">Also Read:UP govt to introduce new policy to boost AYUSH sector in state</a></p></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Three middlemen arrested for duping patients at SCB Medical College</title>
<link>https://edusehat.com/en/three-middlemen-arrested-for-duping-patients-at-scb-medical-college</link>
<guid>https://edusehat.com/en/three-middlemen-arrested-for-duping-patients-at-scb-medical-college</guid>
<description><![CDATA[ Cuttack: The Cuttack Police have arrested three middlemen accused of defrauding patients and their attendants at SCB Medical College and Hospital by promising rare blood units in exchange for money.  According to news reports, the accused have been part of an organised gang targeting needy families in urgent need of blood at the hospital.  Also Read: Fire at Cuttack Hospital ICU: 10 patients killed, 11 staff injuredIt is alleged that the accused approached the attendants accompanying the patients, assured them that they would arrange for blood as quickly as possible, and subsequently extorted money from them by making false promises. According to the Ommcomnews media news report, the matter came to light when Bibekananda Behera of Balikuda filed a complaint. According to the complaint, he alleged that the accused defrauded him while he was attempting to arrange for blood.Upon receiving the complaint, the Mangalbag Police Station immediately registered a case and initiated an investigation, and subsequently arrested the three individuals. However, they have been produced in court.Meanwhile, further investigations are underway to determine whether additional individuals are involved in this network, and inquiries are also being conducted to identify potential links to private healthcare operators.The police stated that such middlemen often exploit the chaotic conditions prevailing in busy government hospitals, where patients&#039; families face significant difficulties arranging essential medical assistance, including blood units. In numerous instances, these agents are also suspected of persuading patients to transfer from government hospitals to private nursing homes by luring them with the promise of superior medical treatment; this has heightened suspicions regarding the existence of a large-scale and organised racket.This incident has once again highlighted the persistent challenge posed by unauthorized middlemen operating within and around public health institutions, despite repeated strict action taken against them by the authorities.Also Read: SCB Medical College Doctor detained, Rs 2.63 lakh cash seized ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340201-dalals.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:14 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Three, middlemen, arrested, for, duping, patients, SCB, Medical, College</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340201-dalals.webp"><p><b>Cuttack: </b>The Cuttack Police have arrested three middlemen accused of defrauding patients and their attendants at <a href="https://medicaldialogues.in/topics/scb-medical-college-hospital" target="_blank">SCB Medical College and Hospital</a> by promising rare blood units in exchange for money.  </p><div class="pasted-from-word-wrapper"><p dir="ltr">According to news reports, the accused have been part of an organised gang targeting needy families in urgent need of blood at the hospital.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/fire-at-cuttack-hospital-icu-10-patients-killed-11-staff-injured-166583"><b>Also Read: </b>Fire at Cuttack Hospital ICU: 10 patients killed, 11 staff injured</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">It is alleged that the accused approached the attendants accompanying the patients, assured them that they would arrange for blood as quickly as possible, and subsequently extorted money from them by making false promises. </p><p dir="ltr">According to the <a href="https://ommcomnews.com/odisha-news/three-dalals-arrested-for-cheating-patients-at-scb-medical-college/" target="_blank" rel="nofollow">Ommcomnews </a>media news report, the matter came to light when Bibekananda Behera of Balikuda filed a complaint. According to the complaint, he alleged that the accused defrauded him while he was attempting to arrange for blood.</p><p dir="ltr">Upon receiving the complaint, the Mangalbag Police Station immediately registered a case and initiated an investigation, and subsequently arrested the three individuals. However, they have been produced in court.</p><p dir="ltr">Meanwhile, further investigations are underway to determine whether additional individuals are involved in this network, and inquiries are also being conducted to identify potential links to private healthcare operators.</p><p dir="ltr">The police stated that such middlemen often exploit the chaotic conditions prevailing in busy <a href="https://medicaldialogues.in/topics/government-hospital" target="_blank">government hospitals</a>, where patients' families face significant difficulties arranging essential medical assistance, including blood units. </p><p dir="ltr">In numerous instances, these agents are also suspected of persuading patients to transfer from government hospitals to private nursing homes by luring them with the promise of superior medical treatment; this has heightened suspicions regarding the existence of a large-scale and organised racket.</p><p dir="ltr">This incident has once again highlighted the persistent challenge posed by unauthorized middlemen operating within and around public health institutions, despite repeated strict action taken against them by the authorities.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/scb-medical-college-doctor-detained-rs-263-lakh-cash-seized-163865"><b>Also Read: </b>SCB Medical College Doctor detained, Rs 2.63 lakh cash seized</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>NMC draft amendment proposes single state registration for AFMS doctors</title>
<link>https://edusehat.com/en/nmc-draft-amendment-proposes-single-state-registration-for-afms-doctors</link>
<guid>https://edusehat.com/en/nmc-draft-amendment-proposes-single-state-registration-for-afms-doctors</guid>
<description><![CDATA[ New Delhi: Proposing relaxed registration norms for doctors serving in the Armed Forces Medical Services (AFMS), the National Medical Commission (NMC) has issued draft amendments to the Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023.The proposed changes aim to address the operational challenges faced by AFMS doctors by allowing them to remain registered with a single State Medical Council during their service, instead of obtaining multiple registrations across states due to frequent transfers and postings.According to a recent ANI report, the NMC has notified draft amendments to the &#039;&#039;Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023&#039;&#039; in the official gazette to ease registration requirements for AFMS doctors, in view of their distinct service conditions.Recognising the services rendered by Armed Forces personnel for the safety and security of the nation during conflict situations as well as humanitarian and disaster relief (HADR) operations, the NMC has proposed allowing AFMS doctors to remain registered with one State Medical Council during their period of service instead of requiring multiple state registrations.The commission noted that AFMS doctors function under conditions different from civilian medical practitioners, including postings at remote and operational areas at short notice governed by service exigencies and national security imperatives rather than personal choice of location.Also Read:NMC draft amendment revises documentation for medical colleges, incomplete applications to be rejectedAFMS doctors are commissioned medical officers of the Armed Forces who hold recognised and registered undergraduate and postgraduate medical qualifications and are registered with a State Medical Council or the erstwhile Medical Council of India. They are also subject to strict professional, ethical and disciplinary provisions under the Army Act in addition to NMC norms.Doctors joining AFMS from civilian institutions are commissioned only after validation of their degree and registration. Upon retirement, AFMS doctors register with the State Medical Council as per their place of work and are governed by NMC provisions like other medical practitioners.The operational nature of duties of AFMS doctors includes deployments ranging from short-term assignments of up to 179 days to long-term postings of up to three years, casualty evacuation and patient-related tasks, disaster relief operations and operational deployment across multiple states and regions. Such duties involve constant movement across state borders at short notice, and due to security protocols, locations of deployment are usually not disclosed to outside agencies.At present, under the provisions of the &quot;Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023&quot;, every doctor is required to register and seek a licence to practice medicine in the concerned state or states where he or she intends to practice. However, frequent transfers of AFMS doctors to various locations create administrative burdens requiring multiple registrations, repeated completion of administrative formalities for the same professional credentials and repeated payment of registration fees to different State Medical Councils.Keeping these operational requirements in view and based on a request from the office of the Director General of Armed Forces Medical Services (DGAFMS), the NMC has initiated amendments to the &quot;Registration of Medical Practitioners and Licence to Practice Medicine (Amendment) Regulations, 2026.&quot;The draft amendment includes the inclusion of the definition of AFMS and proposes that AFMS doctors may opt to be registered and licensed with one State Medical Council of their choice at the time of joining AFMS for the duration of their service and be authorised to practice in any state or Union Territory in India by virtue of service obligations. Upon retirement or release from service, they would register with or transfer to the State Medical Council where they intend to practice, adds ANI report.The amendment also provides that medical practitioners commissioned in AFMS may register any additional medical qualification with the State Medical Council with which they are registered during their period of service, and such entries will remain valid across all states and Union Territories for the duration of their service.Further, the licence of AFMS medical practitioners shall not be rendered inactive solely due to non-submission of renewal applications within the prescribed time by the concerned State Medical Council. The office of the DGAFMS will furnish details of commissioned medical practitioners along with renewal applications, wherever applicable, to the concerned State Medical Councils annually and also provide records to the National Medical Commission.The provisions relating to transfer of licence to practice will not apply to medical practitioners serving in AFMS during their service period, and such practitioners will be deemed authorised to practice across all states and Union Territories by virtue of their service obligations.In cases of alleged professional misconduct by AFMS doctors, jurisdiction to decide the matter will rest with the State Medical Council with which the practitioner is registered, based on recommendations from the State Medical Council within whose territorial jurisdiction the cause of action arose.The regulation also clarifies that the amendments do not preclude disciplinary or administrative action against AFMS doctors under applicable Armed Forces service laws.Also Read:NMC draft TEQ proposes exemption from 1-year senior residency for doctors with foreign PG medical qualificationsMedical Dialogues earlier reported that through a recent notice, the National Medical Commission (NMC) informed all medical colleges and institutions to disseminate information about an upcoming Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PMJAY) Auto-Adjudication Hackathon 2026 initiative held by the National Health Authority and encourage participation from researchers and professionals.National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY. Sharing this information, the Apex Medical Commission has asked all medical colleges and institutions to spread awareness about the initiative and encourage participation from researchers, innovators, professionals from academic and professional network.Also Read:NMC issues notice for medical colleges, seeks participation from researchers, professionals in NHA AB PMJAY auto adjudication Hackathon 2026 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/08/320131-nmc-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:13 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, draft, amendment, proposes, single, state, registration, for, AFMS, doctors</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/08/320131-nmc-1.webp"><div class="pasted-from-word-wrapper"><p><span>New Delhi: P</span>roposing relaxed registration norms for doctors serving in the Armed Forces Medical Services (AFMS), the National Medical Commission (NMC) has issued draft amendments to the Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023.</p><p>The proposed changes aim to address the operational challenges faced by AFMS doctors by allowing them to remain registered with a single State Medical Council during their service, instead of obtaining multiple registrations across states due to frequent transfers and postings.</p><p><span>According to a recent ANI report, t</span><span>he </span><a href="https://medicaldialogues.in/topics/nmc" target="_blank">NMC</a><span> has notified draft amendments to the ''Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023'' in the official gazette to ease registration requirements for AFMS doctors, in view of their distinct service conditions.</span></p><p>Recognising the services rendered by Armed Forces personnel for the safety and security of the nation during conflict situations as well as humanitarian and disaster relief (HADR) operations, the NMC has proposed allowing <a href="https://medicaldialogues.in/topics/AFMS" target="_blank">AFMS </a>doctors to remain registered with one State Medical Council during their period of service instead of requiring multiple state registrations.</p><p>The commission noted that AFMS doctors function under conditions different from civilian medical practitioners, including postings at remote and operational areas at short notice governed by service exigencies and national security imperatives rather than personal choice of location.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/nmc-draft-amendment-revises-documentation-for-medical-colleges-incomplete-applications-to-be-rejected-165536"><b>Also Read:NMC draft amendment revises documentation for medical colleges, incomplete applications to be rejected</b></a></p><p>AFMS doctors are commissioned medical officers of the Armed Forces who hold recognised and registered undergraduate and postgraduate medical qualifications and are registered with a State Medical Council or the erstwhile Medical Council of India. They are also subject to strict professional, ethical and disciplinary provisions under the Army Act in addition to <a href="https://medicaldialogues.in/topics/nmc" target="_blank">NMC </a>norms.</p><p>Doctors joining <a href="https://medicaldialogues.in/topics/AFMS" target="_blank">AFMS </a>from civilian institutions are commissioned only after validation of their degree and registration. Upon retirement, AFMS doctors register with the State Medical Council as per their place of work and are governed by NMC provisions like other medical practitioners.</p><p>The operational nature of duties of AFMS doctors includes deployments ranging from short-term assignments of up to 179 days to long-term postings of up to three years, casualty evacuation and patient-related tasks, disaster relief operations and operational deployment across multiple states and regions. Such duties involve constant movement across state borders at short notice, and due to security protocols, locations of deployment are usually not disclosed to outside agencies.</p><p>At present, under the provisions of the "Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023", every doctor is required to register and seek a licence to practice medicine in the concerned state or states where he or she intends to practice. However, frequent transfers of AFMS doctors to various locations create administrative burdens requiring multiple registrations, repeated completion of administrative formalities for the same professional credentials and repeated payment of registration fees to different State Medical Councils.</p><p>Keeping these operational requirements in view and based on a request from the office of the Director General of Armed Forces Medical Services (DGAFMS), the NMC has initiated amendments to the "Registration of Medical Practitioners and Licence to Practice Medicine (Amendment) Regulations, 2026."</p><p>The draft amendment includes the inclusion of the definition of AFMS and proposes that AFMS doctors may opt to be registered and licensed with one State Medical Council of their choice at the time of joining AFMS for the duration of their service and be authorised to practice in any state or Union Territory in India by virtue of service obligations. Upon retirement or release from service, they would register with or transfer to the State Medical Council where they intend to practice, adds ANI report.</p><p>The amendment also provides that medical practitioners commissioned in AFMS may register any additional medical qualification with the State Medical Council with which they are registered during their period of service, and such entries will remain valid across all states and Union Territories for the duration of their service.</p><p>Further, the licence of AFMS medical practitioners shall not be rendered inactive solely due to non-submission of renewal applications within the prescribed time by the concerned State Medical Council. The office of the DGAFMS will furnish details of commissioned medical practitioners along with renewal applications, wherever applicable, to the concerned State Medical Councils annually and also provide records to the National Medical Commission.</p><p>The provisions relating to transfer of licence to practice will not apply to medical practitioners serving in AFMS during their service period, and such practitioners will be deemed authorised to practice across all states and Union Territories by virtue of their service obligations.</p><p>In cases of alleged professional misconduct by AFMS doctors, jurisdiction to decide the matter will rest with the State Medical Council with which the practitioner is registered, based on recommendations from the State Medical Council within whose territorial jurisdiction the cause of action arose.</p><p>The regulation also clarifies that the amendments do not preclude disciplinary or administrative action against AFMS doctors under applicable Armed Forces service laws.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/nmc-draft-teq-proposes-exemption-from-1-year-senior-residency-for-doctors-with-foreign-pg-medical-qualifications-142055"><b>Also Read:NMC draft TEQ proposes exemption from 1-year senior residency for doctors with foreign PG medical qualifications</b></a></p><p>Medical Dialogues earlier reported that through a recent notice, the <a href="https://medicaldialogues.in/topics//nmc" target="_blank">National Medical Commission</a> (NMC) informed all medical colleges and institutions to disseminate information about an upcoming Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (<a href="https://medicaldialogues.in/topics/ab-pmjay" target="_blank">AB PMJAY</a>) Auto-Adjudication Hackathon 2026 initiative held by the National Health Authority and encourage participation from researchers and professionals.</p></div><div class="pasted-from-word-wrapper"><div></div><p>National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY. Sharing this information, the Apex Medical Commission has asked all medical colleges and institutions to spread awareness about the initiative and encourage participation from researchers, innovators, professionals from academic and professional network.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/health-news/nmc/nmc-issues-notice-for-medical-colleges-seeks-participation-from-researchers-professionals-in-nha-ab-pmjay-auto-adjudication-hackathon-2026-168135"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/02/21/328848-nmc-2.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/nmc-issues-notice-for-medical-colleges-seeks-participation-from-researchers-professionals-in-nha-ab-pmjay-auto-adjudication-hackathon-2026-168135"><span class="read-this-also">Also Read:</span>NMC issues notice for medical colleges, seeks participation from researchers, professionals in NHA AB PMJAY auto adjudication Hackathon 2026</a></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>World Health Day 2026: PM Modi lauds healthcare workers, calls for healthier nation</title>
<link>https://edusehat.com/en/world-health-day-2026-pm-modi-lauds-healthcare-workers-calls-for-healthier-nation</link>
<guid>https://edusehat.com/en/world-health-day-2026-pm-modi-lauds-healthcare-workers-calls-for-healthier-nation</guid>
<description><![CDATA[ New Delhi: Prime Minister Narendra Modi on Tuesday extended his gratitude to healthcare workers and reaffirmed the government&#039;s commitment to strengthening healthcare systems on the occasion of World Health Day.  Taking to social media platform X, the Prime Minister said, &quot;On World Health Day, we express our gratitude to all those who dedicate themselves tirelessly to the service of others and work towards a healthier planet.&quot;Reiterating the government&#039;s focus on public health, he added, &quot;We also reaffirm our commitment to building a healthier society. Let us all keep working together to strengthen healthcare systems and prioritise well-being for every individual&quot;, news agency ANI reported.Also Read:JP Nadda launches 100-day TB Mukt Bharat campaign to accelerate elimination effortsUnion Health Minister JP Nadda also extended greetings, emphasising India&#039;s healthcare approach and the ongoing reforms. &quot;Greetings to everyone on World Health Day! This day reminds us to take better care of our health and follow a balanced lifestyle. India&#039;s approach to healthcare combines age-old wisdom with modern science, helping improve lives not just at home but across the world,&quot; Nadda wrote on X.Praising government initiatives, he added, &quot;Under the visionary leadership of Hon&#039;ble PM Shri Narendra Modi ji, transformative initiatives like Ayushman Bharat and the PM Bharatiya Janaushadhi Pariyojana have strengthened the healthcare system, making quality treatment more accessible, affordable, and inclusive for every citizen.&quot;He also lauded healthcare professionals, stating, &quot;We express our heartfelt gratitude to all doctors, nurses, and frontline workers whose dedication keeps our healthcare system strong. Let us all work together towards building a healthier and stronger nation.&quot; World Health Day is observed annually on April 7 to highlight pressing global health issues and encourage people to prioritise their well-being. The day marks the founding of the World Health Organisation in 1948, which works to improve public health standards worldwide.Celebrated since 1950, the occasion aims to raise awareness about healthcare access, promote healthy lifestyles, and emphasise both physical and mental well-being. Governments, organisations, and citizens use the occasion to drive awareness and collective action. On World Health Day 2026, WHO unites and mobilises the world under the theme &quot;Together for health. Stand with science,&quot; celebrating the power of scientific collaboration to protect the health of people, animals, plants, and the planet. The year-long campaign spotlights both scientific achievements and the multilateral cooperation needed to turn evidence into action, according to WHO. Also Read:PM Modi inaugurates Rs 94.64 crore Regional Cancer Center at JIPMER Puducherry ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/10/268425-modi.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:10 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>World, Health, Day, 2026:, Modi, lauds, healthcare, workers, calls, for, healthier, nation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/10/268425-modi.webp"><div class="pasted-from-word-wrapper"><p><span>New Delhi: Prime Minister <a href="https://medicaldialogues.in/topics/Narendra-Modi" target="_blank">Narendra Modi</a> on Tuesday extended his gratitude to healthcare workers and reaffirmed the government's commitment to strengthening healthcare systems on the occasion of World Health Day.  </span></p><p>Taking to social media platform X, the Prime Minister said, "On World Health Day, we express our gratitude to all those who dedicate themselves tirelessly to the service of others and work towards a healthier planet."</p><p>Reiterating the government's focus on public health, he added, "We also reaffirm our commitment to building a healthier society. Let us all keep working together to strengthen healthcare systems and prioritise well-being for every individual", news agency ANI reported.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/jp-nadda-launches-100-day-tb-mukh-bharat-campaign-to-accelerate-elimination-efforts-167247"><b>Also Read:JP Nadda launches 100-day TB Mukt Bharat campaign to accelerate elimination efforts</b></a></p><p>Union Health Minister <a href="https://medicaldialogues.in/topics/JP-Nadda" target="_blank">JP Nadda</a> also extended greetings, emphasising India's healthcare approach and the ongoing reforms. </p><p>"Greetings to everyone on World Health Day! This day reminds us to take better care of our health and follow a balanced lifestyle. India's approach to healthcare combines age-old wisdom with modern science, helping improve lives not just at home but across the world," Nadda wrote on X.</p><p>Praising government initiatives, he added, "Under the visionary leadership of Hon'ble PM Shri Narendra Modi ji, transformative initiatives like Ayushman Bharat and the PM Bharatiya Janaushadhi Pariyojana have strengthened the healthcare system, making quality treatment more accessible, affordable, and inclusive for every citizen."</p><p>He also lauded healthcare professionals, stating, "We express our heartfelt gratitude to all doctors, nurses, and frontline workers whose dedication keeps our healthcare system strong. Let us all work together towards building a healthier and stronger nation." </p><p>World Health Day is observed annually on April 7 to highlight pressing global health issues and encourage people to prioritise their well-being. The day marks the founding of the World Health Organisation in 1948, which works to improve public health standards worldwide.</p><p>Celebrated since 1950, the occasion aims to raise awareness about healthcare access, promote healthy lifestyles, and emphasise both physical and mental well-being. Governments, organisations, and citizens use the occasion to drive awareness and collective action.</p><p> On World Health Day 2026, WHO unites and mobilises the world under the theme "Together for health. Stand with science," celebrating the power of scientific collaboration to protect the health of people, animals, plants, and the planet. The year-long campaign spotlights both scientific achievements and the multilateral cooperation needed to turn evidence into action, according to WHO. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/pm-modi-inaugurates-rs-9464-crore-regional-cancer-center-at-jipmer-puducherry-165754"><b>Also Read:PM Modi inaugurates Rs 94.64 crore Regional Cancer Center at JIPMER Puducherry</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>MCC adds 18 seats, withdraws 1 from round 2 NEET SS counselling 2025</title>
<link>https://edusehat.com/en/mcc-adds-18-seats-withdraws-1-from-round-2-neet-ss-counselling-2025</link>
<guid>https://edusehat.com/en/mcc-adds-18-seats-withdraws-1-from-round-2-neet-ss-counselling-2025</guid>
<description><![CDATA[ New Delhi: The Medical Counselling Committee (MCC), under the Directorate General of Health Services (DGHS), has issued an notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (NEET SS) Super Speciality Counselling 2025.As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.According to the updated seat matrix, several newly approved seats have been added across various states and specialities. All these additions have been made based on information received from institutes regarding newly approved seats.Also Read: MCC extends choice filling for round 2 NEET SS counsellingThere are a total of 19 seats; of these, one seat has been removed and a total of 18 seats have been added. The following seats are added/ withdrawn in the seat matrix of Round II-S.NOSTATEINSTITUTE NAME AND ADDRESSSPECIALITYSEATSREASON FOR ADDITION/WITHDRAWAL1TelanganaYashoda Health Care Services Private Limited (YHSPL) (Formerly known as Yashoda Super Speciality Hospital) Raj Bhavan Road, Somajiguda, Hyderabad-500082 Telangana.Vascular Surgery1Seats have been ADDED as per information received from the Institute (Newly approved seats) 2MaharashtraBombay Hospital &amp; Instt. of Med. Sciences 12, Marine Lines, Mumbai-20, Maharashtra Critical Care Medicine 4Seats have been ADDED as per information received from the Institute (Newly approved seats) 3TelanganaRENOVA SOUMYA CANCER CENTRE, 3-7-218/P J- 19/P, KARKHANA , SECUNDERBAD , Telangana-500015Surgical Oncology1Seats have been ADDED as per information received from the Institute (Newly approved seats) 4Uttar PradeshVivekananda Polyclinic and Institute of Medical Sciences, Vivekananda Puram, Lucknow, Uttar Pradesh-226007Medical Gastroenterology 1Seats have been ADDED as per information received from the Institute (Newly approved seats) 5West Bengal Institute of Neurosciences, 185/1, A J C Bose Road, Kolkata, West Bengal-700017 Clinical Immunology and Rheumatology  2Seats have been ADDED as per information received from the Institute (Newly approved seats) 6PunjabGovt. Medical College, Amritsar D. M. Cardiology1Seats have been ADDED as per information received from the Institute (Newly approved seats) 7MaharashtraKRISHNA INSTITUTE OF MEDICAL SCIENCES, KARAD M.CH. Urology1Seats have been ADDED as per information received from the Institute (Newly approved seats) 8MaharashtraMGM Medical College, Aurangabad M.CH. HepatoPancreatto Billary Surgery2Seats have been ADDED as per information received from the Institute (Newly approved seats) 9UttarakhandGovernment Doon Medical College, Dehradun M.CH. Urology2Seats have been ADDED as per information received from the Institute (Newly approved seats) 10Uttar PradeshHeritage Institute of Medical Sciences, Varanasi  D.M. Endocrinology  2Seats have been ADDED as per information received from the Institute (Newly approved seats) 11Uttar Pradesh Heritage Institute of Medical Sciences, Varanasi  D.M. Medical Gastroenterology 1Seats have been ADDED as per information received from the Institute (Newly approved seats) 12RajasthanParas Hospital, plotno.1 Lane Shobhagpura Circle, Udaipur, Rajasthan-313001, plot no. 1 jk lane shobhagpura  DNBSS Critical Care Medicine 1Seats have been REMOVED as per information received from the InstituteTOTAL19 To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/08/mcc-revises-neet-ss-counselling-2025-round-2-seat-matrix-18-seats-added-and-1-withdrawn-340306.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/08/340305-seat-matrix-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:09 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MCC, adds, seats, withdraws, from, round, NEET, counselling, 2025</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/08/340305-seat-matrix-1.webp"><p><b>New Delhi:</b> The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/mcc" target="_blank">MCC</a>), under the Directorate General of Health Services (<a href="https://medicaldialogues.in/topics/dghs" target="_blank">DGHS</a>), has issued an notice regarding the addition and withdrawal of seats in the Round 2 seat matrix of the National Eligibility and Entrance Test (<a href="https://medicaldialogues.in/topics/neet" target="_blank">NEET</a> SS) Super Speciality Counselling 2025.</p><div class="pasted-from-word-wrapper"><p dir="ltr">As per the notice, MCC has received updated information from participating institutes, leading to a revision of available seats before the Round 2 allotment process.</p><p dir="ltr">According to the updated seat matrix, several newly approved seats have been added across various states and specialities. All these additions have been made based on information received from institutes regarding newly approved seats.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/mcc-extends-choice-filling-for-round-2-neet-ss-counselling-167964"><b>Also Read: </b>MCC extends choice filling for round 2 NEET SS counselling</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">There are a total of 19 seats; of these, one seat has been removed and a total of 18 seats have been added. The following seats are added/ withdrawn in the seat matrix of Round II-</p><div dir="ltr"><table><colgroup><col width="54"><col width="111"><col width="147"><col width="104"><col width="104"><col width="104"></colgroup><tbody><tr><td><p dir="ltr"><b>S.NO</b></p></td><td><p dir="ltr"><b>STATE</b></p></td><td><p dir="ltr"><b>INSTITUTE NAME AND ADDRESS</b></p></td><td><p dir="ltr"><b>SPECIALITY</b></p></td><td><p dir="ltr"><b>SEATS</b></p></td><td><p dir="ltr"><b>REASON FOR ADDITION/WITHDRAWAL</b></p></td></tr><tr><td><p dir="ltr">1</p></td><td><p dir="ltr">Telangana</p></td><td><p dir="ltr">Yashoda Health Care Services Private Limited (YHSPL) (Formerly known as Yashoda Super Speciality Hospital) Raj Bhavan Road, Somajiguda, Hyderabad-500082 Telangana.</p></td><td><p dir="ltr">Vascular Surgery</p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">2</p></td><td><p dir="ltr">Maharashtra</p></td><td><p dir="ltr">Bombay Hospital & Instt. of Med. Sciences 12, Marine Lines, Mumbai-20, Maharashtra </p></td><td><p dir="ltr">Critical Care Medicine </p></td><td><p dir="ltr">4</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">3</p></td><td><p dir="ltr">Telangana</p></td><td><p dir="ltr">RENOVA SOUMYA CANCER CENTRE, 3-7-218/P J- 19/P, KARKHANA , SECUNDERBAD , Telangana-500015</p></td><td><p dir="ltr">Surgical Oncology</p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">4</p></td><td><p dir="ltr">Uttar Pradesh</p></td><td><p dir="ltr">Vivekananda Polyclinic and Institute of Medical Sciences, Vivekananda Puram, Lucknow, Uttar Pradesh-226007</p></td><td><p dir="ltr">Medical Gastroenterology </p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">5</p></td><td><p dir="ltr">West Bengal </p></td><td><p dir="ltr">Institute of Neurosciences, 185/1, A J C Bose Road, Kolkata, West Bengal-700017 </p></td><td><p dir="ltr">Clinical Immunology and Rheumatology  </p></td><td><p dir="ltr">2</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">6</p></td><td><p dir="ltr">Punjab</p></td><td><p dir="ltr">Govt. Medical College, Amritsar </p></td><td><p dir="ltr">D. M. Cardiology</p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">7</p></td><td><p dir="ltr">Maharashtra</p></td><td><p dir="ltr">KRISHNA INSTITUTE OF MEDICAL SCIENCES, KARAD </p></td><td><p dir="ltr">M.CH. Urology</p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">8</p></td><td><p dir="ltr">Maharashtra</p></td><td><p dir="ltr">MGM Medical College, Aurangabad </p></td><td><p dir="ltr">M.CH. HepatoPancreatto Billary Surgery</p></td><td><p dir="ltr">2</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">9</p></td><td><p dir="ltr">Uttarakhand</p></td><td><p dir="ltr">Government Doon Medical College, Dehradun </p></td><td><p dir="ltr">M.CH. Urology</p></td><td><p dir="ltr">2</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">10</p></td><td><p dir="ltr">Uttar Pradesh</p></td><td><p dir="ltr">Heritage Institute of Medical Sciences, Varanasi  </p></td><td><p dir="ltr">D.M. Endocrinology  </p></td><td><p dir="ltr">2</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">11</p></td><td><p dir="ltr">Uttar Pradesh </p></td><td><p dir="ltr">Heritage Institute of Medical Sciences, Varanasi  </p></td><td><p dir="ltr">D.M. Medical Gastroenterology </p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been ADDED as per information received from the Institute (Newly approved seats) </p></td></tr><tr><td><p dir="ltr">12</p></td><td><p dir="ltr">Rajasthan</p></td><td><p dir="ltr">Paras Hospital, plotno.1 Lane Shobhagpura Circle, Udaipur, Rajasthan-313001, plot no. 1 jk lane shobhagpura  </p></td><td><p dir="ltr">DNBSS Critical Care Medicine </p></td><td><p dir="ltr">1</p></td><td><p dir="ltr">Seats have been REMOVED as per information received from the Institute</p></td></tr><tr><td colspan="4"><p dir="ltr"><b>TOTAL</b></p></td><td><p dir="ltr"><b>19 </b></p></td><td></td></tr></tbody></table></div><p dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/mcc-revises-neet-ss-counselling-2025-round-2-seat-matrix-18-seats-added-and-1-withdrawn-340306.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/08/mcc-revises-neet-ss-counselling-2025-round-2-seat-matrix-18-seats-added-and-1-withdrawn-340306.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Metformin: Anchoring Potential in GLP&#45;1 RA Care Journey</title>
<link>https://edusehat.com/en/metformin-anchoring-potential-in-glp-1-ra-care-journey</link>
<guid>https://edusehat.com/en/metformin-anchoring-potential-in-glp-1-ra-care-journey</guid>
<description><![CDATA[ India is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 million with abdominal obesity[1], nearly 90 million living with diabetes[2], and a metabolic syndrome burden of 44.6% across urban and rural populations.[3] However, in a promising transition for all metabolic health stakeholders, the treatment landscape is likely to drastically shift with generic GLP-1 receptor agonists (GLP-RAs) becoming available in India for the first time, marking a meaningful change in access for a class that was, until recently, out of reach for most patients. Interestingly, metformin continues to hold its ground in this evolving therapeutic landscape towards wider access to GLP-RAs, as a potential anchor of the GLP-1 RA care journey.[4]
Metformin with GLP-1 RA: Early Promising Evidence Presented at EASD Conference
The evidence supporting the use of metformin in the GLP-1 RA care continuum is gaining momentum. Data presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) 2025, a few months back, have provided new insights into the potential role of metformin within a GLP-1 RA-based regimen continuum, with findings that extend beyond glycaemic outcomes into territory that carries greater clinical weight. These are early signals, but ones that deserve careful attention and have clinical implications for how combination therapy of metformin and GLP-RA is approached in routine practice.[5]
Metformin with GLP-1 RA: Rationale for Consideration in Obese T2D Patients 
The rationale for combining metformin with a GLP-1 receptor agonist lies in their complementary mechanisms across metabolic tissues. Metformin suppresses hepatic gluconeogenesis via AMPK activation,[6] while GLP-1 receptor agonists enhance glucose-dependent insulin secretion and promote satiety, improving both fasting and postprandial glycaemic control.[7] Both metformin and GLP-1RAs are known to improve leptin sensitivity, making the brain more responsive to the anorexigenic effects of the adipokine.[8] Together, they provide synergistic efficacy with potential benefits on weight reduction. 
Metformin Use with GLP-1 RA: Synergy Towards Better Outcomes
Metformin with GLP-RA – Effect on Weight-Lowering Response: A 52-week prospective study including 194 obese T2D patients showed concomitant initiation of metformin alongside GLP-1 receptor agonist therapy is associated with enhanced weight loss efficacy, suggesting a potential synergistic metabolic interaction that improves the likelihood of achieving clinically meaningful weight reduction.[8]
Metformin with GLP-RA &amp; Long-term Outcomes: In patients with T2D, dual therapy with metformin and GLP-RA has demonstrated a 39% lower incidence of adiposity-related cancers (HR 0.61) and a 67% reduction in all-cause mortality (HR 0.33) compared to DPP-4 inhibitor use, with effects most pronounced in younger people with obesity.[9]
Metformin Use Post-GLP-1 RA: Weight Maintenance Effect
The post-GLP-1 RA period represents a significant clinical vulnerability. Discontinuation rates range from 37% to 81% within the first year, driven by cost, side effects, and access barriers, with weight regain thereafter mediated through hormonal dysregulation, CNS maladaptation to reduced GLP-1 signaling, and β-cell dysfunction. In this context, metformin emerges as the most pragmatic maintenance strategy.[10,11] In a real-world cohort transitioning off GLP-1 RA therapy to cost-effective medications with weight-lowering effects, metformin was the most frequently utilized agent as maintenance treatment in about 80% patients. Patients achieved substantial weight loss during the initial GLP-1 RA phase (~18–22% at 12 months), which was subsequently maintained after its discontinuation, with total weight reduction reaching 25.5% (95% CI 23.1–27.9%) at 593 days, with most patients on metformin.  These findings indicate that metformin could help sustain weight loss achieved with GLP-1 RAs, supporting their role in long-term weight maintenance across the treatment continuum.[12]
Metformin: Anchor in the GLP-1 RA Care Continuum Journey
The mechanistic, real-world, clinical trials and pharmacovigilance evidence landscape suggests metformin as the potential anchor pharmacological agent across the entire GLP-1 RA care continuum, during therapy and beyond.Table 1 summarises the key potential outcome benefits at each phase. Table 1. Metformin- Anchoring Benefits with and Post GLP-1 RA Therapy
Metformin with GLP-RA -Safety Edge:
A pooled analysis across four major cardiovascular outcome trials (n=16,996; LEADER, STEP 2, SUSTAIN-6, PIONEER 6) showed that metformin use did not increase the incidence or severity of gastrointestinal adverse events or drive treatment discontinuation; notably, metformin non-users experienced numerically higher gastrointestinal event rates.[13]  These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added.[14]
Together, these data support the continued use of metformin across the GLP-1 RA care journey without additional safety compromise.[9]
Key Takeaways
✔	With rising GLP-1 RA access in India’s metabolic crisis revolutionizing treatment paradigm in the real world, metformin remains the anchor of the gluco-metabolic care journey.
✔	The combination of metformin and GLP-1 RAs, via complementary mechanisms and improved leptin sensitivity, translates into greater weight loss success response and reduced GLP-1RA-related adverse events, particularly with concurrent initiation of both agents.
✔	Research indicates concomitant metformin emerges as a pragmatic maintenance strategy in the post–GLP-1 RA period, used in 80% of patients following discontinuation.
✔	The evidence consistently indicates the potential of metformin as the anchor pharmacological agent  drug across the entire GLP-1 RA care continuum, during therapy and beyond, when clinically indicated.
Abbreviations: GLP-1 RA = glucagon-like peptide-1 receptor agonist; EASD = European Association for the Study of Diabetes; AMPK = adenosine monophosphate-activated protein kinase; FAERS = FDA Adverse Event Reporting System; GI = gastrointestinal; OR = odds ratio; CI = confidence interval; HR = hazard ratio; ROR = reporting odds ratio; DPP-4i = dipeptidyl peptidase-4 inhibitor; CNS = central nervous system; BMI = body mass index.
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340055-featured-images-1-14.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Metformin:, Anchoring, Potential, GLP-1, Care, Journey</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340055-featured-images-1-14.webp"><p>India is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 million with abdominal obesity<sup>[1]</sup>, nearly 90 million living with diabetes<sup>[2]</sup>, and a metabolic syndrome burden of 44.6% across urban and rural populations.<sup>[3]</sup> However, in a promising transition for all metabolic health stakeholders, the treatment landscape is likely to drastically shift with generic GLP-1 receptor agonists (GLP-RAs) becoming available in India for the first time, marking a meaningful change in access for a class that was, until recently, out of reach for most patients. Interestingly, metformin continues to hold its ground in this evolving therapeutic landscape towards wider access to GLP-RAs, as a potential anchor of the GLP-1 RA care journey.<sup>[4]</sup>
</p><h3><b>Metformin with GLP-1 RA: Early Promising Evidence Presented at EASD Conference
</b></h3><p>The evidence supporting the use of metformin in the GLP-1 RA care continuum is gaining momentum. Data presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) 2025, a few months back, have provided new insights into the potential role of metformin within a GLP-1 RA-based regimen continuum, with findings that extend beyond glycaemic outcomes into territory that carries greater clinical weight. These are early signals, but ones that deserve careful attention and have clinical implications for how combination therapy of metformin and GLP-RA is approached in routine practice.<sup>[5]</sup>
</p><h3><b>Metformin with GLP-1 RA: Rationale for Consideration in Obese T2D Patients 
</b></h3><p>The rationale for combining metformin with a GLP-1 receptor agonist lies in their complementary mechanisms across metabolic tissues. Metformin suppresses hepatic gluconeogenesis via AMPK activation,<sup>[6]</sup> while GLP-1 receptor agonists enhance glucose-dependent insulin secretion and promote satiety, improving both fasting and postprandial glycaemic control.<sup>[7]</sup> Both metformin and GLP-1RAs are known to improve leptin sensitivity, making the brain more responsive to the anorexigenic effects of the adipokine.<sup>[8]</sup> Together, they provide synergistic efficacy with potential benefits on weight reduction. 
</p><h3><b>Metformin Use with GLP-1 RA: Synergy Towards Better Outcomes
</b></h3><p><b>Metformin with GLP-RA – Effect on Weight-Lowering Response:</b> A 52-week prospective study including 194 obese T2D patients showed concomitant initiation of metformin alongside GLP-1 receptor agonist therapy is associated with enhanced weight loss efficacy, suggesting a potential synergistic metabolic interaction that improves the likelihood of achieving clinically meaningful weight reduction.<sup>[8]</sup>
</p><p><b>Metformin with GLP-RA & Long-term Outcomes:</b> In patients with T2D, dual therapy with metformin and GLP-RA has demonstrated a 39% lower incidence of adiposity-related cancers (HR 0.61) and a 67% reduction in all-cause mortality (HR 0.33) compared to DPP-4 inhibitor use, with effects most pronounced in younger people with obesity.<sup>[9]</sup>
</p><h3><b>Metformin Use Post-GLP-1 RA: Weight Maintenance Effect
</b></h3><p>The post-GLP-1 RA period represents a significant clinical vulnerability. Discontinuation rates range from 37% to 81% within the first year, driven by cost, side effects, and access barriers, with weight regain thereafter mediated through hormonal dysregulation, CNS maladaptation to reduced GLP-1 signaling, and β-cell dysfunction. In this context, metformin emerges as the most pragmatic maintenance strategy.<sup>[10,11]</sup> In a real-world cohort transitioning off GLP-1 RA therapy to cost-effective medications with weight-lowering effects, metformin was the most frequently utilized agent as maintenance treatment in about 80% patients. Patients achieved substantial weight loss during the initial GLP-1 RA phase (~18–22% at 12 months), which was subsequently maintained after its discontinuation, with total weight reduction reaching 25.5% (95% CI 23.1–27.9%) at 593 days, with most patients on metformin.  These findings indicate that metformin could help sustain weight loss achieved with GLP-1 RAs, supporting their role in long-term weight maintenance across the treatment continuum.<sup>[12]</sup>
</p><h3><b>Metformin: Anchor in the GLP-1 RA Care Continuum Journey
</b></h3><p>The mechanistic, real-world, clinical trials and pharmacovigilance evidence landscape suggests metformin as the potential anchor pharmacological agent across the entire GLP-1 RA care continuum, during therapy and beyond.Table 1 summarises the key potential outcome benefits at each phase.</p><div contenteditable="false" data-width="100%" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/04/06/339931-green-clean-investment-benefits-infographic-instagram-post-1.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="2369087ILVyjj4hjPCmNJtItIXBjKdXRC4X0O8938868" data-watermark="false" info-selector="#info_item_1775468939414"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"></div></div><p> </p><p><b>Table 1. Metformin- Anchoring Benefits with and Post GLP-1 RA Therapy
</b></p><h3><b>Metformin with GLP-RA -Safety Edge:
</b></h3><p>A pooled analysis across four major cardiovascular outcome trials (n=16,996; LEADER, STEP 2, SUSTAIN-6, PIONEER 6) showed that metformin use did not increase the incidence or severity of gastrointestinal adverse events or drive treatment discontinuation; notably, metformin non-users experienced numerically higher gastrointestinal event rates.<sup>[13]</sup>  These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added.<sup>[14]</sup>
</p><p>Together, these data support the continued use of metformin across the GLP-1 RA care journey without additional safety compromise.<sup>[9]</sup>
</p><h3><b>Key Takeaways
</b></h3><p>✔	With rising GLP-1 RA access in India’s metabolic crisis revolutionizing treatment paradigm in the real world, metformin remains the anchor of the gluco-metabolic care journey.
</p><p>✔	The combination of metformin and GLP-1 RAs, via complementary mechanisms and improved leptin sensitivity, translates into greater weight loss success response and reduced GLP-1RA-related adverse events, particularly with concurrent initiation of both agents.
</p><p>✔	Research indicates concomitant metformin emerges as a pragmatic maintenance strategy in the post–GLP-1 RA period, used in 80% of patients following discontinuation.
</p><p>✔	The evidence consistently indicates the potential of metformin as the anchor pharmacological agent  drug across the entire GLP-1 RA care continuum, during therapy and beyond, when clinically indicated.
</p><p><span>Abbreviations: GLP-1 RA = glucagon-like peptide-1 receptor agonist; EASD = European Association for the Study of Diabetes; AMPK = adenosine monophosphate-activated protein kinase; FAERS = FDA Adverse Event Reporting System; GI = gastrointestinal; OR = odds ratio; CI = confidence interval; HR = hazard ratio; ROR = reporting odds ratio; DPP-4i = dipeptidyl peptidase-4 inhibitor; CNS = central nervous system; BMI = body mass index.</span>
</p>]]> </content:encoded>
</item>

<item>
<title>75&#45;year&#45;old Pune doctor scammed of Rs 12.3 crore in share trading fraud</title>
<link>https://edusehat.com/en/75-year-old-pune-doctor-scammed-of-rs-123-crore-in-share-trading-fraud</link>
<guid>https://edusehat.com/en/75-year-old-pune-doctor-scammed-of-rs-123-crore-in-share-trading-fraud</guid>
<description><![CDATA[ Pune: In a shocking cyber fraud case in Hadapsar, Pune, a 75-year-old doctor reportedly lost Rs 12.31 crore to online fraudsters who promised high returns through share trading.  According to the news reports, the scam unfolded between January 30 and March 20, during which the doctor transferred amounts ranging from Rs 30 lakh to Rs 3 crore to the fraudsters who had lured him with promises of 8–10% returns within a few months. This has been reported as the second-largest cyber fraud in Pune so far this year. The victim, a general physician (GP), whose son is also a prominent doctor, reportedly lost the amount in just 39 days. Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 monthsSpeaking to TOI, Senior inspector Swapnali Shinde of Pune Cyber Police said, &quot;The GP told us that his cellphone was added to a group on a messaging application, where its members discussed high returns generated from online share-trading. He read all these messages and was impressed with the profits the group members generated based on tips from the group admin. He then contacted the group admin and showed interest in making such investments.”The group admin then sent the physician a link to download an online share trading mobile application. The doctor began investing but did not initially make significant profits. Seeing this, the admin persuaded him to invest in so-called high-value shares.
Initially, the physician’s investments failed to yield the promised returns. The scammers then convinced him to invest in “high-value shares” and provided eight different bank accounts for transferring money. Over 39 days, the doctor reportedly lost a total of Rs 12.31 crore. The app displayed a fake profit of Rs 54 crore.
Realising something was amiss, the physician approached the Pune Cyber Police. Senior Inspector Shinde said, “When the complainant decided to sell the shares for profit, the fraudsters kept on demanding more money from him. He then realised that he had been cheated.&quot; Also Read:Pune doctor duped of Rs 2.09 lakh by fraudsters posing as bank officials ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/16/230219-cyber-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>75-year-old, Pune, doctor, scammed, 12.3, crore, share, trading, fraud</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/16/230219-cyber-fraud.webp"><p><b>Pune:</b> In a shocking cyber fraud case in Hadapsar, Pune, a 75-year-old doctor reportedly lost Rs 12.31 crore to online <a href="https://medicaldialogues.in/topics/cyber-fraud">fraudsters</a> who promised high returns through share trading.  </p><p>According to the news reports, the scam unfolded between January 30 and March 20, during which the doctor transferred amounts ranging from Rs 30 lakh to Rs 3 crore to the fraudsters who had lured him with promises of 8–10% returns within a few months. </p><p>This has been reported as the second-largest cyber fraud in Pune so far this year. The victim, a general physician (GP), whose son is also a prominent <a href="https://medicaldialogues.in/topics/doctors">doctor</a>, reportedly lost the amount in just 39 days. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ahmedabad-doctor-loses-rs-1-lakh-in-cyber-fraud-fir-registered-after-2-months-167408"><b>Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 months</b></a></p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/pune/general-physician-loses-rs12-3-crore-in-second-biggest-online-share-trading-fraud-so-far-in-city/articleshow/130096296.cms" rel="nofollow">TOI</a>, Senior inspector Swapnali Shinde of Pune Cyber Police said, "The GP told us that his cellphone was added to a group on a messaging application, where its members discussed high returns generated from online share-trading. He read all these messages and was impressed with the profits the group members generated based on tips from the group admin. He then contacted the group admin and showed interest in making such investments.”</p><p>The group admin then sent the physician a link to download an online share trading mobile application. The doctor began investing but did not initially make significant profits. Seeing this, the admin persuaded him to invest in so-called high-value shares.
</p><p>Initially, the physician’s investments failed to yield the promised returns. The scammers then convinced him to invest in “high-value shares” and provided eight different bank accounts for transferring money. Over 39 days, the doctor reportedly lost a total of Rs 12.31 crore. The app displayed a fake profit of Rs 54 crore.
</p><p>Realising something was amiss, the physician approached the Pune Cyber Police. Senior Inspector Shinde said, “When the complainant decided to sell the shares for profit, the fraudsters kept on demanding more money from him. He then realised that he had been cheated." </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/pune-doctor-duped-of-rs-209-lakh-by-fraudsters-posing-as-bank-officials-163476"><b>Also Read:Pune doctor duped of Rs 2.09 lakh by fraudsters posing as bank officials</b></a><br></p>]]> </content:encoded>
</item>

<item>
<title>NMC directs medical colleges to charge MBBS fees only for 4.5 years, warns against non&#45;compliance</title>
<link>https://edusehat.com/en/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years-warns-against-non-compliance</link>
<guid>https://edusehat.com/en/nmc-directs-medical-colleges-to-charge-mbbs-fees-only-for-45-years-warns-against-non-compliance</guid>
<description><![CDATA[ New Delhi: Noting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the National Medical Commission (NMC) has strictly directed all medical colleges to charge fees only for the prescribed academic duration of four and a half years.The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.Issuing a public notice in this regard on April 7, 2026, the Commission also said that such practices are not consistent with the prescribed academic structure of the MBBS programme and result in charging fees for periods that do not constitute academic teaching.&quot;It has been brought to the notice of the National Medical Commission (NMC) that certain Medical Colleges / Institutions / Universities, under the purview of NMC, are charging fees for the entire duration of five (5) years or five and a half (5½) years from the MBBS students. Such practices are not consistent with the prescribed academic structure of the MBBS programme and result in charging fees for periods which do not constitute academic teaching,&quot; the notice read. Drawing the attention of the medical colleges, institutions and universities to Section 10 and Section 24 of the National Medical Commission Act, 2019 and the Competency Based Medical Education (CBME) Guidelines, 2024 framed under the Graduate Medical Education Regulations (GMER), the Commission stated that these provisions clearly state that the duration of the MBBS course comprises 4½ years (54 months) of academic study, followed by one (01) year of compulsory rotating internship (CRMI).The Commission further referred to the interim directions issued by the Supreme Court of India in the case of Abhishek Yadav v. Union of India, where concerns such as non-payment of stipends and the imposition of internship-related charges or fees were examined and taken seriously.Referring to another Supreme Court ruling in T.M.A. Pai Foundation v. State of Karnataka, Islamic Academy of Education v. State of Karnataka, and P. A. Inamdar v. State of Maharashtra, the Apex Medical Commission noted that fee structures must be reasonable, transparent, non-exploitative, and commensurate with the academic facilities and services actually rendered.&quot;Accordingly, levy of fees for periods beyond the prescribed academic study duration, where no corresponding academic instruction is imparted, would be inconsistent with the aforesaid principles,&quot; the Commission said in the notice. Following this, the Commission has directed all medical colleges, institutions, and universities to charge fees only for the 4½-year academic period of the MBBS course.&quot;All Medical Colleges / Institutions / Universities are hereby directed to strictly comply with the statutory provisions contained in National Medical Commission Act 2019, applicable Regulations and Judgements passed by the Hon’ble Courts. Any instance of non-compliance shall be viewed seriously and appropriate action initiated by the Commission, as per the extant statutory &amp; regulatory provisions,&quot; the notice further added. To view the notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/08/nmc-clarification-on-fee-chargeable-for-mbbs-course-duration-340310.pdfAlso read- High MBBS fees pushing students abroad? Centre says states fix fee structure ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/22/241888-fees.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 14:50:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, directs, medical, colleges, charge, MBBS, fees, only, for, 4.5, years, warns, against, non-compliance</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/22/241888-fees.webp"><p><b>New Delhi: </b>Noting that certain medical colleges under its purview are charging fees for the entire duration of five years or five and a half years from the MBBS students, the <a href="https://medicaldialogues.in/topics//nmc" target="_blank">National Medical Commission</a> (NMC) has strictly directed all medical colleges to charge<a href="https://medicaldialogues.in/topics/mbbs-fees" target="_blank"> fees</a> only for the prescribed academic duration of four and a half years.</p><p>The Commission stated that any instance of non-compliance with the directive will be viewed seriously, and appropriate action will be taken as per existing statutory and regulatory provisions.</p><p>Issuing a public notice in this regard on April 7, 2026, the Commission also said that such practices are not consistent with the prescribed academic structure of the MBBS programme and result in charging fees for periods that do not constitute academic teaching.</p><p><i>"It has been brought to the notice of the National Medical Commission (NMC) that certain Medical Colleges / Institutions / Universities, under the purview of NMC, are charging fees for the entire duration of five (5) years or five and a half (5½) years from the MBBS students. Such practices are not consistent with the prescribed academic structure of the MBBS programme and result in charging fees for periods which do not constitute academic teaching," </i>the notice read. </p><p>Drawing the attention of the medical colleges, institutions and universities to Section 10 and Section 24 of the National Medical Commission Act, 2019 and the Competency Based Medical Education (CBME) Guidelines, 2024 framed under the Graduate Medical Education Regulations (GMER), the Commission stated that these provisions clearly state that the duration of the MBBS course comprises 4½ years (54 months) of academic study, followed by one (01) year of compulsory rotating internship (CRMI).</p><p>The Commission further referred to the interim directions issued by the Supreme Court of India in the case of Abhishek Yadav v. Union of India, where concerns such as non-payment of stipends and the imposition of internship-related charges or fees were examined and taken seriously.</p><p>Referring to another Supreme Court ruling in T.M.A. Pai Foundation v. State of Karnataka, Islamic Academy of Education v. State of Karnataka, and P. A. Inamdar v. State of Maharashtra, the Apex Medical Commission noted that fee structures must be reasonable, transparent, non-exploitative, and commensurate with the academic facilities and services actually rendered.</p><p><i>"Accordingly, levy of fees for periods beyond the prescribed academic study duration, where no corresponding academic instruction is imparted, would be inconsistent with the aforesaid principles," </i>the Commission said in the notice. </p><p>Following this, the Commission has directed all medical colleges, institutions, and universities to charge fees only for the 4½-year academic period of the MBBS course.</p><p><i>"All Medical Colleges / Institutions / Universities are hereby directed to strictly comply with the statutory provisions contained in National Medical Commission Act 2019, applicable Regulations and Judgements passed by the Hon’ble Courts. Any instance of non-compliance shall be viewed seriously and appropriate action initiated by the Commission, as per the extant statutory & regulatory provisions,"</i> the notice further added. </p><p><b>To view the notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/08/nmc-clarification-on-fee-chargeable-for-mbbs-course-duration-340310.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/08/nmc-clarification-on-fee-chargeable-for-mbbs-course-duration-340310.pdf</b></a></div><p><b>Also read-<a href="https://medicaldialogues.in/news/education/high-mbbs-fees-pushing-students-abroad-centre-says-states-fix-fee-structure-165081" target="_blank"> High MBBS fees pushing students abroad? Centre says states fix fee structure</a></b></p>]]> </content:encoded>
</item>

<item>
<title>NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026</title>
<link>https://edusehat.com/en/nppa-revises-coronary-stent-prices-des-at-rs-39186-and-bms-at-rs-10762-from-april-2026</link>
<guid>https://edusehat.com/en/nppa-revises-coronary-stent-prices-des-at-rs-39186-and-bms-at-rs-10762-from-april-2026</guid>
<description><![CDATA[ New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has notified revised ceiling prices for coronary stents, factoring in the Wholesale Price Index (WPI) increase of 0.64956% for the year 2025 over 2024.The revised ceiling prices of coronary stents have been fixed at ₹10,762.15 per unit for Bare Metal Stents (BMS), while Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffolds (BVS)/biodegradable stents, have been priced at ₹39,186.03 per unit.These prices are applicable per stent and are exclusive of GST.The revision has been issued through Order S.O. 1587(E), in continuation of earlier notifications released between 2018 and 2025 regarding price fixation of coronary stents listed under Sl. No. 28 in Schedule-I of the Drugs (Prices Control) Order, 2013. The revised ceiling prices will come into effect from April 1, 2026, exclusive of Goods and Services Tax (GST), as applicable.Also Read:Heart disease risk tied to certain molecules made by gut microbes, suggests researchThe notice stated,&quot;In continuation of the notifications issued by the National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, 1464(E) dated 02.04.2018, 1488(E) dated 29.03.2019, 1217(E) dated 25.03.2020, 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024, 1605(E) dated 03.04.2024 and 1473(E) dated 27.03.2025 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2026, as under:Sl. No.Coronary Stents (Sl. No. 28 in Schedule-I of the DPCO, 2013)Unit (in Number)Ceiling Price (w.e.f. 01.04.2026 with WPI @ 0.64956%) (in Rs)(1)(2)(3)(4)1Bare Metal Stents110,762.152Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents139,186.03Further, the notification added,(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 0.64956% for the year 2025 over 2024 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.(b) The manufacturers/ importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.To view the official notice, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/07/7861f48beb2b1e5d2ec8ff7182385168-340258.pdfAlso Read:Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/11/21/191534-coronary-stent.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NPPA, Revises, Coronary, Stent, Prices, DES, 39, 186, and, BMS, 10, 762, from, April, 2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/11/21/191534-coronary-stent.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has notified revised ceiling prices for coronary stents, factoring in the Wholesale Price Index (WPI) increase of 0.64956% for the year 2025 over 2024.</p></div><div class="pasted-from-word-wrapper"><p>The revised ceiling prices of coronary stents have been fixed at ₹10,762.15 per unit for Bare Metal Stents (BMS), while Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffolds (BVS)/biodegradable stents, have been priced at ₹39,186.03 per unit.These prices are applicable per stent and are exclusive of GST.</p><p>The revision has been issued through Order S.O. 1587(E), in continuation of earlier notifications released between 2018 and 2025 regarding price fixation of coronary stents listed under Sl. No. 28 in Schedule-I of the Drugs (Prices Control) Order, 2013. The revised ceiling prices will come into effect from April 1, 2026, exclusive of Goods and Services Tax (GST), as applicable.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/gastroenterology/news/heart-disease-risk-tied-to-certain-molecules-made-by-gut-microbes-suggests-research-168161">Also Read:Heart disease risk tied to certain molecules made by gut microbes, suggests research</a></div><p>The notice stated,</p><p>"In continuation of the notifications issued by the National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, 1464(E) dated 02.04.2018, 1488(E) dated 29.03.2019, 1217(E) dated 25.03.2020, 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024, 1605(E) dated 03.04.2024 and 1473(E) dated 27.03.2025 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2026, as under:</p><div class="pasted-from-word-wrapper"><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td width="47" valign="top"><p><b>Sl. No.</b></p></td><td width="293" valign="top"><p><b>Coronary Stents (Sl. No. 28 in Schedule-I of the DPCO, 2013)</b></p></td><td width="129" valign="top"><p><b>Unit (in Number)</b></p></td><td valign="top"><p><b>Ceiling Price (w.e.f. 01.04.2026 with WPI @ 0.64956%) (in Rs)</b></p></td></tr><tr><td width="47" valign="top"><p><b>(1)</b></p></td><td width="293" valign="top"><p><b>(2)</b></p></td><td width="129" valign="top"><p><b>(3)</b></p></td><td valign="top"><p><b>(4)</b></p></td></tr><tr><td width="47" valign="top"><p>1</p></td><td width="293" valign="top"><p>Bare Metal Stents</p></td><td width="129" valign="top"><p>1</p></td><td valign="top"><p>10,762.15</p></td></tr><tr><td width="47" valign="top"><p>2</p></td><td width="293" valign="top"><p>Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents</p></td><td width="129" valign="top"><p>1</p></td><td valign="top"><p>39,186.03</p></td></tr></tbody></table></div><p>Further, the notification added,</p><p>(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 0.64956% for the year 2025 over 2024 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.</p><p>(b) The manufacturers/ importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.</p><p>(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.</p><p><b><i>To view the official notice, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/7861f48beb2b1e5d2ec8ff7182385168-340258.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/7861f48beb2b1e5d2ec8ff7182385168-340258.pdf</a></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/pharma-firms-seek-50-price-hike-in-key-cancer-drugs-including-carboplatin-cisplatin-approach-nppa-report-168111">Also Read:Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report</a></div></div><div class="pasted-from-word-wrapper"></div><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/7861f48beb2b1e5d2ec8ff7182385168-340258.pdf" target="_blank"></a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed</title>
<link>https://edusehat.com/en/delhi-police-bust-rs-2-crore-fake-drug-racket-6-arrested-rs-50-crore-gst-fraud-network-exposed</link>
<guid>https://edusehat.com/en/delhi-police-bust-rs-2-crore-fake-drug-racket-6-arrested-rs-50-crore-gst-fraud-network-exposed</guid>
<description><![CDATA[ New Delhi: The Delhi Police has busted an organised interstate racket involved in manufacturing and supplying spurious life-saving medicines, arresting six persons and seizing counterfeit drugs worth around Rs 2 crore, an official said on Sunday.During the operation, the police also exposed a network of fake GST firms used to generate bogus invoices and launder proceeds of the illegal trade, with investigators estimating the fake billing to the tune of nearly Rs 50 crore.According to the police, the racket was engaged in large-scale manufacturing, storage and distribution of counterfeit Schedule-H drugs, which are commonly prescribed for ailments such as diabetes, hypertension, and liver disorders, posing a serious risk to public health.The accused have been identified as Nikhil Arora alias Sunny, a wholesale medicine dealer based in Shahdara, Shivam Tyagi and Mayank Aggarwal, both suppliers from Uttar Pradesh, Mohit Kumar Sharma, a key supplier from Uttarakhand, and Shahrukh and Rahul, who allegedly operated fake GST firms to facilitate the illegal trade.&quot;The case came to light following specific inputs, after which a raid was conducted on March 11 in Bihari Colony in Shahdara. During the operation, Arora, who ran a wholesale medical shop in Bhagirathi Palace, was apprehended,&quot; a senior police officer said.Also Read: Former IFS Officer Arrested in Spurious Medicines Racket in PuducherryHe said that over 1.2 lakh counterfeit tablets and capsules were recovered during the raid, including fake versions of widely used medicines such as Rabemac-DSR, Telma-AM, Sporolac-DS, Signoflam, Chymoral Forte, Ursocol-300, Gluconorm, Jalra-50 and several others.These medicines are frequently prescribed and consumed by patients suffering from chronic illnesses, the officer said.&quot;The circulation of counterfeit drugs of this nature can have severe and potentially fatal consequences,&quot; he added.Further investigation revealed that the accused had developed a modus operandi to evade detection. The counterfeit medicines were supplied using fake invoices generated through fictitious GST firms that existed only on paper. All these shell entities were created to conceal the actual nature of business operations, evade tax scrutiny and lend a semblance of legitimacy to illegal transactions, the officer said.&quot;The financial trail was deliberately routed through these fake firms to mask both the origin and destination of the spurious medicines,&quot; the officer said.Shahrukh and Rahul were found to be key players in this aspect of the operation. They allegedly operated the fake GST network using encrypted communication platforms, supplying ready-made firms and bogus billing services to clients across multiple states.Analysis of their mobile phones revealed details of numerous shell companies and fake invoices amounting to approximately Rs 50 crore, along with links to several beneficiaries.During the entire investigation, a team traced the supply chain to an illegal pharmaceutical manufacturing unit in Muzaffarnagar in Uttar Pradesh. The unit, spread across nearly 1,000 square yards, was allegedly being operated by one Mohammad Aqdas Siddiqui, who is currently absconding. A raid conducted at the facility led to the recovery of around 2,000 kg of raw materials used in drug manufacturing, including Metformin HCL, calcium carbonate, lactose, starch and magnesium stearate.Police also seized advanced machinery such as tablet compression machines, coating units, capsule filling machines, blister packaging systems and even testing equipment, indicating the scale and sophistication of the operation.&quot;Additionally, 10,000 empty bottles falsely labelled as products of reputed pharmaceutical companies, along with packaging material and printing sets of branded medicines, were recovered from the site,&quot; the officer said.Also Read: Delhi Tramadol Premix Interception Leads Police to Illegal Drug Unit in BiharThe premises involved in the storage and sale of these drugs had no valid licence, and the medicines were not sourced from legitimate distributors. During interrogation, the accused disclosed a multi-layered supply chain involving illegal manufacturers, distributors and GST operators working in tandem across different states.&quot;Police records show that one of the accused, Mayank Aggarwal, has prior involvement in cases registered by the Narcotics Control Bureau as well as a recent FIR in Uttar Pradesh under provisions related to drugs and cosmetics violations,&quot; the officer said, adding that further investigation into the matter is underway. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340143-fake-medicine.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Delhi, Police, Bust, Crore, Fake, Drug, Racket, Arrested, Crore, GST, Fraud, Network, Exposed</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340143-fake-medicine.webp"><p><b>New Delhi:</b> The Delhi Police has busted an organised interstate <a href="https://medicaldialogues.in/topics/racket" target="_blank">racket</a> involved in manufacturing and supplying spurious life-saving medicines, arresting six persons and seizing counterfeit drugs worth around Rs 2 crore, an official said on Sunday.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>During the operation, the police also exposed a network of fake <a href="https://medicaldialogues.in/topics/gst" target="_blank">GST</a> firms used to generate bogus invoices and launder proceeds of the illegal trade, with investigators estimating the fake billing to the tune of nearly Rs 50 crore.</p><p>According to the police, the racket was engaged in large-scale manufacturing, storage and distribution of counterfeit Schedule-H drugs, which are commonly prescribed for ailments such as diabetes, hypertension, and liver disorders, posing a serious risk to public health.</p><p>The accused have been identified as Nikhil Arora alias Sunny, a wholesale medicine dealer based in Shahdara, Shivam Tyagi and Mayank Aggarwal, both suppliers from Uttar Pradesh, Mohit Kumar Sharma, a key supplier from Uttarakhand, and Shahrukh and Rahul, who allegedly operated fake GST firms to facilitate the illegal trade.</p><p>"The case came to light following specific inputs, after which a raid was conducted on March 11 in Bihari Colony in Shahdara. During the operation, Arora, who ran a wholesale medical shop in Bhagirathi Palace, was apprehended," a senior police officer said.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/former-ifs-officer-arrested-in-spurious-medicines-racket-in-puducherry-161386">Also Read: Former IFS Officer Arrested in Spurious Medicines Racket in Puducherry</a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>He said that over 1.2 lakh counterfeit tablets and capsules were recovered during the raid, including fake versions of widely used medicines such as Rabemac-DSR, Telma-AM, Sporolac-DS, Signoflam, Chymoral Forte, Ursocol-300, Gluconorm, Jalra-50 and several others.</p><p>These medicines are frequently prescribed and consumed by patients suffering from chronic illnesses, the officer said.</p><p>"The circulation of counterfeit drugs of this nature can have severe and potentially fatal consequences," he added.</p><p>Further investigation revealed that the accused had developed a modus operandi to evade detection. The counterfeit medicines were supplied using fake invoices generated through fictitious GST firms that existed only on paper. All these shell entities were created to conceal the actual nature of business operations, evade tax scrutiny and lend a semblance of legitimacy to illegal transactions, the officer said.</p><p>"The financial trail was deliberately routed through these fake firms to mask both the origin and destination of the spurious medicines," the officer said.</p><p>Shahrukh and Rahul were found to be key players in this aspect of the operation. They allegedly operated the fake GST network using encrypted communication platforms, supplying ready-made firms and bogus billing services to clients across multiple states.</p><p>Analysis of their mobile phones revealed details of numerous shell companies and fake invoices amounting to approximately Rs 50 crore, along with links to several beneficiaries.</p><p>During the entire investigation, a team traced the supply chain to an illegal pharmaceutical manufacturing unit in Muzaffarnagar in Uttar Pradesh. The unit, spread across nearly 1,000 square yards, was allegedly being operated by one Mohammad Aqdas Siddiqui, who is currently absconding. A raid conducted at the facility led to the recovery of around 2,000 kg of raw materials used in drug manufacturing, including Metformin HCL, calcium carbonate, lactose, starch and magnesium stearate.</p><p>Police also seized advanced machinery such as tablet compression machines, coating units, capsule filling machines, blister packaging systems and even testing equipment, indicating the scale and sophistication of the operation.</p><p>"Additionally, 10,000 empty bottles falsely labelled as products of reputed pharmaceutical companies, along with packaging material and printing sets of branded medicines, were recovered from the site," the officer said.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/delhi-tramadol-premix-interception-leads-police-to-illegal-drug-unit-in-bihar-166240">Also Read: Delhi Tramadol Premix Interception Leads Police to Illegal Drug Unit in Bihar</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><p>The premises involved in the storage and sale of these drugs had no valid licence, and the medicines were not sourced from legitimate distributors. During interrogation, the accused disclosed a multi-layered supply chain involving illegal manufacturers, distributors and GST operators working in tandem across different states.</p><p>"Police records show that one of the accused, Mayank Aggarwal, has prior involvement in cases registered by the Narcotics Control Bureau as well as a recent FIR in Uttar Pradesh under provisions related to drugs and cosmetics violations," the officer said, adding that further investigation into the matter is underway.</p></div></div>]]> </content:encoded>
</item>

<item>
<title>Oral Weight&#45;Loss Pills Gain Ground as Patients Prefer Cheaper, Needle&#45;Free Options Over Injections</title>
<link>https://edusehat.com/en/oral-weight-loss-pills-gain-ground-as-patients-prefer-cheaper-needle-free-options-over-injections</link>
<guid>https://edusehat.com/en/oral-weight-loss-pills-gain-ground-as-patients-prefer-cheaper-needle-free-options-over-injections</guid>
<description><![CDATA[ Washington: Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk or Eli Lilly, according to seven doctors who specialize in obesity.Novo&#039;s Wegovy pill has been on ​the market since January, while Lilly&#039;s just-approved Foundayo joins the fray this week.Reuters interviews with the specialists show a promising landscape for oral weight-loss drugs as the companies compete for share in the fast-changing obesity treatment market seen topping $100 billion a year in the next decade.Danish drugmaker Novo Nordisk launched injectable Wegovy in 2021. The pill, like injectable Wegovy and Ozempic for diabetes, has the active ingredient semaglutide.In the three months since its approval, the oral version ‌has appealed to patients for ⁠its lower cost ⁠and ease, the doctors said.The pills don&#039;t need refrigeration, are more discreet and don&#039;t require the use of needles, said Dr. Christina Nguyen, an obesity and family medicine physician in Atlanta.&quot;One person said I&#039;d rather stay fat than ever use a ​needle. That&#039;s a true fear,&quot; she said. Lilly&#039;s Foundayo pill, with active ingredient orforglipron, will begin shipping on Monday.Also Read: USFDA Approves Eli Lilly&#039;s Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo NordiskPILLS VS INJECTIONSAll seven doctors said they had begun prescribing oral Wegovy, and three said they have prescribed ​the pill to about 10% of their patients.Of those patients, most are taking a GLP-1 for the first time, rather than switching from injectables, and have not yet reached the highest dose, the doctors said.&quot;It is expanding access to people who are not sure that an injectable is something they would feel comfortable doing on themselves, might be leery of needles, and they&#039;re excited to have an ​option that is easier and more familiar to take,&quot; said Dr. Stefie Deeds, an internal and obesity medicine specialist in Seattle.If patients ⁠are tolerating ‌an injectable GLP-1, doctors are reluctant to switch them to pills unless requested.&quot;The patients we see who are taking medicines, whether it&#039;s Wegovy or (Lilly&#039;s) Zepbound, we&#039;re ​not telling them to switch to ​oral Wegovy if they&#039;re doing well,&quot; said Dr. Louis Aronne, director of the Comprehensive Weight Control Center at Weill Cornell Medical College. Aronne has consulted ⁠for Lilly and was an investigator on the orforglipron clinical trial, and is an advisory board member of both ​Lilly and Novo.Zepbound, with the active ingredient tirzepatide, has been shown in trials to reduce weight by some 20% or more. That ​makes it the preferred option for treating patients with severe obesity, especially those with more complex cases, doctors said.&quot;For somebody who is in the lower end of the weight spectrum, people who are more likely to be seen by primary care physicians, they would be more likely to use the orals,&quot; Aronne said.In trials, Foundayo led to a 12% reduction in body weight and oral Wegovy led to about a 14% reduction.LILLY PILL EXPANDS OPTIONSSeveral of the doctors said they were eager for Lilly&#039;s pill, chemically known as orforglipron, to be approved so they would have a more flexible option to present to patients.Oral Wegovy must be taken on an empty stomach with just a sip of water 30 minutes before any other medications or food and drink. Lilly&#039;s Foundayo can be ‌taken any time of day without food or water restrictions.Nguyen said that if the Lilly pill is competitive on price with oral Wegovy, &quot;most likely everyone will go with the orforglipron.&quot;Novo spokesperson Liz Skrbova said that based on its survey results, most patients would not find the timing restrictions to be disruptive.Also Read:Crackdown on Weight-Loss Drug Misuse, Centre Issues Legal WarningSemaglutide has also been ​found in trials to have ​other health benefits like reducing cardiovascular risks.&quot;I can&#039;t guarantee ⁠that this totally different type of molecule is going to carry the same benefits,&quot; Dr. Michael Weintraub, an endocrinologist at NYU Langone Health, said of the new Lilly drug.A Lilly spokesperson said the company is still studying Foundayo and that many participants in its clinical trial saw some reduction in markers of cardiovascular risk.DRUGS STILL PRICEYPatients consider many factors when picking a GLP-1, but ​by far the most significant is cost, the doctors said.And there, pills have an advantage. The self-pay price for both oral Wegovy and Foundayo starts at $149 per month for the lowest dose, compared to $299 for Zepbound and $349 for Ozempic and injectable Wegovy.Because of restrictions introduced on insurance coverage for GLP-1 medications, doctors said they spend significant time discussing with patients how to afford the drugs. When covered, out-of-pocket costs could be as little as $25 or $50 per month.&quot;I feel more like a financial planner these days than a physician,&quot; said Dr. Catherine Varney, an obesity medicine physician and associate professor at the University of Virginia School of Medicine who is also part of the Lilly speakers bureau and advisory board.Varney and other doctors expressed concern that even with lower-cost pills, weight-loss drugs are still largely unaffordable.&quot;This still is a market for upper-middle-class and above,&quot; Varney said. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340148-pill-vs-shot.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Oral, Weight-Loss, Pills, Gain, Ground, Patients, Prefer, Cheaper, Needle-Free, Options, Over, Injections</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340148-pill-vs-shot.webp"><p><b>Washington:</b> Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk or Eli Lilly, according to seven doctors who specialize in obesity.</p><div class="pasted-from-word-wrapper"><p>Novo's Wegovy pill has been on ​the market since January, while Lilly's just-approved Foundayo joins the fray this week.</p><p>Reuters interviews with the specialists show a promising landscape for oral weight-loss drugs as the companies compete for share in the fast-changing obesity treatment market seen topping $100 billion a year in the next decade.</p><p>Danish drugmaker Novo Nordisk launched injectable Wegovy in 2021. The pill, like injectable Wegovy and Ozempic for diabetes, has the active ingredient semaglutide.</p><p>In the three months since its approval, the oral version ‌has appealed to patients for ⁠its lower cost ⁠and ease, the doctors said.The pills don't need refrigeration, are more discreet and don't require the use of needles, said Dr. Christina Nguyen, an obesity and family medicine physician in Atlanta.</p><p>"One person said I'd rather stay fat than ever use a ​needle. That's a true fear," she said. Lilly's Foundayo pill, with active ingredient orforglipron, will begin shipping on Monday.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/usfda-approves-eli-lillys-weight-loss-pill-foundayo-intensifies-rivalry-with-novo-nordisk-167873">Also Read: USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p><b>PILLS VS INJECTIONS</b></p><p>All seven doctors said they had begun prescribing oral Wegovy, and three said they have prescribed ​the pill to about 10% of their patients.</p><p>Of those patients, most are taking a GLP-1 for the first time, rather than switching from injectables, and have not yet reached the highest dose, the doctors said.</p><p>"It is expanding access to people who are not sure that an injectable is something they would feel comfortable doing on themselves, might be leery of needles, and they're excited to have an ​option that is easier and more familiar to take," said Dr. Stefie Deeds, an internal and obesity medicine specialist in Seattle.</p><p>If patients ⁠are tolerating ‌an injectable GLP-1, doctors are reluctant to switch them to pills unless requested.</p><p>"The patients we see who are taking medicines, whether it's Wegovy or (Lilly's) Zepbound, we're ​not telling them to switch to ​oral Wegovy if they're doing well," said Dr. Louis Aronne, director of the Comprehensive Weight Control Center at Weill Cornell Medical College. Aronne has consulted ⁠for Lilly and was an investigator on the orforglipron clinical trial, and is an advisory board member of both ​Lilly and Novo.</p><p>Zepbound, with the active ingredient tirzepatide, has been shown in trials to reduce weight by some 20% or more. That ​makes it the preferred option for treating patients with severe obesity, especially those with more complex cases, doctors said.</p><p>"For somebody who is in the lower end of the weight spectrum, people who are more likely to be seen by primary care physicians, they would be more likely to use the orals," Aronne said.</p><p>In trials, Foundayo led to a 12% reduction in body weight and oral Wegovy led to about a 14% reduction.</p><p><b>LILLY PILL EXPANDS OPTIONS</b></p><p>Several of the doctors said they were eager for Lilly's pill, chemically known as orforglipron, to be approved so they would have a more flexible option to present to patients.</p><p>Oral Wegovy must be taken on an empty stomach with just a sip of water 30 minutes before any other medications or food and drink. Lilly's Foundayo can be ‌taken any time of day without food or water restrictions.</p><p>Nguyen said that if the Lilly pill is competitive on price with oral Wegovy, "most likely everyone will go with the orforglipron."</p><p>Novo spokesperson Liz Skrbova said that based on its survey results, most patients would not find the timing restrictions to be disruptive.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/crackdown-on-weight-loss-drug-misuse-centre-issues-legal-warning-167824">Also Read:Crackdown on Weight-Loss Drug Misuse, Centre Issues Legal Warning</a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>Semaglutide has also been ​found in trials to have ​other health benefits like reducing cardiovascular risks.</p><p>"I can't guarantee ⁠that this totally different type of molecule is going to carry the same benefits," Dr. Michael Weintraub, an endocrinologist at NYU Langone Health, said of the new Lilly drug.</p><p>A Lilly spokesperson said the company is still studying Foundayo and that many participants in its clinical trial saw some reduction in markers of cardiovascular risk.</p><p><b>DRUGS STILL PRICEY</b></p><p>Patients consider many factors when picking a GLP-1, but ​by far the most significant is cost, the doctors said.</p><p>And there, pills have an advantage. The self-pay price for both oral Wegovy and Foundayo starts at $149 per month for the lowest dose, compared to $299 for Zepbound and $349 for Ozempic and injectable Wegovy.</p><p>Because of restrictions introduced on insurance coverage for GLP-1 medications, doctors said they spend significant time discussing with patients how to afford the drugs. When covered, out-of-pocket costs could be as little as $25 or $50 per month.</p><p>"I feel more like a financial planner these days than a physician," said Dr. Catherine Varney, an obesity medicine physician and associate professor at the University of Virginia School of Medicine who is also part of the Lilly speakers bureau and advisory board.</p><p>Varney and other doctors expressed concern that even with lower-cost pills, weight-loss drugs are still largely unaffordable.</p><p>"This still is a market for upper-middle-class and above," Varney said.</p></div>]]> </content:encoded>
</item>

<item>
<title>Granules India&amp;apos;s US Arm Gets 4 USFDA Observations</title>
<link>https://edusehat.com/en/granules-indias-us-arm-gets-4-usfda-observations</link>
<guid>https://edusehat.com/en/granules-indias-us-arm-gets-4-usfda-observations</guid>
<description><![CDATA[ New Delhi: Granules India Limited has announced that its US-based subsidiary, Granules Pharmaceuticals, Inc. (GPI), has successfully completed a routine US Food and Drug Administration (USFDA) cGMP audit at its Chantilly, Virginia facility, with four Form 483 observations and no data integrity issue reported.The inspection was conducted between March 30 and April 3, 2026, marking the second USFDA inspection at the Chantilly site within a year. The company clarified that the observations raised are procedural in nature and do not involve any data integrity concerns.Granules India stated that it remains committed to maintaining high standards of quality, safety, and regulatory compliance, and will address the observations within the stipulated timelines.Also Read: Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action RequiredThe development reflects the company’s continued focus on strengthening compliance and operational excellence across its global manufacturing network.Granules India Limited, headquartered in Hyderabad, is a vertically integrated pharmaceutical company involved in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), finished dosages, and peptides CDMO services. The company serves over 300 customers across regulated and semi-regulated markets, with a presence in more than 80 countries.The company operates 10 manufacturing facilities globally, including seven in India, two in the United States, and one in Switzerland. Its facilities are approved by multiple global regulatory authorities, including the USFDA, EDQM, EU GMP, WHO GMP, TGA, COFEPRIS, KFDA, DEA, MCC, and HALAL.Granules India emphasized that the audit outcome underscores its commitment to regulatory adherence and continuous improvement in manufacturing standards.Also Read: Granules India arm gets 5 USFDA observations for Hyderabad facility ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/10/197293-granules-india-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Granules, Indias, Arm, Gets, USFDA, Observations</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/10/197293-granules-india-1.webp"><p><b>New Delhi: </b>Granules India Limited has announced that its US-based subsidiary, Granules Pharmaceuticals, Inc. (GPI), has successfully completed a routine US Food and Drug Administration (USFDA) cGMP audit at its Chantilly, Virginia facility, with four Form 483 observations and no data integrity issue reported.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The inspection was conducted between March 30 and April 3, 2026, marking the second USFDA inspection at the Chantilly site within a year. The company clarified that the observations raised are procedural in nature and do not involve any data integrity concerns.</p><p>Granules India stated that it remains committed to maintaining high standards of quality, safety, and regulatory compliance, and will address the observations within the stipulated timelines.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/granules-india-arm-gets-usfda-vai-status-for-shamirpet-facility-no-action-required-167757">Also Read: Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action Required</a></div></div><p>The development reflects the company’s continued focus on strengthening compliance and operational excellence across its global manufacturing network.</p><p>Granules India Limited, headquartered in Hyderabad, is a vertically integrated pharmaceutical company involved in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), finished dosages, and peptides CDMO services. The company serves over 300 customers across regulated and semi-regulated markets, with a presence in more than 80 countries.</p><p>The company operates 10 manufacturing facilities globally, including seven in India, two in the United States, and one in Switzerland. Its facilities are approved by multiple global regulatory authorities, including the USFDA, EDQM, EU GMP, WHO GMP, TGA, COFEPRIS, KFDA, DEA, MCC, and HALAL.</p><p>Granules India emphasized that the audit outcome underscores its commitment to regulatory adherence and continuous improvement in manufacturing standards.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/granules-india-arm-gets-5-usfda-observations-for-hyderabad-facility-161021">Also Read: Granules India arm gets 5 USFDA observations for Hyderabad facility</a></div></div></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Zydus Wellness Arm Faces EUR 19,472 VAT Penalty in Spain, Plans to Appeal</title>
<link>https://edusehat.com/en/zydus-wellness-arm-faces-eur-19472-vat-penalty-in-spain-plans-to-appeal</link>
<guid>https://edusehat.com/en/zydus-wellness-arm-faces-eur-19472-vat-penalty-in-spain-plans-to-appeal</guid>
<description><![CDATA[ New Delhi: Zydus Wellness Limited has informed that its step-down wholly owned subsidiary, Comfort Click Limited (CCL), UK, has received a penalty order of EUR 19,472.57 from the Spanish Tax Authority for alleged unpaid value added tax (VAT) for the first quarter of 2021, and the company plans to challenge the order.The order, received on April 3, 2026, at 3:15 p.m., relates to an alleged discrepancy arising from incorrect mapping of VAT payments to an old VAT account instead of the new VAT system. The penalty has been imposed under applicable tax regulations by the Spanish authority.Zydus Wellness clarified that CCL believes it has strong merits in the case and intends to file an appeal against the order. The company expressed confidence in securing a favourable outcome through the appellate process.Also Read: Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC IrregularitiesThe disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with relevant SEBI circulars, which mandate reporting of material regulatory developments.According to the details provided in Annexure-1, the alleged violation pertains specifically to unpaid VAT for Q1 2021. The company emphasized that there is no impact on its financial, operational, or other activities due to this order at present.It further stated that any financial implication will be limited to the final tax liability along with any applicable penalty, subject to the outcome of the appeal process.Also Read: Zydus Completes Pivotal Study for Keytruda Biosimilar, Prepares USFDA BLA Filing ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/15/238275-zydus-wellness-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Zydus, Wellness, Arm, Faces, EUR, 19, 472, VAT, Penalty, Spain, Plans, Appeal</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/15/238275-zydus-wellness-50.webp"><p><b>New Delhi: </b>Zydus Wellness Limited has informed that its step-down wholly owned subsidiary, Comfort Click Limited (CCL), UK, has received a penalty order of EUR 19,472.57 from the Spanish Tax Authority for alleged unpaid value added tax (VAT) for the first quarter of 2021, and the company plans to challenge the order.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The order, received on April 3, 2026, at 3:15 p.m., relates to an alleged discrepancy arising from incorrect mapping of VAT payments to an old VAT account instead of the new VAT system. The penalty has been imposed under applicable tax regulations by the Spanish authority.</p><p>Zydus Wellness clarified that CCL believes it has strong merits in the case and intends to file an appeal against the order. The company expressed confidence in securing a favourable outcome through the appellate process.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-wellness-arm-faces-rs-63-million-gst-penalty-over-itc-irregularities-167756">Also Read: Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC Irregularities</a></div></div><p>The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with relevant SEBI circulars, which mandate reporting of material regulatory developments.</p><p>According to the details provided in Annexure-1, the alleged violation pertains specifically to unpaid VAT for Q1 2021. The company emphasized that there is no impact on its financial, operational, or other activities due to this order at present.</p><p>It further stated that any financial implication will be limited to the final tax liability along with any applicable penalty, subject to the outcome of the appeal process.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/zydus-completes-pivotal-study-for-keytruda-biosimilar-prepares-usfda-bla-filing-165634">Also Read: Zydus Completes Pivotal Study for Keytruda Biosimilar, Prepares USFDA BLA Filing</a></div></div></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Rajasthan Flags Spurious Antibiotic Qcepod 200 After Tests Find No Active Ingredient</title>
<link>https://edusehat.com/en/rajasthan-flags-spurious-antibiotic-qcepod-200-after-tests-find-no-active-ingredient</link>
<guid>https://edusehat.com/en/rajasthan-flags-spurious-antibiotic-qcepod-200-after-tests-find-no-active-ingredient</guid>
<description><![CDATA[ New Delhi: Rajasthan drug control authorities have issued a statewide alert after laboratory tests found that a widely sold antibiotic, Qcepod 200, contained no active ingredient, rendering it ineffective for treating serious infections such as meningitis, pneumonia, respiratory tract, skin, and urinary tract infections.The drug sample, belonging to batch number VT 242312, was declared spurious after failing quality tests. Officials stated that the absence of the key antibiotic component, cephalosporin, means the medicine cannot provide any therapeutic benefit and poses a significant public health risk.Authorities revealed that around 3,100 strips of the affected batch were supplied to Rajasthan by Himachal Pradesh-based VADSP Pharmaceutical. Of these, 2,186 strips have been seized along with additional sample and control strips, while efforts are ongoing to trace and recover the remaining stock from the market.Also Read: Rajasthan offers Rs 25 lakh cashless treatment at 31,000 hospitals across IndiaThe state health department has directed all drug control officers to immediately withdraw the medicine from circulation to prevent further sale. Officials have also initiated coordination with authorities in Himachal Pradesh to take regulatory and legal action against the manufacturer.A special team from Rajasthan is set to visit the manufacturing unit in Baddi to investigate the origin and production of the spurious batch. The probe aims to identify lapses and ensure strict enforcement of drug safety regulations.According to a recent media report in The Times of India, the issue came to light after drug inspectors collected samples from the Indian Medical Agency in Bharatpur more than a month ago. Further investigation traced the supply chain to Jaipur-based Iqumed Healthcare, where spurious drugs worth over ₹4 lakh were found stocked for sale and subsequently seized following court orders.Authorities have stressed that stringent action will be taken against those responsible, underlining the serious risks posed by the circulation of ineffective or counterfeit medicines.Also Read: Rajasthan man arrested for cheating students of lakhs in medical admission scam ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/28/305875-fake.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Rajasthan, Flags, Spurious, Antibiotic, Qcepod, 200, After, Tests, Find, Active, Ingredient</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/28/305875-fake.webp"><p><b>New Delhi: </b>Rajasthan drug control authorities have issued a statewide alert after laboratory tests found that a widely sold antibiotic, Qcepod 200, contained no active ingredient, rendering it ineffective for treating serious infections such as meningitis, pneumonia, respiratory tract, skin, and urinary tract infections.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>The drug sample, belonging to batch number VT 242312, was declared spurious after failing quality tests. Officials stated that the absence of the key antibiotic component, cephalosporin, means the medicine cannot provide any therapeutic benefit and poses a significant public health risk.</p><p>Authorities revealed that around 3,100 strips of the affected batch were supplied to Rajasthan by Himachal Pradesh-based VADSP Pharmaceutical. Of these, 2,186 strips have been seized along with additional sample and control strips, while efforts are ongoing to trace and recover the remaining stock from the market.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/rajasthan-offers-rs-25-lakh-cashless-treatment-at-31000-hospitals-across-india-167355">Also Read: Rajasthan offers Rs 25 lakh cashless treatment at 31,000 hospitals across India</a></div></div><p>The state health department has directed all drug control officers to immediately withdraw the medicine from circulation to prevent further sale. Officials have also initiated coordination with authorities in Himachal Pradesh to take regulatory and legal action against the manufacturer.</p><p>A special team from Rajasthan is set to visit the manufacturing unit in Baddi to investigate the origin and production of the spurious batch. The probe aims to identify lapses and ensure strict enforcement of drug safety regulations.</p><p>According to a recent media report in <a href="https://timesofindia.indiatimes.com/city/jaipur/no-active-ingredient-rajdrug-controllers-soundalert-over-fake-antibiotic/articleshow/130026484.cms" rel="nofollow">The Times of India</a>, the issue came to light after drug inspectors collected samples from the Indian Medical Agency in Bharatpur more than a month ago. Further investigation traced the supply chain to Jaipur-based Iqumed Healthcare, where spurious drugs worth over ₹4 lakh were found stocked for sale and subsequently seized following court orders.</p><p>Authorities have stressed that stringent action will be taken against those responsible, underlining the serious risks posed by the circulation of ineffective or counterfeit medicines.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/rajasthan/rajasthan-man-arrested-for-cheating-students-of-lakhs-in-medical-admission-scam-165626">Also Read: Rajasthan man arrested for cheating students of lakhs in medical admission scam</a></div></div></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Pregnant Women with Controlled GDM Show No Added Obesity Risk in Offspring: Study</title>
<link>https://edusehat.com/en/pregnant-women-with-controlled-gdm-show-no-added-obesity-risk-in-offspring-study</link>
<guid>https://edusehat.com/en/pregnant-women-with-controlled-gdm-show-no-added-obesity-risk-in-offspring-study</guid>
<description><![CDATA[ USA: Researchers have found in a new study that among women with gestational diabetes who maintain stable and optimal blood glucose levels during pregnancy, the risk of having children with obesity is comparable to that of women without gestational diabetes. In contrast, when glycemic control is suboptimal, the likelihood of obesity in offspring increases significantly.These findings highlight that effective glucose management during pregnancy plays a crucial role in mitigating the long-term metabolic risk in children.The study, published in Diabetes Care by Rana F. Chehab and colleagues from Kaiser Permanente Northern California, examined how different patterns of blood glucose control during pregnancy influence childhood growth and obesity risk. Gestational diabetes mellitus (GDM) has long been associated with adverse metabolic outcomes in offspring. Still, this large population-based analysis provides deeper insight into how the quality and consistency of glycemic control may alter that risk.For this purpose, the researchers analyzed data from over 206,000 pregnant individuals who delivered between 2011 and 2017, along with follow-up data on their children up to 10 years of age. Among these, 14,870 individuals were diagnosed with GDM. The investigators categorized maternal glucose control into four distinct trajectories based on how consistently blood sugar targets, defined by the American Diabetes Association, were achieved from diagnosis until delivery.These trajectories included consistently optimal control, rapid improvement to optimal levels, gradual improvement to near-optimal levels, and persistently suboptimal control.   The researchers reported the following findings;There was a clear gradient in outcomes based on maternal glycemic control during pregnancy.Children of mothers with consistently optimal glucose control had BMI and obesity risk comparable to those born to mothers without gestational diabetes.As glycemic control worsened across trajectory groups, the risk of higher BMI and obesity in offspring increased progressively.Offspring of mothers with improving but non-optimal or persistently suboptimal glucose levels had significantly higher BMI and greater obesity risk by age 10.A dose-response relationship was observed, indicating that partial improvement in glycemic control may not be sufficient to eliminate risk.The associations persisted even after adjusting for maternal prepregnancy BMI, although the strength of the relationship was reduced.These findings suggest that glycemic control during pregnancy independently influences long-term metabolic outcomes in children.The findings highlight the importance of early identification and sustained management of gestational diabetes. Achieving and maintaining optimal glucose levels throughout pregnancy may offer a critical window for preventing childhood obesity and its associated health risks.The authors emphasized that these results open avenues for better prenatal risk stratification and targeted interventions. By identifying women with suboptimal glycemic trajectories early, healthcare providers may implement more intensive management strategies to improve maternal and child health outcomes.Reference:Rana F. Chehab, Mara B. Greenberg, Catherine Lee, Amanda L. Ngo, Juanran Feng, Yeyi Zhu, Assiamira Ferrara; Gestational Diabetes, Glycemic Management Trajectories, and Offspring Growth Patterns and Obesity Risk. Diabetes Care 2026; dc251643. https://doi.org/10.2337/dc25-1643 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/21/241706-gestational-diabetes-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pregnant, Women, with, Controlled, GDM, Show, Added, Obesity, Risk, Offspring:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/21/241706-gestational-diabetes-50.webp"><p><span>USA: Researchers have found in a new study that among women with<a href="https://medicaldialogues.in/topics/gestational-diabetes"> gestational diabetes </a>who maintain stable and optimal blood glucose levels during <a href="https://medicaldialogues.in/topics/pregnancy">pregnancy</a>, the risk of having children with <a href="https://medicaldialogues.in/topics/obesity">obesity </a>is comparable to that of women without gestational diabetes. In contrast, when glycemic control is suboptimal, the likelihood of obesity in offspring increases significantly.</span></p><div class="pasted-from-word-wrapper"><div>These findings highlight that effective <a href="https://medicaldialogues.in/topics/blood-sugar">glucose management </a>during pregnancy plays a crucial role in mitigating the long-term metabolic risk in children.</div><div>The study, published in <i>Diabetes Care </i>by Rana F. Chehab and colleagues from Kaiser Permanente Northern California, examined how different patterns of blood glucose control during pregnancy influence childhood growth and obesity risk. Gestational diabetes mellitus (GDM) has long been associated with adverse metabolic outcomes in offspring. Still, this large population-based analysis provides deeper insight into how the quality and consistency of glycemic control may alter that risk.</div><div>For this purpose, the researchers analyzed data from over 206,000 pregnant individuals who delivered between 2011 and 2017, along with follow-up data on their children up to 10 years of age. Among these, 14,870 individuals were diagnosed with GDM. The investigators categorized maternal glucose control into four distinct trajectories based on how consistently blood sugar targets, defined by the American Diabetes Association, were achieved from diagnosis until delivery.</div><div>These trajectories included consistently optimal control, rapid improvement to optimal levels, gradual improvement to near-optimal levels, and persistently suboptimal control.   </div><div>The researchers reported the following findings;</div><ul><li>There was a clear gradient in outcomes based on maternal glycemic control during pregnancy.</li><li>Children of mothers with consistently optimal glucose control had BMI and obesity risk comparable to those born to mothers without gestational diabetes.</li><li>As glycemic control worsened across trajectory groups, the risk of higher BMI and obesity in offspring increased progressively.</li><li>Offspring of mothers with improving but non-optimal or persistently suboptimal glucose levels had significantly higher BMI and greater obesity risk by age 10.</li><li>A dose-response relationship was observed, indicating that partial improvement in glycemic control may not be sufficient to eliminate risk.</li><li>The associations persisted even after adjusting for maternal prepregnancy BMI, although the strength of the relationship was reduced.</li><li>These findings suggest that glycemic control during pregnancy independently influences long-term metabolic outcomes in children.</li></ul><div>The findings highlight the importance of early identification and sustained management of gestational diabetes. Achieving and maintaining optimal glucose levels throughout pregnancy may offer a critical window for preventing childhood obesity and its associated health risks.</div><div>The authors emphasized that these results open avenues for better prenatal risk stratification and targeted interventions. By identifying women with suboptimal glycemic trajectories early, healthcare providers may implement more intensive management strategies to improve maternal and child health outcomes.</div><div>Reference:</div><div>Rana F. Chehab, Mara B. Greenberg, Catherine Lee, Amanda L. Ngo, Juanran Feng, Yeyi Zhu, Assiamira Ferrara; Gestational Diabetes, Glycemic Management Trajectories, and Offspring Growth Patterns and Obesity Risk. Diabetes Care 2026; dc251643. https://doi.org/10.2337/dc25-1643</div></div>]]> </content:encoded>
</item>

<item>
<title>IVUS and Angiography in Left Main PCI: OPTIMAL Trial Show Comparable Outcomes</title>
<link>https://edusehat.com/en/ivus-and-angiography-in-left-main-pci-optimal-trial-show-comparable-outcomes</link>
<guid>https://edusehat.com/en/ivus-and-angiography-in-left-main-pci-optimal-trial-show-comparable-outcomes</guid>
<description><![CDATA[ A major clinical trial recently demonstrated that intravascular ultrasonography (IVUS) guidance during percutaneous coronary intervention (PCI) yielded similar results regarding long-term clinical outcomes for patients with unprotected left main coronary artery disease. Over a median follow-up of 2.9 years, primary composite endpoints, including stroke and mortality, were statistically similar across both treatment groups.These findings are published in March 2026 in the New England Journal of Medicine.The Clinical Burden of Unprotected Left Main Coronary Disease Percutaneous coronary intervention is increasingly being utilized for the revascularization of unprotected left main coronary artery disease. Because this condition involves the primary artery supplying blood to the heart, procedural precision is vital for long-term survival. While intravascular ultrasonography allows for detailed imaging from within the coronary vessels, clinicians have debated whether this advanced guidance actually improves patient outcomes compared to conventional angiographic guidance alone. This international study sought to resolve this uncertainty within a large clinical setting.Study OverviewIn the international, multicenter, open-label trial, known as the OPTIMAL study, 806 patients were randomized in a 1:1 ratio. The study population, which had a mean age of 71.4 years (plus or minus a standard deviation of 10.7), included a significant proportion of patients with diabetes (34.7%) and was predominantly male (78.4%). Half of the participants received IVUS-guided PCI, while the remaining half underwent standard angiography-guided procedures. The primary endpoint measured was a patient-oriented composite of any stroke, any myocardial infarction (heart attack), any revascularization, or death from any cause. The trial was funded by Philips Image Guided Therapy Devices and Boston Scientific.The Key findings from the study include: • At a median follow-up of 2.9 years, primary endpoint events occurred in 33.7% of the IVUS-guided group and 30.9% in the angiography-guided group. • Statistical analysis showed a hazard ratio of 1.11 and a p-value of 0.40, confirming that the difference between the two groups was not significant. • The incidence rates of death, myocardial infarction, or the necessity for further revascularization appeared similar across both patient groups. • Safety profiles remained consistent, with no significant differences noted in procedure-related or overall safety events between the two modalities.Clinical Relevance and Targeted Guidance For practicing cardiologists, the study clarifies that IVUS-guided PCI does not necessarily yield superior clinical results compared to traditional angiography in the management of unprotected left main coronary artery disease. Despite the technological appeal of intravascular imaging, the trial suggests that standard angiographic techniques achieve comparable safety and efficacy profiles over a nearly three-year period. These findings underscore that clinicians should focus on overall procedural excellence, as the choice between these two guidance methods did not significantly impact the long-term risk of stroke, heart attack, or mortality.Reference:Testa L, De la Torre Hernandez JM, De Maria GL, et al. IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. New England Journal of Medicine. 2026 Mar 30. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/15/238220-cvd-diagnosis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>IVUS, and, Angiography, Left, Main, PCI:, OPTIMAL, Trial, Show, Comparable, Outcomes</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/15/238220-cvd-diagnosis.webp"><p>A major clinical trial recently demonstrated that <a href="https://medicaldialogues.in/health-dialogues/heart-health/how-intravascular-imaging-with-ivus-is-transforming-coronary-artery-disease-management-dr-ajith-pillai-118146">intravascular ultrasonography</a> (IVUS) guidance during <a href="https://medicaldialogues.in/cardiology-ctvs/news/pci-with-no-sos-as-good-as-pci-at-centres-with-on-site-surgery-scais-consensus-statement-106399">percutaneous coronary intervention</a> (PCI) yielded similar results regarding long-term clinical outcomes for patients with unprotected left main coronary artery disease. Over a median follow-up of 2.9 years, primary composite endpoints, including <a href="https://speciality.medicaldialogues.in/stroke-facts-in-nutshell-by-american-stroke-association">stroke</a> and mortality, were statistically similar across both treatment groups.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings are published in March 2026 in the <i>New England Journal of Medicine</i>.</p><p dir="ltr"><b>The Clinical Burden of Unprotected Left Main Coronary Disease </b></p><p dir="ltr">Percutaneous coronary intervention is increasingly being utilized for the revascularization of unprotected left main coronary artery disease. Because this condition involves the primary artery supplying blood to the heart, procedural precision is vital for long-term survival. While intravascular ultrasonography allows for detailed imaging from within the coronary vessels, clinicians have debated whether this advanced guidance actually improves patient outcomes compared to conventional angiographic guidance alone. This international study sought to resolve this uncertainty within a large clinical setting.</p><p dir="ltr"><b>Study Overview</b></p><p dir="ltr">In the international, multicenter, open-label trial, known as the OPTIMAL study, 806 patients were randomized in a 1:1 ratio. The study population, which had a mean age of 71.4 years (plus or minus a standard deviation of 10.7), included a significant proportion of patients with diabetes (34.7%) and was predominantly male (78.4%). Half of the participants received IVUS-guided PCI, while the remaining half underwent standard angiography-guided procedures. The primary endpoint measured was a patient-oriented composite of any stroke, any myocardial infarction (heart attack), any revascularization, or death from any cause. The trial was funded by Philips Image Guided Therapy Devices and Boston Scientific.</p><p dir="ltr"><b>The Key findings from the study include: </b></p><p dir="ltr">• At a median follow-up of 2.9 years, primary endpoint events occurred in 33.7% of the IVUS-guided group and 30.9% in the angiography-guided group. </p><p dir="ltr">• Statistical analysis showed a hazard ratio of 1.11 and a p-value of 0.40, confirming that the difference between the two groups was not significant. </p><p dir="ltr">• The incidence rates of death, myocardial infarction, or the necessity for further revascularization appeared similar across both patient groups. </p><p dir="ltr">• Safety profiles remained consistent, with no significant differences noted in procedure-related or overall safety events between the two modalities.</p><p dir="ltr"><b>Clinical Relevance and Targeted Guidance </b></p><p dir="ltr"><i>For practicing cardiologists, the study clarifies that IVUS-guided PCI does not necessarily yield superior clinical results compared to traditional angiography in the management of unprotected left main coronary artery disease. Despite the technological appeal of intravascular imaging, the trial suggests that standard angiographic techniques achieve comparable safety and efficacy profiles over a nearly three-year period. These findings underscore that clinicians should focus on overall procedural excellence, as the choice between these two guidance methods did not significantly impact the long-term risk of stroke, heart attack, or mortality.</i></p><p dir="ltr"><b>Reference:</b></p><p dir="ltr">Testa L, De la Torre Hernandez JM, De Maria GL, et al. IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease. New England Journal of Medicine. 2026 Mar 30.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Spironolactone may not reduce CV mortality and hospitalizations in patients with HFpEF or HFmrEF: SPIRIT&#45;HF Trial</title>
<link>https://edusehat.com/en/spironolactone-may-not-reduce-cv-mortality-and-hospitalizations-in-patients-with-hfpef-or-hfmref-spirit-hf-trial</link>
<guid>https://edusehat.com/en/spironolactone-may-not-reduce-cv-mortality-and-hospitalizations-in-patients-with-hfpef-or-hfmref-spirit-hf-trial</guid>
<description><![CDATA[ Spironolactone showed no significant benefit in reducing the composite of cardiovascular mortality and heart failure hospitalizations, recording 12.7 events per 100 patient-years versus 10.8 for the control group, which may suggest a re-evaluation of its role in heart failure with preserved or mildly reduced ejection fraction.These findings from the SPIRIT-HF trial were presented at the American College of Cardiology’s Annual Scientific Session (ACC.26) in March 2026Heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) present complex management challenges involving impaired cardiac relaxation and pumping; although spironolactone—a diuretic that blocks aldosterone and modifies heart tissue—is effective in cases of heart failure with reduced ejection fraction (HFrEF), prior findings from the TOPCAT trial remained inconclusive due to regional variations, leading Frank Edelmann, MD, chair of cardiovascular prevention at the Heart Center of Charité University Medicine, Berlin, to investigate whether this therapy could truly address the clinical gap in outcomes for these patients.The SPIRIT-HF trial utilized a randomized, placebo-controlled design involving 730 symptomatic patients with a median age of 78 years across 56 European centers to evaluate the impact of spironolactone over a 24-month period. This study aimed to determine the efficacy of the drug against a placebo by measuring a primary composite endpoint of cardiovascular-related death and heart failure hospitalizations, while secondary assessments included monitoring for renal dysfunction, hypotension, and hyperkalemia to identify potential safety risks in this elderly population.Key Clinical Findings of the Study Include:Primary Outcome: The SPIRIT-HF trial found no statistical difference in the primary composite endpoint, recording 12.7 events per 100 patient-years for spironolactone versus 10.8 for the placebo. Safety Profile: Clinicians noted a significant increase in adverse renal events, low blood pressure, and elevated potassium levels among participants receiving the active treatment. Hospitalization Trends: Unexpectedly, the study recorded a higher rate of total hospitalizations and a trend toward more cardiovascular-related hospital stays in the spironolactone arm.Subgroup Analysis: Results remained consistently negative across all demographics, showing no benefit regardless of the patient’s age, gender, or specific ejection fraction. Pandemic Influence: The investigation faced significant hurdles as over half of the treatment group stopped their medication due to the logistical constraints of the COVID-19 pandemic.The results suggest that spironolactone does not provide a significant reduction in the composite of cardiovascular death and heart failure hospitalizations, as the treatment group ultimately surpassed the event rates of the placebo group with 12.7 versus 10.8 events per 100 patient-years by the end of the 24-month follow-up period.Thus, the study concludes physicians should exercise caution and prioritize the monitoring of renal function and electrolyte levels when managing patients with these specific heart failure phenotypes.Although the high rate of drug discontinuation during the pandemic potentially limited the trial’s ability to show definitive differences, further evidence from ongoing registry studies is required to fully understand the long-term safety and efficacy of this treatment.ReferenceAmerican College of Cardiology. Study Finds No Significant Benefit of Spironolactone in HFpEF or HFmrEF. Presented at: American College of Cardiology’s Annual Scientific Session (ACC.26); March 29, 2026; New Orleans, LA. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/10/277852-heart-failure.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Spironolactone, may, not, reduce, mortality, and, hospitalizations, patients, with, HFpEF, HFmrEF:, SPIRIT-HF, Trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/10/277852-heart-failure.webp"><p><a href="https://medicaldialogues.in/generics/spironolactone-2721837">Spironolactone</a> showed no significant benefit in reducing the composite of cardiovascular mortality and<a href="https://medicaldialogues.in/articles/dealing-with-heart-failure-understand-various-types-of-cardiac-devices-dr-r-anantharaman-121632"> heart failure</a> hospitalizations, recording 12.7 events per 100 patient-years versus 10.8 for the control group, which may suggest a re-evaluation of its role in heart failure with preserved or <a href="https://medicaldialogues.in/cardiology-ctvs/news/finerenone-benefits-in-hf-with-mildly-reduced-or-preserved-ejection-fraction-regardless-of-baseline-risk-jama-144476">mildly reduced ejection fraction.</a></p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings from the SPIRIT-HF trial were presented at the <i>American College of Cardiology’s Annual Scientific Session (ACC.26)</i> in March 2026</p><p dir="ltr">Heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) present complex management challenges involving impaired cardiac relaxation and pumping; although spironolactone—a diuretic that blocks aldosterone and modifies heart tissue—is effective in cases of heart failure with reduced ejection fraction (HFrEF), prior findings from the TOPCAT trial remained inconclusive due to regional variations, leading Frank Edelmann, MD, chair of cardiovascular prevention at the <i>Heart Center of Charité University Medicine, Berlin,</i> to investigate whether this therapy could truly address the clinical gap in outcomes for these patients.</p><p dir="ltr">The SPIRIT-HF trial utilized a randomized, placebo-controlled design involving 730 symptomatic patients with a median age of 78 years across 56 European centers to evaluate the impact of spironolactone over a 24-month period. This study aimed to determine the efficacy of the drug against a placebo by measuring a primary composite endpoint of cardiovascular-related death and heart failure hospitalizations, while secondary assessments included monitoring for renal dysfunction, hypotension, and hyperkalemia to identify potential safety risks in this elderly population.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Primary Outcome: </b>The SPIRIT-HF trial found no statistical difference in the primary composite endpoint, recording 12.7 events per 100 patient-years for spironolactone versus 10.8 for the placebo. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Safety Profile:</b> Clinicians noted a significant increase in adverse renal events, low blood pressure, and elevated potassium levels among participants receiving the active treatment. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Hospitalization Trends: </b>Unexpectedly, the study recorded a higher rate of total hospitalizations and a trend toward more cardiovascular-related hospital stays in the spironolactone arm.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Subgroup Analysis: </b>Results remained consistently negative across all demographics, showing no benefit regardless of the patient’s age, gender, or specific ejection fraction. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Pandemic Influence:</b> The investigation faced significant hurdles as over half of the treatment group stopped their medication due to the logistical constraints of the COVID-19 pandemic.</p></li></ul><p dir="ltr">The results suggest that spironolactone does not provide a significant reduction in the composite of cardiovascular death and heart failure hospitalizations, as the treatment group ultimately surpassed the event rates of the placebo group with 12.7 versus 10.8 events per 100 patient-years by the end of the 24-month follow-up period.</p><p dir="ltr">Thus, the study concludes physicians should exercise caution and prioritize the monitoring of renal function and electrolyte levels when managing patients with these specific heart failure phenotypes.</p><p dir="ltr">Although the high rate of drug discontinuation during the pandemic potentially limited the trial’s ability to show definitive differences, further evidence from ongoing registry studies is required to fully understand the long-term safety and efficacy of this treatment.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">American College of Cardiology. Study Finds No Significant Benefit of Spironolactone in HFpEF or HFmrEF. Presented at: American College of Cardiology’s Annual Scientific Session (ACC.26); March 29, 2026; New Orleans, LA.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Haryana to recruit 195 specialist doctors in Govt Hospitals</title>
<link>https://edusehat.com/en/haryana-to-recruit-195-specialist-doctors-in-govt-hospitals</link>
<guid>https://edusehat.com/en/haryana-to-recruit-195-specialist-doctors-in-govt-hospitals</guid>
<description><![CDATA[ Chandigarh: Haryana Health Minister Arti Singh Rao on Monday said that 195 specialist doctors will be recruited on a contractual basis in government hospitals to address the shortage of specialists across the state. She stated the recruitment process will be transparent and merit-based.“For districts other than Nuh, specialist doctors with MBBS and diploma qualifications will be paid Rs 1 lakh per month, while those with MBBS and MD (doctor of medicine)/MS (master of surgery)/DNB (a postgraduate master’s medical qualification) qualifications will receive Rs 1.5 lakh per month, news agency PTI reported.“For the Nuh district, higher remuneration has been approved to attract specialists. Doctors with MBBS and diploma qualifications will be paid Rs 1.5 lakh per month, while those with MBBS and MD/MS/DNB qualifications will receive Rs 2 lakh per month,” she said, according to an official statement. Also Read:Haryana Govt to recruit 500 doctors soon, says Health minister RaoThe health minister said the government aims to ensure better and timely healthcare services for all citizens of the state.Appointment of specialist doctors in government hospitals will not only improve the quality of medical care but also reduce the workload on existing doctors, she said.The minister further stated that specialists will be recruited in key departments, including gynaecology, paediatrics, anaesthesia, medicine, surgery and orthopaedics.The highest number of posts will be in gynaecology and paediatrics, with a focus on strengthening maternal and child healthcare services, the minister said. To expedite and streamline the recruitment process, selection will be conducted through walk-in interviews, based on candidates’ academic qualifications and experience.The minister further said that this initiative is a significant step towards strengthening the public healthcare system and ensuring the availability of specialist medical services even in remote areas, reports PTI. She expressed confidence that the decision will lead to a substantial improvement in healthcare services across Haryana and directly benefit the public.Also Read:Haryana designates 100 hospitals as first referral units to boost emergency care ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340063-vacancy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 11:15:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Haryana, recruit, 195, specialist, doctors, Govt, Hospitals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340063-vacancy.webp"><div class="pasted-from-word-wrapper"><p><span>Chandigarh: Haryana Health Minister <a href="https://medicaldialogues.in/topics/Arti-Singh-Rao" target="_blank">Arti Singh Rao</a> on Monday said that 195 specialist doctors will be recruited on a contractual basis in government hospitals to address the shortage of specialists across the state. She stated</span><span> the </span><a href="https://medicaldialogues.in/topics/recruitment" target="_blank">recruitment </a><span>process will be transparent and merit-based.</span></p><p>“For districts other than Nuh, specialist doctors with MBBS and diploma qualifications will be paid Rs 1 lakh per month, while those with MBBS and MD (doctor of medicine)/MS (master of surgery)/DNB (a postgraduate master’s medical qualification) qualifications will receive Rs 1.5 lakh per month, news agency PTI reported.</p><p>“For the Nuh district, higher remuneration has been approved to attract specialists. Doctors with MBBS and diploma qualifications will be paid Rs 1.5 lakh per month, while those with MBBS and MD/MS/DNB qualifications will receive Rs 2 lakh per month,” she said, according to an official statement. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/haryana-govt-to-recruit-500-doctors-soon-says-health-minister-rao-155130"><b>Also Read:Haryana Govt to recruit 500 doctors soon, says Health minister Rao</b></a></p><p>The health minister said the government aims to ensure better and timely healthcare services for all citizens of the state.</p><p>Appointment of specialist doctors in government hospitals will not only improve the quality of medical care but also reduce the workload on existing doctors, she said.</p><p>The minister further stated that specialists will be recruited in key departments, including gynaecology, paediatrics, anaesthesia, medicine, surgery and orthopaedics.</p><p>The highest number of posts will be in gynaecology and paediatrics, with a focus on strengthening maternal and child healthcare services, the minister said. </p><p>To expedite and streamline the recruitment process, selection will be conducted through walk-in interviews, based on candidates’ academic qualifications and experience.</p><p>The minister further said that this initiative is a significant step towards strengthening the public healthcare system and ensuring the availability of specialist medical services even in remote areas, reports PTI. </p><p>She expressed confidence that the decision will lead to a substantial improvement in healthcare services across Haryana and directly benefit the public.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/haryana-designates-100-hospitals-as-first-referral-units-to-boost-emergency-care-166411"><b>Also Read:Haryana designates 100 hospitals as first referral units to boost emergency care</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Enhanced Academic Performance with 30&#45;Minute Pre&#45;Sleep Mobile Usage Restriction: Suggests Review</title>
<link>https://edusehat.com/en/enhanced-academic-performance-with-30-minute-pre-sleep-mobile-usage-restriction-suggests-review</link>
<guid>https://edusehat.com/en/enhanced-academic-performance-with-30-minute-pre-sleep-mobile-usage-restriction-suggests-review</guid>
<description><![CDATA[ A recent review discovered that even a brief 30-minute reduction in pre-sleep mobile phone usage can significantly enhance academic performance and mental health. It highlights how these ubiquitous devices disrupt vital circadian rhythms and cellular biological processes, as detailed in a recent review published in Cureus in January 2025.While smartphones offer unparalleled social connectivity, they are increasingly linked to detrimental health outcomes such as neck pain and sleep disturbances, with previous surveys indicating that approximately 39% to 44% of Indian adolescents exhibit signs of addiction. This clinical gap, where mental health professionals lack actionable evidence to balance these risks, led Nischal Krishna Macharla and colleagues from the Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Centre to conduct the review aiming to explore the intersection of smartphone usage, sleep patterns, and academic achievement.Therefore, the investigation utilized a comprehensive search strategy across major databases, including Medline, PubMed, and Google Scholar, to evaluate the impact of mobile device screen time on the adolescent population. The review focused on identifying disruptions to sleep architecture and psychological health by employing specific keywords and Boolean operators, while supplementing findings with bibliographic reviews to ensure a thorough analysis of primary and secondary outcomes related to cognitive health and circadian entrainment.Key Clinical Findings of the Investigation Include:Circadian Interruption: The review confirms that short-wavelength blue light (446-484 nm) suppresses melatonin secretion and induces a phase delay in the suprachiasmatic nucleus (SCN), disrupting the 24-hour biological rhythm.Physiological Alterations: Decreased core body temperature and altered cortisol awakening responses, alongside reduced electroencephalogram (EEG) brain activity, result from 30 minutes of screen exposure, highlights the study.Sleep Quality Deterioration: The review shows that increased sleep latency, later rising times, and reduced sleep efficiency are significantly associated with bedtime device usage.Cognitive Impact: Higher prevalence of psychiatric comorbidities, hyperactivity, and inattention are linked to screen-induced sleep curtailment.Interventional Efficacy: Restricting mobile phone use for just 30 minutes prior to bed serves as a potent tool for improving educational outcomes and mental health.The results suggest that the pervasive use of smartphones can severely disrupt the autonomous transcription-translation feedback loops present in every cell, which normally synchronize with the central circadian clock. Furthermore, with nearly 300 million smartphone users in India, the widespread sleep deprivation observed is directly correlated with suboptimal academic performance and long-term health risks.Thus, the study concludes clinicians should consider implementing screen time restrictions and documenting levels of sleep impairment during mental health assessments to mitigate the risks of memory loss and negative mood swings in the adolescent population.While the review provides critical insights, the absence of definitive causative links to date suggests a pressing need for longitudinal research to further examine how specific shift schedules and light exposure patterns might serve as potential carcinogens or precursors to metabolic disorders.ReferenceMacharla N K, Palanichamy C, Thirunarayanan M, et al. (January 05, 2025) Impact of Smartphone Usage on Sleep in Adolescents: A Clinically Oriented Review. Cureus 17(1): e76973. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/05/13/176264-mobile-phone.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Enhanced, Academic, Performance, with, 30-Minute, Pre-Sleep, Mobile, Usage, Restriction:, Suggests, Review</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/05/13/176264-mobile-phone.webp"><p>A recent review discovered that even a brief 30-minute reduction in pre-sleep mobile phone usage can significantly enhance academic performance and <a href="https://medicaldialogues.in/photo-stories/7-things-you-can-do-to-improve-your-mental-health-499">mental health</a>. It highlights how these ubiquitous devices disrupt <a href="https://medicaldialogues.in/cardiology-ctvs/news/uthealth-houston-research-unveilslink-between-circadian-rhythm-and-heart-attack-severity-147210">vital circadian rhythms</a> and cellular biological processes, as detailed in a recent review published in <i>Cureus</i> in January 2025.</p><div class="pasted-from-word-wrapper"><p dir="ltr">While smartphones offer unparalleled social connectivity, they are increasingly linked to detrimental health outcomes such as neck pain and sleep disturbances, with previous surveys indicating that approximately 39% to 44% of Indian adolescents exhibit signs of addiction. This clinical gap, where mental health professionals lack actionable evidence to balance these risks, led Nischal Krishna Macharla and colleagues from the <i>Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Centre </i>to conduct the review aiming to explore the intersection of smartphone usage, sleep patterns, and academic achievement.</p><p dir="ltr">Therefore, the investigation utilized a comprehensive search strategy across major databases, including Medline, PubMed, and Google Scholar, to evaluate the impact of mobile device screen time on the adolescent population. The review focused on identifying disruptions to sleep architecture and psychological health by employing specific keywords and Boolean operators, while supplementing findings with bibliographic reviews to ensure a thorough analysis of primary and secondary outcomes related to cognitive health and circadian entrainment.</p><p dir="ltr"><b>Key Clinical Findings of the Investigation Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Circadian Interruption: </b>The review confirms that short-wavelength blue light (446-484 nm) suppresses melatonin secretion and induces a phase delay in the suprachiasmatic nucleus (SCN), disrupting the 24-hour biological rhythm.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Physiological Alterations: </b>Decreased core body temperature and altered cortisol awakening responses, alongside reduced electroencephalogram (EEG) brain activity, result from 30 minutes of screen exposure, highlights the study.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Sleep Quality Deterioration: </b>The review shows that increased sleep latency, later rising times, and reduced sleep efficiency are significantly associated with bedtime device usage.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Cognitive Impact:</b> Higher prevalence of psychiatric comorbidities, hyperactivity, and inattention are linked to screen-induced sleep curtailment.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Interventional Efficacy:</b> Restricting <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/restrict-mobile-phone-use-on-duty-no-jewellery-below-elbow-dghs-advisory-for-healthcare-workers-127858">mobile phone </a>use for just 30 minutes prior to bed serves as a potent tool for improving educational outcomes and mental health.</p></li></ul><p dir="ltr">The results suggest that the pervasive use of smartphones can severely disrupt the autonomous transcription-translation feedback loops present in every cell, which normally synchronize with the central circadian clock. Furthermore, with nearly 300 million smartphone users in India, the widespread sleep deprivation observed is directly correlated with suboptimal academic performance and long-term health risks.</p><p dir="ltr">Thus, the study concludes clinicians should consider implementing screen time restrictions and documenting levels of sleep impairment during mental health assessments to mitigate the risks of memory loss and negative mood swings in the adolescent population.</p><p dir="ltr">While the review provides critical insights, the absence of definitive causative links to date suggests a pressing need for longitudinal research to further examine how specific shift schedules and light exposure patterns might serve as potential carcinogens or precursors to metabolic disorders.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Macharla N K, Palanichamy C, Thirunarayanan M, et al. (January 05, 2025) Impact of Smartphone Usage on Sleep in Adolescents: A Clinically Oriented Review. Cureus 17(1): e76973.</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>The health impacts of alcohol depend on what you drink – and how much</title>
<link>https://edusehat.com/en/the-health-impacts-of-alcohol-depend-on-what-you-drink-and-how-much</link>
<guid>https://edusehat.com/en/the-health-impacts-of-alcohol-depend-on-what-you-drink-and-how-much</guid>
<description><![CDATA[ While high alcohol intake has been associated with worse health outcomes regardless of the type of alcohol consumed, the potential impacts of low to moderate alcohol intake appear to vary by beverage type, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
The study of more than 340,000 British adults adds to previous research showing less alcohol consumption is better for health and provides new insights into the impacts of drinking at low and moderate levels.
“These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher,” said Zhangling Chen, MD, PhD, a professor at the Second Xiangya Hospital, Central South University in China and the study’s senior author.
Researchers analyzed alcohol consumption habits and mortality outcomes among 340,924 adults who participated in the UK Biobank study between 2006-2022. Each participant completed a dietary questionnaire when they enrolled in the study and were grouped into four categories based on their alcohol intake, measured in terms of grams of pure alcohol per day and week. For reference, a 12-ounce can of beer, a 5-ounce glass of wine and a 1.5-ounce shot of spirits each contain about 14 grams of pure alcohol. People consuming less than 20 g (about 1.5 standard drinks) per week were classified as never or occasional drinkers. Men consuming between 20 g per week and 20 g per day and women consuming between 20 g per week and 10 g per day were considered to have low alcohol consumption. Daily consumption of 20 g to 40 g (about 1.5 to three standard drinks) for men and 10 g to 20 g for women was considered moderate. Daily consumption of more than 40 g (about three drinks) for men and 20 g (about 1.5 drinks) for women was considered high. Health outcomes were tracked for over 13 years on average.
Compared with never or occasional drinkers, those with high alcohol consumption were 24% more likely to die from any cause, 36% more likely to die from cancer and 14% more likely to die from heart disease. Differences in risk by alcohol type emerged at low and moderate levels of consumption, where drinking spirits, beer or cider was associated with a significantly higher risk of death while the same level of wine consumption was associated with a significantly lower risk of death.
Looking at deaths from cardiovascular disease in particular, researchers found that moderate wine drinkers had a 21% lower risk of dying from cardiovascular disease compared with never or occasional drinkers. By contrast, even low intake of spirits, beer or cider was associated with a 9% higher risk of dying from cardiovascular disease compared with drinking never or occasionally.
“Our findings help clarify previously mixed evidence on low to moderate alcohol consumption,” Chen said. “These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed, but also on the type of beverage. Even low to moderate intake of spirits, beer or cider is linked to higher mortality, while low to moderate intake of wine may carry lower risk.”
Researchers said that several factors may account for the differences by alcohol type. Certain compounds present in red wine, such as polyphenols and antioxidants, may have benefits for cardiovascular health. Wine is also more likely to be consumed with meals and by people who have higher-quality diets and healthier behaviors in general, while spirits, beer and cider are more likely to be consumed outside of meals and were associated with lower overall diet quality and other lifestyle risk factors.
“Taken together, these factors suggest that the type of alcohol, how it is consumed and the associated lifestyle behaviors all contribute to the observed differences in mortality risk,” Chen said.
In their analyses, researchers adjusted the data to account for demographic factors, socioeconomic status, lifestyle factors, cardiometabolic factors and family history of diabetes, cardiovascular disease and cancer. However, they said that the research has inherent limitations as an observational study and suggested that high-quality randomized trials could help to better understand the impacts of alcohol consumption. Alcohol consumption was assessed based on self-reporting at baseline and did not capture changes in drinking patterns over time. In addition, UK Biobank participants are generally healthier than the overall population, which may limit the study’s generalizability.
Despite these limitations, the study’s large sample size and length of follow-up strengthen its statistical power. Researchers said the study provides a more comprehensive and nuanced picture of the health impacts of alcohol consumption than many prior studies, offering a high degree of granularity in terms of the amount and type of alcohol consumed as well as a variety of mortality outcomes.  Reference:The health impacts of alcohol depend on what you drink – and how much, American College of Cardiology, Meeting:American College of Cardiology&#039;s Annual Scientific Session ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/03/01/233379-alcohol-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>The, health, impacts, alcohol, depend, what, you, drink, –, and, how, much</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/03/01/233379-alcohol-50.webp"><p>While high alcohol intake has been associated with worse health outcomes regardless of the type of alcohol consumed, the potential impacts of low to moderate alcohol intake appear to vary by beverage type, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).
</p><p>The study of more than 340,000 British adults adds to previous research showing less alcohol consumption is better for health and provides new insights into the impacts of drinking at low and moderate levels.
</p><p>“These results come from the general population, and in certain high-risk groups, such as people with chronic diseases or cardiovascular conditions, the risks could be even higher,” said Zhangling Chen, MD, PhD, a professor at the Second Xiangya Hospital, Central South University in China and the study’s senior author.
</p><p>Researchers analyzed alcohol consumption habits and mortality outcomes among 340,924 adults who participated in the UK Biobank study between 2006-2022. Each participant completed a dietary questionnaire when they enrolled in the study and were grouped into four categories based on their alcohol intake, measured in terms of grams of pure alcohol per day and week. For reference, a 12-ounce can of beer, a 5-ounce glass of wine and a 1.5-ounce shot of spirits each contain about 14 grams of pure alcohol. People consuming less than 20 g (about 1.5 standard drinks) per week were classified as never or occasional drinkers. Men consuming between 20 g per week and 20 g per day and women consuming between 20 g per week and 10 g per day were considered to have low alcohol consumption. Daily consumption of 20 g to 40 g (about 1.5 to three standard drinks) for men and 10 g to 20 g for women was considered moderate. Daily consumption of more than 40 g (about three drinks) for men and 20 g (about 1.5 drinks) for women was considered high. Health outcomes were tracked for over 13 years on average.
</p><p>Compared with never or occasional drinkers, those with high alcohol consumption were 24% more likely to die from any cause, 36% more likely to die from cancer and 14% more likely to die from heart disease. Differences in risk by alcohol type emerged at low and moderate levels of consumption, where drinking spirits, beer or cider was associated with a significantly higher risk of death while the same level of wine consumption was associated with a significantly lower risk of death.
</p><p>Looking at deaths from cardiovascular disease in particular, researchers found that moderate wine drinkers had a 21% lower risk of dying from cardiovascular disease compared with never or occasional drinkers. By contrast, even low intake of spirits, beer or cider was associated with a 9% higher risk of dying from cardiovascular disease compared with drinking never or occasionally.
</p><p>“Our findings help clarify previously mixed evidence on low to moderate alcohol consumption,” Chen said. “These findings can help refine guidance, emphasizing that the health risks of alcohol depend not only on the amount of alcohol consumed, but also on the type of beverage. Even low to moderate intake of spirits, beer or cider is linked to higher mortality, while low to moderate intake of wine may carry lower risk.”
</p><p>Researchers said that several factors may account for the differences by alcohol type. Certain compounds present in red wine, such as polyphenols and antioxidants, may have benefits for cardiovascular health. Wine is also more likely to be consumed with meals and by people who have higher-quality diets and healthier behaviors in general, while spirits, beer and cider are more likely to be consumed outside of meals and were associated with lower overall diet quality and other lifestyle risk factors.
</p><p>“Taken together, these factors suggest that the type of alcohol, how it is consumed and the associated lifestyle behaviors all contribute to the observed differences in mortality risk,” Chen said.
</p><p>In their analyses, researchers adjusted the data to account for demographic factors, socioeconomic status, lifestyle factors, cardiometabolic factors and family history of diabetes, cardiovascular disease and cancer. However, they said that the research has inherent limitations as an observational study and suggested that high-quality randomized trials could help to better understand the impacts of alcohol consumption. Alcohol consumption was assessed based on self-reporting at baseline and did not capture changes in drinking patterns over time. In addition, UK Biobank participants are generally healthier than the overall population, which may limit the study’s generalizability.
</p><p>Despite these limitations, the study’s large sample size and length of follow-up strengthen its statistical power. Researchers said the study provides a more comprehensive and nuanced picture of the health impacts of alcohol consumption than many prior studies, offering a high degree of granularity in terms of the amount and type of alcohol consumed as well as a variety of mortality outcomes.  </p><p>Reference:</p><p>The health impacts of alcohol depend on what you drink – and how much, American College of Cardiology, Meeting:American College of Cardiology's Annual Scientific Session</p>]]> </content:encoded>
</item>

<item>
<title>Older adults’ driving habits offer window into brain health, cognitive decline: Study</title>
<link>https://edusehat.com/en/older-adults-driving-habits-offer-window-into-brain-health-cognitive-decline-study</link>
<guid>https://edusehat.com/en/older-adults-driving-habits-offer-window-into-brain-health-cognitive-decline-study</guid>
<description><![CDATA[ Older adults’ driving habits revealed clues about their brain health and may provide early warning signs of cognitive decline or dementia, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2026. The meeting is in New Orleans, Feb. 4-6, 2026, and is a world premier global event dedicated to advancing stroke and brain health science.
“Driving habits in older adults can reveal early changes in brain health. How often people drive, where they go, and how much they vary their routes may signal underlying damage to the brain’s white matter, which is linked to cognitive decline and dementia,” said study author Chia-Ling Phuah, M.D., M.M.Sc., an associate professor of neurocritical care and co-director of the Neuro Analytics Center at Barrow Neurological Institute in Phoenix. “These findings suggest that even small shifts in daily driving patterns can offer important clues about brain changes — sometimes before traditional memory and thinking symptoms are noticeable.”
According to the American Heart Association 2026 Heart and Stroke Statistics, about 6.9 million (10.9%) – or 1 in 9 - adults 65 years or older in the United States were living with Alzheimer’s disease in 2024.Researchers reviewed driving habits for 220 adult volunteers, ages 65 and older, living independently in St. Louis, Missouri. Detailed cognitive assessments indicated participants were free of dementia at the start of the study. Car sensors were used to track participants’ driving behavior (including speeding, collisions, hard braking or hard cornering) for more than five years. They conducted additional brain imaging studies within the first year of the study to measure changes in the brain’s white matter, specifically white matter hyperintensities — areas of white matter damage caused by reduced blood flow to brain tissue.The analysis found:Older adults who had more white matter hyperintensities tended to drive less and show sharper declines in their willingness or ability to change driving routes and habits.Over more than five years of follow-up, 17% of participants developed cognitive impairment and most of these individuals were later diagnosed with Alzheimer’s disease.Among the 17% of participants who developed cognitive impairment, higher white matter hyperintensity burden on brain imaging was linked to a greater likelihood of unsafe driving practices, such as hard braking, and to more crashes.“Participants with white matter hyperintensities located in the back of the brain — a region responsible for processing what people see and how they move — were at even higher risk of crashes than those with changes in other brain areas, making them more likely to experience unsafe driving episodes and car accidents over time,“ Phuah explained.Participants taking medications to manage high blood pressure, especially angiotensin-converting enzyme (ACE) inhibitors, were less likely to exhibit risky driving when compared with those who were not taking any blood pressure medication.Overall, the study’s findings suggest that monitoring driving behavior with commercial in-vehicle data loggers may help identify older adults at higher risk for unsafe driving, loss of independence and subtle cognitive problems, Phuah noted.“One especially promising finding was that people taking blood pressure medications, particularly ACE inhibitors, tended to maintain safer driving habits even when their brain scans revealed more damage. This effect was observed regardless of whether their blood pressure levels were at target levels,” Phuah said. “This suggests that these medications may help support brain health as we age.”Nada El Husseini, M.D., M.H.Sc., FAHA, chair of the American Heart Association’s 2023 scientific statement, Cognitive Impairment After Ischemic and Hemorrhagic Stroke said, “What’s surprising about these findings is that people taking ACE inhibitors were less likely to have impairment in their driving despite the extent of white matter disease. The impact of ACE inhibitors on cognitive function and driving safety in people with white matter disease requires further investigation. Also, these results suggest cognitive screening and brain imaging might be considered for people with driving difficulties.” El Husseini is an associate professor of neurology at Duke University Medical Center in Durham, North Carolina and was not involved in this study.
Normal blood pressure is less than 120/80, and treatment is recommended for people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension). Recent research confirms that blood pressure affects brain health, including cognitive function and dementia, so early treatment is recommended for people diagnosed with high blood pressure to maintain brain health and cognition, according to the 2025 American Heart Association High Blood Pressure Guideline.Key limitations include a small study size, most participants were white, college-educated adults, so results may not generalize to people from more diverse backgrounds, and medication use was self-reported, which could introduce errors.The next step will be larger studies that include more diverse participants to confirm and extend these findings.Study details, background and design:The study included 220 adults (average age of 73 years; 54% men, 46% women, 88% white and 12% Black) living in St. Louis, Missouri, who did not have dementia when they enrolled in the study.Data was collected over a nine-year period, from 2016 to 2024, as part of the Driving Real-World In-Vehicle Evaluation System (DRIVES) project based at Washington University in St. Louis.Participants were monitored for continuous in-vehicle driving metrics, such as trip frequency, distance and destination, as well as safety events, including time spent speeding, collisions, hard braking or hard cornering.All participants had brain magnetic resonance imaging (MRI) scans to measure white matter hyperintensities at enrollment, which was around the time they started their driving assessments. About half (102 participants) had a second MRI scan at least 12 months after their first scan. Participants also underwent annual clinical and cognitive assessments.Researchers analyzed the relationship between total and regional white matter hyperintensities and driving patterns and safety.Statistical models were used to adjust for demographics, social/economic factors and health factors.Patient perspective: A caregiver’s view of driving and cognitive declineFor Larry Duncan, a retired business owner from Pinehurst, North Carolina, driving was part of his independence. But subtle changes began to appear before his Alzheimer’s diagnosis in 2023. “Larry was fine driving in familiar areas,” recalls his wife and caregiver, Pam Duncan. “But in new places where he had to make quick decisions, he became anxious.”As his cognitive challenges progressed, Duncan’s doctor advised him to stop driving, a decision she describes as heartbreaking but necessary.“In early-stage cognitive impairment, symptoms can be subtle, and driving is one of them,” said Pam Duncan, who now volunteers for the American Stroke Association, a division of the American Heart Association. “Don’t ignore these changes. As caregivers, our role is to support independence while having the courage to make tough decisions. You can live well with dementia, but it starts with awareness and action.”Reference:Older adults’ driving habits offer window into brain health, cognitive decline, American Heart Association, Meeting: ASA International Stroke Conference 2026 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Older, adults’, driving, habits, offer, window, into, brain, health, cognitive, decline:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.webp"><div class="pasted-from-word-wrapper"><p>Older adults’ driving habits revealed clues about their <a href="https://medicaldialogues.in/topics/brain-health">brain health </a>and may provide early warning signs of <a href="https://medicaldialogues.in/topics/cognitive-decline">cognitive decline </a>or <a href="https://medicaldialogues.in/topics/dementia">dementia</a>, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2026. The meeting is in New Orleans, Feb. 4-6, 2026, and is a world premier global event dedicated to advancing stroke and brain health science.
</p><p>“Driving habits in older adults can reveal early changes in brain health. How often people drive, where they go, and how much they vary their routes may signal underlying damage to the brain’s white matter, which is linked to cognitive decline and dementia,” said study author Chia-Ling Phuah, M.D., M.M.Sc., an associate professor of neurocritical care and co-director of the Neuro Analytics Center at Barrow Neurological Institute in Phoenix. “These findings suggest that even small shifts in daily driving patterns can offer important clues about brain changes — sometimes before traditional memory and thinking symptoms are noticeable.”
</p><p>According to the American Heart Association 2026 Heart and Stroke Statistics, about 6.9 million (10.9%) – or 1 in 9 - adults 65 years or older in the United States were living with Alzheimer’s disease in 2024.</p><p>Researchers reviewed driving habits for 220 adult volunteers, ages 65 and older, living independently in St. Louis, Missouri. Detailed cognitive assessments indicated participants were free of dementia at the start of the study. Car sensors were used to track participants’ driving behavior (including speeding, collisions, hard braking or hard cornering) for more than five years. They conducted additional brain imaging studies within the first year of the study to measure changes in the brain’s white matter, specifically white matter hyperintensities — areas of white matter damage caused by reduced blood flow to brain tissue.</p><p>The analysis found:</p><ul><li>Older adults who had more white matter hyperintensities tended to drive less and show sharper declines in their willingness or ability to change driving routes and habits.</li><li>Over more than five years of follow-up, 17% of participants developed cognitive impairment and most of these individuals were later diagnosed with Alzheimer’s disease.</li><li>Among the 17% of participants who developed cognitive impairment, higher white matter hyperintensity burden on brain imaging was linked to a greater likelihood of unsafe driving practices, such as hard braking, and to more crashes.</li><li>“Participants with white matter hyperintensities located in the back of the brain — a region responsible for processing what people see and how they move — were at even higher risk of crashes than those with changes in other brain areas, making them more likely to experience unsafe driving episodes and car accidents over time,“ Phuah explained.</li><li><p>Participants taking medications to manage high blood pressure, especially angiotensin-converting enzyme (ACE) inhibitors, were less likely to exhibit risky driving when compared with those who were not taking any blood pressure medication.</p></li></ul><p>Overall, the study’s findings suggest that monitoring driving behavior with commercial in-vehicle data loggers may help identify older adults at higher risk for unsafe driving, loss of independence and subtle cognitive problems, Phuah noted.</p><p>“One especially promising finding was that people taking blood pressure medications, particularly ACE inhibitors, tended to maintain safer driving habits even when their brain scans revealed more damage. This effect was observed regardless of whether their blood pressure levels were at target levels,” Phuah said. “This suggests that these medications may help support brain health as we age.”</p><p>Nada El Husseini, M.D., M.H.Sc., FAHA, chair of the American Heart Association’s 2023 scientific statement, Cognitive Impairment After Ischemic and Hemorrhagic Stroke said, “What’s surprising about these findings is that people taking ACE inhibitors were less likely to have impairment in their driving despite the extent of white matter disease. The impact of ACE inhibitors on cognitive function and driving safety in people with white matter disease requires further investigation. Also, these results suggest cognitive screening and brain imaging might be considered for people with driving difficulties.” El Husseini is an associate professor of neurology at Duke University Medical Center in Durham, North Carolina and was not involved in this study.
</p><p>Normal blood pressure is less than 120/80, and treatment is recommended for people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension). Recent research confirms that blood pressure affects brain health, including cognitive function and dementia, so early treatment is recommended for people diagnosed with high blood pressure to maintain brain health and cognition, according to the 2025 American Heart Association High Blood Pressure Guideline.</p><p>Key limitations include a small study size, most participants were white, college-educated adults, so results may not generalize to people from more diverse backgrounds, and medication use was self-reported, which could introduce errors.</p><p>The next step will be larger studies that include more diverse participants to confirm and extend these findings.</p><p>Study details, background and design:</p><ul><li>The study included 220 adults (average age of 73 years; 54% men, 46% women, 88% white and 12% Black) living in St. Louis, Missouri, who did not have dementia when they enrolled in the study.</li><li>Data was collected over a nine-year period, from 2016 to 2024, as part of the Driving Real-World In-Vehicle Evaluation System (DRIVES) project based at Washington University in St. Louis.</li><li>Participants were monitored for continuous in-vehicle driving metrics, such as trip frequency, distance and destination, as well as safety events, including time spent speeding, collisions, hard braking or hard cornering.</li><li>All participants had brain magnetic resonance imaging (MRI) scans to measure white matter hyperintensities at enrollment, which was around the time they started their driving assessments. About half (102 participants) had a second MRI scan at least 12 months after their first scan. Participants also underwent annual clinical and cognitive assessments.</li><li>Researchers analyzed the relationship between total and regional white matter hyperintensities and driving patterns and safety.</li><li>Statistical models were used to adjust for demographics, social/economic factors and health factors.</li></ul><p>Patient perspective: A caregiver’s view of driving and cognitive decline</p><p>For Larry Duncan, a retired business owner from Pinehurst, North Carolina, driving was part of his independence. But subtle changes began to appear before his Alzheimer’s diagnosis in 2023. “Larry was fine driving in familiar areas,” recalls his wife and caregiver, Pam Duncan. “But in new places where he had to make quick decisions, he became anxious.”</p><p>As his cognitive challenges progressed, Duncan’s doctor advised him to stop driving, a decision she describes as heartbreaking but necessary.</p><p>“In early-stage cognitive impairment, symptoms can be subtle, and driving is one of them,” said Pam Duncan, who now volunteers for the American Stroke Association, a division of the American Heart Association. “Don’t ignore these changes. As caregivers, our role is to support independence while having the courage to make tough decisions. You can live well with dementia, but it starts with awareness and action.”</p><p>Reference:</p><p>Older adults’ driving habits offer window into brain health, cognitive decline, American Heart Association, Meeting: ASA International Stroke Conference 2026</p></div>]]> </content:encoded>
</item>

<item>
<title>Beta&#45;Blockers Discontinuation Safe After One Year in Selected Patients after MI: SMART&#45;DECISION Trial</title>
<link>https://edusehat.com/en/beta-blockers-discontinuation-safe-after-one-year-in-selected-patients-after-mi-smart-decision-trial</link>
<guid>https://edusehat.com/en/beta-blockers-discontinuation-safe-after-one-year-in-selected-patients-after-mi-smart-decision-trial</guid>
<description><![CDATA[ South Korea: The SMART-DECISION trial has found that in stabilized patients after myocardial infarction (MI) without heart failure or left ventricular systolic dysfunction, discontinuing beta-blockers after one year is a reasonable option. Stopping therapy showed similar major clinical outcomes compared to continuation, including all-cause death, recurrent MI, or heart failure hospitalization (7.2% vs 9.0%; HR 0.80, 95% CI 0.57–1.13). This suggests that long-term beta-blocker use may not be necessary in this low-risk group.A new study published in the New England Journal of Medicine by Ki Hong Choi and colleagues provides important insights into the ongoing debate regarding the duration of beta-blocker therapy following myocardial infarction. While beta-blockers have long been a cornerstone of post-MI management, particularly in patients with reduced cardiac function, their long-term role in patients with preserved left ventricular function remains uncertain in the modern era of advanced reperfusion strategies and secondary prevention.To address this question, researchers conducted an open-label, randomized, noninferiority trial across 25 centers in South Korea. The study enrolled patients who had experienced an MI but remained clinically stable, had a left ventricular ejection fraction of at least 40%, and showed no signs of heart failure. All participants had already completed at least one year of beta-blocker therapy before enrollment. They were then randomly assigned to either discontinue or continue beta-blocker treatment.A total of 2,540 patients were included in the trial, with 1,246 assigned to discontinue therapy and 1,294 continuing treatment. The average age of participants was 63.2 years, and women accounted for 12.8% of the cohort. Patients were followed for a median duration of 3.1 years to assess long-term outcomes.The primary endpoint was a composite of all-cause mortality, recurrent myocardial infarction, or hospitalization for heart failure.  The researchers reported the following findings:Discontinuation of beta-blockers was found to be noninferior to continued therapy based on predefined statistical criteria.Rates of serious adverse events were similar between the discontinuation and continuation groups.Stopping beta-blockers did not increase safety risks.In stable patients without heart failure and with preserved ventricular function, long-term continuation may not provide additional clinical benefit.The findings suggest that extending beta-blocker therapy beyond one year may be unnecessary in this low-risk group.Reducing prolonged use could help avoid side effects such as fatigue, bradycardia, and impaired quality of life.The study reflects evolving treatment paradigms in cardiology, where therapies are increasingly tailored based on individual risk profiles rather than applied uniformly. In the context of improved revascularization techniques and comprehensive secondary prevention measures, the necessity of indefinite beta-blocker therapy is being reconsidered.While the findings are promising, the authors note that treatment decisions should still be individualized, taking into account patient-specific factors and clinical judgment. Nonetheless, this trial provides robust evidence supporting a more flexible approach to beta-blocker use after myocardial infarction in low-risk patients.Reference:DOI: 10.1056/NEJMoa2601005 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/06/27/130946-beta-blockers.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Beta-Blockers, Discontinuation, Safe, After, One, Year, Selected, Patients, after, MI:, SMART-DECISION, Trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/06/27/130946-beta-blockers.webp"><p><span>South Korea: The SMART-DECISION trial has found that in stabilized patients after <a href="https://medicaldialogues.in/topics/myocardial-infarction">myocardial infarction (MI) </a>without<a href="https://medicaldialogues.in/topics/heart-failure"> heart failure </a>or left ventricular systolic dysfunction, discontinuing<a href="https://medicaldialogues.in/topics/beta-blockers"> beta-blockers </a>after one year is a reasonable option. Stopping therapy showed similar major clinical outcomes compared to continuation, including all-cause death, recurrent MI, or heart failure hospitalization (7.2% vs 9.0%; HR 0.80, 95% CI 0.57–1.13). This suggests that long-term beta-blocker use may not be necessary in this low-risk group.</span></p><div class="pasted-from-word-wrapper"><div>A new study published in the <i>New England Journal of Medicine</i> by Ki Hong Choi and colleagues provides important insights into the ongoing debate regarding the duration of beta-blocker therapy following myocardial infarction. While beta-blockers have long been a cornerstone of post-MI management, particularly in patients with reduced cardiac function, their long-term role in patients with preserved left ventricular function remains uncertain in the modern era of advanced reperfusion strategies and secondary prevention.</div><div>To address this question, researchers conducted an open-label, randomized, noninferiority trial across 25 centers in South Korea. The study enrolled patients who had experienced an MI but remained clinically stable, had a left ventricular ejection fraction of at least 40%, and showed no signs of heart failure. All participants had already completed at least one year of beta-blocker therapy before enrollment. They were then randomly assigned to either discontinue or continue beta-blocker treatment.</div><div>A total of 2,540 patients were included in the trial, with 1,246 assigned to discontinue therapy and 1,294 continuing treatment. The average age of participants was 63.2 years, and women accounted for 12.8% of the cohort. Patients were followed for a median duration of 3.1 years to assess long-term outcomes.</div><div>The primary endpoint was a composite of all-cause mortality, recurrent myocardial infarction, or hospitalization for heart failure.  </div><div>The researchers reported the following findings:</div><ul><li>Discontinuation of beta-blockers was found to be noninferior to continued therapy based on predefined statistical criteria.</li><li>Rates of serious adverse events were similar between the discontinuation and continuation groups.</li><li>Stopping beta-blockers did not increase safety risks.</li><li>In stable patients without heart failure and with preserved ventricular function, long-term continuation may not provide additional clinical benefit.</li><li>The findings suggest that extending beta-blocker therapy beyond one year may be unnecessary in this low-risk group.</li><li>Reducing prolonged use could help avoid side effects such as fatigue, bradycardia, and impaired quality of life.</li></ul><div>The study reflects evolving treatment paradigms in cardiology, where therapies are increasingly tailored based on individual risk profiles rather than applied uniformly. In the context of improved revascularization techniques and comprehensive secondary prevention measures, the necessity of indefinite beta-blocker therapy is being reconsidered.</div><div>While the findings are promising, the authors note that treatment decisions should still be individualized, taking into account patient-specific factors and clinical judgment. Nonetheless, this trial provides robust evidence supporting a more flexible approach to beta-blocker use after myocardial infarction in low-risk patients.</div><div>Reference:</div><div>DOI: 10.1056/NEJMoa2601005</div></div>]]> </content:encoded>
</item>

<item>
<title>Dairy Intake linked to Increased Risk of Parkinson’s Disease, finds study</title>
<link>https://edusehat.com/en/dairy-intake-linked-to-increased-risk-of-parkinsons-disease-finds-study</link>
<guid>https://edusehat.com/en/dairy-intake-linked-to-increased-risk-of-parkinsons-disease-finds-study</guid>
<description><![CDATA[ A new study published in the journal of Public Health found that higher dairy consumption, especially milk, is associated with an increased risk of Parkinson’s disease (PD).Parkinson’s disease affects movement and is characterized by symptoms like tremors, stiffness, and slowed motion. While its exact causes remain unclear, scientists believe a combination of genetic, environmental, and lifestyle factors contributes to its development. In recent years, attention has turned toward diet, especially the potential role of dairy consumption.This systematic review and meta-analysis examined the relationship between dairy intake and PD risk. This research analyzed data from 9 studies (8 cohort studies and one case-control study) across populations in North America, Europe, and Asia. In total, the cohort studies included over 634,000 participants, among whom more than 4,200 cases of Parkinson’s disease were identified.The analysis showed that individuals with high total dairy intake had a statistically significant 21% higher risk of developing Parkinson’s disease when compared to those with lower intake. The association appeared stronger in men, who showed a 28% increased risk, while the effect in women was minimal and not statistically significant.The participants with higher milk intake had a 13% increased risk of Parkinson’s disease, with similar sex-specific patterns as seen in overall dairy consumption. Also, other dairy products (including yogurt, fermented milk, cheese, butter, and ice cream) did not show a meaningful association with PD risk.These findings suggest that the link may be related to biological mechanisms involving the gut–brain axis. One hypothesis was that dairy intake could influence the gut microbiome in ways that promote the accumulation or spread of alpha-synuclein. Despite the findings, this study caution that the evidence is not yet definitive. The included studies were observational, meaning they can identify associations but cannot prove cause and effect. Also, the results varied across populations, and factors such as genetics, lifestyle, and overall diet may influence outcomes.Overall, the findings of this study emphasize the need for further research involving more diverse populations and clearer distinctions between genetic and non-genetic forms of Parkinson’s disease. They also call for deeper investigation into how specific dietary patterns interact with biological pathways linked to neurodegeneration.Source:Yang, D., Nepal, G., Ojha, R., &amp; Tu, Z. (2026). Association between dairy consumption and Parkinson’s disease: A systematic review and meta-analysis. Public Health, 252(106143), 106143. https://doi.org/10.1016/j.puhe.2026.106143 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/17/185765-dairy-products.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Dairy, Intake, linked, Increased, Risk, Parkinson’s, Disease, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/17/185765-dairy-products.webp"><p>A new study published in the journal of <i>Public Health</i> found that higher dairy consumption, especially milk, is associated with an increased risk of Parkinson’s disease (PD).</p><p>Parkinson’s disease affects movement and is characterized by symptoms like tremors, stiffness, and slowed motion. While its exact causes remain unclear, scientists believe a combination of genetic, environmental, and lifestyle factors contributes to its development. In recent years, attention has turned toward diet, especially the potential role of dairy consumption.</p><p>This systematic review and meta-analysis examined the relationship between dairy intake and PD risk. This research analyzed data from 9 studies (8 cohort studies and one case-control study) across populations in North America, Europe, and Asia. In total, the cohort studies included over 634,000 participants, among whom more than 4,200 cases of Parkinson’s disease were identified.</p><p>The analysis showed that individuals with high total dairy intake had a statistically significant 21% higher risk of developing Parkinson’s disease when compared to those with lower intake. The association appeared stronger in men, who showed a 28% increased risk, while the effect in women was minimal and not statistically significant.</p><p>The participants with higher milk intake had a 13% increased risk of Parkinson’s disease, with similar sex-specific patterns as seen in overall dairy consumption. Also, other dairy products (including yogurt, fermented milk, cheese, butter, and ice cream) did not show a meaningful association with PD risk.</p><p>These findings suggest that the link may be related to biological mechanisms involving the gut–brain axis. One hypothesis was that dairy intake could influence the gut microbiome in ways that promote the accumulation or spread of alpha-synuclein. </p><p>Despite the findings, this study caution that the evidence is not yet definitive. The included studies were observational, meaning they can identify associations but cannot prove cause and effect. Also, the results varied across populations, and factors such as genetics, lifestyle, and overall diet may influence outcomes.</p><p>Overall, the findings of this study emphasize the need for further research involving more diverse populations and clearer distinctions between genetic and non-genetic forms of Parkinson’s disease. They also call for deeper investigation into how specific dietary patterns interact with biological pathways linked to neurodegeneration.</p><p>Source:</p><p>Yang, D., Nepal, G., Ojha, R., & Tu, Z. (2026). Association between dairy consumption and Parkinson’s disease: A systematic review and meta-analysis. Public Health, 252(106143), 106143. <a href="https://www.sciencedirect.com/science/article/abs/pii/S0033350626000107?via%3Dihub#xd_co_f=OGRmN2QxMmQtMzBjZC00NjkyLWI3YzItNzZhOTg5ZTEwMWFl~" rel="nofollow">https://doi.org/10.1016/j.puhe.2026.106143</a></p>]]> </content:encoded>
</item>

<item>
<title>Early Menarche and Late Menopause Key Determinants of Ovarian Cancer Risk: JAMA</title>
<link>https://edusehat.com/en/early-menarche-and-late-menopause-key-determinants-of-ovarian-cancer-risk-jama</link>
<guid>https://edusehat.com/en/early-menarche-and-late-menopause-key-determinants-of-ovarian-cancer-risk-jama</guid>
<description><![CDATA[ Korea: Researchers have found in a new study that across both premenopausal and postmenopausal women, early menarche, later age at menopause, and a longer reproductive span were associated with a higher risk of ovarian cancer, whereas higher parity was consistently associated with a lower risk of ovarian cancer.The findings are from a large nationwide cohort study published in JAMA Network Open by Jin-Hwi Kim, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, and colleagues. The investigators explored how reproductive factors influence ovarian cancer risk, examining whether these associations vary according to menopausal status and birth cohort.For this purpose, the researchers analyzed data from the Korean National Health Insurance Service (NHIS), which covers nearly the entire population of South Korea. The study included 2,285,774 women aged 40 years or older who underwent national health screening in 2009 and had detailed reproductive and clinical information available. Participants were followed until a diagnosis of ovarian cancer, death, or December 31, 2022. The average follow-up period was 10.7 years, during which 10,729 cases of ovarian cancer were identified.    The analysis revealed the following findings:Early menarche (≤12 years) was associated with a significantly higher risk of ovarian cancer compared with menarche after 16 years in both premenopausal and postmenopausal women.Having two or more children was linked to a substantially lower risk of ovarian cancer across both menopausal groups.Among premenopausal women, breastfeeding for 12 months or longer was associated with a reduced risk of ovarian cancer.Oral contraceptive use for at least one year was associated with lower ovarian cancer risk in premenopausal women.In postmenopausal women, menopause at age 55 years or older was associated with increased ovarian cancer risk.A reproductive span of 40 years or more was linked to a higher risk in postmenopausal women.Hormone replacement therapy use for two to five years was associated with increased ovarian cancer risk in postmenopausal women.The protective effect of higher parity appeared weaker among women born in the 1960s compared with earlier birth cohorts, though this interaction was not statistically significant.Overall, the findings suggest that cumulative lifetime exposure to endogenous and exogenous hormones may play a key role in ovarian cancer development, with variations depending on menopausal status and generational reproductive trends. In aging societies with declining fertility rates, such as South Korea, these shifting reproductive patterns may have meaningful implications for cancer prevention strategies.The authors noted several limitations, including self-reported reproductive data, potential recall bias, a lack of tumor subtype details, and the absence of key confounders such as family history, BRCA status, and tubal ligation. As an observational study, it cannot prove causation. However, the findings align with previous biological and epidemiological research, underscoring the need for individualized risk assessment and tailored prevention strategies.Reference:Kim J, Hwang I, Lee S, Kim C, Lee S, Han K. Reproductive Shifts and Ovarian Cancer Risk in Women Aged 40 Years or Older. JAMA Netw Open. 2026;9(2):e2556840. doi:10.1001/jamanetworkopen.2025.56840 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/15/278608-ovarian-cancer-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Early, Menarche, and, Late, Menopause, Key, Determinants, Ovarian, Cancer, Risk:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/15/278608-ovarian-cancer-2.webp"><p><span>Korea: Researchers have found in a new study that across both premenopausal and <a href="https://medicaldialogues.in/topics/postmenopausal-women">postmenopausal women</a>, early menarche, later age at menopause, and a longer<a href="https://medicaldialogues.in/topics/reproductive-factors"> reproductive span</a> were associated with a higher risk of <a href="https://speciality.medicaldialogues.in/topics/ovarian-cancer">ovarian cancer</a>, whereas higher parity was consistently associated with a lower risk of ovarian cancer.</span></p><div class="pasted-from-word-wrapper"><div>The findings are from a large nationwide cohort study published in <i>JAMA Network Open </i>by Jin-Hwi Kim, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, and colleagues. The investigators explored how reproductive factors influence ovarian cancer risk, examining whether these associations vary according to menopausal status and birth cohort.</div><div>For this purpose, the researchers analyzed data from the Korean National Health Insurance Service (NHIS), which covers nearly the entire population of South Korea. The study included 2,285,774 women aged 40 years or older who underwent national health screening in 2009 and had detailed reproductive and clinical information available. Participants were followed until a diagnosis of ovarian cancer, death, or December 31, 2022. The average follow-up period was 10.7 years, during which 10,729 cases of ovarian cancer were identified.    </div><div>The analysis revealed the following findings:</div><ul><li>Early menarche (≤12 years) was associated with a significantly higher risk of ovarian cancer compared with menarche after 16 years in both premenopausal and postmenopausal women.</li><li>Having two or more children was linked to a substantially lower risk of ovarian cancer across both menopausal groups.</li><li>Among premenopausal women, breastfeeding for 12 months or longer was associated with a reduced risk of ovarian cancer.</li><li>Oral contraceptive use for at least one year was associated with lower ovarian cancer risk in premenopausal women.</li><li>In postmenopausal women, menopause at age 55 years or older was associated with increased ovarian cancer risk.</li><li>A reproductive span of 40 years or more was linked to a higher risk in postmenopausal women.</li><li>Hormone replacement therapy use for two to five years was associated with increased ovarian cancer risk in postmenopausal women.</li><li>The protective effect of higher parity appeared weaker among women born in the 1960s compared with earlier birth cohorts, though this interaction was not statistically significant.</li></ul><div>Overall, the findings suggest that cumulative lifetime exposure to endogenous and exogenous hormones may play a key role in ovarian cancer development, with variations depending on menopausal status and generational reproductive trends. In aging societies with declining fertility rates, such as South Korea, these shifting reproductive patterns may have meaningful implications for cancer prevention strategies.</div><div>The authors noted several limitations, including self-reported reproductive data, potential recall bias, a lack of tumor subtype details, and the absence of key confounders such as family history, BRCA status, and tubal ligation. As an observational study, it cannot prove causation. However, the findings align with previous biological and epidemiological research, underscoring the need for individualized risk assessment and tailored prevention strategies.</div><div>Reference:</div><div>Kim J, Hwang I, Lee S, Kim C, Lee S, Han K. Reproductive Shifts and Ovarian Cancer Risk in Women Aged 40 Years or Older. JAMA Netw Open. 2026;9(2):e2556840. doi:10.1001/jamanetworkopen.2025.56840</div></div>]]> </content:encoded>
</item>

<item>
<title>Bariatric surgery, particularly gastric bypass associated with decline in BMD, suggests research</title>
<link>https://edusehat.com/en/bariatric-surgery-particularly-gastric-bypass-associated-with-decline-in-bmd-suggests-research</link>
<guid>https://edusehat.com/en/bariatric-surgery-particularly-gastric-bypass-associated-with-decline-in-bmd-suggests-research</guid>
<description><![CDATA[ According to a new study metabolic and bariatric surgery—especially gastric bypass—is linked to reduced bone mineral density, along with decreased calcium and vitamin D levels and increased parathyroid hormone. These findings highlight the need for early postoperative monitoring of bone health using DXA scans and biochemical markers, particularly in high-risk patients and those with poor supplement adherence.Bariatric surgery is approved to promote weight loss and induce remission of obesity-related medical conditions. However, the impact of these procedures on bone density is still debated. This study aimed to assess the effect of bariatric surgeries on bone mineral density using dual-energy X-ray absorptiometry (DXA) scan in sleeve gastrectomy and bypass surgery.The prospective cohort study recruited 32 patients with severe obesity, who underwent metabolic and bariatric surgery. Patients were divided into two groups and monitored for one year. Laparoscopic sleeve gastrectomy group included 18 patients; the Bypass group included 14 patients. The primary outcome was the assessment of bone density by DXA scan. Secondary outcomes included serum calcium, parathyroid hormone, and vitamin D levels. Patients who underwent gastric bypass surgery had a higher incidence of bone loss at the femoral neck (p = 0.030) and radius (p = 0.043) compared to those who underwent sleeve gastrectomy. In the sleeve gastrectomy group, bone density at the spine was significantly reduced at one year postoperatively, while no statistically significant change was observed in the gastric bypass group. Vitamin D level was significantly higher in the sleeve gastrectomy group than in the bypass group (p = 0.029). Patients compliant with medications demonstrated significantly less bone loss with higher calcium and vitamin D and lower parathyroid hormone levels compared to noncompliant patients (p  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/25/334903-images-2026-03-24t212934130.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bariatric, surgery, particularly, gastric, bypass, associated, with, decline, BMD, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/25/334903-images-2026-03-24t212934130.webp"><p>According to a new study metabolic and bariatric surgery—especially gastric bypass—is linked to reduced bone mineral density, along with decreased calcium and vitamin D levels and increased parathyroid hormone. These findings highlight the need for early postoperative monitoring of bone health using DXA scans and biochemical markers, particularly in high-risk patients and those with poor supplement adherence.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Bariatric surgery is approved to promote weight loss and induce remission of obesity-related medical conditions. However, the impact of these procedures on bone density is still debated. This study aimed to assess the effect of bariatric surgeries on bone mineral density using dual-energy X-ray absorptiometry (DXA) scan in sleeve gastrectomy and bypass surgery.</p><p dir="ltr">The prospective cohort study recruited 32 patients with severe obesity, who underwent metabolic and bariatric surgery. Patients were divided into two groups and monitored for one year. Laparoscopic sleeve gastrectomy group included 18 patients; the Bypass group included 14 patients. The primary outcome was the assessment of bone density by DXA scan. Secondary outcomes included serum calcium, parathyroid hormone, and vitamin D levels. Patients who underwent gastric bypass surgery had a higher incidence of bone loss at the femoral neck (p = 0.030) and radius (p = 0.043) compared to those who underwent sleeve gastrectomy. In the sleeve gastrectomy group, bone density at the spine was significantly reduced at one year postoperatively, while no statistically significant change was observed in the gastric bypass group. Vitamin D level was significantly higher in the sleeve gastrectomy group than in the bypass group (p = 0.029). Patients compliant with medications demonstrated significantly less bone loss with higher calcium and vitamin D and lower parathyroid hormone levels compared to noncompliant patients (p < 0.05).</p><p dir="ltr">Metabolic and bariatric surgery is associated with changes in bone mineral density, most notably after gastric bypass procedures, accompanied by reductions in calcium and vitamin D levels and increased parathyroid hormone. These findings underscore the importance of early postoperative monitoring of bone health using DXA and biochemical markers, particularly after bypass procedures and in patients with poor adherence to supplementation.</p><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Elansary, A.M.S.E.O., Fahmy, M.H.A., Zaghloul, M. et al. Impact of bariatric surgeries on bone density in patients with severe obesity. BMC Surg (2026). https://doi.org/10.1186/s12893-026-03572-1</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Bariatric surgery, particularly,  gastric bypass,  associated, decline, BMD, Elansary, A.M.S.E.O., Fahmy, M.H.A., Zaghloul, M, Bariatric surgeries , Severe obesity, Bone mineral density, Dual-Energy X-ray Absorptiometry (DXA)</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Zasocitinib Shows Strong Efficacy in Plaque Psoriasis in Phase 3 trials</title>
<link>https://edusehat.com/en/zasocitinib-shows-strong-efficacy-in-plaque-psoriasis-in-phase-3-trials</link>
<guid>https://edusehat.com/en/zasocitinib-shows-strong-efficacy-in-plaque-psoriasis-in-phase-3-trials</guid>
<description><![CDATA[ Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of participants receiving once-daily oral zasocitinib achieved clear or almost clear skin within 16 weeks, indicating a rapid and meaningful clinical response. The treatment not only showed quick improvement but also demonstrated durable skin clearance over time. Additionally, the safety profile of zasocitinib remained consistent, with no significant new concerns identified. These findings, presented at the American Academy of Dermatology Annual Meeting, suggest that zasocitinib may represent an effective and well-tolerated oral therapeutic option for patients with moderate to severe plaque psoriasis.“Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasocitinib to become a leading oral treatment option for plaque psoriasis.”
In the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled Latitude PsO 3001 and 3002 studies, more than half of patients treated with zasocitinib achieved clear or almost clear skin at week 16, a key measure of treatment success: • 71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339332-psoriasis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Zasocitinib, Shows, Strong, Efficacy, Plaque, Psoriasis, Phase, trials</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339332-psoriasis.webp"><p>Two Phase 3 clinical studies evaluated the efficacy and safety of <a href="https://medicaldialogues.in/topics/zasocitinib">zasocitinib</a> in patients with moderate to severe <a href="https://medicaldialogues.in/topics/plaque-psoriasis">plaque psoriasis</a> and found promising results. Approximately 70% of participants receiving once-daily oral zasocitinib achieved clear or almost clear skin within 16 weeks, indicating a rapid and meaningful clinical response. The treatment not only showed quick improvement but also demonstrated durable skin clearance over time. Additionally, the safety profile of zasocitinib remained consistent, with no significant new concerns identified. </p><p>These findings, presented at the American Academy of Dermatology Annual Meeting, suggest that zasocitinib may represent an effective and well-tolerated oral therapeutic option for patients with moderate to severe plaque psoriasis.</p><p>“Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasocitinib to become a leading oral treatment option for plaque psoriasis.”
</p><p>In the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled Latitude PsO 3001 and 3002 studies, more than half of patients treated with zasocitinib achieved clear or almost clear skin at week 16, a key measure of treatment success: </p><p><span>• </span>71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0.001).</p><p>• 61.3% and 51.9% of patients treated with zasocitinib achieved Psoriasis Area and Severity Index (PASI) 90 versus placebo (5.0% and 4.0%) and apremilast (16.8% and 15.9%) at week 16 (p<0.001).2
</p><p>Zasocitinib also demonstrated statistically significant improvements in complete skin clearance, an increasingly important treatment goal for patients with plaque psoriasis:</p><p>• 39.9% and 33.7% of patients treated with zasocitinib achieved an sPGA score of 0 versus placebo (0.7% and 1.4%) and apremilast (8.0% and 6.5%) at week 16 (p<0.001).</p><p>• 33.4% and 25.2% of patients treated with zasocitinib achieved a PASI 100 versus placebo (0.7% and 1.1%) and apremilast (2.9% and 4.3%) at week 16 (p<0.001).</p><p>• Responses for co-primary and key secondary endpoints continued to increase through week 24 in both studies.</p><p>In Latitude PsO 3002, rapidity of response was demonstrated as early as week 4 versus placebo (PASI 75: 16.8% for zasocitinib vs 4.3% for placebo, p<0.001). Among patients who achieved a PASI 75, PASI 90 or sPGA 0/1 response at week 40 and continued on zasocitinib throughout the study, over 90% maintained their response at week 60.</p><p>Zasocitinib was generally well-tolerated. The safety and tolerability profile of zasocitinib in the Phase 3 studies remained consistent with prior studies. Key findings across the two studies include:
</p><p><span>• </span>Treatment-emergent adverse events (TEAEs) through week 16 were 62.1% for zasocitinib, 46.9% for placebo and 50.5% for apremilast.</p><p>• The most common adverse events for zasocitinib treated patients through week 16 (≥5%) were upper respiratory tract infection (10.1%), nasopharyngitis (6.2%) and acne (6.5%), with no new safety signals identified.</p><p>• Serious TEAEs through week 16 were 3.0% for zasocitinib, <1% for placebo and 1.5% for apremilast.</p><p>“Our Phase 3 results demonstrate that highly selective TYK2 inhibition can offer many people with moderate-to-severe plaque psoriasis the potential for clear or nearly clear skin,” said Chinwe Ukomadu, MD, PhD, senior vice president and head, Gastrointestinal & Inflammation Therapeutic Area Unit at Takeda. “The positive data also underscore zasocitinib’s potential to deliver rapid and durable results with a favorable safety profile consistent with Phase 2b studies. We are working as quickly as possible with regulators to advance a potential new therapeutic option for patients seeking a safe, effective and convenient oral treatment.”
</p><p>Takeda is on track to submit a New Drug Application with the United States Food and Drug Administration and other regulatory authorities starting in fiscal year 2026.
</p><p>Results from the Phase 3 studies have no significant impact on the full-year consolidated forecast for the fiscal year ending March 31, 2026.</p>]]> </content:encoded>
</item>

<item>
<title>Clear Aligners Improve Oral Microbiological and Periodontal Health Over Fixed Appliances: Study</title>
<link>https://edusehat.com/en/clear-aligners-improve-oral-microbiological-and-periodontal-health-over-fixed-appliances-study</link>
<guid>https://edusehat.com/en/clear-aligners-improve-oral-microbiological-and-periodontal-health-over-fixed-appliances-study</guid>
<description><![CDATA[ A recent study published in the journal of Clinical and Experimental Dental Research revealed that clear aligners are associated with better oral microbiological balance and periodontal health compared to fixed appliances (FA). This advantage is likely due to easier oral hygiene maintenance and reduced plaque accumulation. Patients using clear aligners show consistently lower levels of Streptococcus mutans.Oral malocclusion, affects a significant portion of the global population. Beyond cosmetic concerns, it can impair chewing, speech, and overall oral hygiene. Orthodontic treatment has long relied on fixed appliances such as braces, but clear aligners have emerged as a modern solution, prized for their discreet appearance and removability.This study analyzed data from major scientific databases, including PubMed, Medline, Cochrane Library, Embase, and Scopus, to better understand how these treatments influence the oral microbiome. Their search focused on bacterial and microbiological changes associated with clear aligner therapy. Out of numerous studies, 12 met the strict inclusion criteria. Together, they provided valuable insights into how orthodontic devices influence oral bacteria over time. Study found that clear aligners can cause rapid changes in the oral microbiome. Within just 24 hours of use, measurable shifts in bacterial diversity were observed.Over longer periods (from one month to a year), patients using clear aligners consistently showed better oral health indicators when compared to those with fixed braces. These included lower plaque levels, reduced gum inflammation, and shallower periodontal pockets which associated with healthier gums.These improvements largely attribute to the removable nature of aligners. Unlike fixed braces, which can trap food and make brushing and flossing more difficult, clear aligners can be taken out during meals and oral hygiene routines. This allows users to maintain a cleaner oral environment, reducing the buildup of harmful bacteria.Another important finding involved reduced levels of Streptococcus mutans, which is strongly linked to tooth decay. Patients undergoing aligner therapy consistently exhibited lower concentrations of this microorganism, which suggests a decreased risk of cavities during treatment. Overall, the current evidence points toward clear aligners as a favorable option not only for straightening teeth but also for preserving oral health. Source:Tabone, M., Carreras-Presas, C. M., Cenzato, N., Del Fabbro, M., &amp; Soltero, R. G. (2026). Impact of clear aligners on the oral microbiome: A systematic review of current evidence. Clinical and Experimental Dental Research, 12(2), e70265. https://doi.org/10.1002/cre2.70265 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/11/209477-607a38464a396228ce93921ainvisalign-faqs-e1513624610575.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Clear, Aligners, Improve, Oral, Microbiological, and, Periodontal, Health, Over, Fixed, Appliances:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/11/209477-607a38464a396228ce93921ainvisalign-faqs-e1513624610575.webp"><p>A recent study published in the journal of <i>Clinical and Experimental Dental Research</i> revealed that clear aligners are associated with better oral microbiological balance and periodontal health compared to fixed appliances (FA). This advantage is likely due to easier oral hygiene maintenance and reduced plaque accumulation. Patients using clear aligners show consistently lower levels of Streptococcus mutans.</p><p>Oral malocclusion, affects a significant portion of the global population. Beyond cosmetic concerns, it can impair chewing, speech, and overall oral hygiene. Orthodontic treatment has long relied on fixed appliances such as braces, but clear aligners have emerged as a modern solution, prized for their discreet appearance and removability.</p><p>This study analyzed data from major scientific databases, including PubMed, Medline, Cochrane Library, Embase, and Scopus, to better understand how these treatments influence the oral microbiome. Their search focused on bacterial and microbiological changes associated with clear aligner therapy. </p><p>Out of numerous studies, 12 met the strict inclusion criteria. Together, they provided valuable insights into how orthodontic devices influence oral bacteria over time. Study found that clear aligners can cause rapid changes in the oral microbiome. Within just 24 hours of use, measurable shifts in bacterial diversity were observed.</p><p>Over longer periods (from one month to a year), patients using clear aligners consistently showed better oral health indicators when compared to those with fixed braces. These included lower plaque levels, reduced gum inflammation, and shallower periodontal pockets which associated with healthier gums.</p><p>These improvements largely attribute to the removable nature of aligners. Unlike fixed braces, which can trap food and make brushing and flossing more difficult, clear aligners can be taken out during meals and oral hygiene routines. This allows users to maintain a cleaner oral environment, reducing the buildup of harmful bacteria.</p><p>Another important finding involved reduced levels of Streptococcus mutans, which is strongly linked to tooth decay. Patients undergoing aligner therapy consistently exhibited lower concentrations of this microorganism, which suggests a decreased risk of cavities during treatment. Overall, the current evidence points toward clear aligners as a favorable option not only for straightening teeth but also for preserving oral health. </p><p>Source:</p><p>Tabone, M., Carreras-Presas, C. M., Cenzato, N., Del Fabbro, M., & Soltero, R. G. (2026). Impact of clear aligners on the oral microbiome: A systematic review of current evidence. Clinical and Experimental Dental Research, 12(2), e70265. <a href="https://onlinelibrary.wiley.com/doi/10.1002/cre2.70265" rel="nofollow">https://doi.org/10.1002/cre2.70265</a></p>]]> </content:encoded>
</item>

<item>
<title>Low Fischer’s Ratio Associated with Increased Mortality in Chronic Kidney Disease: Study</title>
<link>https://edusehat.com/en/low-fischers-ratio-associated-with-increased-mortality-in-chronic-kidney-disease-study</link>
<guid>https://edusehat.com/en/low-fischers-ratio-associated-with-increased-mortality-in-chronic-kidney-disease-study</guid>
<description><![CDATA[ Sweden: Researchers have found in a new study that a lower Fischer’s ratio—a marker reflecting the balance between branched-chain and aromatic amino acids—is linked to a higher risk of death among patients with kidney failure, particularly those with underlying cardiovascular disease.A study published in Scientific Reports by Qianying Zhang and colleagues from Karolinska Institutet, Sweden, sheds light on the prognostic significance of metabolic alterations in individuals initiating dialysis. The findings suggest that disruptions in amino acid balance may serve as an important indicator of survival outcomes in this vulnerable population.Fischer’s ratio (FR), calculated as the ratio of branched-chain amino acids (BCAAs)—valine, isoleucine, and leucine—to aromatic amino acids (AAAs)—phenylalanine and tyrosine—has been previously associated with metabolic health. In kidney failure, metabolic disturbances are common, and the researchers aimed to explore whether FR could predict mortality risk.For this purpose, the researchers analyzed 328 patients with kidney failure who had recently started dialysis. The median age of participants was 54 years, and 60% were men. Plasma concentrations of amino acids were measured using high-performance liquid chromatography (HPLC). The study employed competing-risk regression models, accounting for renal transplantation as a competing event, to assess survival over five years. Additionally, advanced statistical models were used to evaluate continuous relationships between amino acid levels and mortality.   The study led to the following findings:The median follow-up duration was approximately 29 months, during which over half of the patients underwent kidney transplantation and about one-quarter died.Patients with lower Fischer’s ratio (FR), including those in the middle and lowest tertiles, had a significantly higher risk of mortality compared to those with higher FR levels.The risk of death was approximately 74% higher among individuals with reduced FR.Lower FR was associated with increased levels of inflammation.Reduced FR was also linked to protein-energy wasting, a condition known to adversely affect outcomes in chronic kidney disease.These associations indicate that FR may reflect underlying metabolic and nutritional disturbances contributing to disease progression.The relationship between low FR and mortality was particularly pronounced in patients with pre-existing cardiovascular disease.In this subgroup, patients with lower FR had more than a fourfold increased risk of death.The findings suggest a potential interaction between metabolic imbalance and cardiovascular disease in influencing survival outcomes.Overall, the findings indicate that Fischer’s ratio could serve as a useful biomarker for risk stratification in patients with kidney failure. Monitoring amino acid profiles may help clinicians identify high-risk individuals and guide targeted interventions. The authors emphasize that further research is needed to determine whether modifying amino acid balance could improve survival in this population.Reference:Zhang, Q., Suliman, M. E., Qureshi, A. R., Guo, F., Troise, D., Xu, R., Bárány, P., Heimbürger, O., Stenvinkel, P., &amp; Lindholm, B. (2026). Low Fischer’s ratio is associated with increased mortality in patients with kidney failure. Scientific Reports. https://doi.org/10.1038/s41598-026-46326-y ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277384-kidney-failure.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Low, Fischer’s, Ratio, Associated, with, Increased, Mortality, Chronic, Kidney, Disease:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277384-kidney-failure.webp"><p><span>Sweden: Researchers have found in a new study that a lower Fischer’s ratio—a marker reflecting the balance between branched-chain and aromatic<a href="https://medicaldialogues.in/topics/amino-acid"> amino acids</a>—is linked to a higher risk of death among patients with<a href="https://medicaldialogues.in/topics/kidney-failure"> kidney failure</a>, particularly those with underlying <a href="https://medicaldialogues.in/topics/cardiovascular-disease">cardiovascular disease</a>.</span></p><div class="pasted-from-word-wrapper"><div>A study published in <i>Scientific Reports</i> by Qianying Zhang and colleagues from Karolinska Institutet, Sweden, sheds light on the prognostic significance of metabolic alterations in individuals initiating dialysis. The findings suggest that disruptions in amino acid balance may serve as an important indicator of survival outcomes in this vulnerable population.</div><div>Fischer’s ratio (FR), calculated as the ratio of branched-chain amino acids (BCAAs)—valine, isoleucine, and leucine—to aromatic amino acids (AAAs)—phenylalanine and tyrosine—has been previously associated with metabolic health. In kidney failure, metabolic disturbances are common, and the researchers aimed to explore whether FR could predict mortality risk.</div><div>For this purpose, the researchers analyzed 328 patients with kidney failure who had recently started dialysis. The median age of participants was 54 years, and 60% were men. Plasma concentrations of amino acids were measured using high-performance liquid chromatography (HPLC). The study employed competing-risk regression models, accounting for renal transplantation as a competing event, to assess survival over five years. Additionally, advanced statistical models were used to evaluate continuous relationships between amino acid levels and mortality.   </div><div>The study led to the following findings:</div><ul><li>The median follow-up duration was approximately 29 months, during which over half of the patients underwent kidney transplantation and about one-quarter died.</li><li>Patients with lower Fischer’s ratio (FR), including those in the middle and lowest tertiles, had a significantly higher risk of mortality compared to those with higher FR levels.</li><li>The risk of death was approximately 74% higher among individuals with reduced FR.</li><li>Lower FR was associated with increased levels of inflammation.</li><li>Reduced FR was also linked to protein-energy wasting, a condition known to adversely affect outcomes in chronic kidney disease.</li><li>These associations indicate that FR may reflect underlying metabolic and nutritional disturbances contributing to disease progression.</li><li>The relationship between low FR and mortality was particularly pronounced in patients with pre-existing cardiovascular disease.</li><li>In this subgroup, patients with lower FR had more than a fourfold increased risk of death.</li><li>The findings suggest a potential interaction between metabolic imbalance and cardiovascular disease in influencing survival outcomes.</li></ul><div>Overall, the findings indicate that Fischer’s ratio could serve as a useful biomarker for risk stratification in patients with kidney failure. Monitoring amino acid profiles may help clinicians identify high-risk individuals and guide targeted interventions. The authors emphasize that further research is needed to determine whether modifying amino acid balance could improve survival in this population.</div><div>Reference:</div><div>Zhang, Q., Suliman, M. E., Qureshi, A. R., Guo, F., Troise, D., Xu, R., Bárány, P., Heimbürger, O., Stenvinkel, P., & Lindholm, B. (2026). Low Fischer’s ratio is associated with increased mortality in patients with kidney failure. Scientific Reports. https://doi.org/10.1038/s41598-026-46326-y</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Early Antiviral Prophylaxis Reduces Influenza Hospitalizations in Nursing Homes: Study</title>
<link>https://edusehat.com/en/early-antiviral-prophylaxis-reduces-influenza-hospitalizations-in-nursing-homes-study</link>
<guid>https://edusehat.com/en/early-antiviral-prophylaxis-reduces-influenza-hospitalizations-in-nursing-homes-study</guid>
<description><![CDATA[ According to a new study  prompt initiation of antiviral chemoprophylaxis in at least 70% of nursing home residents within 2 days of an influenza outbreak can significantly reduce influenza-related hospitalizations.Influenza outbreaks in nursing homes (NHs) can cause high morbidity and mortality. Antiviral chemoprophylaxis with oseltamivir is recommended, yet optimal implementation strategies remain unclear. A study was done toexamine whether initiating antiviral chemoprophylaxis for 70% or more of eligible NH residents within 2 days of influenza outbreak detection is associated with lower all-cause mortality and hospitalization at 14 and 30 days. Retrospective cohort study using a sequential cluster-randomized target trial emulation and randomize-censor-weight approach for influenza outbreaks (September 1, 2018–May 31, 2022) in 12 US NH corporations. Eligibility criteria were age 18 years or older, present on the outbreak-detection day, no antiviral use in the preceding 7 days, no influenza in the past 14 days, and complete baseline data. Residents were followed up until hospitalization or death, an NH discharge to a nonacute-care location, or the end of follow-up. Data were analyzed from February 2023 to January 2026. Intensive antiviral chemoprophylaxis with oseltamivir (≥70% of eligible residents within 2 days of outbreak detection) or nonintensive antiviral chemoprophylaxis (0% to  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/339010-images-2026-04-01t192745189.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Early, Antiviral, Prophylaxis, Reduces, Influenza, Hospitalizations, Nursing, Homes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/339010-images-2026-04-01t192745189.webp"><p>According to a new study  prompt initiation of antiviral chemoprophylaxis in at least 70% of nursing home residents within 2 days of an influenza outbreak can significantly reduce influenza-related hospitalizations.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Influenza outbreaks in nursing homes (NHs) can cause high morbidity and mortality. Antiviral chemoprophylaxis with oseltamivir is recommended, yet optimal implementation strategies remain unclear. A study was done toexamine whether initiating antiviral chemoprophylaxis for 70% or more of eligible NH residents within 2 days of influenza outbreak detection is associated with lower all-cause mortality and hospitalization at 14 and 30 days. Retrospective cohort study using a sequential cluster-randomized target trial emulation and randomize-censor-weight approach for influenza outbreaks (September 1, 2018–May 31, 2022) in 12 US NH corporations. Eligibility criteria were age 18 years or older, present on the outbreak-detection day, no antiviral use in the preceding 7 days, no influenza in the past 14 days, and complete baseline data. Residents were followed up until hospitalization or death, an NH discharge to a nonacute-care location, or the end of follow-up. Data were analyzed from February 2023 to January 2026. Intensive antiviral chemoprophylaxis with oseltamivir (≥70% of eligible residents within 2 days of outbreak detection) or nonintensive antiviral chemoprophylaxis (0% to <70% of eligible residents). Outcomes were all-cause death and hospitalizations within 14 and 30 days of outbreak detection. Discrete-time hazard models with pooled logistic regression were applied to estimate weighted risks, risk differences (RDs), and risk ratios (RRs).</p><p dir="ltr">Results  Among 404 outbreaks in 318 NHs, 35 086 resident-trial observations (29 683 residents; median age 78 [IQR, 68- 86] years; 60% women; 81% White; 76% vaccinated) met eligibility criteria. Intensive oseltamivir prophylaxis was randomized to 17 155 observations; 17 931 were randomized to nonintensive care. At 14 days, intensive prophylaxis vs nonintensive yielded an RD of –0.06% (95% CI, −0.73% to 0.93%) and an RR of 0.96 (95% CI, 0.56-1.57) for death, and an RD of –0.96% (95% CI, −1.78% to −0.19%) and an RR of 0.79 (95% CI, 0.64-0.96) for hospitalization. At 30 days, the hospitalization differences persisted but were less precise and there continued to be no difference in death.  Study results suggest that clinicians should initiate antiviral chemoprophylaxis for at least 70% of eligible NH residents within 2 days of outbreak detection to lower risk of hospitalization.</p><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Silva JBB, Hsieh HT, Howe CJ, Gravenstein S, Reich LA, Zullo AR. Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks. JAMA Intern Med. Published online March 30, 2026. doi:10.1001/jamainternmed.2026.0401</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Early,  Antiviral,  Prophylaxis,  Reduces,  Influenza,  Hospitalizations, Nursing Homes, Study, Silva JBB, Hsieh HT, Howe CJ, Gravenstein S, Reich LA, Zullo AR</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Wrist Splinting Shows No Significant Benefit in Carpal Tunnel Syndrome: Study</title>
<link>https://edusehat.com/en/wrist-splinting-shows-no-significant-benefit-in-carpal-tunnel-syndrome-study</link>
<guid>https://edusehat.com/en/wrist-splinting-shows-no-significant-benefit-in-carpal-tunnel-syndrome-study</guid>
<description><![CDATA[ In a randomized trial of 142 patients with carpal tunnel syndrome, researchers have found that rigid wrist splinting did not provide meaningful improvement compared to a soft placebo bandage. Both groups showed minimal reduction in symptom scores at 12 weeks, and slightly more patients in the splint group progressed to surgery within one year. However, these differences were not statistically significant, suggesting limited effectiveness of wrist splinting as a conservative treatment.These findings are published in the NEJM Evidence in March 2026.While wrist splinting is widely utilized as a first-line conservative treatment for CTS, there is currently a lack of high-quality evidence to confirm its clinical benefit, prompting Dr. Isam Atroshi and colleagues to investigate whether rigid splints truly outperform placebo alternatives in alleviating symptoms and preventing the need for operative care.In the parallel-group clinical trial, 142 patients diagnosed with untreated, primary idiopathic CTS for at least one month were randomly assigned to wear either a rigid wrist splint or a placebo soft bandage that allowed full motion for a duration of six to twelve weeks, with researchers monitoring changes in a six-item symptoms score and assessing the necessity for surgery after one year of follow-up while excluding anyone with prior treatments.Key Clinical Findings of the Study Include:Insignificant 0.08 Symptom Difference: The trial demonstrated that the adjusted mean difference in the 12-week symptom score change between the two groups was statistically negligible (95% confidence interval [CI], -0.15 to 0.31; P=0.478). Comparable 51-57% Surgery Rates: Trial observed that at the one-year assessment, 57.1% of patients in the rigid splint group and 51.4% in the placebo group proceeded to surgery, yielding an adjusted relative risk of 1.10 (95% CI, 0.81–1.48). Sub-threshold 0.36 Improvement: Investigation found that neither group achieved the predefined minimal clinically important difference of 0.9, with symptoms decreasing by only 0.36 in the splint group and 0.28 in the placebo arm from their respective baselines.Uniform Safety with 12 Local Events: Research noted that minor local adverse events were identical across both treatment arms, with 12 patients in each group reporting issues and no serious complications recorded during the investigation. Identical ~2.80 Baseline Scores: Analysis revealed that cohorts were well-matched at the start of the trial, with baseline CTS symptom scores of 2.81 for the rigid splint group and 2.80 for the placebo bandage group.The results suggest that for patients managing CTS, rigid wrist splinting does not provide a significantly better clinical outcome than a placebo bandage, as both interventions failed to meet the threshold for clinically important symptom improvement, and more than half of all patients eventually opted for surgery.Thus, the trail concludes that healthcare practitioners might consider that traditional rigid splinting may not be more effective than minimal supportive bandaging for long-term symptom control in idiopathic carpal tunnel syndrome cases.Although the study offers robust data on conservative management, specific limitations and future research needs were not explicitly outlined in the provided text, yet the findings highlight the critical need for continued investigation into effective non-surgical therapies for this common condition.ReferenceAtroshi I, Nordenskjöld J, Möllestam K. Wrist Splinting versus a Placebo Soft Bandage for Carpal Tunnel Syndrome. NEJM Evid 2026;5(4). ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/12/24/316724-wristpainblog-1024x881.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Wrist, Splinting, Shows, Significant, Benefit, Carpal, Tunnel, Syndrome:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/12/24/316724-wristpainblog-1024x881.webp"><p>In a randomized trial of 142 patients with <a href="https://medicaldialogues.in/orthopaedics/guidelines/carpal-tunnel-syndrome-aaos-updates-clinical-practice-guideline-130023">carpal tunnel syndrome</a>, researchers have found that rigid wrist splinting did not provide meaningful improvement compared to a soft placebo bandage. Both groups showed minimal reduction in symptom scores at 12 weeks, and slightly more patients in the splint group progressed to surgery within one year. However, these differences were not statistically significant, suggesting limited effectiveness of wrist splinting as a conservative treatment.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings are published in the <i>NEJM Evidence</i> in March 2026.</p><p dir="ltr">While <a href="https://medicaldialogues.in/orthopaedics/cases/mass-like-calcific-peri-arthritis-of-wrist-presenting-as-acute-carpal-tunnel-syndrome-case-report-99689">wrist splinting</a> is widely utilized as a first-line conservative treatment for CTS, there is currently a lack of high-quality evidence to confirm its clinical benefit, prompting Dr. Isam Atroshi and colleagues to investigate whether rigid splints truly outperform placebo alternatives in alleviating symptoms and preventing the need for operative care.</p><p dir="ltr">In the parallel-group clinical trial, 142 patients diagnosed with untreated, primary idiopathic CTS for at least one month were randomly assigned to wear either a rigid wrist splint or a <a href="https://medicaldialogues.in/medical-courses/curriculum/dnb-physical-medicine-and-rehabilitation-in-india-check-out-nbe-released-curriculum-101769">placebo soft bandage</a> that allowed full motion for a duration of six to twelve weeks, with researchers monitoring changes in a six-item symptoms score and assessing the necessity for surgery after one year of follow-up while excluding anyone with prior treatments.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Insignificant 0.08 Symptom Difference: </b>The trial demonstrated that the adjusted mean difference in the 12-week symptom score change between the two groups was statistically negligible (95% confidence interval [CI], -0.15 to 0.31; P=0.478). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Comparable 51-57% Surgery Rates: </b>Trial observed that at the one-year assessment, 57.1% of patients in the rigid splint group and 51.4% in the placebo group proceeded to surgery, yielding an adjusted relative risk of 1.10 (95% CI, 0.81–1.48). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Sub-threshold 0.36 Improvement:</b> Investigation found that neither group achieved the predefined minimal clinically important difference of 0.9, with symptoms decreasing by only 0.36 in the splint group and 0.28 in the placebo arm from their respective baselines.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Uniform Safety with 12 Local Events:</b> Research noted that minor local adverse events were identical across both treatment arms, with 12 patients in each group reporting issues and no serious complications recorded during the investigation.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b> Identical ~2.80 Baseline Scores: </b>Analysis revealed that cohorts were well-matched at the start of the trial, with baseline CTS symptom scores of 2.81 for the rigid splint group and 2.80 for the placebo bandage group.</p></li></ul><p dir="ltr">The results suggest that for patients managing CTS, rigid wrist splinting does not provide a significantly better clinical outcome than a placebo bandage, as both interventions failed to meet the threshold for clinically important symptom improvement, and more than half of all patients eventually opted for surgery.</p><p dir="ltr">Thus, the trail concludes that healthcare practitioners might consider that traditional rigid splinting may not be more effective than minimal supportive bandaging for long-term symptom control in idiopathic carpal tunnel syndrome cases.</p><p dir="ltr">Although the study offers robust data on conservative management, specific limitations and future research needs were not explicitly outlined in the provided text, yet the findings highlight the critical need for continued investigation into effective non-surgical therapies for this common condition.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Atroshi I, Nordenskjöld J, Möllestam K. Wrist Splinting versus a Placebo Soft Bandage for Carpal Tunnel Syndrome. NEJM Evid 2026;5(4).</p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Gradual rise in myeloid leukemia witnessed after chemotherapy or radiation therapy , reveals study</title>
<link>https://edusehat.com/en/gradual-rise-in-myeloid-leukemia-witnessed-after-chemotherapy-or-radiation-therapy-reveals-study</link>
<guid>https://edusehat.com/en/gradual-rise-in-myeloid-leukemia-witnessed-after-chemotherapy-or-radiation-therapy-reveals-study</guid>
<description><![CDATA[ Some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood. A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia (tAML) in recent years, especially after breast cancer treatment. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
tAML is an aggressive cancer of the blood and bone marrow that develops after prior chemotherapy or radiation for an earlier, primary cancer, likely arising in part due to DNA damage from these treatments. To assess whether tAML is increasing as a post-cancer therapy complication as the number of cancer survivors increases, investigators analyzed data from the Osaka Cancer Registry pertaining to patients in Japan who were diagnosed with AML between 1990 and 2020.
Among 9,841 patients with AML, 636 (6.5%) had tAML. The annual tAML incidence increased from 0.13 per 100,000 population in 1990 to 0.36 per 100,000 population in 2020. The proportion of tAML cases in overall AML cases almost doubled.
The most common primary cancer that was treated before tAML developed was another form of blood cancer (23.1%), followed by breast cancer (14.6%), colorectal cancer (11.5%), and gastric cancer (8.7%). The distribution of primary cancers changed over time, with a prominent increase in breast cancer and a decrease in gastric cancer.
“The study provides an important step towards better understanding how the nature of tAML is changing with the increasing number of cancer survivors,” said lead author Kenji Kishimoto, MD, PhD, of the Osaka International Cancer Institute.Reference:Kenji Kishimoto, Kayo Nakata, Mizuki Shimadzu Kato, Toshiki Ikawa, Haruka Kudo, Yoko Iwaki, Yoshihiro Kuwabara, Toshitaka Morishima, Isao Miyashiro, Increasing incidence and changing distribution of primary cancers in therapy-related acute myeloid leukemia: A population-based study in Osaka, Japan, 1990–2020, Cancer, https://doi.org/10.1002/cncr.70316 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/14/185532-chemotherapy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gradual, rise, myeloid, leukemia, witnessed, after, chemotherapy, radiation, therapy, reveals, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/14/185532-chemotherapy.webp"><p>Some therapies used to treat <a href="https://medicaldialogues.in/topics/cancer">cancer </a>may increase the risk of later developing cancers that affect the blood. A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia (tAML) in recent years, especially after <a href="https://medicaldialogues.in/topics/breast-cancer">breast cancer </a>treatment. The findings are published by Wiley online in <i>CANCER</i>, a peer-reviewed journal of the American Cancer Society.
</p><p>tAML is an aggressive cancer of the blood and bone marrow that develops after prior <a href="https://medicaldialogues.in/topics/chemotherapy">chemotherapy </a>or radiation for an earlier, primary cancer, likely arising in part due to DNA damage from these treatments. To assess whether tAML is increasing as a post-cancer therapy complication as the number of cancer survivors increases, investigators analyzed data from the Osaka Cancer Registry pertaining to patients in Japan who were diagnosed with AML between 1990 and 2020.
</p><p>Among 9,841 patients with AML, 636 (6.5%) had tAML. The annual tAML incidence increased from 0.13 per 100,000 population in 1990 to 0.36 per 100,000 population in 2020. The proportion of tAML cases in overall AML cases almost doubled.
</p><p>The most common primary cancer that was treated before tAML developed was another form of blood cancer (23.1%), followed by breast cancer (14.6%), colorectal cancer (11.5%), and gastric cancer (8.7%). The distribution of primary cancers changed over time, with a prominent increase in breast cancer and a decrease in gastric cancer.
</p><p>“The study provides an important step towards better understanding how the nature of tAML is changing with the increasing number of cancer survivors,” said lead author Kenji Kishimoto, MD, PhD, of the Osaka International Cancer Institute.</p><p>Reference:</p><p>Kenji Kishimoto, Kayo Nakata, Mizuki Shimadzu Kato, Toshiki Ikawa, Haruka Kudo, Yoko Iwaki, Yoshihiro Kuwabara, Toshitaka Morishima, Isao Miyashiro, Increasing incidence and changing distribution of primary cancers in therapy-related acute myeloid leukemia: A population-based study in Osaka, Japan, 1990–2020, Cancer, https://doi.org/10.1002/cncr.70316</p>]]> </content:encoded>
</item>

<item>
<title>Heart disease risk tied to certain molecules made by gut microbes,  suggests research</title>
<link>https://edusehat.com/en/heart-disease-risk-tied-to-certain-molecules-made-by-gut-microbes-suggests-research</link>
<guid>https://edusehat.com/en/heart-disease-risk-tied-to-certain-molecules-made-by-gut-microbes-suggests-research</guid>
<description><![CDATA[ In a study involving data from thousands of people, the risk of a new coronary heart disease diagnosis was statistically associated with bloodstream levels of nine specific molecules that are produced by gut microbes. Danxia Yu of Vanderbilt University Medical Center, U.S., and colleagues present these findings on March 17th in the open-access journal PLOS Medicine.
The human digestive tract naturally contains a large population of microbes. Different people have different proportions of different species of gut microbes, which produce different molecules during their normal, metabolic chemical reactions. These metabolites can enter the bloodstream and exert a broad range of impacts, good and bad, on human health. Some gut microbe metabolites may be linked with a person’s risk of coronary heart disease—the world’s leading cause of death.
However, the full extent of these potential links remains unclear. To deepen understanding, Yu and colleagues conducted a multi-stage analysis of blood samples from a total of several thousand Black, White, and Asian adults from across the U.S. and Shanghai, China. First, using data from nearly 2,000 of the participants, they discovered several gut microbe metabolites associated with the risk of developing coronary heart disease. Then, they used the rest of the data to validate and refine these links—including external and quantitative validations, and accounting for many other factors known to be associated with risk of coronary heart disease, such as age, family health history, and diet.
The final analysis revealed nine specific gut microbe metabolites in the bloodstream that were associated with a higher or lower chance of developing coronary heart disease. These links remained consistent across some participants when stratified by lifestyle or family history. However, some differences in links between specific metabolites and heart disease risk were found when individuals were stratified by race or age.
This study underscores the link between gut microbes and heart health. On the basis of the findings, the researchers call for follow-up research into the nine metabolites they identified to determine whether they represent potentially promising avenues for development of novel ways to treat or prevent coronary heart disease.
The authors add, “This is one of the most comprehensive metabolomics studies to date, encompassing discovery, in silico validation, and quantitative validation across individuals from diverse ethnic backgrounds and geographic regions. Our findings underscore the importance of gut microbial metabolism in cardiovascular disease development and highlight promising molecules that may serve as novel biomarkers or therapeutic targets for future mechanistic and interventional studies.”Reference:Yulu Zheng, Jae Jeong Yang, Deepak K. Gupta, David M. Herrington, Bing Yu, Ngoc Quynh H. Nguyen,Rui Pinto, Ioanna Tzoulaki, Hui Cai, Qiuyin Cai, Loren Lipworth, Xiao-Ou Shu,Wei Zheng, Danxia Yu, Circulating gut microbial metabolites and risk of coronary heart disease: A prospective multi-stage metabolomics study, PLOS Medicine, DOI: 10.1371/journal.pmed.1004750  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/04/267576-heart-disease-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Heart, disease, risk, tied, certain, molecules, made, gut, microbes, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/04/267576-heart-disease-50.webp"><p>In a study involving data from thousands of people, the risk of a new <a href="https://medicaldialogues.in/topics/coronary-heart-disease">coronary heart disease</a> diagnosis was statistically associated with bloodstream levels of nine specific molecules that are produced by <a href="https://medicaldialogues.in/topics/gut-microbes">gut microbes</a>. Danxia Yu of Vanderbilt University Medical Center, U.S., and colleagues present these findings on March 17th in the open-access journal <i>PLOS Medicine</i>.
</p><p>The human digestive tract naturally contains a large population of microbes. Different people have different proportions of different species of gut microbes, which produce different molecules during their normal, metabolic chemical reactions. These metabolites can enter the bloodstream and exert a broad range of impacts, good and bad, on human health. Some gut microbe metabolites may be linked with a person’s risk of coronary heart disease—the world’s leading cause of death.
</p><p>However, the full extent of these potential links remains unclear. To deepen understanding, Yu and colleagues conducted a multi-stage analysis of blood samples from a total of several thousand Black, White, and Asian adults from across the U.S. and Shanghai, China. First, using data from nearly 2,000 of the participants, they discovered several gut microbe metabolites associated with the risk of developing coronary heart disease. Then, they used the rest of the data to validate and refine these links—including external and quantitative validations, and accounting for many other factors known to be associated with risk of coronary heart disease, such as age, family health history, and diet.
</p><p>The final analysis revealed nine specific gut microbe metabolites in the bloodstream that were associated with a higher or lower chance of developing coronary heart disease. These links remained consistent across some participants when stratified by lifestyle or family history. However, some differences in links between specific metabolites and heart disease risk were found when individuals were stratified by race or age.
</p><p>This study underscores the link between gut microbes and heart health. On the basis of the findings, the researchers call for follow-up research into the nine metabolites they identified to determine whether they represent potentially promising avenues for development of novel ways to treat or prevent coronary heart disease.
</p><p>The authors add, “This is one of the most comprehensive metabolomics studies to date, encompassing discovery, in silico validation, and quantitative validation across individuals from diverse ethnic backgrounds and geographic regions. Our findings underscore the importance of gut microbial metabolism in cardiovascular disease development and highlight promising molecules that may serve as novel biomarkers or therapeutic targets for future mechanistic and interventional studies.”</p><p>Reference:</p><p>Yulu Zheng, Jae Jeong Yang, Deepak K. Gupta, David M. Herrington, Bing Yu, Ngoc Quynh H. Nguyen,Rui Pinto, Ioanna Tzoulaki, Hui Cai, Qiuyin Cai, Loren Lipworth, Xiao-Ou Shu,Wei Zheng, Danxia Yu, Circulating gut microbial metabolites and risk of coronary heart disease: A prospective multi-stage metabolomics study, PLOS Medicine, DOI: 10.1371/journal.pmed.1004750 </p>]]> </content:encoded>
</item>

<item>
<title>People With HIV has higher Long COVID Risk, reveals research</title>
<link>https://edusehat.com/en/people-with-hiv-has-higher-long-covid-risk-reveals-research</link>
<guid>https://edusehat.com/en/people-with-hiv-has-higher-long-covid-risk-reveals-research</guid>
<description><![CDATA[ A new study published in the Journal of Acquired Immune Deficiency Syndrome revealed that people with HIV (PWH) have a significantly higher risk of developing long COVID across multiple organ systems when compared to people without HIV (PWoH).The study analyzed integrated electronic health records from South Carolina, covering COVID-19-positive patients tested between March 2, 2020, and January 15, 2022. This study compared long COVID outcomes among people with HIV and people without HIV, which examined 13 broad diagnosis groups that included 131 potential long COVID conditions.Out of 838,520 COVID-19-positive individuals included in the analysis, 2,662 were living with HIV and 835,858 were not. This research adjusted for key factors like age, sex, race, and vaccination status to ensure a fair comparison between the two groups.The results revealed that approximately 16.3 percent of people with HIV developed at least one long COVID condition, when compared to 10.6% of those without HIV. Overall, people living with HIV were 29% more likely to experience long COVID-related health issues.The most pronounced risks were observed in neurological, mental health, and respiratory conditions. People with HIV were more than twice as likely to develop diseases affecting the nervous system. They also showed substantially higher risks for mental health disorders and respiratory complications following COVID-19 infection.This research used advanced statistical methods, including inverse probability weighting and Cox proportional hazard modeling, to estimate risks across diagnosis categories. These techniques helped balance demographic and clinical characteristics between the HIV-positive and HIV-negative groups.Elevated risks may be linked to immune system differences in people living with HIV, even among those receiving effective treatment. Chronic inflammation and immune dysregulation may make recovery from COVID-19 more difficult and increase vulnerability to persistent symptoms.The findings highlight the importance of long-term follow-up care for COVID-19 survivors with HIV. Clinicians are encouraged to monitor neurological symptoms, mental health changes, and respiratory function in this population to reduce complications and improve quality of life. Targeted interventions, including early screening and rehabilitation services, may be particularly beneficial for people living with HIV.Overall, the findings of this research conclude that sustained clinical attention is essential to reduce the long COVID burden in this population and to prevent long-term disability and morbidity. The study adds to growing proof that vulnerable groups may face disproportionate long-term consequences from COVID-19 infection.Source:Shi, F., Xia, H., Li, X., Olatosi, B., Weissman, S., &amp; Yang, X. (2026). Long COVID between people with and without HIV: A statewide cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999). https://doi.org/10.1097/QAI.0000000000003840 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/15/294564-hiv.jpg" length="49398" type="image/jpeg"/>
<pubDate>Wed, 08 Apr 2026 00:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>People, With, HIV, has, higher, Long, COVID, Risk, reveals, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/15/294564-hiv.webp"><p>A new study published in the <i>Journal of Acquired Immune Deficiency Syndrome</i> revealed that people with HIV (PWH) have a significantly higher risk of developing long COVID across multiple organ systems when compared to people without HIV (PWoH).</p><p>The study analyzed integrated electronic health records from South Carolina, covering COVID-19-positive patients tested between March 2, 2020, and January 15, 2022. This study compared long COVID outcomes among people with HIV and people without HIV, which examined 13 broad diagnosis groups that included 131 potential long COVID conditions.</p><p>Out of 838,520 COVID-19-positive individuals included in the analysis, 2,662 were living with HIV and 835,858 were not. This research adjusted for key factors like age, sex, race, and vaccination status to ensure a fair comparison between the two groups.</p><p>The results revealed that approximately 16.3 percent of people with HIV developed at least one long COVID condition, when compared to 10.6% of those without HIV. Overall, people living with HIV were 29% more likely to experience long COVID-related health issues.</p><p>The most pronounced risks were observed in neurological, mental health, and respiratory conditions. People with HIV were more than twice as likely to develop diseases affecting the nervous system. They also showed substantially higher risks for mental health disorders and respiratory complications following COVID-19 infection.</p><p>This research used advanced statistical methods, including inverse probability weighting and Cox proportional hazard modeling, to estimate risks across diagnosis categories. These techniques helped balance demographic and clinical characteristics between the HIV-positive and HIV-negative groups.</p><p>Elevated risks may be linked to immune system differences in people living with HIV, even among those receiving effective treatment. Chronic inflammation and immune dysregulation may make recovery from COVID-19 more difficult and increase vulnerability to persistent symptoms.</p><p>The findings highlight the importance of long-term follow-up care for COVID-19 survivors with HIV. Clinicians are encouraged to monitor neurological symptoms, mental health changes, and respiratory function in this population to reduce complications and improve quality of life. Targeted interventions, including early screening and rehabilitation services, may be particularly beneficial for people living with HIV.</p><p>Overall, the findings of this research conclude that sustained clinical attention is essential to reduce the long COVID burden in this population and to prevent long-term disability and morbidity. The study adds to growing proof that vulnerable groups may face disproportionate long-term consequences from COVID-19 infection.</p><p>Source:</p><p>Shi, F., Xia, H., Li, X., Olatosi, B., Weissman, S., & Yang, X. (2026). Long COVID between people with and without HIV: A statewide cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999). <a href="https://journals.lww.com/jaids/abstract/9900/long_covid_between_people_with_and_without_hiv__a.790.aspx" rel="nofollow">https://doi.org/10.1097/QAI.0000000000003840</a></p>]]> </content:encoded>
</item>

<item>
<title>Odisha MBBS doctors protest over pending medical officer appointments</title>
<link>https://edusehat.com/en/odisha-mbbs-doctors-protest-over-pending-medical-officer-appointments</link>
<guid>https://edusehat.com/en/odisha-mbbs-doctors-protest-over-pending-medical-officer-appointments</guid>
<description><![CDATA[ Cuttack: In a peaceful protest on Monday outside the Odisha Public Service Commission (OPSC) office, hundreds of MBBS doctors demanded clarity and action on their delayed appointments, expressing frustration over delays in receiving appointment letters despite qualifying for medical officer posts.The protestors highlighted the uncertainty surrounding their professional futures. According to them, OPSC had invited applications in May last year for 5,284 medical officer posts. Nearly 3,000 candidates appeared for the examination, with 1,840 successfully qualifying. Following document verification, only around 822 candidates were issued appointment letters, leaving approximately 1,018 qualified doctors waiting indefinitely for postings. Also Read:CPS doctors protest at NMC over exam delays, demand pan-India recognitionThe doctors alleged that the lack of clarity and delays in issuing appointments had left them in limbo, causing widespread frustration. Many gathered outside the OPSC office to stage a peaceful protest, urging authorities to ensure transparency and fairness in the recruitment process. They also called upon the State government to take immediate steps to resolve the issue and provide clarity regarding the pending appointments.Speaking to Odisha TV, an agitating MBBS doctor stated, “OPSC has only released a final list of around 800 (candidates). However, for thousands of other candidates from the 1,840 who have qualified and passed out, OPSC has not taken any steps so far. When so many passed-out doctors are ready to go to villages and provide their services, it is necessary for you all (the media) to consider how appropriate it is for the State government to ignore them? We appeal to the government to instruct OPSC to take steps for the appointment of all 1,840 qualified doctors.” 
Another protester said they had been running from pillar to post and had even met the Health minister, apprising him of their concern, but to no avail. “The state government says there is a shortage of doctors, but qualified doctors are not being given postings. We request the OPSC to grant posting to all qualified doctors,” he said, reports TNIE.   In response, OPSC Secretary Bijay Kumar Khandayat Ray clarified that the recruitment process was conducted in strict compliance with rules and directives from the Orissa High Court. The court had mandated appointments for 822 candidates, which have already been completed. Any further appointments will depend on decisions by the State government.
“We had called a total of 1,840 candidates for document verification. We called those who had qualified. Out of them, 1,722 were present. The others were absent. Hence, we had to fill up 1,722 posts. As per the order we received from the Orissa High Court and respecting the Court’s order, we recommended 411 UR category candidates and 411 reserved category candidates,” OPSC Secretary, Bijay Kumar Khandayat Ray, said, Odisha TV.
Also Read:Newborn dies at Kanpur Hospital; family alleges doctor consulted through video call ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/05/14/128732-medical-students.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Odisha, MBBS, doctors, protest, over, pending, medical, officer, appointments</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/05/14/128732-medical-students.webp"><p><b>Cuttack:</b> In a <span>peaceful </span><a href="https://medicaldialogues.in/topics/protest">protest</a><span> on Monday outside the Odisha Public Service Commission (OPSC) office, h</span>undreds of MBBS doctors demanded clarity and action on their delayed appointments, expressing frustration over delays in receiving appointment letters despite qualifying for medical officer posts.</p><p>The protestors highlighted the uncertainty surrounding their professional futures. According to them, OPSC had invited applications in May last year for 5,284 medical officer posts. Nearly 3,000 candidates appeared for the examination, with 1,840 successfully qualifying. Following document verification, only around 822 candidates were issued appointment letters, leaving approximately 1,018 qualified doctors waiting indefinitely for postings. <br></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/cps-doctors-protest-at-nmc-over-exam-delays-demand-pan-india-recognition-167912"><b>Also Read:CPS doctors protest at NMC over exam delays, demand pan-India recognition</b></a></p><div class="pasted-from-word-wrapper"><div><span>The doctors alleged that the lack of clarity and delays in issuing appointments had left them in limbo, causing widespread frustration. Many gathered outside the OPSC office to stage a peaceful protest, urging authorities to ensure transparency and fairness in the recruitment process. They also called upon the State government to take immediate steps to resolve the issue and provide clarity regarding the pending appointments.</span></div></div><p>Speaking to Odisha TV, an agitating MBBS doctor stated, “OPSC has only released a final list of around 800 (candidates). However, for thousands of other candidates from the 1,840 who have qualified and passed out, OPSC has not taken any steps so far. When so many passed-out doctors are ready to go to villages and provide their services, it is necessary for you all (the media) to consider how appropriate it is for the State government to ignore them? We appeal to the government to instruct OPSC to take steps for the appointment of all 1,840 qualified doctors.” 
</p><p>Another protester said they had been running from pillar to post and had even met the Health minister, apprising him of their concern, but to no avail. “The state government says there is a shortage of doctors, but qualified doctors are not being given postings. We request the OPSC to grant posting to all qualified doctors,” he said, reports <a href="https://www.newindianexpress.com/amp/story/states/odisha/2026/Apr/07/mbbs-doctors-stage-dharna-in-front-of-opsc-office-seeking-appointment-letter" rel="nofollow">TNIE</a>.   </p><p>In response, OPSC Secretary Bijay Kumar Khandayat Ray clarified that the recruitment process was conducted in strict compliance with rules and directives from the Orissa High Court. The court had mandated appointments for 822 candidates, which have already been completed. Any further appointments will depend on decisions by the State government.
</p><p>“We had called a total of 1,840 candidates for document verification. We called those who had qualified. Out of them, 1,722 were present. The others were absent. Hence, we had to fill up 1,722 posts. As per the order we received from the Orissa High Court and respecting the Court’s order, we recommended 411 UR category candidates and 411 reserved category candidates,” OPSC Secretary, Bijay Kumar Khandayat Ray, said,<a href="https://odishatv.in/odisha/hundreds-of-odisha-mbbs-doctors-hit-the-streets-demanding-appointment-letters-11458550" rel="nofollow"> Odisha TV</a>.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/newborn-dies-at-kanpur-hospital-family-alleges-doctor-consulted-through-video-call-167851"><b>Also Read:Newborn dies at Kanpur Hospital; family alleges doctor consulted through video call</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Dr DY Patil Vidyapeeth among top 500 globally in medicine, 150 in dentistry: QS rankings</title>
<link>https://edusehat.com/en/dr-dy-patil-vidyapeeth-among-top-500-globally-in-medicine-150-in-dentistry-qs-rankings</link>
<guid>https://edusehat.com/en/dr-dy-patil-vidyapeeth-among-top-500-globally-in-medicine-150-in-dentistry-qs-rankings</guid>
<description><![CDATA[ Pune: In an achievement, Dr DY Patil Vidyapeeth, Pune, has secured a place in the top 51-150 band globally for Dentistry and in the top 451-500 band globally for Medicine in the QS World Rankings by Subject 2026.This dual accreditation places Dr DY Patil Vidyapeeth Pune among the ranks of international healthcare institutions. Also, strengthening its position as India&#039;s premier hub for dental and medical education, clinical excellence, and high-impact research.Also Read: Dr DY Patil Medical College, Johns Hopkins University join hands for Collaborative ResearchIn this regard, speaking to the TOI, Smita Jadhav, pro-vice-chancellor of the university, said, &quot;This dual global recognition in the QS Rankings for both dentistry and medicine is a testament to the meticulous execution of our strategic vision. Under the guidance of our leadership, we remain steadfast in our commitment to foster a globally competitive environment through innovation, interdisciplinary collaboration and international excellence in patient care.&quot;Meanwhile, a statement has also been issued in this regard. According to the statement, this achievement stands as a direct testament to the visionary leadership and tireless efforts of DPU Chancellor Dr. P. D. Patil, whose commitment to creating a world-class academic environment has completely transformed the landscape of professional education in India.Medical Dialogues had earlier reported that Dr DY Patil Medical College, Hospital and Research Centre in Pimpri, Pune, announced that three of its esteemed scientists—Dr. Amitav Banerjee, Professor of Community Medicine; Dr. Sarika Chaturvedi, Senior Scientist; and Dr. Sachin Atre, Research Consultant and Adjunct Faculty—have been recognized among the Top 2% Scientists in the World according to Stanford University&#039;s prestigious 2024 global rankings. Also Read: Three Scientists from Dr DY Patil Medical College earn spot in 2024 Stanford University&#039;s Top 2% Global Researchers Ranking ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340085-ranking.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patil, Vidyapeeth, among, top, 500, globally, medicine, 150, dentistry:, rankings</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340085-ranking.webp"><p><b>Pune: </b>In an achievement, <a href="https://medicaldialogues.in/topics/dr-dy-patil-medical-college-and-hospital" target="_blank">Dr DY Patil Vidyapeeth</a>, Pune, has secured a place in the top 51-150 band globally for Dentistry and in the top 451-500 band globally for Medicine in the QS <a href="https://medicaldialogues.in/topics/world-rankings" target="_blank">World Rankings</a> by Subject 2026.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This dual accreditation places Dr DY Patil Vidyapeeth Pune among the ranks of international healthcare institutions. Also, strengthening its position as India's premier hub for dental and medical education, clinical excellence, and high-impact research.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/dr-dy-patil-medical-college-johns-hopkins-university-join-hands-for-collaborative-research-125812"><b>Also Read: </b>Dr DY Patil Medical College, Johns Hopkins University join hands for Collaborative Research</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">In this regard, speaking to the <a href="https://timesofindia.indiatimes.com/city/pune/dr-d-y-patil-dental-and-medical-colleges-achieve-global-recognition-in-qs-rankings/articleshow/130070230.cms" target="_blank" rel="nofollow">TOI</a>, Smita Jadhav, pro-vice-chancellor of the university, said, "This dual global recognition in the QS Rankings for both dentistry and medicine is a testament to the meticulous execution of our strategic vision. Under the guidance of our leadership, we remain steadfast in our commitment to foster a globally competitive environment through innovation, interdisciplinary collaboration and international excellence in patient care."</p><p dir="ltr">Meanwhile, a statement has also been issued in this regard. According to the statement, this achievement stands as a direct testament to the visionary leadership and tireless efforts of DPU Chancellor Dr. P. D. Patil, whose commitment to creating a world-class academic environment has completely transformed the landscape of professional education in India.</p><p dir="ltr">Medical Dialogues had earlier reported that Dr DY Patil Medical College, Hospital and Research Centre in Pimpri, Pune, announced that three of its esteemed scientists—Dr. Amitav Banerjee, Professor of Community Medicine; Dr. Sarika Chaturvedi, Senior Scientist; and Dr. Sachin Atre, Research Consultant and Adjunct Faculty—have been recognized among the Top 2% Scientists in the World according to Stanford University's prestigious 2024 global rankings. </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/three-scientists-from-dr-dy-patil-medical-college-earn-spot-in-2024-stanford-universitys-top-2-global-researchers-ranking-136231"><b>Also Read: </b>Three Scientists from Dr DY Patil Medical College earn spot in 2024 Stanford University's Top 2% Global Researchers Ranking</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>MH Nursing CET 2026 application correction window open till April 9</title>
<link>https://edusehat.com/en/mh-nursing-cet-2026-application-correction-window-open-till-april-9</link>
<guid>https://edusehat.com/en/mh-nursing-cet-2026-application-correction-window-open-till-april-9</guid>
<description><![CDATA[ Mumbai: The State Common Entrance Test Cell Maharashtra, Maha CET Cell, has announced a correction window for candidates appearing in the MH Nursing CET 2026, allowing them to rectify errors in their application forms ahead of the examination scheduled on May 6 and 7, 2026.In its notice, the CET cell mentioned, &quot;It is observed from past records that many candidates make mistakes while filling the application form and request to change the same after release of Hall ticket or during the CAP process.&quot;In view of the above the state CET Cell has given that the opportunity for correcting or modifying errors/details in your application form for
MH NURSING CET 2026 will be available as per schedule given below.
 
 
 
 
 
  Examination
  Duration for
  correction in particulars
  Fields for correction
 
 
  From
  To
 
 
  MH
  Nursing CET 2026
  7/4/2026
  9/4/2026
  1) Candidate Name; 2) Date of
  Birth; 3) Gender; 4) Signature; 5) Photo
 The window for correction shall be available till 09/04/2026 upto 11.59 pm.
After this deadline, no further correction will be permitted under any
circumstances. All the concern should take not of the same.Also Read:MH Nursing CET 2026 registration deadline further extendedMedical dialogues had earlier reported that, the State Common Entrance Test Cell, Maharashtra, had extended the online application process to provide relief to aspiring candidates. The decision came after receiving multiple representations from students and stakeholders requesting additional time to complete their registrations.The online registration schedule and information brochure for this examination has been made available on the official website. To view the official notice, click here: https://medicaldialogues.in/pdf_upload/2026/04/07/notice-no05nursing-cet-2026-340061.pdfAround 300 resident doctors are leaving their postgraduate seats in government medical colleges in Maharashtra every year, reportedly due to excessive workload and long duty hours, a recent report by Dainik Bhaskar has suggested.The report, which has gone viral on social media, pointed out how junior and senior residents are frequently required to work continuous 24 to 36-hour shifts, leading to severe mental and physical stress. In the past few years, 25 deaths from suicide have also been reported, allegedly linked to this pressure.Also Read:300 Medicos Leave PG Seats in Maharashtra; 25 Suicides Highlight Excessive Duty Hours ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/05/10/286278-correction-window.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Nursing, CET, 2026, application, correction, window, open, till, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/05/10/286278-correction-window.webp"><p><b>Mumbai: </b>The State Common Entrance Test Cell Maharashtra, Maha CET Cell, has announced a correction window for candidates appearing in the <a href="https://medicaldialogues.in/topics/MH-Nursing-CET-2026">MH Nursing CET 2026</a>, allowing them to rectify errors in their application forms ahead of the examination scheduled on May 6 and 7, 2026.</p><p>In its notice, the CET cell mentioned, "It is observed from past records that many candidates make mistakes while filling the application form and request to change the same after release of Hall ticket or during the CAP process."</p><p><span>In view of the above the state CET Cell has given that the opportunity for correcting or modifying errors/details in your application form for
MH NURSING CET 2026 will be available as per schedule given below.</span></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="533">
 <colgroup><col width="110">
 <col width="145">
 <col width="149">
 <col width="129">
 </colgroup><tbody><tr height="19">
  <td rowspan="2" height="38" class="xl63" width="110"><b>Examination</b></td>
  <td colspan="2" class="xl63" width="294"><b>Duration for
  correction in particulars</b></td>
  <td rowspan="2" class="xl63" width="129"><b>Fields for correction</b></td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="145"><b>From</b></td>
  <td class="xl64" width="149"><b>To</b></td>
 </tr>
 <tr height="96">
  <td height="96" class="xl64" width="110">MH
  Nursing CET 2026</td>
  <td class="xl65" width="145">7/4/2026</td>
  <td class="xl65" width="149">9/4/2026</td>
  <td class="xl64" width="129">1) Candidate Name; 2) Date of
  Birth; 3) Gender; 4) Signature; 5) Photo</td>
 </tr></tbody></table></div><p><span>The window for correction shall be available till 09/04/2026 upto 11.59 pm.
After this deadline, no further correction will be permitted under any
circumstances. All the concern should take not of the same.</span></p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nursing/mh-nursing-cet-2026-registration-deadline-further-extended-167769">Also Read:MH Nursing CET 2026 registration deadline further extended</a></div><p><span>Medical dialogues had earlier reported that, </span>the State Common Entrance Test Cell, Maharashtra, had extended the online application process to provide relief to aspiring candidates. The decision came after receiving multiple representations from students and stakeholders requesting additional time to complete their registrations.</p><div class="pasted-from-word-wrapper"><p>The online registration schedule and information brochure for this examination has been made available on the official website. </p></div><p><b><i><span>To view the official notice, click here: </span><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/notice-no05nursing-cet-2026-340061.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/notice-no05nursing-cet-2026-340061.pdf</a></i></b></p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p>Around 300 resident doctors are leaving their postgraduate seats in government medical colleges in Maharashtra every year, reportedly due to excessive workload and long duty hours, a recent report by Dainik Bhaskar has suggested.</p><div class="inside-post-ad-3 inside-post-ad ads_common_inside_post"></div><p>The report, which has gone viral on social media, pointed out how junior and senior residents are frequently required to work continuous 24 to 36-hour shifts, leading to severe mental and physical stress. In the past few years, 25 deaths from suicide have also been reported, allegedly linked to this pressure.</p></div><div class="hocal-draggable" data-alcp_ajhbdcgf_prev-draggable-attr="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/top-videos/300-medicos-leave-pg-seats-in-maharashtra-25-suicides-highlight-excessive-duty-hours-167762">Also Read:300 Medicos Leave PG Seats in Maharashtra; 25 Suicides Highlight Excessive Duty Hours</a></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Over 2,300 CPS doctors in limbo as exams delayed, NMC intervention urged</title>
<link>https://edusehat.com/en/over-2300-cps-doctors-in-limbo-as-exams-delayed-nmc-intervention-urged</link>
<guid>https://edusehat.com/en/over-2300-cps-doctors-in-limbo-as-exams-delayed-nmc-intervention-urged</guid>
<description><![CDATA[ New Delhi: Highlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors&#039; body has written to the National Medical Commission (NMC), requesting its intervention in the matter.In a letter addressed to the Chairperson of the Apex Medical Commission, the Federation of All India Medical Association (FAIMA) has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year. The last exams were conducted in October 2024 and since then, these doctors have remained in a state of uncertainty, which has adversely affected their careers and well-being, FAIMA said.&quot;This prolonged delay is primarily due to ongoing litigation before the Hon&#039;ble Supreme Court of India concerning regulatory issues related to CPS (College of Physicians and Surgeons) courses. While we understand the importance of due process, it is crucial to emphasize that such delays are causing significant hardship to the affected residents, including financial strain, psychological stress, and disruption of clinical practice,&quot; the letter addressed to the NMC chief further mentioned.Accordingly, the association has urged the Apex Medical Commission to take cognizance of this matter and expedite the process of resolution. The association has asked the NMC to ensure that the Commission and other relevant authorities submit their responses promptly before the Supreme Court to prevent further delays, facilitate the swift scheduling and conduct of the final exit examinations for the affected residents, and streamline the regulatory process by implementing measures to prevent such delays in the future, ensuring timely assessments and examinations for postgraduate students.&quot;The medical fraternity and the nation at large depend on the timely graduation of competent and qualified healthcare professionals. Delays in examinations compromise the quality of healthcare delivery and the future of these young doctors,&quot; the association added in the letter.Background:Medical Dialogues had earlier reported that over 2,300 postgraduate CPS doctors are facing uncertainty as their final examinations for specialist qualification have not been conducted for more than a year. On March 5, 2026, a large group of affected doctors staged a peaceful protest at Azad Maidan, demanding that the state government and the medical education department conduct their long-delayed postgraduate examinations.The protesting doctors said they have already completed their academic training and hospital postings, but remain unable to obtain their specialist qualifications because the final exams have not been held.The issue began after the recognition of CPS diplomas and postgraduate programmes was withdrawn in 2022. However, students who had taken admission in the 2021–22 academic session through NEET-PG were allowed to continue their courses. Authorities had assured them that they would be able to complete the programme.Many of these students have now completed their two-year training programmes. However, their final examinations have not been conducted since November 2024, leaving them without certificates and unable to practise as specialists.Last year, the Bombay High Court passed an order cancelling the CPS recognition. Following this, the Directorate of Medical Education and Research stopped conducting further exams, leaving students who had already completed their courses but not taken the exams in a difficult situation.The Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) derecognised all the courses offered by CPS on August 16, 2024, on the grounds of failure to comply with the regulatory mechanism under the National Medical Commission Act, 2019.Earlier in 2025, the Bombay High Court dismissed the plea filed by the College of Physicians and Surgeons (CPS) challenging the derecognition of many postgraduate diploma courses that were deleted from the schedule of the Maharashtra Medical Council (MMC), 1965.On the same day, the High Court bench had allowed a Public Interest Litigation (PIL) challenging permission given to CPS to conduct 10 additional PG courses. The PIL was filed before the High Court by a Mumbai-based doctor, Suhas Pingle.Following this, the matter came for consideration before the Supreme Court in 2025. The Attorney General for India had informed the Apex Court that a viable solution would be arrived at to secure the future of students after the Bombay High Court upheld the derecognition of all PG medical courses offered by CPS Mumbai. Taking note of the issue, the Supreme Court on September 12 requested the intervention of the Attorney General for India to arrive at a viable solution in this regard.Later, the Central Government agreed before the Supreme Court to grant such students two final opportunities to clear their final examinations. This relief will apply to 852 students of CPS Mumbai, and after clearing their final examinations, they will also be enrolled with the State and National Medical Councils.Also Read: 2,300 CPS PG Doctors Await Exams, Doctors Seek Government Intervention ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/02/208660-cps-courses-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Over, 2, 300, CPS, doctors, limbo, exams, delayed, NMC, intervention, urged</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/02/208660-cps-courses-1.webp"><p><b>New Delhi: </b>Highlighting the issue of more than 2,300 CPS resident doctors, who are still waiting for their final exit examinations, a doctors' body has written to the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>), requesting its intervention in the matter.</p><p>In a letter addressed to the Chairperson of the Apex Medical Commission, the <a href="https://medicaldialogues.in/topics/FAIMA">Federation of All India Medical Association (FAIMA)</a> has pointed out that the resident doctors who pursued their postgraduate medical courses from the College of Physicians and Surgeons (CPS) are waiting for the exams for more than one year. </p><p>The last exams were conducted in October 2024 and since then, these doctors have remained in a state of uncertainty, which has adversely affected their careers and well-being, FAIMA said.</p><p>"This prolonged delay is primarily due to ongoing litigation before the Hon'ble Supreme Court of India concerning regulatory issues related to CPS (College of Physicians and Surgeons) courses. While we understand the importance of due process, it is crucial to emphasize that such delays are causing significant hardship to the affected residents, including financial strain, psychological stress, and disruption of clinical practice," the letter addressed to the NMC chief further mentioned.</p><p>Accordingly, the association has urged the Apex Medical Commission to take cognizance of this matter and expedite the process of resolution.</p><p> The association has asked the NMC to ensure that the Commission and other relevant authorities submit their responses promptly before the Supreme Court to prevent further delays, facilitate the swift scheduling and conduct of the final exit examinations for the affected residents, and streamline the regulatory process by implementing measures to prevent such delays in the future, ensuring timely assessments and examinations for postgraduate students.</p><p>"The medical fraternity and the nation at large depend on the timely graduation of competent and qualified healthcare professionals. Delays in examinations compromise the quality of healthcare delivery and the future of these young doctors," the association added in the letter.</p><p><b>Background:</b></p><div class="pasted-from-word-wrapper"><p>Medical Dialogues had earlier reported that over 2,300 postgraduate CPS doctors are facing uncertainty as their final examinations for specialist qualification have not been conducted for more than a year. On March 5, 2026, a large group of affected doctors staged a peaceful protest at Azad Maidan, demanding that the state government and the medical education department conduct their long-delayed postgraduate examinations.</p><p>The protesting doctors said they have already completed their academic training and hospital postings, but remain unable to obtain their specialist qualifications because the final exams have not been held.</p><p>The issue began after the recognition of CPS diplomas and postgraduate programmes was withdrawn in 2022. However, students who had taken admission in the 2021–22 academic session through NEET-PG were allowed to continue their courses. Authorities had assured them that they would be able to complete the programme.</p><p>Many of these students have now completed their two-year training programmes. However, their final examinations have not been conducted since November 2024, leaving them without certificates and unable to practise as specialists.</p><p>Last year, the Bombay High Court passed an order cancelling the CPS recognition. Following this, the Directorate of Medical Education and Research stopped conducting further exams, leaving students who had already completed their courses but not taken the exams in a difficult situation.</p><p>The Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) derecognised all the courses offered by CPS on August 16, 2024, on the grounds of failure to comply with the regulatory mechanism under the National Medical Commission Act, 2019.</p><p>Earlier in 2025, the Bombay High Court dismissed the plea filed by the <a href="https://medicaldialogues.in/topics/college-of-physicians-and-surgeons">College of Physicians and Surgeons (CPS)</a> challenging the derecognition of many postgraduate diploma courses that were deleted from the schedule of the Maharashtra Medical Council (MMC), 1965.</p><p>On the same day, the High Court bench had allowed a Public Interest Litigation (PIL) challenging permission given to CPS to conduct 10 additional PG courses. The PIL was filed before the High Court by a Mumbai-based doctor, Suhas Pingle.</p><p>Following this, the matter came for consideration before the Supreme Court in 2025. The Attorney General for India had informed the Apex Court that a viable solution would be arrived at to secure the future of students after the Bombay High Court upheld the derecognition of all PG medical courses offered by CPS Mumbai. Taking note of the issue, the Supreme Court on September 12 requested the intervention of the Attorney General for India to arrive at a viable solution in this regard.</p><p>Later, the Central Government agreed before the Supreme Court to grant such students two final opportunities to clear their final examinations. This relief will apply to 852 students of CPS Mumbai, and after clearing their final examinations, they will also be enrolled with the State and National Medical Councils.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/2300-cps-pg-doctors-await-exams-doctors-seek-government-intervention-166423"><b><i>Also Read: 2,300 CPS PG Doctors Await Exams, Doctors Seek Government Intervention</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 07/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-07april2026</link>
<guid>https://edusehat.com/en/health-bulletin-07april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:8 Additional Super Specialty Seats Approved by NMC in 5 Colleges After Appeals8 additional super speciality seats across five medical colleges have been approved by the National Medical Commission (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.This comes right after the Medical Assessment &amp; Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.For more details, check out the full story on the link below:NMC nod to 8 more Super speciality seats in 5 medical colleges after appealsCBI Registers FIR Against Doctors, Hospitals in ECHS Fraud Over Fake BillsIn a major crackdown, the Central Bureau of Investigation (CBI) has unearthed a multi-crore fraud involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS).As per an HT report, the agency has registered an FIR against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.For more details, check out the full story on the link below:Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraudDoctor Quits Hours After Joining Hospital, Alleges Inflated ICU StaysA young doctor quit a reputed private hospital within hours on her first day, alleging unethical practices aimed at boosting revenue. In a viral video, she claimed the hospital’s owner, a senior gynaecologist, instructed staff to admit nearly all patients regardless of need and prolong ICU stays unnecessarily to inflate bills. The doctor said she was hired as a physician in name only, while treatment decisions were controlled entirely by the owner. Disturbed by the approach, she refused to participate in practices that could harm patients and compromise medical ethics.The incident sparked mixed reactions online. While many users said such practices reflect a broader issue in private healthcare, others cautioned against generalising based on an unverified claim, reports Financial Express. Some compared the situation to the movie Gabbar Is Back, highlighting ongoing concerns about profiteering in healthcare. The doctor emphasized that no salary was worth risking patient safety, choosing to prioritise professional integrity over financial gain.PGI Neurosurgeon Loses Rs 1.10 Crore in Fraud Linked to Trading AppIn a shocking incident, a 33-year-old neurosurgeon from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud.According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”For more details, check out the full story on the link below:PGI Neurosurgeon loses Rs 1.10 crore to fake trading app ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340185-health-bulletin-10.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 07April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340185-health-bulletin-10.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>8 Additional Super Specialty Seats Approved by NMC in 5 Colleges After Appeals</b></p><p>8 additional <a href="https://medicaldialogues.in/topics/super-speciality-seats" target="_blank">super speciality seats</a> across five medical colleges have been approved by the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.</p><div class="pasted-from-word-wrapper"><p>This comes right after the Medical Assessment & Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/health-news/nmc/nmc-nod-to-8-more-super-speciality-seats-in-5-medical-colleges-after-appeals-168054"><i><b>NMC nod to 8 more Super speciality seats in 5 medical colleges after appeals</b></i></a></p></div><p><b></b></p><p><b>CBI Registers FIR Against Doctors, Hospitals in ECHS Fraud Over Fake Bills</b></p><div class="pasted-from-word-wrapper"><div><p>In a major crackdown, the <a href="https://medicaldialogues.in/topics/cbi" target="_blank">Central Bureau of Investigation </a>(CBI) has unearthed a multi-crore <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud </a>involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS).</p><p>As per an HT report, the agency has registered an FIR against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-bills-forged-documents-cbi-registers-fir-against-doctors-hospitals-in-echs-fraud-168033"><i><b>Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud</b></i></a></p><p><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-bills-forged-documents-cbi-registers-fir-against-doctors-hospitals-in-echs-fraud-168033"></a></p><p><b>Doctor Quits Hours After Joining Hospital, Alleges Inflated ICU Stays</b></p><p>A young doctor quit a reputed private hospital within hours on her first day, alleging unethical practices aimed at boosting revenue. In a viral video, she claimed the hospital’s owner, a senior gynaecologist, instructed staff to admit nearly all patients regardless of need and prolong ICU stays unnecessarily to inflate bills. The doctor said she was hired as a physician in name only, while treatment decisions were controlled entirely by the owner. Disturbed by the approach, she refused to participate in practices that could harm patients and compromise medical ethics.<br></p></div></div><div class="pasted-from-word-wrapper"><p>The incident sparked mixed reactions online. While many users said such practices reflect a broader issue in private healthcare, others cautioned against generalising based on an unverified claim, reports Financial Express.</p><p> Some compared the situation to the movie Gabbar Is Back, highlighting ongoing concerns about profiteering in healthcare. The doctor emphasized that no salary was worth risking patient safety, choosing to prioritise professional integrity over financial gain.</p><p><br></p></div><div class="pasted-from-word-wrapper"><div><p><b>PGI Neurosurgeon Loses Rs 1.10 Crore in Fraud Linked to Trading App</b></p></div></div><div class="pasted-from-word-wrapper"><p>In a shocking incident, a 33-year-old <a href="https://medicaldialogues.in/topics/neurosurgeon">neurosurgeon</a> from the <a href="https://medicaldialogues.in/topics/pgimer">Post Graduate Institute of Medical Education and Research</a> (PGIMER), Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud.</p><p>According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”</p><p><i>For more details, check out the full story on the link below:</i></p><p><a href="https://medicaldialogues.in/news/health/doctors/pgi-neurosurgeon-loses-rs-110-crore-to-fake-trading-app-168061"><i>PGI Neurosurgeon loses Rs 1.10 crore to fake trading app</i></a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>CBI Registers FIR Against Doctors, Hospitals in ECHS Fraud Over Fake Bills</title>
<link>https://edusehat.com/en/cbi-registers-fir-against-doctors-hospitals-in-echs-fraud-over-fake-bills</link>
<guid>https://edusehat.com/en/cbi-registers-fir-against-doctors-hospitals-in-echs-fraud-over-fake-bills</guid>
<description><![CDATA[ In a major crackdown, the Central Bureau of Investigation (CBI) has unearthed a multi-crore fraud involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS). As per a HT report, the agency has registered an FIR  against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.For more details, check out the full story on the link below:Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340145-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-47.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>CBI, Registers, FIR, Against, Doctors, Hospitals, ECHS, Fraud, Over, Fake, Bills</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340145-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-47.webp"><div class="pasted-from-word-wrapper"><p>In a major crackdown, the <a href="https://medicaldialogues.in/topics/cbi" target="_blank">Central Bureau of Investigation </a>(CBI) has unearthed a multi-crore <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud </a>involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS). </p><p>As per a HT report, the agency has registered an FIR  against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-bills-forged-documents-cbi-registers-fir-against-doctors-hospitals-in-echs-fraud-168033"><b><i>Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Doctor Quits Hours After Joining Hospital, Alleges Inflated ICU Stays</title>
<link>https://edusehat.com/en/doctor-quits-hours-after-joining-hospital-alleges-inflated-icu-stays</link>
<guid>https://edusehat.com/en/doctor-quits-hours-after-joining-hospital-alleges-inflated-icu-stays</guid>
<description><![CDATA[ A young doctor quit a reputed private hospital within hours on her first day, alleging unethical practices aimed at boosting revenue. In a viral video, she claimed the hospital’s owner, a senior gynaecologist, instructed staff to admit nearly all patients regardless of need and prolong ICU stays unnecessarily to inflate bills. The doctor said she was hired as a physician in name only, while treatment decisions were controlled entirely by the owner. Disturbed by the approach, she refused to participate in practices that could harm patients and compromise medical ethics.The incident sparked mixed reactions online. While many users said such practices reflect a broader issue in private healthcare, others cautioned against generalising based on an unverified claim, reports Financial Express.Some compared the situation to the movie Gabbar Is Back, highlighting ongoing concerns about profiteering in healthcare. The doctor emphasized that no salary was worth risking patient safety, choosing to prioritise professional integrity over financial gain. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340157-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-48.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Doctor, Quits, Hours, After, Joining, Hospital, Alleges, Inflated, ICU, Stays</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340157-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-48.webp"><p>A young doctor quit a reputed private hospital within hours on her first day, alleging unethical practices aimed at boosting revenue. In a viral video, she claimed the hospital’s owner, a senior gynaecologist, instructed staff to admit nearly all patients regardless of need and prolong ICU stays unnecessarily to inflate bills. The doctor said she was hired as a physician in name only, while treatment decisions were controlled entirely by the owner. Disturbed by the approach, she refused to participate in practices that could harm patients and compromise medical ethics.</p><p>The incident sparked mixed reactions online. While many users said such practices reflect a broader issue in private healthcare, others cautioned against generalising based on an unverified claim, reports Financial Express.</p><p>Some compared the situation to the movie Gabbar Is Back, highlighting ongoing concerns about profiteering in healthcare. The doctor emphasized that no salary was worth risking patient safety, choosing to prioritise professional integrity over financial gain.</p>]]> </content:encoded>
</item>

<item>
<title>Exam malpractice: NTRUHS VC warns MBBS students of debarment</title>
<link>https://edusehat.com/en/exam-malpractice-ntruhs-vc-warns-mbbs-students-of-debarment</link>
<guid>https://edusehat.com/en/exam-malpractice-ntruhs-vc-warns-mbbs-students-of-debarment</guid>
<description><![CDATA[ Vijayawada: Taking a strict stand against exam malpractice, the Vice-Chancellor of Dr NTR University of Health Sciences, (NTRUHS) Dr P Chandrasekhar, recently warned MBBS students of debarment if they are found cheating during the final year Part-II examinations.The warning came from Dr P. Chandrasekhar after the university observed smooth conduct of exams so far. During a surprise inspection at Kurnool Medical College on Saturday, the Vice-Chancellor expressed satisfaction with the examination arrangements and offered suggestions to further improve monitoring.Also read- HC sets aside expulsion of 2 more MBBS students in alleged exam malpractice caseTo ensure transparency, the vice chancellor, as reported by Deccan Chronicle, said that the university has deployed special inspection teams across medical colleges. He advised students to prepare well and added that strict vigilance is being maintained, with live webcasting used to monitor examinations.Beyond academics, the university is also promoting academic, research, sports and cultural activities among students.The Medical Dialogues team had previously reported that Dr P Chandrasekhar, Vice-Chancellor of Dr NTR University of Health Sciences (NTRUHS), stated that special funds are being allocated to promote research and sports in the government medical colleges of Andhra Pradesh. These initiatives are being undertaken to enhance the standards of medical education. Therefore, each GMC will receive an annual grant of Rs 10 lakh to improve infrastructure and to organise inter-university, state, or national tournaments.To promote research among students, the university will provide a stipend of Rs 30,000 to at least 1,000 students annually (Rs 5,000 per month for six months). Currently, only 500 undergraduate medical students receive Rs 10,000.Also read- HC sets aside MBBS student&#039;s expulsion in exam malpractice case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339963-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-45.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Exam, malpractice:, NTRUHS, warns, MBBS, students, debarment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339963-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-45.webp"><p><b>Vijayawada:</b> Taking a strict stand against exam malpractice, the Vice-Chancellor of <a href="https://medicaldialogues.in/topics/dr-ntr-university-of-health-sciences" target="_blank">Dr NTR University of Health Sciences</a>, (NTRUHS) Dr P Chandrasekhar, recently warned MBBS students of debarment if they are found cheating during the final year Part-II examinations.</p><p>The warning came from Dr P. Chandrasekhar after the university observed smooth conduct of<a href="https://medicaldialogues.in/topics/exam" target="_blank"> exams</a> so far. During a surprise inspection at Kurnool Medical College on Saturday, the Vice-Chancellor expressed satisfaction with the examination arrangements and offered suggestions to further improve monitoring.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/hc-sets-aside-expulsion-of-2-more-mbbs-students-in-alleged-exam-malpractice-case-167209" target="_blank">HC sets aside expulsion of 2 more MBBS students in alleged exam malpractice case</a></b></p><p>To ensure transparency, the vice chancellor, as reported by <a href="https://www.deccanchronicle.com/southern-states/andhra-pradesh/ntr-health-varsity-vc-warns-of-debarment-for-exam-malpractice-1948544" target="_blank" rel="nofollow">Deccan Chronicle</a>, said that the university has deployed special inspection teams across medical colleges. He advised students to prepare well and added that strict vigilance is being maintained, with live webcasting used to monitor examinations.</p><p>Beyond academics, the university is also promoting academic, research, sports and cultural activities among students.The <br></p><p>Medical Dialogues team had previously reported that Dr P Chandrasekhar, Vice-Chancellor of Dr NTR University of Health Sciences (NTRUHS), stated that special funds are being allocated to promote research and sports in the government medical colleges of Andhra Pradesh. These initiatives are being undertaken to enhance the standards of medical education. Therefore, each GMC will receive an annual grant of Rs 10 lakh to improve infrastructure and to organise inter-university, state, or national tournaments.</p><p>To promote research among students, the university will provide a stipend of Rs 30,000 to at least 1,000 students annually (Rs 5,000 per month for six months). Currently, only 500 undergraduate medical students receive Rs 10,000.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/hc-sets-aside-mbbs-students-expulsion-in-exam-malpractice-case-166641" target="_blank">HC sets aside MBBS student's expulsion in exam malpractice case</a></b></p>]]> </content:encoded>
</item>

<item>
<title>PGI Neurosurgeon Loses Rs 1.10 Crore in Fraud Linked to Trading App</title>
<link>https://edusehat.com/en/pgi-neurosurgeon-loses-rs-110-crore-in-fraud-linked-to-trading-app</link>
<guid>https://edusehat.com/en/pgi-neurosurgeon-loses-rs-110-crore-in-fraud-linked-to-trading-app</guid>
<description><![CDATA[ In a shocking incident, a 33-year-old neurosurgeon from the Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud. According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”For more details, check out the full story on the link below:PGI Neurosurgeon loses Rs 1.10 crore to fake trading app ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340174-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-49.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>PGI, Neurosurgeon, Loses, 1.10, Crore, Fraud, Linked, Trading, App</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340174-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-49.webp"><div class="pasted-from-word-wrapper"><p>In a shocking incident, a 33-year-old <a href="https://medicaldialogues.in/topics/neurosurgeon">neurosurgeon</a> from the <a href="https://medicaldialogues.in/topics/pgimer">Post Graduate Institute of Medical Education and Research</a> (PGIMER) Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud. </p><p>According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/doctors/pgi-neurosurgeon-loses-rs-110-crore-to-fake-trading-app-168061"><b><i>PGI Neurosurgeon loses Rs 1.10 crore to fake trading app</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>8 Additional Super Specialty Seats Approved by NMC in 5 Colleges After Appeals</title>
<link>https://edusehat.com/en/8-additional-super-specialty-seats-approved-by-nmc-in-5-colleges-after-appeals</link>
<guid>https://edusehat.com/en/8-additional-super-specialty-seats-approved-by-nmc-in-5-colleges-after-appeals</guid>
<description><![CDATA[ 8 additional super speciality seats across five medical colleges have been approved by the National Medical Commission (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.This comes right after the Medical Assessment &amp; Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.For more details, check out the full story on the link below:NMC nod to 8 more Super speciality seats in 5 medical colleges after appeals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340141-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-46.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Additional, Super, Specialty, Seats, Approved, NMC, Colleges, After, Appeals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340141-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-46.webp"><div class="pasted-from-word-wrapper"><p>8 additional <a href="https://medicaldialogues.in/topics/super-speciality-seats" target="_blank">super speciality seats</a> across five medical colleges have been approved by the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.</p><p>This comes right after the Medical Assessment & Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/health-news/nmc/nmc-nod-to-8-more-super-speciality-seats-in-5-medical-colleges-after-appeals-168054"><b><i>NMC nod to 8 more Super speciality seats in 5 medical colleges after appeals</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Operating surgeon best judge of procedure&#45; SC quashes criminal proceedings against paediatric surgeon in toddler&amp;apos;s orchidectomy case</title>
<link>https://edusehat.com/en/operating-surgeon-best-judge-of-procedure-sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case</link>
<guid>https://edusehat.com/en/operating-surgeon-best-judge-of-procedure-sc-quashes-criminal-proceedings-against-paediatric-surgeon-in-toddlers-orchidectomy-case</guid>
<description><![CDATA[ New Delhi: Granting relief to a paediatric surgeon who performed an orchidectomy on a toddler, the Supreme Court quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.On this, the Division Bench Justices PS Narasimha and Manoj Misra noted that the Medical Board had opined that orchidectomy is a recognised alternative procedure in such cases to prevent future malignancy.The Court further observed that a consent form was obtained prior to surgery, which included both orchidopexy and orchidectomy as options, and even the Director of Medical and Rural Health Services found no fault with it.The case originated from a complaint filed by the father of a one-and-a-half-year-old child. He alleged that his son was admitted to a hospital for treatment of an undescended testicle. According to him, consent was given only for an Orchidopexy procedure (a surgery to move the testicle into the scrotum), and not for Orchidectomy (removal of the testicle).The complainant also alleged that prior to the surgery, the operating surgeon had explained that in 99 percent of such cases, there is no need to remove the testicle. Therefore, specific consent for Orchidectomy was neither sought nor given. Yet, Orchidectomy was performed, and in the consent form, by interpolation, Orchidectomy was inserted, which amounted to an offence of forgery.Based on the aforesaid allegations, an FIR was registered on 08.08.2006 under Sections 312, 325, 426, 120-B, 406, 465, 468, 471 and Section 501 (1) &amp; (2) of the Indian Penal Code.Following the investigation, the police filed a charge sheet against the operating surgeon. The Magistrate took cognisance of the case and registered it as C.C. No. 13 of 2008. Subsequently, two petitions were filed before the High Court under Section 482 CrPC - one by the complainant seeking constitution of a Medical Board for an independent opinion, and the other by the surgeon seeking quashing of the proceedings. These petitions were disposed of by the High Court on March 19, 2013.The appellant’s counsel argued that both the Medical Board report and the Investigating Officer’s final report do not find any negligence on the doctor’s part, and that performing an orchidectomy was medically appropriate in the case.The counsel submitted that the main dispute, according to the complainant, is only about whether proper consent was obtained from the child’s father. It was submitted that a signed consent form already existed, which clearly mentioned &quot;Bilateral Orchidopexy/Orchidectomy.&quot; The allegation that &quot;orchidectomy&quot; was later added is unfounded, as the document was examined by the Director of Medical and Rural Health Services, who found nothing suspicious.Additionally, the counsel stated that there was no forensic evidence to prove any interpolation in terms of ink or handwriting. Therefore, the counsel contended that the consent form is valid, and the High Court erred in refusing to quash the criminal proceedings despite medical evidence supporting the doctor.However, the State’s counsel argued that even if there was no negligence in performing the orchidectomy, the doctor was required to obtain prior consent for that specific procedure.It was stated that since the complainant alleged that he had not consented to an orchidectomy, it is a matter of trial whether such consent was there or not. In such circumstances, whether there was a valid consent or not, and whether the consent letter has been manipulated or not, can best be determined in a trial. Hence, the state&#039;s counsel stated that the order of the High Court calls for no interference.Similarly, the complainant submitted that during the surgery, the doctor had called him to seek permission for performing an orchidectomy, warning that not removing the testicle could carry a future risk of malignancy. However, he claimed that he clearly refused consent at that time and stated he would decide later about removal. Despite this, he alleged that the doctor had removed the testicle without his approval. He further alleged that the consent form was later manipulated to indicate that consent for orchidectomy had been given falsely.Aggrieved by the charge-sheet and the consequential proceedings, which continued even after the additional reports of medical experts, the appellant approached this court seeking the quashing of the entire proceeding pending against him after Madras High Court refused to quash the case and instead directed that the trial be expedited.After examining the case, the Court noted that although the complainant alleged a lack of consent for orchidectomy, records show that a consent form was indeed obtained before surgery.It also noted that the question of whether the consent was limited only to orchidopexy. The appellant argued that due to limited space in the form, “orchidectomy” was added below “orchidopexy” with a slash.&quot;What is important is that the consent form was sent by the Investigating Officer to the Director of the Medical and Rural Health Services for his opinion. The Director had not found any fault in the consent form. Rather, the Medical Board opines that Orchidectomy is an alternative procedure which may be undertaken to obviate chances of malignancy in future. Thus, in the opinion of the Medical Board the procedure adopted was appropriate. Moreover, the operating surgeon is the best judge of which one of the two procedures is to be adopted. Therefore, the only issue which requires consideration is whether there was any interpolation in the consent form to add the alternative procedure (i.e., Orchidectomy),&quot; the court held. Regarding the High Court&#039;s refusal to quash the criminal proceedings, the Apex Court said, &quot;Ordinarily, an issue of tampering/ interpolation in a document being a question of fact is to be determined in a trial based on evidence led therein and, therefore, courts must be loath to examine such issues in a summary proceeding, like the one under Section 482 Cr.P.C. However, there can be no absolute bar on High Court’s power to consider questions of fact in exercise of jurisdiction under Section 482 Cr.P.C., particularly when such consideration is necessary to prevent the abuse of the process of the court or to secure the ends of justice.&quot;Based on the evidence and the opinions of the Medical Board, the court held, &quot;In the instant case, no malice is attributed to the doctor, and there is no dispute that the consent form was executed for undertaking a medical procedure. Further, the medical opinion is to the effect that the procedure adopted by the doctor was one of the alternatives recognized to meet such a medical exigency. No doubt, the Medical Board&#039;s opinion indicates that such a procedure should be carried out after obtaining consent, but there is nothing to indicate that the consent form already obtained was not in order or that no consent was obtained. Besides, the consent letter has been brought on record. A perusal thereof would indicate that in the column where the nature of proposed surgery is to be mentioned, both types of surgery i.e., Orchidopexy and Orchiectomy, are mentioned by putting a slash (/), which means that the other surgery, namely, Orchidectomy, was one of the options available.&quot;It further observed, &quot;Taking a conspectus of all the facts and circumstances as also that there is no material on record that alternative surgery, namely, Orchidectomy, was entered by a different ink or in a different handwriting, and having regard to the Medical Board’s opinion that in such medical situations Orchidectomy is a normal alternative, we are of the view that continuance of criminal proceeding against the appellant would be nothing but abuse of the process of the court and, therefore to secure the ends of justice, the same is liable to be quashed.&quot;To view the court order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/07/4650120232026-04-06-665997-340116.pdfAlso read- &quot;Failure to provide written grounds renders arrest illegal&quot;: Supreme Court grants bail to two doctors ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/09/24/302091-supreme-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Operating, surgeon, best, judge, procedure-, quashes, criminal, proceedings, against, paediatric, surgeon, toddlers, orchidectomy, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/09/24/302091-supreme-court.webp"><p><b>New Delhi:</b> Granting relief to a <a href="https://medicaldialogues.in/topics/paediatric-surgeon" target="_blank">paediatric surgeon</a> who performed an orchidectomy on a toddler, the<a href="https://medicaldialogues.in/topics/supreme-court" target="_blank"> Supreme Court</a> quashed the criminal proceedings against the doctor. The apex court observed that no malice could be attributed to the doctor and that the procedure adopted by the doctor was one of the alternatives recognised to meet such a medical exigency.</p><p>The child’s father had alleged that he had consented only to orchidopexy for his son’s undescended testicle; however, the surgeon performed an orchidectomy (removal of the testicle) without consent and later manipulated the consent form.</p><p>On this, the Division Bench Justices PS Narasimha and Manoj Misra noted that the Medical Board had opined that orchidectomy is a recognised alternative procedure in such cases to prevent future malignancy.</p><p>The Court further observed that a consent form was obtained prior to surgery, which included both orchidopexy and orchidectomy as options, and even the Director of Medical and Rural Health Services found no fault with it.</p><p><span>The case originated from a complaint filed by the father of a one-and-a-half-year-old child. He alleged that his son was admitted to a hospital for treatment of an undescended testicle. According to him, consent was given only for an Orchidopexy procedure (a surgery to move the testicle into the scrotum), and not for Orchidectomy (removal of the testicle).</span></p><p>The complainant also alleged that prior to the surgery, the operating surgeon had explained that in 99 percent of such cases, there is no need to remove the testicle. Therefore, specific consent for Orchidectomy was neither sought nor given. Yet, Orchidectomy was performed, and in the consent form, by interpolation, Orchidectomy was inserted, which amounted to an offence of forgery.</p><p>Based on the aforesaid allegations, an FIR was registered on 08.08.2006 under Sections 312, 325, 426, 120-B, 406, 465, 468, 471 and Section 501 (1) & (2) of the Indian Penal Code.</p><p>Following the investigation, the police filed a charge sheet against the operating surgeon. The Magistrate took cognisance of the case and registered it as C.C. No. 13 of 2008. </p><p>Subsequently, two petitions were filed before the High Court under Section 482 CrPC - one by the complainant seeking constitution of a Medical Board for an independent opinion, and the other by the surgeon seeking quashing of the proceedings. These petitions were disposed of by the High Court on March 19, 2013.</p><p>The appellant’s counsel argued that both the Medical Board report and the Investigating Officer’s final report do not find any negligence on the doctor’s part, and that performing an orchidectomy was medically appropriate in the case.</p><p>The counsel submitted that the main dispute, according to the complainant, is only about whether proper consent was obtained from the child’s father. It was submitted that a signed consent form already existed, which clearly mentioned "Bilateral Orchidopexy/Orchidectomy." The allegation that "orchidectomy" was later added is unfounded, as the document was examined by the Director of Medical and Rural Health Services, who found nothing suspicious.</p><p>Additionally, the counsel stated that there was no forensic evidence to prove any interpolation in terms of ink or handwriting. Therefore, the counsel contended that the consent form is valid, and the High Court erred in refusing to quash the criminal proceedings despite medical evidence supporting the doctor.</p><p>However, the State’s counsel argued that even if there was no negligence in performing the orchidectomy, the doctor was required to obtain prior consent for that specific procedure.</p><p>It was stated that since the complainant alleged that he had not consented to an orchidectomy, it is a matter of trial whether such consent was there or not. In such circumstances, whether there was a valid consent or not, and whether the consent letter has been manipulated or not, can best be determined in a trial. Hence, the state's counsel stated that the order of the High Court calls for no interference.</p><p>Similarly, the complainant submitted that during the surgery, the doctor had called him to seek permission for performing an orchidectomy, warning that not removing the testicle could carry a future risk of malignancy. However, he claimed that he clearly refused consent at that time and stated he would decide later about removal. </p><p>Despite this, he alleged that the doctor had removed the testicle without his approval. He further alleged that the consent form was later manipulated to indicate that consent for orchidectomy had been given falsely.</p><p>Aggrieved by the charge-sheet and the consequential proceedings, which continued even after the additional reports of medical experts, the appellant approached this court seeking the quashing of the entire proceeding pending against him after Madras High Court refused to quash the case and instead directed that the trial be expedited.</p><p>After examining the case, the Court noted that although the complainant alleged a lack of consent for orchidectomy, records show that a consent form was indeed obtained before surgery.</p><p>It also noted that the question of whether the consent was limited only to orchidopexy. The appellant argued that due to limited space in the form, “orchidectomy” was added below “orchidopexy” with a slash.</p><blockquote>"What is important is that the consent form was sent by the Investigating Officer to the Director of the Medical and Rural Health Services for his opinion. The Director had not found any fault in the consent form. Rather, the Medical Board opines that Orchidectomy is an alternative procedure which may be undertaken to obviate chances of malignancy in future. Thus, in the opinion of the Medical Board the procedure adopted was appropriate. Moreover, the operating surgeon is the best judge of which one of the two procedures is to be adopted. Therefore, the only issue which requires consideration is whether there was any interpolation in the consent form to add the alternative procedure (i.e., Orchidectomy)," the court held. </blockquote><p>Regarding the High Court's refusal to quash the criminal proceedings, the Apex Court said, </p><blockquote>"Ordinarily, an issue of tampering/ interpolation in a document being a question of fact is to be determined in a trial based on evidence led therein and, therefore, courts must be loath to examine such issues in a summary proceeding, like the one under Section 482 Cr.P.C. However, there can be no absolute bar on High Court’s power to consider questions of fact in exercise of jurisdiction under Section 482 Cr.P.C., particularly when such consideration is necessary to prevent the abuse of the process of the court or to secure the ends of justice."</blockquote><p>Based on the evidence and the opinions of the Medical Board, the court held, </p><blockquote>"In the instant case, no malice is attributed to the doctor, and there is no dispute that the consent form was executed for undertaking a medical procedure. Further, the medical opinion is to the effect that the procedure adopted by the doctor was one of the alternatives recognized to meet such a medical exigency. No doubt, the Medical Board's opinion indicates that such a procedure should be carried out after obtaining consent, but there is nothing to indicate that the consent form already obtained was not in order or that no consent was obtained. Besides, the consent letter has been brought on record. A perusal thereof would indicate that in the column where the nature of proposed surgery is to be mentioned, both types of surgery i.e., Orchidopexy and Orchiectomy, are mentioned by putting a slash (/), which means that the other surgery, namely, Orchidectomy, was one of the options available."</blockquote><p>It further observed, </p><blockquote>"Taking a conspectus of all the facts and circumstances as also that there is no material on record that alternative surgery, namely, Orchidectomy, was entered by a different ink or in a different handwriting, and having regard to the Medical Board’s opinion that in such medical situations Orchidectomy is a normal alternative, we are of the view that continuance of criminal proceeding against the appellant would be nothing but abuse of the process of the court and, therefore to secure the ends of justice, the same is liable to be quashed."</blockquote><p><b>To view the court order, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/4650120232026-04-06-665997-340116.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/07/4650120232026-04-06-665997-340116.pdf</b></a></div><p><b>Also read-<a href="https://medicaldialogues.in/news/health/doctors/failure-to-provide-written-grounds-renders-arrest-illegal-supreme-court-grants-bail-to-two-doctors-168083" target="_blank"> "Failure to provide written grounds renders arrest illegal": Supreme Court grants bail to two doctors</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Chhattisgarh HC pulls up State Govt over delay in psychiatrist recruitment</title>
<link>https://edusehat.com/en/chhattisgarh-hc-pulls-up-state-govt-over-delay-in-psychiatrist-recruitment</link>
<guid>https://edusehat.com/en/chhattisgarh-hc-pulls-up-state-govt-over-delay-in-psychiatrist-recruitment</guid>
<description><![CDATA[ Bilaspur: Expressing concern over delays in the recruitment of psychiatrists, the Chhattisgarh High Court has asked the state government to speed up the process, noting that such delays impact mental healthcare services. A division Bench comprising Chief Justice Ramesh Sinha and Justice Ravindra Kumar Agrawal stated, &quot;This Court expects and trusts that the State shall make earnest efforts to complete the recruitment process for the post of MD Psychiatrist at the earliest and avoid any unwarranted delay. The continued pendency of recruitment for such specialized posts, particularly in the field of mental healthcare, results in serious prejudice to the public at large. Seeking time on procedural grounds in such circumstances does not appear to be justified.&quot;The Court was hearing a public interest litigation filed by the High Court Legal Services Committee against the State of Chhattisgarh and others. Senior Advocate Abhishek Sinha, assisted by Ghanshyam Patel, appeared as Amicus Curiae and Shashank Thakur, Additional Advocate General for the State, and Anmol Sharma, counsel, represented the Union of India.During the previous hearing on February 4, 2026, the Court had directed the Secretary of the Health and Family Welfare Department, Government of Chhattisgarh, Raipur, to submit a fresh affidavit. In compliance with this direction, the government filed an affidavit on March 23, 2026. Amicus Curiae Abhishek Sinha submitted that although the posts of MD Psychiatrists had already been advertised earlier, the State has again started the process of seeking financial approval, which may lead to further delay. He argued that repeatedly insisting on such approval, despite earlier sanction, unnecessarily prolongs the recruitment process.In response, Additional Advocate General Shashank Thakur stated that obtaining financial approval is a mandatory procedural requirement whenever a fresh recruitment process is initiated.After reviewing the affidavit, the Court noted that the proposal to recruit six MD Psychiatrists was already sent on March 5, 2026, and is currently awaiting approval from the Finance Department. Since financial approval had been granted earlier, the court said asking for it again appears to be only a formality and should not cause unnecessary delay. The process should therefore move forward quickly.The Court said it expects the State to make sincere efforts to complete the recruitment of psychiatrists as soon as possible and avoid any unnecessary delay. It observed that keeping such important posts vacant, especially in mental healthcare, harms the public. The Court also noted that seeking more time on procedural grounds in such cases is not justified.Further, the Court directed the Secretary of the Health and Family Welfare Department, Government of Chhattisgarh, to file another affidavit giving an updated status of the recruitment process, in line with earlier directions.The matter has been listed for the next hearing on April 28, 2026.To view the court order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/07/viewmedical-665994-340184.pdfAlso read- Right to life includes timely medical treatment: Chhattisgarh HC orders prisoner&#039;s parole decision in 10 days ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/04/13/236135-chhattisgarh-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 20:55:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chhattisgarh, pulls, State, Govt, over, delay, psychiatrist, recruitment</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/04/13/236135-chhattisgarh-high-court.webp"><p><b>Bilaspur: </b>Expressing concern over delays in the recruitment of psychiatrists, the <a href="https://medicaldialogues.in/topics/chhattisgarh-high-court" target="_blank">Chhattisgarh High Court</a> has asked the state government to speed up the process, noting that such delays impact mental healthcare services. </p><p>A division Bench comprising Chief Justice Ramesh Sinha and Justice Ravindra Kumar Agrawal stated, <i>"This Court expects and trusts that the State shall make earnest efforts to complete the recruitment process for the post of MD Psychiatrist at the earliest and avoid any unwarranted delay. The continued pendency of recruitment for such specialized posts, particularly in the field of mental healthcare, results in serious prejudice to the public at large. Seeking time on procedural grounds in such circumstances does not appear to be justified."</i></p><p>The Court was hearing a public interest litigation filed by the High Court Legal Services Committee against the State of Chhattisgarh and others. Senior Advocate Abhishek Sinha, assisted by Ghanshyam Patel, appeared as Amicus Curiae and Shashank Thakur, Additional Advocate General for the State, and Anmol Sharma, counsel, represented the Union of India.</p><p>During the previous hearing on February 4, 2026, the Court had directed the Secretary of the Health and Family Welfare Department, Government of Chhattisgarh, Raipur, to submit a fresh affidavit. In compliance with this direction, the government filed an affidavit on March 23, 2026. </p><p>Amicus Curiae Abhishek Sinha submitted that although the posts of MD Psychiatrists had already been advertised earlier, the State has again started the process of seeking financial approval, which may lead to further delay. He argued that repeatedly insisting on such approval, despite earlier sanction, unnecessarily prolongs the recruitment process.</p><p>In response, Additional Advocate General Shashank Thakur stated that obtaining financial approval is a mandatory procedural requirement whenever a fresh recruitment process is initiated.</p><p>After reviewing the affidavit, the Court noted that the proposal to recruit six MD Psychiatrists was already sent on March 5, 2026, and is currently awaiting approval from the Finance Department. Since financial approval had been granted earlier, the court said asking for it again appears to be only a formality and should not cause unnecessary delay. The process should therefore move forward quickly.</p><p>The Court said it expects the State to make sincere efforts to complete the recruitment of psychiatrists as soon as possible and avoid any unnecessary delay. It observed that keeping such important posts vacant, especially in mental healthcare, harms the public. The Court also noted that seeking more time on procedural grounds in such cases is not justified.</p><p>Further, the Court directed the Secretary of the Health and Family Welfare Department, Government of Chhattisgarh, to file another affidavit giving an updated status of the recruitment process, in line with earlier directions.</p><p>The matter has been listed for the next hearing on April 28, 2026.</p><p><b>To view the court order, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/viewmedical-665994-340184.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/07/viewmedical-665994-340184.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/health/right-to-life-includes-timely-medical-treatment-chhattisgarh-hc-orders-prisoners-parole-decision-in-10-days-166365" target="_blank">Right to life includes timely medical treatment: Chhattisgarh HC orders prisoner's parole decision in 10 days</a></b></p>]]> </content:encoded>
</item>

<item>
<title>AIIMS New Delhi launches Virtual Reality training centre for medical students</title>
<link>https://edusehat.com/en/aiims-new-delhi-launches-virtual-reality-training-centre-for-medical-students</link>
<guid>https://edusehat.com/en/aiims-new-delhi-launches-virtual-reality-training-centre-for-medical-students</guid>
<description><![CDATA[ New Delhi: To enhance students&#039; medical education and clinical training, the All India Institute of Medical Sciences, AIIMS New Delhi, has recently launched a Virtual Reality (VR) training centre.This new feature utilises immersive VR technology to accurately simulate real-life medical scenarios. It will provide students with the opportunity to practice procedures and decision-making in a controlled and risk-free environment. It is expected that this approach will strengthen students&#039; practical skills and boost their confidence before they treat actual patients.According to IANS report, the All India Institute of Medical Sciences (AIIMS), New Delhi, on Monday launched the VR training centre for medical and nursing education, a step towards adopting immersive technologies in healthcare learning. The prominent health institute set up the facility at the SET Facility of AIIMS in collaboration with MediSim VR, and will enable structured, simulation-based training for students and healthcare professionals. The partnership will focus on researching and evaluating the use of AI-enabled VR solutions in medical curricula, including their impact on skill development, assessment, and training standardisation, with the long-term goal of integrating such technologies into mainstream education.AIIMS -- a premier medical education and research institution in India -- is expected to play a major role in setting benchmarks for the adoption of new learning methods across the healthcare ecosystem.Speaking at the launch, AIIMS Director M. Srinivas stated: &quot;If the country as a whole is to be in the best league, that has to extend to all spheres, including medical innovations, medical teaching, training and learning as well.&quot;He added that VR-based simulation training enables an immersive learning environment that closely mirrors real clinical settings, helping enhance skill development, assessment and training standardisation.AIIMS Professor of Cardiology and Head, SET Facility, Ambuj Roy, said the integration of VR could redefine medical education by equipping healthcare professionals with greater precision and confidence, while setting new benchmarks in training standards.From the industry side, MediSim VR COO and co-founder Adith Chinnaswami said the collaboration aims to build a structured pathway for integrating VR into standard medical training, backed by research and long-term validation.MediSim VR CEO and co-founder Sabarish Chandrasekaran added that the initiative reflects a shared commitment to leveraging technology to improve teaching practices and prepare the next generation of healthcare professionals.Also Read: Virtual Reality Reduces Pain Scores and Anxiety: November 2025, Narrative Review HighlightsThis initiative is part of a comprehensive effort to integrate advanced technology into medical training and to keep pace with global standards in healthcare education. This VR centre will enhance the learning process across various disciplines and provide interactive modules tailored to suit different medical specialisations. This launch marks a significant step towards the modernisation of medical education in India, providing students with innovative tools to gain practical experience and improve patient care outcomes.Medical Dialogues had earlier reported that in a bid to make Human papillomavirus (HPV) tests more accessible and affordable, the All India Institute of Medical Sciences (AIIMS) Delhi has launched a study to evaluate indigenous HPV tests for cervical cancer screening in India. According to Dr Neerja Bhatla, HOD, Obstetrics and Gynaecology, AIIMS, Delhi, the results will be quick and cost-effective. &quot;There are several HPV tests that are now being manufactured in India, but we have taken three tests that are a point of care. The results will come within one hour or one and a half hours and we can plan for the next step,&quot; Dr Bhatla said.Also Read: Integrating AI, VR, and 3D Modeling: The Future of Personalized Cardiac Care, AHJ December 2025 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340078-mbbs-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, New, Delhi, launches, Virtual, Reality, training, centre, for, medical, students</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340078-mbbs-3.webp"><p><b>New Delhi:</b> To enhance students' medical education and clinical training, the All India Institute of Medical Sciences, <a href="https://medicaldialogues.in/topics/aiims-delhi" target="_blank">AIIMS New Delhi</a>, has recently launched a Virtual Reality (VR) training centre.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This new feature utilises immersive VR technology to accurately simulate real-life medical scenarios. It will provide students with the opportunity to practice procedures and decision-making in a controlled and risk-free environment. It is expected that this approach will strengthen students' practical skills and boost their confidence before they treat actual patients.</p><p dir="ltr">According to IANS report, the All India Institute of Medical Sciences (AIIMS), New Delhi, on Monday launched the VR training centre for medical and nursing education, a step towards adopting immersive technologies in healthcare learning. The prominent health institute set up the facility at the SET Facility of AIIMS in collaboration with MediSim VR, and will enable structured, simulation-based training for students and healthcare professionals. </p><p dir="ltr">The partnership will focus on researching and evaluating the use of AI-enabled VR solutions in medical curricula, including their impact on skill development, assessment, and training standardisation, with the long-term goal of integrating such technologies into mainstream education.</p></div><div class="pasted-from-word-wrapper"><p>AIIMS -- a premier medical education and research institution in India -- is expected to play a major role in setting benchmarks for the adoption of new learning methods across the healthcare ecosystem.</p><p>Speaking at the launch, AIIMS Director M. Srinivas stated: "If the country as a whole is to be in the best league, that has to extend to all spheres, including medical innovations, medical teaching, training and learning as well."</p><p>He added that VR-based simulation training enables an immersive learning environment that closely mirrors real clinical settings, helping enhance skill development, assessment and training standardisation.</p><p>AIIMS Professor of Cardiology and Head, SET Facility, Ambuj Roy, said the integration of VR could redefine medical education by equipping healthcare professionals with greater precision and confidence, while setting new benchmarks in training standards.</p><p>From the industry side, MediSim VR COO and co-founder Adith Chinnaswami said the collaboration aims to build a structured pathway for integrating VR into standard medical training, backed by research and long-term validation.</p><p>MediSim VR CEO and co-founder Sabarish Chandrasekaran added that the initiative reflects a shared commitment to leveraging technology to improve teaching practices and prepare the next generation of healthcare professionals.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/psychiatry/news/virtual-reality-reduces-pain-scores-and-anxiety-november-2025-narrative-review-highlights-166058"><b>Also Read: </b>Virtual Reality Reduces Pain Scores and Anxiety: November 2025, Narrative Review Highlights</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">This initiative is part of a comprehensive effort to integrate advanced technology into medical training and to keep pace with global standards in healthcare education. This VR centre will enhance the learning process across various disciplines and provide interactive modules tailored to suit different medical specialisations. </p><p dir="ltr">This launch marks a significant step towards the modernisation of medical education in India, providing students with innovative tools to gain practical experience and improve patient care outcomes.</p><p dir="ltr">Medical Dialogues had earlier reported that in a bid to make Human papillomavirus (HPV) tests more accessible and affordable, the All India Institute of Medical Sciences (AIIMS) Delhi has launched a study to evaluate indigenous HPV tests for cervical cancer screening in India. </p></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"><p>According to Dr Neerja Bhatla, HOD, Obstetrics and Gynaecology, AIIMS, Delhi, the results will be quick and cost-effective. "There are several HPV tests that are now being manufactured in India, but we have taken three tests that are a point of care. The results will come within one hour or one and a half hours and we can plan for the next step," Dr Bhatla said.</p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div></div><div class="inside-post-ad-2 inside-post-ad ads_common_inside_post"></div></div></div><div class="pasted-from-word-wrapper"><div></div><div class="pasted-from-word-wrapper"></div></div><div class="pasted-from-word-wrapper"><div></div><div class="inside-post-ad-1 inside-post-ad ads_common_inside_post"></div></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/cardiology-ctvs/news/integrating-ai-vr-and-3d-modeling-the-future-of-personalized-cardiac-care-ahj-december-2025-159943"><b>Also Read: </b>Integrating AI, VR, and 3D Modeling: The Future of Personalized Cardiac Care, AHJ December 2025</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Rajnath Singh lays foundation stones for 3 new centres at Army Hospital</title>
<link>https://edusehat.com/en/rajnath-singh-lays-foundation-stones-for-3-new-centres-at-army-hospital</link>
<guid>https://edusehat.com/en/rajnath-singh-lays-foundation-stones-for-3-new-centres-at-army-hospital</guid>
<description><![CDATA[ New Delhi: Raksha Mantri Shri Rajnath Singh on Monday laid the foundation stones of Ophthalmology, Oncology and Joint Replacement Centres at Army Hospital (Research &amp; Referral) and new infrastructure at Base Hospital, Delhi Cantt, as part of the 262nd Army Medical Corps Raising Day celebrations. The state-of-the-art facilities at Army Hospital (Research &amp; Referral) are envisaged to significantly enhance the tertiary care capabilities of the Armed Forces Medical Services (AFMS), particularly in the domains of advanced eye care, cancer treatment, and complex joint replacement surgeries, while the new hospital infrastructure at Base Hospital is being developed with a capacity of 998 beds along with an additional 100 crisis expansion beds, to address routine and emergency healthcare requirements of the Defence Forces personnel.In his address, Raksha Mantri underlined the importance of continued innovation, capacity building, and integration of modern technologies to meet the emerging challenges in military medicine. He exuded confidence that the new facilities, equipped with modern technologies and infrastructure, will provide quality medical care to the serving personnel, veterans &amp; their dependents, the PIB stated.Also Read:Army Hospital Delhi performs India&#039;s first 3D Flex Aqueous Angiography with iStentShri Rajnath Singh commended the dedication, professionalism, and compassion of the AFMS personnel for rendering services to every nook and corner of the country, from towering mountains to inaccessible forests, from times of peace to moments of disaster. He appreciated them for organising medical camps across the country and neighboring nations, including Nepal, while specially mentioning the successful conduct of Cataract and Glaucoma surgeries and eye care services. “Such initiatives strengthen our ties with friendly nations while simultaneously bringing about positive transformations in the lives of people. Your services have emerged as a powerful testament to India&#039;s &#039;soft power’,” he said.While Raksha Mantri reiterated the Government’s commitment to providing world-class healthcare facilities for the soldiers &amp; their families, and termed it as top priority, he exhorted AFMS to lay special emphasis on ‘research’, stressing on the integration of modern medical science with ancient philosophy to present a truly effective healthcare model to the public. “Under the leadership of Prime Minister Shri Narendra Modi, the nation has made significant strides in the medical domain, from continuous expansion of healthcare infrastructure, increase in the number of institutions such as AIIMS to the access of healthcare facilities to everyone through the Ayushman Card, and advancements in fields such as cancer treatment, bypass surgery, and critical care.However, when it comes to frontier technologies and deep research, we still have a long journey ahead. For instance, in cancer research, specifically early detection technologies and personalised medicine, several countries are currently ahead of us. We also must further strengthen our capabilities in developing advanced predictive models for cardiovascular diseases, as well as in neuro-research related to mental health,” he said.Underscoring the importance of achieving self-reliance in the pharmaceuticals sector, Shri Rajnath Singh asserted that while India is a major global supplier of medicines, dependency on external sources remains evident in the fields of high-end drug innovation and original research. He highlighted the need to move beyond generic production and focus on fostering an innovation-driven pharmaceutical ecosystem.He added that concurrently, priority must be given to the discovery of new drugs, strengthening of clinical research, and adoption of global quality standards. He endorsed the integration of MSMEs and start-ups into the pharmaceutical innovation landscape, development of robust testing infrastructure, and cultivation of a skilled workforce. This approach will not only fulfill domestic requirements but also enable India to emerge as a global leader in these sectors, he said.Drawing attention on the crucial subject of clinical trials, Raksha Mantri said that clinical trials are industry-sponsored in many advanced nations, and equal emphasis is placed on research, treatment &amp; innovation. He pointed out that while efforts in this direction are being made in India, there is a need for reforms within the clinical trial framework. “We must explore how AFMS can make a meaningful contribution in this domain, ensuring that our medical capabilities extend beyond mere curative treatment to encompass the creation of new knowledge,” he said.Shri Rajnath Singh also pitched for creating robust Standard Operating Procedures and standardised protocols for dissemination of clinical experience regarding a specific disease to other doctors and hospitals through systemic channels. “This would render faster, more efficient, and evidence-based treatment, enhancing not only individual capability but overall system efficiency. Establishing a national-level data pool would be a monumental step in this direction. It would provide better inputs for policy formulation, aid in validating new medical practices, and enable large-scale replication of effective treatments, thereby gradually transforming our healthcare system from a reactive into a proactive model,” he said.On the heavy workload in hospitals, Raksha Mantri stated that doctors remain constantly occupied with providing treatment &amp; performing surgeries, and crucial aspects such as research, training, and teaching tend to take a backseat. This is a practical challenge that needs to be acknowledged, urging AFMS to explore ways to effectively balance the immense workload.Shri Rajnath Singh also urged AFMS to examine the feasibility of setting up institutions at par with Army Hospital (R&amp;R) in all four corners of the country with the aim to provide the soldiers at every region and location, superior medical facilities. “It is not strictly necessary to establish a greenfield project or construct an entirely new institution. There are immense possibilities within brownfield projects. Command Hospitals or Base Hospitals at various locations can be upgraded with modern facilities and elevated to this very same standard,” he suggested.Raksha Mantri emphasised that in today’s context, ‘security’ encompasses far more than merely safeguarding borders, with health security holding equal significance. “Health security plays a pivotal role when we successfully execute major operations like Operation Sindoor. When our soldiers possess the confidence that superior medical support is available to them, they accomplish their missions without apprehension. Therefore, it is imperative to adopt a consistently proactive and positive approach toward health security,” he said.Shri Rajnath Singh stressed that the parameters of growth of a nation are not solely economic, but encompasses other significant dimensions; the most critical being the health of the people. “The medical sector needs to continuously understand these evolving challenges, address them effectively, and constantly update itself in sync with the changing times. We must move forward with a vision where progress is not confined merely to economic growth but is holistic in nature, where health is recognised as a central pillar of that development,” he said.Raksha Mantri concluded his address by acknowledging the services rendered by the nurses of the Military Nursing Service, who, he said, serve as the bedrock of the medical forces. He stated that the recent decision to grant them the status of ‘ex-servicemen’ upon retirement underlines the Government’s commitment towards the welfare of the defence forces personnel as well as medical professionals.As part of the visit, Shri Rajnath Singh witnessed a live demonstration and toured the Technology Exhibition area, where cutting-edge innovations and advancements in combat medical care were showcased. These included developments in trauma management, battlefield evacuation systems, prosthetics, telemedicine, and critical care technologies, reflecting AFMS’s sustained efforts towards modernisation and self-reliance.Shri Rajnath Singh also presented the Raksha Mantri trophy of the Best Hospital of AFMS to Command Hospital (Southern Command), Pune, while the award for the Second Best Hospital went to Indian Naval Hospital Ship (INHS) Asvini, Mumbai. The awards recognise the two hospitals’ outstanding performance, excellence in patient care, innovation, and administrative efficiency within the network of Defence Forces hospitals. Raksha Mantri termed these accolades as a testament to their collective dedication and tireless efforts.Raksha Mantri also released a book titled ‘Precision Protocols in Early Neurodevelopmental Intervention’, a significant academic contribution aimed at standardising and improving early diagnosis &amp; intervention strategies for neurodevelopmental conditions. The publication underscores the growing focus of AFMS on research-driven, evidence-based medical practices.Chief of Defence Staff General Anil Chauhan, Chief of the Naval Staff Admiral Dinesh K Tripathi, Chief of the Army Staff General Upendra Dwivedi, Defence Secretary Shri Rajesh Kumar Singh, DG AFMS Surgeon Vice Admiral Arti Sarin, Vice Chief of the Air Staff Air Marshal Nagesh Kapoor, and other senior officers attended the event.Also Read:Army Hospital launches state-of-the-art Femto-LASIK Suite for spectacle removal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340073-afms.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Rajnath, Singh, lays, foundation, stones, for, new, centres, Army, Hospital</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340073-afms.webp"><div class="pasted-from-word-wrapper"><p>New Delhi: Raksha Mantri Shri Rajnath Singh on Monday laid the foundation stones of Ophthalmology, Oncology and Joint Replacement Centres at Army Hospital (Research & Referral) and new infrastructure at Base Hospital, Delhi Cantt, as part of the 262nd Army Medical Corps Raising Day celebrations. </p><p>The state-of-the-art facilities at Army Hospital (Research & Referral) are envisaged to significantly enhance the tertiary care capabilities of the Armed Forces Medical Services (AFMS), particularly in the domains of advanced eye care, cancer treatment, and complex joint replacement surgeries, while the new hospital infrastructure at Base Hospital is being developed with a capacity of 998 beds along with an additional 100 crisis expansion beds, to address routine and emergency healthcare requirements of the Defence Forces personnel.</p><p>In his address, Raksha Mantri underlined the importance of continued innovation, capacity building, and integration of modern technologies to meet the emerging challenges in military medicine. He exuded confidence that the new facilities, equipped with modern technologies and infrastructure, will provide quality medical care to the serving personnel, veterans & their dependents, the PIB stated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/army-hospital-delhi-performs-indias-first-3d-flex-aqueous-angiography-with-istent-161797"><b>Also Read:Army Hospital Delhi performs India's first 3D Flex Aqueous Angiography with iStent</b></a></p><p>Shri Rajnath Singh commended the dedication, professionalism, and compassion of the AFMS personnel for rendering services to every nook and corner of the country, from towering mountains to inaccessible forests, from times of peace to moments of disaster. He appreciated them for organising medical camps across the country and neighboring nations, including Nepal, while specially mentioning the successful conduct of Cataract and Glaucoma surgeries and eye care services. “Such initiatives strengthen our ties with friendly nations while simultaneously bringing about positive transformations in the lives of people. Your services have emerged as a powerful testament to India's 'soft power’,” he said.</p><p>While Raksha Mantri reiterated the Government’s commitment to providing world-class healthcare facilities for the soldiers & their families, and termed it as top priority, he exhorted AFMS to lay special emphasis on ‘research’, stressing on the integration of modern medical science with ancient philosophy to present a truly effective healthcare model to the public. “Under the leadership of Prime Minister Shri Narendra Modi, the nation has made significant strides in the medical domain, from continuous expansion of healthcare infrastructure, increase in the number of institutions such as AIIMS to the access of healthcare facilities to everyone through the Ayushman Card, and advancements in fields such as cancer treatment, bypass surgery, and critical care.</p><p>However, when it comes to frontier technologies and deep research, we still have a long journey ahead. For instance, in cancer research, specifically early detection technologies and personalised medicine, several countries are currently ahead of us. We also must further strengthen our capabilities in developing advanced predictive models for cardiovascular diseases, as well as in neuro-research related to mental health,” he said.</p><p>Underscoring the importance of achieving self-reliance in the pharmaceuticals sector, Shri Rajnath Singh asserted that while India is a major global supplier of medicines, dependency on external sources remains evident in the fields of high-end drug innovation and original research. He highlighted the need to move beyond generic production and focus on fostering an innovation-driven pharmaceutical ecosystem.</p><p>He added that concurrently, priority must be given to the discovery of new drugs, strengthening of clinical research, and adoption of global quality standards. He endorsed the integration of MSMEs and start-ups into the pharmaceutical innovation landscape, development of robust testing infrastructure, and cultivation of a skilled workforce. This approach will not only fulfill domestic requirements but also enable India to emerge as a global leader in these sectors, he said.</p><p>Drawing attention on the crucial subject of clinical trials, Raksha Mantri said that clinical trials are industry-sponsored in many advanced nations, and equal emphasis is placed on research, treatment & innovation. He pointed out that while efforts in this direction are being made in India, there is a need for reforms within the clinical trial framework. “We must explore how AFMS can make a meaningful contribution in this domain, ensuring that our medical capabilities extend beyond mere curative treatment to encompass the creation of new knowledge,” he said.</p><p>Shri Rajnath Singh also pitched for creating robust Standard Operating Procedures and standardised protocols for dissemination of clinical experience regarding a specific disease to other doctors and hospitals through systemic channels. “This would render faster, more efficient, and evidence-based treatment, enhancing not only individual capability but overall system efficiency. Establishing a national-level data pool would be a monumental step in this direction. It would provide better inputs for policy formulation, aid in validating new medical practices, and enable large-scale replication of effective treatments, thereby gradually transforming our healthcare system from a reactive into a proactive model,” he said.</p><p>On the heavy workload in hospitals, Raksha Mantri stated that doctors remain constantly occupied with providing treatment & performing surgeries, and crucial aspects such as research, training, and teaching tend to take a backseat. This is a practical challenge that needs to be acknowledged, urging AFMS to explore ways to effectively balance the immense workload.</p><p>Shri Rajnath Singh also urged AFMS to examine the feasibility of setting up institutions at par with Army Hospital (R&R) in all four corners of the country with the aim to provide the soldiers at every region and location, superior medical facilities. “It is not strictly necessary to establish a greenfield project or construct an entirely new institution. There are immense possibilities within brownfield projects. Command Hospitals or Base Hospitals at various locations can be upgraded with modern facilities and elevated to this very same standard,” he suggested.</p><p>Raksha Mantri emphasised that in today’s context, ‘security’ encompasses far more than merely safeguarding borders, with health security holding equal significance. “Health security plays a pivotal role when we successfully execute major operations like Operation Sindoor. When our soldiers possess the confidence that superior medical support is available to them, they accomplish their missions without apprehension. Therefore, it is imperative to adopt a consistently proactive and positive approach toward health security,” he said.</p><p>Shri Rajnath Singh stressed that the parameters of growth of a nation are not solely economic, but encompasses other significant dimensions; the most critical being the health of the people. “The medical sector needs to continuously understand these evolving challenges, address them effectively, and constantly update itself in sync with the changing times. We must move forward with a vision where progress is not confined merely to economic growth but is holistic in nature, where health is recognised as a central pillar of that development,” he said.</p><p>Raksha Mantri concluded his address by acknowledging the services rendered by the nurses of the Military Nursing Service, who, he said, serve as the bedrock of the medical forces. He stated that the recent decision to grant them the status of ‘ex-servicemen’ upon retirement underlines the Government’s commitment towards the welfare of the defence forces personnel as well as medical professionals.</p><p>As part of the visit, Shri Rajnath Singh witnessed a live demonstration and toured the Technology Exhibition area, where cutting-edge innovations and advancements in combat medical care were showcased. These included developments in trauma management, battlefield evacuation systems, prosthetics, telemedicine, and critical care technologies, reflecting AFMS’s sustained efforts towards modernisation and self-reliance.</p><p>Shri Rajnath Singh also presented the Raksha Mantri trophy of the Best Hospital of AFMS to Command Hospital (Southern Command), Pune, while the award for the Second Best Hospital went to Indian Naval Hospital Ship (INHS) Asvini, Mumbai. The awards recognise the two hospitals’ outstanding performance, excellence in patient care, innovation, and administrative efficiency within the network of Defence Forces hospitals. Raksha Mantri termed these accolades as a testament to their collective dedication and tireless efforts.</p><p>Raksha Mantri also released a book titled ‘Precision Protocols in Early Neurodevelopmental Intervention’, a significant academic contribution aimed at standardising and improving early diagnosis & intervention strategies for neurodevelopmental conditions. The publication underscores the growing focus of AFMS on research-driven, evidence-based medical practices.</p><p>Chief of Defence Staff General Anil Chauhan, Chief of the Naval Staff Admiral Dinesh K Tripathi, Chief of the Army Staff General Upendra Dwivedi, Defence Secretary Shri Rajesh Kumar Singh, DG AFMS Surgeon Vice Admiral Arti Sarin, Vice Chief of the Air Staff Air Marshal Nagesh Kapoor, and other senior officers attended the event.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/army-hospital-launches-state-of-the-art-femto-lasik-suite-for-spectacle-removal-148367"><b>Also Read:Army Hospital launches state-of-the-art Femto-LASIK Suite for spectacle removal</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>NMC issues notice for medical colleges, seeks participation from researchers, professionals in NHA AB PMJAY auto adjudication Hackathon 2026</title>
<link>https://edusehat.com/en/nmc-issues-notice-for-medical-colleges-seeks-participation-from-researchers-professionals-in-nha-ab-pmjay-auto-adjudication-hackathon-2026</link>
<guid>https://edusehat.com/en/nmc-issues-notice-for-medical-colleges-seeks-participation-from-researchers-professionals-in-nha-ab-pmjay-auto-adjudication-hackathon-2026</guid>
<description><![CDATA[ New Delhi: Through a recent notice, the National Medical Commission (NMC) has informed all medical colleges and institutions to disseminate information about an upcoming Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PMJAY) Auto-Adjudication Hackathon 2026 initiative held by the National Health Authority and encourage participation from researchers and professionals.National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY.Sharing this information, the Apex Medical Commission has asked all medical colleges and institutions to spread awareness about the initiative and encourage participation from researchers, innovators, professionals from academic and professional network.Issuing a public notice to the Dean, Principals of all medical colleges and institutions on 05.04.2026, the policy and coordination division of NMC stated, &quot;National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY.&quot;The hackathon will conclude in an offline event scheduled on May 8–9, 2026, at the Indian Institute of Science (IISc), Bengaluru. Registrations for the hackathon are open from March 31 to April 13, 2026, and interested participants can find detailed information, including timelines, agenda and participation guidelines is available at www.nha.gov.in/hackathon. &quot;The details of programme of conclusion of the Hackathon is attached herewith. Detailed information on the hackathon, including timelines, agenda and participation guidelines is available. For any query, e-mail may be sent . Registrations for participation in the Hackathon are open from 31st March to 13 th April 2026,&quot; the notice read. It further added, &quot;All Medical Colleges / Institutions are advised to hereby advised to disseminate the information on the hackathon among the stakeholders and encourage participation of researchers, innovators and professionals from academic and professional network.&quot;The two-day concluding event will include opening sessions by Dr Sunil Kumar Barnwal, CEO of NHA, Sh. Harsh Gupta, Principal Secy to the Govt of Karnataka, Dept of Health and Family Welfare, Ms. Jyoti Yadav, JS NHA (PMJAY), Dr. Devi Prasad Shetty, Chairman Narayana Health and Prof. Govindan Rangarajan, Dir IISc, Bangalore.To check the details, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/07/nmc-ayushman-bharat-pradhan-mantri-jan-aarogya-yojna-ab-pmjay-autoadjudication-hackathon-regarding-340071.pdfAlso read- AI models in healthcare must be tested on diverse populations: NHA CEO ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/21/328848-nmc-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, issues, notice, for, medical, colleges, seeks, participation, from, researchers, professionals, NHA, PMJAY, auto, adjudication, Hackathon, 2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/21/328848-nmc-2.webp"><p><b>New Delhi: </b>Through a recent notice, the <a href="https://medicaldialogues.in/topics//nmc" target="_blank">National Medical Commission</a> (NMC) has informed all medical colleges and institutions to disseminate information about an upcoming Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (<a href="https://medicaldialogues.in/topics/ab-pmjay" target="_blank">AB PMJAY</a>) Auto-Adjudication Hackathon 2026 initiative held by the National Health Authority and encourage participation from researchers and professionals.</p><p>National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY.</p><p>Sharing this information, the Apex Medical Commission has asked all medical colleges and institutions to spread awareness about the initiative and encourage participation from researchers, innovators, professionals from academic and professional network.</p><p>Issuing a public notice to the Dean, Principals of all medical colleges and institutions on 05.04.2026, the policy and coordination division of NMC stated, <i>"National Health Authority, Ministry of Health and Family Welfare, Government of India is organising the Ayushman Bharat-Pradhan Mantri Jan Aarogya Yojna (AB PMJAY) Auto‑Adjudication Hackathon, to develop innovative, scalable, technology‑driven solutions to facilitate automation of claims adjudication in the AB PMJAY."</i></p><p>The hackathon will conclude in an offline event scheduled on May 8–9, 2026, at the Indian Institute of Science (IISc), Bengaluru. Registrations for the hackathon are open from March 31 to April 13, 2026, and interested participants can find detailed information, including timelines, agenda and participation guidelines is available at www.nha.gov.in/hackathon. </p><p><i>"The details of programme of conclusion of the Hackathon is attached herewith. Detailed information on the hackathon, including timelines, agenda and participation guidelines is available. For any query, e-mail may be sent . Registrations for participation in the Hackathon are open from 31st March to 13 th April 2026,"</i> the notice read. </p><p>It further added, <i>"All Medical Colleges / Institutions are advised to hereby advised to disseminate the information on the hackathon among the stakeholders and encourage participation of researchers, innovators and professionals from academic and professional network."</i></p><p>The two-day concluding event will include opening sessions by Dr Sunil Kumar Barnwal, CEO of NHA, Sh. Harsh Gupta, Principal Secy to the Govt of Karnataka, Dept of Health and Family Welfare, Ms. Jyoti Yadav, JS NHA (PMJAY), Dr. Devi Prasad Shetty, Chairman Narayana Health and Prof. Govindan Rangarajan, Dir IISc, Bangalore.</p><p><b>To check the details, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/nmc-ayushman-bharat-pradhan-mantri-jan-aarogya-yojna-ab-pmjay-autoadjudication-hackathon-regarding-340071.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/07/nmc-ayushman-bharat-pradhan-mantri-jan-aarogya-yojna-ab-pmjay-autoadjudication-hackathon-regarding-340071.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/news/health/hospital-diagnostics/ai-models-in-healthcare-must-be-tested-on-diverse-populations-nha-ceo-163379" target="_blank">AI models in healthcare must be tested on diverse populations: NHA CEO</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Jamshedpur: Junior doctors strike at MGM Hospital over stipend hike, services disrupted</title>
<link>https://edusehat.com/en/jamshedpur-junior-doctors-strike-at-mgm-hospital-over-stipend-hike-services-disrupted</link>
<guid>https://edusehat.com/en/jamshedpur-junior-doctors-strike-at-mgm-hospital-over-stipend-hike-services-disrupted</guid>
<description><![CDATA[ Jamshedpur: Junior doctors at Mahatma Gandhi Memorial (MGM) Medical College and Hospital in Jamshedpur went on strike from 8:30 am on Monday, demanding an increase in their stipends. The strike was later called off after authorities provided assurances. Health services at the Mahatma Gandhi Memorial (MGM) Medical College and Hospital in Jamshedpur were affected on Monday after junior doctors went on an indefinite strike to demand an increase in stipends, according to hospital sources. Additionally, the strike disrupted routine functioning in several departments and affected patient care, particularly outpatient services.  Medical Dialogues had recently reported that, demanding a stipend hike, fair salaries, and improved working conditions, junior resident doctors in Jharkhand staged a protest on Monday by wearing black bands during duty and warned that they would launch a statewide indefinite strike from April 6 if their long-pending demands are not met. Doctors from five medical college hospitals across the state, including MGM Medical College Hospital, Jamshedpur, participated in the protest under the banner of the IMA–Junior Doctors’ Network (IMA-JDN).   The protesting doctors said they had been raising the stipend issue for a long time and had earlier staged symbolic protests, including wearing black badges, before resorting to the strike, news agency UNI reported.  According to The Avenue Mail media report, more than 600 patients had to return without treatment as registration services remained suspended. Junior doctors locked the registration counter gates early in the morning, leaving staff inside and halting the issuance of registration slips. Also Read:Kerala hospitals&#039; association calls nurses&#039; strike illegal, urges Government interventionThe protesting doctors said the decision to go on an indefinite strike was taken after repeated representations failed to yield any response.Patients and attendants were seen facing inconvenience as treatment and consultations were delayed in parts of the hospital.According to The Daily, Principal Dr. Sanjay Kumar and Superintendent Dr. Balram met with the striking doctors. Following the discussions, officials assured the doctors that the government is taking their demands seriously and that the required administrative measures are already underway.Also Read:JnK NHM staff launch 72-Hour strike over demand for regularisation, salary deductions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340060-strike-5.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jamshedpur:, Junior, doctors, strike, MGM, Hospital, over, stipend, hike, services, disrupted</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340060-strike-5.webp"><div class="pasted-from-word-wrapper"><p><span>Jamshedpur: Junior doctors at </span>Mahatma Gandhi Memorial (MGM) Medical College and Hospital in Jamshedpur went on strike from 8:30 am on Monday, demanding an increase in their stipends. The strike was later called off after authorities provided assurances. </p><p><span>Health services at the Mahatma Gandhi Memorial (MGM) Medical College and Hospital in Jamshedpur were affected on Monday after junior doctors went on an indefinite <a href="https://medicaldialogues.in/topics/strike" target="_blank">strike </a>to demand an increase in stipends, according to hospital sources. </span></p><p>Additionally, the <a href="https://medicaldialogues.in/topics/strike" target="_blank">strike</a> disrupted routine functioning in several departments and affected patient care, particularly outpatient services.  </p><p>Medical Dialogues had recently reported that, demanding a stipend hike, fair salaries, and improved working conditions, junior resident doctors in Jharkhand staged a protest on Monday by wearing black bands during duty and warned that they would launch a statewide indefinite strike from April 6 if their long-pending demands are not met. </p><p>Doctors from five medical college hospitals across the state, including MGM Medical College Hospital, Jamshedpur, participated in the protest under the banner of the IMA–Junior Doctors’ Network (IMA-JDN).   <br></p><p>The protesting doctors said they had been raising the stipend issue for a long time and had earlier staged symbolic <a href="https://medicaldialogues.in/topics/protests" target="_blank">protests</a>, including wearing black badges, before resorting to the strike, news agency UNI reported.  </p><p>According to <a href="https://avenuemail.in/mgm-hospital-strike-disrupts-services-in-jamshedpur-600-patients-affected/" rel="nofollow">The Avenue Mail</a> media report, more than 600 patients had to return without treatment as registration services remained suspended. Junior doctors locked the registration counter gates early in the morning, leaving staff inside and halting the issuance of registration slips. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/kerala-hospitals-association-calls-nurses-strike-illegal-urges-government-intervention-167815"><b>Also Read:Kerala hospitals' association calls nurses' strike illegal, urges Government intervention</b></a></p><p>The protesting doctors said the decision to go on an indefinite strike was taken after repeated representations failed to yield any response.</p><p>Patients and attendants were seen facing inconvenience as treatment and consultations were delayed in parts of the hospital.</p><p>According to The Daily, Principal Dr. Sanjay Kumar and Superintendent Dr. Balram met with the striking doctors. Following the discussions, officials assured the doctors that the government is taking their demands seriously and that the required administrative measures are already underway.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/jnk-nhm-staff-launch-72-hour-strike-over-demand-for-regularisation-salary-deductions-167895"><b>Also Read:JnK NHM staff launch 72-Hour strike over demand for regularisation, salary deductions</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Environmental Factors Found to Significantly Affect Biological Age of Brain: Study</title>
<link>https://edusehat.com/en/environmental-factors-found-to-significantly-affect-biological-age-of-brain-study</link>
<guid>https://edusehat.com/en/environmental-factors-found-to-significantly-affect-biological-age-of-brain-study</guid>
<description><![CDATA[ A major international study led by the Global Brain Health Institute and Trinity College Dublin, published in Nature Medicine, reveals that brain aging is not shaped by a single factor—but by a complex interaction of environmental, social, and political conditions.
Analyzing data from 18,701 individuals across 34 countries, researchers explored the concept of the exposome—the total set of environmental and social influences a person experiences throughout life. They found that these factors act together in a “syndemic” way, meaning multiple exposures interact and amplify each other’s effects on brain health.
The study assessed 73 variables, including air pollution, climate conditions, green space availability, water quality, socioeconomic inequality, and political stability. When combined, these factors explained up to 15 times more variation in brain aging than any single factor alone. 
Different types of exposures affected the brain in distinct ways. Physical factors such as pollution, extreme temperatures, and lack of green spaces were linked to structural brain aging, particularly in regions responsible for memory and emotional regulation. These changes are associated with biological processes like neuroinflammation, oxidative stress, and vascular damage.
In contrast, social factors—such as poverty, inequality, and limited social support—were strongly associated with accelerated aging in brain networks involved in thinking, emotional control, and social behavior. Chronic stress from these conditions may drive long-term adaptations that negatively impact brain function. Notably, these social influences sometimes had a greater effect than conditions like dementia.
The findings carry significant public health implications. While individual habits like diet and exercise remain important, they address only part of the risk. Broader interventions—such as reducing pollution, improving urban design, expanding green spaces, and strengthening social systems—could play a critical role in promoting healthy brain aging.
REFERENCE: Legaz, A., et al. (2026). The exposome of brain aging across 34 countries. Nature Medicine. DOI: 10.1038/s41591-026-04302-z. https://www.nature.com/articles/s41591-026-04302-z
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340070-environmental-factors-found-to-significantly-affect-biological-age-of-brain-study.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Environmental, Factors, Found, Significantly, Affect, Biological, Age, Brain:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340070-environmental-factors-found-to-significantly-affect-biological-age-of-brain-study.webp"><p>A major international study led by the Global Brain Health Institute and Trinity College Dublin, published in <i>Nature Medicine</i>, reveals that brain aging is not shaped by a single factor—but by a complex interaction of environmental, social, and political conditions.
</p><p>Analyzing data from 18,701 individuals across 34 countries, researchers explored the concept of the exposome—the total set of environmental and social influences a person experiences throughout life. They found that these factors act together in a “syndemic” way, meaning multiple exposures interact and amplify each other’s effects on brain health.
</p><p>The study assessed 73 variables, including air pollution, climate conditions, green space availability, water quality, socioeconomic inequality, and political stability. When combined, these factors explained up to 15 times more variation in brain aging than any single factor alone. 
</p><p>Different types of exposures affected the brain in distinct ways. Physical factors such as pollution, extreme temperatures, and lack of green spaces were linked to structural brain aging, particularly in regions responsible for memory and emotional regulation. These changes are associated with biological processes like neuroinflammation, oxidative stress, and vascular damage.
</p><p>In contrast, social factors—such as poverty, inequality, and limited social support—were strongly associated with accelerated aging in brain networks involved in thinking, emotional control, and social behavior. Chronic stress from these conditions may drive long-term adaptations that negatively impact brain function. Notably, these social influences sometimes had a greater effect than conditions like dementia.
</p><p>The findings carry significant public health implications. While individual habits like diet and exercise remain important, they address only part of the risk. Broader interventions—such as reducing pollution, improving urban design, expanding green spaces, and strengthening social systems—could play a critical role in promoting healthy brain aging.
</p><p><b>REFERENCE:</b> Legaz, A., et al. (2026). The exposome of brain aging across 34 countries. Nature Medicine. DOI: 10.1038/s41591-026-04302-z. https://www.nature.com/articles/s41591-026-04302-z
</p>]]> </content:encoded>
</item>

<item>
<title>Researchers Develop Rapid Test to Transform UTI Treatment With Accurate Same&#45;Day Results</title>
<link>https://edusehat.com/en/researchers-develop-rapid-test-to-transform-uti-treatment-with-accurate-same-day-results</link>
<guid>https://edusehat.com/en/researchers-develop-rapid-test-to-transform-uti-treatment-with-accurate-same-day-results</guid>
<description><![CDATA[ A new diagnostic breakthrough could transform how urinary tract infections (UTIs) are treated, allowing doctors to prescribe the right antibiotic within hours instead of days. Developed by researchers at the University of Reading in collaboration with the University of Southampton and Hampshire Hospitals NHS Foundation Trust, the rapid urine test delivers results in under six hours.
Published in the Journal of Antimicrobial Chemotherapy, the study evaluated 352 urine samples from patients with suspected UTIs. The test demonstrated an impressive 96.95% accuracy when compared to traditional laboratory methods across seven commonly used antibiotics. A secondary analysis of 90 duplicate samples confirmed reliability, showing 98.75% agreement regardless of whether preservatives were used.
Currently, UTI diagnosis relies on culturing bacteria in a lab, a process that takes two to three days. During this delay, patients are often prescribed broad-spectrum antibiotics, which may be ineffective. This not only prolongs symptoms but also contributes to antimicrobial resistance, a growing global health threat.
The new method eliminates the need for overnight culturing. Instead, urine samples are placed into a cartridge containing multiple antibiotics. Using optical imaging, the system monitors bacterial growth in real time. If bacteria stop growing in a specific tube, that antibiotic is effective; if not, it is unsuitable. This direct-from-urine approach significantly speeds up decision-making.
The implications are substantial. Faster, targeted treatment could reduce complications such as kidney infections or sepsis, improve patient outcomes, and limit unnecessary antibiotic use. With millions of UTI cases diagnosed annually and rising antibiotic resistance rates, such innovation is urgently needed.
Researchers believe this technology could soon be integrated into routine clinical practice, offering a practical and scalable solution. 
REFERENCE: Sarah Helen Needs, HoYin Lam, Jessica E Hayward, Richa Sharma, Manisha Gurung, Oliver Hancox, Julie Hart, Stephen P Kidd, Alexander Daniel Edwards. Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection. JAC-Antimicrobial Resistance, 2026; 8 (2) DOI: 10.1093/jacamr/dlag035
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340068-researchers-develop-rapid-test-to-transform-uti-treatment-with-accurate-same-day-results.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Researchers, Develop, Rapid, Test, Transform, UTI, Treatment, With, Accurate, Same-Day, Results</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340068-researchers-develop-rapid-test-to-transform-uti-treatment-with-accurate-same-day-results.webp"><p>A new diagnostic breakthrough could transform how urinary tract infections (UTIs) are treated, allowing doctors to prescribe the right antibiotic within hours instead of days. Developed by researchers at the University of Reading in collaboration with the University of Southampton and Hampshire Hospitals NHS Foundation Trust, the rapid urine test delivers results in under six hours.
</p><p>Published in the <i>Journal of Antimicrobial Chemotherapy</i>, the study evaluated 352 urine samples from patients with suspected UTIs. The test demonstrated an impressive 96.95% accuracy when compared to traditional laboratory methods across seven commonly used antibiotics. A secondary analysis of 90 duplicate samples confirmed reliability, showing 98.75% agreement regardless of whether preservatives were used.
</p><p>Currently, UTI diagnosis relies on culturing bacteria in a lab, a process that takes two to three days. During this delay, patients are often prescribed broad-spectrum antibiotics, which may be ineffective. This not only prolongs symptoms but also contributes to antimicrobial resistance, a growing global health threat.
</p><p>The new method eliminates the need for overnight culturing. Instead, urine samples are placed into a cartridge containing multiple antibiotics. Using optical imaging, the system monitors bacterial growth in real time. If bacteria stop growing in a specific tube, that antibiotic is effective; if not, it is unsuitable. This direct-from-urine approach significantly speeds up decision-making.
</p><p>The implications are substantial. Faster, targeted treatment could reduce complications such as kidney infections or sepsis, improve patient outcomes, and limit unnecessary antibiotic use. With millions of UTI cases diagnosed annually and rising antibiotic resistance rates, such innovation is urgently needed.
</p><p>Researchers believe this technology could soon be integrated into routine clinical practice, offering a practical and scalable solution. 
</p><p><b>REFERENCE:</b> Sarah Helen Needs, HoYin Lam, Jessica E Hayward, Richa Sharma, Manisha Gurung, Oliver Hancox, Julie Hart, Stephen P Kidd, Alexander Daniel Edwards. Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection. JAC-Antimicrobial Resistance, 2026; 8 (2) DOI: 10.1093/jacamr/dlag035
</p>]]> </content:encoded>
</item>

<item>
<title>Five&#45;Day Diet Found to Rapidly Improve Symptoms in Crohn&amp;apos;s Disease Patients, Study Shows</title>
<link>https://edusehat.com/en/five-day-diet-found-to-rapidly-improve-symptoms-in-crohns-disease-patients-study-shows</link>
<guid>https://edusehat.com/en/five-day-diet-found-to-rapidly-improve-symptoms-in-crohns-disease-patients-study-shows</guid>
<description><![CDATA[ A new clinical trial from Stanford Medicine, published in Nature Medicine, suggests that a short, monthly fasting-style diet may significantly improve symptoms and reduce inflammation in people with Crohn’s disease.
Crohn’s disease is a chronic condition that causes inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. Treatment options remain limited, especially for mild cases, where long-term steroid use can lead to serious side effects. This has made diet an area of growing interest, though evidence has historically been scarce.
In this randomized controlled trial, researchers followed 97 patients with mild-to-moderate Crohn’s disease over three months. Participants were divided into two groups: 65 followed a fasting-mimicking diet (FMD), while 32 continued their usual eating habits. The FMD group consumed a reduced-calorie, plant-based diet—around 700 to 1,100 calories per day—for five consecutive days each month, returning to normal eating for the remainder of the time.
The results were notable. About two-thirds of patients in the FMD group reported improvements in symptoms, compared to fewer than half in the control group. Benefits were observed as early as after the first cycle. While some participants experienced mild side effects like fatigue and headaches, no serious adverse events were reported.
Importantly, the improvements were not just subjective. Biological analysis showed a significant drop in fecal calprotectin, a key marker of gut inflammation. Other inflammatory signals, including lipid mediators and immune cell activity, were also reduced. These findings suggest that the diet may directly influence inflammatory pathways.
Overall, the study provides promising evidence that structured dietary interventions like fasting-mimicking diets could become a valuable tool in managing Crohn’s disease, offering patients a non-drug strategy to complement existing treatments.
REFERENCE: C. Kulkarni, T. Fardeen, J. Gubatan, J. Ye, K. Jarr, E. Dickson, H. Jang, M. Temby, A. Patel, Y. Jiang, G. Singh, K. Keyashian, S. Streett, E. Ho, G. Barber, S. Singh, D. Limsui, N. Anaizi, L. Becker, S. P. Spencer, D. Mehrish, D. Perelman, V. D. Longo, V. Charu, J. F. Ashouri, M. M. Davis, A. Habtezion, J. L. Sonnenburg, C. Gardner, S. R. Sinha. A fasting-mimicking diet in patients with mild-to-moderate Crohn’s disease: a randomized controlled trial. Nature Medicine, 2026; 32 (3): 1023 DOI: 10.1038/s41591-025-04173-w
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340062-five-day-diet-found-to-rapidly-improve-symptoms-in-crohns-disease-patients-study-shows.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Five-Day, Diet, Found, Rapidly, Improve, Symptoms, Crohns, Disease, Patients, Study, Shows</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340062-five-day-diet-found-to-rapidly-improve-symptoms-in-crohns-disease-patients-study-shows.webp"><p>A new clinical trial from Stanford Medicine, published in <i>Nature Medicine</i>, suggests that a short, monthly fasting-style diet may significantly improve symptoms and reduce inflammation in people with Crohn’s disease.
</p><p>Crohn’s disease is a chronic condition that causes inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. Treatment options remain limited, especially for mild cases, where long-term steroid use can lead to serious side effects. This has made diet an area of growing interest, though evidence has historically been scarce.
</p><p>In this randomized controlled trial, researchers followed 97 patients with mild-to-moderate Crohn’s disease over three months. Participants were divided into two groups: 65 followed a fasting-mimicking diet (FMD), while 32 continued their usual eating habits. The FMD group consumed a reduced-calorie, plant-based diet—around 700 to 1,100 calories per day—for five consecutive days each month, returning to normal eating for the remainder of the time.
</p><p>The results were notable. About two-thirds of patients in the FMD group reported improvements in symptoms, compared to fewer than half in the control group. Benefits were observed as early as after the first cycle. While some participants experienced mild side effects like fatigue and headaches, no serious adverse events were reported.
</p><p>Importantly, the improvements were not just subjective. Biological analysis showed a significant drop in fecal calprotectin, a key marker of gut inflammation. Other inflammatory signals, including lipid mediators and immune cell activity, were also reduced. These findings suggest that the diet may directly influence inflammatory pathways.
</p><p>Overall, the study provides promising evidence that structured dietary interventions like fasting-mimicking diets could become a valuable tool in managing Crohn’s disease, offering patients a non-drug strategy to complement existing treatments.
</p><p><b>REFERENCE: </b>C. Kulkarni, T. Fardeen, J. Gubatan, J. Ye, K. Jarr, E. Dickson, H. Jang, M. Temby, A. Patel, Y. Jiang, G. Singh, K. Keyashian, S. Streett, E. Ho, G. Barber, S. Singh, D. Limsui, N. Anaizi, L. Becker, S. P. Spencer, D. Mehrish, D. Perelman, V. D. Longo, V. Charu, J. F. Ashouri, M. M. Davis, A. Habtezion, J. L. Sonnenburg, C. Gardner, S. R. Sinha. A fasting-mimicking diet in patients with mild-to-moderate Crohn’s disease: a randomized controlled trial. Nature Medicine, 2026; 32 (3): 1023 DOI: 10.1038/s41591-025-04173-w
</p>]]> </content:encoded>
</item>

<item>
<title>New Research Highlights TIVA&amp;apos;s Advantage in Reducing Inflammation During Microdiscectomy</title>
<link>https://edusehat.com/en/new-research-highlights-tivas-advantage-in-reducing-inflammation-during-microdiscectomy-9314</link>
<guid>https://edusehat.com/en/new-research-highlights-tivas-advantage-in-reducing-inflammation-during-microdiscectomy-9314</guid>
<description><![CDATA[ The Anesthesia Dilemma: Does Technique Influence Recovery?When it comes to surgical recovery, the choice of anesthesia may be more than just a technical detail—it could shape the body’s response to stress and inflammation. A recent double-blind study published in BMC Anesthesiology explores whether total intravenous anesthesia (TIVA) with propofol or inhalation anesthesia with sevoflurane offers a better profile for controlling perioperative inflammation in lumbar microdiscectomy patients.Study Design: A Closer Look at Inflammatory MarkersThe research involved 40 patients, aged 18–65, undergoing elective lumbar disc herniation surgery. They were randomized to receive either TIVA (propofol-based) or sevoflurane anesthesia. The key focus was on measuring and comparing interleukin-6 (IL-6)—a core inflammatory cytokine—at multiple timepoints before, during, and after surgery. Additional markers included C-reactive protein (CRP), procalcitonin (PCT), and the neutrophil-to-lymphocyte ratio (NLR).Key Findings: TIVA Damps Down the Inflammatory SurgeBoth anesthesia approaches led to increased IL-6 after surgery, but the rise was significantly less pronounced in the TIVA group. At 24 hours post-surgery, IL-6 levels in TIVA patients were markedly lower compared to those who received sevoflurane. Similarly, CRP levels—a general marker of inflammation—were also lower with TIVA. PCT levels, often linked to infection, remained stable and similar between groups, and NLR values did not show significant differences postoperatively.Why Does This Matter?Excessive or poorly controlled inflammation can slow healing, increase infection risk, and complicate recovery. The study’s results suggest that TIVA with propofol may help better modulate this response, potentially offering patients smoother recoveries. Interestingly, although many previous studies focused on cancer or major surgeries, this research zeroed in on a minimally invasive, non-oncologic procedure—giving new insight into anesthesia’s impact in routine spine surgery.Weighing the Evidence: Practical Implications and Next StepsWhile the study found no difference in length of hospital stay or immediate complications, the findings raise the possibility that TIVA could be the preferred option when minimizing surgical inflammation is a priority. However, larger and more diverse studies are needed to confirm these results, assess long-term outcomes, and determine if the benefits translate to other patient populations or types of surgery.Key TakeawaysTIVA with propofol led to significantly lower postoperative IL-6 and CRP levels compared to sevoflurane in microdiscectomy.No differences were observed in PCT (infection marker) or postoperative NLR values.Both anesthesia techniques were safe, with no difference in complications or hospital stay.TIVA may offer a real advantage for patients needing tight inflammation control during surgery.Further large-scale, multicenter studies are warranted to expand on these promising findings.Citation:Yediyıldız MB, Durmuş İ, Yılmaz Ak H, Taşkın K, Devrüş Ceylan MA, Yüce Y, Çevik B, Aydoğmuş E. Comparison of inhalation and total intravenous anesthesia on inflammatory markers in microdiscectomy: a double-blind study. BMC Anesthesiology. 2025;25:238. https://doi.org/10.1186/s12871-025-03119-6 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/29/210695-spine-surgery.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Research, Highlights, TIVAs, Advantage, Reducing, Inflammation, During, Microdiscectomy</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/29/210695-spine-surgery.webp"><p align="justify">The Anesthesia Dilemma: Does Technique Influence Recovery?</p><p align="justify">When it comes to surgical recovery, the choice of anesthesia may be more than just a technical detail—it could shape the body’s response to stress and inflammation. A recent double-blind study published in BMC Anesthesiology explores whether total intravenous anesthesia (TIVA) with propofol or inhalation anesthesia with sevoflurane offers a better profile for controlling perioperative inflammation in lumbar microdiscectomy patients.</p><p align="justify">Study Design: A Closer Look at Inflammatory Markers</p><p align="justify">The research involved 40 patients, aged 18–65, undergoing elective lumbar disc herniation surgery. They were randomized to receive either TIVA (propofol-based) or sevoflurane anesthesia. The key focus was on measuring and comparing interleukin-6 (IL-6)—a core inflammatory cytokine—at multiple timepoints before, during, and after surgery. Additional markers included C-reactive protein (CRP), procalcitonin (PCT), and the neutrophil-to-lymphocyte ratio (NLR).</p><p align="justify">Key Findings: TIVA Damps Down the Inflammatory Surge</p><p align="justify">Both anesthesia approaches led to increased IL-6 after surgery, but the rise was significantly less pronounced in the TIVA group. At 24 hours post-surgery, IL-6 levels in TIVA patients were markedly lower compared to those who received sevoflurane. Similarly, CRP levels—a general marker of inflammation—were also lower with TIVA. PCT levels, often linked to infection, remained stable and similar between groups, and NLR values did not show significant differences postoperatively.</p><p align="justify">Why Does This Matter?</p><p align="justify">Excessive or poorly controlled inflammation can slow healing, increase infection risk, and complicate recovery. The study’s results suggest that TIVA with propofol may help better modulate this response, potentially offering patients smoother recoveries. Interestingly, although many previous studies focused on cancer or major surgeries, this research zeroed in on a minimally invasive, non-oncologic procedure—giving new insight into anesthesia’s impact in routine spine surgery.</p><p align="justify">Weighing the Evidence: Practical Implications and Next Steps</p><p align="justify">While the study found no difference in length of hospital stay or immediate complications, the findings raise the possibility that TIVA could be the preferred option when minimizing surgical inflammation is a priority. However, larger and more diverse studies are needed to confirm these results, assess long-term outcomes, and determine if the benefits translate to other patient populations or types of surgery.</p><p align="justify">Key Takeaways</p><p align="justify">TIVA with propofol led to significantly lower postoperative IL-6 and CRP levels compared to sevoflurane in microdiscectomy.</p><p align="justify">No differences were observed in PCT (infection marker) or postoperative NLR values.</p><p align="justify">Both anesthesia techniques were safe, with no difference in complications or hospital stay.</p><p align="justify">TIVA may offer a real advantage for patients needing tight inflammation control during surgery.</p><p align="justify">Further large-scale, multicenter studies are warranted to expand on these promising findings.</p><p align="justify">Citation:</p><p align="justify">Yediyıldız MB, Durmuş İ, Yılmaz Ak H, Taşkın K, Devrüş Ceylan MA, Yüce Y, Çevik B, Aydoğmuş E. Comparison of inhalation and total intravenous anesthesia on inflammatory markers in microdiscectomy: a double-blind study. BMC Anesthesiology. 2025;25:238. https://doi.org/10.1186/s12871-025-03119-6</p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 07/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-07april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-07april2026</guid>
<description><![CDATA[ Here are the top medical news for today:Five-Day Diet Found to Rapidly Improve Symptoms in Crohn’s Disease Patients, Study Shows
A new clinical trial from Stanford Medicine, published in Nature Medicine, suggests that a short, monthly fasting-style diet may significantly improve symptoms and reduce inflammation in people with Crohn’s disease.
Crohn’s disease is a chronic condition that causes inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. Treatment options remain limited, especially for mild cases, where long-term steroid use can lead to serious side effects. This has made diet an area of growing interest, though evidence has historically been scarce.
In this randomized controlled trial, researchers followed 97 patients with mild-to-moderate Crohn’s disease over three months. Participants were divided into two groups: 65 followed a fasting-mimicking diet (FMD), while 32 continued their usual eating habits. The FMD group consumed a reduced-calorie, plant-based diet—around 700 to 1,100 calories per day—for five consecutive days each month, returning to normal eating for the remainder of the time.
The results were notable. About two-thirds of patients in the FMD group reported improvements in symptoms, compared to fewer than half in the control group. Benefits were observed as early as after the first cycle. While some participants experienced mild side effects like fatigue and headaches, no serious adverse events were reported.
Importantly, the improvements were not just subjective. Biological analysis showed a significant drop in fecal calprotectin, a key marker of gut inflammation. Other inflammatory signals, including lipid mediators and immune cell activity, were also reduced. These findings suggest that the diet may directly influence inflammatory pathways.
Overall, the study provides promising evidence that structured dietary interventions like fasting-mimicking diets could become a valuable tool in managing Crohn’s disease, offering patients a non-drug strategy to complement existing treatments.
REFERENCE: C. Kulkarni, T. Fardeen, J. Gubatan, J. Ye, K. Jarr, E. Dickson, H. Jang, M. Temby, A. Patel, Y. Jiang, G. Singh, K. Keyashian, S. Streett, E. Ho, G. Barber, S. Singh, D. Limsui, N. Anaizi, L. Becker, S. P. Spencer, D. Mehrish, D. Perelman, V. D. Longo, V. Charu, J. F. Ashouri, M. M. Davis, A. Habtezion, J. L. Sonnenburg, C. Gardner, S. R. Sinha. A fasting-mimicking diet in patients with mild-to-moderate Crohn’s disease: a randomized controlled trial. Nature Medicine, 2026; 32 (3): 1023 DOI: 10.1038/s41591-025-04173-w
Researchers Develop Rapid Test to Transform UTI Treatment With Accurate Same-Day Results
A new diagnostic breakthrough could transform how urinary tract infections (UTIs) are treated, allowing doctors to prescribe the right antibiotic within hours instead of days. Developed by researchers at University of Reading in collaboration with University of Southampton and Hampshire Hospitals NHS Foundation Trust, the rapid urine test delivers results in under six hours.Published in the Journal of Antimicrobial Chemotherapy, the study evaluated 352 urine samples from patients with suspected UTIs. The test demonstrated an impressive 96.95% accuracy when compared to traditional laboratory methods across seven commonly used antibiotics. A secondary analysis of 90 duplicate samples confirmed reliability, showing 98.75% agreement regardless of whether preservatives were used.
Currently, UTI diagnosis relies on culturing bacteria in a lab, a process that takes two to three days. During this delay, patients are often prescribed broad-spectrum antibiotics, which may be ineffective. This not only prolongs symptoms but also contributes to antimicrobial resistance, a growing global health threat.
The new method eliminates the need for overnight culturing. Instead, urine samples are placed into a cartridge containing multiple antibiotics. Using optical imaging, the system monitors bacterial growth in real time. If bacteria stop growing in a specific tube, that antibiotic is effective; if not, it is unsuitable. This direct-from-urine approach significantly speeds up decision-making.
The implications are substantial. Faster, targeted treatment could reduce complications such as kidney infections or sepsis, improve patient outcomes, and limit unnecessary antibiotic use. With millions of UTI cases diagnosed annually and rising antibiotic resistance rates, such innovation is urgently needed.
Researchers believe this technology could soon be integrated into routine clinical practice, offering a practical and scalable solution. 
REFERENCE: Sarah Helen Needs, HoYin Lam, Jessica E Hayward, Richa Sharma, Manisha Gurung, Oliver Hancox, Julie Hart, Stephen P Kidd, Alexander Daniel Edwards. Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection. JAC-Antimicrobial Resistance, 2026; 8 (2) DOI: 10.1093/jacamr/dlag035
Environmental Factors Found to Significantly Affect Biological Age of Brain: Study
A major international study led by the Global Brain Health Institute and Trinity College Dublin, published in Nature Medicine, reveals that brain aging is not shaped by a single factor—but by a complex interaction of environmental, social, and political conditions.
Analyzing data from 18,701 individuals across 34 countries, researchers explored the concept of the exposome—the total set of environmental and social influences a person experiences throughout life. They found that these factors act together in a “syndemic” way, meaning multiple exposures interact and amplify each other’s effects on brain health.
The study assessed 73 variables, including air pollution, climate conditions, green space availability, water quality, socioeconomic inequality, and political stability. When combined, these factors explained up to 15 times more variation in brain aging than any single factor alone. 
Different types of exposures affected the brain in distinct ways. Physical factors such as pollution, extreme temperatures, and lack of green spaces were linked to structural brain aging, particularly in regions responsible for memory and emotional regulation. These changes are associated with biological processes like neuroinflammation, oxidative stress, and vascular damage.
In contrast, social factors—such as poverty, inequality, and limited social support—were strongly associated with accelerated aging in brain networks involved in thinking, emotional control, and social behavior. Chronic stress from these conditions may drive long-term adaptations that negatively impact brain function. Notably, these social influences sometimes had a greater effect than conditions like dementia.
The findings carry significant public health implications. While individual habits like diet and exercise remain important, they address only part of the risk. Broader interventions—such as reducing pollution, improving urban design, expanding green spaces, and strengthening social systems—could play a critical role in promoting healthy brain aging.
REFERENCE: Legaz, A., et al. (2026). The exposome of brain aging across 34 countries. Nature Medicine. DOI: 10.1038/s41591-026-04302-z. https://www.nature.com/articles/s41591-026-04302-z
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340072-top-medical-2026-04-07t115637372.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 07April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340072-top-medical-2026-04-07t115637372.webp"><p><b>Here are the top medical news for today:</b></p><p><b>Five-Day Diet Found to Rapidly Improve Symptoms in Crohn’s Disease Patients, Study Shows
</b></p><p>A new clinical trial from Stanford Medicine, published in Nature Medicine, suggests that a short, monthly fasting-style diet may significantly improve symptoms and reduce inflammation in people with Crohn’s disease.
</p><p>Crohn’s disease is a chronic condition that causes inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. Treatment options remain limited, especially for mild cases, where long-term steroid use can lead to serious side effects. This has made diet an area of growing interest, though evidence has historically been scarce.
</p><p>In this randomized controlled trial, researchers followed 97 patients with mild-to-moderate Crohn’s disease over three months. Participants were divided into two groups: 65 followed a fasting-mimicking diet (FMD), while 32 continued their usual eating habits. The FMD group consumed a reduced-calorie, plant-based diet—around 700 to 1,100 calories per day—for five consecutive days each month, returning to normal eating for the remainder of the time.
</p><p>The results were notable. About two-thirds of patients in the FMD group reported improvements in symptoms, compared to fewer than half in the control group. Benefits were observed as early as after the first cycle. While some participants experienced mild side effects like fatigue and headaches, no serious adverse events were reported.
</p><p>Importantly, the improvements were not just subjective. Biological analysis showed a significant drop in fecal calprotectin, a key marker of gut inflammation. Other inflammatory signals, including lipid mediators and immune cell activity, were also reduced. These findings suggest that the diet may directly influence inflammatory pathways.
</p><p>Overall, the study provides promising evidence that structured dietary interventions like fasting-mimicking diets could become a valuable tool in managing Crohn’s disease, offering patients a non-drug strategy to complement existing treatments.
</p><p><b>REFERENCE: </b>C. Kulkarni, T. Fardeen, J. Gubatan, J. Ye, K. Jarr, E. Dickson, H. Jang, M. Temby, A. Patel, Y. Jiang, G. Singh, K. Keyashian, S. Streett, E. Ho, G. Barber, S. Singh, D. Limsui, N. Anaizi, L. Becker, S. P. Spencer, D. Mehrish, D. Perelman, V. D. Longo, V. Charu, J. F. Ashouri, M. M. Davis, A. Habtezion, J. L. Sonnenburg, C. Gardner, S. R. Sinha. A fasting-mimicking diet in patients with mild-to-moderate Crohn’s disease: a randomized controlled trial. Nature Medicine, 2026; 32 (3): 1023 DOI: 10.1038/s41591-025-04173-w
</p><p><b><br></b></p><p><b>Researchers Develop Rapid Test to Transform UTI Treatment With Accurate Same-Day Results
</b></p><p>A new diagnostic breakthrough could transform how urinary tract infections (UTIs) are treated, allowing doctors to prescribe the right antibiotic within hours instead of days. Developed by researchers at University of Reading in collaboration with University of Southampton and Hampshire Hospitals NHS Foundation Trust, the rapid urine test delivers results in under six hours.</p><p>Published in the Journal of Antimicrobial Chemotherapy, the study evaluated 352 urine samples from patients with suspected UTIs. The test demonstrated an impressive 96.95% accuracy when compared to traditional laboratory methods across seven commonly used antibiotics. A secondary analysis of 90 duplicate samples confirmed reliability, showing 98.75% agreement regardless of whether preservatives were used.
</p><p>Currently, UTI diagnosis relies on culturing bacteria in a lab, a process that takes two to three days. During this delay, patients are often prescribed broad-spectrum antibiotics, which may be ineffective. This not only prolongs symptoms but also contributes to antimicrobial resistance, a growing global health threat.
</p><p>The new method eliminates the need for overnight culturing. Instead, urine samples are placed into a cartridge containing multiple antibiotics. Using optical imaging, the system monitors bacterial growth in real time. If bacteria stop growing in a specific tube, that antibiotic is effective; if not, it is unsuitable. This direct-from-urine approach significantly speeds up decision-making.
</p><p>The implications are substantial. Faster, targeted treatment could reduce complications such as kidney infections or sepsis, improve patient outcomes, and limit unnecessary antibiotic use. With millions of UTI cases diagnosed annually and rising antibiotic resistance rates, such innovation is urgently needed.
</p><p>Researchers believe this technology could soon be integrated into routine clinical practice, offering a practical and scalable solution. 
</p><p><b>REFERENCE:</b> Sarah Helen Needs, HoYin Lam, Jessica E Hayward, Richa Sharma, Manisha Gurung, Oliver Hancox, Julie Hart, Stephen P Kidd, Alexander Daniel Edwards. Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection. JAC-Antimicrobial Resistance, 2026; 8 (2) DOI: 10.1093/jacamr/dlag035
</p><p><b><br></b></p><p><b>Environmental Factors Found to Significantly Affect Biological Age of Brain: Study
</b></p><p>A major international study led by the Global Brain Health Institute and Trinity College Dublin, published in Nature Medicine, reveals that brain aging is not shaped by a single factor—but by a complex interaction of environmental, social, and political conditions.
</p><p>Analyzing data from 18,701 individuals across 34 countries, researchers explored the concept of the exposome—the total set of environmental and social influences a person experiences throughout life. They found that these factors act together in a “syndemic” way, meaning multiple exposures interact and amplify each other’s effects on brain health.
</p><p>The study assessed 73 variables, including air pollution, climate conditions, green space availability, water quality, socioeconomic inequality, and political stability. When combined, these factors explained up to 15 times more variation in brain aging than any single factor alone. 
</p><p>Different types of exposures affected the brain in distinct ways. Physical factors such as pollution, extreme temperatures, and lack of green spaces were linked to structural brain aging, particularly in regions responsible for memory and emotional regulation. These changes are associated with biological processes like neuroinflammation, oxidative stress, and vascular damage.
</p><p>In contrast, social factors—such as poverty, inequality, and limited social support—were strongly associated with accelerated aging in brain networks involved in thinking, emotional control, and social behavior. Chronic stress from these conditions may drive long-term adaptations that negatively impact brain function. Notably, these social influences sometimes had a greater effect than conditions like dementia.
</p><p>The findings carry significant public health implications. While individual habits like diet and exercise remain important, they address only part of the risk. Broader interventions—such as reducing pollution, improving urban design, expanding green spaces, and strengthening social systems—could play a critical role in promoting healthy brain aging.
</p><p><b>REFERENCE:</b> Legaz, A., et al. (2026). The exposome of brain aging across 34 countries. Nature Medicine. DOI: 10.1038/s41591-026-04302-z. https://www.nature.com/articles/s41591-026-04302-z
</p>]]> </content:encoded>
</item>

<item>
<title>MUHS invites applications for Summer Internship programme 2026, check schedule, eligibility, stipend, all details here</title>
<link>https://edusehat.com/en/muhs-invites-applications-for-summer-internship-programme-2026-check-schedule-eligibility-stipend-all-details-here</link>
<guid>https://edusehat.com/en/muhs-invites-applications-for-summer-internship-programme-2026-check-schedule-eligibility-stipend-all-details-here</guid>
<description><![CDATA[ Maharashtra: The Maharashtra University of Health Sciences (MUHS) Nashik has announced the online admission process for its Summer Internship Program (SIP) 2026, inviting applications from undergraduate health science students up to the third year including MBBS, BDS, AYUSH and nursing students.As per the official notification, the application window has opened from April 6 and will remain active till April 20, 2026, offering eligible students an opportunity to gain hands-on training across various enrolled SIP centres during the summer vacation period.Time Schedule and Guidelines / InstructionsTentative Time Schedule for Centralized Online Admission Process of MUHS SUMMER INTERNSHIP PROGRAM (SIP) -2026:
 
 
 
 
  Sr. No.
  Particular
  Date
 
 
  1
  Publication of Draft List
  of enrolled SIP Centers(s) with learning goal,
  Intake Capacity for A.Y. 2026 for submission of their willingness, review and
  confirmation for participation in MUHS SIP 2026
  01/04/2026
 
 
  2
  Last date to receive the confirmation
  from enrolled SIP Centers(s) SIP Centers to verify the Name, area of Learning
  goal and other details
    given.(If any correction, Kindly intimate to the University via email only
  on
    ieh@muhs.ac.in)
  5/4/2026 upto 23:59 Hrs.
 
 
  3
  Publication of Final List
  of enrolled SIP Centers(s) with learning goal,
  Intake Capacity for A.Y. 2026 for participation in MUHS
  SIP 2026.
  6/4/2026
 
 
  4
  University
  Admission Notification to be published on MUHS website www.muhs.ac.in for
  MUHS SIP 2026
  6/4/2026
 
 
  5
  Date
  of Availability of Online Application Forms Link on MUHS website. Desirous
  MUHS Students up to 3rd Year on going can apply Online by paying Application
  Form Fees Rs. 500/- non-refundable expect for the clause mentioned (For
  further details please visit MUHS SIP Rules Notification)
  6/4/2026
 
 
  6
  Last
  date of filling and submission of Online Application Form
  20/04/2026 upto
  23:59 Hrs.
 
 
  7
  Last date within which online
  scrutiny and Evaluation of SOP for application forms received for SIP - 2026
  shall be done by faculty / experts / staff nominated by MUHS.
  Up to 04/05/2026
 
 
  8
  Publications of Provisional General List of candidates
  46147
 
 
  9
  Date for submission of discrepancy, if any by
  email on ieh@muhs.ac.in.
  6/5/2026 upto 23:59 Hrs.
 
 
  10
  Publications of Provisional
  General Merit List
  7/5/2026
 
 
  11
  To call for Objection/ Suggestion, If any;
  8/5/2026 upto 23:59 Hrs.
 
 
  12
  Publications of General
  Merit List
  11/5/2026
 
 
  13
  Admission
  1st Round with allotment of SIP Centre to the selected candidate (Allotment
  Letter will be generated online and selected candidates shall login to their
  account with OTP on registered mobile number and shall take print out of
  allotment letter in case of allotment)
  18/05/2026
 
 
  14
  Wild Card Entry Round
  19/05/2026
 
 
  15
  Reporting and joining of selected candidates
  at respective SIP Centres will start
  20/05/2026
 
 
  16
  Last Date of Reporting and joining of
  selected candidates at respective SIP Centers
  26/05/2026
 
 
  13
  Admission
  1st Round with allotment of SIP Centre to the selected candidate (Allotment
  Letter will be generated online and selected candidates shall login to their
  account with OTP on registered mobile number and shall take print out of
  allotment letter in case of allotment)
  18/05/2026
 
 
  14
  Wild Card Entry Round
  19/05/2026
 
 
  15
  Reporting and joining of selected candidates
  at respective SIP Centres will start
  20/05/2026
 
 
  16
  Last Date of Reporting and joining of
  selected candidates at respective SIP Centers
  26/05/2026
 Guidelines1)	University reserves right to amend the above Time Schedule.
2)	While confirming the application for admission to Summer Internship Program (SIP) for the A.Y. 26 to be conducted at various SIP Centers enrolled by MUHS, all the concerned should note the provisions of University Notification No. 10/2022 and act accordingly.
3)	If any seats remain vacant, it shall be filled as per the general merit list in second round, or subsequent rounds if any; Further, University may carry out the Spot Admission Round / MOP UP Round as per the policy decision of the University.
4)	The desirous applicant / Candidate(s) shall have to apply online and need to pay the prescribed application form fees online Rs.500/- (non refundable). Applicant who is financially incapable of paying processing fee or those who belongs to below poverty line (BPL) family, such Candidates shall have to submit the certificate in that respect and undertaking duly certified by concerned Dean / Principal to the University. The Vice-Chancellor shall have right to grant the processing fee waiver in such case of applicant.
5)	The MUHS Avishkar Research Festival Winners for the academic year 2025 (held in Jan 2025), if the winner (up to third year) apply under the said scheme and they got allotment for Summer Internship program then their 100% application fees will be refunded in such event. Also, they will get the opportunity to interact with team BETIC, IIT Bombay, Mumbai.
6)	The period of this summer Internship spent at respective enrolled SIP Centers, (incase apart from summer vacation) this period shall be considered as study period for the allotted students and shall be treated same as the regular attendance. The Dean/Principal of the affiliated college may also adjust the said period for elective posting of CBME, if applicable;
7)	In view of the feedback and responses from previous year, it has decided by the MUHS that, allotment of the student(s) will be done on pro-rata basis, considering the number of applications received from each faculty so that sufficient representation to each faculty students can be done.
8)	It shall be mandatory for the Candidate to submit Statement of Purpose for any one of the learning goal opted by the candidate, while submitting online application form. It will carry 03 Marks weightage. Which shall be evaluated by the University and candidate shall awarded a proportionate mark(s)(either :1 or 2 or 3) on the basis of statement of purpose submitted by candidate.
9)	12th /HSC percentage OR Cumulative Grade Point Average (CGPA) Candidate to shall have fill the prospective percentage after conversion equivalent percentage of marks as per concerned examination body guidelines. Marks 10 will be converted in to (as applicable).
10)	The merit list shall be prepared on the basis of marks or score secured by the candidate as per above marking criteria of 13 Marks (Marks obtained out of 03 Marks Statement of purpose + Marks obtained out of 10 marks assigned to 12th / HSC percentage ≤ 13 Marks). The seats will be allotted to Candidates as per Inter-Se-Merit.
11)	The merit list shall be prepared on the basis of marks or score secured by the candidate as per marking criteria of 13 Marks (Marks obtained out of 03 Marks Statement of purpose + Marks obtained out of 10 marks assigned to 12th / HSC percentage ≤ 13 Marks). The seats will be allotted to Candidates as per Inter-Se-Merit.
12)	Wherever, there is a tie, Marks obtained by the applicant in the 12th / HSC marks will be considered and shall be given preference in the merit list.
13)	Further, if still the tie persists, then Marks obtained by the applicant in the 10th / SSC marks will be considered and shall be given preference in the merit list.
14)	Further, if still the tie persists, then the Candidate(s) with higher age shall be given preference in the merit list)
15)	Scrutiny of application(s) and evaluation of statement of purpose shall be carried out by MUHS.
16)	Merit list will be publishing and Letter of allotment will be made available online.
17)	Candidate has to report at the concerned SIP Centre at their own cost and submit the joining letter through concerned Nodal Officer nominated by MUHS at respective SIP Centre.
18)	Accommodation and mess facilities will subject to availability and subject to payment of necessary charges at par with that paid by Candidates living in hostels.
19)	If required, all interns will be issued a temporary institute ID online by MUHS.
20)	On successful completion of the internship, Certificate, Badge and weekly stipend (Rs. 2500/- max. up to 04 weeks) will be awarded to SIP interns by MUHS (as prescribed by the MUHS authorities from time to time).
21)	From SIP–2026, a ‘Special Quota’ (Wild Card Entry) is being introduced. Under this provision, admissions will be granted to eligible applicants who have already applied for SIP through the official online notification. Up to 25% of the total intake capacity of each SIP Centre, or a minimum of one student, may be considered under this quota As per this provision, SIP Centres will have the flexibility to recommend eligible candidate(s) at the centre level; however, the final selection shall be made exclusively by a competent committee at the University level.STIPEND:Each Allotted candidate shall be awarded a weekly stipend of ₹2500/ week (maximum up to Four weeks) or as may be decided by MUHS from time to time.ELIGIBILITY CRITERIA:Normally, the eligibility criteria for SIP shall be as per the requirement of concerned learning goal of SIP and shall be as decided by the MUHS from time to time.
Candidates up to 3rd year ongoing who are currently admitted in under graduate Health Science Curriculum (MBBS / BDS / BAMS / BHMS / BUMS / BPTH / BSC. Nursing / BOTH / BNYS / BPMT/B.A.S.L.P/BPO/BSC (HLS) in a college affiliated to MUHS, Nashik.
 
 
 
  Sr. No.
  List of
  Documents to be uploaded / filled in while Submitting the Online application
  form
 
 
  1
  Mark list (s) of qualifying examination HSC 12th
  Standard is mandatory (reflecting percentage of marks obtained out of total
  marks calculation) 12th /HSC Percentage OR Cumulative Grade Point Average
  (CGPA) (Candidate shall have to fill the prospective percentage after
  conversion equivalent percentage of marks as per concerned examination body
  guidelines (as applicable) will be converted in to 10 Marks. 
 
 
  2
  It shall be mandatory for the Candidate to submit Statement of Purpose for any one of
  the leaning goal opted by the candidate, while submitting online application
  form. It will carry 03 Marks weightage. Which shall be evaluated by the University and candidate
  shall awarded a proportionate mark(s) (either :1 or 2 or 3) on the basis of
  statement of purpose submitted by candidate.
 
 
  3
  No Objection Certificate (NOC)
  from the college / institute, where the applicant candidate currently
  studying, in the format prescribed by the University as (ANNEXURE - A) If
  many students are applying for SIP from one college, then such college may
  issue single NOC letter containing LIST of such applicant students.
 
 
  4
  Need to print the copy of Undertaking in the format
  prescribed by the University (ANNEXURE - C) and fill the information and
  mandatory to upload the same.
 
 
  5
  Need to submit Certificate if
  the candidate is from below poverty line (BPL) family, such Candidates
  willing to get exemptions of Rs. 500/- processing fees shall have to submit
  the certificate in that respect from the concerned authority.
 To View the Provisional list of SIP Centre(s) with learning goal and intake capacity, click here: https://medicaldialogues.in/pdf_upload/2026/04/07/website2-centre-learning-report-801775477931329-340094.pdfIt is pertinent to note that, the above said provisional list is provisional and temporary
nature and is subject to change as per the position of proposal &amp; information received from SIP
Centre(s) from time to time. The University keeps right to update or amend the provisional list at
any stage of admission process.To check out the brief description of learning goal for each SIP, click here: https://medicaldialogues.in/pdf_upload/2026/04/07/website3-learninggoal-report1775477950970-340095.pdfEach Allotted candidate shall be awarded a weekly stipend of ₹ 2500/ week (maximum up to Four weeks) or as may be decided by the University from time to time. It is also noteworthy to mentioned that, University Certificate and Badge will be awarded to each the participants by MUHS, those who will successfully complete the SIP- 2026.To view the manual for student for summer internship program, click here: https://medicaldialogues.in/pdf_upload/2026/04/07/website4manual-for-student-for-sip1775477976131-340097.pdfThe desirous applicant / Candidate(s) shall have to apply online and need to pay the prescribed application form fees online Rs.500/- (non-refundable).Applicant who is financially incapable of paying processing fee or those who belongs to below poverty line (BPL) family, such Candidates shall have to submit the certificate in that respect and undertaking duly certified by concerned Dean / Principal to the University. The Vice Chancellor shall have right to grant the processing fee waiver in such case of applicant.The MUHS Avishkar Research Festival Winners for the academic year 2026 (held in Jan 2026), if the winner (up to third year) apply under the said scheme and they got allotment for Summer Internship program then their 100% application fees will be refunded in such event. Also, selected ones will get the opportunity to interact with team BETIC, IIT Bombay, Mumbai.In view of the feedback and responses from previous year it has decided by the MUHS that, allotment of the student(s) will be done on pro-rata basis, considering the number of applications received from each faculty so that sufficient representation to each faculty students can be done.To check out the manual for sip centres for summer internship program, click here: https://medicaldialogues.in/pdf_upload/2026/04/07/website5manual-for-sip-centre1775477995173-340099.pdfThe period of this summer Internship spent at respective enrolled SIP Centers, (incase apart
from summer vacation) this period shall be considered as study period for the allotted students
and shall be treated same as the regular attendance. The Dean/Principal of the affiliated college
may also adjust the said period for elective posting of CBME, if applicable;Further, it is made clear that, all the necessary communication shall be made online only; no
any written communication will be made for any SIP Center or the desirous Candidate(s) /
applicant(s) by the University. Hence, it is the duty of the candidate / concerned applicant and
SIP Center or visit to the University website regularly in order to get necessary updates.It is also noteworthy to mention that, the reputed firms in the software sector with whom
MUHS have entered into MoUs has consented to offer the digital content webinars to these
students. Also, lectures and e-learning sessions like last year by expert faculties from MPGI
Institute of the University will be conducted for these SIP interns too. Furthermore, the Dean / Principal are requested to bring this Notification to the notice of all
desirous candidate(s) and shall give wide publicity to it by displaying the same at College / SIP
Center Notice board. To view the official notice, click the link mentioned below- https://medicaldialogues.in/pdf_upload/2026/04/07/sipadmissionnotification-no-1120260604261775478247429-340101.pdf  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/05/03/285443-summer-internship-programme-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MUHS, invites, applications, for, Summer, Internship, programme, 2026, check, schedule, eligibility, stipend, all, details, here</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/05/03/285443-summer-internship-programme-1.webp"><div class="pasted-from-word-wrapper"><p><b>Maharashtra:</b> The Maharashtra University of Health Sciences (<a href="https://medicaldialogues.in/topics/MUHS">MUHS</a>) Nashik has announced the online admission process for its Summer Internship Program (SIP) 2026, inviting applications from undergraduate health science students up to the third year including MBBS, BDS, AYUSH and nursing students.</p><p>As per the official notification, the application window has opened from April 6 and will remain active till April 20, 2026, offering eligible students an opportunity to gain hands-on training across various enrolled SIP centres during the summer vacation period.</p></div><div class="pasted-from-word-wrapper"><b>Time Schedule and Guidelines / Instructions</b></div><div class="pasted-from-word-wrapper"><span>Tentative Time Schedule for Centralized Online Admission Process of </span><span><u>MUHS SUMMER INTERNSHIP PROGRAM (SIP) -2026</u>:</span></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="697">
 <colgroup><col width="64">
 <col width="462">
 <col width="171">
 </colgroup><tbody><tr height="19">
  <td height="19" class="xl67" width="64"><b>Sr. No.</b></td>
  <td class="xl67" width="462"><b>Particular</b></td>
  <td class="xl67" width="171"><b>Date</b></td>
 </tr>
 <tr height="116">
  <td height="116" class="xl67" width="64">1</td>
  <td class="xl67" width="462">Publication of Draft List
  of enrolled SIP Centers(s) with learning goal,
  Intake Capacity for A.Y. 2026 for submission of their willingness, review and
  confirmation for participation in MUHS SIP 2026</td>
  <td class="xl67" width="171"><p><span>01/04/2026</span></p></td>
 </tr>
 <tr height="96">
  <td height="96" class="xl67" width="64">2</td>
  <td class="xl67" width="462">Last date to receive the confirmation
  from enrolled SIP Centers(s) SIP Centers to verify the Name, area of Learning
  goal and other details
    given.(If any correction, Kindly intimate to the University via email only
  on
    ieh@muhs.ac.in)</td>
  <td class="xl67" width="171">5/4/2026 upto 23:59 Hrs.</td>
 </tr>
 <tr height="38">
  <td height="38" class="xl67" width="64">3</td>
  <td class="xl67" width="462">Publication of Final List
  of enrolled SIP Centers(s) with learning goal,
  Intake Capacity for A.Y. 2026 for participation in MUHS
  SIP 2026.</td>
  <td class="xl69">6/4/2026</td>
 </tr>
 <tr height="38">
  <td height="38" class="xl67" width="64">4</td>
  <td class="xl67" width="462">University
  Admission Notification to be published on MUHS website www.muhs.ac.in for
  MUHS SIP 2026</td>
  <td class="xl66">6/4/2026</td>
 </tr>
 <tr height="167">
  <td height="167" class="xl67" width="64">5</td>
  <td class="xl67" width="462">Date
  of Availability of Online Application Forms Link on MUHS website. Desirous
  MUHS Students up to 3rd Year on going can apply Online by paying Application
  Form Fees Rs. 500/- non-refundable expect for the clause mentioned (For
  further details please visit MUHS SIP Rules Notification)</td>
  <td class="xl66">6/4/2026</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl67" width="64">6</td>
  <td class="xl67" width="462">Last
  date of filling and submission of Online Application Form</td>
  <td class="xl67" width="171">20/04/2026 upto
  23:59 Hrs.</td>
 </tr>
 <tr height="99">
  <td height="99" class="xl68" width="64">7</td>
  <td class="xl65" width="462">Last date within which online
  scrutiny and Evaluation of SOP for application forms received for SIP - 2026
  shall be done by faculty / experts / staff nominated by MUHS.</td>
  <td>Up to 04/05/2026</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl67" width="64">8</td>
  <td class="xl67" width="462">Publications of Provisional General List of candidates</td>
  <td class="xl67" width="171">46147</td>
 </tr>
 <tr height="51">
  <td height="51" class="xl67" width="64">9</td>
  <td class="xl67" width="462">Date for submission of discrepancy, if any by
  email on ieh@muhs.ac.in.</td>
  <td class="xl67" width="171">6/5/2026 upto 23:59 Hrs.</td>
 </tr>
 <tr height="46">
  <td height="46" class="xl67" width="64">10</td>
  <td class="xl67" width="462">Publications of Provisional
  General Merit List</td>
  <td class="xl66">7/5/2026</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl68" width="64">11</td>
  <td>To call for Objection/ Suggestion, If any;</td>
  <td>8/5/2026 upto 23:59 Hrs.</td>
 </tr>
 <tr height="42">
  <td height="42" class="xl67" width="64">12</td>
  <td class="xl67" width="462">Publications of General
  Merit List</td>
  <td class="xl66">11/5/2026</td>
 </tr>
 <tr height="95">
  <td height="95" class="xl67" width="64">13</td>
  <td class="xl67" width="462">Admission
  1st Round with allotment of SIP Centre to the selected candidate (Allotment
  Letter will be generated online and selected candidates shall login to their
  account with OTP on registered mobile number and shall take print out of
  allotment letter in case of allotment)</td>
  <td class="xl67" width="171">18/05/2026</td>
 </tr>
 <tr height="32">
  <td height="32" class="xl67" width="64">14</td>
  <td class="xl67" width="462">Wild Card Entry Round</td>
  <td class="xl67" width="171">19/05/2026</td>
 </tr>
 <tr height="20">
  <td height="20" class="xl67" width="64">15</td>
  <td class="xl67" width="462">Reporting and joining of selected candidates
  at respective SIP Centres will start</td>
  <td class="xl67" width="171">20/05/2026</td>
 </tr>
 <tr height="41">
  <td height="41" class="xl67" width="64">16</td>
  <td class="xl67" width="462">Last Date of Reporting and joining of
  selected candidates at respective SIP Centers</td>
  <td class="xl67" width="171">26/05/2026</td>
 </tr>
 <tr height="76">
  <td height="76" class="xl67" width="64">13</td>
  <td class="xl67" width="462">Admission
  1st Round with allotment of SIP Centre to the selected candidate (Allotment
  Letter will be generated online and selected candidates shall login to their
  account with OTP on registered mobile number and shall take print out of
  allotment letter in case of allotment)</td>
  <td class="xl67" width="171">18/05/2026</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl67" width="64">14</td>
  <td class="xl67" width="462">Wild Card Entry Round</td>
  <td class="xl67" width="171">19/05/2026</td>
 </tr>
 <tr height="38">
  <td height="38" class="xl67" width="64">15</td>
  <td class="xl67" width="462">Reporting and joining of selected candidates
  at respective SIP Centres will start</td>
  <td class="xl67" width="171">20/05/2026</td>
 </tr>
 <tr height="38">
  <td height="38" class="xl67" width="64">16</td>
  <td class="xl67" width="462">Last Date of Reporting and joining of
  selected candidates at respective SIP Centers</td>
  <td class="xl67" width="171">26/05/2026</td>
 </tr></tbody></table></div><div class="pasted-from-word-wrapper"><p><b><u>Guidelines</u></b></p><p>1)	University reserves right to amend the above Time Schedule.
</p><p>2)	While confirming the application for admission to Summer Internship Program (SIP) for the A.Y. 26 to be conducted at various SIP Centers enrolled by MUHS, all the concerned should note the provisions of University Notification No. 10/2022 and act accordingly.
</p><p>3)	If any seats remain vacant, it shall be filled as per the general merit list in second round, or subsequent rounds if any; Further, University may carry out the Spot Admission Round / MOP UP Round as per the policy decision of the University.
</p><p>4)	The desirous applicant / Candidate(s) shall have to apply online and need to pay the prescribed application form fees online Rs.500/- (non refundable). Applicant who is financially incapable of paying processing fee or those who belongs to below poverty line (BPL) family, such Candidates shall have to submit the certificate in that respect and undertaking duly certified by concerned Dean / Principal to the University. The Vice-Chancellor shall have right to grant the processing fee waiver in such case of applicant.
</p><p>5)	The MUHS Avishkar Research Festival Winners for the academic year 2025 (held in Jan 2025), if the winner (up to third year) apply under the said scheme and they got allotment for Summer Internship program then their 100% application fees will be refunded in such event. Also, they will get the opportunity to interact with team BETIC, IIT Bombay, Mumbai.
</p><p>6)	The period of this summer Internship spent at respective enrolled SIP Centers, (incase apart from summer vacation) this period shall be considered as study period for the allotted students and shall be treated same as the regular attendance. The Dean/Principal of the affiliated college may also adjust the said period for elective posting of CBME, if applicable;
</p><p>7)	In view of the feedback and responses from previous year, it has decided by the MUHS that, allotment of the student(s) will be done on pro-rata basis, considering the number of applications received from each faculty so that sufficient representation to each faculty students can be done.
</p><p>8)	It shall be mandatory for the Candidate to submit Statement of Purpose for any one of the learning goal opted by the candidate, while submitting online application form. It will carry 03 Marks weightage. Which shall be evaluated by the University and candidate shall awarded a proportionate mark(s)(either :1 or 2 or 3) on the basis of statement of purpose submitted by candidate.
</p><p>9)	12th /HSC percentage OR Cumulative Grade Point Average (CGPA) Candidate to shall have fill the prospective percentage after conversion equivalent percentage of marks as per concerned examination body guidelines. Marks 10 will be converted in to (as applicable).
</p><p>10)	The merit list shall be prepared on the basis of marks or score secured by the candidate as per above marking criteria of 13 Marks (Marks obtained out of 03 Marks Statement of purpose + Marks obtained out of 10 marks assigned to 12th / HSC percentage ≤ 13 Marks). The seats will be allotted to Candidates as per Inter-Se-Merit.
</p><p>11)	The merit list shall be prepared on the basis of marks or score secured by the candidate as per marking criteria of 13 Marks (Marks obtained out of 03 Marks Statement of purpose + Marks obtained out of 10 marks assigned to 12th / HSC percentage ≤ 13 Marks). The seats will be allotted to Candidates as per Inter-Se-Merit.
</p><p>12)	Wherever, there is a tie, Marks obtained by the applicant in the 12th / HSC marks will be considered and shall be given preference in the merit list.
</p><p>13)	Further, if still the tie persists, then Marks obtained by the applicant in the 10th / SSC marks will be considered and shall be given preference in the merit list.
</p><p>14)	Further, if still the tie persists, then the Candidate(s) with higher age shall be given preference in the merit list)
</p><p>15)	Scrutiny of application(s) and evaluation of statement of purpose shall be carried out by MUHS.
</p><p>16)	Merit list will be publishing and Letter of allotment will be made available online.
</p><p>17)	Candidate has to report at the concerned SIP Centre at their own cost and submit the joining letter through concerned Nodal Officer nominated by MUHS at respective SIP Centre.
</p><p>18)	Accommodation and mess facilities will subject to availability and subject to payment of necessary charges at par with that paid by Candidates living in hostels.
</p><p>19)	If required, all interns will be issued a temporary institute ID online by MUHS.
</p><p>20)	On successful completion of the internship, Certificate, Badge and weekly stipend (Rs. 2500/- max. up to 04 weeks) will be awarded to SIP interns by MUHS (as prescribed by the MUHS authorities from time to time).
</p><p>21)	From SIP–2026, a ‘Special Quota’ (Wild Card Entry) is being introduced. Under this provision, admissions will be granted to eligible applicants who have already applied for SIP through the official online notification. Up to 25% of the total intake capacity of each SIP Centre, or a minimum of one student, may be considered under this quota As per this provision, SIP Centres will have the flexibility to recommend eligible candidate(s) at the centre level; however, the final selection shall be made exclusively by a competent committee at the University level.</p><p><b><u>STIPEND</u>:</b></p><p>Each Allotted candidate shall be awarded a weekly stipend of ₹2500/ week (maximum up to Four weeks) or as may be decided by MUHS from time to time.</p><p><b><u>ELIGIBILITY CRITERIA</u>:</b></p><p>Normally, the eligibility criteria for SIP shall be as per the requirement of concerned learning goal of SIP and shall be as decided by the MUHS from time to time.
</p><p>Candidates up to 3rd year ongoing who are currently admitted in under graduate Health Science Curriculum (MBBS / BDS / BAMS / BHMS / BUMS / BPTH / BSC. Nursing / BOTH / BNYS / BPMT/B.A.S.L.P/BPO/BSC (HLS) in a college affiliated to MUHS, Nashik.</p></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="624">
 <colgroup><col width="139">
 <col width="485">
 </colgroup><tbody><tr height="54">
  <td height="54" class="xl69" width="139"><b>Sr. No.</b></td>
  <td class="xl68" width="485"><b>List of
  Documents to be uploaded / filled in while Submitting the Online application
  form</b></td>
 </tr>
 <tr height="171">
  <td height="171" class="xl70" width="139">1</td>
  <td class="xl71" width="485">Mark list (s) of qualifying examination HSC 12th
  Standard is mandatory (reflecting percentage of marks obtained out of total
  marks calculation) 12th /HSC Percentage OR Cumulative Grade Point Average
  (CGPA) (Candidate shall have to fill the prospective percentage after
  conversion equivalent percentage of marks as per concerned examination body
  guidelines (as applicable) will be converted in to 10 Marks. </td>
 </tr>
 <tr height="124">
  <td height="124" class="xl67" width="139">2</td>
  <td class="xl71" width="485">It shall be mandatory for the Candidate to submit Statement of Purpose for any one of
  the leaning goal opted by the candidate, while submitting online application
  form. It will carry 03 Marks weightage. Which shall be evaluated by the University and candidate
  shall awarded a proportionate mark(s) (either :1 or 2 or 3) on the basis of
  statement of purpose submitted by candidate.</td>
 </tr>
 <tr height="97">
  <td height="97" class="xl67" width="139">3</td>
  <td class="xl66" width="485">No Objection Certificate (NOC)
  from the college / institute, where the applicant candidate currently
  studying, in the format prescribed by the University as (ANNEXURE - A) If
  many students are applying for SIP from one college, then such college may
  issue single NOC letter containing LIST of such applicant students.</td>
 </tr>
 <tr height="39">
  <td height="39" class="xl67" width="139">4</td>
  <td class="xl66" width="485">Need to print the copy of Undertaking in the format
  prescribed by the University (ANNEXURE - C) and fill the information and
  mandatory to upload the same.</td>
 </tr>
 <tr height="81">
  <td height="81" class="xl67" width="139">5</td>
  <td class="xl65" width="485">Need to submit Certificate if
  the candidate is from below poverty line (BPL) family, such Candidates
  willing to get exemptions of Rs. 500/- processing fees shall have to submit
  the certificate in that respect from the concerned authority.</td>
 </tr></tbody></table></div><div class="pasted-from-word-wrapper"><p><b><i>To View the Provisional list of SIP Centre(s) with learning goal and intake capacity, click here: <a href="https://medicaldialogues.in/pdf_upload/2026/04/07/website2-centre-learning-report-801775477931329-340094.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/website2-centre-learning-report-801775477931329-340094.pdf</a></i></b></p></div><div class="pasted-from-word-wrapper"><p><span>It is pertinent to note that, the above said provisional list is provisional and temporary
nature and is subject to change as per the position of proposal & information received from SIP
Centre(s) from time to time. The University keeps right to update or amend the provisional list at
any stage of admission process.</span></p></div><div class="pasted-from-word-wrapper"><p><b><i>To check out the brief description of learning goal for each SIP, click here: <a href="https://medicaldialogues.in/pdf_upload/2026/04/07/website3-learninggoal-report1775477950970-340095.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/website3-learninggoal-report1775477950970-340095.pdf</a></i></b></p></div><div class="pasted-from-word-wrapper"><p>Each Allotted candidate shall be awarded a weekly stipend of ₹ 2500/ week (maximum up to Four weeks) or as may be decided by the University from time to time. </p><p>It is also noteworthy to mentioned that, University Certificate and Badge will be awarded to each the participants by MUHS, those who will successfully complete the SIP- 2026.</p><p><b><i>To view the manual for student for summer internship program, click here: <a href="https://medicaldialogues.in/pdf_upload/2026/04/07/website4manual-for-student-for-sip1775477976131-340097.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/website4manual-for-student-for-sip1775477976131-340097.pdf</a></i></b></p></div><div class="pasted-from-word-wrapper"><p>The desirous applicant / Candidate(s) shall have to apply online and need to pay the prescribed application form fees online Rs.500/- (non-refundable).</p><p>Applicant who is financially incapable of paying processing fee or those who belongs to below poverty line (BPL) family, such Candidates shall have to submit the certificate in that respect and undertaking duly certified by concerned Dean / Principal to the University. The Vice Chancellor shall have right to grant the processing fee waiver in such case of applicant.</p><p>The MUHS Avishkar Research Festival Winners for the academic year 2026 (held in Jan 2026), if the winner (up to third year) apply under the said scheme and they got allotment for Summer Internship program then their 100% application fees will be refunded in such event. Also, selected ones will get the opportunity to interact with team BETIC, IIT Bombay, Mumbai.</p><p>In view of the feedback and responses from previous year it has decided by the MUHS that, allotment of the student(s) will be done on pro-rata basis, considering the number of applications received from each faculty so that sufficient representation to each faculty students can be done.</p><p><b><i>To check out the manual for sip centres for summer internship program, click here: <a href="https://medicaldialogues.in/pdf_upload/2026/04/07/website5manual-for-sip-centre1775477995173-340099.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/07/website5manual-for-sip-centre1775477995173-340099.pdf</a></i></b></p></div><div class="pasted-from-word-wrapper"><p><span>The period of this summer Internship spent at respective enrolled SIP Centers, (incase apart
from summer vacation) this period shall be considered as study period for the allotted students
and shall be treated same as the regular attendance. The Dean/Principal of the affiliated college
may also adjust the said period for elective posting of CBME, if applicable;</span></p></div><div class="pasted-from-word-wrapper"><div>Further, it is made clear that, all the necessary communication shall be made online only; no
any written communication will be made for any SIP Center or the desirous Candidate(s) /
applicant(s) by the University. Hence, it is the duty of the candidate / concerned applicant and
SIP Center or visit to the University website regularly in order to get necessary updates.</div><div>It is also noteworthy to mention that, the reputed firms in the software sector with whom
MUHS have entered into MoUs has consented to offer the digital content webinars to these
students. Also, lectures and e-learning sessions like last year by expert faculties from MPGI
Institute of the University will be conducted for these SIP interns too. </div><div>Furthermore, the Dean / Principal are requested to bring this Notification to the notice of all
desirous candidate(s) and shall give wide publicity to it by displaying the same at College / SIP
Center Notice board. </div></div><div class="pasted-from-word-wrapper"><p><b><i>To view the official notice, click the link mentioned below- </i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/07/sipadmissionnotification-no-1120260604261775478247429-340101.pdf" target="_blank"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/07/sipadmissionnotification-no-1120260604261775478247429-340101.pdf</i></b></a></p></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"> </div>]]> </content:encoded>
</item>

<item>
<title>Delhi Govt to spend Rs 7 Crore on security for partially constructed hospitals</title>
<link>https://edusehat.com/en/delhi-govt-to-spend-rs-7-crore-on-security-for-partially-constructed-hospitals</link>
<guid>https://edusehat.com/en/delhi-govt-to-spend-rs-7-crore-on-security-for-partially-constructed-hospitals</guid>
<description><![CDATA[ New Delhi: The Delhi government is soon going to spend over ₹7 crore on the security of three partially constructed hospital complexes that have not yet become operational, according to a senior government official.These three hospitals include the new blocks at Madipur, Jwalapuri, and LNJP Hospital. However, the government plans to appoint agencies to secure the premises located at these sites, which also involves developing infrastructure for barricading, improved lighting, and surveillance systems across the hospital complexes.Also Read: Delhi govt plans Rs 806 crore medical college in DwarkaAdditionally, the complexes also need to be safeguarded against theft and vandalism. Agencies will ensure round-the-clock surveillance, for which CCTV operators will be deployed in three shifts. However, this project will run for a period of one year.  In this regard, speaking to the HT, a senior government official said, “Around ₹2.43 crore will be spent on Madipur hospital, ₹2.39 crore on Jwalapuri and ₹2.22 crore on the new block of LNJP hospital.” “Since the sites were left incomplete, many areas also require wiring and dewatering,” the official added.Meanwhile, concerns have been raised regarding public expenditure on unfinished hospitals, where construction work has been stalled for the past two years.Earlier, in January of this year, the government stated that it had decided to restart and complete long-stalled hospital projects. To this end, these projects will be shifted to a Public-Private Partnership (PPP) model, and a timeline will be established for their completion.However, by April 2025, more than ₹1,000 crore had been spent on hospitals, yet none of these projects had been completed. Work progress across all projects ranged between 65% and 80%. Medical Dialogues had recently reported that in a move which can significantly boost medical education in Delhi, the government is planning to establish a medical college in the Dwarka area at an estimated cost of over Rs 800 crore. Also Read: HC asks Delhi Govt to respond on ILBS limiting free treatment for EWS  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/09/30/186659-hospital.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Delhi, Govt, spend, Crore, security, for, partially, constructed, hospitals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/09/30/186659-hospital.webp"><p><b>New Delhi:</b> The <a href="https://medicaldialogues.in/topics/delhi-government" target="_blank">Delhi government</a> is soon going to spend over ₹7 crore on the security of three partially constructed hospital complexes that have not yet become operational, according to a senior government official.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These three hospitals include the new blocks at Madipur, Jwalapuri, and LNJP Hospital. However, the government plans to appoint agencies to secure the premises located at these sites, which also involves developing infrastructure for barricading, improved lighting, and surveillance systems across the hospital complexes.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/delhi/delhi-govt-plans-rs-806-crore-medical-college-in-dwarka-167264"><b>Also Read: </b>Delhi govt plans Rs 806 crore medical college in Dwarka</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Additionally, the complexes also need to be safeguarded against theft and vandalism. Agencies will ensure round-the-clock surveillance, for which CCTV operators will be deployed in three shifts. However, this project will run for a period of one year.  </p><p dir="ltr">In this regard, speaking to the <a href="https://www.hindustantimes.com/cities/delhi-news/govt-proposes-7-crore-plan-to-protect-half-built-hospitals-101775413441803.html" rel="nofollow">HT</a>, a senior government official said, “Around ₹2.43 crore will be spent on Madipur hospital, ₹2.39 crore on Jwalapuri and ₹2.22 crore on the new block of LNJP hospital.” </p><p dir="ltr">“Since the sites were left incomplete, many areas also require wiring and dewatering,” the official added.</p><p dir="ltr">Meanwhile, concerns have been raised regarding public expenditure on unfinished hospitals, where construction work has been stalled for the past two years.</p><p dir="ltr">Earlier, in January of this year, the government stated that it had decided to restart and complete long-stalled hospital projects. To this end, these projects will be shifted to a Public-Private Partnership (<a href="https://medicaldialogues.in/topics/ppp-model" target="_blank">PPP) model</a>, and a timeline will be established for their completion.</p><p dir="ltr">However, by April 2025, more than ₹1,000 crore had been spent on hospitals, yet none of these projects had been completed. Work progress across all projects ranged between 65% and 80%. </p><p dir="ltr">Medical Dialogues had recently reported that in a move which can significantly boost medical education in Delhi, the government is planning to establish a medical college in the Dwarka area at an estimated cost of over Rs 800 crore. </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/hc-asks-delhi-govt-to-respond-on-ilbs-limiting-free-treatment-for-ews-166795"><b>Also Read: </b>HC asks Delhi Govt to respond on ILBS limiting free treatment for EWS</a> </p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>KGMU proposes real&#45;time tracking of ventilator beds in Govt Hospitals</title>
<link>https://edusehat.com/en/kgmu-proposes-real-time-tracking-of-ventilator-beds-in-govt-hospitals</link>
<guid>https://edusehat.com/en/kgmu-proposes-real-time-tracking-of-ventilator-beds-in-govt-hospitals</guid>
<description><![CDATA[ Lucknow: The King George Medical University (KGMU), Lucknow, has recently submitted a proposal to the government for displaying the availability of ventilator beds in government hospitals in real-time. The initiative aims to help doctors and patients check the status before reaching the hospital, reducing delays in emergency care.This proposal has been introduced with the aim of addressing existing shortcomings in the referral process. Currently, patients referred from district hospitals, CHCs, and PHCs are often forwarded without prior confirmation of ventilator availability. Consequently, in critical situations, the accompanying family members are forced to shuttle from one hospital to another.  Also Read: Chaos at KGMU: Barricades erected around centuries-old shrineUnder the proposed system, district hospitals would be linked to major facilities, enabling doctors to confirm the availability of ventilators before referring patients.The need for such an arrangement is clearly evident from the current utilisation of resources. Officials from various hospitals stated that, due to a shortage of trained staff and specialists, approximately 60–65 ventilators in the city&#039;s government hospitals are lying idle.At Lokbandhu Hospital, only 10 out of 40 ventilators are functional, as the renovation work on the ICU following a fire last year remains incomplete; meanwhile, at Balrampur Hospital, 28 out of 60 ventilator beds are in working condition. There are also reports of limited usage at Thakurganj Hospital and Rani Lakshmibai Hospital.Furthermore, tertiary centres such as the Sanjay Gandhi Postgraduate Institute of Medical Sciences, King George Medical University, and the Dr Ram Manohar Lohia Institute of Medical Sciences collectively possess approximately 500 ventilators.However, they face an overwhelming influx of patients arriving from across Uttar Pradesh and Bihar, which frequently places immense pressure on their capacity.Meanwhile, explaining the urgency, speaking to TOI, chief medical superintendent of the trauma centre at KGMU, Prof Premraj Singh, said, &quot;Many critically ill patients reach us when no ventilator is available. In emergencies, every minute matters. We sent the proposal and will soon call a meeting of govt hospitals in the city to finalise the model”. Also Read: Chargesheet filed against former KGMU resident for forced conversion, sexual exploitation ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340115-hospital.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>KGMU, proposes, real-time, tracking, ventilator, beds, Govt, Hospitals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340115-hospital.webp"><p><b>Lucknow:</b> The King George Medical University (<a href="https://medicaldialogues.in/topics/kgmu" target="_blank" rel="nofollow">KGMU</a>), Lucknow, has recently submitted a proposal to the government for displaying the availability of ventilator beds in government hospitals in real-time. The initiative aims to help doctors and patients check the status before reaching the hospital, reducing delays in emergency care.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This proposal has been introduced with the aim of addressing existing shortcomings in the referral process. Currently, patients referred from district hospitals, CHCs, and PHCs are often forwarded without prior confirmation of ventilator availability. Consequently, in critical situations, the accompanying family members are forced to shuttle from one hospital to another.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/chaos-at-kgmu-barricades-erected-around-centuries-old-shrine-165995"><b>Also Read: </b>Chaos at KGMU: Barricades erected around centuries-old shrine</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Under the proposed system, district hospitals would be linked to major facilities, enabling doctors to confirm the availability of ventilators before referring patients.</p><p dir="ltr">The need for such an arrangement is clearly evident from the current utilisation of resources. Officials from various hospitals stated that, due to a shortage of trained staff and specialists, approximately 60–65 ventilators in the city's government hospitals are lying idle.</p><p dir="ltr">At Lokbandhu Hospital, only 10 out of 40 ventilators are functional, as the renovation work on the ICU following a fire last year remains incomplete; meanwhile, at Balrampur Hospital, 28 out of 60 ventilator beds are in working condition. </p><p dir="ltr">There are also reports of limited usage at Thakurganj Hospital and Rani Lakshmibai Hospital.</p><p dir="ltr">Furthermore, tertiary centres such as the Sanjay Gandhi Postgraduate Institute of Medical Sciences, King George Medical University, and the Dr Ram Manohar Lohia Institute of Medical Sciences collectively possess approximately 500 ventilators.</p><p dir="ltr">However, they face an overwhelming influx of patients arriving from across Uttar Pradesh and Bihar, which frequently places immense pressure on their capacity.</p><p dir="ltr">Meanwhile, explaining the urgency, speaking to <a href="https://timesofindia.indiatimes.com/city/lucknow/kgmu-dashboard-for-ventilator-beds-in-govt-hosps-soon/articleshow/130046300.cms" target="_blank" rel="nofollow">TOI</a>, chief medical superintendent of the trauma centre at KGMU, Prof Premraj Singh, said, "Many critically ill patients reach us when no ventilator is available. In emergencies, every minute matters. We sent the proposal and will soon call a meeting of govt hospitals in the city to finalise the model”. </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/chargesheet-filed-against-former-kgmu-resident-for-forced-conversion-sexual-exploitation-165667"><b>Also Read: </b>Chargesheet filed against former KGMU resident for forced conversion, sexual exploitation</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS Bibinagar issues warning against fake 2026 job advertisement</title>
<link>https://edusehat.com/en/aiims-bibinagar-issues-warning-against-fake-2026-job-advertisement</link>
<guid>https://edusehat.com/en/aiims-bibinagar-issues-warning-against-fake-2026-job-advertisement</guid>
<description><![CDATA[ Hyderabad: The All India Institute of Medical Sciences (AIIMS), Bibinagar, has issued a public warning regarding a fraudulent recruitment advertisement circulating online under the title “AIIMS Bibinagar Job Opportunities 2026.” The fake notice falsely claimed that candidates could secure direct selection without appearing for any examination.  The institute stated that it has not released any such notification and emphasised that all recruitment at AIIMS Bibinagar is conducted strictly through official channels, including authorised media advertisements and its official website. Also Read:Job scam: Aspirants duped under pretext of jobs at Sundargarh Government Medical College  The advisory urged aspirants to exercise extreme caution and avoid sharing personal details or making any payments in response to such fraudulent messages. Candidates are advised to verify all recruitment-related information only through official sources to prevent falling victim to scams.   The institute further stated that strict action would be taken against those responsible for spreading misinformation and attempting to mislead aspirants, reports TOI.  This advisory comes amid growing concerns over fraudulent job offers targeting job seekers in the healthcare sector. Earlier, AIIMS New Delhi had also cautioned aspirants against fake recruitment advertisements, clarifying that it had not issued notices for certain contractual appointments.    Medical Dialogues had previously reported that a public warning had been issued by the All India Institute of Medical Sciences (AIIMS), New Delhi, cautioning job seekers against fake and unauthorised recruitment advertisements being circulated in the institute’s name. AIIMS clarified that it has not issued any recruitment notice for contractual appointments bearing reference numbers such as “2329” and does not accept handwritten or offline application forms under any circumstances. The institute stated that contractual staff is engaged only through authorised outsourcing agencies selected via the Government e-Marketplace (GeM) portal, strictly following approved tender procedures.  Also Read:Fake Job Advertisements Alert: AIIMS Delhi issues warning ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/19/309433-fraud-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Bibinagar, issues, warning, against, fake, 2026, job, advertisement</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/19/309433-fraud-2.webp"><p><b>Hyderabad: </b>The All India Institute of Medical Sciences (<a href="https://medicaldialogues.in/topics/aiims-bibinagar">AIIMS</a>), Bibinagar, has issued a public warning regarding a <a href="https://medicaldialogues.in/topics/job-scam">fraudulent recruitment </a>advertisement circulating online under the title “AIIMS Bibinagar Job Opportunities 2026.” The fake notice falsely claimed that candidates could secure direct selection without appearing for any examination.  </p><p>The institute stated that it has not released any such notification and emphasised that all recruitment at AIIMS Bibinagar is conducted strictly through official channels, including authorised media advertisements and its official website. </p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/job-scam-aspirants-duped-under-pretext-of-jobs-at-sundargarh-government-medical-college-109819">Also Read:Job scam: Aspirants duped under pretext of jobs at Sundargarh Government Medical College</a>  </b></p><p>The advisory urged aspirants to exercise extreme caution and avoid sharing personal details or making any payments in response to such fraudulent messages. Candidates are advised to verify all recruitment-related information only through official sources to prevent falling victim to scams.   </p><p>The institute further stated that strict action would be taken against those responsible for spreading misinformation and attempting to mislead aspirants, reports <a href="https://timesofindia.indiatimes.com/city/hyderabad/aiims-bibinagar-warns-public-over-fake-job-ad/articleshow/130025974.cms" rel="nofollow">TOI</a>.  </p><p>This advisory comes amid growing concerns over fraudulent job offers targeting job seekers in the healthcare sector. Earlier, AIIMS New Delhi had also cautioned aspirants against fake recruitment advertisements, clarifying that it had not issued notices for certain contractual appointments.    </p><p>Medical Dialogues had previously reported that a public warning had been issued by the All India Institute of Medical Sciences (AIIMS), New Delhi, cautioning job seekers against fake and unauthorised recruitment advertisements being circulated in the institute’s name. AIIMS clarified that it has not issued any recruitment notice for contractual appointments bearing reference numbers such as “2329” and does not accept handwritten or offline application forms under any circumstances. The institute stated that contractual staff is engaged only through authorised outsourcing agencies selected via the Government e-Marketplace (GeM) portal, strictly following approved tender procedures.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/fake-job-advertisements-alert-aiims-delhi-issues-warning-163514"><b>Also Read:Fake Job Advertisements Alert: AIIMS Delhi issues warning</b></a></p>]]> </content:encoded>
</item>

<item>
<title>ICMR recommends HemoQR, low&#45;cost anaemia screening tool</title>
<link>https://edusehat.com/en/icmr-recommends-hemoqr-low-cost-anaemia-screening-tool</link>
<guid>https://edusehat.com/en/icmr-recommends-hemoqr-low-cost-anaemia-screening-tool</guid>
<description><![CDATA[ Kolkata: The Indian Council of Medical Research (ICMR) has recommended a new low-cost anaemia screening tool developed at IIT Kharagpur, providing a simple and rapid way to check haemoglobin levels without bulky machines, an institute spokesperson said on Monday.   Called HemoQR, the portable kit, developed by SmartQR Technologies under the mentorship of IIT Kharagpur Director Suman Chakraborty, uses a drop of blood from a finger prick, news agency PTI reported.The sample is placed on a special paper strip, and a smartphone camera scans it to estimate haemoglobin levels within minutes.Also Read:Nationwide HPV Vaccination Drive a Milestone in Public Health, Says Former ICMR Director GeneralIn simple terms, this means doctors or health workers can quickly check for anaemia, even in remote areas, without needing laboratory equipment. The device has been tested at VMMC &amp; Safdarjung Hospital and found suitable for initial anaemia screening in hospitals as well as in the broader diagnostic process.&quot;This is a step towards affordable and accessible healthcare. HemoQR shows how technology can directly help tackle widespread problems like anaemia,&quot; Chakraborty said.The recommendation is expected to support government initiatives such as the &#039;Anaemia Mukt Bhara&#039;t and the National Health Mission, which aim to reduce anaemia across the country through early detection and treatment.Officials said the tool could be widely used in both hospitals and community health camps, helping identify patients faster and start treatment sooner.The development highlights IIT Kharagpur&#039;s focus on creating practical, low-cost healthcare solutions with real-world impact, particularly as India looks to strengthen its public health systems.  Medical Dialogues had earlier reported that the National Institute of One Health (NIOH), Nagpur, under the Department of Health Research (DHR), Ministry of Health and Family Welfare, in collaboration with the ICMR-RMRC, Bhubaneswar organized a two-day national workshop titled &#039;&#039;Operational Frameworks for One Health: National vision and state action&#039;&#039;.  Also Read:ICMR Study shows shorter TB regimes are cost-effective in India ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/07/340090-icmr-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>ICMR, recommends, HemoQR, low-cost, anaemia, screening, tool</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/07/340090-icmr-2.webp"><div class="pasted-from-word-wrapper"><p><span>Kolkata: The Indian Council of Medical Research (ICMR) has recommended a new low-cost <a href="https://medicaldialogues.in/topics/anaemia" target="_blank">anaemia </a>screening tool developed at IIT Kharagpur, providing a simple and rapid way to check haemoglobin levels without bulky machines, an institute spokesperson said on Monday.   </span></p><p>Called HemoQR, the portable kit, developed by SmartQR Technologies under the mentorship of IIT Kharagpur Director Suman Chakraborty, uses a drop of blood from a finger prick, news agency PTI reported.</p><p>The sample is placed on a special paper strip, and a smartphone camera scans it to estimate haemoglobin levels within minutes.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/nationwide-hpv-vaccination-drive-a-milestone-in-public-health-says-former-icmr-director-general-165617"><b>Also Read:Nationwide HPV Vaccination Drive a Milestone in Public Health, Says Former ICMR Director General</b></a></p><p>In simple terms, this means doctors or health workers can quickly check for anaemia, even in remote areas, without needing laboratory equipment. </p><p>The device has been tested at VMMC &<a href="https://medicaldialogues.in/topics/Safdarjung-Hospital" target="_blank"> Safdarjung Hospital</a> and found suitable for initial <a href="https://medicaldialogues.in/topics/anaemia" target="_blank">anaemia</a> screening in hospitals as well as in the broader diagnostic process.</p><p>"This is a step towards affordable and accessible healthcare. HemoQR shows how technology can directly help tackle widespread problems like anaemia," Chakraborty said.</p><p>The recommendation is expected to support government initiatives such as the 'Anaemia Mukt Bhara't and the National Health Mission, which aim to reduce anaemia across the country through early detection and treatment.</p><p>Officials said the tool could be widely used in both hospitals and community health camps, helping identify patients faster and start treatment sooner.</p><p>The development highlights IIT Kharagpur's focus on creating practical, low-cost healthcare solutions with real-world impact, particularly as India looks to strengthen its public health systems.  </p><p>Medical Dialogues had earlier reported that the National Institute of One Health (NIOH), Nagpur, under the Department of Health Research (DHR), Ministry of Health and Family Welfare, in collaboration with the ICMR-RMRC, Bhubaneswar organized a two-day national workshop titled ''Operational Frameworks for One Health: National vision and state action''.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/icmr-study-shows-shorter-tb-regimes-are-cost-effective-in-india-164597"><b>Also Read:ICMR Study shows shorter TB regimes are cost-effective in India</b></a><br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Fake doctor busted in Surat; illegal clinic exposed</title>
<link>https://edusehat.com/en/fake-doctor-busted-in-surat-illegal-clinic-exposed</link>
<guid>https://edusehat.com/en/fake-doctor-busted-in-surat-illegal-clinic-exposed</guid>
<description><![CDATA[ Surat: In a shocking incident, a spate of unqualified individuals posing as doctors has come to light in Surat district, raising serious questions about public health and safety in rural areas. Acting on a tip-off, the Surat Special Operations Group (SOG) conducted a raid in the Navapura GIDC area of Mangrol taluka and apprehended a man allegedly running an illegal medical practice. The accused was reportedly operating a clinic without possessing any valid medical degree or certification from the Gujarat Medical Council.Also Read:Two Quacks arrested for running illegal clinics in GovandiAccording to the information received about the incident, the police received information that a man was opening a clinic in the Navapura GIDC area. When the police checked the clinic, it was found that the operator did not have any degree for medical practice. The clinic also had 2 beds for the treatment of patients, which shows that there was a claim to treat serious diseases here, reports the Sandesh.During the raid, police seized allopathic medicines, injections, and medical equipment worth approximately Rs 4,400. Investigators revealed that the accused had been administering drugs to patients without any formal medical knowledge or training—an act that could have led to life-threatening consequences.
Following the raid, the accused was detained, and legal proceedings were initiated. However, in accordance with existing legal provisions, he was later released on bail. Police officials emphasized that the investigation is ongoing and further action may follow based on findings.
Medical Dialogues had previously reported that the Borsad rural police arrested a fake doctor for allegedly operating a clinic and treating patients without a valid medical degree in Gujarat&#039;s Anand district. This comes just two days after a similar arrest in Napad Talpad village. According to the news reports, the accused was running a makeshift clinic near a madrasa in Borsad taluka, where he was allegedly treating numerous patients using both ayurvedic and allopathic medicines—despite lacking formal medical qualifications. Also Read:Another Quack busted in Gujarat, medicines seized ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 17:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fake, doctor, busted, Surat, illegal, clinic, exposed</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.webp"><p><b>Surat: </b>In a shocking incident, a spate of unqualified individuals posing as <a href="https://medicaldialogues.in/topics/doctors">doctors </a>has come to light in Surat district, raising serious questions about public health and safety in rural areas. </p><p>Acting on a tip-off, the Surat Special Operations Group (SOG) conducted a raid in the Navapura GIDC area of Mangrol taluka and apprehended a man allegedly running an illegal medical practice. The accused was reportedly operating a clinic without possessing any valid medical degree or certification from the <a href="https://medicaldialogues.in/topics/gujarat-medical-council">Gujarat Medical Council</a>.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/two-quacks-arrested-for-running-illegal-clinics-in-govandi-167925"><b>Also Read:Two Quacks arrested for running illegal clinics in Govandi</b></a></p><p>According to the information received about the incident, the police received information that a man was opening a clinic in the Navapura GIDC area. When the police checked the clinic, it was found that the operator did not have any degree for medical practice. The clinic also had 2 beds for the treatment of patients, which shows that there was a claim to treat serious diseases here, reports the <a href="https://sandesh.com/gujarat/news/maru-saher-maru-gaam/surat/mangrol-navapura-gidc-bogus-doctor-arrested-sog-police-raid" rel="nofollow">Sandesh.</a></p><p>During the raid, police seized allopathic medicines, injections, and medical equipment worth approximately Rs 4,400. Investigators revealed that the accused had been administering drugs to patients without any formal medical knowledge or training—an act that could have led to life-threatening consequences.
</p><p>Following the raid, the accused was detained, and legal proceedings were initiated. However, in accordance with existing legal provisions, he was later released on bail. Police officials emphasized that the investigation is ongoing and further action may follow based on findings.
</p><p>Medical Dialogues had previously reported that the Borsad rural police arrested a fake doctor for allegedly operating a clinic and treating patients without a valid medical degree in Gujarat's Anand district. This comes just two days after a similar arrest in Napad Talpad village. According to the news reports, the accused was running a makeshift clinic near a madrasa in Borsad taluka, where he was allegedly treating numerous patients using both ayurvedic and allopathic medicines—despite lacking formal medical qualifications. </p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/another-quack-busted-in-gujarat-medicines-seized-156867">Also Read:Another Quack busted in Gujarat, medicines seized</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Tirzepatide Shows Superior Glycemic Control in Early Type 2 Diabetes,  suggests research</title>
<link>https://edusehat.com/en/tirzepatide-shows-superior-glycemic-control-in-early-type-2-diabetes-suggests-research</link>
<guid>https://edusehat.com/en/tirzepatide-shows-superior-glycemic-control-in-early-type-2-diabetes-suggests-research</guid>
<description><![CDATA[ Researchers have found in a new study that Tirzepatide is more effective than conventional care for improving glycemic control and overall metabolic health in early type 2 diabetes.Tirzepatide also led to better improvements in multiple cardiometabolic parameters. The study was published in the journal Expert Opinion on Drug Safety by Karolina H. and colleagues. It was revealed that in recently diagnosed type 2 diabetes patients experienced a significantly greater  in HbA1c with tirzepatide compared to conventional treatment.After 2 years, 60.2% of patients on tirzepatide achieved HbA1c &lt; 5.7% (near-normal levels).This systematic review and network meta-analysis consisted of 13 randomized controlled trials involving a total of 14,007 participants with type 2 diabetes mellitus and/or obesity. The comparison was made for once-weekly administration of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with placebo, insulin, and other glucagon-like peptide-1 receptor agonists.The analysis was carried out using the results from the random-effects model to obtain mean differences for weight loss and HbA1c reduction, and relative risk for the achievement of weight loss targets and normoglycemia. The treatment ranking was performed using the Surface Under the Cumulative Ranking Curve, and evidence certainty was determined using the CINeMA framework.Key findings:• Tirzepatide has shown significant dose-dependent efficacy in both weight loss and glycemic control compared to insulin treatment.• The efficacy has been significantly increased in higher doses.• The 15 mg dose has shown the most significant efficacy in weight loss, with a relative risk of 4.83 for achieving at least 15% body weight loss.• The efficacy in glycemic control has also been significantly increased, with a mean HbA1c reduction of -12.6 mmol/mol, along with a significantly increased probability of achieving normoglycemia (relative risk 11.3).• The safety profile of tirzepatide has been significantly superior to that of insulin treatment, with a significantly lower risk of serious adverse events (relative risks ranging from 0.71 to 0.77). The risk of hypoglycemia has also been significantly reduced (relative risks ranging from 0.44 to 0.50).• However, gastrointestinal side effects have been more common with tirzepatide treatment, as expected for this class of drugs.Tirzepatide showed dose-response superiority to insulin in weight loss and glucose control, with lower risk of hypoglycemia and serious adverse events, indicating its efficacy as first-line treatment for type 2 diabetes mellitus and obesity.Reference:Hoffmann, K., Michalak, M., Rizzo, M., Maggio, V., &amp; Paczkowska, A. (2025). The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis. Expert Opinion on Drug Safety, 1–16. https://doi.org/10.1080/14740338.2025.2586703 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/26/233050-tirzepatide.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 13:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Tirzepatide, Shows, Superior, Glycemic, Control, Early, Type, Diabetes, suggests, research</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/26/233050-tirzepatide.webp"><p>Researchers have found in a new study that Tirzepatide is more effective than conventional care for improving glycemic control and overall metabolic health in early type 2 diabetes.Tirzepatide also led to better improvements in multiple cardiometabolic parameters. The study was published in the journal <i>Expert Opinion on Drug Safety</i> by Karolina H. and colleagues. It was revealed that in recently diagnosed type 2 diabetes patients experienced a significantly greater  in HbA1c with tirzepatide compared to conventional treatment.After 2 years, 60.2% of patients on tirzepatide achieved HbA1c < 5.7% (near-normal levels).</p><div class="pasted-from-word-wrapper"><p dir="ltr">This systematic review and network meta-analysis consisted of 13 randomized controlled trials involving a total of 14,007 participants with type 2 diabetes mellitus and/or obesity. The comparison was made for once-weekly administration of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with placebo, insulin, and other glucagon-like peptide-1 receptor agonists.</p><p dir="ltr">The analysis was carried out using the results from the random-effects model to obtain mean differences for weight loss and HbA1c reduction, and relative risk for the achievement of weight loss targets and normoglycemia. The treatment ranking was performed using the Surface Under the Cumulative Ranking Curve, and evidence certainty was determined using the CINeMA framework.</p><p dir="ltr">Key findings:</p><p dir="ltr">• Tirzepatide has shown significant dose-dependent efficacy in both weight loss and glycemic control compared to insulin treatment.</p><p dir="ltr">• The efficacy has been significantly increased in higher doses.</p><p dir="ltr">• The 15 mg dose has shown the most significant efficacy in weight loss, with a relative risk of 4.83 for achieving at least 15% body weight loss.</p><p dir="ltr">• The efficacy in glycemic control has also been significantly increased, with a mean HbA1c reduction of -12.6 mmol/mol, along with a significantly increased probability of achieving normoglycemia (relative risk 11.3).</p><p dir="ltr">• The safety profile of tirzepatide has been significantly superior to that of insulin treatment, with a significantly lower risk of serious adverse events (relative risks ranging from 0.71 to 0.77). The risk of hypoglycemia has also been significantly reduced (relative risks ranging from 0.44 to 0.50).</p><p dir="ltr"><span>• </span>However, gastrointestinal side effects have been more common with tirzepatide treatment, as expected for this class of drugs.</p><p dir="ltr">Tirzepatide showed dose-response superiority to insulin in weight loss and glucose control, with lower risk of hypoglycemia and serious adverse events, indicating its efficacy as first-line treatment for type 2 diabetes mellitus and obesity.</p><p dir="ltr">Reference:</p><p dir="ltr">Hoffmann, K., Michalak, M., Rizzo, M., Maggio, V., & Paczkowska, A. (2025). The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis. Expert Opinion on Drug Safety, 1–16. https://doi.org/10.1080/14740338.2025.2586703</p><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Mediterranean Diet More Effective Than Low&#45;Fat Diet for Cardiovascular Risk Reduction: Study</title>
<link>https://edusehat.com/en/mediterranean-diet-more-effective-than-low-fat-diet-for-cardiovascular-risk-reduction-study</link>
<guid>https://edusehat.com/en/mediterranean-diet-more-effective-than-low-fat-diet-for-cardiovascular-risk-reduction-study</guid>
<description><![CDATA[ A new research published in the journal of Medicine showed that Mediterranean Diet shows greater effectiveness than a Low-Fat Diet in improving cardiovascular risk factors and outcomes. These findings support prioritizing the Mediterranean diet for secondary prevention of Cardiovascular Disease, although further research is needed to evaluate long-term adherence and implementation across diverse populationsCardiovascular disease remains one of the leading causes of death worldwide, making dietary interventions a critical component of prevention and long-term management. This systematic review of randomized controlled trials compared the Mediterranean diet and low-fat diet for preventing heart disease.The review followed the widely used Preferred Reporting Items for Systematic Reviews and Meta‑Analyses (PRISMA) framework to ensure transparency and reliability in the selection and evaluation of studies. Scientists performed an extensive literature search across major academic databases including PubMed, Google Scholar, Scopus, and ScienceDirect.In total, the review analyzed 11 randomized controlled trials involving 5,942 adult participants. Each study directly compared the effects of the Mediterranean diet and the low-fat diet on cardiovascular risk factors or clinical outcomes.The Mediterranean diet emphasized fruits, vegetables, whole grains, legumes, nuts, olive oil, and moderate fish consumption, demonstrated notable advantages. According to the analysis, participants following the Mediterranean diet experienced a significant reduction in procoagulant and prothrombotic micro-vesicles.Beyond these biological markers, the Mediterranean diet also produced stronger improvements in several widely recognized indicators of cardiovascular health. Participants on the diet showed greater reductions in total cholesterol levels and in the ratio between cholesterol and high-density lipoproteins (HDL).When compared to individuals following a low-fat diet, those adhering to the Mediterranean pattern experienced larger decreases in insulin levels, blood glucose levels, leukocyte counts and body mass index (BMI). These combined improvements suggest that the Mediterranean diet may address multiple pathways linked to cardiovascular disease, including metabolic control, inflammation, and blood clot formation.These results support the growing view that dietary quality may be more important than simply reducing fat intake. While low-fat diets have long been recommended for heart health, the emphasis of Mediterranean diet on healthy fats appears to provide broader cardiovascular benefits.Overall, Mediterranean diet demonstrates superior effectiveness in improving cardiovascular risk factors and clinical outcomes when compared to a low-fat diet. The findings emphasize the need for further studies examining long-term adherence to these diets and their effectiveness across different cultural and demographic populations. Reference:Mylavarapu, M., Batra, A., Garcia, I., Balasubramanian, A., Husnain, M. A., Atla, R. H., Muttuluru, P. S. H., Abboud, E., &amp; Silva, A. (2026). Mediterranean diet versus low-fat diet on cardiovascular disease (CVD) risk factors and outcomes: A systematic review of RCTs. Medicine, 105(11), e47971. https://doi.org/10.1097/MD.0000000000047971 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/01/06/267761-mediterranean-diet-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 13:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mediterranean, Diet, More, Effective, Than, Low-Fat, Diet, for, Cardiovascular, Risk, Reduction:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/01/06/267761-mediterranean-diet-50.webp"><p>A new research published in the journal of <i>Medicine</i> showed that Mediterranean Diet shows greater effectiveness than a Low-Fat Diet in improving cardiovascular risk factors and outcomes. These findings support prioritizing the Mediterranean diet for secondary prevention of Cardiovascular Disease, although further research is needed to evaluate long-term adherence and implementation across diverse populations</p><p>Cardiovascular disease remains one of the leading causes of death worldwide, making dietary interventions a critical component of prevention and long-term management. This systematic review of randomized controlled trials compared the Mediterranean diet and low-fat diet for preventing heart disease.</p><p>The review followed the widely used Preferred Reporting Items for Systematic Reviews and Meta‑Analyses (PRISMA) framework to ensure transparency and reliability in the selection and evaluation of studies. Scientists performed an extensive literature search across major academic databases including PubMed, Google Scholar, Scopus, and ScienceDirect.</p><p>In total, the review analyzed 11 randomized controlled trials involving 5,942 adult participants. Each study directly compared the effects of the Mediterranean diet and the low-fat diet on cardiovascular risk factors or clinical outcomes.</p><p>The Mediterranean diet emphasized fruits, vegetables, whole grains, legumes, nuts, olive oil, and moderate fish consumption, demonstrated notable advantages. According to the analysis, participants following the Mediterranean diet experienced a significant reduction in procoagulant and prothrombotic micro-vesicles.</p><p>Beyond these biological markers, the Mediterranean diet also produced stronger improvements in several widely recognized indicators of cardiovascular health. Participants on the diet showed greater reductions in total cholesterol levels and in the ratio between cholesterol and high-density lipoproteins (HDL).</p><p>When compared to individuals following a low-fat diet, those adhering to the Mediterranean pattern experienced larger decreases in insulin levels, blood glucose levels, leukocyte counts and body mass index (BMI). These combined improvements suggest that the Mediterranean diet may address multiple pathways linked to cardiovascular disease, including metabolic control, inflammation, and blood clot formation.</p><p>These results support the growing view that dietary quality may be more important than simply reducing fat intake. While low-fat diets have long been recommended for heart health, the emphasis of Mediterranean diet on healthy fats appears to provide broader cardiovascular benefits.</p><p>Overall, Mediterranean diet demonstrates superior effectiveness in improving cardiovascular risk factors and clinical outcomes when compared to a low-fat diet. The findings emphasize the need for further studies examining long-term adherence to these diets and their effectiveness across different cultural and demographic populations. </p><p>Reference:</p><p>Mylavarapu, M., Batra, A., Garcia, I., Balasubramanian, A., Husnain, M. A., Atla, R. H., Muttuluru, P. S. H., Abboud, E., & Silva, A. (2026). Mediterranean diet versus low-fat diet on cardiovascular disease (CVD) risk factors and outcomes: A systematic review of RCTs. Medicine, 105(11), e47971. <a href="https://medicaldialogues.in/diet-nutrition/news/journals.lww.com/md-journal/fulltext/2026/03130/mediterranean_diet_versus_low_fat_diet_on.89.aspx" rel="nofollow">https://doi.org/10.1097/MD.0000000000047971</a></p>]]> </content:encoded>
</item>

<item>
<title>Sirolimus&#45;Coated Balloons Reduce Major Adverse Limb Events at One Year: NEJM</title>
<link>https://edusehat.com/en/sirolimus-coated-balloons-reduce-major-adverse-limb-events-at-one-year-nejm</link>
<guid>https://edusehat.com/en/sirolimus-coated-balloons-reduce-major-adverse-limb-events-at-one-year-nejm</guid>
<description><![CDATA[ An open-label, prospective, large-scale trial was carried out to evaluate the benefits of coating these balloons with sirolimus, which is an antiproliferative drug. The trial followed a noninferiority approach using a superior design sequence and produced a definitive result: when compared to patients who had undergone angioplasty using plain balloons, patients who had their infrainguinal artery disease managed through angioplasty using sirolimus-coated balloons were found to have significantly fewer major adverse limb events within a year of follow-up. This trial clearly demonstrates the effectiveness of using coated drug technology in maintaining limb integrity. The study was published in The New England Journal of Medicine by Stefano B. and colleagues.In this study, 1,252 patients with infrainguinal artery disease were selected, and each group was made up of 626 participants for either a sirolimus-coated balloon angioplasty procedure or balloon angioplasty alone. The mean age of the study participants was 75 years old, with 35.1% of the subjects being women. In addition, the investigators observed a primary composite endpoint of unplanned major amputation of the target limb or endovascular/revascularization procedure of the target lesion for critical limb ischemia within one year after enrollment. Moreover, the investigators assessed an important secondary endpoint of all unplanned amputations or revascularization procedures for critical limb ischemia and noncritical limb ischemia. To assure safety, the investigators defined a noninferiority margin of 5%, and all-cause mortality served as a primary safety endpoint.Key findings:• The primary endpoint event was observed in 55 patients (8.8%) among the sirolimus-coated group whereas the same event occurred in 94 patients (15.0%) among the uncoated group.• Consequently, there was a median unbiased estimate of risk difference of -4.9 percentage points (95% confidence interval of -8.5 to -1.3) that led to p value of less than 0.001 in terms of non-inferiority and 0.009 for superiority.• Also, in relation to the secondary endpoint, 144 (23.0%) patients had event occurrence among the sirolimus coated group whereas 193 (30.8%) patients experienced the secondary outcome event, showing that the risk difference was -7.8 percentage points (95% confidence interval, -12.7 to -2.9; P = 0.002).• Safety issues were highly considered throughout the one year follow-up period.• There were no differences noted between the two groups in terms of the mortality rate which was noted in 74 (11.8%) among the sirolimus-coated and 80 (12.8%) among the uncoated balloon group.It is thus evident that the use of sirolimus-coated balloon angioplasty is indeed a major improvement when it comes to the endovascular approach to treating infrainguinal artery disease. In addition to an equivalent level of safety and high efficiency, this technique could become a crucial element in managing the problem of limb loss among older patients.Reference:Barco, S., Engelberger, R. P., Held, U., Fumagalli, R. M., Grigorean, A., Hayoz, D., Münger, M., Sebastian, T., Stadler, R., Voci, D., Wolf, S., Baumann, F., Tritschler, T., von Stempel, C., Périard, D., Kucher, N., &amp; SirPAD Investigators (2026). Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease. The New England journal of medicine, 10.1056/NEJMoa2600360. Advance online publication. https://doi.org/10.1056/NEJMoa2600360 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/09/27/221069-sirolimus-gel.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 13:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sirolimus-Coated, Balloons, Reduce, Major, Adverse, Limb, Events, One, Year:, NEJM</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/09/27/221069-sirolimus-gel.webp"><p>An open-label, prospective, large-scale trial was carried out to evaluate the benefits of coating these balloons with sirolimus, which is an antiproliferative drug. The trial followed a noninferiority approach using a superior design sequence and produced a definitive result: when compared to patients who had undergone angioplasty using plain balloons, patients who had their infrainguinal artery disease managed through angioplasty using sirolimus-coated balloons were found to have significantly fewer major adverse limb events within a year of follow-up. This trial clearly demonstrates the effectiveness of using coated drug technology in maintaining limb integrity. The study was published in <i>The New England Journal of Medicine</i> by Stefano B. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">In this study, 1,252 patients with infrainguinal artery disease were selected, and each group was made up of 626 participants for either a sirolimus-coated balloon angioplasty procedure or balloon angioplasty alone. The mean age of the study participants was 75 years old, with 35.1% of the subjects being women. In addition, the investigators observed a primary composite endpoint of unplanned major amputation of the target limb or endovascular/revascularization procedure of the target lesion for critical limb ischemia within one year after enrollment. Moreover, the investigators assessed an important secondary endpoint of all unplanned amputations or revascularization procedures for critical limb ischemia and noncritical limb ischemia. To assure safety, the investigators defined a noninferiority margin of 5%, and all-cause mortality served as a primary safety endpoint.</p><p dir="ltr">Key findings:</p><p dir="ltr">• The primary endpoint event was observed in 55 patients (8.8%) among the sirolimus-coated group whereas the same event occurred in 94 patients (15.0%) among the uncoated group.</p><p dir="ltr">• Consequently, there was a median unbiased estimate of risk difference of -4.9 percentage points (95% confidence interval of -8.5 to -1.3) that led to p value of less than 0.001 in terms of non-inferiority and 0.009 for superiority.</p><p dir="ltr">• Also, in relation to the secondary endpoint, 144 (23.0%) patients had event occurrence among the sirolimus coated group whereas 193 (30.8%) patients experienced the secondary outcome event, showing that the risk difference was -7.8 percentage points (95% confidence interval, -12.7 to -2.9; P = 0.002).</p><p dir="ltr">• Safety issues were highly considered throughout the one year follow-up period.</p><p dir="ltr"><span>• </span>There were no differences noted between the two groups in terms of the mortality rate which was noted in 74 (11.8%) among the sirolimus-coated and 80 (12.8%) among the uncoated balloon group.</p><p dir="ltr">It is thus evident that the use of sirolimus-coated balloon angioplasty is indeed a major improvement when it comes to the endovascular approach to treating infrainguinal artery disease. In addition to an equivalent level of safety and high efficiency, this technique could become a crucial element in managing the problem of limb loss among older patients.</p><p dir="ltr">Reference:</p><p dir="ltr">Barco, S., Engelberger, R. P., Held, U., Fumagalli, R. M., Grigorean, A., Hayoz, D., Münger, M., Sebastian, T., Stadler, R., Voci, D., Wolf, S., Baumann, F., Tritschler, T., von Stempel, C., Périard, D., Kucher, N., & SirPAD Investigators (2026). Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease. The New England journal of medicine, 10.1056/NEJMoa2600360. Advance online publication. https://doi.org/10.1056/NEJMoa2600360</p><div></div></div>]]> </content:encoded>
</item>

<item>
<title>MS Surgery resident at SRN Hospital found dead under suspicious circumstances</title>
<link>https://edusehat.com/en/ms-surgery-resident-at-srn-hospital-found-dead-under-suspicious-circumstances</link>
<guid>https://edusehat.com/en/ms-surgery-resident-at-srn-hospital-found-dead-under-suspicious-circumstances</guid>
<description><![CDATA[ Prayagraj: In an unfortunate incident, a second-year postgraduate resident doctor in the department of surgery at Swaroop Rani Nehru (SRN) Hospital, Prayagraj, died under suspicious circumstances late Sunday night, police said.  According to a UNI report, the deceased, a second-year postgraduate student in the surgery department, had gone to visit a female doctor friend at her flat in Georgetown after completing his duty.According to reports, he went to the washroom but did not return for a long time. Concerned, the woman doctor called colleagues for help.Also Read:Kerala Cardiothoracic Surgeon dies while taking holy dip in GangaThe incident came to light when the washroom door was forced open, and he was found unconscious. He was immediately rushed to Swaroop Rani Nehru Hospital, where doctors attempted CPR.  Though he briefly regained consciousness, his condition soon deteriorated, and he died after about 90 minutes, sources said on Monday.  Police noted that he had an IV cannula (vigo) inserted in his hand, reportedly due to a fever the previous day. The exact cause of death will be determined following the postmortem examination.  No formal complaint has been filed so far. Medical Dialogues had earlier reported that in a tragic incident, a postgraduate medical student in the department of Ophthalmology at a private medical college in Dehradun was found dead inside a parked car in Patel Nagar under suspicious circumstances.The family of the deceased medico has alleged that the student committed suicide due to harassment by the new head of the Ophthalmology department. They accused the doctor of abetment of suicide. The deceased, a native of Haryana, was pursuing her MS in Ophthalmology since September 2023 at a reputable medical college in Dehradun. She had been staying with her mother in Dehrakhas.Also Read:My son was meritorious: Father of doctor killed in Jharkhand air ambulance crash ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/25/334945-death-6.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 13:40:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Surgery, resident, SRN, Hospital, found, dead, under, suspicious, circumstances</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/25/334945-death-6.webp"><div class="pasted-from-word-wrapper"><p>Prayagraj: In an unfortunate incident, a second-year postgraduate resident doctor in the department of surgery at <a href="https://medicaldialogues.in/topics/Swaroop-Rani-Nehru-Hospital" target="_blank">Swaroop Rani Nehru (SRN) Hospital</a><span>, </span>Prayagraj, died under suspicious circumstances late Sunday night, police said.  </p></div><div class="pasted-from-word-wrapper"><p>According to a UNI report, the deceased, a second-year postgraduate student in the surgery department, had gone to visit a female doctor friend at her flat in Georgetown after completing his duty.</p><p>According to reports, he went to the washroom but did not return for a long time. Concerned, the woman doctor called colleagues for help.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/kerala-cardiothoracic-surgeon-dies-while-taking-holy-dip-in-ganga-168051"><b>Also Read:Kerala Cardiothoracic Surgeon dies while taking holy dip in Ganga</b></a></p><p>The incident came to light when the washroom door was forced open, and he was found unconscious. He was immediately rushed to <a href="https://medicaldialogues.in/topics/Swaroop-Rani-Nehru-Hospital" target="_blank">Swaroop Rani Nehru Hospital</a>, where doctors attempted CPR.  </p><p>Though he briefly regained consciousness, his condition soon deteriorated, and he died after about 90 minutes, sources said on Monday.  </p><p>Police noted that he had an IV cannula (vigo) inserted in his hand, reportedly due to a fever the previous day. The exact cause of death will be determined following the postmortem examination.  </p><p>No formal complaint has been filed so far. </p><p>Medical Dialogues had earlier reported that in a tragic incident, a postgraduate medical student in the department of Ophthalmology at a private medical college in Dehradun was found dead inside a parked car in Patel Nagar under suspicious circumstances.</p><p>The family of the deceased medico has alleged that the student committed suicide due to harassment by the new head of the Ophthalmology department. They accused the doctor of abetment of suicide. The deceased, a native of Haryana, was pursuing her MS in Ophthalmology since September 2023 at a reputable medical college in Dehradun. She had been staying with her mother in Dehrakhas.<br></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/my-son-was-meritorious-father-of-doctor-killed-in-jharkhand-air-ambulance-crash-165417"><b>Also Read:My son was meritorious: Father of doctor killed in Jharkhand air ambulance crash</b></a><br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Hospitals to face legal action for failing to report minor pregnancies: Karnataka Govt</title>
<link>https://edusehat.com/en/hospitals-to-face-legal-action-for-failing-to-report-minor-pregnancies-karnataka-govt</link>
<guid>https://edusehat.com/en/hospitals-to-face-legal-action-for-failing-to-report-minor-pregnancies-karnataka-govt</guid>
<description><![CDATA[ Bengaluru: Taking a significant step to ensure the safety of minors, the Karnataka Government has issued new directives mandating all hospitals in the state to report cases of pregnancy involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.  As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports The Indian Express. Also Read:AP Health Minister urges reduction of cesarean deliveries in private hospitalsThe new guidelines have already been issued to government hospitals and the Indian Medical Association (IMA), and they will take effect immediately. If anyone fails to report any such cases of a minor&#039;s pregnancy, they might face strict legal action, in some cases, even imprisonment for a term of up to one year and a fine. &quot;Legal action will be taken against doctors and private hospitals who fail to report cases,” stated the guidelines.According to the Daily, the guidelines further mentioned that if the authorities  are made aware of child pregnancies, “The child helpline number 1098 should be called immediately, and information should be provided,” which “will enable necessary protective and rehabilitation measures to be taken.&quot;POCSO stands for the Protection of Children from Sexual Offences Act, 2012, in India. It is a strict, gender-neutral law designed to protect children under 18 from sexual assault, harassment, and pornography, providing specialized procedures and child-friendly judicial processes. Cases of pregnancy in minors below the age of 18 should be dealt with seriousness and must be  legally reported under the Pocso Act. Section 19(1) of the Act states that when anyone gets any information about such a crime, they should immediately contact the authorities and give details to the special juvenile police unit or the local police.All hospitals in the state have to record details of POCSO cases to properly store  medical records for legal purposes while maintaining patient confidentiality. The hospitals should also cooperate with the investigation.All private hospitals should create awareness among their doctors and staff about the provisions of the Pocso Act. Steps should be taken to ensure that these instructions are strictly followed,” the guidelines stated.Also Read:POSCO: Man gets 18 years jail for sexually abusing MBBS student ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/24/230826-pregnant-woman-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 13:40:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Hospitals, face, legal, action, for, failing, report, minor, pregnancies:, Karnataka, Govt</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/24/230826-pregnant-woman-2.webp"><p><b>Bengaluru:</b> Taking a significant step to ensure the safety of minors, the <a href="https://medicaldialogues.in/state-news/karnataka">Karnataka</a> Government has issued new directives mandating all hospitals in the state to report cases of <a href="https://medicaldialogues.in/topics/pregnant">pregnancy</a> involving girls under 18 years of age, enabling the initiation of criminal action under the Protection of Children against Sexual Offences (POCSO) Act, 2012.  </p><p>As per the instructions issued by the director of the state Health and Family Welfare Department on April 1, any case of pregnancy involving a minor that is recorded at a private hospital must be reported without delay. The attending doctor is obligated to promptly notify the nearest Special Juvenile Justice Police Unit or the local police station, reports <a href="https://indianexpress.com/article/cities/bangalore/report-child-pregnancies-or-face-action-karnataka-issues-stern-mandate-for-all-hospitals-to-initiate-pocso-cases-10616814/" rel="nofollow">The Indian Express</a>. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/ap-health-minister-urges-reduction-of-cesarean-deliveries-in-private-hospitals-168049"><b>Also Read:AP Health Minister urges reduction of cesarean deliveries in private hospitals</b></a></p><p>The new guidelines have already been issued to government hospitals and the Indian Medical Association (IMA), and they will take effect immediately. If anyone fails to report any such cases of a minor's pregnancy, they might face strict legal action, in some cases, even imprisonment for a term of up to one year and a fine. "Legal action will be taken against doctors and private hospitals who fail to report cases,” stated the guidelines.</p><p>According to the Daily, the guidelines further mentioned that if the authorities  are made aware of child pregnancies, “The child helpline number 1098 should be called immediately, and information should be provided,” which “will enable necessary protective and rehabilitation measures to be taken."</p><p>POCSO stands for the Protection of Children from Sexual Offences Act, 2012, in India. It is a strict, gender-neutral law designed to protect children under 18 from sexual assault, harassment, and pornography, providing specialized procedures and child-friendly judicial processes. </p><p>Cases of pregnancy in minors below the age of 18 should be dealt with seriousness and must be  legally reported under the Pocso Act. Section 19(1) of the Act states that when anyone gets any information about such a crime, they should immediately contact the authorities and give details to the special juvenile police unit or the local police.</p><p>All hospitals in the state have to record details of POCSO cases to properly store  medical records for legal purposes while maintaining patient confidentiality. The hospitals should also cooperate with the investigation.</p><p>All private hospitals should create awareness among their doctors and staff about the provisions of the Pocso Act. Steps should be taken to ensure that these instructions are strictly followed,” the guidelines stated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/kerala/posco-man-gets-18-years-jail-for-sexually-abusing-mbbs-student-165900"><b>Also Read:POSCO: Man gets 18 years jail for sexually abusing MBBS student</b></a></p>]]> </content:encoded>
</item>

<item>
<title>From Policy to Practice: Closing the Global Cervical Cancer Divide</title>
<link>https://edusehat.com/en/from-policy-to-practice-closing-the-global-cervical-cancer-divide</link>
<guid>https://edusehat.com/en/from-policy-to-practice-closing-the-global-cervical-cancer-divide</guid>
<description><![CDATA[ Written by Stephani Montesino, MPH, Global Policy Fellow and Vaishnavi Sambandam, PhD, Oncology Scientist/Medical Writer from the National Comprehensive Cancer Network® (NCCN®) Cervical Cancer in Numbers: Prevention, Screening, and Treatment […] ]]></description>
<enclosure url="https://globalhealth.org/wp-content/uploads/2026/04/iStock-1133567802-768x509.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 07 Apr 2026 07:00:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>From, Policy, Practice:, Closing, the, Global, Cervical, Cancer, Divide</media:keywords>
<content:encoded><![CDATA[<p><em>Written by Stephani Montesino, MPH, Global Policy Fellow</em> <em>and Vaishnavi Sambandam, PhD, Oncology Scientist/Medical Writer from the National Comprehensive Cancer Network® (NCCN®)</em></p>



<p><strong>Cervical Cancer in Numbers: Prevention, Screening, and Treatment</strong></p>



<p>Cervical cancer is the fourth most common cancer in women worldwide, with 660,000 new cases in 2022, and 94% of deaths occurring in low‑ and middle‑income countries, largely due to limited access to human papillomavirus (HPV) vaccination, screening, and treatment. About 95% of cervical cancers are caused by persistent infection with high‑risk HPV, a commonly acquired virus transmitted through skin-to-skin contact during sexual activity. Persistent infection can lead to precancerous changes that may progress to cancer over many years. Widespread prevention of cervical cancer begins with population-focused HPV vaccination, which protects against the high‑risk HPV types responsible for most cervical cancers; expanding access to vaccination is one of the most effective ways to reduce global cervical cancer rates.</p>



<p>Screening is also an essential part of prevention. <a href="http://asccp.org/clinical-practice/guidelines/screening-guidelines">The American Society for Colposcopy and Cervical Pathology (ASCCP) Guidelines</a> recommend routine cervical cancer screening using high-risk HPV testing, cervical cytology tests, or both, depending on age and risk status. Other international bodies have developed population‑level screening recommendations, including those from the <a href="https://cancer-screening-and-care.jrc.ec.europa.eu/en/ec-cvc/european-cervical-cancer-guidelines?topic=328&usertype=327#guideline">European Commission</a> and <a href="https://www.sciencedirect.com/science/article/pii/S2667164623000891">China</a>.</p>



<p>The <a href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426">NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cervical Cancer</a> provide healthcare providers with stage-specific treatment recommendations and post-recurrence surveillance guidance. When precancerous lesions or cancer are found, treatment options range from localized removal of precancerous cells to surgery, radiation, and/or chemotherapy. For patients and caregivers, the <a href="https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=62">NCCN Guidelines for Patients® for Cervical Cancer</a> offer accessible versions to help understand cervical cancer from screening to survivorship.</p>



<p><strong>Cervical Cancer: Spotlight on the Multilateral Stage</strong></p>



<p>Recognizing that cervical cancer deaths can be largely avoidable with appropriate prevention strategies, the World Health Organization (WHO) launched a global elimination initiative that mobilizes countries to expand HPV vaccination and strengthen prevention efforts. To achieve elimination, countries are working towards reducing incidence to fewer than 4 cases per 100,000 women annually by meeting the <strong>90–70–90</strong> targets for 2030:</p>



<ul class="wp-block-list">
<li>vaccinating <strong>90%</strong> of girls by age 15;</li>



<li>screening <strong>70%</strong> of women at ages 35 and 45; and</li>



<li>ensuring <strong>90%</strong> of women with precancer or cancer receive appropriate treatment.</li>
</ul>



<p>This effort was reinforced at the UN General Assembly (UNGA80) High-Level Meeting (HLM) on Non-Communicable Diseases (NCDs) and Mental Health, with Member States committing to scaling up HPV vaccination, expanding effective screening, ensuring early, high-quality treatment, and integrating breast and cervical cancer prevention into national programs.</p>



<p>Under France’s 2026 G7 Presidency, a Health Working Group has been established to mainstream health priorities into the official tracks of the G7 Leaders’ Summit in June. One priority health area for this group is strengthening the fight against NCDs, including leveraging Artificial Intelligence (AI) for cervical cancer prevention.</p>



<p>Alongside global commitments, many countries have developed specific cervical cancer control plans outlining how they will expand HPV vaccination, strengthen screening programs, and improve access to treatment. These national plans, available on the International Cancer Control Partnership <a href="https://www.iccp-portal.org/">(ICCP</a>) website, demonstrate that governments are focusing on concrete goals and country-specific actions.</p>



<p><strong>Call to Action</strong></p>



<p>These public targets and commitments to address cervical cancer provide powerful tools for accountability and advocacy. Furthermore, additional efforts should focus on countries that face the highest burden and mortality from cervical cancer, many of which are still developing their health care infrastructure. Unitaid’s <a href="https://unitaid.org/call-for-proposal/accelerating-cervical-cancer-elimination-through-secondary-prevention-in-low-and-middle-income-countries/">new funding</a> call, focused on improving cervical cancer screening and early treatment in low‑ and middle‑income countries, creates an opportunity to close prevalent gaps in access. By establishing ways to expand HPV testing, strengthen treatment services, and reach women who are most often left behind, this initiative provides a way to speed up progress toward cervical cancer elimination.</p>



<p><strong>References:</strong></p>



<p>American Society for Colonoscopy and Cervical Pathology (ASCCP) Guidelines for Cervical</p>



<p>Screening (Mobile app available): <a href="http://asccp.org/clinical-practice/guidelines/screening-guidelines">http://asccp.org/clinical-practice/guidelines/screening-guidelines</a></p>



<p>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cervical Cancer V.2.2026. © National Comprehensive Cancer Network, Inc. 2026.  All rights reserved.  Accessed March 31, 2026.  To view the most recent and complete version of the guideline, go online to NCCN.org</p>



<p>NCCN Guidelines for Patients<sup>®</sup> for Cervical Cancer, 2026. © National Comprehensive Cancer Network, Inc. 2026. All rights reserved. Accessed March 31, 2026. To view the most recent and complete version of the NCCN Guidelinesfor Patients, go online to NCCN.org/patientguidelines.</p>



<p>World Health Organization. (2025, December 2). <em>Cervical cancer</em>. Retrieved from World Health Organization: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer</p>]]> </content:encoded>
</item>

<item>
<title>Adiposity and inflammation may be linked with all&#45;cause and CV mortality among postmenopausal women: Study</title>
<link>https://edusehat.com/en/adiposity-and-inflammation-may-be-linked-with-all-cause-and-cv-mortality-among-postmenopausal-women-study</link>
<guid>https://edusehat.com/en/adiposity-and-inflammation-may-be-linked-with-all-cause-and-cv-mortality-among-postmenopausal-women-study</guid>
<description><![CDATA[ Life’s Essential 8 (LE8) and Life’s Crucial 9 (LC9) from the American Heart Association are industry-accepted metrics that summarize overall cardiovascular health.A recent study published in Menopause found that certain health indicators are inversely associated with both all-cause and cardiovascular mortality in postmenopausal women, suggesting a protective effect. The study also revealed that factors like adiposity (body fat) and systemic inflammation partially mediate these relationships, indicating that reduced fat levels and inflammation may contribute to improved survival outcomes.Cardiovascular disease remains the leading cause of morbidity and mortality in women worldwide. Due to hormone changes, metabolic alterations, and vascular aging, this risk significantly increases after menopause. Comprehensive assessment of cardiovascular health is therefore essential for identifying high-risk populations and building prevention strategies in postmenopausal women.
Although higher LE8 and LC9 scores have been associated with reduced risks of cardiovascular events and mortality, the underlying causes of these associations have not been completely identified. Postmenopausal women undergo substantial shifts in body composition and fat redistribution (especially around a woman’s midsection) that elevate cardiometabolic risk. In addition, in this population, higher adiposity is frequently associated with an increased frequency of inflammatory markers and metabolic dysregulation.
That’s why this new study involving more than 7,800 postmenopausal women (of whom 1,313 had died during follow-up) sought to examine the relationships between LE8 and LC9 and all-cause and cardiovascular mortality and to evaluate whether adiposity-related and inflammation-related indicators statistically mediate these associations. Based on the results, the researchers concluded that higher LC9 and LE8 scores were associated with lower risks of all-cause and cardiovascular mortality in postmenopausal women. Moreover, adiposity-related, and inflammation-related indicators partially mediated these associations. These findings underscore the importance of comprehensive cardiovascular health assessment and suggest the benefits of maintaining favorable cardiometabolic profiles.
Study results are published in the article “Mediation analysis of adiposity and inflammation in the associations of Life’s Crucial 9 and Life’s Essential 8 with mortality among postmenopausal women.”
“We already know that lifestyle factors such as diet, exercise, sleep, and not smoking are important for heart health, but the findings of this study highlight just how powerful they may be. Women with better overall cardiometabolic health profiles after menopause are more likely to live longer, suggesting that many of the factors influencing our health span are within our control,” says Dr. Stephanie Faubion, medical director for The Menopause Society.Reference:Jun Wei, Yang Liu, Mediation analysis of adiposity and inflammation in the associations of Life&#039;s Crucial 9 and Life&#039;s Essential 8 with mortality among postmenopausal women, Menopause, DOI:10.1097/GME.0000000000000002761  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/29/280732-cardiovascular-disease.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Adiposity, and, inflammation, may, linked, with, all-cause, and, mortality, among, postmenopausal, women:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/29/280732-cardiovascular-disease.webp"><p>Life’s Essential 8 (LE8) and Life’s Crucial 9 (LC9) from the American Heart Association are industry-accepted metrics that summarize overall <a href="https://medicaldialogues.in/topics/cardiovascular-health">cardiovascular health</a>.</p><p>A recent study published in Menopause found that certain health indicators are inversely associated with both all-cause and cardiovascular mortality in postmenopausal women, suggesting a protective effect. The study also revealed that factors like adiposity (body fat) and systemic inflammation partially mediate these relationships, indicating that reduced fat levels and inflammation may contribute to improved survival outcomes.</p><p><a href="https://medicaldialogues.in/topics/cardiovascular-disease">Cardiovascular disease </a>remains the leading cause of morbidity and mortality in women worldwide. Due to hormone changes, metabolic alterations, and vascular aging, this risk significantly increases after <a href="https://medicaldialogues.in/topics/menopause">menopause</a>. Comprehensive assessment of cardiovascular health is therefore essential for identifying high-risk populations and building prevention strategies in postmenopausal women.
</p><p>Although higher LE8 and LC9 scores have been associated with reduced risks of cardiovascular events and mortality, the underlying causes of these associations have not been completely identified. Postmenopausal women undergo substantial shifts in body composition and fat redistribution (especially around a woman’s midsection) that elevate cardiometabolic risk. In addition, in this population, higher adiposity is frequently associated with an increased frequency of inflammatory markers and metabolic dysregulation.
</p><p>That’s why this new study involving more than 7,800 postmenopausal women (of whom 1,313 had died during follow-up) sought to examine the relationships between LE8 and LC9 and all-cause and cardiovascular mortality and to evaluate whether adiposity-related and inflammation-related indicators statistically mediate these associations. Based on the results, the researchers concluded that higher LC9 and LE8 scores were associated with lower risks of all-cause and cardiovascular mortality in postmenopausal women. Moreover, adiposity-related, and inflammation-related indicators partially mediated these associations. These findings underscore the importance of comprehensive cardiovascular health assessment and suggest the benefits of maintaining favorable cardiometabolic profiles.
</p><p>Study results are published in the article “Mediation analysis of adiposity and inflammation in the associations of Life’s Crucial 9 and Life’s Essential 8 with mortality among postmenopausal women.”
</p><p>“We already know that lifestyle factors such as diet, exercise, sleep, and not smoking are important for heart health, but the findings of this study highlight just how powerful they may be. Women with better overall cardiometabolic health profiles after menopause are more likely to live longer, suggesting that many of the factors influencing our health span are within our control,” says Dr. Stephanie Faubion, medical director for The Menopause Society.</p><p>Reference:</p><p>Jun Wei, Yang Liu, Mediation analysis of adiposity and inflammation in the associations of Life's Crucial 9 and Life's Essential 8 with mortality among postmenopausal women, Menopause, DOI:10.1097/GME.0000000000000002761 </p>]]> </content:encoded>
</item>

<item>
<title>Pharma Director Flags Rising Input Costs, Says No Drug Price Hike Without Govt Nod</title>
<link>https://edusehat.com/en/pharma-director-flags-rising-input-costs-says-no-drug-price-hike-without-govt-nod</link>
<guid>https://edusehat.com/en/pharma-director-flags-rising-input-costs-says-no-drug-price-hike-without-govt-nod</guid>
<description><![CDATA[ Bengaluru: The ongoing conflict in West Asia is sending ripples through the pharmaceutical industry, with raw material costs on the rise, says Jatish Sheth, Director, Srushti Pharmaceuticals.While speaking to an news agency, Sheth highlighted that pharmaceuticals are vulnerable to disruptions in petrochemical supply chains, as many raw materials used in formulation are petrol-based.Also Read: NCLT Approves Merger of Shilpa Therapeutics with Shilpa Medicare&quot;Pharmaceuticals are affected. Raw materials which are used for manufacturing formulation, they use petrol-based products... If the petrochemical supply is affected, the synthesis raw material will be affected, and in turn, medicines will be affected.&quot; Sheth explained. While the impact hasn&#039;t been severe so far, prolonged conflict could lead to shortages and increased costs.&quot;So far, it is not affecting badly, but if it goes on for long, it will get affected... Rates of input materials have gone up,&quot; Sheth noted, adding that the company is exercising caution on pricing.&quot;We do not increase the price of the medicines without the permission of the government. As far as pharmaceutical medicines are concerned, there won&#039;t be an increase in the price till the government gives the indication,&quot; he added.Meanwhile, the Government on Wednesday announced a full customs duty exemption on select critical petrochemical products, in a move to cushion domestic industries from global supply disruptions due to the ongoing conflict in West Asia.According to an official statement, the exemption will remain in force till June 30, 2026, and aims to ensure the uninterrupted availability of essential petrochemical inputs for domestic manufacturing sectors.The decision comes amid heightened geopolitical tensions in West Asia, which have led to disruptions in global supply chains and increased cost pressures on industries reliant on petrochemical feedstock and intermediates.The government said the measure is intended as a temporary relief to stabilise supplies, ease input costs, and support downstream industries that depend heavily on such raw materials.A wide range of sectors is expected to benefit from the exemption, including plastics, packaging, textiles, pharmaceuticals, chemicals, automotive components, and other manufacturing segments. The move is also likely to provide indirect relief to consumers by moderating the prices of final products.The list of exempted items includes key petrochemical inputs such as anhydrous ammonia, methanol, toluene, styrene, vinyl chloride monomer, monoethylene glycol (MEG), phenol, acetic acid, and purified terephthalic acid (PTA), among others.Also Read: Tax Setback for GSK as IT Dept Raises Rs 2.01 Crore TDS Demand ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/06/297064-medicine-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pharma, Director, Flags, Rising, Input, Costs, Says, Drug, Price, Hike, Without, Govt, Nod</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/06/297064-medicine-50.webp"><p><b>Bengaluru</b>: The ongoing conflict in West Asia is sending ripples through the <a href="https://medicaldialogues.in/topics/pharmaceutical-industry">pharmaceutical industry</a>, with raw material costs on the rise, says Jatish Sheth, Director, Srushti Pharmaceuticals.</p><div class="pasted-from-word-wrapper"><p>While speaking to an news agency, Sheth highlighted that pharmaceuticals are vulnerable to disruptions in petrochemical supply chains, as many <a href="https://medicaldialogues.in/topics/raw-materials">raw materials</a> used in formulation are petrol-based.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/nclt-approves-merger-of-shilpa-therapeutics-with-shilpa-medicare-167021">Also Read: NCLT Approves Merger of Shilpa Therapeutics with Shilpa Medicare</a></div><p>"Pharmaceuticals are affected. Raw materials which are used for manufacturing formulation, they use petrol-based products... If the petrochemical supply is affected, the synthesis raw material will be affected, and in turn, medicines will be affected." Sheth explained. While the impact hasn't been severe so far, prolonged conflict could lead to shortages and increased costs.</p><p>"So far, it is not affecting badly, but if it goes on for long, it will get affected... Rates of input materials have gone up," Sheth noted, adding that the company is exercising caution on pricing.</p><p>"We do not increase the price of the medicines without the permission of the government. As far as pharmaceutical medicines are concerned, there won't be an increase in the price till the government gives the indication," he added.</p><p>Meanwhile, the Government on Wednesday announced a full customs duty exemption on select critical petrochemical products, in a move to cushion domestic industries from global supply disruptions due to the ongoing conflict in West Asia.</p><p>According to an official statement, the exemption will remain in force till June 30, 2026, and aims to ensure the uninterrupted availability of essential petrochemical inputs for domestic manufacturing sectors.</p><p>The decision comes amid heightened geopolitical tensions in West Asia, which have led to disruptions in global supply chains and increased cost pressures on industries reliant on petrochemical feedstock and intermediates.</p><p>The government said the measure is intended as a temporary relief to stabilise supplies, ease input costs, and support downstream industries that depend heavily on such raw materials.</p><p>A wide range of sectors is expected to benefit from the exemption, including plastics, packaging, textiles, pharmaceuticals, chemicals, automotive components, and other manufacturing segments. The move is also likely to provide indirect relief to consumers by moderating the prices of final products.</p><p>The list of exempted items includes key petrochemical inputs such as anhydrous ammonia, methanol, toluene, styrene, vinyl chloride monomer, monoethylene glycol (MEG), phenol, acetic acid, and purified terephthalic acid (PTA), among others.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/tax-setback-for-gsk-as-it-dept-raises-rs-201-crore-tds-demand-167953">Also Read: Tax Setback for GSK as IT Dept Raises Rs 2.01 Crore TDS Demand</a></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Jan Vishwas Bill 2026 Decriminalises Pharma Offences, Replaces Minor Violations with Monetary Penalties</title>
<link>https://edusehat.com/en/jan-vishwas-bill-2026-decriminalises-pharma-offences-replaces-minor-violations-with-monetary-penalties</link>
<guid>https://edusehat.com/en/jan-vishwas-bill-2026-decriminalises-pharma-offences-replaces-minor-violations-with-monetary-penalties</guid>
<description><![CDATA[ New Delhi: The Jan Vishwas (Amendment of Provisions) Bill, 2026 has been passed by both Houses of Parliament, marking a significant step towards further enhancing Ease of Doing Business and Ease of Living in the country.The Bill reflects the Government’s commitment to fostering a trust-based governance framework and ensuring proportionate regulation by reducing the compliance burden on individuals and businesses.As per the provisions of the Bill, 784 provisions across 79 Central Acts administered by 23 Ministries have been amended. Of these, 717 provisions have been decriminalized to promote Ease of Doing Business, while 67 provisions have been amended to facilitate Ease of Living. Overall, the Bill seeks to rationalize more than 1,000 offences by removing minor offences, thereby improving the regulatory environment and enabling a more conducive ecosystem for businesses and citizens alike.Also Read: Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical Devices RulesWithin the health sector, the amendments span key legislations including the Drugs and Cosmetics Act, 1940; the Pharmacy Act, 1948; the Food Safety and Standards Act; the Clinical Establishments (Registration and Regulation) Act, 2010; and the National Commission for Allied and Healthcare Professions Act, 2021. These reforms align with the broader objective of simplifying compliance while maintaining robust safeguards for public health.A central feature of these reforms is the replacement of criminal penalties, particularly imprisonment for minor procedural violations, with graded monetary penalties. This marks a shift towards a more facilitative regulatory framework while retaining strict action for serious violations affecting public health and safety.In the Drugs and Cosmetics Act, 1940, several provisions have been amended to substitute imprisonment with financial penalties and to introduce a structured adjudication mechanism. Notably, an adjudication mechanism has been introduced for violations under Section 27A(ii) and Section 28A. This ensures that minor violations in the case of cosmetics (other than spurious or adulterated) will not require court intervention and can instead be addressed through a civil penalty framework.Further, violations such as non-maintenance of documents or non-submission of information, which were earlier punishable through court-imposed fines or imprisonment, can now be adjudicated through this civil penalty mechanism. For the first time, the Act provides for the appointment of adjudicating authorities by the Central Government and State Governments, along with a defined process involving issuance of show cause notices, provision for personal hearing, and an appellate mechanism.This reform will significantly reduce the burden on courts, minimize layers of litigation and enable faster resolution of minor compliance issues. It will particularly benefit the cosmetics industry by allowing structured and predictable handling of minor infringements, including procedural lapses such as non-maintenance of statutory records or documents, which are now free from prolonged litigation.Similarly, amendments to the Pharmacy Act, 1948 aim to modernize penalty provisions and enhance accountability through increased financial penalties for non-compliance. The reforms also ensure alignment with updated legal frameworks.Also Read: CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease ApprovalsUnder the Food Safety and Standards Act, 2006, provisions have been streamlined to strengthen enforcement while ensuring that penalties are proportionate to the nature of the offence. This supports a balanced approach between regulatory oversight and ease of compliance.The Clinical Establishments (Registration and Regulation) Act, 2010 has been updated to emphasize monetary penalties for non-compliance, particularly in cases where deficiencies do not pose immediate risks to patient safety. This encourages corrective action without resorting to criminal proceedings.Further, the National Commission for Allied and Healthcare Professions Act, 2021 has been strengthened to ensure compliance with professional standards and regulatory requirements, with penalties designed to deter violations while maintaining proportionality.The alignment of these reforms across multiple health-related legislations reflects a coherent policy approach aimed at harmonizing regulatory frameworks. By standardizing the shift from criminal penalties to civil penalties and introducing adjudication mechanisms, the amendments ensure consistency, predictability and proportionality in enforcement. This alignment reduces regulatory fragmentation, simplifies compliance requirements and provides clarity to stakeholders operating across different segments of the health sector.The involvement of 23 Ministries in implementing these reforms underscores a whole-of-government approach towards improving the regulatory ecosystem. This broad-based participation reflects the Government’s strong resolve to advance Ease of Doing Business and Ease of Living across sectors, ensuring that reforms are comprehensive, coordinated and impactful.Overall, these measures are expected to improve compliance, reduce litigation and build greater trust between stakeholders and regulatory authorities, while continuing to safeguard public health and public interest. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/09/06/300073-essential-medicines.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Jan, Vishwas, Bill, 2026, Decriminalises, Pharma, Offences, Replaces, Minor, Violations, with, Monetary, Penalties</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/09/06/300073-essential-medicines.webp"><p><b>New Delhi: </b>The Jan Vishwas (Amendment of Provisions) Bill, 2026 has been passed by both Houses of <a href="https://medicaldialogues.in/topics/Parliament">Parliament</a>, marking a significant step towards further enhancing Ease of Doing Business and Ease of Living in the country.</p><div class="pasted-from-word-wrapper"><p>The Bill reflects the Government’s commitment to fostering a trust-based governance framework and ensuring proportionate regulation by reducing the compliance burden on individuals and businesses.</p><p>As per the provisions of the Bill, 784 provisions across 79 Central Acts administered by 23 Ministries have been amended. Of these, 717 provisions have been decriminalized to promote Ease of Doing Business, while 67 provisions have been amended to facilitate Ease of Living. Overall, the Bill seeks to rationalize more than 1,000 offences by removing minor offences, thereby improving the regulatory environment and enabling a more conducive ecosystem for businesses and citizens alike.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/health-ministry-notifies-new-qualification-norms-for-inspectors-government-analysts-under-medical-devices-rules-167044">Also Read: Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical Devices Rules</a></p><div></div></div><p>Within the health sector, the amendments span key legislations including the Drugs and Cosmetics Act, 1940; the Pharmacy Act, 1948; the Food Safety and Standards Act; the Clinical Establishments (Registration and Regulation) Act, 2010; and the National Commission for Allied and Healthcare Professions Act, 2021. These reforms align with the broader objective of simplifying compliance while maintaining robust safeguards for public health.</p><p>A central feature of these reforms is the replacement of criminal penalties, particularly imprisonment for minor procedural violations, with graded monetary penalties. This marks a shift towards a more facilitative regulatory framework while retaining strict action for serious violations affecting public health and safety.</p><p>In the Drugs and Cosmetics Act, 1940, several provisions have been amended to substitute imprisonment with financial penalties and to introduce a structured adjudication mechanism. Notably, an adjudication mechanism has been introduced for violations under Section 27A(ii) and Section 28A. This ensures that minor violations in the case of cosmetics (other than spurious or adulterated) will not require court intervention and can instead be addressed through a civil penalty framework.</p><p>Further, violations such as non-maintenance of documents or non-submission of information, which were earlier punishable through court-imposed fines or imprisonment, can now be adjudicated through this civil penalty mechanism. For the first time, the Act provides for the appointment of adjudicating authorities by the Central Government and State Governments, along with a defined process involving issuance of show cause notices, provision for personal hearing, and an appellate mechanism.</p><p>This reform will significantly reduce the burden on courts, minimize layers of litigation and enable faster resolution of minor compliance issues. It will particularly benefit the cosmetics industry by allowing structured and predictable handling of minor infringements, including procedural lapses such as non-maintenance of statutory records or documents, which are now free from prolonged litigation.</p><p>Similarly, amendments to the Pharmacy Act, 1948 aim to modernize penalty provisions and enhance accountability through increased financial penalties for non-compliance. The reforms also ensure alignment with updated legal frameworks.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/cdsco-delegates-veterinary-drug-licensing-powers-to-zonal-offices-to-ease-approvals-167022">Also Read: CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease Approvals</a></div><p>Under the Food Safety and Standards Act, 2006, provisions have been streamlined to strengthen enforcement while ensuring that penalties are proportionate to the nature of the offence. This supports a balanced approach between regulatory oversight and ease of compliance.</p><p>The Clinical Establishments (Registration and Regulation) Act, 2010 has been updated to emphasize monetary penalties for non-compliance, particularly in cases where deficiencies do not pose immediate risks to patient safety. This encourages corrective action without resorting to criminal proceedings.</p><p>Further, the National Commission for Allied and Healthcare Professions Act, 2021 has been strengthened to ensure compliance with professional standards and regulatory requirements, with penalties designed to deter violations while maintaining proportionality.</p><p>The alignment of these reforms across multiple health-related legislations reflects a coherent policy approach aimed at harmonizing regulatory frameworks. By standardizing the shift from criminal penalties to civil penalties and introducing adjudication mechanisms, the amendments ensure consistency, predictability and proportionality in enforcement. This alignment reduces regulatory fragmentation, simplifies compliance requirements and provides clarity to stakeholders operating across different segments of the health sector.</p><p>The involvement of 23 Ministries in implementing these reforms underscores a whole-of-government approach towards improving the regulatory ecosystem. This broad-based participation reflects the Government’s strong resolve to advance Ease of Doing Business and Ease of Living across sectors, ensuring that reforms are comprehensive, coordinated and impactful.</p><p>Overall, these measures are expected to improve compliance, reduce litigation and build greater trust between stakeholders and regulatory authorities, while continuing to safeguard public health and public interest.</p></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Nandrolone Decanoate Shows Limited Functional Benefits Despite Modest Muscle Gain: Meta&#45;Analysis</title>
<link>https://edusehat.com/en/nandrolone-decanoate-shows-limited-functional-benefits-despite-modest-muscle-gain-meta-analysis</link>
<guid>https://edusehat.com/en/nandrolone-decanoate-shows-limited-functional-benefits-despite-modest-muscle-gain-meta-analysis</guid>
<description><![CDATA[ UK: A recent systematic review and meta-analysis published in the Journal of Cachexia, Sarcopenia and Muscle has evaluated the effectiveness of nandrolone decanoate in improving muscle strength, body composition, and bone health in adults, raising important questions about its clinical utility.
The study, led by Konstantinos Prokopidis from the Department of Musculoskeletal Biology at the University of Liverpool, examined whether this anabolic agent could counteract muscle loss and functional decline associated with ageing and chronic conditions such as sarcopenia and cachexia. While pharmacological strategies continue to attract attention in this field, robust evidence supporting their benefits remains limited.
For the analysis, the researchers systematically reviewed randomized controlled trials comparing nandrolone decanoate with placebo in adults aged 18 years and above. Multiple databases, including PubMed, Scopus, Web of Science, and the Cochrane Library, were searched up to April 2025 in accordance with PRISMA guidelines. A total of 20 trials met the inclusion criteria and were pooled using a random-effects meta-analysis. The quality of evidence and risk of bias were also carefully assessed.    Key
Findings:


 Nandrolone
     decanoate resulted in a modest but statistically significant increase in
     lean soft tissue, with an average gain of around 1.6 kg. 
 The
     increase in muscle mass did not lead to meaningful improvements in
     functional outcomes. 
 No
     significant changes were observed in handgrip strength compared to
     placebo. 
 Knee
     extension strength also remained unaffected. 
 Fat
     mass showed no significant difference between the nandrolone and placebo
     groups.
Bone health outcomes were inconsistent across studies. While a small improvement was noted in bone mineral density at the proximal femur, no significant benefits were observed at other skeletal sites. Overall, the evidence did not demonstrate a clear or reliable advantage of nandrolone decanoate in enhancing musculoskeletal health.
The authors noted several limitations, including limited muscle strength data and a lack of dietary control, which may have influenced body composition outcomes. Women were underrepresented, preventing sex-specific analysis, and most trials were short-term, limiting long-term insights. Variability in study populations, methods, and older trial designs further affected consistency, while key physical performance outcomes were not reported.Although most studies had a low risk of bias, the overall certainty of evidence was low, warranting cautious interpretation and the need for further high-quality research.
In conclusion, while nandrolone decanoate may slightly increase lean body mass, it does not appear to improve muscle strength or consistently enhance bone density. Given its limited functional benefits and known safety concerns, the findings do not support its routine clinical use. The authors emphasize that non-pharmacological interventions, particularly resistance exercise, adequate nutrition, and rehabilitation strategies, should remain the cornerstone of maintaining and improving musculoskeletal health.Reference:Prokopidis, K., Ispoglou, T., Thompson, T., Sanchez-Rodriguez, D., Hergelegiu, A. M., Balci, C., Alves, M., Pizzol, D., McLean, J., Soysal, P., Unim, B., Cherubini, A., &amp; Veronese, N. (2026). Effects of Nandrolone Decanoate on Muscle Strength, Body Composition and Bone Density: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 17(2), e70276. https://doi.org/10.1002/jcsm.70276 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339839-bone-density.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Nandrolone, Decanoate, Shows, Limited, Functional, Benefits, Despite, Modest, Muscle, Gain:, Meta-Analysis</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339839-bone-density.webp"><p>UK: A recent systematic review and meta-analysis published in the <em data-start="62" data-end="106">Journal of Cachexia, Sarcopenia and Muscle</em> has evaluated the effectiveness of nandrolone decanoate in improving <a href="https://medicaldialogues.in/topics/muscle-strength">muscle strength</a>, body composition, and<a href="https://medicaldialogues.in/topics/bone-health"> bone health </a>in adults, raising important questions about its clinical utility.</p><div class="pasted-from-word-wrapper"><div class="flex flex-col text-sm pb-25"><section class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&:has([data-writing-block])>*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-WEB:de162da0-18ab-4206-ad1a-3a64f96670db-0" data-testid="conversation-turn-2" data-scroll-anchor="true" data-turn="assistant"><div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)"><div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn"><div class="flex max-w-full flex-col gap-4 grow"><div data-message-author-role="assistant" data-message-id="0814db08-89a1-4f39-b2a9-d0998fa4a4b7" dir="auto" data-message-model-slug="gpt-5-3" class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&]:mt-1" data-turn-start-message="true" tabindex="0"><div class="flex w-full flex-col gap-1 empty:hidden"><div class="markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling">
<p data-start="295" data-end="720">The study, led by Konstantinos Prokopidis from the Department of Musculoskeletal Biology at the University of Liverpool, examined whether this anabolic agent could counteract muscle loss and functional decline associated with ageing and chronic conditions such as sarcopenia and <a href="https://medicaldialogues.in/topics/cancer-cachexia">cachexia</a>. While pharmacological strategies continue to attract attention in this field, robust evidence supporting their benefits remains limited.</p>
<p data-start="722" data-end="1218">For the analysis, the researchers systematically reviewed randomized controlled trials comparing nandrolone decanoate with placebo in adults aged 18 years and above. Multiple databases, including PubMed, Scopus, Web of Science, and the Cochrane Library, were searched up to April 2025 in accordance with PRISMA guidelines. A total of 20 trials met the inclusion criteria and were pooled using a random-effects meta-analysis. The quality of evidence and risk of bias were also carefully assessed.    </p></div></div></div></div></div></div></section></div></div><div class="pasted-from-word-wrapper"><p>Key
Findings:</p>

<ul type="disc">
 <li>Nandrolone
     decanoate resulted in a modest but statistically significant increase in
     lean soft tissue, with an average gain of around 1.6 kg. </li>
 <li>The
     increase in muscle mass did not lead to meaningful improvements in
     functional outcomes. </li>
 <li>No
     significant changes were observed in handgrip strength compared to
     placebo. </li>
 <li>Knee
     extension strength also remained unaffected. </li>
 <li>Fat
     mass showed no significant difference between the nandrolone and placebo
     groups.</li></ul></div><div class="pasted-from-word-wrapper"><div class="flex flex-col text-sm pb-25"><section class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&:has([data-writing-block])>*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-WEB:de162da0-18ab-4206-ad1a-3a64f96670db-0" data-testid="conversation-turn-2" data-scroll-anchor="true" data-turn="assistant"><div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)"><div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn"><div class="flex max-w-full flex-col gap-4 grow"><div data-message-author-role="assistant" data-message-id="0814db08-89a1-4f39-b2a9-d0998fa4a4b7" dir="auto" data-message-model-slug="gpt-5-3" class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&]:mt-1" data-turn-start-message="true" tabindex="0"><div class="flex w-full flex-col gap-1 empty:hidden"><div class="markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling">
<p data-start="1220" data-end="1678">Bone health outcomes were inconsistent across studies. While a small improvement was noted in bone mineral density at the proximal femur, no significant benefits were observed at other skeletal sites. Overall, the evidence did not demonstrate a clear or reliable advantage of nandrolone decanoate in enhancing musculoskeletal health.</p>
<p>The authors noted several limitations, including limited muscle strength data and a lack of dietary control, which may have influenced body composition outcomes. Women were underrepresented, preventing sex-specific analysis, and most trials were short-term, limiting long-term insights. Variability in study populations, methods, and older trial designs further affected consistency, while key physical performance outcomes were not reported.</p><p>Although most studies had a low risk of bias, the overall certainty of evidence was low, warranting cautious interpretation and the need for further high-quality research.</p>
<p data-start="2983" data-end="3495" data-is-last-node="" data-is-only-node="">In conclusion, while nandrolone decanoate may slightly increase lean body mass, it does not appear to improve muscle strength or consistently enhance bone density. Given its limited functional benefits and known safety concerns, the findings do not support its routine clinical use. The authors emphasize that non-pharmacological interventions, particularly resistance exercise, adequate nutrition, and rehabilitation strategies, should remain the cornerstone of maintaining and improving musculoskeletal health.</p></div></div></div></div><div class="z-0 flex min-h-[46px] justify-start"></div><div class="mt-3 w-full empty:hidden"><div class="text-center"></div></div></div></div></section></div><div aria-hidden="true" data-edge="true" class="pointer-events-none h-px w-px absolute bottom-0"></div></div><p>Reference:</p><p>Prokopidis, K., Ispoglou, T., Thompson, T., Sanchez-Rodriguez, D., Hergelegiu, A. M., Balci, C., Alves, M., Pizzol, D., McLean, J., Soysal, P., Unim, B., Cherubini, A., & Veronese, N. (2026). Effects of Nandrolone Decanoate on Muscle Strength, Body Composition and Bone Density: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 17(2), e70276. https://doi.org/10.1002/jcsm.70276</p>]]> </content:encoded>
</item>

<item>
<title>Periprosthetic Joint Infection Doubles Long&#45;Term Mortality Risk After Hip Replacement: Study</title>
<link>https://edusehat.com/en/periprosthetic-joint-infection-doubles-long-term-mortality-risk-after-hip-replacement-study</link>
<guid>https://edusehat.com/en/periprosthetic-joint-infection-doubles-long-term-mortality-risk-after-hip-replacement-study</guid>
<description><![CDATA[ Researchers have found in a new study that Periprosthetic joint infection (PJI) following primary total hip arthroplasty (THA) is associated with a more than twofold increase in long-term mortality. Although complications after THA are uncommon, PJI can result in serious consequences, including repeat surgeries, prolonged hospital stays, extended antibiotic therapy, poor functional outcomes, and death. Evidence regarding its impact on medium- to long-term mortality has been limited and inconsistent, but this study highlights a significant association. The study was published in the Journal of Infection by Andreas W. and colleagues.The study assessed data on 215,678 patients registered in the Swiss Joint Registry, of whom only 89,709 fulfilled the inclusion criteria. The distribution of male and female patients was equal in the sample population, as 51.3% of the participants were females. Additionally, the median age at which surgery was performed in the cohort was 69 years. The study followed the patients&#039; progression for up to 10 years using Gompertz regression analysis to determine the adjusted hazard ratios (aHR) by accounting for various covariates like age, sex, BMI, and ASA physical status. Among this patient population, 745 patients (0.8%) developed PJI, whereas 2,752 patients (3.1%) had aseptic revision.Key findings:The patients with the diagnosis of PJI had an aHR for mortality of 2.15 (95% CI, 1.79-2.57; p ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/03/16/234424-periprosthetic-joint-infection.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Periprosthetic, Joint, Infection, Doubles, Long-Term, Mortality, Risk, After, Hip, Replacement:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/03/16/234424-periprosthetic-joint-infection.webp"><p>Researchers have found in a new study that Periprosthetic joint infection (PJI) following primary total hip arthroplasty (THA) is associated with a more than twofold increase in long-term mortality. Although complications after THA are uncommon, PJI can result in serious consequences, including repeat surgeries, prolonged hospital stays, extended antibiotic therapy, poor functional outcomes, and death. Evidence regarding its impact on medium- to long-term mortality has been limited and inconsistent, but this study highlights a significant association. The study was published in the <i>Journal of Infection</i> by Andreas W. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The study assessed data on 215,678 patients registered in the Swiss Joint Registry, of whom only 89,709 fulfilled the inclusion criteria. The distribution of male and female patients was equal in the sample population, as 51.3% of the participants were females. Additionally, the median age at which surgery was performed in the cohort was 69 years. The study followed the patients' progression for up to 10 years using Gompertz regression analysis to determine the adjusted hazard ratios (aHR) by accounting for various covariates like age, sex, BMI, and ASA physical status. Among this patient population, 745 patients (0.8%) developed PJI, whereas 2,752 patients (3.1%) had aseptic revision.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The patients with the diagnosis of PJI had an aHR for mortality of 2.15 (95% CI, 1.79-2.57; p<0.001), suggesting that the hazard for death was greater than twice that of patients without PJI. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">However, the patients who underwent aseptic revision surgery were not shown to have any increased hazard of death with an aHR of 0.92 (95% CI, 0.80-1.06; p=0.27). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The highest mortality hazard was that posed by Enterobacterales at 3.17 (95% CI, 2.09-4.83). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The other organism responsible for posing a great hazard was highly virulent Staphylococcus aureus, which was responsible for an aHR of 2.32 (95% CI, 1.65-3.27). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Cutibacterium acnes, which is normally considered to be a slow-growing and less virulent organism, had a surprisingly higher mortality hazard of 2.31 (95% CI, 1.20-4.45).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Similarly, coagulase-negative staphylococci (CoNS) were associated with an increase in risk (aHR 1.65; 95% CI, 1.16–2.35). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">On the contrary, there was no significant association between Streptococcal infections and increased mortality risk (aHR 1.24; 95% CI, 0.62–2.49).</p></li></ul><p dir="ltr">This study provides evidence on the significance of the influence of periprosthetic joint infection on mortality in patients who have undergone total hip arthroplasty. This is based on the increased hazard rate of mortality due to PJI, twice the risk of revision surgery, and the higher mortality risks associated with the infections of particular bacteria, such as Enterobacterales and S. aureus. It must also be noted that the mortality risks caused by C. acnes are not insignificant, despite being considered non-pathogenic.</p><p dir="ltr">Reference:</p><p dir="ltr">Widmer, A., Imhasly, N., Brand, C., Zdravkovi, V., Spoerri, A., Schmidlin, K., Wicki, M., Beck, M., Sommerstein, R., & for SIRIS and SWISSNOSO (2026). Increased long-term mortality of patients with prosthetic joint infection after primary total hip arthroplasty - A large observational cohort study. The Journal of infection, 92(2), 106689. <a href="https://doi.org/10.1016/j.jinf.2026.106689">https://doi.org/10.1016/j.jinf.2026.106689</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Most blood thinners safe to resume after flap surgery: Study</title>
<link>https://edusehat.com/en/most-blood-thinners-safe-to-resume-after-flap-surgery-study</link>
<guid>https://edusehat.com/en/most-blood-thinners-safe-to-resume-after-flap-surgery-study</guid>
<description><![CDATA[ Blood thinners are a common medication for much of the older adult population, prescribed to prevent blood clots that can cause adverse events like heart attack or stroke. They are often stopped prior to most surgeries because of the risk of bleeding. However, according to a new study from the University of Missouri School of Medicine, holding blood thinners for too long could jeopardize the surgery’s success.
The researchers examined the outcomes of 470 patients who underwent free flap reconstruction, a common technique in head and neck surgeries that involves transplanting tissue from one part of the body to another. Most blood thinners were not associated with increased complications.
“There’s no set standard to follow on managing blood thinners before and after surgery, and that’s because these studies just haven’t been done with modern medications,” said Patrick Tassone, one of the study authors. “Our research is a nice way to start the conversation and bridge these two viewpoints.”
Complications occurred in roughly 17% of patients overall, including those not taking blood thinners. The real risk came from stopping blood thinners too early before surgery and waiting too long to restart them afterward.
“We’re looking at two competing risks: too much clotting or too much bleeding,” said Megan Gillespie, the study’s lead author. “We found that the timing of stopping and restarting blood thinners around surgery matters. When these medications were held longer, patients experienced more complications. Our goal is to better define that sweet spot for restarting blood thinners, so patients are protected from excessive bleeding and dangerous clotting alike.”
The average wait time to resume blood thinners was five days after surgery, but this long length may not be necessary, Tassone said.
“In my personal practice, I’ve become more confident with resuming blood thinners after about 48 hours,” Tassone said. “I would not do this for patients who had a bleeding event. To be definitive about it would require more data and further research.”
Free flap reconstruction surgeries in the head and neck are complicated operations on parts of the body that have robust blood supply. Although 95% are successful, understanding how to prevent bleeding events and entering the operating room again is key.
“Setting a standard on how to manage blood thinners during the operative period will help make more surgeries a success,” Tassone said.Reference:M.Gillespie, D.Hood, A. K.Dwivedi, T.Galloway, and P.Tassone, “Bleeding, Clotting, and Flap Failures: Management of Blood Thinners in Head &amp; Neck Free Flaps,” The Laryngoscope (2026): 1–12, https://doi.org/10.1002/lary.70405.
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/20/265705-blood-thinner-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Most, blood, thinners, safe, resume, after, flap, surgery:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/20/265705-blood-thinner-50.webp"><p>Blood thinners are a common medication for much of the older adult population, prescribed to prevent <a href="https://medicaldialogues.in/topics/blood-clots">blood clots</a> that can cause adverse events like <a href="https://medicaldialogues.in/topics/heart-attack">heart attack </a>or <a href="https://medicaldialogues.in/topics/stroke">stroke</a>. They are often stopped prior to most surgeries because of the risk of bleeding. However, according to a new study from the University of Missouri School of Medicine, holding blood thinners for too long could jeopardize the surgery’s success.
</p><p>The researchers examined the outcomes of 470 patients who underwent free flap reconstruction, a common technique in head and neck surgeries that involves transplanting tissue from one part of the body to another. Most blood thinners were not associated with increased complications.
</p><p>“There’s no set standard to follow on managing blood thinners before and after surgery, and that’s because these studies just haven’t been done with modern medications,” said Patrick Tassone, one of the study authors. “Our research is a nice way to start the conversation and bridge these two viewpoints.”
</p><p>Complications occurred in roughly 17% of patients overall, including those not taking blood thinners. The real risk came from stopping blood thinners too early before surgery and waiting too long to restart them afterward.
</p><p>“We’re looking at two competing risks: too much clotting or too much bleeding,” said Megan Gillespie, the study’s lead author. “We found that the timing of stopping and restarting blood thinners around surgery matters. When these medications were held longer, patients experienced more complications. Our goal is to better define that sweet spot for restarting blood thinners, so patients are protected from excessive bleeding and dangerous clotting alike.”
</p><p>The average wait time to resume blood thinners was five days after surgery, but this long length may not be necessary, Tassone said.
</p><p>“In my personal practice, I’ve become more confident with resuming blood thinners after about 48 hours,” Tassone said. “I would not do this for patients who had a bleeding event. To be definitive about it would require more data and further research.”
</p><p>Free flap reconstruction surgeries in the head and neck are complicated operations on parts of the body that have robust blood supply. Although 95% are successful, understanding how to prevent bleeding events and entering the operating room again is key.
</p><p>“Setting a standard on how to manage blood thinners during the operative period will help make more surgeries a success,” Tassone said.</p><p>Reference:</p><p>M.Gillespie, D.Hood, A. K.Dwivedi, T.Galloway, and P.Tassone, “Bleeding, Clotting, and Flap Failures: Management of Blood Thinners in Head & Neck Free Flaps,” The Laryngoscope (2026): 1–12, https://doi.org/10.1002/lary.70405.
</p>]]> </content:encoded>
</item>

<item>
<title>Medical Device Development Tool reliable Durability Test for Resin&#45;Composite Systems: Study</title>
<link>https://edusehat.com/en/medical-device-development-tool-reliable-durability-test-for-resin-composite-systems-study</link>
<guid>https://edusehat.com/en/medical-device-development-tool-reliable-durability-test-for-resin-composite-systems-study</guid>
<description><![CDATA[ A recent study published in the journal of Dental Materials revealed that the proposed Medical Device Development Tool (MDDT)  is a consistent and dependable method for assessing the durability of resin-composite systems, demonstrating good reproducibility and reliability.Durability at the interface between tooth and restoration is critical for long-term dental health. Failures at this junction can lead to fractures, secondary decay, and the need for replacement procedures. To address this, this study developed an accelerated fatigue test that simulates the stresses dental restorations endure in real-life conditions.The method uses small dentin-composite disc specimens subjected to cyclic diametral compression. During testing, the load applied to each specimen increases progressively until failure occurs. To evaluate the reproducibility of the tool, three independent operators conducted the test separately, each using 30 specimens. Despite being performed independently, all 3 sets of experiments yielded remarkably consistent results. The mean number of cycles to failure was nearly identical across runs, and survival probability curves which is used to predict failure likelihood was closely aligned.These findings demonstrate a high level of reproducibility, which is essential for any testing method intended for widespread adoption. The consistency across operators suggests that the tool can be reliably used in different laboratories without significant variability in outcomes.In addition to performance consistency, this research examined whether minor differences in specimen geometry (size or thickness) affected the results. Their analysis found no strong correlation between these dimensional variations and the number of cycles to failure. This indicates that the test is robust and not overly sensitive to small manufacturing inconsistencies.The study also compared fatigue parameters derived from the new method with those reported in existing literature, particularly tests using beam specimens in 4-point bending setups. Also, several of the fatigue characteristics were in agreement, suggesting that the new disc-based method provides results consistent with established testing approaches while offering potential practical advantages.Overall, these development are significant for both researchers and manufacturers in the dental field. A reproducible and reliable testing tool can streamline the evaluation of new restorative materials, accelerate product development, and ultimately improve patient outcomes. As resin-composite restorations continue to be a mainstay in clinical practice, tools like this could play a key role in ensuring their long-term performance and durability.Reference:Larrañaga-Ordaz, D., Chen, R., VanHeel, B., Zhang, L., Lima, B. P., Chew, H. P., &amp; Fok, A. (2026). Reproducibility of accelerated fatigue test of dentin-composite discs under cyclic diametral compression. Dental Materials: Official Publication of the Academy of Dental Materials. https://doi.org/10.1016/j.dental.2026.03.157 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/29/299286-teeth-whitening-mouthwash-1680957881480-compressed-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Device, Development, Tool, reliable, Durability, Test, for, Resin-Composite, Systems:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/29/299286-teeth-whitening-mouthwash-1680957881480-compressed-1.webp"><p>A recent study published in the journal of <i>Dental Materials</i> revealed that the proposed Medical Device Development Tool (MDDT)  is a consistent and dependable method for assessing the durability of resin-composite systems, demonstrating good reproducibility and reliability.</p><p>Durability at the interface between tooth and restoration is critical for long-term dental health. Failures at this junction can lead to fractures, secondary decay, and the need for replacement procedures. To address this, this study developed an accelerated fatigue test that simulates the stresses dental restorations endure in real-life conditions.</p><p>The method uses small dentin-composite disc specimens subjected to cyclic diametral compression. During testing, the load applied to each specimen increases progressively until failure occurs. </p><p>To evaluate the reproducibility of the tool, three independent operators conducted the test separately, each using 30 specimens. Despite being performed independently, all 3 sets of experiments yielded remarkably consistent results. The mean number of cycles to failure was nearly identical across runs, and survival probability curves which is used to predict failure likelihood was closely aligned.</p><p>These findings demonstrate a high level of reproducibility, which is essential for any testing method intended for widespread adoption. The consistency across operators suggests that the tool can be reliably used in different laboratories without significant variability in outcomes.</p><p>In addition to performance consistency, this research examined whether minor differences in specimen geometry (size or thickness) affected the results. Their analysis found no strong correlation between these dimensional variations and the number of cycles to failure. This indicates that the test is robust and not overly sensitive to small manufacturing inconsistencies.</p><p>The study also compared fatigue parameters derived from the new method with those reported in existing literature, particularly tests using beam specimens in 4-point bending setups. Also, several of the fatigue characteristics were in agreement, suggesting that the new disc-based method provides results consistent with established testing approaches while offering potential practical advantages.</p><p>Overall, these development are significant for both researchers and manufacturers in the dental field. A reproducible and reliable testing tool can streamline the evaluation of new restorative materials, accelerate product development, and ultimately improve patient outcomes. As resin-composite restorations continue to be a mainstay in clinical practice, tools like this could play a key role in ensuring their long-term performance and durability.</p><p>Reference:</p><p>Larrañaga-Ordaz, D., Chen, R., VanHeel, B., Zhang, L., Lima, B. P., Chew, H. P., & Fok, A. (2026). Reproducibility of accelerated fatigue test of dentin-composite discs under cyclic diametral compression. Dental Materials: Official Publication of the Academy of Dental Materials. <a href="https://www.sciencedirect.com/science/article/abs/pii/S0109564126002356?via%3Dihub" rel="nofollow">https://doi.org/10.1016/j.dental.2026.03.157</a></p>]]> </content:encoded>
</item>

<item>
<title>Speed&#45;of&#45;Processing Cognitive Training Reduces Long&#45;Term Dementia Risk, suggests study</title>
<link>https://edusehat.com/en/speed-of-processing-cognitive-training-reduces-long-term-dementia-risk-suggests-study</link>
<guid>https://edusehat.com/en/speed-of-processing-cognitive-training-reduces-long-term-dementia-risk-suggests-study</guid>
<description><![CDATA[ A new study published in the journal of Alzheimer’s &amp; Dementia found that speed-of-processing cognitive training with booster sessions was associated with a significantly lower risk of dementia over 20 years. In contrast, memory and reasoning training did not significantly reduce dementia risk.The findings come from follow-up research tied to the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study, one of the largest and longest randomized controlled trials examining whether cognitive training can protect aging brains. While cognitive exercises have long been marketed as a way to sharpen memory and thinking, their very long-term impact on dementia risk has remained uncertain.This research linked data from ACTIVE participants to Medicare claims spanning 1999 to 2019. To be included in the analysis, participants had to be enrolled in traditional Medicare at the start of the study, which resulted in a final sample of 2,021 older adults. Dementia diagnoses were identified using the Chronic Conditions Warehouse algorithm, for detecting Alzheimer’s disease and related dementias (ADRD).The original ACTIVE trial randomly assigned participants into speed-of-processing training, memory training, reasoning training, or a control group. Some participants also received “booster” training sessions months and years after the initial program. The participants who completed at least one booster session had a 25% lower risk of being diagnosed with ADRD compared to controls. Statistically, their hazard ratio was 0.75, meaning their risk was significantly reduced. The confidence interval ran from 0.59 to 0.95, which indicated the finding was unlikely to be due to chance. In contrast, speed-trained participants who did not complete any booster sessions showed no protective benefit. Their hazard ratio was 1.01, with a confidence interval of 0.81 to 1.27, effectively no difference from the control group.Memory and reasoning training groups did not demonstrate a statistically significant reduction in dementia risk. Only the speed-focused training appeared to produce long-term protective effects. The study compared dementia risk across training groups using hazard ratios (HRs). A hazard ratio below 1.0 suggests reduced risk, while a value above 1.0 suggests increased risk. Only the speed-training group with booster sessions met that threshold. Overall, the findings suggest that improving the brain’s ability to quickly process information may delay the clinical diagnosis of Alzheimer’s and related dementias. Source:Coe, N. B., Miller, K. E. M., Sun, C., Taggert, E., Gross, A. L., Jones, R. N., Felix, C., Albert, M. S., Rebok, G. W., Marsiske, M., Ball, K. K., &amp; Willis, S. L. (2026). Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study. Alzheimer’s &amp; Dementia (New York, N. Y.), 12(1), e70197. https://doi.org/10.1002/trc2.70197 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/07/277387-dementia-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Speed-of-Processing, Cognitive, Training, Reduces, Long-Term, Dementia, Risk, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/07/277387-dementia-2.webp"><p>A new study published in the journal of<i> Alzheimer’s & Dementia</i> found that speed-of-processing cognitive training with booster sessions was associated with a significantly lower risk of dementia over 20 years. In contrast, memory and reasoning training did not significantly reduce dementia risk.</p><p>The findings come from follow-up research tied to the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study, one of the largest and longest randomized controlled trials examining whether cognitive training can protect aging brains. While cognitive exercises have long been marketed as a way to sharpen memory and thinking, their very long-term impact on dementia risk has remained uncertain.</p><p>This research linked data from ACTIVE participants to Medicare claims spanning 1999 to 2019. To be included in the analysis, participants had to be enrolled in traditional Medicare at the start of the study, which resulted in a final sample of 2,021 older adults. Dementia diagnoses were identified using the Chronic Conditions Warehouse algorithm, for detecting Alzheimer’s disease and related dementias (ADRD).</p><p>The original ACTIVE trial randomly assigned participants into speed-of-processing training, memory training, reasoning training, or a control group. Some participants also received “booster” training sessions months and years after the initial program. The participants who completed at least one booster session had a 25% lower risk of being diagnosed with ADRD compared to controls. </p><p>Statistically, their hazard ratio was 0.75, meaning their risk was significantly reduced. The confidence interval ran from 0.59 to 0.95, which indicated the finding was unlikely to be due to chance. In contrast, speed-trained participants who did not complete any booster sessions showed no protective benefit. Their hazard ratio was 1.01, with a confidence interval of 0.81 to 1.27, effectively no difference from the control group.</p><p>Memory and reasoning training groups did not demonstrate a statistically significant reduction in dementia risk. Only the speed-focused training appeared to produce long-term protective effects. The study compared dementia risk across training groups using hazard ratios (HRs). A hazard ratio below 1.0 suggests reduced risk, while a value above 1.0 suggests increased risk. </p><p>Only the speed-training group with booster sessions met that threshold. Overall, the findings suggest that improving the brain’s ability to quickly process information may delay the clinical diagnosis of Alzheimer’s and related dementias. </p><p>Source:</p><p>Coe, N. B., Miller, K. E. M., Sun, C., Taggert, E., Gross, A. L., Jones, R. N., Felix, C., Albert, M. S., Rebok, G. W., Marsiske, M., Ball, K. K., & Willis, S. L. (2026). Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study. Alzheimer’s & Dementia (New York, N. Y.), 12(1), e70197. <a href="https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70197" rel="nofollow">https://doi.org/10.1002/trc2.70197</a></p>]]> </content:encoded>
</item>

<item>
<title>Bombay HC Grants Relief to Sun Pharma, Restrains Use of PANTOZED Over Similarity with PANTOCID</title>
<link>https://edusehat.com/en/bombay-hc-grants-relief-to-sun-pharma-restrains-use-of-pantozed-over-similarity-with-pantocid</link>
<guid>https://edusehat.com/en/bombay-hc-grants-relief-to-sun-pharma-restrains-use-of-pantozed-over-similarity-with-pantocid</guid>
<description><![CDATA[ New Delhi: In a significant ruling on pharmaceutical trademark disputes, the Bombay High Court in Sun Pharma Laboratories Limited vs. Zawadi Healthcare Limited has granted interim relief in favor of Sun Pharma Laboratories Limited, restraining infringement of its registered trademark &quot;PANTOCID&quot; by the defendants using the mark &quot;PANTOZED-40&quot;.The case background stems from a commercial intellectual property suit filed by Sun Pharma alleging infringement and passing off against Zawadi Healthcare Limited and another defendant.Sun Pharma asserted proprietary rights over its registered trademark “PANTOCID”, originally adopted in 1998 and widely used for medicines containing Pantoprazole, a drug used to treat acid-related gastrointestinal conditions. The company demonstrated long-standing use, significant sales turnover, and promotional expenditure to establish goodwill and reputation. The dispute arose in January 2023 when Sun Pharma discovered that the defendants were marketing a similar drug under the mark “PANTOZED-40”, manufactured in India and exported to Kenya, without seeking trademark registration in India.The petitioner (plaintiff), Sun Pharma, argued that it is the prior adopter and registered proprietor of the trademark “PANTOCID” and that the defendants’ mark “PANTOZED-40” is deceptively similar, particularly as both marks are derived from the same molecule “Pantoprazole” and are used for identical therapeutic purposes. It was contended that the defendants’ act of manufacturing in India and exporting the product constitutes infringement under Sections 29(6) and 56 of the Trade Marks Act, 1999.The plaintiff further argued that the combination of “PANTO” with “CID” forms a distinctive mark and that the defendants cannot claim that the prefix “PANTO” is generic to avoid liability. It also rejected the defence that the mark was based on International Non-Proprietary Names (INN), stating that its trademark was registered prior to the introduction of such restrictions and therefore enjoys statutory protection.On the other hand, the defendants strongly opposed the claim, arguing that the plaintiff had suppressed material facts, including opposition proceedings related to a subsequent trademark application. They contended that “PANTO” is derived from the generic drug Pantoprazole and is widely used across the pharmaceutical industry, with numerous trademarks containing the same prefix.The defendants argued that no monopoly can be claimed over such a generic component and highlighted the existence of thousands of similar marks on the registry. They also submitted that their mark “PANTOZED” is registered in Kenya and is structurally distinct. Additionally, they questioned the jurisdiction of the Bombay High Court and argued that there was no deceptive similarity when the marks are considered as a whole.After examining the rival submissions, statutory provisions, and judicial precedents, the Court made several key observations. It held that the plaintiff had successfully established prior adoption and use of the registered trademark “PANTOCID” since 1998.The Court clarified that although the prefix “PANTO” may be derived from a generic molecule, the distinctive combination with “CID” is entitled to protection.Also Read: Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma&#039;s BEVETEXIt further noted that the defendants failed to provide any explanation for adopting a similar mark and that mere existence of similar marks on the register does not prove widespread usage or negate infringement. Importantly, the Court emphasized that trademarks must be compared as a whole and found that “PANTOCID” and “PANTOZED” are phonetically similar, especially considering that “CID” and “ZED” sound alike, increasing the likelihood of confusion.The Court also underscored that in pharmaceutical products, even minimal confusion must be avoided due to potential risks to public health. It held that manufacturing in India for export purposes constitutes “use” of a trademark under the law, thereby bringing the defendants’ activities within the scope of infringement.Also Read: Delhi HC Bars Dr Reddy&#039;s from Selling Olymviq Over Similarity with Novo Nordisk&#039;s OzempicHowever, the Court declined to grant relief on the ground of passing off, noting the absence of sufficient evidence to establish misrepresentation or damage to goodwill in India.Concluding the matter, the Court ruled in favour of the plaintiff and granted an interim injunction against trademark infringement. The operative part of the order states:“In view of above, Interim Application is allowed in terms of prayer clause (a).”To view the court order, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/06/sunpharmalaboratorieslimitedvszawadihealthcarelimitedon1april2026-340007.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/31/324777-bombay-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bombay, Grants, Relief, Sun, Pharma, Restrains, Use, PANTOZED, Over, Similarity, with, PANTOCID</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/31/324777-bombay-high-court.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> In a significant ruling on pharmaceutical trademark disputes, the Bombay High Court in Sun Pharma Laboratories Limited vs. Zawadi Healthcare Limited has granted interim relief in favor of Sun Pharma Laboratories Limited, restraining infringement of its registered trademark "PANTOCID" by the defendants using the mark "PANTOZED-40".</p></div><div class="pasted-from-word-wrapper"><p>The case background stems from a commercial intellectual property suit filed by Sun Pharma alleging infringement and passing off against Zawadi Healthcare Limited and another defendant.</p><p>Sun Pharma asserted proprietary rights over its registered trademark “PANTOCID”, originally adopted in 1998 and widely used for medicines containing Pantoprazole, a drug used to treat acid-related gastrointestinal conditions. The company demonstrated long-standing use, significant sales turnover, and promotional expenditure to establish goodwill and reputation. The dispute arose in January 2023 when Sun Pharma discovered that the defendants were marketing a similar drug under the mark “PANTOZED-40”, manufactured in India and exported to Kenya, without seeking trademark registration in India.</p><p>The petitioner (plaintiff), Sun Pharma, argued that it is the prior adopter and registered proprietor of the trademark “PANTOCID” and that the defendants’ mark “PANTOZED-40” is deceptively similar, particularly as both marks are derived from the same molecule “Pantoprazole” and are used for identical therapeutic purposes. It was contended that the defendants’ act of manufacturing in India and exporting the product constitutes infringement under Sections 29(6) and 56 of the Trade Marks Act, 1999.</p><p>The plaintiff further argued that the combination of “PANTO” with “CID” forms a distinctive mark and that the defendants cannot claim that the prefix “PANTO” is generic to avoid liability. It also rejected the defence that the mark was based on International Non-Proprietary Names (INN), stating that its trademark was registered prior to the introduction of such restrictions and therefore enjoys statutory protection.</p><p>On the other hand, the defendants strongly opposed the claim, arguing that the plaintiff had suppressed material facts, including opposition proceedings related to a subsequent trademark application. They contended that “PANTO” is derived from the generic drug Pantoprazole and is widely used across the pharmaceutical industry, with numerous trademarks containing the same prefix.</p><p>The defendants argued that no monopoly can be claimed over such a generic component and highlighted the existence of thousands of similar marks on the registry. They also submitted that their mark “PANTOZED” is registered in Kenya and is structurally distinct. Additionally, they questioned the jurisdiction of the Bombay High Court and argued that there was no deceptive similarity when the marks are considered as a whole.</p><p>After examining the rival submissions, statutory provisions, and judicial precedents, the Court made several key observations. It held that the plaintiff had successfully established prior adoption and use of the registered trademark “PANTOCID” since 1998.</p><p>The Court clarified that although the prefix “PANTO” may be derived from a generic molecule, the distinctive combination with “CID” is entitled to protection.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/intas-pharma-barred-from-using-cancer-drug-brand-bevatas-similar-to-sun-pharmas-bevetex-167885">Also Read: Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX</a></div><p>It further noted that the defendants failed to provide any explanation for adopting a similar mark and that mere existence of similar marks on the register does not prove widespread usage or negate infringement. Importantly, the Court emphasized that trademarks must be compared as a whole and found that “PANTOCID” and “PANTOZED” are phonetically similar, especially considering that “CID” and “ZED” sound alike, increasing the likelihood of confusion.</p><p>The Court also underscored that in pharmaceutical products, even minimal confusion must be avoided due to potential risks to public health. It held that manufacturing in India for export purposes constitutes “use” of a trademark under the law, thereby bringing the defendants’ activities within the scope of infringement.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/delhi-hc-bars-dr-reddys-from-selling-olymviq-over-similarity-with-novo-nordisks-ozempic-167462">Also Read: Delhi HC Bars Dr Reddy's from Selling Olymviq Over Similarity with Novo Nordisk's Ozempic</a></div><p>However, the Court declined to grant relief on the ground of passing off, noting the absence of sufficient evidence to establish misrepresentation or damage to goodwill in India.</p><p>Concluding the matter, the Court ruled in favour of the plaintiff and granted an interim injunction against trademark infringement. The operative part of the order states:</p><p>“In view of above, Interim Application is allowed in terms of prayer clause (a).”</p><p><b><i>To view the court order, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/sunpharmalaboratorieslimitedvszawadihealthcarelimitedon1april2026-340007.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/06/sunpharmalaboratorieslimitedvszawadihealthcarelimitedon1april2026-340007.pdf</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Study of robotic bronchoscopy suggests it&amp;apos;s safer, faster path to diagnosing lung cancer</title>
<link>https://edusehat.com/en/study-of-robotic-bronchoscopy-suggests-its-safer-faster-path-to-diagnosing-lung-cancer</link>
<guid>https://edusehat.com/en/study-of-robotic-bronchoscopy-suggests-its-safer-faster-path-to-diagnosing-lung-cancer</guid>
<description><![CDATA[ As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the malignant minority represent the leading cause of cancer death for both men and women. Robotic bronchoscopy may provide a less invasive and more precise approach to diagnosing lung cancer, suggests a five-year, multisite Mayo Clinic study published in Mayo Clinic Proceedings.
The study evaluated 2,115 lung lesions in 1,904 patients across Mayo Clinic campuses in Jacksonville; Phoenix; and Rochester, Minnesota, between 2019 and 2024. Researchers reported 85% sensitivity for malignancy and 76.9% accuracy, or a strict diagnostic yield, under newly standardized national criteria. They also reported a complication rate of 2.8%.
Since adoption of robotic bronchoscopy, the proportion of lung cancers diagnosed at an early stage at Mayo Clinic increased from 46% in 2019 to nearly 69% by mid-2024. While lung cancer was caught earlier, diagnoses at advanced stages decreased from 54% to 31% in 2024.
&quot;Lung cancer survival depends heavily on early detection,&quot; says lead author Sebastian Fernandez-Bussy, M.D., the James C. and Sarah K. Kennedy Dean of Research and a pulmonary and critical care physician at Mayo Clinic in Florida. &quot;Technologies that allow us to diagnose and even treat disease earlier — and with fewer complications — can help improve survival.&quot;
Lung cancer generally starts with a suspicious pulmonary nodule. When that is detected through screenings, a lung biopsy may be required to confirm the diagnosis.
Shape-sensing robotic-assisted bronchoscopy, cleared by the Food and Drug Administration in 2019, allows physicians to perform as many biopsies needed to be able to gather enough tissue for diagnosis and molecular markers that will further guide an individualized treatment approach. This technology provides physicians the precision and stability to sample multiple suspicious nodules throughout both lungs. By adding endobronchial ultrasound, physicians also can perform precise staging for the immune system glands, or mediastinal lymph nodes, all in one procedure.
When combined with real-time 3D imaging or cone beam CT scans, the system also helps physicians confirm the precise placement of the small tool within lesions before biopsy.
&quot;This technology really has been a game-changer for diagnosing lung cancer earlier,&quot; Dr. Fernandez-Bussy says.
In this study, the researchers reported that 56% of lesions sampled were malignant. Twenty-one percent were definitively benign, and 23% were nondiagnostic under strict criteria.
The study applied updated strict diagnostic yield definitions from the American Thoracic Society and American College of Chest Physicians, which exclude certain follow-up data that previously inflated reported success rates.
Robotic-assisted bronchoscopy platforms are increasingly being paired with endobronchial therapies, including pulsed electric field ablation, a minimally invasive treatment for patients who are not eligible for surgery or radiation. Mayo Clinic has begun to offer diagnosis, staging and treatment during a single procedure.
&quot;I call this the &#039;single anesthetic lung surgery pathway,&#039; and it means fewer trips to the hospital, less time away from family and shorter recovery times,&quot; says co-author Janani Reisenauer, M.D., chair of thoracic surgery at Mayo Clinic in Rochester, Minnesota, who has been involved in clinical trials that deliver cancer treatment within minutes of diagnosis.
Five-year survival for localized lung cancer approaches 67%, compared with approximately 12% for metastatic disease. National guidelines recommend timely evaluation and treatment after diagnosis. As lung cancer screening expands and more nodules are detected, demand for precise, minimally invasive diagnostic approaches is expected to grow.
This study illustrates the impact of research with patient-contributed biospecimens, and their associated data, in driving discoveries and advancing cures. Mayo Clinic&#039;s Bioresource initiative is now accelerating the pace of such discoveries by expanding researcher access to valuable biospecimens.Reference:Fernandez-Bussy S, Yu Lee-Mateus A, Abia-Trujillo D ... 2000 Peripheral Pulmonary Lesions Sampled by Shape-Sensing Robotic-Assisted Bronchoscopy and Mobile Cone-Beam Computed Tomography,Mayo Clinic Proceedings, DOI:10.1016/j.mayocp.2025.11.015  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/04/15/207505-lung-cancer.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, robotic, bronchoscopy, suggests, its, safer, faster, path, diagnosing, lung, cancer</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/04/15/207505-lung-cancer.webp"><p>As <a href="https://medicaldialogues.in/topics/lung-cancer">lung cancer </a>screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the malignant minority represent the leading cause of <a href="https://medicaldialogues.in/topics/cancer">cancer </a>death for both men and women. Robotic bronchoscopy may provide a less invasive and more precise approach to diagnosing lung cancer, suggests a five-year, multisite Mayo Clinic study published in <i>Mayo Clinic Proceedings.
</i></p><p>The study evaluated 2,115 lung lesions in 1,904 patients across Mayo Clinic campuses in Jacksonville; Phoenix; and Rochester, Minnesota, between 2019 and 2024. Researchers reported 85% sensitivity for malignancy and 76.9% accuracy, or a strict diagnostic yield, under newly standardized national criteria. They also reported a complication rate of 2.8%.
</p><p>Since adoption of robotic bronchoscopy, the proportion of lung cancers diagnosed at an early stage at Mayo Clinic increased from 46% in 2019 to nearly 69% by mid-2024. While lung cancer was caught earlier, diagnoses at advanced stages decreased from 54% to 31% in 2024.
</p><p>"Lung cancer survival depends heavily on early detection," says lead author Sebastian Fernandez-Bussy, M.D., the James C. and Sarah K. Kennedy Dean of Research and a pulmonary and critical care physician at Mayo Clinic in Florida. "Technologies that allow us to diagnose and even treat disease earlier — and with fewer complications — can help improve survival."
</p><p>Lung cancer generally starts with a suspicious pulmonary nodule. When that is detected through screenings, a lung biopsy may be required to confirm the diagnosis.
</p><p>Shape-sensing robotic-assisted bronchoscopy, cleared by the Food and Drug Administration in 2019, allows physicians to perform as many biopsies needed to be able to gather enough tissue for diagnosis and molecular markers that will further guide an individualized treatment approach. This technology provides physicians the precision and stability to sample multiple suspicious nodules throughout both lungs. By adding endobronchial ultrasound, physicians also can perform precise staging for the immune system glands, or mediastinal lymph nodes, all in one procedure.
</p><p>When combined with real-time 3D imaging or cone beam CT scans, the system also helps physicians confirm the precise placement of the small tool within lesions before biopsy.
</p><p>"This technology really has been a game-changer for diagnosing lung cancer earlier," Dr. Fernandez-Bussy says.
</p><p>In this study, the researchers reported that 56% of lesions sampled were malignant. Twenty-one percent were definitively benign, and 23% were nondiagnostic under strict criteria.
</p><p>The study applied updated strict diagnostic yield definitions from the American Thoracic Society and American College of Chest Physicians, which exclude certain follow-up data that previously inflated reported success rates.
</p><p>Robotic-assisted bronchoscopy platforms are increasingly being paired with endobronchial therapies, including pulsed electric field ablation, a minimally invasive treatment for patients who are not eligible for surgery or radiation. Mayo Clinic has begun to offer diagnosis, staging and treatment during a single procedure.
</p><p>"I call this the 'single anesthetic lung surgery pathway,' and it means fewer trips to the hospital, less time away from family and shorter recovery times," says co-author Janani Reisenauer, M.D., chair of thoracic surgery at Mayo Clinic in Rochester, Minnesota, who has been involved in clinical trials that deliver cancer treatment within minutes of diagnosis.
</p><p>Five-year survival for localized lung cancer approaches 67%, compared with approximately 12% for metastatic disease. National guidelines recommend timely evaluation and treatment after diagnosis. As lung cancer screening expands and more nodules are detected, demand for precise, minimally invasive diagnostic approaches is expected to grow.
</p><p>This study illustrates the impact of research with patient-contributed biospecimens, and their associated data, in driving discoveries and advancing cures. Mayo Clinic's Bioresource initiative is now accelerating the pace of such discoveries by expanding researcher access to valuable biospecimens.</p><p>Reference:</p><p>Fernandez-Bussy S, Yu Lee-Mateus A, Abia-Trujillo D ... 2000 Peripheral Pulmonary Lesions Sampled by Shape-Sensing Robotic-Assisted Bronchoscopy and Mobile Cone-Beam Computed Tomography,Mayo Clinic Proceedings, DOI:10.1016/j.mayocp.2025.11.015 </p>]]> </content:encoded>
</item>

<item>
<title>Oral Vaccination of Dogs: Systematic review Finds a Strategy for Rabies Elimination</title>
<link>https://edusehat.com/en/oral-vaccination-of-dogs-systematic-review-finds-a-strategy-for-rabies-elimination</link>
<guid>https://edusehat.com/en/oral-vaccination-of-dogs-systematic-review-finds-a-strategy-for-rabies-elimination</guid>
<description><![CDATA[ A recent systematic review concludes that integrating oral immunization into national health frameworks as a localized pilot could finally achieve the 70% dog immunity threshold necessary to eliminate the 59,000 annual deaths associated with the 35% global rabies burden found in India, according to a recent study published in the Indian Journal of Community Medicine in February 2025.Rabies remains a critical public health threat in India, yet achieving necessary vaccination targets is currently impeded by the logistical impossibility of traditional parenteral methods for the nation&#039;s 6.2 crore free-roaming dogs (FRDs). Addressing this clinical gap, Dr. Haripriya H and associates from the Department of Community and Family Medicine at the All India Institute of Medical Sciences (AIIMS) Patna aimed to evaluate the feasibility of the oral vaccination of dogs (OVD) strategy by reviewing previous international field trials and its potential integration into the National Action Plan for Rabies Elimination (NAPRE). Therefore, the systematic review employed a rigorous methodology involving a comprehensive PubMed database search using specific Boolean operators to identify 220 relevant publications, which were subsequently refined to 19 core full-text articles focusing on the practical adoption and outcomes of field trials over the last ten years. The study design prioritized assessing OVD efficacy within roaming dog populations, examining endpoints such as bait acceptance rates and vaccination coverage without the need for the exclusionary and labor-intensive physical restraint required in traditional Capture-Vaccinate-Release (CVR) models.Key Clinical Findings of the Systematic Review Include:Enhanced Coverage: In the study OVD consistently reached inaccessible, aggressive, or shy dog populations that parenteral methods often miss, ensuring a more robust barrier against viral transmission. Exceptional Acceptance: International evidence suggests that bait acceptance is remarkably high among roaming dogs, with success rates documented as high as 97.2% in Haiti and 92.9% in Thailand. Economic Efficiency: Oral distribution models outperformed traditional methods in cost-effectiveness, significantly reducing the financial and human resource burden compared to labor-intensive capture campaigns. Scalable Impact: Evidence shows that combining oral baits with existing door-to-door parenteral strategies resulted in superior total population coverage, which is essential for maintaining the 70% immunity level required for disease eradication. Operational Ease: OVD requires significantly less specialized training and fewer personnel than CVR, making it a more viable strategy for large-scale national implementation in resource-limited settings.The results suggest that implementing mass oral vaccination programs can provide a sustainable, cost-effective pathway to eliminate dog-mediated rabies, potentially managing the 6.2 crore free-roaming dog population more effectively than a CVR campaign that would require 1.1 million vaccinators, thereby moving India closer to its target of zero human rabies deaths by 2030.Thus, the study concludes clinicians and public health authorities may find value in supporting the integration of oral baiting as a complementary tool alongside traditional parenteral vaccines to enhance community-wide immunity.While the study acknowledges that factors such as maintaining a consistent cold chain and ensuring the safety of live-recombinant vaccines for non-target species must be addressed, future research focusing on locally produced, cost-effective bait materials could further optimize this promising strategy for diverse geographic regions.ReferencePrathapan A, Debbarma S, Haripriya H, Pandey S. Oral vaccination of dogs in India as a strategy for elimination of rabies: Scope of implementation. Indian J Community Med 2025;50:413-6. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/19/328447-anti-rabies-clinics.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Oral, Vaccination, Dogs:, Systematic, review, Finds, Strategy, for, Rabies, Elimination</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/19/328447-anti-rabies-clinics.webp"><div class="pasted-from-word-wrapper"><p>A recent systematic review concludes that integrating <a href="https://medicaldialogues.in/generics/oral-polio-vaccine-opv-2726223">oral immunization </a>into national health frameworks as a localized pilot could finally achieve the 70% dog immunity threshold necessary to eliminate the 59,000 annual deaths associated with the 35% global rabies burden found in India, according to a recent study published in the <i>Indian Journal of Community Medicine</i> in February 2025.</p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Rabies remains a critical public health threat in India, yet achieving necessary vaccination targets is currently impeded by the logistical impossibility of traditional parenteral methods for the nation's 6.2 crore free-roaming dogs (FRDs). Addressing this clinical gap, Dr. Haripriya H and associates from the <i>Department of Community and Family Medicine at the All India Institute of Medical Sciences (AIIMS) Patna </i>aimed to evaluate the feasibility of the oral vaccination of dogs (OVD) strategy by reviewing previous international field trials and its potential integration into the National Action Plan for Rabies Elimination (NAPRE). </p><p dir="ltr">Therefore, the systematic review employed a rigorous methodology involving a comprehensive PubMed database search using specific Boolean operators to identify 220 relevant publications, which were subsequently refined to 19 core full-text articles focusing on the practical adoption and outcomes of field trials over the last ten years. The study design prioritized assessing OVD efficacy within roaming dog populations, examining endpoints such as bait acceptance rates and vaccination coverage without the need for the exclusionary and labor-intensive physical restraint required in traditional Capture-Vaccinate-Release (CVR) models.</p><p dir="ltr"><b>Key Clinical Findings of the Systematic Review Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Enhanced Coverage:</b> In the study OVD consistently reached inaccessible, aggressive, or shy dog populations that parenteral methods often miss, ensuring a more robust barrier against viral transmission. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Exceptional Acceptance: </b>International evidence suggests that bait acceptance is remarkably high among roaming dogs, with success rates documented as high as 97.2% in Haiti and 92.9% in Thailand. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Economic Efficiency:</b> Oral distribution models outperformed traditional methods in cost-effectiveness, significantly reducing the financial and human resource burden compared to labor-intensive capture campaigns. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Scalable Impact:</b> Evidence shows that combining oral baits with existing door-to-door parenteral strategies resulted in superior total population coverage, which is essential for maintaining the 70% immunity level required for disease eradication. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Operational Ease: </b>OVD requires significantly less specialized training and fewer personnel than CVR, making it a more viable strategy for large-scale national implementation in resource-limited settings.</p></li></ul><p dir="ltr">The results suggest that implementing mass oral <a href="https://medicaldialogues.in/generics/rabies-vaccine-2726068">vaccination</a> programs can provide a sustainable, cost-effective pathway to eliminate dog-mediated <a href="https://medicaldialogues.in/generics/rabies-vaccine-2726068">rabies</a>, potentially managing the 6.2 crore free-roaming dog population more effectively than a CVR campaign that would require 1.1 million vaccinators, thereby moving India closer to its target of zero human rabies deaths by 2030.</p><p dir="ltr">Thus, the study concludes clinicians and public health authorities may find value in supporting the integration of oral baiting as a complementary tool alongside traditional parenteral vaccines to enhance community-wide immunity.</p><p dir="ltr">While the study acknowledges that factors such as maintaining a consistent cold chain and ensuring the safety of live-recombinant vaccines for non-target species must be addressed, future research focusing on locally produced, cost-effective bait materials could further optimize this promising strategy for diverse geographic regions.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Prathapan A, Debbarma S, Haripriya H, Pandey S. Oral vaccination of dogs in India as a strategy for elimination of rabies: Scope of implementation. Indian J Community Med 2025;50:413-6.</p><div><br></div></div><div class="pasted-from-word-wrapper"><p><br></p></div><div class="pasted-from-word-wrapper"><br></div><div class="pasted-from-word-wrapper"><p><br></p><br></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report</title>
<link>https://edusehat.com/en/pharma-firms-seek-50-price-hike-in-key-cancer-drugs-including-carboplatin-cisplatin-approach-nppa-report</link>
<guid>https://edusehat.com/en/pharma-firms-seek-50-price-hike-in-key-cancer-drugs-including-carboplatin-cisplatin-approach-nppa-report</guid>
<description><![CDATA[ New Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin, citing a sharp surge in platinum prices that has made production financially unviable, according to a recent media report by The Economic Times.Pharmaceutical companies have approached the National Pharmaceutical Pricing Authority (NPPA), warning that without a price revision, the supply of these critical chemotherapy drugs could be at risk. Platinum, a core raw material used in these medicines, has nearly doubled in price over the past six months, rising from around ₹3,869 per gram to about ₹8,000 per gram.The current ceiling prices of these drugs remain tightly regulated. For instance, carboplatin is priced at about ₹61.10 per 10 mg/ml vial, while cisplatin ranges between ₹70 and ₹300 depending on strength. Industry players argue that these price caps have not kept pace with input cost inflation, making manufacturing unsustainable.Also Read: Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma&#039;s BEVETEXMajor Indian pharmaceutical companies, including Cipla, Dr. Reddy’s Laboratories, Zydus Lifesciences, Emcure, Intas, Fresenius and Hetero, are among those producing these drugs. Industry executives have cautioned that failure to revise prices could impact both profitability and availability of these essential treatments.Platinum-based drugs form the backbone of chemotherapy for several cancers, including head and neck, breast, and gastrointestinal cancers. Despite being among the most affordable and widely used cancer treatments, their low pricing has created a paradox—while they remain accessible, manufacturers face limited incentives to continue production due to rising costs.These medicines have been under price control since 2013, and price increases have remained modest. For example, carboplatin prices have risen only about 21.7% since 2015, translating into a low annual growth rate, far below the recent spike in raw material costs.The Economic Times reports that the market for platinum-based cancer drugs in India is estimated at around ₹110 crore and is growing at about 14% annually, although actual usage may be significantly higher due to institutional and hospital-based sales.Industry stakeholders have urged government intervention, noting that a similar one-time price increase for essential medicines facing viability issues had previously been recommended by a NITI Aayog committee.Also Read: Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/07/240457-medicine-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pharma, Firms, Seek, 50, Price, Hike, Key, Cancer, Drugs, Including, Carboplatin, Cisplatin, Approach, NPPA:, Report</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/07/240457-medicine-2.webp"><p><b>New Delhi:</b> Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin, citing a sharp surge in platinum prices that has made production financially unviable, according to a recent media report by The Economic Times.</p><div class="pasted-from-word-wrapper"><p>Pharmaceutical companies have approached the National Pharmaceutical Pricing Authority (NPPA), warning that without a price revision, the supply of these critical chemotherapy drugs could be at risk. Platinum, a core raw material used in these medicines, has nearly doubled in price over the past six months, rising from around ₹3,869 per gram to about ₹8,000 per gram.</p><p>The current ceiling prices of these drugs remain tightly regulated. For instance, carboplatin is priced at about ₹61.10 per 10 mg/ml vial, while cisplatin ranges between ₹70 and ₹300 depending on strength. Industry players argue that these price caps have not kept pace with input cost inflation, making manufacturing unsustainable.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/intas-pharma-barred-from-using-cancer-drug-brand-bevatas-similar-to-sun-pharmas-bevetex-167885">Also Read: Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX</a></div></div><p>Major Indian pharmaceutical companies, including Cipla, Dr. Reddy’s Laboratories, Zydus Lifesciences, Emcure, Intas, Fresenius and Hetero, are among those producing these drugs. Industry executives have cautioned that failure to revise prices could impact both profitability and availability of these essential treatments.</p><p>Platinum-based drugs form the backbone of chemotherapy for several cancers, including head and neck, breast, and gastrointestinal cancers. Despite being among the most affordable and widely used cancer treatments, their low pricing has created a paradox—while they remain accessible, manufacturers face limited incentives to continue production due to rising costs.</p><p>These medicines have been under price control since 2013, and price increases have remained modest. For example, carboplatin prices have risen only about 21.7% since 2015, translating into a low annual growth rate, far below the recent spike in raw material costs.</p><p><a href="https://pharma.economictimes.indiatimes.com/news/pharma-industry/cancer-drug-makers-seek-50-price-hike-as-platinum-surge-hits-production-viability/130048844" rel="nofollow">The Economic Times</a> reports that the market for platinum-based cancer drugs in India is estimated at around ₹110 crore and is growing at about 14% annually, although actual usage may be significantly higher due to institutional and hospital-based sales.</p><p>Industry stakeholders have urged government intervention, noting that a similar one-time price increase for essential medicines facing viability issues had previously been recommended by a NITI Aayog committee.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/bristol-myers-squibb-wins-usfda-approval-for-opdivo-combo-in-hodgkin-lymphoma-167132">Also Read: Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Young Men With Prediabetes exhibit High Burden of Hypogonadism and ED, suggests study</title>
<link>https://edusehat.com/en/young-men-with-prediabetes-exhibit-high-burden-of-hypogonadism-and-ed-suggests-study</link>
<guid>https://edusehat.com/en/young-men-with-prediabetes-exhibit-high-burden-of-hypogonadism-and-ed-suggests-study</guid>
<description><![CDATA[ Researchers have found in a new study that Young males with prediabetes have a significant prevalence of Hypogonadism and Erectile Dysfunction. This highlights the need for early screening and timely intervention to prevent adverse health outcomes.Prediabetes is associated with sexual health complications, including erectile dysfunction (ED) and hypogonadism. This study aimed to evaluate the prevalence of low testosterone, hypogonadism, and ED in men with prediabetes. It also explored the correlation of hypogonadism with indices of metabolic syndrome (MetS). This cross-sectional investigation was undertaken at a public teaching institution in northern India. It sampled 103 males with prediabetes and 103 euglycemic controls aged between 18 and 50 years. The participants were assessed using the qADAM questionnaire, the IIEF-5 scale, and total testosterone levels. Analyses were conducted using standard statistical tests. The mean age of participants in the prediabetes and euglycemic groups was comparable (35.28 ± 8.22 vs. 35.53 ± 8.69 years; P = 0.831). However, individuals with prediabetes exhibited significantly higher fasting blood glucose levels (100.57 mg/dL vs. 89.38 mg/dL; P = 0.001) and HbA1c values (6.02% vs. 5.13%; P = 0.001), along with a higher prevalence of MetS (32.0% vs. 13.6%; P = 0.002). Moreover, ED and hypogonadism were frequent among men with prediabetes compared with their normoglycemic counterparts (72.8% vs. 51.5%; P = 0.002 and 38.8% vs. 25.2%; P = 0.032, respectively). Additionally, 53.4% patients with prediabetes had low testosterone levels. (177.11 ± 150.62 ng/dl). Normogonadotropic hypogonadism was the most prevalent subtype.There is a substantial burden of hypogonadism and ED among young males with prediabetes, underscoring the importance of early detection and timely intervention to mitigate adverse outcomes.Reference:Gupta, M., Kaur, J., Singh, R., Singla, M., Garg, S., Singh, K., &amp; Gupta, H. (2026). Assessment of Hypogonadism and Erectile Dysfunction in Males with Prediabetes: A Cross-Sectional Study from North India. Indian Journal of Endocrinology and Metabolism, 30(1), 45–50. https://doi.org/10.4103/ijem.ijem_842_25Keywords:Young Men, Prediabetes,  exhibit, High Burden, Hypogonadism, ED, suggests, study, Gupta, M., Kaur, J., Singh, R., Singla, M., Garg, S., Singh, K., &amp; Gupta,  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339826-images-2026-04-05t221010381.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Young, Men, With, Prediabetes, exhibit, High, Burden, Hypogonadism, and, ED, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339826-images-2026-04-05t221010381.webp"><p>Researchers have found in a new study that Young males with prediabetes have a significant prevalence of Hypogonadism and Erectile Dysfunction. This highlights the need for early screening and timely intervention to prevent adverse health outcomes.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Prediabetes is associated with sexual health complications, including erectile dysfunction (ED) and hypogonadism. This study aimed to evaluate the prevalence of low testosterone, hypogonadism, and ED in men with prediabetes. It also explored the correlation of hypogonadism with indices of metabolic syndrome (MetS). This cross-sectional investigation was undertaken at a public teaching institution in northern India. It sampled 103 males with prediabetes and 103 euglycemic controls aged between 18 and 50 years. The participants were assessed using the qADAM questionnaire, the IIEF-5 scale, and total testosterone levels. Analyses were conducted using standard statistical tests. The mean age of participants in the prediabetes and euglycemic groups was comparable (35.28 ± 8.22 vs. 35.53 ± 8.69 years; P = 0.831). However, individuals with prediabetes exhibited significantly higher fasting blood glucose levels (100.57 mg/dL vs. 89.38 mg/dL; P = 0.001) and HbA1c values (6.02% vs. 5.13%; P = 0.001), along with a higher prevalence of MetS (32.0% vs. 13.6%; P = 0.002). Moreover, ED and hypogonadism were frequent among men with prediabetes compared with their normoglycemic counterparts (72.8% vs. 51.5%; P = 0.002 and 38.8% vs. 25.2%; P = 0.032, respectively). Additionally, 53.4% patients with prediabetes had low testosterone levels. (177.11 ± 150.62 ng/dl). Normogonadotropic hypogonadism was the most prevalent subtype.</p><p dir="ltr">There is a substantial burden of hypogonadism and ED among young males with prediabetes, underscoring the importance of early detection and timely intervention to mitigate adverse outcomes.</p><p dir="ltr">Reference:</p><p dir="ltr">Gupta, M., Kaur, J., Singh, R., Singla, M., Garg, S., Singh, K., & Gupta, H. (2026). Assessment of Hypogonadism and Erectile Dysfunction in Males with Prediabetes: A Cross-Sectional Study from North India. Indian Journal of Endocrinology and Metabolism, 30(1), 45–50. <a href="https://doi.org/10.4103/ijem.ijem_842_25">https://doi.org/10.4103/ijem.ijem_842_25</a></p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Young Men, Prediabetes,  exhibit, High Burden, Hypogonadism, ED, suggests, study, Gupta, M., Kaur, J., Singh, R., Singla, M., Garg, S., Singh, K., & Gupta, </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Aurobindo Pharma Transfers Domestic Branded Business to Auropharm for Rs 143.21 Crore</title>
<link>https://edusehat.com/en/aurobindo-pharma-transfers-domestic-branded-business-to-auropharm-for-rs-14321-crore</link>
<guid>https://edusehat.com/en/aurobindo-pharma-transfers-domestic-branded-business-to-auropharm-for-rs-14321-crore</guid>
<description><![CDATA[ New Delhi: Aurobindo Pharma Limited has approved the transfer of its domestic branded generic pharmaceutical formulations business to its wholly owned subsidiary Auropharm Limited for a lump sum consideration of Rs 143.21 crore, as part of its strategy to streamline and accelerate domestic growth.The decision was taken by the company’s Board of Directors at a meeting held on April 6, 2026, which commenced at 7:00 a.m. and concluded at 8:10 a.m. The transfer will be executed through a Business Transfer Agreement (BTA) signed on the same day.The business being transferred contributed ₹1,753.40 million to turnover, accounting for 0.55% of the company’s consolidated revenue, and ₹1,481.40 million to net worth, representing 0.45% of consolidated net worth in the last financial year.Also Read: Aurobindo Pharma Delays 26% Stake Buy in Swarnaakshu Solar Over Pending ApprovalsThe transaction is expected to be completed within 90 to 120 days from the date of the agreement, subject to fulfilment of customary conditions. Upon completion, the economic benefits of the business will be transferred to Auropharm Limited with effect from April 1, 2026.Auropharm Limited, previously known as Auro Pharma Limited, is a wholly owned subsidiary engaged in the trading of branded generic formulations and pharmaceutical products in India. The transfer includes all associated assets and liabilities such as movable assets, employees, contracts, intellectual property, licenses, approvals, receivables, inventory, and payables on a going concern basis.The transaction qualifies as a related party transaction since it is between the holding company and its wholly owned subsidiary. However, as per applicable provisions of the Companies Act, 2013 and SEBI Listing Regulations, such transactions are exempt from related party compliance requirements and will have no impact on a consolidated basis.The company clarified that the transfer is being carried out outside a scheme of arrangement and is structured as a slump sale. It does not constitute the sale of the whole or substantially the whole undertaking under relevant provisions of the Companies Act.For the financial year ended March 31, 2025, Aurobindo Pharma reported standalone revenue of ₹1,09,333 million, while the domestic branded formulations business contributed ₹1,753.40 million. Auropharm Limited reported nil turnover during the same period.The rationale behind the transaction is to consolidate the company’s domestic pharmaceutical operations under Auropharm Limited, which currently manages the non-oncology formulations business acquired earlier. The move is expected to enhance operational efficiency and enable a more focused approach to expanding the domestic business.The company also confirmed that there will be no change in its shareholding pattern following the transaction.Also Read: Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/10/197265-aurobindo-pharma-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aurobindo, Pharma, Transfers, Domestic, Branded, Business, Auropharm, for, 143.21, Crore</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/10/197265-aurobindo-pharma-2.webp"><p><b>New Delhi:</b> Aurobindo Pharma Limited has approved the transfer of its domestic branded generic pharmaceutical formulations business to its wholly owned subsidiary Auropharm Limited for a lump sum consideration of Rs 143.21 crore, as part of its strategy to streamline and accelerate domestic growth.</p><div class="pasted-from-word-wrapper"><p>The decision was taken by the company’s Board of Directors at a meeting held on April 6, 2026, which commenced at 7:00 a.m. and concluded at 8:10 a.m. The transfer will be executed through a Business Transfer Agreement (BTA) signed on the same day.</p><p>The business being transferred contributed ₹1,753.40 million to turnover, accounting for 0.55% of the company’s consolidated revenue, and ₹1,481.40 million to net worth, representing 0.45% of consolidated net worth in the last financial year.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-delays-26-stake-buy-in-swarnaakshu-solar-over-pending-approvals-167951">Also Read: Aurobindo Pharma Delays 26% Stake Buy in Swarnaakshu Solar Over Pending Approvals</a></div></div><p>The transaction is expected to be completed within 90 to 120 days from the date of the agreement, subject to fulfilment of customary conditions. Upon completion, the economic benefits of the business will be transferred to Auropharm Limited with effect from April 1, 2026.</p><p>Auropharm Limited, previously known as Auro Pharma Limited, is a wholly owned subsidiary engaged in the trading of branded generic formulations and pharmaceutical products in India. The transfer includes all associated assets and liabilities such as movable assets, employees, contracts, intellectual property, licenses, approvals, receivables, inventory, and payables on a going concern basis.</p><p>The transaction qualifies as a related party transaction since it is between the holding company and its wholly owned subsidiary. However, as per applicable provisions of the Companies Act, 2013 and SEBI Listing Regulations, such transactions are exempt from related party compliance requirements and will have no impact on a consolidated basis.</p><p>The company clarified that the transfer is being carried out outside a scheme of arrangement and is structured as a slump sale. It does not constitute the sale of the whole or substantially the whole undertaking under relevant provisions of the Companies Act.</p><p>For the financial year ended March 31, 2025, Aurobindo Pharma reported standalone revenue of ₹1,09,333 million, while the domestic branded formulations business contributed ₹1,753.40 million. Auropharm Limited reported nil turnover during the same period.</p><p>The rationale behind the transaction is to consolidate the company’s domestic pharmaceutical operations under Auropharm Limited, which currently manages the non-oncology formulations business acquired earlier. The move is expected to enhance operational efficiency and enable a more focused approach to expanding the domestic business.</p><p>The company also confirmed that there will be no change in its shareholding pattern following the transaction.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-subsidiary-eugia-launches-generic-pomalyst-capsules-in-us-165910">Also Read: Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>New Research Highlights TIVA’s Advantage in Reducing Inflammation During Microdiscectomy</title>
<link>https://edusehat.com/en/new-research-highlights-tivas-advantage-in-reducing-inflammation-during-microdiscectomy</link>
<guid>https://edusehat.com/en/new-research-highlights-tivas-advantage-in-reducing-inflammation-during-microdiscectomy</guid>
<description><![CDATA[ The Anesthesia Dilemma: Does Technique Influence Recovery?When it comes to surgical recovery, the choice of anesthesia may be more than just a technical detail—it could shape the body’s response to stress and inflammation. A recent double-blind study published in BMC Anesthesiology explores whether total intravenous anesthesia (TIVA) with propofol or inhalation anesthesia with sevoflurane offers a better profile for controlling perioperative inflammation in lumbar microdiscectomy patients.Study Design: A Closer Look at Inflammatory MarkersThe research involved 40 patients, aged 18–65, undergoing elective lumbar disc herniation surgery. They were randomized to receive either TIVA (propofol-based) or sevoflurane anesthesia. The key focus was on measuring and comparing interleukin-6 (IL-6)—a core inflammatory cytokine—at multiple timepoints before, during, and after surgery. Additional markers included C-reactive protein (CRP), procalcitonin (PCT), and the neutrophil-to-lymphocyte ratio (NLR).Key Findings: TIVA Damps Down the Inflammatory SurgeBoth anesthesia approaches led to increased IL-6 after surgery, but the rise was significantly less pronounced in the TIVA group. At 24 hours post-surgery, IL-6 levels in TIVA patients were markedly lower compared to those who received sevoflurane. Similarly, CRP levels—a general marker of inflammation—were also lower with TIVA. PCT levels, often linked to infection, remained stable and similar between groups, and NLR values did not show significant differences postoperatively.Why Does This Matter?Excessive or poorly controlled inflammation can slow healing, increase infection risk, and complicate recovery. The study’s results suggest that TIVA with propofol may help better modulate this response, potentially offering patients smoother recoveries. Interestingly, although many previous studies focused on cancer or major surgeries, this research zeroed in on a minimally invasive, non-oncologic procedure—giving new insight into anesthesia’s impact in routine spine surgery.Weighing the Evidence: Practical Implications and Next StepsWhile the study found no difference in length of hospital stay or immediate complications, the findings raise the possibility that TIVA could be the preferred option when minimizing surgical inflammation is a priority. However, larger and more diverse studies are needed to confirm these results, assess long-term outcomes, and determine if the benefits translate to other patient populations or types of surgery.Key TakeawaysTIVA with propofol led to significantly lower postoperative IL-6 and CRP levels compared to sevoflurane in microdiscectomy.No differences were observed in PCT (infection marker) or postoperative NLR values.Both anesthesia techniques were safe, with no difference in complications or hospital stay.TIVA may offer a real advantage for patients needing tight inflammation control during surgery.Further large-scale, multicenter studies are warranted to expand on these promising findings.Citation:Yediyıldız MB, Durmuş İ, Yılmaz Ak H, Taşkın K, Devrüş Ceylan MA, Yüce Y, Çevik B, Aydoğmuş E. Comparison of inhalation and total intravenous anesthesia on inflammatory markers in microdiscectomy: a double-blind study. BMC Anesthesiology. 2025;25:238. https://doi.org/10.1186/s12871-025-03119-6 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/05/29/210695-spine-surgery.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>New, Research, Highlights, TIVA’s, Advantage, Reducing, Inflammation, During, Microdiscectomy</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/05/29/210695-spine-surgery.webp"><p align="justify">The Anesthesia Dilemma: Does Technique Influence Recovery?</p><p align="justify">When it comes to surgical recovery, the choice of anesthesia may be more than just a technical detail—it could shape the body’s response to stress and inflammation. A recent double-blind study published in BMC Anesthesiology explores whether total intravenous anesthesia (TIVA) with propofol or inhalation anesthesia with sevoflurane offers a better profile for controlling perioperative inflammation in lumbar microdiscectomy patients.</p><p align="justify">Study Design: A Closer Look at Inflammatory Markers</p><p align="justify">The research involved 40 patients, aged 18–65, undergoing elective lumbar disc herniation surgery. They were randomized to receive either TIVA (propofol-based) or sevoflurane anesthesia. The key focus was on measuring and comparing interleukin-6 (IL-6)—a core inflammatory cytokine—at multiple timepoints before, during, and after surgery. Additional markers included C-reactive protein (CRP), procalcitonin (PCT), and the neutrophil-to-lymphocyte ratio (NLR).</p><p align="justify">Key Findings: TIVA Damps Down the Inflammatory Surge</p><p align="justify">Both anesthesia approaches led to increased IL-6 after surgery, but the rise was significantly less pronounced in the TIVA group. At 24 hours post-surgery, IL-6 levels in TIVA patients were markedly lower compared to those who received sevoflurane. Similarly, CRP levels—a general marker of inflammation—were also lower with TIVA. PCT levels, often linked to infection, remained stable and similar between groups, and NLR values did not show significant differences postoperatively.</p><p align="justify">Why Does This Matter?</p><p align="justify">Excessive or poorly controlled inflammation can slow healing, increase infection risk, and complicate recovery. The study’s results suggest that TIVA with propofol may help better modulate this response, potentially offering patients smoother recoveries. Interestingly, although many previous studies focused on cancer or major surgeries, this research zeroed in on a minimally invasive, non-oncologic procedure—giving new insight into anesthesia’s impact in routine spine surgery.</p><p align="justify">Weighing the Evidence: Practical Implications and Next Steps</p><p align="justify">While the study found no difference in length of hospital stay or immediate complications, the findings raise the possibility that TIVA could be the preferred option when minimizing surgical inflammation is a priority. However, larger and more diverse studies are needed to confirm these results, assess long-term outcomes, and determine if the benefits translate to other patient populations or types of surgery.</p><p align="justify">Key Takeaways</p><p align="justify">TIVA with propofol led to significantly lower postoperative IL-6 and CRP levels compared to sevoflurane in microdiscectomy.</p><p align="justify">No differences were observed in PCT (infection marker) or postoperative NLR values.</p><p align="justify">Both anesthesia techniques were safe, with no difference in complications or hospital stay.</p><p align="justify">TIVA may offer a real advantage for patients needing tight inflammation control during surgery.</p><p align="justify">Further large-scale, multicenter studies are warranted to expand on these promising findings.</p><p align="justify">Citation:</p><p align="justify">Yediyıldız MB, Durmuş İ, Yılmaz Ak H, Taşkın K, Devrüş Ceylan MA, Yüce Y, Çevik B, Aydoğmuş E. Comparison of inhalation and total intravenous anesthesia on inflammatory markers in microdiscectomy: a double-blind study. BMC Anesthesiology. 2025;25:238. https://doi.org/10.1186/s12871-025-03119-6</p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>Sun Pharma Names Former PwC India COO Satyavati Berera as Independent Director</title>
<link>https://edusehat.com/en/sun-pharma-names-former-pwc-india-coo-satyavati-berera-as-independent-director</link>
<guid>https://edusehat.com/en/sun-pharma-names-former-pwc-india-coo-satyavati-berera-as-independent-director</guid>
<description><![CDATA[ New Delhi: Sun Pharmaceutical Industries Limited has approved the appointment of Satyavati Berera as an Independent Director on its Board for a term of five consecutive years, subject to shareholder approval.The decision was taken by the company’s Board of Directors based on the recommendation of the Nomination and Remuneration Committee. The appointment will become effective upon approval by shareholders through a postal ballot.Sun Pharma stated that the inclusion of Berera will strengthen the Board’s independence, governance standards, and overall expertise in oversight and decision-making, ensuring continued compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Satyavati Berera is a seasoned professional with over four decades of experience. She previously served as the Chief Operating Officer (COO) of PwC India and retired in 2023 after holding multiple leadership roles within the firm. She is an Economics graduate from Lady Shri Ram College, Delhi University, and a fellow member of the Institute of Chartered Accountants of India (ICAI).Also Read: Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology AdvancesShe qualified as a Chartered Accountant in 1984 and became a Partner at Price Waterhouse in 1995. Over the years, she has held key positions including heading the consulting practice and serving as Managing Partner for the firm’s northern region. She also worked as an Audit Partner from 1995 to 2005.Her professional experience spans assurance, consulting, governance, risk and compliance (GRC), as well as implementing control and process improvement solutions for domestic and multinational companies. Her tenure as COO provided her with deep expertise in finance, operations, human capital, technology, risk management, and regulatory compliance.The company confirmed that Berera is not related to any director, key managerial personnel, or promoter of Sun Pharma and is not debarred from holding the office of director by any regulatory authority.Also Read: Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and Biosimilars ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/06/04/240154-sun-pharma-new-50-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sun, Pharma, Names, Former, PwC, India, COO, Satyavati, Berera, Independent, Director</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/06/04/240154-sun-pharma-new-50-1.webp"><p><b>New Delhi: </b>Sun Pharmaceutical Industries Limited has approved the appointment of Satyavati Berera as an Independent Director on its Board for a term of five consecutive years, subject to shareholder approval.</p><div class="pasted-from-word-wrapper"><p>The decision was taken by the company’s Board of Directors based on the recommendation of the Nomination and Remuneration Committee. The appointment will become effective upon approval by shareholders through a postal ballot.</p><p>Sun Pharma stated that the inclusion of Berera will strengthen the Board’s independence, governance standards, and overall expertise in oversight and decision-making, ensuring continued compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.</p><p>Satyavati Berera is a seasoned professional with over four decades of experience. She previously served as the Chief Operating Officer (COO) of PwC India and retired in 2023 after holding multiple leadership roles within the firm. She is an Economics graduate from Lady Shri Ram College, Delhi University, and a fellow member of the Institute of Chartered Accountants of India (ICAI).</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/sun-pharma-to-present-ilumya-leqselvi-winlevi-data-at-aad-2026-showcases-dermatology-advances-167532">Also Read: Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances</a></div></div><p>She qualified as a Chartered Accountant in 1984 and became a Partner at Price Waterhouse in 1995. Over the years, she has held key positions including heading the consulting practice and serving as Managing Partner for the firm’s northern region. She also worked as an Audit Partner from 1995 to 2005.</p><p>Her professional experience spans assurance, consulting, governance, risk and compliance (GRC), as well as implementing control and process improvement solutions for domestic and multinational companies. Her tenure as COO provided her with deep expertise in finance, operations, human capital, technology, risk management, and regulatory compliance.</p><p>The company confirmed that Berera is not related to any director, key managerial personnel, or promoter of Sun Pharma and is not debarred from holding the office of director by any regulatory authority.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/sun-pharma-rules-out-big-bang-acquisitions-bets-on-organic-growth-and-biosimilars-164255">Also Read: Sun Pharma Rules Out Big-Bang Acquisitions, Bets on Organic Growth and Biosimilars</a></p></div>]]> </content:encoded>
</item>

<item>
<title>WHO updates guidelines on opioid dependence treatment and overdose prevention</title>
<link>https://edusehat.com/en/who-updates-guidelines-on-opioid-dependence-treatment-and-overdose-prevention</link>
<guid>https://edusehat.com/en/who-updates-guidelines-on-opioid-dependence-treatment-and-overdose-prevention</guid>
<description><![CDATA[ WHO announces the update of several recommendations in the forthcoming guidelines for the treatment of opioid dependence and the community management of opioid overdose.
Opioid dependence remains a major contributor to global morbidity and mortality. An estimated 316 million people worldwide used drugs in 2023, including around 61 million people who engaged in non-medical opioid use. Opioids continue to account for the largest share of the drug-related health burden, including fatal overdose. Of approximately 600 000 deaths attributed to drug use globally, about 450 000 are due to opioid use.
Ensuring that people with opioid dependence-and those at risk of opioid overdose-have access to affordable, ethical, high-quality and evidence-based support and care is essential. Although an estimated 64 million people worldwide are living with drug use disorders, fewer than 10% currently receive treatment.
To support countries in addressing this gap, WHO develops and updates guidelines on the treatment of opioid dependence and community management of opioid overdose. These guidelines aim to expand access to effective care and reduce deaths from opioid overdose through evidence-based recommendations.
In accordance with WHO methods for the guideline development, the updated recommendations were informed by a rigorous process that considered the balance of benefits and harms, values and preferences, cost-effectiveness, equity, acceptability and feasibility. Comprehensive findings from systematic literature reviews of quantitative and qualitative evidence were examined by the Guideline Development Group (GDG), which updated the existing and formulated the new recommendations.
In the updated guidelines, WHO reaffirms its recommendation for the opioid agonist maintenance treatment (OAMT)-defined as the administration of rigorously evaluated opioid agonists by accredited professionals within recognized medical practice to people with opioid dependence to achieve defined treatment goals. Alongside the continued strong recommendations for OAMT with methadone and oral buprenorphine, WHO now extends its guidance to include new formulations of long-acting injectable buprenorphine (conditional recommendation).
Under the oversight of the WHO Guidelines Review Committee, and in consultation with the GDG and the guidelines methodologist, the Steering Group is advancing the peer‑review, finalization, and publication of the full guidelines, which are expected later this year or in early 2027. These guidelines will include detailed recommendations, the supporting rationale, evidence profiles, implementation considerations, identified research gaps, and other relevant information.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/16/232374-opioid-abuse.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>WHO, updates, guidelines, opioid, dependence, treatment, and, overdose, prevention</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/16/232374-opioid-abuse.webp"><p><a href="https://medicaldialogues.in/topics/WHO">WHO</a> announces the update of several recommendations in the forthcoming guidelines for the treatment of <a href="https://medicaldialogues.in/topics/Opioid">opioid</a> dependence and the community management of opioid overdose.
</p><p>Opioid dependence remains a major contributor to global morbidity and mortality. An estimated 316 million people worldwide used drugs in 2023, including around 61 million people who engaged in non-medical opioid use. Opioids continue to account for the largest share of the drug-related health burden, including fatal overdose. Of approximately 600 000 deaths attributed to drug use globally, about 450 000 are due to opioid use.
</p><p>Ensuring that people with opioid dependence-and those at risk of opioid overdose-have access to affordable, ethical, high-quality and evidence-based support and care is essential. Although an estimated 64 million people worldwide are living with drug use disorders, fewer than 10% currently receive treatment.
</p><p>To support countries in addressing this gap, WHO develops and updates guidelines on the treatment of opioid dependence and community management of opioid overdose. These guidelines aim to expand access to effective care and reduce deaths from opioid overdose through evidence-based recommendations.
</p><p>In accordance with WHO methods for the guideline development, the updated recommendations were informed by a rigorous process that considered the balance of benefits and harms, values and preferences, cost-effectiveness, equity, acceptability and feasibility. Comprehensive findings from systematic literature reviews of quantitative and qualitative evidence were examined by the Guideline Development Group (GDG), which updated the existing and formulated the new recommendations.
</p><p>In the updated guidelines, WHO reaffirms its recommendation for the opioid agonist maintenance treatment (OAMT)-defined as the administration of rigorously evaluated opioid agonists by accredited professionals within recognized medical practice to people with opioid dependence to achieve defined treatment goals. Alongside the continued strong recommendations for OAMT with methadone and oral buprenorphine, WHO now extends its guidance to include new formulations of long-acting injectable buprenorphine (conditional recommendation).
</p><p>Under the oversight of the WHO Guidelines Review Committee, and in consultation with the GDG and the guidelines methodologist, the Steering Group is advancing the peer‑review, finalization, and publication of the full guidelines, which are expected later this year or in early 2027. These guidelines will include detailed recommendations, the supporting rationale, evidence profiles, implementation considerations, identified research gaps, and other relevant information. </p>]]> </content:encoded>
</item>

<item>
<title>Aggressive Obsessions common and distressing in Obsessive&#45;Compulsive Disorder,  finds study</title>
<link>https://edusehat.com/en/aggressive-obsessions-common-and-distressing-in-obsessive-compulsive-disorder-finds-study</link>
<guid>https://edusehat.com/en/aggressive-obsessions-common-and-distressing-in-obsessive-compulsive-disorder-finds-study</guid>
<description><![CDATA[ Aggressive obsessions are a common and highly distressing feature of obsessive-compulsive disorder (OCD). A systematic review and meta-analysis published in the Journal of Psychiatric Research found that approximately 70% of individuals with Obsessive-compulsive disorderexperience aggressive obsessions at some point in their lifetime. The prevalence of these obsessions varies based on factors such as age, age at onset of Obsessive-compulsive disorder, and the presence of comorbid conditions, including social anxiety.Obsessive-compulsive disorder (OCD) is a heterogeneous condition often characterized in relation to major symptom dimensions, including contamination, symmetry/exactness, religious, aggressive, sexual, hoarding/saving, somatic, and miscellaneous. Aggressive obsessions, defined as intrusive thoughts of (unintentionally or intentionally) harming oneself or others, are experienced as distressing, commonly misdiagnosed by healthcare providers, and highly stigmatized. The aims of the current study were to: (a) provide an aggregate estimate of the worldwide prevalence of aggressive obsessions among adults (18+ years) with clinician-diagnosed Obsessive-compulsive disorder; and (b) quantify sources of heterogeneity amongst prevalence estimates using moderator analyses. A systematic review was conducted using PubMed, PsycINFO, and CINAHL databases. Of the 7794 studies screened, 110 were coded for analysis. Lifetime and current (e.g., past-week) prevalence rates were estimated to be 70.3 %, CI95 % [61.6, 77.7], and 52.6 %, CI95 % [46.3, 59.0], respectively, and reflected substantial heterogeneity. For 28.0 % of individuals, aggressive obsessions were categorized as their primary and most distressing symptom. Moderator analyses revealed higher current prevalence of aggressive obsessions across samples with a greater mean age, longer mean illness duration, lower mean age of Obsessive-compulsive disorder onset, and greater comorbid social anxiety disorder prevalence, while significantly fewer aggressive obsessions were reported in samples from the Asia Pacific region, and with higher percentages of married individuals. Finally, risk ratio analyses revealed that individuals with: a) early vs. late Obsessive-compulsive disorder onset; and b) suicidal ideation vs. not, were 1.17 times, CI95 % [1.07, 1.27], and 1.98 times, CI95 %[1.47, 2.66], more likely to report aggressive obsessions, respectively. Results support the need for early identification and increased monitoring among individuals experiencing aggressive obsessions.Reference:Emily J. Fawcett, Quinn Morris, Chelsea Lahey, Charlotte Corran, Sandra Krause, Olivia C. Bishop, Joshua A. Rash, Jacqueline Carter, Jonathan M. Fawcett,The prevalence and predictors of aggressive obsessions in obsessive-compulsive disorder: A meta-analytic review. Journal of Psychiatric Research, Volume 195, 2026, Pages 264-283,ISSN 0022-3956. https://doi.org/10.1016/j.jpsychires.2026.01.051.Keywords:Aggressive,  Obsessions,  common, distressing, Obsessive-Compulsive,  Disorder,  finds,  study, Aggressive,  obsessions, Prevalence, Meta-analysis, Emily J. Fawcett, Quinn Morris, Chelsea Lahey, Charlotte Corran, Sandra Krause, Olivia C. Bishop, Joshua A. Rash, Jacqueline Carter, Jonathan M. Fawcett ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/22/329030-5f378bc3577fc7a49c4fd380d884f50578bf22mv2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aggressive, Obsessions, common, and, distressing, Obsessive-Compulsive, Disorder, finds, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/22/329030-5f378bc3577fc7a49c4fd380d884f50578bf22mv2.webp"><p>Aggressive obsessions are a common and highly distressing feature of obsessive-compulsive disorder (OCD). A systematic review and meta-analysis published in the Journal of Psychiatric Research found that approximately 70% of individuals with Obsessive-compulsive disorderexperience aggressive obsessions at some point in their lifetime. The prevalence of these obsessions varies based on factors such as age, age at onset of Obsessive-compulsive disorder, and the presence of comorbid conditions, including social anxiety.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Obsessive-compulsive disorder (OCD) is a heterogeneous condition often characterized in relation to major symptom dimensions, including contamination, symmetry/exactness, religious, aggressive, sexual, hoarding/saving, somatic, and miscellaneous. Aggressive obsessions, defined as intrusive thoughts of (unintentionally or intentionally) harming oneself or others, are experienced as distressing, commonly misdiagnosed by healthcare providers, and highly stigmatized. The aims of the current study were to: (a) provide an aggregate estimate of the worldwide prevalence of aggressive obsessions among adults (18+ years) with clinician-diagnosed Obsessive-compulsive disorder; and (b) quantify sources of heterogeneity amongst prevalence estimates using moderator analyses. A systematic review was conducted using PubMed, PsycINFO, and CINAHL databases. Of the 7794 studies screened, 110 were coded for analysis. Lifetime and current (e.g., past-week) prevalence rates were estimated to be 70.3 %, CI95 % [61.6, 77.7], and 52.6 %, CI95 % [46.3, 59.0], respectively, and reflected substantial heterogeneity. For 28.0 % of individuals, aggressive obsessions were categorized as their primary and most distressing symptom. Moderator analyses revealed higher current prevalence of aggressive obsessions across samples with a greater mean age, longer mean illness duration, lower mean age of Obsessive-compulsive disorder onset, and greater comorbid social anxiety disorder prevalence, while significantly fewer aggressive obsessions were reported in samples from the Asia Pacific region, and with higher percentages of married individuals. Finally, risk ratio analyses revealed that individuals with: a) early vs. late Obsessive-compulsive disorder onset; and b) suicidal ideation vs. not, were 1.17 times, CI95 % [1.07, 1.27], and 1.98 times, CI95 %[1.47, 2.66], more likely to report aggressive obsessions, respectively. Results support the need for early identification and increased monitoring among individuals experiencing aggressive obsessions.</p><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Emily J. Fawcett, Quinn Morris, Chelsea Lahey, Charlotte Corran, Sandra Krause, Olivia C. Bishop, Joshua A. Rash, Jacqueline Carter, Jonathan M. Fawcett,</p><p dir="ltr">The prevalence and predictors of aggressive obsessions in obsessive-compulsive disorder: A meta-analytic review. Journal of Psychiatric Research, Volume 195, 2026, Pages 264-283,</p><p dir="ltr">ISSN 0022-3956. https://doi.org/10.1016/j.jpsychires.2026.01.051.</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Aggressive,  Obsessions,  common, distressing, Obsessive-Compulsive,  Disorder,  finds,  study, Aggressive,  obsessions, Prevalence, Meta-analysis, Emily J. Fawcett, Quinn Morris, Chelsea Lahey, Charlotte Corran, Sandra Krause, Olivia C. Bishop, Joshua A. Rash, Jacqueline Carter, Jonathan M. Fawcett</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Microneedling with TXA, Effective and promising Treatment for Melasma, suggests study</title>
<link>https://edusehat.com/en/microneedling-with-txa-effective-and-promising-treatment-for-melasma-suggests-study</link>
<guid>https://edusehat.com/en/microneedling-with-txa-effective-and-promising-treatment-for-melasma-suggests-study</guid>
<description><![CDATA[ Melasma is a pigmentary disorder that typically appears on the face. Given its tendency to relapse, resistance to treatment and significant impact on social and emotional well-being, melasma poses considerable challenges.A study was done to compare the effectiveness and adverse effects of tranexamic acid (TXA) in reducing modified Melasma Area and Severity Index (mMASI) scores when given along with microneedling versus intradermal injections in the treatment of melasma. This was a hospital-based randomised controlled study conducted in the outpatient Department of Dermatology, Venereology and Leprosy, Aarupadai Veedu Medical College, among patients with melasma, between November 2022 and April 2024. In Group A (n = 35), patients received microneedling with TXA (4 mg/mL) and intradermal injections of TXA (4 mg/mL) in Group B (n = 35). Treatment was administered every 4 weeks for four sessions and followed-up once a month for 2 months.The baseline characteristics of the study groups did not vary significantly by age (in years), gender, Fitzpatrick skin type, precipitating factors, clinical type of melasma, and pattern of melasma. Both groups showed significant reduction in mMASI scores from baseline to 20 weeks (7.1 ± 2.3 to 4.6 ± 0.5 in Group A and 7.0 ± 3.1 to 5.3 ± 0.7 in Group B, respectively). From 12th week onwards, Group A had significantly lower mMASI scores than Group B (P &lt; 0.05). A total of 83% of Group A patients had nearly cleared melasma compared to 37.0% in Group B (P &lt; 0.05). Photographic documentation revealed that over 75.0% of Group A patients had more than 50.0% improvement, against 40.0% in Group B (P &lt; 0.05). Adverse events such as erythema, pain, burning sensation, and pigmentation were slightly more common in Group B, but the difference was not statistically significant.The study highlights microneedling with TXA as a promising and effective treatment option for melasma, offering substantial clinical improvement and patient satisfaction.Reference:Srijha, M.; Kaliyaperumal, Damayandhi; Dileep, Jude Ernest; Kuruvila, Sheela. Efficacy of Tranexamic acid Microneedling versus Intradermal Injection of Tranexamic Acid in the Treatment of Melasma – A Randomised Controlled Trial. Indian Journal of Dermatology 71(2):p 109-114, Mar–Apr 2026. | DOI: 10.4103/ijd.ijd_1041_24Keywords:Microneedling, TXA, Effective, promising,  Treatment, Melasma, suggests, study, Srijha, M.; Kaliyaperumal, Damayandhi; Dileep, Jude Ernest; Kuruvila, Sheela. ]]></description>
<enclosure url="https://medicaldialogues.in/images/logo.png" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Microneedling, with, TXA, Effective, and, promising, Treatment, for, Melasma, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/dermatology/news/microneedling-with-txa-effective-and-promising-treatment-for-melasma-suggests-study-167996"><p>Melasma is a pigmentary disorder that typically appears on the face. Given its tendency to relapse, resistance to treatment and significant impact on social and emotional well-being, melasma poses considerable challenges.</p><div class="pasted-from-word-wrapper"><p dir="ltr">A study was done to compare the effectiveness and adverse effects of tranexamic acid (TXA) in reducing modified Melasma Area and Severity Index (mMASI) scores when given along with microneedling versus intradermal injections in the treatment of melasma. This was a hospital-based randomised controlled study conducted in the outpatient Department of Dermatology, Venereology and Leprosy, Aarupadai Veedu Medical College, among patients with melasma, between November 2022 and April 2024. In Group A (n = 35), patients received microneedling with TXA (4 mg/mL) and intradermal injections of TXA (4 mg/mL) in Group B (n = 35). Treatment was administered every 4 weeks for four sessions and followed-up once a month for 2 months.</p><p dir="ltr">The baseline characteristics of the study groups did not vary significantly by age (in years), gender, Fitzpatrick skin type, precipitating factors, clinical type of melasma, and pattern of melasma. Both groups showed significant reduction in mMASI scores from baseline to 20 weeks (7.1 ± 2.3 to 4.6 ± 0.5 in Group A and 7.0 ± 3.1 to 5.3 ± 0.7 in Group B, respectively). From 12th week onwards, Group A had significantly lower mMASI scores than Group B (P < 0.05). A total of 83% of Group A patients had nearly cleared melasma compared to 37.0% in Group B (P < 0.05). Photographic documentation revealed that over 75.0% of Group A patients had more than 50.0% improvement, against 40.0% in Group B (P < 0.05). Adverse events such as erythema, pain, burning sensation, and pigmentation were slightly more common in Group B, but the difference was not statistically significant.</p><p dir="ltr">The study highlights microneedling with TXA as a promising and effective treatment option for melasma, offering substantial clinical improvement and patient satisfaction.</p><p dir="ltr">Reference:</p><p dir="ltr">Srijha, M.; Kaliyaperumal, Damayandhi; Dileep, Jude Ernest; Kuruvila, Sheela. Efficacy of Tranexamic acid Microneedling versus Intradermal Injection of Tranexamic Acid in the Treatment of Melasma – A Randomised Controlled Trial. Indian Journal of Dermatology 71(2):p 109-114, Mar–Apr 2026. | DOI: 10.4103/ijd.ijd_1041_24</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Microneedling, TXA, Effective, promising,  Treatment, Melasma, suggests, study, Srijha, M.; Kaliyaperumal, Damayandhi; Dileep, Jude Ernest; Kuruvila, Sheela.</p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Preterm Birth and Low Birth Weight Linked to Lifelong Cognitive Disadvantages: JAMA</title>
<link>https://edusehat.com/en/preterm-birth-and-low-birth-weight-linked-to-lifelong-cognitive-disadvantages-jama</link>
<guid>https://edusehat.com/en/preterm-birth-and-low-birth-weight-linked-to-lifelong-cognitive-disadvantages-jama</guid>
<description><![CDATA[ An umbrella review and meta-analysis published in the Journal of the American Medical Association found that preterm birth and low birth weight are associated with persistent cognitive and educational disadvantages throughout life. These findings highlight the need for early identification and long-term monitoring to guide healthcare and educational support strategies.Recent advances in perinatal care have dramatically improved survival rates for babies born preterm or with low birth weight. Thus, this study synthesized evidence from 40 systematic reviews, including 22 meta-analyses, drawing on hundreds of primary studies across major research databases up to April 2025. This research reanalyzed 788 effect estimates to better understand how being born before 37 weeks’ gestation or weighing less than 2500 grams affects long-term intellectual and educational performance.The findings reveal that individuals born preterm or with low birth weight tend to score significantly lower on measures of general cognitive ability. On average, intelligence quotient (IQ) scores were notably reduced when compared to peers born at full term and normal weight. Beyond IQ, the analysis found substantial deficits in dedicated academic domains, including reading, mathematics, and spelling.Children born under these conditions were more likely to require special educational support services, which pointed to increased learning needs within school systems. While data on broader outcomes such as total years of schooling and associated educational costs were more limited, available evidence suggests lower rates of school completion and higher overall expenses tied to additional support.This research points that the degree of impact varies depending on how early a child is born or how low their birth weight is. The earlier the gestational age and the lower the birth weight, the stronger the association with poorer outcomes. Some of these differences appear to reduce during adolescence, though they do not disappear entirely and can still be observed into adult life.Overall, these findings illuminate a critical gap between medical success and developmental equity. While neonatal care has advanced to save more lives, the long-term support systems for these individuals need more probing. The results point to the need for early identification of at-risk children and sustained monitoring throughout their development.Schools and governments may need to allocate more targeted support to accommodate the higher likelihood of learning difficulties in this population. Early interventions, tailored educational programs, and long-term follow-up could play key roles in narrowing these gaps.Source:Hu, M., Truong, T., Zhu, S., Vidiella-Martin, J., Johnson, S., Quigley, M. A., &amp; Petrou, S. (2026). Cognitive and educational outcomes after preterm birth or low birth weight: An umbrella review and meta-analysis: An umbrella review and meta-analysis. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2026.0533 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/06/26/292309-preterm-birth.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Preterm, Birth, and, Low, Birth, Weight, Linked, Lifelong, Cognitive, Disadvantages:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/06/26/292309-preterm-birth.webp"><p>An umbrella review and meta-analysis published in the <i>Journal of the American Medical Association</i> found that preterm birth and low birth weight are associated with persistent cognitive and educational disadvantages throughout life. These findings highlight the need for early identification and long-term monitoring to guide healthcare and educational support strategies.</p><p>Recent advances in perinatal care have dramatically improved survival rates for babies born preterm or with low birth weight. Thus, this study synthesized evidence from 40 systematic reviews, including 22 meta-analyses, drawing on hundreds of primary studies across major research databases up to April 2025. </p><p>This research reanalyzed 788 effect estimates to better understand how being born before 37 weeks’ gestation or weighing less than 2500 grams affects long-term intellectual and educational performance.</p><p>The findings reveal that individuals born preterm or with low birth weight tend to score significantly lower on measures of general cognitive ability. On average, intelligence quotient (IQ) scores were notably reduced when compared to peers born at full term and normal weight. Beyond IQ, the analysis found substantial deficits in dedicated academic domains, including reading, mathematics, and spelling.</p><p>Children born under these conditions were more likely to require special educational support services, which pointed to increased learning needs within school systems. While data on broader outcomes such as total years of schooling and associated educational costs were more limited, available evidence suggests lower rates of school completion and higher overall expenses tied to additional support.</p><p>This research points that the degree of impact varies depending on how early a child is born or how low their birth weight is. The earlier the gestational age and the lower the birth weight, the stronger the association with poorer outcomes. Some of these differences appear to reduce during adolescence, though they do not disappear entirely and can still be observed into adult life.</p><p>Overall, these findings illuminate a critical gap between medical success and developmental equity. While neonatal care has advanced to save more lives, the long-term support systems for these individuals need more probing. The results point to the need for early identification of at-risk children and sustained monitoring throughout their development.</p><p>Schools and governments may need to allocate more targeted support to accommodate the higher likelihood of learning difficulties in this population. Early interventions, tailored educational programs, and long-term follow-up could play key roles in narrowing these gaps.</p><p>Source:</p><p>Hu, M., Truong, T., Zhu, S., Vidiella-Martin, J., Johnson, S., Quigley, M. A., & Petrou, S. (2026). Cognitive and educational outcomes after preterm birth or low birth weight: An umbrella review and meta-analysis: An umbrella review and meta-analysis. JAMA Pediatrics. <a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/2846792?guestAccessKey=594a1b77-5b12-47ff-80bc-b7cae76c27f5&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jamapediatrics&utm_content=olf-tfl_&utm_term=033026" rel="nofollow">https://doi.org/10.1001/jamapediatrics.2026.0533</a></p>]]> </content:encoded>
</item>

<item>
<title>Incidental Findings on low dose CT lung cancer screening May Signal Risk of Hidden Cancers: JAMA</title>
<link>https://edusehat.com/en/incidental-findings-on-low-dose-ct-lung-cancer-screening-may-signal-risk-of-hidden-cancers-jama</link>
<guid>https://edusehat.com/en/incidental-findings-on-low-dose-ct-lung-cancer-screening-may-signal-risk-of-hidden-cancers-jama</guid>
<description><![CDATA[ A retrospective cohort study published in the Journal of the American Medical Association found significant incidental findings on low-dose CT lung cancer screening which are linked to an increased risk of detecting extrapulmonary cancers within the following year. The risk was particularly higher for urinary cancers, lymphoma, and leukemia. These findings suggest that such incidental abnormalities should be carefully evaluated as possible indicators of previously undiagnosed cancers.Low-dose computed tomography (LDCT), widely used to screen high-risk individuals for lung cancer, often reveals abnormalities in other parts of the body. While many of these findings are benign, some may hint at cancers outside the lungs. Until now, it has been unclear whether these incidental findings carry meaningful predictive value.This study focused exclusively on participants in the LDCT arm of the National Lung Screening Trial (NLST), which was conducted between 2002 and 2009. The analysis included more than 75,000 screening rounds among over 26,000 individuals aged 55 to 74, all considered at high risk for lung cancer due to smoking history.This research identified cancer-related incidental findings, referred to as “significant incidental findings” (SIFs) in about 3% of screening rounds. These findings appeared in nearly 7% of participants across three rounds of screening.Among those with cancer SIFs, approximately 3% were diagnosed with an extrapulmonary cancer within one year of the scan. After adjusting for various factors, the study found a significant increase in risk, which was about 14 additional cancer cases per 1,000 individuals with such findings when compared to those without.Cancers of the urinary system showed the highest increased risk, followed by hematologic cancers such as lymphoma and leukemia. These patterns suggest that some incidental findings may not be random but instead early indicators of underlying disease.Now, incidental findings are often handled inconsistently, with some receiving follow-up and others dismissed as low priority. This study suggests a more systematic approach may be warranted, especially when findings are potentially linked to malignancy.However, not all incidental findings indicate cancer, and unnecessary follow-up testing can lead to patient anxiety, additional costs, and potential harm from invasive procedures. Further studies are needed to refine guidelines and determine how to integrate incidental findings into cancer detection strategies. Source:Gareen, I. F., Gutman, R., Thangarajah, M., Trivedi, A. N., Tailor, T. D., Flores, E., Chiles, C., Sicks, J., &amp; Hoffman, R. M. (2026). Significant incidental findings in the National Lung Screening Trial and diagnosis of extrapulmonary cancer. JAMA Network Open, 9(3), e263398. https://doi.org/10.1001/jamanetworkopen.2026.3398 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/13/320999-ldct-for-lung-cancer-screening.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Incidental, Findings, low, dose, lung, cancer, screening, May, Signal, Risk, Hidden, Cancers:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/13/320999-ldct-for-lung-cancer-screening.webp"><p>A retrospective cohort study published in the Journal of the American Medical Association found significant incidental findings on low-dose CT lung cancer screening which are linked to an increased risk of detecting extrapulmonary cancers within the following year. The risk was particularly higher for urinary cancers, lymphoma, and leukemia. These findings suggest that such incidental abnormalities should be carefully evaluated as possible indicators of previously undiagnosed cancers.</p><p>Low-dose computed tomography (LDCT), widely used to screen high-risk individuals for lung cancer, often reveals abnormalities in other parts of the body. While many of these findings are benign, some may hint at cancers outside the lungs. Until now, it has been unclear whether these incidental findings carry meaningful predictive value.</p><p>This study focused exclusively on participants in the LDCT arm of the National Lung Screening Trial (NLST), which was conducted between 2002 and 2009. The analysis included more than 75,000 screening rounds among over 26,000 individuals aged 55 to 74, all considered at high risk for lung cancer due to smoking history.</p><p>This research identified cancer-related incidental findings, referred to as “significant incidental findings” (SIFs) in about 3% of screening rounds. These findings appeared in nearly 7% of participants across three rounds of screening.</p><p>Among those with cancer SIFs, approximately 3% were diagnosed with an extrapulmonary cancer within one year of the scan. After adjusting for various factors, the study found a significant increase in risk, which was about 14 additional cancer cases per 1,000 individuals with such findings when compared to those without.</p><p>Cancers of the urinary system showed the highest increased risk, followed by hematologic cancers such as lymphoma and leukemia. These patterns suggest that some incidental findings may not be random but instead early indicators of underlying disease.</p><p>Now, incidental findings are often handled inconsistently, with some receiving follow-up and others dismissed as low priority. This study suggests a more systematic approach may be warranted, especially when findings are potentially linked to malignancy.</p><p>However, not all incidental findings indicate cancer, and unnecessary follow-up testing can lead to patient anxiety, additional costs, and potential harm from invasive procedures. Further studies are needed to refine guidelines and determine how to integrate incidental findings into cancer detection strategies. </p><p>Source:</p><p>Gareen, I. F., Gutman, R., Thangarajah, M., Trivedi, A. N., Tailor, T. D., Flores, E., Chiles, C., Sicks, J., & Hoffman, R. M. (2026). Significant incidental findings in the National Lung Screening Trial and diagnosis of extrapulmonary cancer. JAMA Network Open, 9(3), e263398. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2847140" rel="nofollow">https://doi.org/10.1001/jamanetworkopen.2026.3398</a></p>]]> </content:encoded>
</item>

<item>
<title>Risto&#45;cel Gene Therapy Shows High Fetal Hemoglobin and Elimination of Severe VOCs in Sickle Cell Disease: NEJM</title>
<link>https://edusehat.com/en/risto-cel-gene-therapy-shows-high-fetal-hemoglobin-and-elimination-of-severe-vocs-in-sickle-cell-disease-nejm</link>
<guid>https://edusehat.com/en/risto-cel-gene-therapy-shows-high-fetal-hemoglobin-and-elimination-of-severe-vocs-in-sickle-cell-disease-nejm</guid>
<description><![CDATA[ USA: In an interim analysis of the phase I/II BEACON study, treatment with ristoglogene autogetemcel (risto-cel) demonstrated encouraging outcomes in patients with sickle cell disease.Participants achieved mean fetal hemoglobin levels exceeding 60%, along with a sustained reduction in sickle hemoglobin to below 40%. Hematologic recovery was prompt, with median neutrophil and platelet engraftment occurring at 17.5 and 19 days, respectively. Notably, no investigator-reported severe vaso-occlusive crises were observed after engraftment.The findings, published in the New England Journal of Medicine, come from a study led by Dr. Ashish O. Gupta from the University of Minnesota and colleagues. The trial evaluated a novel gene-editing therapy designed to address the underlying pathology of sickle cell disease, a condition marked by chronic hemolytic anemia and recurrent painful vaso-occlusive episodes.Risto-cel is an autologous cell therapy that uses base editing to modify the promoters of the HBG1 and HBG2 genes. This approach disrupts the binding of the BCL11A protein, a key regulator that suppresses fetal hemoglobin production. By doing so, the therapy reactivates fetal hemoglobin (HbF), which has anti-sickling properties, thereby reducing the proportion of sickle hemoglobin (HbS) without directly altering BCL11A expression.The phase 1–2 study enrolled patients aged 12 to 35 years who had experienced at least four severe vaso-occlusive crises in the two years before participation. Following myeloablative conditioning with busulfan, patients received a single infusion of risto-cel, consisting of gene-edited CD34+ hematopoietic stem and progenitor cells. The primary efficacy endpoint was the absence of severe vaso-occlusive crises for a continuous 12-month period, beginning at least 60 days after the last red blood cell transfusion.A total of 31 patients were treated and followed for an average of 6.6 months. Stem-cell collection typically requires only one cycle. Engraftment occurred rapidly, with neutrophil recovery at a median of 17.5 days and platelet recovery at 19 days, indicating effective hematopoietic reconstitution.   Key Findings:At six months, the mean proportion of on-target edited alleles in peripheral blood exceeded 67%.Fetal hemoglobin levels increased substantially, accounting for more than 60% of total hemoglobin.Sickle hemoglobin levels declined to below 40% of total hemoglobin.These hematologic improvements were maintained throughout follow-up, indicating sustained therapeutic effect.No severe vaso-occlusive crises were reported after the early post-treatment phase.All patients experienced at least one adverse event during the study period.A majority of participants reported grade 3 or higher adverse events.Serious adverse events occurred in nearly 40% of patients.One death was reported, attributed to idiopathic pneumonia syndrome.Overall, the interim results indicate that base editing of HBG1 and HBG2 promoters using risto-cel can achieve rapid engraftment and sustained hemoglobin switching, offering a promising therapeutic strategy for sickle cell disease. The authors emphasize that further studies with longer follow-up are needed to confirm long-term efficacy and safety.Reference:DOI: 10.1056/NEJMoa2504835 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/12/09/227418-sickle-cell-disease.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 23:20:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Risto-cel, Gene, Therapy, Shows, High, Fetal, Hemoglobin, and, Elimination, Severe, VOCs, Sickle, Cell, Disease:, NEJM</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/12/09/227418-sickle-cell-disease.webp"><p><span>USA: In an interim analysis of the phase I/II BEACON study, treatment with ristoglogene autogetemcel (risto-cel) demonstrated encouraging outcomes in patients with <a href="https://medicaldialogues.in/topics/sickle-cell">sickle cell disease</a>.</span></p><div class="pasted-from-word-wrapper"><div>Participants achieved mean fetal <a href="https://medicaldialogues.in/topics/hemoglobin">hemoglobin </a>levels exceeding 60%, along with a sustained reduction in sickle hemoglobin to below 40%. Hematologic recovery was prompt, with median neutrophil and platelet engraftment occurring at 17.5 and 19 days, respectively. Notably, no investigator-reported severe vaso-occlusive crises were observed after engraftment.</div><div>The findings, published in the <i><a href="https://medicaldialogues.in/topics/new-england-journal-of-medicine">New England Journal of Medicine</a>,</i> come from a study led by Dr. Ashish O. Gupta from the University of Minnesota and colleagues. The trial evaluated a novel gene-editing therapy designed to address the underlying pathology of sickle cell disease, a condition marked by chronic hemolytic anemia and recurrent painful vaso-occlusive episodes.</div><div>Risto-cel is an autologous cell therapy that uses base editing to modify the promoters of the HBG1 and HBG2 genes. This approach disrupts the binding of the BCL11A protein, a key regulator that suppresses fetal hemoglobin production. By doing so, the therapy reactivates fetal hemoglobin (HbF), which has anti-sickling properties, thereby reducing the proportion of sickle hemoglobin (HbS) without directly altering BCL11A expression.</div><div>The phase 1–2 study enrolled patients aged 12 to 35 years who had experienced at least four severe vaso-occlusive crises in the two years before participation. Following myeloablative conditioning with busulfan, patients received a single infusion of risto-cel, consisting of gene-edited CD34+ hematopoietic stem and progenitor cells. The primary efficacy endpoint was the absence of severe vaso-occlusive crises for a continuous 12-month period, beginning at least 60 days after the last red blood cell transfusion.</div><div>A total of 31 patients were treated and followed for an average of 6.6 months. Stem-cell collection typically requires only one cycle. Engraftment occurred rapidly, with neutrophil recovery at a median of 17.5 days and platelet recovery at 19 days, indicating effective hematopoietic reconstitution.   </div><div>Key Findings:</div><ul><li>At six months, the mean proportion of on-target edited alleles in peripheral blood exceeded 67%.</li><li>Fetal hemoglobin levels increased substantially, accounting for more than 60% of total hemoglobin.</li><li>Sickle hemoglobin levels declined to below 40% of total hemoglobin.</li><li>These hematologic improvements were maintained throughout follow-up, indicating sustained therapeutic effect.</li><li>No severe vaso-occlusive crises were reported after the early post-treatment phase.</li><li>All patients experienced at least one adverse event during the study period.</li><li>A majority of participants reported grade 3 or higher adverse events.</li><li>Serious adverse events occurred in nearly 40% of patients.</li><li>One death was reported, attributed to idiopathic pneumonia syndrome.</li></ul><div>Overall, the interim results indicate that base editing of HBG1 and HBG2 promoters using risto-cel can achieve rapid engraftment and sustained hemoglobin switching, offering a promising therapeutic strategy for sickle cell disease. The authors emphasize that further studies with longer follow-up are needed to confirm long-term efficacy and safety.</div><div>Reference:</div><div><p>DOI: 10.1056/NEJMoa2504835</p></div></div>]]> </content:encoded>
</item>

<item>
<title>Study Suggests Higher Meat Intake May Lower Alzheimer&amp;apos;s Risk in Some Individuals</title>
<link>https://edusehat.com/en/study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals-9245</link>
<guid>https://edusehat.com/en/study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals-9245</guid>
<description><![CDATA[ A new study from Karolinska Institutet, published in JAMA Network Open, offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
REFERENCE: Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339842-study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Suggests, Higher, Meat, Intake, May, Lower, Alzheimers, Risk, Some, Individuals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339842-study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals.webp"><p>A new study from Karolinska Institutet, published in <i>JAMA Network Open</i>, offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
</p><p>The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
</p><p>The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
</p><p>In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
</p><p>Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
</p><p>Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
</p><p>Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
</p><p><b>REFERENCE: </b>Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
</p>]]> </content:encoded>
</item>

<item>
<title>Kanpur Kidney Racket: Recovered audio reveals operations across UP</title>
<link>https://edusehat.com/en/kanpur-kidney-racket-recovered-audio-reveals-operations-across-up</link>
<guid>https://edusehat.com/en/kanpur-kidney-racket-recovered-audio-reveals-operations-across-up</guid>
<description><![CDATA[ Kanpur: Following a breakthrough in the Kanpur kidney transplant scam, police have recovered a crucial audio recording from the mobile phone of the alleged mastermind, shedding light on the gang’s operations and its network across multiple cities in Uttar Pradesh.  Medical Dialogues had previously reported that the district health department in Meerut has started a separate investigation and issued a notice to a private hospital located on Garh Road, seeking clarification over its alleged involvement in an illegal kidney transplant racket busted in Kanpur. Also Read:Meerut Hospital under probe for alleged links to kidney transplant racketAccording to Deputy Commissioner of Police (West) SM Qasim Abidi, the recording was sent by the mastermind to a resident of Prayagraj and an associate in the racket. In the clip, the associate mentions a broker, claiming he collected Rs 22 lakh using the mastermind’s name. The mastermind, in response, is heard dismissing the matter, claiming he and the doctor casually handle crores of rupees.Police teams conducted a raid at the associate’s residence in Prayagraj, but he was not found. Meanwhile, the wife of the mastermind was brought in for questioning at Rawatpur police station, where she disclosed that the associate had long-standing links with the doctor, a Ghaziabad-based figure suspected to be a central player in the racket. She claimed that her husband, the mastermind, had been associated with the doctor for about a year.
Authorities are preparing to approach the district court to seek the mastermind&#039;s remand, aiming to deepen the investigation. The recovered audio, believed to date back to December last year, has not yet been made public. So far, 9 people have been arrested in the kidney scam.
The recording also references a woman who died following a kidney transplant. The mastermind mentions that the woman, initially brought to Delhi and admitted to Max Hospital Dwarka, passed away, prompting the associate to question the lack of medical facilities during her transport. Police confirmed she had undergone the transplant at Medilife Hospital in December, after which her condition worsened. A doctor from Kannauj has been taken into custody in connection with her death, while two other doctors remain at large.
Investigators revealed that the broker defrauded a patient of ₹20 lakh. The broker promised a kidney transplant at half the official cost and then absconded with the money. Police are conducting raids in multiple locations to locate him.
None of the gang members identified so far is a surgeon. The network includes doctors, hospital operators, and medical technicians working in different capacities.
Speaking to Bhaskar English, the DCP said that the mastermind’s wife was interrogated for about 6 hours on Friday. During this, she named the manager of Ramashiv Hospital, located opposite Hallet. The manager was in contact with a Ghaziabad-based doctor. When the police interrogated him, he revealed that he had built a private hospital in Lucknow, opposite SGPGI. The doctor had asked him to get a kidney transplant done at his hospital, but he did not undergo the transplant. The operators of Medilife are also being interrogated.
Investigation also revealed that a travel agent booked vehicles under fake names for the gang, transporting the team multiple times for hospital visits. Taxi drivers were paid a nominal rate per kilometre for these trips.
Another doctor linked to Alpha Hospital in Meerut remains absconding; police are actively tracing his location.
DCP Abidi stated that two OT technicians had said during interrogation that they had performed all operations at Ahuja Hospital, but an examination of their mobile phones revealed numbers of several other hospitals in the city. This includes Medilife Hospital located in Maswanpur, reports Bhaskar English.
Also Read:Kanpur Kidney Transplant Racket: Lookout notices issued for four doctors as probe expands ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/06/07/211351-kidney-transplant.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kanpur, Kidney, Racket:, Recovered, audio, reveals, operations, across</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/06/07/211351-kidney-transplant.webp"><p><b>Kanpur:</b> Following a breakthrough in the Kanpur <a href="https://medicaldialogues.in/topics/illegal-kidney-transplant">kidney transplant scam</a>, police have recovered a crucial audio recording from the mobile phone of the alleged mastermind, shedding light on the gang’s operations and its network across multiple cities in <a href="https://medicaldialogues.in/state-news/uttar-pradesh">Uttar Pradesh</a>.  </p><p>Medical Dialogues had previously reported that the district health department in Meerut has started a separate investigation and issued a notice to a private hospital located on Garh Road, seeking clarification over its alleged involvement in an illegal kidney transplant racket busted in Kanpur. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/meerut-hospital-under-probe-for-alleged-links-to-kidney-transplant-racket-167891"><b>Also Read:Meerut Hospital under probe for alleged links to kidney transplant racket</b></a></p><p>According to Deputy Commissioner of Police (West) SM Qasim Abidi, the recording was sent by the mastermind to a resident of Prayagraj and an associate in the racket. In the clip, the associate mentions a broker, claiming he collected Rs 22 lakh using the mastermind’s name. The mastermind, in response, is heard dismissing the matter, claiming he and the doctor casually handle crores of rupees.</p><p>Police teams conducted a raid at the associate’s residence in Prayagraj, but he was not found. Meanwhile, the wife of the mastermind was brought in for questioning at Rawatpur police station, where she disclosed that the associate had long-standing links with the doctor, a Ghaziabad-based figure suspected to be a central player in the racket. She claimed that her husband, the mastermind, had been associated with the doctor for about a year.
</p><p>Authorities are preparing to approach the district court to seek the mastermind's remand, aiming to deepen the investigation. The recovered audio, believed to date back to December last year, has not yet been made public. So far, 9 people have been arrested in the kidney scam.
</p><p>The recording also references a woman who died following a kidney transplant. The mastermind mentions that the woman, initially brought to Delhi and admitted to Max Hospital Dwarka, passed away, prompting the associate to question the lack of medical facilities during her transport. Police confirmed she had undergone the transplant at Medilife Hospital in December, after which her condition worsened. A doctor from Kannauj has been taken into custody in connection with her death, while two other doctors remain at large.
</p><p>Investigators revealed that the broker defrauded a patient of ₹20 lakh. The broker promised a kidney transplant at half the official cost and then absconded with the money. Police are conducting raids in multiple locations to locate him.
</p><p>None of the gang members identified so far is a surgeon. The network includes doctors, hospital operators, and medical technicians working in different capacities.
</p><p>Speaking to Bhaskar English, the DCP said that the mastermind’s wife was interrogated for about 6 hours on Friday. During this, she named the manager of Ramashiv Hospital, located opposite Hallet. The manager was in contact with a Ghaziabad-based doctor. When the police interrogated him, he revealed that he had built a private hospital in Lucknow, opposite SGPGI. The doctor had asked him to get a kidney transplant done at his hospital, but he did not undergo the transplant. The operators of Medilife are also being interrogated.
</p><p>Investigation also revealed that a travel agent booked vehicles under fake names for the gang, transporting the team multiple times for hospital visits. Taxi drivers were paid a nominal rate per kilometre for these trips.
</p><p>Another doctor linked to Alpha Hospital in Meerut remains absconding; police are actively tracing his location.
</p><p>DCP Abidi stated that two OT technicians had said during interrogation that they had performed all operations at Ahuja Hospital, but an examination of their mobile phones revealed numbers of several other hospitals in the city. This includes Medilife Hospital located in Maswanpur, reports <a href="https://www.bhaskarenglish.in/local/uttar-pradesh/news/kannauj-doctor-caught-kanpur-kidney-scam-mastermind-audio-recovered-137618493.html" rel="nofollow">Bhaskar English</a>.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/kanpur-kidney-transplant-racket-lookout-notices-issued-for-four-doctors-as-probe-expands-167786"><b>Also Read:Kanpur Kidney Transplant Racket: Lookout notices issued for four doctors as probe expands</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 06/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-06april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-06april2026</guid>
<description><![CDATA[ Here are the top medical news for today:Study Suggests Higher Meat Intake May Lower Alzheimer’s Risk in Some Individuals
A new study from Karolinska Institutet, published in JAMA Network Open, offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
REFERENCE: Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
Study Examines Whether Genes Influence How Lifestyle Choices Affect Aging Outcomes
A new international study led by researchers at University of Adelaide highlights how lifestyle, socioeconomic factors, and genetics work together to shape healthy aging. Published in The Journals of Gerontology: Biological Sciences, the research provides fresh insight into why people age differently, even when they share similar habits.
The study analyzed data from over 13,000 participants in the Canadian Longitudinal Study on Aging. Researchers focused on “intrinsic capacity,” a key measure of healthy aging that reflects a person’s physical and mental abilities, including mobility, cognition, and social functioning. Higher intrinsic capacity indicates better independence and quality of life as people age.
Findings showed that healthier aging is strongly linked to modifiable lifestyle and social factors. Regular physical activity, a balanced diet, higher education, employment, and active social engagement were all associated with better functional ability. In contrast, smoking and poor sleep—both insufficient and excessive—were tied to lower intrinsic capacity and faster decline.
Importantly, the study revealed that these effects are not uniform. Genetic predisposition can influence how strongly lifestyle factors impact aging. For instance, individuals with a favorable genetic profile experienced less harm from short sleep duration. However, long sleep duration in middle age (45–64 years) was linked to worse outcomes, even among those with genetic advantages.
Adopting a Mediterranean-style diet and achieving higher educational levels showed consistent benefits, regardless of genetic background. Researchers also found that genetic influence on aging is more pronounced in midlife, while accumulated lifestyle and environmental exposures become increasingly important later in life.
The findings emphasize the concept of gene–environment interaction, where biology and daily habits jointly determine health outcomes. While genetics cannot be changed, many key factors—such as diet, exercise, sleep, and social engagement—are modifiable.
Overall, the study underscores a critical message: focusing on maintaining functional ability, rather than simply preventing disease, can significantly improve long-term health and independence. 
REFERENCE: Melkamu Bedimo Beyene, Renuka Visvanathan, Robel Alemu, Olga Theou, Beben Benyamin, Matteo Cesari, John Beard, Azmeraw T Amare, Associations and interaction effects of socioeconomic, lifestyle, and genetic factors on intrinsic capacity, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag057, https://doi.org/10.1093/gerona/glag057Researchers Identify Mechanism Behind Appetite Loss When You Are SickA groundbreaking study from University of California San Francisco, published in Nature, reveals how the gut communicates with the brain to suppress appetite during infection. The findings uncover a precise biological pathway explaining why appetite loss often appears later in illness rather than immediately.
Researchers discovered that the process begins with specialized gut cells called tuft cells, which act as immune sentinels. These cells detect parasitic infections by sensing compounds such as succinate released by worms. Once activated, tuft cells release acetylcholine, a signaling molecule typically associated with nerve cells. This was a surprising finding, as tuft cells are not neurons but can mimic their communication style.
The signal is then picked up by neighboring enterochromaffin cells, which respond by releasing serotonin. This chemical activates the vagus nerve, a key communication pathway between the gut and the brain. Through this gut–brain axis, the brain receives signals that reduce appetite and alter behavior during infection.
A key insight from the study is the two փուլ signaling pattern. Initially, tuft cells release a brief burst of acetylcholine. As the immune response intensifies and tuft cell numbers increase, they shift to a prolonged, sustained release. This delayed but stronger signal explains why appetite suppression often develops after the infection has taken hold rather than at its onset.
Animal experiments confirmed the mechanism. Mice with normal tuft cell function ate less during infection, while those unable to produce acetylcholine continued eating normally. This demonstrates that the pathway directly drives appetite loss.
Beyond infections, the discovery may have broader clinical implications. Disruptions in this signaling system could contribute to gastrointestinal disorders such as irritable bowel syndrome and food intolerances.
Overall, the study provides a clearer understanding of how immune responses influence behavior through the nervous system, opening new possibilities for targeted treatments that could regulate appetite and gut-related symptoms.
REFERENCE: Kouki K. Touhara, Jinhao Xu, Joel Castro, Hong-Erh Liang, Guochuan Li, Mariana Brizuela, Andrea M. Harrington, Sonia Garcia-Caraballo, Tracey O’Donnell, Daniel Neumann, Nathan D. Rossen, Fei Deng, Gudrun Schober, Yulong Li, Richard M. Locksley, Stuart M. Brierley, David Julius. Parasites trigger epithelial cell crosstalk to drive gut–brain signalling. Nature, 2026; DOI: 10.1038/s41586-026-10281-5
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339850-top-medical-2026-04-06t113019220.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 06April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339850-top-medical-2026-04-06t113019220.webp"><p><b>Here are the top medical news for today:</b></p><p><b>Study Suggests Higher Meat Intake May Lower Alzheimer’s Risk in Some Individuals
</b></p><p>A new study from Karolinska Institutet, published in <i>JAMA Network Open,</i> offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
</p><p>The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
</p><p>The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
</p><p>In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
</p><p>Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
</p><p>Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
</p><p>Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
</p><p><b>REFERENCE: </b>Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
</p><p><b><br></b></p><p><b>Study Examines Whether Genes Influence How Lifestyle Choices Affect Aging Outcomes
</b></p><p>A new international study led by researchers at University of Adelaide highlights how lifestyle, socioeconomic factors, and genetics work together to shape healthy aging. Published in The Journals of Gerontology: Biological Sciences, the research provides fresh insight into why people age differently, even when they share similar habits.
</p><p>The study analyzed data from over 13,000 participants in the Canadian Longitudinal Study on Aging. Researchers focused on “intrinsic capacity,” a key measure of healthy aging that reflects a person’s physical and mental abilities, including mobility, cognition, and social functioning. Higher intrinsic capacity indicates better independence and quality of life as people age.
</p><p>Findings showed that healthier aging is strongly linked to modifiable lifestyle and social factors. Regular physical activity, a balanced diet, higher education, employment, and active social engagement were all associated with better functional ability. In contrast, smoking and poor sleep—both insufficient and excessive—were tied to lower intrinsic capacity and faster decline.
</p><p>Importantly, the study revealed that these effects are not uniform. Genetic predisposition can influence how strongly lifestyle factors impact aging. For instance, individuals with a favorable genetic profile experienced less harm from short sleep duration. However, long sleep duration in middle age (45–64 years) was linked to worse outcomes, even among those with genetic advantages.
</p><p>Adopting a Mediterranean-style diet and achieving higher educational levels showed consistent benefits, regardless of genetic background. Researchers also found that genetic influence on aging is more pronounced in midlife, while accumulated lifestyle and environmental exposures become increasingly important later in life.
</p><p>The findings emphasize the concept of gene–environment interaction, where biology and daily habits jointly determine health outcomes. While genetics cannot be changed, many key factors—such as diet, exercise, sleep, and social engagement—are modifiable.
</p><p>Overall, the study underscores a critical message: focusing on maintaining functional ability, rather than simply preventing disease, can significantly improve long-term health and independence. 
</p><p><b>REFERENCE:</b> Melkamu Bedimo Beyene, Renuka Visvanathan, Robel Alemu, Olga Theou, Beben Benyamin, Matteo Cesari, John Beard, Azmeraw T Amare, Associations and interaction effects of socioeconomic, lifestyle, and genetic factors on intrinsic capacity, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag057, https://doi.org/10.1093/gerona/glag057</p><p><b><br></b></p><p><b>Researchers Identify Mechanism Behind Appetite Loss When You Are Sick</b></p><p>A groundbreaking study from University of California San Francisco, published in Nature, reveals how the gut communicates with the brain to suppress appetite during infection. The findings uncover a precise biological pathway explaining why appetite loss often appears later in illness rather than immediately.
</p><p>Researchers discovered that the process begins with specialized gut cells called tuft cells, which act as immune sentinels. These cells detect parasitic infections by sensing compounds such as succinate released by worms. Once activated, tuft cells release acetylcholine, a signaling molecule typically associated with nerve cells. This was a surprising finding, as tuft cells are not neurons but can mimic their communication style.
</p><p>The signal is then picked up by neighboring enterochromaffin cells, which respond by releasing serotonin. This chemical activates the vagus nerve, a key communication pathway between the gut and the brain. Through this gut–brain axis, the brain receives signals that reduce appetite and alter behavior during infection.
</p><p>A key insight from the study is the two փուլ signaling pattern. Initially, tuft cells release a brief burst of acetylcholine. As the immune response intensifies and tuft cell numbers increase, they shift to a prolonged, sustained release. This delayed but stronger signal explains why appetite suppression often develops after the infection has taken hold rather than at its onset.
</p><p>Animal experiments confirmed the mechanism. Mice with normal tuft cell function ate less during infection, while those unable to produce acetylcholine continued eating normally. This demonstrates that the pathway directly drives appetite loss.
</p><p>Beyond infections, the discovery may have broader clinical implications. Disruptions in this signaling system could contribute to gastrointestinal disorders such as irritable bowel syndrome and food intolerances.
</p><p>Overall, the study provides a clearer understanding of how immune responses influence behavior through the nervous system, opening new possibilities for targeted treatments that could regulate appetite and gut-related symptoms.
</p><p><b>REFERENCE:</b> Kouki K. Touhara, Jinhao Xu, Joel Castro, Hong-Erh Liang, Guochuan Li, Mariana Brizuela, Andrea M. Harrington, Sonia Garcia-Caraballo, Tracey O’Donnell, Daniel Neumann, Nathan D. Rossen, Fei Deng, Gudrun Schober, Yulong Li, Richard M. Locksley, Stuart M. Brierley, David Julius. Parasites trigger epithelial cell crosstalk to drive gut–brain signalling. Nature, 2026; DOI: 10.1038/s41586-026-10281-5
</p>]]> </content:encoded>
</item>

<item>
<title>Doctors, faculty call for immediate rollout of NExT exam for MBBS students</title>
<link>https://edusehat.com/en/doctors-faculty-call-for-immediate-rollout-of-next-exam-for-mbbs-students</link>
<guid>https://edusehat.com/en/doctors-faculty-call-for-immediate-rollout-of-next-exam-for-mbbs-students</guid>
<description><![CDATA[ New Delhi: Resident doctors, MBBS students, and faculty from leading institutions, including All India Institute of Medical Sciences, AIIMS New Delhi, have called for the immediate implementation of the National Exit Test (NExT).In an editorial published last month in the Journal of Family Medicine and Primary Care, titled &quot;Immediate NExT rollout is vital for MBBS students and the medical education ecosystem of India&quot;, medicos, resident doctors and faculty associated with the departments of medicine, gynaecology, psychiatry, paediatric surgery from institutes such as AIIMS New Delhi, AIIMS Nagpur, AIIMS Patna, and RML have sought implementation of the National Exit Test- arguing that the exam may enhance validity and reliability of assessments, support student learning, increase institutional transparency, and contribute to the development of a competent medical workforce.Also Read:NExT exam divides medical fraternity: Immediate rollout or phased implementation?They added that these exams are often poorly aligned with competency-based training. The authors said NExT aims to introduce a uniform, transparent and clinically relevant evaluation framework.
NExT, introduced through the National Medical Commission Act, 2019, and further elaborated in the 2023 Gazette notification, was envisaged as a singular qualifying examination to replace three existing exams in the field of medicine-the final MBBS exams, the National Eligibility-Entrance Test for post-graduate seats (NEET-PG), and the Foreign Medical Graduate Examination (FMGE) for foreign medical graduates to practice medicine in India.However, the test has been postponed multiple times, creating uncertainty and delaying reforms, the authors said. The editorial explains why immediate implementation is essential.
It said NExT can improve the validity and reliability of assessments, support student learning, and increase institutional transparency. It also aimed to help build a more competent medical workforce.
The authors noted that university-based MBBS final exams vary widely in quality and fairness. Theory papers are often subjective. Content does not always align with national competencies, and evaluation standards differ across institutions.“This creates inconsistency in determining whether a graduate is ready to practise medicine,” they said. They also pointed out that current PG entrance tests rely on a relatively small pool of about 200 Multiple Choice Questions (MCQs) to assess the entire MBBS curriculum.
This limited sampling reduces reliability and increases the role of chance. The focus on recall-based questions also promotes coaching-driven preparation over clinical learning. Currently, students must prepare for two very different exams.
The university final exam is theory-heavy and long-answer-based, while the PG entrance test is entirely MCQ-based. “This mismatch forces students to adopt different strategies and adds to stress,” the authors said. The NExT aims to unify both into a single standardised exam.
“A national exit examination is not just a format change. It is a shift towards clinically oriented assessment with a larger and uniform question pool,” they said. This, they added, will improve learning outcomes and raise standards. The authors said NExT Step 1 includes a larger MCQ pool based on clinical vignettes and applied reasoning.This reflects real-life decision-making. NExT Step 2 aims to assess practical skills, communication and clinical competence through structured clinical exams, though details are still awaited.
They added that NExT applies to all students, including those from government and private colleges, as well as foreign medical graduates.
“By assessing all candidates through the same national standard, it strengthens public confidence in medical training and ensures that every licensed doctor demonstrates a uniform threshold of competence, regardless of where they received their education,” the authors said.
The editorial said a unified test will reduce the burden of preparing for multiple exams with different formats. The NExT Step 1 scores may be used not only for postgraduate admissions but also for government service positions, and various fellowships or scholarship opportunities. A single score, it said, will improve transparency and reduce arbitrary selection processes.
The editorial highlighted that a uniform national benchmark will allow colleges, especially new and private institutions, to demonstrate their training quality through measurable student outcomes.
“Experiences from engineering, management, and dental education over the past two decades illustrate how rapid expansion without strong evaluation mechanisms can compromise quality.Many institutions in these sectors lacked rigorous student assessment processes and gradually became degree-granting centres rather than fostering meaningful learning. The closure of several such colleges highlights the long-term risks associated with expansion in the absence of credible quality assurance,” the editorial stated.
“In medicine, poor training can lead to serious harm. NExT will set a national minimum standard that every graduate must achieve before independent practice, thereby protecting public health and ensuring trust in the profession,” the editorial stressed. To ensure a smooth rollout, the authors recommended preparatory support, including multiple mock tests, sample questions, workbooks, and detailed syllabus material.Also Read:Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKEThe NExT Controversy:
Ever since its first announcement, the issue of the NExT exam has been making waves in the medical fraternity. Although back in 2023, NMC released the NExT regulations and announced conducting the exam for the 2019 MBBS batch, it was ultimately put on hold for an indefinite time.
NMC had deferred the exam after the Ministry intervened following the protests in this regard by the 2019 MBBS batch, who had termed it a violation of the NMC Act, 2019. After announcing the postponement of the NExT exam, NMC had also cancelled the mock test for NExT.
Amidst the debate and uncertainty regarding the conduct of the NExT exam, NMC made the issue open to all the stakeholders. Medical Dialogues had earlier reported that the stakeholders were asked to submit their opinion on whether the NExT exam should replace the conventional MBBS final year exam, held separately in addition to the MBBS final year exam, or be conducted in any other manner.
Further, the stakeholders were asked to share their opinions on various aspects, such as the time and manner, exam pattern, way of conducting the exam, syllabus of NExT, and several other issues.
Last year, NMC Chairperson, Dr. Abhijat Sheth, had pointed out that the proposed licentiate-entrance test, National Exit Test (NExT), may not see implementation for the next couple of years till the National Medical Commission (NMC) perfects the model for the exam.
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/06/29/213157-next-exam-in-may-2024-nmc-releases-information-brochure-for-the-mock-test-check-out-details.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Doctors, faculty, call, for, immediate, rollout, NExT, exam, for, MBBS, students</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/06/29/213157-next-exam-in-may-2024-nmc-releases-information-brochure-for-the-mock-test-check-out-details.webp"><p><b>New Delhi: </b>Resident doctors, MBBS students, and faculty from leading institutions, including All India Institute of Medical Sciences, AIIMS New Delhi, have called for the immediate implementation of the <a href="https://medicaldialogues.in/topics/NExT">National Exit Test (NExT).</a></p><p>In an editorial published last month in the Journal of Family Medicine and Primary Care, titled "Immediate <a href="https://medicaldialogues.in/topics/NExT">NExT </a>rollout is vital for MBBS students and the medical education ecosystem of India", medicos, resident doctors and faculty associated with the departments of medicine, gynaecology, psychiatry, paediatric surgery from institutes such as AIIMS New Delhi, AIIMS Nagpur, AIIMS Patna, and RML have sought implementation of the National Exit Test- arguing that the exam may enhance validity and reliability of assessments, support student learning, increase institutional transparency, and contribute to the development of a competent medical workforce.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/next-exam-divides-medical-fraternity-immediate-rollout-or-phased-implementation-168068">Also Read:NExT exam divides medical fraternity: Immediate rollout or phased implementation?</a></p><p>They added that these exams are often poorly aligned with competency-based training. The authors said NExT aims to introduce a uniform, transparent and clinically relevant evaluation framework.
</p><p>NExT, introduced through the National Medical Commission Act, 2019, and further elaborated in the 2023 Gazette notification, was envisaged as a singular qualifying examination to replace three existing exams in the field of medicine-the final MBBS exams, the National Eligibility-Entrance Test for post-graduate seats (NEET-PG), and the Foreign Medical Graduate Examination (FMGE) for foreign medical graduates to practice medicine in India.</p><p>However, the test has been postponed multiple times, creating uncertainty and delaying reforms, the authors said. The editorial explains why immediate implementation is essential.
</p><p>It said NExT can improve the validity and reliability of assessments, support student learning, and increase institutional transparency. It also aimed to help build a more competent medical workforce.
</p><p>The authors noted that university-based MBBS final exams vary widely in quality and fairness. Theory papers are often subjective. Content does not always align with national competencies, and evaluation standards differ across institutions.</p><p>“This creates inconsistency in determining whether a graduate is ready to practise medicine,” they said. They also pointed out that current PG entrance tests rely on a relatively small pool of about 200 Multiple Choice Questions (MCQs) to assess the entire MBBS curriculum.
</p><p>This limited sampling reduces reliability and increases the role of chance. The focus on recall-based questions also promotes coaching-driven preparation over clinical learning. Currently, students must prepare for two very different exams.
</p><p>The university final exam is theory-heavy and long-answer-based, while the PG entrance test is entirely MCQ-based. “This mismatch forces students to adopt different strategies and adds to stress,” the authors said. The NExT aims to unify both into a single standardised exam.
</p><p>“A national exit examination is not just a format change. It is a shift towards clinically oriented assessment with a larger and uniform question pool,” they said. This, they added, will improve learning outcomes and raise standards. The authors said NExT Step 1 includes a larger MCQ pool based on clinical vignettes and applied reasoning.</p><p>This reflects real-life decision-making. NExT Step 2 aims to assess practical skills, communication and clinical competence through structured clinical exams, though details are still awaited.
</p><p>They added that NExT applies to all students, including those from government and private colleges, as well as foreign medical graduates.
</p><p>“By assessing all candidates through the same national standard, it strengthens public confidence in medical training and ensures that every licensed doctor demonstrates a uniform threshold of competence, regardless of where they received their education,” the authors said.
</p><p>The editorial said a unified test will reduce the burden of preparing for multiple exams with different formats. The NExT Step 1 scores may be used not only for postgraduate admissions but also for government service positions, and various fellowships or scholarship opportunities. A single score, it said, will improve transparency and reduce arbitrary selection processes.
</p><p>The editorial highlighted that a uniform national benchmark will allow colleges, especially new and private institutions, to demonstrate their training quality through measurable student outcomes.
</p><p>“Experiences from engineering, management, and dental education over the past two decades illustrate how rapid expansion without strong evaluation mechanisms can compromise quality.</p><p>Many institutions in these sectors lacked rigorous student assessment processes and gradually became degree-granting centres rather than fostering meaningful learning. The closure of several such colleges highlights the long-term risks associated with expansion in the absence of credible quality assurance,” the editorial stated.
</p><p>“In medicine, poor training can lead to serious harm. NExT will set a national minimum standard that every graduate must achieve before independent practice, thereby protecting public health and ensuring trust in the profession,” the editorial stressed. To ensure a smooth rollout, the authors recommended preparatory support, including multiple mock tests, sample questions, workbooks, and detailed syllabus material.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/fact-check/fact-check-viral-notice-claiming-next-exam-from-2022-mbbs-batch-onwards-is-fake-167887">Also Read:Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE</a></p><p>The NExT Controversy:
</p><p>Ever since its first announcement, the issue of the NExT exam has been making waves in the medical fraternity. Although back in 2023, NMC released the NExT regulations and announced conducting the exam for the 2019 MBBS batch, it was ultimately put on hold for an indefinite time.
</p><p>NMC had deferred the exam after the Ministry intervened following the protests in this regard by the 2019 MBBS batch, who had termed it a violation of the NMC Act, 2019. After announcing the postponement of the NExT exam, NMC had also cancelled the mock test for NExT.
</p><p>Amidst the debate and uncertainty regarding the conduct of the NExT exam, NMC made the issue open to all the stakeholders. Medical Dialogues had earlier reported that the stakeholders were asked to submit their opinion on whether the NExT exam should replace the conventional MBBS final year exam, held separately in addition to the MBBS final year exam, or be conducted in any other manner.
</p><p>Further, the stakeholders were asked to share their opinions on various aspects, such as the time and manner, exam pattern, way of conducting the exam, syllabus of NExT, and several other issues.
</p><p>Last year, NMC Chairperson, Dr. Abhijat Sheth, had pointed out that the proposed licentiate-entrance test, National Exit Test (NExT), may not see implementation for the next couple of years till the National Medical Commission (NMC) perfects the model for the exam.
</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Odisha hikes SC, ST quota, introduces SEBC reservation in medical, dental, ayurveda, homeopathy, nursing education</title>
<link>https://edusehat.com/en/odisha-hikes-sc-st-quota-introduces-sebc-reservation-in-medical-dental-ayurveda-homeopathy-nursing-education</link>
<guid>https://edusehat.com/en/odisha-hikes-sc-st-quota-introduces-sebc-reservation-in-medical-dental-ayurveda-homeopathy-nursing-education</guid>
<description><![CDATA[ Bhubaneswar: The Odisha government has enhanced the quotas for Scheduled Caste (SC) and Scheduled Tribe (ST) category students and introduced reservation for the Socially and Economically Backward Classes (SEBC) in medical, dental, ayurveda, homeopathy and nursing education.The decision was taken at the cabinet meeting chaired by Chief Minister Mohan Charan Majhi on Saturday.Also Read:Odisha to set up 4 new medical colleges, 150 more MBBS seats to be added&quot;While the quota for the ST students has been raised from 12 per cent to 22.50 per cent, it has been enhanced from 8 per cent to 16.25 per cent for SCs. The state government has introduced an 11.25 per cent reservation for OBC students, who are known as SEBC in Odisha,&quot; Majhi told reporters after the meeting, quotes PTIHe said this new reservation system will be implemented across universities, their affiliated colleges and educational institutions, ITIs and polytechnics in the state in the fields of medicine, surgery, dental, nursing, pharmacy, allied health sciences, psychiatry, ayurveda, homeopathy, as well as engineering, technology, management, computer applications, agriculture and allied sciences, architecture, planning and cinematic arts.This new reservation system will also be implemented in awarding certificates, diplomas and degrees at the undergraduate and postgraduate levels in any other courses notified by the state government from time to time, a document released by the Chief Minister&#039;s Office (CMO) said.
Majhi pointed out that even though the ST population in the state is more than 22 per cent, for a long time, the reservation for them in technical, professional, medical and allied courses was only 12 per cent.Also Read:Odisha suspends ten hospitals over irregularities in Ayushman BharatMedical Dialogues had earlier reported that to expand access to medical education, the Odisha government is planning to open four new medical colleges across the state.Currently, the state has a total of 3,025 Bachelor of Medicine and Bachelor of Surgery (MBBS) seats. Eight nursing colleges and 21 ANM training centres are operational in Odisha.Health and Family Welfare Minister Dr Mukesh Mahaling provided this information in the State Assembly on Monday. This information was shared in response to a written question asked by Mohana MLA Dasharathi Gomango.While replying to the questions, the minister informed the State Assembly that, out of the existing 3,025 seats, 1,800 seats are in 14 government medical colleges, 1,100 seats are in six private colleges, and 125 seats are at AIIMS Bhubaneswar. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339905-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-39.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Odisha, hikes, SC, quota, introduces, SEBC, reservation, medical, dental, ayurveda, homeopathy, nursing, education</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339905-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-39.webp"><p><b>Bhubaneswar: </b>The Odisha government has enhanced the quotas for <a href="https://medicaldialogues.in/topics/Scheduled-Caste">Scheduled Caste</a> (SC) and Scheduled Tribe (ST) category students and introduced reservation for the Socially and Economically Backward Classes (SEBC) in medical, dental, ayurveda, homeopathy and nursing education.</p><p>The decision was taken at the cabinet meeting chaired by <a href="https://medicaldialogues.in/topics/Chief-Minister">Chief Minister</a> <a href="https://medicaldialogues.in/topics/Mohan-Charan-Majhi">Mohan Charan Majhi</a> on Saturday.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/odisha/odisha-to-set-up-4-new-medical-colleges-150-more-mbbs-seats-to-be-added-167733">Also Read:Odisha to set up 4 new medical colleges, 150 more MBBS seats to be added</a></div><p>"While the quota for the ST students has been raised from 12 per cent to 22.50 per cent, it has been enhanced from 8 per cent to 16.25 per cent for SCs. The state government has introduced an 11.25 per cent reservation for OBC students, who are known as SEBC in Odisha," Majhi told reporters after the meeting, quotes PTI</p><p>He said this new reservation system will be implemented across universities, their affiliated colleges and educational institutions, ITIs and polytechnics in the state in the fields of medicine, surgery, dental, nursing, pharmacy, allied health sciences, psychiatry, ayurveda, homeopathy, as well as engineering, technology, management, computer applications, agriculture and allied sciences, architecture, planning and cinematic arts.</p><p>This new reservation system will also be implemented in awarding certificates, diplomas and degrees at the undergraduate and postgraduate levels in any other courses notified by the state government from time to time, a document released by the Chief Minister's Office (CMO) said.
</p><p>Majhi pointed out that even though the ST population in the state is more than 22 per cent, for a long time, the reservation for them in technical, professional, medical and allied courses was only 12 per cent.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/odisha-suspends-ten-hospitals-over-irregularities-in-ayushman-bharat-167662">Also Read:Odisha suspends ten hospitals over irregularities in Ayushman Bharat</a></div><div class="pasted-from-word-wrapper"><p>Medical Dialogues had earlier reported that to expand access to medical education, the Odisha government is planning to open four new medical colleges across the state.</p><p>Currently, the state has a total of 3,025 Bachelor of Medicine and Bachelor of Surgery (MBBS) seats. Eight nursing colleges and 21 ANM training centres are operational in Odisha.</p><p>Health and Family Welfare Minister Dr Mukesh Mahaling provided this information in the State Assembly on Monday. This information was shared in response to a written question asked by Mohana MLA Dasharathi Gomango.</p><p>While replying to the questions, the minister informed the State Assembly that, out of the existing 3,025 seats, 1,800 seats are in 14 government medical colleges, 1,100 seats are in six private colleges, and 125 seats are at AIIMS Bhubaneswar.</p></div>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 06/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-06april2026</link>
<guid>https://edusehat.com/en/health-bulletin-06april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:Parliamentary Panel Flags Doctor Burnout, Urges Clinical Duty Hour Rules With Mandatory RestTaking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods and monitored rosters.For more details, check out the full story on the link below:Doctors&#039; burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rostersNMC’s MBBS Student Feedback System Gains Support from DoctorsThe online feedback system for MBBS students, which was recently introduced by the National Medical Commission (NMC) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback.For more details, check out the full story on the link below:Will NMC&#039;s MBBS student feedback system improve medical education quality? Here&#039;s what doctors sayPatient Data Leak Case: Bombay High Court Refuses to Quash FIR Against DoctorThe Nagpur bench of the Bombay High Court recently denied quashing an FIR against a doctor, accused of using leaked patient data to grow his own practice.It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. &quot;On plain reading of the complaint and other investigation papers, the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission, he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,&quot; the bench noted.For more details, check out the full story on the link below:Bombay HC refuses to quash criminal proceedings against doctor in patient data leak caseCounterfeit Goods From Toothpaste to Paneer Penetrate Homes, Raids Put Essentials Under ScannerA wave of police raids across India has exposed large-scale counterfeiting of everyday consumables, raising serious public health concerns. From fake toothpaste and soft drinks to adulterated paneer and ginger-garlic paste, illegal units have been found producing substandard goods using harmful chemicals in unhygienic conditions. The Food Safety and Standards Authority of India (FSSAI) recently filed an FIR with the Delhi Police over social media posts alleging widespread fake paneer sales, triggering debate over transparency. Authorities have invoked provisions under the Bharatiya Nyaya Sanhita and the Food Safety Act to crack down on offenders, reports The Print.Investigations revealed organised rackets, including counterfeit Sensodyne toothpaste units in Delhi and reconditioned expired soft drinks relabelled for sale. Raids in Surat and Hyderabad uncovered adulterated paneer and contaminated ginger-garlic paste made with inferior ingredients. Officials seized thousands of kilograms of unsafe products and arrested the key accused. The FSSAI reported that over 5.18 lakh food samples were tested in three years, with thousands found unsafe, underscoring the scale of the crisis and the need for stricter enforcement and consumer awareness. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339935-health-bulletin-9.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 06April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339935-health-bulletin-9.webp"><p>Here are the top health stories for the day:</p><p><b>Parliamentary Panel Flags Doctor Burnout, Urges Clinical Duty Hour Rules With Mandatory Rest</b></p><p><span>Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.</span></p><div class="pasted-from-word-wrapper"><p>Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a "Clinical <a href="https://medicaldialogues.in/topics/duty-hours">Duty Hours</a> Regulation" policy with mandatory rest periods and monitored rosters.</p><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/doctors/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters-167982"><i><b>Doctors' burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters</b></i></a></p><p><b></b></p><p><b>NMC’s MBBS Student Feedback System Gains Support from Doctors</b></p><p>The online feedback system for MBBS students, which was recently introduced by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.</p><p>For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback.</p><p><i>For more details, check out the full story on the link below:</i></p><p><a href="https://medicaldialogues.in/news/education/will-nmcs-mbbs-student-feedback-system-improve-medical-education-quality-heres-what-doctors-say-167961"><i>Will NMC's MBBS student feedback system improve medical education quality? Here's what doctors say</i></a></p><p><b></b></p><p><b>Patient Data Leak Case: Bombay High Court Refuses to Quash FIR Against Doctor</b></p><p>The Nagpur bench of the <a href="https://medicaldialogues.in/topics/bombay-high-court">Bombay High Court </a>recently denied quashing an <a href="https://medicaldialogues.in/topics/FIR">FIR</a> against a doctor, accused of using leaked patient data to grow his own practice.<b></b></p><div class="pasted-from-word-wrapper"><p>It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. <i>"On plain reading of the complaint and other investigation papers, the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission, he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,"</i> the bench noted.</p></div><p><i><b>For more details, check out the full story on the link below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/doctors/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case-167978"><i><b>Bombay HC refuses to quash criminal proceedings against doctor in patient data leak case</b></i></a></p><p><b></b></p><p><b>Counterfeit Goods From Toothpaste to Paneer Penetrate Homes, Raids Put Essentials Under Scanner</b></p><p>A wave of police raids across India has exposed large-scale counterfeiting of everyday consumables, raising serious public health concerns. From fake toothpaste and soft drinks to adulterated paneer and ginger-garlic paste, illegal units have been found producing substandard goods using harmful chemicals in unhygienic conditions. </p><p>The Food Safety and Standards Authority of India (FSSAI) recently filed an FIR with the Delhi Police over social media posts alleging widespread fake paneer sales, triggering debate over transparency. Authorities have invoked provisions under the Bharatiya Nyaya Sanhita and the Food Safety Act to crack down on offenders, reports The Print.</p><p>Investigations revealed organised rackets, including counterfeit Sensodyne toothpaste units in Delhi and reconditioned expired soft drinks relabelled for sale. Raids in Surat and Hyderabad uncovered adulterated paneer and contaminated ginger-garlic paste made with inferior ingredients. Officials seized thousands of kilograms of unsafe products and arrested the key accused. The FSSAI reported that over 5.18 lakh food samples were tested in three years, with thousands found unsafe, underscoring the scale of the crisis and the need for stricter enforcement and consumer awareness.</p></div>]]> </content:encoded>
</item>

<item>
<title>&amp;quot;Failure to provide written grounds renders arrest illegal&amp;quot;: Supreme Court grants bail to two doctors</title>
<link>https://edusehat.com/en/failure-to-provide-written-grounds-renders-arrest-illegal-supreme-court-grants-bail-to-two-doctors</link>
<guid>https://edusehat.com/en/failure-to-provide-written-grounds-renders-arrest-illegal-supreme-court-grants-bail-to-two-doctors</guid>
<description><![CDATA[ New Delhi: Holding that failure to provide written grounds of arrest violates constitutional rights and renders the arrests illegal, the Supreme Court of India has granted bail to two doctors from a corporate hospital in Amritsar who were arrested in connection with a narcotics case involving the procurement of a large quantity of Tramadol tablets. While granting relief to the doctors, the Division bench of Justices Vikram Nath and Sandeep Mehta observed that it is the duty of the arresting officer to provide the grounds of arrest in writing at least two hours before producing the accused before the Magistrate, as mandated in its Mihir Rajesh Shah case ruling. However, this requirement was not followed in this case.The Court reiterated that failure to comply with this mandate renders the arrest illegal and entitles the accused to immediate release.Emphasising that the rules were not followed before arresting the doctors, the Bench held, &quot;It is no longer res integra that supplying the grounds of arrest to the accused in writing before the arrest or, in a given case, under exceptional circumstances, immediately thereafter, is the mandate of the constitutional guarantees provided under Article 22(1) read with Article 21 of the Constitution of India.&quot;The Apex Court was hearing the appellants in this case, who are two medical professionals associated with the management of a corporate hospital located on Batala Road, Amritsar.On April 19, 2025, an order for Tramadol tablets was placed with the manufacturer, M/s Ballista Pharmaceuticals, through a written request signed by Dr ***, who was handling the operations of Corporate Medicos, the pharmacy unit within the hospital.According to the appellants, due to an error on the supplier’s side, the company mistakenly sent 2000 tablets instead of the 200 tablets that were actually ordered. The consignment was received on April 21, 2025. Upon noticing the excess quantity, the appellants claim that the package was neither opened nor used and remained sealed.They further stated that on April 27, 2025, the hospital wrote to the supplier requesting the return of the extra 1800 tablets. The tablets had originally been ordered for treating admitted patients. However, before the excess stock could be returned, officials from the Narcotics Control Bureau (NCB), Amritsar Zonal Unit, conducted a search at the premises of M/s Ballista Pharmaceuticals on May 1, 2025, and recovered 31,900 Tramadol tablets.Following this, a case was registered against the proprietor of M/s Ballista Pharmaceuticals. As part of the investigation, the NCB also raided Corporate Medicos located within the hospital and seized the 2000 tablets, which were still in a sealed condition.Subsequently, both the appealants, a senior orthopaedic surgeon who is the owner of the hospital, and the proprietor of the pharmacy, were summoned under Section 67 of the Narcotic Drugs and Psychotropic Substances Act, 1985. After recording their statements, both were arrested on May 3, 2025, and sent to judicial custody.The appellants later approached the Punjab and Haryana High Court seeking regular bail. However, their bail applications were rejected by a Single Judge through two separate orders dated November 13, 2025.In their bail applications filed under Section 483 of the Bharatiya Nagarik Suraksha Sanhita, 2023, the appellants argued that they were not provided with the &quot;grounds of arrest&quot; before being taken into custody in this case.After their bail pleas were rejected by the High Court, the appellants approached the Supreme Court by filing appeals through special leave.Senior advocates Shri S. Nagamuthu and Shri P.V. Dinesh, appearing for the appellants, relied on the Supreme Court judgment in Mihir Rajesh Shah v. State of Maharashtra &amp; Another (2026) and argued that not providing the grounds of arrest in writing violates the fundamental rights guaranteed under Articles 21 and 22 of the Constitution. They further submitted that if an arrested person is not informed of the grounds of arrest, the arrest itself becomes illegal, and the person must be released from custody. They vehemently and fervently contended that &quot;mere mentioning of the case details in the arrest memo would not be a substitute for the mandatory requirement of furnishing the accused with the grounds of arrest.&quot;On the other hand, Additional Solicitor General Shri Anil Kaushik, representing the respondents, opposed these arguments. He argued that the grounds of arrest were clearly mentioned in the arrest memo itself, and therefore, the legal requirements laid down in the Mihir Rajesh Shah case were properly followed. He further submitted that the compliance report filed under Section 57 of the NDPS Act also mentions that the grounds of arrest were explained to the accused.Additionally, the respondents argued that the appellants had knowingly obtained a large quantity of Tramadol tablets from the manufacturer, even though their hospital’s license did not permit dealing with Tramadol.Court&#039;s ObservationAfter hearing both sides and going through the materials, the Apex Court held, &quot;It is no longer res integra that supplying the grounds of arrest to the accused in writing before the arrest or, in a given case, under exceptional circumstances, immediately thereafter, is the mandate of the constitutional guarantees provided under Article 22(1) read with Article 21 of the Constitution of India.&quot;While referring to its ruling in Mihir Rajesh Shah, the court said that it clearly ruled that any failure to follow the requirement of providing the grounds of arrest in writing would render the arrest illegal, and the accused would be entitled to immediate release.In the present case, the Court noted that the arrest memo was prepared in a standard template format and included a statement that the grounds of arrest had been explained to the accused before the arrest. This indicates that the grounds were communicated only orally prior to the formal arrest.&quot;Consequently, it was incumbent upon the arresting officer to have supplied the memo of grounds of arrest in writing to the accused two hours prior to producing them before the Magistrate as per the mandate of Mihir Rajesh Shah (supra) which apparently has not been followed in this case,&quot; the bench observed. In view of these findings, the Court held that the appellants are entitled to be released from custody by applying the principles laid down in Mihir Rajesh Shah. Accordingly, the Court directed that the appellants be released on bail immediately.To view the court order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/06/73877202525469599finalorder01-apr-2026-339953.pdfAlso read- Stem cell therapy: NMC issues advisory for medical colleges to comply with Supreme Court directions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/10/13/304308-supreme-court-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Failure, provide, written, grounds, renders, arrest, illegal:, Supreme, Court, grants, bail, two, doctors</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/10/13/304308-supreme-court-1.webp"><p><b>New Delhi: </b>Holding that failure to provide written grounds of arrest violates constitutional rights and renders the arrests illegal, the <a href="https://medicaldialogues.in/topics/supreme-court" target="_blank">Supreme Court</a> of India has granted bail to two <a href="https://medicaldialogues.in/news/health/doctors" target="_blank">doctors</a> from a corporate hospital in Amritsar who were arrested in connection with a narcotics case involving the procurement of a large quantity of Tramadol tablets. </p><p>While granting relief to the doctors, the Division bench of Justices Vikram Nath and Sandeep Mehta observed that it is the duty of the arresting officer to provide the grounds of arrest in writing at least two hours before producing the accused before the Magistrate, as mandated in its Mihir Rajesh Shah case ruling. However, this requirement was not followed in this case.</p><p>The Court reiterated that failure to comply with this mandate renders the arrest illegal and entitles the accused to immediate release.</p><p>Emphasising that the rules were not followed before arresting the doctors, the Bench held, </p><blockquote>"It is no longer res integra that supplying the grounds of arrest to the accused in writing before the arrest or, in a given case, under exceptional circumstances, immediately thereafter, is the mandate of the constitutional guarantees provided under Article 22(1) read with Article 21 of the Constitution of India."</blockquote><p>The Apex Court was hearing the appellants in this case, who are two medical professionals associated with the management of a corporate hospital located on Batala Road, Amritsar.</p><p>On April 19, 2025, an order for Tramadol tablets was placed with the manufacturer, M/s Ballista Pharmaceuticals, through a written request signed by Dr ***, who was handling the operations of Corporate Medicos, the pharmacy unit within the hospital.</p><p>According to the appellants, due to an error on the supplier’s side, the company mistakenly sent 2000 tablets instead of the 200 tablets that were actually ordered. The consignment was received on April 21, 2025. Upon noticing the excess quantity, the appellants claim that the package was neither opened nor used and remained sealed.</p><p>They further stated that on April 27, 2025, the hospital wrote to the supplier requesting the return of the extra 1800 tablets. The tablets had originally been ordered for treating admitted patients. However, before the excess stock could be returned, officials from the Narcotics Control Bureau (NCB), Amritsar Zonal Unit, conducted a search at the premises of M/s Ballista Pharmaceuticals on May 1, 2025, and recovered 31,900 Tramadol tablets.</p><p>Following this, a case was registered against the proprietor of M/s Ballista Pharmaceuticals. As part of the investigation, the NCB also raided Corporate Medicos located within the hospital and seized the 2000 tablets, which were still in a sealed condition.</p><p>Subsequently, both the appealants, a senior orthopaedic surgeon who is the owner of the hospital, and the proprietor of the pharmacy, were summoned under Section 67 of the Narcotic Drugs and Psychotropic Substances Act, 1985. After recording their statements, both were arrested on May 3, 2025, and sent to judicial custody.</p><p>The appellants later approached the Punjab and Haryana High Court seeking regular bail. However, their bail applications were rejected by a Single Judge through two separate orders dated November 13, 2025.</p><p>In their bail applications filed under Section 483 of the Bharatiya Nagarik Suraksha Sanhita, 2023, the appellants argued that they were not provided with the "grounds of arrest" before being taken into custody in this case.</p><p>After their bail pleas were rejected by the High Court, the appellants approached the Supreme Court by filing appeals through special leave.</p><p>Senior advocates Shri S. Nagamuthu and Shri P.V. Dinesh, appearing for the appellants, relied on the Supreme Court judgment in Mihir Rajesh Shah v. State of Maharashtra & Another (2026) and argued that not providing the grounds of arrest in writing violates the fundamental rights guaranteed under Articles 21 and 22 of the Constitution. They further submitted that if an arrested person is not informed of the grounds of arrest, the arrest itself becomes illegal, and the person must be released from custody. </p><p>They vehemently and fervently contended that <i>"mere mentioning of the case details in the arrest memo would not be a substitute for the mandatory requirement of furnishing the accused with the grounds of arrest."</i></p><p>On the other hand, Additional Solicitor General Shri Anil Kaushik, representing the respondents, opposed these arguments. He argued that the grounds of arrest were clearly mentioned in the arrest memo itself, and therefore, the legal requirements laid down in the Mihir Rajesh Shah case were properly followed. </p><p>He further submitted that the compliance report filed under Section 57 of the NDPS Act also mentions that the grounds of arrest were explained to the accused.</p><p>Additionally, the respondents argued that the appellants had knowingly obtained a large quantity of Tramadol tablets from the manufacturer, even though their hospital’s license did not permit dealing with Tramadol.</p><p><b>Court's Observation</b></p><p>After hearing both sides and going through the materials, the Apex Court held, <i>"It is no longer res integra that supplying the grounds of arrest to the accused in writing before the arrest or, in a given case, under exceptional circumstances, immediately thereafter, is the mandate of the constitutional guarantees provided under Article 22(1) read with Article 21 of the Constitution of India."</i></p><p>While referring to its ruling in Mihir Rajesh Shah, the court said that it clearly ruled that any failure to follow the requirement of providing the grounds of arrest in writing would render the arrest illegal, and the accused would be entitled to immediate release.</p><p>In the present case, the Court noted that the arrest memo was prepared in a standard template format and included a statement that the grounds of arrest had been explained to the accused before the arrest. This indicates that the grounds were communicated only orally prior to the formal arrest.</p><blockquote>"Consequently, it was incumbent upon the arresting officer to have supplied the memo of grounds of arrest in writing to the accused two hours prior to producing them before the Magistrate as per the mandate of Mihir Rajesh Shah (supra) which apparently has not been followed in this case," the bench observed. </blockquote><p>In view of these findings, the Court held that the appellants are entitled to be released from custody by applying the principles laid down in Mihir Rajesh Shah. Accordingly, the Court directed that the appellants be released on bail immediately.</p><p><b>To view the court order, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/73877202525469599finalorder01-apr-2026-339953.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/06/73877202525469599finalorder01-apr-2026-339953.pdf</b></a></div><p><b>Also read-<a href="https://medicaldialogues.in/health-news/nmc/stem-cell-therapy-nmc-issues-advisory-for-medical-colleges-to-comply-with-supreme-court-directions-167316" target="_blank"> Stem cell therapy: NMC issues advisory for medical colleges to comply with Supreme Court directions</a></b></p>]]> </content:encoded>
</item>

<item>
<title>NExT exam divides medical fraternity: Immediate rollout or phased implementation?</title>
<link>https://edusehat.com/en/next-exam-divides-medical-fraternity-immediate-rollout-or-phased-implementation</link>
<guid>https://edusehat.com/en/next-exam-divides-medical-fraternity-immediate-rollout-or-phased-implementation</guid>
<description><![CDATA[ New Delhi: The National Medical Commission&#039;s proposed common exit -licentiate examination, i.e., the National Exit Test (NExT), is yet to see the light of day. Amid this, a fresh debate has emerged within the medical community over the exam&#039;s necessity and timing of implementation.While a section of doctors have sought the implementation of NExT examination for MBBS students, some have expressed concerns regarding the immediate rollout.NExT was introduced through the National Medical Commission Act, 2019, as a common exit-licentiate examination, which will replace three existing exams- the final MBBS exams, the National Eligibility-Entrance Test for post-graduate seats (NEET-PG), and the Foreign Medical Graduate Examination (FMGE), the screening test for the medical graduates from abroad.Editorial Stresses the Necessity of NExT to Reform the Existing Medical Education System: In an editorial published last month in the Journal of Family Medicine and Primary Care, titled &quot;Immediate NExT rollout is vital for MBBS students and the medical education ecosystem of India&quot;, medicos, resident doctors and faculty associated with the departments of medicine, gynaecology, psychiatry, paediatric surgery from institutes such as AIIMS New Delhi, AIIMS Nagpur, AIIMS Patna, and RML have sought implementation of the National Exit Test- arguing that the exam may enhance validity and reliability of assessments, support student learning, increase institutional transparency, and contribute to the development of a competent medical workforce.The authors of the editorial have highlighted the shortcomings in the existing university final examinations and postgraduate entrance tests. &quot;University-based MBBS final examinations differ widely in quality, validity, and fairness across institutions. Theory exams remain largely subjective, content may not uniformly map to national competencies, and evaluations vary across states and universities. This creates inconsistency in determining whether a graduate is adequately prepared to practice medicine,&quot; they argued.Regarding the PG entrance test, the doctors and MBBS medicos pointed out that such tests rely on a relatively small pool of 200 MCQs to sample an entire MBBS curriculum. Therefore, the authors opined that such limited sampling reduces reliability and increases the role of chance. They also argued that emphasis on recall-based questions encourages coaching-driven preparation rather than clinically meaningful learning.Further, they pointed out how the students currently have to prepare for multiple examinations of different format- final University examinations, PG entrance exam, etc.The doctors opined that &quot;A national exit examination is not merely a change in format; it represents a significant reform toward a more clinically oriented assessment, with an increased number of questions that are uniform for all students, thereby enhancing both learning outcomes and standards of doctors in our country.&quot;According to the authors, NExT examination will have enhanced validity through better curriculum alignment as NExT Step 1 includes a larger MCQ pool built primarily around clinical vignettes and applied reasoning.The reliability of the exam will also be better through larger question sampling. Apart from this, Step 2 of the NExT examination will objectively assess clinical skills and ultimately NExT will set a fair and uniform standard for all graduates.&quot;A national exit examination is not merely a change in format; it represents a significant reform toward a more clinically oriented assessment, with an increased number of questions that are uniform for all students, thereby enhancing both learning outcomes and standards of doctors in our country,&quot; the doctors said in the editorial.&quot;NExT applies equally to students from government medical colleges, private and newly established institutions, and foreign medical graduates (FMGs). By assessing all candidates through the same national standard, it strengthens public confidence in medical training and ensures that every licensed doctor demonstrates a uniform threshold of competence, regardless of where they received their education,&quot; they added.Further, the editorial opined that a unified test instead of many examinations will ultimately reduce the burden on students of preparing for multiple examinations with different formats. The authors also opined that NExT will promote consistent learning rather than shotcut methods of MCQs solving and it will also reduce stress on students through transparent, and structured evaluation.&quot;A uniform national benchmark will allow colleges, especially newer and private institutions, to demonstrate their training quality through measurable student outcomes. This might shift public perception from reputation-based subjective judgments to objective performance-based comparisons. Institutions that invest in quality teaching can rapidly gain credibility,&quot; the authors of the editorial opined.&quot;The strengthening of medical education requires robust and valid assessment systems. Experiences from engineering, management, and dental education over the past two decades illustrate how rapid expansion without strong evaluation mechanisms can compromise quality.[9] Many institutions in these sectors lacked rigorous student assessment processes and gradually became degree-granting centers rather than environments that foster meaningful learning. The closure of several such colleges highlights the long-term risks associated with expansion in the absence of credible quality assurance,&quot; they further added.In order to ensure a smooth rollout and minimize apprehension, the doctors opined that comprehensive preparatory support should be provided, including multiple mock tests, sample questions, workbooks, and detailed syllabus material. They also opined that during the initial years, the students may be permitted to attempt only a fixed proportion of questions in NExT Step, for example, 540 out of 600 to ease the transition while preserving the examination’s validity.Concerns over Immediate Implementation of NExT:Meanwhile, the Federation of All India Medical Association (FAIMA) has expressed serious concern regarding the possibility of an immediate implementation of the National Exit Test (NExT) across the country.Speaking to Medical Dialogues, the Chief Patron of the Association, Dr. Rohan Krishnan, clarified that FAIMA is not opposed to reform and it recognises the need for standardization,  transparency, and quality assurance in India’s medical education system. However, he opined that the timing, structure, and preparedness for NExT raise significant and legitimate concerns.Pointing out that reform must address root causes and not create new burdens, Dr. Krishnan added, &quot;The challenges in medical education today are well known—uneven clinical exposure, faculty shortages, and infrastructure gaps across institutions. Introducing a centralized exit examination without first addressing these systemic deficiencies risks placing an unfair burden on students, without meaningfully improving competency.&quot;&quot;India already has a competitive and merit-based system in the form of NEET PG. The introduction of NExT, in its current form, effectively replaces one high-stakes examination with another—without reducing stress, uncertainty, or redundancy. Instead, it risks further intensifying the exam-centric culture in undergraduate medical training,&quot; he added.Dr Krishnan highlighted the risk to clinical training and patient-centred learning and mentioned, &quot;Medical education cannot be reduced to a single high-stakes theoretical assessment. There is a real and present danger that NExT will shift student focus away from bedside learning and patient interaction toward coaching-driven preparation. This undermines the very essence of clinical training and could have long-term implications for patient care quality.&quot;Apart from this, he also pointed out that repeated changes, lack of detailed guidelines, and uncertainty regarding the examination pattern, scoring, and implementation timeline have created anxiety among medical students nationwide. Therefore, he expressed that any reform of this magnitude must be preceded by clear communication, pilot testing, and stakeholder consultation.He has urged the policymakers to adopt a phased implementation strategy, including pilot testing across selected institutions, parallel runs without immediate high-stakes consequences, structured feedback from students, faculty, and medical bodies, alignment of undergraduate teaching methodologies before rollout.&quot;Reform in medical education must be thoughtful, inclusive, and evidence-based. An abrupt implementation of NExT, without systemic readiness, risks doing more harm than good,&quot; he added.Similar opinions have been expressed by Dr. Meet Ghonia, the National General Secretary of the Federation of Resident Doctors Association (FORDA). When asked his opinions on the immediate implementation of NExT exam, he told Medical Dialogues, &quot;NExT is a necessary reform for the future of Indian medical education, but its immediate implementation without adequate preparation risks undermining both its objectives and student confidence. A phased, transparent, and well-tested rollout would be far more effective than abrupt enforcement.&quot;Dr. Indranil Deshmukh, the National Secretary of the Indian Medical Association Junior Doctors Network (IMA-JDN), appreciated the efforts taken by the Government of India and the National Medical Commission in reforming medical education in the country, adding how such steps have been progressive and aimed at improving the overall quality and credibility of our healthcare system.However, he also highlighted the concerns raised by the doctors regarding NExT exam. He mentioned, &quot;While the idea of having a uniform benchmark is well-intentioned, the ground reality across medical colleges in India is quite varied. Nearly half of the medical colleges have come up in the last 10- 15 years, and the level of infrastructure, teaching, and clinical exposure is not uniform everywhere.&quot;&quot;There is also a fundamental issue in combining a licensing exam with a postgraduate entrance exam. Both serve very different purposes, and merging them into a single exam may not be the most appropriate approach. If a common licensing exam is introduced, its pattern and intent should ideally remain distinct from that of a PG entrance test. There is a concern that, in the absence of uniform standards, a high-stakes national licensing exam may create uncertainty among students who are on the verge of becoming doctors. This could lead to frustration and may even discourage future aspirants from pursuing medical education, especially in newer institutions,&quot; he added.Highlighting the need to consult wider stakeholders, he mentioned, &quot;We humbly request the authorities to undertake wider stakeholder consultations involving the Indian Medical Association and the IMA Junior Doctors Network.&quot;The NExT Controversy:Ever since its first announcement, the issue of the NExT exam has been making waves in the medical fraternity. Although back in 2023, NMC released the NExT regulations and announced conducting the exam for the 2019 MBBS batch, it was ultimately put on hold for an indefinite time.NMC had deferred the exam after the Ministry intervened following the protests in this regard by the 2019 MBBS batch, who had termed it a violation of the NMC Act, 2019. After announcing the postponement of the NExT exam, NMC had also cancelled the mock test for NExT.Amidst the debate and uncertainty regarding the conduct of the NExT exam, NMC made the issue open to all the stakeholders. Medical Dialogues had earlier reported that the stakeholders were asked to submit their opinion on whether the NExT exam should replace the conventional MBBS final year exam, held separately in addition to the MBBS final year exam, or be conducted in any other manner.Further, the stakeholders were asked to share their opinions on various aspects, such as the time and manner, exam pattern, way of conducting the exam, syllabus of NExT, and several other issues.Last year, NMC Chairperson, Dr. Abhijat Sheth, had pointed out that the proposed licentiate-entrance test, National Exit Test (NExT), may not see implementation for the next couple of years till the National Medical Commission (NMC) perfects the model for the exam.Also Read: Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/07/13/131634-next-exam.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NExT, exam, divides, medical, fraternity:, Immediate, rollout, phased, implementation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/07/13/131634-next-exam.webp"><p><b>New Delhi:</b> The <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission's</a> proposed common exit -licentiate examination, i.e., the National Exit Test (NExT), is yet to see the light of day. Amid this, a fresh debate has emerged within the medical community over the exam's necessity and timing of implementation.</p><p>While a section of doctors have sought the implementation of NExT examination for MBBS students, some have expressed concerns regarding the immediate rollout.</p><p><span>NExT was introduced through the National Medical Commission Act, 2019, as a common exit-licentiate examination, which will </span>replace three existing exams- the final MBBS exams, the National Eligibility-Entrance Test for post-graduate seats (NEET-PG), and the Foreign Medical Graduate Examination (FMGE), the screening test for the medical graduates from abroad.</p><p><b>Editorial Stresses the Necessity of NExT to Reform the Existing Medical Education System:</b> </p><p>In an editorial published last month in the Journal of Family Medicine and Primary Care, titled "Immediate NExT rollout is vital for MBBS students and the medical education ecosystem of India", medicos, resident doctors and faculty associated with the departments of medicine, gynaecology, psychiatry, paediatric surgery from institutes such as AIIMS New Delhi, AIIMS Nagpur, AIIMS Patna, and RML have sought implementation of the National Exit Test- arguing that the exam may enhance validity and reliability of assessments, support student learning, increase institutional transparency, and contribute to the development of a competent medical workforce.</p><p>The authors of the editorial have highlighted the shortcomings in the existing university final examinations and postgraduate entrance tests. "University-based MBBS final examinations differ widely in quality, validity, and fairness across institutions. Theory exams remain largely subjective, content may not uniformly map to national competencies, and evaluations vary across states and universities. This creates inconsistency in determining whether a graduate is adequately prepared to practice medicine," they argued.</p><p>Regarding the PG entrance test, the doctors and MBBS medicos pointed out that such tests rely on a relatively small pool of 200 MCQs to sample an entire MBBS curriculum. Therefore, the authors opined that such limited sampling reduces reliability and increases the role of chance. They also argued that emphasis on recall-based questions encourages coaching-driven preparation rather than clinically meaningful learning.</p><p>Further, they pointed out how the students currently have to prepare for multiple examinations of different format- final University examinations, PG entrance exam, etc.</p><p>The doctors opined that "A national exit examination is not merely a change in format; it represents a significant reform toward a more clinically oriented assessment, with an increased number of questions that are uniform for all students, thereby enhancing both learning outcomes and standards of doctors in our country."</p><p>According to the authors, NExT examination will have enhanced validity through better curriculum alignment as NExT Step 1 includes a larger MCQ pool built primarily around clinical vignettes and applied reasoning.</p><p>The reliability of the exam will also be better through larger question sampling. Apart from this, Step 2 of the NExT examination will objectively assess clinical skills and ultimately NExT will set a fair and uniform standard for all graduates.</p><p>"A national exit examination is not merely a change in format; it represents a significant reform toward a more clinically oriented assessment, with an increased number of questions that are uniform for all students, thereby enhancing both learning outcomes and standards of doctors in our country," the doctors said in the editorial.</p><p>"NExT applies equally to students from government medical colleges, private and newly established institutions, and foreign medical graduates (FMGs). By assessing all candidates through the same national standard, it strengthens public confidence in medical training and ensures that every licensed doctor demonstrates a uniform threshold of competence, regardless of where they received their education," they added.</p><p>Further, the editorial opined that a unified test instead of many examinations will ultimately reduce the burden on students of preparing for multiple examinations with different formats. The authors also opined that NExT will promote consistent learning rather than shotcut methods of MCQs solving and it will also reduce stress on students through transparent, and structured evaluation.</p><p>"A uniform national benchmark will allow colleges, especially newer and private institutions, to demonstrate their training quality through measurable student outcomes. This might shift public perception from reputation-based subjective judgments to objective performance-based comparisons. Institutions that invest in quality teaching can rapidly gain credibility," the authors of the editorial opined.</p><p>"The strengthening of medical education requires robust and valid assessment systems. Experiences from engineering, management, and dental education over the past two decades illustrate how rapid expansion without strong evaluation mechanisms can compromise quality.[9] Many institutions in these sectors lacked rigorous student assessment processes and gradually became degree-granting centers rather than environments that foster meaningful learning. The closure of several such colleges highlights the long-term risks associated with expansion in the absence of credible quality assurance," they further added.</p><p>In order to ensure a smooth rollout and minimize apprehension, the doctors opined that comprehensive preparatory support should be provided, including multiple mock tests, sample questions, workbooks, and detailed syllabus material. They also opined that during the initial years, the students may be permitted to attempt only a fixed proportion of questions in NExT Step, for example, 540 out of 600 to ease the transition while preserving the examination’s validity.</p><p><b>Concerns over Immediate Implementation of NExT:</b></p><p>Meanwhile, the Federation of All India Medical Association (FAIMA) has expressed serious concern regarding the possibility of an immediate implementation of the National Exit Test (NExT) across the country.</p><p>Speaking to Medical Dialogues, the Chief Patron of the Association, Dr. Rohan Krishnan, clarified that FAIMA is not opposed to reform and it recognises the need for standardization,  transparency, and quality assurance in India’s medical education system. However, he opined that the timing, structure, and preparedness for NExT raise significant and legitimate concerns.</p><p>Pointing out that reform must address root causes and not create new burdens, Dr. Krishnan added, "The challenges in medical education today are well known—uneven clinical exposure, faculty shortages, and infrastructure gaps across institutions. Introducing a centralized exit examination without first addressing these systemic deficiencies risks placing an unfair burden on students, without meaningfully improving competency."</p><p>"India already has a competitive and merit-based system in the form of NEET PG. The introduction of NExT, in its current form, effectively replaces one high-stakes examination with another—without reducing stress, uncertainty, or redundancy. Instead, it risks further intensifying the exam-centric culture in undergraduate medical training," he added.</p><p>Dr Krishnan highlighted the risk to clinical training and patient-centred learning and mentioned, "Medical education cannot be reduced to a single high-stakes theoretical assessment. There is a real and present danger that NExT will shift student focus away from bedside learning and patient interaction toward coaching-driven preparation. This undermines the very essence of clinical training and could have long-term implications for patient care quality."</p><p>Apart from this, he also pointed out that repeated changes, lack of detailed guidelines, and uncertainty regarding the examination pattern, scoring, and implementation timeline have created anxiety among medical students nationwide. Therefore, he expressed that any reform of this magnitude must be preceded by clear communication, pilot testing, and stakeholder consultation.</p><p>He has urged the policymakers to adopt a phased implementation strategy, including pilot testing across selected institutions, parallel runs without immediate high-stakes consequences, structured feedback from students, faculty, and medical bodies, alignment of undergraduate teaching methodologies before rollout.</p><p>"Reform in medical education must be thoughtful, inclusive, and evidence-based. An abrupt implementation of NExT, without systemic readiness, risks doing more harm than good," he added.</p><p>Similar opinions have been expressed by Dr. Meet Ghonia, the National General Secretary of the Federation of Resident Doctors Association (FORDA). When asked his opinions on the immediate implementation of NExT exam, he told Medical Dialogues, "NExT is a necessary reform for the future of Indian medical education, but its immediate implementation without adequate preparation risks undermining both its objectives and student confidence. A phased, transparent, and well-tested rollout would be far more effective than abrupt enforcement."</p><p>Dr. Indranil Deshmukh, the National Secretary of the Indian Medical Association Junior Doctors Network (IMA-JDN), appreciated the efforts taken by the Government of India and the National Medical Commission in reforming medical education in the country, adding how such steps have been progressive and aimed at improving the overall quality and credibility of our healthcare system.</p><p>However, he also highlighted the concerns raised by the doctors regarding NExT exam. He mentioned, "While the idea of having a uniform benchmark is well-intentioned, the ground reality across medical colleges in India is quite varied. Nearly half of the medical colleges have come up in the last 10- 15 years, and the level of infrastructure, teaching, and clinical exposure is not uniform everywhere."</p><p>"There is also a fundamental issue in combining a licensing exam with a postgraduate entrance exam. Both serve very different purposes, and merging them into a single exam may not be the most appropriate approach. If a common licensing exam is introduced, its pattern and intent should ideally remain distinct from that of a PG entrance test. There is a concern that, in the absence of uniform standards, a high-stakes national licensing exam may create uncertainty among students who are on the verge of becoming doctors. This could lead to frustration and may even discourage future aspirants from pursuing medical education, especially in newer institutions," he added.</p><p>Highlighting the need to consult wider stakeholders, he mentioned, "We humbly request the authorities to undertake wider stakeholder consultations involving the Indian Medical Association and the IMA Junior Doctors Network."</p><div class="pasted-from-word-wrapper"><p><b>The NExT Controversy:</b></p><p>Ever since its first announcement, the issue of the NExT exam has been making waves in the medical fraternity. Although back in 2023, NMC released the NExT regulations and announced conducting the exam for the 2019 MBBS batch, it was ultimately put on hold for an indefinite time.</p><div class="pasted-from-word-wrapper"><p>NMC had deferred the exam after the Ministry intervened following the protests in this regard by the 2019 MBBS batch, who had termed it a violation of the NMC Act, 2019. After announcing the postponement of the NExT exam, NMC had also cancelled the mock test for NExT.</p><p>Amidst the debate and uncertainty regarding the conduct of the NExT exam, NMC made the issue open to all the stakeholders. Medical Dialogues had earlier reported that the stakeholders were asked to submit their opinion on whether the NExT exam should replace the conventional MBBS final year exam, held separately in addition to the MBBS final year exam, or be conducted in any other manner.</p><p>Further, the stakeholders were asked to share their opinions on various aspects, such as the time and manner, exam pattern, way of conducting the exam, syllabus of NExT, and several other issues.</p><p>Last year, NMC Chairperson, Dr. Abhijat Sheth, had pointed out that the proposed licentiate-entrance test, <a href="https://medicaldialogues.in/topics/next%20exam">National Exit Test (NExT)</a>, may not see implementation for the next couple of years till the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>) perfects the model for the exam.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/fact-check/fact-check-viral-notice-claiming-next-exam-from-2022-mbbs-batch-onwards-is-fake-167887"><b><i>Also Read: Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE</i></b></a></p></div></div>]]> </content:encoded>
</item>

<item>
<title>Patient Data Leak Case: Bombay High Court Refuses to Quash FIR Against Doctor</title>
<link>https://edusehat.com/en/patient-data-leak-case-bombay-high-court-refuses-to-quash-fir-against-doctor</link>
<guid>https://edusehat.com/en/patient-data-leak-case-bombay-high-court-refuses-to-quash-fir-against-doctor</guid>
<description><![CDATA[ The Nagpur bench of the Bombay High Court recently denied quashing an FIR against a doctor, accused of using leaked patient data to grow his own practice.It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. &quot;On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,&quot; the bench noted.For more details, check out the full story on the link below:Bombay HC refuses to quash criminal proceedings against doctor in patient data leak case ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339927-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-43.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patient, Data, Leak, Case:, Bombay, High, Court, Refuses, Quash, FIR, Against, Doctor</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339927-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-43.webp"><p>The Nagpur bench of the <a href="https://medicaldialogues.in/topics/bombay-high-court">Bombay High Court </a>recently denied quashing an <a href="https://medicaldialogues.in/topics/FIR">FIR</a> against a doctor, accused of using leaked patient data to grow his own practice.</p><div class="pasted-from-word-wrapper"><p>It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. <i>"On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,"</i> the bench noted.</p></div><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/doctors/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case-167978"><b><i>Bombay HC refuses to quash criminal proceedings against doctor in patient data leak case</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Parliamentary Panel Flags Doctor Burnout, Urges Clinical Duty Hour Rules With Mandatory Rest</title>
<link>https://edusehat.com/en/parliamentary-panel-flags-doctor-burnout-urges-clinical-duty-hour-rules-with-mandatory-rest</link>
<guid>https://edusehat.com/en/parliamentary-panel-flags-doctor-burnout-urges-clinical-duty-hour-rules-with-mandatory-rest</guid>
<description><![CDATA[ Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods and monitored rosters.For more details, check out the full story on the link below:Doctors&#039; burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339917-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-40.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Parliamentary, Panel, Flags, Doctor, Burnout, Urges, Clinical, Duty, Hour, Rules, With, Mandatory, Rest</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339917-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-40.webp"><div class="pasted-from-word-wrapper"><p>Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.</p><p>Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a "Clinical <a href="https://medicaldialogues.in/topics/duty-hours">Duty Hours</a> Regulation" policy with mandatory rest periods and monitored rosters.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/doctors/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters-167982"><b><i>Doctors' burnout due to 24-36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>After Ayushman Bharat fraud, PGI Chandigarh revamps procurement system</title>
<link>https://edusehat.com/en/after-ayushman-bharat-fraud-pgi-chandigarh-revamps-procurement-system</link>
<guid>https://edusehat.com/en/after-ayushman-bharat-fraud-pgi-chandigarh-revamps-procurement-system</guid>
<description><![CDATA[ Chandigarh: The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has recently implemented comprehensive changes to its procurement process following a high-profile scam linked to the Ayushman Bharat scheme, where funds were allegedly misappropriated through the use of forged bills and records of deceased patients.The institute has decided to eliminate third-party vendors from the procurement chain for implants and medical consumables.Also Read: International Patients&#039; Union Conference 2026 brings patients, doctors, policymakers together for healthcare dialogueUnder the new system, all transactions related to surgeries and specialised treatments under cashless schemes will be conducted directly between the hospital and authorized manufacturers or in-house pharmacies, leaving no scope for private intermediaries to interact with the medical staff.To further prevent the influence of external elements, the administration has strictly prohibited vendors from engaging in direct transactions with doctors, hospital staff, or patients. Also, to maintain transparency, all requirements will now be submitted through a centralized internal system. According to the ET media report, these vendors previously often acted as middlemen in procuring implants, leading to price manipulation and billing fraud.PGI is now transitioning toward a secure online indenting system. This digital solution, integrated with the Hospital Information System, utilises a real-time tracking system to replace manual records. Under this initiative, every medication and implant issued is digitally linked to a specific patient&#039;s ID and the approval of the treating consultant.To further safeguard patients against the &quot;resale of medicines&quot; racket, the institution is increasing its staff strength to ensure that medicines and implants are delivered directly to the patients&#039; bedsides. By eliminating the need for attendants to carry handwritten prescriptions to external pharmacies, the hospital aims to curb the use of counterfeit stamps and forged documents, practices that lay at the root of the recent scam.  Also Read: PGI Chandigarh announces dedicated transplant centre ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339913-pgi-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>After, Ayushman, Bharat, fraud, PGI, Chandigarh, revamps, procurement, system</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339913-pgi-1.webp"><p><b>Chandigarh:</b> The Postgraduate Institute of Medical Education and Research (<a href="https://medicaldialogues.in/topics/pgimer" target="_blank">PGIMER</a>), Chandigarh, has recently implemented comprehensive changes to its procurement process following a high-profile scam linked to the Ayushman Bharat scheme, where funds were allegedly misappropriated through the use of forged bills and records of deceased patients.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The institute has decided to eliminate third-party vendors from the procurement chain for implants and medical consumables.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/international-patients-union-conference-2026-brings-patients-doctors-policymakers-together-for-healthcare-dialogue-167936"><b>Also Read: </b>International Patients' Union Conference 2026 brings patients, doctors, policymakers together for healthcare dialogue</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Under the new system, all transactions related to surgeries and specialised treatments under cashless schemes will be conducted directly between the hospital and authorized manufacturers or in-house pharmacies, leaving no scope for private intermediaries to interact with the medical staff.</p><p dir="ltr">To further prevent the influence of external elements, the administration has strictly prohibited vendors from engaging in direct transactions with doctors, hospital staff, or patients. Also, to maintain transparency, all requirements will now be submitted through a centralized internal system. </p><p dir="ltr">According to the <a href="https://health.economictimes.indiatimes.com/news/hospitals/pgi-revamps-procurement-after-ayushman-bharat-scam/130035189#:~:text=Chandigarh%3A%20Following%20the%20high-profile,and%20prevent%20future%20financial%20irregularities." target="_blank" rel="nofollow">ET </a>media report, these vendors previously often acted as middlemen in procuring implants, leading to price manipulation and billing fraud.</p><p dir="ltr">PGI is now transitioning toward a secure online indenting system. This digital solution, integrated with the Hospital Information System, utilises a real-time tracking system to replace manual records. Under this initiative, every medication and implant issued is digitally linked to a specific patient's ID and the approval of the treating consultant.</p><p dir="ltr">To further safeguard patients against the "resale of medicines" racket, the institution is increasing its staff strength to ensure that medicines and implants are delivered directly to the patients' bedsides. By eliminating the need for attendants to carry handwritten prescriptions to external pharmacies, the hospital aims to curb the use of counterfeit stamps and forged documents, practices that lay at the root of the recent scam.  </p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/pgi-chandigarh-announces-dedicated-transplant-centre-167079"><b>Also Read: </b>PGI Chandigarh announces dedicated transplant centre</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>PGI Neurosurgeon loses Rs 1.10 crore to fake trading app</title>
<link>https://edusehat.com/en/pgi-neurosurgeon-loses-rs-110-crore-to-fake-trading-app</link>
<guid>https://edusehat.com/en/pgi-neurosurgeon-loses-rs-110-crore-to-fake-trading-app</guid>
<description><![CDATA[ Chandigarh: In a shocking incident, a 33-year-old neurosurgeon from the Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud. According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 monthsInitial investments were modest, with ₹10,000 invested via Unified Payments Interface (UPI) on February 5, but the app displayed fabricated profits, encouraging him to invest larger sums. Promises of daily returns of up to 5% and lucrative IPO trading plans were used to lure him further.Over the next two months, the doctor transferred ₹1.1 crore in 25 separate transactions through various banking channels, including UPI, immediate payment service (IMPS), real-time gross settlement (RTGS), and National Electronic Funds Transfer (NEFT), into multiple bank accounts. By the end of March, the app reflected a balance of ₹4.73 crore, including alleged profits of over ₹4.15 crore. However, when the victim requested withdrawal on March 23, he was asked to pay an additional ₹41.59 lakh as “brokerage charges”, reports Hindustan Times.  Despite growing suspicions, the doctor complied after other group members allegedly claimed to have successfully withdrawn large profits. Soon after, the fraudsters demanded another ₹10 lakh as a “security deposit,” claiming it was required by the Reserve Bank of India due to suspected money laundering. It was at this point that the doctor realized he had been defrauded.
Realising the fraud, the victim approached the cybercrime police. All communications with the accused were carried out via WhatsApp, using multiple Indian and international numbers. Police have registered a zero FIR dated April 3 and initiated an investigation, reports Hindustan Times.
Also Read:Anantapur doctor loses Rs 98 lakh in online trading scamSpeaking to Tribune India, a senior official at the police station said efforts were being made to identify and arrest the accused. Additionally, the police have made an appeal to the general public to remain vigilant regarding investment proposals received via unknown links, calls or messages on their phones. They have been advised to conduct a thorough verification before putting their money into any lucrative scheme. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/16/230219-cyber-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>PGI, Neurosurgeon, loses, 1.10, crore, fake, trading, app</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/16/230219-cyber-fraud.webp"><p><b>Chandigarh: </b>In a shocking incident, a 33-year-old <a href="https://medicaldialogues.in/topics/neurosurgeon">neurosurgeon</a> from the <a href="https://medicaldialogues.in/topics/pgimer">Post Graduate Institute of Medical Education and Research</a> (PGIMER) Chandigarh, has reportedly lost Rs 1.10 crore in a sophisticated online trading fraud. </p><p>According to a complaint filed at the Sector 17 cyber crime police station, the doctor, a resident of Sector 38-C, was introduced to the scheme via a WhatsApp group named “Po8-5 Paisa Wealth Horizon” in January 2026. The group, reportedly consisting of around 250 members, was allegedly run by individuals posing as investment advisors who persuaded the doctor to open a trading account on the mobile app “5-P.”</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/ahmedabad-doctor-loses-rs-1-lakh-in-cyber-fraud-fir-registered-after-2-months-167408"><b>Also Read:Ahmedabad doctor loses Rs 1 lakh in cyber fraud, FIR registered after 2 months</b></a></p><p>Initial investments were modest, with ₹10,000 invested via Unified Payments Interface (UPI) on February 5, but the app displayed fabricated profits, encouraging him to invest larger sums. Promises of daily returns of up to 5% and lucrative IPO trading plans were used to lure him further.</p><p>Over the next two months, the doctor transferred ₹1.1 crore in 25 separate transactions through various banking channels, including UPI, immediate payment service (IMPS), real-time gross settlement (RTGS), and National Electronic Funds Transfer (NEFT), into multiple bank accounts. By the end of March, the app reflected a balance of ₹4.73 crore, including alleged profits of over ₹4.15 crore. However, when the victim requested withdrawal on March 23, he was asked to pay an additional ₹41.59 lakh as “brokerage charges”, reports Hindustan Times.  </p><p>Despite growing suspicions, the doctor complied after other group members allegedly claimed to have successfully withdrawn large profits. Soon after, the fraudsters demanded another ₹10 lakh as a “security deposit,” claiming it was required by the Reserve Bank of India due to suspected money laundering. It was at this point that the doctor realized he had been defrauded.
</p><p>Realising the fraud, the victim approached the cybercrime police. All communications with the accused were carried out via WhatsApp, using multiple Indian and international numbers. Police have registered a zero FIR dated April 3 and initiated an investigation, reports <a href="https://www.hindustantimes.com/cities/chandigarh-news/chandigarh-pgi-doctor-loses-rs1-crore-in-online-trading-fraud-101775414218687.html" rel="nofollow">Hindustan Times</a>.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/anantapur-doctor-loses-rs-98-lakh-in-online-trading-scam-165857"><b>Also Read:Anantapur doctor loses Rs 98 lakh in online trading scam</b></a></p><p>Speaking to Tribune India, a senior official at the police station said efforts were being made to identify and arrest the accused. Additionally, the police have made an appeal to the general public to remain vigilant regarding investment proposals received via unknown links, calls or messages on their phones. They have been advised to conduct a thorough verification before putting their money into any lucrative scheme.</p>]]> </content:encoded>
</item>

<item>
<title>NMC’s MBBS Student Feedback System Gains Support from Doctors</title>
<link>https://edusehat.com/en/nmcs-mbbs-student-feedback-system-gains-support-from-doctors</link>
<guid>https://edusehat.com/en/nmcs-mbbs-student-feedback-system-gains-support-from-doctors</guid>
<description><![CDATA[ The online feedback system for MBBS students, which was recently introduced by the National Medical Commission (NMC) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback.For more details, check out the full story on the link below:Will NMC&#039;s MBBS student feedback system improve medical education quality? Here&#039;s what doctors say ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339921-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-42.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC’s, MBBS, Student, Feedback, System, Gains, Support, from, Doctors</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339921-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-42.webp"><div class="pasted-from-word-wrapper"><p>The online feedback system for MBBS students, which was recently introduced by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.</p><p>For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback.</p><p><b><i>For more details, check out the full story on the link below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/will-nmcs-mbbs-student-feedback-system-improve-medical-education-quality-heres-what-doctors-say-167961"><b><i>Will NMC's MBBS student feedback system improve medical education quality? Here's what doctors say</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS NORCET 10 exam city slip out, admit card to be released on April 8</title>
<link>https://edusehat.com/en/aiims-norcet-10-exam-city-slip-out-admit-card-to-be-released-on-april-8</link>
<guid>https://edusehat.com/en/aiims-norcet-10-exam-city-slip-out-admit-card-to-be-released-on-april-8</guid>
<description><![CDATA[ New Delhi: The All India Institute of Medical Sciences (AIIMS) recently released the Exam City Slip for the Nursing Officer Recruitment Common Eligibility Test (NORCET) 10 Phase I. This recruitment drive is being conducted to fill a total of 2,551 posts for Nursing Officers across various AIIMS institutions throughout India.Students who have already registered for the examination can check their allotted city prior to their preliminary exam. The admit card for this examination will be available online on the official website of AIIMS New Delhi on April 8, 2026.Also Read: AIIMS NORCET 10 registrations begin, check complete details HERE!The admit card for the NORCET 10 Stage I examination will be released prior to the exam, providing candidates with sufficient time to familiarise themselves with the details related to their examination.To obtain their admit cards, candidates must log in to the official website and then navigate to the admit card download link. They must download the admit card and print a copy for future reference.STEPS TO DOWNLOAD NORCET 10 CITY SLIP 2026STEP 1- Go to the official websiteSTEP 2- On the homepage, click on the &#039;Recruitments&#039; tab.STEP 3- Then click on the &#039;Nursing Officer Recruitment Common Eligibility Test (NORCET 10)&#039; tabSTEP 4- Log in by entering the AIIMS NORCET 10 registration credentials.STEP 5- The NORCET 10 city information slip 2026 is displayed on the screen.STEP 6- Check the allotted NORCET 10 exam city details.STEP 7- Download and take a printout of the AIIMS NORCET 10 city intimation slip 2026 for future reference.It will be mandatory to display this card at the entrance of the examination hall. All candidates must ensure that all information provided on the admit card is correct.According to the official schedule, the NORCET 10 Stage I examination will be conducted on April 11, 2026. NORCET 10 Stage II examination will be conducted on April 30, 2026. No date has yet been fixed for the declaration of the results, and it will be announced at an appropriate time.Also Read: AIIMS NORCET 10 exam dates out ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339897-exam-city-slip.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, NORCET, exam, city, slip, out, admit, card, released, April</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339897-exam-city-slip.webp"><p><b>New Delhi: </b>The <a href="https://medicaldialogues.in/topics/all-india-institute-of-medical-sciences" target="_blank">All India Institute of Medical Sciences</a> (AIIMS) recently released the Exam City Slip for the <a href="https://medicaldialogues.in/topics/nursing" target="_blank">Nursing </a>Officer Recruitment Common Eligibility Test (<a href="https://medicaldialogues.in/topics/norcet" target="_blank">NORCET</a>) 10 Phase I.</p><p> This recruitment drive is being conducted to fill a total of 2,551 posts for Nursing Officers across various AIIMS institutions throughout India.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Students who have already registered for the examination can check their allotted city prior to their preliminary exam. The admit card for this examination will be available online on the official website of AIIMS New Delhi on April 8, 2026.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-registrations-begin-check-complete-details-here-165416"><b>Also Read: </b>AIIMS NORCET 10 registrations begin, check complete details HERE!</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The admit card for the NORCET 10 Stage I examination will be released prior to the exam, providing candidates with sufficient time to familiarise themselves with the details related to their examination.</p><p dir="ltr">To obtain their admit cards, candidates must log in to the official website and then navigate to the admit card download link. They must download the admit card and print a copy for future reference.</p><p dir="ltr"><b><u>STEPS TO DOWNLOAD NORCET 10 CITY SLIP 2026</u></b></p><p dir="ltr"><b>STEP 1-</b> Go to the official website</p><p dir="ltr"><b>STEP 2-</b> On the homepage, click on the 'Recruitments' tab.</p><p dir="ltr"><b>STEP 3-</b> Then click on the 'Nursing Officer Recruitment Common Eligibility Test (NORCET 10)' tab</p><p dir="ltr"><b>STEP 4-</b> Log in by entering the AIIMS NORCET 10 registration credentials.</p><p dir="ltr"><b>STEP 5-</b> The NORCET 10 city information slip 2026 is displayed on the screen.</p><p dir="ltr"><b>STEP 6-</b> Check the allotted NORCET 10 exam city details.</p><p dir="ltr"><b>STEP 7</b>- Download and take a printout of the AIIMS NORCET 10 city intimation slip 2026 for future reference.</p><p dir="ltr">It will be mandatory to display this card at the entrance of the examination hall. All candidates must ensure that all information provided on the admit card is correct.</p><p dir="ltr">According to the official schedule, the NORCET 10 Stage I examination will be conducted on April 11, 2026. NORCET 10 Stage II examination will be conducted on April 30, 2026. No date has yet been fixed for the declaration of the results, and it will be announced at an appropriate time.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/aiims-norcet-10-exam-dates-out-162298"><b>Also Read: </b>AIIMS NORCET 10 exam dates out</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Counterfeit Goods From Toothpaste to Paneer Penetrate Homes, Raids Put Essentials Under Scanner</title>
<link>https://edusehat.com/en/counterfeit-goods-from-toothpaste-to-paneer-penetrate-homes-raids-put-essentials-under-scanner</link>
<guid>https://edusehat.com/en/counterfeit-goods-from-toothpaste-to-paneer-penetrate-homes-raids-put-essentials-under-scanner</guid>
<description><![CDATA[ A wave of police raids across India has exposed large-scale counterfeiting of everyday consumables, raising serious public health concerns. From fake toothpaste and soft drinks to adulterated paneer and ginger-garlic paste, illegal units have been found producing substandard goods using harmful chemicals in unhygienic conditions. The Food Safety and Standards Authority of India (FSSAI) recently filed an FIR with the Delhi Police over social media posts alleging widespread fake paneer sales, triggering debate over transparency. Authorities have invoked provisions under the Bharatiya Nyaya Sanhita and the Food Safety Act to crack down on offenders, reports The Print.Investigations revealed organised rackets, including counterfeit Sensodyne toothpaste units in Delhi and reconditioned expired soft drinks relabelled for sale. Raids in Surat and Hyderabad uncovered adulterated paneer and contaminated ginger-garlic paste made with inferior ingredients. Officials seized thousands of kilograms of unsafe products and arrested key accused. The FSSAI reported that over 5.18 lakh food samples were tested in three years, with thousands found unsafe, underscoring the scale of the crisis and the need for stricter enforcement and consumer awareness. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339932-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-44.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 19:45:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Counterfeit, Goods, From, Toothpaste, Paneer, Penetrate, Homes, Raids, Put, Essentials, Under, Scanner</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339932-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-44.webp"><p>A wave of police raids across India has exposed large-scale counterfeiting of everyday consumables, raising serious public health concerns. From fake toothpaste and soft drinks to adulterated paneer and ginger-garlic paste, illegal units have been found producing substandard goods using harmful chemicals in unhygienic conditions. </p><p>The Food Safety and Standards Authority of India (FSSAI) recently filed an FIR with the Delhi Police over social media posts alleging widespread fake paneer sales, triggering debate over transparency. Authorities have invoked provisions under the Bharatiya Nyaya Sanhita and the Food Safety Act to crack down on offenders, reports The Print.</p><p>Investigations revealed organised rackets, including counterfeit Sensodyne toothpaste units in Delhi and reconditioned expired soft drinks relabelled for sale. Raids in Surat and Hyderabad uncovered adulterated paneer and contaminated ginger-garlic paste made with inferior ingredients. Officials seized thousands of kilograms of unsafe products and arrested key accused. The FSSAI reported that over 5.18 lakh food samples were tested in three years, with thousands found unsafe, underscoring the scale of the crisis and the need for stricter enforcement and consumer awareness.</p>]]> </content:encoded>
</item>

<item>
<title>Fake bills, forged documents: CBI registers FIR against doctors, hospitals in ECHS fraud</title>
<link>https://edusehat.com/en/fake-bills-forged-documents-cbi-registers-fir-against-doctors-hospitals-in-echs-fraud</link>
<guid>https://edusehat.com/en/fake-bills-forged-documents-cbi-registers-fir-against-doctors-hospitals-in-echs-fraud</guid>
<description><![CDATA[ Chandigarh: In a major crackdown, the Central Bureau of Investigation (CBI) has unearthed a multi-crore fraud involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS). As per a HT report, the agency has registered an FIR  against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.The FIR has been registered under Sections 120-B (criminal conspiracy), 420 (cheating) and 471 (using forged documents) of the IPC, with relevant provisions of the Bharatiya Nyaya Sanhita, along with Sections 13(2) read with 13(1)(d) of the Prevention of Corruption Act, 1988.According to the agency, the case is described as a “well-organised racket” involving private hospitals, middlemen, and suspected involvement of officials. Also read- CBI arrests medical officer, Noida hospital executive in Rs 3 lakh bribery caseAccording to the CBI, the accused allegedly exploited loopholes in the ECHS system to generate fake or inflated reimbursement claims. The modus operandi allegedly involved misusing “emergency admission” provisions to bypass standard referral protocols, manipulating referral systems to channel patients into select hospitals, fabricating medical records, prescriptions, and diagnostic reports, and inflating treatment costs and pharmacy bills to claim higher reimbursements.The agency told HT, &quot;ECHS beneficiaries were systematically identified and routed through intermediaries to empanelled hospitals, where admissions were frequently projected as emergency cases without adequate medical justification, thereby enabling higher reimbursement claims.&quot;Acting on the tip-off, a joint surprise check was carried out on February 24, 2026, at Manthan Health Care in Sector 38 and Dharam Hospital in Sector 15, Chandigarh, in the presence of ECHS vigilance officials.During the searches, the CBI recovered several incriminating materials and seized them, which include patient files and emergency/referral documents, blank letterheads, hospital stamps, digital signature credentials, WhatsApp chats indicating coordination and storage devices containing records from 2018 to 2026. The agency also found documents linked to other hospitals, suggesting the racket may be wider.The investigation revealed that Manthan Health Care, which is not empanelled under ECHS, was allegedly working closely with Dharam Hospital, an empanelled facility.Shocking, the ECHS desk of Dharam Hospital was effectively being run from the premises of Manthan Health Care. The accused reportedly processed the claims and submitted them on the ECHS portal in the name of Dharam Hospital from the premises of Manthan Health Care.This, according to the agency, indicated unauthorised diversion of a regulated hospital interface to a non-empanelled intermediary. The agency officials also found official stamps, blank letterheads, and digital signature credentials of Dharam Hospital.The CBI found repeated admissions of the same patients within short periods for similar illnesses across multiple hospitals. Several patients were admitted multiple times at Dharam Hospital, Kare Partner Heart Centre, and others.According to the Daily, CBI officials noted that such patterns &quot;strongly indicate that hospitalisations were orchestrated for claim generation rather than genuine medical necessity.&quot;The investigation also uncovered large-scale fabrication of medical documents, including emergency admission papers, prescriptions, pathology reports, and discharge summaries.&quot;Signatures attributed to Dr Aggarwal appeared to be forged upon preliminary comparison, while several diagnostic reports were found to be fake, with laboratories and doctors denying having issued them. The recovery of blank letterheads of multiple hospitals and labs further points to a structured document fabrication mechanism,&quot; officials said.Evidence suggests that the racket involved financial deals between hospitals and intermediaries. The CBI found referral-based commission agreements, where middlemen were paid per patient or given a share of the billed amount. An unsigned agreement between Manthan Health Care and Dharam Hospital reportedly mentioned a 50:50 revenue-sharing model.CBI said, “This reflects a commercially organised operation aimed at wrongful gain through fraudulent reimbursements.”The CBI said, &quot;Crucially, WhatsApp chats retrieved during the search provide direct insight into the alleged conspiracy. Messages indicate prior coordination regarding admission and discharge timing, preparation and alteration of medical records and post facto fabrication of documents to support claims. These chats clearly show that records were tailored to fit reimbursement requirements.&quot;The agency is also looking into the role of ECHS officials, and an investigation is underway to understand the full extent of the conspiracy.Also read- Rs 4 crore fraud: 36 loans allegedly using Jaipur doctor&#039;s identity ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/05/331117-fraud.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fake, bills, forged, documents:, CBI, registers, FIR, against, doctors, hospitals, ECHS, fraud</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/05/331117-fraud.webp"><p><b>Chandigarh:</b> In a major crackdown, the <a href="https://medicaldialogues.in/topics/cbi" target="_blank">Central Bureau of Investigation </a>(CBI) has unearthed a multi-crore <a href="https://medicaldialogues.in/topics/fraud" target="_blank">fraud </a>involving fraudulent medical reimbursement claims under the Ex-Servicemen Contributory Health Scheme (ECHS). </p><p>As per a HT report, the agency has registered an FIR  against the two directors of Manthan Health Care, along with Dharam Hospital, Kare Partner Heart Centre, and several other individuals. The role of unknown ECHS officials is also under the scrutiny.</p><p>The FIR has been registered under Sections 120-B (criminal conspiracy), 420 (cheating) and 471 (using forged documents) of the IPC, with relevant provisions of the Bharatiya Nyaya Sanhita, along with Sections 13(2) read with 13(1)(d) of the Prevention of Corruption Act, 1988.</p><p>According to the agency, the case is described as a “well-organised racket” involving private hospitals, middlemen, and suspected involvement of officials. </p><p><b>Also read-<a href="https://medicaldialogues.in/news/health/doctors/cbi-arrests-medical-officer-noida-hospital-executive-in-rs-3-lakh-bribery-case-166768" target="_blank"> CBI arrests medical officer, Noida hospital executive in Rs 3 lakh bribery case</a></b></p><p>According to the CBI, the accused allegedly exploited loopholes in the ECHS system to generate fake or inflated reimbursement claims. The modus operandi allegedly involved misusing “emergency admission” provisions to bypass standard referral protocols, manipulating referral systems to channel patients into select hospitals, fabricating medical records, prescriptions, and diagnostic reports, and inflating treatment costs and pharmacy bills to claim higher reimbursements.</p><p>The agency told <a href="https://www.hindustantimes.com/cities/chandigarh-news/docs-hospitals-booked-as-cbi-unearths-fraud-in-ex-servicemen-s-medical-reimbursements-101775243635090.html" target="_blank">HT</a>, "ECHS beneficiaries were systematically identified and routed through intermediaries to empanelled hospitals, where admissions were frequently projected as emergency cases without adequate medical justification, thereby enabling higher reimbursement claims."</p><p>Acting on the tip-off, a joint surprise check was carried out on February 24, 2026, at Manthan Health Care in Sector 38 and Dharam Hospital in Sector 15, Chandigarh, in the presence of ECHS vigilance officials.</p><p>During the searches, the CBI recovered several incriminating materials and seized them, which include patient files and emergency/referral documents, blank letterheads, hospital stamps, digital signature credentials, WhatsApp chats indicating coordination and storage devices containing records from 2018 to 2026. The agency also found documents linked to other hospitals, suggesting the racket may be wider.</p><p>The investigation revealed that Manthan Health Care, which is not empanelled under ECHS, was allegedly working closely with Dharam Hospital, an empanelled facility.</p><p>Shocking, the ECHS desk of Dharam Hospital was effectively being run from the premises of Manthan Health Care. The accused reportedly processed the claims and submitted them on the ECHS portal in the name of Dharam Hospital from the premises of Manthan Health Care.</p><p>This, according to the agency, indicated unauthorised diversion of a regulated hospital interface to a non-empanelled intermediary. The agency officials also found official stamps, blank letterheads, and digital signature credentials of Dharam Hospital.</p><p>The CBI found repeated admissions of the same patients within short periods for similar illnesses across multiple hospitals. Several patients were admitted multiple times at Dharam Hospital, Kare Partner Heart Centre, and others.</p><p>According to the Daily, CBI officials noted that such patterns "strongly indicate that hospitalisations were orchestrated for claim generation rather than genuine medical necessity."</p><p>The investigation also uncovered large-scale fabrication of medical documents, including emergency admission papers, prescriptions, pathology reports, and discharge summaries.</p><p>"Signatures attributed to Dr Aggarwal appeared to be forged upon preliminary comparison, while several diagnostic reports were found to be fake, with laboratories and doctors denying having issued them. The recovery of blank letterheads of multiple hospitals and labs further points to a structured document fabrication mechanism," officials said.</p><p>Evidence suggests that the racket involved financial deals between hospitals and intermediaries. The CBI found referral-based commission agreements, where middlemen were paid per patient or given a share of the billed amount. An unsigned agreement between Manthan Health Care and Dharam Hospital reportedly mentioned a 50:50 revenue-sharing model.</p><p>CBI said, “This reflects a commercially organised operation aimed at wrongful gain through fraudulent reimbursements.”</p><p>The CBI said, "Crucially, WhatsApp chats retrieved during the search provide direct insight into the alleged conspiracy. Messages indicate prior coordination regarding admission and discharge timing, preparation and alteration of medical records and post facto fabrication of documents to support claims. These chats clearly show that records were tailored to fit reimbursement requirements."</p><p>The agency is also looking into the role of ECHS officials, and an investigation is underway to understand the full extent of the conspiracy.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/rs-4-crore-fraud-36-loans-taken-allegedly-using-jaipur-doctors-identity-167799" target="_blank">Rs 4 crore fraud: 36 loans allegedly using Jaipur doctor's identity</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Eris Lifesciences Introduces DEMELAN NEXA Serum: Next&#45;Generation Melanophagy&#45;Focused Approach for Melasma Management in India</title>
<link>https://edusehat.com/en/eris-lifesciences-introduces-demelan-nexa-serum-next-generation-melanophagy-focused-approach-for-melasma-management-in-india-9222</link>
<guid>https://edusehat.com/en/eris-lifesciences-introduces-demelan-nexa-serum-next-generation-melanophagy-focused-approach-for-melasma-management-in-india-9222</guid>
<description><![CDATA[ Recognizing
the evolving understanding of pigmentation biology, Eris Lifesciences has
launched DEMELAN NEXA Serum, a next-generation melanophagy-focused brightening serum
designed for the comprehensive management of recurrent melasma, and
photo-aging.

DEMELAN® NEXA Serum - available in a 30 ml pack,
incorporates Melazero®, a third generation brightening agent. The
serum provides a dual-action approach, promoting melanophagy, i.e., clearing
existing melanin and reducing new melanin synthesis, with clinical study showing
visible melanin reduction within two to four weeks.

Current Challenges in Melasma Care –
Incomplete Addressal of Pathogenic Pathways 

Melasma continues to pose a significant
therapeutic challenge in dermatology. Characterized by chronic, relapsing hyperpigmented
patches, it most commonly affects sun-exposed facial areas.1 The
condition is widely recognized as multifactorial,
involving ultraviolet radiation, hormonal influences, genetic susceptibility,
inflammation, vascular factors and skin barrier dysfunction. 2 

Despite the availability of several topical
and procedural therapies, long-term
disease control remains difficult, with recurrence frequently reported
in clinical practice. 1, 2 One of the key limitations of existing
therapies is that many primarily target melanin
production rather than the removal of already accumulated pigment, leaving
important pathogenic pathways insufficiently addressed. 2

Melanophagy – Novel Treatment Approach in
Melasma Care

To bridge current treatment gaps, dermatological
research has increasingly focused on melanophagy,
a cellular mechanism involved in the degradation and clearance of
melanin-containing organelles known as melanosomes. 3 Melanophagy
refers to the autophagic breakdown of
melanosomes within keratinocytes, enabling the removal of excess pigment
from the epidermis. 3

Impaired melanophagy has been associated with
pigment persistence in melasma and photoaging, making the pathway an emerging
therapeutic target in pigmentation disorders. 3, 4 Growing evidence
suggests that enhancing melanophagy may help improve pigmentation outcomes by addressing both pigment accumulation and
ongoing melanogenesis. 3

Melazero®: A Novel Approach Targeting
Hyperpigmentation through Melanophagy

Melazero® is a patented active derived from the Korean
plant Arisaema amurense that utilizes a
novel mechanism, melanophagy, to target hyperpigmentation. It promotes
melanophagy in melanocytes, facilitating the clearance of existing
intracellular melanin and simultaneously reducing melanin synthesis. Clinical studies
have shown that 1% Melazero® significantly reduces melanin levels within two to
four weeks, demonstrating faster onset of action and superior pigmentation
reduction. Additionally, Melazero® offers good skin tolerability, making it
suitable for topical use in pigmentation management.

Other Key Active Ingredients in the
Formulation

The serum contains other key ingredients namely Liposomal
Tranexamic Acid (Vegan DDS formulation),
Glycolic acid, Niacinamide, pTerowhite®, Alpha-arbutin, Fermentex Rice Mak and Hyaluronan 16 Multi-Complex,
each targeting different aspects of pigmentation and skin health. Tranexamic acid helps reduce
pigmentation by inhibiting plasmin activity and lowering inflammatory mediators
that stimulate melanocytes. 5 Vegan DDS Tranexamic Acid is a patented complex with 15 times higher liposomal concentration,
allowing for better efficiency and enhanced skin
tolerability. Niacinamide reduces melanosome transfer from melanocytes to
keratinocytes, decreasing visible pigmentation while supporting the skin
barrier. 6  pTerowhite® downregulates
MITF expression, leading to suppression of tyrosinase and reducing melanin
synthesis. 7 Alpha-arbutin interferes
with melanosome maturation, reducing effective pigment production.
8 Hyaluronan 16 Multi-Complex
enhances hydration and supports barrier repair, crucial for maintaining healthy
skin during pigmentation treatments. 9

DEMELAN® NEXA - Technology Designed
for Targeted Skin Delivery

DEMELAN® NEXA Serum also utilizes Deep Delivery System (DDS) technology,
which aims to improve dermal penetration and optimize the delivery of active
ingredients. DDS technology offers potential advantages such as enhanced
penetration of active molecules into the skin, improved bioavailability of
ingredients, controlled and sustained release of actives and better
tolerability for long-term dermatological use.

Potential Clinical Applications in
Pigmentation Management

By targeting pigment triggers, melanin synthesis, melanosome transfer, and pigment
clearance, DEMELAN® NEXA Serum represents a multi-pathway approach to
pigmentation management. Dermatologists
may consider such therapies in patients with chronic or relapsing melasma, post-inflammatory
hyperpigmentation, photoaging-related pigmentation, and patients requiring
long-term maintenance therapy following procedural treatments.

Speaking to Medical Dialogues, Ms. Nita Borkar
(President - Sales &amp; Marketing, Dermatology Business) at Eris Lifesciences
said, “With DEMELAN® Nexa serum, we aim to address gaps in the management
of inflammatory and recurrent melasma. It features Melazero®, a third-generation brightening agent based on a
Nobel Prize-recognized concept of autophagy, that helps to promote melanophagy
and reduces melanin synthesis. Clinical
studies have reported visible reduction within two to four weeks. By
incorporating liposomal tranexamic acid with advanced DDS technology for
enhanced delivery, this formulation offers a comprehensive approach to managing
pigmentation, ensuring faster results and supporting long-term skin health.”

As understanding of pigmentation biology
advances, dermatology is increasingly moving toward multi-mechanistic approaches that address both pigment formation and
clearance pathways. Melanophagy-based strategies may therefore represent
a promising addition to the therapeutic landscape for chronic pigmentary
disorders such as melasma. 2, 3

Eris
Lifesciences, a leading global
pharmaceutical company, has been dedicated to enhancing healthcare through innovative, patient-centric solutions.
 With a strong presence in chronic disease management,
Eris focuses on advancing treatments
in key therapeutic areas such as dermatology, cardiology, and
diabetes care, driven by a commitment to quality, accessibility, and improving patient
outcomes.

 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339379-featured-images-1-14jpg.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Eris, Lifesciences, Introduces, DEMELAN, NEXA, Serum:, Next-Generation, Melanophagy-Focused, Approach, for, Melasma, Management, India</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339379-featured-images-1-14jpg.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p>Recognizing
the evolving understanding of pigmentation biology, Eris Lifesciences has
launched DEMELAN NEXA Serum, a next-generation melanophagy-focused brightening serum
designed for the comprehensive management of recurrent melasma, and
photo-aging.</p>

<p><span>DEMELAN</span><sup>® </sup>NEXA Serum - available in a 30 ml pack<strike>,</strike>
incorporates Melazero<sup>®</sup>, a third generation brightening agent. The
serum provides a dual-action approach, promoting melanophagy, i.e., clearing
existing melanin and reducing new melanin synthesis, with clinical study showing
visible melanin reduction within two to four weeks.</p></div><div class="pasted-from-word-wrapper">

<p><b>Current Challenges in Melasma Care –
Incomplete Addressal of Pathogenic Pathways </b></p>

<p>Melasma continues to pose a significant
therapeutic challenge in dermatology. Characterized by chronic, relapsing hyperpigmented
patches, it most commonly affects sun-exposed facial areas.<sup>1 </sup>The
condition is widely recognized as multifactorial,
involving ultraviolet radiation, hormonal influences, genetic susceptibility,
inflammation, vascular factors and skin barrier dysfunction. <sup>2</sup> </p>

<p>Despite the availability of several topical
and procedural therapies, long-term
disease control remains difficult, with recurrence frequently reported
in clinical practice.<sup> 1, 2 </sup>One of the key limitations of existing
therapies is that many primarily target melanin
production rather than the removal of already accumulated pigment, leaving
important pathogenic pathways insufficiently addressed.<sup> 2</sup></p>

<p><b>Melanophagy – Novel Treatment Approach in
Melasma Care</b></p>

<p>To bridge current treatment gaps, dermatological
research has increasingly focused on melanophagy,
a cellular mechanism involved in the degradation and clearance of
melanin-containing organelles known as melanosomes. <sup>3</sup> Melanophagy
refers to the autophagic breakdown of
melanosomes within keratinocytes, enabling the removal of excess pigment
from the epidermis. <sup>3</sup></p>

<p>Impaired melanophagy has been associated with
pigment persistence in melasma and photoaging, making the pathway an emerging
therapeutic target in pigmentation disorders. <sup>3, 4</sup> Growing evidence
suggests that enhancing melanophagy may help improve pigmentation outcomes by addressing both pigment accumulation and
ongoing melanogenesis. <sup>3</sup></p>

<p><b><span>Melazero</span><sup>®</sup></b><b>: A Novel Approach Targeting
Hyperpigmentation through Melanophagy</b></p></div><div class="pasted-from-word-wrapper">

<p><span>Melazero</span><sup>®</sup> is a patented active derived from the Korean
plant <em>Arisaema amurense</em> that utilizes a
novel mechanism, melanophagy, to target hyperpigmentation. It promotes
melanophagy in melanocytes, facilitating the clearance of existing
intracellular melanin and simultaneously reducing melanin synthesis. Clinical studies
have shown that 1% <span>Melazero</span><sup>® </sup>significantly reduces melanin levels within two to
four weeks, demonstrating faster onset of action and superior pigmentation
reduction. Additionally, <span>Melazero</span><sup>® </sup>offers good skin tolerability, making it
suitable for topical use in pigmentation management.</p></div><div class="pasted-from-word-wrapper">

<p><b>Other Key Active Ingredients in the
Formulation</b></p>

<p>The serum contains other key ingredients namely Liposomal
Tranexamic Acid (Vegan DDS formulation),
Glycolic acid, Niacinamide, <span>pTerowhite</span><sup>®</sup>, Alpha-arbutin, Fermentex Rice Mak and Hyaluronan 16 Multi-Complex,
each targeting different aspects of pigmentation and skin health. Tranexamic acid helps reduce
pigmentation by inhibiting plasmin activity and lowering inflammatory mediators
that stimulate melanocytes. <sup>5</sup> Vegan DDS Tranexamic Acid is a patented complex with 15 times higher liposomal concentration,
allowing for better efficiency and enhanced skin
tolerability. Niacinamide reduces melanosome transfer from melanocytes to
keratinocytes, decreasing visible pigmentation while supporting the skin
barrier. <sup>6 </sup> <span>pTerowhite</span><sup>® </sup>downregulates
MITF expression, leading to suppression of tyrosinase and reducing melanin
synthesis. <sup>7</sup> Alpha-arbutin interferes
with melanosome maturation, reducing effective pigment production.
<sup>8 </sup>Hyaluronan 16 Multi-Complex
enhances hydration and supports barrier repair, crucial for maintaining healthy
skin during pigmentation treatments. <sup>9</sup></p></div><div class="pasted-from-word-wrapper">

<p><b><span>DEMELAN</span><sup>® </sup></b><b>NEXA - Technology Designed
for Targeted Skin Delivery</b></p></div><div class="pasted-from-word-wrapper">

<p><span>DEMELAN</span><sup>® </sup>NEXA Serum also utilizes Deep Delivery System (DDS) technology,
which aims to improve dermal penetration and optimize the delivery of active
ingredients. DDS technology offers potential advantages such as enhanced
penetration of active molecules into the skin, improved bioavailability of
ingredients, controlled and sustained release of actives and better
tolerability for long-term dermatological use.</p></div><div class="pasted-from-word-wrapper">

<p><b>Potential Clinical Applications in
Pigmentation Management</b></p>

<p>By targeting pigment triggers, melanin synthesis, melanosome transfer, and pigment
clearance, <span>DEMELAN</span><sup>® </sup>NEXA Serum represents a multi-pathway approach to
pigmentation management. Dermatologists
may consider such therapies in patients with chronic or relapsing melasma, post-inflammatory
hyperpigmentation, photoaging-related pigmentation, and patients requiring
long-term maintenance therapy following procedural treatments.</p></div><div class="pasted-from-word-wrapper">

<p><b>Speaking to Medical Dialogues, </b><b>Ms. Nita Borkar
(President - Sales & Marketing, Dermatology Business) at Eris Lifesciences
said</b><b>,</b> <i>“With </i><span>DEMELAN</span><sup>® </sup><i>Nexa serum, we aim to address gaps in the management
of inflammatory and recurrent melasma. It features </i><span>Melazero</span><sup>®</sup><i>, a third-generation brightening agent based on a
Nobel Prize-recognized concept of autophagy, that helps to promote melanophagy
and reduces melanin synthesis.</i> <i>Clinical
studies have reported visible reduction within two to four weeks. By
incorporating liposomal tranexamic acid with advanced DDS technology for
enhanced delivery, this formulation offers a comprehensive approach to managing
pigmentation, ensuring faster results and supporting long-term skin health.”</i></p></div><div class="pasted-from-word-wrapper">

<p>As understanding of pigmentation biology
advances, dermatology is increasingly moving toward multi-mechanistic approaches that address both pigment formation and
clearance pathways. Melanophagy-based strategies may therefore represent
a promising addition to the therapeutic landscape for chronic pigmentary
disorders such as melasma. <sup>2, 3</sup></p>

<p>Eris
Lifesciences, a leading global
pharmaceutical company, has been dedicated to enhancing healthcare through innovative, patient-centric solutions.
 With a strong presence in chronic disease management,
Eris focuses on advancing treatments
in key therapeutic areas such as dermatology, cardiology, and
diabetes care, driven by a commitment to quality, accessibility, and improving patient
outcomes.
</p></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><ol start="9" type="1">
</ol></div>]]> </content:encoded>
</item>

<item>
<title>Common Drugs&#45;Including Non&#45;Antibiotics&#45;Linked to Increased Risk of C. difficile Infection: Study</title>
<link>https://edusehat.com/en/common-drugs-including-non-antibiotics-linked-to-increased-risk-of-c-difficile-infection-study</link>
<guid>https://edusehat.com/en/common-drugs-including-non-antibiotics-linked-to-increased-risk-of-c-difficile-infection-study</guid>
<description><![CDATA[ Sweden: A Swedish population-based case-control study found that both antibiotics and several commonly prescribed non-antibiotic medications are associated with a significantly increased risk of Clostridioides difficile infection.Among non-antibiotic drugs, the highest risks were observed with antidiarrheals, analgesics, and corticosteroids. While antibiotics and acid-suppressing drugs are already well-known risk factors, this study highlights that other widely used medications may also contribute to infection risk.The study, published in Gut by Annelies Boven and colleagues from the Karolinska Institutet, aimed to explore how a broad range of medications—particularly those that may influence the gut microbiome—affect the risk of developing C. difficile infection (CDI). Although antibiotics have long been recognized as a major driver of CDI, evidence regarding other drug classes has remained limited.For this purpose, the researchers conducted a large population-based case–control analysis using linked Swedish national registries from 2006 to 2019. The study included 42,921 individuals diagnosed with CDI and 355,159 matched controls based on age and sex. Medication exposure within 30 days before diagnosis was assessed, and associations with CDI risk were evaluated using multivariable statistical models that accounted for comorbidities and concurrent drug use.   Key Findings:A strong association was observed between certain antibiotic classes and increased risk of Clostridioides difficile infection.Lincosamides were linked to the highest risk, followed by combinations of penicillins, sulfonamides with trimethoprim, and cephalosporins.Tetracyclines did not show a significant association with increased CDI risk, indicating variability across antibiotic classes.Several non-antibiotic medications were also associated with increased CDI risk.Antidiarrheal drugs showed the highest risk among non-antibiotic medications.Corticosteroids and proton pump inhibitors were also significantly associated with higher CDI risk.Other drug classes linked to increased risk included nervous system medications, constipation treatments, histamine H2-receptor antagonists, antidepressants, and beta blockers.Non-steroidal anti-inflammatory drugs did not demonstrate a significant association with CDI risk.Lipid-lowering medications and aspirin were associated with a modest reduction in CDI risk.The potential protective effects of these drugs require further investigation.The study highlights the complex relationship between commonly prescribed medications and gut microbiome health. While antibiotics remain the primary contributors to CDI, the results suggest that other drugs frequently used in routine clinical practice may also play a meaningful role.The authors emphasized that these findings support the need for careful and judicious prescribing practices. Recognizing the potential risks associated with both antibiotic and non-antibiotic medications could help clinicians make more informed decisions, particularly in patients at higher risk for CDI.Overall, the study provides valuable insights for clinicians and policymakers, highlighting the importance of considering a wider range of medications when evaluating CDI risk and reinforcing ongoing efforts toward antimicrobial stewardship and safer prescribing strategies.Reference:Boven A, Vranken H, Vlieghe E, et alCommonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control studyGut Published Online First: 31 March 2026. doi: 10.1136/gutjnl-2025-337629 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Common, Drugs-Including, Non-Antibiotics-Linked, Increased, Risk, difficile, Infection:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.webp"><p><span>Sweden: A Swedish population-based case-control study found that both antibiotics and several <a href="https://medicaldialogues.in/topics/prescription">commonly prescribed non-antibiotic medications </a>are associated with a significantly increased risk of<a href="https://medicaldialogues.in/topics/clostridioides-difficile-infection"> Clostridioides difficile infection</a>.</span></p><div class="pasted-from-word-wrapper"><div>Among non-antibiotic drugs, the highest risks were observed with antidiarrheals, <a href="https://medicaldialogues.in/topics/analgesics">analgesics</a>, and corticosteroids. While antibiotics and acid-suppressing drugs are already well-known risk factors, this study highlights that other widely used medications may also contribute to infection risk.</div><div>The study, published in <i>Gut </i>by Annelies Boven and colleagues from the Karolinska Institutet, aimed to explore how a broad range of medications—particularly those that may influence the gut microbiome—affect the risk of developing C. difficile infection (CDI). Although antibiotics have long been recognized as a major driver of CDI, evidence regarding other drug classes has remained limited.</div><div>For this purpose, the researchers conducted a large population-based case–control analysis using linked Swedish national registries from 2006 to 2019. The study included 42,921 individuals diagnosed with CDI and 355,159 matched controls based on age and sex. Medication exposure within 30 days before diagnosis was assessed, and associations with CDI risk were evaluated using multivariable statistical models that accounted for comorbidities and concurrent drug use.   </div><div>Key Findings:</div><ul><li>A strong association was observed between certain antibiotic classes and increased risk of Clostridioides difficile infection.</li><li>Lincosamides were linked to the highest risk, followed by combinations of penicillins, sulfonamides with trimethoprim, and cephalosporins.</li><li>Tetracyclines did not show a significant association with increased CDI risk, indicating variability across antibiotic classes.</li><li>Several non-antibiotic medications were also associated with increased CDI risk.</li><li>Antidiarrheal drugs showed the highest risk among non-antibiotic medications.</li><li>Corticosteroids and proton pump inhibitors were also significantly associated with higher CDI risk.</li><li>Other drug classes linked to increased risk included nervous system medications, constipation treatments, histamine H2-receptor antagonists, antidepressants, and beta blockers.</li><li>Non-steroidal anti-inflammatory drugs did not demonstrate a significant association with CDI risk.</li><li>Lipid-lowering medications and aspirin were associated with a modest reduction in CDI risk.</li><li>The potential protective effects of these drugs require further investigation.</li></ul><div>The study highlights the complex relationship between commonly prescribed medications and gut microbiome health. While antibiotics remain the primary contributors to CDI, the results suggest that other drugs frequently used in routine clinical practice may also play a meaningful role.</div><div>The authors emphasized that these findings support the need for careful and judicious prescribing practices. Recognizing the potential risks associated with both antibiotic and non-antibiotic medications could help clinicians make more informed decisions, particularly in patients at higher risk for CDI.</div><div>Overall, the study provides valuable insights for clinicians and policymakers, highlighting the importance of considering a wider range of medications when evaluating CDI risk and reinforcing ongoing efforts toward antimicrobial stewardship and safer prescribing strategies.</div><div>Reference:</div><div>Boven A, Vranken H, Vlieghe E, et alCommonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control studyGut Published Online First: 31 March 2026. doi: 10.1136/gutjnl-2025-337629</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>MBBS intern dies after car overturns in Villupuram, 3 injured</title>
<link>https://edusehat.com/en/mbbs-intern-dies-after-car-overturns-in-villupuram-3-injured</link>
<guid>https://edusehat.com/en/mbbs-intern-dies-after-car-overturns-in-villupuram-3-injured</guid>
<description><![CDATA[ Villupuram: A tragic car accident claimed the life of a 24-year-old MBBS intern at a Government Medical College in Chennai and injured three of her friends after the car they were travelling in overturned near Villupuram.According to the police, the intern who was undergoing an internship after completing her MBBS degree died on the spot, while the injured students are undergoing treatment at the Government Medical College Hospital in Mundiyampakkam.Also read- Govt Siddhartha medical college 1st year MBBS student dies in bike accidentAs per latest media report by DT Next, the incident took place on Sunday when three of her friends came to meet her. The group later set out together in a car to visit another friend in Ulundurpet. The vehicle was being driven by a man from Ariyalur.While travelling along the Virattikuppam road, the driver reportedly swerved to the left in an attempt to avoid a lorry ahead. However, the car went out of control and overturned into a roadside ditch.The intern suffered severe head injuries and died instantly at the scene. The three others sustained injuries and were rushed to the hospital for treatment.On receiving information, Villupuram Taluk police reached the spot and shifted the injured to the hospital. The body of the deceased has been sent for postmortem examination.The police have registered a case and an investigation is underway. Medical Dialogues had previously reported that a third-year MBBS student at BRD Medical College was killed, and three others were injured in a car collision. The incident occurred when a speeding Fortuner car, travelling on the wrong side of the Char Phatak Overbridge, struck the vehicle. Police have since arrested the driver.Also read- BRD medical college MBBS student dies in road accident ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/16/333200-accident-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MBBS, intern, dies, after, car, overturns, Villupuram, injured</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/16/333200-accident-1.webp"><p><b>Villupuram: </b>A tragic car <a href="https://medicaldialogues.in/topics/accident" target="_blank">accident</a> claimed the life of a 24-year-old MBBS intern at a Government Medical College in Chennai and injured three of her friends after the car they were travelling in overturned near Villupuram.</p><p>According to the police, the intern who was undergoing an internship after completing her MBBS degree died on the spot, while the injured students are undergoing treatment at the Government Medical College Hospital in Mundiyampakkam.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/andhra-pradesh/govt-siddhartha-medical-college-1st-year-mbbs-student-dies-in-bike-accident-166628" target="_blank">Govt Siddhartha medical college 1st year MBBS student dies in bike accident</a></b></p><p>As per latest media report by <a href="https://www.dtnext.in/news/tamilnadu/medical-intern-from-city-killed-in-car-overturn" target="_blank" rel="nofollow">DT Next</a>, the incident took place on Sunday when three of her friends came to meet her. The group later set out together in a car to visit another friend in Ulundurpet. The vehicle was being driven by a man from Ariyalur.</p><p>While travelling along the Virattikuppam road, the driver reportedly swerved to the left in an attempt to avoid a lorry ahead. However, the car went out of control and overturned into a roadside ditch.</p><p>The intern suffered severe head injuries and died instantly at the scene. The three others sustained injuries and were rushed to the hospital for treatment.</p><p>On receiving information, Villupuram Taluk police reached the spot and shifted the injured to the hospital. The body of the deceased has been sent for postmortem examination.</p><p>The police have registered a case and an investigation is underway. </p><p>Medical Dialogues had previously reported that a third-year MBBS student at BRD Medical College was killed, and three others were injured in a car collision. The incident occurred when a speeding Fortuner car, travelling on the wrong side of the Char Phatak Overbridge, struck the vehicle. Police have since arrested the driver.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/uttar-pradesh/brd-medical-college-mbbs-student-dies-in-road-accident-165868" target="_blank">BRD medical college MBBS student dies in road accident</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Researchers Identify Mechanism Behind Appetite Loss When You Are Sick</title>
<link>https://edusehat.com/en/researchers-identify-mechanism-behind-appetite-loss-when-you-are-sick</link>
<guid>https://edusehat.com/en/researchers-identify-mechanism-behind-appetite-loss-when-you-are-sick</guid>
<description><![CDATA[ A groundbreaking study from the University of California, San Francisco, published in Nature, reveals how the gut communicates with the brain to suppress appetite during infection. The findings uncover a precise biological pathway explaining why appetite loss often appears later in illness rather than immediately.
Researchers discovered that the process begins with specialized gut cells called tuft cells, which act as immune sentinels. These cells detect parasitic infections by sensing compounds such as succinate released by worms. Once activated, tuft cells release acetylcholine, a signaling molecule typically associated with nerve cells. This was a surprising finding, as tuft cells are not neurons but can mimic their communication style.
The signal is then picked up by neighboring enterochromaffin cells, which respond by releasing serotonin. This chemical activates the vagus nerve, a key communication pathway between the gut and the brain. Through this gut–brain axis, the brain receives signals that reduce appetite and alter behavior during infection.
A key insight from the study is the two փուլ signaling pattern. Initially, tuft cells release a brief burst of acetylcholine. As the immune response intensifies and tuft cell numbers increase, they shift to a prolonged, sustained release. This delayed, but stronger signal, explains why appetite suppression often develops after the infection has taken hold rather than at its onset.
Animal experiments confirmed the mechanism. Mice with normal tuft cell function ate less during infection, while those unable to produce acetylcholine continued eating normally. This demonstrates that the pathway directly drives appetite loss.
Beyond infections, the discovery may have broader clinical implications. Disruptions in this signaling system could contribute to gastrointestinal disorders such as irritable bowel syndrome and food intolerances.
Overall, the study provides a clearer understanding of how immune responses influence behavior through the nervous system, opening new possibilities for targeted treatments that could regulate appetite and gut-related symptoms.
REFERENCE: Kouki K. Touhara, Jinhao Xu, Joel Castro, Hong-Erh Liang, Guochuan Li, Mariana Brizuela, Andrea M. Harrington, Sonia Garcia-Caraballo, Tracey O’Donnell, Daniel Neumann, Nathan D. Rossen, Fei Deng, Gudrun Schober, Yulong Li, Richard M. Locksley, Stuart M. Brierley, David Julius. Parasites trigger epithelial cell crosstalk to drive gut–brain signalling. Nature, 2026; DOI: 10.1038/s41586-026-10281-5
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339847-researchers-identify-mechanism-behind-appetite-loss-when-you-are-sick.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Researchers, Identify, Mechanism, Behind, Appetite, Loss, When, You, Are, Sick</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339847-researchers-identify-mechanism-behind-appetite-loss-when-you-are-sick.webp"><p>A groundbreaking study from the University of California, San Francisco, published in <i>Nature</i>, reveals how the gut communicates with the brain to suppress appetite during infection. The findings uncover a precise biological pathway explaining why appetite loss often appears later in illness rather than immediately.
</p><p>Researchers discovered that the process begins with specialized gut cells called tuft cells, which act as immune sentinels. These cells detect parasitic infections by sensing compounds such as succinate released by worms. Once activated, tuft cells release acetylcholine, a signaling molecule typically associated with nerve cells. This was a surprising finding, as tuft cells are not neurons but can mimic their communication style.
</p><p>The signal is then picked up by neighboring enterochromaffin cells, which respond by releasing serotonin. This chemical activates the vagus nerve, a key communication pathway between the gut and the brain. Through this gut–brain axis, the brain receives signals that reduce appetite and alter behavior during infection.
</p><p>A key insight from the study is the two փուլ signaling pattern. Initially, tuft cells release a brief burst of acetylcholine. As the immune response intensifies and tuft cell numbers increase, they shift to a prolonged, sustained release. This delayed, but stronger signal, explains why appetite suppression often develops after the infection has taken hold rather than at its onset.
</p><p>Animal experiments confirmed the mechanism. Mice with normal tuft cell function ate less during infection, while those unable to produce acetylcholine continued eating normally. This demonstrates that the pathway directly drives appetite loss.
</p><p>Beyond infections, the discovery may have broader clinical implications. Disruptions in this signaling system could contribute to gastrointestinal disorders such as irritable bowel syndrome and food intolerances.
</p><p>Overall, the study provides a clearer understanding of how immune responses influence behavior through the nervous system, opening new possibilities for targeted treatments that could regulate appetite and gut-related symptoms.
</p><p><b>REFERENCE: </b>Kouki K. Touhara, Jinhao Xu, Joel Castro, Hong-Erh Liang, Guochuan Li, Mariana Brizuela, Andrea M. Harrington, Sonia Garcia-Caraballo, Tracey O’Donnell, Daniel Neumann, Nathan D. Rossen, Fei Deng, Gudrun Schober, Yulong Li, Richard M. Locksley, Stuart M. Brierley, David Julius. Parasites trigger epithelial cell crosstalk to drive gut–brain signalling. Nature, 2026; DOI: 10.1038/s41586-026-10281-5
</p>]]> </content:encoded>
</item>

<item>
<title>Study Examines Whether Genes Influence How Lifestyle Choices Affect Aging Outcomes</title>
<link>https://edusehat.com/en/study-examines-whether-genes-influence-how-lifestyle-choices-affect-aging-outcomes</link>
<guid>https://edusehat.com/en/study-examines-whether-genes-influence-how-lifestyle-choices-affect-aging-outcomes</guid>
<description><![CDATA[ A new international study led by researchers at the University of Adelaide highlights how lifestyle, socioeconomic factors, and genetics work together to shape healthy aging. Published in The Journals of Gerontology: Biological Sciences, the research provides fresh insight into why people age differently, even when they share similar habits.
The study analyzed data from over 13,000 participants in the Canadian Longitudinal Study on Aging. Researchers focused on “intrinsic capacity,” a key measure of healthy aging that reflects a person’s physical and mental abilities, including mobility, cognition, and social functioning. Higher intrinsic capacity indicates better independence and quality of life as people age.
Findings showed that healthier aging is strongly linked to modifiable lifestyle and social factors. Regular physical activity, a balanced diet, higher education, employment, and active social engagement were all associated with better functional ability. In contrast, smoking and poor sleep—both insufficient and excessive—were tied to lower intrinsic capacity and faster decline.
Importantly, the study revealed that these effects are not uniform. Genetic predisposition can influence how strongly lifestyle factors impact aging. For instance, individuals with a favorable genetic profile experienced less harm from short sleep duration. However, long sleep duration in middle age (45–64 years) was linked to worse outcomes, even among those with genetic advantages.
Adopting a Mediterranean-style diet and achieving higher educational levels showed consistent benefits, regardless of genetic background. Researchers also found that genetic influence on aging is more pronounced in midlife, while accumulated lifestyle and environmental exposures become increasingly important later in life.
The findings emphasize the concept of gene–environment interaction, where biology and daily habits jointly determine health outcomes. While genetics cannot be changed, many key factors—such as diet, exercise, sleep, and social engagement—are modifiable.
Overall, the study underscores a critical message: focusing on maintaining functional ability, rather than simply preventing disease, can significantly improve long-term health and independence. 
REFERENCE: Melkamu Bedimo Beyene, Renuka Visvanathan, Robel Alemu, Olga Theou, Beben Benyamin, Matteo Cesari, John Beard, Azmeraw T Amare, Associations and interaction effects of socioeconomic, lifestyle, and genetic factors on intrinsic capacity, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag057, https://doi.org/10.1093/gerona/glag057 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339844-untitled-design-2026-04-06t111657293.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Examines, Whether, Genes, Influence, How, Lifestyle, Choices, Affect, Aging, Outcomes</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339844-untitled-design-2026-04-06t111657293.webp"><p>A new international study led by researchers at the University of Adelaide highlights how lifestyle, socioeconomic factors, and genetics work together to shape healthy aging. Published in <i>The Journals of Gerontology: Biological Sciences</i>, the research provides fresh insight into why people age differently, even when they share similar habits.
</p><p>The study analyzed data from over 13,000 participants in the Canadian Longitudinal Study on Aging. Researchers focused on “intrinsic capacity,” a key measure of healthy aging that reflects a person’s physical and mental abilities, including mobility, cognition, and social functioning. Higher intrinsic capacity indicates better independence and quality of life as people age.
</p><p>Findings showed that healthier aging is strongly linked to modifiable lifestyle and social factors. Regular physical activity, a balanced diet, higher education, employment, and active social engagement were all associated with better functional ability. In contrast, smoking and poor sleep—both insufficient and excessive—were tied to lower intrinsic capacity and faster decline.
</p><p>Importantly, the study revealed that these effects are not uniform. Genetic predisposition can influence how strongly lifestyle factors impact aging. For instance, individuals with a favorable genetic profile experienced less harm from short sleep duration. However, long sleep duration in middle age (45–64 years) was linked to worse outcomes, even among those with genetic advantages.
</p><p>Adopting a Mediterranean-style diet and achieving higher educational levels showed consistent benefits, regardless of genetic background. Researchers also found that genetic influence on aging is more pronounced in midlife, while accumulated lifestyle and environmental exposures become increasingly important later in life.
</p><p>The findings emphasize the concept of gene–environment interaction, where biology and daily habits jointly determine health outcomes. While genetics cannot be changed, many key factors—such as diet, exercise, sleep, and social engagement—are modifiable.
</p><p>Overall, the study underscores a critical message: focusing on maintaining functional ability, rather than simply preventing disease, can significantly improve long-term health and independence. 
</p><p><b>REFERENCE:</b> Melkamu Bedimo Beyene, Renuka Visvanathan, Robel Alemu, Olga Theou, Beben Benyamin, Matteo Cesari, John Beard, Azmeraw T Amare, Associations and interaction effects of socioeconomic, lifestyle, and genetic factors on intrinsic capacity, The Journals of Gerontology: Series A, Volume 81, Issue 4, April 2026, glag057, https://doi.org/10.1093/gerona/glag057</p>]]> </content:encoded>
</item>

<item>
<title>Study Suggests Higher Meat Intake May Lower Alzheimer’s Risk in Some Individuals</title>
<link>https://edusehat.com/en/study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals</link>
<guid>https://edusehat.com/en/study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals</guid>
<description><![CDATA[ A new study from Karolinska Institutet, published in JAMA Network Open, offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
REFERENCE: Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339842-study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:08 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Suggests, Higher, Meat, Intake, May, Lower, Alzheimer’s, Risk, Some, Individuals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339842-study-suggests-higher-meat-intake-may-lower-alzheimers-risk-in-some-individuals.webp"><p>A new study from Karolinska Institutet, published in <i>JAMA Network Open</i>, offers a surprising perspective on diet and brain health. Researchers found that higher meat consumption may help protect against cognitive decline in older adults who carry high-risk variants of the APOE gene.
</p><p>The APOE gene plays a central role in determining the risk of Alzheimer’s disease. Individuals with APOE 3/4 or 4/4 variants are significantly more likely to develop dementia. However, this long-term study suggests that diet could influence how this genetic risk unfolds.
</p><p>The research followed over 2,100 adults aged 60 and above for up to 15 years as part of the Swedish National Study on Aging and Care. Participants’ dietary habits were analyzed alongside cognitive performance. Among those who consumed lower amounts of meat, individuals with high-risk APOE variants had more than double the risk of developing dementia compared to those without these variants.
</p><p>In contrast, this increased risk was not observed in participants with the highest meat intake. In fact, individuals with APOE 3/4 or 4/4 who consumed more meat showed slower cognitive decline and a reduced risk of dementia. The median intake in this group was around 870 grams of meat per week.
</p><p>Importantly, the type of meat mattered. Higher consumption of unprocessed meat was associated with better outcomes, while a greater proportion of processed meat was linked to increased dementia risk, regardless of genetic background. The study also found that higher unprocessed meat intake in high-risk individuals was associated with a lower risk of death from any cause.
</p><p>Despite these promising findings, researchers caution that the study is observational and does not establish cause and effect. Further clinical trials are needed to confirm whether dietary changes can directly modify dementia risk.
</p><p>Overall, the findings highlight the potential for personalized nutrition strategies, where dietary recommendations could be tailored based on an individual’s genetic profile, opening new avenues in the prevention of Alzheimer’s disease.
</p><p><b>REFERENCE: </b>Jakob Norgren, Adrián Carballo-Casla, Giulia Grande, Anne Börjesson-Hanson, Hong Xu, Maria Eriksdotter, Erika J. Laukka, Sara Garcia-Ptacek. Meat Consumption and Cognitive Health by APOE Genotype. JAMA Network Open, 2026; 9 (3): e266489 DOI: 10.1001/jamanetworkopen.2026.6489
</p>]]> </content:encoded>
</item>

<item>
<title>NBE Declares FDST 2026 results for BDS. MDS, PG diploma, details</title>
<link>https://edusehat.com/en/nbe-declares-fdst-2026-results-for-bds-mds-pg-diploma-details</link>
<guid>https://edusehat.com/en/nbe-declares-fdst-2026-results-for-bds-mds-pg-diploma-details</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has announced the results of the Foreign Dental Screening Test, FDST 2026 (BDS), and MDS Degree and PG Diploma, Theory tests conducted earlier this year.BDS:The results and scores obtained by the candidates in Paper I &amp; II of the theory test for FDS Test (BDS) 2026 can be seen on the official website of NBE. The result includes important details such as the application ID, roll no., and result (theory), etc.Also Read: NBE to hold Foreign Dental Screening Test FDST BDS 2026 on March at New Delhi Centre, Check detailsThe FDST 2026 theory examination was held on March 1, 2026, in computer-based mode at New Delhi. The screening test is a mandatory requirement for foreign dental graduates seeking registration to practice dentistry in India.To pass the Screening Test, a candidate has to separately score 50% in the viva-voce examination. The date and venue for the viva-voce examination shall be intimated to the theory-qualified candidates individually.According to the official notice, each and every question in FDST 2026, BDS was reviewed by subject-matter experts from the concerned speciality after the conduct of FDST 2026, BDS, to re-check the technical correctness of the questions and answer keys. As per inputs from the subject matter experts, none of the questions was found to be technically incorrect in the Question Papers of FDST 2026 BDS. As per the Dental Council of India (DCI) Screening Test Regulations 2009 (amended up to September 2018), candidates are required to score at least 50% marks in each paper individually (Paper I and Paper II) to qualify for the next stage, which is the viva-voce examination.NBEMS stated that all questions and answer keys were thoroughly reviewed by subject matter experts after the examination. Following this review, it was confirmed that none of the questions was technically incorrect, ensuring the integrity and fairness of the examination process.To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-bds-theory-resultsjpg-339855.pdfMDS:Along with this, the NBEMS has also announced the results of the FDST 2026 for MDS Degree and PG Diploma, Theory Test, conducted earlier this year.The FDST 2026 (MDS Degree &amp; PG Diploma) theory examination was held on February 21, 2026, in a computer-based format at New Delhi.As per the official notice, each and every question in FDST 2026- MDS/PG Diploma was reviewed by the subject matter experts from the concerned speciality after the conduct of FDST 2026, MDS/PG Diploma, to re-check for technical correctness of the questions as well as answer keys. As per inputs from the subject matter experts, three (03) questions were found to be technically incorrect in the Question Papers of FDST 2026 MDS/PG Diploma. Full marks have been awarded to all the candidates who appeared in the exam, irrespective of the fact whether these questions have been attempted or not attempted by the candidates.As per the Dental Council of India Screening Test Regulations 2009 (amended up to September 2018), a candidate has to score 50% in each theory paper individually to qualify for appearing in the viva-voce examination.The scores obtained by the candidates in Paper I &amp; II of the theory test for Foreign Dental Screening Test (MDS Degree &amp; PG Diploma) 2026 are mentioned.To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-results-for-bds-mds-pg-diploma-339856.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339852-result-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NBE, Declares, FDST, 2026, results, for, BDS., MDS, diploma, details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339852-result-1.webp"><p><b>New Delhi: </b>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) has announced the results of the Foreign Dental Screening Test, <a href="https://medicaldialogues.in/topics/fdst" target="_blank">FDST</a> 2026 (BDS), and MDS Degree and PG Diploma, Theory tests conducted earlier this year.</p><p>BDS:</p><div class="pasted-from-word-wrapper"><p dir="ltr">The results and scores obtained by the candidates in Paper I & II of the theory test for FDS Test (<a href="https://medicaldialogues.in/topics/bds" target="_blank">BDS</a>) 2026 can be seen on the official website of NBE. The result includes important details such as the application ID, roll no., and result (theory), etc.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/dentistry/nbe-to-hold-foreign-dental-screening-test-fdst-bds-2026-on-march-at-new-delhi-centre-check-details-165264"><b>Also Read: </b>NBE to hold Foreign Dental Screening Test FDST BDS 2026 on March at New Delhi Centre, Check details</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The FDST 2026 theory examination was held on March 1, 2026, in computer-based mode at New Delhi. The screening test is a mandatory requirement for foreign dental graduates seeking registration to practice dentistry in India.</p><p dir="ltr">To pass the Screening Test, a candidate has to separately score 50% in the viva-voce examination. The date and venue for the viva-voce examination shall be intimated to the theory-qualified candidates individually.</p><p dir="ltr">According to the official notice, each and every question in FDST 2026, BDS was reviewed by subject-matter experts from the concerned speciality after the conduct of FDST 2026, BDS, to re-check the technical correctness of the questions and answer keys. </p><p dir="ltr">As per inputs from the subject matter experts, none of the questions was found to be technically incorrect in the Question Papers of FDST 2026 BDS. </p><p dir="ltr">As per the Dental Council of India (DCI) Screening Test Regulations 2009 (amended up to September 2018), candidates are required to score at least 50% marks in each paper individually (Paper I and Paper II) to qualify for the next stage, which is the viva-voce examination.</p><p dir="ltr">NBEMS stated that all questions and answer keys were thoroughly reviewed by subject matter experts after the examination. Following this review, it was confirmed that none of the questions was technically incorrect, ensuring the integrity and fairness of the examination process.</p><p dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-bds-theory-resultsjpg-339855.pdf">https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-bds-theory-resultsjpg-339855.pdf</a><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-bds-theory-resultsjpg-339855.pdf" target="_blank"></a></p><p dir="ltr">MDS:</p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Along with this, the NBEMS has also announced the results of the FDST 2026 for MDS Degree and PG Diploma, Theory Test, conducted earlier this year.</p><p dir="ltr">The FDST 2026 (MDS Degree & PG Diploma) theory examination was held on February 21, 2026, in a computer-based format at New Delhi.</p><p dir="ltr">As per the official notice, each and every question in FDST 2026- MDS/PG Diploma was reviewed by the subject matter experts from the concerned speciality after the conduct of FDST 2026, MDS/PG Diploma, to re-check for technical correctness of the questions as well as answer keys. </p><p dir="ltr">As per inputs from the subject matter experts, three (03) questions were found to be technically incorrect in the Question Papers of FDST 2026 MDS/PG Diploma. Full marks have been awarded to all the candidates who appeared in the exam, irrespective of the fact whether these questions have been attempted or not attempted by the candidates.</p><p dir="ltr">As per the Dental Council of India Screening Test Regulations 2009 (amended up to September 2018), a candidate has to score 50% in each theory paper individually to qualify for appearing in the viva-voce examination.</p><p dir="ltr">The scores obtained by the candidates in Paper I & II of the theory test for Foreign Dental Screening Test (MDS Degree & PG Diploma) 2026 are mentioned.</p><div dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></div><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-results-for-bds-mds-pg-diploma-339856.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-declares-fdst-2026-results-for-bds-mds-pg-diploma-339856.pdf</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>AP Health Minister urges reduction of cesarean deliveries in private hospitals</title>
<link>https://edusehat.com/en/ap-health-minister-urges-reduction-of-cesarean-deliveries-in-private-hospitals</link>
<guid>https://edusehat.com/en/ap-health-minister-urges-reduction-of-cesarean-deliveries-in-private-hospitals</guid>
<description><![CDATA[ Vijayawada: Andhra Pradesh Health Minister Satya Kumar Yadav on Saturday emphasised the need to reduce the number of cesarean deliveries, noting that most of the deliveries took place in private hospitals. In a release here, the minister said that 68 percent of cesarean deliveries were performed in private hospitals and underlined the need of reducing them to 40 percent.He also highlighted that the rate of teenage pregnancy in the state is about 9 percent and the target is to reduce it to 3 percent. Also Read:Doctor, nurses booked for alleged medical negligence at Wayanad HospitalYadav said the government has identified the problems of maternal health due to teenage pregnancy, malnutrition, a high number of caesarean births, a large number of family planning operations for women, and frequent deliveries. He opined that proper counselling is needed for women regarding pre- and post-pregnancy measures, reports UNI.He said that the currently implemented 180 days of maternity leave will be converted into 12 months of parenthood leave, which can be used equally by both parents.The government is ready to remove the obstacles being faced by women to emerge as an economic productive force on par with men. As part of this, Yadav said that the need to set up child care centers in every place with more than 50 employees for the care of children up to the age of six has been identified, and steps have been proposed in that direction.The Minister also stated that steps would be taken to set up one &#039;working women&#039;s hostel&#039; for every lakh population in urban areas.The Health Minister also announced that a &#039;Center of Excellence in Reproductive Health&#039; will be set up under the &#039;Matrutva&#039; scheme. Along with this, the Minister explained that a 6-month diploma course and a year-long advanced course will be started regarding these services. Also Read:Protest erupts at Jajpur Hospital after woman dies post-delivery ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/06/21/212307-cesarean-delivery.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Minister, urges, reduction, cesarean, deliveries, private, hospitals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/06/21/212307-cesarean-delivery.webp"><div class="pasted-from-word-wrapper"><p><span>Vijayawada: Andhra Pradesh Health Minister Satya Kumar Yadav on Saturday emphasised the need to reduce the number of cesarean deliveries, noting that </span><span>most of the deliveries took place in private hospitals. </span></p><p>In a release here, the minister said that 68 percent of <a href="https://medicaldialogues.in/topics/cesarean" target="_blank">cesarean </a>deliveries were performed in private hospitals and underlined the need of reducing them to 40 percent.</p><p>He also highlighted that the rate of teenage pregnancy in the state is about 9 percent and the target is to reduce it to 3 percent. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/doctor-nurses-booked-for-alleged-medical-negligence-at-wayanad-hospital-162574"><b>Also Read:Doctor, nurses booked for alleged medical negligence at Wayanad Hospital</b></a></p><p>Yadav said the government has identified the problems of maternal health due to teenage pregnancy, malnutrition, a high number of <a href="https://medicaldialogues.in/topics/cesarean" target="_blank">caesarean </a>births, a large number of family planning operations for women, and frequent deliveries. He opined that proper counselling is needed for women regarding pre- and post-pregnancy measures, reports UNI.</p><p>He said that the currently implemented 180 days of maternity leave will be converted into 12 months of parenthood leave, which can be used equally by both parents.</p><p>The government is ready to remove the obstacles being faced by women to emerge as an economic productive force on par with men. As part of this, Yadav said that the need to set up child care centers in every place with more than 50 employees for the care of children up to the age of six has been identified, and steps have been proposed in that direction.</p><p>The Minister also stated that steps would be taken to set up one 'working women's hostel' for every lakh population in urban areas.</p><p>The Health Minister also announced that a 'Center of Excellence in Reproductive Health' will be set up under the 'Matrutva' scheme. Along with this, the Minister explained that a 6-month diploma course and a year-long advanced course will be started regarding these services. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/protest-erupts-at-jajpur-hospital-after-woman-dies-post-delivery-161736"><b>Also Read:Protest erupts at Jajpur Hospital after woman dies post-delivery</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Tripura introduces digital health program to improve healthcare services</title>
<link>https://edusehat.com/en/tripura-introduces-digital-health-program-to-improve-healthcare-services</link>
<guid>https://edusehat.com/en/tripura-introduces-digital-health-program-to-improve-healthcare-services</guid>
<description><![CDATA[ Agartala: To enhance accessibility, transparency, and efficiency of healthcare services, the Tripura Government has initiated a significant digital health program by implementing the Integrated Health Management Information System (IHMIS) in all district and subdivision hospitals, rural hospitals, and primary health centres. With this system, patients can quickly generate outpatient tickets by scanning a QR code and access their complete health records online. The initiative aims to provide modern, data-driven healthcare to all residents, including those in remote regions.According to a UNI report, Health Secretary Kiran Gitte said that IHMIS has the importance of state doctors and healthcare staff taking an active role, ensuring that all necessary resources are available for a seamless rollout.Also Read:NMC orders medical colleges to integrate HMIS of attached hospitals with Ayushman Bharat Digital Mission PortalThe department has signed a Memorandum of Understanding (MoU) with BECIL to operationalize IHIMS, which aims to fully digitise healthcare services in Tripura.It facilitates every citizen will have a digital medical history that doctors can access at any government hospital. Integration with Ayusman Bharat Digital Mission, linking their health records to the national system.Online registration will help reduce long queues in outpatient and emergency departments. Residents, particularly in remote areas, will have the ability to consult specialists in Agartala.   Medical Dialogues had earlier reported that Tripura Chief Minister Manik Saha said that the state government is committed to providing the best possible assistance to people in need and ensuring access to quality healthcare within the state, highlighting that telemedicine is playing a crucial role in delivering advanced medical services.Speaking during the 62nd episode of Mukhya Mantri Samipeshu (CM’s Aam Darbar), Saha said that patients from economically weaker sections should avoid unnecessary expenditure by seeking treatment outside the state unless specialised care is required. Also Read:Provide online info on hospital beds, doctors availability through HMIS: Delhi HC tells govt ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339583-ihmis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Tripura, introduces, digital, health, program, improve, healthcare, services</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339583-ihmis.webp"><div class="pasted-from-word-wrapper"><p><span>Agartala: To </span>enhance accessibility, transparency, and efficiency of healthcare services,<span> the </span><a href="https://medicaldialogues.in/topics/Tripura-Government" target="_blank">Tripura Government</a><span> has initiated a significant digital health program by implementing the Integrated Health Management Information System (IHMIS) in all district and subdivision hospitals, rural hospitals, and primary health centres. </span></p><p>With this system, patients can quickly generate outpatient tickets by scanning a QR code and access their complete health records online. The initiative aims to provide modern, data-driven healthcare to all residents, including those in remote regions.</p><p>According to a UNI report, Health Secretary Kiran Gitte said that IHMIS has the importance of state doctors and healthcare staff taking an active role, ensuring that all necessary resources are available for a seamless rollout.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/nmc-orders-medical-colleges-to-integrate-hmis-of-attached-hospitals-with-ayushman-bharat-digital-mission-portal-165965"><b>Also Read:NMC orders medical colleges to integrate HMIS of attached hospitals with Ayushman Bharat Digital Mission Portal</b></a></p><p>The department has signed a Memorandum of Understanding (MoU) with BECIL to operationalize IHIMS, which aims to fully digitise healthcare services in Tripura.</p><p>It facilitates every citizen will have a digital medical history that doctors can access at any government hospital. Integration with Ayusman Bharat Digital Mission, linking their health records to the national system.</p><p>Online registration will help reduce long queues in outpatient and emergency departments. Residents, particularly in remote areas, will have the ability to consult specialists in Agartala.   </p><p>Medical Dialogues had earlier reported that Tripura Chief Minister Manik Saha said that the state government is committed to providing the best possible assistance to people in need and ensuring access to quality healthcare within the state, highlighting that telemedicine is playing a crucial role in delivering advanced medical services.</p><p>Speaking during the 62nd episode of Mukhya Mantri Samipeshu (CM’s Aam Darbar), Saha said that patients from economically weaker sections should avoid unnecessary expenditure by seeking treatment outside the state unless specialised care is required. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/provide-online-info-on-hospital-beds-doctors-availability-through-hmis-delhi-hc-tells-govt-154981"><b>Also Read:Provide online info on hospital beds, doctors availability through HMIS: Delhi HC tells govt</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>31&#45;year&#45;old Anaesthesiologist found dead in Chennai amid marriage dispute</title>
<link>https://edusehat.com/en/31-year-old-anaesthesiologist-found-dead-in-chennai-amid-marriage-dispute</link>
<guid>https://edusehat.com/en/31-year-old-anaesthesiologist-found-dead-in-chennai-amid-marriage-dispute</guid>
<description><![CDATA[ Chennai: In a tragic incident, a 31-year-old woman doctor in Chennai allegedly died by suicide after facing prolonged opposition from her family over her choice of marriage partner. According to the news reports, the deceased doctor had been working as an anaesthesiologist at the hospital for the past year. She lost her parents during her college days and was raised by her elder brother, a doctor based in Chengalpattu. The incident came to light after she completed her duty. The doctor entered the duty doctor’s cabin and locked the door. When she did not respond to repeated calls, a nurse alerted other hospital staff, who later found her unresponsive.Also Read:Hyderabad doctor ends life after injecting himself; wife booked for abetmentPolice sources said the doctor was in a relationship with a 31-year-old orthopaedic doctor working at a private hospital in Kodambakkam. When she informed her brother about the relationship, the response was not favourable. Her partner had also delayed talking to his family about the relationship, police said, reports TNIE.Meanwhile, the doctor’s relatives had begun searching for a suitable marriage alliance for her, which she had reportedly opposed for the past four months. Following a recent argument with her family, she moved out of her brother’s residence and has been staying at a friend’s apartment near Sathya Sai Hospital in Thiruporur.
According to the news reports, on the day of the incident, her brother, along with other relatives, visited the hospital and asked her to return home, which reportedly led to an argument. Later that night, after completing her duty, she went into the duty doctor’s cabin and locked the door. When she did not respond to repeated calls, a nurse alerted other hospital staff. She was subsequently found unresponsive inside the room. Despite efforts to revive her, she was declared dead.
The hospital authorities informed her family and the Maraimalai Nagar police. The body was sent to Chengalpattu Government Hospital for postmortem examination and later handed over to her kin.
Police have registered a case under Section 194 of the Bharatiya Nyaya Sanhita (BNS), and further investigation is underway to ascertain the exact circumstances leading to her death.
Also Read:AIIMS Bhopal doctor attempts suicide with Family in Andhra, wife, 3-year-old daughter dead ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/30/338444-dead.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>31-year-old, Anaesthesiologist, found, dead, Chennai, amid, marriage, dispute</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/30/338444-dead.webp"><p><b>Chennai: </b>In a tragic incident, a 31-year-old woman <a href="https://medicaldialogues.in/topics/doctors">doctor</a> in Chennai allegedly died by <a href="https://medicaldialogues.in/topics/suicide">suicide</a> after facing prolonged opposition from her family over her choice of marriage partner. </p><p>According to the news reports, the deceased doctor had been working as an anaesthesiologist at the hospital for the past year. She lost her parents during her college days and was raised by her elder brother, a doctor based in Chengalpattu. </p><p>The incident came to light after she completed her duty. The doctor entered the duty doctor’s cabin and locked the door. When she did not respond to repeated calls, a nurse alerted other hospital staff, who later found her unresponsive.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/hyderabad-doctor-ends-life-after-injecting-himself-wife-booked-for-abetment-167785"><b>Also Read:Hyderabad doctor ends life after injecting himself; wife booked for abetment</b></a></p><p>Police sources said the doctor was in a relationship with a 31-year-old orthopaedic doctor working at a private hospital in Kodambakkam. When she informed her brother about the relationship, the response was not favourable. Her partner had also delayed talking to his family about the relationship, police said, reports <a href="https://www.newindianexpress.com/cities/chennai/2026/Apr/06/chennai-doctor-dies-by-suicide-due-to-opposition-from-kin-over-choice-of-life-partner" rel="nofollow">TNIE</a>.</p><p>Meanwhile, the doctor’s relatives had begun searching for a suitable marriage alliance for her, which she had reportedly opposed for the past four months. Following a recent argument with her family, she moved out of her brother’s residence and has been staying at a friend’s apartment near Sathya Sai Hospital in Thiruporur.
</p><p>According to the news reports, on the day of the incident, her brother, along with other relatives, visited the hospital and asked her to return home, which reportedly led to an argument. Later that night, after completing her duty, she went into the duty doctor’s cabin and locked the door. When she did not respond to repeated calls, a nurse alerted other hospital staff. She was subsequently found unresponsive inside the room. Despite efforts to revive her, she was declared dead.
</p><p>The hospital authorities informed her family and the Maraimalai Nagar police. The body was sent to Chengalpattu Government Hospital for postmortem examination and later handed over to her kin.
</p><p>Police have registered a case under Section 194 of the Bharatiya Nyaya Sanhita (BNS), and further investigation is underway to ascertain the exact circumstances leading to her death.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/aiims-bhopal-doctor-attempts-suicide-with-family-in-andhra-wife-3-year-old-daughter-dead-167553"><b>Also Read:AIIMS Bhopal doctor attempts suicide with Family in Andhra, wife, 3-year-old daughter dead</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Pioneer Cardiologist, Padma Shri Dr Mani Chhetri passes away at 106</title>
<link>https://edusehat.com/en/pioneer-cardiologist-padma-shri-dr-mani-chhetri-passes-away-at-106</link>
<guid>https://edusehat.com/en/pioneer-cardiologist-padma-shri-dr-mani-chhetri-passes-away-at-106</guid>
<description><![CDATA[ Kolkata: Eminent cardiologist and Padma Shri awardee Dr Mani Chhetri passed away late on Sunday at his residence at the age of 106.  According to family sources, Dr Chhetri had suffered a head injury after a fall about a fortnight ago and had largely been bedridden since returning home from the hospital.“He had shown signs of recovery after being discharged. But his condition deteriorated gradually over the past few days,” a family member said.Also Read:Arunachal&#039;s first oncologist, Mari Basar, passes away at 67Dr Chhetri was born on May 23, 1920, in Darjeeling, West Bengal. After passing his intermediate examination from St. Paul&#039;s Cathedral Mission College, Kolkata, he secured a graduate degree in medicine (MBBS) from the Medical College and Hospital, Kolkata, in 1944. Later, in 1956, he secured the degree of FRCP from London on a government scholarship.  He later returned to India and built a distinguished career as a cardiologist, earning widespread recognition for his contributions to the field.Dr Chhetri served as the director of the premier state-run SSKM Hospital and also held the position of director of health services in West Bengal.In 1997, when the Advanced Medical Research Institute was started in Dhakuria, Dr Chetri was made the managing director, but he continued his association with IPGMER &amp; SSKM Hospital as an adviser.  Despite his administrative responsibilities, he continued to attend to patients throughout his career.In recognition of his contributions in the field of medicine, Dr Chhetri was awarded the Padma Shri in 1974. Even after retiring from government service in 1982, he remained actively involved in medical practice for decades.Chhetri had been suffering from dementia in recent years, which forced him to cut down on his clinical engagements. “He continued attending to patients until about two years ago,” a family member said, reports PTI.Also Read:Eminent pathologist Dr Maya Nanda passes away at 85 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339846-dr-mani-chhetri.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Pioneer, Cardiologist, Padma, Shri, Mani, Chhetri, passes, away, 106</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339846-dr-mani-chhetri.webp"><div class="pasted-from-word-wrapper"><p><span>Kolkata: Eminent cardiologist and Padma Shri awardee Dr Mani Chhetri passed away late on Sunday at his residence at the age of 106.  </span></p><p>According to family sources, Dr Chhetri had suffered a head injury after a fall about a fortnight ago and had largely been bedridden since returning home from the hospital.</p><p>“He had shown signs of recovery after being discharged. But his condition deteriorated gradually over the past few days,” a family member said.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/arunachals-first-oncologist-mari-basar-passes-away-at-67-165989"><b>Also Read:Arunachal's first oncologist, Mari Basar, passes away at 67</b></a><br></p><p>Dr Chhetri was born on May 23, 1920, in Darjeeling, West Bengal. After passing his intermediate examination from St. Paul's Cathedral Mission College, Kolkata, he secured a graduate degree in medicine (MBBS) from the Medical College and Hospital, Kolkata, in 1944. Later, in 1956, he secured the degree of FRCP from London on a government scholarship.  </p><p>He later returned to India and built a distinguished career as a cardiologist, earning widespread recognition for his contributions to the field.</p><p>Dr Chhetri served as the director of the premier state-run <a href="https://medicaldialogues.in/topics/SSKM-Hospital" target="_blank">SSKM Hospital</a> and also held the position of director of health services in West Bengal.</p><p>In 1997, when the Advanced Medical Research Institute was started in Dhakuria, Dr Chetri was made the managing director, but he continued his association with IPGMER & SSKM Hospital as an adviser.  </p><p>Despite his administrative responsibilities, he continued to attend to patients throughout his career.</p><p>In recognition of his contributions in the field of medicine, Dr Chhetri was awarded the Padma Shri in 1974. Even after retiring from government service in 1982, he remained actively involved in medical practice for decades.</p><p>Chhetri had been suffering from dementia in recent years, which forced him to cut down on his clinical engagements. “He continued attending to patients until about two years ago,” a family member said, reports PTI.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/eminent-pathologist-dr-maya-nanda-passes-away-at-85-165402"><b>Also Read:Eminent pathologist Dr Maya Nanda passes away at 85</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>NMC nod to 8 more Super speciality seats in 5 medical colleges after appeals</title>
<link>https://edusehat.com/en/nmc-nod-to-8-more-super-speciality-seats-in-5-medical-colleges-after-appeals</link>
<guid>https://edusehat.com/en/nmc-nod-to-8-more-super-speciality-seats-in-5-medical-colleges-after-appeals</guid>
<description><![CDATA[ New Delhi: 8 additional super speciality seats across five medical colleges have been approved by the National Medical Commission (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.This comes right after the Medical Assessment &amp; Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.Issuing a fresh notice on 04.04.2026, the MARB approved 8 super specialty seats across five medical colleges including MGM Medical College &amp; Hospital, Chhatrapati Sambhajinagar, Government Medical College, Amritsar, M.K. Shah Medical College, Hospital and Research Centre, Ahmedabad, Krishna Institute of Medical Sciences, Karad, and Netaji Subhash Chandra Bose Medical College, Jabalpur. According to the notice, MGM Medical College &amp; Hospital, Aurangabad, has been granted 2 seats in M.Ch Hepato Pancreato Biliary Surgery. Government Medical College, Amritsar, has received 1 seat in DM Cardiology. M.K. Shah Medical College, Ahmedabad, has been allotted 2 seats in M.Ch Urology. Krishna Institute of Medical Sciences, Karad, has received 1 additional seat in M.Ch Urology, taking its total to 3 seats. Meanwhile, Netaji Subhash Chandra Bose Medical College, Jabalpur, has been granted 2 seats in DM Cardiology.Addressing Deans, Principals and other stakeholders in the notice, the board stated that these seats were granted after reviewing appeals filed by medical colleges under Section 28(5) of the NMC Act, 2019. Further, MARB clarified that the Letters of Permission (LoPs) for these seats will be issued shortly. However, the list of approved seats itself will be treated as a valid document for the counselling process. Counselling authorities have been asked not to wait for LoPs to include these seats in the counselling process.&quot;In reference to the appeals preferred by Medical Colleges under Section 28(5) of the NMC Act, 2019 against the decisions of the MARB for the seats granted during Academic Year 2025–26, the matter was examined by the First Appeal Committee. The list of seats granted by the First Appeal Committee is attached herewith for the information of all stakeholders. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. This list uploaded on the website shall be considered as valid document for counselling process,&quot; the notice read. Referring to the MARB notice, the NMC Secretary Dr. Raghav Langer, asked all concerned stakeholders to take note of the development for necessary action on their part.The letter mentioned, &quot;Kind reference is invited to the Medical Assessment &amp; Rating Board (MARB) of National Medical Commission (NMC) Public Notice of even number dated 04-04-2026 (copy enclosed) on the subject mentioned above being self-explanatory inter-alia duly enclosing the list of seats granted by the First Appeal Committee which shall be considered as valid document for counselling process. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. Accordingly, all concerned stakeholders are requested to take note of the same for necessary action on their part.&quot;PG seats granted pursuant to the decisions of the First Appeal Committee meeting held on 01.04.2026.
 
 
 
 
 
 
 
  S.
    no
  Name    of    the College
  Date        of Appeal
  Details
  Additional seats    
  given
    by      
  Appeal Committee
  Total    Seats (after
  decision     of Appeal
    Committee)
 
 
  1.
  MGM      Medical
    College            &amp; Hospital, ChhatrapatiSam
  bhajinagar,
    Aurangabad
  23.03.2026
  M.Ch-
    HepatoPancrea to           Biliary Surgery
  02
  02
 
 
  2.
  Government Medical 
  College, Amirtsar,
    Punjab
  19.03.2026
  DM-
    Cardiology
  01
  01
 
 
  3.
  M.K.          Shah
  Medical  College, Hospital       and Research Centre,
    Ahmedabad
  23.03.2026
  M.Ch–Urology
  02
  02
 
 
  4.
  Krishna Institute         
  of Medical Sciences, Karad,
    Maharashtra
  25.03.2026
  M.Ch–Urology
  01
  03
 
 
  5.
  Netaji   Subhash
  Chandra     Bose Medical  College,
    Jabalpur, M.P.
  31.03.2026
  DM-
    Cardiology
  02
  02
 To view the notice, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/06/nmc-additional-seats-granted-by-the-1st-appeal-committee-for-post-graduate-courses-super-specialty-in-medical-colleges-institutions-for-the-academic-year-1-339880.pdfAlso read- NMC clears 49 additional DM, MCh seats for 2025-26 after appeals ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/08/13/183247-neet-ss-seats.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, nod, more, Super, speciality, seats, medical, colleges, after, appeals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/08/13/183247-neet-ss-seats.webp"><p><b>New Delhi: </b>8 additional <a href="https://medicaldialogues.in/topics/super-speciality-seats" target="_blank">super speciality seats</a> across five medical colleges have been approved by the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC) for the academic year 2025-26, following decisions taken by its First Appeal Committee.</p><p>This comes right after the Medical Assessment & Rating Board (MARB) of NMC approved 49 additional DM and MCh seats in other institutes after reviewing their appeals on March 30, 2026.</p><p>Issuing a fresh notice on 04.04.2026, the MARB approved 8 super specialty seats across five medical colleges including MGM Medical College & Hospital, Chhatrapati Sambhajinagar, Government Medical College, Amritsar, M.K. Shah Medical College, Hospital and Research Centre, Ahmedabad, Krishna Institute of Medical Sciences, Karad, and Netaji Subhash Chandra Bose Medical College, Jabalpur. </p><p>According to the notice, MGM Medical College & Hospital, Aurangabad, has been granted 2 seats in M.Ch Hepato Pancreato Biliary Surgery. Government Medical College, Amritsar, has received 1 seat in DM Cardiology. M.K. Shah Medical College, Ahmedabad, has been allotted 2 seats in M.Ch Urology. Krishna Institute of Medical Sciences, Karad, has received 1 additional seat in M.Ch Urology, taking its total to 3 seats. Meanwhile, Netaji Subhash Chandra Bose Medical College, Jabalpur, has been granted 2 seats in DM Cardiology.</p><p>Addressing Deans, Principals and other stakeholders in the notice, the board stated that these seats were granted after reviewing appeals filed by medical colleges under Section 28(5) of the NMC Act, 2019. </p><p>Further, MARB clarified that the Letters of Permission (LoPs) for these seats will be issued shortly. However, the list of approved seats itself will be treated as a valid document for the counselling process. Counselling authorities have been asked not to wait for LoPs to include these seats in the counselling process.</p><p><i>"In reference to the appeals preferred by Medical Colleges under Section 28(5) of the NMC Act, 2019 against the decisions of the MARB for the seats granted during Academic Year 2025–26, the matter was examined by the First Appeal Committee. The list of seats granted by the First Appeal Committee is attached herewith for the information of all stakeholders. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. This list uploaded on the website shall be considered as valid document for counselling process," </i>the notice read. </p><p>Referring to the MARB notice, the NMC Secretary Dr. Raghav Langer, asked all concerned stakeholders to take note of the development for necessary action on their part.</p><p>The letter mentioned, <i>"Kind reference is invited to the Medical Assessment & Rating Board (MARB) of National Medical Commission (NMC) Public Notice of even number dated 04-04-2026 (copy enclosed) on the subject mentioned above being self-explanatory inter-alia duly enclosing the list of seats granted by the First Appeal Committee which shall be considered as valid document for counselling process. The LOPs for these sanctioned PG seats for AY 2025-26 will be issued shortly. The counselling authorities need not wait for the LOPs from institutions to include them in the counselling process. Accordingly, all concerned stakeholders are requested to take note of the same for necessary action on their part."</i></p><p><b>PG seats granted pursuant to the decisions of the First Appeal Committee meeting held on 01.04.2026.</b></p><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="798">
 <colgroup><col width="43">
 <col width="170">
 <col width="131">
 <col width="158">
 <col width="149">
 <col width="147">
 </colgroup><tbody><tr height="86">
  <td height="86" class="xl65" width="43"><b>S.<br>
    no</b></td>
  <td class="xl66" width="170"><b>Name    of    the College</b></td>
  <td class="xl66" width="131"><b>Date        of Appeal</b></td>
  <td class="xl66" width="158"><b>Details</b></td>
  <td class="xl65" width="149"><b>Additional seats    
  given<br>
    by      
  Appeal Committee</b></td>
  <td class="xl65" width="147"><b>Total    Seats (after
  decision     of Appeal<br>
    Committee)</b></td>
 </tr>
 <tr height="103">
  <td height="103" class="xl67">1.</td>
  <td class="xl65" width="170">MGM      Medical<br>
    College            & Hospital, ChhatrapatiSam
  bhajinagar,<br>
    Aurangabad</td>
  <td class="xl68">23.03.2026</td>
  <td class="xl65" width="158">M.Ch-<br>
    HepatoPancrea to           Biliary Surgery</td>
  <td class="xl69">02</td>
  <td class="xl69">02</td>
 </tr>
 <tr height="74">
  <td height="74" class="xl67">2.</td>
  <td class="xl65" width="170">Government Medical 
  College, Amirtsar,<br>
    Punjab</td>
  <td class="xl68">19.03.2026</td>
  <td class="xl65" width="158">DM-<br>
    Cardiology</td>
  <td class="xl69">01</td>
  <td class="xl69">01</td>
 </tr>
 <tr height="110">
  <td height="110" class="xl67">3.</td>
  <td class="xl65" width="170">M.K.          Shah
  Medical  College, Hospital       and Research Centre,<br>
    Ahmedabad</td>
  <td class="xl68">23.03.2026</td>
  <td class="xl70" width="158">M.Ch–Urology</td>
  <td class="xl69">02</td>
  <td class="xl69">02</td>
 </tr>
 <tr height="92">
  <td height="92" class="xl67">4.</td>
  <td class="xl65" width="170">Krishna Institute         
  of Medical Sciences, Karad,<br>
    Maharashtra</td>
  <td class="xl68">25.03.2026</td>
  <td class="xl70" width="158">M.Ch–Urology</td>
  <td class="xl69">01</td>
  <td class="xl69">03</td>
 </tr>
 <tr height="69">
  <td height="69" class="xl67">5.</td>
  <td class="xl65" width="170">Netaji   Subhash
  Chandra     Bose Medical  College,<br>
    Jabalpur, M.P.</td>
  <td class="xl68">31.03.2026</td>
  <td class="xl65" width="158">DM-<br>
    Cardiology</td>
  <td class="xl69">02</td>
  <td class="xl69">02</td>
 </tr></tbody></table></div><p><b>To view the notice, click on the link below:</b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/nmc-additional-seats-granted-by-the-1st-appeal-committee-for-post-graduate-courses-super-specialty-in-medical-colleges-institutions-for-the-academic-year-1-339880.pdf" target="_blank"><b>https://medicaldialogues.in/pdf_upload/2026/04/06/nmc-additional-seats-granted-by-the-1st-appeal-committee-for-post-graduate-courses-super-specialty-in-medical-colleges-institutions-for-the-academic-year-1-339880.pdf</b></a></div><p><b>Also read- <a href="https://medicaldialogues.in/health-news/nmc/nmc-clears-49-additional-dm-mch-seats-for-2025-26-after-appeals-167648" target="_blank">NMC clears 49 additional DM, MCh seats for 2025-26 after appeals</a></b></p>]]> </content:encoded>
</item>

<item>
<title>NBE invites applications for Diploma final exams June 2026 session, check details</title>
<link>https://edusehat.com/en/nbe-invites-applications-for-diploma-final-exams-june-2026-session-check-details</link>
<guid>https://edusehat.com/en/nbe-invites-applications-for-diploma-final-exams-june-2026-session-check-details</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has invited online applications for the NBE Diploma Final Examination for the June 2026 session, with the theory exams scheduled to be conducted in May 2026 across India.The NBEMS Diploma Final Theory Examination will be held on May 14, 15, and 16, 2026, in a hybrid mode at multiple examination centres nationwide.Also Read: NBE releases 2026 tentative exam calendar, check FMGE, GPAT, DNB PDCET, Diploma exams dates hereAs per the official notice, the online application process will end on April 22, 2026, 11:55 PM.Test City intimation to the candidates: 04-05-2026Issue of Admit Cards: 11-05-2026To view the notice, click the link belowhttps://medicaldialogues.in/pdf_upload/2026/04/06/nbe-opens-applications-for-diploma-final-exam-june-2026-339866.pdfSTEPS TO APPLY ONLINESTEP 1- Visit the official NBEMS website.STEP 2- Click on the Examinations tab in the top bar, then navigate to Exit Examination &gt;&gt; NBEMS Diploma Final Examination.STEP 3- Click on the Application Link for the June 2026 session.STEP 4- Register as a New User by providing your name, email ID (OTP verified), and mobile number.STEP 5- Log in using the system-generated User ID and Password received in your email.STEP 6- Fill out the application form carefully, including personal details, NBEMS registration number, training details, and select your first and second choice for the exam city.STEP 7- Upload scanned copies of the required documents.STEP 8- Pay the examination fee of ₹5,250/- online. Ensure the payment status shows “Successful” (S).STEP 9- Submit the form, download the confirmation page, and save the Application ID for future reference.Candidate must score at least 150 / 300 in the aggregate of 3 papers to qualify the theory examination. The grand total of marks obtained in Final theory examination shall be a whole number. Accordingly, aggregate marks of all theory papers obtained in decimals of 0.5 or more shall be rounded up to the next higher whole number. Further, aggregate marks of all theory papers obtained in decimals of less than 0.5 shall be rounded down to the nearest whole number. There shall be no “rounding off” of marks obtained in individual theory papers.Also Read: NBE invites applications for Diploma Final Exams December 2025, check details ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339865-application-invited.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NBE, invites, applications, for, Diploma, final, exams, June, 2026, session, check, details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339865-application-invited.webp"><p><b>New Delhi: </b>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) has invited online applications for the NBE <a href="https://medicaldialogues.in/topics/diploma" target="_blank">Diploma </a>Final Examination for the June 2026 session, with the theory exams scheduled to be conducted in May 2026 across India.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The NBEMS Diploma Final Theory Examination will be held on May 14, 15, and 16, 2026, in a hybrid mode at multiple examination centres nationwide.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nbe-releases-2026-tentative-exam-calendar-check-fmge-gpat-dnb-pdcet-diploma-exams-dates-here-161644"><b>Also Read: </b>NBE releases 2026 tentative exam calendar, check FMGE, GPAT, DNB PDCET, Diploma exams dates here</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">As per the official notice, the online application process will end on April 22, 2026, 11:55 PM.</p><p>Test City intimation to the candidates: 04-05-2026</p><p>Issue of Admit Cards: 11-05-2026</p><p dir="ltr"><b><u><i>To view the notice, click the link below</i></u></b></p><p dir="ltr"><a href="https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-opens-applications-for-diploma-final-exam-june-2026-339866.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/06/nbe-opens-applications-for-diploma-final-exam-june-2026-339866.pdf</a></p></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>STEPS TO APPLY ONLINE</u></b></p><p dir="ltr"><b>STEP 1-</b> Visit the official NBEMS website.</p><p dir="ltr"><b>STEP 2-</b> Click on the Examinations tab in the top bar, then navigate to Exit Examination >> NBEMS Diploma Final Examination.</p><p dir="ltr"><b>STEP 3-</b> Click on the Application Link for the June 2026 session.</p><p dir="ltr"><b>STEP 4-</b> Register as a New User by providing your name, email ID (OTP verified), and mobile number.</p><p dir="ltr"><b>STEP 5-</b> Log in using the system-generated User ID and Password received in your email.</p><p dir="ltr"><b>STEP 6- </b>Fill out the application form carefully, including personal details, NBEMS registration number, training details, and select your first and second choice for the exam city.</p><p dir="ltr"><b>STEP 7-</b> Upload scanned copies of the required documents.</p><p dir="ltr"><b>STEP 8-</b> Pay the examination fee of ₹5,250/- online. Ensure the payment status shows “Successful” (S).</p><p dir="ltr"><b>STEP 9- </b>Submit the form, download the confirmation page, and save the Application ID for future reference.</p><p>Candidate must score at least 150 / 300 in the aggregate of 3 papers to qualify the theory examination. The grand total of marks obtained in Final theory examination shall be a whole number. Accordingly, aggregate marks of all theory papers obtained in decimals of 0.5 or more shall be rounded up to the next higher whole number. Further, aggregate marks of all theory papers obtained in decimals of less than 0.5 shall be rounded down to the nearest whole number. There shall be no “rounding off” of <span>marks obtained in individual theory papers.</span></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/nbe-invites-applications-for-diploma-final-exams-december-2025-check-details-158195"><b>Also Read: </b>NBE invites applications for Diploma Final Exams December 2025, check details</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Kerala Cardiothoracic Surgeon dies while taking holy dip in Ganga</title>
<link>https://edusehat.com/en/kerala-cardiothoracic-surgeon-dies-while-taking-holy-dip-in-ganga</link>
<guid>https://edusehat.com/en/kerala-cardiothoracic-surgeon-dies-while-taking-holy-dip-in-ganga</guid>
<description><![CDATA[ Thiruvananthapuram: In a tragic incident, a renowned cardiothoracic surgeon from Kerala was found dead after going missing while taking a holy dip in the Ganga River in Varanasi. 
According to the news reports, Dr. Mohan Krishnan, a native of Thiruvananthapuram, went missing on Saturday morning while taking a holy dip in the river along with his wife and family. His body was later discovered at Mansarovar Ghat, approximately 200 meters downstream from the spot where he disappeared. Authorities later shifted the body to Shivpur Government Hospital for postmortem procedures. Cremation is scheduled to take place at the revered Manikarnika Ghat.Also Read:Pioneer Cardiologist, Padma Shri Dr Mani Chhetri passes away at 106Family members, including his wife, son, daughter-in-law, and grandson, are expected to return home after completing the final rites, while additional rituals will be conducted in his hometown.Dr. Krishnan was widely known not only for his medical expertise but also for his compassion and dedication to patient care. An alumnus of Thiruvananthapuram Medical College, he served for many years in its cardiothoracic department and eventually retired as a professor. He later continued his service at Sree Ramakrishna Hospital in Sasthamangalam.
Colleagues and friends remember him as a doctor who prioritized service over financial gain.
As per Kerala Kaumudi, friends and colleagues are mourning the loss of Dr Mohan Krishnan of Sree Ramakrishna Hospital, Sasthamangalam. Many were in disbelief over the news. Despite his busy schedule, Mohan Krishnan always found time for travelling. His zest for visiting new places was unquenchable. Even though crossed 70, the doctor made sure to find time for pilgrimages and pleasure trips. The latest on his bucket list was Varanasi, but tragedy was lurking in the holy city.
An active member of the Kannammoola Sree Narayana Club, he was also known for his love of travel and spiritual journeys. Despite his age, he remained energetic and enthusiastic, with plans for an upcoming trip to Mumbai and Gujarat later this month.
Also Read:Sitapur 69-year-old BAMS doctor allegedly shoots self with licensed revolver, probe on ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/06/339889-1742198634310-902409843-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 16:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Kerala, Cardiothoracic, Surgeon, dies, while, taking, holy, dip, Ganga</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/06/339889-1742198634310-902409843-1.webp"><p><b>Thiruvananthapuram: </b>In a tragic incident, a renowned <a href="https://medicaldialogues.in/topics/cardiac%20surgeon">cardiothoracic surgeon</a> from <a href="https://medicaldialogues.in/state-news/kerala">Kerala </a>was found dead after going missing while taking a holy dip in the Ganga River in Varanasi. 
</p><p>According to the news reports, Dr. Mohan Krishnan, a native of Thiruvananthapuram, went missing on Saturday morning while taking a holy dip in the river along with his wife and family. His body was later discovered at Mansarovar Ghat, approximately 200 meters downstream from the spot where he disappeared. Authorities later shifted the body to Shivpur Government Hospital for postmortem procedures. Cremation is scheduled to take place at the revered Manikarnika Ghat.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/pioneer-cardiologist-padma-shri-dr-mani-chhetri-passes-away-at-106-168038"><b>Also Read:Pioneer Cardiologist, Padma Shri Dr Mani Chhetri passes away at 106</b></a></p><p>Family members, including his wife, son, daughter-in-law, and grandson, are expected to return home after completing the final rites, while additional rituals will be conducted in his hometown.</p><p>Dr. Krishnan was widely known not only for his medical expertise but also for his compassion and dedication to patient care. An alumnus of Thiruvananthapuram Medical College, he served for many years in its cardiothoracic department and eventually retired as a professor. He later continued his service at Sree Ramakrishna Hospital in Sasthamangalam.
</p><p>Colleagues and friends remember him as a doctor who prioritized service over financial gain.
</p><p>As per <a href="https://keralakaumudi.com/en/news/news.php?id=1727072&u=malayali-doctors-body-recovered-from-mansarovar-ghat-after-24-hour-search" rel="nofollow">Kerala Kaumudi</a>, friends and colleagues are mourning the loss of Dr Mohan Krishnan of Sree Ramakrishna Hospital, Sasthamangalam. Many were in disbelief over the news. Despite his busy schedule, Mohan Krishnan always found time for travelling. His zest for visiting new places was unquenchable. Even though crossed 70, the doctor made sure to find time for pilgrimages and pleasure trips. The latest on his bucket list was Varanasi, but tragedy was lurking in the holy city.
</p><p>An active member of the Kannammoola Sree Narayana Club, he was also known for his love of travel and spiritual journeys. Despite his age, he remained energetic and enthusiastic, with plans for an upcoming trip to Mumbai and Gujarat later this month.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/sitapur-69-year-old-bams-doctor-allegedly-shoots-self-with-licensed-revolver-probe-on-167483"><b>Also Read:Sitapur 69-year-old BAMS doctor allegedly shoots self with licensed revolver, probe on</b></a></p>]]> </content:encoded>
</item>

<item>
<title>CGM may reveal insights into steroid&#45;induced hyperglycemia: Study</title>
<link>https://edusehat.com/en/cgm-may-reveal-insights-into-steroid-induced-hyperglycemia-study</link>
<guid>https://edusehat.com/en/cgm-may-reveal-insights-into-steroid-induced-hyperglycemia-study</guid>
<description><![CDATA[ Researchers have found that continuous glucose monitoring (CGM) may provide detailed insights into steroid-induced hyperglycemia (SIH), showing distinct patterns based on the type of steroid and patient demographics. Dexamethasone showed a consistent glucose excursion phase, methylprednisolone had a delayed response, and triamcinolone demonstrated variable patterns. The first 48–72 hours emerged as the most reliable period for monitoring, highlighting the clinical value of CGM in detecting and managing SIH. The study was published in the Journal of Pain Research by Birthi P. and colleagues.This prospective single-arm observational study recruited 58 adult patients with diabetes undergoing interventional pain management with a single standard-of-care steroid injection. Patients were treated with dexamethasone (n = 38), methylprednisolone (n = 15), or triamcinolone (n = 5).Glucose levels were monitored with the Dexcom G7 CGM device, which recorded glucose every 5 minutes for up to 10 days after the injection, thereby enabling detailed analysis of glucose levels and recovery patterns. Stratified analysis was performed by steroid type, sex, and age ( ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2021/09/10/160273-continuous-glucose-monitoring.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 12:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>CGM, may, reveal, insights, into, steroid-induced, hyperglycemia:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2021/09/10/160273-continuous-glucose-monitoring.webp"><p>Researchers have found that continuous glucose monitoring (CGM) may provide detailed insights into steroid-induced hyperglycemia (SIH), showing distinct patterns based on the type of steroid and patient demographics. Dexamethasone showed a consistent glucose excursion phase, methylprednisolone had a delayed response, and triamcinolone demonstrated variable patterns. The first 48–72 hours emerged as the most reliable period for monitoring, highlighting the clinical value of CGM in detecting and managing SIH. The study was published in the <i>Journal of Pain Research</i> by Birthi P. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">This prospective single-arm observational study recruited 58 adult patients with diabetes undergoing interventional pain management with a single standard-of-care steroid injection. Patients were treated with dexamethasone (n = 38), methylprednisolone (n = 15), or triamcinolone (n = 5).</p><p dir="ltr">Glucose levels were monitored with the Dexcom G7 CGM device, which recorded glucose every 5 minutes for up to 10 days after the injection, thereby enabling detailed analysis of glucose levels and recovery patterns. Stratified analysis was performed by steroid type, sex, and age (<64.6 years vs. ≥64.6 years).</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The participants were 58 adults with diabetes treated with steroid injections. These were dexamethasone (38 participants), methylprednisolone (15 participants), and triamcinolone (5 participants).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels rose within 2 hours of injection for all participants.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels for dexamethasone rose to a maximum of 220–225 mg/dl and fell to baseline within 24–36 hours.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels for methylprednisolone rose to a maximum of 175–185 mg/dl with a delay and plateau for several days.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels for triamcinolone rose to a maximum of 220 mg/dl with large variability.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels were higher and earlier for females than for males.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The blood glucose levels were more dynamic for participants under 64.6 years of age and stable for participants over 64.6 years of age.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">CGM monitors blood glucose every 5 minutes for 10 days.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The period when blood glucose is best monitored is 48–72 hours post-injection.</p></li></ul><p dir="ltr">Continuous glucose monitoring has identified that there are different patterns of early and steroid-specific hyperglycemia, with the first 48-72 hours considered the most important period for monitoring and managing patients with steroid-induced hyperglycemia.</p><p dir="ltr">Reference:</p><p dir="ltr">Birthi P, Pattabiraman M, Ramaswamy A, Kumar M, Agrawal A, Dua A, Nalamachu SR, Chandra S. Multi-Patient Analysis of Steroid-Induced Hyperglycemia in Diabetic Patients Using Continuous Glucose Monitoring. J Pain Res. 2026;19:1-13</p><p dir="ltr"><a href="https://doi.org/10.2147/JPR.S569171">https://doi.org/10.2147/JPR.S569171</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>EMPEROR&#45;Preserved Score Predicts Outcomes and Identifies Greater Absolute Benefit with Finerenone</title>
<link>https://edusehat.com/en/emperor-preserved-score-predicts-outcomes-and-identifies-greater-absolute-benefit-with-finerenone</link>
<guid>https://edusehat.com/en/emperor-preserved-score-predicts-outcomes-and-identifies-greater-absolute-benefit-with-finerenone</guid>
<description><![CDATA[ In the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the relative treatment effect of Finerenone, higher-risk patients derived greater absolute benefit. Overall, the score is a useful tool for individualized risk stratification, estimating treatment benefit, and improving patient selection in future HFmrEF and HFpEF trials. The study was published in JAMA Cardiology by Misato C. and colleagues.Consistent therapeutic effects of finerenone were observed across all risk level categories in patients with heart failure and mildly reduced ejection fraction, and biomarker-driven risk models were shown to predict prognosis effectively. Patients with heart failure and preserved ejection fraction (HFpEF) and mildly reduced ejection fraction (HFmrEF) display significant variability in clinical outcomes, making risk stratification and therapeutic decision-making difficult. This secondary analysis of a pre-specified hypothesis explored prognostic risk models based on the EMPEROR-Preserved trial in the context of the FINEARTS-HF population.This secondary analysis was carried out using data collected in the randomized clinical trial FINEARTS-HF, which included patients from 653 sites in 37 different countries. Patients aged 40 years and above with symptomatic heart failure and left ventricular ejection fraction (LVEF) ≥40% were included.In this trial, there were 6,001 patients with a mean age of 72.0 (±9.6) years. Of these, 2,732 (45.5%) were women. Patients were randomized to receive either finerenone or placebo. Patients receiving finerenone totaled 3,003, while those receiving placebo totaled 2,998. The median time to event was 32 months (IQR 23–37).Key findings:A total of 6,001 patients were analyzed across 653 sites in 37 countries.Patients in the highest risk quintile (Q5) had a hazard ratio of 10.49 (95% CI 8.14–13.52) for HF hospitalization or cardiovascular death compared with Q1.For cardiovascular death alone, Q5 vs Q1 hazard ratio was 13.47 (95% CI 8.79–20.64).Finerenone treatment effects across risk quintiles were:Q1: HR 0.93 (95% CI 0.58–1.49)Q2: HR 1.04 (95% CI 0.76–1.43)Q3: HR 0.82 (95% CI 0.62–1.07)Q4: HR 0.81 (95% CI 0.65–1.01)Q5: HR 0.88 (95% CI 0.74–1.05)No significant interaction across risk groups was observed (P = 0.68).Risk models driven by biomarkers have been shown to accurately predict outcomes in patients with HFpEF and HFmrEF, and finerenone has shown consistent clinical benefit across all risk profiles.Reference:Chimura M, McDowell K, Jhund PS, et al. EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF. JAMA Cardiol. Published online March 28, 2026. doi:10.1001/jamacardio.2026.1049  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/04/18/236367-heart-failure-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 12:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>EMPEROR-Preserved, Score, Predicts, Outcomes, and, Identifies, Greater, Absolute, Benefit, with, Finerenone</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/04/18/236367-heart-failure-50.webp"><p>In the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the relative treatment effect of Finerenone, higher-risk patients derived greater absolute benefit. Overall, the score is a useful tool for individualized risk stratification, estimating treatment benefit, and improving patient selection in future HFmrEF and HFpEF trials. The study was published in <i>JAMA Cardiology</i> by Misato C. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Consistent therapeutic effects of finerenone were observed across all risk level categories in patients with heart failure and mildly reduced ejection fraction, and biomarker-driven risk models were shown to predict prognosis effectively. Patients with heart failure and preserved ejection fraction (HFpEF) and mildly reduced ejection fraction (HFmrEF) display significant variability in clinical outcomes, making risk stratification and therapeutic decision-making difficult. This secondary analysis of a pre-specified hypothesis explored prognostic risk models based on the EMPEROR-Preserved trial in the context of the FINEARTS-HF population.</p><p dir="ltr">This secondary analysis was carried out using data collected in the randomized clinical trial FINEARTS-HF, which included patients from 653 sites in 37 different countries. Patients aged 40 years and above with symptomatic heart failure and left ventricular ejection fraction (LVEF) ≥40% were included.</p><p dir="ltr">In this trial, there were 6,001 patients with a mean age of 72.0 (±9.6) years. Of these, 2,732 (45.5%) were women. Patients were randomized to receive either finerenone or placebo. Patients receiving finerenone totaled 3,003, while those receiving placebo totaled 2,998. The median time to event was 32 months (IQR 23–37).</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">A total of 6,001 patients were analyzed across 653 sites in 37 countries.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Patients in the highest risk quintile (Q5) had a hazard ratio of 10.49 (95% CI 8.14–13.52) for HF hospitalization or cardiovascular death compared with Q1.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">For cardiovascular death alone, Q5 vs Q1 hazard ratio was 13.47 (95% CI 8.79–20.64).</p></li></ul><p dir="ltr">Finerenone treatment effects across risk quintiles were:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Q1: HR 0.93 (95% CI 0.58–1.49)</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Q2: HR 1.04 (95% CI 0.76–1.43)</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Q3: HR 0.82 (95% CI 0.62–1.07)</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Q4: HR 0.81 (95% CI 0.65–1.01)</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Q5: HR 0.88 (95% CI 0.74–1.05)</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">No significant interaction across risk groups was observed (P = 0.68).</p></li></ul><p dir="ltr">Risk models driven by biomarkers have been shown to accurately predict outcomes in patients with HFpEF and HFmrEF, and finerenone has shown consistent clinical benefit across all risk profiles.</p><p dir="ltr">Reference:</p><p dir="ltr">Chimura M, McDowell K, Jhund PS, et al. EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF. JAMA Cardiol. Published online March 28, 2026. doi:10.1001/jamacardio.2026.1049 </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Tirzepatide Lowers Cardiovascular and Kidney Events vs Dulaglutide in High&#45;Risk Diabetes: Study</title>
<link>https://edusehat.com/en/tirzepatide-lowers-cardiovascular-and-kidney-events-vs-dulaglutide-in-high-risk-diabetes-study</link>
<guid>https://edusehat.com/en/tirzepatide-lowers-cardiovascular-and-kidney-events-vs-dulaglutide-in-high-risk-diabetes-study</guid>
<description><![CDATA[ In a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with Dulaglutide in patients with diabetes and established cardiovascular disease, suggesting superior cardiorenal benefit in this high-risk population. The study was published in JAMA Cardiology by Steven E. and colleagues.The incidence of major cardiovascular and kidney outcomes is reduced by tirzepatide compared to dulaglutide in patients with type 2 diabetes and cardiovascular disease. The cardiometabolic advantage of tirzepatide extends beyond glucose control. Cardiovascular and kidney complications are major causes of morbidity and mortality among patients with type 2 diabetes. Previous studies have shown the non-inferiority of tirzepatide compared to dulaglutide for major cardiovascular outcomes. The current post hoc analysis extends the scope of previous studies by assessing a wider composite of adverse cardiorenal outcomes.This post hoc analysis was based on a large, double-blind, randomized clinical trial carried out in 640 centers in North and South America, Europe, Asia, and Oceania. The trial enrolled 13,165 patients with type 2 diabetes and pre-existing cardiovascular disease from May 29, 2020, to June 27, 2022, with analysis carried out from July 2025 to February 2026. The patients enrolled in this trial were 64 (±8.8) years of age on average, with 71.0% male (n=9,348) and 29.0% female (n=3,817). The mean baseline HbA1c levels were 8.4% (±0.93%), indicating suboptimal control.Participants were randomly assigned to receive once-weekly subcutaneous injections of tirzepatide up to 15 mg (n=6,586) or dulaglutide 1.5 mg (n=6,579). Median treatment duration was 46.9 months (IQR 34.6–50.6), which is sufficient to evaluate the long-term outcome. The composite outcome included six major cardiorenal events, including all-cause death, myocardial infarction, stroke, coronary revascularization, hospitalization for heart failure, and adverse kidney outcomes. Other analyses included composite outcomes with narrower event sets excluding kidney and/or heart failure.Key findings:A total of 13,165 patients were included in the analysis.The primary composite cardiorenal outcome was seen in 1,559 patients (23.7%) in the tirzepatide group compared with 1,803 patients (27.4%) in the dulaglutide group.Tirzepatide resulted in reduction with hazard ratio (HR) 0.84 (95% CI 0.79–0.90; p &lt; 0.001).In the 5-component outcome excluding kidney outcomes, the HR was 0.86 (95% CI 0.80–0.93).In the 4-component outcome excluding kidney and heart failure outcomes, the HR again was 0.86 (95% CI 0.80–0.93).Gastrointestinal adverse events were seen in 2,827 patients (42.5%) receiving tirzepatide and 2,387 patients (35.9%) receiving dulaglutide.Tirzepatide is shown to decrease the risk of major cardiovascular and kidney outcomes compared to dulaglutide in patients with type 2 diabetes and cardiovascular disease, which makes it a comprehensive cardiometabolic therapy.Reference:Nissen SE, Wolski K, D’Alessio D, et al. Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial. JAMA Cardiol. Published online March 28, 2026. doi:10.1001/jamacardio.2026.0767  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/26/233050-tirzepatide.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 12:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Tirzepatide, Lowers, Cardiovascular, and, Kidney, Events, Dulaglutide, High-Risk, Diabetes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/26/233050-tirzepatide.webp"><p>In a new post hoc analysis, tirzepatide was associated with a lower incidence of a composite cardiovascular and kidney outcome compared with Dulaglutide in patients with diabetes and established cardiovascular disease, suggesting superior cardiorenal benefit in this high-risk population. The study was published in <i>JAMA Cardiology</i> by Steven E. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The incidence of major cardiovascular and kidney outcomes is reduced by tirzepatide compared to dulaglutide in patients with type 2 diabetes and cardiovascular disease. The cardiometabolic advantage of tirzepatide extends beyond glucose control. Cardiovascular and kidney complications are major causes of morbidity and mortality among patients with type 2 diabetes. Previous studies have shown the non-inferiority of tirzepatide compared to dulaglutide for major cardiovascular outcomes. The current post hoc analysis extends the scope of previous studies by assessing a wider composite of adverse cardiorenal outcomes.</p><p dir="ltr">This post hoc analysis was based on a large, double-blind, randomized clinical trial carried out in 640 centers in North and South America, Europe, Asia, and Oceania. The trial enrolled 13,165 patients with type 2 diabetes and pre-existing cardiovascular disease from May 29, 2020, to June 27, 2022, with analysis carried out from July 2025 to February 2026. The patients enrolled in this trial were 64 (±8.8) years of age on average, with 71.0% male (n=9,348) and 29.0% female (n=3,817). The mean baseline HbA1c levels were 8.4% (±0.93%), indicating suboptimal control.</p><p dir="ltr">Participants were randomly assigned to receive once-weekly subcutaneous injections of tirzepatide up to 15 mg (n=6,586) or dulaglutide 1.5 mg (n=6,579). Median treatment duration was 46.9 months (IQR 34.6–50.6), which is sufficient to evaluate the long-term outcome. The composite outcome included six major cardiorenal events, including all-cause death, myocardial infarction, stroke, coronary revascularization, hospitalization for heart failure, and adverse kidney outcomes. Other analyses included composite outcomes with narrower event sets excluding kidney and/or heart failure.</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">A total of 13,165 patients were included in the analysis.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The primary composite cardiorenal outcome was seen in 1,559 patients (23.7%) in the tirzepatide group compared with 1,803 patients (27.4%) in the dulaglutide group.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Tirzepatide resulted in reduction with hazard ratio (HR) 0.84 (95% CI 0.79–0.90; p < 0.001).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In the 5-component outcome excluding kidney outcomes, the HR was 0.86 (95% CI 0.80–0.93).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">In the 4-component outcome excluding kidney and heart failure outcomes, the HR again was 0.86 (95% CI 0.80–0.93).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Gastrointestinal adverse events were seen in 2,827 patients (42.5%) receiving tirzepatide and 2,387 patients (35.9%) receiving dulaglutide.</p></li></ul><p dir="ltr">Tirzepatide is shown to decrease the risk of major cardiovascular and kidney outcomes compared to dulaglutide in patients with type 2 diabetes and cardiovascular disease, which makes it a comprehensive cardiometabolic therapy.</p><p dir="ltr">Reference:</p><p dir="ltr">Nissen SE, Wolski K, D’Alessio D, et al. Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial. JAMA Cardiol. Published online March 28, 2026. doi:10.1001/jamacardio.2026.0767 </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Eris Lifesciences Introduces DEMELAN® NEXA Serum: Next&#45;Generation Melanophagy&#45;Focused Approach for Melasma Management in India</title>
<link>https://edusehat.com/en/eris-lifesciences-introduces-demelan-nexa-serum-next-generation-melanophagy-focused-approach-for-melasma-management-in-india</link>
<guid>https://edusehat.com/en/eris-lifesciences-introduces-demelan-nexa-serum-next-generation-melanophagy-focused-approach-for-melasma-management-in-india</guid>
<description><![CDATA[ Recognizing
the evolving understanding of pigmentation biology, Eris Lifesciences has
launched DEMELAN® NEXA Serum, a next-generation melanophagy-focused brightening serum
designed for the comprehensive management of recurrent melasma, and
photo-aging.

DEMELAN® NEXA Serum - available in a 30 ml pack,
incorporates Melazero®, a third generation brightening agent. The
serum provides a dual-action approach, promoting melanophagy, i.e., clearing
existing melanin and reducing new melanin synthesis, with clinical study showing
visible melanin reduction within two to four weeks.

Current Challenges in Melasma Care –
Incomplete Addressal of Pathogenic Pathways 

Melasma continues to pose a significant
therapeutic challenge in dermatology. Characterized by chronic, relapsing hyperpigmented
patches, it most commonly affects sun-exposed facial areas.1 The
condition is widely recognized as multifactorial,
involving ultraviolet radiation, hormonal influences, genetic susceptibility,
inflammation, vascular factors and skin barrier dysfunction. 2 

Despite the availability of several topical
and procedural therapies, long-term
disease control remains difficult, with recurrence frequently reported
in clinical practice. 1, 2 One of the key limitations of existing
therapies is that many primarily target melanin
production rather than the removal of already accumulated pigment, leaving
important pathogenic pathways insufficiently addressed. 2

Melanophagy – Novel Treatment Approach in
Melasma Care

To bridge current treatment gaps, dermatological
research has increasingly focused on melanophagy,
a cellular mechanism involved in the degradation and clearance of
melanin-containing organelles known as melanosomes. 3 Melanophagy
refers to the autophagic breakdown of
melanosomes within keratinocytes, enabling the removal of excess pigment
from the epidermis. 3

Impaired melanophagy has been associated with
pigment persistence in melasma and photoaging, making the pathway an emerging
therapeutic target in pigmentation disorders. 3, 4 Growing evidence
suggests that enhancing melanophagy may help improve pigmentation outcomes by addressing both pigment accumulation and
ongoing melanogenesis. 3

Melazero®: A Novel Approach Targeting
Hyperpigmentation through Melanophagy

Melazero® is a patented active derived from the Korean
plant Arisaema amurense that utilizes a
novel mechanism, melanophagy, to target hyperpigmentation. It promotes
melanophagy in melanocytes, facilitating the clearance of existing
intracellular melanin and simultaneously reducing melanin synthesis. Clinical studies
have shown that 1% Melazero® significantly reduces melanin levels within two to
four weeks, demonstrating faster onset of action and superior pigmentation
reduction. Additionally, Melazero® offers good skin tolerability, making it
suitable for topical use in pigmentation management.

Other Key Active Ingredients in the
Formulation

The serum contains other key ingredients namely Liposomal
Tranexamic Acid (Vegan DDS formulation),
Glycolic acid, Niacinamide, pTerowhite®, Alpha-arbutin, Fermentex Rice Mak and Hyaluronan 16 Multi-Complex,
each targeting different aspects of pigmentation and skin health. Tranexamic acid helps reduce
pigmentation by inhibiting plasmin activity and lowering inflammatory mediators
that stimulate melanocytes. 5 Vegan DDS Tranexamic Acid is a patented complex with 15 times higher liposomal concentration,
allowing for better efficiency and enhanced skin
tolerability. Niacinamide reduces melanosome transfer from melanocytes to
keratinocytes, decreasing visible pigmentation while supporting the skin
barrier. 6  pTerowhite® downregulates
MITF expression, leading to suppression of tyrosinase and reducing melanin
synthesis. 7 Alpha-arbutin interferes
with melanosome maturation, reducing effective pigment production.
8 Hyaluronan 16 Multi-Complex
enhances hydration and supports barrier repair, crucial for maintaining healthy
skin during pigmentation treatments. 9

DEMELAN® NEXA - Technology Designed
for Targeted Skin Delivery

DEMELAN® NEXA Serum also utilizes Deep Delivery System (DDS) technology,
which aims to improve dermal penetration and optimize the delivery of active
ingredients. DDS technology offers potential advantages such as enhanced
penetration of active molecules into the skin, improved bioavailability of
ingredients, controlled and sustained release of actives and better
tolerability for long-term dermatological use.

Potential Clinical Applications in
Pigmentation Management

By targeting pigment triggers, melanin synthesis, melanosome transfer, and pigment
clearance, DEMELAN® NEXA Serum represents a multi-pathway approach to
pigmentation management. Dermatologists
may consider such therapies in patients with chronic or relapsing melasma, post-inflammatory
hyperpigmentation, photoaging-related pigmentation, and patients requiring
long-term maintenance therapy following procedural treatments.

Speaking to Medical Dialogues, Ms. Nita Borkar
(President - Sales &amp; Marketing, Dermatology Business) at Eris Lifesciences
said, “With DEMELAN® Nexa serum, we aim to address gaps in the management
of inflammatory and recurrent melasma. It features Melazero®, a third-generation brightening agent based on a
Nobel Prize-recognized concept of autophagy, that helps to promote melanophagy
and reduces melanin synthesis. Clinical
studies have reported visible reduction within two to four weeks. By
incorporating liposomal tranexamic acid with advanced DDS technology for
enhanced delivery, this formulation offers a comprehensive approach to managing
pigmentation, ensuring faster results and supporting long-term skin health.”

As understanding of pigmentation biology
advances, dermatology is increasingly moving toward multi-mechanistic approaches that address both pigment formation and
clearance pathways. Melanophagy-based strategies may therefore represent
a promising addition to the therapeutic landscape for chronic pigmentary
disorders such as melasma. 2, 3

Eris
Lifesciences, a leading global
pharmaceutical company, has been dedicated to enhancing healthcare through innovative, patient-centric solutions.
 With a strong presence in chronic disease management,
Eris focuses on advancing treatments
in key therapeutic areas such as dermatology, cardiology, and
diabetes care, driven by a commitment to quality, accessibility, and improving patient
outcomes.

 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339379-featured-images-1-14jpg.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 12:25:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Eris, Lifesciences, Introduces, DEMELAN®, NEXA, Serum:, Next-Generation, Melanophagy-Focused, Approach, for, Melasma, Management, India</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339379-featured-images-1-14jpg.webp"><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p>Recognizing
the evolving understanding of pigmentation biology, Eris Lifesciences has
launched DEMELAN<sup>®</sup> NEXA Serum, a next-generation melanophagy-focused brightening serum
designed for the comprehensive management of recurrent melasma, and
photo-aging.</p>

<p><span>DEMELAN</span><sup>® </sup>NEXA Serum - available in a 30 ml pack<strike>,</strike>
incorporates Melazero<sup>®</sup>, a third generation brightening agent. The
serum provides a dual-action approach, promoting melanophagy, i.e., clearing
existing melanin and reducing new melanin synthesis, with clinical study showing
visible melanin reduction within two to four weeks.</p></div><div class="pasted-from-word-wrapper">

<p><b>Current Challenges in Melasma Care –
Incomplete Addressal of Pathogenic Pathways </b></p>

<p>Melasma continues to pose a significant
therapeutic challenge in dermatology. Characterized by chronic, relapsing hyperpigmented
patches, it most commonly affects sun-exposed facial areas.<sup>1 </sup>The
condition is widely recognized as multifactorial,
involving ultraviolet radiation, hormonal influences, genetic susceptibility,
inflammation, vascular factors and skin barrier dysfunction. <sup>2</sup> </p>

<p>Despite the availability of several topical
and procedural therapies, long-term
disease control remains difficult, with recurrence frequently reported
in clinical practice.<sup> 1, 2 </sup>One of the key limitations of existing
therapies is that many primarily target melanin
production rather than the removal of already accumulated pigment, leaving
important pathogenic pathways insufficiently addressed.<sup> 2</sup></p>

<p><b>Melanophagy – Novel Treatment Approach in
Melasma Care</b></p>

<p>To bridge current treatment gaps, dermatological
research has increasingly focused on melanophagy,
a cellular mechanism involved in the degradation and clearance of
melanin-containing organelles known as melanosomes. <sup>3</sup> Melanophagy
refers to the autophagic breakdown of
melanosomes within keratinocytes, enabling the removal of excess pigment
from the epidermis. <sup>3</sup></p>

<p>Impaired melanophagy has been associated with
pigment persistence in melasma and photoaging, making the pathway an emerging
therapeutic target in pigmentation disorders. <sup>3, 4</sup> Growing evidence
suggests that enhancing melanophagy may help improve pigmentation outcomes by addressing both pigment accumulation and
ongoing melanogenesis. <sup>3</sup></p>

<p><b><span>Melazero</span><sup>®</sup></b><b>: A Novel Approach Targeting
Hyperpigmentation through Melanophagy</b></p></div><div class="pasted-from-word-wrapper">

<p><span>Melazero</span><sup>®</sup> is a patented active derived from the Korean
plant <em>Arisaema amurense</em> that utilizes a
novel mechanism, melanophagy, to target hyperpigmentation. It promotes
melanophagy in melanocytes, facilitating the clearance of existing
intracellular melanin and simultaneously reducing melanin synthesis. Clinical studies
have shown that 1% <span>Melazero</span><sup>® </sup>significantly reduces melanin levels within two to
four weeks, demonstrating faster onset of action and superior pigmentation
reduction. Additionally, <span>Melazero</span><sup>® </sup>offers good skin tolerability, making it
suitable for topical use in pigmentation management.</p></div><div class="pasted-from-word-wrapper">

<p><b>Other Key Active Ingredients in the
Formulation</b></p>

<p>The serum contains other key ingredients namely Liposomal
Tranexamic Acid (Vegan DDS formulation),
Glycolic acid, Niacinamide, <span>pTerowhite</span><sup>®</sup>, Alpha-arbutin, Fermentex Rice Mak and Hyaluronan 16 Multi-Complex,
each targeting different aspects of pigmentation and skin health. Tranexamic acid helps reduce
pigmentation by inhibiting plasmin activity and lowering inflammatory mediators
that stimulate melanocytes. <sup>5</sup> Vegan DDS Tranexamic Acid is a patented complex with 15 times higher liposomal concentration,
allowing for better efficiency and enhanced skin
tolerability. Niacinamide reduces melanosome transfer from melanocytes to
keratinocytes, decreasing visible pigmentation while supporting the skin
barrier. <sup>6 </sup> <span>pTerowhite</span><sup>® </sup>downregulates
MITF expression, leading to suppression of tyrosinase and reducing melanin
synthesis. <sup>7</sup> Alpha-arbutin interferes
with melanosome maturation, reducing effective pigment production.
<sup>8 </sup>Hyaluronan 16 Multi-Complex
enhances hydration and supports barrier repair, crucial for maintaining healthy
skin during pigmentation treatments. <sup>9</sup></p></div><div class="pasted-from-word-wrapper">

<p><b><span>DEMELAN</span><sup>® </sup></b><b>NEXA - Technology Designed
for Targeted Skin Delivery</b></p></div><div class="pasted-from-word-wrapper">

<p><span>DEMELAN</span><sup>® </sup>NEXA Serum also utilizes Deep Delivery System (DDS) technology,
which aims to improve dermal penetration and optimize the delivery of active
ingredients. DDS technology offers potential advantages such as enhanced
penetration of active molecules into the skin, improved bioavailability of
ingredients, controlled and sustained release of actives and better
tolerability for long-term dermatological use.</p></div><div class="pasted-from-word-wrapper">

<p><b>Potential Clinical Applications in
Pigmentation Management</b></p>

<p>By targeting pigment triggers, melanin synthesis, melanosome transfer, and pigment
clearance, <span>DEMELAN</span><sup>® </sup>NEXA Serum represents a multi-pathway approach to
pigmentation management. Dermatologists
may consider such therapies in patients with chronic or relapsing melasma, post-inflammatory
hyperpigmentation, photoaging-related pigmentation, and patients requiring
long-term maintenance therapy following procedural treatments.</p></div><div class="pasted-from-word-wrapper">

<p><b>Speaking to Medical Dialogues, </b><b>Ms. Nita Borkar
(President - Sales & Marketing, Dermatology Business) at Eris Lifesciences
said</b><b>,</b> <i>“With </i><span>DEMELAN</span><sup>® </sup><i>Nexa serum, we aim to address gaps in the management
of inflammatory and recurrent melasma. It features </i><span>Melazero</span><sup>®</sup><i>, a third-generation brightening agent based on a
Nobel Prize-recognized concept of autophagy, that helps to promote melanophagy
and reduces melanin synthesis.</i> <i>Clinical
studies have reported visible reduction within two to four weeks. By
incorporating liposomal tranexamic acid with advanced DDS technology for
enhanced delivery, this formulation offers a comprehensive approach to managing
pigmentation, ensuring faster results and supporting long-term skin health.”</i></p></div><div class="pasted-from-word-wrapper">

<p>As understanding of pigmentation biology
advances, dermatology is increasingly moving toward multi-mechanistic approaches that address both pigment formation and
clearance pathways. Melanophagy-based strategies may therefore represent
a promising addition to the therapeutic landscape for chronic pigmentary
disorders such as melasma. <sup>2, 3</sup></p>

<p>Eris
Lifesciences, a leading global
pharmaceutical company, has been dedicated to enhancing healthcare through innovative, patient-centric solutions.
 With a strong presence in chronic disease management,
Eris focuses on advancing treatments
in key therapeutic areas such as dermatology, cardiology, and
diabetes care, driven by a commitment to quality, accessibility, and improving patient
outcomes.
</p></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><ol start="9" type="1">
</ol></div>]]> </content:encoded>
</item>

<item>
<title>Aortic Calcification on Chest X&#45;Ray Signals Poorer Survival After Minor Limb Amputation: Study</title>
<link>https://edusehat.com/en/aortic-calcification-on-chest-x-ray-signals-poorer-survival-after-minor-limb-amputation-study</link>
<guid>https://edusehat.com/en/aortic-calcification-on-chest-x-ray-signals-poorer-survival-after-minor-limb-amputation-study</guid>
<description><![CDATA[ Finland: Aortic calcifications (ACs) visible on routine chest radiographs may signal worse survival prospects for patients undergoing minor lower limb amputation, a study published in JVS: Vascular Insights has shown.The research, led by Miska Vuorlaakso from the Faculty of Medicine and Health Technology at Tampere University, Finland, suggests that this simple imaging finding could serve as an important prognostic marker in a high-risk vascular population.The investigators conducted a single-center, retrospective observational study involving 383 patients who underwent minor amputations below the ankle between 2007 and 2020. All participants had received an upright anteroposterior chest x-ray within three months before surgery. The amputations were performed primarily due to complications of peripheral arterial disease and diabetes—conditions strongly linked to systemic atherosclerosis.Two researchers independently reviewed the preoperative chest radiographs to determine the presence and extent of aortic calcifications. Calcifications were graded using three classification systems—the Symeonidis system, the Tian system, and a newly introduced AV classification—categorizing findings as none or mild, moderate, or severe based on the size and distribution of calcified deposits. Severe calcification was defined as circumferential or near-circumferential involvement of the aorta.     The study led to the following findings:A total of 62.1% of patients had detectable aortic calcifications on preoperative chest x-ray.Severe AC was present in 21.9% of patients.In unadjusted analyses, severe AC was associated with more than a threefold increased risk of poorer overall survival (HR 3.165).Severe AC was linked to nearly threefold higher risk of reduced amputation-free survival (HR 2.972).Severe AC was also associated with a significantly increased risk of impaired leg salvage (HR 2.495).After adjustment for other variables, severe AC remained significantly associated with worse overall survival and amputation-free survival.The association between severe AC and leg salvage did not remain significant in multivariable analysis.The overall presence of ACs was associated with poorer overall survival (HR 1.669).The presence of ACs was also linked to reduced amputation-free survival (HR 1.587).Lower extremity amputation represents a serious and increasingly frequent complication of advanced peripheral arterial disease and diabetes, often accompanied by diminished quality of life and elevated mortality risk. The high prevalence of aortic calcifications observed in this cohort reflects widespread systemic atherosclerosis, which may contribute to adverse outcomes after surgery.The authors emphasize that chest radiography is inexpensive, widely available, and routinely performed before surgery. Recognizing aortic calcifications on these images could therefore enhance preoperative risk assessment without requiring additional testing. Incorporating this readily identifiable marker into clinical decision-making may help clinicians better stratify risk and tailor treatment strategies for patients facing limb-threatening conditions.Reference:Vuorlaakso, M., Kaartinen, I., Hirvonen, J., &amp; Arponen, O. (2026). Aortic calcifications on chest radiographs associated with survival after lower extremity minor amputation. JVS-Vascular Insights, 100373. https://doi.org/10.1016/j.jvsvi.2026.100373 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/14/327548-aortic-calcifications-on-chest-radiographs.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 01:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aortic, Calcification, Chest, X-Ray, Signals, Poorer, Survival, After, Minor, Limb, Amputation:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/14/327548-aortic-calcifications-on-chest-radiographs.webp"><p><span>Finland: Aortic calcifications (ACs) visible on routine <a href="https://medicaldialogues.in/topics/chest-radiography">chest radiographs</a> may signal worse survival prospects for patients undergoing minor lower limb amputation, a study published in <i>JVS: Vascular Insights </i>has shown.</span></p><div class="pasted-from-word-wrapper"><div>The research, led by Miska Vuorlaakso from the Faculty of Medicine and Health Technology at Tampere University, Finland, suggests that this simple imaging finding could serve as an important prognostic marker in a high-risk vascular population.</div><div>The investigators conducted a single-center, retrospective observational study involving 383 patients who underwent minor amputations below the ankle between 2007 and 2020. All participants had received an upright anteroposterior chest x-ray within three months before surgery. The <a href="https://medicaldialogues.in/topics/amputation">amputations </a>were performed primarily due to complications of <a href="https://speciality.medicaldialogues.in/topics/peripheral-artery-disease">peripheral arterial disease</a> and <a href="https://speciality.medicaldialogues.in/topics/diabetes">diabetes</a>—conditions strongly linked to systemic atherosclerosis.</div><div>Two researchers independently reviewed the preoperative chest radiographs to determine the presence and extent of aortic calcifications. Calcifications were graded using three classification systems—the Symeonidis system, the Tian system, and a newly introduced AV classification—categorizing findings as none or mild, moderate, or severe based on the size and distribution of calcified deposits. Severe calcification was defined as circumferential or near-circumferential involvement of the aorta.     </div><div>The study led to the following findings:</div><ul><li>A total of 62.1% of patients had detectable aortic calcifications on preoperative chest x-ray.</li><li>Severe AC was present in 21.9% of patients.</li><li>In unadjusted analyses, severe AC was associated with more than a threefold increased risk of poorer overall survival (HR 3.165).</li><li>Severe AC was linked to nearly threefold higher risk of reduced amputation-free survival (HR 2.972).</li><li>Severe AC was also associated with a significantly increased risk of impaired leg salvage (HR 2.495).</li><li>After adjustment for other variables, severe AC remained significantly associated with worse overall survival and amputation-free survival.</li><li>The association between severe AC and leg salvage did not remain significant in multivariable analysis.</li><li>The overall presence of ACs was associated with poorer overall survival (HR 1.669).</li><li>The presence of ACs was also linked to reduced amputation-free survival (HR 1.587).</li></ul><div>Lower extremity amputation represents a serious and increasingly frequent complication of advanced peripheral arterial disease and diabetes, often accompanied by diminished quality of life and elevated mortality risk. The high prevalence of aortic calcifications observed in this cohort reflects widespread systemic atherosclerosis, which may contribute to adverse outcomes after surgery.</div><div>The authors emphasize that chest radiography is inexpensive, widely available, and routinely performed before surgery. Recognizing aortic calcifications on these images could therefore enhance preoperative risk assessment without requiring additional testing. Incorporating this readily identifiable marker into clinical decision-making may help clinicians better stratify risk and tailor treatment strategies for patients facing limb-threatening conditions.</div><div>Reference:</div><div>Vuorlaakso, M., Kaartinen, I., Hirvonen, J., & Arponen, O. (2026). Aortic calcifications on chest radiographs associated with survival after lower extremity minor amputation. JVS-Vascular Insights, 100373. https://doi.org/10.1016/j.jvsvi.2026.100373</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Vitamin B3 Supplements May Reduce Chemotherapy Effectiveness in Pancreatic Cancer: Study</title>
<link>https://edusehat.com/en/vitamin-b3-supplements-may-reduce-chemotherapy-effectiveness-in-pancreatic-cancer-study</link>
<guid>https://edusehat.com/en/vitamin-b3-supplements-may-reduce-chemotherapy-effectiveness-in-pancreatic-cancer-study</guid>
<description><![CDATA[ A recent study suggests that popular vitamin B3 (niacin) supplements-especially NAD⁺ precursors like NMN, NR, and NAM-may reduce the effectiveness of chemotherapy in pancreatic cancer. Millions of Americans take daily supplements-nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide (NAM)-to boost energy, slow aging and protect the heart and brain.Many cancer patients also take these supplements to help manage the excruciating side effects of chemotherapy.But a new study, led by researchers at Case Western Reserve University’s School of Medicine and recently published in the journal Cancer Letters, found that these popular vitamin B3 derivatives may be doing more harm than good-helping cancer cells survive and resist treatment.
Researchers set out to investigate how common NAD+ precursor supplements affect pancreatic cancer, among the most deadliest cancers, with a five-year survival rate of just 13%, according to the American Cancer Society.NAD+ is a molecule that every cell in the body-healthy and cancerous-needs to function and survive. Taking an NAD+ supplement essentially floods the body’s cells with fuel.In healthy people, this may offer genuine benefits. But cancer cells hijack that same fuel to power up their energy systems, repair DNA damage from chemotherapy and avoid the cell death that chemo triggers, allowing tumors to survive doses that should be lethal, the researchers learned.In both laboratory experiments and mouse models, the supplements—particularly NMN—shielded pancreatic cancer cells from three standard chemotherapy drugs:  oxaliplatin, 5-flurorouacil and gemcitabine.The supplements undermined treatment in three critical ways:Boosting cancer cell energy, making tumors stronger and more resilient.Reducing oxidative stress in tumors, neutralizing one of chemotherapy’s key mechanisms for destroying cancer cells.Suppressing DNA damage and cell death, blocking the very process chemotherapy depends on to work.“Our findings highlight a potentially concerning role for NAD+-boosting supplements in the context of an active cancer, especially when used in conjunction with chemotherapy,” said study lead Jordan Winter, Case Western Reserve School of Medicine professor and co-leader of the developmental therapeutics program at the National Cancer Institute-designated Cancer Comprehensive Cancer Center. “Our discovery is a call to action for the medical community.”The study does not suggest these supplements are dangerous for healthy people. But for active cancer patients—particularly those on chemotherapy—the risks are serious and demand immediate attention.“This research is a critical reminder that ‘natural’ doesn’t always mean safe,” Winter said, “especially in the complex biology of cancer treatment.”The researchers are calling for routine screening of supplement use in all cancer patients and further clinical research about the interaction between NAD+ supplements and cancer therapies.For now, Winter advised cancer patients to discuss the potential risks with their oncologist and medical team immediately.Reference:Faith Nakazzi, Mehrdad Zarei, Mariana Lopes, Hallie J. Graor, William C. Beegan, Eric Gu, Sakineh Rezaei, Peder J. Lund, Jordan M. Winter, Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance, Cancer Letters, https://doi.org/10.1016/j.canlet.2026.218334. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339580-vitamin-b3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 01:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Vitamin, Supplements, May, Reduce, Chemotherapy, Effectiveness, Pancreatic, Cancer:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339580-vitamin-b3.webp"><p>A recent study suggests that popular <a href="https://medicaldialogues.in/topics/vitamin-B3">vitamin B3 </a>(niacin) supplements-especially NAD⁺ precursors like NMN, NR, and NAM-may reduce the effectiveness of <a href="https://medicaldialogues.in/topics/chemotherapy">chemotherapy</a> in <a href="https://medicaldialogues.in/topics/pancreatic-cancer">pancreatic cancer</a>. </p><div class="pasted-from-word-wrapper"><p>Millions of Americans take daily supplements-nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide (NAM)-to boost energy, slow aging and protect the heart and brain.</p><p>Many cancer patients also take these supplements to help manage the excruciating side effects of chemotherapy.</p><p>But a new study, led by researchers at Case Western Reserve University’s School of Medicine and recently published in the journal Cancer Letters, found that these popular vitamin B3 derivatives may be doing more harm than good-helping cancer cells survive and resist treatment.
</p><p>Researchers set out to investigate how common NAD+ precursor supplements affect pancreatic cancer, among the most deadliest cancers, with a five-year survival rate of just 13%, according to the American Cancer Society.</p><p>NAD+ is a molecule that every cell in the body-healthy and cancerous-needs to function and survive. Taking an NAD+ supplement essentially floods the body’s cells with fuel.</p><p>In healthy people, this may offer genuine benefits. But cancer cells hijack that same fuel to power up their energy systems, repair DNA damage from chemotherapy and avoid the cell death that chemo triggers, allowing tumors to survive doses that should be lethal, the researchers learned.</p><p>In both laboratory experiments and mouse models, the supplements—particularly NMN—shielded pancreatic cancer cells from three standard chemotherapy drugs:  oxaliplatin, 5-flurorouacil and gemcitabine.</p><p>The supplements undermined treatment in three critical ways:</p><ul><li>Boosting cancer cell energy, making tumors stronger and more resilient.</li><li>Reducing oxidative stress in tumors, neutralizing one of chemotherapy’s key mechanisms for destroying cancer cells.</li><li>Suppressing DNA damage and cell death, blocking the very process chemotherapy depends on to work.</li></ul><p>“Our findings highlight a potentially concerning role for NAD+-boosting supplements in the context of an active cancer, especially when used in conjunction with chemotherapy,” said study lead Jordan Winter, Case Western Reserve School of Medicine professor and co-leader of the developmental therapeutics program at the National Cancer Institute-designated Cancer Comprehensive Cancer Center. “Our discovery is a call to action for the medical community.”</p><p>The study does not suggest these supplements are dangerous for healthy people. But for active cancer patients—particularly those on chemotherapy—the risks are serious and demand immediate attention.</p><p>“This research is a critical reminder that ‘natural’ doesn’t always mean safe,” Winter said, “especially in the complex biology of cancer treatment.”</p><p>The researchers are calling for routine screening of supplement use in all cancer patients and further clinical research about the interaction between NAD+ supplements and cancer therapies.</p><p>For now, Winter advised cancer patients to discuss the potential risks with their oncologist and medical team immediately.</p><p>Reference:</p><p>Faith Nakazzi, Mehrdad Zarei, Mariana Lopes, Hallie J. Graor, William C. Beegan, Eric Gu, Sakineh Rezaei, Peder J. Lund, Jordan M. Winter, Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance, Cancer Letters, https://doi.org/10.1016/j.canlet.2026.218334.</p></div>]]> </content:encoded>
</item>

<item>
<title>Low&#45;Dose Atropine Slows Myopia Progression in Children, finds Phase 3 STAR Trial</title>
<link>https://edusehat.com/en/low-dose-atropine-slows-myopia-progression-in-children-finds-phase-3-star-trial</link>
<guid>https://edusehat.com/en/low-dose-atropine-slows-myopia-progression-in-children-finds-phase-3-star-trial</guid>
<description><![CDATA[ In children aged 3-12 years, low-dose atropine (SYD-101) significantly reduced myopia progression compared to placebo (0.77 D vs 1.07 D). The effect was even greater in rapid progressors (0.51 D vs 1.18 D). Over 36 months, SYD-101 effectively slowed myopia progression, particularly in younger children and those with faster disease progression.The Phase 3 STAR trial is the largest global clinical program completed to date in pediatric myopia. It evaluated a broad population of 847 children aged 3–14 at treatment initiation. Participants with myopia of -0.50 diopters (D) to -6.00 D, with a mean baseline progression of -2.65 D, were enrolled across the U.S. and Europe and randomized (1:1:1) to vehicle (placebo) and SYD-101 0.01%. The study’s primary efficacy endpoint was the proportion of patients with confirmed progression of -0.75 D, and a key secondary endpoint was annual progression rate. SYD-101 0.01% successfully met both the primary endpoint (p ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/06/14/211796-myopia.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 06 Apr 2026 01:40:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Low-Dose, Atropine, Slows, Myopia, Progression, Children, finds, Phase, STAR, Trial</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/06/14/211796-myopia.webp"><p>In children aged 3-12 years, low-dose <a href="https://medicaldialogues.in/topics/atropine">atropine</a> (SYD-101) significantly reduced <a href="https://medicaldialogues.in/topics/myopia">myopia </a>progression compared to placebo (0.77 D vs 1.07 D). The effect was even greater in rapid progressors (0.51 D vs 1.18 D). Over 36 months, SYD-101 effectively slowed myopia progression, particularly in younger children and those with faster disease progression.</p><p>The Phase 3 STAR trial is the largest global clinical program completed to date in pediatric myopia. It evaluated a broad population of 847 children aged 3–14 at treatment initiation. Participants with myopia of -0.50 diopters (D) to -6.00 D, with a mean baseline progression of -2.65 D, were enrolled across the U.S. and Europe and randomized (1:1:1) to vehicle (placebo) and SYD-101 0.01%. The study’s primary efficacy endpoint was the proportion of patients with confirmed progression of -0.75 D, and a key secondary endpoint was annual progression rate. SYD-101 0.01% successfully met both the primary endpoint (p<0.001) and the key secondary endpoint. Additionally, SYD-101 was well tolerated with no unexpected atropine-related adverse events. 
</p><p>“The STAR trial is the largest rigorously designed study of low-dose atropine conducted to date. The research was performed in a diverse patient population across 47 clinical sites in the United States and Europe. The subgroup analyses tell an important clinical story: young children with a history of myopia progression benefited most from SYD-101,” said Tina Rutar, MD, pediatric ophthalmologist and partner at Cataract and Laser Institute of Southern Oregon, P.C., and lead author of the AAPOS presentation.  
</p><h3>Summary of Key Findings from the AAPOS Presentation 
</h3><p><span>• </span>SYD-101 0.01% significantly reduced myopia progression across all time points tested and met the primary efficacy endpoint at 36 months of confirmed myopia progression of -0.75D or worse (Vehicle vs. 0.01%; p=0.0226).   
</p><p>• SYD-101 0.01% met the key secondary endpoint of mean annual myopic progression rate at 12, 24, and 36 months. At month 36, the APR was -0.30 D/year for 0.01% versus -0.38 D/year for vehicle (p<0.001). 
</p><p>• Treatment benefit of SYD-101 0.01% was highest in younger children compared with older children. In children aged 3 to 12 years at treatment initiation myopia progression was reduced by 47.9% at 12 months, 37.6% at 24 months, and 28.0% at 36 months versus vehicle1.07 D; 0.01% -0.77 D (p=0.0002). Participants aged 13 to 14 years at treatment initiation showed minimal progression regardless of treatment. 
</p><p>• Treatment benefit was greatest in children exhibiting Fast progression (>0.5D year) and with mild to moderate baseline myopia (-0.50D to -3.00D). In this subgroup, SYD-101 0.01% reduced myopia progression by 76.3% at 12 months, 65.1% at 24 months, and 56.9% at 36 months versus vehicle -1.18 D; 0.01% -0.51D (p=0.0004). 
</p><p>• SYD-101 was well tolerated with no unexpected atropine-related adverse events.  
</p><p>“The analyses presented at AAPOS reinforce a growing body of evidence supporting the use of low-dose atropine in PPM,” said Christie Morse, MD, Executive Vice President of the American Association for Pediatric Ophthalmology and Strabismus. “Pediatric myopia is a progressive disease, and the earlier it is identified, the greater the opportunity to intervene in a meaningful way. These findings help clarify which patients stand to benefit most and underscore the importance of timely, evidence-based care to truly change the trajectory of the disease.”  
</p><p>SYD-101 is currently approved in the European Union and UK, where it is licensed to Santen S.A. and marketed as Ryjunea®. 
</p><p>“While STAR met both its primary endpoint and a key secondary endpoint, the subgroup analyses presented at AAPOS provide important context for understanding which children benefit most from SYD-101,” said Perry Sternberg, Chief Executive Officer of Sydnexis. “Treatment benefit was observed broadly across the study population, with the most meaningful reductions seen in younger children ages 3-12 and fast progressors which aligns with the known natural history of the disease. These results reinforce the importance of early intervention and are integral to our ongoing discussions with the FDA.”</p>]]> </content:encoded>
</item>

<item>
<title>GLP&#45;1 Receptor Agonists Reduce Cardiovascular Risk Among Atopic Dermatitis Patients, Suggests Study</title>
<link>https://edusehat.com/en/glp-1-receptor-agonists-reduce-cardiovascular-risk-among-atopic-dermatitis-patients-suggests-study</link>
<guid>https://edusehat.com/en/glp-1-receptor-agonists-reduce-cardiovascular-risk-among-atopic-dermatitis-patients-suggests-study</guid>
<description><![CDATA[ USA: Researchers have found in a new study that patients with atopic dermatitis who used GLP-1 receptor agonists showed a lower long-term risk of adverse cardiovascular outcomes. While these drugs are known to provide cardiovascular benefits in other inflammatory conditions, this study highlights their potential protective role in individuals with atopic dermatitis as well.
The study, published in Dermatitis by Abigail Katz and colleagues from the Icahn School of Medicine at Mount Sinai, explored whether GLP-1 receptor agonists (GLP-1RAs) could reduce the risk of major adverse cardiovascular events (MACE) in patients with atopic dermatitis (AD). AD, a chronic inflammatory skin disorder, has increasingly been linked to higher cardiovascular risk, prompting interest in therapies that may address both dermatologic and metabolic pathways.
For this purpose, the researchers conducted a large retrospective cohort study using data from the TriNetX Research Network. The analysis included patients aged 12 years and older diagnosed with AD between April 2005 and December 2020. Among more than 547,000 individuals with AD, approximately 24,900 had been treated with GLP-1RAs. These patients were matched in a 1:1 ratio with those not receiving GLP-1RAs, ensuring comparable baseline characteristics such as demographics and cardiovascular risk factors.
The primary outcome assessed was the incidence of major cardiovascular events, including cerebrovascular disease, heart failure, atherosclerosis, ischemic heart disease, and the need for percutaneous coronary intervention. Outcomes were evaluated over extended follow-up periods of 5, 10, and 20 years.   The key
findings were as follows:


 GLP-1
     receptor agonist use was consistently associated with a reduction in
     cardiovascular risk. 
 At
     20 years, patients on GLP-1RAs had significantly lower odds of developing
     cerebrovascular disease. 
 The
     risk of heart failure was also significantly reduced among GLP-1RA users. 
 A
     lower likelihood of atherosclerosis was observed in patients receiving
     GLP-1RAs. 
 A
     modest but meaningful reduction in ischemic heart disease risk was noted. 
 The
     findings indicate a sustained cardioprotective effect of GLP-1RAs over the
     long term in patients with atopic dermatitis.
The study adds to the growing body of evidence supporting the systemic benefits of GLP-1RAs beyond glycemic control. Their anti-inflammatory and metabolic effects may be particularly relevant in conditions like atopic dermatitis, where chronic inflammation may contribute to long-term cardiovascular complications.
Although the observational design limits the ability to establish causality, the large sample size and robust matching methodology strengthen the findings. The authors noted that further prospective studies are needed to confirm these associations and better understand the underlying mechanisms.
Overall, the results suggest that GLP-1 receptor agonists may offer dual benefits for patients with atopic dermatitis by addressing both dermatologic symptoms and long-term cardiovascular risk. This could have important implications for clinical decision-making, particularly in patients with coexisting metabolic or cardiovascular risk factors.Reference:Katz, A., Nong, Y., Ma, E. J., Roberts, A. M., Chou, P. P., Jeong, C. Y., Yan, M. J., Johnsen, N., &amp; Armstrong, A. W. Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study. Dermatitis®. https://doi.org/10.1177_17103568251410211 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/24/279944-glp-1-drug.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GLP-1, Receptor, Agonists, Reduce, Cardiovascular, Risk, Among, Atopic, Dermatitis, Patients, Suggests, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/24/279944-glp-1-drug.webp"><p>USA: Researchers have found in a new study that patients with atopic dermatitis who used <a href="https://medicaldialogues.in/topics/glp-1-receptor-agonist">GLP-1 receptor agonists</a> showed a lower long-term risk of <a href="https://medicaldialogues.in/topics/adverse-cardiovascular-outcomes">adverse cardiovascular outcomes</a>. While these drugs are known to provide cardiovascular benefits in other inflammatory conditions, this study highlights their potential protective role in individuals with<a href="https://medicaldialogues.in/topics/atopic-dermatitis"> atopic dermatitis </a>as well.</p><div class="pasted-from-word-wrapper"><div class="flex flex-col text-sm pb-25"><section class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&:has([data-writing-block])>*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-WEB:1c310ca2-6c4b-49d7-8115-4e1866e02850-19" data-testid="conversation-turn-40" data-scroll-anchor="true" data-turn="assistant"><div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)"><div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn"><div class="flex max-w-full flex-col gap-4 grow"><div data-message-author-role="assistant" data-message-id="c01e302b-8ee7-4867-acc3-69a2acaae7b4" dir="auto" data-message-model-slug="gpt-5-3" class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&]:mt-1" data-turn-start-message="true" tabindex="0"><div class="flex w-full flex-col gap-1 empty:hidden"><div class="markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling">
<p data-start="417" data-end="888">The study, published in <em data-start="441" data-end="453">Dermatitis</em> by Abigail Katz and colleagues from the Icahn School of Medicine at Mount Sinai, explored whether GLP-1 receptor agonists (GLP-1RAs) could reduce the risk of major adverse cardiovascular events (MACE) in patients with atopic dermatitis (AD). AD, a chronic inflammatory skin disorder, has increasingly been linked to higher cardiovascular risk, prompting interest in therapies that may address both dermatologic and metabolic pathways.</p>
<p data-start="890" data-end="1400">For this purpose, the researchers conducted a large retrospective cohort study using data from the TriNetX Research Network. The analysis included patients aged 12 years and older diagnosed with AD between April 2005 and December 2020. Among more than 547,000 individuals with AD, approximately 24,900 had been treated with GLP-1RAs. These patients were matched in a 1:1 ratio with those not receiving GLP-1RAs, ensuring comparable baseline characteristics such as demographics and cardiovascular risk factors.</p>
<p data-start="1402" data-end="1704">The primary outcome assessed was the incidence of major cardiovascular events, including cerebrovascular disease, heart failure, atherosclerosis, ischemic heart disease, and the need for percutaneous coronary intervention. Outcomes were evaluated over extended follow-up periods of 5, 10, and 20 years.   </p></div></div></div></div></div></div></section></div></div><div class="pasted-from-word-wrapper"><p>The key
findings were as follows:</p>

<ul type="disc">
 <li>GLP-1
     receptor agonist use was consistently associated with a reduction in
     cardiovascular risk. </li>
 <li>At
     20 years, patients on GLP-1RAs had significantly lower odds of developing
     cerebrovascular disease. </li>
 <li>The
     risk of heart failure was also significantly reduced among GLP-1RA users. </li>
 <li>A
     lower likelihood of atherosclerosis was observed in patients receiving
     GLP-1RAs. </li>
 <li>A
     modest but meaningful reduction in ischemic heart disease risk was noted. </li>
 <li>The
     findings indicate a sustained cardioprotective effect of GLP-1RAs over the
     long term in patients with atopic dermatitis.</li></ul></div><div class="pasted-from-word-wrapper"><div class="flex flex-col text-sm pb-25"><section class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&:has([data-writing-block])>*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-WEB:1c310ca2-6c4b-49d7-8115-4e1866e02850-19" data-testid="conversation-turn-40" data-scroll-anchor="true" data-turn="assistant"><div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)"><div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn"><div class="flex max-w-full flex-col gap-4 grow"><div data-message-author-role="assistant" data-message-id="c01e302b-8ee7-4867-acc3-69a2acaae7b4" dir="auto" data-message-model-slug="gpt-5-3" class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&]:mt-1" data-turn-start-message="true" tabindex="0"><div class="flex w-full flex-col gap-1 empty:hidden"><div class="markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling">
<p data-start="2190" data-end="2504">The study adds to the growing body of evidence supporting the systemic benefits of GLP-1RAs beyond glycemic control. Their anti-inflammatory and metabolic effects may be particularly relevant in conditions like atopic dermatitis, where chronic inflammation may contribute to long-term cardiovascular complications.</p>
<p data-start="2506" data-end="2802">Although the observational design limits the ability to establish causality, the large sample size and robust matching methodology strengthen the findings. The authors noted that further prospective studies are needed to confirm these associations and better understand the underlying mechanisms.</p>
<p data-start="2804" data-end="3149" data-is-last-node="" data-is-only-node="">Overall, the results suggest that GLP-1 receptor agonists may offer dual benefits for patients with atopic dermatitis by addressing both dermatologic symptoms and long-term cardiovascular risk. This could have important implications for clinical decision-making, particularly in patients with coexisting metabolic or cardiovascular risk factors.</p><p data-start="2804" data-end="3149" data-is-last-node="" data-is-only-node="">Reference:</p><p>Katz, A., Nong, Y., Ma, E. J., Roberts, A. M., Chou, P. P., Jeong, C. Y., Yan, M. J., Johnsen, N., & Armstrong, A. W. Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study. Dermatitis®. https://doi.org/10.1177_17103568251410211</p></div></div></div></div></div></div></section></div></div>]]> </content:encoded>
</item>

<item>
<title>Catheter&#45;Directed Fibrinolysis Reduces Risks in Intermediate&#45;Risk Pulmonary Embolism: NEJM</title>
<link>https://edusehat.com/en/catheter-directed-fibrinolysis-reduces-risks-in-intermediate-risk-pulmonary-embolism-nejm</link>
<guid>https://edusehat.com/en/catheter-directed-fibrinolysis-reduces-risks-in-intermediate-risk-pulmonary-embolism-nejm</guid>
<description><![CDATA[ A multi-national, adaptive design study was done to assess the benefits associated with the combination of catheter-directed fibrinolysis along with anticoagulation in comparison with the standard care option that is anticoagulation alone. It was concluded that in cases of patients with acute intermediate-risk PE, combining catheter-directed fibrinolysis and anticoagulation results in an improved risk profile with respect to composite end points such as PE-associated death, cardio-respiratory arrest, and recurrence symptoms within seven days in comparison with isolated use of anticoagulation. The study was published in The New England Journal of Medicine by Kenneth R. and colleagues.The study utilized blinded outcome assessment methodology to ensure that the quality of data collected remained the best possible. Specifically, this study focused on intermediate-risk pulmonary embolism subjects as per the inclusion criteria, which specified that only those patients who had an elevated ratio between their right ventricular and left ventricular end-diastolic diameters (&gt;1.0) and troponin levels (indicating myocardial injury) would be recruited. In addition, they needed to show signs of two or more indicators of cardiorespiratory compromise, such as heart rate (&gt;100/min), respiratory rate (&gt;20/min), or systolic blood pressure ( ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/04/237469-pulmonary-embolism-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Catheter-Directed, Fibrinolysis, Reduces, Risks, Intermediate-Risk, Pulmonary, Embolism:, NEJM</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/04/237469-pulmonary-embolism-50.webp"><p>A multi-national, adaptive design study was done to assess the benefits associated with the combination of catheter-directed fibrinolysis along with anticoagulation in comparison with the standard care option that is anticoagulation alone. It was concluded that in cases of patients with acute intermediate-risk PE, combining catheter-directed fibrinolysis and anticoagulation results in an improved risk profile with respect to composite end points such as PE-associated death, cardio-respiratory arrest, and recurrence symptoms within seven days in comparison with isolated use of anticoagulation. The study was published in <i>The New England Journal of Medicine</i> by Kenneth R. and colleagues.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The study utilized blinded outcome assessment methodology to ensure that the quality of data collected remained the best possible. Specifically, this study focused on intermediate-risk pulmonary embolism subjects as per the inclusion criteria, which specified that only those patients who had an elevated ratio between their right ventricular and left ventricular end-diastolic diameters (>1.0) and troponin levels (indicating myocardial injury) would be recruited. In addition, they needed to show signs of two or more indicators of cardiorespiratory compromise, such as heart rate (>100/min), respiratory rate (>20/min), or systolic blood pressure (<110 mm Hg). The final number of subjects recruited was 544, with an average age of 58.2 years and a proportion of 42.6% females. They were subsequently randomized to receive either the treatment (n=273) or the placebo (n=271).</p><p dir="ltr">Key findings:</p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The intervention proved its therapeutic superiority since the number of cases with the primary outcome event was significantly lower among the intervention group participants (n = 11, 4.0%, 95% CI, 2.3 to 7.1) than among those who received placebo (n = 28, 10.3%, 95% CI, 7.2 to 14.5). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The relative risk for developing a major outcome was 0.39 (95% CI, 0.20 to 0.77; P=0.005). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">One of the most important risks associated with the use of fibrinolytic agents is major bleeding. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Within the first week after starting the treatment, the incidence of major bleeding was higher among the intervention group patients (n = 11, 4.1%) than among those from the control group (n = 6, 2.2%), but the difference was not statistically significant (P=0.32). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The incidence of major bleeding did not substantially change during the entire 30-day period (n = 11, 4.1% vs n = 8, 3.0%; P=0.64). </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">No cases of intracranial hemorrhage were observed within both groups during the course of the study. </p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">There were no significant differences between the groups regarding other severe adverse events within the first 30 days after admission.</p></li></ul><p dir="ltr">The findings of this study indicate that ultrasound-assisted catheter-directed thrombolysis with anticoagulation is a more superior therapeutic strategy compared to the standard regimen of anticoagulation alone. It decreases the occurrence of cardio-respiratory failure and reoccurrence of symptoms during the first week by a significant amount, thus providing a safer way to recover from the condition than through anticoagulation alone. The safety aspect, including no incidence of intracranial bleeding, also makes catheter-directed methods a more suitable choice for treatment when a patient shows high-risk factors.</p><p dir="ltr">Reference:</p><p dir="ltr">Rosenfield, K., Klok, F. A., Piazza, G., Sharp, A. S. P., Ní Áinle, F., Jaff, M. R., Barco, S., Goldhaber, S. Z., Kucher, N., Lang, I. M., Schmidtmann, I., Sterling, K. M., Araszkiewicz, A., Arora, V., Cires-Drouet, R., Coghlan, J., Hobohm, L., Ito, W. D., Jacobson, K., Kaiser, C., … HI-PEITHO Investigators (2026). Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism. The New England journal of medicine, 10.1056/NEJMoa2516567. Advance online publication. <a href="https://doi.org/10.1056/NEJMoa2516567">https://doi.org/10.1056/NEJMoa2516567</a> </p><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Soft Bandage Immobilisation: A Cost&#45;Effective Alternative to Rigid Splinting,  suggests study</title>
<link>https://edusehat.com/en/soft-bandage-immobilisation-a-cost-effective-alternative-to-rigid-splinting-suggests-study</link>
<guid>https://edusehat.com/en/soft-bandage-immobilisation-a-cost-effective-alternative-to-rigid-splinting-suggests-study</guid>
<description><![CDATA[ Researchers have discovered in a new research that Soft bandage (SB) immobilisation was associated with fewer follow-up visits, reduced need for imaging, and lower overall direct and indirect costs compared to rigid splinting. These findings support Soft bandage immobilisation as a cost-effective and efficient strategy, particularly in resource-limited healthcare settings.Distal radius torus fractures (DRTFs) are among the most common pediatric skeletal injuries, yet management strategies vary widely between institutions. Repeated outpatient visits and imaging associated with rigid immobilisation impose direct medical costs and indirect burdens on families that are rarely quantified. This study aimed to compare outpatient revisit frequency, imaging burden, direct medical costs, indirect caregiver costs, and total societal costs among children with DRTFs managed with soft bandage (SB), short arm splint (SAS), or long arm splint (LAS).A retrospective cohort study was conducted at a tertiary orthopaedic centre. Consecutive patients aged 0–16 years with a radiographically confirmed DRTF presenting between 2024 and 2025 were stratified by immobilisation type. Direct costs comprised outpatient visit fees, imaging, and immobilisation material costs derived from National Social Security Institution reimbursement tariffs. Indirect costs were estimated using the human capital approach, valuing caregiver time at the 2025 national minimum wage (0.053 USD/minute). Between-group comparisons were performed using the Kruskal-Wallis and Mann-Whitney U tests. A total of 667 patients were included (mean age 8.6 ± 3.9 years; 67.0% male). SB was associated with significantly fewer outpatient visits (median 2 vs 3 vs 4; p &lt; 0.001), fewer radiographs (median 2 vs 3 vs 3; p &lt; 0.001), and lower total caregiver time (median 120 vs 176 vs 204 min; p = 0.005). Mean direct cost was lower in the SB group ($12.35 vs $19.74 vs $27.00; p &lt; 0.001), as were indirect ($11.11 vs $15.08 vs $17.06; p = 0.005) and total societal costs ($23.46 vs $34.82 vs $44.06; p &lt; 0.001). Immobilisation material cost was the most discriminating component, differing 4.2-fold between Soft bandage and SAS and 8.7-fold between Soft bandage and long arm splint. Had all splint-treated patients been managed with Soft bandage, a combined societal saving of $7773 could have been achieved over the study period.Soft bandage immobilisation was associated with fewer revisits, reduced imaging burden, and lower direct and indirect costs compared with rigid splinting, supporting its adoption as a cost-effective strategy in resource-conscious healthcare settings.Reference:Kaya S, Pür B, Karabak B. Soft bandage vs rigid immobilisation in pediatric distal radius torus fractures: A cost and patient burden analysis — A retrospective cohort studyInjury, 2026; 57Keywords:Soft, Bandage,  Immobilisation, Cost-Effective,  Alternative, Rigid Splinting, Kaya S, Pür B, Karabak B  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/339011-images-2026-04-01t193558275.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Soft, Bandage, Immobilisation:, Cost-Effective, Alternative, Rigid, Splinting, suggests, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/339011-images-2026-04-01t193558275.webp"><p>Researchers have discovered in a new research that Soft bandage (SB) immobilisation was associated with fewer follow-up visits, reduced need for imaging, and lower overall direct and indirect costs compared to rigid splinting. These findings support Soft bandage immobilisation as a cost-effective and efficient strategy, particularly in resource-limited healthcare settings.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Distal radius torus fractures (DRTFs) are among the most common pediatric skeletal injuries, yet management strategies vary widely between institutions. Repeated outpatient visits and imaging associated with rigid immobilisation impose direct medical costs and indirect burdens on families that are rarely quantified. This study aimed to compare outpatient revisit frequency, imaging burden, direct medical costs, indirect caregiver costs, and total societal costs among children with DRTFs managed with soft bandage (SB), short arm splint (SAS), or long arm splint (LAS).</p><p dir="ltr">A retrospective cohort study was conducted at a tertiary orthopaedic centre. Consecutive patients aged 0–16 years with a radiographically confirmed DRTF presenting between 2024 and 2025 were stratified by immobilisation type. Direct costs comprised outpatient visit fees, imaging, and immobilisation material costs derived from National Social Security Institution reimbursement tariffs. Indirect costs were estimated using the human capital approach, valuing caregiver time at the 2025 national minimum wage (0.053 USD/minute). Between-group comparisons were performed using the Kruskal-Wallis and Mann-Whitney U tests. A total of 667 patients were included (mean age 8.6 ± 3.9 years; 67.0% male). SB was associated with significantly fewer outpatient visits (median 2 vs 3 vs 4; p < 0.001), fewer radiographs (median 2 vs 3 vs 3; p < 0.001), and lower total caregiver time (median 120 vs 176 vs 204 min; p = 0.005). Mean direct cost was lower in the SB group ($12.35 vs $19.74 vs $27.00; p < 0.001), as were indirect ($11.11 vs $15.08 vs $17.06; p = 0.005) and total societal costs ($23.46 vs $34.82 vs $44.06; p < 0.001). Immobilisation material cost was the most discriminating component, differing 4.2-fold between Soft bandage and SAS and 8.7-fold between Soft bandage and long arm splint. Had all splint-treated patients been managed with Soft bandage, a combined societal saving of $7773 could have been achieved over the study period.</p><p dir="ltr">Soft bandage immobilisation was associated with fewer revisits, reduced imaging burden, and lower direct and indirect costs compared with rigid splinting, supporting its adoption as a cost-effective strategy in resource-conscious healthcare settings.</p><div><br></div><div><br></div><p dir="ltr">Reference:</p><p dir="ltr">Kaya S, Pür B, Karabak B. Soft bandage vs rigid immobilisation in pediatric distal radius torus fractures: A cost and patient burden analysis — A retrospective cohort study</p><p dir="ltr">Injury, 2026; 57</p><div><br></div><p dir="ltr">Keywords:</p><p dir="ltr">Soft, Bandage,  Immobilisation, Cost-Effective,  Alternative, Rigid Splinting, Kaya S, Pür B, Karabak B </p><div><br></div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Smoking and Alcohol Increase oropharyngeal cancer Mortality Risk, Especially with Tooth Loss: Study</title>
<link>https://edusehat.com/en/smoking-and-alcohol-increase-oropharyngeal-cancer-mortality-risk-especially-with-tooth-loss-study</link>
<guid>https://edusehat.com/en/smoking-and-alcohol-increase-oropharyngeal-cancer-mortality-risk-especially-with-tooth-loss-study</guid>
<description><![CDATA[ A recent research published in the journal of Oral Oncology discovered that both smoking and alcohol consumption were linked to a higher risk of oropharyngeal cancer (OPC) mortality, with the risk being particularly elevated in individuals with fewer teeth.The study drew on data from the Japan Gerontological Evaluation Study, by tracking 39,882 functionally independent adults aged 65 and older over a 12-year period from 2010 to 2022. Participants had an average age of 73.7 years at the start, and nearly half were men. Over the follow-up period, which averaged about 10 years, 0.2% of participants died from OPC.This study analyzed how smoking, drinking, and the number of remaining teeth influenced mortality risk. Using a Cox proportional hazards model, they found that individuals who both smoked and drank alcohol had nearly 3-times the risk of dying from OPC when compared to those who did neither. The hazard ratio (HR) was 2.87, which indicated a significantly elevated risk.The participants with fewer than 20 teeth faced almost double the risk of OPC mortality when compared to those with 20 or more teeth (HR: 1.96). Tooth loss is often considered an indicator of cumulative oral health problems, including gum disease and long-term neglect, which may contribute to broader health vulnerabilities.Individuals who both smoked and drank alcohol and also had significant tooth loss (0–19 teeth) were at the highest risk. Their risk of OPC mortality was more than 5-times greater than those without these combined risk factors (HR: 5.02).The relative excess risk due to interaction (RERI) was 2.97, suggesting that the combined effect of these factors is greater than the sum of their individual risks. In simpler terms, smoking, drinking, and poor oral health do not just add risk, but they amplify each other.These findings highlight the importance of integrated health strategies for older adults. While smoking cessation and reduced alcohol consumption remain critical public health priorities, maintaining oral health may play a critical role in lowering cancer mortality risk.Overall, the findings of this study revealed that dental care and lifestyle interventions should be more closely aligned, particularly for aging populations. Regular dental check-ups, early treatment of oral diseases, and public awareness campaigns could help reduce these risks.Reference:Kiuchi, S., Matsuyama, Y., Takeuchi, K., Kusama, T., Ojima, T., Saito, M., Kondo, K., Harada, H., Osaka, K., &amp; Aida, J. (2026). Smoking, drinking, tooth loss and risk of oral-pharyngeal cancer mortality. Oral Oncology, 176(107937), 107937. https://doi.org/10.1016/j.oraloncology.2026.107937 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/25/298703-quit-smoking.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Smoking, and, Alcohol, Increase, oropharyngeal, cancer, Mortality, Risk, Especially, with, Tooth, Loss:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/25/298703-quit-smoking.webp"><p>A recent research published in the journal of <i>Oral Oncology</i> discovered that both smoking and alcohol consumption were linked to a higher risk of oropharyngeal cancer (OPC) mortality, with the risk being particularly elevated in individuals with fewer teeth.</p><p>The study drew on data from the Japan Gerontological Evaluation Study, by tracking 39,882 functionally independent adults aged 65 and older over a 12-year period from 2010 to 2022. Participants had an average age of 73.7 years at the start, and nearly half were men. Over the follow-up period, which averaged about 10 years, 0.2% of participants died from OPC.</p><p>This study analyzed how smoking, drinking, and the number of remaining teeth influenced mortality risk. Using a Cox proportional hazards model, they found that individuals who both smoked and drank alcohol had nearly 3-times the risk of dying from OPC when compared to those who did neither. The hazard ratio (HR) was 2.87, which indicated a significantly elevated risk.</p><p>The participants with fewer than 20 teeth faced almost double the risk of OPC mortality when compared to those with 20 or more teeth (HR: 1.96). Tooth loss is often considered an indicator of cumulative oral health problems, including gum disease and long-term neglect, which may contribute to broader health vulnerabilities.</p><p>Individuals who both smoked and drank alcohol and also had significant tooth loss (0–19 teeth) were at the highest risk. Their risk of OPC mortality was more than 5-times greater than those without these combined risk factors (HR: 5.02).</p><p>The relative excess risk due to interaction (RERI) was 2.97, suggesting that the combined effect of these factors is greater than the sum of their individual risks. In simpler terms, smoking, drinking, and poor oral health do not just add risk, but they amplify each other.</p><p>These findings highlight the importance of integrated health strategies for older adults. While smoking cessation and reduced alcohol consumption remain critical public health priorities, maintaining oral health may play a critical role in lowering cancer mortality risk.</p><p>Overall, the findings of this study revealed that dental care and lifestyle interventions should be more closely aligned, particularly for aging populations. Regular dental check-ups, early treatment of oral diseases, and public awareness campaigns could help reduce these risks.</p><p>Reference:</p><p>Kiuchi, S., Matsuyama, Y., Takeuchi, K., Kusama, T., Ojima, T., Saito, M., Kondo, K., Harada, H., Osaka, K., & Aida, J. (2026). Smoking, drinking, tooth loss and risk of oral-pharyngeal cancer mortality. Oral Oncology, 176(107937), 107937. <a href="https://www.sciencedirect.com/science/article/pii/S1368837526000904?via%3Dihub" rel="nofollow">https://doi.org/10.1016/j.oraloncology.2026.107937</a></p>]]> </content:encoded>
</item>

<item>
<title>Desmopressin ODT Shows Favorable Long&#45;Term Safety in Men With Nocturia: Japan Surveillance Study</title>
<link>https://edusehat.com/en/desmopressin-odt-shows-favorable-long-term-safety-in-men-with-nocturia-japan-surveillance-study</link>
<guid>https://edusehat.com/en/desmopressin-odt-shows-favorable-long-term-safety-in-men-with-nocturia-japan-surveillance-study</guid>
<description><![CDATA[ Japan: A large post-marketing surveillance study in Japan has provided important real-world insights into the long-term safety of desmopressin orally disintegrating tablets (ODT) in men with nocturia caused by nocturnal polyuria. The findings, published in Low Urinary Tract Symptoms, highlight both the tolerability of the drug and key risk factors that clinicians should consider when treating patients.Desmopressin, an antidiuretic hormone analogue, is commonly prescribed to reduce nighttime urine production. While its efficacy is well established, concerns around safety—particularly electrolyte imbalance—have prompted the need for long-term observational data in routine clinical settings. To address this, Yoshimasa Ogawa and colleagues conducted a post-marketing surveillance study involving Japanese men initiating desmopressin ODT therapy for the first time.The study enrolled 1,113 patients into a centralized registry, of whom 1,049 were included in the final safety analysis after exclusions. Participants were followed for up to one year, offering a comprehensive view of adverse events over extended use. The average age of the study population was 75 years, reflecting the condition’s higher prevalence among older adults.   The key findings were as follows:A total of 351 adverse drug reactions were reported in 259 patients.Serious ADRs were rare, occurring in only 7 patients (0.7%).Hyponatremia was the most common adverse event, observed in 13.3% of patients.Some patients with hyponatremia experienced related symptoms; however, no cases of severe neurological complications such as seizures, confusion, stupor, or coma were reported.Age ≥75 years was identified as a significant risk factor for developing hyponatremia.A history of benign prostatic hyperplasia was associated with an increased risk.Lower baseline serum sodium levels prior to treatment also increased susceptibility to hyponatremia.These findings highlight the need for careful patient selection and close monitoring during treatment.The study also emphasized the need for vigilance in patients with underlying comorbidities or abnormal laboratory parameters, such as impaired renal function or baseline serum sodium levels below 140 mmol/L. Regular monitoring of sodium levels during treatment is particularly critical in these populations to mitigate potential risks.Overall, the results support the acceptable safety profile of desmopressin ODT in routine clinical practice when used appropriately. However, they also reinforce that individualized risk assessment and ongoing monitoring are essential, especially in elderly patients and those with predisposing conditions.These real-world findings provide valuable guidance for clinicians managing nocturia due to nocturnal polyuria, helping to balance therapeutic benefits with patient safety in long-term care.Reference:Ogawa Y, Kuramoto K, Nakano A. Long-Term Safety of Desmopressin Orally Disintegrating Tablets in Men With Nocturia due to Nocturnal Polyuria: Final Results of a Specified Drug Use-Results Survey in Japan. Low Urin Tract Symptoms. 2026 Mar;18(2):e70052. doi: 10.1111/luts.70052. PMID: 41844238; PMCID: PMC12995508. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/338825-nocturia-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Desmopressin, ODT, Shows, Favorable, Long-Term, Safety, Men, With, Nocturia:, Japan, Surveillance, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/338825-nocturia-2.webp"><p><span>Japan: A large post-marketing surveillance study in Japan has provided important real-world insights into the long-term safety of <a href="https://medicaldialogues.in/topics/desmopressin">desmopressin </a>orally disintegrating tablets (ODT) in men with nocturia caused by nocturnal polyuria. The findings, published in<i> Low Urinary Tract Symptoms, </i>highlight both the tolerability of the drug and key risk factors that clinicians should consider when treating patients.</span></p><div class="pasted-from-word-wrapper"><div>Desmopressin, an antidiuretic hormone analogue, is commonly prescribed to reduce nighttime <a href="https://medicaldialogues.in/topics/urine-test">urine production</a>. While its efficacy is well established, concerns around safety—particularly<a href="https://medicaldialogues.in/topics/electrolyte-abnormalities"> electrolyte imbalance</a>—have prompted the need for long-term observational data in routine clinical settings. To address this, Yoshimasa Ogawa and colleagues conducted a post-marketing surveillance study involving Japanese men initiating desmopressin ODT therapy for the first time.</div><div>The study enrolled 1,113 patients into a centralized registry, of whom 1,049 were included in the final safety analysis after exclusions. Participants were followed for up to one year, offering a comprehensive view of adverse events over extended use. The average age of the study population was 75 years, reflecting the condition’s higher prevalence among older adults.   </div><div>The key findings were as follows:</div><ul><li>A total of 351 adverse drug reactions were reported in 259 patients.</li><li>Serious ADRs were rare, occurring in only 7 patients (0.7%).</li><li>Hyponatremia was the most common adverse event, observed in 13.3% of patients.</li><li>Some patients with hyponatremia experienced related symptoms; however, no cases of severe neurological complications such as seizures, confusion, stupor, or coma were reported.</li><li>Age ≥75 years was identified as a significant risk factor for developing hyponatremia.</li><li>A history of benign prostatic hyperplasia was associated with an increased risk.</li><li>Lower baseline serum sodium levels prior to treatment also increased susceptibility to hyponatremia.</li><li>These findings highlight the need for careful patient selection and close monitoring during treatment.</li></ul><div>The study also emphasized the need for vigilance in patients with underlying comorbidities or abnormal laboratory parameters, such as impaired renal function or baseline serum sodium levels below 140 mmol/L. Regular monitoring of sodium levels during treatment is particularly critical in these populations to mitigate potential risks.</div><div>Overall, the results support the acceptable safety profile of desmopressin ODT in routine clinical practice when used appropriately. However, they also reinforce that individualized risk assessment and ongoing monitoring are essential, especially in elderly patients and those with predisposing conditions.</div><div>These real-world findings provide valuable guidance for clinicians managing nocturia due to nocturnal polyuria, helping to balance therapeutic benefits with patient safety in long-term care.</div><div>Reference:</div><div>Ogawa Y, Kuramoto K, Nakano A. Long-Term Safety of Desmopressin Orally Disintegrating Tablets in Men With Nocturia due to Nocturnal Polyuria: Final Results of a Specified Drug Use-Results Survey in Japan. Low Urin Tract Symptoms. 2026 Mar;18(2):e70052. doi: 10.1111/luts.70052. PMID: 41844238; PMCID: PMC12995508.</div><div><br></div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Excessive smartphone use tied to symptoms of eating disorder and body dissatisfaction in young people: Study</title>
<link>https://edusehat.com/en/excessive-smartphone-use-tied-to-symptoms-of-eating-disorder-and-body-dissatisfaction-in-young-people-study</link>
<guid>https://edusehat.com/en/excessive-smartphone-use-tied-to-symptoms-of-eating-disorder-and-body-dissatisfaction-in-young-people-study</guid>
<description><![CDATA[ New research from the Institute of Psychiatry, Psychology &amp; Neuroscience (IoPPN) at King’s College London has found that excessive smartphone use is closely associated with disordered eating, including uncontrolled eating and emotional overeating, as well greater symptoms of food addiction in young people with no diagnosis of an eating disorder. 
The research, published in the Journal of Medical Internet Research, established a significant and consistent association between Problematic Smartphone Use (PSU) - whereby an individual becomes behaviorally or psychologically reliant on their smartphone - and eating disorder symptom severity. Researchers argue this highlights the need for early intervention strategies specific to excessive phone use for young people displaying eating disorder symptoms. 
While there has been research conducted into the negative impact that problematic internet usage, exposure to social media, and harmful online content can have on body image and body dysphoria in both clinical and non-clinical populations, none have specifically examined PSU.  
Researchers identified 35 studies in which to include in this systematic review. The studies were from across the globe and provided researchers with a sample size of 52,584 participants with an average age of 17. 
Their analysis of the data found that higher daily smartphone use was also related to greater food addiction symptoms, broader disordered eating behaviours like uncontrolled eating or emotional overeating, and body dissatisfaction in people with no diagnosis of an eating disorder. The association was particularly strong in those who use their phones for more than seven hours a day. 
Ben Carter, Professor of Medical Statistics at King’s IoPPN and the study’s senior author said, “Smartphones have become ubiquitous in our everyday lives. It is apparent from our study that, even for people without a diagnosis of an eating disorder, the overuse of a smartphone is associated with poor body satisfaction and altered eating behaviours, and is a potential source of distress” 
Dr Johanna Keeler, a Visiting Lecturer at King’s IoPPN and the study’s first author said, “Adolescence is a key stage of development as individuals evolve their sense of self by observing others. While smartphones might present an easy way for this to happen, being consistently exposed to idealised images can lead them to compare their own appearance with these “standards”, leading to poor self-esteem and appearance dissatisfaction - both risk factors for the development of an eating disorder.” Reference:Johanna Keeler,  Laura Conde Ludtke, Associations of Problematic Smartphone Use and Smartphone Screen Time With Eating Disorder Psychopathology in Non-Clinical Samples: A Systematic Review, Journal of Medical Internet Research, https://preprints.jmir.org/preprint/88572. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/21/232692-eating-disorder-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Excessive, smartphone, use, tied, symptoms, eating, disorder, and, body, dissatisfaction, young, people:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/21/232692-eating-disorder-50.webp"><p>New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that excessive smartphone use is closely associated with disordered eating, including uncontrolled eating and emotional overeating, as well greater symptoms of food addiction in young people with no diagnosis of an <a href="https://medicaldialogues.in/topics/eating-disorder">eating disorder</a>. 
</p><p>The research, published in the <i>Journal of Medical Internet Research</i>, established a significant and consistent association between Problematic Smartphone Use (PSU) - whereby an individual becomes behaviorally or psychologically reliant on their smartphone - and eating disorder symptom severity. Researchers argue this highlights the need for early intervention strategies specific to excessive phone use for young people displaying eating disorder symptoms. 
</p><p>While there has been research conducted into the negative impact that problematic internet usage, exposure to social media, and harmful online content can have on body image and body dysphoria in both clinical and non-clinical populations, none have specifically examined PSU.  
</p><p>Researchers identified 35 studies in which to include in this systematic review. The studies were from across the globe and provided researchers with a sample size of 52,584 participants with an average age of 17. 
</p><p>Their analysis of the data found that higher daily smartphone use was also related to greater food addiction symptoms, broader disordered eating behaviours like uncontrolled eating or emotional overeating, and body dissatisfaction in people with no diagnosis of an eating disorder. The association was particularly strong in those who use their phones for more than seven hours a day. 
</p><p>Ben Carter, Professor of Medical Statistics at King’s IoPPN and the study’s senior author said, “Smartphones have become ubiquitous in our everyday lives. It is apparent from our study that, even for people without a diagnosis of an eating disorder, the overuse of a smartphone is associated with poor body satisfaction and altered eating behaviours, and is a potential source of distress” 
</p><p>Dr Johanna Keeler, a Visiting Lecturer at King’s IoPPN and the study’s first author said, “Adolescence is a key stage of development as individuals evolve their sense of self by observing others. While smartphones might present an easy way for this to happen, being consistently exposed to idealised images can lead them to compare their own appearance with these “standards”, leading to poor self-esteem and appearance dissatisfaction - both risk factors for the development of an eating disorder.” </p><p>Reference:</p><p>Johanna Keeler,  Laura Conde Ludtke, Associations of Problematic Smartphone Use and Smartphone Screen Time With Eating Disorder Psychopathology in Non-Clinical Samples: A Systematic Review, Journal of Medical Internet Research, https://preprints.jmir.org/preprint/88572.</p>]]> </content:encoded>
</item>

<item>
<title>Exercise and intensive pharmacological interventions not linked to significant cognitive benefits in elderly: JAMA</title>
<link>https://edusehat.com/en/exercise-and-intensive-pharmacological-interventions-not-linked-to-significant-cognitive-benefits-in-elderly-jama</link>
<guid>https://edusehat.com/en/exercise-and-intensive-pharmacological-interventions-not-linked-to-significant-cognitive-benefits-in-elderly-jama</guid>
<description><![CDATA[ A recent study published in the Journal of the American Medical Association found that exercise, intensive pharmacological management of cardiovascular risk factors, or their combination did not lead to statistically significant improvements in cognitive function over 24 months among older adults with a family history of dementia or subjective cognitive decline.The study evaluated if targeting multiple modifiable cardiovascular risk factors (physical inactivity, high blood pressure, and high cholesterol) at once, offer stronger protection against cognitive decline. Across two years from 4 clinical sites this research enrolled 513 adults aged 60 to 85 who did not have dementia but were considered at elevated risk due to hypertension, a family history of dementia, or self-reported memory concerns. Participants were randomly assigned to one of four groups such as aerobic exercise, intensive pharmacological reduction of vascular risk factors (IRVR), a combination of both, or standard care.The IRVR strategy aimed to lower systolic blood pressure below 130 mm Hg and reduce LDL cholesterol using medication. Meanwhile, the exercise group followed structured aerobic training programs. After 24 months, the results showed modest cognitive improvements across all groups, with no statistically significant differences between them.Cognitive performance was measured using the Preclinical Alzheimer Cognitive Composite (PACC), to detect early changes associated with Alzheimer’s disease. Participants in the exercise group improved slightly more than those who did not exercise, but the difference was not statistically meaningful. Similarly, those receiving intensive cardiovascular treatment did not outperform those who did not receive it.Secondary measures (cognitive tests assessing memory, attention, and processing speed), followed the same pattern of small gains across the board, but no clear advantage for any single intervention or combination. While the findings may seem surprising, they do not diminish the importance of managing cardiovascular health or staying physically active. Both exercise and vascular risk reduction are already well-established for improving heart health and overall well-being. Cognitive decline is influenced by genetics, lifestyle, and underlying biological processes, by making it difficult for any single or combined intervention to produce dramatic short-term effects. Longer follow-up periods or earlier intervention in midlife may be necessary to detect more meaningful cognitive changes. Reference:Zhang, R., Vidoni, E., Vongpatanasin, W., Kerwin, D. R., Cullum, C. M., Rossetti, H., Stowe, A. M., Billinger, S. A., Gupta, A., Hall, T., Scheel, N., Zhu, D. C., Hynan, L. S., Burns, J. M., Keller, J. N., &amp; Binder, E. F. (2026). Effects of exercise and intensive vascular risk reduction on cognitive function in older adults: A randomized clinical trial: A randomized clinical trial. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.0359 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Exercise, and, intensive, pharmacological, interventions, not, linked, significant, cognitive, benefits, elderly:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/02/21/202368-cognitive-decline.webp"><p>A recent study published in the <i>Journal of the American Medical Association</i> found that exercise, intensive pharmacological management of cardiovascular risk factors, or their combination did not lead to statistically significant improvements in cognitive function over 24 months among older adults with a family history of dementia or subjective cognitive decline.</p><p>The study evaluated if targeting multiple modifiable cardiovascular risk factors (physical inactivity, high blood pressure, and high cholesterol) at once, offer stronger protection against cognitive decline. Across two years from 4 clinical sites this research enrolled 513 adults aged 60 to 85 who did not have dementia but were considered at elevated risk due to hypertension, a family history of dementia, or self-reported memory concerns. Participants were randomly assigned to one of four groups such as aerobic exercise, intensive pharmacological reduction of vascular risk factors (IRVR), a combination of both, or standard care.</p><p>The IRVR strategy aimed to lower systolic blood pressure below 130 mm Hg and reduce LDL cholesterol using medication. Meanwhile, the exercise group followed structured aerobic training programs. After 24 months, the results showed modest cognitive improvements across all groups, with no statistically significant differences between them.</p><p>Cognitive performance was measured using the Preclinical Alzheimer Cognitive Composite (PACC), to detect early changes associated with Alzheimer’s disease. Participants in the exercise group improved slightly more than those who did not exercise, but the difference was not statistically meaningful. Similarly, those receiving intensive cardiovascular treatment did not outperform those who did not receive it.</p><p>Secondary measures (cognitive tests assessing memory, attention, and processing speed), followed the same pattern of small gains across the board, but no clear advantage for any single intervention or combination. While the findings may seem surprising, they do not diminish the importance of managing cardiovascular health or staying physically active. Both exercise and vascular risk reduction are already well-established for improving heart health and overall well-being. </p><p>Cognitive decline is influenced by genetics, lifestyle, and underlying biological processes, by making it difficult for any single or combined intervention to produce dramatic short-term effects. Longer follow-up periods or earlier intervention in midlife may be necessary to detect more meaningful cognitive changes. </p><p>Reference:</p><p>Zhang, R., Vidoni, E., Vongpatanasin, W., Kerwin, D. R., Cullum, C. M., Rossetti, H., Stowe, A. M., Billinger, S. A., Gupta, A., Hall, T., Scheel, N., Zhu, D. C., Hynan, L. S., Burns, J. M., Keller, J. N., & Binder, E. F. (2026). Effects of exercise and intensive vascular risk reduction on cognitive function in older adults: A randomized clinical trial: A randomized clinical trial. JAMA Neurology. <a href="https://medicaldialogues.in/neurology-neurosurgery/news/jamanetwork.com/journals/jamaneurology/article-abstract/2846826" rel="nofollow">https://doi.org/10.1001/jamaneurol.2026.0359</a></p>]]> </content:encoded>
</item>

<item>
<title>SSRI medication during pregnancy  may increase risk of gestational diabetes but may protect against preterm birth: Study</title>
<link>https://edusehat.com/en/ssri-medication-during-pregnancy-may-increase-risk-of-gestational-diabetes-but-may-protect-against-preterm-birth-study</link>
<guid>https://edusehat.com/en/ssri-medication-during-pregnancy-may-increase-risk-of-gestational-diabetes-but-may-protect-against-preterm-birth-study</guid>
<description><![CDATA[ An international team of researchers has found that the use of SSRI antidepressants during pregnancy is associated with an increased risk of gestational diabetes and early adaptation problems in newborns, even after taking maternal depression into account. The study also discovered that taking SSRI medication during pregnancy may reduce the risks of preterm birth and low birth weight. 
According to an extensive population-based study, the use of selective serotonin reuptake inhibitor (SSRI) medication during pregnancy was associated with an increased risk of gestational diabetes compared to women with depression who did not use medication. In contrast, the risk of caesarean section, very preterm birth, and low and very low birth weight was lower among those taking SSRIs.
In newborns, SSRI exposure was associated with an increased risk of low 1- and 5-minute Apgar scores, breathing problems, and the need for neonatal care or neonatal intensive care unit treatment. There was no increased risk of major congenital malformations.
When compared with women who had discontinued SSRI use before pregnancy, taking the medication during pregnancy was associated with a lower risk of late preterm birth and low birth weight. However, the risks associated with early adaptation problems in newborns remained elevated.
According to the lead author of the study, Docent Heli Malm, the results show that SSRIs have effects on the early adaptation of newborns that are independent of maternal depression.
“Our results emphasise the significance of individualised treatment decisions during pregnancy. The treatment of depression is important, and the use of SSRIs seems to protect against the risk of preterm birth associated with depression. At the same time, however, it is necessary to closely monitor both the progress of the pregnancy and the health of the newborn,” says Malm.
“The association we have observed with gestational diabetes requires further research in order to better understand the possible cause-and-effect relationship and underlying biological mechanisms,” continues Malm.
Extensive registry-based study with several control groups
The study was conducted in collaboration between the Research Centre for Child Psychiatry at the University of Turku in Finland and Columbia University in New York. It is based on national registry data and covers more than 1.27 million children born in Finland between 1996 and 2018.
Mothers who used SSRIs during pregnancy were compared with women diagnosed with depression who did not use antidepressants during pregnancy, as well as with women who had discontinued taking SSRIs before pregnancy. In addition, the study used sibling comparisons, which allow factors related to heredity and growth environment to be taken into account.
The primary aim of the study was to determine whether the previously reported prenatal risks are attributable to the antidepressant medications themselves or to maternal depression and its severity. The analyses adjusted for several indicators of depression severity.Reference:Malm, Heli et al., SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn, American Journal of Obstetrics &amp; Gynecology MFM, DOI:10.1016/j.ajogmf.2026.101910  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/28/323969-statin-in-pregnancy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>SSRI, medication, during, pregnancy, may, increase, risk, gestational, diabetes, but, may, protect, against, preterm, birth:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/28/323969-statin-in-pregnancy.webp"><p>An international team of researchers has found that the use of SSRI <a href="https://medicaldialogues.in/topics/Antidepressants">antidepressants </a>during <a href="https://medicaldialogues.in/topics/pregnancy">pregnancy </a>is associated with an increased risk of <a href="https://medicaldialogues.in/topics/gestational-diabetes">gestational diabetes </a>and early adaptation problems in newborns, even after taking maternal <a href="https://medicaldialogues.in/topics/depression">depression </a>into account. The study also discovered that taking SSRI medication during pregnancy may reduce the risks of preterm birth and low birth weight. 
</p><p>According to an extensive population-based study, the use of selective serotonin reuptake inhibitor (SSRI) medication during pregnancy was associated with an increased risk of gestational diabetes compared to women with depression who did not use medication. In contrast, the risk of caesarean section, very preterm birth, and low and very low birth weight was lower among those taking SSRIs.
</p><p>In newborns, SSRI exposure was associated with an increased risk of low 1- and 5-minute Apgar scores, breathing problems, and the need for neonatal care or neonatal intensive care unit treatment. There was no increased risk of major congenital malformations.
</p><p>When compared with women who had discontinued SSRI use before pregnancy, taking the medication during pregnancy was associated with a lower risk of late preterm birth and low birth weight. However, the risks associated with early adaptation problems in newborns remained elevated.
</p><p>According to the lead author of the study, Docent Heli Malm, the results show that SSRIs have effects on the early adaptation of newborns that are independent of maternal depression.
</p><p>“Our results emphasise the significance of individualised treatment decisions during pregnancy. The treatment of depression is important, and the use of SSRIs seems to protect against the risk of preterm birth associated with depression. At the same time, however, it is necessary to closely monitor both the progress of the pregnancy and the health of the newborn,” says Malm.
</p><p>“The association we have observed with gestational diabetes requires further research in order to better understand the possible cause-and-effect relationship and underlying biological mechanisms,” continues Malm.
</p><h3>Extensive registry-based study with several control groups
</h3><p>The study was conducted in collaboration between the Research Centre for Child Psychiatry at the University of Turku in Finland and Columbia University in New York. It is based on national registry data and covers more than 1.27 million children born in Finland between 1996 and 2018.
</p><p>Mothers who used SSRIs during pregnancy were compared with women diagnosed with depression who did not use antidepressants during pregnancy, as well as with women who had discontinued taking SSRIs before pregnancy. In addition, the study used sibling comparisons, which allow factors related to heredity and growth environment to be taken into account.
</p><p>The primary aim of the study was to determine whether the previously reported prenatal risks are attributable to the antidepressant medications themselves or to maternal depression and its severity. The analyses adjusted for several indicators of depression severity.</p><p>Reference:</p><p>Malm, Heli et al., SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn, American Journal of Obstetrics & Gynecology MFM, DOI:10.1016/j.ajogmf.2026.101910 </p>]]> </content:encoded>
</item>

<item>
<title>Chronic Pain More Common in Children With Developmental Disabilities: JAMA</title>
<link>https://edusehat.com/en/chronic-pain-more-common-in-children-with-developmental-disabilities-jama</link>
<guid>https://edusehat.com/en/chronic-pain-more-common-in-children-with-developmental-disabilities-jama</guid>
<description><![CDATA[ A large national survey study published in JAMA Pediatrics found that children with developmental disabilities have a significantly higher prevalence of chronic pain compared to those without disabilities (13.2% vs 5.5%). The risk was more than twofold higher and was especially pronounced in children with conditions like seizures or cerebral palsy. Additionally, lower parental education, lower income, and adverse childhood experiences further increased the likelihood of chronic pain, highlighting the need for targeted screening and interventions in this vulnerable population.Although pediatric pain can impede healthy development throughout adulthood, the prevalence of chronic pain among US children with developmental disabilities remains unclear. A study was done to evaluate parent-reported chronic pain prevalence and the association between developmental disabilities and chronic pain in US children and adolescents (hereinafter, children). This national survey study included 263 168 children aged 3 to 17 years who participated in the 2016-2023 National Survey of Children’s Health (NSCH). Data were analyzed from June 2025 to August 2025. The weighted prevalence of parent-reported chronic pain in children with or without any of these 10 disabilities was calculated across the study period and by year. Logistic regression models were applied to examine the association between various categories of developmental disabilities and pain among US children as well as potential health disparities.Results  This study included a weighted sample of 224 467 664 children; of them, 135 848 (51.1%) were male with a mean (SD) age of 10.2 (4.5) years. Approximately 18.7% of children reported having at least 1 disability. The weighted prevalence of parent-reported chronic pain was higher in children with at least 1 developmental disability compared to peers without a disability (13.2% vs 5.5%) over the study period. Adjusted analyses revealed significant associations between any of the disabilities and parent-reported chronic pain, with an odds ratio of 2.31 (95% CI, 2.14-2.49). Similar positive associations were also observed for all disability categories, particularly seizure and cerebral palsy. Moreover, higher odds of parent-reported chronic pain were associated with lower levels of parental education and family income, or more adverse childhood experiences.The findings in this study indicate that children with diverse developmental disabilities were more likely to have parent-reported chronic pain, and this likelihood was associated with several socioeconomic factors. These findings provide important insights into targeted screening and interventions for pain in pediatric populations with developmental disabilities.Reference:Shi W, Kan L, Wang T, Li Y, Wang X. Parent-Reported Chronic Pain in Children With and Without Developmental Disabilities. JAMA Pediatr. Published online March 30, 2026. doi:10.1001/jamapediatrics.2026.0512Keywords:Chronic Pain,  Common, Children, Developmental Disabilities, JAMA, Shi W, Kan L, Wang T, Li Y, Wang X  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/339009-images-2026-04-01t192153202.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chronic, Pain, More, Common, Children, With, Developmental, Disabilities:, JAMA</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/339009-images-2026-04-01t192153202.webp"><p>A large national survey study published in JAMA Pediatrics found that children with developmental disabilities have a significantly higher prevalence of chronic pain compared to those without disabilities (13.2% vs 5.5%). The risk was more than twofold higher and was especially pronounced in children with conditions like seizures or cerebral palsy. Additionally, lower parental education, lower income, and adverse childhood experiences further increased the likelihood of chronic pain, highlighting the need for targeted screening and interventions in this vulnerable population.</p><div class="pasted-from-word-wrapper"><p dir="ltr">Although pediatric pain can impede healthy development throughout adulthood, the prevalence of chronic pain among US children with developmental disabilities remains unclear. A study was done to evaluate parent-reported chronic pain prevalence and the association between developmental disabilities and chronic pain in US children and adolescents (hereinafter, children). This national survey study included 263 168 children aged 3 to 17 years who participated in the 2016-2023 National Survey of Children’s Health (NSCH). Data were analyzed from June 2025 to August 2025. The weighted prevalence of parent-reported chronic pain in children with or without any of these 10 disabilities was calculated across the study period and by year. Logistic regression models were applied to examine the association between various categories of developmental disabilities and pain among US children as well as potential health disparities.</p><p dir="ltr">Results  This study included a weighted sample of 224 467 664 children; of them, 135 848 (51.1%) were male with a mean (SD) age of 10.2 (4.5) years. Approximately 18.7% of children reported having at least 1 disability. The weighted prevalence of parent-reported chronic pain was higher in children with at least 1 developmental disability compared to peers without a disability (13.2% vs 5.5%) over the study period. Adjusted analyses revealed significant associations between any of the disabilities and parent-reported chronic pain, with an odds ratio of 2.31 (95% CI, 2.14-2.49). Similar positive associations were also observed for all disability categories, particularly seizure and cerebral palsy. Moreover, higher odds of parent-reported chronic pain were associated with lower levels of parental education and family income, or more adverse childhood experiences.</p><p dir="ltr">The findings in this study indicate that children with diverse developmental disabilities were more likely to have parent-reported chronic pain, and this likelihood was associated with several socioeconomic factors. These findings provide important insights into targeted screening and interventions for pain in pediatric populations with developmental disabilities.</p><p dir="ltr">Reference:</p><p dir="ltr">Shi W, Kan L, Wang T, Li Y, Wang X. Parent-Reported Chronic Pain in Children With and Without Developmental Disabilities. JAMA Pediatr. Published online March 30, 2026. doi:10.1001/jamapediatrics.2026.0512</p><br><p dir="ltr">Keywords:</p><p dir="ltr">Chronic Pain,  Common, Children, Developmental Disabilities, JAMA, Shi W, Kan L, Wang T, Li Y, Wang X </p><br><br></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Common Drugs—Including Non&#45;Antibiotics—Linked to Increased Risk of C. difficile Infection: Study</title>
<link>https://edusehat.com/en/common-drugsincluding-non-antibioticslinked-to-increased-risk-of-c-difficile-infection-study</link>
<guid>https://edusehat.com/en/common-drugsincluding-non-antibioticslinked-to-increased-risk-of-c-difficile-infection-study</guid>
<description><![CDATA[ Sweden: A Swedish population-based case-control study found that both antibiotics and several commonly prescribed non-antibiotic medications are associated with a significantly increased risk of Clostridioides difficile infection.Among non-antibiotic drugs, the highest risks were observed with antidiarrheals, analgesics, and corticosteroids. While antibiotics and acid-suppressing drugs are already well-known risk factors, this study highlights that other widely used medications may also contribute to infection risk.The study, published in Gut by Annelies Boven and colleagues from the Karolinska Institutet, aimed to explore how a broad range of medications—particularly those that may influence the gut microbiome—affect the risk of developing C. difficile infection (CDI). Although antibiotics have long been recognized as a major driver of CDI, evidence regarding other drug classes has remained limited.For this purpose, the researchers conducted a large population-based case–control analysis using linked Swedish national registries from 2006 to 2019. The study included 42,921 individuals diagnosed with CDI and 355,159 matched controls based on age and sex. Medication exposure within 30 days before diagnosis was assessed, and associations with CDI risk were evaluated using multivariable statistical models that accounted for comorbidities and concurrent drug use.   Key Findings:A strong association was observed between certain antibiotic classes and increased risk of Clostridioides difficile infection.Lincosamides were linked to the highest risk, followed by combinations of penicillins, sulfonamides with trimethoprim, and cephalosporins.Tetracyclines did not show a significant association with increased CDI risk, indicating variability across antibiotic classes.Several non-antibiotic medications were also associated with increased CDI risk.Antidiarrheal drugs showed the highest risk among non-antibiotic medications.Corticosteroids and proton pump inhibitors were also significantly associated with higher CDI risk.Other drug classes linked to increased risk included nervous system medications, constipation treatments, histamine H2-receptor antagonists, antidepressants, and beta blockers.Non-steroidal anti-inflammatory drugs did not demonstrate a significant association with CDI risk.Lipid-lowering medications and aspirin were associated with a modest reduction in CDI risk.The potential protective effects of these drugs require further investigation.The study highlights the complex relationship between commonly prescribed medications and gut microbiome health. While antibiotics remain the primary contributors to CDI, the results suggest that other drugs frequently used in routine clinical practice may also play a meaningful role.The authors emphasized that these findings support the need for careful and judicious prescribing practices. Recognizing the potential risks associated with both antibiotic and non-antibiotic medications could help clinicians make more informed decisions, particularly in patients at higher risk for CDI.Overall, the study provides valuable insights for clinicians and policymakers, highlighting the importance of considering a wider range of medications when evaluating CDI risk and reinforcing ongoing efforts toward antimicrobial stewardship and safer prescribing strategies.Reference:Boven A, Vranken H, Vlieghe E, et alCommonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control studyGut Published Online First: 31 March 2026. doi: 10.1136/gutjnl-2025-337629 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Common, Drugs—Including, Non-Antibiotics—Linked, Increased, Risk, difficile, Infection:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/27/231022-clostridioides-difficile-infection.webp"><p><span>Sweden: A Swedish population-based case-control study found that both antibiotics and several <a href="https://medicaldialogues.in/topics/prescription">commonly prescribed non-antibiotic medications </a>are associated with a significantly increased risk of<a href="https://medicaldialogues.in/topics/clostridioides-difficile-infection"> Clostridioides difficile infection</a>.</span></p><div class="pasted-from-word-wrapper"><div>Among non-antibiotic drugs, the highest risks were observed with antidiarrheals, <a href="https://medicaldialogues.in/topics/analgesics">analgesics</a>, and corticosteroids. While antibiotics and acid-suppressing drugs are already well-known risk factors, this study highlights that other widely used medications may also contribute to infection risk.</div><div>The study, published in <i>Gut </i>by Annelies Boven and colleagues from the Karolinska Institutet, aimed to explore how a broad range of medications—particularly those that may influence the gut microbiome—affect the risk of developing C. difficile infection (CDI). Although antibiotics have long been recognized as a major driver of CDI, evidence regarding other drug classes has remained limited.</div><div>For this purpose, the researchers conducted a large population-based case–control analysis using linked Swedish national registries from 2006 to 2019. The study included 42,921 individuals diagnosed with CDI and 355,159 matched controls based on age and sex. Medication exposure within 30 days before diagnosis was assessed, and associations with CDI risk were evaluated using multivariable statistical models that accounted for comorbidities and concurrent drug use.   </div><div>Key Findings:</div><ul><li>A strong association was observed between certain antibiotic classes and increased risk of Clostridioides difficile infection.</li><li>Lincosamides were linked to the highest risk, followed by combinations of penicillins, sulfonamides with trimethoprim, and cephalosporins.</li><li>Tetracyclines did not show a significant association with increased CDI risk, indicating variability across antibiotic classes.</li><li>Several non-antibiotic medications were also associated with increased CDI risk.</li><li>Antidiarrheal drugs showed the highest risk among non-antibiotic medications.</li><li>Corticosteroids and proton pump inhibitors were also significantly associated with higher CDI risk.</li><li>Other drug classes linked to increased risk included nervous system medications, constipation treatments, histamine H2-receptor antagonists, antidepressants, and beta blockers.</li><li>Non-steroidal anti-inflammatory drugs did not demonstrate a significant association with CDI risk.</li><li>Lipid-lowering medications and aspirin were associated with a modest reduction in CDI risk.</li><li>The potential protective effects of these drugs require further investigation.</li></ul><div>The study highlights the complex relationship between commonly prescribed medications and gut microbiome health. While antibiotics remain the primary contributors to CDI, the results suggest that other drugs frequently used in routine clinical practice may also play a meaningful role.</div><div>The authors emphasized that these findings support the need for careful and judicious prescribing practices. Recognizing the potential risks associated with both antibiotic and non-antibiotic medications could help clinicians make more informed decisions, particularly in patients at higher risk for CDI.</div><div>Overall, the study provides valuable insights for clinicians and policymakers, highlighting the importance of considering a wider range of medications when evaluating CDI risk and reinforcing ongoing efforts toward antimicrobial stewardship and safer prescribing strategies.</div><div>Reference:</div><div>Boven A, Vranken H, Vlieghe E, et alCommonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control studyGut Published Online First: 31 March 2026. doi: 10.1136/gutjnl-2025-337629</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Study Suggests New Nomogram Accurately Predicts Nosebleed Risk After Nasotracheal Intubation</title>
<link>https://edusehat.com/en/study-suggests-new-nomogram-accurately-predicts-nosebleed-risk-after-nasotracheal-intubation</link>
<guid>https://edusehat.com/en/study-suggests-new-nomogram-accurately-predicts-nosebleed-risk-after-nasotracheal-intubation</guid>
<description><![CDATA[ Why Nasotracheal Intubation Matters—and Its RisksFor oral and maxillofacial surgeries, nasotracheal intubation (NTI) is the gold standard for securing the airway, as it keeps the surgical field unobstructed. However, this procedure carries a significant risk: epistaxis (nosebleed), which can complicate surgery, obscure the airway, and in rare cases, threaten patient safety. While strategies like tube softening and vasoconstrictor drops have been used to lower this risk, clinicians have lacked a reliable tool to assess a patient’s likelihood of bleeding before intubation—until now.Constructing a Practical Risk Prediction ModelA research team at Shanghai Ninth People’s Hospital conducted a retrospective study involving 574 adults who underwent NTI for oral surgery. Researchers collected comprehensive clinical and imaging data, including CT assessments of nasal septum deviation. They used advanced statistical techniques—LASSO regression and multivariate logistic regression—to pinpoint key predictors of post-NTI epistaxis and build a user-friendly nomogram (visual prediction tool) to guide risk assessment.The Five Key Risk FactorsThe study identified five independent predictors of epistaxis after NTI:    Age – Older adults were more likely to experience bleeding due to age-related changes in the nasal mucosa and blood vessels.    History of Radiotherapy/Chemotherapy – Patients with prior treatments were at higher risk, likely because of increased tissue fragility and coagulation issues.    Nasal Intubation Duration – Longer intubation times, often due to resistance, increased the risk of trauma and bleeding.    Maximum Nasal Septum Deviation (Coronal Plane) – Greater deviation, especially in the coronal plane, meant a higher risk of intubation-induced trauma.    Location of Nasal Septum Deviation (Cross-Sectional Plane) – Deviation in the anterior/posterior versus central nasal septum altered bleeding risk.Excellent Predictive Accuracy and Clinical UtilityThe resulting nomogram demonstrated high predictive accuracy, with an area under the curve (AUC) of 0.957 in the training set and 0.900 in the validation set—both well above benchmarks for excellent prediction. Calibration and decision curve analyses confirmed that the model’s risk estimates closely matched real-world outcomes, and its use could guide more beneficial clinical decisions.Implications for Safer SurgeriesThis intuitive model allows anesthesiologists to quickly and objectively assess a patient’s risk of epistaxis before NTI, supporting personalized preventive measures. Incorporating imaging findings, especially septum deviation, into risk stratification can help clinicians choose the best intubation pathway and anticipate complications.Key Takeaways    Five factors (age, prior radiotherapy/chemotherapy, intubation time, septal deviation amount and location) strongly predict epistaxis risk after NTI.    The nomogram demonstrated superior accuracy (AUC 0.957/0.900) and clinical utility.    Preoperative imaging, particularly for septal deviation, is essential for risk assessment.    The tool supports tailored preventive strategies and improved safety in oral/maxillofacial surgeries.    Future multicenter studies and larger datasets are needed to further validate and refine this model.Citation:Chen J, Fan H, Wang Y, Zhu Y, Zhou R, Kang H, Jiang H. Construction and evaluation of a nomogram prediction model for the risk of epistaxis following nasotracheal intubation: a single-center retrospective cohort study. BMC Anesthesiology. 2025;25:264. https://doi.org/10.1186/s12871-025-03132-9 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2021/05/28/154678-tracheal-intubation.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 22:05:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Study, Suggests, New, Nomogram, Accurately, Predicts, Nosebleed, Risk, After, Nasotracheal, Intubation</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2021/05/28/154678-tracheal-intubation.webp"><p align="justify">Why Nasotracheal Intubation Matters—and Its Risks</p><p align="justify">For oral and maxillofacial surgeries, nasotracheal intubation (NTI) is the gold standard for securing the airway, as it keeps the surgical field unobstructed. However, this procedure carries a significant risk: epistaxis (nosebleed), which can complicate surgery, obscure the airway, and in rare cases, threaten patient safety. While strategies like tube softening and vasoconstrictor drops have been used to lower this risk, clinicians have lacked a reliable tool to assess a patient’s likelihood of bleeding before intubation—until now.</p><p align="justify">Constructing a Practical Risk Prediction Model</p><p align="justify">A research team at Shanghai Ninth People’s Hospital conducted a retrospective study involving 574 adults who underwent NTI for oral surgery. Researchers collected comprehensive clinical and imaging data, including CT assessments of nasal septum deviation. They used advanced statistical techniques—LASSO regression and multivariate logistic regression—to pinpoint key predictors of post-NTI epistaxis and build a user-friendly nomogram (visual prediction tool) to guide risk assessment.</p><p align="justify">The Five Key Risk Factors</p><p align="justify">The study identified five independent predictors of epistaxis after NTI:</p><p align="justify">    Age – Older adults were more likely to experience bleeding due to age-related changes in the nasal mucosa and blood vessels.</p><p align="justify">    History of Radiotherapy/Chemotherapy – Patients with prior treatments were at higher risk, likely because of increased tissue fragility and coagulation issues.</p><p align="justify">    Nasal Intubation Duration – Longer intubation times, often due to resistance, increased the risk of trauma and bleeding.</p><p align="justify">    Maximum Nasal Septum Deviation (Coronal Plane) – Greater deviation, especially in the coronal plane, meant a higher risk of intubation-induced trauma.</p><p align="justify">    Location of Nasal Septum Deviation (Cross-Sectional Plane) – Deviation in the anterior/posterior versus central nasal septum altered bleeding risk.</p><p align="justify">Excellent Predictive Accuracy and Clinical Utility</p><p align="justify">The resulting nomogram demonstrated high predictive accuracy, with an area under the curve (AUC) of 0.957 in the training set and 0.900 in the validation set—both well above benchmarks for excellent prediction. Calibration and decision curve analyses confirmed that the model’s risk estimates closely matched real-world outcomes, and its use could guide more beneficial clinical decisions.</p><p align="justify">Implications for Safer Surgeries</p><p align="justify">This intuitive model allows anesthesiologists to quickly and objectively assess a patient’s risk of epistaxis before NTI, supporting personalized preventive measures. Incorporating imaging findings, especially septum deviation, into risk stratification can help clinicians choose the best intubation pathway and anticipate complications.</p><p align="justify">Key Takeaways</p><p align="justify">    Five factors (age, prior radiotherapy/chemotherapy, intubation time, septal deviation amount and location) strongly predict epistaxis risk after NTI.</p><p align="justify">    The nomogram demonstrated superior accuracy (AUC 0.957/0.900) and clinical utility.</p><p align="justify">    Preoperative imaging, particularly for septal deviation, is essential for risk assessment.</p><p align="justify">    The tool supports tailored preventive strategies and improved safety in oral/maxillofacial surgeries.</p><p align="justify">    Future multicenter studies and larger datasets are needed to further validate and refine this model.</p><p align="justify">Citation:</p><p align="justify">Chen J, Fan H, Wang Y, Zhu Y, Zhou R, Kang H, Jiang H. Construction and evaluation of a nomogram prediction model for the risk of epistaxis following nasotracheal intubation: a single-center retrospective cohort study. BMC Anesthesiology. 2025;25:264. https://doi.org/10.1186/s12871-025-03132-9</p><p align="justify"><br></p>]]> </content:encoded>
</item>

<item>
<title>Amid workload concerns, NHL medical college Ahmedabad reiterates resident doctors duty hour norms</title>
<link>https://edusehat.com/en/amid-workload-concerns-nhl-medical-college-ahmedabad-reiterates-resident-doctors-duty-hour-norms</link>
<guid>https://edusehat.com/en/amid-workload-concerns-nhl-medical-college-ahmedabad-reiterates-resident-doctors-duty-hour-norms</guid>
<description><![CDATA[ Ahmedabad: Amid growing concern across the country regarding long duty hours and the well-being of resident doctors, NHL Municipal Medical College, Ahmedabad, issued a circular reiterating guidelines on duty hours of resident doctors, stating that continuous duty should not normally exceed 12 hours and total working hours should be around 48 hours per week.In the notice dated April 2, 2026, the college asked all superintendents, heads of departments, and unit heads to ensure that duty schedules are aligned with these norms, while also maintaining patient care and academic responsibilities.The circular further cited concerns being reported across the country regarding long working hours, working conditions, and the well-being of resident doctors.&quot;In view of recent concerns being reported across the country regarding duty hours, working conditions, and well-being of resident doctors, it is considered appropriate to reiterate the existing guidelines on the subject. As per the Residency Scheme formulated following the directions of the Hon’ble Supreme Court, duty hours are to be regulated such that continuous duty does not normally exceed 12 hours at a stretch and overall working hours are maintained around 48 hours per week, with provision for adequate rest and weekly off on rotation,&quot; the notice read. The Ministry of Health and Family Welfare implemented the Residency Scheme on June 5, 1992, following directions from the Supreme Court, which clearly limits resident doctors’ duty hours to a maximum of 12 hours per day and 48 hours per week.The notice comes after serious allegations surfaced on social media regarding the working conditions at the NHL Municipal Medical College, following an alleged suicide attempt by a resident doctor.According to a post shared on &#039;X&#039; by a doctor, also a medico-social activist, the resident allegedly consumed around 30 clonazepam tablets and attempted suicide, reportedly due to extreme workload, harassment, and exploitation.The medico-social activist claimed that while 13 residents were officially posted in the department, nearly half were assigned elsewhere, leaving the remaining residents to manage double the workload.Further allegations include residents being forced to write reports in the names of senior doctors and being made to rewrite them multiple times as punishment for errors. The post also alleged that residents were made to run personal errands for seniors, including arranging daily meals, and were forced to work at a professor’s private imaging centre.Questioning when the harassment and torture will end, the X user said, &quot;And the lowest of lows - the professor allegedly asked him to produce a psychiatric certificate so THEY can shift the blame to “mental illness” instead of their brutality. If this doesn’t shake National Medical Commission and Gujarat authorities into action, then what will? How many more residents need to break before this system is held accountable?&quot;Medical Dialogues had earlier reported that Maharashtra directed all medical colleges to follow the Centre&#039;s 1992 Residency Scheme after it recently came to light that around 300 resident doctors leave their postgraduate seats in Maharashtra&#039;s government medical colleges every year, and at least 25 deaths by suicide have been reported in recent years, allegedly due to 26-36 long duty hours.Also read- Maharashtra caps resident doctors&#039; duty hours at 48 per week, enforces 1992 residency scheme ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339651-duty-hours.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 18:30:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Amid, workload, concerns, NHL, medical, college, Ahmedabad, reiterates, resident, doctors, duty, hour, norms</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339651-duty-hours.webp"><p><b>Ahmedabad:</b> Amid growing concern across the country regarding long <a href="https://medicaldialogues.in/topics/duty-hours" target="_blank">duty hours</a> and the well-being of resident doctors, <a href="https://medicaldialogues.in/topics/nhl-municipal-medical-college" target="_blank">NHL Municipal Medical College</a>, Ahmedabad, issued a circular reiterating guidelines on duty hours of resident doctors, stating that continuous duty should not normally exceed 12 hours and total working hours should be around 48 hours per week.</p><p>In the notice dated April 2, 2026, the college asked all superintendents, heads of departments, and unit heads to ensure that duty schedules are aligned with these norms, while also maintaining patient care and academic responsibilities.</p><p>The circular further cited concerns being reported across the country regarding long working hours, working conditions, and the well-being of resident doctors.</p><p><i>"In view of recent concerns being reported across the country regarding duty hours, working conditions, and well-being of resident doctors, it is considered appropriate to reiterate the existing guidelines on the subject. As per the Residency Scheme formulated following the directions of the Hon’ble Supreme Court, duty hours are to be regulated such that continuous duty does not normally exceed 12 hours at a stretch and overall working hours are maintained around 48 hours per week, with provision for adequate rest and weekly off on rotation," </i>the notice read. </p><div contenteditable="false" data-width="100%" class="image-and-caption-wrapper clearfix hocalwire-draggable float-none"><img src="https://medicaldialogues.in/h-upload/2026/04/04/339647-he-yvxbcaaeo2m.webp" draggable="true" class="hocalwire-draggable float-none" data-float-none="true" data-uid="23690e0eLsUODDtBejEoP7FYwQTmGJDuY7fzl8555385" data-watermark="false" info-selector="#info_item_1775298552611"><div class="inside_editor_caption image_caption hocalwire-draggable float-none"><br></div></div><p>The Ministry of Health and Family Welfare implemented the Residency Scheme on June 5, 1992, following directions from the Supreme Court, which clearly limits resident doctors’ duty hours to a maximum of 12 hours per day and 48 hours per week.</p><p>The notice comes after serious allegations surfaced on social media regarding the working conditions at the NHL Municipal Medical College, following an alleged suicide attempt by a resident doctor.</p><p>According to a post shared on 'X' by a doctor, also a medico-social activist, the resident allegedly consumed around 30 clonazepam tablets and attempted suicide, reportedly due to extreme workload, harassment, and exploitation.</p><p>The medico-social activist claimed that while 13 residents were officially posted in the department, nearly half were assigned elsewhere, leaving the remaining residents to manage double the workload.</p><p>Further allegations include residents being forced to write reports in the names of senior doctors and being made to rewrite them multiple times as punishment for errors. The post also alleged that residents were made to run personal errands for seniors, including arranging daily meals, and were forced to work at a professor’s private imaging centre.</p><p>Questioning when the harassment and torture will end, the X user said, "And the lowest of lows - the professor allegedly asked him to produce a psychiatric certificate so THEY can shift the blame to “mental illness” instead of their brutality. If this doesn’t shake National Medical Commission and Gujarat authorities into action, then what will? How many more residents need to break before this system is held accountable?"</p><p>Medical Dialogues had earlier reported that Maharashtra directed all medical colleges to follow the Centre's 1992 Residency Scheme after it recently came to light that around 300 resident doctors leave their postgraduate seats in Maharashtra's government medical colleges every year, and at least 25 deaths by suicide have been reported in recent years, allegedly due to 26-36 long duty hours.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/maharashtra-caps-resident-doctors-duty-hours-at-48-per-week-enforces-1992-residency-scheme-167796" target="_blank">Maharashtra caps resident doctors' duty hours at 48 per week, enforces 1992 residency scheme</a></b></p>]]> </content:encoded>
</item>

<item>
<title>AI&#45;based monitoring to boost dialysis services in Karnataka: Dinesh Gundu Rao</title>
<link>https://edusehat.com/en/ai-based-monitoring-to-boost-dialysis-services-in-karnataka-dinesh-gundu-rao</link>
<guid>https://edusehat.com/en/ai-based-monitoring-to-boost-dialysis-services-in-karnataka-dinesh-gundu-rao</guid>
<description><![CDATA[ Bengaluru: Health Minister Dinesh Gundu Rao said on Thursday that the launch of an AI-enabled monitoring system will significantly boost patient safety and treatment quality under Karnataka&#039;s public-private partnership dialysis programme.The system was inaugurated at KC General Hospital in Bengaluru. Such technological innovations bring dialysis services delivered under the PPP model on par with private healthcare standards, the minister said.&quot;The introduction of an AI-enabled monitoring system will significantly strengthen patient safety and treatment quality under Karnataka&#039;s PPP dialysis programme,&quot; he said, news agency PTI reported.Also Read:Karnataka to set up separate hospitals in areas with colleges-attached District hospitalsThe system, introduced by dialysis care provider NephroPlus, enables real-time monitoring of critical treatment parameters such as blood pressure, fluid removal and electrolyte balance during dialysis, aiming to improve patient outcomes through continuous oversight, a statement said.Currently deployed across seven dialysis centres, the platform tracks 28 key parameters, including patient care, safety, bed availability, staff alertness, emergency preparedness, infection control, hygiene and operational efficiency, NephroPlus said in a statement.The system allows administrators and clinical teams to make data-driven decisions through continuous performance monitoring.The technology replaces periodic audits with always-on monitoring, offering a more transparent and robust governance framework, officials said.NephroPlus CEO Rohit Singh said continuous monitoring is critical in dialysis care, and the AI-based system ensures consistent quality standards across centres while enabling safer and more reliable treatment for patients, reports PTI. The launch event also featured a live demonstration of AI-powered dashboards, showcasing real-time tracking of dialysis procedures. Also Read:Karnataka Plans Organ Transplant Centres in 22 Medical Colleges ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/11/12/260349-dinesh-gundu-rao.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 18:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AI-based, monitoring, boost, dialysis, services, Karnataka:, Dinesh, Gundu, Rao</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/11/12/260349-dinesh-gundu-rao.webp"><div class="pasted-from-word-wrapper"><p><span>Bengaluru: </span><span>Health Minister <a href="https://medicaldialogues.in/topics/Dinesh-Gundu-Rao" target="_blank">Dinesh Gundu Rao</a> said on Thursday that the </span>launch of an AI-enabled monitoring system will significantly boost patient safety and treatment quality under Karnataka's public-private partnership dialysis programme.</p><p>The system was inaugurated at KC General Hospital in Bengaluru. Such technological innovations bring dialysis services delivered under the PPP model on par with private healthcare standards, the minister said.</p><p>"The introduction of an AI-enabled monitoring system will significantly strengthen patient safety and treatment quality under Karnataka's PPP dialysis programme," he said, news agency PTI reported.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/karnataka-to-set-up-separate-hospitals-in-areas-with-colleges-attached-district-hospitals-160977"><b>Also Read:Karnataka to set up separate hospitals in areas with colleges-attached District hospitals</b></a></p><p>The system, introduced by dialysis care provider NephroPlus, enables real-time monitoring of critical treatment parameters such as blood pressure, fluid removal and electrolyte balance during dialysis, aiming to improve patient outcomes through continuous oversight, a statement said.</p><p>Currently deployed across seven dialysis centres, the platform tracks 28 key parameters, including patient care, safety, bed availability, staff alertness, emergency preparedness, infection control, hygiene and operational efficiency, NephroPlus said in a statement.</p><p>The system allows administrators and clinical teams to make data-driven decisions through continuous performance monitoring.</p><p>The technology replaces periodic audits with always-on monitoring, offering a more transparent and robust governance framework, officials said.</p><p>NephroPlus CEO Rohit Singh said continuous monitoring is critical in dialysis care, and the AI-based system ensures consistent quality standards across centres while enabling safer and more reliable treatment for patients, reports PTI. </p><p>The launch event also featured a live demonstration of AI-powered dashboards, showcasing real-time tracking of dialysis procedures.</p><p> <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/karnataka-plans-organ-transplant-centres-in-22-medical-colleges-153017"><b>Also Read:Karnataka Plans Organ Transplant Centres in 22 Medical Colleges</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>65 percent MBBS exam failure turn pass after review, BFUHS re&#45;evaluation row sparks concern</title>
<link>https://edusehat.com/en/65-percent-mbbs-exam-failure-turn-pass-after-review-bfuhs-re-evaluation-row-sparks-concern</link>
<guid>https://edusehat.com/en/65-percent-mbbs-exam-failure-turn-pass-after-review-bfuhs-re-evaluation-row-sparks-concern</guid>
<description><![CDATA[ Punjab: Concerns have been raised regarding the re-evaluation and re-checking processes for MBBS examinations at Baba Farid University of Health Sciences (BFUHS).The matter stems from the drastic changes in the results, wherein 65% of the students initially declared as failed were declared successful following the review process.Also Read: CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema villageIn this regard, according to documents reviewed by HT, the majority of students who passed the examination after re-checking belong to private medical colleges.A total of 1,091 students appeared for the examination. The results were declared on March 3, wherein initially, a total of 70 students had failed. However, following the re-evaluation process, 46 of those students from various medical colleges have now passed.The university declared the revised results on April 2. Of the 70 students who had initially failed, 62 failed in Forensic Medicine and eight in Community Medicine.In response, a professor, speaking on the condition of anonymity, stated that this is the first instance in which such a large number of students, who had initially failed, were declared passed following re-checking.According to the university&#039;s regulations, students are permitted to apply for re-checking; however, there is no provision for re-evaluation (the re-assessment of answer scripts by a different examiner or panel). Re-checking involves verifying only the accuracy of the marking and the calculation of scores. Meanwhile, BFUHS Vice-Chancellor Dr. Rajiv Sood stated that when it was brought to his notice that a large number of students, particularly in one subject, had failed, he ordered a special &#039;re-evaluation&#039; instead of &#039;re-checking&#039;.Dr. Sood stated that an inquiry has been initiated against the concerned examiner, and he has been relieved of his duties until the investigation is complete. Also Read: Punjab issues final ultimatum to 1,500 nurses, calls strike illegal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339659-bfuhs.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 18:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>percent, MBBS, exam, failure, turn, pass, after, review, BFUHS, re-evaluation, row, sparks, concern</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339659-bfuhs.webp"><p><b>Punjab: </b>Concerns have been raised regarding the re-evaluation and re-checking processes for <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>examinations at Baba Farid University of Health Sciences (<a href="https://medicaldialogues.in/topics/bfuhs" target="_blank">BFUHS</a>).</p><div class="pasted-from-word-wrapper"><p dir="ltr">The matter stems from the drastic changes in the results, wherein 65% of the students initially declared as failed were declared successful following the review process.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/cm-mann-inaugurates-sant-attar-singh-ji-maharaj-hospital-in-cheema-village-167863"><b>Also Read: </b>CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema village</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">In this regard, according to documents reviewed by <a href="https://www.hindustantimes.com/cities/chandigarh-news/discrepancies-in-bfuhs-mbbs-results-65-of-failed-students-pass-after-reevaluation-101775244118259.html" target="_blank" rel="nofollow">HT</a>, the majority of students who passed the examination after re-checking belong to private medical colleges.</p><p dir="ltr">A total of 1,091 students appeared for the examination. The results were declared on March 3, wherein initially, a total of 70 students had failed. However, following the re-evaluation process, 46 of those students from various medical colleges have now passed.</p><p dir="ltr">The university declared the revised results on April 2. Of the 70 students who had initially failed, 62 failed in Forensic Medicine and eight in Community Medicine.</p><p dir="ltr">In response, a professor, speaking on the condition of anonymity, stated that this is the first instance in which such a large number of students, who had initially failed, were declared passed following re-checking.</p><p dir="ltr">According to the university's regulations, students are permitted to apply for re-checking; however, there is no provision for re-evaluation (the re-assessment of answer scripts by a different examiner or panel). Re-checking involves verifying only the accuracy of the marking and the calculation of scores. </p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Meanwhile, BFUHS Vice-Chancellor Dr. Rajiv Sood stated that when it was brought to his notice that a large number of students, particularly in one subject, had failed, he ordered a special 're-evaluation' instead of 're-checking'.</p><p dir="ltr">Dr. Sood stated that an inquiry has been initiated against the concerned examiner, and he has been relieved of his duties until the investigation is complete. </p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/punjab-issues-final-ultimatum-to-1500-nurses-calls-strike-illegal-167635"><b>Also Read: </b>Punjab issues final ultimatum to 1,500 nurses, calls strike illegal</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Bihar to launch day&#45;care centres for haemophilia, thalassemia patients</title>
<link>https://edusehat.com/en/bihar-to-launch-day-care-centres-for-haemophilia-thalassemia-patients</link>
<guid>https://edusehat.com/en/bihar-to-launch-day-care-centres-for-haemophilia-thalassemia-patients</guid>
<description><![CDATA[ Patna: To enhance treatment access and improve public healthcare infrastructure, the Bihar Government has decided to establish special &#039;Day-Care Centres&#039; for patients with haemophilia and thalassemia at six major government medical college hospitals across the state. These centres will be developed at major hospitals, including Patna Medical College and Hospital; Sri Krishna Medical College and Hospital, Muzaffarpur; Jawaharlal Nehru Medical College and Hospital, Bhagalpur; All India Institute of Medical Sciences, Patna; Government Medical College, Purnia; and Anugrah Narayan Magadh Medical College and Hospital, Gaya.Also Read: Bihar 18 year old NEET aspirant found dead in hostelThe objective of &#039;Day-Care Centres&#039; is to provide comprehensive care under a single roof to patients suffering from two chronic blood-related diseases. This facility encompasses a range of services, such as free blood transfusions, regular check-ups, and the distribution of essential medicines.Under this initiative, healthcare workers will be deployed around the clock at these centres, which are being equipped with modern medical facilities. According to the Patna Press media news report, officials stated that construction and development work is currently underway at several locations; these include institutions in North Bihar and the Magadh region, as well as Bhagalpur and Patna.This project is part of the State Government&#039;s comprehensive efforts to strengthen healthcare delivery systems across Bihar. Also, parallel investments in medical education and hospital infrastructure.The government has presented this initiative as a step towards improving the accessibility and affordability of specialised care, particularly for patients who require lifelong treatment and monitoring.This initiative is expected to reduce the need for patients to travel outside the state for medical treatment.Last month, Medical Dialogues had reported that AIIMS Darbhanga had received the central government&#039;s approval for an additional Rs 700 crore. The additional fund comes over and above the earlier sanctioned Rs 1,264 crore for the project.  Also Read: AIIMS Darbhanga gets centre&#039;s approval for additional Rs 700 crore ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339588-bihar-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 18:30:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bihar, launch, day-care, centres, for, haemophilia, thalassemia, patients</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339588-bihar-1.webp"><p>Patna: To enhance treatment access and improve public healthcare infrastructure, the Bihar Government has decided to establish special 'Day-Care Centres' for patients with haemophilia and thalassemia at six major government medical college hospitals across the state. </p><div class="pasted-from-word-wrapper"><p dir="ltr">These centres will be developed at major hospitals, including Patna Medical College and Hospital; Sri Krishna Medical College and Hospital, Muzaffarpur; <a href="https://medicaldialogues.in/topics/jawaharlal-nehru-medical-college-and-hospital" target="_blank">Jawaharlal Nehru Medical College and Hospital</a>, Bhagalpur; <a href="https://medicaldialogues.in/topics/all-india-institute-of-medical-science" target="_blank">All India Institute of Medical Sciences</a>, Patna; <a href="https://medicaldialogues.in/topics/government-medical-college" target="_blank">Government Medical College</a>, Purnia; and Anugrah Narayan Magadh Medical College and Hospital, Gaya.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/bihar/bihar-18-year-old-neet-aspirant-found-dead-in-hostel-167228"><b>Also Read: </b>Bihar 18 year old NEET aspirant found dead in hostel</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">The objective of 'Day-Care Centres' is to provide comprehensive care under a single roof to patients suffering from two chronic blood-related diseases. This facility encompasses a range of services, such as free blood transfusions, regular check-ups, and the distribution of essential medicines.</p><p dir="ltr">Under this initiative, healthcare workers will be deployed around the clock at these centres, which are being equipped with modern medical facilities. </p><p dir="ltr">According to the <a href="https://patnapress.com/bihar-day-care-centres-haemophilia-thalassaemia-medical-colleges/" target="_blank" rel="nofollow">Patna Press </a>media news report, officials stated that construction and development work is currently underway at several locations; these include institutions in North Bihar and the Magadh region, as well as Bhagalpur and Patna.</p><p dir="ltr">This project is part of the State Government's comprehensive efforts to strengthen healthcare delivery systems across Bihar. Also, parallel investments in medical education and hospital infrastructure.</p><p dir="ltr">The government has presented this initiative as a step towards improving the accessibility and affordability of specialised care, particularly for patients who require lifelong treatment and monitoring.</p><p dir="ltr">This initiative is expected to reduce the need for patients to travel outside the state for medical treatment.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">Last month, Medical Dialogues had reported that AIIMS Darbhanga had received the central government's approval for an additional Rs 700 crore. The additional fund comes over and above the earlier sanctioned Rs 1,264 crore for the project.  </p><p dir="ltr"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-darbhanga-gets-centres-approval-for-additional-rs-700-crore-167485"><b>Also Read: </b>AIIMS Darbhanga gets centre's approval for additional Rs 700 crore</a></p></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Chemist Body Opposes DTAB Proposals on Drug Ads, Nicotine Gum OTC, Pushes for Regulated Trade</title>
<link>https://edusehat.com/en/chemist-body-opposes-dtab-proposals-on-drug-ads-nicotine-gum-otc-pushes-for-regulated-trade</link>
<guid>https://edusehat.com/en/chemist-body-opposes-dtab-proposals-on-drug-ads-nicotine-gum-otc-pushes-for-regulated-trade</guid>
<description><![CDATA[ New Delhi: The All India Organisation of Chemists and Druggists (AIOCD) has submitted a consolidated representation to the Chairman and Secretary of the Drug Technical Advisory Board (DTAB) regarding key agenda items (2, 5, 7, 9, and 12) discussed during the 93rd DTAB meeting held on February 16, 2026.In its submission, AIOCD leadership, including President J. S. Shinde and General Secretary Rajiv Singhal, reaffirmed their commitment to public health, rational use of medicines, and the protection of the regulated drug distribution system. The organisation also raised serious concerns over the growing menace of illegal and unregulated e-pharmacies, stating that such platforms pose significant risks to patient safety and undermine licensed brick-and-mortar chemists.Addressing Agenda 2 (Good Distribution Practices – GDP), the proposal under discussion aimed to introduce structured guidelines and regulatory standards for the proper storage, handling, and distribution of pharmaceutical products across the supply chain, ensuring drug quality, safety, and traceability from manufacturer to end user.The Organization welcomed this move in principle, recognizing its importance in strengthening the drug distribution system, saying, &quot;This is a progressive step towards ensuring quality, safety, and integrity in the pharmaceutical supply chain in line with international regulation.&quot;Also Read: Medicines Cannot Be Treated Like Agro-Chemicals: AIOCD Opposes PACS Drug Licence ProposalHowever, the organization recommended, &quot; Implementation of said guideline should be phase wise and practical, allowing adequate transition time and small and medium traders should not face disproportionate compliance burden.&quot;On Agenda 5 (Advertisement of Schedule H, H1 &amp; X Drugs), the DTAB recommended that suitable provisions be incorporated in the Drugs Rules, 1945, to allow advertisement of drugs specified under Schedule H, H1 and X only with the prior sanction of the Central Government for licensed entities engaged in sale, stocking, or distribution.These categories—Schedule H, H1, and X—include strictly prescription-only medicines, which are meant to be used under medical supervision due to their potential risks, including misuse and adverse effects.The All India Organisation of Chemists and Druggists strongly opposed this proposal, arguing that allowing advertisements of such drugs would violate the core principle of prescription-only usage. The organization raised concerns that it could encourage self-medication, irrational drug use, and misuse, while also leading to the commercialization of medicines at the cost of ethics and public health. It further pointed out that monitoring digital and indirect advertisements would be impractical.The AIOCD mentioned the following key concerns:• Violates the core principle of prescription-only medicines.• Encourages self-medication, misuse, and irrational drug use.• Monitoring digital and indirect advertisements is impractical.• Leads to the commercialization of medicines at the cost of ethics and public health.Regarding Agenda 7 (Amendment in Rule 64 – Competent Person Qualification), the matter relates to a proposed amendment in the Drugs Rules, 1945 to revise the qualification requirements for the “competent person” responsible for supervising wholesale drug operations.The proposal seeks to modify/strengthen the eligibility criteria (qualification and/or experience) for individuals designated as “competent persons” in wholesale drug establishments, who are responsible for ensuring proper handling, storage, and distribution of medicines.AIOCD has strongly opposed the proposed amendment, raising the following concerns:Wholesale trade is primarily B2B (business-to-business) and has no direct interface with patientsThe proposed qualifications are excessive and impracticalIt would impose a heavy compliance burden on MSME wholesalersIt may lead to supply chain disruptions, especially in rural areas.AIOCD has suggested that the existing regulation should be continued, stating that it is already effective and practical, and does not require such stringent changes.On Agenda 9 (Schedule K Exemption for Nicotine Gum 2 mg), the proposal under consideration was to grant exemption under Schedule K of the Drugs Rules, 1945 to Nicotine Gum (2 mg), which would allow its sale without the requirement of a retail drug license, thereby enabling wider over-the-counter availability.The All India Organisation of Chemists and Druggists strongly and categorically opposed this proposal, stating that nicotine is an addictive substance with a high risk of misuse.AIOCD strongly and categorically opposes this proposal.The All India Organisation of Chemists and Druggists presented the following key concerns:• Nicotine is an addictive substance with risk of misuse.• Safeguards like age restriction and monitoring are not practically enforceable.• May bypass licensed chemists, weakening the regulated system.• Contradicts broader public health and tobacco control objectives.As a recommendation, AIOCD urged that Nicotine Gum (2 mg) should continue to be sold only through licensed chemists, and that granting a Schedule K exemption is not warranted.On Agenda 12 (Stocking of Homoeopathic Medicines by Allopathic Wholesalers), the proposal under consideration was to allow allopathic (conventional) drug wholesalers to stock and distribute homoeopathic medicines, thereby enabling a broader and more integrated distribution network for such products.The All India Organisation of Chemists and Druggists welcomed this progressive proposal.Further, it suggested,• It will be helpful to maintain proper records and traceability.• Avoid additional compliance burden.• Ensure uniform implementation across states.In continuation, the organisation also reiterated its serious concern regarding illegal e-pharmacies operating without valid licenses and called for strict enforcement measures.It added, &quot;Several illegal E-Pharmacies who are operating without licenses required under Drugs and cosmetics act and against order of High courts, will further misuse this exemption. There will be uncontrolled sale of such drugs. There are many Homoeopathic drug which are poisonous if consumed indiscriminately. It is undermining the licensed brick-and-mortar chemist network and compromising patient safety.&quot;In addition, it says:&quot;Immediate and strict stern enforcement action against illegal e-pharmacies is anticipated since long. As submitted on and often before this we again strongly urge that draft e-pharmacy GSR 817 and covid period door delivery GSR 220 be withdrawn immediately in the interest of public health, and regulatory clarity. AIOCD respectfully submits that, public health must remain the paramount consideration. Drug distribution must continue through regulated and licensed channels only. Any policy leading to misuse, regulatory dilution or trade imbalance must be reconsidered.&quot;In its concluding remarks, AIOCD requested the DTAB to reject proposals under Agenda 5, 7, and 9, implement Agenda 2 and Agenda 12.To view the official letter, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/03/dtab-press-note-english-1-4-26-339365.pdfAlso Read: AIOCD Flags AI-Generated Fake Prescriptions, Writes to PM Seeking Shutdown of Unregulated E-Pharmacies ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/05/25/177106-online-pharmacy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Chemist, Body, Opposes, DTAB, Proposals, Drug, Ads, Nicotine, Gum, OTC, Pushes, for, Regulated, Trade</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/05/25/177106-online-pharmacy.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi: </b>The All India Organisation of Chemists and Druggists (AIOCD) has submitted a consolidated representation to the Chairman and Secretary of the Drug Technical Advisory Board (DTAB) regarding key agenda items (2, 5, 7, 9, and 12) discussed during the 93rd DTAB meeting held on February 16, 2026.</p></div><div class="pasted-from-word-wrapper"><p>In its submission, AIOCD leadership, including President J. S. Shinde and General Secretary Rajiv Singhal, reaffirmed their commitment to public health, rational use of medicines, and the protection of the regulated drug distribution system. The organisation also raised serious concerns over the growing menace of illegal and unregulated e-pharmacies, stating that such platforms pose significant risks to patient safety and undermine licensed brick-and-mortar chemists.</p><p>Addressing Agenda 2 (Good Distribution Practices – GDP), the proposal under discussion aimed to introduce structured guidelines and regulatory standards for the proper storage, handling, and distribution of pharmaceutical products across the supply chain, ensuring drug quality, safety, and traceability from manufacturer to end user.</p><p>The Organization welcomed this move in principle, recognizing its importance in strengthening the drug distribution system, saying, "This is a progressive step towards ensuring quality, safety, and integrity in the pharmaceutical supply chain in line with international regulation."</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/industry-perspective/medicines-cannot-be-treated-like-agro-chemicals-aiocd-opposes-pacs-drug-licence-proposal-166168">Also Read: Medicines Cannot Be Treated Like Agro-Chemicals: AIOCD Opposes PACS Drug Licence Proposal</a></div><p>However, the organization recommended, " Implementation of said guideline should be phase wise and practical, allowing adequate transition time and small and medium traders should not face disproportionate compliance burden."</p><p>On Agenda 5 (Advertisement of Schedule H, H1 & X Drugs), the DTAB recommended that suitable provisions be incorporated in the Drugs Rules, 1945, to allow advertisement of drugs specified under Schedule H, H1 and X only with the prior sanction of the Central Government for licensed entities engaged in sale, stocking, or distribution.</p><p>These categories—Schedule H, H1, and X—include strictly prescription-only medicines, which are meant to be used under medical supervision due to their potential risks, including misuse and adverse effects.</p><p>The All India Organisation of Chemists and Druggists strongly opposed this proposal, arguing that allowing advertisements of such drugs would violate the core principle of prescription-only usage. The organization raised concerns that it could encourage self-medication, irrational drug use, and misuse, while also leading to the commercialization of medicines at the cost of ethics and public health. It further pointed out that monitoring digital and indirect advertisements would be impractical.</p><p>The AIOCD mentioned the following key concerns:</p><p>• Violates the core principle of prescription-only medicines.</p><p>• Encourages self-medication, misuse, and irrational drug use.</p><p>• Monitoring digital and indirect advertisements is impractical.</p><p>• Leads to the commercialization of medicines at the cost of ethics and public health.</p><p>Regarding Agenda 7 (Amendment in Rule 64 – Competent Person Qualification), the matter relates to a proposed amendment in the Drugs Rules, 1945 to revise the qualification requirements for the “competent person” responsible for supervising wholesale drug operations.</p><p>The proposal seeks to modify/strengthen the eligibility criteria (qualification and/or experience) for individuals designated as “competent persons” in wholesale drug establishments, who are responsible for ensuring proper handling, storage, and distribution of medicines.</p><p>AIOCD has strongly opposed the proposed amendment, raising the following concerns:</p><ul class="hocalwire-editor-list"><li>Wholesale trade is primarily B2B (business-to-business) and has no direct interface with patients</li><li>The proposed qualifications are excessive and impractical</li><li>It would impose a heavy compliance burden on MSME wholesalers</li><li>It may lead to supply chain disruptions, especially in rural areas.</li></ul><p>AIOCD has suggested that the existing regulation should be continued, stating that it is already effective and practical, and does not require such stringent changes.</p><p>On Agenda 9 (Schedule K Exemption for Nicotine Gum 2 mg), the proposal under consideration was to grant exemption under Schedule K of the Drugs Rules, 1945 to Nicotine Gum (2 mg), which would allow its sale without the requirement of a retail drug license, thereby enabling wider over-the-counter availability.</p><p>The All India Organisation of Chemists and Druggists strongly and categorically opposed this proposal, stating that nicotine is an addictive substance with a high risk of misuse.</p><p>AIOCD strongly and categorically opposes this proposal.</p><p>The All India Organisation of Chemists and Druggists presented the following key concerns:</p><p>• Nicotine is an addictive substance with risk of misuse.</p><p>• Safeguards like age restriction and monitoring are not practically enforceable.</p><p>• May bypass licensed chemists, weakening the regulated system.</p><p>• Contradicts broader public health and tobacco control objectives.</p><p>As a recommendation, AIOCD urged that Nicotine Gum (2 mg) should continue to be sold only through licensed chemists, and that granting a Schedule K exemption is not warranted.</p><p>On Agenda 12 (Stocking of Homoeopathic Medicines by Allopathic Wholesalers), the proposal under consideration was to allow allopathic (conventional) drug wholesalers to stock and distribute homoeopathic medicines, thereby enabling a broader and more integrated distribution network for such products.</p><p>The All India Organisation of Chemists and Druggists welcomed this progressive proposal.</p><p>Further, it suggested,</p><p>• It will be helpful to maintain proper records and traceability.</p><p>• Avoid additional compliance burden.</p><p>• Ensure uniform implementation across states.</p><p>In continuation, the organisation also reiterated its serious concern regarding illegal e-pharmacies operating without valid licenses and called for strict enforcement measures.</p><p>It added, "Several illegal E-Pharmacies who are operating without licenses required under Drugs and cosmetics act and against order of High courts, will further misuse this exemption. There will be uncontrolled sale of such drugs. There are many Homoeopathic drug which are poisonous if consumed indiscriminately. It is undermining the licensed brick-and-mortar chemist network and compromising patient safety."</p><p>In addition, it says:</p><p>"Immediate and strict stern enforcement action against illegal e-pharmacies is anticipated since long. As submitted on and often before this we again strongly urge that draft e-pharmacy GSR 817 and covid period door delivery GSR 220 be withdrawn immediately in the interest of public health, and regulatory clarity. AIOCD respectfully submits that, public health must remain the paramount consideration. Drug distribution must continue through regulated and licensed channels only. Any policy leading to misuse, regulatory dilution or trade imbalance must be reconsidered."</p><p>In its concluding remarks, AIOCD requested the DTAB to reject proposals under Agenda 5, 7, and 9, implement Agenda 2 and Agenda 12.</p><p><b><i>To view the official letter, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/03/dtab-press-note-english-1-4-26-339365.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/03/dtab-press-note-english-1-4-26-339365.pdf</a></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/industry-perspective/aiocd-flags-ai-generated-fake-prescriptions-writes-to-pm-seeking-shutdown-of-unregulated-e-pharmacies-165150">Also Read: AIOCD Flags AI-Generated Fake Prescriptions, Writes to PM Seeking Shutdown of Unregulated E-Pharmacies</a></div></div><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/03/dtab-press-note-english-1-4-26-339365.pdf" target="_blank"></a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Doctors&amp;apos; burnout due to 24&#45;36 hour shifts! Parliamentary panel calls for Clinical Duty hour regulation policy with mandatory rest, monitored rosters</title>
<link>https://edusehat.com/en/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters</link>
<guid>https://edusehat.com/en/doctors-burnout-due-to-24-36-hour-shifts-parliamentary-panel-calls-for-clinical-duty-hour-regulation-policy-with-mandatory-rest-monitored-rosters</guid>
<description><![CDATA[ New Delhi: Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods and monitored rosters.These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.Huge Vacancies in Faculty Positions and workload: In the report, the Health Panel, headed by Samajwadi Party leader and Rajya Sabha member Ram Gopal Yadav, has expressed concern regarding the huge shortage of staff, especially teaching faculty at premier medical institutes like AIIMS Delhi, Vardhman Mahavir Medical College (VMMC), Lady Hardinge Medical College (LHMC), Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) etc.The committee recorded that around 37.75 per cent of faculty and 31.52 per cent non-faculty positions were vacant across the new and established AIIMS institutes across the country.In the case of LHMC, New Delhi, the report revealed that out of a sanctioned strength of 2,225 posts, 652 posts (nearly 29%) remain vacant in the institution, with particularly alarming shortages in critical and supervisory categories such as Tutors in the College of Nursing (91% vacancy), Administrative Officer (100%), Radiotherapy Technologist (100%), OT Technicians and related cadres (70–80%), Nursing Officers (31%), and Doctors in the Teaching Cadre (21%).&quot;Such extensive vacancies, especially in teaching, nursing, and technical posts directly linked to patient care and academic delivery, are likely to adversely affect hospital efficiency, quality of clinical services, research productivity, and faculty workload,&quot; the panel observed in its report.Regarding ABVIMS, the panel noted in the report that there is a vacancy of 47.4% among senior residents. Non-joining of residents at VMMC: The committee was informed that in the year 2023, a total of 41 candidates for the posts of Senior Residents did not join the institute out of the 305 selected candidates. In the year 2024, the recruitment was delayed and shifted to year 2025. In 2025, two recruitments were done, and a total of 52 out of 376 Candidates did not join in the first recruitment, whereas the second recruitment is currently ongoing.In the report, the panel noted that the candidates who did not join the institute cited reasons for not joining the institute, such as selection in other institutions of choice, preparation for super speciality courses, excessive workloads, and opportunities abroad with better emoluments. The committee estimated that a large percentage of resignations is due to working conditions, pay scales, or career progression issues.Committee Expresses Concern over Burnout Risks of Resident Doctors:Referring to extensive vacancies, especially in teaching, nursing, and technical posts, the committee opined that such vacancies are directly linked to patient care and academic delivery, are likely to adversely affect hospital efficiency, quality of clinical services, research productivity, and faculty workload.It noted that persistent human resource shortages, coupled with unregulated and alarmingly prolonged working hours of Junior and Senior Residents, sometimes stretching up to 24-36 hours, pose serious risks to both healthcare providers and patients.According to the panel, excessive continuous duty hours for Junior and Senior Residents result in a risk of clinical errors and burnout, thereby compromising patient safety.Therefore, the committee has recommended implementing a mandatory working-hour regulatory framework for Resident Doctors to minimize fatigue-induced clinical errors and to safeguard their mental and physical well-being, drawing an analogy from regulated working-hour norms in other critical sectors such as fatigue management protocols used for commercial pilots in civil aviation.&quot;The Committee, therefore, recommends that the Department formulate and strictly enforce a &quot;Clinical Duty Hours Regulation&quot; policy with mandatory rest periods, and monitored rosters, drawing a direct analogy from other safety-critical professions like civil aviation to prevent fatigue-induced accidents,&quot; it recommended.&quot;The presence of senior faculty should be ensured in wards and in operating theatres during peak hours by aligning faculty schedules with clinical demand and by appointing designated supervisory rosters. Structured mentorship and protected teaching time should be introduced so that trainees gain supervised clinical experience rather than learning by trial. Additionally, to ensure the retention of high-quality talent, the Committee recommends that medical professionals be provided with improved working conditions, including accommodation, transportation, and administrative support, on par with the facilities afforded to senior civil servants, and transparent career progression with time-bound promotions. The Committee also suggests the integration of Yoga and the Indian Knowledge System (IKS) within the workforce to address the rising incidence of depression and psychiatric issues among the medical community,&quot; the panel further suggested in the report.How to Retain Doctors? Committee&#039;s Recommendations:Meanwhile, addressing the issue of vacancies, the committee has suggested several measures to retain doctors at the medical institutes to tackle the workload. It recommended adopting a time-bound, mission-mode approach to clear all pending vacancies, including those on hold due to court cases, non-finalisation of Recruitment Rules, or absence of feeder cadres. Apart from this, the panel also recommended strengthening the manpower availability by instituting an independent study so that recruitment of specialist doctors is done on a larger scale to provide adequate health support to the patients and to prevent backlog and overcrowding.Additionally, the panel also recommended other measures such as improving the working conditions, including adequate accommodation, transport facilities, career progression avenues, and structured leadership opportunities for doctors with managerial qualifications, to retain and motivate doctors.&quot;The Committee further observes that faculty members are currently burdened with excessive academic, clinical, examination, and research responsibilities due to vacant teaching posts, even though the student-teacher ratio may formally meet regulatory norms. Given the substantial clinical workload and implementation of multiple national health programmes, the Department should ensure expeditious filling of teaching cadre posts and strengthen supportive administrative structures to enable faculty to focus on academic excellence and patient care. In addition, improved working conditions, including adequate accommodation, transport facilities, career progression avenues, and structured leadership opportunities for doctors with managerial qualifications, may be considered to enhance retention and motivation,&quot; it observed.Regarding the high rate of non-joining and frequent resignations among medical professionals, the committee has recommended that the Department must transition from simple recruitment to a holistic retention strategy. It recommended beginning a data-driven &quot;Exit and Non-Joiner Survey&quot; to precisely identify why candidates prefer other institutes or opportunities abroad. For specialized technical cadres currently facing up to 100% vacancy, the Department should introduce &quot;Targeted Lateral Entry&quot; and clear career progression pathways.While the committee has opined that contractual engagement may be used as a short-term stop-gap arrangement, it has also opined that it should not substitute regular appointments, as excessive reliance on contractual staff may dilute institutional accountability and continuity.Instead, the panel has recommended adopting a &quot;Total Support model for medical professionals&quot; to attract and and retain qualified doctors and specialists in the public health system.Also Read: 300 medicos leave PG seats in Maha, 25 suicides reported- Doctors flag 24-36 hour duties as systemic failure ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/09/04/299843-duty-hours2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Doctors, burnout, due, 24-36, hour, shifts, Parliamentary, panel, calls, for, Clinical, Duty, hour, regulation, policy, with, mandatory, rest, monitored, rosters</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/09/04/299843-duty-hours2.webp"><p><b>New Delhi:</b> Taking note of the huge vacancies in the posts of faculty members and residents at the central government medical institutes, a Parliamentary Committee on Health has expressed concern about the excessive workload of doctors.</p><p>Highlighting the possibility of clinical errors and burnout resulting in compromised patient safety, the panel has recommended formulating and strictly enforcing a "Clinical <a href="https://medicaldialogues.in/topics/duty-hours">Duty Hours</a> Regulation" policy with mandatory rest periods and monitored rosters.</p><p>These recommendations were presented before the Parliament by the Department-related Parliamentary Committee on Health and Family Welfare in its 172nd report.</p><p><b>Huge Vacancies in Faculty Positions and workload:</b> </p><p>In the report, the Health Panel, headed by Samajwadi Party leader and Rajya Sabha member Ram Gopal Yadav, has expressed concern regarding the huge shortage of staff, especially teaching faculty at premier medical institutes like AIIMS Delhi, Vardhman Mahavir Medical College (VMMC), <a href="https://medicaldialogues.in/topics/LHMC">Lady Hardinge Medical College (LHMC)</a>, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) etc.</p><p>The committee recorded that around 37.75 per cent of faculty and 31.52 per cent non-faculty positions were vacant across the new and established AIIMS institutes across the country.</p><p>In the case of LHMC, New Delhi, the report revealed that out of a sanctioned strength of 2,225 posts, 652 posts (nearly 29%) remain vacant in the institution, with particularly alarming shortages in critical and supervisory categories such as Tutors in the College of Nursing (91% vacancy), Administrative Officer (100%), Radiotherapy Technologist (100%), OT Technicians and related cadres (70–80%), Nursing Officers (31%), and Doctors in the Teaching Cadre (21%).</p><p>"Such extensive vacancies, especially in teaching, nursing, and technical posts directly linked to patient care and academic delivery, are likely to adversely affect hospital efficiency, quality of clinical services, research productivity, and faculty workload," the panel observed in its report.</p><p>Regarding ABVIMS, the panel noted in the report that there is a vacancy of 47.4% among senior residents. </p><p><b>Non-joining of residents at VMMC:</b> </p><p>The committee was informed that in the year 2023, a total of 41 candidates for the posts of Senior Residents did not join the institute out of the 305 selected candidates. In the year 2024, the recruitment was delayed and shifted to year 2025. In 2025, two recruitments were done, and a total of 52 out of 376 Candidates did not join in the first recruitment, whereas the second recruitment is currently ongoing.</p><p>In the report, the panel noted that the candidates who did not join the institute cited reasons for not joining the institute, such as selection in other institutions of choice, preparation for super speciality courses, excessive workloads, and opportunities abroad with better emoluments. The committee estimated that a large percentage of resignations is due to working conditions, pay scales, or career progression issues.</p><p><b>Committee Expresses Concern over Burnout Risks of Resident Doctors:</b></p><p>Referring to extensive vacancies, especially in teaching, nursing, and technical posts, the committee opined that such vacancies are directly linked to patient care and academic delivery, are likely to adversely affect hospital efficiency, quality of clinical services, research productivity, and faculty workload.</p><p>It noted that persistent human resource shortages, coupled with unregulated and alarmingly prolonged working hours of Junior and Senior Residents, sometimes stretching up to 24-36 hours, pose serious risks to both healthcare providers and patients.</p><p>According to the panel, excessive continuous duty hours for Junior and Senior Residents result in a risk of clinical errors and burnout, thereby compromising patient safety.</p><p>Therefore, the committee has recommended implementing a mandatory working-hour regulatory framework for Resident Doctors to minimize fatigue-induced clinical errors and to safeguard their mental and physical well-being, drawing an analogy from regulated working-hour norms in other critical sectors such as fatigue management protocols used for commercial pilots in civil aviation.</p><p>"The Committee, therefore, recommends that the Department formulate and strictly enforce a "Clinical Duty Hours Regulation" policy with mandatory rest periods, and monitored rosters, drawing a direct analogy from other safety-critical professions like civil aviation to prevent fatigue-induced accidents," it recommended.</p><p>"The presence of senior faculty should be ensured in wards and in operating theatres during peak hours by aligning faculty schedules with clinical demand and by appointing designated supervisory rosters. Structured mentorship and protected teaching time should be introduced so that trainees gain supervised clinical experience rather than learning by trial. Additionally, to ensure the retention of high-quality talent, the Committee recommends that medical professionals be provided with improved working conditions, including accommodation, transportation, and administrative support, on par with the facilities afforded to senior civil servants, and transparent career progression with time-bound promotions. The Committee also suggests the integration of Yoga and the Indian Knowledge System (IKS) within the workforce to address the rising incidence of depression and psychiatric issues among the medical community," the panel further suggested in the report.</p><p><b>How to Retain Doctors? Committee's Recommendations:</b></p><p>Meanwhile, addressing the issue of vacancies, the committee has suggested several measures to retain doctors at the medical institutes to tackle the workload. It recommended adopting a time-bound, mission-mode approach to clear all pending vacancies, including those on hold due to court cases, non-finalisation of Recruitment Rules, or absence of feeder cadres. Apart from this, the panel also recommended strengthening the manpower availability by instituting an independent study so that recruitment of specialist doctors is done on a larger scale to provide adequate health support to the patients and to prevent backlog and overcrowding.</p><p>Additionally, the panel also recommended other measures such as improving the working conditions, including adequate accommodation, transport facilities, career progression avenues, and structured leadership opportunities for doctors with managerial qualifications, to retain and motivate doctors.</p><p>"The Committee further observes that faculty members are currently burdened with excessive academic, clinical, examination, and research responsibilities due to vacant teaching posts, even though the student-teacher ratio may formally meet regulatory norms. Given the substantial clinical workload and implementation of multiple national health programmes, the Department should ensure expeditious filling of teaching cadre posts and strengthen supportive administrative structures to enable faculty to focus on academic excellence and patient care. In addition, improved working conditions, including adequate accommodation, transport facilities, career progression avenues, and structured leadership opportunities for doctors with managerial qualifications, may be considered to enhance retention and motivation," it observed.</p><p>Regarding the high rate of non-joining and frequent resignations among medical professionals, the committee has recommended that the Department must transition from simple recruitment to a holistic retention strategy. It recommended beginning a data-driven "Exit and Non-Joiner Survey" to precisely identify why candidates prefer other institutes or opportunities abroad. </p><p>For specialized technical cadres currently facing up to 100% vacancy, the Department should introduce "Targeted Lateral Entry" and clear career progression pathways.</p><p>While the committee has opined that contractual engagement may be used as a short-term stop-gap arrangement, it has also opined that it should not substitute regular appointments, as excessive reliance on contractual staff may dilute institutional accountability and continuity.</p><p>Instead, the panel has recommended adopting a "Total Support model for medical professionals" to attract and and retain qualified doctors and specialists in the public health system.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/300-medicos-leave-pg-seats-in-maha-25-suicides-reported-doctors-flag-24-36-hour-duties-as-systemic-failure-167666"><b>Also Read: 300 medicos leave PG seats in Maha, 25 suicides reported- Doctors flag 24-36 hour duties as systemic failure</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Tax Setback for GSK as IT Dept Raises Rs 2.01 Crore TDS Demand</title>
<link>https://edusehat.com/en/tax-setback-for-gsk-as-it-dept-raises-rs-201-crore-tds-demand</link>
<guid>https://edusehat.com/en/tax-setback-for-gsk-as-it-dept-raises-rs-201-crore-tds-demand</guid>
<description><![CDATA[ New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) Limited has received a final assessment order from the Income Tax Department raising a total TDS demand liability of Rs 2.01 crore for the assessment year 2020-21, comprising Rs 1.11 crore towards TDS and Rs 0.90 crore as interest, and is set to file an appeal against the order.The order has been issued by the TDS Authority, INT Tax Circle 2(3)(2), under Sections 201(1) and 201(1A) of the Income Tax Act, 1961, through an assessment order dated March 31, 2026. The demand pertains to an alleged TDS default under Section 201 of the Act.While the company has not specified the nature of the alleged violation, it has confirmed that it is contesting the assessment order and is in the process of approaching the appropriate appellate authority.Also Read: GSK Pharma Slapped Rs 23.21 Crore Tax Demand, Plans AppealGlaxoSmithKline Pharmaceuticals clarified that there will be no impact on its financial statements at this stage, given that the matter is under dispute and subject to appeal.The disclosure was made to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed entities to report material regulatory actions and developments.The company emphasized that it will take necessary legal steps in accordance with applicable laws while addressing the issue and pursuing relief through the appellate mechanism.Also Read: GST Blow: Maharashtra Authorities Slap Rs 6.92 Crore Tax Demand on GSK Pharma ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/24/295590-gsk-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Tax, Setback, for, GSK, Dept, Raises, 2.01, Crore, TDS, Demand</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/24/295590-gsk-50.webp"><p><b>New Delhi: </b>GlaxoSmithKline Pharmaceuticals (GSK) Limited has received a final assessment order from the Income Tax Department raising a total TDS demand liability of Rs 2.01 crore for the assessment year 2020-21, comprising Rs 1.11 crore towards TDS and Rs 0.90 crore as interest, and is set to file an appeal against the order.</p><div class="pasted-from-word-wrapper"><p>The order has been issued by the TDS Authority, INT Tax Circle 2(3)(2), under Sections 201(1) and 201(1A) of the Income Tax Act, 1961, through an assessment order dated March 31, 2026. The demand pertains to an alleged TDS default under Section 201 of the Act.</p><p>While the company has not specified the nature of the alleged violation, it has confirmed that it is contesting the assessment order and is in the process of approaching the appropriate appellate authority.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gsk-pharma-slapped-rs-2321-crore-tax-demand-plans-appeal-167537">Also Read: GSK Pharma Slapped Rs 23.21 Crore Tax Demand, Plans Appeal</a></div></div><p>GlaxoSmithKline Pharmaceuticals clarified that there will be no impact on its financial statements at this stage, given that the matter is under dispute and subject to appeal.</p><p>The disclosure was made to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed entities to report material regulatory actions and developments.</p><p>The company emphasized that it will take necessary legal steps in accordance with applicable laws while addressing the issue and pursuing relief through the appellate mechanism.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/gst-blow-maharashtra-authorities-slap-rs-692-crore-tax-demand-on-gsk-pharma-166241">Also Read: GST Blow: Maharashtra Authorities Slap Rs 6.92 Crore Tax Demand on GSK Pharma</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Govt Rules Out &amp;apos;One Nation, One Price&amp;apos; for Medical Devices, Says Price Caps Already in Place</title>
<link>https://edusehat.com/en/govt-rules-out-one-nation-one-price-for-medical-devices-says-price-caps-already-in-place</link>
<guid>https://edusehat.com/en/govt-rules-out-one-nation-one-price-for-medical-devices-says-price-caps-already-in-place</guid>
<description><![CDATA[ New Delhi: The Government has stated that there is currently no proposal under consideration to implement a &quot;One Nation, One Price&quot; framework for essential medical devices, even as it continues to regulate prices to curb high trade margins and ensure affordability.Responding to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilizers, Anupriya Patel, said that the issue of high trade margins in essential medical devices such as coronary stents and knee implants has been addressed through existing regulatory mechanisms.The National Pharmaceutical Pricing Authority (NPPA), functioning under the Department of Pharmaceuticals, fixes ceiling prices of drugs and medical devices listed under the National List of Essential Medicines (NLEM) and incorporated in Schedule I of the Drugs (Prices Control) Order, 2013. Coronary stents, including Bare Metal Stents (BMS) and Drug Eluting Stents (DES), are covered under this framework. The current ceiling prices are ₹10,692.69 for BMS and ₹38,933.14 for DES, applicable nationwide.The government has mandated that all manufacturers, importers, and marketers adhere strictly to these ceiling prices, excluding applicable GST. Hospitals and healthcare institutions performing angioplasty procedures are also required to comply with these price caps and must clearly mention details such as stent category, brand name, manufacturer, batch number, and cost in patient bills.Also Read: NPPA Panel Recommends 5-Year Price Control Exemption for Intas&#039; Clozapine ER CapsulesAdditionally, the NPPA has capped prices for orthopaedic knee implants since August 2017, a measure that has been extended until November 15, 2026, or until further orders. During the COVID-19 pandemic, trade margins on devices such as pulse oximeters, blood pressure monitors, nebulizers, digital thermometers, and glucometers were also regulated under trade margin rationalisation provisions.For non-scheduled medical devices, manufacturers are not allowed to increase the maximum retail price by more than 10% within a 12-month period. The NPPA continuously monitors pricing and takes action against overcharging based on complaints, market data, and inputs from state-level monitoring units.The reply clarified that while multiple regulatory measures are in place to control pricing and prevent profiteering, the government is not currently considering a uniform nationwide pricing model for all essential medical devices.Also Read: NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/19/230532-medical-device-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Govt, Rules, Out, One, Nation, One, Price, for, Medical, Devices, Says, Price, Caps, Already, Place</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/19/230532-medical-device-50.webp"><p><b>New Delhi:</b> The Government has stated that there is currently no proposal under consideration to implement a "One Nation, One Price" framework for essential medical devices, even as it continues to regulate prices to curb high trade margins and ensure affordability.</p><div class="pasted-from-word-wrapper"><p>Responding to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilizers, Anupriya Patel, said that the issue of high trade margins in essential medical devices such as coronary stents and knee implants has been addressed through existing regulatory mechanisms.</p><p>The National Pharmaceutical Pricing Authority (NPPA), functioning under the Department of Pharmaceuticals, fixes ceiling prices of drugs and medical devices listed under the National List of Essential Medicines (NLEM) and incorporated in Schedule I of the Drugs (Prices Control) Order, 2013. Coronary stents, including Bare Metal Stents (BMS) and Drug Eluting Stents (DES), are covered under this framework. The current ceiling prices are ₹10,692.69 for BMS and ₹38,933.14 for DES, applicable nationwide.</p><p>The government has mandated that all manufacturers, importers, and marketers adhere strictly to these ceiling prices, excluding applicable GST. Hospitals and healthcare institutions performing angioplasty procedures are also required to comply with these price caps and must clearly mention details such as stent category, brand name, manufacturer, batch number, and cost in patient bills.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/nppa-panel-recommends-5-year-price-control-exemption-for-intas-clozapine-er-capsules-166047">Also Read: NPPA Panel Recommends 5-Year Price Control Exemption for Intas' Clozapine ER Capsules</a></div></div><p>Additionally, the NPPA has capped prices for orthopaedic knee implants since August 2017, a measure that has been extended until November 15, 2026, or until further orders. During the COVID-19 pandemic, trade margins on devices such as pulse oximeters, blood pressure monitors, nebulizers, digital thermometers, and glucometers were also regulated under trade margin rationalisation provisions.</p><p>For non-scheduled medical devices, manufacturers are not allowed to increase the maximum retail price by more than 10% within a 12-month period. The NPPA continuously monitors pricing and takes action against overcharging based on complaints, market data, and inputs from state-level monitoring units.</p><p>The reply clarified that while multiple regulatory measures are in place to control pricing and prevent profiteering, the government is not currently considering a uniform nationwide pricing model for all essential medical devices.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/nppa-fixes-retail-rates-for-36-key-drugs-like-atorvastatin-dapagliflozin-gemcitabine-163891">Also Read: NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Zydus Healthcare Asked to Revise Phase IV Protocol for Empagliflozin&#45;Metformin Tablets</title>
<link>https://edusehat.com/en/zydus-healthcare-asked-to-revise-phase-iv-protocol-for-empagliflozin-metformin-tablets</link>
<guid>https://edusehat.com/en/zydus-healthcare-asked-to-revise-phase-iv-protocol-for-empagliflozin-metformin-tablets</guid>
<description><![CDATA[ New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked for revisions in the Phase IV clinical trial protocol submitted by Zydus Healthcare Limited for its fixed-dose combination (FDC) of Empagliflozin and Metformin Hydrochloride (ER) tablets.The committee opined that the firm should revise the amended inclusion criteria and provide the justification for the use of the same strength of medications as FDC in patients with uncontrolled diabetes as mentioned in point number 3 of the inclusion criteria.This came after Zydus Healthcare presented the revised Phase IV clinical trial protocol before the committee.The vast majority of glucose filtered through the glomerulus is reabsorbed within the proximal tubule, primarily via SGLT2 (sodium-glucose linked co-transporter-2) which is responsible for ~90% of the total glucose reabsorption within the kidneys. Metformin is a biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS).Based on these observations, the SEC recommended the following: &quot; The firm should submit the revised Phase IV CT protocol to CDSCO for further review by the committee.&quot; ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/11/197471-zydus-lifesciences-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Zydus, Healthcare, Asked, Revise, Phase, Protocol, for, Empagliflozin-Metformin, Tablets</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/11/197471-zydus-lifesciences-3.webp"><p><b>New Delhi:</b> The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked for revisions in the Phase IV clinical trial protocol submitted by Zydus Healthcare Limited for its fixed-dose combination (FDC) of Empagliflozin and Metformin Hydrochloride (ER) tablets.</p><div class="pasted-from-word-wrapper"><p>The committee opined that the firm should revise the amended inclusion criteria and provide the justification for the use of the same strength of medications as FDC in patients with uncontrolled diabetes as mentioned in point number 3 of the inclusion criteria.</p><p>This came after Zydus Healthcare presented the revised Phase IV clinical trial protocol before the committee.</p><p>The vast majority of glucose filtered through the glomerulus is reabsorbed within the proximal tubule, primarily via SGLT2 (sodium-glucose linked co-transporter-2) which is responsible for ~90% of the total glucose reabsorption within the kidneys.</p><p> Metformin is a biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS).</p><p>Based on these observations, the SEC recommended the following: </p><p>" The firm should submit the revised Phase IV CT protocol to CDSCO for further review by the committee."</p></div>]]> </content:encoded>
</item>

<item>
<title>Maharashtra Govt to recruit 5,000 doctors and healthcare staff amid shortage</title>
<link>https://edusehat.com/en/maharashtra-govt-to-recruit-5000-doctors-and-healthcare-staff-amid-shortage</link>
<guid>https://edusehat.com/en/maharashtra-govt-to-recruit-5000-doctors-and-healthcare-staff-amid-shortage</guid>
<description><![CDATA[ Mumbai: Amid a shortage of doctors and
specialists across several healthcare facilities, the Maharashtra government has announced plans to recruit 5,000
doctors and healthcare personnel. The announcement was made by Health Minister
Prakash Abitkar on Wednesday.Also Read:Maharashtra: Over 200 health centres remain non-functional amid fund crunchThe health department has
been facing a persistent shortage of medical professionals, affecting the
functioning of many facilities. To improve healthcare services in rural areas,
450 medical officers have already been appointed, while the process to recruit
another 1,500 medical officers is currently underway, reports Hindustan Times.

According to The Daily,
the minister said the initiative is aimed at making both newly constructed and
currently non-functional healthcare centres operational. Speaking to reporters
during the ‘My Village, Healthy Village’ campaign in Pune, Abitkar noted that
several health institutions, including First Referral Units (FRUs), are not
functioning because of a lack of doctors, while some recently built facilities
have yet to begin operations for the same reason.

“The proposal for
appointing 5,000 doctors and staff is currently with the High-Power Committee.
Approval is expected within a couple of months, after which the manpower will
be deployed at these facilities. All non-functional and new healthcare centres will
be made operational before the monsoon,” Abitkar said. Speaking at the event,
Abitkar said the campaign advocates for prevention over treatment to improve healthcare habits. Having faith in the positive outcome of the initiative
and collective effort, he affirmed that the initiative has received a positive
response throughout the district.

The campaign utilises community
participation and preventive measures to improve rural healthcare this
week. Senior officials, including principal secretary (health) Dr Nipun
Vinayak, secretary E Ravindran, urban commissioner Dr Sunil Bhokare, Pune Zilla
Parishad CEO Gajanan Patil, and director of health services Dr Nitin Ambadekar,
among others, attended the program.Also Read:BJ medical college Pune nursing, paramedical students protest over hostel rules, alleged harassment ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/08/31/250433-doctors-shortage.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Maharashtra, Govt, recruit, 5, 000, doctors, and, healthcare, staff, amid, shortage</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/08/31/250433-doctors-shortage.webp"><p>Mumbai: Amid a <a href="https://medicaldialogues.in/topics/shortage-of-doctors" target="_blank">shortage of doctors</a> and
specialists across several healthcare facilities, the Maharashtra government has announced plans to recruit 5,000
doctors and healthcare personnel. The announcement was made by Health Minister
<a href="https://medicaldialogues.in/topics/prakash-abitkar" target="_blank">Prakash Abitkar</a> on Wednesday.<br></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/news/health/hospital-diagnostics/maharashtra-over-200-health-centres-remain-non-functional-amid-fund-crunch-148575"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2022/12/12/193544-primary-health-centers.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/maharashtra-over-200-health-centres-remain-non-functional-amid-fund-crunch-148575"><span class="read-this-also">Also Read:</span>Maharashtra: Over 200 health centres remain non-functional amid fund crunch</a><div></div></div></div><p>The health department has
been facing a persistent shortage of medical professionals, affecting the
functioning of many facilities. To improve healthcare services in rural areas,
450 medical officers have already been appointed, while the process to recruit
another 1,500 medical officers is currently underway, reports <a href="https://www.hindustantimes.com/cities/pune-news/health-dept-to-appoint-5-000-doctors-staff-to-revive-non-functional-facilities-101775072499836.html" target="_blank" rel="nofollow">Hindustan Times</a>.</p><div class="pasted-from-word-wrapper">

<p>According to The Daily,
the minister said the initiative is aimed at making both newly constructed and
currently non-functional healthcare centres operational. Speaking to reporters
during the ‘My Village, Healthy Village’ campaign in Pune, Abitkar noted that
several health institutions, including First Referral Units (FRUs), are not
functioning because of a lack of doctors, while some recently built facilities
have yet to begin operations for the same reason.</p>

<p>“The proposal for
appointing 5,000 doctors and staff is currently with the High-Power Committee.
Approval is expected within a couple of months, after which the manpower will
be deployed at these facilities. All non-functional and new healthcare centres will
be made operational before the monsoon,” Abitkar said. Speaking at the event,
Abitkar said the campaign advocates for prevention over treatment to improve healthcare habits. Having faith in the positive outcome of the initiative
and collective effort, he affirmed that the initiative has received a positive
response throughout the district.</p>

<p>The campaign utilises community
participation and preventive measures to improve rural healthcare this
week. Senior officials, including principal secretary (health) Dr Nipun
Vinayak, secretary E Ravindran, urban commissioner Dr Sunil Bhokare, Pune Zilla
Parishad CEO Gajanan Patil, and director of health services Dr Nitin Ambadekar,
among others, attended the program.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/maharashtra/bj-medical-college-pune-nursing-paramedical-students-protest-over-hostel-rules-alleged-harassment-167770"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/01/09/320248-protest-2.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/bj-medical-college-pune-nursing-paramedical-students-protest-over-hostel-rules-alleged-harassment-167770"><span class="read-this-also">Also Read:</span>BJ medical college Pune nursing, paramedical students protest over hostel rules, alleged harassment</a></div></div>]]> </content:encoded>
</item>

<item>
<title>USFDA Raises Safety Alert on Amgen&amp;apos;s Tavneos After Liver Injury, Death Cases Surface</title>
<link>https://edusehat.com/en/usfda-raises-safety-alert-on-amgens-tavneos-after-liver-injury-death-cases-surface</link>
<guid>https://edusehat.com/en/usfda-raises-safety-alert-on-amgens-tavneos-after-liver-injury-death-cases-surface</guid>
<description><![CDATA[ Bengaluru: The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen&#039;s drug for a group of rare autoimmune diseases and urged healthcare providers to closely monitor patients and discontinue the treatment promptly if liver damage is suspected.The agency said it ‌had identified ⁠76 cases ⁠of drug-induced liver injury with evidence suggesting a causal link to Tavneos, including seven cases of vanishing bile duct syndrome, a rare condition that can cause permanent liver damage. Eight deaths were reported among those cases.The safety warning adds to mounting regulatory scrutiny of Tavneos, which is approved to ​treat anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, a group ⁠of rare autoimmune ‌diseases that cause inflammation in small- to medium-sized ​blood vessels.Also Read: USFDA warns pharma cos to remove misleading adsIn ​January, Amgen said the FDA had asked the ⁠company to voluntarily withdraw the drug after concerns emerged ​during a re-evaluation of primary endpoint data for nine ​of the 331 patients enrolled in the late-stage trial supporting its approval.Amgen declined to withdraw the drug, saying at the time it was not aware of any issues with the underlying patient data, remained confident in Tavneos&#039; benefit-risk profile and was working with the ‌FDA on next steps.The FDA said the median time to onset of drug-induced liver injury was 46 ​days after ​starting treatment.While Tavneos ⁠labels in Europe and Australia mention post-marketing cases of vanishing bile duct syndrome, the U.S. prescribing information does not currently warn of it, according to ​the FDA&#039;s website.In January, the European Medicines Agency said it started a review of Tavneos, &quot;following emerging information that raises questions regarding the data integrity (of its study).&quot;The FDA approved Tavneos in 2021. Also Read: USFDA Warns of Mix-Ups After Reports of Wrong Epinephrine Injections ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/01/22/230681-amgen-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>USFDA, Raises, Safety, Alert, Amgens, Tavneos, After, Liver, Injury, Death, Cases, Surface</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/01/22/230681-amgen-50.webp"><p><b>Bengaluru</b>: The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking <a href="https://medicaldialogues.in/topics/Amgen" target="_blank">Amgen</a>'s drug for a group of rare autoimmune diseases and urged healthcare providers to closely monitor patients and discontinue the treatment promptly if liver damage is suspected.</p><div class="pasted-from-word-wrapper"><p>The agency said it ‌had identified ⁠76 cases ⁠of drug-induced liver injury with evidence suggesting a causal link to <a href="https://medicaldialogues.in/topics/Tavneos" target="_blank">Tavneos</a>, including seven cases of vanishing bile duct syndrome, a rare condition that can cause permanent liver damage. Eight deaths were reported among those cases.</p><p>The safety warning adds to mounting regulatory scrutiny of Tavneos, which is approved to ​treat anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, a group ⁠of rare autoimmune ‌diseases that cause inflammation in small- to medium-sized ​blood vessels.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/usfda-warns-pharma-cos-to-remove-misleading-ads-155054">Also Read: USFDA warns pharma cos to remove misleading ads</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>In ​January, Amgen said the FDA had asked the ⁠company to voluntarily withdraw the drug after concerns emerged ​during a re-evaluation of primary endpoint data for nine ​of the 331 patients enrolled in the late-stage trial supporting its approval.</p><p>Amgen declined to withdraw the drug, saying at the time it was not aware of any issues with the underlying patient data, remained confident in Tavneos' benefit-risk profile and was working with the ‌FDA on next steps.</p><p>The FDA said the median time to onset of drug-induced liver injury was 46 ​days after ​starting treatment.</p><p>While Tavneos ⁠labels in Europe and Australia mention post-marketing cases of vanishing bile duct syndrome, the U.S. prescribing information does not currently warn of it, according to ​the FDA's website.</p><p>In January, the European Medicines Agency said it started a review of Tavneos, "following emerging information that raises questions regarding the data integrity (of its study)."</p><p>The FDA approved Tavneos in 2021. </p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/usfda-warns-of-mix-ups-after-reports-of-wrong-epinephrine-injections-141770">Also Read: USFDA Warns of Mix-Ups After Reports of Wrong Epinephrine Injections</a></p></div></div><div class="pasted-from-word-wrapper"><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>CDSCO Orders Strict Regulation of IVF, ART Medical Devices, Bars Unlicensed Sale</title>
<link>https://edusehat.com/en/cdsco-orders-strict-regulation-of-ivf-art-medical-devices-bars-unlicensed-sale</link>
<guid>https://edusehat.com/en/cdsco-orders-strict-regulation-of-ivf-art-medical-devices-bars-unlicensed-sale</guid>
<description><![CDATA[ New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has directed strict regulatory oversight on the import, manufacture, sale, and distribution of medical devices used in In Vitro Fertilization (IVF) and Assisted Reproductive Technology (ART) procedures.The directive highlights that all medical devices are regulated under the provisions of the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017, and require appropriate licensing for import, manufacturing, sale, and distribution, except for Class A non-sterile and non-measuring medical devices.It further clarifies that devices used in IVF procedures—including IUI (Intrauterine Insemination) kits and centrifuges for sperm washing—fall within the definition of medical devices under the existing regulatory framework.The CDSCO has taken note of instances where firms are selling medical devices intended for In Vitro Fertilization viz., IUI (Intrauterine Insemination) kits, centrifuges for sperm washing, etc., used for Assisted Reproductive Technology related procedures without obtaining license from the licensing authority under the Medical Devices Rules, 2017.Also Read: Health Ministry Appoints 27 Government Analysts as Medical Device Testing OfficersIn response, the apex drug regulator has instructed all State and Union Territory drug control and licensing authorities to maintain strict vigilance and ensure that no such devices are imported, manufactured, distributed, or sold without compliance with the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017.The notice concluded by directing all State/UT Drugs Control and Licensing Authorities, Zonal, Sub-Zonal and Port Offices of the Central Drugs Standard Control Organization (CDSCO), as well as stakeholders through its official website, stating,&quot;You are requested to keep strict vigil &amp; ensure that no such devices used for In Vitro Fertilization for Assisted Reproductive Technology related procedures are being imported, manufactured, distributed, sold without bidance to the Drugs and Cosmetics Act,1940 and Medical Devices Rules, 2017.&quot;The circular has been addressed to all State/UT Drugs Control and Licensing Authorities, along with all Zonal, Sub-Zonal, and Port Offices of CDSCO. It has also been shared with stakeholders via the CDSCO website for wider awareness and compliance.To view the official notice, click the link below:https://medicaldialogues.in/pdf_upload/2026/04/04/circular-27032026-339570.pdfAlso Read: Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical Devices Rules ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/09/22/253763-cdsco-notice.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>CDSCO, Orders, Strict, Regulation, IVF, ART, Medical, Devices, Bars, Unlicensed, Sale</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/09/22/253763-cdsco-notice.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has directed strict regulatory oversight on the import, manufacture, sale, and distribution of medical devices used in In Vitro Fertilization (IVF) and Assisted Reproductive Technology (ART) procedures.</p></div><div class="pasted-from-word-wrapper"><p>The directive highlights that all medical devices are regulated under the provisions of the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017, and require appropriate licensing for import, manufacturing, sale, and distribution, except for Class A non-sterile and non-measuring medical devices.</p><p>It further clarifies that devices used in IVF procedures—including IUI (Intrauterine Insemination) kits and centrifuges for sperm washing—fall within the definition of medical devices under the existing regulatory framework.</p><p>The CDSCO has taken note of instances where firms are selling medical devices intended for In Vitro Fertilization viz., IUI (Intrauterine Insemination) kits, centrifuges for sperm washing, etc., used for Assisted Reproductive Technology related procedures without obtaining license from the licensing authority under the Medical Devices Rules, 2017.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/medical-devices/health-ministry-appoints-27-government-analysts-as-medical-device-testing-officers-165247">Also Read: Health Ministry Appoints 27 Government Analysts as Medical Device Testing Officers</a></div><p>In response, the apex drug regulator has instructed all State and Union Territory drug control and licensing authorities to maintain strict vigilance and ensure that no such devices are imported, manufactured, distributed, or sold without compliance with the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017.</p><p>The notice concluded by directing all State/UT Drugs Control and Licensing Authorities, Zonal, Sub-Zonal and Port Offices of the Central Drugs Standard Control Organization (CDSCO), as well as stakeholders through its official website, stating,</p><blockquote>"You are requested to keep strict vigil & ensure that no such devices used for In Vitro Fertilization for Assisted Reproductive Technology related procedures are being imported, manufactured, distributed, sold without bidance to the Drugs and Cosmetics Act,1940 and Medical Devices Rules, 2017."</blockquote><p>The circular has been addressed to all State/UT Drugs Control and Licensing Authorities, along with all Zonal, Sub-Zonal, and Port Offices of CDSCO. It has also been shared with stakeholders via the CDSCO website for wider awareness and compliance.</p><p><b><i>To view the official notice, click the link below:</i></b></p><div class="hocal-draggable" draggable="true"><a href="https://medicaldialogues.in/pdf_upload/2026/04/04/circular-27032026-339570.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/04/04/circular-27032026-339570.pdf</a></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/health-ministry-notifies-new-qualification-norms-for-inspectors-government-analysts-under-medical-devices-rules-167044">Also Read: Health Ministry Notifies New Qualification Norms for Inspectors, Government Analysts Under Medical Devices Rules</a></div></div>]]> </content:encoded>
</item>

<item>
<title>Ceiling collapses at NRS Medical College CCU, 12 critically ill patients escape</title>
<link>https://edusehat.com/en/ceiling-collapses-at-nrs-medical-college-ccu-12-critically-ill-patients-escape</link>
<guid>https://edusehat.com/en/ceiling-collapses-at-nrs-medical-college-ccu-12-critically-ill-patients-escape</guid>
<description><![CDATA[ Kolkata: In a disturbing incident, a portion of the ceiling collapsed inside the Critical Care Unit (CCU) of the Medicine Department at Nil Ratan Sircar (NRS) Medical College and Hospital on Friday, raising serious safety concerns about the infrastructure of government-run hospitals across West Bengal. The incident occurred in the UNB building of the hospital, where cracks had reportedly developed earlier across walls and pillars, indicating structural distress. Hospital sources said a portion of the ceiling gave way, damaging parts of the floor and raising alarm among patients and staff. At least 12 critically ill patients admitted to the CCU narrowly escaped injury.In response, authorities immediately shut down the CCU and shifted patients to other units within the hospital. Officials confirmed that no new admissions would be permitted in the affected section until repairs are carried out by the Public Works Department (PWD). Also Read:RG Kar medical college hostel ceiling collapse- intern escapes, students flag neglect, demand repairsThe latest incident comes close on the heels of the recent lift malfunction episode at R.G. Kar Medical College and Hospital, further intensifying scrutiny over maintenance and safety standards in state-run healthcare facilities. Reacting to the development, BJP IT cell head Amit Malviya questioned the state government’s handling of hospital infrastructure.In a statement, he alleged that repeated warnings were being ignored and asked how many lives would be put at risk before corrective measures are taken. The incident has also reignited political criticism directed at Chief Minister Mamata Banerjee, who also holds the Health portfolio. Opposition leaders have alleged that recurring infrastructural failures—from lift malfunctions to structural collapses—point to systemic negligence and lack of accountability, reports UNI.Hospital authorities, however, maintained that prompt action prevented any casualties and assured that necessary repairs would be undertaken on priority. An internal assessment of the building’s condition is also expected as part of follow-up measures. The episode has once again spotlighted the urgent need for regular safety audits and infrastructure upgrades in critical healthcare institutions across the state. Also Read:Mumbai&#039;s GT Hospital doctor injured after ceiling plaster falls ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339576-nrs.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Ceiling, collapses, NRS, Medical, College, CCU, critically, ill, patients, escape</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339576-nrs.webp"><div class="pasted-from-word-wrapper"><p><span>Kolkata: In a disturbing incident, a portion of the ceiling collapsed inside the Critical Care Unit (CCU) of the Medicine Department at <a href="https://medicaldialogues.in/topics/Nil-Ratan-Sircar-Medical-College-and-Hospital" target="_blank">Nil Ratan Sircar (NRS) Medical College and Hospital</a> on Friday, raising serious safety concerns about the infrastructure of government-run hospitals across West Bengal. </span></p><p>The incident occurred in the UNB building of the hospital, where cracks had reportedly developed earlier across walls and pillars, indicating structural distress. Hospital sources said a portion of the ceiling gave way, damaging parts of the floor and raising alarm among patients and staff. At least 12 critically ill patients admitted to the CCU narrowly escaped injury.</p><p>In response, authorities immediately shut down the CCU and shifted patients to other units within the hospital. Officials confirmed that no new admissions would be permitted in the affected section until repairs are carried out by the Public Works Department (PWD). </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-colleges/rg-kar-medical-college-hostel-ceiling-collapse-intern-escapes-students-flag-neglect-demand-repairs-167890"><b>Also Read:RG Kar medical college hostel ceiling collapse- intern escapes, students flag neglect, demand repairs</b></a></p><p>The latest incident comes close on the heels of the recent lift malfunction episode at R.G. Kar Medical College and Hospital, further intensifying scrutiny over maintenance and safety standards in state-run healthcare facilities. Reacting to the development, BJP IT cell head Amit Malviya questioned the state government’s handling of hospital infrastructure.</p><p>In a statement, he alleged that repeated warnings were being ignored and asked how many lives would be put at risk before corrective measures are taken. The incident has also reignited political criticism directed at Chief Minister <a href="https://medicaldialogues.in/topics/Mamata-Banerjee" target="_blank">Mamata Banerjee</a>, who also holds the Health portfolio. Opposition leaders have alleged that recurring infrastructural failures—from lift malfunctions to structural collapses—point to systemic negligence and lack of accountability, reports UNI.</p><p>Hospital authorities, however, maintained that prompt action prevented any casualties and assured that necessary repairs would be undertaken on priority. An internal assessment of the building’s condition is also expected as part of follow-up measures. The episode has once again spotlighted the urgent need for regular safety audits and infrastructure upgrades in critical healthcare institutions across the state. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/mumbais-gt-hospital-doctor-injured-after-ceiling-plaster-falls-157116"><b>Also Read:Mumbai's GT Hospital doctor injured after ceiling plaster falls</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>3 held in Lucknow for Rs 22 lakh MBBS admission fraud</title>
<link>https://edusehat.com/en/3-held-in-lucknow-for-rs-22-lakh-mbbs-admission-fraud</link>
<guid>https://edusehat.com/en/3-held-in-lucknow-for-rs-22-lakh-mbbs-admission-fraud</guid>
<description><![CDATA[ Lucknow: In a fraud MBBS admission case, three individuals have been arrested for defrauding an aspirant of Rs 22 lakh by promising to secure admission into an MBBS course.The Sonbhadra police arrested them on Wednesday in Lucknow. The accused were produced in court on Thursday and subsequently sent to jail.The accused has defrauded a female candidate hailing from Sonbhadra, Uttar Pradesh. Upon realising she had been scammed, she filed a complaint at the Sonbhadra Cyber ​​Police Station on March 17.Also Read: Rs 4 crore fraud: 36 loans taken allegedly using Jaipur doctor&#039;s identityBased on her complaint, some unidentified individuals promised to secure her admission into an MBBS program through the NEET examination. The accused posed as influential figures associated with medical admissions and claimed that they could secure confirmed seats in both government and private medical colleges.Also Read:Fake MBBS, BAMS degrees racket: Woman arrested in Rs 2.34 crore Raipur job scamThey demanded a sum of money to secure MBBS seats. Consequently, the candidate transferred a total of ₹22 lakh to their bank accounts in several instalments via online channels, according to The420.Therefore, upon receiving the complaint, the police immediately initiated a detailed investigation. During the investigation, it was revealed that this gang had been targeting students and aspirants for some time under the guise of MBBS admissions.Also Read:Fake FMGE certificate scam in Chhattisgarh? 3,000 doctors under medical council, NMC, DME scannerHowever, on Wednesday evening, all three accused were apprehended near a shopping mall.Officials stated that following the arrests and recoveries, the investigation is now focused on determining how many other cases the accused were involved in and where the fraudulently obtained funds were utilised. Further arrests are expected in the coming days.Meanwhile, the police have intensified surveillance through both digital monitoring and physical checks.Also Read: Kanpur Doctor Couple Detained in Illegal Kidney Transplant Racket ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339592-fraud-alert.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>held, Lucknow, for, lakh, MBBS, admission, fraud</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339592-fraud-alert.webp"><p><b>Lucknow: </b>In a fraud MBBS admission case, three individuals have been arrested for defrauding an aspirant of Rs 22 lakh by promising to secure admission into an MBBS course.</p><p>The Sonbhadra police arrested them on Wednesday in Lucknow. The accused were produced in court on Thursday and subsequently sent to jail.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The accused has defrauded a female candidate hailing from Sonbhadra, Uttar Pradesh. Upon realising she had been scammed, she filed a complaint at the Sonbhadra Cyber ​​Police Station on March 17.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/rs-4-crore-fraud-36-loans-taken-allegedly-using-jaipur-doctors-identity-167799"><b>Also Read: </b>Rs 4 crore fraud: 36 loans taken allegedly using Jaipur doctor's identity</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">Based on her complaint, some unidentified individuals promised to secure her admission into an MBBS program through the <a href="https://medicaldialogues.in/topics/neet" target="_blank">NEET </a>examination. The accused posed as influential figures associated with medical admissions and claimed that they could secure confirmed seats in both government and private medical colleges.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/chattisgarh/fake-mbbs-bams-degrees-racket-woman-arrested-in-rs-234-crore-raipur-job-scam-167531"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2026/03/05/331117-fraud.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/chattisgarh/fake-mbbs-bams-degrees-racket-woman-arrested-in-rs-234-crore-raipur-job-scam-167531"><span class="read-this-also">Also Read:</span>Fake MBBS, BAMS degrees racket: Woman arrested in Rs 2.34 crore Raipur job scam</a><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">They demanded a sum of money to secure MBBS seats. Consequently, the candidate transferred a total of ₹22 lakh to their bank accounts in several instalments via online channels, according to <a href="https://the420.in/mbbs-admission-scam-sonbhadra-lucknow-neet-fraud-arrests/" target="_blank" rel="nofollow">The420</a>.</p><p dir="ltr">Therefore, upon receiving the complaint, the police immediately initiated a detailed investigation. During the investigation, it was revealed that this gang had been targeting students and aspirants for some time under the guise of <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>admissions.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/state-news/chattisgarh/fake-fmge-certificate-scam-in-chhattisgarh-3000-doctors-under-medical-council-nmc-dme-scanner-167556"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2024/02/10/232022-fmge-certificate.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/chattisgarh/fake-fmge-certificate-scam-in-chhattisgarh-3000-doctors-under-medical-council-nmc-dme-scanner-167556"><span class="read-this-also">Also Read:</span>Fake FMGE certificate scam in Chhattisgarh? 3,000 doctors under medical council, NMC, DME scanner</a><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">However, on Wednesday evening, all three accused were apprehended near a shopping mall.</p><p dir="ltr">Officials stated that following the arrests and recoveries, the investigation is now focused on determining how many other cases the accused were involved in and where the fraudulently obtained funds were utilised. Further arrests are expected in the coming days.</p><p dir="ltr">Meanwhile, the police have intensified surveillance through both digital monitoring and physical checks.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/kanpur-doctor-couple-detained-in-illegal-kidney-transplant-racket-167761"><b>Also Read: </b>Kanpur Doctor Couple Detained in Illegal Kidney Transplant Racket</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS Jodhpur successfully treats 4 children with rare Laughing Epilepsy</title>
<link>https://edusehat.com/en/aiims-jodhpur-successfully-treats-4-children-with-rare-laughing-epilepsy</link>
<guid>https://edusehat.com/en/aiims-jodhpur-successfully-treats-4-children-with-rare-laughing-epilepsy</guid>
<description><![CDATA[ Jaipur: The All India Institute of Medical Sciences (AIIMS) Jodhpur has achieved a significant medical milestone by successfully performing minimally invasive stereotactic radiofrequency ablation surgeries on four patients suffering from hypothalamic hamartoma causing gelastic seizures, commonly known as &#039;&#039;laughing epilepsy,&#039;&#039; a rare and drug-resistant form of epilepsy.With this achievement, AIIMS Jodhpur has become the only hospital in Rajasthan and the second AIIMS in India to offer this highly specialized treatment.Before the surgery, some of the children were experiencing as many as 10 to 20 seizure episodes daily, severely affecting their quality of life. Using a highly advanced computer-guided stereotactic frame-based technique, doctors precisely targeted and ablated the seizure-causing lesion located deep within the brain through a small incision of approximately one inch, thereby avoiding the need for major open brain surgery.  All four patients responded remarkably well to the procedure, with no reported complications. They were safely discharged within 48 hours and are now seizure-free, demonstrating the effectiveness and safety of this advanced minimally invasive approach, the PIB stated.Also Read:AIIMS Jodhpur Superintendent resigns after former Union Minister allegedly summons, reprimands over free treatmentThe neurological assessment and presurgical evaluation of the patients were carried out by Dr Samhita Panda and Dr Lokesh Saini, while advanced MRI localization was performed by Dr Sarbesh Tiwari. Anesthesia support was provided by Dr Swati Chabbra and Dr Manbir Kaur. The surgeries were successfully performed by Dr Mohit Agrawal. The team also acknowledged the academic guidance and encouragement received from Dr Deepak K Jha and Dr Suryanarayanan Bhaskar.AIIMS Jodhpur has been running a Comprehensive Epilepsy Surgery Program since 2019, under which more than 100 epilepsy surgeries have been successfully performed free of cost under the Ayushman Bharat scheme, ensuring access to advanced care for patients across the region.The team expressed gratitude to Executive Director Dr Goverdhan Dutt Puri for his continued support in strengthening advanced epilepsy surgery services at the institute.This achievement reinforces AIIMS Jodhpur’s commitment to delivering state of the art, patient-centric healthcare and advancing specialized neurosurgical services in the region.Also Read:&#039;Pay Minus Pension&#039; formula applicable to Doctors Re-employed after Retirement- HC slams AIIMS Jodhpur for lackadaisical approach ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/04/01/281152-aiims-jodhpur.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 14:55:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Jodhpur, successfully, treats, children, with, rare, Laughing, Epilepsy</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/04/01/281152-aiims-jodhpur.webp"><div class="pasted-from-word-wrapper"><p><span>Jaipur: The All India Institute of Medical Sciences (AIIMS) Jodhpur has achieved a significant medical milestone by successfully performing minimally invasive stereotactic radiofrequency ablation surgeries on four patients suffering from hypothalamic hamartoma causing gelastic seizures, commonly known as ''laughing <a href="https://medicaldialogues.in/topics/epilepsy" target="_blank">epilepsy</a>,'' a rare and drug-resistant form of epilepsy.</span></p><p>With this achievement, AIIMS Jodhpur has become the only hospital in Rajasthan and the second AIIMS in India to offer this highly specialized treatment.</p><p>Before the surgery, some of the children were experiencing as many as 10 to 20 seizure episodes daily, severely affecting their quality of life. Using a highly advanced computer-guided stereotactic frame-based technique, doctors precisely targeted and ablated the seizure-causing lesion located deep within the brain through a small incision of approximately one inch, thereby avoiding the need for major open brain surgery.  </p><p>All four patients responded remarkably well to the procedure, with no reported complications. They were safely discharged within 48 hours and are now seizure-free, demonstrating the effectiveness and safety of this advanced minimally invasive approach, the PIB stated.</p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/aiims-jodhpur-superintendent-resigns-after-former-union-minister-allegedly-summons-reprimands-over-free-treatment-154241">Also Read:AIIMS Jodhpur Superintendent resigns after former Union Minister allegedly summons, reprimands over free treatment</a></b></p><p>The neurological assessment and presurgical evaluation of the patients were carried out by Dr Samhita Panda and Dr Lokesh Saini, while advanced MRI localization was performed by Dr Sarbesh Tiwari. Anesthesia support was provided by Dr Swati Chabbra and Dr Manbir Kaur. The surgeries were successfully performed by Dr Mohit Agrawal. </p><p>The team also acknowledged the academic guidance and encouragement received from Dr Deepak K Jha and Dr Suryanarayanan Bhaskar.</p><p>AIIMS Jodhpur has been running a Comprehensive Epilepsy Surgery Program since 2019, under which more than 100 epilepsy surgeries have been successfully performed free of cost under the Ayushman Bharat scheme, ensuring access to advanced care for patients across the region.</p><p>The team expressed gratitude to Executive Director Dr Goverdhan Dutt Puri for his continued support in strengthening advanced epilepsy surgery services at the institute.</p><p>This achievement reinforces <a href="https://medicaldialogues.in/topics/AIIMS-Jodhpur" target="_blank">AIIMS Jodhpur</a>’s commitment to delivering state of the art, patient-centric healthcare and advancing specialized neurosurgical services in the region.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/pay-minus-pension-formula-applicable-to-doctors-re-employed-after-retirement-hc-slams-aiims-jodhpur-for-lackadaisical-approach-149915"><b>Also Read:'Pay Minus Pension' formula applicable to Doctors Re-employed after Retirement- HC slams AIIMS Jodhpur for lackadaisical approach</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Bombay HC refuses to quash criminal proceedings against doctor in patient data leak case</title>
<link>https://edusehat.com/en/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case</link>
<guid>https://edusehat.com/en/bombay-hc-refuses-to-quash-criminal-proceedings-against-doctor-in-patient-data-leak-case</guid>
<description><![CDATA[ Nagpur: The Nagpur bench of the Bombay High Court recently denied quashing an FIR against a doctor, accused of using leaked patient data to grow his own practice.It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. &quot;On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,&quot; the bench noted.Therefore, observing that relevant evidence is available against the applicant to sustain the charge, the HC bench rejected the doctor&#039;s application for quashing the FIR registered at Dhantoli Police Station under charges of cheating, criminal breach of trust, and under the Information Technology Act.The complaint was filed by a doctor who runs a hair transplant clinic in Nagpur. It was alleged by the complainant that one of the employees at his clinic secretly shared the details of patients with the accused doctor and another person. Further, it was alleged that the concerned employee also diverted patients to both of those doctors and kept part of the money. Therefore, the complainant was constrained to approach police station and lodged the FIR.While investigating the matter, police found WhatsApp chats and call records that showed regular contact between the accused doctor and the clinic employee. The AAP submitted that the patients were diverted to the accused doctor, who received the monetary gain from said activities. Therefore, submitting that intention of the accused doctor was apparent since inception, the Government counsel prayed for dismissal of the complaint.It was also submitted that the international code of etiquette for the medical professional states that doctor ought to behave towards his colleagues as he would have behaved towards him, and the doctor must not entice patients away from his colleagues. The code of medical etiquette offers advice to other members of the profession that they owe duty to the patients as well as towards their colleagues. Therefore, it was argued that the act of present applicant was not only misconduct or violation of the professional etiquette but intention since inception was apparent.After hearing both the sides and perusing the entire investigation papers, the bench noted that &quot;there is no dispute that applicant as well as non-applicant No.2 both are medical professionals. As per the allegations levelled, the co-accused *** was in the employment of the non-applicant No.2. As per the allegations the job of said *** was to communicate with the patients maintain the data of the patients who are visiting the clinic of the nonapplicant No.2 to obtain the fees from them and to maintain record of the said fees also.&quot;&quot;As per the allegations during period of 14.02.2022 to 09.04.2022 though patient namely *** registered in the clinic of the non-applicant No.2, there names appears to be scratched in the entries and amount paid by them was also not given to non-applicant No.2. Therefore, non-applicant No.2 suspected about co-accused and she was inquired. During inquiry it revealed that she has not only misappropriated the amount collected by her from the patients but she has shared data of the patients with the present applicant and another co-accused and obtained monetary gain from them. Present applicant also communicated with her and obtained the information about patients and said patients were treated by the present applicant and also obtained monetary gain. During investigation Investigating Officer has seized the mobile hand set of the present applicant as well as co accused. On verification of the mobile data of co-accused it revealed that she had WhatsApp chat with the present applicant communicating the details of the patients and present applicant has also approached to her for getting the said details. During the course of investigation the Investigating Officer has also collected the CDR of the present applicant and co-accused and it is apparent that there was continuous communication between present applicant and the co-accused,&quot; it further noted.The court observed that the WhatsApp chat clearly showed the nature of communication between present applicant and other co-accused. Account statement of the husband of the co-accused also substantiated the same. The mobile seizure panchanama of the co-accused when verified it reveals that there are various calls as well as WhatsApp chat between her and present applicant.&quot;Thus, on going through the entire investigation papers admittedly, prima-facie material is there to connect the present applicant with the alleged offence,&quot; the bench observed.The Court observed that even though the offence of criminal breach of trust by a clerk or servant may not directly apply to the accused doctor, there was enough material to show his involvement in cheating. &quot;On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,&quot; observed the court. Accordingly, it dismissed the application.To view the order, click on the link below:https://medicaldialogues.in/pdf_upload/2026/04/04/bombay-hc-order-339669.pdfAlso Read: HC quashes order to disclose ICU patient details at Goa Medical College ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/31/324777-bombay-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 11:20:39 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Bombay, refuses, quash, criminal, proceedings, against, doctor, patient, data, leak, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/31/324777-bombay-high-court.webp"><p><b>Nagpur:</b> The Nagpur bench of the <a href="https://medicaldialogues.in/topics/bombay-high-court">Bombay High Court </a>recently denied quashing an <a href="https://medicaldialogues.in/topics/FIR">FIR</a> against a doctor, accused of using leaked patient data to grow his own practice.</p><p>It was observed by the HC bench comprising Justice Urmila Joshi Phalke that the investigation papers disclosed the intention of the accused doctor. <i>"On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,"</i> the bench noted.</p><p>Therefore, observing that relevant evidence is available against the applicant to sustain the charge, the HC bench rejected the doctor's application for quashing the FIR registered at Dhantoli Police Station under charges of cheating, criminal breach of trust, and under the Information Technology Act.</p><p>The complaint was filed by a doctor who runs a hair transplant clinic in Nagpur. It was alleged by the complainant that one of the employees at his clinic secretly shared the details of patients with the accused doctor and another person. </p><p>Further, it was alleged that the concerned employee also diverted patients to both of those doctors and kept part of the money. Therefore, the complainant was constrained to approach police station and lodged the FIR.</p><p>While investigating the matter, police found WhatsApp chats and call records that showed regular contact between the accused doctor and the clinic employee. The AAP submitted that the patients were diverted to the accused doctor, who received the monetary gain from said activities. Therefore, submitting that intention of the accused doctor was apparent since inception, the Government counsel prayed for dismissal of the complaint.</p><p>It was also submitted that the international code of etiquette for the medical professional states that doctor ought to behave towards his colleagues as he would have behaved towards him, and the doctor must not entice patients away from his colleagues. The code of medical etiquette offers advice to other members of the profession that they owe duty to the patients as well as towards their colleagues. Therefore, it was argued that the act of present applicant was not only misconduct or violation of the professional etiquette but intention since inception was apparent.</p><p>After hearing both the sides and perusing the entire investigation papers, the bench noted that <i>"there is no dispute that applicant as well as non-applicant No.2 both are medical professionals. As per the allegations levelled, the co-accused *** was in the employment of the non-applicant No.2. As per the allegations the job of said *** was to communicate with the patients maintain the data of the patients who are visiting the clinic of the nonapplicant No.2 to obtain the fees from them and to maintain record of the said fees also."</i></p><p><i>"As per the allegations during period of 14.02.2022 to 09.04.2022 though patient namely *** registered in the clinic of the non-applicant No.2, there names appears to be scratched in the entries and amount paid by them was also not given to non-applicant No.2. Therefore, non-applicant No.2 suspected about co-accused and she was inquired. During inquiry it revealed that she has not only misappropriated the amount collected by her from the patients but she has shared data of the patients with the present applicant and another co-accused and obtained monetary gain from them. Present applicant also communicated with her and obtained the information about patients and said patients were treated by the present applicant and also obtained monetary gain. During investigation Investigating Officer has seized the mobile hand set of the present applicant as well as co accused. On verification of the mobile data of co-accused it revealed that she had WhatsApp chat with the present applicant communicating the details of the patients and present applicant has also approached to her for getting the said details. During the course of investigation the Investigating Officer has also collected the CDR of the present applicant and co-accused and it is apparent that there was continuous communication between present applicant and the co-accused,"</i> it further noted.</p><p>The court observed that the WhatsApp chat clearly showed the nature of communication between present applicant and other co-accused. Account statement of the husband of the co-accused also substantiated the same. The mobile seizure panchanama of the co-accused when verified it reveals that there are various calls as well as WhatsApp chat between her and present applicant.</p><p><i>"Thus, on going through the entire investigation papers admittedly, prima-facie material is there to connect the present applicant with the alleged offence,"</i> the bench observed.</p><p>The Court observed that even though the offence of criminal breach of trust by a clerk or servant may not directly apply to the accused doctor, there was enough material to show his involvement in cheating. </p><p><i>"On plain reading of the complaint and other investigation papers the intention of the present applicant since inception is apparent. It is also apparent that by his action or omission he has caused loss to non-applicant No.2 and gained monetarily for his personal use. Therefore, the offence of cheating admittedly is made out against the present applicant,"</i> observed the court. Accordingly, it dismissed the application.</p><p><b><i>To view the order, click on the link below:</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/04/bombay-hc-order-339669.pdf"><b><i>https://medicaldialogues.in/pdf_upload/2026/04/04/bombay-hc-order-339669.pdf</i></b></a></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hc-quashes-order-to-disclose-icu-patient-details-at-goa-medical-college-167335"><b><i>Also Read: HC quashes order to disclose ICU patient details at Goa Medical College</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>5 accused classmates in AIIMS Rajkot MBBS medico&amp;apos;s suicide case get bail</title>
<link>https://edusehat.com/en/5-accused-classmates-in-aiims-rajkot-mbbs-medicos-suicide-case-get-bail</link>
<guid>https://edusehat.com/en/5-accused-classmates-in-aiims-rajkot-mbbs-medicos-suicide-case-get-bail</guid>
<description><![CDATA[ Rajkot: The Rajkot Sessions Court recently granted bail to five final-year MBBS students in AIIMS Rajkot medical student suicide case.These students were accused of abetting the MBBS medico&#039;s suicide, and the court delivered this verdict after considering the &#039;prima facie&#039; arguments.The deceased has been identified as a 25-year-old MBBS intern at AIIMS Rajkot. His body was found on the railway tracks on March 15. The investigation revealed that, due to &quot;extreme&quot; stress, he was &quot;emotionally distressed and harbouring suicidal thoughts.&quot;Also Read: HC grants bail to dismissed sub-inspector in Satara doctor suicide caseThe five accused students are between the ages of 22 and 25. Rajkot Additional Sessions Judge S.A. Galaria granted them conditional bail, subject to the submission of a bail bond of ₹25,000.As per the Indian Express media news report, after considering the arguments put forth by the lawyers representing the accused as well as the submissions made by the police in their documents, the court held that keeping the five accused in judicial custody until the conclusion of the trial would amount to &quot;pre-trial punishment.&quot;Meanwhile, the court order also noted that, based on the statement and OPD prescription of the doctor who had counselled the medico, it was revealed that &quot;suicidal thoughts were active in the deceased&#039;s mind (following acute stress).&quot;Furthermore, the court order also states that the medical records submitted in the police papers indicate that he &quot;had been suffering from a mental illness for a considerable period and was undergoing treatment.&quot;Meanwhile, the court order noted “… as per the statement of the doctor, who treated the deceased… (he) was suffering from emotional distress and having active suicidal idea, following an acute (stress)… (but) prima facie it appears that since January 30 till March 14, there was no contact whatsoever either in person or by phone or any other means between the deceased and the accused, which would indicate no continuous harassment or torture or any sort of pressure from the accused on the deceased.  Thus, there is no proximity of any harassment or instigation before the incident of suicide having taken place immediately…”“The applicant is in judicial custody since March 14… and the investigation is likely to be over qua present applicant, (who) is a final year student of the medical profession and having no criminal antecedents… If (the applicants) are kept behind bars till the trial is over, then it would be pretrial punishment…”, the court order added.The court order also noted “…according to the prosecution’s case, the alleged incident of torture and physical harassment.. occurred on January 27, and then also no complaint seems to have been lodged either by the deceased or his family members…. The record reveals that the deceased was a patient of a psychological ailment… Further, it is material to note that the incident of suicide occurred on March 14 and (as per the submissions), the deceased was not in contact with the (applicants)..”.Furthermore, he was found on the railway tracks near the Nageshwar area of ​​Rajkot at 8:30 AM on January 28. In this regard, the Court noted that neither the student nor his parents had lodged &quot;any complaint.&quot; The Court also observed that in the statement recorded after he was found on January 28, he had stated that he had become &quot;emotional and left the campus&quot; because one of the accused—&quot; was his best friend, but following a argument that took place last month... they were not speaking to each other.&quot;The Court also took into consideration that, following the incident of January 28, he had left for his ancestral place (Jaisalmer, Rajasthan) on January 30 with the &quot;permission of the Institute,&quot; and subsequently, he allegedly &quot;circulated a purported suicide note&quot; on WhatsApp on February 4, 2026.Also Read: Karnataka BAMS student dies by suicide after harassment over affair rumours with lecturer, 6 booked ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339637-suicide-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 11:20:39 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>accused, classmates, AIIMS, Rajkot, MBBS, medicos, suicide, case, get, bail</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339637-suicide-2.webp"><p><b>Rajkot: </b>The Rajkot Sessions Court recently granted bail to five final-year <a href="https://medicaldialogues.in/topics/mbbs" target="_blank">MBBS </a>students in AIIMS Rajkot medical student suicide case.</p><p>These students were accused of abetting the MBBS medico's <a href="https://medicaldialogues.in/topics/suicide" target="_blank">suicide</a>, and the court delivered this verdict after considering the 'prima facie' arguments.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The deceased has been identified as a 25-year-old MBBS intern at AIIMS Rajkot. His body was found on the railway tracks on March 15. The investigation revealed that, due to "extreme" stress, he was "emotionally distressed and harbouring suicidal thoughts."</p><div></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/hc-grants-bail-to-dismissed-sub-inspector-in-satara-doctor-suicide-case-167875"><b>Also Read: </b>HC grants bail to dismissed sub-inspector in Satara doctor suicide case</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr">The five accused students are between the ages of 22 and 25. Rajkot Additional Sessions Judge S.A. Galaria granted them conditional bail, subject to the submission of a bail bond of ₹25,000.</p><p dir="ltr">As per the <a href="https://indianexpress.com/article/cities/ahmedabad/aiims-rajkot-suicide-case-bail-mbbs-students-10617750/lite/" target="_blank" rel="nofollow">Indian Express </a>media news report, after considering the arguments put forth by the lawyers representing the accused as well as the submissions made by the police in their documents, the court held that keeping the five accused in judicial custody until the conclusion of the trial would amount to "pre-trial punishment."</p><p dir="ltr">Meanwhile, the court order also noted that, based on the statement and <a href="https://medicaldialogues.in/topics/opd" target="_blank">OPD </a>prescription of the doctor who had counselled the medico, it was revealed that "suicidal thoughts were active in the deceased's mind (following acute stress)."</p><p dir="ltr">Furthermore, the court order also states that the medical records submitted in the police papers indicate that he "had been suffering from a mental illness for a considerable period and was undergoing treatment."</p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Meanwhile, the court order noted “… as per the statement of the doctor, who treated the deceased… (he) was suffering from emotional distress and having active suicidal idea, following an acute (stress)… (but) prima facie it appears that since January 30 till March 14, there was no contact whatsoever either in person or by phone or any other means between the deceased and the accused, which would indicate no continuous harassment or torture or any sort of pressure from the accused on the deceased.  Thus, there is no proximity of any harassment or instigation before the incident of suicide having taken place immediately…”</p><p dir="ltr">“The applicant is in judicial custody since March 14… and the investigation is likely to be over qua present applicant, (who) is a final year student of the medical profession and having no criminal antecedents… If (the applicants) are kept behind bars till the trial is over, then it would be pretrial punishment…”, the court order added.</p><p dir="ltr">The court order also noted “…according to the prosecution’s case, the alleged incident of torture and physical harassment.. occurred on January 27, and then also no complaint seems to have been lodged either by the deceased or his family members…. The record reveals that the deceased was a patient of a psychological ailment… Further, it is material to note that the incident of suicide occurred on March 14 and (as per the submissions), the deceased was not in contact with the (applicants)..”.</p></div><div class="pasted-from-word-wrapper"><p dir="ltr">Furthermore, he was found on the railway tracks near the Nageshwar area of ​​Rajkot at 8:30 AM on January 28. In this regard, the Court noted that neither the student nor his parents had lodged "any complaint." The Court also observed that in the statement recorded after he was found on January 28, he had stated that he had become "emotional and left the campus" because one of the accused—" was his best friend, but following a argument that took place last month... they were not speaking to each other."</p></div><div class="pasted-from-word-wrapper"><p dir="ltr">The Court also took into consideration that, following the incident of January 28, he had left for his ancestral place (Jaisalmer, Rajasthan) on January 30 with the "permission of the Institute," and subsequently, he allegedly "circulated a purported suicide note" on WhatsApp on February 4, 2026.</p><div></div></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"><div></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/karnataka/karnataka-bams-student-dies-by-suicide-after-harassment-over-affair-rumours-with-lecturer-6-booked-167865"><b>Also Read: </b>Karnataka BAMS student dies by suicide after harassment over affair rumours with lecturer, 6 booked</a></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Aurobindo Pharma Delays 26% Stake Buy in Swarnaakshu Solar Over Pending Approvals</title>
<link>https://edusehat.com/en/aurobindo-pharma-delays-26-stake-buy-in-swarnaakshu-solar-over-pending-approvals</link>
<guid>https://edusehat.com/en/aurobindo-pharma-delays-26-stake-buy-in-swarnaakshu-solar-over-pending-approvals</guid>
<description><![CDATA[ Hyderabad:  Aurobindo Pharma Limited has deferred the completion timeline for its planned investment in Swarnaakshu Solar Power Private Limited, citing pending state government approval for setting up a captive solar power plant.The company had earlier planned to enter into a captive solar power purchase agreement and acquire up to a 26% stake in Swarnaakshu by March 31, 2026. However, due to regulatory delays, the investment is now expected to be completed on or before June 30, 2026, subject to necessary approvals.This move forms part of Aurobindo Pharma’s broader strategy to adopt renewable energy solutions and strengthen its sustainability initiatives through captive solar power sourcing.Also Read: Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in EuropeThe company has been consistently updating stock exchanges regarding this development through multiple communications issued on February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, and December 30, 2025.The latest update has been formally submitted to both the National Stock Exchange of India Limited and BSE Limited.Also Read: Aurobindo Pharma Gets 11 USFDA Observations at Eugia Unit ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/03/02/233467-aurobindo-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 11:20:39 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Aurobindo, Pharma, Delays, 26, Stake, Buy, Swarnaakshu, Solar, Over, Pending, Approvals</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/03/02/233467-aurobindo-50.webp"><p><b>Hyderabad</b>:  Aurobindo Pharma Limited has deferred the completion timeline for its planned investment in Swarnaakshu Solar Power Private Limited, citing pending state government approval for setting up a captive solar power plant.</p><div class="pasted-from-word-wrapper"><p>The company had earlier planned to enter into a captive solar power purchase agreement and acquire up to a 26% stake in Swarnaakshu by March 31, 2026. However, due to regulatory delays, the investment is now expected to be completed on or before June 30, 2026, subject to necessary approvals.</p><p>This move forms part of Aurobindo Pharma’s broader strategy to adopt renewable energy solutions and strengthen its sustainability initiatives through captive solar power sourcing.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-arm-curateq-partners-stada-arzneimittel-ag-to-commercialise-biosimilars-in-europe-167361">Also Read: Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe</a><div></div></div></div><p>The company has been consistently updating stock exchanges regarding this development through multiple communications issued on February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, and December 30, 2025.</p><p>The latest update has been formally submitted to both the National Stock Exchange of India Limited and BSE Limited.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-gets-11-usfda-observations-at-eugia-unit-164196">Also Read: Aurobindo Pharma Gets 11 USFDA Observations at Eugia Unit</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>GMC Rajouri gets major infrastructure upgrade under Ayushman Bharat</title>
<link>https://edusehat.com/en/gmc-rajouri-gets-major-infrastructure-upgrade-under-ayushman-bharat</link>
<guid>https://edusehat.com/en/gmc-rajouri-gets-major-infrastructure-upgrade-under-ayushman-bharat</guid>
<description><![CDATA[ Rajouri: The Government Medical College &amp; Associated Hospital (GMC&amp;AH) in Rajouri, Jammu and Kashmir, has received a significant infrastructure and technology upgrade under the central government&#039;s flagship Ayushman Bharat scheme. Medical Superintendent, GMC&amp;AH, Dr Shamim Ahmed Choudhary, emphasised the improvements in the medical college thanks to the scheme.&quot;The rate of surgeries and deliveries has increased. A special feeder was proposed for here, and the work for that has already started. Specialist doctors and faculty are increasing here. We have purchased a floor for the gynaecology department. We are catering to a lot of patients for dialysis...We are focusing on improving the services here,&quot; Dr Choudhary told ANI.Also Read:Relief for Junior Resident aspirants: GMC Rajouri revises schedule to avoid clashLaunched in 2018, the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana is the world&#039;s largest public healthcare scheme that aims at providing health insurance of up to Rs 5 lakhs to each eligible household annually. It aims to make quality healthcare more affordable for over 12 crore vulnerable families.AB-PMJAY is one pillar of the larger Ayushman Bharat scheme launched in 2018, a health initiative designed to provide equitable health coverage, especially for rural and economically weaker sections, according to a release from PIB HQ.The other pillars under Ayushman Bharat include Ayushman Aarogya Mandirs (AAM), which ensure that primary healthcare is accessible to people near their homes or through a phone call, reports ANI.Ayushman Bharat Digital Mission (ABDM) is another pillar that digitally links all health facilities, from village clinics to big hospitals. It aims to develop the integrated digital health infrastructure of the country. It will connect different stakeholders of the healthcare ecosystem through digital highways.PM-Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), launched in 2021, builds robust healthcare capacity from village health centres to district hospitals.Also Read:UP to expand Ayushman Bharat scheme to Cantonment Hospitals; ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339368-ayushman-bharat-3.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sun, 05 Apr 2026 11:20:39 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>GMC, Rajouri, gets, major, infrastructure, upgrade, under, Ayushman, Bharat</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339368-ayushman-bharat-3.webp"><div class="pasted-from-word-wrapper"><p><span>Rajouri: The Government Medical College & Associated Hospital (GMC&AH) in Rajouri, Jammu and Kashmir, has received a significant infrastructure and technology upgrade under the central government's flagship Ayushman Bharat scheme. </span></p><p>Medical Superintendent, GMC&AH, Dr Shamim Ahmed Choudhary, emphasised the improvements in the medical college thanks to the scheme.</p><p>"The rate of surgeries and deliveries has increased. A special feeder was proposed for here, and the work for that has already started. Specialist doctors and faculty are increasing here. We have purchased a floor for the gynaecology department. We are catering to a lot of patients for dialysis...We are focusing on improving the services here," Dr Choudhary told ANI.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/relief-for-junior-resident-aspirants-gmc-rajouri-revises-schedule-to-avoid-clash-163676"><b>Also Read:Relief for Junior Resident aspirants: GMC Rajouri revises schedule to avoid clash</b></a></p><p>Launched in 2018, the <a href="https://medicaldialogues.in/topics/Ayushman-Bharat" target="_blank">Ayushman Bharat</a>-Pradhan Mantri Jan Arogya Yojana is the world's largest public healthcare scheme that aims at providing health insurance of up to Rs 5 lakhs to each eligible household annually. It aims to make quality healthcare more affordable for over 12 crore vulnerable families.</p><p>AB-PMJAY is one pillar of the larger <a href="https://medicaldialogues.in/topics/Ayushman-Bharat" target="_blank">Ayushman Bharat</a> scheme launched in 2018, a health initiative designed to provide equitable health coverage, especially for rural and economically weaker sections, according to a release from PIB HQ.</p><p>The other pillars under Ayushman Bharat include Ayushman Aarogya Mandirs (AAM), which ensure that primary healthcare is accessible to people near their homes or through a phone call, reports ANI.</p><p>Ayushman Bharat Digital Mission (ABDM) is another pillar that digitally links all health facilities, from village clinics to big hospitals. It aims to develop the integrated digital health infrastructure of the country. It will connect different stakeholders of the healthcare ecosystem through digital highways.</p><p>PM-Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), launched in 2021, builds robust healthcare capacity from village health centres to district hospitals.</p><p><b><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/up-to-expand-ayushman-bharat-scheme-to-cantonment-hospitals-165683">Also Read:UP to expand Ayushman Bharat scheme to Cantonment Hospitals</a>;</b></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>India Has 1.28 Lakh MBBS, 68,175 PG Seats: Government Informs Parliament</title>
<link>https://edusehat.com/en/india-has-128-lakh-mbbs-68175-pg-seats-government-informs-parliament</link>
<guid>https://edusehat.com/en/india-has-128-lakh-mbbs-68175-pg-seats-government-informs-parliament</guid>
<description><![CDATA[ India has 1,28,976 MBBS seats and 68,175 postgraduate medical seats for the academic year 2025-26, Union Minister of State for Health Smt Anupriya Patel informed the Lok Sabha, citing data from the National Medical Commission (NMC).Over the last five years, MBBS seats have increased from 92,065 in 2021-22 to 1,28,976 in 2025-26, while PG seats have risen from 47,419 to 68,175, reflecting steady expansion in medical education capacity.For more details, check out the full story on the link mentioned below:1,28,976 MBBS, 68,175 PG medical seats in India, highest in Karnataka: Health Ministry gives breakup in Parliament ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339620-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-31.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>India, Has, 1.28, Lakh, MBBS, 68, 175, Seats:, Government, Informs, Parliament</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339620-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-31.webp"><div class="pasted-from-word-wrapper"><p>India has 1,28,976 MBBS seats and 68,175 postgraduate medical seats for the academic year 2025-26, Union Minister of State for Health Smt Anupriya Patel informed the <a href="https://medicaldialogues.in/topics/lok-sabha" target="_blank">Lok Sabha</a>, citing data from the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC).</p><p>Over the last five years, MBBS seats have increased from 92,065 in 2021-22 to 1,28,976 in 2025-26, while PG seats have risen from 47,419 to 68,175, reflecting steady expansion in medical education capacity.</p><p><b><i>For more details, check out the full story on the link mentioned below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/128976-mbbs-68175-pg-medical-seats-in-india-highest-in-karnataka-health-ministry-gives-breakup-in-parliament-167906"><b><i>1,28,976 MBBS, 68,175 PG medical seats in India, highest in Karnataka: Health Ministry gives breakup in Parliament</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>Patna: Accused arrested for Rs 10 lakh extortion threat to Paediatrician</title>
<link>https://edusehat.com/en/patna-accused-arrested-for-rs-10-lakh-extortion-threat-to-paediatrician</link>
<guid>https://edusehat.com/en/patna-accused-arrested-for-rs-10-lakh-extortion-threat-to-paediatrician</guid>
<description><![CDATA[ Patna: In connection with an extortion (rangdari) threat demanding Rs 10 lakh from an eminent paediatrician, Patna police arrested the accused from Ramakrishnanagar on Friday, after tracing the threatening calls to his mobile number. During the arrest, the police recovered two mobile phones and two SIM cards. The suspect is currently being interrogated to determine whether he acted on someone else’s instructions or orchestrated the extortion attempt himself.Also Read:Rajkot BHMS doctor arrested for allegedly filming colleague with hidden camera, demanding Rs 25 lakhAccording to City SP Purvi Parichay Kumar, the incident began on March 30, when the doctor, who runs a hospital in Mithapur, reportedly received threatening calls demanding Rs 10 lakh. Acting swiftly after the incident, the city police formed a special team to investigate the matter.The team traced the calls to a mobile number linked with a SIM card registered in the name of the accused, a resident of Sakrapura village in Nawada district. Initial inquiries revealed that he was not present in his native village, prompting further surveillance.
Using mobile location data, the police finally tracked him down to a rented house in Ramakrishnanagar, where he was arrested on Friday.
City Superintendent of Police Purvi Parichay Kumar said that the police suspect that someone else is behind the extortion demand, hence an investigation is also going on on this point, reports Live Hindustan.
The incident underscores increasing concerns over the safety of healthcare providers and highlights the need for strict action against extortion attempts targeting doctors.
Medical Dialogues had previously reported that a 30-year-old assistant doctor at a private hospital in Nashik had been allegedly targeted in an extortion racket by a history-sheeter and his female associate. A police case has been registered at Mhasrul Police Station. According to police officials, the main accused is currently lodged in jail in connection with another criminal case.Also Read:Nashik Assistant Doctor alleges extortion by history-sheeter; case registered ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/06/12/290496-extortion.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patna:, Accused, arrested, for, lakh, extortion, threat, Paediatrician</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/06/12/290496-extortion.webp"><p><b>Patna: </b>In connection with an <a href="https://medicaldialogues.in/topics/extortion">extortion</a> (rangdari) threat demanding Rs 10 lakh from an eminent <a href="https://medicaldialogues.in/topics/paediatrics">paediatrician</a>, Patna police arrested the accused from Ramakrishnanagar on Friday, after tracing the threatening calls to his mobile number. </p><p>During the arrest, the police recovered two mobile phones and two SIM cards. The suspect is currently being interrogated to determine whether he acted on someone else’s instructions or orchestrated the extortion attempt himself.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/rajkot-bhms-doctor-arrested-for-allegedly-filming-colleague-with-hidden-camera-demanding-rs-25-lakh-167081"><b>Also Read:Rajkot BHMS doctor arrested for allegedly filming colleague with hidden camera, demanding Rs 25 lakh</b></a></p><p>According to City SP Purvi Parichay Kumar, the incident began on March 30, when the doctor, who runs a hospital in Mithapur, reportedly received threatening calls demanding Rs 10 lakh. Acting swiftly after the incident, the city police formed a special team to investigate the matter.</p><p>The team traced the calls to a mobile number linked with a SIM card registered in the name of the accused, a resident of Sakrapura village in Nawada district. Initial inquiries revealed that he was not present in his native village, prompting further surveillance.
</p><p>Using mobile location data, the police finally tracked him down to a rented house in Ramakrishnanagar, where he was arrested on Friday.
</p><p>City Superintendent of Police Purvi Parichay Kumar said that the police suspect that someone else is behind the extortion demand, hence an investigation is also going on on this point, reports<a href="https://www.livehindustan.com/bihar/patna/story-police-arrest-extortionist-demanding-10-lakhs-from-doctor-in-patna-201775223628331.html" rel="nofollow"> Live Hindustan</a>.
</p><p>The incident underscores increasing concerns over the safety of healthcare providers and highlights the need for strict action against extortion attempts targeting doctors.
</p><p>Medical Dialogues had previously reported that a 30-year-old assistant doctor at a private hospital in Nashik had been allegedly targeted in an extortion racket by a history-sheeter and his female associate. A police case has been registered at Mhasrul Police Station. According to police officials, the main accused is currently lodged in jail in connection with another criminal case.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/nashik-assistant-doctor-alleges-extortion-by-history-sheeter-case-registered-164614"><b>Also Read:Nashik Assistant Doctor alleges extortion by history-sheeter; case registered</b></a></p>]]> </content:encoded>
</item>

<item>
<title>CM Sukhu inaugurates nuclear medicine block at IGMC Shimla</title>
<link>https://edusehat.com/en/cm-sukhu-inaugurates-nuclear-medicine-block-at-igmc-shimla</link>
<guid>https://edusehat.com/en/cm-sukhu-inaugurates-nuclear-medicine-block-at-igmc-shimla</guid>
<description><![CDATA[ Shimla: Himachal Pradesh Chief Minister Thakur Sukhvinder Singh Sukhu inaugurated the Nuclear Medicine Block at Indira Gandhi Medical College (IGMC), Shimla, aimed at strengthening advanced healthcare services across the state.He said that the facility would enable patients to access advanced Positron Emission Tomography (PET) scan services within the state in the government sector and would reduce the need to travel outside for such diagnostics. He added that this is the first facility of its kind in the public healthcare system of the state, marking a significant step towards strengthening specialized medical services in the state.He said that the PET scan facility enables early detection of diseases at the metabolic and molecular levels. Unlike conventional imaging modalities such as CT and MRI, which identify structural changes at later stages, PET technology detects physiological alterations at a much earlier stage. The facility would play a vital role in the staging and restaging of cancers, evaluation of treatment response, detection of recurrence and prognostication, the press release stated.Also Read:Himachal Govt strengthens healthcare infrastructure in Una districtCM Sukhu stated that it is widely used in the diagnosis and management of various malignancies, including brain tumors, head and neck cancers, thyroid carcinoma, lung carcinoma, pleural malignancies, thymic tumours, esophagogastric carcinoma, gastrointestinal stromal tumors (GIST), breast carcinoma, colorectal carcinoma, as well as urological and testicular malignancies.With advancements in tracers and techniques, its role in oncology continues to expand. In addition to oncology, PET scans are increasingly being utilized in cardiology and neurology, as well as in the assessment of infections and inflammatory diseases, particularly in cases where conventional imaging proves inconclusive.Chief Minister said, “The present state government remains committed to introducing high-end technologies in the health sector. Recently, I have inaugurated a new 3 Tesla MRI machine at this premier health institution. In the coming times, we will invest over Rs 3,000 crore to upgrade technology across all medical colleges and other health institutions in the state, with the aim of providing affordable, world-class healthcare services at the doorstep of the people.”He also announced an allocation of Rs. eight crore for establishing the SPECT-CT scan machine at IGMC Shimla.Health Minister Dr. (Col.) Dhani Ram Shandil, MLAs Harish Janartha and Sanjay Awasthy, Secretary Health M Sudha Devi and other senior officers of the Health department were also present on the occasion. Also Read:CM Sukhu directs new committee to review IGMC Incident ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339349-igmc-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sukhu, inaugurates, nuclear, medicine, block, IGMC, Shimla</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339349-igmc-2.webp"><div class="pasted-from-word-wrapper"><p><span>Shimla: Himachal Pradesh Chief Minister Thakur Sukhvinder Singh Sukhu inaugurated the Nuclear Medicine Block at <a href="https://medicaldialogues.in/topics/Indira-Gandhi-Medical-College" target="_blank">Indira Gandhi Medical College</a> (IGMC), Shimla, aimed at strengthening advanced healthcare services across the state.</span></p><p>He said that the facility would enable patients to access advanced Positron Emission Tomography (PET) scan services within the state in the government sector and would reduce the need to travel outside for such diagnostics. He added that this is the first facility of its kind in the public healthcare system of the state, marking a significant step towards strengthening specialized medical services in the state.</p><p>He said that the PET scan facility enables early detection of diseases at the metabolic and molecular levels. Unlike conventional imaging modalities such as CT and MRI, which identify structural changes at later stages, PET technology detects physiological alterations at a much earlier stage. The facility would play a vital role in the staging and restaging of cancers, evaluation of treatment response, detection of recurrence and prognostication, the press release stated.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/himachal-pradesh/himachal-govt-strengthens-healthcare-infrastructure-in-una-district-166117"><b>Also Read:Himachal Govt strengthens healthcare infrastructure in Una district</b></a></p><p>CM Sukhu stated that it is widely used in the diagnosis and management of various malignancies, including brain tumors, head and neck cancers, thyroid carcinoma, lung carcinoma, pleural malignancies, thymic tumours, esophagogastric carcinoma, gastrointestinal stromal tumors (GIST), breast carcinoma, colorectal carcinoma, as well as urological and testicular malignancies.</p><p>With advancements in tracers and techniques, its role in oncology continues to expand. In addition to oncology, PET scans are increasingly being utilized in cardiology and neurology, as well as in the assessment of infections and inflammatory diseases, particularly in cases where conventional imaging proves inconclusive.</p><p>Chief Minister said, “The present state government remains committed to introducing high-end technologies in the health sector. Recently, I have inaugurated a new 3 Tesla MRI machine at this premier health institution. In the coming times, we will invest over Rs 3,000 crore to upgrade technology across all medical colleges and other health institutions in the state, with the aim of providing affordable, world-class healthcare services at the doorstep of the people.”</p><p>He also announced an allocation of Rs. eight crore for establishing the SPECT-CT scan machine at IGMC Shimla.</p><p>Health Minister Dr. (Col.) <a href="https://medicaldialogues.in/topics/Dhani-Ram-Shandil" target="_blank">Dhani Ram Shandil</a>, MLAs Harish Janartha and Sanjay Awasthy, Secretary Health M Sudha Devi and other senior officers of the Health department were also present on the occasion. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/cm-sukhu-directs-new-committee-to-review-igmc-incident-161647"><b>Also Read:CM Sukhu directs new committee to review IGMC Incident</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>Over 200 hospitals in Telangana served notices for violations</title>
<link>https://edusehat.com/en/over-200-hospitals-in-telangana-served-notices-for-violations</link>
<guid>https://edusehat.com/en/over-200-hospitals-in-telangana-served-notices-for-violations</guid>
<description><![CDATA[ Hyderabad: The Telangana Fire Department has issued notices to at least 230 hospitals across the city for not complying with mandatory fire safety norms, particularly in buildings exceeding 15 metres. The action is part of a large-scale inspection drive covering around 800 hospitals so far. As per the news reports, the inspections, being conducted simultaneously by all 145 fire stations, are part of a focused 10-12 day exercise targeting healthcare facilities. Each station is tasked with inspecting at least one building per day, with the aim of covering between 1,400 and 1,600 government and private hospitals in total.Also Read:Fire at NIMHANS Bengaluru, over 1,000 medical records destroyedAudits conducted during the drive revealed alarming gaps in fire preparedness. Many hospitals were found lacking essential infrastructure such as functional fire alarm systems, smoke detectors, automatic sprinklers, hose reels, and properly serviced fire extinguishers. In several cases, emergency exits were blocked or inaccessible, and evacuation plans and staff training were inadequate.Officials are closely assessing compliance with key requirements, including valid fire no-objection certificates (NOCs), operational fire-fighting systems, and overall emergency readiness. High-risk areas such as Intensive Care Units (ICUs), Neonatal ICUs, operating theatres, and medical gas storage units are receiving special attention.
Speaking to TOI, a senior district fire officer said, &quot;During inspections, we are repeatedly finding missing or non-functional fire extinguishers, non-working smoke detectors, absence of sprinkler systems, and poorly maintained fire alarm panels.&quot;  &quot;In some hospitals, emergency exits are locked or encroached upon, while critical systems like hydrants and hose reels are either not installed or not in working condition.&quot;
The officer also highlighted unsafe practices, including the storage of oxygen cylinders in confined basement areas and overloaded electrical circuits, both of which significantly increase the risk of fires.
Hospitals found with serious violations risk denial of fire no objection certificate (NOC) renewals and prosecution under the Telangana Fire Service Act, 1999. Those with minor deficiencies have been given a two-week deadline to rectify the issues, failing which stricter action will follow.
Officials said the drive was intensified following recent fire incidents. On March 29, a fire broke out at a private hospital in Masab Tank after an air-conditioner reportedly exploded, triggering panic among patients and staff, though no injuries were reported. In another incident, a blaze at SCB Medical College Hospital caused by an electrical short circuit in an ICU claimed 12 lives, underscoring the urgent need for strict compliance with fire safety norms, reports TOI.
Also Read:Fire at Cuttack Hospital ICU: 10 patients killed, 11 staff injured ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/11/20/261484-fire-safety.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Over, 200, hospitals, Telangana, served, notices, for, violations</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/11/20/261484-fire-safety.webp"><p><b>Hyderabad: </b>The Telangana Fire Department has issued notices to at least 230 hospitals across the city for not complying with mandatory <a href="https://medicaldialogues.in/topics/fire-safety">fire safety</a> norms, particularly in buildings exceeding 15 metres. The action is part of a large-scale inspection drive covering around 800 hospitals so far. </p><p>As per the news reports, the inspections, being conducted simultaneously by all 145 fire stations, are part of a focused 10-12 day exercise targeting healthcare facilities. Each station is tasked with inspecting at least one building per day, with the aim of covering between 1,400 and 1,600 government and <a href="https://medicaldialogues.in/topics/private-hospitals">private hospitals</a> in total.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/fire-at-nimhans-bengaluru-over-1000-medical-records-destroyed-167194"><b>Also Read:Fire at NIMHANS Bengaluru, over 1,000 medical records destroyed</b></a></p><p>Audits conducted during the drive revealed alarming gaps in fire preparedness. Many hospitals were found lacking essential infrastructure such as functional fire alarm systems, smoke detectors, automatic sprinklers, hose reels, and properly serviced fire extinguishers. In several cases, emergency exits were blocked or inaccessible, and evacuation plans and staff training were inadequate.</p><p>Officials are closely assessing compliance with key requirements, including valid fire no-objection certificates (NOCs), operational fire-fighting systems, and overall emergency readiness. High-risk areas such as Intensive Care Units (ICUs), Neonatal ICUs, operating theatres, and medical gas storage units are receiving special attention.
</p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/hyderabad/over-230-hyd-hospitals-fail-fire-test-get-notices/amp_articleshow/130008408.cms" rel="nofollow">TOI</a>, a senior district fire officer said, "During inspections, we are repeatedly finding missing or non-functional fire extinguishers, non-working smoke detectors, absence of sprinkler systems, and poorly maintained fire alarm panels."  "In some hospitals, emergency exits are locked or encroached upon, while critical systems like hydrants and hose reels are either not installed or not in working condition."
</p><p>The officer also highlighted unsafe practices, including the storage of oxygen cylinders in confined basement areas and overloaded electrical circuits, both of which significantly increase the risk of fires.
</p><p>Hospitals found with serious violations risk denial of fire no objection certificate (NOC) renewals and prosecution under the Telangana Fire Service Act, 1999. Those with minor deficiencies have been given a two-week deadline to rectify the issues, failing which stricter action will follow.
</p><p>Officials said the drive was intensified following recent fire incidents. On March 29, a fire broke out at a private hospital in Masab Tank after an air-conditioner reportedly exploded, triggering panic among patients and staff, though no injuries were reported. In another incident, a blaze at SCB Medical College Hospital caused by an electrical short circuit in an ICU claimed 12 lives, underscoring the urgent need for strict compliance with fire safety norms, reports TOI.
</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/fire-at-cuttack-hospital-icu-10-patients-killed-11-staff-injured-166583"><b>Also Read:Fire at Cuttack Hospital ICU: 10 patients killed, 11 staff injured</b></a></p>]]> </content:encoded>
</item>

<item>
<title>MCC extends choice filling for round 2 NEET SS counselling</title>
<link>https://edusehat.com/en/mcc-extends-choice-filling-for-round-2-neet-ss-counselling</link>
<guid>https://edusehat.com/en/mcc-extends-choice-filling-for-round-2-neet-ss-counselling</guid>
<description><![CDATA[ New Delhi: The Medical Counselling Committee (MCC) has extended the choice filling process for Round 2 of the National Eligibility and Entrance Test Super Speciality (NEET SS) counselling for the academic year 2025.As per the official MCC website, the “Choice filling for Round 2 SS Counselling 2025 has been extended until 11:55 PM on 07.04.2026”.Also Read: Seat Matrix Revised: 152 Seats Added, Four Removed in NEET SS 2025 Round Two CounsellingSTEPS FOR ROUND 2 CHOICE FILLINGSTEP 1- Visit the official MCC portal and select the &quot;Super Speciality&quot; tab.STEP 2- Use your NEET SS roll number and password.STEP 3- New candidates or those who didn&#039;t join R1 must pay registration fees.STEP 4- Select preferred courses and colleges. Seat matrix includes newly added (133), clear (1,858), and virtual (4,600) seats.STEP 5-  Lock choices before the deadline (11:55 PM, April 7). However, according to the official schedule released by the MCC, the choice filling and locking process for Round 2 of the NEET SS 2025 Counselling was scheduled to conclude today. Thereafter, the processing of seat allotment was to be done from 5th April, 2026 and the result will be declared on 7th April, 2026. Below is the complete schedule as earlier released by the MCC on its official website-SCHEDULE FOR ALL-INDIA COUNSELING (ALLOTMENT PROCESS) FOR NEET SUPER SPECIALITY COURSES (D.M/ MCH &amp; DrNB SS) – 20252nd ROUNDVERIFICATION OF SEAT MATRIX BY INSTITUTESREGISTRATION/PAYMENT FACILITYCHOICE FILLING/LOCKINGPROCESSING OF SEAT ALLOTMENTRESULTRESPORTING26 and 27 March, 2026Registration Facility will be available from 28 March, 2026 up to 12:00 NOON of 3 April, 2026( as per Server Time)Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 20265 April, 2026 to 6 April, 20267 April, 20268 April, 2026 to 16 April, 2026 (till 11:00 pm)Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server TimeChoice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026DAYS(7-Days)(7-Days)(2-Days)(1-Day)(9- Days)Also Read: MCC NEET SS counselling 2025 round 2 choice filling to end tomorrow ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339641-extend.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>MCC, extends, choice, filling, for, round, NEET, counselling</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339641-extend.webp"><p><b>New Delhi: </b>The Medical Counselling Committee (<a href="https://medicaldialogues.in/topics/mcc" target="_blank">MCC</a>) has extended the choice filling process for Round 2 of the National Eligibility and Entrance Test Super Speciality (NEET SS) counselling for the academic year 2025.</p><div class="pasted-from-word-wrapper"><p dir="ltr">As per the official MCC website, the “Choice filling for Round 2 SS Counselling 2025 has been extended until 11:55 PM on 07.04.2026”.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/seat-matrix-revised-152-seats-added-four-removed-in-neet-ss-2025-round-two-counselling-167903"><b>Also Read: </b>Seat Matrix Revised: 152 Seats Added, Four Removed in NEET SS 2025 Round Two Counselling</a></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>STEPS FOR ROUND 2 CHOICE FILLING</u></b></p><p dir="ltr"><b>STEP 1-</b> Visit the official MCC portal and select the "Super Speciality" tab.</p><p dir="ltr"><b>STEP 2-</b> Use your <a href="https://medicaldialogues.in/topics/neet-ss" target="_blank">NEET SS</a> roll number and password.</p><p dir="ltr"><b>STEP 3-</b> New candidates or those who didn't join R1 must pay registration fees.</p><p dir="ltr"><b>STEP 4-</b> Select preferred courses and colleges. Seat matrix includes newly added (133), clear (1,858), and virtual (4,600) seats.</p><p dir="ltr"><b>STEP 5- </b> Lock choices before the deadline (11:55 PM, April 7). </p><p dir="ltr">However, according to the official schedule released by the MCC, the choice filling and locking process for Round 2 of the NEET SS 2025 Counselling was scheduled to conclude today. </p><p dir="ltr">Thereafter, the processing of seat allotment was to be done from 5th April, 2026 and the result will be declared on 7th April, 2026. </p></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div>Below is the complete schedule as earlier released by the MCC on its official website-</div></div></div><div class="pasted-from-word-wrapper"><p dir="ltr"><b><u>SCHEDULE FOR ALL-INDIA COUNSELING (ALLOTMENT PROCESS) FOR NEET SUPER SPECIALITY COURSES (D.M/ <a href="https://medicaldialogues.in/topics/mch">MCH </a>& DrNB SS) – 2025</u></b></p><div dir="ltr"><table><colgroup><col width="100"><col width="166"><col width="123"><col width="89"><col width="57"><col width="89"></colgroup><tbody><tr><td colspan="6"><p dir="ltr"><b>2nd ROUND</b></p></td></tr><tr><td><p dir="ltr"><b>VERIFICATION OF SEAT MATRIX BY INSTITUTES</b></p></td><td><p dir="ltr"><b>REGISTRATION/PAYMENT FACILITY</b></p></td><td><p dir="ltr"><b>CHOICE FILLING/LOCKING</b></p></td><td><p dir="ltr"><b>PROCESSING OF SEAT ALLOTMENT</b></p></td><td><p dir="ltr"><b>RESULT</b></p></td><td><p dir="ltr"><b>RESPORTING</b></p></td></tr><tr><td><p dir="ltr">26 and 27 March, 2026</p></td><td><p dir="ltr">Registration Facility will be available from 28 March, 2026 up to 12:00 NOON of 3 April, 2026( as per Server Time)</p></td><td><p dir="ltr">Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 2026</p></td><td><p dir="ltr">5 April, 2026 to 6 April, 2026</p></td><td><p dir="ltr">7 April, 2026</p></td><td><p dir="ltr">8 April, 2026 to 16 April, 2026 (till 11:00 pm)</p></td></tr><tr><td></td><td><p dir="ltr">Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server Time</p></td><td><p dir="ltr">Choice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026</p></td><td></td><td></td><td></td></tr><tr><td><p dir="ltr"><b>DAYS</b></p></td><td><p dir="ltr"><b>(7-Days)</b></p></td><td><p dir="ltr"><b>(7-Days)</b></p></td><td><p dir="ltr"><b>(2-Days)</b></p></td><td><p dir="ltr"><b>(1-Day)</b></p></td><td><p dir="ltr"><b>(9- Days)</b></p></td></tr></tbody></table></div></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/mcc-neet-ss-counselling-2025-round-2-choice-filling-to-end-tomorrow-167910"><b>Also Read: </b>MCC NEET SS counselling 2025 round 2 choice filling to end tomorrow</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Health Bulletin 04/April/2026</title>
<link>https://edusehat.com/en/health-bulletin-04april2026</link>
<guid>https://edusehat.com/en/health-bulletin-04april2026</guid>
<description><![CDATA[ Here are the top health stories for the day:India Has 1.28 Lakh MBBS, 68,175 PG Seats: Government Informs ParliamentIndia has 1,28,976 MBBS seats and 68,175 postgraduate medical seats for the academic year 2025-26, Union Minister of State for Health Smt Anupriya Patel informed the Lok Sabha, citing data from the National Medical Commission (NMC).Over the last five years, MBBS seats have increased from 92,065 in 2021-22 to 1,28,976 in 2025-26, while PG seats have risen from 47,419 to 68,175, reflecting steady expansion in medical education capacity.For more details, check out the full story on the link mentioned below:1,28,976 MBBS, 68,175 PG medical seats in India, highest in Karnataka: Health Ministry gives breakup in ParliamentNMC Provides Additional Opportunity for FMGE Eligibility Certificate Applications, Check DetailsThrough a recent notice, the Ethics and Medical Registration Board (EMRB) of the National Medical Commission (NMC) has given one more opportunity for applications for Eligibility Certificates by foreign medical graduates, which is mandatory to appear in the screening test i.e. Foreign Medical Graduates Examination (FMGE).In a recently issued public notice dated 1st April 2026, the Ethics and Medical Registration Board (EMRB), NMC decided to grant an additional opportunity for candidates who could not apply for the Eligibility Certificate earlier due to technical issues.For more details, check out the full story on the link mentioned below:FMGE: NMC gives additional opportunity for eligibility certificate applications, check new deadlineFact Check: Viral NExT Exam Notice for 2022 MBBS Batch Is FakeThe viral notice, allegedly issued by the National Medical Commission (NMC), which claimed that the much-anticipated National Exit Test (NExT) shall be applicable from the 2022 MBBS batch onwards, is a fake, an NMC official has clarified.When the Medical Dialogues team raised the query regarding the authenticity of the concerned viral notice dated 01.04.2026, the official from the Apex Medical Commission confirmed it to be a fake and added that a clarification in this regard will be issued by NMC soon.For more details, check out the full story on the link mentioned below:Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE47 Government Hospitals, 3 Central Institutes Form India&#039;s Mental Health Network: Health MinistryApproval has been granted to implement the District Mental Health Programme (DMHP) across 767 districts in India, with support provided to States and Union Territories through the National Health Mission (NHM).Under the DMHP, Community Health Centres (CHC) and Primary Health Centres (PHC) offer a range of mental health services, including outpatient services, assessment, counselling/psychosocial interventions, continuous care and support for individuals suffering from severe mental disorders, medications, outreach services, and ambulance services.For more details, check out the full story on the link mentioned below:India has 47 Govt Mental Hospitals, including 3 Central Institutions: Health Ministry ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339631-health-bulletin-8.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, Bulletin, 04April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339631-health-bulletin-8.webp"><p><b>Here are the top health stories for the day:</b></p><p><b>India Has 1.28 Lakh MBBS, 68,175 PG Seats: Government Informs Parliament</b></p><div class="pasted-from-word-wrapper"><p>India has 1,28,976 MBBS seats and 68,175 postgraduate medical seats for the academic year 2025-26, Union Minister of State for Health Smt Anupriya Patel informed the <a href="https://medicaldialogues.in/topics/lok-sabha" target="_blank">Lok Sabha</a>, citing data from the <a href="https://medicaldialogues.in/topics/nmc" target="_blank">National Medical Commission</a> (NMC).</p><p>Over the last five years, MBBS seats have increased from 92,065 in 2021-22 to 1,28,976 in 2025-26, while PG seats have risen from 47,419 to 68,175, reflecting steady expansion in medical education capacity.</p><p><i><b>For more details, check out the full story on the link mentioned below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/128976-mbbs-68175-pg-medical-seats-in-india-highest-in-karnataka-health-ministry-gives-breakup-in-parliament-167906"><i><b>1,28,976 MBBS, 68,175 PG medical seats in India, highest in Karnataka: Health Ministry gives breakup in Parliament</b></i></a></p><p><b></b></p><p><b>NMC Provides Additional Opportunity for FMGE Eligibility Certificate Applications, Check Details</b></p><p>Through a recent notice, the Ethics and Medical Registration Board (<a href="https://medicaldialogues.in/topics/emrb" target="_blank">EMRB</a>) of the National Medical Commission (<a href="https://medicaldialogues.in/topics//nmc" target="_blank">NMC</a>) has given one more opportunity for applications for Eligibility Certificates by foreign medical graduates, which is mandatory to appear in the screening test i.e. Foreign Medical Graduates Examination (<a href="https://medicaldialogues.in/topics/fmge" target="_blank">FMGE</a>).</p><div class="pasted-from-word-wrapper"><div></div><p>In a recently issued public notice dated 1st April 2026, the Ethics and Medical Registration Board (EMRB), NMC decided to grant an additional opportunity for candidates who could not apply for the Eligibility Certificate earlier due to technical issues.</p><p><i><b>For more details, check out the full story on the link mentioned below:</b></i></p><p><a href="https://medicaldialogues.in/news/education/fmge-nmc-gives-additional-opportunity-for-eligibility-certificate-applications-check-new-deadline-167854"><i><b>FMGE: NMC gives additional opportunity for eligibility certificate applications, check new deadline</b></i></a></p><p><b></b></p><p><b>Fact Check: Viral NExT Exam Notice for 2022 MBBS Batch Is Fake</b></p><p>The viral notice, allegedly issued by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission</a> (NMC), which claimed that the much-anticipated National Exit Test (NExT) shall be applicable from the 2022 MBBS batch onwards, is a fake, an NMC official has clarified.</p><p>When the Medical Dialogues team raised the query regarding the authenticity of the concerned viral notice dated 01.04.2026, the official from the Apex Medical Commission confirmed it to be a fake and added that a clarification in this regard will be issued by NMC soon.</p><p><i><b>For more details, check out the full story on the link mentioned below:</b></i></p><p><a href="https://medicaldialogues.in/fact-check/fact-check-viral-notice-claiming-next-exam-from-2022-mbbs-batch-onwards-is-fake-167887"><i><b>Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE</b></i></a></p><p><br><b></b></p><p><b>47 Government Hospitals, 3 Central Institutes Form India's Mental Health Network: Health Ministry</b></p><p>Approval has been granted to implement the District Mental Health Programme (DMHP) across 767 districts in India, with support provided to States and Union Territories through the <a href="https://medicaldialogues.in/topics/national-health-mission" target="_blank">National Health Mission</a> (NHM).</p><div class="pasted-from-word-wrapper"><p dir="ltr">Under the DMHP, Community Health Centres (CHC) and <a href="https://medicaldialogues.in/topics/primary-health-centre" target="_blank">Primary Health Centre</a>s (PHC) offer a range of mental health services, including outpatient services, assessment, counselling/psychosocial interventions, continuous care and support for individuals suffering from severe mental disorders, medications, outreach services, and ambulance services.</p><p><i><b>For more details, check out the full story on the link mentioned below:</b></i></p><p><a href="https://medicaldialogues.in/news/health/india-has-47-govt-mental-hospitals-including-3-central-institutions-health-ministry-167713"><i><b>India has 47 Govt Mental Hospitals, including 3 Central Institutions: Health Ministry</b></i></a></p></div></div></div>]]> </content:encoded>
</item>

<item>
<title>47 Government Hospitals, 3 Central Institutes Form India&amp;apos;s Mental Health Network: Health Ministry</title>
<link>https://edusehat.com/en/47-government-hospitals-3-central-institutes-form-indias-mental-health-network-health-ministry</link>
<guid>https://edusehat.com/en/47-government-hospitals-3-central-institutes-form-indias-mental-health-network-health-ministry</guid>
<description><![CDATA[ Approval has been granted to implement the District Mental Health Programme (DMHP) across 767 districts in India, with support provided to States and Union Territories through the National Health Mission (NHM). Under the DMHP, Community Health Centres (CHC) and Primary Health Centres (PHC) offer a range of mental health services, including outpatient services, assessment, counselling/psychosocial interventions, continuous care and support for individuals suffering from severe mental disorders, medications, outreach services, and ambulance services.For more details, check out the full story on the link mentioned below:India has 47 Govt Mental Hospitals, including 3 Central Institutions: Health Ministry ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339629-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-34.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Government, Hospitals, Central, Institutes, Form, Indias, Mental, Health, Network:, Health, Ministry</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339629-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-34.webp"><div class="pasted-from-word-wrapper"><p>Approval has been granted to implement the District Mental Health Programme (DMHP) across 767 districts in India, with support provided to States and Union Territories through the <a href="https://medicaldialogues.in/topics/national-health-mission" target="_blank">National Health Mission</a> (NHM). </p><div class="pasted-from-word-wrapper"><p dir="ltr">Under the DMHP, Community Health Centres (CHC) and <a href="https://medicaldialogues.in/topics/primary-health-centre" target="_blank">Primary Health Centre</a>s (PHC) offer a range of mental health services, including outpatient services, assessment, counselling/psychosocial interventions, continuous care and support for individuals suffering from severe mental disorders, medications, outreach services, and ambulance services.</p><p><b><i>For more details, check out the full story on the link mentioned below:</i></b></p><p><a href="https://medicaldialogues.in/news/health/india-has-47-govt-mental-hospitals-including-3-central-institutions-health-ministry-167713"><b><i>India has 47 Govt Mental Hospitals, including 3 Central Institutions: Health Ministry</i></b></a></p></div></div>]]> </content:encoded>
</item>

<item>
<title>Fact Check: Viral NExT Exam Notice for 2022 MBBS Batch Is Fake</title>
<link>https://edusehat.com/en/fact-check-viral-next-exam-notice-for-2022-mbbs-batch-is-fake</link>
<guid>https://edusehat.com/en/fact-check-viral-next-exam-notice-for-2022-mbbs-batch-is-fake</guid>
<description><![CDATA[ The viral notice, allegedly issued by the National Medical Commission (NMC), which claimed that the much-anticipated National Exit Test (NExT) shall be applicable from the 2022 MBBS batch onwards, is a fake, an NMC official has clarified.When the Medical Dialogues team raised the query regarding the authenticity of the concerned viral notice dated 01.04.2026, the official from the Apex Medical Commission confirmed it to be a fake and added that a clarification in this regard will be issued by NMC soon.For more details, check out the full story on the link mentioned below:Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339628-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-33.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Fact, Check:, Viral, NExT, Exam, Notice, for, 2022, MBBS, Batch, Fake</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339628-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-33.webp"><div class="pasted-from-word-wrapper"><p>The viral notice, allegedly issued by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission</a> (NMC), which claimed that the much-anticipated National Exit Test (NExT) shall be applicable from the 2022 MBBS batch onwards, is a fake, an NMC official has clarified.</p><p>When the Medical Dialogues team raised the query regarding the authenticity of the concerned viral notice dated 01.04.2026, the official from the Apex Medical Commission confirmed it to be a fake and added that a clarification in this regard will be issued by NMC soon.</p><p><b><i>For more details, check out the full story on the link mentioned below:</i></b></p><p><a href="https://medicaldialogues.in/fact-check/fact-check-viral-notice-claiming-next-exam-from-2022-mbbs-batch-onwards-is-fake-167887"><b><i>Fact Check: Viral notice claiming NExT exam from 2022 MBBS batch onwards is FAKE</i></b></a></p></div>]]> </content:encoded>
</item>

<item>
<title>NMC Provides Additional Opportunity for FMGE Eligibility Certificate Applications, Check Details</title>
<link>https://edusehat.com/en/nmc-provides-additional-opportunity-for-fmge-eligibility-certificate-applications-check-details</link>
<guid>https://edusehat.com/en/nmc-provides-additional-opportunity-for-fmge-eligibility-certificate-applications-check-details</guid>
<description><![CDATA[ Through a recent notice, the Ethics and Medical Registration Board (EMRB) of the National Medical Commission (NMC) has given one more opportunity for applications for Eligibility Certificates by foreign medical graduates, which is mandatory to appear in the screening test i.e. Foreign Medical Graduates Examination (FMGE).In a recently issued public notice dated 1st April 2026, the Ethics and Medical Registration Board (EMRB), NMC decided to grant an additional opportunity for candidates who could not apply for the Eligibility Certificate earlier due to technical issues.For more details, check out the full story on the link mentioned below:FMGE: NMC gives additional opportunity for eligibility certificate applications, check new deadline ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339624-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-32.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 21:00:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NMC, Provides, Additional, Opportunity, for, FMGE, Eligibility, Certificate, Applications, Check, Details</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339624-study-links-obesity-driven-organ-enlargement-to-increased-risk-of-cancer-development-32.webp"><div class="pasted-from-word-wrapper"><p>Through a recent notice, the Ethics and Medical Registration Board (<a href="https://medicaldialogues.in/topics/emrb" target="_blank">EMRB</a>) of the National Medical Commission (<a href="https://medicaldialogues.in/topics//nmc" target="_blank">NMC</a>) has given one more opportunity for applications for Eligibility Certificates by foreign medical graduates, which is mandatory to appear in the screening test i.e. Foreign Medical Graduates Examination (<a href="https://medicaldialogues.in/topics/fmge" target="_blank">FMGE</a>).</p><div class="pasted-from-word-wrapper"><div></div><p>In a recently issued public notice dated 1st April 2026, the Ethics and Medical Registration Board (EMRB), NMC decided to grant an additional opportunity for candidates who could not apply for the Eligibility Certificate earlier due to technical issues.</p><p><b><i>For more details, check out the full story on the link mentioned below:</i></b></p><p><a href="https://medicaldialogues.in/news/education/fmge-nmc-gives-additional-opportunity-for-eligibility-certificate-applications-check-new-deadline-167854"><b><i>FMGE: NMC gives additional opportunity for eligibility certificate applications, check new deadline</i></b></a></p></div></div>]]> </content:encoded>
</item>

<item>
<title>TN Health notifies virtual vacancies for NEET SS round 2 counselling, 19 seats available, check details here</title>
<link>https://edusehat.com/en/tn-health-notifies-virtual-vacancies-for-neet-ss-round-2-counselling-19-seats-available-check-details-here</link>
<guid>https://edusehat.com/en/tn-health-notifies-virtual-vacancies-for-neet-ss-round-2-counselling-19-seats-available-check-details-here</guid>
<description><![CDATA[ Chennai: Tamil Nadu Medical education department (TN Health) has released the virtual vacancies for Round 2 NEET super speciality counselling for DM and MCh admissions 2025-2026 session.As per the virtual vacancies list issued on the official website of TN Health, a total of 19 seats are vacant for Round 2 super speciality course 2025 - 2026 session. Of these, a total of 19 seats are vacant 2 seats in DM Cardiology, 1 seat in DM Critical Care Medicine, 1 seat in DM Endocrinology, 2 seats in DM Medical Oncology, 2 seats in DM Neurology, 2 seats in M.Ch. Plastic &amp; Reconstructive Surgery, 5 seats in M.Ch. Surgical Gastroenterology, 2 seats in M.Ch. Surgical Oncology, 2 seats in M.Ch. Urology.VIRTUAL VACANCY FOR ROUND-2 SUPER SPECIALITY COURSE 2025 - 2026 SESSION
 
 
 
  SPECIALITY
  SEAT
 
 
  DM - Cardiology
  2
 
 
  DM - Critical Care Medicine
  1
 
 
  DM - Endocrinology
  1
 
 
  DM - Medical Oncology
  2
 
 
  DM - Neurology
  2
 
 
  M.Ch. - Plastic &amp; Reconstructive Surgery
  2
 
 
  M.Ch. - Surgical Gastroenterology
  5
 
 
  M.Ch. - Surgical Oncology
  2
 
 
  M.Ch. - Urology
  2
 
 
  Total Seats
  19
 To view the virtual vacancies, click the link below-https://medicaldialogues.in/pdf_upload/2026/04/04/03042026093559-339582.pdfThe Medical Counselling Committee (MCC) has recently released the seat matrix for the 2nd round of counselling for the National Eligibility and Entrance Test Super Speciality (NEET SS) for the academic year 2025.
This seat matrix includes newly added seats, vacant seats, and virtual vacant seats for participating candidates.
According to the official NEET SS Seat Matrix 2025, a total of 6,591 seats are available for Round 2. Of these, 133 seats have been newly added, 1,858 seats are clearly vacant, and 4,600 seats are virtually vacant.Below is the complete schedule as released by the MCC on its official website-SCHEDULE FOR ALL-INDIA COUNSELING (ALLOTMENT PROCESS) FOR NEET SUPER SPECIALITY COURSES (D.M/ MCH &amp; DrNB SS) – 20252nd ROUNDVERIFICATION OF SEAT MATRIX BY INSTITUTESREGISTRATION/PAYMENT FACILITYCHOICE FILLING/LOCKINGPROCESSING OF SEAT ALLOTMENTRESULTRESPORTING26 and 27 March, 2026Registration Facility will be available from 28 March, 2026, up to 12:00 NOON of 3 April, 2026( as per Server Time)Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 20265 April, 2026 to 6 April, 20267 April, 20268 April, 2026 to 16 April, 2026 (till 11:00 pm)Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server TimeChoice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026DAYS(7-Days)(7-Days)(2-Days)(1-Day)(9- Days)Also Read:6,591 seats up for grabs in MCC NEET SS counselling 2025 round 2 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/20/328695-vacancy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Health, notifies, virtual, vacancies, for, NEET, round, counselling, seats, available, check, details, here</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/20/328695-vacancy.webp"><p><b>Chennai:</b> Tamil Nadu Medical education department (<a href="https://medicaldialogues.in/topics/tamil-nadu" target="_blank">TN Health</a>) has released the virtual vacancies for Round 2 NEET super speciality counselling for DM and MCh admissions 2025-2026 session.</p><p>As per the virtual vacancies list issued on the official website of TN Health, a total of 19 seats are vacant for Round 2 super speciality course 2025 - 2026 session. Of these, a total of 19 seats are vacant 2 seats in DM Cardiology, 1 seat in DM Critical Care Medicine, 1 seat in DM Endocrinology, 2 seats in DM Medical Oncology, 2 seats in DM Neurology, 2 seats in M.Ch. Plastic & Reconstructive Surgery, 5 seats in M.Ch. Surgical Gastroenterology, 2 seats in M.Ch. Surgical Oncology, 2 seats in M.Ch. Urology.</p><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p><b><u>VIRTUAL VACANCY FOR ROUND-2 SUPER SPECIALITY COURSE 2025 - 2026 SESSION</u></b></p></div></div><div class="pasted-from-word-wrapper"><table border="0" cellpadding="0" cellspacing="0" width="670">
 <colgroup><col width="395">
 <col width="275">
 </colgroup><tbody><tr height="19">
  <td height="19" class="xl63" width="395"><b>SPECIALITY</b></td>
  <td class="xl63" width="275"><b>SEAT</b></td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">DM - Cardiology</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">DM - Critical Care Medicine</td>
  <td class="xl66">1</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">DM - Endocrinology</td>
  <td class="xl66">1</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl65" width="395">DM - Medical Oncology</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl65" width="395">DM - Neurology</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">M.Ch. - Plastic & Reconstructive Surgery</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl65" width="395">M.Ch. - Surgical Gastroenterology</td>
  <td class="xl66">5</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">M.Ch. - Surgical Oncology</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="19">
  <td height="19" class="xl64" width="395">M.Ch. - Urology</td>
  <td class="xl66">2</td>
 </tr>
 <tr height="18">
  <td height="18" class="xl67"><b>Total Seats</b></td>
  <td class="xl67"><b>19</b></td>
 </tr></tbody></table></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p><b><i>To view the virtual vacancies, click the link below-</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/04/04/03042026093559-339582.pdf">https://medicaldialogues.in/pdf_upload/2026/04/04/03042026093559-339582.pdf</a><a href="https://medicaldialogues.in/pdf_upload/2026/04/04/03042026093559-339582.pdf" target="_blank"><b><i></i></b></a></p><p>The Medical Counselling Committee (MCC) has recently released the seat matrix for the 2nd round of counselling for the National Eligibility and Entrance Test Super Speciality (NEET SS) for the academic year 2025.
</p><p>This seat matrix includes newly added seats, vacant seats, and virtual vacant seats for participating candidates.
</p><p>According to the official NEET SS Seat Matrix 2025, a total of 6,591 seats are available for Round 2. Of these, 133 seats have been newly added, 1,858 seats are clearly vacant, and 4,600 seats are virtually vacant.</p></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><p dir="ltr">Below is the complete schedule as released by the MCC on its official website-</p><div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><p dir="ltr"><u>SCHEDULE FOR ALL-INDIA COUNSELING (ALLOTMENT PROCESS) FOR NEET SUPER SPECIALITY COURSES (D.M/ <a href="https://medicaldialogues.in/topics/mch" target="_blank">MCH </a>& DrNB SS) – 2025</u></p><div dir="ltr"><table><colgroup><col width="75"><col width="158"><col width="147"><col width="89"><col width="76"><col width="79"></colgroup><tbody><tr><td colspan="6"><p dir="ltr"><u>2nd ROUND</u></p></td></tr><tr><td><p dir="ltr">VERIFICATION OF SEAT MATRIX BY INSTITUTES</p></td><td><p dir="ltr">REGISTRATION/PAYMENT FACILITY</p></td><td><p dir="ltr">CHOICE FILLING/LOCKING</p></td><td><p dir="ltr">PROCESSING OF SEAT ALLOTMENT</p></td><td><p dir="ltr">RESULT</p></td><td><p dir="ltr">RESPORTING</p></td></tr><tr><td><p dir="ltr">26 and 27 March, 2026</p></td><td><p dir="ltr">Registration Facility will be available from 28 March, 2026, up to 12:00 NOON of 3 April, 2026( as per Server Time)</p></td><td><p dir="ltr">Choice Filling available from 29 March, 2026 upto 11:55 P.M of 4 April, 2026</p></td><td><p dir="ltr">5 April, 2026 to 6 April, 2026</p></td><td><p dir="ltr">7 April, 2026</p></td><td><p dir="ltr">8 April, 2026 to 16 April, 2026 (till 11:00 pm)</p></td></tr><tr><td></td><td><p dir="ltr">Payment facility will be available from 28 March 2026 up to 03:00 PM on 3 April 2026 as per Server Time</p></td><td><p dir="ltr">Choice Locking Facility available from 03:00 P.M of 4th April, upto 11:55 P.M of 4th April, 2026</p></td><td></td><td></td><td></td></tr><tr><td>DAYS</td><td><p dir="ltr">(7-Days)</p></td><td><p dir="ltr">(7-Days)</p></td><td><p dir="ltr">(2-Days)</p></td><td><p dir="ltr">(1-Day)</p></td><td><p dir="ltr">(9- Days)</p></td></tr></tbody></table></div></div><div class="pasted-from-word-wrapper"></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/6591-seats-up-for-grabs-in-mcc-neet-ss-counselling-2025-round-2-167546"><span class="read-this-also">Also Read:</span>6,591 seats up for grabs in MCC NEET SS counselling 2025 round 2</a></div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"></div></div>]]> </content:encoded>
</item>

<item>
<title>NEET MDS 2026 application correction window opens today</title>
<link>https://edusehat.com/en/neet-mds-2026-application-correction-window-opens-today</link>
<guid>https://edusehat.com/en/neet-mds-2026-application-correction-window-opens-today</guid>
<description><![CDATA[ New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) will open the correction window for the National Eligibility and Entrance Test Master of Dental Surgery (NEET MDS) exam for the academic year 2026. Registered candidates will be able to make corrections to their forms by visiting the official website of the NBE.During this period, candidates may make changes to any information or documents, with the exception of their name, nationality, email ID, mobile number, examination centre city, and Aadhaar number. Subsequently, the final edit window for NEET MDS will become available.Also Read: NEET MDS 2026: All Information You Need to KnowAccording to the official schedule released by the NBE, the NEET MDS correction window will open on April 4, 2026, and close on April 6, 2026. The final edit window will remain available from April 21 to April 22, 2026.STEPS TO EDIT NEET MDS 2026 APPLICATION FORMCandidates need to follow the steps given below to make the NEET MDS application form correction-STEP 1- Visit the NEET MDS official website.STEP 2- Click on the NEET MDS tab.STEP 3- Click on the Application Link and click on the Login tab.STEP 4- Log in through the user ID and password.STEP 5-  Edit the relevant fields.STEP 6- Click on the agreement checkbox, enter the captcha and submit the form.Meanwhile, in this regard, as per the official information bulletin released by the NBE, candidates who have successfully submitted their payment for the application during the Application Submission window shall only be allowed to edit their applications.No new application can be registered, or payment can be made during the edit window. Any information/document can be changed/corrected during the edit window except for Name, Test City, Nationality, Mobile Number, Aadhaar Number and Email ID. Information can be edited any number of times before the closure of the window. The last submitted information will be saved in the records.All editable fields in the application form shall be open for the candidate to make any corrections, if so required. Details of the field which cannot be edited are mentioned below.Information entered in the application form can be changed during the “Edit Window”. However, the following fields in the application form shall remain non-editable-1 Name of the Candidate.2 Email ID.3 Mobile number.4 Nationality.5 Test City.6 Aadhaar.No editing of information provided shall be permissible in the application form, once the edit window is over.NBEMS disclaims any liability that may arise due to incorrect information provided by the candidate during online application form submission.Subsequent to the closure of the edit window, any deficiency, if any, related to images/documents uploaded in the application form shall be communicated to the concerned candidatesAlso Read: NBE begins NEET MDS 2026 registrations, exam on May 2 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/01/338946-neet-mds-2026.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, MDS, 2026, application, correction, window, opens, today</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/01/338946-neet-mds-2026.webp"><p><b>New Delhi: </b>The National Board of Examinations in Medical Sciences (<a href="https://medicaldialogues.in/topics/nbems" target="_blank">NBEMS</a>) will open the correction window for the National Eligibility and Entrance Test Master of Dental Surgery (NEET MDS) exam for the academic year 2026.</p><p> Registered candidates will be able to make corrections to their forms by visiting the official website of the NBE.</p><div class="pasted-from-word-wrapper"><p dir="ltr">During this period, candidates may make changes to any information or documents, with the exception of their name, nationality, email ID, mobile number, examination centre city, and Aadhaar number. Subsequently, the final edit window for NEET MDS will become available.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/neet-mds-2026-all-information-you-need-to-know-166623"><b>Also Read: </b>NEET MDS 2026: All Information You Need to Know</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">According to the official schedule released by the NBE, the NEET MDS correction window will open on April 4, 2026, and close on April 6, 2026. The final edit window will remain available from April 21 to April 22, 2026.</p><p dir="ltr"><b><u>STEPS TO EDIT <a href="https://medicaldialogues.in/topics/neet-mds-2026" target="_blank">NEET MDS 2026</a> APPLICATION FORM</u></b></p><p dir="ltr"><b><i>Candidates need to follow the steps given below to make the NEET MDS application form correction-</i></b></p><p dir="ltr"><b>STEP 1-</b> Visit the NEET MDS official website.</p><p dir="ltr"><b>STEP 2-</b> Click on the NEET MDS tab.</p><p dir="ltr"><b>STEP 3- Click</b> on the Application Link and click on the Login tab.</p><p dir="ltr"><b>STEP 4-</b> Log in through the user ID and password.</p><p dir="ltr"><b>STEP 5- </b> Edit the relevant fields.</p><p dir="ltr"><b>STEP 6-</b> Click on the agreement checkbox, enter the captcha and submit the form.</p><p dir="ltr">Meanwhile, in this regard, as per the official information bulletin released by the NBE, candidates who have successfully submitted their payment for the application during the Application Submission window shall only be allowed to edit their applications.</p><p dir="ltr">No new application can be registered, or payment can be made during the edit window. Any information/document can be changed/corrected during the edit window except for Name, Test City, Nationality, Mobile Number, Aadhaar Number and Email ID. </p><p dir="ltr">Information can be edited any number of times before the closure of the window. The last submitted information will be saved in the records.</p><p dir="ltr">All editable fields in the application form shall be open for the candidate to make any corrections, if so required. Details of the field which cannot be edited are mentioned below.</p><p dir="ltr">Information entered in the application form can be changed during the “Edit Window”. However, the following fields in the application form shall remain non-editable-</p><p dir="ltr">1 Name of the Candidate.</p><p dir="ltr">2 Email ID.</p><p dir="ltr">3 Mobile number.</p><p dir="ltr">4 Nationality.</p><p dir="ltr">5 Test City.</p><p dir="ltr">6 Aadhaar.</p><p dir="ltr">No editing of information provided shall be permissible in the application form, once the edit window is over.</p><p dir="ltr">NBEMS disclaims any liability that may arise due to incorrect information provided by the candidate during online application form submission.</p><p dir="ltr">Subsequent to the closure of the edit window, any deficiency, if any, related to images/documents uploaded in the application form shall be communicated to the concerned candidates</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/medical-admissions/nbe-begins-neet-mds-2026-registrations-exam-on-may-2-166481"><b>Also Read: </b>NBE begins NEET MDS 2026 registrations, exam on May 2</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>Surgery delay: WB medical council finds surgeon guilty of medical negligence, issues notice</title>
<link>https://edusehat.com/en/surgery-delay-wb-medical-council-finds-surgeon-guilty-of-medical-negligence-issues-notice</link>
<guid>https://edusehat.com/en/surgery-delay-wb-medical-council-finds-surgeon-guilty-of-medical-negligence-issues-notice</guid>
<description><![CDATA[ Kolkata: The West Bengal Medical Council (WBMC) recently found a city-based surgeon prima facie guilty of medical negligence in connection with the death of a 42-year-old patient.Taking disciplinary action, the council has directed the surgeon to submit his reply to the charges within three weeks of receiving the official notice.The case dates back to February 2, 2024, when a patient was admitted to a Clinic with acute abdominal pain. Medical tests reportedly confirmed appendicitis. However, the patient’s family has alleged that the surgery was delayed by two days despite his condition.Also read- 95 percent complaints dismissed without probe: Corruption, unlawful practices alleged at WB medical councilAccording to the patient’s wife, &quot;He (doctor) told me the surgery was minor, but it took two and a half hours.&quot;Following the operation, the patient&#039;s condition worsened, and he was shifted to the ICU later that night and put on ventilator support. Her wife was informed that he had lost nearly two litres of blood, after which a second surgery was performed.With no improvement in his health, the family decided to shift him to a hospital in Hyderabad for further treatment. The doctors there said that one of his intestines got punctured during the surgery in Kolkata. Despite treatment, the patient later succumbed to his condition in Hyderabad.Following this, the WBMC, in a communication to the surgeon, mentioned, &quot;You have been found prima facie guilty of infamous conduct in a profession,&quot; reports TOI. Responding to the development, the surgeon said that he is yet to receive a copy of the WBMC order.Also read- Misconduct, misrepresentation, negligence! Gujarat medical council suspends 3 doctors ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/07/307363-doctor-14.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Surgery, delay:, medical, council, finds, surgeon, guilty, medical, negligence, issues, notice</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/07/307363-doctor-14.webp"><p><b>Kolkata: </b>The <a href="https://medicaldialogues.in/topics/west-Bengal-medical-council" target="_blank">West Bengal Medical Council </a>(WBMC) recently found a city-based surgeon prima facie guilty of <a href="https://medicaldialogues.in/topics/medical-negligence" target="_blank">medical negligence</a> in connection with the death of a 42-year-old patient.</p><p>Taking disciplinary action, the council has directed the surgeon to submit his reply to the charges within three weeks of receiving the official notice.</p><p>The case dates back to February 2, 2024, when a patient was admitted to a Clinic with acute abdominal pain. Medical tests reportedly confirmed appendicitis. However, the patient’s family has alleged that the surgery was delayed by two days despite his condition.</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/west-bengal/95-percent-complaints-dismissed-without-probe-corruption-unlawful-practices-alleged-at-wb-medical-council-161919" target="_blank">95 percent complaints dismissed without probe: Corruption, unlawful practices alleged at WB medical council</a></b></p><p>According to the patient’s wife, "He (doctor) told me the surgery was minor, but it took two and a half hours."</p><p>Following the operation, the patient's condition worsened, and he was shifted to the ICU later that night and put on ventilator support. Her wife was informed that he had lost nearly two litres of blood, after which a second surgery was performed.</p><p>With no improvement in his health, the family decided to shift him to a hospital in Hyderabad for further treatment. The doctors there said that one of his intestines got punctured during the surgery in Kolkata. Despite treatment, the patient later succumbed to his condition in Hyderabad.</p><p>Following this, the WBMC, in a communication to the surgeon, mentioned, "You have been found prima facie guilty of infamous conduct in a profession," <span>reports </span><a href="https://timesofindia.indiatimes.com/city/kolkata/med-body-finds-doc-guilty-of-negligence/articleshow/129986437.cms" target="_blank" rel="nofollow">TOI</a><span>. </span></p><p>Responding to the development, the surgeon said that he is yet to receive a copy of the WBMC order.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/misconduct-misrepresentation-negligence-gujarat-medical-council-suspends-3-doctors-166464" target="_blank">Misconduct, misrepresentation, negligence! Gujarat medical council suspends 3 doctors</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Moderate Wine Consumption May Slow Biological Aging in Men, Study Finds</title>
<link>https://edusehat.com/en/moderate-wine-consumption-may-slow-biological-aging-in-men-study-finds</link>
<guid>https://edusehat.com/en/moderate-wine-consumption-may-slow-biological-aging-in-men-study-finds</guid>
<description><![CDATA[ A recent study published in the International Journal of Public Health explored how wine consumption patterns relate to biological aging, offering new insights into how lifestyle choices may influence long-term health.
Unlike chronological age, Biological Age reflects the body’s physiological condition and is considered a stronger predictor of disease risk and longevity. Researchers analyzed data from over 22,000 adults in Italy’s Moli-sani cohort, using a deep learning model based on 36 biomarkers to estimate aging differences (Δage).
Participants were grouped by wine consumption levels, ranging from abstainers to heavy drinkers. The findings showed that men who consumed wine moderately—consistent with the Mediterranean Diet (about 125–500 mL daily)—experienced slightly slower biological aging compared to non-drinkers. The most notable benefit appeared at around 170 mL per day (roughly one to two glasses), where biological age was reduced by approximately 0.34 years.
However, this effect followed a U-shaped pattern. Both low and high levels of wine consumption showed neutral or negative associations with aging. Heavy drinking, in particular, was linked to accelerated aging, emphasizing that excess alcohol negates any potential benefits. Interestingly, total alcohol intake from all sources did not show the same positive association, suggesting that wine-specific compounds may play a role.
Researchers believe bioactive components such as Polyphenols—rather than alcohol itself—may contribute to these effects. These compounds are known for their antioxidant and anti-inflammatory properties, which may support healthier aging processes.
Notably, the observed associations were more evident in men, while results in women were not statistically significant, possibly due to differences in alcohol metabolism.
Overall, the study suggests that moderate wine consumption may be linked to slightly slower biological aging, but it does not establish causation. Experts emphasize that lifestyle factors such as diet quality, physical activity, and overall health habits remain far more influential in promoting healthy aging.
REFERENCE: Esposito, S., Di Castelnuovo, A., Costanzo, S., Gialluisi, A., Pepe, A., Ruggiero, E., De Curtis, A., Magnacca, S., Persichillo, M., Casanovas-Garriga, F., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., &amp; Bonaccio, M. (2026). Moderate Wine Consumption, Defined by the Mediterranean Diet, Is Associated With Delayed Biological Aging in Men From the Moli-sani Study. Int. J. Public Health. 71. DOI: 10.3389/ijph.2026.1609410, https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2026.1609410/full
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339591-untitled-design-2026-04-04t121243375.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Moderate, Wine, Consumption, May, Slow, Biological, Aging, Men, Study, Finds</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339591-untitled-design-2026-04-04t121243375.webp"><p>A recent study published in the<i> International Journal of Public Health </i>explored how wine consumption patterns relate to biological aging, offering new insights into how lifestyle choices may influence long-term health.
</p><p>Unlike chronological age, Biological Age reflects the body’s physiological condition and is considered a stronger predictor of disease risk and longevity. Researchers analyzed data from over 22,000 adults in Italy’s Moli-sani cohort, using a deep learning model based on 36 biomarkers to estimate aging differences (Δage).
</p><p>Participants were grouped by wine consumption levels, ranging from abstainers to heavy drinkers. The findings showed that men who consumed wine moderately—consistent with the Mediterranean Diet (about 125–500 mL daily)—experienced slightly slower biological aging compared to non-drinkers. The most notable benefit appeared at around 170 mL per day (roughly one to two glasses), where biological age was reduced by approximately 0.34 years.
</p><p>However, this effect followed a U-shaped pattern. Both low and high levels of wine consumption showed neutral or negative associations with aging. Heavy drinking, in particular, was linked to accelerated aging, emphasizing that excess alcohol negates any potential benefits. Interestingly, total alcohol intake from all sources did not show the same positive association, suggesting that wine-specific compounds may play a role.
</p><p>Researchers believe bioactive components such as Polyphenols—rather than alcohol itself—may contribute to these effects. These compounds are known for their antioxidant and anti-inflammatory properties, which may support healthier aging processes.
</p><p>Notably, the observed associations were more evident in men, while results in women were not statistically significant, possibly due to differences in alcohol metabolism.
</p><p>Overall, the study suggests that moderate wine consumption may be linked to slightly slower biological aging, but it does not establish causation. Experts emphasize that lifestyle factors such as diet quality, physical activity, and overall health habits remain far more influential in promoting healthy aging.
</p><p><b>REFERENCE: </b>Esposito, S., Di Castelnuovo, A., Costanzo, S., Gialluisi, A., Pepe, A., Ruggiero, E., De Curtis, A., Magnacca, S., Persichillo, M., Casanovas-Garriga, F., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., & Bonaccio, M. (2026). Moderate Wine Consumption, Defined by the Mediterranean Diet, Is Associated With Delayed Biological Aging in Men From the Moli-sani Study. Int. J. Public Health. 71. DOI: 10.3389/ijph.2026.1609410, https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2026.1609410/full
</p>]]> </content:encoded>
</item>

<item>
<title>This Simple Japanese Eating Habit is Linked to Longer Life Without Strict Dieting: Study Shows</title>
<link>https://edusehat.com/en/this-simple-japanese-eating-habit-is-linked-to-longer-life-without-strict-dieting-study-shows</link>
<guid>https://edusehat.com/en/this-simple-japanese-eating-habit-is-linked-to-longer-life-without-strict-dieting-study-shows</guid>
<description><![CDATA[ The Japanese philosophy of Hara Hachi Bu-eating until about 80% full-has gained global attention as a simple, sustainable approach to better health. Rooted in Confucian teachings, this practice promotes moderation, encouraging individuals to stop eating before reaching complete fullness and instead stay attuned to their body’s natural hunger and satiety signals.
Although direct scientific research on hara hachi bu is limited, studies on populations that follow similar eating patterns suggest meaningful benefits. People who eat this way tend to consume fewer calories, maintain a healthier body weight, and show lower average body mass index (BMI). 
This approach aligns closely with Mindful Eating and Intuitive Eating, both of which are associated with improved diet quality and reduced emotional eating.
Beyond weight management, hara hachi bu supports a healthier relationship with food. In today’s fast-paced world, many people eat while distracted—often using screens—which can lead to overeating and poor food choices. 
By slowing down, focusing on meals, and savoring each bite, individuals are more likely to recognize fullness cues and make balanced dietary decisions.
Practicing this method involves simple behavioral shifts. Eating without distractions, chewing slowly, and pausing during meals can help identify when the body feels comfortably satisfied rather than overly full. 
The goal is not restriction but awareness—stopping at a point where hunger is satisfied without discomfort.
However, this approach may not suit everyone. Individuals with higher nutritional demands, such as athletes, children, or those with specific medical conditions, may require tailored dietary strategies.
Ultimately, hara hachi bu is less about eating less and more about eating consciously. By fostering mindfulness and moderation, it offers a practical, long-term strategy for improving metabolic health, preventing overeating, and building a more balanced connection with food.REFERENCE: The Conversation. &quot;This simple Japanese eating habit could help you live longer without dieting.&quot; ScienceDaily. ScienceDaily, 2 April 2026. . ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339586-this-simple-japanese-eating-habit-is-linked-to-longer-life-without-strict-dieting.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>This, Simple, Japanese, Eating, Habit, Linked, Longer, Life, Without, Strict, Dieting:, Study, Shows</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339586-this-simple-japanese-eating-habit-is-linked-to-longer-life-without-strict-dieting.webp"><p>The Japanese philosophy of Hara Hachi Bu-eating until about 80% full-has gained global attention as a simple, sustainable approach to better health. Rooted in Confucian teachings, this practice promotes moderation, encouraging individuals to stop eating before reaching complete fullness and instead stay attuned to their body’s natural hunger and satiety signals.
</p><p>Although direct scientific research on hara hachi bu is limited, studies on populations that follow similar eating patterns suggest meaningful benefits. People who eat this way tend to consume fewer calories, maintain a healthier body weight, and show lower average body mass index (BMI). 
</p><p>This approach aligns closely with Mindful Eating and Intuitive Eating, both of which are associated with improved diet quality and reduced emotional eating.
</p><p>Beyond weight management, hara hachi bu supports a healthier relationship with food. In today’s fast-paced world, many people eat while distracted—often using screens—which can lead to overeating and poor food choices. 
</p><p>By slowing down, focusing on meals, and savoring each bite, individuals are more likely to recognize fullness cues and make balanced dietary decisions.
</p><p>Practicing this method involves simple behavioral shifts. Eating without distractions, chewing slowly, and pausing during meals can help identify when the body feels comfortably satisfied rather than overly full. 
</p><p>The goal is not restriction but awareness—stopping at a point where hunger is satisfied without discomfort.
</p><p>However, this approach may not suit everyone. Individuals with higher nutritional demands, such as athletes, children, or those with specific medical conditions, may require tailored dietary strategies.
</p><p>Ultimately, hara hachi bu is less about eating less and more about eating consciously. By fostering mindfulness and moderation, it offers a practical, long-term strategy for improving metabolic health, preventing overeating, and building a more balanced connection with food.</p><p><b>REFERENCE: </b>The Conversation. "This simple Japanese eating habit could help you live longer without dieting." ScienceDaily. ScienceDaily, 2 April 2026. <www.sciencedaily.com releases="">.</www.sciencedaily.com></p><p><br></p>]]> </content:encoded>
</item>

<item>
<title>American Heart Association Shares Nine Diet Rules to Lower Heart Disease Risk</title>
<link>https://edusehat.com/en/american-heart-association-shares-nine-diet-rules-to-lower-heart-disease-risk</link>
<guid>https://edusehat.com/en/american-heart-association-shares-nine-diet-rules-to-lower-heart-disease-risk</guid>
<description><![CDATA[ A recent scientific statement from the American Heart Association outlines evidence-based dietary patterns to reduce cardiovascular disease (CVD) risk and improve long-term heart health. The guidance emphasizes overall eating habits rather than focusing on single nutrients, highlighting that consistent, balanced diets play a central role in prevention.
Heart-healthy eating begins early in life and evolves through different life stages. Diets rich in vegetables, fruits, whole grains, lean proteins, and plant-based oils are strongly associated with lower risks of coronary heart disease, Type 2 Diabetes, and metabolic syndrome. In contrast, poor dietary habits in childhood can lead to obesity, hypertension, and dyslipidemia, increasing long-term cardiovascular risk.
A key principle is maintaining energy balance, aligning calorie intake with physical activity to support a healthy weight. The guidelines recommend regular movement, including at least 150 minutes of moderate activity per week for adults and daily physical activity for children.
The AHA highlights several core dietary features. First, consuming a wide variety of fruits and vegetables improves blood pressure, lipid levels, and glycemic control. Whole grains such as oats, brown rice, and quinoa are preferred over refined grains due to their fiber and nutrient content, which support gut health and reduce inflammation.
Protein quality is also crucial. Plant-based sources like legumes and nuts, along with fish and seafood, are linked to lower cardiovascular risk. Intake of red and processed meats should be minimized. Similarly, replacing saturated fats with unsaturated fats from oils like olive or canola helps lower LDL cholesterol.
The guidelines strongly advise limiting ultraprocessed foods, added sugars, and sodium, all of which are linked to higher risks of CVD and mortality. Increasing potassium intake through fruits and vegetables further supports blood pressure control.
Finally, alcohol consumption should be avoided or strictly limited, as no safe level has been established for cardiovascular health. Overall, these nine dietary principles provide a practical, lifelong approach to protecting heart health.
REFERENCE: Lichtenstein HA. et al. (2026) 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. American Heart Association. DOI: https://doi.org/10.1161/CIR.0000000000001435. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001435
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339584-untitled-design-2026-04-04t115335523.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:07 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>American, Heart, Association, Shares, Nine, Diet, Rules, Lower, Heart, Disease, Risk</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339584-untitled-design-2026-04-04t115335523.webp"><p>A recent scientific statement from the American Heart Association outlines evidence-based dietary patterns to reduce cardiovascular disease (CVD) risk and improve long-term heart health. The guidance emphasizes overall eating habits rather than focusing on single nutrients, highlighting that consistent, balanced diets play a central role in prevention.
</p><p>Heart-healthy eating begins early in life and evolves through different life stages. Diets rich in vegetables, fruits, whole grains, lean proteins, and plant-based oils are strongly associated with lower risks of coronary heart disease, Type 2 Diabetes, and metabolic syndrome. In contrast, poor dietary habits in childhood can lead to obesity, hypertension, and dyslipidemia, increasing long-term cardiovascular risk.
</p><p>A key principle is maintaining energy balance, aligning calorie intake with physical activity to support a healthy weight. The guidelines recommend regular movement, including at least 150 minutes of moderate activity per week for adults and daily physical activity for children.
</p><p>The AHA highlights several core dietary features. First, consuming a wide variety of fruits and vegetables improves blood pressure, lipid levels, and glycemic control. Whole grains such as oats, brown rice, and quinoa are preferred over refined grains due to their fiber and nutrient content, which support gut health and reduce inflammation.
</p><p>Protein quality is also crucial. Plant-based sources like legumes and nuts, along with fish and seafood, are linked to lower cardiovascular risk. Intake of red and processed meats should be minimized. Similarly, replacing saturated fats with unsaturated fats from oils like olive or canola helps lower LDL cholesterol.
</p><p>The guidelines strongly advise limiting ultraprocessed foods, added sugars, and sodium, all of which are linked to higher risks of CVD and mortality. Increasing potassium intake through fruits and vegetables further supports blood pressure control.
</p><p>Finally, alcohol consumption should be avoided or strictly limited, as no safe level has been established for cardiovascular health. Overall, these nine dietary principles provide a practical, lifelong approach to protecting heart health.
</p><p><b>REFERENCE: </b>Lichtenstein HA. et al. (2026) 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. American Heart Association. DOI: https://doi.org/10.1161/CIR.0000000000001435. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001435
</p>]]> </content:encoded>
</item>

<item>
<title>Medical Bulletin 04/April/2026</title>
<link>https://edusehat.com/en/medical-bulletin-04april2026</link>
<guid>https://edusehat.com/en/medical-bulletin-04april2026</guid>
<description><![CDATA[ Here are the top medical news for today:American Heart Association Shares Nine Diet Rules to Lower Heart Disease Risk
A recent scientific statement from the American Heart Association outlines evidence-based dietary patterns to reduce cardiovascular disease (CVD) risk and improve long-term heart health. The guidance emphasizes overall eating habits rather than focusing on single nutrients, highlighting that consistent, balanced diets play a central role in prevention.
Heart-healthy eating begins early in life and evolves through different life stages. Diets rich in vegetables, fruits, whole grains, lean proteins, and plant-based oils are strongly associated with lower risks of coronary heart disease, Type 2 Diabetes, and metabolic syndrome. In contrast, poor dietary habits in childhood can lead to obesity, hypertension, and dyslipidemia, increasing long-term cardiovascular risk.
A key principle is maintaining energy balance—aligning calorie intake with physical activity to support a healthy weight. The guidelines recommend regular movement, including at least 150 minutes of moderate activity per week for adults and daily physical activity for children.
The AHA highlights several core dietary features. First, consuming a wide variety of fruits and vegetables improves blood pressure, lipid levels, and glycemic control. Whole grains such as oats, brown rice, and quinoa are preferred over refined grains due to their fiber and nutrient content, which support gut health and reduce inflammation.
Protein quality is also crucial. Plant-based sources like legumes and nuts, along with fish and seafood, are linked to lower cardiovascular risk. Intake of red and processed meats should be minimized. Similarly, replacing saturated fats with unsaturated fats from oils like olive or canola helps lower LDL cholesterol.
The guidelines strongly advise limiting ultraprocessed foods, added sugars, and sodium, all of which are linked to higher risks of CVD and mortality. Increasing potassium intake through fruits and vegetables further supports blood pressure control.
Finally, alcohol consumption should be avoided or strictly limited, as no safe level has been established for cardiovascular health. Overall, these nine dietary principles provide a practical, lifelong approach to protecting heart health.
REFERENCE: Lichtenstein HA. et al. (2026) 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. American Heart Association. DOI: https://doi.org/10.1161/CIR.0000000000001435. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001435
This Simple Japanese Eating Habit is Linked to Longer Life Without Strict Dieting
The Japanese philosophy of Hara Hachi Bu—eating until about 80% full—has gained global attention as a simple, sustainable approach to better health. Rooted in Confucian teachings, this practice promotes moderation, encouraging individuals to stop eating before reaching complete fullness and instead stay attuned to their body’s natural hunger and satiety signals.
Although direct scientific research on hara hachi bu is limited, studies on populations that follow similar eating patterns suggest meaningful benefits. People who eat this way tend to consume fewer calories, maintain a healthier body weight, and show lower average body mass index (BMI). 
This approach aligns closely with Mindful Eating and Intuitive Eating, both of which are associated with improved diet quality and reduced emotional eating.
Beyond weight management, hara hachi bu supports a healthier relationship with food. In today’s fast-paced world, many people eat while distracted—often using screens—which can lead to overeating and poor food choices. 
By slowing down, focusing on meals, and savoring each bite, individuals are more likely to recognize fullness cues and make balanced dietary decisions.
Practicing this method involves simple behavioral shifts. Eating without distractions, chewing slowly, and pausing during meals can help identify when the body feels comfortably satisfied rather than overly full. 
The goal is not restriction but awareness—stopping at a point where hunger is satisfied without discomfort.
However, this approach may not suit everyone. Individuals with higher nutritional demands, such as athletes, children, or those with specific medical conditions, may require tailored dietary strategies.
Ultimately, hara hachi bu is less about eating less and more about eating consciously. By fostering mindfulness and moderation, it offers a practical, long-term strategy for improving metabolic health, preventing overeating, and building a more balanced connection with food.
REFERENCE: The Conversation. &quot;This simple Japanese eating habit could help you live longer without dieting.&quot; ScienceDaily. ScienceDaily, 2 April 2026. .
Moderate Wine Consumption May Slow Biological Aging in Men, Study Finds
A recent study published in the International Journal of Public Health explored how wine consumption patterns relate to biological aging, offering new insights into how lifestyle choices may influence long-term health.
Unlike chronological age, Biological Age reflects the body’s physiological condition and is considered a stronger predictor of disease risk and longevity. Researchers analyzed data from over 22,000 adults in Italy’s Moli-sani cohort, using a deep learning model based on 36 biomarkers to estimate aging differences (Δage).
Participants were grouped by wine consumption levels, ranging from abstainers to heavy drinkers. The findings showed that men who consumed wine moderately—consistent with the Mediterranean Diet (about 125–500 mL daily)—experienced slightly slower biological aging compared to non-drinkers. The most notable benefit appeared at around 170 mL per day (roughly one to two glasses), where biological age was reduced by approximately 0.34 years.
However, this effect followed a U-shaped pattern. Both low and high levels of wine consumption showed neutral or negative associations with aging. Heavy drinking, in particular, was linked to accelerated aging, emphasizing that excess alcohol negates any potential benefits. Interestingly, total alcohol intake from all sources did not show the same positive association, suggesting that wine-specific compounds may play a role.
Researchers believe bioactive components such as Polyphenols—rather than alcohol itself—may contribute to these effects. These compounds are known for their antioxidant and anti-inflammatory properties, which may support healthier aging processes.
Notably, the observed associations were more evident in men, while results in women were not statistically significant, possibly due to differences in alcohol metabolism.
Overall, the study suggests that moderate wine consumption may be linked to slightly slower biological aging, but it does not establish causation. Experts emphasize that lifestyle factors such as diet quality, physical activity, and overall health habits remain far more influential in promoting healthy aging.
REFERENCE: Esposito, S., Di Castelnuovo, A., Costanzo, S., Gialluisi, A., Pepe, A., Ruggiero, E., De Curtis, A., Magnacca, S., Persichillo, M., Casanovas-Garriga, F., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., &amp; Bonaccio, M. (2026). Moderate Wine Consumption, Defined by the Mediterranean Diet, Is Associated With Delayed Biological Aging in Men From the Moli-sani Study. Int. J. Public Health. 71. DOI: 10.3389/ijph.2026.1609410, https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2026.1609410/full
 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339594-top-medical-2026-04-04t121823212.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Medical, Bulletin, 04April2026</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339594-top-medical-2026-04-04t121823212.webp"><p><b>Here are the top medical news for today:</b></p><p><b>American Heart Association Shares Nine Diet Rules to Lower Heart Disease Risk
</b></p><p>A recent scientific statement from the American Heart Association outlines evidence-based dietary patterns to reduce cardiovascular disease (CVD) risk and improve long-term heart health. The guidance emphasizes overall eating habits rather than focusing on single nutrients, highlighting that consistent, balanced diets play a central role in prevention.
</p><p>Heart-healthy eating begins early in life and evolves through different life stages. Diets rich in vegetables, fruits, whole grains, lean proteins, and plant-based oils are strongly associated with lower risks of coronary heart disease, Type 2 Diabetes, and metabolic syndrome. In contrast, poor dietary habits in childhood can lead to obesity, hypertension, and dyslipidemia, increasing long-term cardiovascular risk.
</p><p>A key principle is maintaining energy balance—aligning calorie intake with physical activity to support a healthy weight. The guidelines recommend regular movement, including at least 150 minutes of moderate activity per week for adults and daily physical activity for children.
</p><p>The AHA highlights several core dietary features. First, consuming a wide variety of fruits and vegetables improves blood pressure, lipid levels, and glycemic control. Whole grains such as oats, brown rice, and quinoa are preferred over refined grains due to their fiber and nutrient content, which support gut health and reduce inflammation.
</p><p>Protein quality is also crucial. Plant-based sources like legumes and nuts, along with fish and seafood, are linked to lower cardiovascular risk. Intake of red and processed meats should be minimized. Similarly, replacing saturated fats with unsaturated fats from oils like olive or canola helps lower LDL cholesterol.
</p><p>The guidelines strongly advise limiting ultraprocessed foods, added sugars, and sodium, all of which are linked to higher risks of CVD and mortality. Increasing potassium intake through fruits and vegetables further supports blood pressure control.
</p><p>Finally, alcohol consumption should be avoided or strictly limited, as no safe level has been established for cardiovascular health. Overall, these nine dietary principles provide a practical, lifelong approach to protecting heart health.
</p><p><b>REFERENCE:</b> Lichtenstein HA. et al. (2026) 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. American Heart Association. DOI: https://doi.org/10.1161/CIR.0000000000001435. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001435
</p><p><b><br></b></p><p><b>This Simple Japanese Eating Habit is Linked to Longer Life Without Strict Dieting
</b></p><p>The Japanese philosophy of Hara Hachi Bu—eating until about 80% full—has gained global attention as a simple, sustainable approach to better health. Rooted in Confucian teachings, this practice promotes moderation, encouraging individuals to stop eating before reaching complete fullness and instead stay attuned to their body’s natural hunger and satiety signals.
</p><p>Although direct scientific research on hara hachi bu is limited, studies on populations that follow similar eating patterns suggest meaningful benefits. People who eat this way tend to consume fewer calories, maintain a healthier body weight, and show lower average body mass index (BMI). 
</p><p>This approach aligns closely with Mindful Eating and Intuitive Eating, both of which are associated with improved diet quality and reduced emotional eating.
</p><p>Beyond weight management, hara hachi bu supports a healthier relationship with food. In today’s fast-paced world, many people eat while distracted—often using screens—which can lead to overeating and poor food choices. 
</p><p>By slowing down, focusing on meals, and savoring each bite, individuals are more likely to recognize fullness cues and make balanced dietary decisions.
</p><p>Practicing this method involves simple behavioral shifts. Eating without distractions, chewing slowly, and pausing during meals can help identify when the body feels comfortably satisfied rather than overly full. 
</p><p>The goal is not restriction but awareness—stopping at a point where hunger is satisfied without discomfort.
</p><p>However, this approach may not suit everyone. Individuals with higher nutritional demands, such as athletes, children, or those with specific medical conditions, may require tailored dietary strategies.
</p><p>Ultimately, hara hachi bu is less about eating less and more about eating consciously. By fostering mindfulness and moderation, it offers a practical, long-term strategy for improving metabolic health, preventing overeating, and building a more balanced connection with food.
</p><p><b>REFERENCE: </b>The Conversation. "This simple Japanese eating habit could help you live longer without dieting." ScienceDaily. ScienceDaily, 2 April 2026. <www.sciencedaily.com releases="">.
</www.sciencedaily.com></p><p><b><br></b></p><p><b>Moderate Wine Consumption May Slow Biological Aging in Men, Study Finds
</b></p><p>A recent study published in the International Journal of Public Health explored how wine consumption patterns relate to biological aging, offering new insights into how lifestyle choices may influence long-term health.
</p><p>Unlike chronological age, Biological Age reflects the body’s physiological condition and is considered a stronger predictor of disease risk and longevity. Researchers analyzed data from over 22,000 adults in Italy’s Moli-sani cohort, using a deep learning model based on 36 biomarkers to estimate aging differences (Δage).
</p><p>Participants were grouped by wine consumption levels, ranging from abstainers to heavy drinkers. The findings showed that men who consumed wine moderately—consistent with the Mediterranean Diet (about 125–500 mL daily)—experienced slightly slower biological aging compared to non-drinkers. The most notable benefit appeared at around 170 mL per day (roughly one to two glasses), where biological age was reduced by approximately 0.34 years.
</p><p>However, this effect followed a U-shaped pattern. Both low and high levels of wine consumption showed neutral or negative associations with aging. Heavy drinking, in particular, was linked to accelerated aging, emphasizing that excess alcohol negates any potential benefits. Interestingly, total alcohol intake from all sources did not show the same positive association, suggesting that wine-specific compounds may play a role.
</p><p>Researchers believe bioactive components such as Polyphenols—rather than alcohol itself—may contribute to these effects. These compounds are known for their antioxidant and anti-inflammatory properties, which may support healthier aging processes.
</p><p>Notably, the observed associations were more evident in men, while results in women were not statistically significant, possibly due to differences in alcohol metabolism.
</p><p>Overall, the study suggests that moderate wine consumption may be linked to slightly slower biological aging, but it does not establish causation. Experts emphasize that lifestyle factors such as diet quality, physical activity, and overall health habits remain far more influential in promoting healthy aging.
</p><p><b>REFERENCE:</b> Esposito, S., Di Castelnuovo, A., Costanzo, S., Gialluisi, A., Pepe, A., Ruggiero, E., De Curtis, A., Magnacca, S., Persichillo, M., Casanovas-Garriga, F., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., & Bonaccio, M. (2026). Moderate Wine Consumption, Defined by the Mediterranean Diet, Is Associated With Delayed Biological Aging in Men From the Moli-sani Study. Int. J. Public Health. 71. DOI: 10.3389/ijph.2026.1609410, https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2026.1609410/full
</p>]]> </content:encoded>
</item>

<item>
<title>Intas Pharma Secures 5&#45;Year NPPA Price Control Exemption for Patented Clozapine ER Capsules</title>
<link>https://edusehat.com/en/intas-pharma-secures-5-year-nppa-price-control-exemption-for-patented-clozapine-er-capsules</link>
<guid>https://edusehat.com/en/intas-pharma-secures-5-year-nppa-price-control-exemption-for-patented-clozapine-er-capsules</guid>
<description><![CDATA[ New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has granted a five-year exemption from price control provisions under the Drugs (Prices Control) Order, 2013 (DPCO) to Intas Pharmaceuticals Limited for its patented formulations &quot;Clozapine Extended Release Capsules 12.5 mg/25 mg /50 mg /100 mg /200 mg&quot; from the date of commencement of commercial production in the country by the manufacturer or expiry of the Indian patent, whichever may be earlier.Further, the notice stated that Intas Pharmaceuticals Limited shall inform NPPA of the date of commercial production of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg” in the country and the Price to Retailer (PTR) and Maximum Retail Price fixed by the company in respect of the said formulations by issuing a price list in Form V under DPCO, 2013.This came after an application was received from Intas Pharmaceuticals Limited seeking exemption from the provisions of DPCO, 2013 under Para 32 (ii) and (iii) of the said order in respect of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg.&quot;Further, the Patent Office, Government of India, has granted Patent to Intas Pharmaceuticals Limited for an invention entitled “Extended Release pharmaceutical composition of Clozapine” in accordance with the provisions of the Patents Act, 1970 (Patent No. 437433 and date of Grant 05.07.2023).Also Read: Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg TabletsThe National Pharmaceutical Pricing Authority (NPPA) was established vide the Resolution of the Government of India in the Ministry of Chemicals and Fertilizers No. 33/7/97-PI. I dated 29th August, 1997, inter alia, to fix prices and notify the changes therein, if any, of bulk drugs and formulations, monitor the prices of non-scheduled drugs and formulations; and oversee the implementation of the provisions of the Drugs (Price Control) Order (DPCO).Further, the Ministry of Chemicals and Fertilizers, vide S.O.1394 (E) dated 30th May, 2013, in exercise of the powers conferred by Sections 3 and 5 of the Essential Commodities Act, 1955, has delegated powers under specified provisions of the DPCO, 2013, including para 32, to be exercised by the NPPA on behalf of the Central Government.In addition, the notice highlighted that the NPPA, in its 144th meeting held on 24.03.2026, observed that M/s Intas Pharmaceuticals Limited meets the requirements of para 32(ii) of DPCO, 2013 and that the formulations are covered under a granted patent.Accordingly, the Authority decided that exemption may be granted to M/s Intas Pharmaceuticals Limited under para 32(ii) of DPCO, 2013 for the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg”.In line with the above, the notice added,&quot;In exercise of the powers delegated under para 32 of the Drugs (Prices Control) Order, 2013 vide S.O.1394(E) dated 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, M/s Intas Pharmaceuticals Limited is exempted from the provisions of DPCO, 2013 under para 32(ii) of the said order in respect of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg” for a period of five years from the date of the commencement of commercial production in the country by the manufacturer or expiry of the Indian patent, whichever may be earlier.&quot;In addition, the notice stated that Intas Pharmaceuticals Limited shall, after the expiry of the period of exemption granted under para. 32(ii) of DPCO, 2013, shall follow the notified ceiling price or seek retail price approval three months before the expiry of the exemption, as applicable, for the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg.To view the official notice, click the link below:https://medicaldialogues.in/pdf_upload/2026/03/31/87471a042b62714d4b65ceb516a3deee-338610.pdf ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2023/01/11/197637-intas-pharma-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Intas, Pharma, Secures, 5-Year, NPPA, Price, Control, Exemption, for, Patented, Clozapine, Capsules</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2023/01/11/197637-intas-pharma-2.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi</b>: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has granted a five-year exemption from price control provisions under the Drugs (Prices Control) Order, 2013 (DPCO) to Intas Pharmaceuticals Limited for its patented formulations "Clozapine Extended Release Capsules 12.5 mg/25 mg /50 mg /100 mg /200 mg" from the date of commencement of commercial production in the country by the manufacturer or expiry of the Indian patent, whichever may be earlier.</p></div><div class="pasted-from-word-wrapper"><p>Further, the notice stated that Intas Pharmaceuticals Limited shall inform NPPA of the date of commercial production of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg” in the country and the Price to Retailer (PTR) and Maximum Retail Price fixed by the company in respect of the said formulations by issuing a price list in Form V under DPCO, 2013.</p><p>This came after an application was received from Intas Pharmaceuticals Limited seeking exemption from the provisions of DPCO, 2013 under Para 32 (ii) and (iii) of the said order in respect of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg."</p><p>Further, the Patent Office, Government of India, has granted Patent to Intas Pharmaceuticals Limited for an invention entitled “Extended Release pharmaceutical composition of Clozapine” in accordance with the provisions of the Patents Act, 1970 (Patent No. 437433 and date of Grant 05.07.2023).</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/wockhardt-gets-5-year-nppa-price-control-exemption-for-nafithromycin-400-mg-tablets-167632"><b><i>Also Read: Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg Tablets</i></b></a></div><p>The National Pharmaceutical Pricing Authority (NPPA) was established vide the Resolution of the Government of India in the Ministry of Chemicals and Fertilizers No. 33/7/97-PI. I dated 29th August, 1997, inter alia, to fix prices and notify the changes therein, if any, of bulk drugs and formulations, monitor the prices of non-scheduled drugs and formulations; and oversee the implementation of the provisions of the Drugs (Price Control) Order (DPCO).</p><p>Further, the Ministry of Chemicals and Fertilizers, vide S.O.1394 (E) dated 30th May, 2013, in exercise of the powers conferred by Sections 3 and 5 of the Essential Commodities Act, 1955, has delegated powers under specified provisions of the DPCO, 2013, including para 32, to be exercised by the NPPA on behalf of the Central Government.</p><p>In addition, the notice highlighted that the NPPA, in its 144th meeting held on 24.03.2026, observed that M/s Intas Pharmaceuticals Limited meets the requirements of para 32(ii) of DPCO, 2013 and that the formulations are covered under a granted patent.</p><p>Accordingly, the Authority decided that exemption may be granted to M/s Intas Pharmaceuticals Limited under para 32(ii) of DPCO, 2013 for the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg”.</p><p>In line with the above, the notice added,</p><blockquote>"In exercise of the powers delegated under para 32 of the Drugs (Prices Control) Order, 2013 vide S.O.1394(E) dated 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, M/s Intas Pharmaceuticals Limited is exempted from the provisions of DPCO, 2013 under para 32(ii) of the said order in respect of the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg” for a period of five years from the date of the commencement of commercial production in the country by the manufacturer or expiry of the Indian patent, whichever may be earlier."</blockquote><p>In addition, the notice stated that Intas Pharmaceuticals Limited shall, after the expiry of the period of exemption granted under para. 32(ii) of DPCO, 2013, shall follow the notified ceiling price or seek retail price approval three months before the expiry of the exemption, as applicable, for the formulations “Clozapine Extended Release Capsules 12.5 mg / 25 mg / 50 mg / 100 mg / 200 mg.</p><p><b><i>To view the official notice, click the link below:</i></b></p><p><a href="https://medicaldialogues.in/pdf_upload/2026/03/31/87471a042b62714d4b65ceb516a3deee-338610.pdf" target="_blank">https://medicaldialogues.in/pdf_upload/2026/03/31/87471a042b62714d4b65ceb516a3deee-338610.pdf</a></p></div>]]> </content:encoded>
</item>

<item>
<title>International Patients&amp;apos; Union Conference 2026 brings patients, doctors, policymakers together for healthcare dialogue</title>
<link>https://edusehat.com/en/international-patients-union-conference-2026-brings-patients-doctors-policymakers-together-for-healthcare-dialogue</link>
<guid>https://edusehat.com/en/international-patients-union-conference-2026-brings-patients-doctors-policymakers-together-for-healthcare-dialogue</guid>
<description><![CDATA[ New Delhi: From quiet hospital corridors to crowded pharmacy queues, patients in India carry stories that rarely reach the rooms where decisions are made. On 8 April 2026, those stories will finally move to the front row at the International Patients’ Union Conference (IPUC) at the India International Centre (IIC), New Delhi. The summit will bring together over 220 patients, caregivers, clinicians, policymakers, insurers and industry leaders under the theme, Voices to Action. Action to Impact.Joining the dialogue will be distinguished leaders, including Prof. (Dr.) K. Srinath Reddy, Founding President of the Public Health Foundation of India (PHFI); Dr. K. K. Talwar, Former Chairman of the Medical Council of India and Former Head of the Department of Cardiology at AIIMS, New Delhi and Director of PGIMER Chandigarh; Dr. Neelam Mohan, National President, Indian Academy of Paediatrics and Senior Director &amp; HOD of Paediatric Gastroenterology, Hepatology and Liver Transplantation at Medanta – The Medicity; and Dr. Shirshendu Mukherjee, Managing Director of the Wadhwani Innovation Network, amongst others.Also Read:AI-Driven clinical tools to remove subjectivity, improve accuracy: Dr Jitendra SinghForget the usual parade of PowerPoints and buzzwords. Picture patients and caregivers grabbing the spotlight alongside former ministers, regulators and pharma bosses, firing off the question everyone&#039;s dodging. If &quot;patient-centric&quot; is the mantra, why do so many still feel stranded in the system?A “reverse panel” where patients question the audience pushes people out of the comfort of speeches and into real dialogue. Every session is meant to move from story to solution, and from complaint to a clear next step.Setting the tone for the conference, Dr. Rajendra Pratap Gupta, Founder, International Patients’ Union, will deliver the opening address, presenting key findings from the IPUC 2026 survey. These insights will highlight critical areas where healthcare stakeholders must act without further delay.Right after, “From Patient-Centric to Patient-Driven: Turning Voice into Action &amp; Impact” will unleash real patient journeys. ADHD battles, interstitial lung disease struggles, cancer and AIDS fights. They&#039;ll zero in on empathy black holes, communication breakdowns, and accountability dodges, daring everyone to own up and act.Money worries sit at the heart of most illnesses, and “From Coverage to Care: Insurance, Assurance and Real Cost of Healthcare” faces that reality directly. Senior voices from hospitals, insurance, national health agencies and the media will look at whether insurance is the right model for India, what really happens in the golden hour of an emergency, why TPA approvals take so long and how VIP culture quietly decides who is seen first.In the next session, “Longevity vs. HALE: Are we living longer or living healthier?”, leading clinicians, public health experts, and health-tech innovators will examine whether more years of life are actually translating into more years of good health. Geriatric care, lifestyle diseases and system design will come into focus, with a live poll asking the audience to imagine the quality of life India is heading towards.“Educating and Empowering Patients: A Critical but Overlooked Pillar of Care” shifts the focus to a quieter but powerful change. Legal, policy, medical and digital health experts, along with government representatives, will examine how misinformation spreads faster than medicine, how fear of side effects leads to under-treatment, and how low awareness of cancer screening, vaccines, and government schemes leaves many people behind. As patients increasingly turn to online platforms, including tools like ChatGPT, for health information and guidance, the discussion will also explore the opportunities and risks of this evolving digital landscape. The conversation ranges from AYUSH and allopathy to the double-edged nature of health information online, making a strong case for treating patient education as a core part of care.In “Responsible Pharma: Is the Pharmaceutical Industry truly Patient-driven?”, senior leaders from major pharmaceutical companies and health policy step into a space where patients and caregivers often feel unheard. They will take on questions about drug prices, the quality of generic medicines, the place of patients in conversations on trials, the marketing of antibiotics and weight loss drugs in the absence of an OTC list, and what happens when familiar brands suddenly go missing from the market.“Who really guarantees care when the healthcare system fails? Who failed whom?” brings together former regulators, medical council leaders, student representatives and senior clinicians to take on tough questions about rural access, NEET cut-offs and doctor quality, crowded OPDs, the real role of accreditation and the unregulated pricing of diagnostics. In a country where families often sell land, take loans or simply abandon treatment, this session asks who is truly accountable when things go wrong.The day will also showcase the raw, unscripted voices taking center stage at an Open Mic session, where patients, caregivers, and everyday citizens will lay bare their stories and struggles. Pathfinder Awards will spotlight the real change-makers, individuals and groups who&#039;ve delivered true patient-centric care, not just talked about it.A Special Address and heartfelt Vote of Thanks will circle back to the International Patients’ Union&#039;s bold mission: flipping healthcare from supplier-driven to careseeker-led. Over the four years, this has become the go-to place for everyone, from policymakers and industry to patient groups and civil society. It remains the most important gathering for the real advocates of patient-centric healthcare and shows that we are still far behind where we ought to be.The list of dignitaries who have spoken in the past includes who’s who of healthcare - Dr. Thomas Zeltner, Chairman, WHO Foundation; Dr. Vinod K. Paul, Member (Health), NITI Aayog; Dr. B. N. Gangadhar, Psychiatrist and Former Director, National Institute of Mental Health and Neurosciences (NIMHANS); and Shri. Bharat Lal, Secretary General, National Human Rights Commission.For patients and caregivers, this is one of the few rooms where your experience is not a footnote, it is the starting point. For doctors, nurses, hospital administrators and insurers, it is an invitation to listen closely, answer frankly and think about how trust can be rebuilt. For policymakers, journalists and civil society, it offers a clear view of what lies between policy documents and real life.On 8 April 2026 at IIC Delhi, the International Patients’ Union Conference 2026 will ask everyone in the room to choose between leaving with a good quote or leaving with a promise they are willing to be held to. If you believe healthcare should move beyond slogans and show real action and real impact, this is where you need to be.Also Read:Kanpur Doctor Couple Detained in Illegal Kidney Transplant Racket ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339427-patient-confrence.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>International, Patients, Union, Conference, 2026, brings, patients, doctors, policymakers, together, for, healthcare, dialogue</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339427-patient-confrence.webp"><div class="pasted-from-word-wrapper"><p><span>New Delhi: From quiet hospital corridors to crowded pharmacy queues, patients in India carry stories that rarely reach the rooms where decisions are made. </span></p><p>On 8 April 2026, those stories will finally move to the front row at the International Patients’ Union Conference (IPUC) at the India International Centre (IIC), New Delhi. The summit will bring together over 220 patients, caregivers, clinicians, policymakers, insurers and industry leaders under the theme, Voices to Action. Action to Impact.</p><p>Joining the dialogue will be distinguished leaders, including Prof. (Dr.) K. Srinath Reddy, Founding President of the Public Health Foundation of India (PHFI); Dr. K. K. Talwar, Former Chairman of the Medical Council of India and Former Head of the Department of Cardiology at <a href="https://medicaldialogues.in/topics/AIIMS" target="_blank">AIIMS</a>, New Delhi and Director of <a href="https://medicaldialogues.in/topics/PGIMER" target="_blank">PGIMER </a>Chandigarh; Dr. Neelam Mohan, National President, Indian Academy of Paediatrics and Senior Director & HOD of Paediatric Gastroenterology, Hepatology and Liver Transplantation at Medanta – The Medicity; and Dr. Shirshendu Mukherjee, Managing Director of the Wadhwani Innovation Network, amongst others.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/ai-driven-clinical-tools-to-remove-subjectivity-improve-accuracy-dr-jitendra-singh-165204"><b>Also Read:AI-Driven clinical tools to remove subjectivity, improve accuracy: Dr Jitendra Singh</b></a></p><p>Forget the usual parade of PowerPoints and buzzwords. Picture patients and caregivers grabbing the spotlight alongside former ministers, regulators and pharma bosses, firing off the question everyone's dodging. If "patient-centric" is the mantra, why do so many still feel stranded in the system?</p><p>A “reverse panel” where patients question the audience pushes people out of the comfort of speeches and into real dialogue. Every session is meant to move from story to solution, and from complaint to a clear next step.</p><p>Setting the tone for the conference, Dr. Rajendra Pratap Gupta, Founder, International Patients’ Union, will deliver the opening address, presenting key findings from the IPUC 2026 survey. These insights will highlight critical areas where healthcare stakeholders must act without further delay.</p><p>Right after, “From Patient-Centric to Patient-Driven: Turning Voice into Action & Impact” will unleash real patient journeys. ADHD battles, interstitial lung disease struggles, cancer and AIDS fights. They'll zero in on empathy black holes, communication breakdowns, and accountability dodges, daring everyone to own up and act.</p><p>Money worries sit at the heart of most illnesses, and “From Coverage to Care: Insurance, Assurance and Real Cost of Healthcare” faces that reality directly. Senior voices from hospitals, insurance, national health agencies and the media will look at whether insurance is the right model for India, what really happens in the golden hour of an emergency, why TPA approvals take so long and how VIP culture quietly decides who is seen first.</p><p>In the next session, “Longevity vs. HALE: Are we living longer or living healthier?”, leading clinicians, public health experts, and health-tech innovators will examine whether more years of life are actually translating into more years of good health. Geriatric care, lifestyle diseases and system design will come into focus, with a live poll asking the audience to imagine the quality of life India is heading towards.</p><p>“Educating and Empowering Patients: A Critical but Overlooked Pillar of Care” shifts the focus to a quieter but powerful change. Legal, policy, medical and digital health experts, along with government representatives, will examine how misinformation spreads faster than medicine, how fear of side effects leads to under-treatment, and how low awareness of cancer screening, vaccines, and government schemes leaves many people behind. As patients increasingly turn to online platforms, including tools like ChatGPT, for health information and guidance, the discussion will also explore the opportunities and risks of this evolving digital landscape. The conversation ranges from AYUSH and allopathy to the double-edged nature of health information online, making a strong case for treating patient education as a core part of care.</p><p>In “Responsible Pharma: Is the Pharmaceutical Industry truly Patient-driven?”, senior leaders from major pharmaceutical companies and health policy step into a space where patients and caregivers often feel unheard. They will take on questions about drug prices, the quality of generic medicines, the place of patients in conversations on trials, the marketing of antibiotics and weight loss drugs in the absence of an OTC list, and what happens when familiar brands suddenly go missing from the market.</p><p>“Who really guarantees care when the healthcare system fails? Who failed whom?” brings together former regulators, medical council leaders, student representatives and senior clinicians to take on tough questions about rural access, NEET cut-offs and doctor quality, crowded OPDs, the real role of accreditation and the unregulated pricing of diagnostics. In a country where families often sell land, take loans or simply abandon treatment, this session asks who is truly accountable when things go wrong.</p><p>The day will also showcase the raw, unscripted voices taking center stage at an Open Mic session, where patients, caregivers, and everyday citizens will lay bare their stories and struggles. Pathfinder Awards will spotlight the real change-makers, individuals and groups who've delivered true patient-centric care, not just talked about it.</p><p>A Special Address and heartfelt Vote of Thanks will circle back to the International Patients’ Union's bold mission: flipping healthcare from supplier-driven to careseeker-led. Over the four years, this has become the go-to place for everyone, from policymakers and industry to patient groups and civil society. It remains the most important gathering for the real advocates of patient-centric healthcare and shows that we are still far behind where we ought to be.</p><p>The list of dignitaries who have spoken in the past includes who’s who of healthcare - Dr. Thomas Zeltner, Chairman, WHO Foundation; Dr. Vinod K. Paul, Member (Health), NITI Aayog; Dr. B. N. Gangadhar, Psychiatrist and Former Director, National Institute of Mental Health and Neurosciences (NIMHANS); and Shri. Bharat Lal, Secretary General, National Human Rights Commission.</p><p>For patients and caregivers, this is one of the few rooms where your experience is not a footnote, it is the starting point. For doctors, nurses, hospital administrators and insurers, it is an invitation to listen closely, answer frankly and think about how trust can be rebuilt. For policymakers, journalists and civil society, it offers a clear view of what lies between policy documents and real life.</p><p>On 8 April 2026 at IIC Delhi, the International Patients’ Union Conference 2026 will ask everyone in the room to choose between leaving with a good quote or leaving with a promise they are willing to be held to. If you believe healthcare should move beyond slogans and show real action and real impact, this is where you need to be.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/kanpur-doctor-couple-detained-in-illegal-kidney-transplant-racket-167761"><b>Also Read:Kanpur Doctor Couple Detained in Illegal Kidney Transplant Racket</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>FMGs allege registration delays despite NMC guidelines, 430 await clearance in Maharashtra</title>
<link>https://edusehat.com/en/fmgs-allege-registration-delays-despite-nmc-guidelines-430-await-clearance-in-maharashtra</link>
<guid>https://edusehat.com/en/fmgs-allege-registration-delays-despite-nmc-guidelines-430-await-clearance-in-maharashtra</guid>
<description><![CDATA[ New Delhi: After the National Medical Commission issued clear guidelines on eligibility for foreign medical graduates (FMGs), thousands of FMGs across the country are still unable to start medical practice due to delays in obtaining permanent registration.In Maharashtra, around 430 FMGs are awaiting permanent registration. The medicos alleged that the Maharashtra Medical Council (MMC) has not fully implemented the latest rules issued by the Apex Medical Commission, leaving them in uncertainty even after meeting all eligibility criteria.The Undergraduate Medical Education Board (UGMEB) of NMC, in its revised notice on 18.3.2026, clarified that FMGs who had to attend online classes during their MBBS course abroad due to the COVID-19 pandemic or war will not be required to undergo additional clerkship in India if they have already completed the required compensation through physical classes at their parent foreign medical institution.Such candidates must produce a valid compensatory certificate issued by their foreign medical institute, confirming that the online portion of their course has been duly covered through physical training, additional classes, or extended course duration. Once verified, these FMGs will be considered eligible for registration in India.&quot;If a candidate/Foreign Medical Graduate (FMG) has cleared the FMGE and completed one year of Compulsory Rotatory Medical Internship (CRMI) in India, along| with production of compensatory certificate or clerkship completion certificate, as the case may be, the FMG becomes eligible for the registration, subject to the satisfaction of the State Medical Council about the authenticity of the Compensatory Certificate, &amp; if required, to be corroborated from the entry-exit details in the passport of the FEMG,&quot; mentioned the notice. However, these graduates who completed their medical education abroad, underwent a one-year mandatory internship and fulfilled all the criteria, are alleging that the state medical council are delaying their registration and a lack of transparency from the council is affecting their future.Some students further claim that they are being informally told to undergo one to two more years of internship in India, despite already completing training abroad. If enforced, this could delay their careers and add a financial burden.The medicos claim that even after multiple visits to the MMC office, they have not received any written clarification. Responses to Right to Information (RTI) applications have also been delayed or unclear.Also read- No extra clerkship if compensated abroad: NMC issues fresh clarification on FMG online classes compensationSpeaking to Free Press Journal, a doctor who completed her MBBS from Shandong University’s Cheeloo College of Medicine in China is among many graduates awaiting registration. She alleged that the MMC is not fully implementing guidelines issued by the National Medical Commission, resulting in delays.Another doctor said her medical education was significantly affected by disruptions during the COVID-19 pandemic. Despite this, she cleared the Foreign Medical Graduate Examination in January 2026, completed a one-year internship abroad, and met all the requirements laid down by the NMC. She added that nearly 430 students are still waiting for permanent registration.A doctor from Nashik, who also completed her MBBS in China, finished her one-year internship and cleared FMGE in January 2026, said &quot;I am still awaiting registration to pursue further studies. MMC is not giving a concrete reply. They are giving vague answers and, surprisingly, different responses to different students.&quot;With no clear timeline for resolution, the affected graduates are now planning protests urging authorities to grant permanent registration in line with the NMC’s March 18 notification, establish a fast-track mechanism for processing applications, and ensure transparency and uniform implementation across states.In Kerala, the situation is also the same. On March 28, the All FMGs Association (AFA) uploaded a video on its official X handle showing a large number of FMGs in Kerala protesting against the Kerala State Medical Council (KSMC) for its non‑compliance with the rules laid down by NMC.According to the post, KSMC is neither granting permanent registration nor accepting the compensation certificate, despite clear national guidelines. &quot;The usual waiting time for securing an internship in Kerala is nearly one year, which adds to the hardship faced by FMGs. These delays and denials have created a pattern of injustice that Kerala FMGs have been enduring for far too long,&quot; said AFA. Addressing the registrar of KSMC, the Foreign Medical Students&#039; wing of All India Medical Students&#039; Association (AIMSA-FMSW) also urged the council to implement the NMC notice and grant permanent registration to eligible Foreign Medical Graduates.&quot;On behalf of Foreign Medical Graduates (FMGs) of Kerala, we All India Medical Students’ Association-Foreign Medical Students’ Wing submit this representation seeking the immediate implementation of the National Medical Commission (NMC) Public Notice dated 18 March 2026 and the grant of Permanent Registration to all eligible FMGs who fall under the provisions of the Screening Test Regulations, 2002,&quot; mentioned the letter. Despite NMC clarifying that State Medical Councils must grant Permanent Registration to eligible FMGs and verification may be conducted based on academic records, compensatory certificates, and passport entry/exit records, the association said that eligible FMGs in Kerala continue to face delays and denial of Permanent Registration despite completing medical education, passing FMGE, fulfilling compensatory requirements, and completing internship in the parent institution.The association further stated that the continued delay has resulted in the restriction on the right to practice medicine despite meeting all statutory requirements, delay in pursuing postgraduate education, residency, and employment opportunities, financial and professional hardship to FMG doctors and their families and loss of valuable medical workforce at a time when more doctors are needed.Therefore, they demanded immediate implementation of the NMC Public Notice dated 18/03/2026, permanent registration to eligible FMGs governed under the Screening Test Regulations, 2002, establishment of a transparent and time-bound mechanism for verification and registrationa and equal and fair treatment for FMGs in accordance with national directives.The issue is not limited to Maharashtra and Kerala; a similar situation is being reported in Rajasthan and Chhattisgarh as well. AFA raised the matter on social media, urging the NMC to intervene, as several State Medical Councils are allegedly refusing to follow its guidelines. The association has also requested the NMC to hold a meeting with all State Medical Councils and direct them to implement its public notices uniformly.&quot;States like Kerala, Rajasthan, Maharashtra, and Chhattisgarh are currently denying the NMC clarification issued on 18‑03‑2026, which clearly states that the 6 March notice has been withdrawn, and that the compensation letters already issued by colleges will remain valid. Students who have taken admission before 18 nov 21 will be governed by the Screening Regulation 2002,&quot; AFA said in its March 25 post on &#039;X&#039;. Commenting on the matter, Dr Mohammad Momin Khan, External Affairs Vice President of AIMSA told Medical Dialogues, &quot;State medical councils often take extra time to verify foreign degrees, transcripts, and university authenticity. Even if NMC issues a notice, some state councils do not implement it quickly due to administrative delays. Many councils still use manual file-based systems instead of fast online verification.&quot;He also said that &quot;Limited staff in medical councils results in slower application processing. Some councils also do extra scrutiny because documents are from outside India, which slows things down. Small issues like name spelling differences or missing attestations cause long delays. Even after verification, the final approval often requires signatures from senior officials who may not clear files quickly.&quot;Dr Kanishka Kalra, general secretary, AIMSA FMGW said &quot;A major concern is the lack of uniformity, where the same NMC notice results in different internship durations across states (6 months in some states and 1 year in others) for the same category of students. Additionally, poor digital integration and communication gaps between NMC, state councils, and candidates create a lack of transparency in application tracking. FMGs who fulfill all criteria are still facing delays due to systematic issues. We are working on uniformity between NMC and State Medical Councils.&quot;Also read- FMGs Claim Victory as NMC Agrees to Revise FMGE Guidelines Following Protest Over Online Class Compensation ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/06/331321-neet-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>FMGs, allege, registration, delays, despite, NMC, guidelines, 430, await, clearance, Maharashtra</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/06/331321-neet-1.webp"><p><b>New Delhi: </b>After the <a href="https://medicaldialogues.in/topics/national-medical-commission" target="_blank">National Medical Commission</a> issued clear guidelines on eligibility for<a href="https://medicaldialogues.in/topics/foreign-medical-graduates" target="_blank"> foreign medical graduates</a> (FMGs), thousands of FMGs across the country are still unable to start medical practice due to delays in obtaining permanent registration.</p><p>In Maharashtra, around 430 FMGs are awaiting permanent registration. The medicos alleged that the Maharashtra Medical Council (MMC) has not fully implemented the latest rules issued by the Apex Medical Commission, leaving them in uncertainty even after meeting all eligibility criteria.</p><p>The Undergraduate Medical Education Board (UGMEB) of NMC, in its revised notice on 18.3.2026, clarified that FMGs who had to attend online classes during their MBBS course abroad due to the COVID-19 pandemic or war will not be required to undergo additional clerkship in India if they have already completed the required compensation through physical classes at their parent foreign medical institution.</p><p>Such candidates must produce a valid compensatory certificate issued by their foreign medical institute, confirming that the online portion of their course has been duly covered through physical training, additional classes, or extended course duration. Once verified, these FMGs will be considered eligible for registration in India.</p><p><i>"If a candidate/Foreign Medical Graduate (FMG) has cleared the FMGE and completed one year of Compulsory Rotatory Medical Internship (CRMI) in India, along| with production of compensatory certificate or clerkship completion certificate, as the case may be, the FMG becomes eligible for the registration, subject to the satisfaction of the State Medical Council about the authenticity of the Compensatory Certificate, & if required, to be corroborated from the entry-exit details in the passport of the FEMG,"</i> mentioned the notice. </p><p>However, these graduates who completed their medical education abroad, underwent a one-year mandatory internship and fulfilled all the criteria, are alleging that the state medical council are delaying their registration and a lack of transparency from the council is affecting their future.</p><p>Some students further claim that they are being informally told to undergo one to two more years of internship in India, despite already completing training abroad. If enforced, this could delay their careers and add a financial burden.</p><p>The medicos claim that even after multiple visits to the MMC office, they have not received any written clarification. Responses to Right to Information (RTI) applications have also been delayed or unclear.</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/study-abroad/no-extra-clerkship-if-compensated-abroad-nmc-issues-fresh-clarification-on-fmg-online-classes-compensation-166820" target="_blank">No extra clerkship if compensated abroad: NMC issues fresh clarification on FMG online classes compensation</a></b></p><p>Speaking to <a href="https://www.freepressjournal.in/mumbai/maharashtra-news-delay-in-registration-leaves-430-foreign-medical-graduates-in-limbo-despite-nmc-guidelines" target="_blank" rel="nofollow">Free Press Journal</a>, a doctor who completed her MBBS from Shandong University’s Cheeloo College of Medicine in China is among many graduates awaiting registration. She alleged that the MMC is not fully implementing guidelines issued by the National Medical Commission, resulting in delays.</p><p>Another doctor said her medical education was significantly affected by disruptions during the COVID-19 pandemic. Despite this, she cleared the Foreign Medical Graduate Examination in January 2026, completed a one-year internship abroad, and met all the requirements laid down by the NMC. She added that nearly 430 students are still waiting for permanent registration.</p><p>A doctor from Nashik, who also completed her MBBS in China, finished her one-year internship and cleared FMGE in January 2026, said "I am still awaiting registration to pursue further studies. MMC is not giving a concrete reply. They are giving vague answers and, surprisingly, different responses to different students."</p><p>With no clear timeline for resolution, the affected graduates are now planning protests urging authorities to grant permanent registration in line with the NMC’s March 18 notification, establish a fast-track mechanism for processing applications, and ensure transparency and uniform implementation across states.</p><p>In Kerala, the situation is also the same. On March 28, the All FMGs Association (AFA) uploaded a video on its official X handle showing a large number of FMGs in Kerala protesting against the Kerala State Medical Council (KSMC) for its non‑compliance with the rules laid down by NMC.</p><p>According to the post, KSMC is neither granting permanent registration nor accepting the compensation certificate, despite clear national guidelines. </p><p>"The usual waiting time for securing an internship in Kerala is nearly one year, which adds to the hardship faced by FMGs. These delays and denials have created a pattern of injustice that Kerala FMGs have been enduring for far too long," said AFA. </p><p>Addressing the registrar of KSMC, the Foreign Medical Students' wing of All India Medical Students' Association (AIMSA-FMSW) also urged the council to implement the NMC notice and grant permanent registration to eligible Foreign Medical Graduates.</p><p><i>"On behalf of Foreign Medical Graduates (FMGs) of Kerala, we All India Medical Students’ Association-Foreign Medical Students’ Wing submit this representation seeking the immediate implementation of the National Medical Commission (NMC) Public Notice dated 18 March 2026 and the grant of Permanent Registration to all eligible FMGs who fall under the provisions of the Screening Test Regulations, 2002," </i>mentioned the letter. </p><p>Despite NMC clarifying that State Medical Councils must grant Permanent Registration to eligible FMGs and verification may be conducted based on academic records, compensatory certificates, and passport entry/exit records, the association said that eligible FMGs in Kerala continue to face delays and denial of Permanent Registration despite completing medical education, passing FMGE, fulfilling compensatory requirements, and completing internship in the parent institution.</p><p>The association further stated that the continued delay has resulted in the restriction on the right to practice medicine despite meeting all statutory requirements, delay in pursuing postgraduate education, residency, and employment opportunities, financial and professional hardship to FMG doctors and their families and loss of valuable medical workforce at a time when more doctors are needed.</p><p>Therefore, they demanded immediate implementation of the NMC Public Notice dated 18/03/2026, permanent registration to eligible FMGs governed under the Screening Test Regulations, 2002, establishment of a transparent and time-bound mechanism for verification and registrationa and equal and fair treatment for FMGs in accordance with national directives.</p><p>The issue is not limited to Maharashtra and Kerala; a similar situation is being reported in Rajasthan and Chhattisgarh as well. AFA raised the matter on social media, urging the NMC to intervene, as several State Medical Councils are allegedly refusing to follow its guidelines. The association has also requested the NMC to hold a meeting with all State Medical Councils and direct them to implement its public notices uniformly.</p><p>"States like Kerala, Rajasthan, Maharashtra, and Chhattisgarh are currently denying the NMC clarification issued on 18‑03‑2026, which clearly states that the 6 March notice has been withdrawn, and that the compensation letters already issued by colleges will remain valid. Students who have taken admission before 18 nov 21 will be governed by the Screening Regulation 2002," AFA said in its March 25 post on 'X'. </p><p>Commenting on the matter, Dr Mohammad Momin Khan, External Affairs Vice President of AIMSA told Medical Dialogues, "State medical councils often take extra time to verify foreign degrees, transcripts, and university authenticity. Even if NMC issues a notice, some state councils do not implement it quickly due to administrative delays. Many councils still use manual file-based systems instead of fast online verification."</p><p>He also said that "Limited staff in medical councils results in slower application processing. Some councils also do extra scrutiny because documents are from outside India, which slows things down. Small issues like name spelling differences or missing attestations cause long delays. Even after verification, the final approval often requires signatures from senior officials who may not clear files quickly."</p><p>Dr Kanishka Kalra, general secretary, AIMSA FMGW said "A major concern is the lack of uniformity, where the same NMC notice results in different internship durations across states (6 months in some states and 1 year in others) for the same category of students. Additionally, poor digital integration and communication gaps between NMC, state councils, and candidates create a lack of transparency in application tracking. FMGs who fulfill all criteria are still facing delays due to systematic issues. We are working on uniformity between NMC and State Medical Councils."</p><p><b>Also read- <a href="https://medicaldialogues.in/news/education/study-abroad/fmgs-claim-victory-as-nmc-agrees-to-revise-fmge-guidelines-following-protest-over-online-class-compensation-166698" target="_blank">FMGs Claim Victory as NMC Agrees to Revise FMGE Guidelines Following Protest Over Online Class Compensation</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month</title>
<link>https://edusehat.com/en/emcure-pharma-cuts-poviztra-price-by-55-starting-dose-now-rs-3999-per-month</link>
<guid>https://edusehat.com/en/emcure-pharma-cuts-poviztra-price-by-55-starting-dose-now-rs-3999-per-month</guid>
<description><![CDATA[ New Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug Poviztra (semaglutide injection), aiming to improve patient access amid rising obesity rates in India.The company stated that the revised pricing will come into effect from April 3, 2026, with the starting dose (0.25 mg) now available at ₹3,999 per month (₹999 per week), compared to the earlier price of ₹8,790. Overall, prices across different dosage strengths have been reduced by an average of 47%.Poviztra®, a once-weekly semaglutide injection available in multiple strengths ranging from 0.25 mg to 2.4 mg, is administered through a pen device designed for ease of use and accurate dosing. The revised monthly prices now range from ₹3,999 for 0.25 mg to ₹8,999 for the 2.4 mg maintenance dose.Emcure, which exclusively distributes and commercializes Poviztra® in India as a second brand of Novo Nordisk’s semaglutide, said the move is intended to expand access to a globally established therapy backed by extensive clinical and real-world evidence.Also Read: Emcure Pharma Appoints Former Sun Pharma CFO C S Muralidharan as Independent DirectorHighlighting the public health context, the company noted that India is facing a growing obesity burden, with an estimated 254 million people affected by generalized obesity and 351 million by abdominal obesity. Semaglutide, a well-studied biologic molecule with nearly a decade of global use, has been supported by close to 50 clinical trials and extensive patient exposure worldwide.Commenting on the development, CEO and Managing Director Satish Mehta said that the price reduction is aimed at making scientifically validated weight management treatments more affordable and accessible to a wider patient population.Obesity is associated with over 230 health complications, including cardiovascular diseases, type 2 diabetes, hypertension, fatty liver disease, osteoarthritis, polycystic ovary syndrome, kidney disease, and Alzheimer’s disease. The company emphasized that improved access to effective therapies is crucial to addressing these challenges at scale.Emcure Pharmaceuticals, headquartered in Pune, is an R&amp;D-driven pharmaceutical company with a presence in over 70 countries and a broad portfolio of products across multiple therapeutic segments.Also Read: Fire at Emcure Pharma&#039;s Pune Plant, Operations Temporarily Halted ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/11/28/311381-50-53.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Emcure, Pharma, Cuts, Poviztra, Price, 55, Starting, Dose, Now, 3, 999, per, Month</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/11/28/311381-50-53.webp"><p><b>New Delhi:</b> Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug Poviztra (semaglutide injection), aiming to improve patient access amid rising obesity rates in India.</p><div class="pasted-from-word-wrapper"><p>The company stated that the revised pricing will come into effect from April 3, 2026, with the starting dose (0.25 mg) now available at ₹3,999 per month (₹999 per week), compared to the earlier price of ₹8,790. Overall, prices across different dosage strengths have been reduced by an average of 47%.</p><p>Poviztra®, a once-weekly semaglutide injection available in multiple strengths ranging from 0.25 mg to 2.4 mg, is administered through a pen device designed for ease of use and accurate dosing. The revised monthly prices now range from ₹3,999 for 0.25 mg to ₹8,999 for the 2.4 mg maintenance dose.</p><p>Emcure, which exclusively distributes and commercializes Poviztra® in India as a second brand of Novo Nordisk’s semaglutide, said the move is intended to expand access to a globally established therapy backed by extensive clinical and real-world evidence.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/emcure-pharma-appoints-former-sun-pharma-cfo-c-s-muralidharan-as-independent-director-166304">Also Read: Emcure Pharma Appoints Former Sun Pharma CFO C S Muralidharan as Independent Director</a></div></div><p>Highlighting the public health context, the company noted that India is facing a growing obesity burden, with an estimated 254 million people affected by generalized obesity and 351 million by abdominal obesity. Semaglutide, a well-studied biologic molecule with nearly a decade of global use, has been supported by close to 50 clinical trials and extensive patient exposure worldwide.</p><p>Commenting on the development, CEO and Managing Director Satish Mehta said that the price reduction is aimed at making scientifically validated weight management treatments more affordable and accessible to a wider patient population.</p><p>Obesity is associated with over 230 health complications, including cardiovascular diseases, type 2 diabetes, hypertension, fatty liver disease, osteoarthritis, polycystic ovary syndrome, kidney disease, and Alzheimer’s disease. The company emphasized that improved access to effective therapies is crucial to addressing these challenges at scale.</p><p>Emcure Pharmaceuticals, headquartered in Pune, is an R&D-driven pharmaceutical company with a presence in over 70 countries and a broad portfolio of products across multiple therapeutic segments.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/fire-at-emcure-pharmas-pune-plant-operations-temporarily-halted-164245">Also Read: Fire at Emcure Pharma's Pune Plant, Operations Temporarily Halted</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>US Slaps 100% Tariff on Patented Drug Imports from India, Generics Spared for Now</title>
<link>https://edusehat.com/en/us-slaps-100-tariff-on-patented-drug-imports-from-india-generics-spared-for-now</link>
<guid>https://edusehat.com/en/us-slaps-100-tariff-on-patented-drug-imports-from-india-generics-spared-for-now</guid>
<description><![CDATA[ New Delhi: The United States has introduced sweeping trade measures targeting patented pharmaceutical imports and certain metal products after President Donald Trump signed two key executive actions, imposing a 100 percent tariff on patented drug imports from countries like India that lack reshoring agreements with the US Commerce Department or MFN pricing deals with the Department of Health and Human Services (HHS).The United States has announced sweeping new trade measures targeting patented pharmaceutical imports and metals, as President Donald Trump signed two significant executive actions.Under the new framework on Thursday, a 100% tariff will apply to patented drug imports from countries, including India, that have neither signed a reshoring agreement with the US Commerce Department nor a Most Favoured Nation (MFN) pricing deal with the Department of Health and Human Services (HHS), reports ANI.Also Read: India-EU Free Trade Agreement Opens USD 572 Billion Pharma, MedTech Market for Indian IndustryA senior White House official said the measure was designed to reduce America&#039;s dependence on foreign nations for essential medicines. The official further told ANI, &quot;100% tariff is on patented products. Any patented drug imports from India made by companies that do not get approved for a reshoring plan will be subject to a 100% tariff.&quot;Generic medicines are currently exempt, though officials cautioned this could change if the generics industry does not move production back to the United States swiftly enough.&quot;Generics, which are the majority of Indian pharma exports, are exempt from tariffs, but the Commerce Department will evaluate the state of generics reshoring and re-evaluate generics tariffs accordingly,&quot; the official further told ANI.The tariff comes into effect on July 31 for larger companies and September 29 for smaller ones.Five country groupings have been offered preferential rates. The European Union, Japan, South Korea, and Switzerland will each face a 15% tariff. The United Kingdom, whose major pharmaceutical companies, including GSK, have already signed reshoring and MFN agreements, will face a lower rate of 10%, with the expectation that this could eventually reach zero.The administration also announced changes to how existing tariffs on steel, aluminum, and copper are calculated, a revision that will have direct implications for Indian metal exporters.Also Read: No Tariff for Pharma Firms with US Facilities, Says Trump as 100% Duty on Branded Drug Imports Kicks InFor products that contain these metals, the rules have been simplified. Goods where the metal content accounts for less than 15% of the product&#039;s weight will attract no separate metals tariff, facing only the standard country-level duty. Where metal content exceeds 15% by weight, a flat 25% tariff will apply to the full product value, irrespective of the precise metal composition.Thursday&#039;s announcements coincide with the first anniversary of Trump&#039;s so-called &quot;Liberation Day,&quot; the moment last year when the president unveiled a sweeping global tariff plan that sent shockwaves through international markets and fundamentally reshaped the landscape of world trade. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2020/07/25/132304-trump.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Slaps, 100, Tariff, Patented, Drug, Imports, from, India, Generics, Spared, for, Now</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2020/07/25/132304-trump.webp"><div class="pasted-from-word-wrapper"><p><b>New Delhi:</b> The United States has introduced sweeping trade measures targeting patented pharmaceutical imports and certain metal products after President Donald Trump signed two key executive actions, imposing a 100 percent tariff on patented drug imports from countries like India that lack reshoring agreements with the US Commerce Department or MFN pricing deals with the Department of Health and Human Services (HHS).</p></div><div class="pasted-from-word-wrapper"><p>The United States has announced sweeping new trade measures targeting patented pharmaceutical imports and metals, as President Donald Trump signed two significant executive actions.</p><p>Under the new framework on Thursday, a 100% tariff will apply to patented drug imports from countries, including India, that have neither signed a reshoring agreement with the US Commerce Department nor a Most Favoured Nation (MFN) pricing deal with the Department of Health and Human Services (HHS), reports ANI.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/india-eu-free-trade-agreement-opens-usd-572-billion-pharma-medtech-market-for-indian-industry-163488"><b><i>Also Read: India-EU Free Trade Agreement Opens USD 572 Billion Pharma, MedTech Market for Indian Industry</i></b></a></div><p>A senior White House official said the measure was designed to reduce America's dependence on foreign nations for essential medicines. The official further told ANI, "100% tariff is on patented products. Any patented drug imports from India made by companies that do not get approved for a reshoring plan will be subject to a 100% tariff."</p><p>Generic medicines are currently exempt, though officials cautioned this could change if the generics industry does not move production back to the United States swiftly enough.</p><p>"Generics, which are the majority of Indian pharma exports, are exempt from tariffs, but the Commerce Department will evaluate the state of generics reshoring and re-evaluate generics tariffs accordingly," the official further told ANI.</p><p>The tariff comes into effect on July 31 for larger companies and September 29 for smaller ones.</p><p>Five country groupings have been offered preferential rates. The European Union, Japan, South Korea, and Switzerland will each face a 15% tariff. The United Kingdom, whose major pharmaceutical companies, including GSK, have already signed reshoring and MFN agreements, will face a lower rate of 10%, with the expectation that this could eventually reach zero.</p><p>The administration also announced changes to how existing tariffs on steel, aluminum, and copper are calculated, a revision that will have direct implications for Indian metal exporters.</p><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/no-tariff-for-pharma-firms-with-us-facilities-says-trump-as-100-duty-on-branded-drug-imports-kicks-in-155946"><b><i>Also Read: No Tariff for Pharma Firms with US Facilities, Says Trump as 100% Duty on Branded Drug Imports Kicks In</i></b></a></div><p>For products that contain these metals, the rules have been simplified. Goods where the metal content accounts for less than 15% of the product's weight will attract no separate metals tariff, facing only the standard country-level duty. Where metal content exceeds 15% by weight, a flat 25% tariff will apply to the full product value, irrespective of the precise metal composition.</p><p>Thursday's announcements coincide with the first anniversary of Trump's so-called "Liberation Day," the moment last year when the president unveiled a sweeping global tariff plan that sent shockwaves through international markets and fundamentally reshaped the landscape of world trade.</p></div>]]> </content:encoded>
</item>

<item>
<title>UPSSSC to Hold Pharmacist Main Exam on June 21 for 564 Vacancies</title>
<link>https://edusehat.com/en/upsssc-to-hold-pharmacist-main-exam-on-june-21-for-564-vacancies</link>
<guid>https://edusehat.com/en/upsssc-to-hold-pharmacist-main-exam-on-june-21-for-564-vacancies</guid>
<description><![CDATA[ Lucknow: The Uttar Pradesh Subordinate Services Selection Commission (UPSSSC) has announced important updates regarding the Pharmacist (Bheshajik) Recruitment 2026, including the schedule of the main examination and details of the selection process.The recruitment drive aims to fill a total of 564 pharmacist vacancies, providing a significant opportunity for candidates seeking government jobs in the healthcare sector.As per the latest update, the UPSSSC Pharmacist Main Examination will be conducted on June 21, 2026. Candidates who have qualified in the Preliminary Eligibility Test (PET) 2025 will be eligible to appear for the main examination, which will play a decisive role in the final selection.The selection process will be carried out in multiple stages, beginning with shortlisting based on PET scores, followed by a main written examination of objective type. Candidates who successfully qualify this stage will proceed to document verification and medical examination, after which the final selection will be made.Also Read: UPSSSC Begins Recruitment for 560 Pharmacist Posts, Applications Open Till March 29To be eligible for the post, candidates must possess a Diploma in Pharmacy (D.Pharm) or an equivalent qualification from a recognized institution and must be registered with the State Pharmacy Council. The age limit for applicants is 18 to 40 years, with relaxation applicable for reserved categories as per government norms.Selected candidates will be appointed under the Group C category with a pay scale of ₹5,200 to ₹20,200 along with a Grade Pay of ₹2,800, corresponding to Level 5 of the 7th Pay Commission. In addition to the basic pay, candidates will be entitled to allowances and other benefits as per state government rules.The application process for the recruitment began on March 9, 2026, and concluded by the end of March 2026. A correction window was also provided to candidates to make necessary changes in their application forms. According to a recent media report in the India Herald, these updates provide clarity on the examination timeline and recruitment process.With the main examination date now announced, candidates are advised to focus on their preparation and stay updated with official notifications. This recruitment offers a promising opportunity for pharmacy professionals aiming to secure a stable government career in Uttar Pradesh.Also Read: UPSSSC Hikes Pharmacist Vacancies to 564 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/25/329519-exam.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>UPSSSC, Hold, Pharmacist, Main, Exam, June, for, 564, Vacancies</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/25/329519-exam.webp"><p><b>Lucknow</b>: The Uttar Pradesh Subordinate Services Selection Commission (UPSSSC) has announced important updates regarding the Pharmacist (Bheshajik) Recruitment 2026, including the schedule of the main examination and details of the selection process.</p><div class="pasted-from-word-wrapper"><p>The recruitment drive aims to fill a total of 564 pharmacist vacancies, providing a significant opportunity for candidates seeking government jobs in the healthcare sector.</p><p>As per the latest update, the UPSSSC Pharmacist Main Examination will be conducted on June 21, 2026. Candidates who have qualified in the Preliminary Eligibility Test (PET) 2025 will be eligible to appear for the main examination, which will play a decisive role in the final selection.</p><p>The selection process will be carried out in multiple stages, beginning with shortlisting based on PET scores, followed by a main written examination of objective type. Candidates who successfully qualify this stage will proceed to document verification and medical examination, after which the final selection will be made.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/upsssc-begins-recruitment-for-560-pharmacist-posts-applications-open-till-march-29-166547">Also Read: UPSSSC Begins Recruitment for 560 Pharmacist Posts, Applications Open Till March 29</a></div></div><p>To be eligible for the post, candidates must possess a Diploma in Pharmacy (D.Pharm) or an equivalent qualification from a recognized institution and must be registered with the State Pharmacy Council. The age limit for applicants is 18 to 40 years, with relaxation applicable for reserved categories as per government norms.</p><p>Selected candidates will be appointed under the Group C category with a pay scale of ₹5,200 to ₹20,200 along with a Grade Pay of ₹2,800, corresponding to Level 5 of the 7th Pay Commission. In addition to the basic pay, candidates will be entitled to allowances and other benefits as per state government rules.</p><p>The application process for the recruitment began on March 9, 2026, and concluded by the end of March 2026. A correction window was also provided to candidates to make necessary changes in their application forms. According to a recent media report in the <a href="https://www.indiaherald.com/Education/Read/994886313/-UPSSSC-Pharmacist-Exam-Main-Exam-Recruitment-Details" rel="nofollow">India Herald</a>, these updates provide clarity on the examination timeline and recruitment process.</p><p>With the main examination date now announced, candidates are advised to focus on their preparation and stay updated with official notifications. This recruitment offers a promising opportunity for pharmacy professionals aiming to secure a stable government career in Uttar Pradesh.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/upsssc-hikes-pharmacist-vacancies-to-564-167630">Also Read: UPSSSC Hikes Pharmacist Vacancies to 564</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Biogen Bets Big on Kidney Drugs with USD 5.6 Billion Apellis Pharmaceuticals Deal</title>
<link>https://edusehat.com/en/biogen-bets-big-on-kidney-drugs-with-usd-56-billion-apellis-pharmaceuticals-deal</link>
<guid>https://edusehat.com/en/biogen-bets-big-on-kidney-drugs-with-usd-56-billion-apellis-pharmaceuticals-deal</guid>
<description><![CDATA[ Bengaluru: Biogen will buy Apellis Pharmaceuticals for about USD 5.6 billion, adding a promising kidney disease drug to broaden ‌its rare-disease portfolio ⁠amid efforts ⁠to diversify beyond its slowing multiple sclerosis franchise.The deal, announced on Tuesday, is among the largest under CEO Chris ​Viehbacher as he resets the business after the initial uptake of its closely watched Alzheimer&#039;s treatment, Leqembi, also fell ​short of lofty expectations.The acquisition gives a foothold in kidney disease, providing a commercial base with nephrologists that could support future launches, including late-stage kidney drug felzartamab, Viehbacher told Reuters.Apellis&#039; Empaveli is approved for two rare kidney diseases as well as a ⁠rare blood ‌disorder while its Syfovre is approved to treat geographic atrophy, an advanced eye condition that is a leading cause of blindness.Also Read: Biogen Wins USFDA Nod for Higher-Dose Spinraza Amid Rising SMA Therapy CompetitionUnder the terms of the deal, expected ⁠to close in the second quarter, Apellis shareholders will receive $41 per ​share in cash, representing a premium of about 140% to the ​stock&#039;s last close.They are also eligible for up to $4 per share in milestone payments tied to Syfovre achieving global annual sales thresholds of $1.5 billion and $2 billion between 2027 and 2030.Analysts broadly agreed Apellis is a strong strategic fit, providing needed near-term growth for Biogen, though some raised concerns about the premium paid.&quot;We don&#039;t think that just looking at the spot price was really the ‌right reference,&quot; Viehbacher said, adding &quot;what really matters is the intrinsic value and we see a lot of value in that kidney franchise in particular.&quot;Shares of ​Apellis rose more ​than twofold in early ⁠trading, while Biogen fell nearly 5%.Also Read: Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer&#039;s Disease&quot;Through the addition of near-term revenue from Syfovre and Empaveli, Biogen&#039;s acquisition of Apellis could meaningfully change how investors think about near-term revenue growth as the company continues to ​manage MS declines,&quot; said BMO Capital analyst Evan Seigerman.The two drugs generated combined revenue of about $689 million last year and are expected to grow in the mid-to-high-teens rate at least through 2028, the companies said. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/02/26/233041-biogen-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Biogen, Bets, Big, Kidney, Drugs, with, USD, 5.6, Billion, Apellis, Pharmaceuticals, Deal</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/02/26/233041-biogen-50.webp"><p><b>Bengaluru:</b> <a href="https://medicaldialogues.in/topics/Biogen" target="_blank">Biogen</a> will buy Apellis Pharmaceuticals for about USD 5.6 billion, adding a promising kidney disease drug to broaden ‌its rare-disease portfolio ⁠amid efforts ⁠to diversify beyond its slowing multiple sclerosis franchise.</p><div class="pasted-from-word-wrapper"><p>The deal, announced on Tuesday, is among the largest under CEO Chris ​Viehbacher as he resets the business after the initial uptake of its closely watched Alzheimer's treatment, Leqembi, also fell ​short of lofty expectations.</p><p>The acquisition gives a foothold in kidney disease, providing a commercial base with nephrologists that could support future launches, including late-stage kidney drug felzartamab, Viehbacher told Reuters.</p><p>Apellis' Empaveli is approved for two rare kidney diseases as well as a ⁠rare blood ‌disorder while its Syfovre is approved to treat geographic atrophy, an advanced eye condition that is a leading cause of blindness.</p><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/biogen-wins-usfda-nod-for-higher-dose-spinraza-amid-rising-sma-therapy-competition-167700"><b><i>Also Read: Biogen Wins USFDA Nod for Higher-Dose Spinraza Amid Rising SMA Therapy Competition</i></b></a></div><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><div class="pasted-from-word-wrapper"></div><div class="pasted-from-word-wrapper"><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>Under the terms of the deal, expected ⁠to close in the second quarter, Apellis shareholders will receive $41 per ​share in cash, representing a premium of about 140% to the ​stock's last close.</p><p>They are also eligible for up to $4 per share in milestone payments tied to Syfovre achieving global annual sales thresholds of $1.5 billion and $2 billion between 2027 and 2030.</p><p>Analysts broadly agreed Apellis is a strong strategic fit, providing needed near-term growth for Biogen, though some raised concerns about the premium paid.</p><p>"We don't think that just looking at the spot price was really the ‌right reference," Viehbacher said, adding "what really matters is the intrinsic value and we see a lot of value in that kidney franchise in particular."</p><p>Shares of ​Apellis rose more ​than twofold in early ⁠trading, while Biogen fell nearly 5%.</p><div class="pasted-from-word-wrapper"><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/biogen-eisai-get-usfda-nod-for-leqembi-iqlik-subcutaneous-injection-for-maintenance-dosing-for-early-alzheimers-disease-154316"><b><i>Also Read: Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer's Disease</i></b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div><p>"Through the addition of near-term revenue from Syfovre and Empaveli, Biogen's acquisition of Apellis could meaningfully change how investors think about near-term revenue growth as the company continues to ​manage MS declines," said BMO Capital analyst Evan Seigerman.</p><p>The two drugs generated combined revenue of about $689 million last year and are expected to grow in the mid-to-high-teens rate at least through 2028, the companies said.</p></div>]]> </content:encoded>
</item>

<item>
<title>Minor allegedly raped by compounder at Saran Hospital; accused arrested</title>
<link>https://edusehat.com/en/minor-allegedly-raped-by-compounder-at-saran-hospital-accused-arrested</link>
<guid>https://edusehat.com/en/minor-allegedly-raped-by-compounder-at-saran-hospital-accused-arrested</guid>
<description><![CDATA[ Patna: In a shocking incident, an 11-year-old girl was allegedly raped inside a private hospital in Bihar’s Saran district on Friday. The accused compounder has been arrested, the police said.According to police, the minor had been admitted to the hospital by her family after complaining of food poisoning. The incident reportedly took place when the girl went to the washroom, where the accused, employed at the hospital, allegedly followed her inside and committed the crime.Also Read:Newborn dies at Kanpur Hospital; family alleges doctor consulted through video callThe incident came to light when the minor girl raised an alarm, alerting her family members and others present in the hospital. Upon receiving the information, a team of local police arrived at the hospital and began an investigation.  Speaking to TOI, Saran’s SSP, Vineet Kumar, said, “As soon as the matter came to our notice, we immediately arrested the accused and registered a case at the local police station based on the statement of the girl’s family members. A case has been lodged against the accused under Sections 65(2), 351(2)(3), 354 of the BNS and serious sections of the Pocso Act.”
The SSP added that the hospital premises have been sealed to facilitate the collection of scientific and forensic evidence. Police have also seized the victim’s clothes and other crucial materials as part of the investigation. Medical examinations of both the victim and the accused have been conducted at the Sadar Hospital, officials confirmed.
Assuring strict action, the SSP stated that the case will be fast-tracked to ensure the harshest possible punishment for the accused.
Medical Dialogues had previously reported that a Delhi doctor has been arrested for allegedly molesting a minor girl at a mohalla clinic in the Kanjhawala area of Rohini district in the national capital area, police said. The incident took place when the 12-year-old Dalit girl went to the clinic in Delhi&#039;s Shiv Vihar area in Karala to purchase medicines because she was not feeling well. Also Read:Delhi doctor arrested for allegedly molesting minor at Mohalla clinic ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/30/296253-sexual-harassment.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Minor, allegedly, raped, compounder, Saran, Hospital, accused, arrested</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/30/296253-sexual-harassment.webp"><p><b>Patna: </b>In a shocking incident, an 11-year-old girl was allegedly <a href="https://medicaldialogues.in/topics/rape">raped </a>inside a <a href="https://medicaldialogues.in/topics/private-hospital">private hospital</a> in Bihar’s Saran district on Friday. The accused compounder has been arrested, the police said.</p><p>According to police, the minor had been admitted to the hospital by her family after complaining of food poisoning. The incident reportedly took place when the girl went to the washroom, where the accused, employed at the hospital, allegedly followed her inside and committed the crime.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/newborn-dies-at-kanpur-hospital-family-alleges-doctor-consulted-through-video-call-167851"><b>Also Read:Newborn dies at Kanpur Hospital; family alleges doctor consulted through video call</b></a></p><p>The incident came to light when the minor girl raised an alarm, alerting her family members and others present in the hospital. Upon receiving the information, a team of local police arrived at the hospital and began an investigation.  </p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/patna/compounder-held-on-charge-of-raping-girl-at-saran-hospital/articleshow/130007852.cms" rel="nofollow">TOI</a>, Saran’s SSP, Vineet Kumar, said, “As soon as the matter came to our notice, we immediately arrested the accused and registered a case at the local police station based on the statement of the girl’s family members. A case has been lodged against the accused under Sections 65(2), 351(2)(3), 354 of the BNS and serious sections of the Pocso Act.”
</p><p>The SSP added that the hospital premises have been sealed to facilitate the collection of scientific and forensic evidence. Police have also seized the victim’s clothes and other crucial materials as part of the investigation. Medical examinations of both the victim and the accused have been conducted at the Sadar Hospital, officials confirmed.
</p><p>Assuring strict action, the SSP stated that the case will be fast-tracked to ensure the harshest possible punishment for the accused.
</p><p>Medical Dialogues had previously reported that a Delhi doctor has been arrested for allegedly molesting a minor girl at a mohalla clinic in the Kanjhawala area of Rohini district in the national capital area, police said. The incident took place when the 12-year-old Dalit girl went to the clinic in Delhi's Shiv Vihar area in Karala to purchase medicines because she was not feeling well. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/delhi-doctor-arrested-for-allegedly-molesting-minor-at-mohalla-clinic-84993"><b>Also Read:Delhi doctor arrested for allegedly molesting minor at Mohalla clinic</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Two Quacks arrested for running illegal clinics in Govandi</title>
<link>https://edusehat.com/en/two-quacks-arrested-for-running-illegal-clinics-in-govandi</link>
<guid>https://edusehat.com/en/two-quacks-arrested-for-running-illegal-clinics-in-govandi</guid>
<description><![CDATA[ Mumbai: Two quacks were arrested by the Mumbai Crime Branch’s Unit 6 in a major crackdown on illegal medical practices in the Shivajinagar area of Govandi. The accused had been operating separate clinics without any valid medical degrees or licences. According to the news reports, the action was carried out by Crime Branch Unit 6, following credible intelligence inputs. A police team, along with an assistant medical officer from the BMC’s M Ward (E), conducted simultaneous raids at the two clinics. During the operation, both individuals were caught red-handed while examining patients and administering treatments. Also Read:Fake dentist operates clinic for years in Malkajgiri, arrestedDespite lacking any formal medical training or authorization from the Maharashtra Medical Council, the accused had been treating patients for various ailments and charging substantial consultation fees.During the raids, police seized significant medical supplies, including injection bottles, syringes, and antibiotic tablets from the premises, reports TOI.
According to UNI, FIRs were registered against them at Shivajinagar Police Station under Sections 33 and 36 of the Medical Practitioners Act, 1961. Further investigation is underway.
Meanwhile, to address rising concerns over illegal medical practices, the Maharashtra government has constituted a state-level task force in March to crack down on bogus doctors and unregistered nursing homes.
Medical Dialogues had previously reported that to tackle rising concerns over illegal medical practices, the Maharashtra government has constituted a state-level task force to crack down on bogus doctors and unregistered nursing homes across the state. The task force, which will be headed by the Additional Chief Secretary of Urban Development and senior Health Department officials, will submit a detailed action report in the next legislative session. Addressing concerns raised in the House, Minister Uday Samant acknowledged that the problem is widespread and not limited to Mumbai. Also Read:Maharashtra steps up action against unregistered nursing homes, bogus doctors ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Two, Quacks, arrested, for, running, illegal, clinics, Govandi</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/09/293999-fake-doctor-1.webp"><p><b>Mumbai: </b>Two <a href="https://medicaldialogues.in/topics/quack">quacks</a> were arrested by the Mumbai Crime Branch’s Unit 6 in a major crackdown on illegal medical practices in the Shivajinagar area of Govandi. The accused had been operating separate <a href="https://medicaldialogues.in/topics/illegal-clinics">clinic</a>s without any valid medical degrees or licences. </p><p>According to the news reports, the action was carried out by Crime Branch Unit 6, following credible intelligence inputs. A police team, along with an assistant medical officer from the BMC’s M Ward (E), conducted simultaneous raids at the two clinics. During the operation, both individuals were caught red-handed while examining patients and administering treatments. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/fake-dentist-operates-clinic-for-years-in-malkajgiri-arrested-167302"><b>Also Read:Fake dentist operates clinic for years in Malkajgiri, arrested</b></a></p><div class="pasted-from-word-wrapper"><div><span>Despite lacking any formal medical training or authorization from the Maharashtra Medical Council, the accused had been treating patients for various ailments and charging substantial consultation fees.</span></div></div><p>During the raids, police seized significant medical supplies, including injection bottles, syringes, and antibiotic tablets from the premises, reports <a href="https://timesofindia.indiatimes.com/city/mumbai/mumbai-crime-branch-arrests-two-quack-doctors-running-clinics-in-govandi/articleshow/130004742.cms" rel="nofollow">TOI</a>.
</p><p>According to UNI, FIRs were registered against them at Shivajinagar Police Station under Sections 33 and 36 of the Medical Practitioners Act, 1961. Further investigation is underway.
</p><p>Meanwhile, to address rising concerns over illegal medical practices, the Maharashtra government has constituted a state-level task force in March to crack down on bogus doctors and unregistered nursing homes.
</p><p>Medical Dialogues had previously reported that to tackle rising concerns over illegal medical practices, the Maharashtra government has constituted a state-level task force to crack down on bogus doctors and unregistered nursing homes across the state. The task force, which will be headed by the Additional Chief Secretary of Urban Development and senior Health Department officials, will submit a detailed action report in the next legislative session. Addressing concerns raised in the House, Minister Uday Samant acknowledged that the problem is widespread and not limited to Mumbai. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/maharashtra-steps-up-action-against-unregistered-nursing-homes-bogus-doctors-166759"><b>Also Read:Maharashtra steps up action against unregistered nursing homes, bogus doctors</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Will NMC&amp;apos;s MBBS student feedback system improve medical education quality? Here&amp;apos;s what doctors say</title>
<link>https://edusehat.com/en/will-nmcs-mbbs-student-feedback-system-improve-medical-education-quality-heres-what-doctors-say</link>
<guid>https://edusehat.com/en/will-nmcs-mbbs-student-feedback-system-improve-medical-education-quality-heres-what-doctors-say</guid>
<description><![CDATA[ New Delhi: The online feedback system for MBBS students, which was recently introduced by the National Medical Commission (NMC) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback. However, at the same time, they have expressed their concerns regarding the success of such a move.Medical Dialogues had earlier reported that NMC had introduced the online Student Feedback Form for MBBS students to gather anonymous and confidential feedback on various aspects of medical colleges across the country, and also on the medical education experience of the students in their respective institutes. The students have been asked to wholeheartedly participate in filling out the Online &quot;Student Feedback Form&quot; and submit valuable feedback.Also Read: NMC launches online feedback form for MBBS students to assess medical education qualityThe aspects as listed by the apex medical commission include Quality of Teaching, Faculty Availability, Clinical Training, Labs, Dissection Halls ad Practical Training, Community Medicine and Rural Training, Ragging &amp; Student Safety, Campus Culture, as well as Student Welfare, Anti-Ragging Measures &amp; Grievance Redressal, Mental Health Support, Extracurricular Activities, Curriculum, College Administration &amp; Governance, etc.While the doctors have welcomed the decision, they have also expressed their doubts regarding the effectiveness of the initiative. Dr. Deshmukh opined that the success of this initiative will depend on how effectively the feedback is acted upon. &quot;It is important that every response whether positive or critical is taken seriously and leads to visible improvements. Ensuring confidentiality and building trust will be essential so that students can share their views without hesitation,&quot; he added.&quot;The decision highlights a forward-thinking vision by the Government and the NMC towards building a more responsive and student-centric medical education framework. This is a much-needed and timely step. For a long time, students have had limited formal avenues to express their concerns or share constructive suggestions about their training. By opening this channel, the NMC has acknowledged that students are key stakeholders in medical education. From our perspective, this system has strong potential to improve the quality of teaching, clinical exposure, and the overall academic environment in medical colleges. Students experience the system firsthand, and their feedback can highlight practical issues that may not always reach administrative levels,&quot; said Dr. Indranil Deshmukh, the National Secretary of IMA-JDN.A similar opinion was expressed by Dr. Rohan Krishnan, a health activist and Chief Patron of FAIMA Doctors Association. &quot;The introduction of a structured feedback mechanism for MBBS students by the National Medical Commission is a welcome and much-needed reform in Indian medical education. For the first time, it formally acknowledges the student as a stakeholder in shaping the quality of medical training. From FAIMA’s perspective, this initiative has the potential to significantly improve teaching standards, institutional accountability, and learning environments across medical colleges. However, its success will depend not merely on data collection, but on the credibility of the process and the willingness of the regulator to act on the feedback received,&quot; he said.&quot;It is crucial to ensure that the system guarantees true anonymity and protects students from any form of academic or professional retaliation. Without this assurance, the feedback risks becoming superficial and non-representative. Additionally, FAIMA believes that feedback outcomes must be meaningfully linked to institutional assessment, including accreditation, inspections, and corrective actions. Transparency in aggregated findings will further enhance trust in the system,&quot; Dr. Krishnan further added.He also emphasized the need to sensitize both students and faculty—students to provide responsible, objective feedback, and faculty to view feedback as a tool for improvement rather than criticism.&quot;In its current form, the system is a strong step forward. With robust safeguards, transparent implementation, and firm regulatory action, it can evolve into a transformative instrument for improving medical education in India,&quot; he opined.Similarly, Dr. Meet Ghonia, the National General Secretary of the Federation of Resident Doctors Association (FORDA) also expressed that the success of the initiative will depend on proper implementation - especially ensuring anonymity, preventing misuse, and taking timely action on feedback.&quot;If handled sincerely, it can be effective; otherwise, it may remain only a formality,&quot; he said. While welcoming the NMC move, Dr. Lakshya Mittal, the Chairperson of the United Doctors Front (UDF), described it as a useful step toward improving the quality of medical education. However, he also expressed dismay that the transparency provisions of the &#039;NMC Act, 2019&#039;—enacted by Parliament specifically to curb the arbitrary conduct of medical colleges—are being disregarded.&quot;According to this law, it is mandatory to publicly disclose full details regarding the assessment and rating of all medical colleges on the website. The objective behind this was to prevent accreditation scams driven by the submission of false information. Unless these provisions are fully complied with, any feedback system remains futile and merely a sham,&quot; he said.Stressing on the importance to make the assessment reports public, he added, &quot;Several provisions within the NMC Act, 2019, mandate the public disclosure of all information pertaining to medical colleges. Section 24 of the UG Board and Section 25 of the PG Board provide for the annual disclosure of college-related information to ensure that students have access to complete details. Furthermore, Section 26 of the Medical Assessment and Rating Board mandates the public disclosure of all such reports on the website. A similar provision applicable to all medical colleges is outlined in Section 48. The NMC has been entrusted with a specific obligation in this regard under Section 57. Although the law repeatedly emphasizes the continuous uploading of college-related documents to the website, the reality is quite different; far from uploading them, an arbitrary rule has been established to even restrict the disclosure of such information in response to RTI (Right to Information) requests. Had these documents been made public in accordance with the parliamentary legislation, the fraudulent practices surrounding medical college accreditation would not have been so easy to perpetrate.&quot;&quot;In its 14th meeting held on May 1, 2024, the NMC took the decision that the &#039;Standard Assessment Forms&#039; would not be made public. In its order dated April 9, 2024, the Central Information Commission issued clear directives mandating that the assessment reports of all medical colleges be uploaded to the website. However, instead of complying with this order, the NMC passed a resolution during its meeting prohibiting the uploading of these reports to the website as well as their disclosure under the RTI Act. Such tampering with a law enacted by Parliament constitutes a mockery of the Constitution and a grave offense,&quot; he further mentioned.Also Read: Make medical college assessment reports public: NMC receives deadline from CIC ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/13/264812-feedback.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Will, NMCs, MBBS, student, feedback, system, improve, medical, education, quality, Heres, what, doctors, say</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/13/264812-feedback.webp"><p><b>New Delhi:</b> The online feedback system for MBBS students, which was recently introduced by the <a href="https://medicaldialogues.in/topics/NMC">National Medical Commission (NMC</a>) to collect inputs regarding the quality of medical education across medical colleges, has been welcomed by the members of the medical fraternity.</p><p>For a long time, doctors have been raising alarm on the rapidly increasing number of medical colleges and the quality of medical education in those institutions. Amid this, doctors have welcomed the decision to make students a part of the assessment process by considering their feedback.</p><p> However, at the same time, they have expressed their concerns regarding the success of such a move.</p><p>Medical Dialogues had earlier reported that NMC had introduced the online Student Feedback Form for MBBS students to gather anonymous and confidential feedback on various aspects of medical colleges across the country, and also on the medical education experience of the students in their respective institutes. The students have been asked to wholeheartedly participate in filling out the Online "Student Feedback Form" and submit valuable feedback.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/health-news/nmc/nmc-launches-online-feedback-form-for-mbbs-students-to-assess-medical-education-quality-167400"><b><i>Also Read: NMC launches online feedback form for MBBS students to assess medical education quality</i></b></a></p><p>The aspects as listed by the apex medical commission include Quality of Teaching, Faculty Availability, Clinical Training, Labs, Dissection Halls ad Practical Training, Community Medicine and Rural Training, Ragging & Student Safety, Campus Culture, as well as Student Welfare, Anti-Ragging Measures & Grievance Redressal, Mental Health Support, Extracurricular Activities, Curriculum, College Administration & Governance, etc.</p><p>While the doctors have welcomed the decision, they have also expressed their doubts regarding the effectiveness of the initiative. Dr. Deshmukh opined that the success of this initiative will depend on how effectively the feedback is acted upon. "It is important that every response whether positive or critical is taken seriously and leads to visible improvements. Ensuring confidentiality and building trust will be essential so that students can share their views without hesitation," he added.</p><p>"The decision highlights a forward-thinking vision by the Government and the NMC towards building a more responsive and student-centric medical education framework. This is a much-needed and timely step. For a long time, students have had limited formal avenues to express their concerns or share constructive suggestions about their training. By opening this channel, the NMC has acknowledged that students are key stakeholders in medical education. From our perspective, this system has strong potential to improve the quality of teaching, clinical exposure, and the overall academic environment in medical colleges. Students experience the system firsthand, and their feedback can highlight practical issues that may not always reach administrative levels," said Dr. Indranil Deshmukh, the National Secretary of IMA-JDN.</p><p>A similar opinion was expressed by Dr. Rohan Krishnan, a health activist and Chief Patron of <a href="https://medicaldialogues.in/topics/FAIMA">FAIMA</a> Doctors Association. "The introduction of a structured feedback mechanism for MBBS students by the National Medical Commission is a welcome and much-needed reform in Indian medical education. For the first time, it formally acknowledges the student as a stakeholder in shaping the quality of medical training. From FAIMA’s perspective, this initiative has the potential to significantly improve teaching standards, institutional accountability, and learning environments across medical colleges. However, its success will depend not merely on data collection, but on the credibility of the process and the willingness of the regulator to act on the feedback received," he said.</p><p>"It is crucial to ensure that the system guarantees true anonymity and protects students from any form of academic or professional retaliation. Without this assurance, the feedback risks becoming superficial and non-representative. Additionally, FAIMA believes that feedback outcomes must be meaningfully linked to institutional assessment, including accreditation, inspections, and corrective actions. Transparency in aggregated findings will further enhance trust in the system," Dr. Krishnan further added.</p><p>He also emphasized the need to sensitize both students and faculty—students to provide responsible, objective feedback, and faculty to view feedback as a tool for improvement rather than criticism.</p><p>"In its current form, the system is a strong step forward. With robust safeguards, transparent implementation, and firm regulatory action, it can evolve into a transformative instrument for improving medical education in India," he opined.</p><p>Similarly, Dr. Meet Ghonia, the National General Secretary of the Federation of Resident Doctors Association (FORDA) also expressed that the success of the initiative will depend on proper implementation - especially ensuring anonymity, preventing misuse, and taking timely action on feedback.</p><p>"If handled sincerely, it can be effective; otherwise, it may remain only a formality," he said. </p><p>While welcoming the NMC move, Dr. Lakshya Mittal, the Chairperson of the United Doctors Front (UDF), described it as a useful step toward improving the quality of medical education. However, he also expressed dismay that the transparency provisions of the 'NMC Act, 2019'—enacted by Parliament specifically to curb the arbitrary conduct of medical colleges—are being disregarded.</p><p>"According to this law, it is mandatory to publicly disclose full details regarding the assessment and rating of all medical colleges on the website. The objective behind this was to prevent accreditation scams driven by the submission of false information. Unless these provisions are fully complied with, any feedback system remains futile and merely a sham," he said.</p><p>Stressing on the importance to make the assessment reports public, he added, "Several provisions within the NMC Act, 2019, mandate the public disclosure of all information pertaining to medical colleges. Section 24 of the UG Board and Section 25 of the PG Board provide for the annual disclosure of college-related information to ensure that students have access to complete details. Furthermore, Section 26 of the Medical Assessment and Rating Board mandates the public disclosure of all such reports on the website. A similar provision applicable to all medical colleges is outlined in Section 48. The NMC has been entrusted with a specific obligation in this regard under Section 57. Although the law repeatedly emphasizes the continuous uploading of college-related documents to the website, the reality is quite different; far from uploading them, an arbitrary rule has been established to even restrict the disclosure of such information in response to RTI (Right to Information) requests. Had these documents been made public in accordance with the parliamentary legislation, the fraudulent practices surrounding medical college accreditation would not have been so easy to perpetrate."</p><p>"In its 14th meeting held on May 1, 2024, the NMC took the decision that the 'Standard Assessment Forms' would not be made public. In its order dated April 9, 2024, the Central Information Commission issued clear directives mandating that the assessment reports of all medical colleges be uploaded to the website. However, instead of complying with this order, the NMC passed a resolution during its meeting prohibiting the uploading of these reports to the website as well as their disclosure under the RTI Act. Such tampering with a law enacted by Parliament constitutes a mockery of the Constitution and a grave offense," he further mentioned.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/make-medical-college-assessment-reports-public-nmc-receives-deadline-from-cic-132241"><b><i>Also Read: Make medical college assessment reports public: NMC receives deadline from CIC</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Patiala hospital staff dismissed after viral assault video</title>
<link>https://edusehat.com/en/patiala-hospital-staff-dismissed-after-viral-assault-video</link>
<guid>https://edusehat.com/en/patiala-hospital-staff-dismissed-after-viral-assault-video</guid>
<description><![CDATA[ Patiala: Punjab Health Minister, Dr Balbir Singh, has ordered the dismissal of a contractual employee at Government Mata Kaushalya Hospital in Patiala after a video went viral on social media, allegedly showing him behaving violently towards a patient.The contractual employee, who had been working at the hospital since 2021, had no prior complaints regarding his behaviour, reportedly struck a glass partition at the OPD registration counter following a dispute. The glass shattered due to the impact, and a female patient waiting in line was reportedly injured by the shards.Also Read: Punjab issues final ultimatum to 1,500 nurses, calls strike illegalThe entire incident was recorded, and the video was later circulated on Wednesday across social media platforms such as X (formerly Twitter) and WhatsApp. The emergence of this video sparked widespread outrage among the public, triggering a major debate regarding the conduct of staff at government health centres and the safety of patients.Following this incident, Dr Balbir Singh made a surprise visit to the hospital. Before taking administrative action, he reviewed the evidence and visited the scene before taking administrative action.According to the TOI media news report, the Health Minister stated that the employee has been suspended with immediate effect. He also directed that he be served a one-month notice, following which his services will be permanently terminated.&quot;The behaviour captured in that video is unacceptable. We cannot allow those who are supposed to help the sick to become a source of injury,&quot; the health minister stated.Meanwhile, a departmental inquiry has also been initiated to determine whether other employees or systemic flaws played any role in the escalation of this matter.Also Read: CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema village ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339604-punjab-5.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Patiala, hospital, staff, dismissed, after, viral, assault, video</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339604-punjab-5.webp"><p><b>Patiala:</b> Punjab Health Minister, Dr <a href="https://medicaldialogues.in/topics/balbir-singh" target="_blank">Balbir Singh</a>, has ordered the dismissal of a contractual employee at Government Mata Kaushalya Hospital in Patiala after a video went viral on social media, allegedly showing him behaving violently towards a patient.</p><div class="pasted-from-word-wrapper"><p dir="ltr">The contractual employee, who had been working at the hospital since 2021, had no prior complaints regarding his behaviour, reportedly struck a glass partition at the OPD registration counter following a dispute. The glass shattered due to the impact, and a female patient waiting in line was reportedly injured by the shards.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/punjab-issues-final-ultimatum-to-1500-nurses-calls-strike-illegal-167635"><b>Also Read: </b>Punjab issues final ultimatum to 1,500 nurses, calls strike illegal</a></div><div class="pasted-from-word-wrapper"><p dir="ltr">The entire incident was recorded, and the video was later circulated on Wednesday across social media platforms such as X (formerly Twitter) and WhatsApp. The emergence of this video sparked widespread outrage among the public, triggering a major debate regarding the conduct of staff at government health centres and the safety of patients.</p><p dir="ltr">Following this incident, Dr Balbir Singh made a surprise visit to the hospital. Before taking administrative action, he reviewed the evidence and visited the scene before taking administrative action.</p><p dir="ltr">According to the <a href="https://timesofindia.indiatimes.com/city/chandigarh/hospital-employee-sacked-over-violent-behaviour/articleshow/129986908.cms" target="_blank" rel="nofollow">TOI </a>media news report, the Health Minister stated that the employee has been suspended with immediate effect. He also directed that he be served a one-month notice, following which his services will be permanently terminated.</p><p dir="ltr">"The behaviour captured in that video is unacceptable. We cannot allow those who are supposed to help the sick to become a source of injury," the health minister stated.</p><p dir="ltr">Meanwhile, a departmental inquiry has also been initiated to determine whether other employees or systemic flaws played any role in the escalation of this matter.</p></div><div class="pasted-from-word-wrapper"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/cm-mann-inaugurates-sant-attar-singh-ji-maharaj-hospital-in-cheema-village-167863"><b>Also Read: </b>CM Mann inaugurates Sant Attar Singh Ji Maharaj Hospital in Cheema village</a></div><div class="pasted-from-word-wrapper"><div></div></div>]]> </content:encoded>
</item>

<item>
<title>NEET PG: Rajasthan HC relief to doctor denied admission over permanent registration certificate</title>
<link>https://edusehat.com/en/neet-pg-rajasthan-hc-relief-to-doctor-denied-admission-over-permanent-registration-certificate</link>
<guid>https://edusehat.com/en/neet-pg-rajasthan-hc-relief-to-doctor-denied-admission-over-permanent-registration-certificate</guid>
<description><![CDATA[ Jodhpur: The Rajasthan High Court provided relief to a NEET PG 2025 candidate who was earlier denied postgraduate medical admission due to the lack of a Permanent Registration Certificate.Referring to Rule 8(3) of the Post Graduate Medical Education Regulations, 2000, the HC bench comprising Dr. Justice Nupur Bhati clarified that as per these regulations, candidates are given a period of one month after admission for obtaining permanent registration and when the law provides a period of one month, the State Government cannot impose a more stringent condition through the information booklet.The bench clarified that administrative instructions or information bulletins cannot weaken or repeal any statutory rule and directed the college to grant her admission.Also Read:Rajasthan High Court Grants Relief to PwD NEET Qualifier, Declares Eligibility for AIIMS MBBS SeatAs per the latest media report by Live Law, the concerned petitioner in this case obtained a temporary registration from the Chhattisgarh Medical Council after completing MBBS and was performing the necessary service for permanent registration. However, during this time, the petitioner appeared in the National Eligibility-Entrance Test Postgraduate (NEET-PG) 2025 examination and was allotted a medical college.When the petitioner reported to the college, admission was denied on the grounds that the petitioner did not have a permanent registration certificate.While considering the matter, the bench cited Rule 8(3) of the Post Graduate Medical Education Regulations, 2000 and observed, &quot;This provision has been made with the objective that meritorious students who are in the registration process at that time should not face unnecessary hardship.&quot;In this regard, the bench clarified that when the law itself provides a periof of one month, the State Government impose a more stringent condition through the information booklet.Terming this move of the State as arbitrary and against the law, the bench said that it was wrong to deny admission only based on lack of certificate. Accordingly, the bench issued directions to the State Government to grant immediate admission to the petitioner.Also Read: NEET SS: Rajasthan HC scraps Rs 25 lakh bank guarantee rule for DM, MCh admissions ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/12/16/265116-rajasthan-high-court.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 17:25:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>NEET, PG:, Rajasthan, relief, doctor, denied, admission, over, permanent, registration, certificate</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/12/16/265116-rajasthan-high-court.webp"><p><b>Jodhpur:</b> The<a href="https://medicaldialogues.in/topics/rajasthan-high-court"> Rajasthan High Court </a>provided relief to a <a href="https://medicaldialogues.in/topics/NEET-PG-2025">NEET PG 2025</a> candidate who was earlier denied postgraduate medical admission due to the lack of a Permanent Registration Certificate.</p><p>Referring to Rule 8(3) of the Post Graduate Medical Education Regulations, 2000, the HC bench comprising Dr. Justice Nupur Bhati clarified that as per these regulations, candidates are given a period of one month after admission for obtaining permanent registration and when the law provides a period of one month, the State Government cannot impose a more stringent condition through the information booklet.</p><p><span>The bench clarified that administrative instructions or information bulletins cannot weaken or repeal any statutory rule and directed the college to grant her admission.</span></p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/mdtv/healthshorts/rajasthan-high-court-grants-relief-to-pwd-neet-qualifier-declares-eligibility-for-aiims-mbbs-seat-167603"><b><i>Also Read:Rajasthan High Court Grants Relief to PwD NEET Qualifier, Declares Eligibility for AIIMS MBBS Seat</i></b></a></p><p><span>As per the latest media report by <a href="https://hindi.livelaw.in/rajasthan-high-court/justice-nupur-bhati-admission-denial-neet-pg-2025-permanent-registration-certificate-528492" rel="nofollow">Live Law</a>, the concerned petitioner in this case obtained a temporary registration from the Chhattisgarh Medical Council after completing MBBS and was performing the necessary service for permanent registration. However, during this time, the petitioner appeared in the National Eligibility-Entrance Test Postgraduate (NEET-PG) 2025 examination and was allotted a medical college.</span></p><p><span>When the petitioner reported to the college, admission was denied on the grounds that the petitioner did not have a permanent registration certificate.</span></p><p><span>While considering the matter, the bench cited </span>Rule 8(3) of the Post Graduate Medical Education Regulations, 2000 and observed, <i>"This provision has been made with the objective that meritorious students who are in the registration process at that time should not face unnecessary hardship."</i></p><p>In this regard, the bench clarified that when the law itself provides a periof of one month, the State Government impose a more stringent condition through the information booklet.</p><p>Terming this move of the State as arbitrary and against the law, the bench said that it was wrong to deny admission only based on lack of certificate. Accordingly, the bench issued directions to the State Government to grant immediate admission to the petitioner.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/education/neet-ss-rajasthan-hc-scraps-rs-25-lakh-bank-guarantee-rule-for-dm-mch-admissions-167677"><b><i>Also Read: NEET SS: Rajasthan HC scraps Rs 25 lakh bank guarantee rule for DM, MCh admissions</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Maha Medical Council Elections Row: Former members allege political interference</title>
<link>https://edusehat.com/en/maha-medical-council-elections-row-former-members-allege-political-interference</link>
<guid>https://edusehat.com/en/maha-medical-council-elections-row-former-members-allege-political-interference</guid>
<description><![CDATA[ Mumbai: After some members of the Maharashtra Medical Council raised concerns over the removal of nearly 72,000 doctors from the voters’ list ahead of the upcoming elections, former members have now pointed to political interference and internal rifts within the medical community as the polling date approaches.As per a latest TOI report, former members of the council have claimed that the upcoming April 26 election, which would be the first to be held in a decade, is being influenced by political forces, reportedly leading to a split within the Indian Medical Association (IMA) into two rival factions, both claiming to be the sole legitimate representative of the association. At the centre of the row are two competing panels: One, the &quot;Official IMA MMC Panel,&quot; backed by current state president Dr Santosh Kulkarni and allegedly supported by BJP-affiliated Vaidkiya Aghadi. The other, the “IMA Members MMC Panel,” is supported by 14 past presidents and senior members of the association. Also read- Maha Medical Council Elections: Why 72,000 doctors were removed from the listMedical Dialogues had previously reported that, as the Maharashtra Medical Council (MMC) elections are set for 26 April 2025, some members have raised concerns over the removal of nearly 72,000 doctors from the voters’ list.Registration with the MMC is mandatory for every medical graduate, and it must be renewed every five years. However, around 70,000 practitioners did not complete this renewal process, leading to the deletion of their names from the electoral rolls. The MMC currently has a total membership of approximately 1.3 lakh doctors.The MMC is a quasi-judicial body responsible for overseeing the medical profession and addressing malpractice and negligence cases. The elections were supposed to be conducted every five years, but it has been pending since 2022. Polls were scheduled for April 3, 2025, but were postponed to April 26.The stakes in this election are high, as the MMC has been functioning under a state-appointed administrator since 2022. The council structure includes nine elected members and nine government nominees, aimed at maintaining a balance between the medical fraternity and the state.Commenting on the matter, Dr Suhas Pingle, a former MMC member, said, &quot;Dr Kulkarni bypassed official protocol by scrapping a panel previously vetted in 2025. Even as there was a majority IMA member consensus to retain that original panel, the leadership &#039;arbitrarily&#039; changed eligibility rules and appointed a selection committee of newcomers to hand-pick a new group. The move was so contentious that four senior members reportedly walked out of the process in protest.&quot;Past MMC president Dr Shivkumar Utture said, &quot;Members of the original 2025 panel received threatening phone calls from Vaidkiya Aghadi pressuring them to jump ship to the new panel. One member even left because of the pressure.&quot;Responding to the allegations, Dr Kulkarni told TOI, &quot;The allegations are all baseless. My panel is the only official one. My panel includes an alliance with the Maharashtra State Medical Teachers Association; therefore, all other candidates are IMA members. Past presidents do not have any authority. I am the Maharashtra state president, so the panel I am calling the official panel is indeed an official panel.&quot;Also read- Supreme Court gives deadline to hold Maharashtra Medical Council elections ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/08/16/297858-specialist-doctor.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Maha, Medical, Council, Elections, Row:, Former, members, allege, political, interference</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/08/16/297858-specialist-doctor.webp"><p><b>Mumbai: </b>After some members of the<a href="https://medicaldialogues.in/topics/maharashtra-medical-council" target="_blank"> Maharashtra Medical Council</a> raised concerns over the removal of nearly 72,000 doctors from the voters’ list ahead of the upcoming<a href="https://medicaldialogues.in/topics/mmc-elections" target="_blank"> elections</a>, former members have now pointed to political interference and internal rifts within the medical community as the polling date approaches.</p><p>As per a latest TOI report, former members of the council have claimed that the upcoming April 26 election, which would be the first to be held in a decade, is being influenced by political forces, reportedly leading to a split within the Indian Medical Association (IMA) into two rival factions, both claiming to be the sole legitimate representative of the association. </p><p>At the centre of the row are two competing panels: One, the "Official IMA MMC Panel," backed by current state president Dr Santosh Kulkarni and allegedly supported by BJP-affiliated Vaidkiya Aghadi. The other, the “IMA Members MMC Panel,” is supported by 14 past presidents and senior members of the association. </p><p><b>Also read- <a href="https://medicaldialogues.in/news/health/doctors/maha-medical-council-electionswhy-72000-doctors-were-removed-from-the-list-166868" target="_blank">Maha Medical Council Elections: Why 72,000 doctors were removed from the list</a></b></p><p>Medical Dialogues had previously reported that, as the Maharashtra Medical Council (MMC) elections are set for 26 April 2025, some members have raised concerns over the removal of nearly 72,000 doctors from the voters’ list.</p><p>Registration with the MMC is mandatory for every medical graduate, and it must be renewed every five years. However, around 70,000 practitioners did not complete this renewal process, leading to the deletion of their names from the electoral rolls. The MMC currently has a total membership of approximately 1.3 lakh doctors.</p><p>The MMC is a quasi-judicial body responsible for overseeing the medical profession and addressing malpractice and negligence cases. The elections were supposed to be conducted every five years, but it has been pending since 2022. Polls were scheduled for April 3, 2025, but were postponed to April 26.</p><p>The stakes in this election are high, as the MMC has been functioning under a state-appointed administrator since 2022. The council structure includes nine elected members and nine government nominees, aimed at maintaining a balance between the medical fraternity and the state.</p><p>Commenting on the matter, Dr Suhas Pingle, a former MMC member, said, "Dr Kulkarni bypassed official protocol by scrapping a panel previously vetted in 2025. Even as there was a majority IMA member consensus to retain that original panel, the leadership 'arbitrarily' changed eligibility rules and appointed a selection committee of newcomers to hand-pick a new group. The move was so contentious that four senior members reportedly walked out of the process in protest."</p><p>Past MMC president Dr Shivkumar Utture said, "Members of the original 2025 panel received threatening phone calls from Vaidkiya Aghadi pressuring them to jump ship to the new panel. One member even left because of the pressure."</p><p>Responding to the allegations, Dr Kulkarni told <a href="https://timesofindia.indiatimes.com/city/mumbai/political-interference-allegations-split-indian-medical-association-ahead-of-maharashtra-medical-council-elections/articleshow/129885300.cms" target="_blank" rel="nofollow">TOI</a>, "The allegations are all baseless. My panel is the only official one. My panel includes an alliance with the Maharashtra State Medical Teachers Association; therefore, all other candidates are IMA members. Past presidents do not have any authority. I am the Maharashtra state president, so the panel I am calling the official panel is indeed an official panel."</p><p><b>Also read- <a href="https://medicaldialogues.in/state-news/maharashtra/supreme-court-gives-deadline-to-hold-maharashtra-medical-council-elections-162399" target="_blank">Supreme Court gives deadline to hold Maharashtra Medical Council elections</a></b></p>]]> </content:encoded>
</item>

<item>
<title>Manipur doctor saves passenger mid&#45;air on Tokyo Delhi Flight; CM lauds timely action</title>
<link>https://edusehat.com/en/manipur-doctor-saves-passenger-mid-air-on-tokyo-delhi-flight-cm-lauds-timely-action</link>
<guid>https://edusehat.com/en/manipur-doctor-saves-passenger-mid-air-on-tokyo-delhi-flight-cm-lauds-timely-action</guid>
<description><![CDATA[ Imphal: A critical care specialist from Manipur, Dr Loni Liriina, helped prevent a possible emergency
landing by providing timely medical assistance to a passenger who was experiencing breathing difficulties on board an Air India flight travelling from Tokyo to New Delhi.The incident occurred on February 28, 2026, on board flight AI357, nearly 8 hours into the journey, when cabin crew announced a medical emergency, and she stepped in to assist a 21-year-old fellow traveller who suddenly fell ill.  Also Read:Nizamabad doctor&#039;s timely action saves life of cardiac patient Mid-AirDr. Liriina, who works as
a consultant at the American Oncology Institute and Babina Speciality Hospital
in Imphal, responded to an onboard announcement requesting medical help nearly
eight hours into the 10-hour journey of Flight AI357.  

Recalling the incident, the doctor shared that two hours before the landing, she responded to an emergency
announcement for medical help. By the time the doctor responded to the call,
the crew was already panicking. The patient was a young woman who suddenly had
intense chest pain and difficulty breathing. When the doctor first checked the
patient, she noticed that her heart rate was elevated to nearly 160 beats per
minute, while her blood pressure was considerably low. She also checked that
her oxygen saturation was around 80 percent and she was visibly suffering from acute
respiratory distress, reports Assam Tribune. The passenger had a history of asthma
since childhood, but unfortunately, she was not carrying any medication.

The medical resources
found onboard were limited, but Dr. Liriina secured assistance from another medical
professional and started emergency treatment. The doctors
ensured oxygen support and nebulisation for the patient, and with the timely
intervention of the doctor, the patient could be stabilised within 20 to 30
minutes, reports The Daily. “By the grace of God, this is a situation we deal with daily in my workplace. We used the medicines available on board, and everything
went smoothly. The flight was able to continue to its destination,” the doctor
added.

According to the Daily,
for a moment, the condition of the patient became worse, and the cabin crew was
even thinking of diverting the flight. Thanks to the quick help of the doctor,
the patient remained stable when the flight ultimately landed in Delhi. Dr.
Liriina was born in the Senapati district of Manipur and is currently based in
Imphal. She noted that timely intervention from well-qualified medical
professionals can prove to be life-saving in such cases of medical emergencies
mid-air, which is not uncommon nowadays.Also Read:2 Kerala nurses save passenger mid-air on Abu Dhabi flightChief Minister Yumnam
Khemchand Singh also lauded her effort and stated, “A life saved is a testament
to both skill and compassion. I extend my heartfelt appreciation to Dr. Loni
Lirina of Senapati District, Manipurfor her exemplary courage and timely
medical intervention in saving the life of a 21-year-old passenger who
experienced severe chest pain and breathlessness onboard. Her swift response,
clinical excellence, and unwavering commitment to the noble profession reflect
the highest ideals of medical service. Such acts of humanity and
professionalism bring immense pride to Manipur and stand as an inspiration to
all.”  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339476-he62fmobqaa451a.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Manipur, doctor, saves, passenger, mid-air, Tokyo, Delhi, Flight, lauds, timely, action</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339476-he62fmobqaa451a.webp"><p>Imphal: A critical care specialist from Manipur, Dr Loni Liriina, helped prevent a possible emergency
landing by providing timely medical assistance to a passenger who was experiencing breathing difficulties on board an Air India flight travelling from Tokyo to New Delhi.</p><p>The incident occurred on February 28, 2026, on board flight AI357, nearly 8 hours into the journey, when cabin crew announced a medical emergency, and she stepped in to assist a 21-year-old fellow traveller who suddenly fell ill.  </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/nizamabad-doctors-timely-action-saves-life-of-cardiac-patient-mid-air-142708"><span class="read-this-also">Also Read:</span>Nizamabad doctor's timely action saves life of cardiac patient Mid-Air</a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div><div class="pasted-from-word-wrapper"><p>Dr. Liriina, who works as
a consultant at the American Oncology Institute and Babina Speciality Hospital
in Imphal, responded to an onboard announcement requesting medical help nearly
eight hours into the 10-hour journey of Flight AI357.  </p>

<p>Recalling the incident, the doctor shared that two hours before the landing, she responded to an emergency
announcement for medical help. By the time the doctor responded to the call,
the crew was already panicking. The patient was a young woman who suddenly had
intense chest pain and difficulty breathing. When the doctor first checked the
patient, she noticed that her heart rate was elevated to nearly 160 beats per
minute, while her blood pressure was considerably low. She also checked that
her oxygen saturation was around 80 percent and she was visibly suffering from acute
respiratory distress, reports <a href="https://assamtribune.com/north-east/manipur-doctor-averts-mid-air-crisis-on-air-india-tokyodelhi-flight-1610154" target="_blank" rel="nofollow">Assam Tribune</a>. The passenger had a history of asthma
since childhood, but unfortunately, she was not carrying any medication.</p>

<p>The medical resources
found onboard were limited, but Dr. Liriina secured assistance from another medical
professional and started emergency treatment. The doctors
ensured oxygen support and nebulisation for the patient, and with the timely
intervention of the doctor, the patient could be stabilised within 20 to 30
minutes, reports The Daily. “By the grace of God, this is a situation we deal with daily in my workplace. We used the medicines available on board, and everything
went smoothly. The flight was able to continue to its destination,” the doctor
added.</p>

<p>According to the Daily,
for a moment, the condition of the patient became worse, and the cabin crew was
even thinking of diverting the flight. Thanks to the quick help of the doctor,
the patient remained stable when the flight ultimately landed in Delhi. </p><p>Dr.
Liriina was born in the Senapati district of Manipur and is currently based in
Imphal. She noted that timely intervention from well-qualified medical
professionals can prove to be life-saving in such cases of medical emergencies
mid-air, which is not uncommon nowadays.</p></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="also-read-media-wrap" href="https://medicaldialogues.in/nursing/news/2-kerala-nurses-save-passenger-mid-air-on-abu-dhabi-flight-157727"><img class="also-read-media" data-src="https://medicaldialogues.in/h-upload/2024/06/04/240055-airplane-50.webp"></a><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/2-kerala-nurses-save-passenger-mid-air-on-abu-dhabi-flight-157727"><span class="read-this-also">Also Read:</span>2 Kerala nurses save passenger mid-air on Abu Dhabi flight</a><div></div></div></div><div class="pasted-from-word-wrapper"><p>Chief Minister Yumnam
Khemchand Singh also lauded her effort and stated, “A life saved is a testament
to both skill and compassion. I extend my heartfelt appreciation to Dr. Loni
Lirina of Senapati District, Manipurfor her exemplary courage and timely
medical intervention in saving the life of a 21-year-old passenger who
experienced severe chest pain and breathlessness onboard. Her swift response,
clinical excellence, and unwavering commitment to the noble profession reflect
the highest ideals of medical service. Such acts of humanity and
professionalism bring immense pride to Manipur and stand as an inspiration to
all.” </p></div>]]> </content:encoded>
</item>

<item>
<title>Postprandial Glucose Dip Linked to Increased Hunger, Suggests Study</title>
<link>https://edusehat.com/en/postprandial-glucose-dip-linked-to-increased-hunger-suggests-study</link>
<guid>https://edusehat.com/en/postprandial-glucose-dip-linked-to-increased-hunger-suggests-study</guid>
<description><![CDATA[ Researchers have found in a new study that among adults without diabetes, postprandial glucose dip (PGD) was associated with greater perceived hunger and earlier subsequent eating. These findings suggest that postprandial glucose dip (PGD) may serve as a potential biomarker for appetite regulation and a target for weight management strategies.These findings are published in the JAMA Network Open in March 2026.With obesity now affecting over one billion people globally, identifying sustainable nonpharmacologic strategies for appetite suppression remains a critical priority; however, while earlier research by Wyatt et al. linked glucose dips to hunger after standardized breakfasts in Western populations, there is a lack of real-world evidence regarding free-choice meals across diverse ethnic groups. Consequently, Jiali Yao and colleagues from the Saw Swee Hock School of Public Health at the National University of Singapore aimed to evaluate the link between these glycemic drops and appetite regulation across all daily meals in an Asian population.The 9-day intensive longitudinal cohort study, nested within the Singapore Multi-Ethnic Cohort, monitored 895 multiethnic Singaporean adults—comprising Chinese, Indian, and Malay participants—without diabetes, while excluding individuals with major chronic diseases or constraints. Utilizing masked continuous glucose monitoring (CGM) and smartphone-based ecologic momentary assessments (EMA), researchers analyzed 7650 free-choice meals, focusing on primary and secondary endpoints such as momentary hunger intensity and the interval until the next eating episode via multivariable generalized estimating equation (GEE) models.Key Clinical Findings of the Study Include:Intensified Hunger Sensation: The investigation revealed that every 10% magnitude in postprandial glucose reduction was significantly associated with a 0.05 increase in hunger levels at 2 to 3 hours and a 0.09 increase at 3 to 4 hours.Shortened Inter-Meal Interval: The study observed that meals followed by glucose levels dropping below the premeal baseline resulted in a median time to the next meal of 380 minutes, significantly shorter than the 425 minutes recorded when no such drop occurred.Accelerated Caloric Demand: For every 10% decrease in glucose magnitude, researchers noted that the time to the next meal or snack was shortened by approximately 6.54 minutes according to the findings.Extensive Variability Noted: Postprandial glucose levels dropped below the premeal baseline in 54% of all free-choice meals analyzed by the study, though the frequency of these occurrences varied significantly among the 895 participants.Meal-Specific Hunger Increases: The investigation identified that larger glucose drops were particularly associated with greater hunger increases 2 to 3 hours after lunch and dinner, though this association was not significant following breakfast meals.The results suggest that postprandial glucose level decreases are a meaningful predictor of post-meal hunger and the timing of subsequent caloric intake, with drops below baseline being associated with eating over 27 minutes sooner than those with stable glucose levels.Thus, the study concludes clinicians could utilize glucose tracking as a potential biomarker to help patients identify metabolic triggers for appetite and tailor weight management interventions.While the study provides vital insights, it is limited by its reliance on self-reported hunger scores, and future research should clarify the underlying biological mechanisms to determine if these glucose patterns can be successfully modified for long-term weight control.ReferenceYao J, Edney SM, Tan LWL, et al. Postprandial Glucose Level Decreases and Appetite in Adults Without Diabetes. JAMA Netw Open. 2026;9(3):e263426.  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/10/326615-diabetes-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Postprandial, Glucose, Dip, Linked, Increased, Hunger, Suggests, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/10/326615-diabetes-1.webp"><p>Researchers have found in a new study that among adults without diabetes, postprandial glucose dip (PGD) was associated with greater perceived hunger and earlier subsequent eating. These findings suggest that postprandial glucose dip (PGD) may serve as a potential biomarker for appetite regulation and a target for weight management strategies.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings are published in the <i>JAMA Network Open</i> in March 2026.</p><p dir="ltr">With obesity now affecting over one billion people globally, identifying sustainable nonpharmacologic strategies for appetite suppression remains a critical priority; however, while earlier research by Wyatt et al. linked glucose dips to hunger after standardized breakfasts in Western populations, there is a lack of real-world evidence regarding free-choice meals across diverse ethnic groups. Consequently, Jiali Yao and colleagues from the <i>Saw Swee Hock School of Public Health</i> at the <i>National University of Singapore</i> aimed to evaluate the link between these glycemic drops and appetite regulation across all daily meals in an Asian population.</p><p dir="ltr">The 9-day intensive longitudinal cohort study, nested within the Singapore Multi-Ethnic Cohort, monitored 895 multiethnic Singaporean adults—comprising Chinese, Indian, and Malay participants—without diabetes, while excluding individuals with major chronic diseases or constraints. Utilizing masked continuous glucose monitoring (CGM) and smartphone-based ecologic momentary assessments (EMA), researchers analyzed 7650 free-choice meals, focusing on primary and secondary endpoints such as momentary hunger intensity and the interval until the next eating episode via multivariable generalized estimating equation (GEE) models.</p><p dir="ltr"><b>Key Clinical Findings of the Study Include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Intensified Hunger Sensation:</b> The investigation revealed that every 10% magnitude in postprandial glucose reduction was significantly associated with a 0.05 increase in hunger levels at 2 to 3 hours and a 0.09 increase at 3 to 4 hours.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Shortened Inter-Meal Interval: </b>The study observed that meals followed by glucose levels dropping below the premeal baseline resulted in a median time to the next meal of 380 minutes, significantly shorter than the 425 minutes recorded when no such drop occurred.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Accelerated Caloric Demand: </b>For every 10% decrease in glucose magnitude, researchers noted that the time to the next meal or snack was shortened by approximately 6.54 minutes according to the findings.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Extensive Variability Noted:</b> Postprandial glucose levels dropped below the premeal baseline in 54% of all free-choice meals analyzed by the study, though the frequency of these occurrences varied significantly among the 895 participants.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation"><b>Meal-Specific Hunger Increases: </b>The investigation identified that larger glucose drops were particularly associated with greater hunger increases 2 to 3 hours after lunch and dinner, though this association was not significant following breakfast meals.</p></li></ul><p dir="ltr">The results suggest that postprandial glucose level decreases are a meaningful predictor of post-meal hunger and the timing of subsequent caloric intake, with drops below baseline being associated with eating over 27 minutes sooner than those with stable glucose levels.</p><p dir="ltr">Thus, the study concludes clinicians could utilize glucose tracking as a potential biomarker to help patients identify metabolic triggers for appetite and tailor weight management interventions.</p><p dir="ltr">While the study provides vital insights, it is limited by its reliance on self-reported hunger scores, and future research should clarify the underlying biological mechanisms to determine if these glucose patterns can be successfully modified for long-term weight control.</p><p dir="ltr"><b>Reference</b></p><p dir="ltr">Yao J, Edney SM, Tan LWL, et al. Postprandial Glucose Level Decreases and Appetite in Adults Without Diabetes. JAMA Netw Open. 2026;9(3):e263426. </p></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Sustained Complete Response to Brigatinib in a Young ALK+ NSCLC Patient</title>
<link>https://edusehat.com/en/sustained-complete-response-to-brigatinib-in-a-young-alk-nsclc-patient</link>
<guid>https://edusehat.com/en/sustained-complete-response-to-brigatinib-in-a-young-alk-nsclc-patient</guid>
<description><![CDATA[ Managing Resistance in ALK-Positive Lung Cancer -  Case Applying Precision Oncology Approach
In this expert case presentation, Dr. Akhil Kapoor shares the journey of a young, non-smoking patient with ALK-positive non-small cell lung cancer who developed resistance to alectinib due to an ALK I1171N mutation.
Through repeat molecular testing, the treatment was precisely adapted to brigatinib—leading to a remarkable and durable complete response, including CNS disease control.
This case highlights the importance of repeat molecular testing for guiding treatment sequencing and demonstrates brigatinib&#039;s effectiveness against specific ALK resistance mutations, underscoring the role of precision oncology in personalized therapy for ALK-positive NSCLC.
Key takeaway: Not all ALK inhibitors are interchangeable; treatment must be mutation-specific. Individualised approach is important  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/04/339569-takeda-featuredjpg.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Sustained, Complete, Response, Brigatinib, Young, ALK, NSCLC, Patient</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/04/339569-takeda-featuredjpg.webp"><p>Managing Resistance in <b>ALK-Positive Lung Cancer</b> -  Case Applying Precision Oncology Approach
</p><p>In this expert case presentation, <b>Dr. Akhil Kapoor</b> shares the journey of a young, non-smoking patient with ALK-positive non-small cell lung cancer who developed resistance to alectinib due to an <b>ALK I1171N</b> mutation.
</p><p>Through repeat molecular testing, the treatment was precisely adapted to brigatinib—leading to a remarkable and durable complete response, including CNS disease control.
</p><p>This case highlights the importance of repeat molecular testing for guiding treatment sequencing and demonstrates brigatinib's effectiveness against specific ALK resistance mutations, underscoring the role of precision oncology in personalized therapy for ALK-positive NSCLC.
</p><p><b>Key takeaway:</b> Not all ALK inhibitors are interchangeable; treatment must be mutation-specific. Individualised approach is important </p>]]> </content:encoded>
</item>

<item>
<title>Four women arrested in Malappuram gynaecologist assault case</title>
<link>https://edusehat.com/en/four-women-arrested-in-malappuram-gynaecologist-assault-case</link>
<guid>https://edusehat.com/en/four-women-arrested-in-malappuram-gynaecologist-assault-case</guid>
<description><![CDATA[ Malappuram: Four women were arrested on Friday in connection with the alleged assault of a gynaecologist from a government hospital in Perinthalmanna, police said.Police said the attack was linked to the death of a woman who had recently visited the Perinthalmanna District Hospital for delivery. However, the Kerala Government Medical Officers’ Association (KGMOA) said the young woman, who developed severe complications due to postpartum haemorrhage, was treated as per protocol without delay and was later referred to a better-equipped hospital, news agency PTI reported.Also Read:Woman doctor attacked inside Malappuram clinic over alleged medical negligenceDespite all possible efforts by doctors, her life could not be saved, the association said in a statement.The association alleged that a group of individuals misrepresented what appeared to be a natural complication in childbirth as medical negligence, forcibly entered the doctor’s consultation room, and attacked her, resulting in serious injuries.Strongly condemning “the brutal and premeditated attack on a gynaecologist,&quot; the KGMOA demanded strict and exemplary punishment for those involved.It said such acts of taking the law into one’s own hands, without understanding the scientific challenges in healthcare, are unacceptable and would affect the morale of health workers.The association also said that over 50 government hospitals in the state that handle deliveries currently lack adequate staff.Despite repeated demands to ensure proper facilities and human resources in these institutions, the issue has not been addressed seriously, it said.To prevent such incidents in the future, the KGMOA said delivery centres must be strengthened as a long-term solution.It called for the creation of posts for at least seven gynaecologists, seven paediatricians, and seven anaesthetists at each delivery centre to ensure 24-hour services, reports PTI.The association also stressed the need for well-equipped operating theatres, blood banks, and other basic infrastructure at such centres. Also Read:Paediatrician attacked by patient attendant at Adilabad hospital, doctors demand action ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/07/15/294598-arrest-50.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Four, women, arrested, Malappuram, gynaecologist, assault, case</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/07/15/294598-arrest-50.webp"><div class="pasted-from-word-wrapper"><p><span>Malappuram: Four women were arrested on Friday in connection with the alleged assault of a </span>gynaecologist from a government hospital in Perinthalmanna, police said.</p><p><span>Police said the </span><a href="https://medicaldialogues.in/topics/doctor-attacked" target="_blank">attack </a><span>was linked to the death of a woman who had recently visited the Perinthalmanna District Hospital for delivery. </span><br></p><p>However, the Kerala Government Medical Officers’ Association (<a href="https://medicaldialogues.in/topics/KGMOA" target="_blank">KGMOA</a>) said the young woman, who developed severe complications due to postpartum haemorrhage, was treated as per protocol without delay and was later referred to a better-equipped hospital, news agency PTI reported.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/woman-doctor-attacked-inside-malappuram-clinic-over-alleged-medical-negligence-167860"><b>Also Read:Woman doctor attacked inside Malappuram clinic over alleged medical negligence</b></a></p><p>Despite all possible efforts by doctors, her life could not be saved, the association said in a statement.</p></div><div class="pasted-from-word-wrapper">The association alleged that a group of individuals misrepresented what appeared to be a natural complication in childbirth as <a href="https://medicaldialogues.in/topics/doctor-attacked" target="_blank">medical negligence</a>, forcibly entered the doctor’s consultation room, and attacked her, resulting in serious injuries.</div><div class="pasted-from-word-wrapper"><p>Strongly condemning “the brutal and premeditated attack on a gynaecologist," the KGMOA demanded strict and exemplary punishment for those involved.<br></p><p>It said such acts of taking the law into one’s own hands, without understanding the scientific challenges in healthcare, are unacceptable and would affect the morale of health workers.</p><p>The association also said that over 50 government hospitals in the state that handle deliveries currently lack adequate staff.</p><p>Despite repeated demands to ensure proper facilities and human resources in these institutions, the issue has not been addressed seriously, it said.</p><p>To prevent such incidents in the future, the <a href="https://medicaldialogues.in/topics/KGMOA" target="_blank">KGMOA </a>said delivery centres must be strengthened as a long-term solution.</p><p>It called for the creation of posts for at least seven gynaecologists, seven paediatricians, and seven anaesthetists at each delivery centre to ensure 24-hour services, reports PTI.</p><p>The association also stressed the need for well-equipped operating theatres, blood banks, and other basic infrastructure at such centres.</p><p> <a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/paediatrician-attacked-by-patient-attendant-at-adilabad-hospital-doctors-demand-action-167402"><b>Also Read:Paediatrician attacked by patient attendant at Adilabad hospital, doctors demand action</b></a></p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>AIIMS Raipur, Sri Sathya Sai Trust join hands for healthcare education</title>
<link>https://edusehat.com/en/aiims-raipur-sri-sathya-sai-trust-join-hands-for-healthcare-education</link>
<guid>https://edusehat.com/en/aiims-raipur-sri-sathya-sai-trust-join-hands-for-healthcare-education</guid>
<description><![CDATA[ Raipur: The All India Institute of Medical Sciences (AIIMS) Raipur on Thursday signed a Memorandum of Understanding (MoU) with the Sri Sathya Sai Health and Education Trust to enhance academic collaboration and capacity-building initiatives in the healthcare sector.The MoU was signed by Dr. C. Sreenivas, Chairman of Sri Sathya Sai Health and Education Trust, and Lieutenant General Ashok Jindal (Retired), Executive Director and Chief Executive Officer of All India Institute of Medical Sciences, Raipur, at a ceremony attended by senior faculty members and administrative officials.Among those present were Dr. Eli Mohapatra, Dean (Academics); Dr. Abhiruchi Galhotra, Dean (Research); Dr. Krishnadutt Chavli, Dean (Student Welfare); Dr. Avinash Ingle, Dean (Examinations); and Lieutenant Colonel Dharamveer Singh Chauhan, Deputy Director (Administration), along with other officers and faculty members.Also Read:AIIMS Raipur conducts Sickle Cell Disease screening campThe agreement seeks to establish robust academic linkages between the two institutions, facilitating collaboration in academic exchange, structured training programmes, and capacity-building initiatives. The partnership is expected to promote knowledge sharing, joint academic activities, and professional development in healthcare education and training, the PIB stated.Speaking on the occasion, Lieutenant General Ashok Jindal said that collaborations with institutions committed to public welfare significantly enhance institutional outreach and impact. He underscored the notable contributions of Sri Sathya Sai Health and Education Trust in the healthcare sector and expressed confidence that the partnership could expand into research collaborations in the future.Dr. C. Sreenivas welcomed the initiative and reaffirmed that the Trust’s mission is anchored in service, compassion, and holistic healthcare development. He described the collaboration as a significant step towards strengthening academic and institutional partnerships aimed at improving healthcare education, training, and service delivery.The Memorandum of Understanding marks a strategic initiative to advance collaborative efforts in healthcare education and capacity building, with a focus on delivering long-term benefits to society.Also Read:AIIMS Raipur join hands with Bilaspur Super Specialty Hospital to boost healthcare services ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339356-aiims-raipur.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>AIIMS, Raipur, Sri, Sathya, Sai, Trust, join, hands, for, healthcare, education</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339356-aiims-raipur.webp"><div class="pasted-from-word-wrapper"><p><span>Raipur: The All India Institute of Medical Sciences (AIIMS) Raipur on Thursday signed a Memorandum of Understanding (MoU) with the Sri Sathya Sai Health and Education Trust to enhance academic collaboration and capacity-building initiatives in the healthcare sector.</span></p><p>The MoU was signed by Dr. C. Sreenivas, Chairman of Sri Sathya Sai Health and Education Trust, and Lieutenant General Ashok Jindal (Retired), Executive Director and Chief Executive Officer of All India Institute of Medical Sciences, Raipur, at a ceremony attended by senior faculty members and administrative officials.</p><p>Among those present were Dr. Eli Mohapatra, Dean (Academics); Dr. Abhiruchi Galhotra, Dean (Research); Dr. Krishnadutt Chavli, Dean (Student Welfare); Dr. Avinash Ingle, Dean (Examinations); and Lieutenant Colonel Dharamveer Singh Chauhan, Deputy Director (Administration), along with other officers and faculty members.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-raipur-conducts-sickle-cell-disease-screening-camp-156159"><b>Also Read:AIIMS Raipur conducts Sickle Cell Disease screening camp</b></a></p><p>The agreement seeks to establish robust academic linkages between the two institutions, facilitating collaboration in academic exchange, structured training programmes, and capacity-building initiatives. The partnership is expected to promote knowledge sharing, joint academic activities, and professional development in healthcare education and training, the PIB stated.</p><p>Speaking on the occasion, Lieutenant General Ashok Jindal said that collaborations with institutions committed to public welfare significantly enhance institutional outreach and impact. He underscored the notable contributions of Sri Sathya Sai Health and Education Trust in the healthcare sector and expressed confidence that the partnership could expand into research collaborations in the future.</p><p>Dr. C. Sreenivas welcomed the initiative and reaffirmed that the Trust’s mission is anchored in service, compassion, and holistic healthcare development. He described the collaboration as a significant step towards strengthening academic and institutional partnerships aimed at improving healthcare education, training, and service delivery.</p><p>The Memorandum of Understanding marks a strategic initiative to advance collaborative efforts in healthcare education and capacity building, with a focus on delivering long-term benefits to society.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/hospital-diagnostics/aiims-raipur-join-hands-with-bilaspur-super-specialty-hospital-to-boost-healthcare-services-154150"><b>Also Read:AIIMS Raipur join hands with Bilaspur Super Specialty Hospital to boost healthcare services</b></a></p><div></div><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><div></div></div></div></div>]]> </content:encoded>
</item>

<item>
<title>JnK NHM staff launch 72&#45;Hour strike over demand for regularisation, salary deductions</title>
<link>https://edusehat.com/en/jnk-nhm-staff-launch-72-hour-strike-over-demand-for-regularisation-salary-deductions</link>
<guid>https://edusehat.com/en/jnk-nhm-staff-launch-72-hour-strike-over-demand-for-regularisation-salary-deductions</guid>
<description><![CDATA[ Jammu: To protest the deduction of 2.5 days’ salary from their monthly wages, medical staff under the National Health Mission (NHM) in Bhalessa district launched a 72-hour strike on Thursday. The protest began outside the Sub-District Hospital in Gandoh, where staff held posters demanding the release of the withheld payment.
The strike was called following an official notice issued by the Medical Employees Federation of Jammu and Kashmir. Also Read:BJ medical college Pune nursing, paramedical students protest over hostel rules, alleged harassmentAccording to the protesting employees, the deducted amount was traditionally paid for overtime work on Sundays, public holidays, and night shifts. Many highlighted disparities between NHM staff and regular government employees.Speaking to TOI, the protester said, “This protest is for the salary of 2.5 days. We used to get the salary for 2.5 days because we did our duty on Sundays, gazetted holidays, and nights.” Another demonstrator alleged disparity between NHM and regular staff. “Our regular staff&#039;s salary for 2.5 days should be released... Why are we from NHM not getting equal salary? I request the state government to increase our salary or make us regular.”The strike is led by the Joint Action Committee (JAC) of Health and Medical College Employees, supported by the Jammu Kashmir Medical Employees Federation (JKMEF). Jaswinder Singh, JKMEF president, criticized the inaction of a special committee formed on March 11 to resolve the issue, saying it has failed to engage with JAC representatives.
Sushil Sudan, chairman of JKMEF, alongside members of the Paramedical Council of India (PCI), highlighted the Government’s delayed response over the past three months. Arun Sharma (president, GMC Jammu) strongly condemned the allowance withdrawal, terming it a clear violation of previous government mandates, reports Daily Excelsior.
The strike triggered coordinated protests across multiple institutions, including GMC Kathua, GMC Rajouri, GMC Udhampur, GMC Doda, SMGS Hospital Jammu, IG Dental College, and district hospitals in Poonch, Samba, and Reasi. During the protest, OPD services and elective surgeries were suspended from 9:00 AM to 5:00 PM, though emergency services continued to ensure critical patient care.The National Health Mission, a central government initiative, provides financial and technical support to states and Union Territories to improve healthcare access, particularly for vulnerable populations. The programme emphasises strengthening rural healthcare infrastructure, enhancing human resources, and improving service delivery, with district-level decentralized planning, according to the Ministry of Health and Family Welfare.Also Read:Punjab issues final ultimatum to 1,500 nurses, calls strike illegal ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/01/09/320248-protest-2.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>JnK, NHM, staff, launch, 72-Hour, strike, over, demand, for, regularisation, salary, deductions</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/01/09/320248-protest-2.webp"><p><b>Jammu: </b>To protest the deduction of 2.5 days’ salary from their monthly wages, medical staff under the National Health Mission (<a href="https://medicaldialogues.in/topics/national-health-mission">NHM</a>) in Bhalessa district launched a 72-hour strike on Thursday. The protest began outside the <a href="https://medicaldialogues.in/topics/sub-district-hospital">Sub-District Hospital</a> in Gandoh, where staff held posters demanding the release of the withheld payment.
</p><p>The strike was called following an official notice issued by the Medical Employees Federation of Jammu and Kashmir. </p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/state-news/maharashtra/bj-medical-college-pune-nursing-paramedical-students-protest-over-hostel-rules-alleged-harassment-167770"><b>Also Read:BJ medical college Pune nursing, paramedical students protest over hostel rules, alleged harassment</b></a></p><p>According to the protesting employees, the deducted amount was traditionally paid for overtime work on Sundays, public holidays, and night shifts. Many highlighted disparities between NHM staff and regular government employees.</p><p>Speaking to <a href="https://timesofindia.indiatimes.com/city/jammu/equal-pay-for-equal-work-national-health-mission-medical-staff-in-jks-bhalessa-begin-72-hour-strike-over-salary-cuts/articleshow/129992640.cms" rel="nofollow">TOI</a>, the protester said, “This protest is for the salary of 2.5 days. We used to get the salary for 2.5 days because we did our duty on Sundays, gazetted holidays, and nights.” Another demonstrator alleged disparity between NHM and regular staff. “Our regular staff's salary for 2.5 days should be released... Why are we from NHM not getting equal salary? I request the state government to increase our salary or make us regular.”</p><p>The strike is led by the Joint Action Committee (JAC) of Health and Medical College Employees, supported by the Jammu Kashmir Medical Employees Federation (JKMEF). Jaswinder Singh, JKMEF president, criticized the inaction of a special committee formed on March 11 to resolve the issue, saying it has failed to engage with JAC representatives.
</p><p>Sushil Sudan, chairman of JKMEF, alongside members of the Paramedical Council of India (PCI), highlighted the Government’s delayed response over the past three months. Arun Sharma (president, GMC Jammu) strongly condemned the allowance withdrawal, terming it a clear violation of previous government mandates, reports <a href="https://www.dailyexcelsior.com/health-employees-across-jk-begin-72-hr-strike-over-discontinuation-of-salary-allowances/" rel="nofollow">Daily Excelsior</a>.
</p><p>The strike triggered coordinated protests across multiple institutions, including GMC Kathua, GMC Rajouri, GMC Udhampur, GMC Doda, SMGS Hospital Jammu, IG Dental College, and district hospitals in Poonch, Samba, and Reasi. During the protest, OPD services and elective surgeries were suspended from 9:00 AM to 5:00 PM, though emergency services continued to ensure critical patient care.</p><p>The National Health Mission, a central government initiative, provides financial and technical support to states and Union Territories to improve healthcare access, particularly for vulnerable populations. The programme emphasises strengthening rural healthcare infrastructure, enhancing human resources, and improving service delivery, with district-level decentralized planning, according to the Ministry of Health and Family Welfare.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/nursing/news/punjab-issues-final-ultimatum-to-1500-nurses-calls-strike-illegal-167635"><b>Also Read:Punjab issues final ultimatum to 1,500 nurses, calls strike illegal</b></a></p>]]> </content:encoded>
</item>

<item>
<title>Intensive LDL&#45;C Targeting Enhances Clinical Outcomes in CVD: NEJM</title>
<link>https://edusehat.com/en/intensive-ldl-c-targeting-enhances-clinical-outcomes-in-cvd-nejm</link>
<guid>https://edusehat.com/en/intensive-ldl-c-targeting-enhances-clinical-outcomes-in-cvd-nejm</guid>
<description><![CDATA[ A recent randomized clinical trial has demonstrated that targeting a low-density lipoprotein (LDL) cholesterol level of less than 55 mg per deciliter significantly reduces the risk of major cardiovascular events in patients with established atherosclerotic cardiovascular disease (ASCVD). This intensive management strategy outperformed the conventional target of less than 70 mg per deciliter over a three-year follow-up period.These findings were published on March 28, 2026, in the New England Journal of Medicine.The Clinical Challenge of Secondary PreventionEffective management of lipids is a cornerstone of secondary prevention for individuals who have already experienced manifestations of atherosclerotic cardiovascular disease (ASCVD), such as heart attacks or strokes. While international clinical guidelines have increasingly recommended more aggressive targets for low-density lipoprotein (LDL) cholesterol, robust evidence from large-scale randomized trials comparing specific low-level targets remains surprisingly limited. Historically, the &quot;lower is better&quot; hypothesis has been supported by various observational studies, but the exact threshold for optimal secondary prevention—whether to aim for less than 70 mg per deciliter or to push even lower—has been a subject of ongoing debate among clinicians. The Ez-PAVE trial sought to address this gap by providing direct comparative data within a high-risk patient population.Study OverviewThe Ez-PAVE trial was an open-label superiority study conducted across multiple centers in South Korea. The researchers randomly assigned 3,048 adult patients with diagnosed atherosclerotic cardiovascular disease (ASCVD) in a 1:1 ratio to one of two treatment strategies: an intensive-targeting group (aiming for LDL cholesterol  ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2024/05/29/239578-atherosclerosis.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 13:50:05 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Intensive, LDL-C, Targeting, Enhances, Clinical, Outcomes, CVD:, NEJM</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2024/05/29/239578-atherosclerosis.webp"><p>A recent randomized clinical trial has demonstrated that targeting a <a href="https://medicaldialogues.in/cardiology-ctvs/news/low-ldl-cholesterol-linked-to-higher-bleeding-risk-in-vte-patients-on-anticoagulants-jama-148805">low-density lipoprotein </a>(LDL) cholesterol level of less than 55 mg per deciliter significantly reduces the risk of major cardiovascular events in patients with established <a href="https://medicaldialogues.in/cardiology-ctvs/news/elevated-lipoproteina-predicts-ascvd-risk-despite-low-cac-score-study-167370">atherosclerotic cardiovascular disease</a> (ASCVD). This intensive management strategy outperformed the conventional target of less than 70 mg per deciliter over a three-year follow-up period.</p><div class="pasted-from-word-wrapper"><p dir="ltr">These findings were published on March 28, 2026, in the <i>New England Journal of Medicine</i>.</p><p dir="ltr"><b>The Clinical Challenge of Secondary Prevention</b></p><p dir="ltr">Effective management of lipids is a cornerstone of secondary prevention for individuals who have already experienced manifestations of atherosclerotic cardiovascular disease (ASCVD), such as heart attacks or strokes. While international clinical guidelines have increasingly recommended more aggressive targets for low-density lipoprotein (LDL) cholesterol, robust evidence from large-scale randomized trials comparing specific low-level targets remains surprisingly limited. Historically, the "lower is better" hypothesis has been supported by various observational studies, but the exact threshold for optimal secondary prevention—whether to aim for less than 70 mg per deciliter or to push even lower—has been a subject of ongoing debate among clinicians. The Ez-PAVE trial sought to address this gap by providing direct comparative data within a high-risk patient population.</p><p dir="ltr"><b>Study Overview</b></p><p dir="ltr">The Ez-PAVE trial was an open-label superiority study conducted across multiple centers in South Korea. The researchers randomly assigned 3,048 adult patients with diagnosed atherosclerotic cardiovascular disease (ASCVD) in a 1:1 ratio to one of two treatment strategies: an intensive-targeting group (aiming for LDL cholesterol <55 mg per deciliter) or a conventional-targeting group (aiming for LDL cholesterol <70 mg per deciliter). The primary endpoint evaluated over three years was a composite measure of significant clinical outcomes, including death from cardiovascular (CV) causes, nonfatal myocardial infarction (MI), nonfatal <a href="https://speciality.medicaldialogues.in/stroke-facts-in-nutshell-by-american-stroke-association">stroke</a>, any coronary or peripheral revascularization, or hospitalization required for unstable angina. Safety assessments were also integral to the study, monitoring for potential adverse effects associated with very low cholesterol levels.</p><p dir="ltr"><b>The key findings from the study include:</b></p><ul><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The median LDL cholesterol levels achieved during the trial were 56 mg per deciliter in the intensive group versus 66 mg per deciliter in the conventional group.</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">A primary endpoint event occurred in 6.6% of patients in the intensive-targeting group (100 patients) compared to 9.7% in the conventional-targeting group (147 patients).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">The intensive strategy resulted in a hazard ratio (HR) of 0.67, representing a statistically significant 33% reduction in the risk of major adverse cardiovascular events (P=0.002).</p></li><li dir="ltr" aria-level="1"><p dir="ltr" role="presentation">Safety profiles were generally comparable between groups; however, there was a notably lower incidence of creatinine elevation observed in the intensive-targeting cohort.</p></li></ul><p dir="ltr"><b>Clinical Relevance and Implementation</b></p><p dir="ltr"><i>For practicing cardiologists and primary care physicians, the study provides strong evidence that a target of less than 55 mg per deciliter should be the standard of care for high-risk patients with atherosclerotic cardiovascular disease (ASCVD). Achieving these lower levels resulted in a clear, 3.1% absolute reduction in the cumulative incidence of major cardiovascular events over just three years. The fact that safety outcomes, including renal function (indicated by creatinine levels), were either similar or improved in the intensive group should alleviate concerns regarding the potential toxicity of aggressive lipid-lowering therapy. Moving forward, clinicians should prioritize the use of potent statins and non-statin therapies to reach these more stringent targets, ensuring that patient management aligns with the latest evidence for maximizing cardiovascular protection.</i></p><p dir="ltr"><b>Reference: </b></p><p dir="ltr">Lee YJ, Lee SJ, Kim JW, et al. Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease. New England Journal of Medicine. 2026 Mar 28.</p></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>Rising Use of GLP&#45;1 Receptor Agonists in Youth With Type 2 Diabetes: Study</title>
<link>https://edusehat.com/en/rising-use-of-glp-1-receptor-agonists-in-youth-with-type-2-diabetes-study</link>
<guid>https://edusehat.com/en/rising-use-of-glp-1-receptor-agonists-in-youth-with-type-2-diabetes-study</guid>
<description><![CDATA[ A study published in Pediatrics journal revealed that the use of GLP-1 receptor agonists (GLP-1 RAs) in youth aged 10–17 years with type 2 diabetes increased from 10.9% in 2020 to 35.6% in 2023. Despite updated guidelines favoring non-insulin therapies, GLP-1 RAs were still used less frequently than insulin. The study also identified insurance-related disparities like commercially insured youth were more likely to receive off-label semaglutide and medicaid-insured youth were more likely to receive daily injectable medications.The study examined trends in GLP-1RA dispensing among youth aged 10 to 17 diagnosed with type 2 diabetes from 2020 to 2023. This research used claims and encounter data from the Merative MarketScan Multi-State Medicaid and Commercial Database, which includes millions of records from both Medicaid and private insurance plans.The proportion of youth with type 2 diabetes receiving a GLP-1RA prescription increased sharply during the study period. In 2020, only 10.9% of youth with the condition were dispensed one of these medications. By 2023, that number had climbed to 35.6%, which represented more than a 3-fold increase. Statistical analysis confirmed a strong upward trend over the 4-year period.Despite this growth, GLP-1RAs were still prescribed less frequently than insulin therapies. In 2023, nearly half of youth with type 2 diabetes received long-acting insulin (49.5%), while 43.4% received short-acting insulin. These findings suggest that insulin remains the most common pharmacologic treatment in this population, even as newer therapies gain traction.Also, this study investigated whether insurance coverage affected the incidence of receiving GLP-1RA medications. The use of the drug class in 2023 was similar among youth covered by Medicaid and those with commercial insurance. However, the specific medications prescribed varied notably between the two groups.Youth insured through Medicaid were significantly less likely to receive semaglutide when compared to those with commercial insurance. Instead, Medicaid-insured patients were more likely to receive other GLP-1RA medications like dulaglutide, exenatide, or liraglutide. Medicaid-insured youth were roughly 70% less likely to be prescribed semaglutide but significantly more likely to receive several other drugs in the same class.The reasons behind these differences were not examined in the study, but they may relate to insurance formularies, cost considerations, or prescribing practices. Overall, the findings emphasize the need for comparative effectiveness research to determine which medications work best for young patients, as the use of GLP-1RAs grows.Source:Chu, P. Y., Kelly, A., Hennessy, S., Vajravelu, M. E., Huang, J., &amp; Amaral, S. (2026). GLP-1RA dispensing in youth with type 2 diabetes: 2020 to 2023. Pediatrics, e2025071971. https://doi.org/10.1542/peds.2025-071971 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/05/31/289081-glp-1-therapy-for-obesity.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 10:15:04 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Rising, Use, GLP-1, Receptor, Agonists, Youth, With, Type, Diabetes:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/05/31/289081-glp-1-therapy-for-obesity.webp"><p>A study published in <i>Pediatrics</i> journal revealed that the use of GLP-1 receptor agonists (GLP-1 RAs) in youth aged 10–17 years with type 2 diabetes increased from 10.9% in 2020 to 35.6% in 2023. Despite updated guidelines favoring non-insulin therapies, GLP-1 RAs were still used less frequently than insulin. </p><p>The study also identified insurance-related disparities like commercially insured youth were more likely to receive off-label semaglutide and medicaid-insured youth were more likely to receive daily injectable medications.</p><p>The study examined trends in GLP-1RA dispensing among youth aged 10 to 17 diagnosed with type 2 diabetes from 2020 to 2023. This research used claims and encounter data from the Merative MarketScan Multi-State Medicaid and Commercial Database, which includes millions of records from both Medicaid and private insurance plans.</p><p>The proportion of youth with type 2 diabetes receiving a GLP-1RA prescription increased sharply during the study period. In 2020, only 10.9% of youth with the condition were dispensed one of these medications. By 2023, that number had climbed to 35.6%, which represented more than a 3-fold increase. Statistical analysis confirmed a strong upward trend over the 4-year period.</p><p>Despite this growth, GLP-1RAs were still prescribed less frequently than insulin therapies. In 2023, nearly half of youth with type 2 diabetes received long-acting insulin (49.5%), while 43.4% received short-acting insulin. These findings suggest that insulin remains the most common pharmacologic treatment in this population, even as newer therapies gain traction.</p><p>Also, this study investigated whether insurance coverage affected the incidence of receiving GLP-1RA medications. The use of the drug class in 2023 was similar among youth covered by Medicaid and those with commercial insurance. However, the specific medications prescribed varied notably between the two groups.</p><p>Youth insured through Medicaid were significantly less likely to receive semaglutide when compared to those with commercial insurance. Instead, Medicaid-insured patients were more likely to receive other GLP-1RA medications like dulaglutide, exenatide, or liraglutide. Medicaid-insured youth were roughly 70% less likely to be prescribed semaglutide but significantly more likely to receive several other drugs in the same class.</p><p>The reasons behind these differences were not examined in the study, but they may relate to insurance formularies, cost considerations, or prescribing practices. Overall, the findings emphasize the need for comparative effectiveness research to determine which medications work best for young patients, as the use of GLP-1RAs grows.</p><p>Source:</p><p>Chu, P. Y., Kelly, A., Hennessy, S., Vajravelu, M. E., Huang, J., & Amaral, S. (2026). GLP-1RA dispensing in youth with type 2 diabetes: 2020 to 2023. Pediatrics, e2025071971. <a href="https://publications.aap.org/pediatrics/article-abstract/doi/10.1542/peds.2025-071971/206759/GLP-1RA-Dispensing-in-Youth-With-Type-2-Diabetes?redirectedFrom=fulltext?autologincheck=redirected" rel="nofollow">https://doi.org/10.1542/peds.2025-071971</a></p>]]> </content:encoded>
</item>

<item>
<title>PCI Approves Two MPharm Courses with 15 Seats Each at Gorakhpur University from 2026&#45;27</title>
<link>https://edusehat.com/en/pci-approves-two-mpharm-courses-with-15-seats-each-at-gorakhpur-university-from-2026-27</link>
<guid>https://edusehat.com/en/pci-approves-two-mpharm-courses-with-15-seats-each-at-gorakhpur-university-from-2026-27</guid>
<description><![CDATA[ New Delhi: The Pharmacy Council of India (PCI) has approved the introduction of two Master of Pharmacy (MPharm) courses at Deen Dayal Upadhyay Gorakhpur University from the 2026-27 academic session, paving the way for advanced pharmaceutical education in the region.According to university officials, approval has been granted for MPharm courses in Pharmaceutical Chemistry and Pharmaceutics, with 15 seats each. The university had applied to PCI for permission to start these postgraduate programmes, which has now been formally granted.The move is expected to boost opportunities in areas such as drug research, manufacturing, quality control, and the broader pharmaceutical industry. PCI has also directed the university to ensure compliance with norms, including appointment of teaching and technical staff and updating required details on the AEBAS portal.University Vice-Chancellor Prof. Poonam Tandon stated that the approval will help establish a complete academic ecosystem for pharmacy education on campus, ranging from teaching to advanced research. She highlighted that the development reflects improved infrastructure, modern laboratories, qualified faculty, and a research-oriented environment at the institution.Also Read:PCI Scraps Exit Exam Mandate for D.Pharm 2022-23, Orders States to Issue Registration CertificatesThe approval is particularly significant as the university had already received permission in previous years to run DPharm and BPharm courses, with 60 seats each, and later expansion of BPharm seats to 100. Additionally, PhD programmes in pharmacy were introduced from the 2025–26 session. With the inclusion of MPharm, the university will now offer the full spectrum of pharmacy education.According to a recent Amar Ujala report, students from eastern Uttar Pradesh often had to move to other states to pursue postgraduate or doctoral studies in pharmacy. The introduction of MPharm courses locally is expected to reduce this migration and strengthen regional access to higher education in the pharmaceutical field.The university expressed confidence that this step will position it as a leading centre for pharmacy education and innovation in the state.Also Read:PCI Releases Draft Pharmacist Service Rules 2025, Proposes Unified National Cadre ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2022/12/05/192916-pci-new.jpg" length="49398" type="image/jpeg"/>
<pubDate>Sat, 04 Apr 2026 03:05:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>PCI, Approves, Two, MPharm, Courses, with, Seats, Each, Gorakhpur, University, from, 2026-27</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2022/12/05/192916-pci-new.webp"><p><b>New Delhi</b>: The Pharmacy Council of India (PCI) has approved the introduction of two Master of Pharmacy (MPharm) courses at Deen Dayal Upadhyay Gorakhpur University from the 2026-27 academic session, paving the way for advanced pharmaceutical education in the region.</p><div class="pasted-from-word-wrapper"><p>According to university officials, approval has been granted for MPharm courses in Pharmaceutical Chemistry and Pharmaceutics, with 15 seats each. The university had applied to PCI for permission to start these postgraduate programmes, which has now been formally granted.</p><p>The move is expected to boost opportunities in areas such as drug research, manufacturing, quality control, and the broader pharmaceutical industry. PCI has also directed the university to ensure compliance with norms, including appointment of teaching and technical staff and updating required details on the AEBAS portal.</p><p>University Vice-Chancellor Prof. Poonam Tandon stated that the approval will help establish a complete academic ecosystem for pharmacy education on campus, ranging from teaching to advanced research. She highlighted that the development reflects improved infrastructure, modern laboratories, qualified faculty, and a research-oriented environment at the institution.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharmacy-education/pci-scraps-exit-exam-mandate-for-dpharm-2022-23-orders-states-to-issue-registration-certificates-165370">Also Read:PCI Scraps Exit Exam Mandate for D.Pharm 2022-23, Orders States to Issue Registration Certificates</a></div></div><p>The approval is particularly significant as the university had already received permission in previous years to run DPharm and BPharm courses, with 60 seats each, and later expansion of BPharm seats to 100. Additionally, PhD programmes in pharmacy were introduced from the 2025–26 session. With the inclusion of MPharm, the university will now offer the full spectrum of pharmacy education.</p><p>According to a recent <a href="https://www.amarujala.com/gorakhpur/pharmacy-council-of-india-has-given-approval-for-running-two-mpharm-courses-gorakhpur-news-c-7-gkp1038-1247289-2026-03-03" rel="nofollow">Amar Ujala</a> report, students from eastern Uttar Pradesh often had to move to other states to pursue postgraduate or doctoral studies in pharmacy. The introduction of MPharm courses locally is expected to reduce this migration and strengthen regional access to higher education in the pharmaceutical field.</p><p>The university expressed confidence that this step will position it as a leading centre for pharmacy education and innovation in the state.</p><div class="hocal-draggable" draggable="true"><div class="read-this-also-wrap"><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/industry/pharma/pci-releases-draft-pharmacist-service-rules-2025-proposes-unified-national-cadre-160011">Also Read:PCI Releases Draft Pharmacist Service Rules 2025, Proposes Unified National Cadre</a></div></div></div><div class="hocal-draggable" draggable="true"></div>]]> </content:encoded>
</item>

<item>
<title>Low Preoperative Calcium Linked to Higher Postoperative Risk among elderly orthopedic patients: Study</title>
<link>https://edusehat.com/en/low-preoperative-calcium-linked-to-higher-postoperative-risk-among-elderly-orthopedic-patients-study</link>
<guid>https://edusehat.com/en/low-preoperative-calcium-linked-to-higher-postoperative-risk-among-elderly-orthopedic-patients-study</guid>
<description><![CDATA[ China: Researchers have found in a new study that lower preoperative serum calcium levels are associated with an increased risk of postoperative complications in older orthopedic patients. As orthopedic surgeries in older adults continue to rise, monitoring and correcting calcium levels before surgery may help reduce complications.The findings were published in PLOS One by Doudou Li and colleagues from the Clinical Pharmacy Center, Department of Pharmacy at Zhejiang Provincial People’s Hospital in Hangzhou, China. The study explored whether preoperative serum calcium levels could help predict the likelihood of complications after orthopedic surgery in older adults.Serum calcium is an essential biochemical marker that plays a major role in bone metabolism, muscle function, and overall physiological balance. Despite its importance in skeletal health, limited research has examined whether low calcium levels before surgery may influence postoperative outcomes in elderly patients undergoing orthopedic procedures.To investigate this, the researchers conducted a multicenter cohort study involving 690 older adults who underwent orthopedic surgery. Statistical analyses, including multivariate logistic regression and generalized additive models, were used to assess the relationship between preoperative calcium levels and postoperative complications. The researchers also evaluated potential dose-response relationships and explored threshold effects.     The following were the key findings:Common postoperative complications observed in the study included infections, hypoalbuminemia, and electrolyte imbalances.Preoperative serum calcium levels were independently associated with the risk of postoperative complications.Higher calcium levels showed a protective effect, reducing the likelihood of adverse postoperative outcomes.Patients in the lowest serum calcium group had a significantly higher risk of complications compared with those in the highest calcium group.Individuals with lower calcium levels had approximately 79% higher odds of developing postoperative complications.A nonlinear relationship was identified between serum calcium levels and complication risk.A threshold effect was observed at around 2.4 mmol/L.Below 2.4 mmol/L, the risk of complications increased significantly as calcium levels decreased.Above 2.4 mmol/L, the association between calcium levels and complication risk was not statistically significant.Subgroup analyses showed that factors such as age, sex, comorbidities, medication use, cognitive status, cardiac function, and surgical complexity did not significantly influence the relationship between calcium levels and complication risk.The researchers suggest that serum calcium may serve as an early indicator of postoperative risk in elderly orthopedic patients. Screening for low calcium before surgery could help identify high-risk individuals and enable preventive measures.The study had several limitations. It lacked external validation, and key regulators of calcium metabolism—such as vitamin D, renal function, and parathyroid hormone—were not assessed. The follow-up period was also limited to three months, which may not capture long-term complications.Overall, the findings indicate that routine preoperative calcium screening and correction of low levels could be a simple, cost-effective approach to reduce postoperative complications in elderly orthopedic patients. The identified threshold of 2.4 mmol/L may also help guide early calcium supplementation and risk assessment before surgery.Reference:Li, D., Zhang, T., Ning, Y., Miao, J., Shi, J., &amp; Hu, Y. (2026). Preoperative hypocalcemia predicts postoperative complications in older orthopedic patients: A multicenter cohort study. PLOS ONE, 21(3), e0340876. https://doi.org/10.1371/journal.pone.0340876 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/03/13/332601-older-orthopedic-patients.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 03 Apr 2026 23:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Low, Preoperative, Calcium, Linked, Higher, Postoperative, Risk, among, elderly, orthopedic, patients:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/03/13/332601-older-orthopedic-patients.webp"><p><span>China: Researchers have found in a new study that lower preoperative serum calcium levels are associated with an increased risk of <a href="https://medicaldialogues.in/topics/postoperative-complications">postoperative complications</a> in<a href="https://medicaldialogues.in/topics/orthopaedics"> older orthopedic patients</a>. As orthopedic surgeries in <a href="https://medicaldialogues.in/topics/older-adults">older adults </a>continue to rise, monitoring and correcting calcium levels before surgery may help reduce complications.</span></p><div class="pasted-from-word-wrapper"><div>The findings were published in<i> PLOS One </i>by Doudou Li and colleagues from the Clinical Pharmacy Center, Department of Pharmacy at Zhejiang Provincial People’s Hospital in Hangzhou, China. The study explored whether preoperative serum calcium levels could help predict the likelihood of complications after orthopedic surgery in older adults.</div><div>Serum calcium is an essential biochemical marker that plays a major role in bone metabolism, muscle function, and overall physiological balance. Despite its importance in skeletal health, limited research has examined whether low calcium levels before surgery may influence postoperative outcomes in elderly patients undergoing orthopedic procedures.</div><div>To investigate this, the researchers conducted a multicenter cohort study involving 690 older adults who underwent orthopedic surgery. Statistical analyses, including multivariate logistic regression and generalized additive models, were used to assess the relationship between preoperative calcium levels and postoperative complications. The researchers also evaluated potential dose-response relationships and explored threshold effects.     </div><div>The following were the key findings:</div><ul><li>Common postoperative complications observed in the study included infections, hypoalbuminemia, and electrolyte imbalances.</li><li>Preoperative serum calcium levels were independently associated with the risk of postoperative complications.</li><li>Higher calcium levels showed a protective effect, reducing the likelihood of adverse postoperative outcomes.</li><li>Patients in the lowest serum calcium group had a significantly higher risk of complications compared with those in the highest calcium group.</li><li>Individuals with lower calcium levels had approximately 79% higher odds of developing postoperative complications.</li><li>A nonlinear relationship was identified between serum calcium levels and complication risk.</li><li>A threshold effect was observed at around 2.4 mmol/L.</li><li>Below 2.4 mmol/L, the risk of complications increased significantly as calcium levels decreased.</li><li>Above 2.4 mmol/L, the association between calcium levels and complication risk was not statistically significant.</li><li>Subgroup analyses showed that factors such as age, sex, comorbidities, medication use, cognitive status, cardiac function, and surgical complexity did not significantly influence the relationship between calcium levels and complication risk.</li></ul><div>The researchers suggest that serum calcium may serve as an early indicator of postoperative risk in elderly orthopedic patients. Screening for low calcium before surgery could help identify high-risk individuals and enable preventive measures.</div><div>The study had several limitations. It lacked external validation, and key regulators of calcium metabolism—such as vitamin D, renal function, and parathyroid hormone—were not assessed. The follow-up period was also limited to three months, which may not capture long-term complications.</div><div>Overall, the findings indicate that routine preoperative calcium screening and correction of low levels could be a simple, cost-effective approach to reduce postoperative complications in elderly orthopedic patients. The identified threshold of 2.4 mmol/L may also help guide early calcium supplementation and risk assessment before surgery.</div><div>Reference:</div><div>Li, D., Zhang, T., Ning, Y., Miao, J., Shi, J., & Hu, Y. (2026). Preoperative hypocalcemia predicts postoperative complications in older orthopedic patients: A multicenter cohort study. PLOS ONE, 21(3), e0340876. https://doi.org/10.1371/journal.pone.0340876</div></div><p><br></p>]]> </content:encoded>
</item>

<item>
<title>CPS doctors protest at NMC over exam delays, demand pan&#45;India recognition</title>
<link>https://edusehat.com/en/cps-doctors-protest-at-nmc-over-exam-delays-demand-pan-india-recognition</link>
<guid>https://edusehat.com/en/cps-doctors-protest-at-nmc-over-exam-delays-demand-pan-india-recognition</guid>
<description><![CDATA[ New Delhi: Protesting against the huge delay in conducting the CPS examinations and the decision of not allowing CPS graduates to practice pan-India, a large group of CPS doctors and students gathered outside the NMC office in Dwarka recently.The doctors have highlighted two major issues. On one hand, the students who have already completed 2-3 years of training after the NEET-PG admissions and government counselling are still waiting for their exams to be conducted.  According to the doctors, despite repeated follow-ups, meetings, and requests over months, there is still no clarity, and the careers of these doctors are &quot;literally on hold&quot;.Another issue that the doctors pointed out is that there are more than 40,000 CPS-qualified doctors and specialists from CPS Mumbai who have already completed their training and are still waiting for Pan-India recognition.The doctors have questioned how a doctor can be allowed to practice in over 10 states and union territories, but not in the rest of India, how a specialist in Mumbai is not a specialist in Delhi. They are asking if patients in different states are different.&quot;This kind of inconsistency is not just unfair- to doctors, it directly affects healthcare delivery. What is more concerning is the delay. Files have been pending for months and years. There is no clear answer, no timeLine, no accountability. How Long can such decisions be kept pending? At some point, someone has to take responsibility,&quot; CPS Doctors Association mentioned in a release.While the doctors have clarified that they have no objection to any decision the government takes against CPS as an institute, including shutting it down, they have also asked what would happen to thousands of doctors who have already graduated.They have demanded that Pan-India recognition be given to already qualified CPS doctors in a time-bound manner. &quot;At the same time, the issue of pending exams for current students also needs urgent resolution. Roth problems are connected—they show that uncertainty exists at every stage, from admission to practice. Today&#039;s protest had only a few hundred people. It was meant to send a message. But the reality is much bigger. If no action is taken, we will have no option but to come back in much Larger numbers-with 40,000+ CPS doctors from across the country,&quot; the association warned.&quot;Not letting them sit in the exam is just the tip of the iceberg. More than 40,000 doctors cannot practice pan-India,&quot; said Dr. Abhijeet Kumar, the Secretary of CPS Doctors Association.Further explaining the matter, Dr. Kumar added that in States like Gujarat, even after clearing the exam, the CPS graduates will have to undergo a bond for one year and only after that they will be given authority to practice. For one year, those doctors will have to perform duties as Medical Officers and they will not be able to practice their specialties.When asked about the problems faced by CPS graduates, he explained that the issue is not only economic, but it is also social. He mentioned how the parents regret the decision of choosing CPS courses and how such doctors get cornered in family gatherings or in events concerning the medical graduates.&quot;God forbid if any subject takes any action, who will come forward?&quot; he asked.Dr. Kumar further said that the Health Ministry has time and again assured to consider the matter. However, NMC has not come to the table, and nothing has happened yet. Meanwhile, the case hearing before the Supreme Court has also been adjourned four times. The next date of the hearing is on April 22.Background:Medical Dialogues had earlier reported that over 2,300 postgraduate CPS doctors are facing uncertainty as their final examinations for specialist qualification have not been conducted for more than a year. On March 5, 2026, a large group of affected doctors staged a peaceful protest at Azad Maidan, demanding that the state government and the medical education department conduct their long-delayed postgraduate examinations.The protesting doctors said they have already completed their academic training and hospital postings, but remain unable to obtain their specialist qualifications because the final exams have not been held.The issue began after the recognition of CPS diplomas and postgraduate programmes was withdrawn in 2022. However, students who had taken admission in the 2021–22 academic session through NEET-PG were allowed to continue their courses. Authorities had assured them that they would be able to complete the programme.Many of these students have now completed their two-year training programmes. However, their final examinations have not been conducted since November 2024, leaving them without certificates and unable to practise as specialists.Last year, the Bombay High Court passed an order cancelling the CPS recognition. Following this, the Directorate of Medical Education and Research stopped conducting further exams, leaving students who had already completed their courses but not taken the exams in a difficult situation.The Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) derecognised all the courses offered by CPS on August 16, 2024, on the grounds of failure to comply with the regulatory mechanism under the National Medical Commission Act, 2019. Earlier in 2025, the Bombay High Court dismissed the plea filed by the College of Physicians and Surgeons (CPS) challenging the derecognition of many postgraduate diploma courses that were deleted from the schedule of the Maharashtra Medical Council (MMC), 1965.On the same day, the High Court bench had allowed a Public Interest Litigation (PIL) challenging permission given to CPS to conduct 10 additional PG courses. The PIL was filed before the High Court by a Mumbai-based doctor, Suhas Pingle.Following this, the matter came for consideration before the Supreme Court in 2025. The Attorney General for India had informed the Apex Court that a viable solution would be arrived at to secure the future of students after the Bombay High Court upheld the derecognition of all PG medical courses offered by CPS Mumbai. Taking note of the issue, the Supreme Court on September 12 requested the intervention of the Attorney General for India to arrive at a viable solution in this regard.Later, the Central Government agreed before the Supreme Court to grant such students two final opportunities to clear their final examinations. This relief will apply to 852 students of CPS Mumbai, and after clearing their final examinations, they will also be enrolled with the State and National Medical Councils.Also Read: 2,300 CPS PG doctors await final exams amid NMC dispute, doctors&#039; body seeks govt intervention ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/04/03/339470-nmc-collage.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 03 Apr 2026 23:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>CPS, doctors, protest, NMC, over, exam, delays, demand, pan-India, recognition</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/04/03/339470-nmc-collage.webp"><p><b>New Delhi:</b> Protesting against the huge delay in conducting the CPS examinations and the decision of not allowing CPS graduates to practice pan-India, a large group of CPS doctors and students gathered outside the <a href="https://medicaldialogues.in/topics/NMC">NMC</a> office in Dwarka recently.</p><p>The doctors have highlighted two major issues. On one hand, the students who have already completed 2-3 years of training after the NEET-PG admissions and government counselling are still waiting for their exams to be conducted.  According to the doctors, despite repeated follow-ups, meetings, and requests over months, there is still no clarity, and the careers of these doctors are "literally on hold".</p><p>Another issue that the doctors pointed out is that there are more than 40,000 CPS-qualified doctors and specialists from CPS Mumbai who have already completed their training and are still waiting for Pan-India recognition.</p><p>The doctors have questioned how a doctor can be allowed to practice in over 10 states and union territories, but not in the rest of India, how a specialist in Mumbai is not a specialist in Delhi. They are asking if patients in different states are different.</p><p>"This kind of inconsistency is not just unfair- to doctors, it directly affects healthcare delivery. What is more concerning is the delay. Files have been pending for months and years. There is no clear answer, no timeLine, no accountability. How Long can such decisions be kept pending? At some point, someone has to take responsibility," CPS Doctors Association mentioned in a release.</p><p>While the doctors have clarified that they have no objection to any decision the government takes against CPS as an institute, including shutting it down, they have also asked what would happen to thousands of doctors who have already graduated.</p><p>They have demanded that Pan-India recognition be given to already qualified CPS doctors in a time-bound manner. "At the same time, the issue of pending exams for current students also needs urgent resolution. Roth problems are connected—they show that uncertainty exists at every stage, from admission to practice. Today's protest had only a few hundred people. It was meant to send a message. But the reality is much bigger. If no action is taken, we will have no option but to come back in much Larger numbers-with 40,000+ CPS doctors from across the country," the association warned.</p><p>"Not letting them sit in the exam is just the tip of the iceberg. More than 40,000 doctors cannot practice pan-India," said Dr. Abhijeet Kumar, the Secretary of CPS Doctors Association.</p><p>Further explaining the matter, Dr. Kumar added that in States like Gujarat, even after clearing the exam, the CPS graduates will have to undergo a bond for one year and only after that they will be given authority to practice. For one year, those doctors will have to perform duties as Medical Officers and they will not be able to practice their specialties.</p><p>When asked about the problems faced by CPS graduates, he explained that the issue is not only economic, but it is also social. He mentioned how the parents regret the decision of choosing CPS courses and how such doctors get cornered in family gatherings or in events concerning the medical graduates.</p><p>"God forbid if any subject takes any action, who will come forward?" he asked.</p><p>Dr. Kumar further said that the Health Ministry has time and again assured to consider the matter. However, NMC has not come to the table, and nothing has happened yet. Meanwhile, the case hearing before the Supreme Court has also been adjourned four times. The next date of the hearing is on April 22.</p><p><b>Background:</b></p><p>Medical Dialogues had earlier reported that over 2,300 postgraduate CPS doctors are facing uncertainty as their final examinations for specialist qualification have not been conducted for more than a year. On March 5, 2026, a large group of affected doctors staged a peaceful protest at Azad Maidan, demanding that the state government and the medical education department conduct their long-delayed postgraduate examinations.</p><p>The protesting doctors said they have already completed their academic training and hospital postings, but remain unable to obtain their specialist qualifications because the final exams have not been held.</p><p>The issue began after the recognition of CPS diplomas and postgraduate programmes was withdrawn in 2022. However, students who had taken admission in the 2021–22 academic session through NEET-PG were allowed to continue their courses. Authorities had assured them that they would be able to complete the programme.</p><p>Many of these students have now completed their two-year training programmes. However, their final examinations have not been conducted since November 2024, leaving them without certificates and unable to practise as specialists.</p><p>Last year, the Bombay High Court passed an order cancelling the CPS recognition. Following this, the Directorate of Medical Education and Research stopped conducting further exams, leaving students who had already completed their courses but not taken the exams in a difficult situation.</p><p>The Postgraduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) derecognised all the courses offered by CPS on August 16, 2024, on the grounds of failure to comply with the regulatory mechanism under the National Medical Commission Act, 2019. </p><p>Earlier in 2025, the Bombay High Court dismissed the plea filed by the <a href="https://medicaldialogues.in/topics/college-of-physicians-and-surgeons">College of Physicians and Surgeons (CPS)</a> challenging the derecognition of many postgraduate diploma courses that were deleted from the schedule of the Maharashtra Medical Council (MMC), 1965.</p><p>On the same day, the High Court bench had allowed a Public Interest Litigation (PIL) challenging permission given to CPS to conduct 10 additional PG courses. The PIL was filed before the High Court by a Mumbai-based doctor, Suhas Pingle.</p><p>Following this, the matter came for consideration before the Supreme Court in 2025. The Attorney General for India had informed the Apex Court that a viable solution would be arrived at to secure the future of students after the Bombay High Court upheld the derecognition of all PG medical courses offered by CPS Mumbai. Taking note of the issue, the Supreme Court on September 12 requested the intervention of the Attorney General for India to arrive at a viable solution in this regard.</p><p>Later, the Central Government agreed before the Supreme Court to grant such students two final opportunities to clear their final examinations. This relief will apply to 852 students of CPS Mumbai, and after clearing their final examinations, they will also be enrolled with the State and National Medical Councils.</p><p><a class="editor-inserted-link" target="_blank" href="https://medicaldialogues.in/news/health/doctors/2300-cps-pg-doctors-await-final-exams-amid-nmc-dispute-doctors-body-seeks-govt-intervention-166338"><b><i>Also Read: 2,300 CPS PG doctors await final exams amid NMC dispute, doctors' body seeks govt intervention</i></b></a></p>]]> </content:encoded>
</item>

<item>
<title>Cup anteversion significant risk factor for Femoral Neck Notching following THA with Dual Mobility Cups: study</title>
<link>https://edusehat.com/en/cup-anteversion-significant-risk-factor-for-femoral-neck-notching-following-tha-with-dual-mobility-cups-study</link>
<guid>https://edusehat.com/en/cup-anteversion-significant-risk-factor-for-femoral-neck-notching-following-tha-with-dual-mobility-cups-study</guid>
<description><![CDATA[ Dual-mobility cups (DMCs) are increasingly used in total hip arthroplasty (THA) because of their low dislocation rates. However, a unique complication associated with DMCs is femoral neck notching (FNN), which is believed to result from impingement between the metal liner and the femoral stem neck. The risk factors for FNN, however, remain poorly understood.Yuto Kawamura et al conducted a study to identify the risk factors associated with FNN in patients undergoing THA with DMCs. The article has been published in ‘JBJS Open Access’ journal.
This retrospective analysis included 766 patients who underwent THA with DMCs. Patients with follow-up durations of less than 1 year and those with mixed-manufacturer components (i.e., an acetabular cup and a femoral stem from different manufacturers) were excluded. Cup positioning angles and the presence of FNN were assessed using standard radiographs. Spinopelvic alignment was evaluated in a subgroup of 204 patients using EOS imaging.
EOS (EOS Imaging, Paris, France) is a low-dose modality that captures standing and sitting full-body skeletal images, enabling dynamic and detailed spinopelvic and lower limb alignment evaluation. Spinopelvic parameters—including pelvic tilt (PT), pelvic incidence (PI), sacral slope (SS), ante-inclination (AI), pelvic femoral angle (PFA), combined sagittal index (CSI), and lumbar lordosis (LL)—were measured in both standing and sitting positions.The key findings of the study were:
•	FNN was identified in 24 of 766 patients (3.1%). Among these, posterior FNN occurred in 15 cases (68.2%), lateral FNN in 6 (27.3%), and anterior FNN in 1 (4.5%).
•	Patient characteristics revealed no significant differences in age, sex, or BMI between the FNN and non-FNN groups
•	Among these, 14 patients underwent EOS imaging, compared with 190 patients without FNN. 
•	Patients with FNN demonstrated significantly higher cup anteversion (31.4 ± 6.1) than those without FNN (15.2 ± 4.8, p &lt; 0.0001). 
•	Logistic regression analysis showed that increased cup anteversion was significantly associated with FNN, with an odds ratio of 1.62 (95% confidence interval: 1.32-2.27, p &lt; 0.0001), identifying it as the primary risk factor for FNN formation.
The authors concluded – “In this study, the incidence of FNN following DMC-THA was 3.1%. Logistic regression analysis identified cup anteversion as the most significant independent risk factor. By contrast, patient-related factors such as age, sex, and spinopelvic parameters (PI-LL, SS) were not statistically significant. These findings underscore the importance of avoiding excessive anteversion and suggest that dynamic assessments may aid in identifying patients at increased risk of FNN in DMC-THA.”
Level of Evidence: Prognostic Level IV. Further reading:
Impact of Cup Anteversion and Hip-Spine Relationship on Femoral Neck Notching in Dual Mobility Total Hip Arthroplasty- 
Yuto Kawamura et al
JBJS Open Access 2026:e25.00314.http://dx.doi.org/10.2106/JBJS.OA.25.00314 ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2026/02/14/327528-thr-bilateral.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 03 Apr 2026 23:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Cup, anteversion, significant, risk, factor, for, Femoral, Neck, Notching, following, THA, with, Dual, Mobility, Cups:, study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2026/02/14/327528-thr-bilateral.webp"><p>Dual-mobility cups (DMCs) are increasingly used in total hip arthroplasty (THA) because of their low dislocation rates. However, a unique complication associated with DMCs is femoral neck notching (FNN), which is believed to result from impingement between the metal liner and the femoral stem neck. The risk factors for FNN, however, remain poorly understood.</p><p>Yuto Kawamura et al conducted a study to identify the risk factors associated with FNN in patients undergoing THA with DMCs. The article has been published in ‘JBJS Open Access’ journal.
</p><p>This retrospective analysis included 766 patients who underwent THA with DMCs. Patients with follow-up durations of less than 1 year and those with mixed-manufacturer components (i.e., an acetabular cup and a femoral stem from different manufacturers) were excluded. Cup positioning angles and the presence of FNN were assessed using standard radiographs. Spinopelvic alignment was evaluated in a subgroup of 204 patients using EOS imaging.
</p><p>EOS (EOS Imaging, Paris, France) is a low-dose modality that captures standing and sitting full-body skeletal images, enabling dynamic and detailed spinopelvic and lower limb alignment evaluation. Spinopelvic parameters—including pelvic tilt (PT), pelvic incidence (PI), sacral slope (SS), ante-inclination (AI), pelvic femoral angle (PFA), combined sagittal index (CSI), and lumbar lordosis (LL)—were measured in both standing and sitting positions.</p><p>The key findings of the study were:
</p><p>•	FNN was identified in 24 of 766 patients (3.1%). Among these, posterior FNN occurred in 15 cases (68.2%), lateral FNN in 6 (27.3%), and anterior FNN in 1 (4.5%).
</p><p>•	Patient characteristics revealed no significant differences in age, sex, or BMI between the FNN and non-FNN groups
</p><p>•	Among these, 14 patients underwent EOS imaging, compared with 190 patients without FNN. 
</p><p>•	Patients with FNN demonstrated significantly higher cup anteversion (31.4 ± 6.1) than those without FNN (15.2 ± 4.8, p < 0.0001). 
</p><p>•	Logistic regression analysis showed that increased cup anteversion was significantly associated with FNN, with an odds ratio of 1.62 (95% confidence interval: 1.32-2.27, p < 0.0001), identifying it as the primary risk factor for FNN formation.
</p><p>The authors concluded – “In this study, the incidence of FNN following DMC-THA was 3.1%. Logistic regression analysis identified cup anteversion as the most significant independent risk factor. By contrast, patient-related factors such as age, sex, and spinopelvic parameters (PI-LL, SS) were not statistically significant. These findings underscore the importance of avoiding excessive anteversion and suggest that dynamic assessments may aid in identifying patients at increased risk of FNN in DMC-THA.”
</p><p>Level of Evidence: Prognostic Level IV. </p><p>Further reading:
</p><p>Impact of Cup Anteversion and Hip-Spine Relationship on Femoral Neck Notching in Dual Mobility Total Hip Arthroplasty- 
</p><p>Yuto Kawamura et al
</p><p>JBJS Open Access 2026:e25.00314.</p><p>http://dx.doi.org/10.2106/JBJS.OA.25.00314</p>]]> </content:encoded>
</item>

<item>
<title>Gepotidacin Comparable to Nitrofurantoin for Uncomplicated UTI: Study</title>
<link>https://edusehat.com/en/gepotidacin-comparable-to-nitrofurantoin-for-uncomplicated-uti-study</link>
<guid>https://edusehat.com/en/gepotidacin-comparable-to-nitrofurantoin-for-uncomplicated-uti-study</guid>
<description><![CDATA[ USA: Researchers have found in a new study that among adolescent and adult women with uncomplicated urinary tract infection, gepotidacin provides early symptom relief and test-of-cure symptom resolution rates comparable to nitrofurantoin. The findings of the study have been published in Clinical Infectious Diseases.Uncomplicated urinary tract infections (uUTIs) are among the most common bacterial infections affecting women and can cause distressing symptoms such as painful urination, urgency, and frequent urination that interfere with routine daily activities. Although treatment trials typically focus on bacterial clearance, the speed at which symptoms improve is a key concern for patients. The present analysis aimed to evaluate early symptom improvement during treatment for uUTI.The study was conducted by Amanda J Sheets and colleagues from GSK. Researchers performed a pooled analysis of data from two phase 3 randomized clinical trials, EAGLE-2 and EAGLE-3. These trials previously demonstrated that the investigational antibacterial agent Gepotidacin was noninferior to the commonly prescribed antibiotic Nitrofurantoin.The trials enrolled female participants aged 12 years and older who had at least two symptoms of uUTI along with laboratory evidence such as urinary nitrite positivity or pyuria, without complicating factors. In total, 3,136 participants were randomized to receive either oral gepotidacin 1500 mg twice daily or nitrofurantoin 100 mg twice daily for five days.Symptom severity was assessed at baseline (Day 1), during therapy (Days 2–4), and at the test-of-cure visit (Days 10–13). Researchers evaluated urinary symptoms using a standardized scoring system ranging from none to severe, generating a total symptom score between 0 and 12.    The following were the key findings:At baseline, symptom severity was similar between the two groups, with mean symptom scores of 7.1 in the gepotidacin group and 7.2 in the nitrofurantoin group.During treatment, symptom scores decreased markedly, reaching a mean score of 3.6 in both groups at the on-therapy assessment.More than 80% of participants in both treatment arms experienced clinical improvement or complete resolution of symptoms during therapy.Among participants who initially reported moderate to severe symptoms affecting daily activities, about 53% in both groups reported improvement to mild or absent symptoms during treatment.By the test-of-cure visit, symptom improvement was observed in over 93% of participants receiving either gepotidacin or nitrofurantoin.The analysis defined improvement as any reduction in symptom score, which may not always represent a meaningful improvement in quality of life.To address this limitation, researchers also evaluated functional symptom improvement, focusing on patients’ ability to resume normal daily activities.Overall, the findings suggest that gepotidacin and nitrofurantoin provide similar and meaningful early relief of uUTI symptoms. The authors noted that gepotidacin may offer an alternative treatment option for patients who require therapy other than standard-of-care antibiotics and could help individuals resume normal daily activities soon after starting treatment. They also emphasized that early symptom response should be prioritized as an important outcome in future uUTI clinical trials. ]]></description>
<enclosure url="https://medicaldialogues.in/h-upload/2025/03/26/280274-urinary-tract-infections.jpg" length="49398" type="image/jpeg"/>
<pubDate>Fri, 03 Apr 2026 23:30:06 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Gepotidacin, Comparable, Nitrofurantoin, for, Uncomplicated, UTI:, Study</media:keywords>
<content:encoded><![CDATA[<img src="https://medicaldialogues.in/h-upload/2025/03/26/280274-urinary-tract-infections.webp"><p><span>USA: Researchers have found in a new study that among adolescent and adult women with <a href="https://medicaldialogues.in/topics/uncomplicated-utis">uncomplicated urinary tract infection</a>, <a href="https://medicaldialogues.in/topics/gepotidacin">gepotidacin </a>provides early symptom relief and test-of-cure symptom resolution rates comparable to nitrofurantoin. The findings of the study have been published in<a href="https://medicaldialogues.in/topics/clinical-infectious-diseases"> </a><i><a href="https://medicaldialogues.in/topics/clinical-infectious-diseases">Clinical Infectious Diseases</a>.</i></span></p><div class="pasted-from-word-wrapper"><div>Uncomplicated urinary tract infections (uUTIs) are among the most common bacterial infections affecting women and can cause distressing symptoms such as painful urination, urgency, and frequent urination that interfere with routine daily activities. Although treatment trials typically focus on bacterial clearance, the speed at which symptoms improve is a key concern for patients. The present analysis aimed to evaluate early symptom improvement during treatment for uUTI.</div><div>The study was conducted by Amanda J Sheets and colleagues from GSK. Researchers performed a pooled analysis of data from two phase 3 randomized clinical trials, EAGLE-2 and EAGLE-3. These trials previously demonstrated that the investigational antibacterial agent Gepotidacin was noninferior to the commonly prescribed antibiotic Nitrofurantoin.</div><div>The trials enrolled female participants aged 12 years and older who had at least two symptoms of uUTI along with laboratory evidence such as urinary nitrite positivity or pyuria, without complicating factors. In total, 3,136 participants were randomized to receive either oral gepotidacin 1500 mg twice daily or nitrofurantoin 100 mg twice daily for five days.</div><div>Symptom severity was assessed at baseline (Day 1), during therapy (Days 2–4), and at the test-of-cure visit (Days 10–13). Researchers evaluated urinary symptoms using a standardized scoring system ranging from none to severe, generating a total symptom score between 0 and 12.    </div><div>The following were the key findings:</div><ul><li>At baseline, symptom severity was similar between the two groups, with mean symptom scores of 7.1 in the gepotidacin group and 7.2 in the nitrofurantoin group.</li><li>During treatment, symptom scores decreased markedly, reaching a mean score of 3.6 in both groups at the on-therapy assessment.</li><li>More than 80% of participants in both treatment arms experienced clinical improvement or complete resolution of symptoms during therapy.</li><li>Among participants who initially reported moderate to severe symptoms affecting daily activities, about 53% in both groups reported improvement to mild or absent symptoms during treatment.</li><li>By the test-of-cure visit, symptom improvement was observed in over 93% of participants receiving either gepotidacin or nitrofurantoin.</li></ul><div>The analysis defined improvement as any reduction in symptom score, which may not always represent a meaningful improvement in quality of life.</div><div>To address this limitation, researchers also evaluated functional symptom improvement, focusing on patients’ ability to resume normal daily activities.</div><div>Overall, the findings suggest that gepotidacin and nitrofurantoin provide similar and meaningful early relief of uUTI symptoms. The authors noted that gepotidacin may offer an alternative treatment option for patients who require therapy other than standard-of-care antibiotics and could help individuals resume normal daily activities soon after starting treatment. They also emphasized that early symptom response should be prioritized as an important outcome in future uUTI clinical trials.</div></div><p><br></p>]]> </content:encoded>
</item>

</channel>
</rss>